SURVIVAL_TYPE|CANCER_GROUP_SITE|PERIOD_YEARS|SEX|YEARS_AFTER_DIAGNOSIS|AGE_GROUP_YEARS|SURVIVAL|95_CI_LOWER_BOUND|95_CI_UPPER_BOUND
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|00–04|0.962|0.931|0.979
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|05–09|0.987|0.949|0.997
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|10–14|0.94|0.871|0.973
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|15–19|0.927|0.845|0.967
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|20–24|0.899|0.788|0.953
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|25–29|0.884|0.743|0.95
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|30–34|0.885|0.686|0.961
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|35–39|0.819|0.658|0.909
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|40–44|0.778|0.572|0.893
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|45–49|0.902|0.76|0.962
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|50–54|0.837|0.688|0.919
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|55–59|0.744|0.567|0.858
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|60–64|0.831|0.661|0.92
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|65–69|0.511|0.344|0.655
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|70–74|0.501|0.338|0.643
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|75–79|0.565|0.366|0.723
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|1|All ages combined|0.862|0.84|0.881
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|00–04|0.955|0.922|0.974
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|05–09|0.981|0.941|0.994
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|10–14|0.9|0.823|0.945
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|15–19|0.905|0.818|0.951
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|20–24|0.793|0.664|0.877
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|25–29|0.838|0.69|0.919
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|30–34|0.777|0.57|0.893
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|35–39|0.79|0.624|0.889
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|40–44|0.653|0.452|0.795
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|45–49|0.809|0.638|0.905
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|50–54|0.73|0.574|0.836
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|55–59|0.611|0.435|0.748
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|60–64|0.617|0.442|0.752
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|65–69|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|2|All ages combined|0.801|0.776|0.823
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|00–04|0.951|0.917|0.971
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|05–09|0.974|0.933|0.99
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|10–14|0.88|0.799|0.93
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|15–19|0.849|0.754|0.909
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|20–24|0.793|0.664|0.877
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|25–29|0.816|0.666|0.903
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|30–34|0.673|0.467|0.814
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|35–39|0.762|0.593|0.869
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|40–44|0.623|0.425|0.769
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|45–49|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|50–54|0.619|0.462|0.743
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|55–59|0.467|0.306|0.613
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|60–64|0.617|0.442|0.752
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|65–69|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|3|All ages combined|0.768|0.742|0.792
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|00–04|0.947|0.913|0.969
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|05–09|0.968|0.925|0.987
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|10–14|0.87|0.787|0.922
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|15–19|0.813|0.713|0.881
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|20–24|0.793|0.664|0.877
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|25–29|0.816|0.666|0.903
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|30–34|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|35–39|0.736|0.565|0.848
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|40–44|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|45–49|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|50–54|0.619|0.462|0.743
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|55–59|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|60–64|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|65–69|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|4|All ages combined|0.746|0.719|0.77
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|00–04|0.937|0.901|0.961
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|05–09|0.962|0.917|0.983
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|10–14|0.87|0.787|0.922
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|15–19|0.813|0.713|0.881
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|20–24|0.793|0.664|0.877
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|25–29|0.816|0.666|0.903
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|30–34|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|35–39|0.713|0.542|0.829
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|40–44|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|45–49|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|50–54|0.619|0.462|0.743
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|55–59|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|60–64|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|65–69|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Males|5|All ages combined|0.736|0.709|0.761
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|00–04|0.962|0.931|0.98
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|05–09|0.987|0.949|0.997
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|10–14|0.94|0.872|0.973
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|15–19|0.927|0.845|0.967
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|20–24|0.899|0.789|0.954
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|25–29|0.885|0.744|0.951
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|30–34|0.886|0.686|0.962
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|35–39|0.82|0.658|0.91
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|40–44|0.779|0.573|0.895
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|45–49|0.904|0.762|0.964
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|50–54|0.84|0.691|0.922
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|55–59|0.748|0.57|0.862
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|60–64|0.837|0.667|0.927
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|65–69|0.517|0.349|0.663
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|70–74|0.511|0.345|0.656
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|75–79|0.584|0.378|0.748
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|1|All ages combined|0.866|0.844|0.885
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|00–04|0.955|0.922|0.974
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|05–09|0.981|0.942|0.994
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|10–14|0.901|0.823|0.945
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|15–19|0.905|0.819|0.952
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|20–24|0.794|0.665|0.878
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|25–29|0.839|0.691|0.921
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|30–34|0.778|0.571|0.894
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|35–39|0.792|0.626|0.891
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|40–44|0.655|0.454|0.798
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|45–49|0.813|0.641|0.909
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|50–54|0.735|0.578|0.842
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|55–59|0.618|0.44|0.756
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|60–64|0.628|0.449|0.765
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|65–69|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|2|All ages combined|0.807|0.782|0.83
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|00–04|0.951|0.918|0.972
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|05–09|0.975|0.934|0.991
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|10–14|0.881|0.799|0.931
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|15–19|0.85|0.755|0.91
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|20–24|0.794|0.665|0.878
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|25–29|0.818|0.667|0.905
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|30–34|0.675|0.468|0.816
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|35–39|0.765|0.595|0.872
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|40–44|0.626|0.428|0.774
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|45–49|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|50–54|0.626|0.467|0.752
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|55–59|0.476|0.312|0.624
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|60–64|0.634|0.454|0.772
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|65–69|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|3|All ages combined|0.776|0.75|0.8
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|00–04|0.948|0.913|0.969
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|05–09|0.969|0.926|0.987
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|10–14|0.871|0.787|0.923
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|15–19|0.814|0.714|0.883
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|20–24|0.795|0.666|0.879
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|25–29|0.818|0.668|0.906
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|30–34|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|35–39|0.74|0.568|0.853
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|40–44|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|45–49|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|50–54|0.629|0.469|0.755
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|55–59|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|60–64|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|65–69|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|4|All ages combined|0.755|0.728|0.78
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|00–04|0.938|0.902|0.961
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|05–09|0.962|0.918|0.983
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|10–14|0.871|0.788|0.923
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|15–19|0.815|0.715|0.883
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|20–24|0.795|0.666|0.879
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|25–29|0.819|0.668|0.907
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|30–34|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|35–39|0.717|0.545|0.835
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|40–44|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|45–49|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|50–54|0.632|0.471|0.759
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|55–59|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|60–64|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|65–69|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Males|5|All ages combined|0.746|0.718|0.771
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|00–04|0.976|0.947|0.989
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|05–09|0.993|0.951|0.999
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|10–14|0.933|0.83|0.974
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|15–19|0.907|0.77|0.964
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|20–24|0.875|0.661|0.958
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|25–29|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|30–34|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|35–39|0.842|0.632|0.937
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|40–44|0.863|0.634|0.954
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|45–49|0.786|0.584|0.897
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|50–54|0.704|0.496|0.839
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|55–59|0.851|0.679|0.935
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|60–64|0.711|0.506|0.843
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|65–69|0.781|0.595|0.889
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|1|All ages combined|0.858|0.832|0.88
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|00–04|0.964|0.931|0.981
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|05–09|0.978|0.934|0.993
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|10–14|0.884|0.773|0.943
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|15–19|0.824|0.68|0.908
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|20–24|0.838|0.625|0.936
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|25–29|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|30–34|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|35–39|0.694|0.481|0.833
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|40–44|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|45–49|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|50–54|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|55–59|0.6|0.413|0.744
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|60–64|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|65–69|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|2|All ages combined|0.787|0.757|0.813
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|00–04|0.948|0.911|0.969
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|05–09|0.971|0.925|0.989
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|10–14|0.884|0.773|0.943
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|15–19|0.761|0.611|0.86
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|20–24|0.806|0.596|0.914
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|25–29|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|30–34|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|35–39|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|40–44|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|45–49|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|50–54|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|55–59|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|60–64|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|65–69|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|3|All ages combined|0.742|0.711|0.771
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|00–04|0.943|0.906|0.966
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|05–09|0.971|0.925|0.989
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|10–14|0.884|0.773|0.943
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|15–19|0.715|0.56|0.823
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|20–24|0.773|0.564|0.891
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|25–29|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|30–34|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|35–39|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|40–44|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|45–49|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|50–54|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|55–59|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|60–64|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|65–69|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|4|All ages combined|0.725|0.693|0.754
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|00–04|0.943|0.906|0.966
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|05–09|0.971|0.925|0.989
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|10–14|0.884|0.773|0.943
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|15–19|0.692|0.535|0.804
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|20–24|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|25–29|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|30–34|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|35–39|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|40–44|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|45–49|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|50–54|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|55–59|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|60–64|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|65–69|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Females|5|All ages combined|0.716|0.684|0.746
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|00–04|0.976|0.947|0.989
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|05–09|0.993|0.951|0.999
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|10–14|0.933|0.831|0.974
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|15–19|0.907|0.77|0.964
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|20–24|0.875|0.662|0.958
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|25–29|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|30–34|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|35–39|0.842|0.633|0.938
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|40–44|0.864|0.634|0.955
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|45–49|0.787|0.585|0.898
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|50–54|0.705|0.497|0.841
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|55–59|0.854|0.681|0.938
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|60–64|0.715|0.508|0.847
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|65–69|0.787|0.6|0.895
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|1|All ages combined|0.862|0.836|0.884
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|00–04|0.964|0.932|0.981
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|05–09|0.978|0.935|0.993
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|10–14|0.884|0.773|0.943
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|15–19|0.825|0.68|0.908
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|20–24|0.839|0.625|0.936
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|25–29|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|30–34|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|35–39|0.695|0.482|0.834
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|40–44|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|45–49|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|50–54|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|55–59|0.604|0.415|0.749
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|60–64|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|65–69|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|2|All ages combined|0.793|0.763|0.819
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|00–04|0.948|0.912|0.97
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|05–09|0.971|0.925|0.989
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|10–14|0.885|0.773|0.943
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|15–19|0.762|0.611|0.86
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|20–24|0.807|0.596|0.915
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|25–29|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|30–34|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|35–39|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|40–44|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|45–49|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|50–54|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|55–59|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|60–64|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|65–69|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|3|All ages combined|0.749|0.717|0.778
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|00–04|0.944|0.907|0.967
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|05–09|0.971|0.925|0.989
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|10–14|0.885|0.773|0.944
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|15–19|0.715|0.56|0.824
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|20–24|0.774|0.565|0.892
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|25–29|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|30–34|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|35–39|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|40–44|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|45–49|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|50–54|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|55–59|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|60–64|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|65–69|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|4|All ages combined|0.733|0.701|0.762
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|00–04|0.944|0.907|0.967
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|05–09|0.971|0.925|0.989
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|10–14|0.885|0.773|0.944
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|15–19|0.692|0.536|0.805
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|20–24|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|25–29|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|30–34|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|35–39|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|40–44|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|45–49|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|50–54|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|55–59|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|60–64|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|65–69|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Females|5|All ages combined|0.725|0.692|0.755
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|00–04|0.969|0.949|0.981
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|05–09|0.99|0.969|0.997
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|10–14|0.937|0.887|0.966
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|15–19|0.92|0.857|0.956
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|20–24|0.892|0.803|0.942
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|25–29|0.901|0.792|0.954
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|30–34|0.892|0.759|0.953
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|35–39|0.828|0.711|0.901
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|40–44|0.816|0.677|0.9
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|45–49|0.855|0.747|0.919
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|50–54|0.785|0.67|0.864
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|55–59|0.796|0.681|0.874
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|60–64|0.778|0.655|0.862
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|65–69|0.635|0.511|0.736
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|70–74|0.515|0.385|0.63
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|75–79|0.43|0.299|0.555
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|80–84|0.307|0.172|0.454
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|1|All ages combined|0.86|0.844|0.875
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|00–04|0.959|0.938|0.973
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|05–09|0.98|0.955|0.991
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|10–14|0.894|0.836|0.933
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|15–19|0.876|0.806|0.922
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|20–24|0.808|0.706|0.878
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|25–29|0.85|0.732|0.919
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|30–34|0.782|0.632|0.876
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|35–39|0.748|0.622|0.837
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|40–44|0.707|0.555|0.815
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|45–49|0.732|0.604|0.825
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|50–54|0.678|0.557|0.772
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|55–59|0.608|0.483|0.712
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|60–64|0.567|0.439|0.677
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|65–69|0.426|0.31|0.537
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|70–74|0.374|0.256|0.491
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|2|All ages combined|0.795|0.776|0.812
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|00–04|0.949|0.927|0.965
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|05–09|0.973|0.947|0.986
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|10–14|0.882|0.821|0.923
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|15–19|0.818|0.741|0.874
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|20–24|0.797|0.694|0.869
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|25–29|0.833|0.712|0.906
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|30–34|0.695|0.54|0.807
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|35–39|0.702|0.574|0.798
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|40–44|0.662|0.509|0.778
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|45–49|0.689|0.554|0.791
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|50–54|0.557|0.436|0.662
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|55–59|0.474|0.352|0.586
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|60–64|0.505|0.378|0.618
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|65–69|0.317|0.214|0.425
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|70–74|0.284|0.18|0.397
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|3|All ages combined|0.757|0.737|0.776
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|00–04|0.946|0.922|0.962
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|05–09|0.97|0.942|0.984
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|10–14|0.876|0.814|0.918
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|15–19|0.779|0.697|0.841
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|20–24|0.786|0.682|0.859
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|25–29|0.833|0.712|0.906
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|30–34|0.635|0.481|0.755
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|35–39|0.672|0.543|0.772
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|40–44|0.615|0.46|0.738
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|45–49|0.614|0.467|0.731
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|50–54|0.557|0.436|0.662
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|55–59|0.437|0.316|0.551
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|60–64|0.43|0.309|0.545
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|65–69|0.258|0.165|0.36
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|4|All ages combined|0.737|0.716|0.756
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|00–04|0.94|0.916|0.957
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|05–09|0.966|0.938|0.982
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|10–14|0.876|0.814|0.918
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|15–19|0.771|0.689|0.834
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|20–24|0.775|0.67|0.85
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|25–29|0.833|0.712|0.906
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|30–34|0.635|0.481|0.755
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|35–39|0.658|0.529|0.759
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|40–44|0.615|0.46|0.738
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|45–49|0.584|0.434|0.708
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|50–54|0.531|0.412|0.637
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|55–59|0.418|0.297|0.534
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|60–64|0.373|0.258|0.487
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|65–69|0.243|0.153|0.345
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|70–74|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|75–79|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|80–84|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|85+|||
Observed|Acute lymphoblastic leukaemia|2015–2019|Persons|5|All ages combined|0.727|0.707|0.747
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|00–04|0.969|0.95|0.981
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|05–09|0.99|0.969|0.997
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|10–14|0.937|0.887|0.966
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|15–19|0.92|0.857|0.956
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|20–24|0.892|0.803|0.943
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|25–29|0.901|0.793|0.955
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|30–34|0.892|0.76|0.954
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|35–39|0.829|0.712|0.902
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|40–44|0.817|0.678|0.901
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|45–49|0.856|0.748|0.921
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|50–54|0.788|0.672|0.867
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|55–59|0.8|0.684|0.878
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|60–64|0.783|0.659|0.868
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|65–69|0.642|0.516|0.743
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|70–74|0.523|0.391|0.641
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|75–79|0.442|0.308|0.57
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|80–84|0.324|0.182|0.479
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|1|All ages combined|0.864|0.848|0.879
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|00–04|0.959|0.938|0.973
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|05–09|0.98|0.955|0.991
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|10–14|0.895|0.836|0.933
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|15–19|0.877|0.807|0.923
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|20–24|0.809|0.707|0.879
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|25–29|0.851|0.732|0.92
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|30–34|0.783|0.633|0.877
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|35–39|0.749|0.623|0.839
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|40–44|0.709|0.557|0.817
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|45–49|0.735|0.606|0.828
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|50–54|0.682|0.56|0.777
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|55–59|0.613|0.487|0.718
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|60–64|0.575|0.445|0.686
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|65–69|0.435|0.317|0.548
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|70–74|0.386|0.265|0.508
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|2|All ages combined|0.801|0.782|0.818
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|00–04|0.95|0.927|0.966
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|05–09|0.973|0.947|0.987
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|10–14|0.882|0.822|0.923
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|15–19|0.819|0.742|0.875
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|20–24|0.798|0.695|0.87
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|25–29|0.835|0.713|0.908
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|30–34|0.697|0.542|0.808
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|35–39|0.704|0.575|0.801
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|40–44|0.665|0.511|0.781
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|45–49|0.694|0.557|0.796
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|50–54|0.563|0.441|0.669
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|55–59|0.48|0.357|0.594
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|60–64|0.516|0.387|0.632
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|65–69|0.328|0.221|0.439
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|70–74|0.299|0.19|0.418
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|3|All ages combined|0.765|0.745|0.783
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|00–04|0.946|0.923|0.963
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|05–09|0.97|0.943|0.984
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|10–14|0.877|0.815|0.919
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|15–19|0.78|0.698|0.842
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|20–24|0.787|0.683|0.861
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|25–29|0.835|0.714|0.909
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|30–34|0.637|0.483|0.757
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|35–39|0.675|0.545|0.775
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|40–44|0.619|0.463|0.743
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|45–49|0.619|0.471|0.737
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|50–54|0.565|0.442|0.671
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|55–59|0.445|0.322|0.562
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|60–64|0.443|0.319|0.562
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|65–69|0.27|0.173|0.377
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|4|All ages combined|0.745|0.725|0.765
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|00–04|0.941|0.916|0.958
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|05–09|0.967|0.938|0.982
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|10–14|0.877|0.815|0.919
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|15–19|0.772|0.69|0.835
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|20–24|0.777|0.672|0.852
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|25–29|0.836|0.714|0.909
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|30–34|0.638|0.483|0.758
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|35–39|0.661|0.531|0.763
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|40–44|0.62|0.464|0.744
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|45–49|0.591|0.439|0.716
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|50–54|0.541|0.419|0.649
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|55–59|0.429|0.305|0.548
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|60–64|0.388|0.269|0.507
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|65–69|0.259|0.163|0.366
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|70–74|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|75–79|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|80–84|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|85+|||
Relative|Acute lymphoblastic leukaemia|2015–2019|Persons|5|All ages combined|0.737|0.716|0.756
Observed|Acute myeloid leukaemia|2015–2019|Males|1|00–04|0.793|0.65|0.883
Observed|Acute myeloid leukaemia|2015–2019|Males|1|05–09|||
Observed|Acute myeloid leukaemia|2015–2019|Males|1|10–14|0.879|0.671|0.959
Observed|Acute myeloid leukaemia|2015–2019|Males|1|15–19|0.902|0.725|0.967
Observed|Acute myeloid leukaemia|2015–2019|Males|1|20–24|0.766|0.599|0.871
Observed|Acute myeloid leukaemia|2015–2019|Males|1|25–29|0.912|0.751|0.971
Observed|Acute myeloid leukaemia|2015–2019|Males|1|30–34|0.896|0.768|0.955
Observed|Acute myeloid leukaemia|2015–2019|Males|1|35–39|0.834|0.727|0.902
Observed|Acute myeloid leukaemia|2015–2019|Males|1|40–44|0.867|0.779|0.922
Observed|Acute myeloid leukaemia|2015–2019|Males|1|45–49|0.76|0.662|0.833
Observed|Acute myeloid leukaemia|2015–2019|Males|1|50–54|0.702|0.624|0.767
Observed|Acute myeloid leukaemia|2015–2019|Males|1|55–59|0.673|0.606|0.731
Observed|Acute myeloid leukaemia|2015–2019|Males|1|60–64|0.607|0.545|0.664
Observed|Acute myeloid leukaemia|2015–2019|Males|1|65–69|0.521|0.469|0.569
Observed|Acute myeloid leukaemia|2015–2019|Males|1|70–74|0.387|0.341|0.432
Observed|Acute myeloid leukaemia|2015–2019|Males|1|75–79|0.247|0.209|0.287
Observed|Acute myeloid leukaemia|2015–2019|Males|1|80–84|0.174|0.14|0.212
Observed|Acute myeloid leukaemia|2015–2019|Males|1|85+|0.047|0.033|0.064
Observed|Acute myeloid leukaemia|2015–2019|Males|1|All ages combined|0.44|0.422|0.457
Observed|Acute myeloid leukaemia|2015–2019|Males|2|00–04|0.755|0.609|0.852
Observed|Acute myeloid leukaemia|2015–2019|Males|2|05–09|||
Observed|Acute myeloid leukaemia|2015–2019|Males|2|10–14|||
Observed|Acute myeloid leukaemia|2015–2019|Males|2|15–19|0.754|0.569|0.868
Observed|Acute myeloid leukaemia|2015–2019|Males|2|20–24|0.719|0.551|0.833
Observed|Acute myeloid leukaemia|2015–2019|Males|2|25–29|0.912|0.751|0.971
Observed|Acute myeloid leukaemia|2015–2019|Males|2|30–34|0.835|0.697|0.914
Observed|Acute myeloid leukaemia|2015–2019|Males|2|35–39|0.776|0.661|0.857
Observed|Acute myeloid leukaemia|2015–2019|Males|2|40–44|0.702|0.594|0.786
Observed|Acute myeloid leukaemia|2015–2019|Males|2|45–49|0.673|0.569|0.758
Observed|Acute myeloid leukaemia|2015–2019|Males|2|50–54|0.589|0.509|0.661
Observed|Acute myeloid leukaemia|2015–2019|Males|2|55–59|0.565|0.496|0.628
Observed|Acute myeloid leukaemia|2015–2019|Males|2|60–64|0.424|0.363|0.484
Observed|Acute myeloid leukaemia|2015–2019|Males|2|65–69|0.355|0.307|0.403
Observed|Acute myeloid leukaemia|2015–2019|Males|2|70–74|0.257|0.218|0.298
Observed|Acute myeloid leukaemia|2015–2019|Males|2|75–79|0.131|0.103|0.163
Observed|Acute myeloid leukaemia|2015–2019|Males|2|80–84|0.089|0.065|0.118
Observed|Acute myeloid leukaemia|2015–2019|Males|2|85+|0.014|0.008|0.024
Observed|Acute myeloid leukaemia|2015–2019|Males|2|All ages combined|0.325|0.309|0.342
Observed|Acute myeloid leukaemia|2015–2019|Males|3|00–04|0.755|0.609|0.852
Observed|Acute myeloid leukaemia|2015–2019|Males|3|05–09|||
Observed|Acute myeloid leukaemia|2015–2019|Males|3|10–14|||
Observed|Acute myeloid leukaemia|2015–2019|Males|3|15–19|0.725|0.539|0.846
Observed|Acute myeloid leukaemia|2015–2019|Males|3|20–24|0.696|0.528|0.814
Observed|Acute myeloid leukaemia|2015–2019|Males|3|25–29|0.878|0.706|0.953
Observed|Acute myeloid leukaemia|2015–2019|Males|3|30–34|0.773|0.627|0.867
Observed|Acute myeloid leukaemia|2015–2019|Males|3|35–39|0.75|0.634|0.835
Observed|Acute myeloid leukaemia|2015–2019|Males|3|40–44|0.69|0.581|0.776
Observed|Acute myeloid leukaemia|2015–2019|Males|3|45–49|0.64|0.534|0.728
Observed|Acute myeloid leukaemia|2015–2019|Males|3|50–54|0.526|0.446|0.6
Observed|Acute myeloid leukaemia|2015–2019|Males|3|55–59|0.499|0.43|0.563
Observed|Acute myeloid leukaemia|2015–2019|Males|3|60–64|0.372|0.313|0.431
Observed|Acute myeloid leukaemia|2015–2019|Males|3|65–69|0.293|0.248|0.339
Observed|Acute myeloid leukaemia|2015–2019|Males|3|70–74|0.179|0.145|0.216
Observed|Acute myeloid leukaemia|2015–2019|Males|3|75–79|0.075|0.054|0.101
Observed|Acute myeloid leukaemia|2015–2019|Males|3|80–84|0.052|0.033|0.075
Observed|Acute myeloid leukaemia|2015–2019|Males|3|85+|0.003|0.001|0.008
Observed|Acute myeloid leukaemia|2015–2019|Males|3|All ages combined|0.275|0.259|0.29
Observed|Acute myeloid leukaemia|2015–2019|Males|4|00–04|0.739|0.593|0.839
Observed|Acute myeloid leukaemia|2015–2019|Males|4|05–09|||
Observed|Acute myeloid leukaemia|2015–2019|Males|4|10–14|||
Observed|Acute myeloid leukaemia|2015–2019|Males|4|15–19|0.701|0.516|0.826
Observed|Acute myeloid leukaemia|2015–2019|Males|4|20–24|0.676|0.509|0.797
Observed|Acute myeloid leukaemia|2015–2019|Males|4|25–29|0.878|0.706|0.953
Observed|Acute myeloid leukaemia|2015–2019|Males|4|30–34|0.754|0.608|0.852
Observed|Acute myeloid leukaemia|2015–2019|Males|4|35–39|0.75|0.634|0.835
Observed|Acute myeloid leukaemia|2015–2019|Males|4|40–44|0.656|0.546|0.745
Observed|Acute myeloid leukaemia|2015–2019|Males|4|45–49|0.595|0.488|0.686
Observed|Acute myeloid leukaemia|2015–2019|Males|4|50–54|0.502|0.422|0.576
Observed|Acute myeloid leukaemia|2015–2019|Males|4|55–59|0.46|0.392|0.525
Observed|Acute myeloid leukaemia|2015–2019|Males|4|60–64|0.324|0.266|0.382
Observed|Acute myeloid leukaemia|2015–2019|Males|4|65–69|0.243|0.201|0.288
Observed|Acute myeloid leukaemia|2015–2019|Males|4|70–74|0.142|0.111|0.177
Observed|Acute myeloid leukaemia|2015–2019|Males|4|75–79|0.053|0.035|0.075
Observed|Acute myeloid leukaemia|2015–2019|Males|4|80–84|0.036|0.021|0.058
Observed|Acute myeloid leukaemia|2015–2019|Males|4|85+|||
Observed|Acute myeloid leukaemia|2015–2019|Males|4|All ages combined|0.249|0.234|0.264
Observed|Acute myeloid leukaemia|2015–2019|Males|5|00–04|0.739|0.593|0.839
Observed|Acute myeloid leukaemia|2015–2019|Males|5|05–09|||
Observed|Acute myeloid leukaemia|2015–2019|Males|5|10–14|||
Observed|Acute myeloid leukaemia|2015–2019|Males|5|15–19|0.701|0.516|0.826
Observed|Acute myeloid leukaemia|2015–2019|Males|5|20–24|0.612|0.448|0.74
Observed|Acute myeloid leukaemia|2015–2019|Males|5|25–29|||
Observed|Acute myeloid leukaemia|2015–2019|Males|5|30–34|0.754|0.608|0.852
Observed|Acute myeloid leukaemia|2015–2019|Males|5|35–39|0.75|0.634|0.835
Observed|Acute myeloid leukaemia|2015–2019|Males|5|40–44|0.656|0.546|0.745
Observed|Acute myeloid leukaemia|2015–2019|Males|5|45–49|0.583|0.476|0.676
Observed|Acute myeloid leukaemia|2015–2019|Males|5|50–54|0.488|0.409|0.563
Observed|Acute myeloid leukaemia|2015–2019|Males|5|55–59|0.434|0.367|0.5
Observed|Acute myeloid leukaemia|2015–2019|Males|5|60–64|0.315|0.258|0.373
Observed|Acute myeloid leukaemia|2015–2019|Males|5|65–69|0.211|0.171|0.255
Observed|Acute myeloid leukaemia|2015–2019|Males|5|70–74|0.131|0.1|0.165
Observed|Acute myeloid leukaemia|2015–2019|Males|5|75–79|0.038|0.024|0.058
Observed|Acute myeloid leukaemia|2015–2019|Males|5|80–84|0.03|0.016|0.051
Observed|Acute myeloid leukaemia|2015–2019|Males|5|85+|||
Observed|Acute myeloid leukaemia|2015–2019|Males|5|All ages combined|0.236|0.221|0.25
Relative|Acute myeloid leukaemia|2015–2019|Males|1|00–04|0.794|0.651|0.884
Relative|Acute myeloid leukaemia|2015–2019|Males|1|05–09|||
Relative|Acute myeloid leukaemia|2015–2019|Males|1|10–14|0.879|0.671|0.959
Relative|Acute myeloid leukaemia|2015–2019|Males|1|15–19|0.902|0.726|0.968
Relative|Acute myeloid leukaemia|2015–2019|Males|1|20–24|0.767|0.6|0.871
Relative|Acute myeloid leukaemia|2015–2019|Males|1|25–29|0.912|0.752|0.971
Relative|Acute myeloid leukaemia|2015–2019|Males|1|30–34|0.897|0.769|0.956
Relative|Acute myeloid leukaemia|2015–2019|Males|1|35–39|0.835|0.728|0.903
Relative|Acute myeloid leukaemia|2015–2019|Males|1|40–44|0.869|0.78|0.924
Relative|Acute myeloid leukaemia|2015–2019|Males|1|45–49|0.762|0.663|0.835
Relative|Acute myeloid leukaemia|2015–2019|Males|1|50–54|0.704|0.627|0.769
Relative|Acute myeloid leukaemia|2015–2019|Males|1|55–59|0.676|0.609|0.735
Relative|Acute myeloid leukaemia|2015–2019|Males|1|60–64|0.612|0.549|0.669
Relative|Acute myeloid leukaemia|2015–2019|Males|1|65–69|0.527|0.475|0.576
Relative|Acute myeloid leukaemia|2015–2019|Males|1|70–74|0.394|0.348|0.44
Relative|Acute myeloid leukaemia|2015–2019|Males|1|75–79|0.255|0.216|0.296
Relative|Acute myeloid leukaemia|2015–2019|Males|1|80–84|0.185|0.149|0.225
Relative|Acute myeloid leukaemia|2015–2019|Males|1|85+|0.054|0.038|0.074
Relative|Acute myeloid leukaemia|2015–2019|Males|1|All ages combined|0.454|0.436|0.472
Relative|Acute myeloid leukaemia|2015–2019|Males|2|00–04|0.756|0.61|0.853
Relative|Acute myeloid leukaemia|2015–2019|Males|2|05–09|||
Relative|Acute myeloid leukaemia|2015–2019|Males|2|10–14|||
Relative|Acute myeloid leukaemia|2015–2019|Males|2|15–19|0.755|0.569|0.869
Relative|Acute myeloid leukaemia|2015–2019|Males|2|20–24|0.72|0.551|0.834
Relative|Acute myeloid leukaemia|2015–2019|Males|2|25–29|0.913|0.752|0.972
Relative|Acute myeloid leukaemia|2015–2019|Males|2|30–34|0.836|0.698|0.915
Relative|Acute myeloid leukaemia|2015–2019|Males|2|35–39|0.778|0.663|0.859
Relative|Acute myeloid leukaemia|2015–2019|Males|2|40–44|0.704|0.596|0.789
Relative|Acute myeloid leukaemia|2015–2019|Males|2|45–49|0.677|0.572|0.761
Relative|Acute myeloid leukaemia|2015–2019|Males|2|50–54|0.594|0.513|0.666
Relative|Acute myeloid leukaemia|2015–2019|Males|2|55–59|0.571|0.501|0.635
Relative|Acute myeloid leukaemia|2015–2019|Males|2|60–64|0.431|0.369|0.492
Relative|Acute myeloid leukaemia|2015–2019|Males|2|65–69|0.364|0.315|0.413
Relative|Acute myeloid leukaemia|2015–2019|Males|2|70–74|0.268|0.227|0.311
Relative|Acute myeloid leukaemia|2015–2019|Males|2|75–79|0.141|0.111|0.175
Relative|Acute myeloid leukaemia|2015–2019|Males|2|80–84|0.101|0.074|0.134
Relative|Acute myeloid leukaemia|2015–2019|Males|2|85+|0.019|0.011|0.032
Relative|Acute myeloid leukaemia|2015–2019|Males|2|All ages combined|0.341|0.324|0.359
Relative|Acute myeloid leukaemia|2015–2019|Males|3|00–04|0.756|0.61|0.853
Relative|Acute myeloid leukaemia|2015–2019|Males|3|05–09|||
Relative|Acute myeloid leukaemia|2015–2019|Males|3|10–14|||
Relative|Acute myeloid leukaemia|2015–2019|Males|3|15–19|0.726|0.54|0.847
Relative|Acute myeloid leukaemia|2015–2019|Males|3|20–24|0.697|0.529|0.816
Relative|Acute myeloid leukaemia|2015–2019|Males|3|25–29|0.88|0.708|0.955
Relative|Acute myeloid leukaemia|2015–2019|Males|3|30–34|0.775|0.629|0.87
Relative|Acute myeloid leukaemia|2015–2019|Males|3|35–39|0.753|0.636|0.838
Relative|Acute myeloid leukaemia|2015–2019|Males|3|40–44|0.693|0.584|0.78
Relative|Acute myeloid leukaemia|2015–2019|Males|3|45–49|0.645|0.539|0.733
Relative|Acute myeloid leukaemia|2015–2019|Males|3|50–54|0.532|0.451|0.607
Relative|Acute myeloid leukaemia|2015–2019|Males|3|55–59|0.507|0.438|0.573
Relative|Acute myeloid leukaemia|2015–2019|Males|3|60–64|0.382|0.321|0.443
Relative|Acute myeloid leukaemia|2015–2019|Males|3|65–69|0.305|0.258|0.353
Relative|Acute myeloid leukaemia|2015–2019|Males|3|70–74|0.191|0.154|0.23
Relative|Acute myeloid leukaemia|2015–2019|Males|3|75–79|0.084|0.061|0.113
Relative|Acute myeloid leukaemia|2015–2019|Males|3|80–84|0.063|0.041|0.092
Relative|Acute myeloid leukaemia|2015–2019|Males|3|85+|0.005|0.001|0.012
Relative|Acute myeloid leukaemia|2015–2019|Males|3|All ages combined|0.292|0.276|0.309
Relative|Acute myeloid leukaemia|2015–2019|Males|4|00–04|0.74|0.594|0.84
Relative|Acute myeloid leukaemia|2015–2019|Males|4|05–09|||
Relative|Acute myeloid leukaemia|2015–2019|Males|4|10–14|||
Relative|Acute myeloid leukaemia|2015–2019|Males|4|15–19|0.702|0.517|0.827
Relative|Acute myeloid leukaemia|2015–2019|Males|4|20–24|0.678|0.511|0.799
Relative|Acute myeloid leukaemia|2015–2019|Males|4|25–29|0.881|0.708|0.955
Relative|Acute myeloid leukaemia|2015–2019|Males|4|30–34|0.757|0.611|0.855
Relative|Acute myeloid leukaemia|2015–2019|Males|4|35–39|0.754|0.637|0.839
Relative|Acute myeloid leukaemia|2015–2019|Males|4|40–44|0.661|0.55|0.751
Relative|Acute myeloid leukaemia|2015–2019|Males|4|45–49|0.601|0.493|0.694
Relative|Acute myeloid leukaemia|2015–2019|Males|4|50–54|0.51|0.429|0.586
Relative|Acute myeloid leukaemia|2015–2019|Males|4|55–59|0.471|0.402|0.538
Relative|Acute myeloid leukaemia|2015–2019|Males|4|60–64|0.336|0.276|0.396
Relative|Acute myeloid leukaemia|2015–2019|Males|4|65–69|0.257|0.212|0.304
Relative|Acute myeloid leukaemia|2015–2019|Males|4|70–74|0.156|0.122|0.194
Relative|Acute myeloid leukaemia|2015–2019|Males|4|75–79|0.062|0.041|0.088
Relative|Acute myeloid leukaemia|2015–2019|Males|4|80–84|0.049|0.028|0.078
Relative|Acute myeloid leukaemia|2015–2019|Males|4|85+|||
Relative|Acute myeloid leukaemia|2015–2019|Males|4|All ages combined|0.268|0.252|0.284
Relative|Acute myeloid leukaemia|2015–2019|Males|5|00–04|0.74|0.594|0.84
Relative|Acute myeloid leukaemia|2015–2019|Males|5|05–09|||
Relative|Acute myeloid leukaemia|2015–2019|Males|5|10–14|||
Relative|Acute myeloid leukaemia|2015–2019|Males|5|15–19|0.702|0.517|0.828
Relative|Acute myeloid leukaemia|2015–2019|Males|5|20–24|0.614|0.449|0.742
Relative|Acute myeloid leukaemia|2015–2019|Males|5|25–29|||
Relative|Acute myeloid leukaemia|2015–2019|Males|5|30–34|0.758|0.611|0.856
Relative|Acute myeloid leukaemia|2015–2019|Males|5|35–39|0.755|0.638|0.84
Relative|Acute myeloid leukaemia|2015–2019|Males|5|40–44|0.662|0.551|0.752
Relative|Acute myeloid leukaemia|2015–2019|Males|5|45–49|0.591|0.483|0.685
Relative|Acute myeloid leukaemia|2015–2019|Males|5|50–54|0.498|0.417|0.575
Relative|Acute myeloid leukaemia|2015–2019|Males|5|55–59|0.448|0.378|0.516
Relative|Acute myeloid leukaemia|2015–2019|Males|5|60–64|0.33|0.271|0.391
Relative|Acute myeloid leukaemia|2015–2019|Males|5|65–69|0.227|0.184|0.274
Relative|Acute myeloid leukaemia|2015–2019|Males|5|70–74|0.147|0.113|0.186
Relative|Acute myeloid leukaemia|2015–2019|Males|5|75–79|0.047|0.03|0.072
Relative|Acute myeloid leukaemia|2015–2019|Males|5|80–84|0.044|0.024|0.075
Relative|Acute myeloid leukaemia|2015–2019|Males|5|85+|||
Relative|Acute myeloid leukaemia|2015–2019|Males|5|All ages combined|0.256|0.24|0.272
Observed|Acute myeloid leukaemia|2015–2019|Females|1|00–04|0.856|0.708|0.933
Observed|Acute myeloid leukaemia|2015–2019|Females|1|05–09|||
Observed|Acute myeloid leukaemia|2015–2019|Females|1|10–14|0.911|0.689|0.977
Observed|Acute myeloid leukaemia|2015–2019|Females|1|15–19|0.849|0.675|0.934
Observed|Acute myeloid leukaemia|2015–2019|Females|1|20–24|0.967|0.79|0.995
Observed|Acute myeloid leukaemia|2015–2019|Females|1|25–29|0.904|0.732|0.968
Observed|Acute myeloid leukaemia|2015–2019|Females|1|30–34|0.913|0.817|0.96
Observed|Acute myeloid leukaemia|2015–2019|Females|1|35–39|0.838|0.727|0.907
Observed|Acute myeloid leukaemia|2015–2019|Females|1|40–44|0.797|0.694|0.869
Observed|Acute myeloid leukaemia|2015–2019|Females|1|45–49|0.672|0.575|0.752
Observed|Acute myeloid leukaemia|2015–2019|Females|1|50–54|0.685|0.606|0.752
Observed|Acute myeloid leukaemia|2015–2019|Females|1|55–59|0.664|0.589|0.729
Observed|Acute myeloid leukaemia|2015–2019|Females|1|60–64|0.592|0.515|0.661
Observed|Acute myeloid leukaemia|2015–2019|Females|1|65–69|0.572|0.508|0.632
Observed|Acute myeloid leukaemia|2015–2019|Females|1|70–74|0.368|0.311|0.426
Observed|Acute myeloid leukaemia|2015–2019|Females|1|75–79|0.265|0.217|0.315
Observed|Acute myeloid leukaemia|2015–2019|Females|1|80–84|0.143|0.105|0.187
Observed|Acute myeloid leukaemia|2015–2019|Females|1|85+|0.026|0.017|0.04
Observed|Acute myeloid leukaemia|2015–2019|Females|1|All ages combined|0.461|0.441|0.482
Observed|Acute myeloid leukaemia|2015–2019|Females|2|00–04|0.765|0.607|0.866
Observed|Acute myeloid leukaemia|2015–2019|Females|2|05–09|||
Observed|Acute myeloid leukaemia|2015–2019|Females|2|10–14|||
Observed|Acute myeloid leukaemia|2015–2019|Females|2|15–19|0.768|0.589|0.876
Observed|Acute myeloid leukaemia|2015–2019|Females|2|20–24|0.903|0.728|0.968
Observed|Acute myeloid leukaemia|2015–2019|Females|2|25–29|0.875|0.7|0.951
Observed|Acute myeloid leukaemia|2015–2019|Females|2|30–34|0.809|0.694|0.884
Observed|Acute myeloid leukaemia|2015–2019|Females|2|35–39|0.733|0.61|0.823
Observed|Acute myeloid leukaemia|2015–2019|Females|2|40–44|0.717|0.609|0.8
Observed|Acute myeloid leukaemia|2015–2019|Females|2|45–49|0.605|0.507|0.689
Observed|Acute myeloid leukaemia|2015–2019|Females|2|50–54|0.542|0.458|0.618
Observed|Acute myeloid leukaemia|2015–2019|Females|2|55–59|0.582|0.504|0.652
Observed|Acute myeloid leukaemia|2015–2019|Females|2|60–64|0.44|0.365|0.512
Observed|Acute myeloid leukaemia|2015–2019|Females|2|65–69|0.414|0.351|0.477
Observed|Acute myeloid leukaemia|2015–2019|Females|2|70–74|0.197|0.152|0.246
Observed|Acute myeloid leukaemia|2015–2019|Females|2|75–79|0.142|0.106|0.183
Observed|Acute myeloid leukaemia|2015–2019|Females|2|80–84|0.049|0.03|0.074
Observed|Acute myeloid leukaemia|2015–2019|Females|2|85+|0.01|0.005|0.018
Observed|Acute myeloid leukaemia|2015–2019|Females|2|All ages combined|0.347|0.327|0.366
Observed|Acute myeloid leukaemia|2015–2019|Females|3|00–04|0.765|0.607|0.866
Observed|Acute myeloid leukaemia|2015–2019|Females|3|05–09|||
Observed|Acute myeloid leukaemia|2015–2019|Females|3|10–14|||
Observed|Acute myeloid leukaemia|2015–2019|Females|3|15–19|0.738|0.558|0.854
Observed|Acute myeloid leukaemia|2015–2019|Females|3|20–24|0.869|0.688|0.949
Observed|Acute myeloid leukaemia|2015–2019|Females|3|25–29|0.845|0.667|0.932
Observed|Acute myeloid leukaemia|2015–2019|Females|3|30–34|0.795|0.678|0.873
Observed|Acute myeloid leukaemia|2015–2019|Females|3|35–39|0.733|0.61|0.823
Observed|Acute myeloid leukaemia|2015–2019|Females|3|40–44|0.67|0.56|0.759
Observed|Acute myeloid leukaemia|2015–2019|Females|3|45–49|0.605|0.507|0.689
Observed|Acute myeloid leukaemia|2015–2019|Females|3|50–54|0.52|0.436|0.597
Observed|Acute myeloid leukaemia|2015–2019|Females|3|55–59|0.548|0.469|0.62
Observed|Acute myeloid leukaemia|2015–2019|Females|3|60–64|0.384|0.312|0.456
Observed|Acute myeloid leukaemia|2015–2019|Females|3|65–69|0.282|0.224|0.342
Observed|Acute myeloid leukaemia|2015–2019|Females|3|70–74|0.143|0.105|0.187
Observed|Acute myeloid leukaemia|2015–2019|Females|3|75–79|0.113|0.081|0.151
Observed|Acute myeloid leukaemia|2015–2019|Females|3|80–84|0.03|0.016|0.051
Observed|Acute myeloid leukaemia|2015–2019|Females|3|85+|0.004|0.001|0.009
Observed|Acute myeloid leukaemia|2015–2019|Females|3|All ages combined|0.307|0.288|0.326
Observed|Acute myeloid leukaemia|2015–2019|Females|4|00–04|0.765|0.607|0.866
Observed|Acute myeloid leukaemia|2015–2019|Females|4|05–09|||
Observed|Acute myeloid leukaemia|2015–2019|Females|4|10–14|||
Observed|Acute myeloid leukaemia|2015–2019|Females|4|15–19|0.738|0.558|0.854
Observed|Acute myeloid leukaemia|2015–2019|Females|4|20–24|0.843|0.663|0.932
Observed|Acute myeloid leukaemia|2015–2019|Females|4|25–29|0.784|0.6|0.891
Observed|Acute myeloid leukaemia|2015–2019|Females|4|30–34|0.78|0.661|0.861
Observed|Acute myeloid leukaemia|2015–2019|Females|4|35–39|0.716|0.591|0.808
Observed|Acute myeloid leukaemia|2015–2019|Females|4|40–44|0.625|0.513|0.717
Observed|Acute myeloid leukaemia|2015–2019|Females|4|45–49|0.595|0.498|0.68
Observed|Acute myeloid leukaemia|2015–2019|Females|4|50–54|0.499|0.415|0.577
Observed|Acute myeloid leukaemia|2015–2019|Females|4|55–59|0.519|0.44|0.592
Observed|Acute myeloid leukaemia|2015–2019|Females|4|60–64|0.334|0.266|0.403
Observed|Acute myeloid leukaemia|2015–2019|Females|4|65–69|0.239|0.184|0.297
Observed|Acute myeloid leukaemia|2015–2019|Females|4|70–74|0.112|0.078|0.152
Observed|Acute myeloid leukaemia|2015–2019|Females|4|75–79|0.085|0.057|0.12
Observed|Acute myeloid leukaemia|2015–2019|Females|4|80–84|0.025|0.012|0.044
Observed|Acute myeloid leukaemia|2015–2019|Females|4|85+|0.003|0.001|0.008
Observed|Acute myeloid leukaemia|2015–2019|Females|4|All ages combined|0.284|0.266|0.302
Observed|Acute myeloid leukaemia|2015–2019|Females|5|00–04|0.765|0.607|0.866
Observed|Acute myeloid leukaemia|2015–2019|Females|5|05–09|||
Observed|Acute myeloid leukaemia|2015–2019|Females|5|10–14|||
Observed|Acute myeloid leukaemia|2015–2019|Females|5|15–19|0.738|0.558|0.854
Observed|Acute myeloid leukaemia|2015–2019|Females|5|20–24|0.843|0.663|0.932
Observed|Acute myeloid leukaemia|2015–2019|Females|5|25–29|0.725|0.538|0.846
Observed|Acute myeloid leukaemia|2015–2019|Females|5|30–34|0.743|0.618|0.832
Observed|Acute myeloid leukaemia|2015–2019|Females|5|35–39|0.699|0.573|0.794
Observed|Acute myeloid leukaemia|2015–2019|Females|5|40–44|0.625|0.513|0.717
Observed|Acute myeloid leukaemia|2015–2019|Females|5|45–49|0.568|0.47|0.654
Observed|Acute myeloid leukaemia|2015–2019|Females|5|50–54|0.483|0.4|0.562
Observed|Acute myeloid leukaemia|2015–2019|Females|5|55–59|0.497|0.417|0.571
Observed|Acute myeloid leukaemia|2015–2019|Females|5|60–64|0.319|0.252|0.387
Observed|Acute myeloid leukaemia|2015–2019|Females|5|65–69|0.232|0.178|0.291
Observed|Acute myeloid leukaemia|2015–2019|Females|5|70–74|0.085|0.056|0.122
Observed|Acute myeloid leukaemia|2015–2019|Females|5|75–79|0.05|0.028|0.082
Observed|Acute myeloid leukaemia|2015–2019|Females|5|80–84|0.017|0.007|0.034
Observed|Acute myeloid leukaemia|2015–2019|Females|5|85+|||
Observed|Acute myeloid leukaemia|2015–2019|Females|5|All ages combined|0.267|0.249|0.285
Relative|Acute myeloid leukaemia|2015–2019|Females|1|00–04|0.857|0.709|0.934
Relative|Acute myeloid leukaemia|2015–2019|Females|1|05–09|||
Relative|Acute myeloid leukaemia|2015–2019|Females|1|10–14|0.911|0.69|0.977
Relative|Acute myeloid leukaemia|2015–2019|Females|1|15–19|0.849|0.675|0.934
Relative|Acute myeloid leukaemia|2015–2019|Females|1|20–24|0.968|0.79|0.996
Relative|Acute myeloid leukaemia|2015–2019|Females|1|25–29|0.905|0.732|0.968
Relative|Acute myeloid leukaemia|2015–2019|Females|1|30–34|0.914|0.818|0.96
Relative|Acute myeloid leukaemia|2015–2019|Females|1|35–39|0.839|0.728|0.908
Relative|Acute myeloid leukaemia|2015–2019|Females|1|40–44|0.798|0.695|0.869
Relative|Acute myeloid leukaemia|2015–2019|Females|1|45–49|0.673|0.576|0.753
Relative|Acute myeloid leukaemia|2015–2019|Females|1|50–54|0.687|0.607|0.754
Relative|Acute myeloid leukaemia|2015–2019|Females|1|55–59|0.666|0.591|0.731
Relative|Acute myeloid leukaemia|2015–2019|Females|1|60–64|0.595|0.517|0.664
Relative|Acute myeloid leukaemia|2015–2019|Females|1|65–69|0.577|0.511|0.637
Relative|Acute myeloid leukaemia|2015–2019|Females|1|70–74|0.373|0.314|0.432
Relative|Acute myeloid leukaemia|2015–2019|Females|1|75–79|0.271|0.222|0.322
Relative|Acute myeloid leukaemia|2015–2019|Females|1|80–84|0.149|0.109|0.195
Relative|Acute myeloid leukaemia|2015–2019|Females|1|85+|0.03|0.019|0.045
Relative|Acute myeloid leukaemia|2015–2019|Females|1|All ages combined|0.472|0.451|0.493
Relative|Acute myeloid leukaemia|2015–2019|Females|2|00–04|0.766|0.608|0.867
Relative|Acute myeloid leukaemia|2015–2019|Females|2|05–09|||
Relative|Acute myeloid leukaemia|2015–2019|Females|2|10–14|||
Relative|Acute myeloid leukaemia|2015–2019|Females|2|15–19|0.768|0.59|0.877
Relative|Acute myeloid leukaemia|2015–2019|Females|2|20–24|0.903|0.728|0.968
Relative|Acute myeloid leukaemia|2015–2019|Females|2|25–29|0.875|0.7|0.952
Relative|Acute myeloid leukaemia|2015–2019|Females|2|30–34|0.81|0.695|0.885
Relative|Acute myeloid leukaemia|2015–2019|Females|2|35–39|0.734|0.611|0.824
Relative|Acute myeloid leukaemia|2015–2019|Females|2|40–44|0.718|0.61|0.802
Relative|Acute myeloid leukaemia|2015–2019|Females|2|45–49|0.606|0.509|0.691
Relative|Acute myeloid leukaemia|2015–2019|Females|2|50–54|0.544|0.46|0.621
Relative|Acute myeloid leukaemia|2015–2019|Females|2|55–59|0.586|0.507|0.656
Relative|Acute myeloid leukaemia|2015–2019|Females|2|60–64|0.444|0.369|0.517
Relative|Acute myeloid leukaemia|2015–2019|Females|2|65–69|0.421|0.356|0.484
Relative|Acute myeloid leukaemia|2015–2019|Females|2|70–74|0.202|0.156|0.252
Relative|Acute myeloid leukaemia|2015–2019|Females|2|75–79|0.149|0.111|0.191
Relative|Acute myeloid leukaemia|2015–2019|Females|2|80–84|0.054|0.033|0.082
Relative|Acute myeloid leukaemia|2015–2019|Females|2|85+|0.012|0.006|0.022
Relative|Acute myeloid leukaemia|2015–2019|Females|2|All ages combined|0.358|0.338|0.378
Relative|Acute myeloid leukaemia|2015–2019|Females|3|00–04|0.766|0.608|0.867
Relative|Acute myeloid leukaemia|2015–2019|Females|3|05–09|||
Relative|Acute myeloid leukaemia|2015–2019|Females|3|10–14|||
Relative|Acute myeloid leukaemia|2015–2019|Females|3|15–19|0.739|0.558|0.855
Relative|Acute myeloid leukaemia|2015–2019|Females|3|20–24|0.87|0.689|0.95
Relative|Acute myeloid leukaemia|2015–2019|Females|3|25–29|0.846|0.668|0.933
Relative|Acute myeloid leukaemia|2015–2019|Females|3|30–34|0.796|0.679|0.874
Relative|Acute myeloid leukaemia|2015–2019|Females|3|35–39|0.735|0.612|0.824
Relative|Acute myeloid leukaemia|2015–2019|Females|3|40–44|0.672|0.561|0.761
Relative|Acute myeloid leukaemia|2015–2019|Females|3|45–49|0.607|0.51|0.692
Relative|Acute myeloid leukaemia|2015–2019|Females|3|50–54|0.523|0.439|0.601
Relative|Acute myeloid leukaemia|2015–2019|Females|3|55–59|0.553|0.474|0.626
Relative|Acute myeloid leukaemia|2015–2019|Females|3|60–64|0.39|0.317|0.462
Relative|Acute myeloid leukaemia|2015–2019|Females|3|65–69|0.289|0.23|0.35
Relative|Acute myeloid leukaemia|2015–2019|Females|3|70–74|0.149|0.109|0.194
Relative|Acute myeloid leukaemia|2015–2019|Females|3|75–79|0.122|0.088|0.162
Relative|Acute myeloid leukaemia|2015–2019|Females|3|80–84|0.034|0.018|0.059
Relative|Acute myeloid leukaemia|2015–2019|Females|3|85+|0.005|0.002|0.013
Relative|Acute myeloid leukaemia|2015–2019|Females|3|All ages combined|0.32|0.3|0.339
Relative|Acute myeloid leukaemia|2015–2019|Females|4|00–04|0.766|0.608|0.867
Relative|Acute myeloid leukaemia|2015–2019|Females|4|05–09|||
Relative|Acute myeloid leukaemia|2015–2019|Females|4|10–14|||
Relative|Acute myeloid leukaemia|2015–2019|Females|4|15–19|0.739|0.558|0.855
Relative|Acute myeloid leukaemia|2015–2019|Females|4|20–24|0.844|0.664|0.932
Relative|Acute myeloid leukaemia|2015–2019|Females|4|25–29|0.785|0.601|0.892
Relative|Acute myeloid leukaemia|2015–2019|Females|4|30–34|0.781|0.662|0.862
Relative|Acute myeloid leukaemia|2015–2019|Females|4|35–39|0.718|0.592|0.811
Relative|Acute myeloid leukaemia|2015–2019|Females|4|40–44|0.627|0.516|0.721
Relative|Acute myeloid leukaemia|2015–2019|Females|4|45–49|0.599|0.501|0.684
Relative|Acute myeloid leukaemia|2015–2019|Females|4|50–54|0.504|0.419|0.582
Relative|Acute myeloid leukaemia|2015–2019|Females|4|55–59|0.527|0.446|0.601
Relative|Acute myeloid leukaemia|2015–2019|Females|4|60–64|0.341|0.271|0.412
Relative|Acute myeloid leukaemia|2015–2019|Females|4|65–69|0.247|0.191|0.308
Relative|Acute myeloid leukaemia|2015–2019|Females|4|70–74|0.118|0.083|0.161
Relative|Acute myeloid leukaemia|2015–2019|Females|4|75–79|0.095|0.064|0.133
Relative|Acute myeloid leukaemia|2015–2019|Females|4|80–84|0.03|0.015|0.055
Relative|Acute myeloid leukaemia|2015–2019|Females|4|85+|0.005|0.002|0.013
Relative|Acute myeloid leukaemia|2015–2019|Females|4|All ages combined|0.297|0.278|0.317
Relative|Acute myeloid leukaemia|2015–2019|Females|5|00–04|0.766|0.608|0.867
Relative|Acute myeloid leukaemia|2015–2019|Females|5|05–09|||
Relative|Acute myeloid leukaemia|2015–2019|Females|5|10–14|||
Relative|Acute myeloid leukaemia|2015–2019|Females|5|15–19|0.739|0.558|0.855
Relative|Acute myeloid leukaemia|2015–2019|Females|5|20–24|0.844|0.664|0.933
Relative|Acute myeloid leukaemia|2015–2019|Females|5|25–29|0.726|0.539|0.847
Relative|Acute myeloid leukaemia|2015–2019|Females|5|30–34|0.744|0.619|0.834
Relative|Acute myeloid leukaemia|2015–2019|Females|5|35–39|0.701|0.575|0.797
Relative|Acute myeloid leukaemia|2015–2019|Females|5|40–44|0.628|0.516|0.721
Relative|Acute myeloid leukaemia|2015–2019|Females|5|45–49|0.572|0.474|0.659
Relative|Acute myeloid leukaemia|2015–2019|Females|5|50–54|0.49|0.405|0.569
Relative|Acute myeloid leukaemia|2015–2019|Females|5|55–59|0.506|0.425|0.582
Relative|Acute myeloid leukaemia|2015–2019|Females|5|60–64|0.327|0.259|0.398
Relative|Acute myeloid leukaemia|2015–2019|Females|5|65–69|0.243|0.186|0.304
Relative|Acute myeloid leukaemia|2015–2019|Females|5|70–74|0.092|0.06|0.131
Relative|Acute myeloid leukaemia|2015–2019|Females|5|75–79|0.058|0.032|0.094
Relative|Acute myeloid leukaemia|2015–2019|Females|5|80–84|0.022|0.009|0.045
Relative|Acute myeloid leukaemia|2015–2019|Females|5|85+|||
Relative|Acute myeloid leukaemia|2015–2019|Females|5|All ages combined|0.282|0.263|0.301
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|00–04|0.822|0.727|0.887
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|05–09|0.842|0.662|0.931
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|10–14|0.894|0.765|0.955
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|15–19|0.874|0.764|0.935
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|20–24|0.855|0.748|0.919
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|25–29|0.908|0.807|0.958
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|30–34|0.906|0.837|0.947
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|35–39|0.836|0.764|0.888
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|40–44|0.834|0.77|0.881
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|45–49|0.714|0.646|0.77
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|50–54|0.694|0.64|0.742
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|55–59|0.669|0.62|0.713
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|60–64|0.601|0.553|0.646
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|65–69|0.541|0.501|0.579
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|70–74|0.38|0.344|0.416
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|75–79|0.254|0.224|0.285
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|80–84|0.162|0.136|0.19
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|85+|0.037|0.028|0.048
Observed|Acute myeloid leukaemia|2015–2019|Persons|1|All ages combined|0.449|0.436|0.462
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|00–04|0.759|0.658|0.834
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|05–09|0.78|0.593|0.888
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|10–14|0.778|0.626|0.874
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|15–19|0.761|0.641|0.846
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|20–24|0.8|0.686|0.876
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|25–29|0.892|0.788|0.947
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|30–34|0.82|0.738|0.879
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|35–39|0.755|0.675|0.818
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|40–44|0.711|0.637|0.773
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|45–49|0.637|0.568|0.699
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|50–54|0.567|0.51|0.62
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|55–59|0.572|0.521|0.62
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|60–64|0.43|0.383|0.477
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|65–69|0.378|0.339|0.416
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|70–74|0.234|0.204|0.266
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|75–79|0.136|0.113|0.16
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|80–84|0.071|0.055|0.091
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|85+|0.012|0.008|0.018
Observed|Acute myeloid leukaemia|2015–2019|Persons|2|All ages combined|0.334|0.322|0.347
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|00–04|0.759|0.658|0.834
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|05–09|0.714|0.521|0.839
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|10–14|0.689|0.532|0.803
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|15–19|0.732|0.609|0.822
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|20–24|0.773|0.657|0.854
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|25–29|0.861|0.75|0.925
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|30–34|0.786|0.7|0.85
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|35–39|0.74|0.659|0.805
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|40–44|0.681|0.606|0.745
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|45–49|0.623|0.553|0.685
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|50–54|0.522|0.465|0.577
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|55–59|0.519|0.467|0.568
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|60–64|0.377|0.331|0.423
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|65–69|0.289|0.254|0.326
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|70–74|0.165|0.139|0.193
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|75–79|0.09|0.072|0.111
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|80–84|0.042|0.029|0.057
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|85+|0.004|0.002|0.007
Observed|Acute myeloid leukaemia|2015–2019|Persons|3|All ages combined|0.288|0.276|0.3
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|00–04|0.749|0.647|0.825
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|05–09|0.714|0.521|0.839
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|10–14|0.689|0.532|0.803
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|15–19|0.719|0.595|0.81
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|20–24|0.75|0.633|0.834
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|25–29|0.828|0.711|0.901
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|30–34|0.769|0.682|0.835
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|35–39|0.733|0.65|0.798
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|40–44|0.641|0.565|0.708
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|45–49|0.597|0.527|0.661
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|50–54|0.5|0.443|0.555
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|55–59|0.484|0.433|0.534
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|60–64|0.328|0.284|0.372
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|65–69|0.242|0.208|0.277
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|70–74|0.131|0.107|0.157
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|75–79|0.065|0.05|0.084
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|80–84|0.032|0.021|0.046
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|85+|0.003|0.001|0.006
Observed|Acute myeloid leukaemia|2015–2019|Persons|4|All ages combined|0.264|0.252|0.275
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|00–04|0.749|0.647|0.825
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|05–09|0.714|0.521|0.839
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|10–14|0.667|0.509|0.784
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|15–19|0.719|0.595|0.81
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|20–24|0.716|0.599|0.804
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|25–29|0.774|0.648|0.86
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|30–34|0.749|0.659|0.819
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|35–39|0.725|0.642|0.791
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|40–44|0.641|0.565|0.708
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|45–49|0.576|0.506|0.641
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|50–54|0.486|0.428|0.54
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|55–59|0.46|0.408|0.51
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|60–64|0.316|0.273|0.36
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|65–69|0.218|0.185|0.253
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|70–74|0.112|0.09|0.137
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|75–79|0.044|0.031|0.06
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|80–84|0.024|0.015|0.037
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|85+|0.001|0|0.002
Observed|Acute myeloid leukaemia|2015–2019|Persons|5|All ages combined|0.249|0.237|0.26
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|00–04|0.823|0.728|0.888
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|05–09|0.842|0.662|0.931
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|10–14|0.894|0.765|0.955
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|15–19|0.874|0.764|0.935
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|20–24|0.856|0.748|0.92
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|25–29|0.909|0.807|0.958
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|30–34|0.907|0.838|0.948
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|35–39|0.837|0.765|0.889
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|40–44|0.835|0.771|0.882
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|45–49|0.715|0.648|0.772
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|50–54|0.696|0.641|0.744
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|55–59|0.672|0.622|0.716
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|60–64|0.605|0.557|0.65
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|65–69|0.546|0.506|0.585
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|70–74|0.386|0.35|0.423
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|75–79|0.262|0.231|0.293
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|80–84|0.171|0.143|0.201
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|85+|0.042|0.032|0.055
Relative|Acute myeloid leukaemia|2015–2019|Persons|1|All ages combined|0.462|0.448|0.475
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|00–04|0.76|0.659|0.835
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|05–09|0.78|0.593|0.888
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|10–14|0.778|0.627|0.874
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|15–19|0.762|0.641|0.847
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|20–24|0.801|0.687|0.877
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|25–29|0.893|0.788|0.948
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|30–34|0.821|0.739|0.88
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|35–39|0.756|0.676|0.82
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|40–44|0.713|0.639|0.775
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|45–49|0.64|0.57|0.701
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|50–54|0.57|0.513|0.624
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|55–59|0.577|0.526|0.625
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|60–64|0.436|0.389|0.483
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|65–69|0.386|0.347|0.425
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|70–74|0.243|0.211|0.275
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|75–79|0.144|0.12|0.17
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|80–84|0.08|0.061|0.102
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|85+|0.016|0.01|0.024
Relative|Acute myeloid leukaemia|2015–2019|Persons|2|All ages combined|0.349|0.336|0.362
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|00–04|0.76|0.659|0.835
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|05–09|0.714|0.522|0.84
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|10–14|0.689|0.532|0.803
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|15–19|0.733|0.61|0.822
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|20–24|0.774|0.658|0.855
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|25–29|0.862|0.751|0.926
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|30–34|0.787|0.701|0.852
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|35–39|0.742|0.661|0.808
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|40–44|0.684|0.609|0.748
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|45–49|0.626|0.556|0.689
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|50–54|0.527|0.469|0.582
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|55–59|0.526|0.474|0.576
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|60–64|0.385|0.338|0.432
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|65–69|0.299|0.262|0.337
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|70–74|0.175|0.147|0.204
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|75–79|0.099|0.079|0.122
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|80–84|0.05|0.035|0.069
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|85+|0.005|0.002|0.01
Relative|Acute myeloid leukaemia|2015–2019|Persons|3|All ages combined|0.304|0.291|0.317
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|00–04|0.75|0.648|0.827
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|05–09|0.714|0.522|0.84
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|10–14|0.69|0.532|0.803
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|15–19|0.72|0.596|0.811
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|20–24|0.751|0.635|0.836
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|25–29|0.83|0.712|0.903
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|30–34|0.771|0.684|0.838
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|35–39|0.736|0.653|0.802
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|40–44|0.645|0.568|0.712
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|45–49|0.602|0.531|0.666
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|50–54|0.507|0.449|0.562
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|55–59|0.494|0.442|0.544
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|60–64|0.338|0.292|0.384
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|65–69|0.254|0.218|0.291
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|70–74|0.141|0.116|0.169
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|75–79|0.075|0.057|0.096
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|80–84|0.041|0.027|0.06
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|85+|0.005|0.002|0.01
Relative|Acute myeloid leukaemia|2015–2019|Persons|4|All ages combined|0.281|0.268|0.293
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|00–04|0.75|0.648|0.827
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|05–09|0.714|0.522|0.84
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|10–14|0.668|0.51|0.785
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|15–19|0.72|0.596|0.811
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|20–24|0.718|0.6|0.806
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|25–29|0.776|0.649|0.862
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|30–34|0.752|0.662|0.821
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|35–39|0.728|0.645|0.796
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|40–44|0.646|0.569|0.713
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|45–49|0.583|0.511|0.648
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|50–54|0.494|0.436|0.55
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|55–59|0.472|0.419|0.523
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|60–64|0.329|0.283|0.375
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|65–69|0.232|0.197|0.27
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|70–74|0.125|0.1|0.152
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|75–79|0.053|0.037|0.072
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|80–84|0.034|0.021|0.052
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|85+|0.002|0|0.005
Relative|Acute myeloid leukaemia|2015–2019|Persons|5|All ages combined|0.267|0.255|0.279
Observed|All blood cancers combined|2015–2019|Males|1|00–04|0.936|0.908|0.956
Observed|All blood cancers combined|2015–2019|Males|1|05–09|0.979|0.953|0.99
Observed|All blood cancers combined|2015–2019|Males|1|10–14|0.958|0.926|0.977
Observed|All blood cancers combined|2015–2019|Males|1|15–19|0.956|0.929|0.973
Observed|All blood cancers combined|2015–2019|Males|1|20–24|0.953|0.928|0.969
Observed|All blood cancers combined|2015–2019|Males|1|25–29|0.97|0.949|0.982
Observed|All blood cancers combined|2015–2019|Males|1|30–34|0.965|0.946|0.977
Observed|All blood cancers combined|2015–2019|Males|1|35–39|0.945|0.927|0.958
Observed|All blood cancers combined|2015–2019|Males|1|40–44|0.955|0.941|0.966
Observed|All blood cancers combined|2015–2019|Males|1|45–49|0.937|0.924|0.948
Observed|All blood cancers combined|2015–2019|Males|1|50–54|0.93|0.919|0.94
Observed|All blood cancers combined|2015–2019|Males|1|55–59|0.918|0.908|0.927
Observed|All blood cancers combined|2015–2019|Males|1|60–64|0.907|0.898|0.915
Observed|All blood cancers combined|2015–2019|Males|1|65–69|0.877|0.868|0.885
Observed|All blood cancers combined|2015–2019|Males|1|70–74|0.842|0.833|0.851
Observed|All blood cancers combined|2015–2019|Males|1|75–79|0.779|0.769|0.79
Observed|All blood cancers combined|2015–2019|Males|1|80–84|0.694|0.681|0.706
Observed|All blood cancers combined|2015–2019|Males|1|85+|0.528|0.514|0.542
Observed|All blood cancers combined|2015–2019|Males|1|All ages combined|0.822|0.819|0.826
Observed|All blood cancers combined|2015–2019|Males|2|00–04|0.917|0.887|0.94
Observed|All blood cancers combined|2015–2019|Males|2|05–09|0.971|0.944|0.986
Observed|All blood cancers combined|2015–2019|Males|2|10–14|0.929|0.891|0.954
Observed|All blood cancers combined|2015–2019|Males|2|15–19|0.929|0.897|0.951
Observed|All blood cancers combined|2015–2019|Males|2|20–24|0.927|0.899|0.947
Observed|All blood cancers combined|2015–2019|Males|2|25–29|0.954|0.93|0.97
Observed|All blood cancers combined|2015–2019|Males|2|30–34|0.942|0.919|0.958
Observed|All blood cancers combined|2015–2019|Males|2|35–39|0.923|0.903|0.939
Observed|All blood cancers combined|2015–2019|Males|2|40–44|0.92|0.902|0.934
Observed|All blood cancers combined|2015–2019|Males|2|45–49|0.906|0.89|0.919
Observed|All blood cancers combined|2015–2019|Males|2|50–54|0.894|0.88|0.905
Observed|All blood cancers combined|2015–2019|Males|2|55–59|0.865|0.852|0.876
Observed|All blood cancers combined|2015–2019|Males|2|60–64|0.845|0.834|0.855
Observed|All blood cancers combined|2015–2019|Males|2|65–69|0.809|0.799|0.818
Observed|All blood cancers combined|2015–2019|Males|2|70–74|0.757|0.746|0.767
Observed|All blood cancers combined|2015–2019|Males|2|75–79|0.674|0.661|0.686
Observed|All blood cancers combined|2015–2019|Males|2|80–84|0.564|0.551|0.578
Observed|All blood cancers combined|2015–2019|Males|2|85+|0.389|0.375|0.403
Observed|All blood cancers combined|2015–2019|Males|2|All ages combined|0.741|0.737|0.745
Observed|All blood cancers combined|2015–2019|Males|3|00–04|0.913|0.882|0.936
Observed|All blood cancers combined|2015–2019|Males|3|05–09|0.961|0.931|0.978
Observed|All blood cancers combined|2015–2019|Males|3|10–14|0.91|0.869|0.939
Observed|All blood cancers combined|2015–2019|Males|3|15–19|0.91|0.876|0.935
Observed|All blood cancers combined|2015–2019|Males|3|20–24|0.921|0.892|0.942
Observed|All blood cancers combined|2015–2019|Males|3|25–29|0.941|0.915|0.959
Observed|All blood cancers combined|2015–2019|Males|3|30–34|0.922|0.897|0.941
Observed|All blood cancers combined|2015–2019|Males|3|35–39|0.903|0.881|0.921
Observed|All blood cancers combined|2015–2019|Males|3|40–44|0.895|0.876|0.912
Observed|All blood cancers combined|2015–2019|Males|3|45–49|0.891|0.875|0.906
Observed|All blood cancers combined|2015–2019|Males|3|50–54|0.861|0.847|0.875
Observed|All blood cancers combined|2015–2019|Males|3|55–59|0.833|0.82|0.846
Observed|All blood cancers combined|2015–2019|Males|3|60–64|0.803|0.791|0.814
Observed|All blood cancers combined|2015–2019|Males|3|65–69|0.76|0.749|0.77
Observed|All blood cancers combined|2015–2019|Males|3|70–74|0.69|0.678|0.701
Observed|All blood cancers combined|2015–2019|Males|3|75–79|0.582|0.569|0.595
Observed|All blood cancers combined|2015–2019|Males|3|80–84|0.465|0.451|0.479
Observed|All blood cancers combined|2015–2019|Males|3|85+|0.285|0.272|0.298
Observed|All blood cancers combined|2015–2019|Males|3|All ages combined|0.681|0.677|0.685
Observed|All blood cancers combined|2015–2019|Males|4|00–04|0.909|0.877|0.932
Observed|All blood cancers combined|2015–2019|Males|4|05–09|0.951|0.918|0.97
Observed|All blood cancers combined|2015–2019|Males|4|10–14|0.903|0.861|0.933
Observed|All blood cancers combined|2015–2019|Males|4|15–19|0.895|0.859|0.922
Observed|All blood cancers combined|2015–2019|Males|4|20–24|0.914|0.884|0.936
Observed|All blood cancers combined|2015–2019|Males|4|25–29|0.937|0.91|0.956
Observed|All blood cancers combined|2015–2019|Males|4|30–34|0.913|0.887|0.934
Observed|All blood cancers combined|2015–2019|Males|4|35–39|0.894|0.871|0.913
Observed|All blood cancers combined|2015–2019|Males|4|40–44|0.884|0.863|0.901
Observed|All blood cancers combined|2015–2019|Males|4|45–49|0.869|0.851|0.885
Observed|All blood cancers combined|2015–2019|Males|4|50–54|0.838|0.823|0.853
Observed|All blood cancers combined|2015–2019|Males|4|55–59|0.802|0.788|0.816
Observed|All blood cancers combined|2015–2019|Males|4|60–64|0.764|0.751|0.776
Observed|All blood cancers combined|2015–2019|Males|4|65–69|0.712|0.7|0.724
Observed|All blood cancers combined|2015–2019|Males|4|70–74|0.621|0.608|0.633
Observed|All blood cancers combined|2015–2019|Males|4|75–79|0.508|0.494|0.521
Observed|All blood cancers combined|2015–2019|Males|4|80–84|0.383|0.37|0.397
Observed|All blood cancers combined|2015–2019|Males|4|85+|0.204|0.192|0.216
Observed|All blood cancers combined|2015–2019|Males|4|All ages combined|0.63|0.625|0.634
Observed|All blood cancers combined|2015–2019|Males|5|00–04|0.902|0.87|0.927
Observed|All blood cancers combined|2015–2019|Males|5|05–09|0.947|0.914|0.968
Observed|All blood cancers combined|2015–2019|Males|5|10–14|0.896|0.852|0.927
Observed|All blood cancers combined|2015–2019|Males|5|15–19|0.895|0.859|0.922
Observed|All blood cancers combined|2015–2019|Males|5|20–24|0.906|0.875|0.929
Observed|All blood cancers combined|2015–2019|Males|5|25–29|0.924|0.895|0.945
Observed|All blood cancers combined|2015–2019|Males|5|30–34|0.906|0.878|0.927
Observed|All blood cancers combined|2015–2019|Males|5|35–39|0.885|0.861|0.905
Observed|All blood cancers combined|2015–2019|Males|5|40–44|0.874|0.853|0.892
Observed|All blood cancers combined|2015–2019|Males|5|45–49|0.853|0.835|0.87
Observed|All blood cancers combined|2015–2019|Males|5|50–54|0.817|0.801|0.832
Observed|All blood cancers combined|2015–2019|Males|5|55–59|0.775|0.76|0.789
Observed|All blood cancers combined|2015–2019|Males|5|60–64|0.727|0.713|0.74
Observed|All blood cancers combined|2015–2019|Males|5|65–69|0.67|0.658|0.682
Observed|All blood cancers combined|2015–2019|Males|5|70–74|0.567|0.554|0.579
Observed|All blood cancers combined|2015–2019|Males|5|75–79|0.447|0.433|0.46
Observed|All blood cancers combined|2015–2019|Males|5|80–84|0.31|0.297|0.324
Observed|All blood cancers combined|2015–2019|Males|5|85+|0.149|0.138|0.16
Observed|All blood cancers combined|2015–2019|Males|5|All ages combined|0.588|0.584|0.593
Relative|All blood cancers combined|2015–2019|Males|1|00–04|0.937|0.909|0.956
Relative|All blood cancers combined|2015–2019|Males|1|05–09|0.979|0.953|0.99
Relative|All blood cancers combined|2015–2019|Males|1|10–14|0.959|0.926|0.977
Relative|All blood cancers combined|2015–2019|Males|1|15–19|0.957|0.93|0.973
Relative|All blood cancers combined|2015–2019|Males|1|20–24|0.953|0.929|0.969
Relative|All blood cancers combined|2015–2019|Males|1|25–29|0.97|0.95|0.983
Relative|All blood cancers combined|2015–2019|Males|1|30–34|0.966|0.947|0.978
Relative|All blood cancers combined|2015–2019|Males|1|35–39|0.946|0.928|0.96
Relative|All blood cancers combined|2015–2019|Males|1|40–44|0.957|0.943|0.967
Relative|All blood cancers combined|2015–2019|Males|1|45–49|0.939|0.926|0.95
Relative|All blood cancers combined|2015–2019|Males|1|50–54|0.933|0.922|0.943
Relative|All blood cancers combined|2015–2019|Males|1|55–59|0.923|0.913|0.932
Relative|All blood cancers combined|2015–2019|Males|1|60–64|0.914|0.906|0.923
Relative|All blood cancers combined|2015–2019|Males|1|65–69|0.888|0.879|0.896
Relative|All blood cancers combined|2015–2019|Males|1|70–74|0.859|0.849|0.867
Relative|All blood cancers combined|2015–2019|Males|1|75–79|0.806|0.795|0.817
Relative|All blood cancers combined|2015–2019|Males|1|80–84|0.737|0.724|0.751
Relative|All blood cancers combined|2015–2019|Males|1|85+|0.607|0.591|0.623
Relative|All blood cancers combined|2015–2019|Males|1|All ages combined|0.848|0.844|0.852
Relative|All blood cancers combined|2015–2019|Males|2|00–04|0.918|0.888|0.941
Relative|All blood cancers combined|2015–2019|Males|2|05–09|0.972|0.944|0.986
Relative|All blood cancers combined|2015–2019|Males|2|10–14|0.929|0.891|0.954
Relative|All blood cancers combined|2015–2019|Males|2|15–19|0.93|0.898|0.952
Relative|All blood cancers combined|2015–2019|Males|2|20–24|0.928|0.9|0.949
Relative|All blood cancers combined|2015–2019|Males|2|25–29|0.955|0.932|0.971
Relative|All blood cancers combined|2015–2019|Males|2|30–34|0.943|0.921|0.96
Relative|All blood cancers combined|2015–2019|Males|2|35–39|0.925|0.905|0.941
Relative|All blood cancers combined|2015–2019|Males|2|40–44|0.923|0.905|0.938
Relative|All blood cancers combined|2015–2019|Males|2|45–49|0.91|0.895|0.924
Relative|All blood cancers combined|2015–2019|Males|2|50–54|0.9|0.887|0.912
Relative|All blood cancers combined|2015–2019|Males|2|55–59|0.874|0.862|0.885
Relative|All blood cancers combined|2015–2019|Males|2|60–64|0.859|0.848|0.869
Relative|All blood cancers combined|2015–2019|Males|2|65–69|0.83|0.819|0.84
Relative|All blood cancers combined|2015–2019|Males|2|70–74|0.789|0.777|0.799
Relative|All blood cancers combined|2015–2019|Males|2|75–79|0.723|0.71|0.736
Relative|All blood cancers combined|2015–2019|Males|2|80–84|0.642|0.626|0.658
Relative|All blood cancers combined|2015–2019|Males|2|85+|0.519|0.5|0.537
Relative|All blood cancers combined|2015–2019|Males|2|All ages combined|0.786|0.782|0.79
Relative|All blood cancers combined|2015–2019|Males|3|00–04|0.914|0.883|0.937
Relative|All blood cancers combined|2015–2019|Males|3|05–09|0.961|0.931|0.978
Relative|All blood cancers combined|2015–2019|Males|3|10–14|0.911|0.87|0.939
Relative|All blood cancers combined|2015–2019|Males|3|15–19|0.912|0.877|0.937
Relative|All blood cancers combined|2015–2019|Males|3|20–24|0.922|0.893|0.944
Relative|All blood cancers combined|2015–2019|Males|3|25–29|0.943|0.917|0.961
Relative|All blood cancers combined|2015–2019|Males|3|30–34|0.925|0.899|0.944
Relative|All blood cancers combined|2015–2019|Males|3|35–39|0.906|0.884|0.925
Relative|All blood cancers combined|2015–2019|Males|3|40–44|0.9|0.88|0.917
Relative|All blood cancers combined|2015–2019|Males|3|45–49|0.898|0.882|0.913
Relative|All blood cancers combined|2015–2019|Males|3|50–54|0.871|0.856|0.885
Relative|All blood cancers combined|2015–2019|Males|3|55–59|0.848|0.834|0.86
Relative|All blood cancers combined|2015–2019|Males|3|60–64|0.824|0.812|0.836
Relative|All blood cancers combined|2015–2019|Males|3|65–69|0.791|0.779|0.802
Relative|All blood cancers combined|2015–2019|Males|3|70–74|0.736|0.724|0.748
Relative|All blood cancers combined|2015–2019|Males|3|75–79|0.652|0.637|0.666
Relative|All blood cancers combined|2015–2019|Males|3|80–84|0.572|0.554|0.589
Relative|All blood cancers combined|2015–2019|Males|3|85+|0.446|0.425|0.466
Relative|All blood cancers combined|2015–2019|Males|3|All ages combined|0.742|0.737|0.746
Relative|All blood cancers combined|2015–2019|Males|4|00–04|0.91|0.878|0.933
Relative|All blood cancers combined|2015–2019|Males|4|05–09|0.951|0.918|0.971
Relative|All blood cancers combined|2015–2019|Males|4|10–14|0.904|0.862|0.934
Relative|All blood cancers combined|2015–2019|Males|4|15–19|0.896|0.86|0.924
Relative|All blood cancers combined|2015–2019|Males|4|20–24|0.916|0.887|0.939
Relative|All blood cancers combined|2015–2019|Males|4|25–29|0.939|0.913|0.958
Relative|All blood cancers combined|2015–2019|Males|4|30–34|0.917|0.89|0.937
Relative|All blood cancers combined|2015–2019|Males|4|35–39|0.899|0.876|0.918
Relative|All blood cancers combined|2015–2019|Males|4|40–44|0.89|0.87|0.908
Relative|All blood cancers combined|2015–2019|Males|4|45–49|0.878|0.86|0.894
Relative|All blood cancers combined|2015–2019|Males|4|50–54|0.852|0.836|0.866
Relative|All blood cancers combined|2015–2019|Males|4|55–59|0.822|0.808|0.836
Relative|All blood cancers combined|2015–2019|Males|4|60–64|0.792|0.779|0.805
Relative|All blood cancers combined|2015–2019|Males|4|65–69|0.753|0.741|0.766
Relative|All blood cancers combined|2015–2019|Males|4|70–74|0.68|0.667|0.694
Relative|All blood cancers combined|2015–2019|Males|4|75–79|0.596|0.581|0.612
Relative|All blood cancers combined|2015–2019|Males|4|80–84|0.514|0.496|0.533
Relative|All blood cancers combined|2015–2019|Males|4|85+|0.38|0.358|0.403
Relative|All blood cancers combined|2015–2019|Males|4|All ages combined|0.704|0.699|0.709
Relative|All blood cancers combined|2015–2019|Males|5|00–04|0.903|0.871|0.928
Relative|All blood cancers combined|2015–2019|Males|5|05–09|0.947|0.914|0.968
Relative|All blood cancers combined|2015–2019|Males|5|10–14|0.897|0.853|0.928
Relative|All blood cancers combined|2015–2019|Males|5|15–19|0.897|0.861|0.924
Relative|All blood cancers combined|2015–2019|Males|5|20–24|0.908|0.878|0.932
Relative|All blood cancers combined|2015–2019|Males|5|25–29|0.927|0.899|0.948
Relative|All blood cancers combined|2015–2019|Males|5|30–34|0.91|0.883|0.932
Relative|All blood cancers combined|2015–2019|Males|5|35–39|0.891|0.867|0.911
Relative|All blood cancers combined|2015–2019|Males|5|40–44|0.882|0.861|0.901
Relative|All blood cancers combined|2015–2019|Males|5|45–49|0.865|0.846|0.882
Relative|All blood cancers combined|2015–2019|Males|5|50–54|0.834|0.818|0.85
Relative|All blood cancers combined|2015–2019|Males|5|55–59|0.8|0.784|0.814
Relative|All blood cancers combined|2015–2019|Males|5|60–64|0.762|0.748|0.776
Relative|All blood cancers combined|2015–2019|Males|5|65–69|0.721|0.708|0.734
Relative|All blood cancers combined|2015–2019|Males|5|70–74|0.64|0.625|0.654
Relative|All blood cancers combined|2015–2019|Males|5|75–79|0.553|0.537|0.57
Relative|All blood cancers combined|2015–2019|Males|5|80–84|0.46|0.44|0.48
Relative|All blood cancers combined|2015–2019|Males|5|85+|0.336|0.312|0.361
Relative|All blood cancers combined|2015–2019|Males|5|All ages combined|0.675|0.67|0.681
Observed|All blood cancers combined|2015–2019|Females|1|00–04|0.945|0.915|0.965
Observed|All blood cancers combined|2015–2019|Females|1|05–09|0.969|0.933|0.986
Observed|All blood cancers combined|2015–2019|Females|1|10–14|0.952|0.906|0.976
Observed|All blood cancers combined|2015–2019|Females|1|15–19|0.96|0.931|0.977
Observed|All blood cancers combined|2015–2019|Females|1|20–24|0.976|0.954|0.987
Observed|All blood cancers combined|2015–2019|Females|1|25–29|0.982|0.965|0.991
Observed|All blood cancers combined|2015–2019|Females|1|30–34|0.972|0.954|0.983
Observed|All blood cancers combined|2015–2019|Females|1|35–39|0.957|0.938|0.971
Observed|All blood cancers combined|2015–2019|Females|1|40–44|0.952|0.935|0.965
Observed|All blood cancers combined|2015–2019|Females|1|45–49|0.94|0.925|0.952
Observed|All blood cancers combined|2015–2019|Females|1|50–54|0.928|0.915|0.94
Observed|All blood cancers combined|2015–2019|Females|1|55–59|0.928|0.917|0.938
Observed|All blood cancers combined|2015–2019|Females|1|60–64|0.918|0.908|0.927
Observed|All blood cancers combined|2015–2019|Females|1|65–69|0.9|0.89|0.909
Observed|All blood cancers combined|2015–2019|Females|1|70–74|0.864|0.854|0.874
Observed|All blood cancers combined|2015–2019|Females|1|75–79|0.804|0.792|0.816
Observed|All blood cancers combined|2015–2019|Females|1|80–84|0.725|0.71|0.739
Observed|All blood cancers combined|2015–2019|Females|1|85+|0.527|0.511|0.543
Observed|All blood cancers combined|2015–2019|Females|1|All ages combined|0.833|0.829|0.837
Observed|All blood cancers combined|2015–2019|Females|2|00–04|0.926|0.893|0.949
Observed|All blood cancers combined|2015–2019|Females|2|05–09|0.954|0.914|0.976
Observed|All blood cancers combined|2015–2019|Females|2|10–14|0.91|0.855|0.945
Observed|All blood cancers combined|2015–2019|Females|2|15–19|0.926|0.891|0.95
Observed|All blood cancers combined|2015–2019|Females|2|20–24|0.968|0.944|0.982
Observed|All blood cancers combined|2015–2019|Females|2|25–29|0.971|0.95|0.983
Observed|All blood cancers combined|2015–2019|Females|2|30–34|0.94|0.916|0.957
Observed|All blood cancers combined|2015–2019|Females|2|35–39|0.934|0.911|0.951
Observed|All blood cancers combined|2015–2019|Females|2|40–44|0.922|0.902|0.938
Observed|All blood cancers combined|2015–2019|Females|2|45–49|0.91|0.892|0.925
Observed|All blood cancers combined|2015–2019|Females|2|50–54|0.895|0.879|0.908
Observed|All blood cancers combined|2015–2019|Females|2|55–59|0.889|0.876|0.901
Observed|All blood cancers combined|2015–2019|Females|2|60–64|0.87|0.858|0.882
Observed|All blood cancers combined|2015–2019|Females|2|65–69|0.846|0.835|0.857
Observed|All blood cancers combined|2015–2019|Females|2|70–74|0.795|0.783|0.807
Observed|All blood cancers combined|2015–2019|Females|2|75–79|0.72|0.706|0.734
Observed|All blood cancers combined|2015–2019|Females|2|80–84|0.614|0.598|0.63
Observed|All blood cancers combined|2015–2019|Females|2|85+|0.393|0.378|0.408
Observed|All blood cancers combined|2015–2019|Females|2|All ages combined|0.763|0.759|0.768
Observed|All blood cancers combined|2015–2019|Females|3|00–04|0.912|0.877|0.937
Observed|All blood cancers combined|2015–2019|Females|3|05–09|0.944|0.901|0.969
Observed|All blood cancers combined|2015–2019|Females|3|10–14|0.904|0.848|0.94
Observed|All blood cancers combined|2015–2019|Females|3|15–19|0.904|0.866|0.932
Observed|All blood cancers combined|2015–2019|Females|3|20–24|0.954|0.927|0.971
Observed|All blood cancers combined|2015–2019|Females|3|25–29|0.966|0.944|0.979
Observed|All blood cancers combined|2015–2019|Females|3|30–34|0.926|0.901|0.946
Observed|All blood cancers combined|2015–2019|Females|3|35–39|0.914|0.888|0.934
Observed|All blood cancers combined|2015–2019|Females|3|40–44|0.901|0.878|0.919
Observed|All blood cancers combined|2015–2019|Females|3|45–49|0.89|0.871|0.907
Observed|All blood cancers combined|2015–2019|Females|3|50–54|0.872|0.855|0.887
Observed|All blood cancers combined|2015–2019|Females|3|55–59|0.858|0.843|0.872
Observed|All blood cancers combined|2015–2019|Females|3|60–64|0.835|0.821|0.848
Observed|All blood cancers combined|2015–2019|Females|3|65–69|0.796|0.783|0.809
Observed|All blood cancers combined|2015–2019|Females|3|70–74|0.738|0.724|0.751
Observed|All blood cancers combined|2015–2019|Females|3|75–79|0.661|0.646|0.676
Observed|All blood cancers combined|2015–2019|Females|3|80–84|0.53|0.514|0.547
Observed|All blood cancers combined|2015–2019|Females|3|85+|0.304|0.29|0.318
Observed|All blood cancers combined|2015–2019|Females|3|All ages combined|0.712|0.707|0.717
Observed|All blood cancers combined|2015–2019|Females|4|00–04|0.909|0.873|0.935
Observed|All blood cancers combined|2015–2019|Females|4|05–09|0.944|0.901|0.969
Observed|All blood cancers combined|2015–2019|Females|4|10–14|0.891|0.833|0.93
Observed|All blood cancers combined|2015–2019|Females|4|15–19|0.892|0.852|0.922
Observed|All blood cancers combined|2015–2019|Females|4|20–24|0.946|0.917|0.965
Observed|All blood cancers combined|2015–2019|Females|4|25–29|0.958|0.934|0.973
Observed|All blood cancers combined|2015–2019|Females|4|30–34|0.924|0.898|0.944
Observed|All blood cancers combined|2015–2019|Females|4|35–39|0.909|0.883|0.929
Observed|All blood cancers combined|2015–2019|Females|4|40–44|0.895|0.872|0.914
Observed|All blood cancers combined|2015–2019|Females|4|45–49|0.873|0.853|0.891
Observed|All blood cancers combined|2015–2019|Females|4|50–54|0.853|0.835|0.869
Observed|All blood cancers combined|2015–2019|Females|4|55–59|0.835|0.819|0.849
Observed|All blood cancers combined|2015–2019|Females|4|60–64|0.801|0.786|0.815
Observed|All blood cancers combined|2015–2019|Females|4|65–69|0.766|0.752|0.779
Observed|All blood cancers combined|2015–2019|Females|4|70–74|0.69|0.675|0.704
Observed|All blood cancers combined|2015–2019|Females|4|75–79|0.601|0.585|0.616
Observed|All blood cancers combined|2015–2019|Females|4|80–84|0.457|0.44|0.473
Observed|All blood cancers combined|2015–2019|Females|4|85+|0.241|0.227|0.254
Observed|All blood cancers combined|2015–2019|Females|4|All ages combined|0.671|0.666|0.676
Observed|All blood cancers combined|2015–2019|Females|5|00–04|0.909|0.873|0.935
Observed|All blood cancers combined|2015–2019|Females|5|05–09|0.944|0.901|0.969
Observed|All blood cancers combined|2015–2019|Females|5|10–14|0.891|0.833|0.93
Observed|All blood cancers combined|2015–2019|Females|5|15–19|0.886|0.846|0.916
Observed|All blood cancers combined|2015–2019|Females|5|20–24|0.94|0.911|0.96
Observed|All blood cancers combined|2015–2019|Females|5|25–29|0.953|0.928|0.969
Observed|All blood cancers combined|2015–2019|Females|5|30–34|0.913|0.885|0.934
Observed|All blood cancers combined|2015–2019|Females|5|35–39|0.904|0.877|0.925
Observed|All blood cancers combined|2015–2019|Females|5|40–44|0.885|0.862|0.905
Observed|All blood cancers combined|2015–2019|Females|5|45–49|0.857|0.836|0.876
Observed|All blood cancers combined|2015–2019|Females|5|50–54|0.835|0.816|0.852
Observed|All blood cancers combined|2015–2019|Females|5|55–59|0.815|0.799|0.831
Observed|All blood cancers combined|2015–2019|Females|5|60–64|0.777|0.762|0.792
Observed|All blood cancers combined|2015–2019|Females|5|65–69|0.728|0.713|0.742
Observed|All blood cancers combined|2015–2019|Females|5|70–74|0.644|0.629|0.659
Observed|All blood cancers combined|2015–2019|Females|5|75–79|0.543|0.527|0.559
Observed|All blood cancers combined|2015–2019|Females|5|80–84|0.39|0.373|0.407
Observed|All blood cancers combined|2015–2019|Females|5|85+|0.18|0.168|0.192
Observed|All blood cancers combined|2015–2019|Females|5|All ages combined|0.633|0.628|0.639
Relative|All blood cancers combined|2015–2019|Females|1|00–04|0.946|0.916|0.965
Relative|All blood cancers combined|2015–2019|Females|1|05–09|0.97|0.933|0.986
Relative|All blood cancers combined|2015–2019|Females|1|10–14|0.952|0.906|0.976
Relative|All blood cancers combined|2015–2019|Females|1|15–19|0.961|0.931|0.978
Relative|All blood cancers combined|2015–2019|Females|1|20–24|0.976|0.955|0.988
Relative|All blood cancers combined|2015–2019|Females|1|25–29|0.982|0.965|0.991
Relative|All blood cancers combined|2015–2019|Females|1|30–34|0.973|0.955|0.984
Relative|All blood cancers combined|2015–2019|Females|1|35–39|0.958|0.938|0.971
Relative|All blood cancers combined|2015–2019|Females|1|40–44|0.953|0.936|0.965
Relative|All blood cancers combined|2015–2019|Females|1|45–49|0.941|0.926|0.953
Relative|All blood cancers combined|2015–2019|Females|1|50–54|0.93|0.917|0.942
Relative|All blood cancers combined|2015–2019|Females|1|55–59|0.931|0.92|0.941
Relative|All blood cancers combined|2015–2019|Females|1|60–64|0.922|0.912|0.932
Relative|All blood cancers combined|2015–2019|Females|1|65–69|0.907|0.897|0.916
Relative|All blood cancers combined|2015–2019|Females|1|70–74|0.875|0.864|0.885
Relative|All blood cancers combined|2015–2019|Females|1|75–79|0.822|0.809|0.834
Relative|All blood cancers combined|2015–2019|Females|1|80–84|0.756|0.74|0.771
Relative|All blood cancers combined|2015–2019|Females|1|85+|0.592|0.575|0.609
Relative|All blood cancers combined|2015–2019|Females|1|All ages combined|0.854|0.85|0.858
Relative|All blood cancers combined|2015–2019|Females|2|00–04|0.926|0.893|0.949
Relative|All blood cancers combined|2015–2019|Females|2|05–09|0.954|0.914|0.976
Relative|All blood cancers combined|2015–2019|Females|2|10–14|0.91|0.855|0.945
Relative|All blood cancers combined|2015–2019|Females|2|15–19|0.927|0.891|0.951
Relative|All blood cancers combined|2015–2019|Females|2|20–24|0.968|0.945|0.982
Relative|All blood cancers combined|2015–2019|Females|2|25–29|0.971|0.95|0.983
Relative|All blood cancers combined|2015–2019|Females|2|30–34|0.941|0.917|0.958
Relative|All blood cancers combined|2015–2019|Females|2|35–39|0.935|0.912|0.952
Relative|All blood cancers combined|2015–2019|Females|2|40–44|0.924|0.903|0.94
Relative|All blood cancers combined|2015–2019|Females|2|45–49|0.912|0.895|0.927
Relative|All blood cancers combined|2015–2019|Females|2|50–54|0.899|0.883|0.912
Relative|All blood cancers combined|2015–2019|Females|2|55–59|0.895|0.882|0.907
Relative|All blood cancers combined|2015–2019|Females|2|60–64|0.879|0.866|0.89
Relative|All blood cancers combined|2015–2019|Females|2|65–69|0.859|0.848|0.87
Relative|All blood cancers combined|2015–2019|Females|2|70–74|0.816|0.803|0.828
Relative|All blood cancers combined|2015–2019|Females|2|75–79|0.754|0.739|0.768
Relative|All blood cancers combined|2015–2019|Females|2|80–84|0.671|0.654|0.689
Relative|All blood cancers combined|2015–2019|Females|2|85+|0.499|0.48|0.518
Relative|All blood cancers combined|2015–2019|Females|2|All ages combined|0.799|0.794|0.804
Relative|All blood cancers combined|2015–2019|Females|3|00–04|0.912|0.877|0.938
Relative|All blood cancers combined|2015–2019|Females|3|05–09|0.944|0.901|0.969
Relative|All blood cancers combined|2015–2019|Females|3|10–14|0.904|0.848|0.94
Relative|All blood cancers combined|2015–2019|Females|3|15–19|0.905|0.867|0.933
Relative|All blood cancers combined|2015–2019|Females|3|20–24|0.955|0.928|0.972
Relative|All blood cancers combined|2015–2019|Females|3|25–29|0.967|0.945|0.98
Relative|All blood cancers combined|2015–2019|Females|3|30–34|0.928|0.902|0.947
Relative|All blood cancers combined|2015–2019|Females|3|35–39|0.915|0.89|0.935
Relative|All blood cancers combined|2015–2019|Females|3|40–44|0.903|0.881|0.922
Relative|All blood cancers combined|2015–2019|Females|3|45–49|0.894|0.875|0.911
Relative|All blood cancers combined|2015–2019|Females|3|50–54|0.878|0.861|0.893
Relative|All blood cancers combined|2015–2019|Females|3|55–59|0.867|0.852|0.881
Relative|All blood cancers combined|2015–2019|Females|3|60–64|0.848|0.834|0.861
Relative|All blood cancers combined|2015–2019|Females|3|65–69|0.816|0.803|0.829
Relative|All blood cancers combined|2015–2019|Females|3|70–74|0.769|0.755|0.783
Relative|All blood cancers combined|2015–2019|Females|3|75–79|0.712|0.696|0.728
Relative|All blood cancers combined|2015–2019|Females|3|80–84|0.613|0.594|0.632
Relative|All blood cancers combined|2015–2019|Females|3|85+|0.442|0.421|0.462
Relative|All blood cancers combined|2015–2019|Females|3|All ages combined|0.761|0.756|0.767
Relative|All blood cancers combined|2015–2019|Females|4|00–04|0.909|0.874|0.935
Relative|All blood cancers combined|2015–2019|Females|4|05–09|0.944|0.901|0.969
Relative|All blood cancers combined|2015–2019|Females|4|10–14|0.892|0.834|0.931
Relative|All blood cancers combined|2015–2019|Females|4|15–19|0.893|0.853|0.923
Relative|All blood cancers combined|2015–2019|Females|4|20–24|0.947|0.918|0.966
Relative|All blood cancers combined|2015–2019|Females|4|25–29|0.959|0.935|0.975
Relative|All blood cancers combined|2015–2019|Females|4|30–34|0.926|0.9|0.946
Relative|All blood cancers combined|2015–2019|Females|4|35–39|0.911|0.885|0.932
Relative|All blood cancers combined|2015–2019|Females|4|40–44|0.899|0.876|0.918
Relative|All blood cancers combined|2015–2019|Females|4|45–49|0.879|0.858|0.897
Relative|All blood cancers combined|2015–2019|Females|4|50–54|0.861|0.843|0.877
Relative|All blood cancers combined|2015–2019|Females|4|55–59|0.847|0.831|0.862
Relative|All blood cancers combined|2015–2019|Females|4|60–64|0.818|0.803|0.832
Relative|All blood cancers combined|2015–2019|Females|4|65–69|0.792|0.778|0.806
Relative|All blood cancers combined|2015–2019|Females|4|70–74|0.731|0.715|0.746
Relative|All blood cancers combined|2015–2019|Females|4|75–79|0.668|0.65|0.685
Relative|All blood cancers combined|2015–2019|Females|4|80–84|0.562|0.542|0.583
Relative|All blood cancers combined|2015–2019|Females|4|85+|0.405|0.383|0.428
Relative|All blood cancers combined|2015–2019|Females|4|All ages combined|0.733|0.727|0.739
Relative|All blood cancers combined|2015–2019|Females|5|00–04|0.91|0.874|0.935
Relative|All blood cancers combined|2015–2019|Females|5|05–09|0.944|0.901|0.969
Relative|All blood cancers combined|2015–2019|Females|5|10–14|0.892|0.834|0.931
Relative|All blood cancers combined|2015–2019|Females|5|15–19|0.887|0.847|0.917
Relative|All blood cancers combined|2015–2019|Females|5|20–24|0.941|0.912|0.961
Relative|All blood cancers combined|2015–2019|Females|5|25–29|0.954|0.929|0.971
Relative|All blood cancers combined|2015–2019|Females|5|30–34|0.915|0.887|0.936
Relative|All blood cancers combined|2015–2019|Females|5|35–39|0.907|0.88|0.928
Relative|All blood cancers combined|2015–2019|Females|5|40–44|0.89|0.866|0.91
Relative|All blood cancers combined|2015–2019|Females|5|45–49|0.865|0.843|0.883
Relative|All blood cancers combined|2015–2019|Females|5|50–54|0.845|0.827|0.862
Relative|All blood cancers combined|2015–2019|Females|5|55–59|0.831|0.814|0.846
Relative|All blood cancers combined|2015–2019|Females|5|60–64|0.799|0.784|0.814
Relative|All blood cancers combined|2015–2019|Females|5|65–69|0.762|0.746|0.776
Relative|All blood cancers combined|2015–2019|Females|5|70–74|0.696|0.679|0.712
Relative|All blood cancers combined|2015–2019|Females|5|75–79|0.626|0.607|0.644
Relative|All blood cancers combined|2015–2019|Females|5|80–84|0.516|0.494|0.538
Relative|All blood cancers combined|2015–2019|Females|5|85+|0.356|0.333|0.38
Relative|All blood cancers combined|2015–2019|Females|5|All ages combined|0.706|0.7|0.712
Observed|All blood cancers combined|2015–2019|Persons|1|00–04|0.94|0.921|0.955
Observed|All blood cancers combined|2015–2019|Persons|1|05–09|0.975|0.956|0.986
Observed|All blood cancers combined|2015–2019|Persons|1|10–14|0.956|0.932|0.972
Observed|All blood cancers combined|2015–2019|Persons|1|15–19|0.958|0.94|0.971
Observed|All blood cancers combined|2015–2019|Persons|1|20–24|0.963|0.948|0.974
Observed|All blood cancers combined|2015–2019|Persons|1|25–29|0.976|0.963|0.984
Observed|All blood cancers combined|2015–2019|Persons|1|30–34|0.969|0.956|0.977
Observed|All blood cancers combined|2015–2019|Persons|1|35–39|0.95|0.938|0.96
Observed|All blood cancers combined|2015–2019|Persons|1|40–44|0.954|0.943|0.962
Observed|All blood cancers combined|2015–2019|Persons|1|45–49|0.938|0.928|0.946
Observed|All blood cancers combined|2015–2019|Persons|1|50–54|0.929|0.921|0.937
Observed|All blood cancers combined|2015–2019|Persons|1|55–59|0.922|0.915|0.929
Observed|All blood cancers combined|2015–2019|Persons|1|60–64|0.912|0.905|0.918
Observed|All blood cancers combined|2015–2019|Persons|1|65–69|0.886|0.88|0.892
Observed|All blood cancers combined|2015–2019|Persons|1|70–74|0.851|0.844|0.858
Observed|All blood cancers combined|2015–2019|Persons|1|75–79|0.79|0.781|0.797
Observed|All blood cancers combined|2015–2019|Persons|1|80–84|0.706|0.697|0.716
Observed|All blood cancers combined|2015–2019|Persons|1|85+|0.528|0.517|0.538
Observed|All blood cancers combined|2015–2019|Persons|1|All ages combined|0.827|0.824|0.83
Observed|All blood cancers combined|2015–2019|Persons|2|00–04|0.921|0.9|0.938
Observed|All blood cancers combined|2015–2019|Persons|2|05–09|0.964|0.943|0.978
Observed|All blood cancers combined|2015–2019|Persons|2|10–14|0.922|0.892|0.943
Observed|All blood cancers combined|2015–2019|Persons|2|15–19|0.928|0.905|0.945
Observed|All blood cancers combined|2015–2019|Persons|2|20–24|0.945|0.927|0.959
Observed|All blood cancers combined|2015–2019|Persons|2|25–29|0.962|0.947|0.973
Observed|All blood cancers combined|2015–2019|Persons|2|30–34|0.941|0.925|0.953
Observed|All blood cancers combined|2015–2019|Persons|2|35–39|0.927|0.913|0.94
Observed|All blood cancers combined|2015–2019|Persons|2|40–44|0.921|0.908|0.932
Observed|All blood cancers combined|2015–2019|Persons|2|45–49|0.907|0.896|0.918
Observed|All blood cancers combined|2015–2019|Persons|2|50–54|0.894|0.884|0.903
Observed|All blood cancers combined|2015–2019|Persons|2|55–59|0.875|0.866|0.883
Observed|All blood cancers combined|2015–2019|Persons|2|60–64|0.855|0.847|0.863
Observed|All blood cancers combined|2015–2019|Persons|2|65–69|0.824|0.816|0.831
Observed|All blood cancers combined|2015–2019|Persons|2|70–74|0.772|0.764|0.78
Observed|All blood cancers combined|2015–2019|Persons|2|75–79|0.692|0.683|0.701
Observed|All blood cancers combined|2015–2019|Persons|2|80–84|0.585|0.574|0.595
Observed|All blood cancers combined|2015–2019|Persons|2|85+|0.391|0.381|0.401
Observed|All blood cancers combined|2015–2019|Persons|2|All ages combined|0.751|0.747|0.754
Observed|All blood cancers combined|2015–2019|Persons|3|00–04|0.912|0.89|0.93
Observed|All blood cancers combined|2015–2019|Persons|3|05–09|0.954|0.931|0.969
Observed|All blood cancers combined|2015–2019|Persons|3|10–14|0.908|0.876|0.931
Observed|All blood cancers combined|2015–2019|Persons|3|15–19|0.908|0.883|0.927
Observed|All blood cancers combined|2015–2019|Persons|3|20–24|0.936|0.917|0.951
Observed|All blood cancers combined|2015–2019|Persons|3|25–29|0.953|0.937|0.965
Observed|All blood cancers combined|2015–2019|Persons|3|30–34|0.924|0.907|0.938
Observed|All blood cancers combined|2015–2019|Persons|3|35–39|0.907|0.891|0.921
Observed|All blood cancers combined|2015–2019|Persons|3|40–44|0.898|0.883|0.91
Observed|All blood cancers combined|2015–2019|Persons|3|45–49|0.891|0.879|0.902
Observed|All blood cancers combined|2015–2019|Persons|3|50–54|0.866|0.855|0.876
Observed|All blood cancers combined|2015–2019|Persons|3|55–59|0.844|0.834|0.853
Observed|All blood cancers combined|2015–2019|Persons|3|60–64|0.816|0.807|0.824
Observed|All blood cancers combined|2015–2019|Persons|3|65–69|0.774|0.766|0.782
Observed|All blood cancers combined|2015–2019|Persons|3|70–74|0.709|0.7|0.718
Observed|All blood cancers combined|2015–2019|Persons|3|75–79|0.614|0.604|0.624
Observed|All blood cancers combined|2015–2019|Persons|3|80–84|0.492|0.482|0.503
Observed|All blood cancers combined|2015–2019|Persons|3|85+|0.294|0.284|0.303
Observed|All blood cancers combined|2015–2019|Persons|3|All ages combined|0.694|0.691|0.697
Observed|All blood cancers combined|2015–2019|Persons|4|00–04|0.909|0.886|0.927
Observed|All blood cancers combined|2015–2019|Persons|4|05–09|0.948|0.924|0.964
Observed|All blood cancers combined|2015–2019|Persons|4|10–14|0.899|0.866|0.923
Observed|All blood cancers combined|2015–2019|Persons|4|15–19|0.893|0.868|0.914
Observed|All blood cancers combined|2015–2019|Persons|4|20–24|0.929|0.909|0.944
Observed|All blood cancers combined|2015–2019|Persons|4|25–29|0.947|0.93|0.96
Observed|All blood cancers combined|2015–2019|Persons|4|30–34|0.918|0.9|0.933
Observed|All blood cancers combined|2015–2019|Persons|4|35–39|0.9|0.884|0.915
Observed|All blood cancers combined|2015–2019|Persons|4|40–44|0.889|0.874|0.902
Observed|All blood cancers combined|2015–2019|Persons|4|45–49|0.871|0.858|0.883
Observed|All blood cancers combined|2015–2019|Persons|4|50–54|0.844|0.833|0.855
Observed|All blood cancers combined|2015–2019|Persons|4|55–59|0.816|0.805|0.826
Observed|All blood cancers combined|2015–2019|Persons|4|60–64|0.779|0.769|0.788
Observed|All blood cancers combined|2015–2019|Persons|4|65–69|0.733|0.724|0.742
Observed|All blood cancers combined|2015–2019|Persons|4|70–74|0.648|0.639|0.658
Observed|All blood cancers combined|2015–2019|Persons|4|75–79|0.545|0.535|0.555
Observed|All blood cancers combined|2015–2019|Persons|4|80–84|0.414|0.403|0.425
Observed|All blood cancers combined|2015–2019|Persons|4|85+|0.221|0.213|0.23
Observed|All blood cancers combined|2015–2019|Persons|4|All ages combined|0.647|0.644|0.651
Observed|All blood cancers combined|2015–2019|Persons|5|00–04|0.905|0.882|0.924
Observed|All blood cancers combined|2015–2019|Persons|5|05–09|0.946|0.921|0.963
Observed|All blood cancers combined|2015–2019|Persons|5|10–14|0.894|0.861|0.919
Observed|All blood cancers combined|2015–2019|Persons|5|15–19|0.891|0.865|0.912
Observed|All blood cancers combined|2015–2019|Persons|5|20–24|0.921|0.901|0.938
Observed|All blood cancers combined|2015–2019|Persons|5|25–29|0.938|0.92|0.952
Observed|All blood cancers combined|2015–2019|Persons|5|30–34|0.909|0.89|0.925
Observed|All blood cancers combined|2015–2019|Persons|5|35–39|0.893|0.876|0.908
Observed|All blood cancers combined|2015–2019|Persons|5|40–44|0.879|0.863|0.893
Observed|All blood cancers combined|2015–2019|Persons|5|45–49|0.855|0.841|0.868
Observed|All blood cancers combined|2015–2019|Persons|5|50–54|0.825|0.813|0.836
Observed|All blood cancers combined|2015–2019|Persons|5|55–59|0.792|0.781|0.802
Observed|All blood cancers combined|2015–2019|Persons|5|60–64|0.747|0.737|0.757
Observed|All blood cancers combined|2015–2019|Persons|5|65–69|0.693|0.683|0.702
Observed|All blood cancers combined|2015–2019|Persons|5|70–74|0.598|0.588|0.608
Observed|All blood cancers combined|2015–2019|Persons|5|75–79|0.486|0.475|0.496
Observed|All blood cancers combined|2015–2019|Persons|5|80–84|0.344|0.334|0.355
Observed|All blood cancers combined|2015–2019|Persons|5|85+|0.164|0.156|0.172
Observed|All blood cancers combined|2015–2019|Persons|5|All ages combined|0.607|0.604|0.611
Relative|All blood cancers combined|2015–2019|Persons|1|00–04|0.941|0.922|0.955
Relative|All blood cancers combined|2015–2019|Persons|1|05–09|0.975|0.956|0.986
Relative|All blood cancers combined|2015–2019|Persons|1|10–14|0.956|0.932|0.972
Relative|All blood cancers combined|2015–2019|Persons|1|15–19|0.958|0.94|0.971
Relative|All blood cancers combined|2015–2019|Persons|1|20–24|0.964|0.948|0.975
Relative|All blood cancers combined|2015–2019|Persons|1|25–29|0.976|0.964|0.984
Relative|All blood cancers combined|2015–2019|Persons|1|30–34|0.969|0.957|0.978
Relative|All blood cancers combined|2015–2019|Persons|1|35–39|0.951|0.938|0.961
Relative|All blood cancers combined|2015–2019|Persons|1|40–44|0.955|0.945|0.964
Relative|All blood cancers combined|2015–2019|Persons|1|45–49|0.94|0.93|0.948
Relative|All blood cancers combined|2015–2019|Persons|1|50–54|0.932|0.924|0.94
Relative|All blood cancers combined|2015–2019|Persons|1|55–59|0.926|0.919|0.933
Relative|All blood cancers combined|2015–2019|Persons|1|60–64|0.918|0.911|0.924
Relative|All blood cancers combined|2015–2019|Persons|1|65–69|0.895|0.889|0.901
Relative|All blood cancers combined|2015–2019|Persons|1|70–74|0.865|0.858|0.872
Relative|All blood cancers combined|2015–2019|Persons|1|75–79|0.813|0.804|0.821
Relative|All blood cancers combined|2015–2019|Persons|1|80–84|0.745|0.735|0.755
Relative|All blood cancers combined|2015–2019|Persons|1|85+|0.6|0.588|0.612
Relative|All blood cancers combined|2015–2019|Persons|1|All ages combined|0.85|0.848|0.853
Relative|All blood cancers combined|2015–2019|Persons|2|00–04|0.922|0.9|0.939
Relative|All blood cancers combined|2015–2019|Persons|2|05–09|0.964|0.943|0.978
Relative|All blood cancers combined|2015–2019|Persons|2|10–14|0.922|0.892|0.944
Relative|All blood cancers combined|2015–2019|Persons|2|15–19|0.928|0.906|0.945
Relative|All blood cancers combined|2015–2019|Persons|2|20–24|0.946|0.928|0.96
Relative|All blood cancers combined|2015–2019|Persons|2|25–29|0.963|0.948|0.974
Relative|All blood cancers combined|2015–2019|Persons|2|30–34|0.942|0.926|0.955
Relative|All blood cancers combined|2015–2019|Persons|2|35–39|0.929|0.915|0.942
Relative|All blood cancers combined|2015–2019|Persons|2|40–44|0.923|0.91|0.935
Relative|All blood cancers combined|2015–2019|Persons|2|45–49|0.911|0.9|0.921
Relative|All blood cancers combined|2015–2019|Persons|2|50–54|0.899|0.89|0.909
Relative|All blood cancers combined|2015–2019|Persons|2|55–59|0.883|0.874|0.891
Relative|All blood cancers combined|2015–2019|Persons|2|60–64|0.867|0.859|0.875
Relative|All blood cancers combined|2015–2019|Persons|2|65–69|0.841|0.834|0.849
Relative|All blood cancers combined|2015–2019|Persons|2|70–74|0.8|0.791|0.808
Relative|All blood cancers combined|2015–2019|Persons|2|75–79|0.736|0.726|0.745
Relative|All blood cancers combined|2015–2019|Persons|2|80–84|0.655|0.643|0.666
Relative|All blood cancers combined|2015–2019|Persons|2|85+|0.509|0.496|0.523
Relative|All blood cancers combined|2015–2019|Persons|2|All ages combined|0.791|0.788|0.795
Relative|All blood cancers combined|2015–2019|Persons|3|00–04|0.913|0.891|0.931
Relative|All blood cancers combined|2015–2019|Persons|3|05–09|0.954|0.931|0.97
Relative|All blood cancers combined|2015–2019|Persons|3|10–14|0.908|0.877|0.932
Relative|All blood cancers combined|2015–2019|Persons|3|15–19|0.908|0.884|0.928
Relative|All blood cancers combined|2015–2019|Persons|3|20–24|0.937|0.918|0.952
Relative|All blood cancers combined|2015–2019|Persons|3|25–29|0.954|0.938|0.967
Relative|All blood cancers combined|2015–2019|Persons|3|30–34|0.926|0.909|0.94
Relative|All blood cancers combined|2015–2019|Persons|3|35–39|0.91|0.894|0.924
Relative|All blood cancers combined|2015–2019|Persons|3|40–44|0.902|0.887|0.914
Relative|All blood cancers combined|2015–2019|Persons|3|45–49|0.896|0.884|0.908
Relative|All blood cancers combined|2015–2019|Persons|3|50–54|0.874|0.863|0.884
Relative|All blood cancers combined|2015–2019|Persons|3|55–59|0.856|0.846|0.865
Relative|All blood cancers combined|2015–2019|Persons|3|60–64|0.834|0.824|0.842
Relative|All blood cancers combined|2015–2019|Persons|3|65–69|0.801|0.792|0.809
Relative|All blood cancers combined|2015–2019|Persons|3|70–74|0.749|0.74|0.758
Relative|All blood cancers combined|2015–2019|Persons|3|75–79|0.677|0.666|0.687
Relative|All blood cancers combined|2015–2019|Persons|3|80–84|0.589|0.576|0.602
Relative|All blood cancers combined|2015–2019|Persons|3|85+|0.444|0.43|0.458
Relative|All blood cancers combined|2015–2019|Persons|3|All ages combined|0.75|0.746|0.753
Relative|All blood cancers combined|2015–2019|Persons|4|00–04|0.909|0.887|0.928
Relative|All blood cancers combined|2015–2019|Persons|4|05–09|0.948|0.924|0.965
Relative|All blood cancers combined|2015–2019|Persons|4|10–14|0.899|0.867|0.924
Relative|All blood cancers combined|2015–2019|Persons|4|15–19|0.895|0.869|0.916
Relative|All blood cancers combined|2015–2019|Persons|4|20–24|0.93|0.91|0.946
Relative|All blood cancers combined|2015–2019|Persons|4|25–29|0.949|0.932|0.962
Relative|All blood cancers combined|2015–2019|Persons|4|30–34|0.921|0.903|0.936
Relative|All blood cancers combined|2015–2019|Persons|4|35–39|0.904|0.887|0.919
Relative|All blood cancers combined|2015–2019|Persons|4|40–44|0.894|0.879|0.907
Relative|All blood cancers combined|2015–2019|Persons|4|45–49|0.878|0.865|0.891
Relative|All blood cancers combined|2015–2019|Persons|4|50–54|0.856|0.844|0.867
Relative|All blood cancers combined|2015–2019|Persons|4|55–59|0.832|0.822|0.843
Relative|All blood cancers combined|2015–2019|Persons|4|60–64|0.803|0.793|0.812
Relative|All blood cancers combined|2015–2019|Persons|4|65–69|0.769|0.76|0.778
Relative|All blood cancers combined|2015–2019|Persons|4|70–74|0.701|0.691|0.711
Relative|All blood cancers combined|2015–2019|Persons|4|75–79|0.626|0.614|0.637
Relative|All blood cancers combined|2015–2019|Persons|4|80–84|0.535|0.521|0.549
Relative|All blood cancers combined|2015–2019|Persons|4|85+|0.393|0.378|0.409
Relative|All blood cancers combined|2015–2019|Persons|4|All ages combined|0.716|0.713|0.72
Relative|All blood cancers combined|2015–2019|Persons|5|00–04|0.906|0.883|0.924
Relative|All blood cancers combined|2015–2019|Persons|5|05–09|0.946|0.922|0.963
Relative|All blood cancers combined|2015–2019|Persons|5|10–14|0.895|0.862|0.92
Relative|All blood cancers combined|2015–2019|Persons|5|15–19|0.892|0.866|0.913
Relative|All blood cancers combined|2015–2019|Persons|5|20–24|0.923|0.903|0.94
Relative|All blood cancers combined|2015–2019|Persons|5|25–29|0.94|0.922|0.955
Relative|All blood cancers combined|2015–2019|Persons|5|30–34|0.912|0.894|0.928
Relative|All blood cancers combined|2015–2019|Persons|5|35–39|0.898|0.881|0.913
Relative|All blood cancers combined|2015–2019|Persons|5|40–44|0.886|0.87|0.9
Relative|All blood cancers combined|2015–2019|Persons|5|45–49|0.865|0.851|0.878
Relative|All blood cancers combined|2015–2019|Persons|5|50–54|0.839|0.827|0.851
Relative|All blood cancers combined|2015–2019|Persons|5|55–59|0.813|0.801|0.823
Relative|All blood cancers combined|2015–2019|Persons|5|60–64|0.777|0.767|0.787
Relative|All blood cancers combined|2015–2019|Persons|5|65–69|0.737|0.727|0.747
Relative|All blood cancers combined|2015–2019|Persons|5|70–74|0.663|0.652|0.674
Relative|All blood cancers combined|2015–2019|Persons|5|75–79|0.584|0.571|0.596
Relative|All blood cancers combined|2015–2019|Persons|5|80–84|0.484|0.469|0.499
Relative|All blood cancers combined|2015–2019|Persons|5|85+|0.346|0.329|0.364
Relative|All blood cancers combined|2015–2019|Persons|5|All ages combined|0.688|0.684|0.692
Observed|All cancers combined|2015–2019|Males|1|00–04|0.92|0.9|0.936
Observed|All cancers combined|2015–2019|Males|1|05–09|0.934|0.908|0.952
Observed|All cancers combined|2015–2019|Males|1|10–14|0.955|0.934|0.97
Observed|All cancers combined|2015–2019|Males|1|15–19|0.961|0.947|0.971
Observed|All cancers combined|2015–2019|Males|1|20–24|0.963|0.953|0.971
Observed|All cancers combined|2015–2019|Males|1|25–29|0.961|0.953|0.968
Observed|All cancers combined|2015–2019|Males|1|30–34|0.954|0.947|0.96
Observed|All cancers combined|2015–2019|Males|1|35–39|0.938|0.931|0.945
Observed|All cancers combined|2015–2019|Males|1|40–44|0.92|0.914|0.926
Observed|All cancers combined|2015–2019|Males|1|45–49|0.901|0.896|0.906
Observed|All cancers combined|2015–2019|Males|1|50–54|0.884|0.88|0.888
Observed|All cancers combined|2015–2019|Males|1|55–59|0.875|0.871|0.878
Observed|All cancers combined|2015–2019|Males|1|60–64|0.864|0.861|0.867
Observed|All cancers combined|2015–2019|Males|1|65–69|0.857|0.854|0.86
Observed|All cancers combined|2015–2019|Males|1|70–74|0.82|0.817|0.823
Observed|All cancers combined|2015–2019|Males|1|75–79|0.762|0.758|0.766
Observed|All cancers combined|2015–2019|Males|1|80–84|0.674|0.669|0.679
Observed|All cancers combined|2015–2019|Males|1|85+|0.515|0.509|0.521
Observed|All cancers combined|2015–2019|Males|1|All ages combined|0.805|0.804|0.807
Observed|All cancers combined|2015–2019|Males|2|00–04|0.88|0.856|0.899
Observed|All cancers combined|2015–2019|Males|2|05–09|0.886|0.854|0.911
Observed|All cancers combined|2015–2019|Males|2|10–14|0.911|0.883|0.932
Observed|All cancers combined|2015–2019|Males|2|15–19|0.922|0.903|0.937
Observed|All cancers combined|2015–2019|Males|2|20–24|0.939|0.927|0.95
Observed|All cancers combined|2015–2019|Males|2|25–29|0.934|0.923|0.943
Observed|All cancers combined|2015–2019|Males|2|30–34|0.926|0.917|0.934
Observed|All cancers combined|2015–2019|Males|2|35–39|0.903|0.894|0.911
Observed|All cancers combined|2015–2019|Males|2|40–44|0.871|0.863|0.879
Observed|All cancers combined|2015–2019|Males|2|45–49|0.845|0.838|0.851
Observed|All cancers combined|2015–2019|Males|2|50–54|0.829|0.824|0.834
Observed|All cancers combined|2015–2019|Males|2|55–59|0.817|0.812|0.821
Observed|All cancers combined|2015–2019|Males|2|60–64|0.802|0.799|0.806
Observed|All cancers combined|2015–2019|Males|2|65–69|0.793|0.789|0.796
Observed|All cancers combined|2015–2019|Males|2|70–74|0.744|0.74|0.747
Observed|All cancers combined|2015–2019|Males|2|75–79|0.668|0.664|0.673
Observed|All cancers combined|2015–2019|Males|2|80–84|0.557|0.552|0.563
Observed|All cancers combined|2015–2019|Males|2|85+|0.381|0.376|0.387
Observed|All cancers combined|2015–2019|Males|2|All ages combined|0.728|0.726|0.729
Observed|All cancers combined|2015–2019|Males|3|00–04|0.87|0.846|0.89
Observed|All cancers combined|2015–2019|Males|3|05–09|0.856|0.822|0.884
Observed|All cancers combined|2015–2019|Males|3|10–14|0.885|0.855|0.91
Observed|All cancers combined|2015–2019|Males|3|15–19|0.9|0.879|0.917
Observed|All cancers combined|2015–2019|Males|3|20–24|0.928|0.915|0.94
Observed|All cancers combined|2015–2019|Males|3|25–29|0.915|0.904|0.925
Observed|All cancers combined|2015–2019|Males|3|30–34|0.904|0.894|0.913
Observed|All cancers combined|2015–2019|Males|3|35–39|0.882|0.872|0.891
Observed|All cancers combined|2015–2019|Males|3|40–44|0.844|0.836|0.853
Observed|All cancers combined|2015–2019|Males|3|45–49|0.814|0.807|0.821
Observed|All cancers combined|2015–2019|Males|3|50–54|0.793|0.787|0.798
Observed|All cancers combined|2015–2019|Males|3|55–59|0.782|0.777|0.786
Observed|All cancers combined|2015–2019|Males|3|60–64|0.765|0.761|0.769
Observed|All cancers combined|2015–2019|Males|3|65–69|0.753|0.749|0.756
Observed|All cancers combined|2015–2019|Males|3|70–74|0.692|0.688|0.695
Observed|All cancers combined|2015–2019|Males|3|75–79|0.603|0.599|0.608
Observed|All cancers combined|2015–2019|Males|3|80–84|0.477|0.472|0.483
Observed|All cancers combined|2015–2019|Males|3|85+|0.291|0.286|0.297
Observed|All cancers combined|2015–2019|Males|3|All ages combined|0.677|0.676|0.679
Observed|All cancers combined|2015–2019|Males|4|00–04|0.86|0.836|0.881
Observed|All cancers combined|2015–2019|Males|4|05–09|0.842|0.807|0.871
Observed|All cancers combined|2015–2019|Males|4|10–14|0.874|0.842|0.899
Observed|All cancers combined|2015–2019|Males|4|15–19|0.875|0.853|0.894
Observed|All cancers combined|2015–2019|Males|4|20–24|0.916|0.901|0.928
Observed|All cancers combined|2015–2019|Males|4|25–29|0.904|0.892|0.914
Observed|All cancers combined|2015–2019|Males|4|30–34|0.89|0.88|0.9
Observed|All cancers combined|2015–2019|Males|4|35–39|0.866|0.856|0.876
Observed|All cancers combined|2015–2019|Males|4|40–44|0.823|0.814|0.832
Observed|All cancers combined|2015–2019|Males|4|45–49|0.793|0.785|0.8
Observed|All cancers combined|2015–2019|Males|4|50–54|0.772|0.766|0.777
Observed|All cancers combined|2015–2019|Males|4|55–59|0.758|0.753|0.762
Observed|All cancers combined|2015–2019|Males|4|60–64|0.737|0.733|0.741
Observed|All cancers combined|2015–2019|Males|4|65–69|0.722|0.718|0.725
Observed|All cancers combined|2015–2019|Males|4|70–74|0.649|0.645|0.653
Observed|All cancers combined|2015–2019|Males|4|75–79|0.552|0.547|0.556
Observed|All cancers combined|2015–2019|Males|4|80–84|0.412|0.407|0.417
Observed|All cancers combined|2015–2019|Males|4|85+|0.225|0.22|0.23
Observed|All cancers combined|2015–2019|Males|4|All ages combined|0.639|0.637|0.64
Observed|All cancers combined|2015–2019|Males|5|00–04|0.849|0.823|0.87
Observed|All cancers combined|2015–2019|Males|5|05–09|0.836|0.801|0.866
Observed|All cancers combined|2015–2019|Males|5|10–14|0.866|0.833|0.892
Observed|All cancers combined|2015–2019|Males|5|15–19|0.865|0.842|0.884
Observed|All cancers combined|2015–2019|Males|5|20–24|0.909|0.894|0.922
Observed|All cancers combined|2015–2019|Males|5|25–29|0.895|0.883|0.906
Observed|All cancers combined|2015–2019|Males|5|30–34|0.882|0.871|0.893
Observed|All cancers combined|2015–2019|Males|5|35–39|0.855|0.845|0.865
Observed|All cancers combined|2015–2019|Males|5|40–44|0.81|0.801|0.819
Observed|All cancers combined|2015–2019|Males|5|45–49|0.778|0.77|0.785
Observed|All cancers combined|2015–2019|Males|5|50–54|0.755|0.749|0.761
Observed|All cancers combined|2015–2019|Males|5|55–59|0.739|0.735|0.744
Observed|All cancers combined|2015–2019|Males|5|60–64|0.716|0.712|0.72
Observed|All cancers combined|2015–2019|Males|5|65–69|0.695|0.691|0.699
Observed|All cancers combined|2015–2019|Males|5|70–74|0.614|0.609|0.618
Observed|All cancers combined|2015–2019|Males|5|75–79|0.507|0.502|0.511
Observed|All cancers combined|2015–2019|Males|5|80–84|0.355|0.35|0.36
Observed|All cancers combined|2015–2019|Males|5|85+|0.173|0.169|0.177
Observed|All cancers combined|2015–2019|Males|5|All ages combined|0.607|0.606|0.609
Relative|All cancers combined|2015–2019|Males|1|00–04|0.921|0.901|0.937
Relative|All cancers combined|2015–2019|Males|1|05–09|0.934|0.908|0.953
Relative|All cancers combined|2015–2019|Males|1|10–14|0.955|0.934|0.97
Relative|All cancers combined|2015–2019|Males|1|15–19|0.961|0.947|0.971
Relative|All cancers combined|2015–2019|Males|1|20–24|0.964|0.954|0.972
Relative|All cancers combined|2015–2019|Males|1|25–29|0.962|0.953|0.968
Relative|All cancers combined|2015–2019|Males|1|30–34|0.955|0.948|0.961
Relative|All cancers combined|2015–2019|Males|1|35–39|0.939|0.932|0.946
Relative|All cancers combined|2015–2019|Males|1|40–44|0.922|0.915|0.928
Relative|All cancers combined|2015–2019|Males|1|45–49|0.903|0.898|0.909
Relative|All cancers combined|2015–2019|Males|1|50–54|0.887|0.883|0.891
Relative|All cancers combined|2015–2019|Males|1|55–59|0.88|0.876|0.883
Relative|All cancers combined|2015–2019|Males|1|60–64|0.871|0.868|0.874
Relative|All cancers combined|2015–2019|Males|1|65–69|0.868|0.865|0.87
Relative|All cancers combined|2015–2019|Males|1|70–74|0.836|0.833|0.839
Relative|All cancers combined|2015–2019|Males|1|75–79|0.788|0.784|0.792
Relative|All cancers combined|2015–2019|Males|1|80–84|0.716|0.71|0.721
Relative|All cancers combined|2015–2019|Males|1|85+|0.592|0.586|0.599
Relative|All cancers combined|2015–2019|Males|1|All ages combined|0.828|0.826|0.829
Relative|All cancers combined|2015–2019|Males|2|00–04|0.88|0.857|0.9
Relative|All cancers combined|2015–2019|Males|2|05–09|0.886|0.854|0.911
Relative|All cancers combined|2015–2019|Males|2|10–14|0.911|0.884|0.933
Relative|All cancers combined|2015–2019|Males|2|15–19|0.923|0.904|0.938
Relative|All cancers combined|2015–2019|Males|2|20–24|0.94|0.928|0.951
Relative|All cancers combined|2015–2019|Males|2|25–29|0.935|0.925|0.944
Relative|All cancers combined|2015–2019|Males|2|30–34|0.927|0.918|0.935
Relative|All cancers combined|2015–2019|Males|2|35–39|0.905|0.897|0.913
Relative|All cancers combined|2015–2019|Males|2|40–44|0.874|0.866|0.882
Relative|All cancers combined|2015–2019|Males|2|45–49|0.849|0.843|0.856
Relative|All cancers combined|2015–2019|Males|2|50–54|0.835|0.83|0.84
Relative|All cancers combined|2015–2019|Males|2|55–59|0.826|0.821|0.83
Relative|All cancers combined|2015–2019|Males|2|60–64|0.816|0.812|0.819
Relative|All cancers combined|2015–2019|Males|2|65–69|0.813|0.81|0.816
Relative|All cancers combined|2015–2019|Males|2|70–74|0.775|0.771|0.778
Relative|All cancers combined|2015–2019|Males|2|75–79|0.717|0.713|0.722
Relative|All cancers combined|2015–2019|Males|2|80–84|0.634|0.628|0.64
Relative|All cancers combined|2015–2019|Males|2|85+|0.509|0.502|0.516
Relative|All cancers combined|2015–2019|Males|2|All ages combined|0.767|0.766|0.769
Relative|All cancers combined|2015–2019|Males|3|00–04|0.871|0.847|0.891
Relative|All cancers combined|2015–2019|Males|3|05–09|0.856|0.822|0.884
Relative|All cancers combined|2015–2019|Males|3|10–14|0.886|0.855|0.91
Relative|All cancers combined|2015–2019|Males|3|15–19|0.901|0.881|0.918
Relative|All cancers combined|2015–2019|Males|3|20–24|0.93|0.917|0.941
Relative|All cancers combined|2015–2019|Males|3|25–29|0.917|0.906|0.927
Relative|All cancers combined|2015–2019|Males|3|30–34|0.907|0.897|0.916
Relative|All cancers combined|2015–2019|Males|3|35–39|0.885|0.876|0.894
Relative|All cancers combined|2015–2019|Males|3|40–44|0.849|0.84|0.857
Relative|All cancers combined|2015–2019|Males|3|45–49|0.821|0.814|0.828
Relative|All cancers combined|2015–2019|Males|3|50–54|0.802|0.797|0.808
Relative|All cancers combined|2015–2019|Males|3|55–59|0.795|0.791|0.8
Relative|All cancers combined|2015–2019|Males|3|60–64|0.785|0.781|0.789
Relative|All cancers combined|2015–2019|Males|3|65–69|0.783|0.78|0.787
Relative|All cancers combined|2015–2019|Males|3|70–74|0.738|0.734|0.742
Relative|All cancers combined|2015–2019|Males|3|75–79|0.675|0.67|0.68
Relative|All cancers combined|2015–2019|Males|3|80–84|0.586|0.58|0.593
Relative|All cancers combined|2015–2019|Males|3|85+|0.457|0.449|0.465
Relative|All cancers combined|2015–2019|Males|3|All ages combined|0.732|0.731|0.734
Relative|All cancers combined|2015–2019|Males|4|00–04|0.861|0.837|0.882
Relative|All cancers combined|2015–2019|Males|4|05–09|0.842|0.807|0.872
Relative|All cancers combined|2015–2019|Males|4|10–14|0.874|0.843|0.9
Relative|All cancers combined|2015–2019|Males|4|15–19|0.877|0.854|0.896
Relative|All cancers combined|2015–2019|Males|4|20–24|0.918|0.903|0.93
Relative|All cancers combined|2015–2019|Males|4|25–29|0.906|0.894|0.917
Relative|All cancers combined|2015–2019|Males|4|30–34|0.894|0.883|0.904
Relative|All cancers combined|2015–2019|Males|4|35–39|0.871|0.86|0.88
Relative|All cancers combined|2015–2019|Males|4|40–44|0.829|0.82|0.838
Relative|All cancers combined|2015–2019|Males|4|45–49|0.801|0.794|0.808
Relative|All cancers combined|2015–2019|Males|4|50–54|0.784|0.778|0.79
Relative|All cancers combined|2015–2019|Males|4|55–59|0.776|0.772|0.781
Relative|All cancers combined|2015–2019|Males|4|60–64|0.765|0.761|0.769
Relative|All cancers combined|2015–2019|Males|4|65–69|0.763|0.76|0.767
Relative|All cancers combined|2015–2019|Males|4|70–74|0.711|0.707|0.716
Relative|All cancers combined|2015–2019|Males|4|75–79|0.647|0.641|0.652
Relative|All cancers combined|2015–2019|Males|4|80–84|0.553|0.546|0.56
Relative|All cancers combined|2015–2019|Males|4|85+|0.42|0.412|0.429
Relative|All cancers combined|2015–2019|Males|4|All ages combined|0.709|0.707|0.711
Relative|All cancers combined|2015–2019|Males|5|00–04|0.85|0.825|0.871
Relative|All cancers combined|2015–2019|Males|5|05–09|0.837|0.801|0.866
Relative|All cancers combined|2015–2019|Males|5|10–14|0.867|0.834|0.893
Relative|All cancers combined|2015–2019|Males|5|15–19|0.867|0.844|0.887
Relative|All cancers combined|2015–2019|Males|5|20–24|0.912|0.897|0.925
Relative|All cancers combined|2015–2019|Males|5|25–29|0.899|0.886|0.91
Relative|All cancers combined|2015–2019|Males|5|30–34|0.887|0.875|0.897
Relative|All cancers combined|2015–2019|Males|5|35–39|0.861|0.85|0.871
Relative|All cancers combined|2015–2019|Males|5|40–44|0.818|0.808|0.827
Relative|All cancers combined|2015–2019|Males|5|45–49|0.789|0.781|0.796
Relative|All cancers combined|2015–2019|Males|5|50–54|0.771|0.765|0.777
Relative|All cancers combined|2015–2019|Males|5|55–59|0.763|0.758|0.768
Relative|All cancers combined|2015–2019|Males|5|60–64|0.751|0.747|0.755
Relative|All cancers combined|2015–2019|Males|5|65–69|0.748|0.744|0.752
Relative|All cancers combined|2015–2019|Males|5|70–74|0.693|0.688|0.697
Relative|All cancers combined|2015–2019|Males|5|75–79|0.626|0.621|0.632
Relative|All cancers combined|2015–2019|Males|5|80–84|0.526|0.518|0.533
Relative|All cancers combined|2015–2019|Males|5|85+|0.392|0.382|0.402
Relative|All cancers combined|2015–2019|Males|5|All ages combined|0.693|0.691|0.695
Observed|All cancers combined|2015–2019|Females|1|00–04|0.933|0.913|0.949
Observed|All cancers combined|2015–2019|Females|1|05–09|0.936|0.908|0.956
Observed|All cancers combined|2015–2019|Females|1|10–14|0.952|0.929|0.968
Observed|All cancers combined|2015–2019|Females|1|15–19|0.967|0.954|0.977
Observed|All cancers combined|2015–2019|Females|1|20–24|0.975|0.966|0.981
Observed|All cancers combined|2015–2019|Females|1|25–29|0.979|0.973|0.984
Observed|All cancers combined|2015–2019|Females|1|30–34|0.971|0.967|0.975
Observed|All cancers combined|2015–2019|Females|1|35–39|0.967|0.963|0.971
Observed|All cancers combined|2015–2019|Females|1|40–44|0.962|0.959|0.965
Observed|All cancers combined|2015–2019|Females|1|45–49|0.955|0.952|0.958
Observed|All cancers combined|2015–2019|Females|1|50–54|0.935|0.932|0.939
Observed|All cancers combined|2015–2019|Females|1|55–59|0.912|0.909|0.915
Observed|All cancers combined|2015–2019|Females|1|60–64|0.893|0.889|0.896
Observed|All cancers combined|2015–2019|Females|1|65–69|0.87|0.867|0.873
Observed|All cancers combined|2015–2019|Females|1|70–74|0.831|0.827|0.835
Observed|All cancers combined|2015–2019|Females|1|75–79|0.761|0.757|0.766
Observed|All cancers combined|2015–2019|Females|1|80–84|0.677|0.671|0.683
Observed|All cancers combined|2015–2019|Females|1|85+|0.518|0.512|0.524
Observed|All cancers combined|2015–2019|Females|1|All ages combined|0.834|0.833|0.835
Observed|All cancers combined|2015–2019|Females|2|00–04|0.9|0.877|0.919
Observed|All cancers combined|2015–2019|Females|2|05–09|0.906|0.874|0.931
Observed|All cancers combined|2015–2019|Females|2|10–14|0.905|0.875|0.928
Observed|All cancers combined|2015–2019|Females|2|15–19|0.946|0.93|0.959
Observed|All cancers combined|2015–2019|Females|2|20–24|0.955|0.944|0.964
Observed|All cancers combined|2015–2019|Females|2|25–29|0.954|0.947|0.961
Observed|All cancers combined|2015–2019|Females|2|30–34|0.939|0.932|0.945
Observed|All cancers combined|2015–2019|Females|2|35–39|0.938|0.932|0.943
Observed|All cancers combined|2015–2019|Females|2|40–44|0.933|0.928|0.937
Observed|All cancers combined|2015–2019|Females|2|45–49|0.923|0.919|0.926
Observed|All cancers combined|2015–2019|Females|2|50–54|0.894|0.891|0.898
Observed|All cancers combined|2015–2019|Females|2|55–59|0.859|0.855|0.863
Observed|All cancers combined|2015–2019|Females|2|60–64|0.839|0.835|0.843
Observed|All cancers combined|2015–2019|Females|2|65–69|0.807|0.803|0.811
Observed|All cancers combined|2015–2019|Females|2|70–74|0.756|0.752|0.76
Observed|All cancers combined|2015–2019|Females|2|75–79|0.672|0.666|0.677
Observed|All cancers combined|2015–2019|Females|2|80–84|0.575|0.569|0.581
Observed|All cancers combined|2015–2019|Females|2|85+|0.402|0.396|0.407
Observed|All cancers combined|2015–2019|Females|2|All ages combined|0.768|0.766|0.769
Observed|All cancers combined|2015–2019|Females|3|00–04|0.883|0.858|0.904
Observed|All cancers combined|2015–2019|Females|3|05–09|0.894|0.859|0.92
Observed|All cancers combined|2015–2019|Females|3|10–14|0.881|0.848|0.906
Observed|All cancers combined|2015–2019|Females|3|15–19|0.925|0.907|0.94
Observed|All cancers combined|2015–2019|Females|3|20–24|0.943|0.93|0.953
Observed|All cancers combined|2015–2019|Females|3|25–29|0.942|0.933|0.949
Observed|All cancers combined|2015–2019|Females|3|30–34|0.92|0.912|0.926
Observed|All cancers combined|2015–2019|Females|3|35–39|0.919|0.912|0.925
Observed|All cancers combined|2015–2019|Females|3|40–44|0.911|0.906|0.916
Observed|All cancers combined|2015–2019|Females|3|45–49|0.899|0.895|0.903
Observed|All cancers combined|2015–2019|Females|3|50–54|0.868|0.863|0.872
Observed|All cancers combined|2015–2019|Females|3|55–59|0.826|0.821|0.83
Observed|All cancers combined|2015–2019|Females|3|60–64|0.803|0.799|0.807
Observed|All cancers combined|2015–2019|Females|3|65–69|0.764|0.759|0.768
Observed|All cancers combined|2015–2019|Females|3|70–74|0.708|0.703|0.712
Observed|All cancers combined|2015–2019|Females|3|75–79|0.615|0.61|0.62
Observed|All cancers combined|2015–2019|Females|3|80–84|0.507|0.501|0.514
Observed|All cancers combined|2015–2019|Females|3|85+|0.323|0.318|0.329
Observed|All cancers combined|2015–2019|Females|3|All ages combined|0.724|0.722|0.725
Observed|All cancers combined|2015–2019|Females|4|00–04|0.875|0.85|0.896
Observed|All cancers combined|2015–2019|Females|4|05–09|0.891|0.856|0.918
Observed|All cancers combined|2015–2019|Females|4|10–14|0.858|0.823|0.886
Observed|All cancers combined|2015–2019|Females|4|15–19|0.911|0.891|0.927
Observed|All cancers combined|2015–2019|Females|4|20–24|0.934|0.921|0.945
Observed|All cancers combined|2015–2019|Females|4|25–29|0.929|0.92|0.938
Observed|All cancers combined|2015–2019|Females|4|30–34|0.905|0.897|0.912
Observed|All cancers combined|2015–2019|Females|4|35–39|0.901|0.894|0.907
Observed|All cancers combined|2015–2019|Females|4|40–44|0.893|0.888|0.899
Observed|All cancers combined|2015–2019|Females|4|45–49|0.878|0.874|0.883
Observed|All cancers combined|2015–2019|Females|4|50–54|0.848|0.843|0.852
Observed|All cancers combined|2015–2019|Females|4|55–59|0.802|0.797|0.807
Observed|All cancers combined|2015–2019|Females|4|60–64|0.775|0.77|0.779
Observed|All cancers combined|2015–2019|Females|4|65–69|0.734|0.729|0.738
Observed|All cancers combined|2015–2019|Females|4|70–74|0.67|0.666|0.675
Observed|All cancers combined|2015–2019|Females|4|75–79|0.569|0.563|0.574
Observed|All cancers combined|2015–2019|Females|4|80–84|0.45|0.443|0.456
Observed|All cancers combined|2015–2019|Females|4|85+|0.261|0.256|0.266
Observed|All cancers combined|2015–2019|Females|4|All ages combined|0.689|0.688|0.691
Observed|All cancers combined|2015–2019|Females|5|00–04|0.871|0.845|0.893
Observed|All cancers combined|2015–2019|Females|5|05–09|0.883|0.847|0.91
Observed|All cancers combined|2015–2019|Females|5|10–14|0.858|0.823|0.886
Observed|All cancers combined|2015–2019|Females|5|15–19|0.904|0.883|0.921
Observed|All cancers combined|2015–2019|Females|5|20–24|0.925|0.911|0.937
Observed|All cancers combined|2015–2019|Females|5|25–29|0.921|0.911|0.93
Observed|All cancers combined|2015–2019|Females|5|30–34|0.892|0.884|0.9
Observed|All cancers combined|2015–2019|Females|5|35–39|0.886|0.879|0.893
Observed|All cancers combined|2015–2019|Females|5|40–44|0.88|0.874|0.886
Observed|All cancers combined|2015–2019|Females|5|45–49|0.864|0.859|0.869
Observed|All cancers combined|2015–2019|Females|5|50–54|0.833|0.828|0.837
Observed|All cancers combined|2015–2019|Females|5|55–59|0.784|0.779|0.789
Observed|All cancers combined|2015–2019|Females|5|60–64|0.753|0.748|0.758
Observed|All cancers combined|2015–2019|Females|5|65–69|0.708|0.704|0.713
Observed|All cancers combined|2015–2019|Females|5|70–74|0.637|0.632|0.642
Observed|All cancers combined|2015–2019|Females|5|75–79|0.527|0.521|0.533
Observed|All cancers combined|2015–2019|Females|5|80–84|0.399|0.393|0.405
Observed|All cancers combined|2015–2019|Females|5|85+|0.211|0.206|0.216
Observed|All cancers combined|2015–2019|Females|5|All ages combined|0.661|0.659|0.663
Relative|All cancers combined|2015–2019|Females|1|00–04|0.934|0.914|0.949
Relative|All cancers combined|2015–2019|Females|1|05–09|0.936|0.908|0.956
Relative|All cancers combined|2015–2019|Females|1|10–14|0.952|0.929|0.968
Relative|All cancers combined|2015–2019|Females|1|15–19|0.967|0.954|0.977
Relative|All cancers combined|2015–2019|Females|1|20–24|0.975|0.966|0.982
Relative|All cancers combined|2015–2019|Females|1|25–29|0.979|0.974|0.984
Relative|All cancers combined|2015–2019|Females|1|30–34|0.972|0.967|0.976
Relative|All cancers combined|2015–2019|Females|1|35–39|0.968|0.963|0.971
Relative|All cancers combined|2015–2019|Females|1|40–44|0.963|0.959|0.966
Relative|All cancers combined|2015–2019|Females|1|45–49|0.956|0.953|0.959
Relative|All cancers combined|2015–2019|Females|1|50–54|0.937|0.934|0.941
Relative|All cancers combined|2015–2019|Females|1|55–59|0.915|0.911|0.918
Relative|All cancers combined|2015–2019|Females|1|60–64|0.897|0.893|0.9
Relative|All cancers combined|2015–2019|Females|1|65–69|0.877|0.873|0.88
Relative|All cancers combined|2015–2019|Females|1|70–74|0.841|0.837|0.845
Relative|All cancers combined|2015–2019|Females|1|75–79|0.778|0.773|0.783
Relative|All cancers combined|2015–2019|Females|1|80–84|0.706|0.7|0.712
Relative|All cancers combined|2015–2019|Females|1|85+|0.582|0.575|0.589
Relative|All cancers combined|2015–2019|Females|1|All ages combined|0.85|0.849|0.852
Relative|All cancers combined|2015–2019|Females|2|00–04|0.901|0.878|0.92
Relative|All cancers combined|2015–2019|Females|2|05–09|0.906|0.874|0.931
Relative|All cancers combined|2015–2019|Females|2|10–14|0.905|0.876|0.928
Relative|All cancers combined|2015–2019|Females|2|15–19|0.946|0.93|0.959
Relative|All cancers combined|2015–2019|Females|2|20–24|0.956|0.944|0.965
Relative|All cancers combined|2015–2019|Females|2|25–29|0.955|0.947|0.962
Relative|All cancers combined|2015–2019|Females|2|30–34|0.939|0.933|0.945
Relative|All cancers combined|2015–2019|Females|2|35–39|0.939|0.934|0.944
Relative|All cancers combined|2015–2019|Females|2|40–44|0.935|0.93|0.939
Relative|All cancers combined|2015–2019|Females|2|45–49|0.925|0.922|0.929
Relative|All cancers combined|2015–2019|Females|2|50–54|0.898|0.894|0.902
Relative|All cancers combined|2015–2019|Females|2|55–59|0.865|0.861|0.869
Relative|All cancers combined|2015–2019|Females|2|60–64|0.848|0.844|0.851
Relative|All cancers combined|2015–2019|Females|2|65–69|0.82|0.816|0.823
Relative|All cancers combined|2015–2019|Females|2|70–74|0.776|0.771|0.78
Relative|All cancers combined|2015–2019|Females|2|75–79|0.703|0.698|0.709
Relative|All cancers combined|2015–2019|Females|2|80–84|0.629|0.622|0.636
Relative|All cancers combined|2015–2019|Females|2|85+|0.51|0.503|0.518
Relative|All cancers combined|2015–2019|Females|2|All ages combined|0.796|0.794|0.798
Relative|All cancers combined|2015–2019|Females|3|00–04|0.884|0.859|0.905
Relative|All cancers combined|2015–2019|Females|3|05–09|0.894|0.859|0.92
Relative|All cancers combined|2015–2019|Females|3|10–14|0.881|0.849|0.907
Relative|All cancers combined|2015–2019|Females|3|15–19|0.926|0.907|0.941
Relative|All cancers combined|2015–2019|Females|3|20–24|0.943|0.931|0.954
Relative|All cancers combined|2015–2019|Females|3|25–29|0.943|0.934|0.95
Relative|All cancers combined|2015–2019|Females|3|30–34|0.921|0.913|0.928
Relative|All cancers combined|2015–2019|Females|3|35–39|0.921|0.914|0.927
Relative|All cancers combined|2015–2019|Females|3|40–44|0.914|0.909|0.919
Relative|All cancers combined|2015–2019|Females|3|45–49|0.903|0.899|0.908
Relative|All cancers combined|2015–2019|Females|3|50–54|0.874|0.869|0.878
Relative|All cancers combined|2015–2019|Females|3|55–59|0.834|0.83|0.838
Relative|All cancers combined|2015–2019|Females|3|60–64|0.815|0.811|0.82
Relative|All cancers combined|2015–2019|Females|3|65–69|0.782|0.778|0.787
Relative|All cancers combined|2015–2019|Females|3|70–74|0.737|0.732|0.742
Relative|All cancers combined|2015–2019|Females|3|75–79|0.662|0.656|0.668
Relative|All cancers combined|2015–2019|Females|3|80–84|0.586|0.579|0.593
Relative|All cancers combined|2015–2019|Females|3|85+|0.471|0.463|0.479
Relative|All cancers combined|2015–2019|Females|3|All ages combined|0.763|0.762|0.765
Relative|All cancers combined|2015–2019|Females|4|00–04|0.876|0.851|0.897
Relative|All cancers combined|2015–2019|Females|4|05–09|0.891|0.856|0.918
Relative|All cancers combined|2015–2019|Females|4|10–14|0.858|0.824|0.886
Relative|All cancers combined|2015–2019|Females|4|15–19|0.912|0.891|0.928
Relative|All cancers combined|2015–2019|Females|4|20–24|0.935|0.922|0.946
Relative|All cancers combined|2015–2019|Females|4|25–29|0.931|0.921|0.939
Relative|All cancers combined|2015–2019|Females|4|30–34|0.906|0.898|0.914
Relative|All cancers combined|2015–2019|Females|4|35–39|0.903|0.896|0.91
Relative|All cancers combined|2015–2019|Females|4|40–44|0.897|0.892|0.902
Relative|All cancers combined|2015–2019|Females|4|45–49|0.884|0.879|0.889
Relative|All cancers combined|2015–2019|Females|4|50–54|0.856|0.851|0.86
Relative|All cancers combined|2015–2019|Females|4|55–59|0.813|0.809|0.818
Relative|All cancers combined|2015–2019|Females|4|60–64|0.792|0.787|0.796
Relative|All cancers combined|2015–2019|Females|4|65–69|0.759|0.755|0.764
Relative|All cancers combined|2015–2019|Females|4|70–74|0.711|0.705|0.716
Relative|All cancers combined|2015–2019|Females|4|75–79|0.632|0.625|0.638
Relative|All cancers combined|2015–2019|Females|4|80–84|0.553|0.546|0.561
Relative|All cancers combined|2015–2019|Females|4|85+|0.441|0.433|0.45
Relative|All cancers combined|2015–2019|Females|4|All ages combined|0.74|0.738|0.742
Relative|All cancers combined|2015–2019|Females|5|00–04|0.872|0.846|0.894
Relative|All cancers combined|2015–2019|Females|5|05–09|0.883|0.847|0.911
Relative|All cancers combined|2015–2019|Females|5|10–14|0.858|0.824|0.886
Relative|All cancers combined|2015–2019|Females|5|15–19|0.905|0.884|0.922
Relative|All cancers combined|2015–2019|Females|5|20–24|0.926|0.912|0.938
Relative|All cancers combined|2015–2019|Females|5|25–29|0.922|0.912|0.931
Relative|All cancers combined|2015–2019|Females|5|30–34|0.894|0.886|0.902
Relative|All cancers combined|2015–2019|Females|5|35–39|0.889|0.882|0.896
Relative|All cancers combined|2015–2019|Females|5|40–44|0.885|0.879|0.89
Relative|All cancers combined|2015–2019|Females|5|45–49|0.871|0.866|0.876
Relative|All cancers combined|2015–2019|Females|5|50–54|0.843|0.838|0.848
Relative|All cancers combined|2015–2019|Females|5|55–59|0.799|0.794|0.803
Relative|All cancers combined|2015–2019|Females|5|60–64|0.774|0.769|0.779
Relative|All cancers combined|2015–2019|Females|5|65–69|0.741|0.736|0.745
Relative|All cancers combined|2015–2019|Females|5|70–74|0.688|0.683|0.694
Relative|All cancers combined|2015–2019|Females|5|75–79|0.607|0.601|0.614
Relative|All cancers combined|2015–2019|Females|5|80–84|0.528|0.52|0.536
Relative|All cancers combined|2015–2019|Females|5|85+|0.421|0.411|0.43
Relative|All cancers combined|2015–2019|Females|5|All ages combined|0.723|0.721|0.724
Observed|All cancers combined|2015–2019|Persons|1|00–04|0.926|0.912|0.938
Observed|All cancers combined|2015–2019|Persons|1|05–09|0.935|0.917|0.949
Observed|All cancers combined|2015–2019|Persons|1|10–14|0.954|0.939|0.965
Observed|All cancers combined|2015–2019|Persons|1|15–19|0.964|0.955|0.971
Observed|All cancers combined|2015–2019|Persons|1|20–24|0.969|0.963|0.974
Observed|All cancers combined|2015–2019|Persons|1|25–29|0.971|0.966|0.975
Observed|All cancers combined|2015–2019|Persons|1|30–34|0.965|0.961|0.968
Observed|All cancers combined|2015–2019|Persons|1|35–39|0.956|0.952|0.96
Observed|All cancers combined|2015–2019|Persons|1|40–44|0.947|0.943|0.95
Observed|All cancers combined|2015–2019|Persons|1|45–49|0.934|0.931|0.937
Observed|All cancers combined|2015–2019|Persons|1|50–54|0.912|0.909|0.914
Observed|All cancers combined|2015–2019|Persons|1|55–59|0.892|0.89|0.894
Observed|All cancers combined|2015–2019|Persons|1|60–64|0.876|0.874|0.878
Observed|All cancers combined|2015–2019|Persons|1|65–69|0.862|0.86|0.864
Observed|All cancers combined|2015–2019|Persons|1|70–74|0.824|0.822|0.827
Observed|All cancers combined|2015–2019|Persons|1|75–79|0.762|0.759|0.765
Observed|All cancers combined|2015–2019|Persons|1|80–84|0.675|0.671|0.679
Observed|All cancers combined|2015–2019|Persons|1|85+|0.517|0.512|0.521
Observed|All cancers combined|2015–2019|Persons|1|All ages combined|0.818|0.817|0.819
Observed|All cancers combined|2015–2019|Persons|2|00–04|0.889|0.873|0.903
Observed|All cancers combined|2015–2019|Persons|2|05–09|0.895|0.873|0.913
Observed|All cancers combined|2015–2019|Persons|2|10–14|0.908|0.889|0.924
Observed|All cancers combined|2015–2019|Persons|2|15–19|0.934|0.922|0.944
Observed|All cancers combined|2015–2019|Persons|2|20–24|0.947|0.939|0.954
Observed|All cancers combined|2015–2019|Persons|2|25–29|0.945|0.939|0.951
Observed|All cancers combined|2015–2019|Persons|2|30–34|0.934|0.928|0.938
Observed|All cancers combined|2015–2019|Persons|2|35–39|0.925|0.92|0.929
Observed|All cancers combined|2015–2019|Persons|2|40–44|0.91|0.906|0.914
Observed|All cancers combined|2015–2019|Persons|2|45–49|0.893|0.889|0.896
Observed|All cancers combined|2015–2019|Persons|2|50–54|0.864|0.861|0.867
Observed|All cancers combined|2015–2019|Persons|2|55–59|0.836|0.833|0.839
Observed|All cancers combined|2015–2019|Persons|2|60–64|0.818|0.815|0.82
Observed|All cancers combined|2015–2019|Persons|2|65–69|0.798|0.796|0.801
Observed|All cancers combined|2015–2019|Persons|2|70–74|0.749|0.746|0.751
Observed|All cancers combined|2015–2019|Persons|2|75–79|0.67|0.666|0.673
Observed|All cancers combined|2015–2019|Persons|2|80–84|0.565|0.561|0.569
Observed|All cancers combined|2015–2019|Persons|2|85+|0.391|0.387|0.395
Observed|All cancers combined|2015–2019|Persons|2|All ages combined|0.746|0.745|0.747
Observed|All cancers combined|2015–2019|Persons|3|00–04|0.876|0.859|0.891
Observed|All cancers combined|2015–2019|Persons|3|05–09|0.872|0.849|0.893
Observed|All cancers combined|2015–2019|Persons|3|10–14|0.883|0.862|0.901
Observed|All cancers combined|2015–2019|Persons|3|15–19|0.912|0.899|0.924
Observed|All cancers combined|2015–2019|Persons|3|20–24|0.935|0.926|0.943
Observed|All cancers combined|2015–2019|Persons|3|25–29|0.93|0.923|0.936
Observed|All cancers combined|2015–2019|Persons|3|30–34|0.914|0.908|0.919
Observed|All cancers combined|2015–2019|Persons|3|35–39|0.905|0.9|0.91
Observed|All cancers combined|2015–2019|Persons|3|40–44|0.887|0.882|0.891
Observed|All cancers combined|2015–2019|Persons|3|45–49|0.866|0.862|0.87
Observed|All cancers combined|2015–2019|Persons|3|50–54|0.833|0.83|0.837
Observed|All cancers combined|2015–2019|Persons|3|55–59|0.802|0.799|0.805
Observed|All cancers combined|2015–2019|Persons|3|60–64|0.781|0.778|0.784
Observed|All cancers combined|2015–2019|Persons|3|65–69|0.757|0.754|0.76
Observed|All cancers combined|2015–2019|Persons|3|70–74|0.698|0.695|0.701
Observed|All cancers combined|2015–2019|Persons|3|75–79|0.608|0.604|0.611
Observed|All cancers combined|2015–2019|Persons|3|80–84|0.49|0.486|0.494
Observed|All cancers combined|2015–2019|Persons|3|85+|0.307|0.303|0.311
Observed|All cancers combined|2015–2019|Persons|3|All ages combined|0.698|0.697|0.699
Observed|All cancers combined|2015–2019|Persons|4|00–04|0.867|0.85|0.883
Observed|All cancers combined|2015–2019|Persons|4|05–09|0.863|0.839|0.884
Observed|All cancers combined|2015–2019|Persons|4|10–14|0.866|0.843|0.885
Observed|All cancers combined|2015–2019|Persons|4|15–19|0.892|0.878|0.905
Observed|All cancers combined|2015–2019|Persons|4|20–24|0.925|0.915|0.933
Observed|All cancers combined|2015–2019|Persons|4|25–29|0.918|0.91|0.925
Observed|All cancers combined|2015–2019|Persons|4|30–34|0.899|0.893|0.905
Observed|All cancers combined|2015–2019|Persons|4|35–39|0.888|0.882|0.893
Observed|All cancers combined|2015–2019|Persons|4|40–44|0.868|0.863|0.872
Observed|All cancers combined|2015–2019|Persons|4|45–49|0.845|0.841|0.849
Observed|All cancers combined|2015–2019|Persons|4|50–54|0.813|0.809|0.816
Observed|All cancers combined|2015–2019|Persons|4|55–59|0.778|0.775|0.781
Observed|All cancers combined|2015–2019|Persons|4|60–64|0.753|0.75|0.756
Observed|All cancers combined|2015–2019|Persons|4|65–69|0.727|0.724|0.729
Observed|All cancers combined|2015–2019|Persons|4|70–74|0.657|0.654|0.66
Observed|All cancers combined|2015–2019|Persons|4|75–79|0.558|0.555|0.562
Observed|All cancers combined|2015–2019|Persons|4|80–84|0.428|0.424|0.432
Observed|All cancers combined|2015–2019|Persons|4|85+|0.243|0.239|0.246
Observed|All cancers combined|2015–2019|Persons|4|All ages combined|0.661|0.66|0.663
Observed|All cancers combined|2015–2019|Persons|5|00–04|0.859|0.841|0.875
Observed|All cancers combined|2015–2019|Persons|5|05–09|0.857|0.832|0.878
Observed|All cancers combined|2015–2019|Persons|5|10–14|0.862|0.839|0.882
Observed|All cancers combined|2015–2019|Persons|5|15–19|0.883|0.868|0.897
Observed|All cancers combined|2015–2019|Persons|5|20–24|0.917|0.907|0.926
Observed|All cancers combined|2015–2019|Persons|5|25–29|0.909|0.901|0.916
Observed|All cancers combined|2015–2019|Persons|5|30–34|0.888|0.882|0.895
Observed|All cancers combined|2015–2019|Persons|5|35–39|0.874|0.868|0.88
Observed|All cancers combined|2015–2019|Persons|5|40–44|0.854|0.849|0.859
Observed|All cancers combined|2015–2019|Persons|5|45–49|0.83|0.826|0.835
Observed|All cancers combined|2015–2019|Persons|5|50–54|0.797|0.793|0.801
Observed|All cancers combined|2015–2019|Persons|5|55–59|0.76|0.756|0.763
Observed|All cancers combined|2015–2019|Persons|5|60–64|0.732|0.728|0.735
Observed|All cancers combined|2015–2019|Persons|5|65–69|0.7|0.697|0.703
Observed|All cancers combined|2015–2019|Persons|5|70–74|0.623|0.619|0.626
Observed|All cancers combined|2015–2019|Persons|5|75–79|0.515|0.511|0.518
Observed|All cancers combined|2015–2019|Persons|5|80–84|0.374|0.37|0.378
Observed|All cancers combined|2015–2019|Persons|5|85+|0.192|0.189|0.195
Observed|All cancers combined|2015–2019|Persons|5|All ages combined|0.631|0.63|0.633
Relative|All cancers combined|2015–2019|Persons|1|00–04|0.927|0.913|0.938
Relative|All cancers combined|2015–2019|Persons|1|05–09|0.935|0.917|0.949
Relative|All cancers combined|2015–2019|Persons|1|10–14|0.954|0.939|0.965
Relative|All cancers combined|2015–2019|Persons|1|15–19|0.964|0.955|0.971
Relative|All cancers combined|2015–2019|Persons|1|20–24|0.97|0.963|0.975
Relative|All cancers combined|2015–2019|Persons|1|25–29|0.971|0.967|0.975
Relative|All cancers combined|2015–2019|Persons|1|30–34|0.965|0.961|0.969
Relative|All cancers combined|2015–2019|Persons|1|35–39|0.957|0.953|0.96
Relative|All cancers combined|2015–2019|Persons|1|40–44|0.948|0.945|0.951
Relative|All cancers combined|2015–2019|Persons|1|45–49|0.936|0.933|0.938
Relative|All cancers combined|2015–2019|Persons|1|50–54|0.914|0.912|0.917
Relative|All cancers combined|2015–2019|Persons|1|55–59|0.896|0.893|0.898
Relative|All cancers combined|2015–2019|Persons|1|60–64|0.882|0.88|0.884
Relative|All cancers combined|2015–2019|Persons|1|65–69|0.871|0.869|0.873
Relative|All cancers combined|2015–2019|Persons|1|70–74|0.838|0.836|0.841
Relative|All cancers combined|2015–2019|Persons|1|75–79|0.784|0.781|0.787
Relative|All cancers combined|2015–2019|Persons|1|80–84|0.711|0.707|0.715
Relative|All cancers combined|2015–2019|Persons|1|85+|0.587|0.583|0.592
Relative|All cancers combined|2015–2019|Persons|1|All ages combined|0.838|0.837|0.839
Relative|All cancers combined|2015–2019|Persons|2|00–04|0.89|0.874|0.904
Relative|All cancers combined|2015–2019|Persons|2|05–09|0.895|0.873|0.913
Relative|All cancers combined|2015–2019|Persons|2|10–14|0.908|0.889|0.925
Relative|All cancers combined|2015–2019|Persons|2|15–19|0.934|0.922|0.945
Relative|All cancers combined|2015–2019|Persons|2|20–24|0.948|0.94|0.955
Relative|All cancers combined|2015–2019|Persons|2|25–29|0.946|0.94|0.951
Relative|All cancers combined|2015–2019|Persons|2|30–34|0.935|0.929|0.94
Relative|All cancers combined|2015–2019|Persons|2|35–39|0.927|0.922|0.931
Relative|All cancers combined|2015–2019|Persons|2|40–44|0.913|0.908|0.916
Relative|All cancers combined|2015–2019|Persons|2|45–49|0.896|0.892|0.899
Relative|All cancers combined|2015–2019|Persons|2|50–54|0.869|0.866|0.872
Relative|All cancers combined|2015–2019|Persons|2|55–59|0.844|0.841|0.847
Relative|All cancers combined|2015–2019|Persons|2|60–64|0.829|0.826|0.832
Relative|All cancers combined|2015–2019|Persons|2|65–69|0.816|0.813|0.818
Relative|All cancers combined|2015–2019|Persons|2|70–74|0.775|0.772|0.778
Relative|All cancers combined|2015–2019|Persons|2|75–79|0.712|0.708|0.715
Relative|All cancers combined|2015–2019|Persons|2|80–84|0.632|0.628|0.636
Relative|All cancers combined|2015–2019|Persons|2|85+|0.51|0.505|0.515
Relative|All cancers combined|2015–2019|Persons|2|All ages combined|0.78|0.779|0.781
Relative|All cancers combined|2015–2019|Persons|3|00–04|0.877|0.86|0.892
Relative|All cancers combined|2015–2019|Persons|3|05–09|0.873|0.849|0.893
Relative|All cancers combined|2015–2019|Persons|3|10–14|0.884|0.862|0.902
Relative|All cancers combined|2015–2019|Persons|3|15–19|0.913|0.9|0.925
Relative|All cancers combined|2015–2019|Persons|3|20–24|0.937|0.928|0.944
Relative|All cancers combined|2015–2019|Persons|3|25–29|0.931|0.924|0.937
Relative|All cancers combined|2015–2019|Persons|3|30–34|0.915|0.909|0.921
Relative|All cancers combined|2015–2019|Persons|3|35–39|0.907|0.902|0.912
Relative|All cancers combined|2015–2019|Persons|3|40–44|0.89|0.886|0.894
Relative|All cancers combined|2015–2019|Persons|3|45–49|0.871|0.867|0.875
Relative|All cancers combined|2015–2019|Persons|3|50–54|0.841|0.837|0.844
Relative|All cancers combined|2015–2019|Persons|3|55–59|0.813|0.81|0.816
Relative|All cancers combined|2015–2019|Persons|3|60–64|0.798|0.795|0.801
Relative|All cancers combined|2015–2019|Persons|3|65–69|0.783|0.78|0.786
Relative|All cancers combined|2015–2019|Persons|3|70–74|0.738|0.735|0.741
Relative|All cancers combined|2015–2019|Persons|3|75–79|0.67|0.666|0.674
Relative|All cancers combined|2015–2019|Persons|3|80–84|0.586|0.582|0.591
Relative|All cancers combined|2015–2019|Persons|3|85+|0.464|0.459|0.47
Relative|All cancers combined|2015–2019|Persons|3|All ages combined|0.746|0.745|0.748
Relative|All cancers combined|2015–2019|Persons|4|00–04|0.868|0.851|0.884
Relative|All cancers combined|2015–2019|Persons|4|05–09|0.864|0.84|0.885
Relative|All cancers combined|2015–2019|Persons|4|10–14|0.866|0.844|0.886
Relative|All cancers combined|2015–2019|Persons|4|15–19|0.894|0.879|0.907
Relative|All cancers combined|2015–2019|Persons|4|20–24|0.926|0.917|0.935
Relative|All cancers combined|2015–2019|Persons|4|25–29|0.92|0.912|0.926
Relative|All cancers combined|2015–2019|Persons|4|30–34|0.902|0.895|0.908
Relative|All cancers combined|2015–2019|Persons|4|35–39|0.891|0.885|0.896
Relative|All cancers combined|2015–2019|Persons|4|40–44|0.872|0.868|0.877
Relative|All cancers combined|2015–2019|Persons|4|45–49|0.852|0.848|0.856
Relative|All cancers combined|2015–2019|Persons|4|50–54|0.823|0.819|0.826
Relative|All cancers combined|2015–2019|Persons|4|55–59|0.793|0.79|0.797
Relative|All cancers combined|2015–2019|Persons|4|60–64|0.776|0.773|0.779
Relative|All cancers combined|2015–2019|Persons|4|65–69|0.762|0.759|0.765
Relative|All cancers combined|2015–2019|Persons|4|70–74|0.711|0.708|0.714
Relative|All cancers combined|2015–2019|Persons|4|75–79|0.641|0.637|0.645
Relative|All cancers combined|2015–2019|Persons|4|80–84|0.553|0.548|0.558
Relative|All cancers combined|2015–2019|Persons|4|85+|0.431|0.425|0.437
Relative|All cancers combined|2015–2019|Persons|4|All ages combined|0.723|0.722|0.724
Relative|All cancers combined|2015–2019|Persons|5|00–04|0.86|0.842|0.876
Relative|All cancers combined|2015–2019|Persons|5|05–09|0.857|0.832|0.878
Relative|All cancers combined|2015–2019|Persons|5|10–14|0.863|0.84|0.882
Relative|All cancers combined|2015–2019|Persons|5|15–19|0.885|0.87|0.899
Relative|All cancers combined|2015–2019|Persons|5|20–24|0.919|0.909|0.928
Relative|All cancers combined|2015–2019|Persons|5|25–29|0.911|0.904|0.919
Relative|All cancers combined|2015–2019|Persons|5|30–34|0.891|0.885|0.898
Relative|All cancers combined|2015–2019|Persons|5|35–39|0.879|0.872|0.884
Relative|All cancers combined|2015–2019|Persons|5|40–44|0.86|0.855|0.865
Relative|All cancers combined|2015–2019|Persons|5|45–49|0.839|0.835|0.843
Relative|All cancers combined|2015–2019|Persons|5|50–54|0.81|0.806|0.814
Relative|All cancers combined|2015–2019|Persons|5|55–59|0.779|0.776|0.783
Relative|All cancers combined|2015–2019|Persons|5|60–64|0.761|0.758|0.764
Relative|All cancers combined|2015–2019|Persons|5|65–69|0.745|0.742|0.748
Relative|All cancers combined|2015–2019|Persons|5|70–74|0.691|0.687|0.695
Relative|All cancers combined|2015–2019|Persons|5|75–79|0.619|0.614|0.623
Relative|All cancers combined|2015–2019|Persons|5|80–84|0.527|0.521|0.532
Relative|All cancers combined|2015–2019|Persons|5|85+|0.407|0.4|0.414
Relative|All cancers combined|2015–2019|Persons|5|All ages combined|0.706|0.705|0.708
Observed|All sarcomas combined|2015–2019|Males|1|00–04|0.854|0.746|0.919
Observed|All sarcomas combined|2015–2019|Males|1|05–09|0.928|0.819|0.972
Observed|All sarcomas combined|2015–2019|Males|1|10–14|0.963|0.89|0.988
Observed|All sarcomas combined|2015–2019|Males|1|15–19|0.915|0.861|0.949
Observed|All sarcomas combined|2015–2019|Males|1|20–24|0.868|0.79|0.918
Observed|All sarcomas combined|2015–2019|Males|1|25–29|0.883|0.811|0.929
Observed|All sarcomas combined|2015–2019|Males|1|30–34|0.966|0.912|0.987
Observed|All sarcomas combined|2015–2019|Males|1|35–39|0.943|0.894|0.97
Observed|All sarcomas combined|2015–2019|Males|1|40–44|0.947|0.904|0.971
Observed|All sarcomas combined|2015–2019|Males|1|45–49|0.917|0.875|0.945
Observed|All sarcomas combined|2015–2019|Males|1|50–54|0.915|0.879|0.941
Observed|All sarcomas combined|2015–2019|Males|1|55–59|0.885|0.851|0.912
Observed|All sarcomas combined|2015–2019|Males|1|60–64|0.871|0.84|0.896
Observed|All sarcomas combined|2015–2019|Males|1|65–69|0.863|0.833|0.888
Observed|All sarcomas combined|2015–2019|Males|1|70–74|0.805|0.772|0.833
Observed|All sarcomas combined|2015–2019|Males|1|75–79|0.807|0.773|0.836
Observed|All sarcomas combined|2015–2019|Males|1|80–84|0.769|0.731|0.802
Observed|All sarcomas combined|2015–2019|Males|1|85+|0.671|0.629|0.708
Observed|All sarcomas combined|2015–2019|Males|1|All ages combined|0.842|0.832|0.851
Observed|All sarcomas combined|2015–2019|Males|2|00–04|0.745|0.622|0.833
Observed|All sarcomas combined|2015–2019|Males|2|05–09|0.89|0.771|0.949
Observed|All sarcomas combined|2015–2019|Males|2|10–14|0.938|0.858|0.974
Observed|All sarcomas combined|2015–2019|Males|2|15–19|0.786|0.712|0.843
Observed|All sarcomas combined|2015–2019|Males|2|20–24|0.758|0.667|0.827
Observed|All sarcomas combined|2015–2019|Males|2|25–29|0.766|0.679|0.832
Observed|All sarcomas combined|2015–2019|Males|2|30–34|0.903|0.831|0.945
Observed|All sarcomas combined|2015–2019|Males|2|35–39|0.866|0.802|0.91
Observed|All sarcomas combined|2015–2019|Males|2|40–44|0.873|0.817|0.913
Observed|All sarcomas combined|2015–2019|Males|2|45–49|0.863|0.814|0.899
Observed|All sarcomas combined|2015–2019|Males|2|50–54|0.825|0.779|0.863
Observed|All sarcomas combined|2015–2019|Males|2|55–59|0.837|0.799|0.869
Observed|All sarcomas combined|2015–2019|Males|2|60–64|0.799|0.763|0.83
Observed|All sarcomas combined|2015–2019|Males|2|65–69|0.765|0.729|0.797
Observed|All sarcomas combined|2015–2019|Males|2|70–74|0.721|0.685|0.754
Observed|All sarcomas combined|2015–2019|Males|2|75–79|0.727|0.689|0.761
Observed|All sarcomas combined|2015–2019|Males|2|80–84|0.651|0.609|0.69
Observed|All sarcomas combined|2015–2019|Males|2|85+|0.49|0.446|0.532
Observed|All sarcomas combined|2015–2019|Males|2|All ages combined|0.749|0.738|0.76
Observed|All sarcomas combined|2015–2019|Males|3|00–04|0.745|0.622|0.833
Observed|All sarcomas combined|2015–2019|Males|3|05–09|0.851|0.724|0.923
Observed|All sarcomas combined|2015–2019|Males|3|10–14|0.872|0.775|0.929
Observed|All sarcomas combined|2015–2019|Males|3|15–19|0.736|0.657|0.799
Observed|All sarcomas combined|2015–2019|Males|3|20–24|0.724|0.631|0.797
Observed|All sarcomas combined|2015–2019|Males|3|25–29|0.708|0.618|0.781
Observed|All sarcomas combined|2015–2019|Males|3|30–34|0.869|0.792|0.919
Observed|All sarcomas combined|2015–2019|Males|3|35–39|0.84|0.773|0.889
Observed|All sarcomas combined|2015–2019|Males|3|40–44|0.814|0.75|0.863
Observed|All sarcomas combined|2015–2019|Males|3|45–49|0.805|0.752|0.849
Observed|All sarcomas combined|2015–2019|Males|3|50–54|0.792|0.744|0.833
Observed|All sarcomas combined|2015–2019|Males|3|55–59|0.807|0.766|0.841
Observed|All sarcomas combined|2015–2019|Males|3|60–64|0.753|0.715|0.787
Observed|All sarcomas combined|2015–2019|Males|3|65–69|0.701|0.662|0.736
Observed|All sarcomas combined|2015–2019|Males|3|70–74|0.67|0.632|0.705
Observed|All sarcomas combined|2015–2019|Males|3|75–79|0.641|0.6|0.678
Observed|All sarcomas combined|2015–2019|Males|3|80–84|0.543|0.499|0.585
Observed|All sarcomas combined|2015–2019|Males|3|85+|0.365|0.323|0.406
Observed|All sarcomas combined|2015–2019|Males|3|All ages combined|0.686|0.673|0.698
Observed|All sarcomas combined|2015–2019|Males|4|00–04|0.699|0.573|0.794
Observed|All sarcomas combined|2015–2019|Males|4|05–09|0.851|0.724|0.923
Observed|All sarcomas combined|2015–2019|Males|4|10–14|0.835|0.732|0.9
Observed|All sarcomas combined|2015–2019|Males|4|15–19|0.652|0.568|0.724
Observed|All sarcomas combined|2015–2019|Males|4|20–24|0.668|0.574|0.746
Observed|All sarcomas combined|2015–2019|Males|4|25–29|0.708|0.618|0.781
Observed|All sarcomas combined|2015–2019|Males|4|30–34|0.836|0.754|0.892
Observed|All sarcomas combined|2015–2019|Males|4|35–39|0.795|0.723|0.851
Observed|All sarcomas combined|2015–2019|Males|4|40–44|0.755|0.686|0.81
Observed|All sarcomas combined|2015–2019|Males|4|45–49|0.774|0.718|0.82
Observed|All sarcomas combined|2015–2019|Males|4|50–54|0.764|0.714|0.806
Observed|All sarcomas combined|2015–2019|Males|4|55–59|0.773|0.73|0.81
Observed|All sarcomas combined|2015–2019|Males|4|60–64|0.724|0.684|0.759
Observed|All sarcomas combined|2015–2019|Males|4|65–69|0.658|0.618|0.695
Observed|All sarcomas combined|2015–2019|Males|4|70–74|0.637|0.598|0.674
Observed|All sarcomas combined|2015–2019|Males|4|75–79|0.581|0.539|0.621
Observed|All sarcomas combined|2015–2019|Males|4|80–84|0.47|0.425|0.514
Observed|All sarcomas combined|2015–2019|Males|4|85+|0.287|0.248|0.328
Observed|All sarcomas combined|2015–2019|Males|4|All ages combined|0.641|0.628|0.654
Observed|All sarcomas combined|2015–2019|Males|5|00–04|0.699|0.573|0.794
Observed|All sarcomas combined|2015–2019|Males|5|05–09|0.832|0.701|0.909
Observed|All sarcomas combined|2015–2019|Males|5|10–14|0.809|0.703|0.88
Observed|All sarcomas combined|2015–2019|Males|5|15–19|0.587|0.5|0.664
Observed|All sarcomas combined|2015–2019|Males|5|20–24|0.652|0.558|0.731
Observed|All sarcomas combined|2015–2019|Males|5|25–29|0.684|0.593|0.759
Observed|All sarcomas combined|2015–2019|Males|5|30–34|0.819|0.736|0.878
Observed|All sarcomas combined|2015–2019|Males|5|35–39|0.789|0.717|0.845
Observed|All sarcomas combined|2015–2019|Males|5|40–44|0.724|0.654|0.782
Observed|All sarcomas combined|2015–2019|Males|5|45–49|0.753|0.697|0.801
Observed|All sarcomas combined|2015–2019|Males|5|50–54|0.752|0.701|0.795
Observed|All sarcomas combined|2015–2019|Males|5|55–59|0.763|0.719|0.8
Observed|All sarcomas combined|2015–2019|Males|5|60–64|0.701|0.66|0.737
Observed|All sarcomas combined|2015–2019|Males|5|65–69|0.629|0.588|0.667
Observed|All sarcomas combined|2015–2019|Males|5|70–74|0.591|0.551|0.63
Observed|All sarcomas combined|2015–2019|Males|5|75–79|0.533|0.49|0.574
Observed|All sarcomas combined|2015–2019|Males|5|80–84|0.399|0.354|0.443
Observed|All sarcomas combined|2015–2019|Males|5|85+|0.218|0.181|0.258
Observed|All sarcomas combined|2015–2019|Males|5|All ages combined|0.608|0.594|0.621
Relative|All sarcomas combined|2015–2019|Males|1|00–04|0.855|0.747|0.92
Relative|All sarcomas combined|2015–2019|Males|1|05–09|0.928|0.819|0.972
Relative|All sarcomas combined|2015–2019|Males|1|10–14|0.963|0.89|0.988
Relative|All sarcomas combined|2015–2019|Males|1|15–19|0.916|0.861|0.949
Relative|All sarcomas combined|2015–2019|Males|1|20–24|0.868|0.791|0.919
Relative|All sarcomas combined|2015–2019|Males|1|25–29|0.884|0.812|0.93
Relative|All sarcomas combined|2015–2019|Males|1|30–34|0.967|0.913|0.988
Relative|All sarcomas combined|2015–2019|Males|1|35–39|0.944|0.895|0.971
Relative|All sarcomas combined|2015–2019|Males|1|40–44|0.949|0.905|0.973
Relative|All sarcomas combined|2015–2019|Males|1|45–49|0.919|0.877|0.947
Relative|All sarcomas combined|2015–2019|Males|1|50–54|0.918|0.882|0.944
Relative|All sarcomas combined|2015–2019|Males|1|55–59|0.89|0.855|0.917
Relative|All sarcomas combined|2015–2019|Males|1|60–64|0.878|0.846|0.903
Relative|All sarcomas combined|2015–2019|Males|1|65–69|0.874|0.843|0.899
Relative|All sarcomas combined|2015–2019|Males|1|70–74|0.82|0.787|0.849
Relative|All sarcomas combined|2015–2019|Males|1|75–79|0.835|0.8|0.865
Relative|All sarcomas combined|2015–2019|Males|1|80–84|0.816|0.776|0.852
Relative|All sarcomas combined|2015–2019|Males|1|85+|0.776|0.728|0.82
Relative|All sarcomas combined|2015–2019|Males|1|All ages combined|0.866|0.856|0.875
Relative|All sarcomas combined|2015–2019|Males|2|00–04|0.746|0.623|0.834
Relative|All sarcomas combined|2015–2019|Males|2|05–09|0.89|0.771|0.949
Relative|All sarcomas combined|2015–2019|Males|2|10–14|0.938|0.858|0.974
Relative|All sarcomas combined|2015–2019|Males|2|15–19|0.787|0.713|0.844
Relative|All sarcomas combined|2015–2019|Males|2|20–24|0.759|0.668|0.828
Relative|All sarcomas combined|2015–2019|Males|2|25–29|0.767|0.68|0.833
Relative|All sarcomas combined|2015–2019|Males|2|30–34|0.904|0.833|0.947
Relative|All sarcomas combined|2015–2019|Males|2|35–39|0.868|0.804|0.913
Relative|All sarcomas combined|2015–2019|Males|2|40–44|0.876|0.82|0.916
Relative|All sarcomas combined|2015–2019|Males|2|45–49|0.867|0.818|0.904
Relative|All sarcomas combined|2015–2019|Males|2|50–54|0.831|0.785|0.869
Relative|All sarcomas combined|2015–2019|Males|2|55–59|0.846|0.808|0.878
Relative|All sarcomas combined|2015–2019|Males|2|60–64|0.812|0.776|0.844
Relative|All sarcomas combined|2015–2019|Males|2|65–69|0.784|0.747|0.817
Relative|All sarcomas combined|2015–2019|Males|2|70–74|0.751|0.713|0.785
Relative|All sarcomas combined|2015–2019|Males|2|75–79|0.781|0.74|0.817
Relative|All sarcomas combined|2015–2019|Males|2|80–84|0.74|0.692|0.784
Relative|All sarcomas combined|2015–2019|Males|2|85+|0.662|0.603|0.719
Relative|All sarcomas combined|2015–2019|Males|2|All ages combined|0.791|0.779|0.803
Relative|All sarcomas combined|2015–2019|Males|3|00–04|0.746|0.623|0.834
Relative|All sarcomas combined|2015–2019|Males|3|05–09|0.851|0.724|0.923
Relative|All sarcomas combined|2015–2019|Males|3|10–14|0.873|0.775|0.93
Relative|All sarcomas combined|2015–2019|Males|3|15–19|0.737|0.658|0.8
Relative|All sarcomas combined|2015–2019|Males|3|20–24|0.725|0.632|0.798
Relative|All sarcomas combined|2015–2019|Males|3|25–29|0.71|0.619|0.782
Relative|All sarcomas combined|2015–2019|Males|3|30–34|0.871|0.794|0.921
Relative|All sarcomas combined|2015–2019|Males|3|35–39|0.843|0.776|0.892
Relative|All sarcomas combined|2015–2019|Males|3|40–44|0.818|0.754|0.867
Relative|All sarcomas combined|2015–2019|Males|3|45–49|0.812|0.757|0.855
Relative|All sarcomas combined|2015–2019|Males|3|50–54|0.801|0.753|0.842
Relative|All sarcomas combined|2015–2019|Males|3|55–59|0.821|0.779|0.855
Relative|All sarcomas combined|2015–2019|Males|3|60–64|0.773|0.734|0.808
Relative|All sarcomas combined|2015–2019|Males|3|65–69|0.729|0.689|0.766
Relative|All sarcomas combined|2015–2019|Males|3|70–74|0.715|0.674|0.753
Relative|All sarcomas combined|2015–2019|Males|3|75–79|0.718|0.673|0.76
Relative|All sarcomas combined|2015–2019|Males|3|80–84|0.667|0.612|0.719
Relative|All sarcomas combined|2015–2019|Males|3|85+|0.58|0.514|0.647
Relative|All sarcomas combined|2015–2019|Males|3|All ages combined|0.743|0.729|0.756
Relative|All sarcomas combined|2015–2019|Males|4|00–04|0.7|0.574|0.796
Relative|All sarcomas combined|2015–2019|Males|4|05–09|0.852|0.725|0.923
Relative|All sarcomas combined|2015–2019|Males|4|10–14|0.835|0.733|0.901
Relative|All sarcomas combined|2015–2019|Males|4|15–19|0.654|0.569|0.725
Relative|All sarcomas combined|2015–2019|Males|4|20–24|0.669|0.575|0.747
Relative|All sarcomas combined|2015–2019|Males|4|25–29|0.71|0.62|0.783
Relative|All sarcomas combined|2015–2019|Males|4|30–34|0.839|0.757|0.895
Relative|All sarcomas combined|2015–2019|Males|4|35–39|0.799|0.727|0.855
Relative|All sarcomas combined|2015–2019|Males|4|40–44|0.76|0.692|0.816
Relative|All sarcomas combined|2015–2019|Males|4|45–49|0.782|0.726|0.829
Relative|All sarcomas combined|2015–2019|Males|4|50–54|0.776|0.725|0.819
Relative|All sarcomas combined|2015–2019|Males|4|55–59|0.791|0.748|0.829
Relative|All sarcomas combined|2015–2019|Males|4|60–64|0.75|0.709|0.787
Relative|All sarcomas combined|2015–2019|Males|4|65–69|0.696|0.654|0.736
Relative|All sarcomas combined|2015–2019|Males|4|70–74|0.698|0.655|0.738
Relative|All sarcomas combined|2015–2019|Males|4|75–79|0.683|0.634|0.729
Relative|All sarcomas combined|2015–2019|Males|4|80–84|0.631|0.57|0.689
Relative|All sarcomas combined|2015–2019|Males|4|85+|0.546|0.471|0.624
Relative|All sarcomas combined|2015–2019|Males|4|All ages combined|0.711|0.697|0.725
Relative|All sarcomas combined|2015–2019|Males|5|00–04|0.7|0.574|0.796
Relative|All sarcomas combined|2015–2019|Males|5|05–09|0.832|0.702|0.909
Relative|All sarcomas combined|2015–2019|Males|5|10–14|0.81|0.704|0.881
Relative|All sarcomas combined|2015–2019|Males|5|15–19|0.588|0.501|0.665
Relative|All sarcomas combined|2015–2019|Males|5|20–24|0.654|0.559|0.733
Relative|All sarcomas combined|2015–2019|Males|5|25–29|0.687|0.595|0.762
Relative|All sarcomas combined|2015–2019|Males|5|30–34|0.823|0.739|0.882
Relative|All sarcomas combined|2015–2019|Males|5|35–39|0.795|0.721|0.851
Relative|All sarcomas combined|2015–2019|Males|5|40–44|0.731|0.66|0.789
Relative|All sarcomas combined|2015–2019|Males|5|45–49|0.764|0.707|0.812
Relative|All sarcomas combined|2015–2019|Males|5|50–54|0.768|0.716|0.812
Relative|All sarcomas combined|2015–2019|Males|5|55–59|0.787|0.742|0.826
Relative|All sarcomas combined|2015–2019|Males|5|60–64|0.735|0.692|0.773
Relative|All sarcomas combined|2015–2019|Males|5|65–69|0.677|0.633|0.718
Relative|All sarcomas combined|2015–2019|Males|5|70–74|0.668|0.622|0.712
Relative|All sarcomas combined|2015–2019|Males|5|75–79|0.662|0.608|0.712
Relative|All sarcomas combined|2015–2019|Males|5|80–84|0.591|0.524|0.656
Relative|All sarcomas combined|2015–2019|Males|5|85+|0.505|0.42|0.596
Relative|All sarcomas combined|2015–2019|Males|5|All ages combined|0.691|0.676|0.705
Observed|All sarcomas combined|2015–2019|Females|1|00–04|0.912|0.782|0.966
Observed|All sarcomas combined|2015–2019|Females|1|05–09|0.924|0.811|0.971
Observed|All sarcomas combined|2015–2019|Females|1|10–14|0.901|0.819|0.947
Observed|All sarcomas combined|2015–2019|Females|1|15–19|0.945|0.881|0.975
Observed|All sarcomas combined|2015–2019|Females|1|20–24|0.955|0.884|0.983
Observed|All sarcomas combined|2015–2019|Females|1|25–29|0.936|0.853|0.973
Observed|All sarcomas combined|2015–2019|Females|1|30–34|0.96|0.913|0.982
Observed|All sarcomas combined|2015–2019|Females|1|35–39|0.944|0.895|0.97
Observed|All sarcomas combined|2015–2019|Females|1|40–44|0.959|0.925|0.978
Observed|All sarcomas combined|2015–2019|Females|1|45–49|0.93|0.897|0.952
Observed|All sarcomas combined|2015–2019|Females|1|50–54|0.917|0.886|0.94
Observed|All sarcomas combined|2015–2019|Females|1|55–59|0.87|0.835|0.898
Observed|All sarcomas combined|2015–2019|Females|1|60–64|0.899|0.867|0.924
Observed|All sarcomas combined|2015–2019|Females|1|65–69|0.852|0.817|0.881
Observed|All sarcomas combined|2015–2019|Females|1|70–74|0.823|0.784|0.856
Observed|All sarcomas combined|2015–2019|Females|1|75–79|0.771|0.724|0.81
Observed|All sarcomas combined|2015–2019|Females|1|80–84|0.734|0.682|0.779
Observed|All sarcomas combined|2015–2019|Females|1|85+|0.65|0.597|0.698
Observed|All sarcomas combined|2015–2019|Females|1|All ages combined|0.858|0.847|0.868
Observed|All sarcomas combined|2015–2019|Females|2|00–04|0.89|0.755|0.953
Observed|All sarcomas combined|2015–2019|Females|2|05–09|0.906|0.788|0.96
Observed|All sarcomas combined|2015–2019|Females|2|10–14|0.804|0.708|0.872
Observed|All sarcomas combined|2015–2019|Females|2|15–19|0.882|0.802|0.931
Observed|All sarcomas combined|2015–2019|Females|2|20–24|0.848|0.752|0.909
Observed|All sarcomas combined|2015–2019|Females|2|25–29|0.887|0.794|0.939
Observed|All sarcomas combined|2015–2019|Females|2|30–34|0.898|0.837|0.937
Observed|All sarcomas combined|2015–2019|Females|2|35–39|0.872|0.809|0.916
Observed|All sarcomas combined|2015–2019|Females|2|40–44|0.896|0.85|0.929
Observed|All sarcomas combined|2015–2019|Females|2|45–49|0.883|0.844|0.913
Observed|All sarcomas combined|2015–2019|Females|2|50–54|0.848|0.81|0.88
Observed|All sarcomas combined|2015–2019|Females|2|55–59|0.78|0.738|0.816
Observed|All sarcomas combined|2015–2019|Females|2|60–64|0.827|0.788|0.86
Observed|All sarcomas combined|2015–2019|Females|2|65–69|0.786|0.746|0.821
Observed|All sarcomas combined|2015–2019|Females|2|70–74|0.747|0.703|0.785
Observed|All sarcomas combined|2015–2019|Females|2|75–79|0.669|0.618|0.714
Observed|All sarcomas combined|2015–2019|Females|2|80–84|0.642|0.587|0.692
Observed|All sarcomas combined|2015–2019|Females|2|85+|0.499|0.445|0.551
Observed|All sarcomas combined|2015–2019|Females|2|All ages combined|0.778|0.766|0.79
Observed|All sarcomas combined|2015–2019|Females|3|00–04|0.89|0.755|0.953
Observed|All sarcomas combined|2015–2019|Females|3|05–09|0.906|0.788|0.96
Observed|All sarcomas combined|2015–2019|Females|3|10–14|0.743|0.642|0.819
Observed|All sarcomas combined|2015–2019|Females|3|15–19|0.797|0.702|0.864
Observed|All sarcomas combined|2015–2019|Females|3|20–24|0.816|0.717|0.883
Observed|All sarcomas combined|2015–2019|Females|3|25–29|0.875|0.781|0.931
Observed|All sarcomas combined|2015–2019|Females|3|30–34|0.848|0.779|0.897
Observed|All sarcomas combined|2015–2019|Females|3|35–39|0.851|0.784|0.899
Observed|All sarcomas combined|2015–2019|Females|3|40–44|0.87|0.82|0.906
Observed|All sarcomas combined|2015–2019|Females|3|45–49|0.833|0.789|0.868
Observed|All sarcomas combined|2015–2019|Females|3|50–54|0.798|0.756|0.833
Observed|All sarcomas combined|2015–2019|Females|3|55–59|0.734|0.689|0.773
Observed|All sarcomas combined|2015–2019|Females|3|60–64|0.793|0.752|0.829
Observed|All sarcomas combined|2015–2019|Females|3|65–69|0.718|0.674|0.756
Observed|All sarcomas combined|2015–2019|Females|3|70–74|0.69|0.644|0.732
Observed|All sarcomas combined|2015–2019|Females|3|75–79|0.607|0.555|0.654
Observed|All sarcomas combined|2015–2019|Females|3|80–84|0.577|0.52|0.63
Observed|All sarcomas combined|2015–2019|Females|3|85+|0.386|0.334|0.437
Observed|All sarcomas combined|2015–2019|Females|3|All ages combined|0.724|0.711|0.737
Observed|All sarcomas combined|2015–2019|Females|4|00–04|0.89|0.755|0.953
Observed|All sarcomas combined|2015–2019|Females|4|05–09|0.906|0.788|0.96
Observed|All sarcomas combined|2015–2019|Females|4|10–14|0.649|0.544|0.736
Observed|All sarcomas combined|2015–2019|Females|4|15–19|0.714|0.61|0.795
Observed|All sarcomas combined|2015–2019|Females|4|20–24|0.804|0.704|0.873
Observed|All sarcomas combined|2015–2019|Females|4|25–29|0.864|0.768|0.922
Observed|All sarcomas combined|2015–2019|Females|4|30–34|0.815|0.74|0.871
Observed|All sarcomas combined|2015–2019|Females|4|35–39|0.813|0.74|0.867
Observed|All sarcomas combined|2015–2019|Females|4|40–44|0.85|0.797|0.89
Observed|All sarcomas combined|2015–2019|Females|4|45–49|0.795|0.748|0.834
Observed|All sarcomas combined|2015–2019|Females|4|50–54|0.773|0.73|0.811
Observed|All sarcomas combined|2015–2019|Females|4|55–59|0.706|0.661|0.747
Observed|All sarcomas combined|2015–2019|Females|4|60–64|0.741|0.696|0.78
Observed|All sarcomas combined|2015–2019|Females|4|65–69|0.681|0.636|0.721
Observed|All sarcomas combined|2015–2019|Females|4|70–74|0.644|0.596|0.688
Observed|All sarcomas combined|2015–2019|Females|4|75–79|0.547|0.495|0.597
Observed|All sarcomas combined|2015–2019|Females|4|80–84|0.508|0.45|0.563
Observed|All sarcomas combined|2015–2019|Females|4|85+|0.281|0.233|0.331
Observed|All sarcomas combined|2015–2019|Females|4|All ages combined|0.679|0.665|0.692
Observed|All sarcomas combined|2015–2019|Females|5|00–04|0.89|0.755|0.953
Observed|All sarcomas combined|2015–2019|Females|5|05–09|0.906|0.788|0.96
Observed|All sarcomas combined|2015–2019|Females|5|10–14|0.649|0.544|0.736
Observed|All sarcomas combined|2015–2019|Females|5|15–19|0.687|0.58|0.772
Observed|All sarcomas combined|2015–2019|Females|5|20–24|0.76|0.656|0.836
Observed|All sarcomas combined|2015–2019|Females|5|25–29|0.834|0.736|0.898
Observed|All sarcomas combined|2015–2019|Females|5|30–34|0.79|0.711|0.849
Observed|All sarcomas combined|2015–2019|Females|5|35–39|0.792|0.717|0.849
Observed|All sarcomas combined|2015–2019|Females|5|40–44|0.821|0.765|0.865
Observed|All sarcomas combined|2015–2019|Females|5|45–49|0.769|0.72|0.81
Observed|All sarcomas combined|2015–2019|Females|5|50–54|0.771|0.727|0.808
Observed|All sarcomas combined|2015–2019|Females|5|55–59|0.683|0.636|0.725
Observed|All sarcomas combined|2015–2019|Females|5|60–64|0.705|0.659|0.747
Observed|All sarcomas combined|2015–2019|Females|5|65–69|0.647|0.601|0.689
Observed|All sarcomas combined|2015–2019|Females|5|70–74|0.607|0.558|0.653
Observed|All sarcomas combined|2015–2019|Females|5|75–79|0.502|0.45|0.552
Observed|All sarcomas combined|2015–2019|Females|5|80–84|0.443|0.385|0.499
Observed|All sarcomas combined|2015–2019|Females|5|85+|0.209|0.166|0.257
Observed|All sarcomas combined|2015–2019|Females|5|All ages combined|0.646|0.632|0.66
Relative|All sarcomas combined|2015–2019|Females|1|00–04|0.912|0.782|0.967
Relative|All sarcomas combined|2015–2019|Females|1|05–09|0.924|0.811|0.971
Relative|All sarcomas combined|2015–2019|Females|1|10–14|0.901|0.819|0.947
Relative|All sarcomas combined|2015–2019|Females|1|15–19|0.945|0.882|0.975
Relative|All sarcomas combined|2015–2019|Females|1|20–24|0.955|0.884|0.983
Relative|All sarcomas combined|2015–2019|Females|1|25–29|0.936|0.853|0.973
Relative|All sarcomas combined|2015–2019|Females|1|30–34|0.961|0.914|0.982
Relative|All sarcomas combined|2015–2019|Females|1|35–39|0.945|0.896|0.971
Relative|All sarcomas combined|2015–2019|Females|1|40–44|0.96|0.926|0.979
Relative|All sarcomas combined|2015–2019|Females|1|45–49|0.931|0.898|0.954
Relative|All sarcomas combined|2015–2019|Females|1|50–54|0.919|0.888|0.942
Relative|All sarcomas combined|2015–2019|Females|1|55–59|0.873|0.837|0.901
Relative|All sarcomas combined|2015–2019|Females|1|60–64|0.903|0.871|0.928
Relative|All sarcomas combined|2015–2019|Females|1|65–69|0.858|0.823|0.888
Relative|All sarcomas combined|2015–2019|Females|1|70–74|0.833|0.794|0.867
Relative|All sarcomas combined|2015–2019|Females|1|75–79|0.788|0.74|0.828
Relative|All sarcomas combined|2015–2019|Females|1|80–84|0.765|0.711|0.812
Relative|All sarcomas combined|2015–2019|Females|1|85+|0.729|0.669|0.782
Relative|All sarcomas combined|2015–2019|Females|1|All ages combined|0.872|0.861|0.881
Relative|All sarcomas combined|2015–2019|Females|2|00–04|0.891|0.756|0.954
Relative|All sarcomas combined|2015–2019|Females|2|05–09|0.906|0.788|0.96
Relative|All sarcomas combined|2015–2019|Females|2|10–14|0.804|0.708|0.872
Relative|All sarcomas combined|2015–2019|Females|2|15–19|0.883|0.802|0.932
Relative|All sarcomas combined|2015–2019|Females|2|20–24|0.848|0.753|0.909
Relative|All sarcomas combined|2015–2019|Females|2|25–29|0.887|0.794|0.94
Relative|All sarcomas combined|2015–2019|Females|2|30–34|0.899|0.838|0.938
Relative|All sarcomas combined|2015–2019|Females|2|35–39|0.874|0.81|0.917
Relative|All sarcomas combined|2015–2019|Females|2|40–44|0.898|0.852|0.931
Relative|All sarcomas combined|2015–2019|Females|2|45–49|0.886|0.846|0.915
Relative|All sarcomas combined|2015–2019|Females|2|50–54|0.852|0.814|0.883
Relative|All sarcomas combined|2015–2019|Females|2|55–59|0.785|0.743|0.821
Relative|All sarcomas combined|2015–2019|Females|2|60–64|0.835|0.796|0.868
Relative|All sarcomas combined|2015–2019|Females|2|65–69|0.798|0.758|0.833
Relative|All sarcomas combined|2015–2019|Females|2|70–74|0.766|0.721|0.806
Relative|All sarcomas combined|2015–2019|Females|2|75–79|0.701|0.647|0.748
Relative|All sarcomas combined|2015–2019|Females|2|80–84|0.703|0.642|0.757
Relative|All sarcomas combined|2015–2019|Females|2|85+|0.634|0.565|0.699
Relative|All sarcomas combined|2015–2019|Females|2|All ages combined|0.802|0.79|0.814
Relative|All sarcomas combined|2015–2019|Females|3|00–04|0.891|0.756|0.954
Relative|All sarcomas combined|2015–2019|Females|3|05–09|0.906|0.788|0.96
Relative|All sarcomas combined|2015–2019|Females|3|10–14|0.743|0.642|0.82
Relative|All sarcomas combined|2015–2019|Females|3|15–19|0.797|0.703|0.865
Relative|All sarcomas combined|2015–2019|Females|3|20–24|0.816|0.717|0.883
Relative|All sarcomas combined|2015–2019|Females|3|25–29|0.876|0.781|0.932
Relative|All sarcomas combined|2015–2019|Females|3|30–34|0.849|0.78|0.899
Relative|All sarcomas combined|2015–2019|Females|3|35–39|0.853|0.786|0.9
Relative|All sarcomas combined|2015–2019|Females|3|40–44|0.872|0.822|0.909
Relative|All sarcomas combined|2015–2019|Females|3|45–49|0.837|0.792|0.872
Relative|All sarcomas combined|2015–2019|Females|3|50–54|0.804|0.761|0.839
Relative|All sarcomas combined|2015–2019|Females|3|55–59|0.741|0.697|0.781
Relative|All sarcomas combined|2015–2019|Females|3|60–64|0.805|0.763|0.841
Relative|All sarcomas combined|2015–2019|Females|3|65–69|0.735|0.691|0.775
Relative|All sarcomas combined|2015–2019|Females|3|70–74|0.719|0.671|0.762
Relative|All sarcomas combined|2015–2019|Females|3|75–79|0.653|0.597|0.705
Relative|All sarcomas combined|2015–2019|Females|3|80–84|0.667|0.601|0.728
Relative|All sarcomas combined|2015–2019|Females|3|85+|0.56|0.484|0.635
Relative|All sarcomas combined|2015–2019|Females|3|All ages combined|0.757|0.743|0.771
Relative|All sarcomas combined|2015–2019|Females|4|00–04|0.891|0.756|0.954
Relative|All sarcomas combined|2015–2019|Females|4|05–09|0.906|0.788|0.96
Relative|All sarcomas combined|2015–2019|Females|4|10–14|0.649|0.544|0.736
Relative|All sarcomas combined|2015–2019|Females|4|15–19|0.715|0.611|0.796
Relative|All sarcomas combined|2015–2019|Females|4|20–24|0.805|0.705|0.874
Relative|All sarcomas combined|2015–2019|Females|4|25–29|0.865|0.769|0.923
Relative|All sarcomas combined|2015–2019|Females|4|30–34|0.817|0.742|0.872
Relative|All sarcomas combined|2015–2019|Females|4|35–39|0.815|0.742|0.87
Relative|All sarcomas combined|2015–2019|Females|4|40–44|0.854|0.801|0.894
Relative|All sarcomas combined|2015–2019|Females|4|45–49|0.8|0.753|0.839
Relative|All sarcomas combined|2015–2019|Females|4|50–54|0.781|0.737|0.819
Relative|All sarcomas combined|2015–2019|Females|4|55–59|0.716|0.67|0.758
Relative|All sarcomas combined|2015–2019|Females|4|60–64|0.757|0.711|0.797
Relative|All sarcomas combined|2015–2019|Females|4|65–69|0.705|0.658|0.746
Relative|All sarcomas combined|2015–2019|Females|4|70–74|0.683|0.632|0.729
Relative|All sarcomas combined|2015–2019|Females|4|75–79|0.609|0.551|0.664
Relative|All sarcomas combined|2015–2019|Females|4|80–84|0.625|0.554|0.693
Relative|All sarcomas combined|2015–2019|Females|4|85+|0.474|0.393|0.558
Relative|All sarcomas combined|2015–2019|Females|4|All ages combined|0.72|0.706|0.735
Relative|All sarcomas combined|2015–2019|Females|5|00–04|0.891|0.756|0.954
Relative|All sarcomas combined|2015–2019|Females|5|05–09|0.906|0.788|0.96
Relative|All sarcomas combined|2015–2019|Females|5|10–14|0.649|0.544|0.736
Relative|All sarcomas combined|2015–2019|Females|5|15–19|0.687|0.58|0.773
Relative|All sarcomas combined|2015–2019|Females|5|20–24|0.761|0.657|0.837
Relative|All sarcomas combined|2015–2019|Females|5|25–29|0.836|0.737|0.9
Relative|All sarcomas combined|2015–2019|Females|5|30–34|0.792|0.712|0.851
Relative|All sarcomas combined|2015–2019|Females|5|35–39|0.795|0.719|0.852
Relative|All sarcomas combined|2015–2019|Females|5|40–44|0.826|0.769|0.87
Relative|All sarcomas combined|2015–2019|Females|5|45–49|0.775|0.726|0.817
Relative|All sarcomas combined|2015–2019|Females|5|50–54|0.781|0.736|0.819
Relative|All sarcomas combined|2015–2019|Females|5|55–59|0.696|0.648|0.738
Relative|All sarcomas combined|2015–2019|Females|5|60–64|0.725|0.677|0.768
Relative|All sarcomas combined|2015–2019|Females|5|65–69|0.677|0.629|0.721
Relative|All sarcomas combined|2015–2019|Females|5|70–74|0.656|0.603|0.705
Relative|All sarcomas combined|2015–2019|Females|5|75–79|0.58|0.519|0.637
Relative|All sarcomas combined|2015–2019|Females|5|80–84|0.586|0.51|0.66
Relative|All sarcomas combined|2015–2019|Females|5|85+|0.414|0.328|0.508
Relative|All sarcomas combined|2015–2019|Females|5|All ages combined|0.696|0.68|0.711
Observed|All sarcomas combined|2015–2019|Persons|1|00–04|0.877|0.801|0.925
Observed|All sarcomas combined|2015–2019|Persons|1|05–09|0.926|0.858|0.962
Observed|All sarcomas combined|2015–2019|Persons|1|10–14|0.93|0.881|0.96
Observed|All sarcomas combined|2015–2019|Persons|1|15–19|0.927|0.889|0.952
Observed|All sarcomas combined|2015–2019|Persons|1|20–24|0.906|0.856|0.939
Observed|All sarcomas combined|2015–2019|Persons|1|25–29|0.904|0.854|0.938
Observed|All sarcomas combined|2015–2019|Persons|1|30–34|0.963|0.932|0.98
Observed|All sarcomas combined|2015–2019|Persons|1|35–39|0.944|0.912|0.964
Observed|All sarcomas combined|2015–2019|Persons|1|40–44|0.954|0.929|0.97
Observed|All sarcomas combined|2015–2019|Persons|1|45–49|0.924|0.9|0.943
Observed|All sarcomas combined|2015–2019|Persons|1|50–54|0.916|0.894|0.934
Observed|All sarcomas combined|2015–2019|Persons|1|55–59|0.877|0.854|0.897
Observed|All sarcomas combined|2015–2019|Persons|1|60–64|0.883|0.861|0.901
Observed|All sarcomas combined|2015–2019|Persons|1|65–69|0.858|0.836|0.878
Observed|All sarcomas combined|2015–2019|Persons|1|70–74|0.812|0.788|0.834
Observed|All sarcomas combined|2015–2019|Persons|1|75–79|0.793|0.767|0.817
Observed|All sarcomas combined|2015–2019|Persons|1|80–84|0.756|0.726|0.783
Observed|All sarcomas combined|2015–2019|Persons|1|85+|0.663|0.63|0.693
Observed|All sarcomas combined|2015–2019|Persons|1|All ages combined|0.849|0.842|0.856
Observed|All sarcomas combined|2015–2019|Persons|2|00–04|0.804|0.718|0.867
Observed|All sarcomas combined|2015–2019|Persons|2|05–09|0.898|0.823|0.942
Observed|All sarcomas combined|2015–2019|Persons|2|10–14|0.867|0.806|0.909
Observed|All sarcomas combined|2015–2019|Persons|2|15–19|0.824|0.771|0.866
Observed|All sarcomas combined|2015–2019|Persons|2|20–24|0.797|0.734|0.847
Observed|All sarcomas combined|2015–2019|Persons|2|25–29|0.814|0.753|0.862
Observed|All sarcomas combined|2015–2019|Persons|2|30–34|0.9|0.857|0.931
Observed|All sarcomas combined|2015–2019|Persons|2|35–39|0.869|0.827|0.902
Observed|All sarcomas combined|2015–2019|Persons|2|40–44|0.886|0.852|0.913
Observed|All sarcomas combined|2015–2019|Persons|2|45–49|0.874|0.845|0.898
Observed|All sarcomas combined|2015–2019|Persons|2|50–54|0.838|0.81|0.863
Observed|All sarcomas combined|2015–2019|Persons|2|55–59|0.809|0.781|0.833
Observed|All sarcomas combined|2015–2019|Persons|2|60–64|0.811|0.786|0.835
Observed|All sarcomas combined|2015–2019|Persons|2|65–69|0.774|0.748|0.798
Observed|All sarcomas combined|2015–2019|Persons|2|70–74|0.731|0.704|0.757
Observed|All sarcomas combined|2015–2019|Persons|2|75–79|0.705|0.675|0.732
Observed|All sarcomas combined|2015–2019|Persons|2|80–84|0.648|0.615|0.679
Observed|All sarcomas combined|2015–2019|Persons|2|85+|0.494|0.46|0.527
Observed|All sarcomas combined|2015–2019|Persons|2|All ages combined|0.762|0.754|0.771
Observed|All sarcomas combined|2015–2019|Persons|3|00–04|0.804|0.718|0.867
Observed|All sarcomas combined|2015–2019|Persons|3|05–09|0.879|0.8|0.928
Observed|All sarcomas combined|2015–2019|Persons|3|10–14|0.803|0.735|0.855
Observed|All sarcomas combined|2015–2019|Persons|3|15–19|0.76|0.701|0.808
Observed|All sarcomas combined|2015–2019|Persons|3|20–24|0.764|0.699|0.817
Observed|All sarcomas combined|2015–2019|Persons|3|25–29|0.776|0.712|0.827
Observed|All sarcomas combined|2015–2019|Persons|3|30–34|0.858|0.809|0.895
Observed|All sarcomas combined|2015–2019|Persons|3|35–39|0.846|0.8|0.881
Observed|All sarcomas combined|2015–2019|Persons|3|40–44|0.845|0.806|0.876
Observed|All sarcomas combined|2015–2019|Persons|3|45–49|0.821|0.788|0.85
Observed|All sarcomas combined|2015–2019|Persons|3|50–54|0.796|0.765|0.823
Observed|All sarcomas combined|2015–2019|Persons|3|55–59|0.77|0.741|0.797
Observed|All sarcomas combined|2015–2019|Persons|3|60–64|0.771|0.743|0.796
Observed|All sarcomas combined|2015–2019|Persons|3|65–69|0.708|0.679|0.734
Observed|All sarcomas combined|2015–2019|Persons|3|70–74|0.678|0.649|0.705
Observed|All sarcomas combined|2015–2019|Persons|3|75–79|0.628|0.597|0.658
Observed|All sarcomas combined|2015–2019|Persons|3|80–84|0.556|0.521|0.589
Observed|All sarcomas combined|2015–2019|Persons|3|85+|0.373|0.341|0.406
Observed|All sarcomas combined|2015–2019|Persons|3|All ages combined|0.703|0.694|0.712
Observed|All sarcomas combined|2015–2019|Persons|4|00–04|0.778|0.689|0.844
Observed|All sarcomas combined|2015–2019|Persons|4|05–09|0.879|0.8|0.928
Observed|All sarcomas combined|2015–2019|Persons|4|10–14|0.735|0.662|0.794
Observed|All sarcomas combined|2015–2019|Persons|4|15–19|0.677|0.613|0.732
Observed|All sarcomas combined|2015–2019|Persons|4|20–24|0.726|0.659|0.782
Observed|All sarcomas combined|2015–2019|Persons|4|25–29|0.771|0.707|0.823
Observed|All sarcomas combined|2015–2019|Persons|4|30–34|0.825|0.772|0.866
Observed|All sarcomas combined|2015–2019|Persons|4|35–39|0.804|0.755|0.844
Observed|All sarcomas combined|2015–2019|Persons|4|40–44|0.806|0.765|0.841
Observed|All sarcomas combined|2015–2019|Persons|4|45–49|0.786|0.751|0.816
Observed|All sarcomas combined|2015–2019|Persons|4|50–54|0.769|0.737|0.798
Observed|All sarcomas combined|2015–2019|Persons|4|55–59|0.74|0.709|0.768
Observed|All sarcomas combined|2015–2019|Persons|4|60–64|0.731|0.702|0.758
Observed|All sarcomas combined|2015–2019|Persons|4|65–69|0.668|0.639|0.696
Observed|All sarcomas combined|2015–2019|Persons|4|70–74|0.639|0.609|0.668
Observed|All sarcomas combined|2015–2019|Persons|4|75–79|0.569|0.536|0.6
Observed|All sarcomas combined|2015–2019|Persons|4|80–84|0.485|0.449|0.519
Observed|All sarcomas combined|2015–2019|Persons|4|85+|0.285|0.254|0.316
Observed|All sarcomas combined|2015–2019|Persons|4|All ages combined|0.658|0.649|0.667
Observed|All sarcomas combined|2015–2019|Persons|5|00–04|0.778|0.689|0.844
Observed|All sarcomas combined|2015–2019|Persons|5|05–09|0.868|0.787|0.92
Observed|All sarcomas combined|2015–2019|Persons|5|10–14|0.723|0.65|0.783
Observed|All sarcomas combined|2015–2019|Persons|5|15–19|0.625|0.559|0.685
Observed|All sarcomas combined|2015–2019|Persons|5|20–24|0.698|0.63|0.756
Observed|All sarcomas combined|2015–2019|Persons|5|25–29|0.745|0.679|0.799
Observed|All sarcomas combined|2015–2019|Persons|5|30–34|0.803|0.749|0.847
Observed|All sarcomas combined|2015–2019|Persons|5|35–39|0.791|0.741|0.832
Observed|All sarcomas combined|2015–2019|Persons|5|40–44|0.776|0.733|0.814
Observed|All sarcomas combined|2015–2019|Persons|5|45–49|0.763|0.727|0.795
Observed|All sarcomas combined|2015–2019|Persons|5|50–54|0.762|0.73|0.791
Observed|All sarcomas combined|2015–2019|Persons|5|55–59|0.723|0.691|0.752
Observed|All sarcomas combined|2015–2019|Persons|5|60–64|0.703|0.673|0.731
Observed|All sarcomas combined|2015–2019|Persons|5|65–69|0.637|0.606|0.665
Observed|All sarcomas combined|2015–2019|Persons|5|70–74|0.598|0.567|0.627
Observed|All sarcomas combined|2015–2019|Persons|5|75–79|0.522|0.489|0.554
Observed|All sarcomas combined|2015–2019|Persons|5|80–84|0.416|0.38|0.451
Observed|All sarcomas combined|2015–2019|Persons|5|85+|0.215|0.186|0.245
Observed|All sarcomas combined|2015–2019|Persons|5|All ages combined|0.625|0.615|0.635
Relative|All sarcomas combined|2015–2019|Persons|1|00–04|0.878|0.802|0.926
Relative|All sarcomas combined|2015–2019|Persons|1|05–09|0.926|0.858|0.962
Relative|All sarcomas combined|2015–2019|Persons|1|10–14|0.931|0.881|0.96
Relative|All sarcomas combined|2015–2019|Persons|1|15–19|0.927|0.889|0.953
Relative|All sarcomas combined|2015–2019|Persons|1|20–24|0.906|0.857|0.939
Relative|All sarcomas combined|2015–2019|Persons|1|25–29|0.905|0.854|0.938
Relative|All sarcomas combined|2015–2019|Persons|1|30–34|0.963|0.932|0.98
Relative|All sarcomas combined|2015–2019|Persons|1|35–39|0.944|0.913|0.965
Relative|All sarcomas combined|2015–2019|Persons|1|40–44|0.955|0.93|0.971
Relative|All sarcomas combined|2015–2019|Persons|1|45–49|0.926|0.901|0.944
Relative|All sarcomas combined|2015–2019|Persons|1|50–54|0.919|0.896|0.937
Relative|All sarcomas combined|2015–2019|Persons|1|55–59|0.881|0.857|0.901
Relative|All sarcomas combined|2015–2019|Persons|1|60–64|0.889|0.867|0.907
Relative|All sarcomas combined|2015–2019|Persons|1|65–69|0.867|0.844|0.887
Relative|All sarcomas combined|2015–2019|Persons|1|70–74|0.826|0.801|0.848
Relative|All sarcomas combined|2015–2019|Persons|1|75–79|0.817|0.789|0.842
Relative|All sarcomas combined|2015–2019|Persons|1|80–84|0.797|0.765|0.826
Relative|All sarcomas combined|2015–2019|Persons|1|85+|0.757|0.721|0.792
Relative|All sarcomas combined|2015–2019|Persons|1|All ages combined|0.868|0.861|0.875
Relative|All sarcomas combined|2015–2019|Persons|2|00–04|0.805|0.719|0.868
Relative|All sarcomas combined|2015–2019|Persons|2|05–09|0.898|0.823|0.942
Relative|All sarcomas combined|2015–2019|Persons|2|10–14|0.867|0.806|0.91
Relative|All sarcomas combined|2015–2019|Persons|2|15–19|0.825|0.772|0.866
Relative|All sarcomas combined|2015–2019|Persons|2|20–24|0.798|0.735|0.848
Relative|All sarcomas combined|2015–2019|Persons|2|25–29|0.815|0.754|0.863
Relative|All sarcomas combined|2015–2019|Persons|2|30–34|0.901|0.858|0.932
Relative|All sarcomas combined|2015–2019|Persons|2|35–39|0.871|0.828|0.904
Relative|All sarcomas combined|2015–2019|Persons|2|40–44|0.888|0.854|0.915
Relative|All sarcomas combined|2015–2019|Persons|2|45–49|0.878|0.848|0.902
Relative|All sarcomas combined|2015–2019|Persons|2|50–54|0.843|0.814|0.868
Relative|All sarcomas combined|2015–2019|Persons|2|55–59|0.816|0.788|0.841
Relative|All sarcomas combined|2015–2019|Persons|2|60–64|0.823|0.796|0.846
Relative|All sarcomas combined|2015–2019|Persons|2|65–69|0.79|0.764|0.815
Relative|All sarcomas combined|2015–2019|Persons|2|70–74|0.757|0.729|0.784
Relative|All sarcomas combined|2015–2019|Persons|2|75–79|0.75|0.718|0.779
Relative|All sarcomas combined|2015–2019|Persons|2|80–84|0.726|0.689|0.761
Relative|All sarcomas combined|2015–2019|Persons|2|85+|0.651|0.607|0.695
Relative|All sarcomas combined|2015–2019|Persons|2|All ages combined|0.796|0.787|0.805
Relative|All sarcomas combined|2015–2019|Persons|3|00–04|0.805|0.719|0.868
Relative|All sarcomas combined|2015–2019|Persons|3|05–09|0.879|0.8|0.928
Relative|All sarcomas combined|2015–2019|Persons|3|10–14|0.803|0.736|0.855
Relative|All sarcomas combined|2015–2019|Persons|3|15–19|0.76|0.702|0.809
Relative|All sarcomas combined|2015–2019|Persons|3|20–24|0.765|0.699|0.818
Relative|All sarcomas combined|2015–2019|Persons|3|25–29|0.777|0.713|0.829
Relative|All sarcomas combined|2015–2019|Persons|3|30–34|0.859|0.81|0.896
Relative|All sarcomas combined|2015–2019|Persons|3|35–39|0.848|0.803|0.884
Relative|All sarcomas combined|2015–2019|Persons|3|40–44|0.848|0.81|0.879
Relative|All sarcomas combined|2015–2019|Persons|3|45–49|0.826|0.793|0.855
Relative|All sarcomas combined|2015–2019|Persons|3|50–54|0.803|0.772|0.83
Relative|All sarcomas combined|2015–2019|Persons|3|55–59|0.781|0.751|0.808
Relative|All sarcomas combined|2015–2019|Persons|3|60–64|0.787|0.759|0.813
Relative|All sarcomas combined|2015–2019|Persons|3|65–69|0.732|0.702|0.759
Relative|All sarcomas combined|2015–2019|Persons|3|70–74|0.717|0.686|0.745
Relative|All sarcomas combined|2015–2019|Persons|3|75–79|0.693|0.658|0.726
Relative|All sarcomas combined|2015–2019|Persons|3|80–84|0.667|0.626|0.707
Relative|All sarcomas combined|2015–2019|Persons|3|85+|0.573|0.523|0.623
Relative|All sarcomas combined|2015–2019|Persons|3|All ages combined|0.75|0.74|0.759
Relative|All sarcomas combined|2015–2019|Persons|4|00–04|0.779|0.69|0.845
Relative|All sarcomas combined|2015–2019|Persons|4|05–09|0.879|0.801|0.928
Relative|All sarcomas combined|2015–2019|Persons|4|10–14|0.735|0.663|0.794
Relative|All sarcomas combined|2015–2019|Persons|4|15–19|0.678|0.614|0.733
Relative|All sarcomas combined|2015–2019|Persons|4|20–24|0.727|0.66|0.784
Relative|All sarcomas combined|2015–2019|Persons|4|25–29|0.773|0.708|0.825
Relative|All sarcomas combined|2015–2019|Persons|4|30–34|0.827|0.774|0.868
Relative|All sarcomas combined|2015–2019|Persons|4|35–39|0.807|0.757|0.848
Relative|All sarcomas combined|2015–2019|Persons|4|40–44|0.811|0.769|0.846
Relative|All sarcomas combined|2015–2019|Persons|4|45–49|0.792|0.757|0.823
Relative|All sarcomas combined|2015–2019|Persons|4|50–54|0.779|0.746|0.808
Relative|All sarcomas combined|2015–2019|Persons|4|55–59|0.754|0.723|0.783
Relative|All sarcomas combined|2015–2019|Persons|4|60–64|0.753|0.723|0.781
Relative|All sarcomas combined|2015–2019|Persons|4|65–69|0.7|0.669|0.729
Relative|All sarcomas combined|2015–2019|Persons|4|70–74|0.691|0.659|0.722
Relative|All sarcomas combined|2015–2019|Persons|4|75–79|0.654|0.616|0.69
Relative|All sarcomas combined|2015–2019|Persons|4|80–84|0.629|0.583|0.673
Relative|All sarcomas combined|2015–2019|Persons|4|85+|0.516|0.46|0.573
Relative|All sarcomas combined|2015–2019|Persons|4|All ages combined|0.716|0.705|0.726
Relative|All sarcomas combined|2015–2019|Persons|5|00–04|0.779|0.69|0.845
Relative|All sarcomas combined|2015–2019|Persons|5|05–09|0.868|0.788|0.92
Relative|All sarcomas combined|2015–2019|Persons|5|10–14|0.723|0.65|0.784
Relative|All sarcomas combined|2015–2019|Persons|5|15–19|0.626|0.56|0.686
Relative|All sarcomas combined|2015–2019|Persons|5|20–24|0.7|0.632|0.758
Relative|All sarcomas combined|2015–2019|Persons|5|25–29|0.747|0.681|0.801
Relative|All sarcomas combined|2015–2019|Persons|5|30–34|0.806|0.751|0.85
Relative|All sarcomas combined|2015–2019|Persons|5|35–39|0.795|0.744|0.837
Relative|All sarcomas combined|2015–2019|Persons|5|40–44|0.782|0.738|0.82
Relative|All sarcomas combined|2015–2019|Persons|5|45–49|0.771|0.735|0.803
Relative|All sarcomas combined|2015–2019|Persons|5|50–54|0.775|0.742|0.804
Relative|All sarcomas combined|2015–2019|Persons|5|55–59|0.741|0.709|0.771
Relative|All sarcomas combined|2015–2019|Persons|5|60–64|0.731|0.7|0.76
Relative|All sarcomas combined|2015–2019|Persons|5|65–69|0.677|0.644|0.707
Relative|All sarcomas combined|2015–2019|Persons|5|70–74|0.663|0.629|0.696
Relative|All sarcomas combined|2015–2019|Persons|5|75–79|0.629|0.589|0.667
Relative|All sarcomas combined|2015–2019|Persons|5|80–84|0.589|0.539|0.639
Relative|All sarcomas combined|2015–2019|Persons|5|85+|0.466|0.404|0.531
Relative|All sarcomas combined|2015–2019|Persons|5|All ages combined|0.693|0.682|0.704
Observed|Ampullary cancer|2015–2019|Males|1|00–04|||
Observed|Ampullary cancer|2015–2019|Males|1|05–09|||
Observed|Ampullary cancer|2015–2019|Males|1|10–14|||
Observed|Ampullary cancer|2015–2019|Males|1|15–19|||
Observed|Ampullary cancer|2015–2019|Males|1|20–24|||
Observed|Ampullary cancer|2015–2019|Males|1|25–29|||
Observed|Ampullary cancer|2015–2019|Males|1|30–34|||
Observed|Ampullary cancer|2015–2019|Males|1|35–39|||
Observed|Ampullary cancer|2015–2019|Males|1|40–44|||
Observed|Ampullary cancer|2015–2019|Males|1|45–49|||
Observed|Ampullary cancer|2015–2019|Males|1|50–54|0.917|0.708|0.979
Observed|Ampullary cancer|2015–2019|Males|1|55–59|0.96|0.848|0.99
Observed|Ampullary cancer|2015–2019|Males|1|60–64|0.83|0.7|0.908
Observed|Ampullary cancer|2015–2019|Males|1|65–69|0.781|0.675|0.856
Observed|Ampullary cancer|2015–2019|Males|1|70–74|0.668|0.567|0.751
Observed|Ampullary cancer|2015–2019|Males|1|75–79|0.699|0.593|0.782
Observed|Ampullary cancer|2015–2019|Males|1|80–84|0.555|0.424|0.668
Observed|Ampullary cancer|2015–2019|Males|1|85+|0.582|0.432|0.705
Observed|Ampullary cancer|2015–2019|Males|1|All ages combined|0.731|0.691|0.767
Observed|Ampullary cancer|2015–2019|Males|2|00–04|||
Observed|Ampullary cancer|2015–2019|Males|2|05–09|||
Observed|Ampullary cancer|2015–2019|Males|2|10–14|||
Observed|Ampullary cancer|2015–2019|Males|2|15–19|||
Observed|Ampullary cancer|2015–2019|Males|2|20–24|||
Observed|Ampullary cancer|2015–2019|Males|2|25–29|||
Observed|Ampullary cancer|2015–2019|Males|2|30–34|||
Observed|Ampullary cancer|2015–2019|Males|2|35–39|||
Observed|Ampullary cancer|2015–2019|Males|2|40–44|||
Observed|Ampullary cancer|2015–2019|Males|2|45–49|||
Observed|Ampullary cancer|2015–2019|Males|2|50–54|||
Observed|Ampullary cancer|2015–2019|Males|2|55–59|0.826|0.681|0.909
Observed|Ampullary cancer|2015–2019|Males|2|60–64|0.666|0.524|0.774
Observed|Ampullary cancer|2015–2019|Males|2|65–69|0.695|0.583|0.782
Observed|Ampullary cancer|2015–2019|Males|2|70–74|0.529|0.425|0.622
Observed|Ampullary cancer|2015–2019|Males|2|75–79|0.567|0.459|0.661
Observed|Ampullary cancer|2015–2019|Males|2|80–84|0.384|0.26|0.507
Observed|Ampullary cancer|2015–2019|Males|2|85+|0.251|0.147|0.37
Observed|Ampullary cancer|2015–2019|Males|2|All ages combined|0.57|0.527|0.611
Observed|Ampullary cancer|2015–2019|Males|3|00–04|||
Observed|Ampullary cancer|2015–2019|Males|3|05–09|||
Observed|Ampullary cancer|2015–2019|Males|3|10–14|||
Observed|Ampullary cancer|2015–2019|Males|3|15–19|||
Observed|Ampullary cancer|2015–2019|Males|3|20–24|||
Observed|Ampullary cancer|2015–2019|Males|3|25–29|||
Observed|Ampullary cancer|2015–2019|Males|3|30–34|||
Observed|Ampullary cancer|2015–2019|Males|3|35–39|||
Observed|Ampullary cancer|2015–2019|Males|3|40–44|||
Observed|Ampullary cancer|2015–2019|Males|3|45–49|||
Observed|Ampullary cancer|2015–2019|Males|3|50–54|||
Observed|Ampullary cancer|2015–2019|Males|3|55–59|0.724|0.563|0.833
Observed|Ampullary cancer|2015–2019|Males|3|60–64|0.571|0.429|0.691
Observed|Ampullary cancer|2015–2019|Males|3|65–69|0.598|0.484|0.695
Observed|Ampullary cancer|2015–2019|Males|3|70–74|0.426|0.325|0.523
Observed|Ampullary cancer|2015–2019|Males|3|75–79|0.426|0.32|0.528
Observed|Ampullary cancer|2015–2019|Males|3|80–84|||
Observed|Ampullary cancer|2015–2019|Males|3|85+|||
Observed|Ampullary cancer|2015–2019|Males|3|All ages combined|0.463|0.419|0.506
Observed|Ampullary cancer|2015–2019|Males|4|00–04|||
Observed|Ampullary cancer|2015–2019|Males|4|05–09|||
Observed|Ampullary cancer|2015–2019|Males|4|10–14|||
Observed|Ampullary cancer|2015–2019|Males|4|15–19|||
Observed|Ampullary cancer|2015–2019|Males|4|20–24|||
Observed|Ampullary cancer|2015–2019|Males|4|25–29|||
Observed|Ampullary cancer|2015–2019|Males|4|30–34|||
Observed|Ampullary cancer|2015–2019|Males|4|35–39|||
Observed|Ampullary cancer|2015–2019|Males|4|40–44|||
Observed|Ampullary cancer|2015–2019|Males|4|45–49|||
Observed|Ampullary cancer|2015–2019|Males|4|50–54|||
Observed|Ampullary cancer|2015–2019|Males|4|55–59|0.724|0.563|0.833
Observed|Ampullary cancer|2015–2019|Males|4|60–64|0.516|0.376|0.639
Observed|Ampullary cancer|2015–2019|Males|4|65–69|0.52|0.407|0.622
Observed|Ampullary cancer|2015–2019|Males|4|70–74|0.333|0.236|0.432
Observed|Ampullary cancer|2015–2019|Males|4|75–79|0.343|0.239|0.449
Observed|Ampullary cancer|2015–2019|Males|4|80–84|||
Observed|Ampullary cancer|2015–2019|Males|4|85+|||
Observed|Ampullary cancer|2015–2019|Males|4|All ages combined|0.397|0.354|0.44
Observed|Ampullary cancer|2015–2019|Males|5|00–04|||
Observed|Ampullary cancer|2015–2019|Males|5|05–09|||
Observed|Ampullary cancer|2015–2019|Males|5|10–14|||
Observed|Ampullary cancer|2015–2019|Males|5|15–19|||
Observed|Ampullary cancer|2015–2019|Males|5|20–24|||
Observed|Ampullary cancer|2015–2019|Males|5|25–29|||
Observed|Ampullary cancer|2015–2019|Males|5|30–34|||
Observed|Ampullary cancer|2015–2019|Males|5|35–39|||
Observed|Ampullary cancer|2015–2019|Males|5|40–44|||
Observed|Ampullary cancer|2015–2019|Males|5|45–49|||
Observed|Ampullary cancer|2015–2019|Males|5|50–54|||
Observed|Ampullary cancer|2015–2019|Males|5|55–59|||
Observed|Ampullary cancer|2015–2019|Males|5|60–64|0.516|0.376|0.639
Observed|Ampullary cancer|2015–2019|Males|5|65–69|0.477|0.364|0.582
Observed|Ampullary cancer|2015–2019|Males|5|70–74|0.318|0.223|0.418
Observed|Ampullary cancer|2015–2019|Males|5|75–79|0.255|0.159|0.362
Observed|Ampullary cancer|2015–2019|Males|5|80–84|||
Observed|Ampullary cancer|2015–2019|Males|5|85+|||
Observed|Ampullary cancer|2015–2019|Males|5|All ages combined|0.366|0.324|0.409
Relative|Ampullary cancer|2015–2019|Males|1|00–04|||
Relative|Ampullary cancer|2015–2019|Males|1|05–09|||
Relative|Ampullary cancer|2015–2019|Males|1|10–14|||
Relative|Ampullary cancer|2015–2019|Males|1|15–19|||
Relative|Ampullary cancer|2015–2019|Males|1|20–24|||
Relative|Ampullary cancer|2015–2019|Males|1|25–29|||
Relative|Ampullary cancer|2015–2019|Males|1|30–34|||
Relative|Ampullary cancer|2015–2019|Males|1|35–39|||
Relative|Ampullary cancer|2015–2019|Males|1|40–44|||
Relative|Ampullary cancer|2015–2019|Males|1|45–49|||
Relative|Ampullary cancer|2015–2019|Males|1|50–54|0.92|0.71|0.982
Relative|Ampullary cancer|2015–2019|Males|1|55–59|0.965|0.852|0.995
Relative|Ampullary cancer|2015–2019|Males|1|60–64|0.837|0.705|0.915
Relative|Ampullary cancer|2015–2019|Males|1|65–69|0.791|0.684|0.866
Relative|Ampullary cancer|2015–2019|Males|1|70–74|0.681|0.578|0.766
Relative|Ampullary cancer|2015–2019|Males|1|75–79|0.723|0.613|0.809
Relative|Ampullary cancer|2015–2019|Males|1|80–84|0.591|0.451|0.711
Relative|Ampullary cancer|2015–2019|Males|1|85+|0.669|0.497|0.811
Relative|Ampullary cancer|2015–2019|Males|1|All ages combined|0.755|0.714|0.792
Relative|Ampullary cancer|2015–2019|Males|2|00–04|||
Relative|Ampullary cancer|2015–2019|Males|2|05–09|||
Relative|Ampullary cancer|2015–2019|Males|2|10–14|||
Relative|Ampullary cancer|2015–2019|Males|2|15–19|||
Relative|Ampullary cancer|2015–2019|Males|2|20–24|||
Relative|Ampullary cancer|2015–2019|Males|2|25–29|||
Relative|Ampullary cancer|2015–2019|Males|2|30–34|||
Relative|Ampullary cancer|2015–2019|Males|2|35–39|||
Relative|Ampullary cancer|2015–2019|Males|2|40–44|||
Relative|Ampullary cancer|2015–2019|Males|2|45–49|||
Relative|Ampullary cancer|2015–2019|Males|2|50–54|||
Relative|Ampullary cancer|2015–2019|Males|2|55–59|0.835|0.689|0.919
Relative|Ampullary cancer|2015–2019|Males|2|60–64|0.677|0.533|0.787
Relative|Ampullary cancer|2015–2019|Males|2|65–69|0.713|0.599|0.803
Relative|Ampullary cancer|2015–2019|Males|2|70–74|0.551|0.443|0.648
Relative|Ampullary cancer|2015–2019|Males|2|75–79|0.609|0.493|0.71
Relative|Ampullary cancer|2015–2019|Males|2|80–84|0.438|0.297|0.578
Relative|Ampullary cancer|2015–2019|Males|2|85+|0.334|0.195|0.492
Relative|Ampullary cancer|2015–2019|Males|2|All ages combined|0.607|0.56|0.65
Relative|Ampullary cancer|2015–2019|Males|3|00–04|||
Relative|Ampullary cancer|2015–2019|Males|3|05–09|||
Relative|Ampullary cancer|2015–2019|Males|3|10–14|||
Relative|Ampullary cancer|2015–2019|Males|3|15–19|||
Relative|Ampullary cancer|2015–2019|Males|3|20–24|||
Relative|Ampullary cancer|2015–2019|Males|3|25–29|||
Relative|Ampullary cancer|2015–2019|Males|3|30–34|||
Relative|Ampullary cancer|2015–2019|Males|3|35–39|||
Relative|Ampullary cancer|2015–2019|Males|3|40–44|||
Relative|Ampullary cancer|2015–2019|Males|3|45–49|||
Relative|Ampullary cancer|2015–2019|Males|3|50–54|||
Relative|Ampullary cancer|2015–2019|Males|3|55–59|0.736|0.573|0.848
Relative|Ampullary cancer|2015–2019|Males|3|60–64|0.587|0.44|0.709
Relative|Ampullary cancer|2015–2019|Males|3|65–69|0.623|0.505|0.724
Relative|Ampullary cancer|2015–2019|Males|3|70–74|0.455|0.347|0.558
Relative|Ampullary cancer|2015–2019|Males|3|75–79|0.477|0.358|0.591
Relative|Ampullary cancer|2015–2019|Males|3|80–84|||
Relative|Ampullary cancer|2015–2019|Males|3|85+|||
Relative|Ampullary cancer|2015–2019|Males|3|All ages combined|0.507|0.459|0.554
Relative|Ampullary cancer|2015–2019|Males|4|00–04|||
Relative|Ampullary cancer|2015–2019|Males|4|05–09|||
Relative|Ampullary cancer|2015–2019|Males|4|10–14|||
Relative|Ampullary cancer|2015–2019|Males|4|15–19|||
Relative|Ampullary cancer|2015–2019|Males|4|20–24|||
Relative|Ampullary cancer|2015–2019|Males|4|25–29|||
Relative|Ampullary cancer|2015–2019|Males|4|30–34|||
Relative|Ampullary cancer|2015–2019|Males|4|35–39|||
Relative|Ampullary cancer|2015–2019|Males|4|40–44|||
Relative|Ampullary cancer|2015–2019|Males|4|45–49|||
Relative|Ampullary cancer|2015–2019|Males|4|50–54|||
Relative|Ampullary cancer|2015–2019|Males|4|55–59|0.742|0.577|0.854
Relative|Ampullary cancer|2015–2019|Males|4|60–64|0.535|0.39|0.663
Relative|Ampullary cancer|2015–2019|Males|4|65–69|0.551|0.431|0.659
Relative|Ampullary cancer|2015–2019|Males|4|70–74|0.365|0.259|0.474
Relative|Ampullary cancer|2015–2019|Males|4|75–79|0.402|0.28|0.526
Relative|Ampullary cancer|2015–2019|Males|4|80–84|||
Relative|Ampullary cancer|2015–2019|Males|4|85+|||
Relative|Ampullary cancer|2015–2019|Males|4|All ages combined|0.448|0.399|0.496
Relative|Ampullary cancer|2015–2019|Males|5|00–04|||
Relative|Ampullary cancer|2015–2019|Males|5|05–09|||
Relative|Ampullary cancer|2015–2019|Males|5|10–14|||
Relative|Ampullary cancer|2015–2019|Males|5|15–19|||
Relative|Ampullary cancer|2015–2019|Males|5|20–24|||
Relative|Ampullary cancer|2015–2019|Males|5|25–29|||
Relative|Ampullary cancer|2015–2019|Males|5|30–34|||
Relative|Ampullary cancer|2015–2019|Males|5|35–39|||
Relative|Ampullary cancer|2015–2019|Males|5|40–44|||
Relative|Ampullary cancer|2015–2019|Males|5|45–49|||
Relative|Ampullary cancer|2015–2019|Males|5|50–54|||
Relative|Ampullary cancer|2015–2019|Males|5|55–59|||
Relative|Ampullary cancer|2015–2019|Males|5|60–64|0.541|0.394|0.67
Relative|Ampullary cancer|2015–2019|Males|5|65–69|0.515|0.393|0.628
Relative|Ampullary cancer|2015–2019|Males|5|70–74|0.36|0.253|0.473
Relative|Ampullary cancer|2015–2019|Males|5|75–79|0.314|0.196|0.447
Relative|Ampullary cancer|2015–2019|Males|5|80–84|||
Relative|Ampullary cancer|2015–2019|Males|5|85+|||
Relative|Ampullary cancer|2015–2019|Males|5|All ages combined|0.424|0.375|0.474
Observed|Ampullary cancer|2015–2019|Females|1|00–04|||
Observed|Ampullary cancer|2015–2019|Females|1|05–09|||
Observed|Ampullary cancer|2015–2019|Females|1|10–14|||
Observed|Ampullary cancer|2015–2019|Females|1|15–19|||
Observed|Ampullary cancer|2015–2019|Females|1|20–24|||
Observed|Ampullary cancer|2015–2019|Females|1|25–29|||
Observed|Ampullary cancer|2015–2019|Females|1|30–34|||
Observed|Ampullary cancer|2015–2019|Females|1|35–39|||
Observed|Ampullary cancer|2015–2019|Females|1|40–44|||
Observed|Ampullary cancer|2015–2019|Females|1|45–49|||
Observed|Ampullary cancer|2015–2019|Females|1|50–54|0.922|0.722|0.98
Observed|Ampullary cancer|2015–2019|Females|1|55–59|0.784|0.581|0.896
Observed|Ampullary cancer|2015–2019|Females|1|60–64|0.88|0.735|0.948
Observed|Ampullary cancer|2015–2019|Females|1|65–69|0.81|0.69|0.887
Observed|Ampullary cancer|2015–2019|Females|1|70–74|0.776|0.651|0.86
Observed|Ampullary cancer|2015–2019|Females|1|75–79|0.795|0.678|0.873
Observed|Ampullary cancer|2015–2019|Females|1|80–84|0.593|0.441|0.716
Observed|Ampullary cancer|2015–2019|Females|1|85+|0.38|0.266|0.493
Observed|Ampullary cancer|2015–2019|Females|1|All ages combined|0.724|0.678|0.765
Observed|Ampullary cancer|2015–2019|Females|2|00–04|||
Observed|Ampullary cancer|2015–2019|Females|2|05–09|||
Observed|Ampullary cancer|2015–2019|Females|2|10–14|||
Observed|Ampullary cancer|2015–2019|Females|2|15–19|||
Observed|Ampullary cancer|2015–2019|Females|2|20–24|||
Observed|Ampullary cancer|2015–2019|Females|2|25–29|||
Observed|Ampullary cancer|2015–2019|Females|2|30–34|||
Observed|Ampullary cancer|2015–2019|Females|2|35–39|||
Observed|Ampullary cancer|2015–2019|Females|2|40–44|||
Observed|Ampullary cancer|2015–2019|Females|2|45–49|||
Observed|Ampullary cancer|2015–2019|Females|2|50–54|||
Observed|Ampullary cancer|2015–2019|Females|2|55–59|0.712|0.506|0.844
Observed|Ampullary cancer|2015–2019|Females|2|60–64|0.672|0.503|0.795
Observed|Ampullary cancer|2015–2019|Females|2|65–69|0.76|0.633|0.847
Observed|Ampullary cancer|2015–2019|Females|2|70–74|0.649|0.507|0.759
Observed|Ampullary cancer|2015–2019|Females|2|75–79|0.615|0.492|0.717
Observed|Ampullary cancer|2015–2019|Females|2|80–84|0.365|0.233|0.498
Observed|Ampullary cancer|2015–2019|Females|2|85+|||
Observed|Ampullary cancer|2015–2019|Females|2|All ages combined|0.561|0.511|0.609
Observed|Ampullary cancer|2015–2019|Females|3|00–04|||
Observed|Ampullary cancer|2015–2019|Females|3|05–09|||
Observed|Ampullary cancer|2015–2019|Females|3|10–14|||
Observed|Ampullary cancer|2015–2019|Females|3|15–19|||
Observed|Ampullary cancer|2015–2019|Females|3|20–24|||
Observed|Ampullary cancer|2015–2019|Females|3|25–29|||
Observed|Ampullary cancer|2015–2019|Females|3|30–34|||
Observed|Ampullary cancer|2015–2019|Females|3|35–39|||
Observed|Ampullary cancer|2015–2019|Females|3|40–44|||
Observed|Ampullary cancer|2015–2019|Females|3|45–49|||
Observed|Ampullary cancer|2015–2019|Females|3|50–54|||
Observed|Ampullary cancer|2015–2019|Females|3|55–59|||
Observed|Ampullary cancer|2015–2019|Females|3|60–64|||
Observed|Ampullary cancer|2015–2019|Females|3|65–69|0.583|0.447|0.696
Observed|Ampullary cancer|2015–2019|Females|3|70–74|0.624|0.479|0.739
Observed|Ampullary cancer|2015–2019|Females|3|75–79|0.458|0.336|0.571
Observed|Ampullary cancer|2015–2019|Females|3|80–84|||
Observed|Ampullary cancer|2015–2019|Females|3|85+|||
Observed|Ampullary cancer|2015–2019|Females|3|All ages combined|0.456|0.405|0.504
Observed|Ampullary cancer|2015–2019|Females|4|00–04|||
Observed|Ampullary cancer|2015–2019|Females|4|05–09|||
Observed|Ampullary cancer|2015–2019|Females|4|10–14|||
Observed|Ampullary cancer|2015–2019|Females|4|15–19|||
Observed|Ampullary cancer|2015–2019|Females|4|20–24|||
Observed|Ampullary cancer|2015–2019|Females|4|25–29|||
Observed|Ampullary cancer|2015–2019|Females|4|30–34|||
Observed|Ampullary cancer|2015–2019|Females|4|35–39|||
Observed|Ampullary cancer|2015–2019|Females|4|40–44|||
Observed|Ampullary cancer|2015–2019|Females|4|45–49|||
Observed|Ampullary cancer|2015–2019|Females|4|50–54|||
Observed|Ampullary cancer|2015–2019|Females|4|55–59|||
Observed|Ampullary cancer|2015–2019|Females|4|60–64|||
Observed|Ampullary cancer|2015–2019|Females|4|65–69|0.495|0.363|0.615
Observed|Ampullary cancer|2015–2019|Females|4|70–74|0.578|0.431|0.7
Observed|Ampullary cancer|2015–2019|Females|4|75–79|0.418|0.297|0.535
Observed|Ampullary cancer|2015–2019|Females|4|80–84|||
Observed|Ampullary cancer|2015–2019|Females|4|85+|||
Observed|Ampullary cancer|2015–2019|Females|4|All ages combined|0.403|0.354|0.453
Observed|Ampullary cancer|2015–2019|Females|5|00–04|||
Observed|Ampullary cancer|2015–2019|Females|5|05–09|||
Observed|Ampullary cancer|2015–2019|Females|5|10–14|||
Observed|Ampullary cancer|2015–2019|Females|5|15–19|||
Observed|Ampullary cancer|2015–2019|Females|5|20–24|||
Observed|Ampullary cancer|2015–2019|Females|5|25–29|||
Observed|Ampullary cancer|2015–2019|Females|5|30–34|||
Observed|Ampullary cancer|2015–2019|Females|5|35–39|||
Observed|Ampullary cancer|2015–2019|Females|5|40–44|||
Observed|Ampullary cancer|2015–2019|Females|5|45–49|||
Observed|Ampullary cancer|2015–2019|Females|5|50–54|||
Observed|Ampullary cancer|2015–2019|Females|5|55–59|||
Observed|Ampullary cancer|2015–2019|Females|5|60–64|||
Observed|Ampullary cancer|2015–2019|Females|5|65–69|0.456|0.325|0.578
Observed|Ampullary cancer|2015–2019|Females|5|70–74|0.55|0.401|0.677
Observed|Ampullary cancer|2015–2019|Females|5|75–79|||
Observed|Ampullary cancer|2015–2019|Females|5|80–84|||
Observed|Ampullary cancer|2015–2019|Females|5|85+|||
Observed|Ampullary cancer|2015–2019|Females|5|All ages combined|0.377|0.328|0.427
Relative|Ampullary cancer|2015–2019|Females|1|00–04|||
Relative|Ampullary cancer|2015–2019|Females|1|05–09|||
Relative|Ampullary cancer|2015–2019|Females|1|10–14|||
Relative|Ampullary cancer|2015–2019|Females|1|15–19|||
Relative|Ampullary cancer|2015–2019|Females|1|20–24|||
Relative|Ampullary cancer|2015–2019|Females|1|25–29|||
Relative|Ampullary cancer|2015–2019|Females|1|30–34|||
Relative|Ampullary cancer|2015–2019|Females|1|35–39|||
Relative|Ampullary cancer|2015–2019|Females|1|40–44|||
Relative|Ampullary cancer|2015–2019|Females|1|45–49|||
Relative|Ampullary cancer|2015–2019|Females|1|50–54|0.924|0.723|0.982
Relative|Ampullary cancer|2015–2019|Females|1|55–59|0.786|0.583|0.899
Relative|Ampullary cancer|2015–2019|Females|1|60–64|0.884|0.738|0.952
Relative|Ampullary cancer|2015–2019|Females|1|65–69|0.816|0.695|0.894
Relative|Ampullary cancer|2015–2019|Females|1|70–74|0.785|0.659|0.871
Relative|Ampullary cancer|2015–2019|Females|1|75–79|0.812|0.694|0.892
Relative|Ampullary cancer|2015–2019|Females|1|80–84|0.617|0.459|0.746
Relative|Ampullary cancer|2015–2019|Females|1|85+|0.428|0.299|0.555
Relative|Ampullary cancer|2015–2019|Females|1|All ages combined|0.746|0.699|0.788
Relative|Ampullary cancer|2015–2019|Females|2|00–04|||
Relative|Ampullary cancer|2015–2019|Females|2|05–09|||
Relative|Ampullary cancer|2015–2019|Females|2|10–14|||
Relative|Ampullary cancer|2015–2019|Females|2|15–19|||
Relative|Ampullary cancer|2015–2019|Females|2|20–24|||
Relative|Ampullary cancer|2015–2019|Females|2|25–29|||
Relative|Ampullary cancer|2015–2019|Females|2|30–34|||
Relative|Ampullary cancer|2015–2019|Females|2|35–39|||
Relative|Ampullary cancer|2015–2019|Females|2|40–44|||
Relative|Ampullary cancer|2015–2019|Females|2|45–49|||
Relative|Ampullary cancer|2015–2019|Females|2|50–54|||
Relative|Ampullary cancer|2015–2019|Females|2|55–59|0.716|0.509|0.849
Relative|Ampullary cancer|2015–2019|Females|2|60–64|0.679|0.508|0.803
Relative|Ampullary cancer|2015–2019|Females|2|65–69|0.771|0.643|0.86
Relative|Ampullary cancer|2015–2019|Females|2|70–74|0.665|0.52|0.778
Relative|Ampullary cancer|2015–2019|Females|2|75–79|0.645|0.516|0.752
Relative|Ampullary cancer|2015–2019|Females|2|80–84|0.399|0.255|0.544
Relative|Ampullary cancer|2015–2019|Females|2|85+|||
Relative|Ampullary cancer|2015–2019|Females|2|All ages combined|0.594|0.541|0.644
Relative|Ampullary cancer|2015–2019|Females|3|00–04|||
Relative|Ampullary cancer|2015–2019|Females|3|05–09|||
Relative|Ampullary cancer|2015–2019|Females|3|10–14|||
Relative|Ampullary cancer|2015–2019|Females|3|15–19|||
Relative|Ampullary cancer|2015–2019|Females|3|20–24|||
Relative|Ampullary cancer|2015–2019|Females|3|25–29|||
Relative|Ampullary cancer|2015–2019|Females|3|30–34|||
Relative|Ampullary cancer|2015–2019|Females|3|35–39|||
Relative|Ampullary cancer|2015–2019|Females|3|40–44|||
Relative|Ampullary cancer|2015–2019|Females|3|45–49|||
Relative|Ampullary cancer|2015–2019|Females|3|50–54|||
Relative|Ampullary cancer|2015–2019|Females|3|55–59|||
Relative|Ampullary cancer|2015–2019|Females|3|60–64|||
Relative|Ampullary cancer|2015–2019|Females|3|65–69|0.597|0.458|0.713
Relative|Ampullary cancer|2015–2019|Females|3|70–74|0.649|0.499|0.769
Relative|Ampullary cancer|2015–2019|Females|3|75–79|0.494|0.363|0.616
Relative|Ampullary cancer|2015–2019|Females|3|80–84|||
Relative|Ampullary cancer|2015–2019|Females|3|85+|||
Relative|Ampullary cancer|2015–2019|Females|3|All ages combined|0.495|0.44|0.548
Relative|Ampullary cancer|2015–2019|Females|4|00–04|||
Relative|Ampullary cancer|2015–2019|Females|4|05–09|||
Relative|Ampullary cancer|2015–2019|Females|4|10–14|||
Relative|Ampullary cancer|2015–2019|Females|4|15–19|||
Relative|Ampullary cancer|2015–2019|Females|4|20–24|||
Relative|Ampullary cancer|2015–2019|Females|4|25–29|||
Relative|Ampullary cancer|2015–2019|Females|4|30–34|||
Relative|Ampullary cancer|2015–2019|Females|4|35–39|||
Relative|Ampullary cancer|2015–2019|Females|4|40–44|||
Relative|Ampullary cancer|2015–2019|Females|4|45–49|||
Relative|Ampullary cancer|2015–2019|Females|4|50–54|||
Relative|Ampullary cancer|2015–2019|Females|4|55–59|||
Relative|Ampullary cancer|2015–2019|Females|4|60–64|||
Relative|Ampullary cancer|2015–2019|Females|4|65–69|0.512|0.375|0.636
Relative|Ampullary cancer|2015–2019|Females|4|70–74|0.611|0.456|0.74
Relative|Ampullary cancer|2015–2019|Females|4|75–79|0.466|0.331|0.596
Relative|Ampullary cancer|2015–2019|Females|4|80–84|||
Relative|Ampullary cancer|2015–2019|Females|4|85+|||
Relative|Ampullary cancer|2015–2019|Females|4|All ages combined|0.448|0.393|0.503
Relative|Ampullary cancer|2015–2019|Females|5|00–04|||
Relative|Ampullary cancer|2015–2019|Females|5|05–09|||
Relative|Ampullary cancer|2015–2019|Females|5|10–14|||
Relative|Ampullary cancer|2015–2019|Females|5|15–19|||
Relative|Ampullary cancer|2015–2019|Females|5|20–24|||
Relative|Ampullary cancer|2015–2019|Females|5|25–29|||
Relative|Ampullary cancer|2015–2019|Females|5|30–34|||
Relative|Ampullary cancer|2015–2019|Females|5|35–39|||
Relative|Ampullary cancer|2015–2019|Females|5|40–44|||
Relative|Ampullary cancer|2015–2019|Females|5|45–49|||
Relative|Ampullary cancer|2015–2019|Females|5|50–54|||
Relative|Ampullary cancer|2015–2019|Females|5|55–59|||
Relative|Ampullary cancer|2015–2019|Females|5|60–64|||
Relative|Ampullary cancer|2015–2019|Females|5|65–69|0.477|0.339|0.605
Relative|Ampullary cancer|2015–2019|Females|5|70–74|0.593|0.432|0.729
Relative|Ampullary cancer|2015–2019|Females|5|75–79|||
Relative|Ampullary cancer|2015–2019|Females|5|80–84|||
Relative|Ampullary cancer|2015–2019|Females|5|85+|||
Relative|Ampullary cancer|2015–2019|Females|5|All ages combined|0.429|0.373|0.485
Observed|Ampullary cancer|2015–2019|Persons|1|00–04|||
Observed|Ampullary cancer|2015–2019|Persons|1|05–09|||
Observed|Ampullary cancer|2015–2019|Persons|1|10–14|||
Observed|Ampullary cancer|2015–2019|Persons|1|15–19|||
Observed|Ampullary cancer|2015–2019|Persons|1|20–24|||
Observed|Ampullary cancer|2015–2019|Persons|1|25–29|||
Observed|Ampullary cancer|2015–2019|Persons|1|30–34|||
Observed|Ampullary cancer|2015–2019|Persons|1|35–39|||
Observed|Ampullary cancer|2015–2019|Persons|1|40–44|||
Observed|Ampullary cancer|2015–2019|Persons|1|45–49|||
Observed|Ampullary cancer|2015–2019|Persons|1|50–54|0.92|0.8|0.969
Observed|Ampullary cancer|2015–2019|Persons|1|55–59|0.896|0.803|0.947
Observed|Ampullary cancer|2015–2019|Persons|1|60–64|0.852|0.763|0.909
Observed|Ampullary cancer|2015–2019|Persons|1|65–69|0.794|0.718|0.851
Observed|Ampullary cancer|2015–2019|Persons|1|70–74|0.709|0.633|0.773
Observed|Ampullary cancer|2015–2019|Persons|1|75–79|0.74|0.665|0.801
Observed|Ampullary cancer|2015–2019|Persons|1|80–84|0.571|0.474|0.658
Observed|Ampullary cancer|2015–2019|Persons|1|85+|0.466|0.373|0.553
Observed|Ampullary cancer|2015–2019|Persons|1|All ages combined|0.728|0.698|0.755
Observed|Ampullary cancer|2015–2019|Persons|2|00–04|||
Observed|Ampullary cancer|2015–2019|Persons|2|05–09|||
Observed|Ampullary cancer|2015–2019|Persons|2|10–14|||
Observed|Ampullary cancer|2015–2019|Persons|2|15–19|||
Observed|Ampullary cancer|2015–2019|Persons|2|20–24|||
Observed|Ampullary cancer|2015–2019|Persons|2|25–29|||
Observed|Ampullary cancer|2015–2019|Persons|2|30–34|||
Observed|Ampullary cancer|2015–2019|Persons|2|35–39|||
Observed|Ampullary cancer|2015–2019|Persons|2|40–44|||
Observed|Ampullary cancer|2015–2019|Persons|2|45–49|||
Observed|Ampullary cancer|2015–2019|Persons|2|50–54|0.726|0.575|0.831
Observed|Ampullary cancer|2015–2019|Persons|2|55–59|0.786|0.674|0.863
Observed|Ampullary cancer|2015–2019|Persons|2|60–64|0.669|0.564|0.754
Observed|Ampullary cancer|2015–2019|Persons|2|65–69|0.722|0.642|0.788
Observed|Ampullary cancer|2015–2019|Persons|2|70–74|0.573|0.491|0.647
Observed|Ampullary cancer|2015–2019|Persons|2|75–79|0.587|0.508|0.659
Observed|Ampullary cancer|2015–2019|Persons|2|80–84|0.374|0.282|0.465
Observed|Ampullary cancer|2015–2019|Persons|2|85+|0.207|0.142|0.281
Observed|Ampullary cancer|2015–2019|Persons|2|All ages combined|0.566|0.534|0.598
Observed|Ampullary cancer|2015–2019|Persons|3|00–04|||
Observed|Ampullary cancer|2015–2019|Persons|3|05–09|||
Observed|Ampullary cancer|2015–2019|Persons|3|10–14|||
Observed|Ampullary cancer|2015–2019|Persons|3|15–19|||
Observed|Ampullary cancer|2015–2019|Persons|3|20–24|||
Observed|Ampullary cancer|2015–2019|Persons|3|25–29|||
Observed|Ampullary cancer|2015–2019|Persons|3|30–34|||
Observed|Ampullary cancer|2015–2019|Persons|3|35–39|||
Observed|Ampullary cancer|2015–2019|Persons|3|40–44|||
Observed|Ampullary cancer|2015–2019|Persons|3|45–49|||
Observed|Ampullary cancer|2015–2019|Persons|3|50–54|0.657|0.502|0.774
Observed|Ampullary cancer|2015–2019|Persons|3|55–59|0.724|0.604|0.813
Observed|Ampullary cancer|2015–2019|Persons|3|60–64|0.564|0.456|0.659
Observed|Ampullary cancer|2015–2019|Persons|3|65–69|0.593|0.507|0.668
Observed|Ampullary cancer|2015–2019|Persons|3|70–74|0.494|0.41|0.573
Observed|Ampullary cancer|2015–2019|Persons|3|75–79|0.439|0.36|0.516
Observed|Ampullary cancer|2015–2019|Persons|3|80–84|0.244|0.167|0.328
Observed|Ampullary cancer|2015–2019|Persons|3|85+|0.122|0.073|0.185
Observed|Ampullary cancer|2015–2019|Persons|3|All ages combined|0.46|0.427|0.492
Observed|Ampullary cancer|2015–2019|Persons|4|00–04|||
Observed|Ampullary cancer|2015–2019|Persons|4|05–09|||
Observed|Ampullary cancer|2015–2019|Persons|4|10–14|||
Observed|Ampullary cancer|2015–2019|Persons|4|15–19|||
Observed|Ampullary cancer|2015–2019|Persons|4|20–24|||
Observed|Ampullary cancer|2015–2019|Persons|4|25–29|||
Observed|Ampullary cancer|2015–2019|Persons|4|30–34|||
Observed|Ampullary cancer|2015–2019|Persons|4|35–39|||
Observed|Ampullary cancer|2015–2019|Persons|4|40–44|||
Observed|Ampullary cancer|2015–2019|Persons|4|45–49|||
Observed|Ampullary cancer|2015–2019|Persons|4|50–54|0.633|0.477|0.754
Observed|Ampullary cancer|2015–2019|Persons|4|55–59|0.705|0.582|0.797
Observed|Ampullary cancer|2015–2019|Persons|4|60–64|0.516|0.408|0.613
Observed|Ampullary cancer|2015–2019|Persons|4|65–69|0.511|0.425|0.59
Observed|Ampullary cancer|2015–2019|Persons|4|70–74|0.419|0.336|0.5
Observed|Ampullary cancer|2015–2019|Persons|4|75–79|0.376|0.297|0.456
Observed|Ampullary cancer|2015–2019|Persons|4|80–84|0.19|0.124|0.267
Observed|Ampullary cancer|2015–2019|Persons|4|85+|0.076|0.038|0.132
Observed|Ampullary cancer|2015–2019|Persons|4|All ages combined|0.4|0.367|0.432
Observed|Ampullary cancer|2015–2019|Persons|5|00–04|||
Observed|Ampullary cancer|2015–2019|Persons|5|05–09|||
Observed|Ampullary cancer|2015–2019|Persons|5|10–14|||
Observed|Ampullary cancer|2015–2019|Persons|5|15–19|||
Observed|Ampullary cancer|2015–2019|Persons|5|20–24|||
Observed|Ampullary cancer|2015–2019|Persons|5|25–29|||
Observed|Ampullary cancer|2015–2019|Persons|5|30–34|||
Observed|Ampullary cancer|2015–2019|Persons|5|35–39|||
Observed|Ampullary cancer|2015–2019|Persons|5|40–44|||
Observed|Ampullary cancer|2015–2019|Persons|5|45–49|||
Observed|Ampullary cancer|2015–2019|Persons|5|50–54|0.633|0.477|0.754
Observed|Ampullary cancer|2015–2019|Persons|5|55–59|0.684|0.557|0.781
Observed|Ampullary cancer|2015–2019|Persons|5|60–64|0.516|0.408|0.613
Observed|Ampullary cancer|2015–2019|Persons|5|65–69|0.469|0.384|0.55
Observed|Ampullary cancer|2015–2019|Persons|5|70–74|0.4|0.317|0.482
Observed|Ampullary cancer|2015–2019|Persons|5|75–79|0.301|0.223|0.384
Observed|Ampullary cancer|2015–2019|Persons|5|80–84|0.156|0.097|0.229
Observed|Ampullary cancer|2015–2019|Persons|5|85+|0.067|0.032|0.121
Observed|Ampullary cancer|2015–2019|Persons|5|All ages combined|0.371|0.339|0.404
Relative|Ampullary cancer|2015–2019|Persons|1|00–04|||
Relative|Ampullary cancer|2015–2019|Persons|1|05–09|||
Relative|Ampullary cancer|2015–2019|Persons|1|10–14|||
Relative|Ampullary cancer|2015–2019|Persons|1|15–19|||
Relative|Ampullary cancer|2015–2019|Persons|1|20–24|||
Relative|Ampullary cancer|2015–2019|Persons|1|25–29|||
Relative|Ampullary cancer|2015–2019|Persons|1|30–34|||
Relative|Ampullary cancer|2015–2019|Persons|1|35–39|||
Relative|Ampullary cancer|2015–2019|Persons|1|40–44|||
Relative|Ampullary cancer|2015–2019|Persons|1|45–49|||
Relative|Ampullary cancer|2015–2019|Persons|1|50–54|0.922|0.802|0.972
Relative|Ampullary cancer|2015–2019|Persons|1|55–59|0.9|0.807|0.951
Relative|Ampullary cancer|2015–2019|Persons|1|60–64|0.858|0.768|0.916
Relative|Ampullary cancer|2015–2019|Persons|1|65–69|0.802|0.726|0.859
Relative|Ampullary cancer|2015–2019|Persons|1|70–74|0.721|0.644|0.786
Relative|Ampullary cancer|2015–2019|Persons|1|75–79|0.762|0.684|0.824
Relative|Ampullary cancer|2015–2019|Persons|1|80–84|0.602|0.499|0.693
Relative|Ampullary cancer|2015–2019|Persons|1|85+|0.529|0.424|0.629
Relative|Ampullary cancer|2015–2019|Persons|1|All ages combined|0.751|0.721|0.779
Relative|Ampullary cancer|2015–2019|Persons|2|00–04|||
Relative|Ampullary cancer|2015–2019|Persons|2|05–09|||
Relative|Ampullary cancer|2015–2019|Persons|2|10–14|||
Relative|Ampullary cancer|2015–2019|Persons|2|15–19|||
Relative|Ampullary cancer|2015–2019|Persons|2|20–24|||
Relative|Ampullary cancer|2015–2019|Persons|2|25–29|||
Relative|Ampullary cancer|2015–2019|Persons|2|30–34|||
Relative|Ampullary cancer|2015–2019|Persons|2|35–39|||
Relative|Ampullary cancer|2015–2019|Persons|2|40–44|||
Relative|Ampullary cancer|2015–2019|Persons|2|45–49|||
Relative|Ampullary cancer|2015–2019|Persons|2|50–54|0.73|0.578|0.836
Relative|Ampullary cancer|2015–2019|Persons|2|55–59|0.793|0.68|0.871
Relative|Ampullary cancer|2015–2019|Persons|2|60–64|0.679|0.572|0.765
Relative|Ampullary cancer|2015–2019|Persons|2|65–69|0.738|0.656|0.805
Relative|Ampullary cancer|2015–2019|Persons|2|70–74|0.594|0.508|0.671
Relative|Ampullary cancer|2015–2019|Persons|2|75–79|0.624|0.539|0.7
Relative|Ampullary cancer|2015–2019|Persons|2|80–84|0.418|0.316|0.52
Relative|Ampullary cancer|2015–2019|Persons|2|85+|0.271|0.186|0.368
Relative|Ampullary cancer|2015–2019|Persons|2|All ages combined|0.601|0.567|0.635
Relative|Ampullary cancer|2015–2019|Persons|3|00–04|||
Relative|Ampullary cancer|2015–2019|Persons|3|05–09|||
Relative|Ampullary cancer|2015–2019|Persons|3|10–14|||
Relative|Ampullary cancer|2015–2019|Persons|3|15–19|||
Relative|Ampullary cancer|2015–2019|Persons|3|20–24|||
Relative|Ampullary cancer|2015–2019|Persons|3|25–29|||
Relative|Ampullary cancer|2015–2019|Persons|3|30–34|||
Relative|Ampullary cancer|2015–2019|Persons|3|35–39|||
Relative|Ampullary cancer|2015–2019|Persons|3|40–44|||
Relative|Ampullary cancer|2015–2019|Persons|3|45–49|||
Relative|Ampullary cancer|2015–2019|Persons|3|50–54|0.663|0.506|0.781
Relative|Ampullary cancer|2015–2019|Persons|3|55–59|0.735|0.613|0.825
Relative|Ampullary cancer|2015–2019|Persons|3|60–64|0.577|0.466|0.673
Relative|Ampullary cancer|2015–2019|Persons|3|65–69|0.613|0.525|0.691
Relative|Ampullary cancer|2015–2019|Persons|3|70–74|0.523|0.434|0.606
Relative|Ampullary cancer|2015–2019|Persons|3|75–79|0.483|0.396|0.568
Relative|Ampullary cancer|2015–2019|Persons|3|80–84|0.291|0.2|0.392
Relative|Ampullary cancer|2015–2019|Persons|3|85+|0.185|0.11|0.279
Relative|Ampullary cancer|2015–2019|Persons|3|All ages combined|0.502|0.466|0.537
Relative|Ampullary cancer|2015–2019|Persons|4|00–04|||
Relative|Ampullary cancer|2015–2019|Persons|4|05–09|||
Relative|Ampullary cancer|2015–2019|Persons|4|10–14|||
Relative|Ampullary cancer|2015–2019|Persons|4|15–19|||
Relative|Ampullary cancer|2015–2019|Persons|4|20–24|||
Relative|Ampullary cancer|2015–2019|Persons|4|25–29|||
Relative|Ampullary cancer|2015–2019|Persons|4|30–34|||
Relative|Ampullary cancer|2015–2019|Persons|4|35–39|||
Relative|Ampullary cancer|2015–2019|Persons|4|40–44|||
Relative|Ampullary cancer|2015–2019|Persons|4|45–49|||
Relative|Ampullary cancer|2015–2019|Persons|4|50–54|0.642|0.484|0.764
Relative|Ampullary cancer|2015–2019|Persons|4|55–59|0.719|0.594|0.814
Relative|Ampullary cancer|2015–2019|Persons|4|60–64|0.532|0.42|0.632
Relative|Ampullary cancer|2015–2019|Persons|4|65–69|0.536|0.446|0.619
Relative|Ampullary cancer|2015–2019|Persons|4|70–74|0.453|0.363|0.54
Relative|Ampullary cancer|2015–2019|Persons|4|75–79|0.431|0.34|0.522
Relative|Ampullary cancer|2015–2019|Persons|4|80–84|0.245|0.159|0.344
Relative|Ampullary cancer|2015–2019|Persons|4|85+|0.135|0.067|0.234
Relative|Ampullary cancer|2015–2019|Persons|4|All ages combined|0.448|0.411|0.484
Relative|Ampullary cancer|2015–2019|Persons|5|00–04|||
Relative|Ampullary cancer|2015–2019|Persons|5|05–09|||
Relative|Ampullary cancer|2015–2019|Persons|5|10–14|||
Relative|Ampullary cancer|2015–2019|Persons|5|15–19|||
Relative|Ampullary cancer|2015–2019|Persons|5|20–24|||
Relative|Ampullary cancer|2015–2019|Persons|5|25–29|||
Relative|Ampullary cancer|2015–2019|Persons|5|30–34|||
Relative|Ampullary cancer|2015–2019|Persons|5|35–39|||
Relative|Ampullary cancer|2015–2019|Persons|5|40–44|||
Relative|Ampullary cancer|2015–2019|Persons|5|45–49|||
Relative|Ampullary cancer|2015–2019|Persons|5|50–54|0.644|0.486|0.768
Relative|Ampullary cancer|2015–2019|Persons|5|55–59|0.702|0.572|0.802
Relative|Ampullary cancer|2015–2019|Persons|5|60–64|0.537|0.425|0.639
Relative|Ampullary cancer|2015–2019|Persons|5|65–69|0.5|0.409|0.586
Relative|Ampullary cancer|2015–2019|Persons|5|70–74|0.443|0.351|0.534
Relative|Ampullary cancer|2015–2019|Persons|5|75–79|0.361|0.267|0.459
Relative|Ampullary cancer|2015–2019|Persons|5|80–84|0.219|0.136|0.321
Relative|Ampullary cancer|2015–2019|Persons|5|85+|0.143|0.067|0.257
Relative|Ampullary cancer|2015–2019|Persons|5|All ages combined|0.426|0.389|0.464
Observed|Anal cancer|2015–2019|Males|1|00–04|||
Observed|Anal cancer|2015–2019|Males|1|05–09|||
Observed|Anal cancer|2015–2019|Males|1|10–14|||
Observed|Anal cancer|2015–2019|Males|1|15–19|||
Observed|Anal cancer|2015–2019|Males|1|20–24|||
Observed|Anal cancer|2015–2019|Males|1|25–29|||
Observed|Anal cancer|2015–2019|Males|1|30–34|||
Observed|Anal cancer|2015–2019|Males|1|35–39|||
Observed|Anal cancer|2015–2019|Males|1|40–44|||
Observed|Anal cancer|2015–2019|Males|1|45–49|0.921|0.821|0.966
Observed|Anal cancer|2015–2019|Males|1|50–54|0.95|0.884|0.979
Observed|Anal cancer|2015–2019|Males|1|55–59|0.946|0.891|0.974
Observed|Anal cancer|2015–2019|Males|1|60–64|0.91|0.85|0.947
Observed|Anal cancer|2015–2019|Males|1|65–69|0.873|0.803|0.919
Observed|Anal cancer|2015–2019|Males|1|70–74|0.89|0.824|0.932
Observed|Anal cancer|2015–2019|Males|1|75–79|0.715|0.606|0.799
Observed|Anal cancer|2015–2019|Males|1|80–84|0.678|0.558|0.773
Observed|Anal cancer|2015–2019|Males|1|85+|0.588|0.461|0.695
Observed|Anal cancer|2015–2019|Males|1|All ages combined|0.858|0.834|0.878
Observed|Anal cancer|2015–2019|Males|2|00–04|||
Observed|Anal cancer|2015–2019|Males|2|05–09|||
Observed|Anal cancer|2015–2019|Males|2|10–14|||
Observed|Anal cancer|2015–2019|Males|2|15–19|||
Observed|Anal cancer|2015–2019|Males|2|20–24|||
Observed|Anal cancer|2015–2019|Males|2|25–29|||
Observed|Anal cancer|2015–2019|Males|2|30–34|||
Observed|Anal cancer|2015–2019|Males|2|35–39|||
Observed|Anal cancer|2015–2019|Males|2|40–44|||
Observed|Anal cancer|2015–2019|Males|2|45–49|0.785|0.665|0.867
Observed|Anal cancer|2015–2019|Males|2|50–54|0.835|0.748|0.894
Observed|Anal cancer|2015–2019|Males|2|55–59|0.883|0.813|0.928
Observed|Anal cancer|2015–2019|Males|2|60–64|0.813|0.739|0.868
Observed|Anal cancer|2015–2019|Males|2|65–69|0.748|0.665|0.814
Observed|Anal cancer|2015–2019|Males|2|70–74|0.767|0.684|0.831
Observed|Anal cancer|2015–2019|Males|2|75–79|0.544|0.434|0.642
Observed|Anal cancer|2015–2019|Males|2|80–84|0.586|0.462|0.691
Observed|Anal cancer|2015–2019|Males|2|85+|0.416|0.296|0.531
Observed|Anal cancer|2015–2019|Males|2|All ages combined|0.744|0.715|0.77
Observed|Anal cancer|2015–2019|Males|3|00–04|||
Observed|Anal cancer|2015–2019|Males|3|05–09|||
Observed|Anal cancer|2015–2019|Males|3|10–14|||
Observed|Anal cancer|2015–2019|Males|3|15–19|||
Observed|Anal cancer|2015–2019|Males|3|20–24|||
Observed|Anal cancer|2015–2019|Males|3|25–29|||
Observed|Anal cancer|2015–2019|Males|3|30–34|||
Observed|Anal cancer|2015–2019|Males|3|35–39|||
Observed|Anal cancer|2015–2019|Males|3|40–44|||
Observed|Anal cancer|2015–2019|Males|3|45–49|0.726|0.602|0.818
Observed|Anal cancer|2015–2019|Males|3|50–54|0.804|0.712|0.869
Observed|Anal cancer|2015–2019|Males|3|55–59|0.827|0.747|0.884
Observed|Anal cancer|2015–2019|Males|3|60–64|0.746|0.668|0.809
Observed|Anal cancer|2015–2019|Males|3|65–69|0.67|0.584|0.743
Observed|Anal cancer|2015–2019|Males|3|70–74|0.671|0.578|0.748
Observed|Anal cancer|2015–2019|Males|3|75–79|0.437|0.332|0.536
Observed|Anal cancer|2015–2019|Males|3|80–84|0.489|0.365|0.601
Observed|Anal cancer|2015–2019|Males|3|85+|0.303|0.196|0.417
Observed|Anal cancer|2015–2019|Males|3|All ages combined|0.668|0.637|0.697
Observed|Anal cancer|2015–2019|Males|4|00–04|||
Observed|Anal cancer|2015–2019|Males|4|05–09|||
Observed|Anal cancer|2015–2019|Males|4|10–14|||
Observed|Anal cancer|2015–2019|Males|4|15–19|||
Observed|Anal cancer|2015–2019|Males|4|20–24|||
Observed|Anal cancer|2015–2019|Males|4|25–29|||
Observed|Anal cancer|2015–2019|Males|4|30–34|||
Observed|Anal cancer|2015–2019|Males|4|35–39|||
Observed|Anal cancer|2015–2019|Males|4|40–44|||
Observed|Anal cancer|2015–2019|Males|4|45–49|0.713|0.589|0.806
Observed|Anal cancer|2015–2019|Males|4|50–54|0.745|0.645|0.82
Observed|Anal cancer|2015–2019|Males|4|55–59|0.787|0.7|0.852
Observed|Anal cancer|2015–2019|Males|4|60–64|0.699|0.618|0.766
Observed|Anal cancer|2015–2019|Males|4|65–69|0.625|0.538|0.701
Observed|Anal cancer|2015–2019|Males|4|70–74|0.621|0.525|0.703
Observed|Anal cancer|2015–2019|Males|4|75–79|0.372|0.273|0.47
Observed|Anal cancer|2015–2019|Males|4|80–84|0.403|0.284|0.52
Observed|Anal cancer|2015–2019|Males|4|85+|||
Observed|Anal cancer|2015–2019|Males|4|All ages combined|0.62|0.588|0.651
Observed|Anal cancer|2015–2019|Males|5|00–04|||
Observed|Anal cancer|2015–2019|Males|5|05–09|||
Observed|Anal cancer|2015–2019|Males|5|10–14|||
Observed|Anal cancer|2015–2019|Males|5|15–19|||
Observed|Anal cancer|2015–2019|Males|5|20–24|||
Observed|Anal cancer|2015–2019|Males|5|25–29|||
Observed|Anal cancer|2015–2019|Males|5|30–34|||
Observed|Anal cancer|2015–2019|Males|5|35–39|||
Observed|Anal cancer|2015–2019|Males|5|40–44|||
Observed|Anal cancer|2015–2019|Males|5|45–49|0.7|0.575|0.794
Observed|Anal cancer|2015–2019|Males|5|50–54|0.707|0.603|0.789
Observed|Anal cancer|2015–2019|Males|5|55–59|0.755|0.664|0.825
Observed|Anal cancer|2015–2019|Males|5|60–64|0.67|0.587|0.74
Observed|Anal cancer|2015–2019|Males|5|65–69|0.593|0.505|0.671
Observed|Anal cancer|2015–2019|Males|5|70–74|0.599|0.502|0.684
Observed|Anal cancer|2015–2019|Males|5|75–79|0.319|0.226|0.416
Observed|Anal cancer|2015–2019|Males|5|80–84|0.328|0.218|0.442
Observed|Anal cancer|2015–2019|Males|5|85+|||
Observed|Anal cancer|2015–2019|Males|5|All ages combined|0.587|0.554|0.618
Relative|Anal cancer|2015–2019|Males|1|00–04|||
Relative|Anal cancer|2015–2019|Males|1|05–09|||
Relative|Anal cancer|2015–2019|Males|1|10–14|||
Relative|Anal cancer|2015–2019|Males|1|15–19|||
Relative|Anal cancer|2015–2019|Males|1|20–24|||
Relative|Anal cancer|2015–2019|Males|1|25–29|||
Relative|Anal cancer|2015–2019|Males|1|30–34|||
Relative|Anal cancer|2015–2019|Males|1|35–39|||
Relative|Anal cancer|2015–2019|Males|1|40–44|||
Relative|Anal cancer|2015–2019|Males|1|45–49|0.924|0.823|0.969
Relative|Anal cancer|2015–2019|Males|1|50–54|0.953|0.887|0.982
Relative|Anal cancer|2015–2019|Males|1|55–59|0.951|0.895|0.979
Relative|Anal cancer|2015–2019|Males|1|60–64|0.917|0.857|0.954
Relative|Anal cancer|2015–2019|Males|1|65–69|0.883|0.813|0.93
Relative|Anal cancer|2015–2019|Males|1|70–74|0.907|0.84|0.95
Relative|Anal cancer|2015–2019|Males|1|75–79|0.739|0.627|0.826
Relative|Anal cancer|2015–2019|Males|1|80–84|0.72|0.592|0.82
Relative|Anal cancer|2015–2019|Males|1|85+|0.681|0.534|0.805
Relative|Anal cancer|2015–2019|Males|1|All ages combined|0.878|0.854|0.899
Relative|Anal cancer|2015–2019|Males|2|00–04|||
Relative|Anal cancer|2015–2019|Males|2|05–09|||
Relative|Anal cancer|2015–2019|Males|2|10–14|||
Relative|Anal cancer|2015–2019|Males|2|15–19|||
Relative|Anal cancer|2015–2019|Males|2|20–24|||
Relative|Anal cancer|2015–2019|Males|2|25–29|||
Relative|Anal cancer|2015–2019|Males|2|30–34|||
Relative|Anal cancer|2015–2019|Males|2|35–39|||
Relative|Anal cancer|2015–2019|Males|2|40–44|||
Relative|Anal cancer|2015–2019|Males|2|45–49|0.789|0.668|0.871
Relative|Anal cancer|2015–2019|Males|2|50–54|0.841|0.754|0.901
Relative|Anal cancer|2015–2019|Males|2|55–59|0.893|0.822|0.938
Relative|Anal cancer|2015–2019|Males|2|60–64|0.827|0.752|0.882
Relative|Anal cancer|2015–2019|Males|2|65–69|0.768|0.682|0.835
Relative|Anal cancer|2015–2019|Males|2|70–74|0.799|0.712|0.866
Relative|Anal cancer|2015–2019|Males|2|75–79|0.585|0.467|0.69
Relative|Anal cancer|2015–2019|Males|2|80–84|0.665|0.524|0.784
Relative|Anal cancer|2015–2019|Males|2|85+|0.559|0.399|0.714
Relative|Anal cancer|2015–2019|Males|2|All ages combined|0.778|0.747|0.805
Relative|Anal cancer|2015–2019|Males|3|00–04|||
Relative|Anal cancer|2015–2019|Males|3|05–09|||
Relative|Anal cancer|2015–2019|Males|3|10–14|||
Relative|Anal cancer|2015–2019|Males|3|15–19|||
Relative|Anal cancer|2015–2019|Males|3|20–24|||
Relative|Anal cancer|2015–2019|Males|3|25–29|||
Relative|Anal cancer|2015–2019|Males|3|30–34|||
Relative|Anal cancer|2015–2019|Males|3|35–39|||
Relative|Anal cancer|2015–2019|Males|3|40–44|||
Relative|Anal cancer|2015–2019|Males|3|45–49|0.732|0.607|0.824
Relative|Anal cancer|2015–2019|Males|3|50–54|0.813|0.72|0.879
Relative|Anal cancer|2015–2019|Males|3|55–59|0.842|0.76|0.9
Relative|Anal cancer|2015–2019|Males|3|60–64|0.766|0.685|0.83
Relative|Anal cancer|2015–2019|Males|3|65–69|0.698|0.608|0.773
Relative|Anal cancer|2015–2019|Males|3|70–74|0.715|0.616|0.798
Relative|Anal cancer|2015–2019|Males|3|75–79|0.491|0.373|0.603
Relative|Anal cancer|2015–2019|Males|3|80–84|0.597|0.446|0.735
Relative|Anal cancer|2015–2019|Males|3|85+|0.472|0.306|0.649
Relative|Anal cancer|2015–2019|Males|3|All ages combined|0.713|0.68|0.744
Relative|Anal cancer|2015–2019|Males|4|00–04|||
Relative|Anal cancer|2015–2019|Males|4|05–09|||
Relative|Anal cancer|2015–2019|Males|4|10–14|||
Relative|Anal cancer|2015–2019|Males|4|15–19|||
Relative|Anal cancer|2015–2019|Males|4|20–24|||
Relative|Anal cancer|2015–2019|Males|4|25–29|||
Relative|Anal cancer|2015–2019|Males|4|30–34|||
Relative|Anal cancer|2015–2019|Males|4|35–39|||
Relative|Anal cancer|2015–2019|Males|4|40–44|||
Relative|Anal cancer|2015–2019|Males|4|45–49|0.721|0.595|0.815
Relative|Anal cancer|2015–2019|Males|4|50–54|0.757|0.656|0.834
Relative|Anal cancer|2015–2019|Males|4|55–59|0.807|0.718|0.873
Relative|Anal cancer|2015–2019|Males|4|60–64|0.725|0.64|0.794
Relative|Anal cancer|2015–2019|Males|4|65–69|0.661|0.569|0.742
Relative|Anal cancer|2015–2019|Males|4|70–74|0.68|0.575|0.77
Relative|Anal cancer|2015–2019|Males|4|75–79|0.439|0.323|0.556
Relative|Anal cancer|2015–2019|Males|4|80–84|0.539|0.379|0.694
Relative|Anal cancer|2015–2019|Males|4|85+|||
Relative|Anal cancer|2015–2019|Males|4|All ages combined|0.676|0.641|0.709
Relative|Anal cancer|2015–2019|Males|5|00–04|||
Relative|Anal cancer|2015–2019|Males|5|05–09|||
Relative|Anal cancer|2015–2019|Males|5|10–14|||
Relative|Anal cancer|2015–2019|Males|5|15–19|||
Relative|Anal cancer|2015–2019|Males|5|20–24|||
Relative|Anal cancer|2015–2019|Males|5|25–29|||
Relative|Anal cancer|2015–2019|Males|5|30–34|||
Relative|Anal cancer|2015–2019|Males|5|35–39|||
Relative|Anal cancer|2015–2019|Males|5|40–44|||
Relative|Anal cancer|2015–2019|Males|5|45–49|0.71|0.583|0.806
Relative|Anal cancer|2015–2019|Males|5|50–54|0.722|0.616|0.805
Relative|Anal cancer|2015–2019|Males|5|55–59|0.779|0.685|0.851
Relative|Anal cancer|2015–2019|Males|5|60–64|0.702|0.615|0.775
Relative|Anal cancer|2015–2019|Males|5|65–69|0.638|0.543|0.722
Relative|Anal cancer|2015–2019|Males|5|70–74|0.676|0.567|0.771
Relative|Anal cancer|2015–2019|Males|5|75–79|0.399|0.283|0.519
Relative|Anal cancer|2015–2019|Males|5|80–84|0.483|0.321|0.652
Relative|Anal cancer|2015–2019|Males|5|85+|||
Relative|Anal cancer|2015–2019|Males|5|All ages combined|0.653|0.617|0.688
Observed|Anal cancer|2015–2019|Females|1|00–04|||
Observed|Anal cancer|2015–2019|Females|1|05–09|||
Observed|Anal cancer|2015–2019|Females|1|10–14|||
Observed|Anal cancer|2015–2019|Females|1|15–19|||
Observed|Anal cancer|2015–2019|Females|1|20–24|||
Observed|Anal cancer|2015–2019|Females|1|25–29|||
Observed|Anal cancer|2015–2019|Females|1|30–34|||
Observed|Anal cancer|2015–2019|Females|1|35–39|||
Observed|Anal cancer|2015–2019|Females|1|40–44|0.941|0.827|0.98
Observed|Anal cancer|2015–2019|Females|1|45–49|0.937|0.865|0.971
Observed|Anal cancer|2015–2019|Females|1|50–54|0.97|0.921|0.989
Observed|Anal cancer|2015–2019|Females|1|55–59|0.902|0.853|0.936
Observed|Anal cancer|2015–2019|Females|1|60–64|0.92|0.877|0.948
Observed|Anal cancer|2015–2019|Females|1|65–69|0.936|0.892|0.962
Observed|Anal cancer|2015–2019|Females|1|70–74|0.878|0.821|0.918
Observed|Anal cancer|2015–2019|Females|1|75–79|0.848|0.774|0.899
Observed|Anal cancer|2015–2019|Females|1|80–84|0.736|0.628|0.817
Observed|Anal cancer|2015–2019|Females|1|85+|0.611|0.514|0.695
Observed|Anal cancer|2015–2019|Females|1|All ages combined|0.88|0.863|0.896
Observed|Anal cancer|2015–2019|Females|2|00–04|||
Observed|Anal cancer|2015–2019|Females|2|05–09|||
Observed|Anal cancer|2015–2019|Females|2|10–14|||
Observed|Anal cancer|2015–2019|Females|2|15–19|||
Observed|Anal cancer|2015–2019|Females|2|20–24|||
Observed|Anal cancer|2015–2019|Females|2|25–29|||
Observed|Anal cancer|2015–2019|Females|2|30–34|||
Observed|Anal cancer|2015–2019|Females|2|35–39|||
Observed|Anal cancer|2015–2019|Females|2|40–44|0.921|0.803|0.97
Observed|Anal cancer|2015–2019|Females|2|45–49|0.863|0.776|0.918
Observed|Anal cancer|2015–2019|Females|2|50–54|0.908|0.844|0.947
Observed|Anal cancer|2015–2019|Females|2|55–59|0.855|0.799|0.896
Observed|Anal cancer|2015–2019|Females|2|60–64|0.853|0.799|0.893
Observed|Anal cancer|2015–2019|Females|2|65–69|0.883|0.829|0.92
Observed|Anal cancer|2015–2019|Females|2|70–74|0.784|0.715|0.838
Observed|Anal cancer|2015–2019|Females|2|75–79|0.761|0.676|0.827
Observed|Anal cancer|2015–2019|Females|2|80–84|0.611|0.497|0.706
Observed|Anal cancer|2015–2019|Females|2|85+|0.39|0.299|0.48
Observed|Anal cancer|2015–2019|Females|2|All ages combined|0.798|0.777|0.818
Observed|Anal cancer|2015–2019|Females|3|00–04|||
Observed|Anal cancer|2015–2019|Females|3|05–09|||
Observed|Anal cancer|2015–2019|Females|3|10–14|||
Observed|Anal cancer|2015–2019|Females|3|15–19|||
Observed|Anal cancer|2015–2019|Females|3|20–24|||
Observed|Anal cancer|2015–2019|Females|3|25–29|||
Observed|Anal cancer|2015–2019|Females|3|30–34|||
Observed|Anal cancer|2015–2019|Females|3|35–39|||
Observed|Anal cancer|2015–2019|Females|3|40–44|0.921|0.803|0.97
Observed|Anal cancer|2015–2019|Females|3|45–49|0.809|0.714|0.875
Observed|Anal cancer|2015–2019|Females|3|50–54|0.848|0.774|0.899
Observed|Anal cancer|2015–2019|Females|3|55–59|0.812|0.752|0.859
Observed|Anal cancer|2015–2019|Females|3|60–64|0.802|0.742|0.849
Observed|Anal cancer|2015–2019|Females|3|65–69|0.849|0.79|0.893
Observed|Anal cancer|2015–2019|Females|3|70–74|0.746|0.674|0.805
Observed|Anal cancer|2015–2019|Females|3|75–79|0.684|0.594|0.759
Observed|Anal cancer|2015–2019|Females|3|80–84|0.522|0.411|0.622
Observed|Anal cancer|2015–2019|Females|3|85+|0.323|0.238|0.411
Observed|Anal cancer|2015–2019|Females|3|All ages combined|0.747|0.723|0.769
Observed|Anal cancer|2015–2019|Females|4|00–04|||
Observed|Anal cancer|2015–2019|Females|4|05–09|||
Observed|Anal cancer|2015–2019|Females|4|10–14|||
Observed|Anal cancer|2015–2019|Females|4|15–19|||
Observed|Anal cancer|2015–2019|Females|4|20–24|||
Observed|Anal cancer|2015–2019|Females|4|25–29|||
Observed|Anal cancer|2015–2019|Females|4|30–34|||
Observed|Anal cancer|2015–2019|Females|4|35–39|||
Observed|Anal cancer|2015–2019|Females|4|40–44|0.921|0.803|0.97
Observed|Anal cancer|2015–2019|Females|4|45–49|0.788|0.691|0.858
Observed|Anal cancer|2015–2019|Females|4|50–54|0.81|0.732|0.868
Observed|Anal cancer|2015–2019|Females|4|55–59|0.767|0.703|0.819
Observed|Anal cancer|2015–2019|Females|4|60–64|0.743|0.678|0.797
Observed|Anal cancer|2015–2019|Females|4|65–69|0.832|0.77|0.878
Observed|Anal cancer|2015–2019|Females|4|70–74|0.702|0.627|0.765
Observed|Anal cancer|2015–2019|Females|4|75–79|0.614|0.521|0.695
Observed|Anal cancer|2015–2019|Females|4|80–84|0.454|0.348|0.553
Observed|Anal cancer|2015–2019|Females|4|85+|0.226|0.15|0.31
Observed|Anal cancer|2015–2019|Females|4|All ages combined|0.699|0.674|0.722
Observed|Anal cancer|2015–2019|Females|5|00–04|||
Observed|Anal cancer|2015–2019|Females|5|05–09|||
Observed|Anal cancer|2015–2019|Females|5|10–14|||
Observed|Anal cancer|2015–2019|Females|5|15–19|||
Observed|Anal cancer|2015–2019|Females|5|20–24|||
Observed|Anal cancer|2015–2019|Females|5|25–29|||
Observed|Anal cancer|2015–2019|Females|5|30–34|||
Observed|Anal cancer|2015–2019|Females|5|35–39|||
Observed|Anal cancer|2015–2019|Females|5|40–44|0.921|0.803|0.97
Observed|Anal cancer|2015–2019|Females|5|45–49|0.778|0.68|0.849
Observed|Anal cancer|2015–2019|Females|5|50–54|0.795|0.715|0.854
Observed|Anal cancer|2015–2019|Females|5|55–59|0.757|0.692|0.81
Observed|Anal cancer|2015–2019|Females|5|60–64|0.732|0.666|0.788
Observed|Anal cancer|2015–2019|Females|5|65–69|0.806|0.741|0.857
Observed|Anal cancer|2015–2019|Females|5|70–74|0.654|0.575|0.721
Observed|Anal cancer|2015–2019|Females|5|75–79|0.576|0.481|0.659
Observed|Anal cancer|2015–2019|Females|5|80–84|0.384|0.285|0.482
Observed|Anal cancer|2015–2019|Females|5|85+|0.175|0.109|0.255
Observed|Anal cancer|2015–2019|Females|5|All ages combined|0.672|0.647|0.696
Relative|Anal cancer|2015–2019|Females|1|00–04|||
Relative|Anal cancer|2015–2019|Females|1|05–09|||
Relative|Anal cancer|2015–2019|Females|1|10–14|||
Relative|Anal cancer|2015–2019|Females|1|15–19|||
Relative|Anal cancer|2015–2019|Females|1|20–24|||
Relative|Anal cancer|2015–2019|Females|1|25–29|||
Relative|Anal cancer|2015–2019|Females|1|30–34|||
Relative|Anal cancer|2015–2019|Females|1|35–39|||
Relative|Anal cancer|2015–2019|Females|1|40–44|0.942|0.828|0.981
Relative|Anal cancer|2015–2019|Females|1|45–49|0.938|0.866|0.972
Relative|Anal cancer|2015–2019|Females|1|50–54|0.972|0.923|0.991
Relative|Anal cancer|2015–2019|Females|1|55–59|0.905|0.855|0.939
Relative|Anal cancer|2015–2019|Females|1|60–64|0.924|0.881|0.952
Relative|Anal cancer|2015–2019|Females|1|65–69|0.942|0.898|0.969
Relative|Anal cancer|2015–2019|Females|1|70–74|0.889|0.831|0.93
Relative|Anal cancer|2015–2019|Females|1|75–79|0.867|0.791|0.919
Relative|Anal cancer|2015–2019|Females|1|80–84|0.769|0.656|0.853
Relative|Anal cancer|2015–2019|Females|1|85+|0.692|0.582|0.787
Relative|Anal cancer|2015–2019|Females|1|All ages combined|0.895|0.877|0.911
Relative|Anal cancer|2015–2019|Females|2|00–04|||
Relative|Anal cancer|2015–2019|Females|2|05–09|||
Relative|Anal cancer|2015–2019|Females|2|10–14|||
Relative|Anal cancer|2015–2019|Females|2|15–19|||
Relative|Anal cancer|2015–2019|Females|2|20–24|||
Relative|Anal cancer|2015–2019|Females|2|25–29|||
Relative|Anal cancer|2015–2019|Females|2|30–34|||
Relative|Anal cancer|2015–2019|Females|2|35–39|||
Relative|Anal cancer|2015–2019|Females|2|40–44|0.923|0.805|0.972
Relative|Anal cancer|2015–2019|Females|2|45–49|0.866|0.778|0.921
Relative|Anal cancer|2015–2019|Females|2|50–54|0.912|0.848|0.951
Relative|Anal cancer|2015–2019|Females|2|55–59|0.86|0.804|0.902
Relative|Anal cancer|2015–2019|Females|2|60–64|0.861|0.807|0.902
Relative|Anal cancer|2015–2019|Females|2|65–69|0.896|0.841|0.934
Relative|Anal cancer|2015–2019|Females|2|70–74|0.804|0.734|0.86
Relative|Anal cancer|2015–2019|Females|2|75–79|0.797|0.708|0.866
Relative|Anal cancer|2015–2019|Females|2|80–84|0.669|0.544|0.774
Relative|Anal cancer|2015–2019|Females|2|85+|0.502|0.385|0.617
Relative|Anal cancer|2015–2019|Females|2|All ages combined|0.824|0.802|0.845
Relative|Anal cancer|2015–2019|Females|3|00–04|||
Relative|Anal cancer|2015–2019|Females|3|05–09|||
Relative|Anal cancer|2015–2019|Females|3|10–14|||
Relative|Anal cancer|2015–2019|Females|3|15–19|||
Relative|Anal cancer|2015–2019|Females|3|20–24|||
Relative|Anal cancer|2015–2019|Females|3|25–29|||
Relative|Anal cancer|2015–2019|Females|3|30–34|||
Relative|Anal cancer|2015–2019|Females|3|35–39|||
Relative|Anal cancer|2015–2019|Females|3|40–44|0.924|0.806|0.973
Relative|Anal cancer|2015–2019|Females|3|45–49|0.813|0.717|0.879
Relative|Anal cancer|2015–2019|Females|3|50–54|0.854|0.78|0.905
Relative|Anal cancer|2015–2019|Females|3|55–59|0.82|0.76|0.868
Relative|Anal cancer|2015–2019|Females|3|60–64|0.814|0.753|0.862
Relative|Anal cancer|2015–2019|Females|3|65–69|0.87|0.809|0.914
Relative|Anal cancer|2015–2019|Females|3|70–74|0.777|0.702|0.838
Relative|Anal cancer|2015–2019|Females|3|75–79|0.738|0.64|0.818
Relative|Anal cancer|2015–2019|Females|3|80–84|0.606|0.477|0.722
Relative|Anal cancer|2015–2019|Females|3|85+|0.478|0.351|0.608
Relative|Anal cancer|2015–2019|Females|3|All ages combined|0.783|0.758|0.806
Relative|Anal cancer|2015–2019|Females|4|00–04|||
Relative|Anal cancer|2015–2019|Females|4|05–09|||
Relative|Anal cancer|2015–2019|Females|4|10–14|||
Relative|Anal cancer|2015–2019|Females|4|15–19|||
Relative|Anal cancer|2015–2019|Females|4|20–24|||
Relative|Anal cancer|2015–2019|Females|4|25–29|||
Relative|Anal cancer|2015–2019|Females|4|30–34|||
Relative|Anal cancer|2015–2019|Females|4|35–39|||
Relative|Anal cancer|2015–2019|Females|4|40–44|0.925|0.807|0.974
Relative|Anal cancer|2015–2019|Females|4|45–49|0.793|0.695|0.863
Relative|Anal cancer|2015–2019|Females|4|50–54|0.818|0.74|0.876
Relative|Anal cancer|2015–2019|Females|4|55–59|0.778|0.713|0.831
Relative|Anal cancer|2015–2019|Females|4|60–64|0.759|0.692|0.814
Relative|Anal cancer|2015–2019|Females|4|65–69|0.86|0.796|0.908
Relative|Anal cancer|2015–2019|Females|4|70–74|0.744|0.664|0.81
Relative|Anal cancer|2015–2019|Females|4|75–79|0.683|0.58|0.773
Relative|Anal cancer|2015–2019|Females|4|80–84|0.562|0.431|0.685
Relative|Anal cancer|2015–2019|Females|4|85+|0.39|0.26|0.537
Relative|Anal cancer|2015–2019|Females|4|All ages combined|0.745|0.718|0.77
Relative|Anal cancer|2015–2019|Females|5|00–04|||
Relative|Anal cancer|2015–2019|Females|5|05–09|||
Relative|Anal cancer|2015–2019|Females|5|10–14|||
Relative|Anal cancer|2015–2019|Females|5|15–19|||
Relative|Anal cancer|2015–2019|Females|5|20–24|||
Relative|Anal cancer|2015–2019|Females|5|25–29|||
Relative|Anal cancer|2015–2019|Females|5|30–34|||
Relative|Anal cancer|2015–2019|Females|5|35–39|||
Relative|Anal cancer|2015–2019|Females|5|40–44|0.926|0.808|0.975
Relative|Anal cancer|2015–2019|Females|5|45–49|0.784|0.685|0.856
Relative|Anal cancer|2015–2019|Females|5|50–54|0.805|0.724|0.865
Relative|Anal cancer|2015–2019|Females|5|55–59|0.771|0.705|0.825
Relative|Anal cancer|2015–2019|Females|5|60–64|0.753|0.684|0.809
Relative|Anal cancer|2015–2019|Females|5|65–69|0.843|0.775|0.896
Relative|Anal cancer|2015–2019|Females|5|70–74|0.706|0.621|0.779
Relative|Anal cancer|2015–2019|Females|5|75–79|0.665|0.555|0.761
Relative|Anal cancer|2015–2019|Females|5|80–84|0.511|0.379|0.642
Relative|Anal cancer|2015–2019|Females|5|85+|0.359|0.223|0.523
Relative|Anal cancer|2015–2019|Females|5|All ages combined|0.728|0.7|0.754
Observed|Anal cancer|2015–2019|Persons|1|00–04|||
Observed|Anal cancer|2015–2019|Persons|1|05–09|||
Observed|Anal cancer|2015–2019|Persons|1|10–14|||
Observed|Anal cancer|2015–2019|Persons|1|15–19|||
Observed|Anal cancer|2015–2019|Persons|1|20–24|||
Observed|Anal cancer|2015–2019|Persons|1|25–29|||
Observed|Anal cancer|2015–2019|Persons|1|30–34|||
Observed|Anal cancer|2015–2019|Persons|1|35–39|0.93|0.749|0.982
Observed|Anal cancer|2015–2019|Persons|1|40–44|0.941|0.851|0.978
Observed|Anal cancer|2015–2019|Persons|1|45–49|0.931|0.878|0.961
Observed|Anal cancer|2015–2019|Persons|1|50–54|0.961|0.927|0.98
Observed|Anal cancer|2015–2019|Persons|1|55–59|0.919|0.885|0.944
Observed|Anal cancer|2015–2019|Persons|1|60–64|0.916|0.883|0.94
Observed|Anal cancer|2015–2019|Persons|1|65–69|0.91|0.874|0.937
Observed|Anal cancer|2015–2019|Persons|1|70–74|0.883|0.843|0.914
Observed|Anal cancer|2015–2019|Persons|1|75–79|0.796|0.736|0.844
Observed|Anal cancer|2015–2019|Persons|1|80–84|0.709|0.631|0.774
Observed|Anal cancer|2015–2019|Persons|1|85+|0.602|0.526|0.67
Observed|Anal cancer|2015–2019|Persons|1|All ages combined|0.871|0.857|0.884
Observed|Anal cancer|2015–2019|Persons|2|00–04|||
Observed|Anal cancer|2015–2019|Persons|2|05–09|||
Observed|Anal cancer|2015–2019|Persons|2|10–14|||
Observed|Anal cancer|2015–2019|Persons|2|15–19|||
Observed|Anal cancer|2015–2019|Persons|2|20–24|||
Observed|Anal cancer|2015–2019|Persons|2|25–29|||
Observed|Anal cancer|2015–2019|Persons|2|30–34|||
Observed|Anal cancer|2015–2019|Persons|2|35–39|0.864|0.678|0.947
Observed|Anal cancer|2015–2019|Persons|2|40–44|0.911|0.812|0.959
Observed|Anal cancer|2015–2019|Persons|2|45–49|0.831|0.764|0.881
Observed|Anal cancer|2015–2019|Persons|2|50–54|0.876|0.826|0.912
Observed|Anal cancer|2015–2019|Persons|2|55–59|0.866|0.825|0.898
Observed|Anal cancer|2015–2019|Persons|2|60–64|0.837|0.795|0.871
Observed|Anal cancer|2015–2019|Persons|2|65–69|0.829|0.783|0.865
Observed|Anal cancer|2015–2019|Persons|2|70–74|0.777|0.726|0.82
Observed|Anal cancer|2015–2019|Persons|2|75–79|0.672|0.604|0.731
Observed|Anal cancer|2015–2019|Persons|2|80–84|0.599|0.517|0.672
Observed|Anal cancer|2015–2019|Persons|2|85+|0.399|0.327|0.471
Observed|Anal cancer|2015–2019|Persons|2|All ages combined|0.776|0.759|0.793
Observed|Anal cancer|2015–2019|Persons|3|00–04|||
Observed|Anal cancer|2015–2019|Persons|3|05–09|||
Observed|Anal cancer|2015–2019|Persons|3|10–14|||
Observed|Anal cancer|2015–2019|Persons|3|15–19|||
Observed|Anal cancer|2015–2019|Persons|3|20–24|||
Observed|Anal cancer|2015–2019|Persons|3|25–29|||
Observed|Anal cancer|2015–2019|Persons|3|30–34|||
Observed|Anal cancer|2015–2019|Persons|3|35–39|0.771|0.58|0.883
Observed|Anal cancer|2015–2019|Persons|3|40–44|0.911|0.812|0.959
Observed|Anal cancer|2015–2019|Persons|3|45–49|0.775|0.702|0.832
Observed|Anal cancer|2015–2019|Persons|3|50–54|0.828|0.773|0.871
Observed|Anal cancer|2015–2019|Persons|3|55–59|0.819|0.773|0.856
Observed|Anal cancer|2015–2019|Persons|3|60–64|0.779|0.733|0.819
Observed|Anal cancer|2015–2019|Persons|3|65–69|0.775|0.726|0.817
Observed|Anal cancer|2015–2019|Persons|3|70–74|0.716|0.661|0.764
Observed|Anal cancer|2015–2019|Persons|3|75–79|0.581|0.511|0.644
Observed|Anal cancer|2015–2019|Persons|3|80–84|0.507|0.425|0.583
Observed|Anal cancer|2015–2019|Persons|3|85+|0.315|0.248|0.385
Observed|Anal cancer|2015–2019|Persons|3|All ages combined|0.715|0.696|0.733
Observed|Anal cancer|2015–2019|Persons|4|00–04|||
Observed|Anal cancer|2015–2019|Persons|4|05–09|||
Observed|Anal cancer|2015–2019|Persons|4|10–14|||
Observed|Anal cancer|2015–2019|Persons|4|15–19|||
Observed|Anal cancer|2015–2019|Persons|4|20–24|||
Observed|Anal cancer|2015–2019|Persons|4|25–29|||
Observed|Anal cancer|2015–2019|Persons|4|30–34|||
Observed|Anal cancer|2015–2019|Persons|4|35–39|0.739|0.546|0.86
Observed|Anal cancer|2015–2019|Persons|4|40–44|0.911|0.812|0.959
Observed|Anal cancer|2015–2019|Persons|4|45–49|0.757|0.683|0.816
Observed|Anal cancer|2015–2019|Persons|4|50–54|0.782|0.723|0.83
Observed|Anal cancer|2015–2019|Persons|4|55–59|0.775|0.726|0.817
Observed|Anal cancer|2015–2019|Persons|4|60–64|0.725|0.675|0.769
Observed|Anal cancer|2015–2019|Persons|4|65–69|0.745|0.694|0.79
Observed|Anal cancer|2015–2019|Persons|4|70–74|0.67|0.612|0.721
Observed|Anal cancer|2015–2019|Persons|4|75–79|0.512|0.442|0.577
Observed|Anal cancer|2015–2019|Persons|4|80–84|0.433|0.354|0.509
Observed|Anal cancer|2015–2019|Persons|4|85+|0.236|0.174|0.303
Observed|Anal cancer|2015–2019|Persons|4|All ages combined|0.668|0.648|0.686
Observed|Anal cancer|2015–2019|Persons|5|00–04|||
Observed|Anal cancer|2015–2019|Persons|5|05–09|||
Observed|Anal cancer|2015–2019|Persons|5|10–14|||
Observed|Anal cancer|2015–2019|Persons|5|15–19|||
Observed|Anal cancer|2015–2019|Persons|5|20–24|||
Observed|Anal cancer|2015–2019|Persons|5|25–29|||
Observed|Anal cancer|2015–2019|Persons|5|30–34|||
Observed|Anal cancer|2015–2019|Persons|5|35–39|0.739|0.546|0.86
Observed|Anal cancer|2015–2019|Persons|5|40–44|0.911|0.812|0.959
Observed|Anal cancer|2015–2019|Persons|5|45–49|0.746|0.671|0.806
Observed|Anal cancer|2015–2019|Persons|5|50–54|0.758|0.697|0.809
Observed|Anal cancer|2015–2019|Persons|5|55–59|0.758|0.707|0.801
Observed|Anal cancer|2015–2019|Persons|5|60–64|0.706|0.656|0.751
Observed|Anal cancer|2015–2019|Persons|5|65–69|0.717|0.664|0.763
Observed|Anal cancer|2015–2019|Persons|5|70–74|0.632|0.572|0.686
Observed|Anal cancer|2015–2019|Persons|5|75–79|0.465|0.396|0.532
Observed|Anal cancer|2015–2019|Persons|5|80–84|0.361|0.287|0.435
Observed|Anal cancer|2015–2019|Persons|5|85+|0.19|0.133|0.255
Observed|Anal cancer|2015–2019|Persons|5|All ages combined|0.638|0.618|0.657
Relative|Anal cancer|2015–2019|Persons|1|00–04|||
Relative|Anal cancer|2015–2019|Persons|1|05–09|||
Relative|Anal cancer|2015–2019|Persons|1|10–14|||
Relative|Anal cancer|2015–2019|Persons|1|15–19|||
Relative|Anal cancer|2015–2019|Persons|1|20–24|||
Relative|Anal cancer|2015–2019|Persons|1|25–29|||
Relative|Anal cancer|2015–2019|Persons|1|30–34|||
Relative|Anal cancer|2015–2019|Persons|1|35–39|0.931|0.75|0.983
Relative|Anal cancer|2015–2019|Persons|1|40–44|0.942|0.852|0.979
Relative|Anal cancer|2015–2019|Persons|1|45–49|0.932|0.88|0.963
Relative|Anal cancer|2015–2019|Persons|1|50–54|0.964|0.929|0.982
Relative|Anal cancer|2015–2019|Persons|1|55–59|0.923|0.888|0.948
Relative|Anal cancer|2015–2019|Persons|1|60–64|0.922|0.889|0.945
Relative|Anal cancer|2015–2019|Persons|1|65–69|0.919|0.883|0.945
Relative|Anal cancer|2015–2019|Persons|1|70–74|0.897|0.856|0.928
Relative|Anal cancer|2015–2019|Persons|1|75–79|0.817|0.755|0.866
Relative|Anal cancer|2015–2019|Persons|1|80–84|0.746|0.664|0.814
Relative|Anal cancer|2015–2019|Persons|1|85+|0.688|0.601|0.765
Relative|Anal cancer|2015–2019|Persons|1|All ages combined|0.888|0.874|0.901
Relative|Anal cancer|2015–2019|Persons|2|00–04|||
Relative|Anal cancer|2015–2019|Persons|2|05–09|||
Relative|Anal cancer|2015–2019|Persons|2|10–14|||
Relative|Anal cancer|2015–2019|Persons|2|15–19|||
Relative|Anal cancer|2015–2019|Persons|2|20–24|||
Relative|Anal cancer|2015–2019|Persons|2|25–29|||
Relative|Anal cancer|2015–2019|Persons|2|30–34|||
Relative|Anal cancer|2015–2019|Persons|2|35–39|0.866|0.679|0.948
Relative|Anal cancer|2015–2019|Persons|2|40–44|0.913|0.814|0.961
Relative|Anal cancer|2015–2019|Persons|2|45–49|0.834|0.767|0.884
Relative|Anal cancer|2015–2019|Persons|2|50–54|0.881|0.831|0.917
Relative|Anal cancer|2015–2019|Persons|2|55–59|0.873|0.832|0.906
Relative|Anal cancer|2015–2019|Persons|2|60–64|0.847|0.805|0.882
Relative|Anal cancer|2015–2019|Persons|2|65–69|0.845|0.798|0.882
Relative|Anal cancer|2015–2019|Persons|2|70–74|0.802|0.749|0.846
Relative|Anal cancer|2015–2019|Persons|2|75–79|0.711|0.639|0.773
Relative|Anal cancer|2015–2019|Persons|2|80–84|0.667|0.575|0.748
Relative|Anal cancer|2015–2019|Persons|2|85+|0.522|0.427|0.616
Relative|Anal cancer|2015–2019|Persons|2|All ages combined|0.806|0.788|0.823
Relative|Anal cancer|2015–2019|Persons|3|00–04|||
Relative|Anal cancer|2015–2019|Persons|3|05–09|||
Relative|Anal cancer|2015–2019|Persons|3|10–14|||
Relative|Anal cancer|2015–2019|Persons|3|15–19|||
Relative|Anal cancer|2015–2019|Persons|3|20–24|||
Relative|Anal cancer|2015–2019|Persons|3|25–29|||
Relative|Anal cancer|2015–2019|Persons|3|30–34|||
Relative|Anal cancer|2015–2019|Persons|3|35–39|0.773|0.581|0.886
Relative|Anal cancer|2015–2019|Persons|3|40–44|0.914|0.815|0.962
Relative|Anal cancer|2015–2019|Persons|3|45–49|0.78|0.706|0.837
Relative|Anal cancer|2015–2019|Persons|3|50–54|0.835|0.78|0.878
Relative|Anal cancer|2015–2019|Persons|3|55–59|0.829|0.783|0.867
Relative|Anal cancer|2015–2019|Persons|3|60–64|0.794|0.747|0.835
Relative|Anal cancer|2015–2019|Persons|3|65–69|0.799|0.748|0.842
Relative|Anal cancer|2015–2019|Persons|3|70–74|0.753|0.695|0.804
Relative|Anal cancer|2015–2019|Persons|3|75–79|0.636|0.559|0.705
Relative|Anal cancer|2015–2019|Persons|3|80–84|0.602|0.505|0.692
Relative|Anal cancer|2015–2019|Persons|3|85+|0.475|0.373|0.58
Relative|Anal cancer|2015–2019|Persons|3|All ages combined|0.755|0.735|0.774
Relative|Anal cancer|2015–2019|Persons|4|00–04|||
Relative|Anal cancer|2015–2019|Persons|4|05–09|||
Relative|Anal cancer|2015–2019|Persons|4|10–14|||
Relative|Anal cancer|2015–2019|Persons|4|15–19|||
Relative|Anal cancer|2015–2019|Persons|4|20–24|||
Relative|Anal cancer|2015–2019|Persons|4|25–29|||
Relative|Anal cancer|2015–2019|Persons|4|30–34|||
Relative|Anal cancer|2015–2019|Persons|4|35–39|0.742|0.548|0.863
Relative|Anal cancer|2015–2019|Persons|4|40–44|0.915|0.816|0.964
Relative|Anal cancer|2015–2019|Persons|4|45–49|0.764|0.689|0.823
Relative|Anal cancer|2015–2019|Persons|4|50–54|0.792|0.732|0.841
Relative|Anal cancer|2015–2019|Persons|4|55–59|0.789|0.739|0.832
Relative|Anal cancer|2015–2019|Persons|4|60–64|0.745|0.694|0.79
Relative|Anal cancer|2015–2019|Persons|4|65–69|0.778|0.724|0.824
Relative|Anal cancer|2015–2019|Persons|4|70–74|0.719|0.657|0.774
Relative|Anal cancer|2015–2019|Persons|4|75–79|0.582|0.503|0.657
Relative|Anal cancer|2015–2019|Persons|4|80–84|0.553|0.452|0.651
Relative|Anal cancer|2015–2019|Persons|4|85+|0.416|0.308|0.535
Relative|Anal cancer|2015–2019|Persons|4|All ages combined|0.717|0.696|0.738
Relative|Anal cancer|2015–2019|Persons|5|00–04|||
Relative|Anal cancer|2015–2019|Persons|5|05–09|||
Relative|Anal cancer|2015–2019|Persons|5|10–14|||
Relative|Anal cancer|2015–2019|Persons|5|15–19|||
Relative|Anal cancer|2015–2019|Persons|5|20–24|||
Relative|Anal cancer|2015–2019|Persons|5|25–29|||
Relative|Anal cancer|2015–2019|Persons|5|30–34|||
Relative|Anal cancer|2015–2019|Persons|5|35–39|0.743|0.549|0.864
Relative|Anal cancer|2015–2019|Persons|5|40–44|0.917|0.817|0.965
Relative|Anal cancer|2015–2019|Persons|5|45–49|0.754|0.678|0.815
Relative|Anal cancer|2015–2019|Persons|5|50–54|0.77|0.708|0.822
Relative|Anal cancer|2015–2019|Persons|5|55–59|0.776|0.723|0.82
Relative|Anal cancer|2015–2019|Persons|5|60–64|0.732|0.679|0.778
Relative|Anal cancer|2015–2019|Persons|5|65–69|0.758|0.702|0.807
Relative|Anal cancer|2015–2019|Persons|5|70–74|0.694|0.629|0.754
Relative|Anal cancer|2015–2019|Persons|5|75–79|0.553|0.47|0.632
Relative|Anal cancer|2015–2019|Persons|5|80–84|0.5|0.397|0.604
Relative|Anal cancer|2015–2019|Persons|5|85+|0.4|0.279|0.536
Relative|Anal cancer|2015–2019|Persons|5|All ages combined|0.698|0.676|0.719
Observed|Appendiceal cancer|2015–2019|Males|1|00–04|||
Observed|Appendiceal cancer|2015–2019|Males|1|05–09|||
Observed|Appendiceal cancer|2015–2019|Males|1|10–14|1|0.912|1
Observed|Appendiceal cancer|2015–2019|Males|1|15–19|1|0.963|1
Observed|Appendiceal cancer|2015–2019|Males|1|20–24|1|0.966|1
Observed|Appendiceal cancer|2015–2019|Males|1|25–29|0.987|0.911|0.998
Observed|Appendiceal cancer|2015–2019|Males|1|30–34|0.987|0.913|0.998
Observed|Appendiceal cancer|2015–2019|Males|1|35–39|0.957|0.873|0.986
Observed|Appendiceal cancer|2015–2019|Males|1|40–44|0.977|0.912|0.994
Observed|Appendiceal cancer|2015–2019|Males|1|45–49|0.945|0.881|0.975
Observed|Appendiceal cancer|2015–2019|Males|1|50–54|0.962|0.902|0.986
Observed|Appendiceal cancer|2015–2019|Males|1|55–59|0.938|0.874|0.97
Observed|Appendiceal cancer|2015–2019|Males|1|60–64|0.948|0.887|0.976
Observed|Appendiceal cancer|2015–2019|Males|1|65–69|0.918|0.849|0.957
Observed|Appendiceal cancer|2015–2019|Males|1|70–74|0.852|0.755|0.913
Observed|Appendiceal cancer|2015–2019|Males|1|75–79|0.869|0.755|0.932
Observed|Appendiceal cancer|2015–2019|Males|1|80–84|0.72|0.58|0.82
Observed|Appendiceal cancer|2015–2019|Males|1|85+|0.711|0.519|0.837
Observed|Appendiceal cancer|2015–2019|Males|1|All ages combined|0.936|0.921|0.948
Observed|Appendiceal cancer|2015–2019|Males|2|00–04|||
Observed|Appendiceal cancer|2015–2019|Males|2|05–09|||
Observed|Appendiceal cancer|2015–2019|Males|2|10–14|1|0.911|1
Observed|Appendiceal cancer|2015–2019|Males|2|15–19|1|0.96|1
Observed|Appendiceal cancer|2015–2019|Males|2|20–24|1|0.965|1
Observed|Appendiceal cancer|2015–2019|Males|2|25–29|0.987|0.911|0.998
Observed|Appendiceal cancer|2015–2019|Males|2|30–34|0.975|0.902|0.994
Observed|Appendiceal cancer|2015–2019|Males|2|35–39|0.957|0.873|0.986
Observed|Appendiceal cancer|2015–2019|Males|2|40–44|0.955|0.884|0.983
Observed|Appendiceal cancer|2015–2019|Males|2|45–49|0.906|0.832|0.948
Observed|Appendiceal cancer|2015–2019|Males|2|50–54|0.897|0.816|0.943
Observed|Appendiceal cancer|2015–2019|Males|2|55–59|0.872|0.793|0.922
Observed|Appendiceal cancer|2015–2019|Males|2|60–64|0.826|0.741|0.886
Observed|Appendiceal cancer|2015–2019|Males|2|65–69|0.805|0.716|0.868
Observed|Appendiceal cancer|2015–2019|Males|2|70–74|0.761|0.652|0.841
Observed|Appendiceal cancer|2015–2019|Males|2|75–79|0.742|0.618|0.83
Observed|Appendiceal cancer|2015–2019|Males|2|80–84|0.7|0.559|0.804
Observed|Appendiceal cancer|2015–2019|Males|2|85+|||
Observed|Appendiceal cancer|2015–2019|Males|2|All ages combined|0.883|0.864|0.899
Observed|Appendiceal cancer|2015–2019|Males|3|00–04|||
Observed|Appendiceal cancer|2015–2019|Males|3|05–09|||
Observed|Appendiceal cancer|2015–2019|Males|3|10–14|1|0.908|1
Observed|Appendiceal cancer|2015–2019|Males|3|15–19|0.985|0.896|0.998
Observed|Appendiceal cancer|2015–2019|Males|3|20–24|1|0.963|1
Observed|Appendiceal cancer|2015–2019|Males|3|25–29|0.987|0.911|0.998
Observed|Appendiceal cancer|2015–2019|Males|3|30–34|0.975|0.902|0.994
Observed|Appendiceal cancer|2015–2019|Males|3|35–39|0.915|0.821|0.961
Observed|Appendiceal cancer|2015–2019|Males|3|40–44|0.944|0.87|0.976
Observed|Appendiceal cancer|2015–2019|Males|3|45–49|0.895|0.819|0.941
Observed|Appendiceal cancer|2015–2019|Males|3|50–54|0.845|0.751|0.906
Observed|Appendiceal cancer|2015–2019|Males|3|55–59|0.823|0.736|0.883
Observed|Appendiceal cancer|2015–2019|Males|3|60–64|0.773|0.68|0.842
Observed|Appendiceal cancer|2015–2019|Males|3|65–69|0.767|0.675|0.836
Observed|Appendiceal cancer|2015–2019|Males|3|70–74|0.707|0.587|0.798
Observed|Appendiceal cancer|2015–2019|Males|3|75–79|0.713|0.589|0.806
Observed|Appendiceal cancer|2015–2019|Males|3|80–84|0.639|0.494|0.752
Observed|Appendiceal cancer|2015–2019|Males|3|85+|||
Observed|Appendiceal cancer|2015–2019|Males|3|All ages combined|0.852|0.831|0.871
Observed|Appendiceal cancer|2015–2019|Males|4|00–04|||
Observed|Appendiceal cancer|2015–2019|Males|4|05–09|||
Observed|Appendiceal cancer|2015–2019|Males|4|10–14|1|0.904|1
Observed|Appendiceal cancer|2015–2019|Males|4|15–19|0.985|0.896|0.998
Observed|Appendiceal cancer|2015–2019|Males|4|20–24|1|0.961|1
Observed|Appendiceal cancer|2015–2019|Males|4|25–29|0.971|0.89|0.993
Observed|Appendiceal cancer|2015–2019|Males|4|30–34|0.975|0.902|0.994
Observed|Appendiceal cancer|2015–2019|Males|4|35–39|0.889|0.79|0.943
Observed|Appendiceal cancer|2015–2019|Males|4|40–44|0.932|0.854|0.969
Observed|Appendiceal cancer|2015–2019|Males|4|45–49|0.853|0.768|0.909
Observed|Appendiceal cancer|2015–2019|Males|4|50–54|0.795|0.688|0.869
Observed|Appendiceal cancer|2015–2019|Males|4|55–59|0.788|0.695|0.855
Observed|Appendiceal cancer|2015–2019|Males|4|60–64|0.708|0.606|0.789
Observed|Appendiceal cancer|2015–2019|Males|4|65–69|0.687|0.589|0.766
Observed|Appendiceal cancer|2015–2019|Males|4|70–74|0.614|0.484|0.72
Observed|Appendiceal cancer|2015–2019|Males|4|75–79|0.618|0.493|0.721
Observed|Appendiceal cancer|2015–2019|Males|4|80–84|0.599|0.454|0.717
Observed|Appendiceal cancer|2015–2019|Males|4|85+|||
Observed|Appendiceal cancer|2015–2019|Males|4|All ages combined|0.812|0.789|0.833
Observed|Appendiceal cancer|2015–2019|Males|5|00–04|||
Observed|Appendiceal cancer|2015–2019|Males|5|05–09|||
Observed|Appendiceal cancer|2015–2019|Males|5|10–14|1|0.902|1
Observed|Appendiceal cancer|2015–2019|Males|5|15–19|0.985|0.896|0.998
Observed|Appendiceal cancer|2015–2019|Males|5|20–24|1|0.96|1
Observed|Appendiceal cancer|2015–2019|Males|5|25–29|0.971|0.89|0.993
Observed|Appendiceal cancer|2015–2019|Males|5|30–34|0.975|0.902|0.994
Observed|Appendiceal cancer|2015–2019|Males|5|35–39|0.889|0.79|0.943
Observed|Appendiceal cancer|2015–2019|Males|5|40–44|0.932|0.854|0.969
Observed|Appendiceal cancer|2015–2019|Males|5|45–49|0.827|0.735|0.889
Observed|Appendiceal cancer|2015–2019|Males|5|50–54|0.753|0.633|0.839
Observed|Appendiceal cancer|2015–2019|Males|5|55–59|0.775|0.68|0.845
Observed|Appendiceal cancer|2015–2019|Males|5|60–64|0.708|0.606|0.789
Observed|Appendiceal cancer|2015–2019|Males|5|65–69|0.631|0.53|0.717
Observed|Appendiceal cancer|2015–2019|Males|5|70–74|0.539|0.407|0.654
Observed|Appendiceal cancer|2015–2019|Males|5|75–79|0.537|0.414|0.645
Observed|Appendiceal cancer|2015–2019|Males|5|80–84|0.538|0.394|0.662
Observed|Appendiceal cancer|2015–2019|Males|5|85+|||
Observed|Appendiceal cancer|2015–2019|Males|5|All ages combined|0.787|0.762|0.809
Relative|Appendiceal cancer|2015–2019|Males|1|00–04|||
Relative|Appendiceal cancer|2015–2019|Males|1|05–09|||
Relative|Appendiceal cancer|2015–2019|Males|1|10–14|1|0.912|1
Relative|Appendiceal cancer|2015–2019|Males|1|15–19|1|0.964|1
Relative|Appendiceal cancer|2015–2019|Males|1|20–24|1.001|0.967|1.001
Relative|Appendiceal cancer|2015–2019|Males|1|25–29|0.988|0.912|0.999
Relative|Appendiceal cancer|2015–2019|Males|1|30–34|0.988|0.914|0.999
Relative|Appendiceal cancer|2015–2019|Males|1|35–39|0.958|0.874|0.987
Relative|Appendiceal cancer|2015–2019|Males|1|40–44|0.979|0.913|0.996
Relative|Appendiceal cancer|2015–2019|Males|1|45–49|0.947|0.883|0.977
Relative|Appendiceal cancer|2015–2019|Males|1|50–54|0.965|0.905|0.989
Relative|Appendiceal cancer|2015–2019|Males|1|55–59|0.943|0.878|0.975
Relative|Appendiceal cancer|2015–2019|Males|1|60–64|0.955|0.894|0.984
Relative|Appendiceal cancer|2015–2019|Males|1|65–69|0.929|0.859|0.968
Relative|Appendiceal cancer|2015–2019|Males|1|70–74|0.869|0.77|0.931
Relative|Appendiceal cancer|2015–2019|Males|1|75–79|0.899|0.782|0.965
Relative|Appendiceal cancer|2015–2019|Males|1|80–84|0.763|0.614|0.869
Relative|Appendiceal cancer|2015–2019|Males|1|85+|0.815|0.596|0.96
Relative|Appendiceal cancer|2015–2019|Males|1|All ages combined|0.947|0.932|0.959
Relative|Appendiceal cancer|2015–2019|Males|2|00–04|||
Relative|Appendiceal cancer|2015–2019|Males|2|05–09|||
Relative|Appendiceal cancer|2015–2019|Males|2|10–14|1|0.911|1
Relative|Appendiceal cancer|2015–2019|Males|2|15–19|1.001|0.961|1.001
Relative|Appendiceal cancer|2015–2019|Males|2|20–24|1.001|0.966|1.001
Relative|Appendiceal cancer|2015–2019|Males|2|25–29|0.988|0.913|1
Relative|Appendiceal cancer|2015–2019|Males|2|30–34|0.976|0.904|0.995
Relative|Appendiceal cancer|2015–2019|Males|2|35–39|0.959|0.875|0.988
Relative|Appendiceal cancer|2015–2019|Males|2|40–44|0.958|0.887|0.986
Relative|Appendiceal cancer|2015–2019|Males|2|45–49|0.91|0.836|0.953
Relative|Appendiceal cancer|2015–2019|Males|2|50–54|0.903|0.822|0.95
Relative|Appendiceal cancer|2015–2019|Males|2|55–59|0.882|0.802|0.932
Relative|Appendiceal cancer|2015–2019|Males|2|60–64|0.84|0.754|0.9
Relative|Appendiceal cancer|2015–2019|Males|2|65–69|0.825|0.734|0.89
Relative|Appendiceal cancer|2015–2019|Males|2|70–74|0.793|0.679|0.875
Relative|Appendiceal cancer|2015–2019|Males|2|75–79|0.798|0.665|0.893
Relative|Appendiceal cancer|2015–2019|Males|2|80–84|0.791|0.631|0.909
Relative|Appendiceal cancer|2015–2019|Males|2|85+|||
Relative|Appendiceal cancer|2015–2019|Males|2|All ages combined|0.903|0.884|0.92
Relative|Appendiceal cancer|2015–2019|Males|3|00–04|||
Relative|Appendiceal cancer|2015–2019|Males|3|05–09|||
Relative|Appendiceal cancer|2015–2019|Males|3|10–14|1.001|0.908|1.001
Relative|Appendiceal cancer|2015–2019|Males|3|15–19|0.986|0.898|0.999
Relative|Appendiceal cancer|2015–2019|Males|3|20–24|1.002|0.965|1.002
Relative|Appendiceal cancer|2015–2019|Males|3|25–29|0.989|0.913|1
Relative|Appendiceal cancer|2015–2019|Males|3|30–34|0.977|0.905|0.996
Relative|Appendiceal cancer|2015–2019|Males|3|35–39|0.919|0.824|0.965
Relative|Appendiceal cancer|2015–2019|Males|3|40–44|0.949|0.875|0.981
Relative|Appendiceal cancer|2015–2019|Males|3|45–49|0.902|0.825|0.948
Relative|Appendiceal cancer|2015–2019|Males|3|50–54|0.854|0.759|0.916
Relative|Appendiceal cancer|2015–2019|Males|3|55–59|0.837|0.749|0.898
Relative|Appendiceal cancer|2015–2019|Males|3|60–64|0.793|0.698|0.864
Relative|Appendiceal cancer|2015–2019|Males|3|65–69|0.798|0.702|0.87
Relative|Appendiceal cancer|2015–2019|Males|3|70–74|0.754|0.626|0.851
Relative|Appendiceal cancer|2015–2019|Males|3|75–79|0.801|0.661|0.906
Relative|Appendiceal cancer|2015–2019|Males|3|80–84|0.776|0.6|0.914
Relative|Appendiceal cancer|2015–2019|Males|3|85+|||
Relative|Appendiceal cancer|2015–2019|Males|3|All ages combined|0.882|0.86|0.901
Relative|Appendiceal cancer|2015–2019|Males|4|00–04|||
Relative|Appendiceal cancer|2015–2019|Males|4|05–09|||
Relative|Appendiceal cancer|2015–2019|Males|4|10–14|1.001|0.905|1.001
Relative|Appendiceal cancer|2015–2019|Males|4|15–19|0.987|0.898|1
Relative|Appendiceal cancer|2015–2019|Males|4|20–24|1.003|0.964|1.003
Relative|Appendiceal cancer|2015–2019|Males|4|25–29|0.974|0.892|0.996
Relative|Appendiceal cancer|2015–2019|Males|4|30–34|0.978|0.906|0.997
Relative|Appendiceal cancer|2015–2019|Males|4|35–39|0.893|0.794|0.948
Relative|Appendiceal cancer|2015–2019|Males|4|40–44|0.939|0.861|0.976
Relative|Appendiceal cancer|2015–2019|Males|4|45–49|0.862|0.776|0.919
Relative|Appendiceal cancer|2015–2019|Males|4|50–54|0.808|0.698|0.883
Relative|Appendiceal cancer|2015–2019|Males|4|55–59|0.807|0.712|0.876
Relative|Appendiceal cancer|2015–2019|Males|4|60–64|0.734|0.628|0.818
Relative|Appendiceal cancer|2015–2019|Males|4|65–69|0.726|0.622|0.81
Relative|Appendiceal cancer|2015–2019|Males|4|70–74|0.671|0.529|0.788
Relative|Appendiceal cancer|2015–2019|Males|4|75–79|0.728|0.581|0.85
Relative|Appendiceal cancer|2015–2019|Males|4|80–84|0.79|0.599|0.947
Relative|Appendiceal cancer|2015–2019|Males|4|85+|||
Relative|Appendiceal cancer|2015–2019|Males|4|All ages combined|0.85|0.826|0.872
Relative|Appendiceal cancer|2015–2019|Males|5|00–04|||
Relative|Appendiceal cancer|2015–2019|Males|5|05–09|||
Relative|Appendiceal cancer|2015–2019|Males|5|10–14|1.001|0.903|1.001
Relative|Appendiceal cancer|2015–2019|Males|5|15–19|0.987|0.899|1
Relative|Appendiceal cancer|2015–2019|Males|5|20–24|1.003|0.963|1.003
Relative|Appendiceal cancer|2015–2019|Males|5|25–29|0.975|0.893|0.997
Relative|Appendiceal cancer|2015–2019|Males|5|30–34|0.979|0.907|0.998
Relative|Appendiceal cancer|2015–2019|Males|5|35–39|0.895|0.795|0.949
Relative|Appendiceal cancer|2015–2019|Males|5|40–44|0.941|0.862|0.978
Relative|Appendiceal cancer|2015–2019|Males|5|45–49|0.839|0.745|0.902
Relative|Appendiceal cancer|2015–2019|Males|5|50–54|0.769|0.646|0.856
Relative|Appendiceal cancer|2015–2019|Males|5|55–59|0.8|0.702|0.872
Relative|Appendiceal cancer|2015–2019|Males|5|60–64|0.742|0.635|0.827
Relative|Appendiceal cancer|2015–2019|Males|5|65–69|0.679|0.57|0.771
Relative|Appendiceal cancer|2015–2019|Males|5|70–74|0.607|0.458|0.736
Relative|Appendiceal cancer|2015–2019|Males|5|75–79|0.667|0.514|0.801
Relative|Appendiceal cancer|2015–2019|Males|5|80–84|0.781|0.571|0.961
Relative|Appendiceal cancer|2015–2019|Males|5|85+|||
Relative|Appendiceal cancer|2015–2019|Males|5|All ages combined|0.835|0.808|0.859
Observed|Appendiceal cancer|2015–2019|Females|1|00–04|||
Observed|Appendiceal cancer|2015–2019|Females|1|05–09|||
Observed|Appendiceal cancer|2015–2019|Females|1|10–14|1|0.954|1
Observed|Appendiceal cancer|2015–2019|Females|1|15–19|1|0.978|1
Observed|Appendiceal cancer|2015–2019|Females|1|20–24|1|0.98|1
Observed|Appendiceal cancer|2015–2019|Females|1|25–29|0.992|0.942|0.999
Observed|Appendiceal cancer|2015–2019|Females|1|30–34|1|0.975|1
Observed|Appendiceal cancer|2015–2019|Females|1|35–39|0.99|0.934|0.999
Observed|Appendiceal cancer|2015–2019|Females|1|40–44|0.99|0.93|0.999
Observed|Appendiceal cancer|2015–2019|Females|1|45–49|0.945|0.881|0.975
Observed|Appendiceal cancer|2015–2019|Females|1|50–54|0.956|0.886|0.983
Observed|Appendiceal cancer|2015–2019|Females|1|55–59|0.963|0.903|0.986
Observed|Appendiceal cancer|2015–2019|Females|1|60–64|0.932|0.863|0.967
Observed|Appendiceal cancer|2015–2019|Females|1|65–69|0.867|0.793|0.917
Observed|Appendiceal cancer|2015–2019|Females|1|70–74|0.886|0.804|0.935
Observed|Appendiceal cancer|2015–2019|Females|1|75–79|0.84|0.735|0.906
Observed|Appendiceal cancer|2015–2019|Females|1|80–84|0.752|0.617|0.844
Observed|Appendiceal cancer|2015–2019|Females|1|85+|0.672|0.497|0.798
Observed|Appendiceal cancer|2015–2019|Females|1|All ages combined|0.944|0.932|0.954
Observed|Appendiceal cancer|2015–2019|Females|2|00–04|||
Observed|Appendiceal cancer|2015–2019|Females|2|05–09|||
Observed|Appendiceal cancer|2015–2019|Females|2|10–14|1|0.954|1
Observed|Appendiceal cancer|2015–2019|Females|2|15–19|1|0.977|1
Observed|Appendiceal cancer|2015–2019|Females|2|20–24|1|0.98|1
Observed|Appendiceal cancer|2015–2019|Females|2|25–29|0.983|0.934|0.996
Observed|Appendiceal cancer|2015–2019|Females|2|30–34|0.991|0.941|0.999
Observed|Appendiceal cancer|2015–2019|Females|2|35–39|0.99|0.934|0.999
Observed|Appendiceal cancer|2015–2019|Females|2|40–44|0.956|0.887|0.983
Observed|Appendiceal cancer|2015–2019|Females|2|45–49|0.916|0.844|0.955
Observed|Appendiceal cancer|2015–2019|Females|2|50–54|0.852|0.759|0.911
Observed|Appendiceal cancer|2015–2019|Females|2|55–59|0.925|0.855|0.962
Observed|Appendiceal cancer|2015–2019|Females|2|60–64|0.835|0.747|0.894
Observed|Appendiceal cancer|2015–2019|Females|2|65–69|0.818|0.737|0.876
Observed|Appendiceal cancer|2015–2019|Females|2|70–74|0.799|0.703|0.867
Observed|Appendiceal cancer|2015–2019|Females|2|75–79|0.798|0.688|0.873
Observed|Appendiceal cancer|2015–2019|Females|2|80–84|0.712|0.574|0.813
Observed|Appendiceal cancer|2015–2019|Females|2|85+|0.498|0.334|0.642
Observed|Appendiceal cancer|2015–2019|Females|2|All ages combined|0.907|0.892|0.92
Observed|Appendiceal cancer|2015–2019|Females|3|00–04|||
Observed|Appendiceal cancer|2015–2019|Females|3|05–09|||
Observed|Appendiceal cancer|2015–2019|Females|3|10–14|1|0.954|1
Observed|Appendiceal cancer|2015–2019|Females|3|15–19|1|0.977|1
Observed|Appendiceal cancer|2015–2019|Females|3|20–24|1|0.979|1
Observed|Appendiceal cancer|2015–2019|Females|3|25–29|0.983|0.934|0.996
Observed|Appendiceal cancer|2015–2019|Females|3|30–34|0.973|0.918|0.991
Observed|Appendiceal cancer|2015–2019|Females|3|35–39|0.979|0.917|0.995
Observed|Appendiceal cancer|2015–2019|Females|3|40–44|0.935|0.861|0.97
Observed|Appendiceal cancer|2015–2019|Females|3|45–49|0.887|0.809|0.934
Observed|Appendiceal cancer|2015–2019|Females|3|50–54|0.821|0.725|0.886
Observed|Appendiceal cancer|2015–2019|Females|3|55–59|0.885|0.806|0.933
Observed|Appendiceal cancer|2015–2019|Females|3|60–64|0.804|0.713|0.869
Observed|Appendiceal cancer|2015–2019|Females|3|65–69|0.8|0.717|0.862
Observed|Appendiceal cancer|2015–2019|Females|3|70–74|0.776|0.677|0.848
Observed|Appendiceal cancer|2015–2019|Females|3|75–79|0.752|0.635|0.836
Observed|Appendiceal cancer|2015–2019|Females|3|80–84|0.642|0.495|0.756
Observed|Appendiceal cancer|2015–2019|Females|3|85+|0.458|0.301|0.602
Observed|Appendiceal cancer|2015–2019|Females|3|All ages combined|0.887|0.87|0.902
Observed|Appendiceal cancer|2015–2019|Females|4|00–04|||
Observed|Appendiceal cancer|2015–2019|Females|4|05–09|||
Observed|Appendiceal cancer|2015–2019|Females|4|10–14|1|0.954|1
Observed|Appendiceal cancer|2015–2019|Females|4|15–19|1|0.976|1
Observed|Appendiceal cancer|2015–2019|Females|4|20–24|1|0.979|1
Observed|Appendiceal cancer|2015–2019|Females|4|25–29|0.983|0.934|0.996
Observed|Appendiceal cancer|2015–2019|Females|4|30–34|0.973|0.918|0.991
Observed|Appendiceal cancer|2015–2019|Females|4|35–39|0.966|0.896|0.989
Observed|Appendiceal cancer|2015–2019|Females|4|40–44|0.903|0.822|0.948
Observed|Appendiceal cancer|2015–2019|Females|4|45–49|0.887|0.809|0.934
Observed|Appendiceal cancer|2015–2019|Females|4|50–54|0.811|0.714|0.878
Observed|Appendiceal cancer|2015–2019|Females|4|55–59|0.865|0.782|0.918
Observed|Appendiceal cancer|2015–2019|Females|4|60–64|0.783|0.69|0.852
Observed|Appendiceal cancer|2015–2019|Females|4|65–69|0.771|0.684|0.837
Observed|Appendiceal cancer|2015–2019|Females|4|70–74|0.764|0.663|0.838
Observed|Appendiceal cancer|2015–2019|Females|4|75–79|0.685|0.561|0.781
Observed|Appendiceal cancer|2015–2019|Females|4|80–84|0.595|0.446|0.717
Observed|Appendiceal cancer|2015–2019|Females|4|85+|0.417|0.267|0.56
Observed|Appendiceal cancer|2015–2019|Females|4|All ages combined|0.872|0.854|0.888
Observed|Appendiceal cancer|2015–2019|Females|5|00–04|||
Observed|Appendiceal cancer|2015–2019|Females|5|05–09|||
Observed|Appendiceal cancer|2015–2019|Females|5|10–14|1|0.953|1
Observed|Appendiceal cancer|2015–2019|Females|5|15–19|1|0.974|1
Observed|Appendiceal cancer|2015–2019|Females|5|20–24|1|0.978|1
Observed|Appendiceal cancer|2015–2019|Females|5|25–29|0.983|0.934|0.996
Observed|Appendiceal cancer|2015–2019|Females|5|30–34|0.973|0.918|0.991
Observed|Appendiceal cancer|2015–2019|Females|5|35–39|0.953|0.88|0.982
Observed|Appendiceal cancer|2015–2019|Females|5|40–44|0.891|0.807|0.94
Observed|Appendiceal cancer|2015–2019|Females|5|45–49|0.848|0.76|0.906
Observed|Appendiceal cancer|2015–2019|Females|5|50–54|0.811|0.714|0.878
Observed|Appendiceal cancer|2015–2019|Females|5|55–59|0.815|0.726|0.878
Observed|Appendiceal cancer|2015–2019|Females|5|60–64|0.751|0.654|0.825
Observed|Appendiceal cancer|2015–2019|Females|5|65–69|0.736|0.643|0.808
Observed|Appendiceal cancer|2015–2019|Females|5|70–74|0.719|0.611|0.802
Observed|Appendiceal cancer|2015–2019|Females|5|75–79|0.581|0.451|0.691
Observed|Appendiceal cancer|2015–2019|Females|5|80–84|0.491|0.346|0.621
Observed|Appendiceal cancer|2015–2019|Females|5|85+|||
Observed|Appendiceal cancer|2015–2019|Females|5|All ages combined|0.846|0.826|0.863
Relative|Appendiceal cancer|2015–2019|Females|1|00–04|||
Relative|Appendiceal cancer|2015–2019|Females|1|05–09|||
Relative|Appendiceal cancer|2015–2019|Females|1|10–14|1|0.954|1
Relative|Appendiceal cancer|2015–2019|Females|1|15–19|1|0.978|1
Relative|Appendiceal cancer|2015–2019|Females|1|20–24|1|0.98|1
Relative|Appendiceal cancer|2015–2019|Females|1|25–29|0.992|0.943|0.999
Relative|Appendiceal cancer|2015–2019|Females|1|30–34|1|0.975|1
Relative|Appendiceal cancer|2015–2019|Females|1|35–39|0.991|0.935|0.999
Relative|Appendiceal cancer|2015–2019|Females|1|40–44|0.991|0.931|0.999
Relative|Appendiceal cancer|2015–2019|Females|1|45–49|0.946|0.882|0.976
Relative|Appendiceal cancer|2015–2019|Females|1|50–54|0.958|0.888|0.985
Relative|Appendiceal cancer|2015–2019|Females|1|55–59|0.966|0.906|0.989
Relative|Appendiceal cancer|2015–2019|Females|1|60–64|0.936|0.867|0.971
Relative|Appendiceal cancer|2015–2019|Females|1|65–69|0.874|0.799|0.923
Relative|Appendiceal cancer|2015–2019|Females|1|70–74|0.897|0.814|0.947
Relative|Appendiceal cancer|2015–2019|Females|1|75–79|0.858|0.752|0.926
Relative|Appendiceal cancer|2015–2019|Females|1|80–84|0.783|0.643|0.88
Relative|Appendiceal cancer|2015–2019|Females|1|85+|0.74|0.547|0.879
Relative|Appendiceal cancer|2015–2019|Females|1|All ages combined|0.951|0.938|0.961
Relative|Appendiceal cancer|2015–2019|Females|2|00–04|||
Relative|Appendiceal cancer|2015–2019|Females|2|05–09|||
Relative|Appendiceal cancer|2015–2019|Females|2|10–14|1|0.954|1
Relative|Appendiceal cancer|2015–2019|Females|2|15–19|1|0.978|1
Relative|Appendiceal cancer|2015–2019|Females|2|20–24|1|0.98|1
Relative|Appendiceal cancer|2015–2019|Females|2|25–29|0.984|0.934|0.996
Relative|Appendiceal cancer|2015–2019|Females|2|30–34|0.992|0.942|1
Relative|Appendiceal cancer|2015–2019|Females|2|35–39|0.992|0.935|1
Relative|Appendiceal cancer|2015–2019|Females|2|40–44|0.958|0.889|0.985
Relative|Appendiceal cancer|2015–2019|Females|2|45–49|0.918|0.847|0.958
Relative|Appendiceal cancer|2015–2019|Females|2|50–54|0.856|0.762|0.915
Relative|Appendiceal cancer|2015–2019|Females|2|55–59|0.931|0.861|0.968
Relative|Appendiceal cancer|2015–2019|Females|2|60–64|0.843|0.755|0.902
Relative|Appendiceal cancer|2015–2019|Females|2|65–69|0.83|0.748|0.889
Relative|Appendiceal cancer|2015–2019|Females|2|70–74|0.82|0.721|0.889
Relative|Appendiceal cancer|2015–2019|Females|2|75–79|0.836|0.721|0.915
Relative|Appendiceal cancer|2015–2019|Females|2|80–84|0.778|0.627|0.887
Relative|Appendiceal cancer|2015–2019|Females|2|85+|0.621|0.416|0.8
Relative|Appendiceal cancer|2015–2019|Females|2|All ages combined|0.919|0.904|0.933
Relative|Appendiceal cancer|2015–2019|Females|3|00–04|||
Relative|Appendiceal cancer|2015–2019|Females|3|05–09|||
Relative|Appendiceal cancer|2015–2019|Females|3|10–14|1|0.954|1
Relative|Appendiceal cancer|2015–2019|Females|3|15–19|1.001|0.977|1.001
Relative|Appendiceal cancer|2015–2019|Females|3|20–24|1.001|0.98|1.001
Relative|Appendiceal cancer|2015–2019|Females|3|25–29|0.984|0.935|0.997
Relative|Appendiceal cancer|2015–2019|Females|3|30–34|0.974|0.919|0.992
Relative|Appendiceal cancer|2015–2019|Females|3|35–39|0.981|0.919|0.997
Relative|Appendiceal cancer|2015–2019|Females|3|40–44|0.938|0.864|0.973
Relative|Appendiceal cancer|2015–2019|Females|3|45–49|0.891|0.813|0.938
Relative|Appendiceal cancer|2015–2019|Females|3|50–54|0.827|0.73|0.892
Relative|Appendiceal cancer|2015–2019|Females|3|55–59|0.894|0.814|0.943
Relative|Appendiceal cancer|2015–2019|Females|3|60–64|0.817|0.724|0.882
Relative|Appendiceal cancer|2015–2019|Females|3|65–69|0.82|0.735|0.882
Relative|Appendiceal cancer|2015–2019|Females|3|70–74|0.808|0.705|0.883
Relative|Appendiceal cancer|2015–2019|Females|3|75–79|0.81|0.684|0.901
Relative|Appendiceal cancer|2015–2019|Females|3|80–84|0.738|0.569|0.869
Relative|Appendiceal cancer|2015–2019|Females|3|85+|0.65|0.427|0.855
Relative|Appendiceal cancer|2015–2019|Females|3|All ages combined|0.905|0.888|0.92
Relative|Appendiceal cancer|2015–2019|Females|4|00–04|||
Relative|Appendiceal cancer|2015–2019|Females|4|05–09|||
Relative|Appendiceal cancer|2015–2019|Females|4|10–14|1.001|0.954|1.001
Relative|Appendiceal cancer|2015–2019|Females|4|15–19|1.001|0.977|1.001
Relative|Appendiceal cancer|2015–2019|Females|4|20–24|1.001|0.98|1.001
Relative|Appendiceal cancer|2015–2019|Females|4|25–29|0.984|0.935|0.997
Relative|Appendiceal cancer|2015–2019|Females|4|30–34|0.975|0.919|0.993
Relative|Appendiceal cancer|2015–2019|Females|4|35–39|0.968|0.899|0.992
Relative|Appendiceal cancer|2015–2019|Females|4|40–44|0.907|0.825|0.952
Relative|Appendiceal cancer|2015–2019|Females|4|45–49|0.893|0.815|0.94
Relative|Appendiceal cancer|2015–2019|Females|4|50–54|0.819|0.721|0.886
Relative|Appendiceal cancer|2015–2019|Females|4|55–59|0.877|0.793|0.931
Relative|Appendiceal cancer|2015–2019|Females|4|60–64|0.8|0.704|0.87
Relative|Appendiceal cancer|2015–2019|Females|4|65–69|0.798|0.707|0.866
Relative|Appendiceal cancer|2015–2019|Females|4|70–74|0.81|0.703|0.888
Relative|Appendiceal cancer|2015–2019|Females|4|75–79|0.762|0.624|0.869
Relative|Appendiceal cancer|2015–2019|Females|4|80–84|0.729|0.546|0.878
Relative|Appendiceal cancer|2015–2019|Females|4|85+|0.677|0.433|0.91
Relative|Appendiceal cancer|2015–2019|Females|4|All ages combined|0.896|0.878|0.913
Relative|Appendiceal cancer|2015–2019|Females|5|00–04|||
Relative|Appendiceal cancer|2015–2019|Females|5|05–09|||
Relative|Appendiceal cancer|2015–2019|Females|5|10–14|1.001|0.953|1.001
Relative|Appendiceal cancer|2015–2019|Females|5|15–19|1.001|0.976|1.001
Relative|Appendiceal cancer|2015–2019|Females|5|20–24|1.001|0.979|1.001
Relative|Appendiceal cancer|2015–2019|Females|5|25–29|0.985|0.935|0.997
Relative|Appendiceal cancer|2015–2019|Females|5|30–34|0.975|0.92|0.993
Relative|Appendiceal cancer|2015–2019|Females|5|35–39|0.957|0.883|0.986
Relative|Appendiceal cancer|2015–2019|Females|5|40–44|0.896|0.812|0.945
Relative|Appendiceal cancer|2015–2019|Females|5|45–49|0.856|0.766|0.914
Relative|Appendiceal cancer|2015–2019|Females|5|50–54|0.821|0.723|0.889
Relative|Appendiceal cancer|2015–2019|Females|5|55–59|0.831|0.74|0.895
Relative|Appendiceal cancer|2015–2019|Females|5|60–64|0.772|0.672|0.847
Relative|Appendiceal cancer|2015–2019|Females|5|65–69|0.769|0.671|0.845
Relative|Appendiceal cancer|2015–2019|Females|5|70–74|0.777|0.66|0.867
Relative|Appendiceal cancer|2015–2019|Females|5|75–79|0.671|0.521|0.797
Relative|Appendiceal cancer|2015–2019|Females|5|80–84|0.648|0.457|0.82
Relative|Appendiceal cancer|2015–2019|Females|5|85+|||
Relative|Appendiceal cancer|2015–2019|Females|5|All ages combined|0.877|0.857|0.895
Observed|Appendiceal cancer|2015–2019|Persons|1|00–04|||
Observed|Appendiceal cancer|2015–2019|Persons|1|05–09|||
Observed|Appendiceal cancer|2015–2019|Persons|1|10–14|1|0.969|1
Observed|Appendiceal cancer|2015–2019|Persons|1|15–19|1|0.986|1
Observed|Appendiceal cancer|2015–2019|Persons|1|20–24|1|0.987|1
Observed|Appendiceal cancer|2015–2019|Persons|1|25–29|0.99|0.96|0.997
Observed|Appendiceal cancer|2015–2019|Persons|1|30–34|0.995|0.964|0.999
Observed|Appendiceal cancer|2015–2019|Persons|1|35–39|0.977|0.94|0.991
Observed|Appendiceal cancer|2015–2019|Persons|1|40–44|0.984|0.951|0.995
Observed|Appendiceal cancer|2015–2019|Persons|1|45–49|0.945|0.904|0.968
Observed|Appendiceal cancer|2015–2019|Persons|1|50–54|0.959|0.92|0.979
Observed|Appendiceal cancer|2015–2019|Persons|1|55–59|0.95|0.911|0.972
Observed|Appendiceal cancer|2015–2019|Persons|1|60–64|0.94|0.899|0.965
Observed|Appendiceal cancer|2015–2019|Persons|1|65–69|0.892|0.844|0.925
Observed|Appendiceal cancer|2015–2019|Persons|1|70–74|0.871|0.812|0.912
Observed|Appendiceal cancer|2015–2019|Persons|1|75–79|0.853|0.781|0.902
Observed|Appendiceal cancer|2015–2019|Persons|1|80–84|0.736|0.644|0.808
Observed|Appendiceal cancer|2015–2019|Persons|1|85+|0.69|0.566|0.785
Observed|Appendiceal cancer|2015–2019|Persons|1|All ages combined|0.94|0.931|0.948
Observed|Appendiceal cancer|2015–2019|Persons|2|00–04|||
Observed|Appendiceal cancer|2015–2019|Persons|2|05–09|||
Observed|Appendiceal cancer|2015–2019|Persons|2|10–14|1|0.969|1
Observed|Appendiceal cancer|2015–2019|Persons|2|15–19|1|0.985|1
Observed|Appendiceal cancer|2015–2019|Persons|2|20–24|1|0.987|1
Observed|Appendiceal cancer|2015–2019|Persons|2|25–29|0.985|0.953|0.995
Observed|Appendiceal cancer|2015–2019|Persons|2|30–34|0.985|0.953|0.995
Observed|Appendiceal cancer|2015–2019|Persons|2|35–39|0.977|0.94|0.991
Observed|Appendiceal cancer|2015–2019|Persons|2|40–44|0.956|0.914|0.978
Observed|Appendiceal cancer|2015–2019|Persons|2|45–49|0.911|0.864|0.942
Observed|Appendiceal cancer|2015–2019|Persons|2|50–54|0.875|0.818|0.915
Observed|Appendiceal cancer|2015–2019|Persons|2|55–59|0.898|0.849|0.932
Observed|Appendiceal cancer|2015–2019|Persons|2|60–64|0.831|0.773|0.875
Observed|Appendiceal cancer|2015–2019|Persons|2|65–69|0.812|0.755|0.857
Observed|Appendiceal cancer|2015–2019|Persons|2|70–74|0.782|0.713|0.836
Observed|Appendiceal cancer|2015–2019|Persons|2|75–79|0.769|0.69|0.83
Observed|Appendiceal cancer|2015–2019|Persons|2|80–84|0.707|0.612|0.783
Observed|Appendiceal cancer|2015–2019|Persons|2|85+|0.535|0.412|0.644
Observed|Appendiceal cancer|2015–2019|Persons|2|All ages combined|0.896|0.884|0.907
Observed|Appendiceal cancer|2015–2019|Persons|3|00–04|||
Observed|Appendiceal cancer|2015–2019|Persons|3|05–09|||
Observed|Appendiceal cancer|2015–2019|Persons|3|10–14|1|0.969|1
Observed|Appendiceal cancer|2015–2019|Persons|3|15–19|0.995|0.962|0.999
Observed|Appendiceal cancer|2015–2019|Persons|3|20–24|1|0.987|1
Observed|Appendiceal cancer|2015–2019|Persons|3|25–29|0.985|0.953|0.995
Observed|Appendiceal cancer|2015–2019|Persons|3|30–34|0.973|0.937|0.989
Observed|Appendiceal cancer|2015–2019|Persons|3|35–39|0.952|0.906|0.976
Observed|Appendiceal cancer|2015–2019|Persons|3|40–44|0.94|0.894|0.966
Observed|Appendiceal cancer|2015–2019|Persons|3|45–49|0.891|0.84|0.926
Observed|Appendiceal cancer|2015–2019|Persons|3|50–54|0.835|0.772|0.881
Observed|Appendiceal cancer|2015–2019|Persons|3|55–59|0.853|0.798|0.895
Observed|Appendiceal cancer|2015–2019|Persons|3|60–64|0.789|0.727|0.839
Observed|Appendiceal cancer|2015–2019|Persons|3|65–69|0.785|0.726|0.833
Observed|Appendiceal cancer|2015–2019|Persons|3|70–74|0.747|0.674|0.806
Observed|Appendiceal cancer|2015–2019|Persons|3|75–79|0.732|0.65|0.798
Observed|Appendiceal cancer|2015–2019|Persons|3|80–84|0.641|0.541|0.725
Observed|Appendiceal cancer|2015–2019|Persons|3|85+|0.464|0.344|0.575
Observed|Appendiceal cancer|2015–2019|Persons|3|All ages combined|0.872|0.859|0.883
Observed|Appendiceal cancer|2015–2019|Persons|4|00–04|||
Observed|Appendiceal cancer|2015–2019|Persons|4|05–09|||
Observed|Appendiceal cancer|2015–2019|Persons|4|10–14|1|0.968|1
Observed|Appendiceal cancer|2015–2019|Persons|4|15–19|0.995|0.962|0.999
Observed|Appendiceal cancer|2015–2019|Persons|4|20–24|1|0.986|1
Observed|Appendiceal cancer|2015–2019|Persons|4|25–29|0.979|0.945|0.992
Observed|Appendiceal cancer|2015–2019|Persons|4|30–34|0.973|0.937|0.989
Observed|Appendiceal cancer|2015–2019|Persons|4|35–39|0.932|0.88|0.962
Observed|Appendiceal cancer|2015–2019|Persons|4|40–44|0.917|0.866|0.949
Observed|Appendiceal cancer|2015–2019|Persons|4|45–49|0.869|0.814|0.908
Observed|Appendiceal cancer|2015–2019|Persons|4|50–54|0.81|0.744|0.86
Observed|Appendiceal cancer|2015–2019|Persons|4|55–59|0.826|0.767|0.872
Observed|Appendiceal cancer|2015–2019|Persons|4|60–64|0.748|0.682|0.803
Observed|Appendiceal cancer|2015–2019|Persons|4|65–69|0.731|0.667|0.784
Observed|Appendiceal cancer|2015–2019|Persons|4|70–74|0.702|0.624|0.767
Observed|Appendiceal cancer|2015–2019|Persons|4|75–79|0.65|0.563|0.723
Observed|Appendiceal cancer|2015–2019|Persons|4|80–84|0.598|0.496|0.686
Observed|Appendiceal cancer|2015–2019|Persons|4|85+|0.407|0.292|0.519
Observed|Appendiceal cancer|2015–2019|Persons|4|All ages combined|0.846|0.831|0.859
Observed|Appendiceal cancer|2015–2019|Persons|5|00–04|||
Observed|Appendiceal cancer|2015–2019|Persons|5|05–09|||
Observed|Appendiceal cancer|2015–2019|Persons|5|10–14|1|0.968|1
Observed|Appendiceal cancer|2015–2019|Persons|5|15–19|0.995|0.962|0.999
Observed|Appendiceal cancer|2015–2019|Persons|5|20–24|1|0.986|1
Observed|Appendiceal cancer|2015–2019|Persons|5|25–29|0.979|0.945|0.992
Observed|Appendiceal cancer|2015–2019|Persons|5|30–34|0.973|0.937|0.989
Observed|Appendiceal cancer|2015–2019|Persons|5|35–39|0.925|0.871|0.957
Observed|Appendiceal cancer|2015–2019|Persons|5|40–44|0.911|0.858|0.944
Observed|Appendiceal cancer|2015–2019|Persons|5|45–49|0.836|0.776|0.882
Observed|Appendiceal cancer|2015–2019|Persons|5|50–54|0.796|0.728|0.849
Observed|Appendiceal cancer|2015–2019|Persons|5|55–59|0.793|0.73|0.843
Observed|Appendiceal cancer|2015–2019|Persons|5|60–64|0.73|0.662|0.787
Observed|Appendiceal cancer|2015–2019|Persons|5|65–69|0.685|0.617|0.743
Observed|Appendiceal cancer|2015–2019|Persons|5|70–74|0.644|0.561|0.715
Observed|Appendiceal cancer|2015–2019|Persons|5|75–79|0.558|0.47|0.637
Observed|Appendiceal cancer|2015–2019|Persons|5|80–84|0.515|0.414|0.608
Observed|Appendiceal cancer|2015–2019|Persons|5|85+|0.342|0.232|0.454
Observed|Appendiceal cancer|2015–2019|Persons|5|All ages combined|0.82|0.805|0.834
Relative|Appendiceal cancer|2015–2019|Persons|1|00–04|||
Relative|Appendiceal cancer|2015–2019|Persons|1|05–09|||
Relative|Appendiceal cancer|2015–2019|Persons|1|10–14|1|0.97|1
Relative|Appendiceal cancer|2015–2019|Persons|1|15–19|1|0.986|1
Relative|Appendiceal cancer|2015–2019|Persons|1|20–24|1|0.988|1
Relative|Appendiceal cancer|2015–2019|Persons|1|25–29|0.99|0.96|0.998
Relative|Appendiceal cancer|2015–2019|Persons|1|30–34|0.996|0.965|1
Relative|Appendiceal cancer|2015–2019|Persons|1|35–39|0.978|0.941|0.992
Relative|Appendiceal cancer|2015–2019|Persons|1|40–44|0.985|0.952|0.996
Relative|Appendiceal cancer|2015–2019|Persons|1|45–49|0.946|0.906|0.97
Relative|Appendiceal cancer|2015–2019|Persons|1|50–54|0.962|0.923|0.982
Relative|Appendiceal cancer|2015–2019|Persons|1|55–59|0.954|0.915|0.976
Relative|Appendiceal cancer|2015–2019|Persons|1|60–64|0.946|0.905|0.971
Relative|Appendiceal cancer|2015–2019|Persons|1|65–69|0.9|0.852|0.934
Relative|Appendiceal cancer|2015–2019|Persons|1|70–74|0.884|0.825|0.926
Relative|Appendiceal cancer|2015–2019|Persons|1|75–79|0.877|0.804|0.928
Relative|Appendiceal cancer|2015–2019|Persons|1|80–84|0.773|0.676|0.849
Relative|Appendiceal cancer|2015–2019|Persons|1|85+|0.773|0.634|0.88
Relative|Appendiceal cancer|2015–2019|Persons|1|All ages combined|0.949|0.939|0.957
Relative|Appendiceal cancer|2015–2019|Persons|2|00–04|||
Relative|Appendiceal cancer|2015–2019|Persons|2|05–09|||
Relative|Appendiceal cancer|2015–2019|Persons|2|10–14|1|0.969|1
Relative|Appendiceal cancer|2015–2019|Persons|2|15–19|1.001|0.986|1.001
Relative|Appendiceal cancer|2015–2019|Persons|2|20–24|1.001|0.988|1.001
Relative|Appendiceal cancer|2015–2019|Persons|2|25–29|0.985|0.954|0.996
Relative|Appendiceal cancer|2015–2019|Persons|2|30–34|0.986|0.955|0.996
Relative|Appendiceal cancer|2015–2019|Persons|2|35–39|0.979|0.942|0.993
Relative|Appendiceal cancer|2015–2019|Persons|2|40–44|0.958|0.916|0.98
Relative|Appendiceal cancer|2015–2019|Persons|2|45–49|0.914|0.867|0.946
Relative|Appendiceal cancer|2015–2019|Persons|2|50–54|0.88|0.823|0.921
Relative|Appendiceal cancer|2015–2019|Persons|2|55–59|0.906|0.857|0.94
Relative|Appendiceal cancer|2015–2019|Persons|2|60–64|0.842|0.783|0.886
Relative|Appendiceal cancer|2015–2019|Persons|2|65–69|0.829|0.77|0.874
Relative|Appendiceal cancer|2015–2019|Persons|2|70–74|0.808|0.736|0.864
Relative|Appendiceal cancer|2015–2019|Persons|2|75–79|0.816|0.732|0.882
Relative|Appendiceal cancer|2015–2019|Persons|2|80–84|0.785|0.679|0.869
Relative|Appendiceal cancer|2015–2019|Persons|2|85+|0.689|0.53|0.828
Relative|Appendiceal cancer|2015–2019|Persons|2|All ages combined|0.912|0.9|0.923
Relative|Appendiceal cancer|2015–2019|Persons|3|00–04|||
Relative|Appendiceal cancer|2015–2019|Persons|3|05–09|||
Relative|Appendiceal cancer|2015–2019|Persons|3|10–14|1|0.969|1
Relative|Appendiceal cancer|2015–2019|Persons|3|15–19|0.996|0.963|1
Relative|Appendiceal cancer|2015–2019|Persons|3|20–24|1.001|0.988|1.001
Relative|Appendiceal cancer|2015–2019|Persons|3|25–29|0.986|0.954|0.996
Relative|Appendiceal cancer|2015–2019|Persons|3|30–34|0.975|0.939|0.991
Relative|Appendiceal cancer|2015–2019|Persons|3|35–39|0.954|0.908|0.978
Relative|Appendiceal cancer|2015–2019|Persons|3|40–44|0.944|0.897|0.97
Relative|Appendiceal cancer|2015–2019|Persons|3|45–49|0.896|0.845|0.932
Relative|Appendiceal cancer|2015–2019|Persons|3|50–54|0.842|0.779|0.889
Relative|Appendiceal cancer|2015–2019|Persons|3|55–59|0.865|0.809|0.907
Relative|Appendiceal cancer|2015–2019|Persons|3|60–64|0.805|0.742|0.856
Relative|Appendiceal cancer|2015–2019|Persons|3|65–69|0.81|0.749|0.86
Relative|Appendiceal cancer|2015–2019|Persons|3|70–74|0.786|0.709|0.848
Relative|Appendiceal cancer|2015–2019|Persons|3|75–79|0.805|0.715|0.877
Relative|Appendiceal cancer|2015–2019|Persons|3|80–84|0.757|0.639|0.856
Relative|Appendiceal cancer|2015–2019|Persons|3|85+|0.688|0.511|0.853
Relative|Appendiceal cancer|2015–2019|Persons|3|All ages combined|0.895|0.882|0.907
Relative|Appendiceal cancer|2015–2019|Persons|4|00–04|||
Relative|Appendiceal cancer|2015–2019|Persons|4|05–09|||
Relative|Appendiceal cancer|2015–2019|Persons|4|10–14|1.001|0.969|1.001
Relative|Appendiceal cancer|2015–2019|Persons|4|15–19|0.996|0.964|1
Relative|Appendiceal cancer|2015–2019|Persons|4|20–24|1.002|0.988|1.002
Relative|Appendiceal cancer|2015–2019|Persons|4|25–29|0.981|0.946|0.994
Relative|Appendiceal cancer|2015–2019|Persons|4|30–34|0.976|0.94|0.991
Relative|Appendiceal cancer|2015–2019|Persons|4|35–39|0.935|0.883|0.965
Relative|Appendiceal cancer|2015–2019|Persons|4|40–44|0.922|0.871|0.954
Relative|Appendiceal cancer|2015–2019|Persons|4|45–49|0.876|0.821|0.916
Relative|Appendiceal cancer|2015–2019|Persons|4|50–54|0.82|0.753|0.871
Relative|Appendiceal cancer|2015–2019|Persons|4|55–59|0.842|0.782|0.888
Relative|Appendiceal cancer|2015–2019|Persons|4|60–64|0.77|0.702|0.826
Relative|Appendiceal cancer|2015–2019|Persons|4|65–69|0.764|0.697|0.82
Relative|Appendiceal cancer|2015–2019|Persons|4|70–74|0.754|0.671|0.823
Relative|Appendiceal cancer|2015–2019|Persons|4|75–79|0.743|0.645|0.827
Relative|Appendiceal cancer|2015–2019|Persons|4|80–84|0.761|0.631|0.872
Relative|Appendiceal cancer|2015–2019|Persons|4|85+|0.705|0.506|0.898
Relative|Appendiceal cancer|2015–2019|Persons|4|All ages combined|0.876|0.862|0.89
Relative|Appendiceal cancer|2015–2019|Persons|5|00–04|||
Relative|Appendiceal cancer|2015–2019|Persons|5|05–09|||
Relative|Appendiceal cancer|2015–2019|Persons|5|10–14|1.001|0.968|1.001
Relative|Appendiceal cancer|2015–2019|Persons|5|15–19|0.996|0.964|1.001
Relative|Appendiceal cancer|2015–2019|Persons|5|20–24|1.002|0.988|1.002
Relative|Appendiceal cancer|2015–2019|Persons|5|25–29|0.981|0.947|0.994
Relative|Appendiceal cancer|2015–2019|Persons|5|30–34|0.977|0.941|0.992
Relative|Appendiceal cancer|2015–2019|Persons|5|35–39|0.929|0.876|0.961
Relative|Appendiceal cancer|2015–2019|Persons|5|40–44|0.917|0.865|0.951
Relative|Appendiceal cancer|2015–2019|Persons|5|45–49|0.846|0.784|0.892
Relative|Appendiceal cancer|2015–2019|Persons|5|50–54|0.809|0.74|0.862
Relative|Appendiceal cancer|2015–2019|Persons|5|55–59|0.813|0.748|0.864
Relative|Appendiceal cancer|2015–2019|Persons|5|60–64|0.757|0.687|0.816
Relative|Appendiceal cancer|2015–2019|Persons|5|65–69|0.726|0.654|0.787
Relative|Appendiceal cancer|2015–2019|Persons|5|70–74|0.707|0.616|0.786
Relative|Appendiceal cancer|2015–2019|Persons|5|75–79|0.668|0.563|0.763
Relative|Appendiceal cancer|2015–2019|Persons|5|80–84|0.714|0.573|0.841
Relative|Appendiceal cancer|2015–2019|Persons|5|85+|0.696|0.472|0.924
Relative|Appendiceal cancer|2015–2019|Persons|5|All ages combined|0.859|0.843|0.873
Observed|Bladder cancer|2015–2019|Males|1|00–04|||
Observed|Bladder cancer|2015–2019|Males|1|05–09|||
Observed|Bladder cancer|2015–2019|Males|1|10–14|||
Observed|Bladder cancer|2015–2019|Males|1|15–19|||
Observed|Bladder cancer|2015–2019|Males|1|20–24|||
Observed|Bladder cancer|2015–2019|Males|1|25–29|||
Observed|Bladder cancer|2015–2019|Males|1|30–34|||
Observed|Bladder cancer|2015–2019|Males|1|35–39|||
Observed|Bladder cancer|2015–2019|Males|1|40–44|0.919|0.83|0.963
Observed|Bladder cancer|2015–2019|Males|1|45–49|0.886|0.818|0.93
Observed|Bladder cancer|2015–2019|Males|1|50–54|0.869|0.823|0.903
Observed|Bladder cancer|2015–2019|Males|1|55–59|0.856|0.823|0.882
Observed|Bladder cancer|2015–2019|Males|1|60–64|0.884|0.861|0.903
Observed|Bladder cancer|2015–2019|Males|1|65–69|0.872|0.853|0.888
Observed|Bladder cancer|2015–2019|Males|1|70–74|0.838|0.82|0.855
Observed|Bladder cancer|2015–2019|Males|1|75–79|0.799|0.779|0.817
Observed|Bladder cancer|2015–2019|Males|1|80–84|0.714|0.692|0.735
Observed|Bladder cancer|2015–2019|Males|1|85+|0.575|0.552|0.598
Observed|Bladder cancer|2015–2019|Males|1|All ages combined|0.777|0.769|0.785
Observed|Bladder cancer|2015–2019|Males|2|00–04|||
Observed|Bladder cancer|2015–2019|Males|2|05–09|||
Observed|Bladder cancer|2015–2019|Males|2|10–14|||
Observed|Bladder cancer|2015–2019|Males|2|15–19|||
Observed|Bladder cancer|2015–2019|Males|2|20–24|||
Observed|Bladder cancer|2015–2019|Males|2|25–29|||
Observed|Bladder cancer|2015–2019|Males|2|30–34|||
Observed|Bladder cancer|2015–2019|Males|2|35–39|||
Observed|Bladder cancer|2015–2019|Males|2|40–44|0.806|0.699|0.878
Observed|Bladder cancer|2015–2019|Males|2|45–49|0.817|0.74|0.874
Observed|Bladder cancer|2015–2019|Males|2|50–54|0.781|0.727|0.825
Observed|Bladder cancer|2015–2019|Males|2|55–59|0.77|0.733|0.803
Observed|Bladder cancer|2015–2019|Males|2|60–64|0.793|0.765|0.818
Observed|Bladder cancer|2015–2019|Males|2|65–69|0.776|0.753|0.797
Observed|Bladder cancer|2015–2019|Males|2|70–74|0.742|0.719|0.762
Observed|Bladder cancer|2015–2019|Males|2|75–79|0.676|0.653|0.697
Observed|Bladder cancer|2015–2019|Males|2|80–84|0.554|0.53|0.578
Observed|Bladder cancer|2015–2019|Males|2|85+|0.408|0.385|0.43
Observed|Bladder cancer|2015–2019|Males|2|All ages combined|0.655|0.645|0.664
Observed|Bladder cancer|2015–2019|Males|3|00–04|||
Observed|Bladder cancer|2015–2019|Males|3|05–09|||
Observed|Bladder cancer|2015–2019|Males|3|10–14|||
Observed|Bladder cancer|2015–2019|Males|3|15–19|||
Observed|Bladder cancer|2015–2019|Males|3|20–24|||
Observed|Bladder cancer|2015–2019|Males|3|25–29|||
Observed|Bladder cancer|2015–2019|Males|3|30–34|||
Observed|Bladder cancer|2015–2019|Males|3|35–39|||
Observed|Bladder cancer|2015–2019|Males|3|40–44|0.806|0.699|0.878
Observed|Bladder cancer|2015–2019|Males|3|45–49|0.777|0.696|0.838
Observed|Bladder cancer|2015–2019|Males|3|50–54|0.736|0.68|0.784
Observed|Bladder cancer|2015–2019|Males|3|55–59|0.712|0.672|0.748
Observed|Bladder cancer|2015–2019|Males|3|60–64|0.739|0.709|0.767
Observed|Bladder cancer|2015–2019|Males|3|65–69|0.722|0.697|0.745
Observed|Bladder cancer|2015–2019|Males|3|70–74|0.656|0.632|0.679
Observed|Bladder cancer|2015–2019|Males|3|75–79|0.598|0.574|0.621
Observed|Bladder cancer|2015–2019|Males|3|80–84|0.456|0.431|0.48
Observed|Bladder cancer|2015–2019|Males|3|85+|0.299|0.278|0.32
Observed|Bladder cancer|2015–2019|Males|3|All ages combined|0.575|0.565|0.585
Observed|Bladder cancer|2015–2019|Males|4|00–04|||
Observed|Bladder cancer|2015–2019|Males|4|05–09|||
Observed|Bladder cancer|2015–2019|Males|4|10–14|||
Observed|Bladder cancer|2015–2019|Males|4|15–19|||
Observed|Bladder cancer|2015–2019|Males|4|20–24|||
Observed|Bladder cancer|2015–2019|Males|4|25–29|||
Observed|Bladder cancer|2015–2019|Males|4|30–34|||
Observed|Bladder cancer|2015–2019|Males|4|35–39|||
Observed|Bladder cancer|2015–2019|Males|4|40–44|0.763|0.651|0.844
Observed|Bladder cancer|2015–2019|Males|4|45–49|0.75|0.669|0.814
Observed|Bladder cancer|2015–2019|Males|4|50–54|0.705|0.648|0.755
Observed|Bladder cancer|2015–2019|Males|4|55–59|0.688|0.648|0.725
Observed|Bladder cancer|2015–2019|Males|4|60–64|0.709|0.678|0.737
Observed|Bladder cancer|2015–2019|Males|4|65–69|0.682|0.656|0.706
Observed|Bladder cancer|2015–2019|Males|4|70–74|0.604|0.579|0.628
Observed|Bladder cancer|2015–2019|Males|4|75–79|0.525|0.5|0.549
Observed|Bladder cancer|2015–2019|Males|4|80–84|0.389|0.365|0.413
Observed|Bladder cancer|2015–2019|Males|4|85+|0.219|0.2|0.239
Observed|Bladder cancer|2015–2019|Males|4|All ages combined|0.519|0.509|0.529
Observed|Bladder cancer|2015–2019|Males|5|00–04|||
Observed|Bladder cancer|2015–2019|Males|5|05–09|||
Observed|Bladder cancer|2015–2019|Males|5|10–14|||
Observed|Bladder cancer|2015–2019|Males|5|15–19|||
Observed|Bladder cancer|2015–2019|Males|5|20–24|||
Observed|Bladder cancer|2015–2019|Males|5|25–29|||
Observed|Bladder cancer|2015–2019|Males|5|30–34|||
Observed|Bladder cancer|2015–2019|Males|5|35–39|||
Observed|Bladder cancer|2015–2019|Males|5|40–44|0.749|0.635|0.832
Observed|Bladder cancer|2015–2019|Males|5|45–49|0.744|0.662|0.808
Observed|Bladder cancer|2015–2019|Males|5|50–54|0.689|0.632|0.74
Observed|Bladder cancer|2015–2019|Males|5|55–59|0.669|0.628|0.707
Observed|Bladder cancer|2015–2019|Males|5|60–64|0.689|0.658|0.718
Observed|Bladder cancer|2015–2019|Males|5|65–69|0.646|0.619|0.671
Observed|Bladder cancer|2015–2019|Males|5|70–74|0.56|0.535|0.585
Observed|Bladder cancer|2015–2019|Males|5|75–79|0.462|0.437|0.486
Observed|Bladder cancer|2015–2019|Males|5|80–84|0.324|0.301|0.347
Observed|Bladder cancer|2015–2019|Males|5|85+|0.158|0.141|0.175
Observed|Bladder cancer|2015–2019|Males|5|All ages combined|0.472|0.462|0.482
Relative|Bladder cancer|2015–2019|Males|1|00–04|||
Relative|Bladder cancer|2015–2019|Males|1|05–09|||
Relative|Bladder cancer|2015–2019|Males|1|10–14|||
Relative|Bladder cancer|2015–2019|Males|1|15–19|||
Relative|Bladder cancer|2015–2019|Males|1|20–24|||
Relative|Bladder cancer|2015–2019|Males|1|25–29|||
Relative|Bladder cancer|2015–2019|Males|1|30–34|||
Relative|Bladder cancer|2015–2019|Males|1|35–39|||
Relative|Bladder cancer|2015–2019|Males|1|40–44|0.921|0.831|0.965
Relative|Bladder cancer|2015–2019|Males|1|45–49|0.888|0.82|0.932
Relative|Bladder cancer|2015–2019|Males|1|50–54|0.872|0.826|0.906
Relative|Bladder cancer|2015–2019|Males|1|55–59|0.86|0.828|0.887
Relative|Bladder cancer|2015–2019|Males|1|60–64|0.891|0.868|0.91
Relative|Bladder cancer|2015–2019|Males|1|65–69|0.882|0.863|0.899
Relative|Bladder cancer|2015–2019|Males|1|70–74|0.855|0.836|0.872
Relative|Bladder cancer|2015–2019|Males|1|75–79|0.826|0.806|0.845
Relative|Bladder cancer|2015–2019|Males|1|80–84|0.759|0.735|0.782
Relative|Bladder cancer|2015–2019|Males|1|85+|0.665|0.638|0.69
Relative|Bladder cancer|2015–2019|Males|1|All ages combined|0.813|0.805|0.821
Relative|Bladder cancer|2015–2019|Males|2|00–04|||
Relative|Bladder cancer|2015–2019|Males|2|05–09|||
Relative|Bladder cancer|2015–2019|Males|2|10–14|||
Relative|Bladder cancer|2015–2019|Males|2|15–19|||
Relative|Bladder cancer|2015–2019|Males|2|20–24|||
Relative|Bladder cancer|2015–2019|Males|2|25–29|||
Relative|Bladder cancer|2015–2019|Males|2|30–34|||
Relative|Bladder cancer|2015–2019|Males|2|35–39|||
Relative|Bladder cancer|2015–2019|Males|2|40–44|0.809|0.702|0.881
Relative|Bladder cancer|2015–2019|Males|2|45–49|0.822|0.744|0.878
Relative|Bladder cancer|2015–2019|Males|2|50–54|0.786|0.732|0.831
Relative|Bladder cancer|2015–2019|Males|2|55–59|0.779|0.741|0.812
Relative|Bladder cancer|2015–2019|Males|2|60–64|0.807|0.778|0.832
Relative|Bladder cancer|2015–2019|Males|2|65–69|0.796|0.772|0.818
Relative|Bladder cancer|2015–2019|Males|2|70–74|0.773|0.75|0.795
Relative|Bladder cancer|2015–2019|Males|2|75–79|0.725|0.701|0.748
Relative|Bladder cancer|2015–2019|Males|2|80–84|0.632|0.604|0.659
Relative|Bladder cancer|2015–2019|Males|2|85+|0.549|0.519|0.58
Relative|Bladder cancer|2015–2019|Males|2|All ages combined|0.715|0.705|0.725
Relative|Bladder cancer|2015–2019|Males|3|00–04|||
Relative|Bladder cancer|2015–2019|Males|3|05–09|||
Relative|Bladder cancer|2015–2019|Males|3|10–14|||
Relative|Bladder cancer|2015–2019|Males|3|15–19|||
Relative|Bladder cancer|2015–2019|Males|3|20–24|||
Relative|Bladder cancer|2015–2019|Males|3|25–29|||
Relative|Bladder cancer|2015–2019|Males|3|30–34|||
Relative|Bladder cancer|2015–2019|Males|3|35–39|||
Relative|Bladder cancer|2015–2019|Males|3|40–44|0.81|0.703|0.883
Relative|Bladder cancer|2015–2019|Males|3|45–49|0.783|0.702|0.845
Relative|Bladder cancer|2015–2019|Males|3|50–54|0.745|0.688|0.793
Relative|Bladder cancer|2015–2019|Males|3|55–59|0.725|0.684|0.761
Relative|Bladder cancer|2015–2019|Males|3|60–64|0.759|0.728|0.787
Relative|Bladder cancer|2015–2019|Males|3|65–69|0.752|0.726|0.776
Relative|Bladder cancer|2015–2019|Males|3|70–74|0.7|0.674|0.725
Relative|Bladder cancer|2015–2019|Males|3|75–79|0.669|0.642|0.695
Relative|Bladder cancer|2015–2019|Males|3|80–84|0.562|0.531|0.591
Relative|Bladder cancer|2015–2019|Males|3|85+|0.476|0.443|0.51
Relative|Bladder cancer|2015–2019|Males|3|All ages combined|0.657|0.646|0.668
Relative|Bladder cancer|2015–2019|Males|4|00–04|||
Relative|Bladder cancer|2015–2019|Males|4|05–09|||
Relative|Bladder cancer|2015–2019|Males|4|10–14|||
Relative|Bladder cancer|2015–2019|Males|4|15–19|||
Relative|Bladder cancer|2015–2019|Males|4|20–24|||
Relative|Bladder cancer|2015–2019|Males|4|25–29|||
Relative|Bladder cancer|2015–2019|Males|4|30–34|||
Relative|Bladder cancer|2015–2019|Males|4|35–39|||
Relative|Bladder cancer|2015–2019|Males|4|40–44|0.769|0.655|0.85
Relative|Bladder cancer|2015–2019|Males|4|45–49|0.758|0.676|0.823
Relative|Bladder cancer|2015–2019|Males|4|50–54|0.717|0.658|0.767
Relative|Bladder cancer|2015–2019|Males|4|55–59|0.705|0.664|0.743
Relative|Bladder cancer|2015–2019|Males|4|60–64|0.735|0.703|0.765
Relative|Bladder cancer|2015–2019|Males|4|65–69|0.721|0.694|0.747
Relative|Bladder cancer|2015–2019|Males|4|70–74|0.662|0.635|0.689
Relative|Bladder cancer|2015–2019|Males|4|75–79|0.616|0.587|0.644
Relative|Bladder cancer|2015–2019|Males|4|80–84|0.525|0.492|0.557
Relative|Bladder cancer|2015–2019|Males|4|85+|0.418|0.382|0.455
Relative|Bladder cancer|2015–2019|Males|4|All ages combined|0.62|0.608|0.631
Relative|Bladder cancer|2015–2019|Males|5|00–04|||
Relative|Bladder cancer|2015–2019|Males|5|05–09|||
Relative|Bladder cancer|2015–2019|Males|5|10–14|||
Relative|Bladder cancer|2015–2019|Males|5|15–19|||
Relative|Bladder cancer|2015–2019|Males|5|20–24|||
Relative|Bladder cancer|2015–2019|Males|5|25–29|||
Relative|Bladder cancer|2015–2019|Males|5|30–34|||
Relative|Bladder cancer|2015–2019|Males|5|35–39|||
Relative|Bladder cancer|2015–2019|Males|5|40–44|0.756|0.641|0.84
Relative|Bladder cancer|2015–2019|Males|5|45–49|0.754|0.671|0.82
Relative|Bladder cancer|2015–2019|Males|5|50–54|0.704|0.645|0.756
Relative|Bladder cancer|2015–2019|Males|5|55–59|0.691|0.648|0.73
Relative|Bladder cancer|2015–2019|Males|5|60–64|0.723|0.69|0.754
Relative|Bladder cancer|2015–2019|Males|5|65–69|0.695|0.667|0.723
Relative|Bladder cancer|2015–2019|Males|5|70–74|0.633|0.604|0.661
Relative|Bladder cancer|2015–2019|Males|5|75–79|0.571|0.54|0.601
Relative|Bladder cancer|2015–2019|Males|5|80–84|0.483|0.448|0.518
Relative|Bladder cancer|2015–2019|Males|5|85+|0.365|0.326|0.405
Relative|Bladder cancer|2015–2019|Males|5|All ages combined|0.589|0.577|0.601
Observed|Bladder cancer|2015–2019|Females|1|00–04|||
Observed|Bladder cancer|2015–2019|Females|1|05–09|||
Observed|Bladder cancer|2015–2019|Females|1|10–14|||
Observed|Bladder cancer|2015–2019|Females|1|15–19|||
Observed|Bladder cancer|2015–2019|Females|1|20–24|||
Observed|Bladder cancer|2015–2019|Females|1|25–29|||
Observed|Bladder cancer|2015–2019|Females|1|30–34|||
Observed|Bladder cancer|2015–2019|Females|1|35–39|||
Observed|Bladder cancer|2015–2019|Females|1|40–44|0.902|0.726|0.967
Observed|Bladder cancer|2015–2019|Females|1|45–49|0.821|0.675|0.906
Observed|Bladder cancer|2015–2019|Females|1|50–54|0.79|0.684|0.864
Observed|Bladder cancer|2015–2019|Females|1|55–59|0.829|0.76|0.879
Observed|Bladder cancer|2015–2019|Females|1|60–64|0.797|0.739|0.843
Observed|Bladder cancer|2015–2019|Females|1|65–69|0.802|0.755|0.841
Observed|Bladder cancer|2015–2019|Females|1|70–74|0.75|0.707|0.788
Observed|Bladder cancer|2015–2019|Females|1|75–79|0.72|0.677|0.759
Observed|Bladder cancer|2015–2019|Females|1|80–84|0.601|0.559|0.641
Observed|Bladder cancer|2015–2019|Females|1|85+|0.457|0.422|0.491
Observed|Bladder cancer|2015–2019|Females|1|All ages combined|0.664|0.647|0.68
Observed|Bladder cancer|2015–2019|Females|2|00–04|||
Observed|Bladder cancer|2015–2019|Females|2|05–09|||
Observed|Bladder cancer|2015–2019|Females|2|10–14|||
Observed|Bladder cancer|2015–2019|Females|2|15–19|||
Observed|Bladder cancer|2015–2019|Females|2|20–24|||
Observed|Bladder cancer|2015–2019|Females|2|25–29|||
Observed|Bladder cancer|2015–2019|Females|2|30–34|||
Observed|Bladder cancer|2015–2019|Females|2|35–39|||
Observed|Bladder cancer|2015–2019|Females|2|40–44|0.837|0.653|0.929
Observed|Bladder cancer|2015–2019|Females|2|45–49|0.76|0.609|0.859
Observed|Bladder cancer|2015–2019|Females|2|50–54|0.71|0.6|0.795
Observed|Bladder cancer|2015–2019|Females|2|55–59|0.719|0.64|0.783
Observed|Bladder cancer|2015–2019|Females|2|60–64|0.681|0.616|0.737
Observed|Bladder cancer|2015–2019|Females|2|65–69|0.684|0.63|0.731
Observed|Bladder cancer|2015–2019|Females|2|70–74|0.648|0.601|0.69
Observed|Bladder cancer|2015–2019|Females|2|75–79|0.583|0.536|0.626
Observed|Bladder cancer|2015–2019|Females|2|80–84|0.48|0.437|0.522
Observed|Bladder cancer|2015–2019|Females|2|85+|0.297|0.266|0.329
Observed|Bladder cancer|2015–2019|Females|2|All ages combined|0.536|0.518|0.553
Observed|Bladder cancer|2015–2019|Females|3|00–04|||
Observed|Bladder cancer|2015–2019|Females|3|05–09|||
Observed|Bladder cancer|2015–2019|Females|3|10–14|||
Observed|Bladder cancer|2015–2019|Females|3|15–19|||
Observed|Bladder cancer|2015–2019|Females|3|20–24|||
Observed|Bladder cancer|2015–2019|Females|3|25–29|||
Observed|Bladder cancer|2015–2019|Females|3|30–34|||
Observed|Bladder cancer|2015–2019|Females|3|35–39|||
Observed|Bladder cancer|2015–2019|Females|3|40–44|0.76|0.56|0.879
Observed|Bladder cancer|2015–2019|Females|3|45–49|0.701|0.549|0.811
Observed|Bladder cancer|2015–2019|Females|3|50–54|0.669|0.559|0.758
Observed|Bladder cancer|2015–2019|Females|3|55–59|0.676|0.594|0.744
Observed|Bladder cancer|2015–2019|Females|3|60–64|0.635|0.569|0.694
Observed|Bladder cancer|2015–2019|Females|3|65–69|0.638|0.584|0.688
Observed|Bladder cancer|2015–2019|Females|3|70–74|0.593|0.545|0.638
Observed|Bladder cancer|2015–2019|Females|3|75–79|0.536|0.49|0.581
Observed|Bladder cancer|2015–2019|Females|3|80–84|0.412|0.37|0.454
Observed|Bladder cancer|2015–2019|Females|3|85+|0.229|0.2|0.258
Observed|Bladder cancer|2015–2019|Females|3|All ages combined|0.479|0.461|0.496
Observed|Bladder cancer|2015–2019|Females|4|00–04|||
Observed|Bladder cancer|2015–2019|Females|4|05–09|||
Observed|Bladder cancer|2015–2019|Females|4|10–14|||
Observed|Bladder cancer|2015–2019|Females|4|15–19|||
Observed|Bladder cancer|2015–2019|Females|4|20–24|||
Observed|Bladder cancer|2015–2019|Females|4|25–29|||
Observed|Bladder cancer|2015–2019|Females|4|30–34|||
Observed|Bladder cancer|2015–2019|Females|4|35–39|||
Observed|Bladder cancer|2015–2019|Females|4|40–44|||
Observed|Bladder cancer|2015–2019|Females|4|45–49|0.606|0.455|0.727
Observed|Bladder cancer|2015–2019|Females|4|50–54|0.649|0.538|0.739
Observed|Bladder cancer|2015–2019|Females|4|55–59|0.66|0.578|0.73
Observed|Bladder cancer|2015–2019|Females|4|60–64|0.611|0.544|0.671
Observed|Bladder cancer|2015–2019|Females|4|65–69|0.606|0.55|0.657
Observed|Bladder cancer|2015–2019|Females|4|70–74|0.567|0.518|0.612
Observed|Bladder cancer|2015–2019|Females|4|75–79|0.482|0.435|0.527
Observed|Bladder cancer|2015–2019|Females|4|80–84|0.368|0.327|0.409
Observed|Bladder cancer|2015–2019|Females|4|85+|0.18|0.154|0.208
Observed|Bladder cancer|2015–2019|Females|4|All ages combined|0.438|0.42|0.455
Observed|Bladder cancer|2015–2019|Females|5|00–04|||
Observed|Bladder cancer|2015–2019|Females|5|05–09|||
Observed|Bladder cancer|2015–2019|Females|5|10–14|||
Observed|Bladder cancer|2015–2019|Females|5|15–19|||
Observed|Bladder cancer|2015–2019|Females|5|20–24|||
Observed|Bladder cancer|2015–2019|Females|5|25–29|||
Observed|Bladder cancer|2015–2019|Females|5|30–34|||
Observed|Bladder cancer|2015–2019|Females|5|35–39|||
Observed|Bladder cancer|2015–2019|Females|5|40–44|||
Observed|Bladder cancer|2015–2019|Females|5|45–49|0.567|0.418|0.691
Observed|Bladder cancer|2015–2019|Females|5|50–54|0.649|0.538|0.739
Observed|Bladder cancer|2015–2019|Females|5|55–59|0.645|0.562|0.717
Observed|Bladder cancer|2015–2019|Females|5|60–64|0.597|0.53|0.658
Observed|Bladder cancer|2015–2019|Females|5|65–69|0.563|0.507|0.615
Observed|Bladder cancer|2015–2019|Females|5|70–74|0.533|0.484|0.579
Observed|Bladder cancer|2015–2019|Females|5|75–79|0.447|0.401|0.492
Observed|Bladder cancer|2015–2019|Females|5|80–84|0.319|0.279|0.359
Observed|Bladder cancer|2015–2019|Females|5|85+|0.151|0.127|0.177
Observed|Bladder cancer|2015–2019|Females|5|All ages combined|0.405|0.388|0.423
Relative|Bladder cancer|2015–2019|Females|1|00–04|||
Relative|Bladder cancer|2015–2019|Females|1|05–09|||
Relative|Bladder cancer|2015–2019|Females|1|10–14|||
Relative|Bladder cancer|2015–2019|Females|1|15–19|||
Relative|Bladder cancer|2015–2019|Females|1|20–24|||
Relative|Bladder cancer|2015–2019|Females|1|25–29|||
Relative|Bladder cancer|2015–2019|Females|1|30–34|||
Relative|Bladder cancer|2015–2019|Females|1|35–39|||
Relative|Bladder cancer|2015–2019|Females|1|40–44|0.903|0.727|0.968
Relative|Bladder cancer|2015–2019|Females|1|45–49|0.823|0.676|0.908
Relative|Bladder cancer|2015–2019|Females|1|50–54|0.792|0.686|0.865
Relative|Bladder cancer|2015–2019|Females|1|55–59|0.831|0.763|0.882
Relative|Bladder cancer|2015–2019|Females|1|60–64|0.801|0.743|0.847
Relative|Bladder cancer|2015–2019|Females|1|65–69|0.808|0.76|0.847
Relative|Bladder cancer|2015–2019|Females|1|70–74|0.76|0.716|0.798
Relative|Bladder cancer|2015–2019|Females|1|75–79|0.736|0.691|0.776
Relative|Bladder cancer|2015–2019|Females|1|80–84|0.627|0.583|0.669
Relative|Bladder cancer|2015–2019|Females|1|85+|0.516|0.477|0.555
Relative|Bladder cancer|2015–2019|Females|1|All ages combined|0.692|0.675|0.709
Relative|Bladder cancer|2015–2019|Females|2|00–04|||
Relative|Bladder cancer|2015–2019|Females|2|05–09|||
Relative|Bladder cancer|2015–2019|Females|2|10–14|||
Relative|Bladder cancer|2015–2019|Females|2|15–19|||
Relative|Bladder cancer|2015–2019|Females|2|20–24|||
Relative|Bladder cancer|2015–2019|Females|2|25–29|||
Relative|Bladder cancer|2015–2019|Females|2|30–34|||
Relative|Bladder cancer|2015–2019|Females|2|35–39|||
Relative|Bladder cancer|2015–2019|Females|2|40–44|0.839|0.654|0.931
Relative|Bladder cancer|2015–2019|Females|2|45–49|0.762|0.611|0.861
Relative|Bladder cancer|2015–2019|Females|2|50–54|0.713|0.602|0.798
Relative|Bladder cancer|2015–2019|Females|2|55–59|0.724|0.645|0.789
Relative|Bladder cancer|2015–2019|Females|2|60–64|0.688|0.623|0.744
Relative|Bladder cancer|2015–2019|Females|2|65–69|0.694|0.64|0.742
Relative|Bladder cancer|2015–2019|Females|2|70–74|0.665|0.617|0.709
Relative|Bladder cancer|2015–2019|Females|2|75–79|0.61|0.562|0.656
Relative|Bladder cancer|2015–2019|Females|2|80–84|0.526|0.479|0.572
Relative|Bladder cancer|2015–2019|Females|2|85+|0.381|0.341|0.422
Relative|Bladder cancer|2015–2019|Females|2|All ages combined|0.58|0.561|0.599
Relative|Bladder cancer|2015–2019|Females|3|00–04|||
Relative|Bladder cancer|2015–2019|Females|3|05–09|||
Relative|Bladder cancer|2015–2019|Females|3|10–14|||
Relative|Bladder cancer|2015–2019|Females|3|15–19|||
Relative|Bladder cancer|2015–2019|Females|3|20–24|||
Relative|Bladder cancer|2015–2019|Females|3|25–29|||
Relative|Bladder cancer|2015–2019|Females|3|30–34|||
Relative|Bladder cancer|2015–2019|Females|3|35–39|||
Relative|Bladder cancer|2015–2019|Females|3|40–44|0.763|0.562|0.881
Relative|Bladder cancer|2015–2019|Females|3|45–49|0.705|0.552|0.814
Relative|Bladder cancer|2015–2019|Females|3|50–54|0.674|0.563|0.763
Relative|Bladder cancer|2015–2019|Females|3|55–59|0.683|0.6|0.752
Relative|Bladder cancer|2015–2019|Females|3|60–64|0.645|0.578|0.705
Relative|Bladder cancer|2015–2019|Females|3|65–69|0.654|0.598|0.705
Relative|Bladder cancer|2015–2019|Females|3|70–74|0.618|0.568|0.665
Relative|Bladder cancer|2015–2019|Females|3|75–79|0.578|0.527|0.626
Relative|Bladder cancer|2015–2019|Females|3|80–84|0.478|0.429|0.526
Relative|Bladder cancer|2015–2019|Females|3|85+|0.336|0.294|0.38
Relative|Bladder cancer|2015–2019|Females|3|All ages combined|0.537|0.517|0.557
Relative|Bladder cancer|2015–2019|Females|4|00–04|||
Relative|Bladder cancer|2015–2019|Females|4|05–09|||
Relative|Bladder cancer|2015–2019|Females|4|10–14|||
Relative|Bladder cancer|2015–2019|Females|4|15–19|||
Relative|Bladder cancer|2015–2019|Females|4|20–24|||
Relative|Bladder cancer|2015–2019|Females|4|25–29|||
Relative|Bladder cancer|2015–2019|Females|4|30–34|||
Relative|Bladder cancer|2015–2019|Females|4|35–39|||
Relative|Bladder cancer|2015–2019|Females|4|40–44|||
Relative|Bladder cancer|2015–2019|Females|4|45–49|0.61|0.458|0.731
Relative|Bladder cancer|2015–2019|Females|4|50–54|0.655|0.544|0.746
Relative|Bladder cancer|2015–2019|Females|4|55–59|0.67|0.586|0.741
Relative|Bladder cancer|2015–2019|Females|4|60–64|0.624|0.556|0.686
Relative|Bladder cancer|2015–2019|Females|4|65–69|0.627|0.57|0.68
Relative|Bladder cancer|2015–2019|Females|4|70–74|0.601|0.55|0.649
Relative|Bladder cancer|2015–2019|Females|4|75–79|0.536|0.484|0.586
Relative|Bladder cancer|2015–2019|Females|4|80–84|0.455|0.404|0.506
Relative|Bladder cancer|2015–2019|Females|4|85+|0.308|0.263|0.354
Relative|Bladder cancer|2015–2019|Females|4|All ages combined|0.51|0.49|0.531
Relative|Bladder cancer|2015–2019|Females|5|00–04|||
Relative|Bladder cancer|2015–2019|Females|5|05–09|||
Relative|Bladder cancer|2015–2019|Females|5|10–14|||
Relative|Bladder cancer|2015–2019|Females|5|15–19|||
Relative|Bladder cancer|2015–2019|Females|5|20–24|||
Relative|Bladder cancer|2015–2019|Females|5|25–29|||
Relative|Bladder cancer|2015–2019|Females|5|30–34|||
Relative|Bladder cancer|2015–2019|Females|5|35–39|||
Relative|Bladder cancer|2015–2019|Females|5|40–44|||
Relative|Bladder cancer|2015–2019|Females|5|45–49|0.572|0.422|0.697
Relative|Bladder cancer|2015–2019|Females|5|50–54|0.657|0.545|0.748
Relative|Bladder cancer|2015–2019|Females|5|55–59|0.658|0.573|0.73
Relative|Bladder cancer|2015–2019|Females|5|60–64|0.614|0.545|0.677
Relative|Bladder cancer|2015–2019|Females|5|65–69|0.589|0.53|0.644
Relative|Bladder cancer|2015–2019|Females|5|70–74|0.576|0.523|0.626
Relative|Bladder cancer|2015–2019|Females|5|75–79|0.516|0.462|0.568
Relative|Bladder cancer|2015–2019|Females|5|80–84|0.424|0.371|0.478
Relative|Bladder cancer|2015–2019|Females|5|85+|0.305|0.256|0.357
Relative|Bladder cancer|2015–2019|Females|5|All ages combined|0.491|0.47|0.512
Observed|Bladder cancer|2015–2019|Persons|1|00–04|||
Observed|Bladder cancer|2015–2019|Persons|1|05–09|||
Observed|Bladder cancer|2015–2019|Persons|1|10–14|||
Observed|Bladder cancer|2015–2019|Persons|1|15–19|||
Observed|Bladder cancer|2015–2019|Persons|1|20–24|||
Observed|Bladder cancer|2015–2019|Persons|1|25–29|||
Observed|Bladder cancer|2015–2019|Persons|1|30–34|||
Observed|Bladder cancer|2015–2019|Persons|1|35–39|0.783|0.581|0.896
Observed|Bladder cancer|2015–2019|Persons|1|40–44|0.914|0.842|0.954
Observed|Bladder cancer|2015–2019|Persons|1|45–49|0.87|0.81|0.911
Observed|Bladder cancer|2015–2019|Persons|1|50–54|0.851|0.81|0.884
Observed|Bladder cancer|2015–2019|Persons|1|55–59|0.85|0.821|0.874
Observed|Bladder cancer|2015–2019|Persons|1|60–64|0.866|0.845|0.884
Observed|Bladder cancer|2015–2019|Persons|1|65–69|0.858|0.84|0.874
Observed|Bladder cancer|2015–2019|Persons|1|70–74|0.82|0.803|0.836
Observed|Bladder cancer|2015–2019|Persons|1|75–79|0.782|0.765|0.799
Observed|Bladder cancer|2015–2019|Persons|1|80–84|0.686|0.666|0.705
Observed|Bladder cancer|2015–2019|Persons|1|85+|0.539|0.52|0.558
Observed|Bladder cancer|2015–2019|Persons|1|All ages combined|0.75|0.743|0.758
Observed|Bladder cancer|2015–2019|Persons|2|00–04|||
Observed|Bladder cancer|2015–2019|Persons|2|05–09|||
Observed|Bladder cancer|2015–2019|Persons|2|10–14|||
Observed|Bladder cancer|2015–2019|Persons|2|15–19|||
Observed|Bladder cancer|2015–2019|Persons|2|20–24|||
Observed|Bladder cancer|2015–2019|Persons|2|25–29|||
Observed|Bladder cancer|2015–2019|Persons|2|30–34|||
Observed|Bladder cancer|2015–2019|Persons|2|35–39|||
Observed|Bladder cancer|2015–2019|Persons|2|40–44|0.815|0.728|0.876
Observed|Bladder cancer|2015–2019|Persons|2|45–49|0.803|0.736|0.854
Observed|Bladder cancer|2015–2019|Persons|2|50–54|0.765|0.718|0.805
Observed|Bladder cancer|2015–2019|Persons|2|55–59|0.759|0.726|0.789
Observed|Bladder cancer|2015–2019|Persons|2|60–64|0.771|0.745|0.794
Observed|Bladder cancer|2015–2019|Persons|2|65–69|0.758|0.737|0.778
Observed|Bladder cancer|2015–2019|Persons|2|70–74|0.722|0.702|0.741
Observed|Bladder cancer|2015–2019|Persons|2|75–79|0.656|0.635|0.676
Observed|Bladder cancer|2015–2019|Persons|2|80–84|0.536|0.515|0.557
Observed|Bladder cancer|2015–2019|Persons|2|85+|0.374|0.356|0.393
Observed|Bladder cancer|2015–2019|Persons|2|All ages combined|0.627|0.618|0.635
Observed|Bladder cancer|2015–2019|Persons|3|00–04|||
Observed|Bladder cancer|2015–2019|Persons|3|05–09|||
Observed|Bladder cancer|2015–2019|Persons|3|10–14|||
Observed|Bladder cancer|2015–2019|Persons|3|15–19|||
Observed|Bladder cancer|2015–2019|Persons|3|20–24|||
Observed|Bladder cancer|2015–2019|Persons|3|25–29|||
Observed|Bladder cancer|2015–2019|Persons|3|30–34|||
Observed|Bladder cancer|2015–2019|Persons|3|35–39|||
Observed|Bladder cancer|2015–2019|Persons|3|40–44|0.795|0.706|0.86
Observed|Bladder cancer|2015–2019|Persons|3|45–49|0.757|0.688|0.813
Observed|Bladder cancer|2015–2019|Persons|3|50–54|0.721|0.672|0.764
Observed|Bladder cancer|2015–2019|Persons|3|55–59|0.704|0.669|0.736
Observed|Bladder cancer|2015–2019|Persons|3|60–64|0.718|0.691|0.743
Observed|Bladder cancer|2015–2019|Persons|3|65–69|0.706|0.683|0.727
Observed|Bladder cancer|2015–2019|Persons|3|70–74|0.643|0.621|0.663
Observed|Bladder cancer|2015–2019|Persons|3|75–79|0.585|0.564|0.606
Observed|Bladder cancer|2015–2019|Persons|3|80–84|0.445|0.424|0.466
Observed|Bladder cancer|2015–2019|Persons|3|85+|0.278|0.261|0.295
Observed|Bladder cancer|2015–2019|Persons|3|All ages combined|0.553|0.544|0.561
Observed|Bladder cancer|2015–2019|Persons|4|00–04|||
Observed|Bladder cancer|2015–2019|Persons|4|05–09|||
Observed|Bladder cancer|2015–2019|Persons|4|10–14|||
Observed|Bladder cancer|2015–2019|Persons|4|15–19|||
Observed|Bladder cancer|2015–2019|Persons|4|20–24|||
Observed|Bladder cancer|2015–2019|Persons|4|25–29|||
Observed|Bladder cancer|2015–2019|Persons|4|30–34|||
Observed|Bladder cancer|2015–2019|Persons|4|35–39|||
Observed|Bladder cancer|2015–2019|Persons|4|40–44|0.751|0.656|0.823
Observed|Bladder cancer|2015–2019|Persons|4|45–49|0.713|0.643|0.773
Observed|Bladder cancer|2015–2019|Persons|4|50–54|0.693|0.643|0.737
Observed|Bladder cancer|2015–2019|Persons|4|55–59|0.682|0.646|0.715
Observed|Bladder cancer|2015–2019|Persons|4|60–64|0.689|0.661|0.715
Observed|Bladder cancer|2015–2019|Persons|4|65–69|0.667|0.643|0.689
Observed|Bladder cancer|2015–2019|Persons|4|70–74|0.597|0.574|0.618
Observed|Bladder cancer|2015–2019|Persons|4|75–79|0.516|0.495|0.538
Observed|Bladder cancer|2015–2019|Persons|4|80–84|0.384|0.363|0.405
Observed|Bladder cancer|2015–2019|Persons|4|85+|0.207|0.192|0.223
Observed|Bladder cancer|2015–2019|Persons|4|All ages combined|0.5|0.491|0.509
Observed|Bladder cancer|2015–2019|Persons|5|00–04|||
Observed|Bladder cancer|2015–2019|Persons|5|05–09|||
Observed|Bladder cancer|2015–2019|Persons|5|10–14|||
Observed|Bladder cancer|2015–2019|Persons|5|15–19|||
Observed|Bladder cancer|2015–2019|Persons|5|20–24|||
Observed|Bladder cancer|2015–2019|Persons|5|25–29|||
Observed|Bladder cancer|2015–2019|Persons|5|30–34|||
Observed|Bladder cancer|2015–2019|Persons|5|35–39|||
Observed|Bladder cancer|2015–2019|Persons|5|40–44|0.729|0.631|0.805
Observed|Bladder cancer|2015–2019|Persons|5|45–49|0.698|0.627|0.759
Observed|Bladder cancer|2015–2019|Persons|5|50–54|0.681|0.63|0.726
Observed|Bladder cancer|2015–2019|Persons|5|55–59|0.664|0.627|0.697
Observed|Bladder cancer|2015–2019|Persons|5|60–64|0.671|0.642|0.697
Observed|Bladder cancer|2015–2019|Persons|5|65–69|0.629|0.605|0.652
Observed|Bladder cancer|2015–2019|Persons|5|70–74|0.555|0.532|0.577
Observed|Bladder cancer|2015–2019|Persons|5|75–79|0.459|0.437|0.481
Observed|Bladder cancer|2015–2019|Persons|5|80–84|0.323|0.303|0.343
Observed|Bladder cancer|2015–2019|Persons|5|85+|0.156|0.142|0.17
Observed|Bladder cancer|2015–2019|Persons|5|All ages combined|0.456|0.448|0.465
Relative|Bladder cancer|2015–2019|Persons|1|00–04|||
Relative|Bladder cancer|2015–2019|Persons|1|05–09|||
Relative|Bladder cancer|2015–2019|Persons|1|10–14|||
Relative|Bladder cancer|2015–2019|Persons|1|15–19|||
Relative|Bladder cancer|2015–2019|Persons|1|20–24|||
Relative|Bladder cancer|2015–2019|Persons|1|25–29|||
Relative|Bladder cancer|2015–2019|Persons|1|30–34|||
Relative|Bladder cancer|2015–2019|Persons|1|35–39|0.784|0.581|0.897
Relative|Bladder cancer|2015–2019|Persons|1|40–44|0.916|0.843|0.956
Relative|Bladder cancer|2015–2019|Persons|1|45–49|0.871|0.812|0.913
Relative|Bladder cancer|2015–2019|Persons|1|50–54|0.854|0.813|0.887
Relative|Bladder cancer|2015–2019|Persons|1|55–59|0.854|0.825|0.878
Relative|Bladder cancer|2015–2019|Persons|1|60–64|0.872|0.851|0.891
Relative|Bladder cancer|2015–2019|Persons|1|65–69|0.868|0.85|0.884
Relative|Bladder cancer|2015–2019|Persons|1|70–74|0.835|0.818|0.851
Relative|Bladder cancer|2015–2019|Persons|1|75–79|0.807|0.789|0.824
Relative|Bladder cancer|2015–2019|Persons|1|80–84|0.726|0.705|0.746
Relative|Bladder cancer|2015–2019|Persons|1|85+|0.619|0.597|0.641
Relative|Bladder cancer|2015–2019|Persons|1|All ages combined|0.785|0.777|0.792
Relative|Bladder cancer|2015–2019|Persons|2|00–04|||
Relative|Bladder cancer|2015–2019|Persons|2|05–09|||
Relative|Bladder cancer|2015–2019|Persons|2|10–14|||
Relative|Bladder cancer|2015–2019|Persons|2|15–19|||
Relative|Bladder cancer|2015–2019|Persons|2|20–24|||
Relative|Bladder cancer|2015–2019|Persons|2|25–29|||
Relative|Bladder cancer|2015–2019|Persons|2|30–34|||
Relative|Bladder cancer|2015–2019|Persons|2|35–39|||
Relative|Bladder cancer|2015–2019|Persons|2|40–44|0.817|0.73|0.879
Relative|Bladder cancer|2015–2019|Persons|2|45–49|0.806|0.74|0.858
Relative|Bladder cancer|2015–2019|Persons|2|50–54|0.77|0.722|0.811
Relative|Bladder cancer|2015–2019|Persons|2|55–59|0.767|0.733|0.797
Relative|Bladder cancer|2015–2019|Persons|2|60–64|0.783|0.757|0.806
Relative|Bladder cancer|2015–2019|Persons|2|65–69|0.776|0.754|0.796
Relative|Bladder cancer|2015–2019|Persons|2|70–74|0.75|0.729|0.77
Relative|Bladder cancer|2015–2019|Persons|2|75–79|0.701|0.679|0.721
Relative|Bladder cancer|2015–2019|Persons|2|80–84|0.605|0.581|0.629
Relative|Bladder cancer|2015–2019|Persons|2|85+|0.497|0.473|0.522
Relative|Bladder cancer|2015–2019|Persons|2|All ages combined|0.684|0.674|0.692
Relative|Bladder cancer|2015–2019|Persons|3|00–04|||
Relative|Bladder cancer|2015–2019|Persons|3|05–09|||
Relative|Bladder cancer|2015–2019|Persons|3|10–14|||
Relative|Bladder cancer|2015–2019|Persons|3|15–19|||
Relative|Bladder cancer|2015–2019|Persons|3|20–24|||
Relative|Bladder cancer|2015–2019|Persons|3|25–29|||
Relative|Bladder cancer|2015–2019|Persons|3|30–34|||
Relative|Bladder cancer|2015–2019|Persons|3|35–39|||
Relative|Bladder cancer|2015–2019|Persons|3|40–44|0.799|0.709|0.864
Relative|Bladder cancer|2015–2019|Persons|3|45–49|0.763|0.693|0.819
Relative|Bladder cancer|2015–2019|Persons|3|50–54|0.729|0.679|0.772
Relative|Bladder cancer|2015–2019|Persons|3|55–59|0.715|0.679|0.748
Relative|Bladder cancer|2015–2019|Persons|3|60–64|0.736|0.708|0.762
Relative|Bladder cancer|2015–2019|Persons|3|65–69|0.733|0.709|0.755
Relative|Bladder cancer|2015–2019|Persons|3|70–74|0.683|0.66|0.705
Relative|Bladder cancer|2015–2019|Persons|3|75–79|0.65|0.626|0.672
Relative|Bladder cancer|2015–2019|Persons|3|80–84|0.541|0.515|0.566
Relative|Bladder cancer|2015–2019|Persons|3|85+|0.433|0.406|0.46
Relative|Bladder cancer|2015–2019|Persons|3|All ages combined|0.629|0.619|0.638
Relative|Bladder cancer|2015–2019|Persons|4|00–04|||
Relative|Bladder cancer|2015–2019|Persons|4|05–09|||
Relative|Bladder cancer|2015–2019|Persons|4|10–14|||
Relative|Bladder cancer|2015–2019|Persons|4|15–19|||
Relative|Bladder cancer|2015–2019|Persons|4|20–24|||
Relative|Bladder cancer|2015–2019|Persons|4|25–29|||
Relative|Bladder cancer|2015–2019|Persons|4|30–34|||
Relative|Bladder cancer|2015–2019|Persons|4|35–39|||
Relative|Bladder cancer|2015–2019|Persons|4|40–44|0.756|0.66|0.829
Relative|Bladder cancer|2015–2019|Persons|4|45–49|0.72|0.649|0.78
Relative|Bladder cancer|2015–2019|Persons|4|50–54|0.703|0.652|0.748
Relative|Bladder cancer|2015–2019|Persons|4|55–59|0.697|0.66|0.731
Relative|Bladder cancer|2015–2019|Persons|4|60–64|0.713|0.684|0.74
Relative|Bladder cancer|2015–2019|Persons|4|65–69|0.703|0.678|0.726
Relative|Bladder cancer|2015–2019|Persons|4|70–74|0.65|0.626|0.673
Relative|Bladder cancer|2015–2019|Persons|4|75–79|0.599|0.574|0.623
Relative|Bladder cancer|2015–2019|Persons|4|80–84|0.507|0.48|0.535
Relative|Bladder cancer|2015–2019|Persons|4|85+|0.384|0.356|0.414
Relative|Bladder cancer|2015–2019|Persons|4|All ages combined|0.594|0.584|0.604
Relative|Bladder cancer|2015–2019|Persons|5|00–04|||
Relative|Bladder cancer|2015–2019|Persons|5|05–09|||
Relative|Bladder cancer|2015–2019|Persons|5|10–14|||
Relative|Bladder cancer|2015–2019|Persons|5|15–19|||
Relative|Bladder cancer|2015–2019|Persons|5|20–24|||
Relative|Bladder cancer|2015–2019|Persons|5|25–29|||
Relative|Bladder cancer|2015–2019|Persons|5|30–34|||
Relative|Bladder cancer|2015–2019|Persons|5|35–39|||
Relative|Bladder cancer|2015–2019|Persons|5|40–44|0.735|0.637|0.812
Relative|Bladder cancer|2015–2019|Persons|5|45–49|0.707|0.635|0.769
Relative|Bladder cancer|2015–2019|Persons|5|50–54|0.694|0.642|0.74
Relative|Bladder cancer|2015–2019|Persons|5|55–59|0.683|0.646|0.718
Relative|Bladder cancer|2015–2019|Persons|5|60–64|0.701|0.671|0.729
Relative|Bladder cancer|2015–2019|Persons|5|65–69|0.674|0.649|0.699
Relative|Bladder cancer|2015–2019|Persons|5|70–74|0.621|0.596|0.646
Relative|Bladder cancer|2015–2019|Persons|5|75–79|0.56|0.533|0.586
Relative|Bladder cancer|2015–2019|Persons|5|80–84|0.468|0.439|0.498
Relative|Bladder cancer|2015–2019|Persons|5|85+|0.347|0.317|0.379
Relative|Bladder cancer|2015–2019|Persons|5|All ages combined|0.566|0.555|0.577
Observed|Bone cancer|2015–2019|Males|1|00–04|||
Observed|Bone cancer|2015–2019|Males|1|05–09|0.918|0.709|0.979
Observed|Bone cancer|2015–2019|Males|1|10–14|0.96|0.849|0.99
Observed|Bone cancer|2015–2019|Males|1|15–19|0.899|0.82|0.944
Observed|Bone cancer|2015–2019|Males|1|20–24|0.954|0.827|0.988
Observed|Bone cancer|2015–2019|Males|1|25–29|1|0.913|1
Observed|Bone cancer|2015–2019|Males|1|30–34|0.94|0.782|0.985
Observed|Bone cancer|2015–2019|Males|1|35–39|0.971|0.814|0.996
Observed|Bone cancer|2015–2019|Males|1|40–44|0.971|0.814|0.996
Observed|Bone cancer|2015–2019|Males|1|45–49|0.929|0.744|0.982
Observed|Bone cancer|2015–2019|Males|1|50–54|0.802|0.63|0.9
Observed|Bone cancer|2015–2019|Males|1|55–59|0.912|0.783|0.966
Observed|Bone cancer|2015–2019|Males|1|60–64|0.845|0.723|0.916
Observed|Bone cancer|2015–2019|Males|1|65–69|0.879|0.763|0.94
Observed|Bone cancer|2015–2019|Males|1|70–74|0.785|0.653|0.872
Observed|Bone cancer|2015–2019|Males|1|75–79|0.797|0.646|0.889
Observed|Bone cancer|2015–2019|Males|1|80–84|0.576|0.386|0.726
Observed|Bone cancer|2015–2019|Males|1|85+|||
Observed|Bone cancer|2015–2019|Males|1|All ages combined|0.88|0.855|0.902
Observed|Bone cancer|2015–2019|Males|2|00–04|||
Observed|Bone cancer|2015–2019|Males|2|05–09|||
Observed|Bone cancer|2015–2019|Males|2|10–14|0.938|0.821|0.98
Observed|Bone cancer|2015–2019|Males|2|15–19|0.77|0.671|0.842
Observed|Bone cancer|2015–2019|Males|2|20–24|0.853|0.701|0.931
Observed|Bone cancer|2015–2019|Males|2|25–29|0.933|0.756|0.983
Observed|Bone cancer|2015–2019|Males|2|30–34|0.94|0.782|0.985
Observed|Bone cancer|2015–2019|Males|2|35–39|0.879|0.71|0.953
Observed|Bone cancer|2015–2019|Males|2|40–44|0.846|0.67|0.933
Observed|Bone cancer|2015–2019|Males|2|45–49|0.86|0.669|0.945
Observed|Bone cancer|2015–2019|Males|2|50–54|0.725|0.549|0.841
Observed|Bone cancer|2015–2019|Males|2|55–59|0.869|0.732|0.939
Observed|Bone cancer|2015–2019|Males|2|60–64|0.685|0.548|0.788
Observed|Bone cancer|2015–2019|Males|2|65–69|0.77|0.637|0.86
Observed|Bone cancer|2015–2019|Males|2|70–74|0.727|0.588|0.825
Observed|Bone cancer|2015–2019|Males|2|75–79|0.724|0.565|0.833
Observed|Bone cancer|2015–2019|Males|2|80–84|||
Observed|Bone cancer|2015–2019|Males|2|85+|||
Observed|Bone cancer|2015–2019|Males|2|All ages combined|0.79|0.759|0.818
Observed|Bone cancer|2015–2019|Males|3|00–04|||
Observed|Bone cancer|2015–2019|Males|3|05–09|||
Observed|Bone cancer|2015–2019|Males|3|10–14|0.887|0.747|0.952
Observed|Bone cancer|2015–2019|Males|3|15–19|0.716|0.613|0.796
Observed|Bone cancer|2015–2019|Males|3|20–24|0.779|0.618|0.878
Observed|Bone cancer|2015–2019|Males|3|25–29|0.856|0.66|0.944
Observed|Bone cancer|2015–2019|Males|3|30–34|0.906|0.735|0.969
Observed|Bone cancer|2015–2019|Males|3|35–39|0.852|0.68|0.935
Observed|Bone cancer|2015–2019|Males|3|40–44|0.789|0.608|0.893
Observed|Bone cancer|2015–2019|Males|3|45–49|0.75|0.546|0.872
Observed|Bone cancer|2015–2019|Males|3|50–54|0.725|0.549|0.841
Observed|Bone cancer|2015–2019|Males|3|55–59|0.846|0.703|0.923
Observed|Bone cancer|2015–2019|Males|3|60–64|0.649|0.51|0.757
Observed|Bone cancer|2015–2019|Males|3|65–69|0.707|0.566|0.81
Observed|Bone cancer|2015–2019|Males|3|70–74|0.689|0.548|0.794
Observed|Bone cancer|2015–2019|Males|3|75–79|0.641|0.475|0.767
Observed|Bone cancer|2015–2019|Males|3|80–84|||
Observed|Bone cancer|2015–2019|Males|3|85+|||
Observed|Bone cancer|2015–2019|Males|3|All ages combined|0.736|0.702|0.767
Observed|Bone cancer|2015–2019|Males|4|00–04|||
Observed|Bone cancer|2015–2019|Males|4|05–09|||
Observed|Bone cancer|2015–2019|Males|4|10–14|0.863|0.718|0.936
Observed|Bone cancer|2015–2019|Males|4|15–19|0.615|0.508|0.705
Observed|Bone cancer|2015–2019|Males|4|20–24|0.705|0.54|0.821
Observed|Bone cancer|2015–2019|Males|4|25–29|0.856|0.66|0.944
Observed|Bone cancer|2015–2019|Males|4|30–34|0.868|0.684|0.949
Observed|Bone cancer|2015–2019|Males|4|35–39|0.747|0.571|0.859
Observed|Bone cancer|2015–2019|Males|4|40–44|0.76|0.577|0.872
Observed|Bone cancer|2015–2019|Males|4|45–49|0.722|0.52|0.85
Observed|Bone cancer|2015–2019|Males|4|50–54|0.725|0.549|0.841
Observed|Bone cancer|2015–2019|Males|4|55–59|0.846|0.703|0.923
Observed|Bone cancer|2015–2019|Males|4|60–64|0.628|0.488|0.739
Observed|Bone cancer|2015–2019|Males|4|65–69|0.634|0.483|0.751
Observed|Bone cancer|2015–2019|Males|4|70–74|0.689|0.548|0.794
Observed|Bone cancer|2015–2019|Males|4|75–79|||
Observed|Bone cancer|2015–2019|Males|4|80–84|||
Observed|Bone cancer|2015–2019|Males|4|85+|||
Observed|Bone cancer|2015–2019|Males|4|All ages combined|0.695|0.659|0.728
Observed|Bone cancer|2015–2019|Males|5|00–04|||
Observed|Bone cancer|2015–2019|Males|5|05–09|||
Observed|Bone cancer|2015–2019|Males|5|10–14|0.839|0.69|0.92
Observed|Bone cancer|2015–2019|Males|5|15–19|0.536|0.427|0.634
Observed|Bone cancer|2015–2019|Males|5|20–24|0.659|0.494|0.782
Observed|Bone cancer|2015–2019|Males|5|25–29|0.783|0.579|0.897
Observed|Bone cancer|2015–2019|Males|5|30–34|0.868|0.684|0.949
Observed|Bone cancer|2015–2019|Males|5|35–39|0.747|0.571|0.859
Observed|Bone cancer|2015–2019|Males|5|40–44|0.76|0.577|0.872
Observed|Bone cancer|2015–2019|Males|5|45–49|0.697|0.498|0.829
Observed|Bone cancer|2015–2019|Males|5|50–54|0.725|0.549|0.841
Observed|Bone cancer|2015–2019|Males|5|55–59|0.821|0.674|0.906
Observed|Bone cancer|2015–2019|Males|5|60–64|0.606|0.465|0.721
Observed|Bone cancer|2015–2019|Males|5|65–69|0.578|0.423|0.705
Observed|Bone cancer|2015–2019|Males|5|70–74|0.575|0.427|0.698
Observed|Bone cancer|2015–2019|Males|5|75–79|||
Observed|Bone cancer|2015–2019|Males|5|80–84|||
Observed|Bone cancer|2015–2019|Males|5|85+|||
Observed|Bone cancer|2015–2019|Males|5|All ages combined|0.655|0.618|0.689
Relative|Bone cancer|2015–2019|Males|1|00–04|||
Relative|Bone cancer|2015–2019|Males|1|05–09|0.918|0.709|0.979
Relative|Bone cancer|2015–2019|Males|1|10–14|0.96|0.85|0.99
Relative|Bone cancer|2015–2019|Males|1|15–19|0.899|0.821|0.945
Relative|Bone cancer|2015–2019|Males|1|20–24|0.954|0.828|0.989
Relative|Bone cancer|2015–2019|Males|1|25–29|1.001|0.913|1.001
Relative|Bone cancer|2015–2019|Males|1|30–34|0.941|0.782|0.986
Relative|Bone cancer|2015–2019|Males|1|35–39|0.972|0.815|0.997
Relative|Bone cancer|2015–2019|Males|1|40–44|0.973|0.816|0.998
Relative|Bone cancer|2015–2019|Males|1|45–49|0.931|0.746|0.984
Relative|Bone cancer|2015–2019|Males|1|50–54|0.805|0.632|0.904
Relative|Bone cancer|2015–2019|Males|1|55–59|0.917|0.787|0.971
Relative|Bone cancer|2015–2019|Males|1|60–64|0.851|0.729|0.923
Relative|Bone cancer|2015–2019|Males|1|65–69|0.89|0.773|0.952
Relative|Bone cancer|2015–2019|Males|1|70–74|0.8|0.666|0.889
Relative|Bone cancer|2015–2019|Males|1|75–79|0.825|0.669|0.92
Relative|Bone cancer|2015–2019|Males|1|80–84|0.611|0.41|0.77
Relative|Bone cancer|2015–2019|Males|1|85+|||
Relative|Bone cancer|2015–2019|Males|1|All ages combined|0.89|0.864|0.912
Relative|Bone cancer|2015–2019|Males|2|00–04|||
Relative|Bone cancer|2015–2019|Males|2|05–09|||
Relative|Bone cancer|2015–2019|Males|2|10–14|0.939|0.821|0.98
Relative|Bone cancer|2015–2019|Males|2|15–19|0.77|0.672|0.843
Relative|Bone cancer|2015–2019|Males|2|20–24|0.854|0.702|0.932
Relative|Bone cancer|2015–2019|Males|2|25–29|0.934|0.757|0.984
Relative|Bone cancer|2015–2019|Males|2|30–34|0.942|0.783|0.986
Relative|Bone cancer|2015–2019|Males|2|35–39|0.882|0.711|0.955
Relative|Bone cancer|2015–2019|Males|2|40–44|0.849|0.672|0.936
Relative|Bone cancer|2015–2019|Males|2|45–49|0.864|0.672|0.949
Relative|Bone cancer|2015–2019|Males|2|50–54|0.73|0.553|0.847
Relative|Bone cancer|2015–2019|Males|2|55–59|0.879|0.74|0.949
Relative|Bone cancer|2015–2019|Males|2|60–64|0.696|0.557|0.801
Relative|Bone cancer|2015–2019|Males|2|65–69|0.791|0.654|0.882
Relative|Bone cancer|2015–2019|Males|2|70–74|0.757|0.613|0.86
Relative|Bone cancer|2015–2019|Males|2|75–79|0.778|0.608|0.896
Relative|Bone cancer|2015–2019|Males|2|80–84|||
Relative|Bone cancer|2015–2019|Males|2|85+|||
Relative|Bone cancer|2015–2019|Males|2|All ages combined|0.808|0.775|0.836
Relative|Bone cancer|2015–2019|Males|3|00–04|||
Relative|Bone cancer|2015–2019|Males|3|05–09|||
Relative|Bone cancer|2015–2019|Males|3|10–14|0.887|0.747|0.952
Relative|Bone cancer|2015–2019|Males|3|15–19|0.717|0.614|0.797
Relative|Bone cancer|2015–2019|Males|3|20–24|0.781|0.619|0.88
Relative|Bone cancer|2015–2019|Males|3|25–29|0.858|0.661|0.946
Relative|Bone cancer|2015–2019|Males|3|30–34|0.908|0.737|0.971
Relative|Bone cancer|2015–2019|Males|3|35–39|0.855|0.682|0.939
Relative|Bone cancer|2015–2019|Males|3|40–44|0.793|0.611|0.898
Relative|Bone cancer|2015–2019|Males|3|45–49|0.756|0.55|0.879
Relative|Bone cancer|2015–2019|Males|3|50–54|0.733|0.556|0.851
Relative|Bone cancer|2015–2019|Males|3|55–59|0.86|0.715|0.939
Relative|Bone cancer|2015–2019|Males|3|60–64|0.665|0.523|0.777
Relative|Bone cancer|2015–2019|Males|3|65–69|0.737|0.59|0.844
Relative|Bone cancer|2015–2019|Males|3|70–74|0.735|0.585|0.847
Relative|Bone cancer|2015–2019|Males|3|75–79|0.719|0.533|0.861
Relative|Bone cancer|2015–2019|Males|3|80–84|||
Relative|Bone cancer|2015–2019|Males|3|85+|||
Relative|Bone cancer|2015–2019|Males|3|All ages combined|0.761|0.725|0.793
Relative|Bone cancer|2015–2019|Males|4|00–04|||
Relative|Bone cancer|2015–2019|Males|4|05–09|||
Relative|Bone cancer|2015–2019|Males|4|10–14|0.863|0.719|0.937
Relative|Bone cancer|2015–2019|Males|4|15–19|0.616|0.509|0.707
Relative|Bone cancer|2015–2019|Males|4|20–24|0.707|0.541|0.823
Relative|Bone cancer|2015–2019|Males|4|25–29|0.859|0.662|0.946
Relative|Bone cancer|2015–2019|Males|4|30–34|0.872|0.687|0.952
Relative|Bone cancer|2015–2019|Males|4|35–39|0.751|0.574|0.864
Relative|Bone cancer|2015–2019|Males|4|40–44|0.765|0.581|0.878
Relative|Bone cancer|2015–2019|Males|4|45–49|0.729|0.525|0.858
Relative|Bone cancer|2015–2019|Males|4|50–54|0.736|0.558|0.854
Relative|Bone cancer|2015–2019|Males|4|55–59|0.866|0.72|0.946
Relative|Bone cancer|2015–2019|Males|4|60–64|0.651|0.505|0.766
Relative|Bone cancer|2015–2019|Males|4|65–69|0.671|0.512|0.795
Relative|Bone cancer|2015–2019|Males|4|70–74|0.754|0.6|0.869
Relative|Bone cancer|2015–2019|Males|4|75–79|||
Relative|Bone cancer|2015–2019|Males|4|80–84|||
Relative|Bone cancer|2015–2019|Males|4|85+|||
Relative|Bone cancer|2015–2019|Males|4|All ages combined|0.725|0.687|0.759
Relative|Bone cancer|2015–2019|Males|5|00–04|||
Relative|Bone cancer|2015–2019|Males|5|05–09|||
Relative|Bone cancer|2015–2019|Males|5|10–14|0.84|0.69|0.921
Relative|Bone cancer|2015–2019|Males|5|15–19|0.538|0.428|0.636
Relative|Bone cancer|2015–2019|Males|5|20–24|0.661|0.495|0.785
Relative|Bone cancer|2015–2019|Males|5|25–29|0.786|0.582|0.9
Relative|Bone cancer|2015–2019|Males|5|30–34|0.873|0.688|0.953
Relative|Bone cancer|2015–2019|Males|5|35–39|0.752|0.575|0.865
Relative|Bone cancer|2015–2019|Males|5|40–44|0.767|0.582|0.88
Relative|Bone cancer|2015–2019|Males|5|45–49|0.706|0.505|0.84
Relative|Bone cancer|2015–2019|Males|5|50–54|0.74|0.561|0.858
Relative|Bone cancer|2015–2019|Males|5|55–59|0.848|0.695|0.936
Relative|Bone cancer|2015–2019|Males|5|60–64|0.635|0.487|0.756
Relative|Bone cancer|2015–2019|Males|5|65–69|0.623|0.456|0.76
Relative|Bone cancer|2015–2019|Males|5|70–74|0.649|0.482|0.787
Relative|Bone cancer|2015–2019|Males|5|75–79|||
Relative|Bone cancer|2015–2019|Males|5|80–84|||
Relative|Bone cancer|2015–2019|Males|5|85+|||
Relative|Bone cancer|2015–2019|Males|5|All ages combined|0.69|0.651|0.726
Observed|Bone cancer|2015–2019|Females|1|00–04|||
Observed|Bone cancer|2015–2019|Females|1|05–09|0.961|0.757|0.994
Observed|Bone cancer|2015–2019|Females|1|10–14|0.914|0.805|0.963
Observed|Bone cancer|2015–2019|Females|1|15–19|0.954|0.83|0.988
Observed|Bone cancer|2015–2019|Females|1|20–24|1|0.892|1
Observed|Bone cancer|2015–2019|Females|1|25–29|||
Observed|Bone cancer|2015–2019|Females|1|30–34|0.942|0.787|0.985
Observed|Bone cancer|2015–2019|Females|1|35–39|||
Observed|Bone cancer|2015–2019|Females|1|40–44|0.939|0.778|0.984
Observed|Bone cancer|2015–2019|Females|1|45–49|0.885|0.685|0.961
Observed|Bone cancer|2015–2019|Females|1|50–54|0.943|0.792|0.986
Observed|Bone cancer|2015–2019|Females|1|55–59|0.836|0.671|0.923
Observed|Bone cancer|2015–2019|Females|1|60–64|1|0.898|1
Observed|Bone cancer|2015–2019|Females|1|65–69|0.776|0.587|0.886
Observed|Bone cancer|2015–2019|Females|1|70–74|0.819|0.619|0.92
Observed|Bone cancer|2015–2019|Females|1|75–79|0.739|0.53|0.866
Observed|Bone cancer|2015–2019|Females|1|80–84|||
Observed|Bone cancer|2015–2019|Females|1|85+|||
Observed|Bone cancer|2015–2019|Females|1|All ages combined|0.885|0.855|0.91
Observed|Bone cancer|2015–2019|Females|2|00–04|||
Observed|Bone cancer|2015–2019|Females|2|05–09|0.961|0.757|0.994
Observed|Bone cancer|2015–2019|Females|2|10–14|0.812|0.686|0.891
Observed|Bone cancer|2015–2019|Females|2|15–19|0.883|0.741|0.949
Observed|Bone cancer|2015–2019|Females|2|20–24|0.921|0.719|0.98
Observed|Bone cancer|2015–2019|Females|2|25–29|||
Observed|Bone cancer|2015–2019|Females|2|30–34|0.85|0.675|0.935
Observed|Bone cancer|2015–2019|Females|2|35–39|||
Observed|Bone cancer|2015–2019|Females|2|40–44|0.909|0.744|0.97
Observed|Bone cancer|2015–2019|Females|2|45–49|0.816|0.613|0.919
Observed|Bone cancer|2015–2019|Females|2|50–54|0.916|0.761|0.972
Observed|Bone cancer|2015–2019|Females|2|55–59|0.757|0.586|0.865
Observed|Bone cancer|2015–2019|Females|2|60–64|0.967|0.786|0.995
Observed|Bone cancer|2015–2019|Females|2|65–69|0.749|0.562|0.866
Observed|Bone cancer|2015–2019|Females|2|70–74|0.819|0.619|0.92
Observed|Bone cancer|2015–2019|Females|2|75–79|||
Observed|Bone cancer|2015–2019|Females|2|80–84|||
Observed|Bone cancer|2015–2019|Females|2|85+|||
Observed|Bone cancer|2015–2019|Females|2|All ages combined|0.814|0.778|0.845
Observed|Bone cancer|2015–2019|Females|3|00–04|||
Observed|Bone cancer|2015–2019|Females|3|05–09|0.961|0.757|0.994
Observed|Bone cancer|2015–2019|Females|3|10–14|0.744|0.612|0.837
Observed|Bone cancer|2015–2019|Females|3|15–19|0.813|0.66|0.902
Observed|Bone cancer|2015–2019|Females|3|20–24|0.921|0.719|0.98
Observed|Bone cancer|2015–2019|Females|3|25–29|||
Observed|Bone cancer|2015–2019|Females|3|30–34|0.741|0.546|0.862
Observed|Bone cancer|2015–2019|Females|3|35–39|||
Observed|Bone cancer|2015–2019|Females|3|40–44|0.877|0.704|0.952
Observed|Bone cancer|2015–2019|Females|3|45–49|0.816|0.613|0.919
Observed|Bone cancer|2015–2019|Females|3|50–54|0.856|0.688|0.938
Observed|Bone cancer|2015–2019|Females|3|55–59|0.727|0.552|0.843
Observed|Bone cancer|2015–2019|Females|3|60–64|0.967|0.786|0.995
Observed|Bone cancer|2015–2019|Females|3|65–69|0.672|0.488|0.802
Observed|Bone cancer|2015–2019|Females|3|70–74|||
Observed|Bone cancer|2015–2019|Females|3|75–79|||
Observed|Bone cancer|2015–2019|Females|3|80–84|||
Observed|Bone cancer|2015–2019|Females|3|85+|||
Observed|Bone cancer|2015–2019|Females|3|All ages combined|0.766|0.727|0.8
Observed|Bone cancer|2015–2019|Females|4|00–04|||
Observed|Bone cancer|2015–2019|Females|4|05–09|0.961|0.757|0.994
Observed|Bone cancer|2015–2019|Females|4|10–14|0.657|0.521|0.763
Observed|Bone cancer|2015–2019|Females|4|15–19|0.702|0.533|0.819
Observed|Bone cancer|2015–2019|Females|4|20–24|||
Observed|Bone cancer|2015–2019|Females|4|25–29|||
Observed|Bone cancer|2015–2019|Females|4|30–34|||
Observed|Bone cancer|2015–2019|Females|4|35–39|||
Observed|Bone cancer|2015–2019|Females|4|40–44|0.877|0.704|0.952
Observed|Bone cancer|2015–2019|Females|4|45–49|0.816|0.613|0.919
Observed|Bone cancer|2015–2019|Females|4|50–54|0.818|0.636|0.915
Observed|Bone cancer|2015–2019|Females|4|55–59|0.692|0.512|0.817
Observed|Bone cancer|2015–2019|Females|4|60–64|0.967|0.786|0.995
Observed|Bone cancer|2015–2019|Females|4|65–69|0.672|0.488|0.802
Observed|Bone cancer|2015–2019|Females|4|70–74|||
Observed|Bone cancer|2015–2019|Females|4|75–79|||
Observed|Bone cancer|2015–2019|Females|4|80–84|||
Observed|Bone cancer|2015–2019|Females|4|85+|||
Observed|Bone cancer|2015–2019|Females|4|All ages combined|0.732|0.691|0.768
Observed|Bone cancer|2015–2019|Females|5|00–04|||
Observed|Bone cancer|2015–2019|Females|5|05–09|||
Observed|Bone cancer|2015–2019|Females|5|10–14|0.657|0.521|0.763
Observed|Bone cancer|2015–2019|Females|5|15–19|0.672|0.501|0.796
Observed|Bone cancer|2015–2019|Females|5|20–24|||
Observed|Bone cancer|2015–2019|Females|5|25–29|||
Observed|Bone cancer|2015–2019|Females|5|30–34|||
Observed|Bone cancer|2015–2019|Females|5|35–39|||
Observed|Bone cancer|2015–2019|Females|5|40–44|0.877|0.704|0.952
Observed|Bone cancer|2015–2019|Females|5|45–49|0.784|0.583|0.897
Observed|Bone cancer|2015–2019|Females|5|50–54|||
Observed|Bone cancer|2015–2019|Females|5|55–59|||
Observed|Bone cancer|2015–2019|Females|5|60–64|||
Observed|Bone cancer|2015–2019|Females|5|65–69|0.612|0.428|0.753
Observed|Bone cancer|2015–2019|Females|5|70–74|||
Observed|Bone cancer|2015–2019|Females|5|75–79|||
Observed|Bone cancer|2015–2019|Females|5|80–84|||
Observed|Bone cancer|2015–2019|Females|5|85+|||
Observed|Bone cancer|2015–2019|Females|5|All ages combined|0.705|0.663|0.743
Relative|Bone cancer|2015–2019|Females|1|00–04|||
Relative|Bone cancer|2015–2019|Females|1|05–09|0.962|0.757|0.995
Relative|Bone cancer|2015–2019|Females|1|10–14|0.914|0.805|0.963
Relative|Bone cancer|2015–2019|Females|1|15–19|0.955|0.83|0.989
Relative|Bone cancer|2015–2019|Females|1|20–24|1|0.893|1
Relative|Bone cancer|2015–2019|Females|1|25–29|||
Relative|Bone cancer|2015–2019|Females|1|30–34|0.942|0.788|0.986
Relative|Bone cancer|2015–2019|Females|1|35–39|||
Relative|Bone cancer|2015–2019|Females|1|40–44|0.94|0.779|0.985
Relative|Bone cancer|2015–2019|Females|1|45–49|0.886|0.686|0.963
Relative|Bone cancer|2015–2019|Females|1|50–54|0.945|0.794|0.988
Relative|Bone cancer|2015–2019|Females|1|55–59|0.839|0.673|0.926
Relative|Bone cancer|2015–2019|Females|1|60–64|1.005|0.903|1.005
Relative|Bone cancer|2015–2019|Females|1|65–69|0.781|0.591|0.892
Relative|Bone cancer|2015–2019|Females|1|70–74|0.829|0.627|0.932
Relative|Bone cancer|2015–2019|Females|1|75–79|0.756|0.543|0.886
Relative|Bone cancer|2015–2019|Females|1|80–84|||
Relative|Bone cancer|2015–2019|Females|1|85+|||
Relative|Bone cancer|2015–2019|Females|1|All ages combined|0.893|0.862|0.918
Relative|Bone cancer|2015–2019|Females|2|00–04|||
Relative|Bone cancer|2015–2019|Females|2|05–09|0.962|0.757|0.995
Relative|Bone cancer|2015–2019|Females|2|10–14|0.812|0.686|0.891
Relative|Bone cancer|2015–2019|Females|2|15–19|0.883|0.741|0.95
Relative|Bone cancer|2015–2019|Females|2|20–24|0.921|0.72|0.98
Relative|Bone cancer|2015–2019|Females|2|25–29|||
Relative|Bone cancer|2015–2019|Females|2|30–34|0.85|0.676|0.935
Relative|Bone cancer|2015–2019|Females|2|35–39|||
Relative|Bone cancer|2015–2019|Females|2|40–44|0.911|0.745|0.972
Relative|Bone cancer|2015–2019|Females|2|45–49|0.818|0.615|0.921
Relative|Bone cancer|2015–2019|Females|2|50–54|0.92|0.764|0.976
Relative|Bone cancer|2015–2019|Females|2|55–59|0.762|0.59|0.871
Relative|Bone cancer|2015–2019|Females|2|60–64|0.976|0.793|1.005
Relative|Bone cancer|2015–2019|Females|2|65–69|0.761|0.57|0.879
Relative|Bone cancer|2015–2019|Females|2|70–74|0.841|0.635|0.945
Relative|Bone cancer|2015–2019|Females|2|75–79|||
Relative|Bone cancer|2015–2019|Females|2|80–84|||
Relative|Bone cancer|2015–2019|Females|2|85+|||
Relative|Bone cancer|2015–2019|Females|2|All ages combined|0.826|0.79|0.858
Relative|Bone cancer|2015–2019|Females|3|00–04|||
Relative|Bone cancer|2015–2019|Females|3|05–09|0.962|0.757|0.995
Relative|Bone cancer|2015–2019|Females|3|10–14|0.744|0.612|0.837
Relative|Bone cancer|2015–2019|Females|3|15–19|0.813|0.66|0.902
Relative|Bone cancer|2015–2019|Females|3|20–24|0.922|0.72|0.98
Relative|Bone cancer|2015–2019|Females|3|25–29|||
Relative|Bone cancer|2015–2019|Females|3|30–34|0.742|0.546|0.863
Relative|Bone cancer|2015–2019|Females|3|35–39|||
Relative|Bone cancer|2015–2019|Females|3|40–44|0.879|0.706|0.955
Relative|Bone cancer|2015–2019|Females|3|45–49|0.819|0.616|0.923
Relative|Bone cancer|2015–2019|Females|3|50–54|0.862|0.693|0.944
Relative|Bone cancer|2015–2019|Females|3|55–59|0.734|0.557|0.852
Relative|Bone cancer|2015–2019|Females|3|60–64|0.981|0.798|1.01
Relative|Bone cancer|2015–2019|Females|3|65–69|0.688|0.499|0.822
Relative|Bone cancer|2015–2019|Females|3|70–74|||
Relative|Bone cancer|2015–2019|Females|3|75–79|||
Relative|Bone cancer|2015–2019|Females|3|80–84|||
Relative|Bone cancer|2015–2019|Females|3|85+|||
Relative|Bone cancer|2015–2019|Females|3|All ages combined|0.782|0.742|0.816
Relative|Bone cancer|2015–2019|Females|4|00–04|||
Relative|Bone cancer|2015–2019|Females|4|05–09|0.962|0.757|0.995
Relative|Bone cancer|2015–2019|Females|4|10–14|0.658|0.521|0.764
Relative|Bone cancer|2015–2019|Females|4|15–19|0.702|0.533|0.82
Relative|Bone cancer|2015–2019|Females|4|20–24|||
Relative|Bone cancer|2015–2019|Females|4|25–29|||
Relative|Bone cancer|2015–2019|Females|4|30–34|||
Relative|Bone cancer|2015–2019|Females|4|35–39|||
Relative|Bone cancer|2015–2019|Females|4|40–44|0.88|0.707|0.956
Relative|Bone cancer|2015–2019|Females|4|45–49|0.821|0.617|0.925
Relative|Bone cancer|2015–2019|Females|4|50–54|0.826|0.643|0.924
Relative|Bone cancer|2015–2019|Females|4|55–59|0.702|0.519|0.829
Relative|Bone cancer|2015–2019|Females|4|60–64|0.987|0.802|1.016
Relative|Bone cancer|2015–2019|Females|4|65–69|0.695|0.504|0.829
Relative|Bone cancer|2015–2019|Females|4|70–74|||
Relative|Bone cancer|2015–2019|Females|4|75–79|||
Relative|Bone cancer|2015–2019|Females|4|80–84|||
Relative|Bone cancer|2015–2019|Females|4|85+|||
Relative|Bone cancer|2015–2019|Females|4|All ages combined|0.752|0.71|0.789
Relative|Bone cancer|2015–2019|Females|5|00–04|||
Relative|Bone cancer|2015–2019|Females|5|05–09|||
Relative|Bone cancer|2015–2019|Females|5|10–14|0.658|0.521|0.764
Relative|Bone cancer|2015–2019|Females|5|15–19|0.673|0.501|0.797
Relative|Bone cancer|2015–2019|Females|5|20–24|||
Relative|Bone cancer|2015–2019|Females|5|25–29|||
Relative|Bone cancer|2015–2019|Females|5|30–34|||
Relative|Bone cancer|2015–2019|Females|5|35–39|||
Relative|Bone cancer|2015–2019|Females|5|40–44|0.881|0.708|0.957
Relative|Bone cancer|2015–2019|Females|5|45–49|0.791|0.587|0.904
Relative|Bone cancer|2015–2019|Females|5|50–54|||
Relative|Bone cancer|2015–2019|Females|5|55–59|||
Relative|Bone cancer|2015–2019|Females|5|60–64|||
Relative|Bone cancer|2015–2019|Females|5|65–69|0.639|0.447|0.786
Relative|Bone cancer|2015–2019|Females|5|70–74|||
Relative|Bone cancer|2015–2019|Females|5|75–79|||
Relative|Bone cancer|2015–2019|Females|5|80–84|||
Relative|Bone cancer|2015–2019|Females|5|85+|||
Relative|Bone cancer|2015–2019|Females|5|All ages combined|0.729|0.686|0.768
Observed|Bone cancer|2015–2019|Persons|1|00–04|||
Observed|Bone cancer|2015–2019|Persons|1|05–09|0.94|0.826|0.98
Observed|Bone cancer|2015–2019|Persons|1|10–14|0.935|0.869|0.969
Observed|Bone cancer|2015–2019|Persons|1|15–19|0.916|0.857|0.951
Observed|Bone cancer|2015–2019|Persons|1|20–24|0.971|0.89|0.993
Observed|Bone cancer|2015–2019|Persons|1|25–29|0.981|0.871|0.997
Observed|Bone cancer|2015–2019|Persons|1|30–34|0.941|0.851|0.977
Observed|Bone cancer|2015–2019|Persons|1|35–39|0.963|0.861|0.991
Observed|Bone cancer|2015–2019|Persons|1|40–44|0.956|0.869|0.986
Observed|Bone cancer|2015–2019|Persons|1|45–49|0.908|0.792|0.96
Observed|Bone cancer|2015–2019|Persons|1|50–54|0.873|0.77|0.932
Observed|Bone cancer|2015–2019|Persons|1|55–59|0.878|0.786|0.933
Observed|Bone cancer|2015–2019|Persons|1|60–64|0.895|0.808|0.944
Observed|Bone cancer|2015–2019|Persons|1|65–69|0.843|0.749|0.904
Observed|Bone cancer|2015–2019|Persons|1|70–74|0.796|0.693|0.868
Observed|Bone cancer|2015–2019|Persons|1|75–79|0.775|0.66|0.855
Observed|Bone cancer|2015–2019|Persons|1|80–84|0.618|0.466|0.739
Observed|Bone cancer|2015–2019|Persons|1|85+|0.598|0.42|0.737
Observed|Bone cancer|2015–2019|Persons|1|All ages combined|0.882|0.863|0.899
Observed|Bone cancer|2015–2019|Persons|2|00–04|||
Observed|Bone cancer|2015–2019|Persons|2|05–09|0.94|0.826|0.98
Observed|Bone cancer|2015–2019|Persons|2|10–14|0.868|0.788|0.92
Observed|Bone cancer|2015–2019|Persons|2|15–19|0.805|0.728|0.862
Observed|Bone cancer|2015–2019|Persons|2|20–24|0.879|0.772|0.938
Observed|Bone cancer|2015–2019|Persons|2|25–29|0.917|0.795|0.968
Observed|Bone cancer|2015–2019|Persons|2|30–34|0.894|0.79|0.948
Observed|Bone cancer|2015–2019|Persons|2|35–39|0.848|0.719|0.921
Observed|Bone cancer|2015–2019|Persons|2|40–44|0.879|0.773|0.938
Observed|Bone cancer|2015–2019|Persons|2|45–49|0.839|0.713|0.912
Observed|Bone cancer|2015–2019|Persons|2|50–54|0.819|0.709|0.891
Observed|Bone cancer|2015–2019|Persons|2|55–59|0.819|0.718|0.887
Observed|Bone cancer|2015–2019|Persons|2|60–64|0.78|0.677|0.853
Observed|Bone cancer|2015–2019|Persons|2|65–69|0.767|0.666|0.841
Observed|Bone cancer|2015–2019|Persons|2|70–74|0.758|0.651|0.837
Observed|Bone cancer|2015–2019|Persons|2|75–79|0.67|0.547|0.767
Observed|Bone cancer|2015–2019|Persons|2|80–84|0.503|0.352|0.636
Observed|Bone cancer|2015–2019|Persons|2|85+|||
Observed|Bone cancer|2015–2019|Persons|2|All ages combined|0.8|0.777|0.822
Observed|Bone cancer|2015–2019|Persons|3|00–04|||
Observed|Bone cancer|2015–2019|Persons|3|05–09|0.919|0.798|0.969
Observed|Bone cancer|2015–2019|Persons|3|10–14|0.806|0.716|0.871
Observed|Bone cancer|2015–2019|Persons|3|15–19|0.746|0.664|0.81
Observed|Bone cancer|2015–2019|Persons|3|20–24|0.834|0.721|0.905
Observed|Bone cancer|2015–2019|Persons|3|25–29|0.852|0.714|0.927
Observed|Bone cancer|2015–2019|Persons|3|30–34|0.823|0.703|0.898
Observed|Bone cancer|2015–2019|Persons|3|35–39|0.829|0.698|0.907
Observed|Bone cancer|2015–2019|Persons|3|40–44|0.833|0.719|0.904
Observed|Bone cancer|2015–2019|Persons|3|45–49|0.787|0.656|0.873
Observed|Bone cancer|2015–2019|Persons|3|50–54|0.79|0.677|0.868
Observed|Bone cancer|2015–2019|Persons|3|55–59|0.793|0.688|0.866
Observed|Bone cancer|2015–2019|Persons|3|60–64|0.757|0.652|0.834
Observed|Bone cancer|2015–2019|Persons|3|65–69|0.697|0.59|0.781
Observed|Bone cancer|2015–2019|Persons|3|70–74|0.667|0.553|0.758
Observed|Bone cancer|2015–2019|Persons|3|75–79|0.622|0.497|0.725
Observed|Bone cancer|2015–2019|Persons|3|80–84|0.413|0.271|0.55
Observed|Bone cancer|2015–2019|Persons|3|85+|||
Observed|Bone cancer|2015–2019|Persons|3|All ages combined|0.749|0.724|0.772
Observed|Bone cancer|2015–2019|Persons|4|00–04|||
Observed|Bone cancer|2015–2019|Persons|4|05–09|0.919|0.798|0.969
Observed|Bone cancer|2015–2019|Persons|4|10–14|0.746|0.65|0.82
Observed|Bone cancer|2015–2019|Persons|4|15–19|0.642|0.554|0.717
Observed|Bone cancer|2015–2019|Persons|4|20–24|0.785|0.664|0.867
Observed|Bone cancer|2015–2019|Persons|4|25–29|0.852|0.714|0.927
Observed|Bone cancer|2015–2019|Persons|4|30–34|0.804|0.679|0.884
Observed|Bone cancer|2015–2019|Persons|4|35–39|0.726|0.588|0.825
Observed|Bone cancer|2015–2019|Persons|4|40–44|0.818|0.701|0.892
Observed|Bone cancer|2015–2019|Persons|4|45–49|0.772|0.64|0.86
Observed|Bone cancer|2015–2019|Persons|4|50–54|0.774|0.657|0.855
Observed|Bone cancer|2015–2019|Persons|4|55–59|0.778|0.671|0.854
Observed|Bone cancer|2015–2019|Persons|4|60–64|0.744|0.637|0.823
Observed|Bone cancer|2015–2019|Persons|4|65–69|0.659|0.549|0.748
Observed|Bone cancer|2015–2019|Persons|4|70–74|0.654|0.539|0.746
Observed|Bone cancer|2015–2019|Persons|4|75–79|0.553|0.425|0.664
Observed|Bone cancer|2015–2019|Persons|4|80–84|||
Observed|Bone cancer|2015–2019|Persons|4|85+|||
Observed|Bone cancer|2015–2019|Persons|4|All ages combined|0.711|0.684|0.735
Observed|Bone cancer|2015–2019|Persons|5|00–04|||
Observed|Bone cancer|2015–2019|Persons|5|05–09|0.892|0.759|0.954
Observed|Bone cancer|2015–2019|Persons|5|10–14|0.736|0.638|0.811
Observed|Bone cancer|2015–2019|Persons|5|15–19|0.578|0.487|0.659
Observed|Bone cancer|2015–2019|Persons|5|20–24|0.739|0.614|0.829
Observed|Bone cancer|2015–2019|Persons|5|25–29|0.813|0.671|0.898
Observed|Bone cancer|2015–2019|Persons|5|30–34|0.782|0.652|0.868
Observed|Bone cancer|2015–2019|Persons|5|35–39|0.726|0.588|0.825
Observed|Bone cancer|2015–2019|Persons|5|40–44|0.818|0.701|0.892
Observed|Bone cancer|2015–2019|Persons|5|45–49|0.744|0.612|0.837
Observed|Bone cancer|2015–2019|Persons|5|50–54|0.774|0.657|0.855
Observed|Bone cancer|2015–2019|Persons|5|55–59|0.764|0.654|0.843
Observed|Bone cancer|2015–2019|Persons|5|60–64|0.713|0.603|0.798
Observed|Bone cancer|2015–2019|Persons|5|65–69|0.601|0.487|0.697
Observed|Bone cancer|2015–2019|Persons|5|70–74|0.545|0.425|0.65
Observed|Bone cancer|2015–2019|Persons|5|75–79|0.514|0.385|0.629
Observed|Bone cancer|2015–2019|Persons|5|80–84|||
Observed|Bone cancer|2015–2019|Persons|5|85+|||
Observed|Bone cancer|2015–2019|Persons|5|All ages combined|0.676|0.649|0.702
Relative|Bone cancer|2015–2019|Persons|1|00–04|||
Relative|Bone cancer|2015–2019|Persons|1|05–09|0.94|0.826|0.98
Relative|Bone cancer|2015–2019|Persons|1|10–14|0.935|0.869|0.969
Relative|Bone cancer|2015–2019|Persons|1|15–19|0.916|0.857|0.952
Relative|Bone cancer|2015–2019|Persons|1|20–24|0.972|0.89|0.993
Relative|Bone cancer|2015–2019|Persons|1|25–29|0.981|0.871|0.998
Relative|Bone cancer|2015–2019|Persons|1|30–34|0.942|0.851|0.978
Relative|Bone cancer|2015–2019|Persons|1|35–39|0.964|0.862|0.992
Relative|Bone cancer|2015–2019|Persons|1|40–44|0.957|0.87|0.987
Relative|Bone cancer|2015–2019|Persons|1|45–49|0.909|0.794|0.962
Relative|Bone cancer|2015–2019|Persons|1|50–54|0.875|0.772|0.934
Relative|Bone cancer|2015–2019|Persons|1|55–59|0.882|0.789|0.937
Relative|Bone cancer|2015–2019|Persons|1|60–64|0.901|0.814|0.951
Relative|Bone cancer|2015–2019|Persons|1|65–69|0.852|0.757|0.913
Relative|Bone cancer|2015–2019|Persons|1|70–74|0.81|0.705|0.883
Relative|Bone cancer|2015–2019|Persons|1|75–79|0.799|0.68|0.881
Relative|Bone cancer|2015–2019|Persons|1|80–84|0.652|0.491|0.778
Relative|Bone cancer|2015–2019|Persons|1|85+|0.685|0.481|0.845
Relative|Bone cancer|2015–2019|Persons|1|All ages combined|0.891|0.872|0.908
Relative|Bone cancer|2015–2019|Persons|2|00–04|||
Relative|Bone cancer|2015–2019|Persons|2|05–09|0.94|0.826|0.98
Relative|Bone cancer|2015–2019|Persons|2|10–14|0.869|0.788|0.92
Relative|Bone cancer|2015–2019|Persons|2|15–19|0.805|0.729|0.862
Relative|Bone cancer|2015–2019|Persons|2|20–24|0.88|0.773|0.938
Relative|Bone cancer|2015–2019|Persons|2|25–29|0.918|0.796|0.969
Relative|Bone cancer|2015–2019|Persons|2|30–34|0.895|0.791|0.949
Relative|Bone cancer|2015–2019|Persons|2|35–39|0.85|0.72|0.923
Relative|Bone cancer|2015–2019|Persons|2|40–44|0.881|0.775|0.94
Relative|Bone cancer|2015–2019|Persons|2|45–49|0.842|0.716|0.916
Relative|Bone cancer|2015–2019|Persons|2|50–54|0.824|0.713|0.896
Relative|Bone cancer|2015–2019|Persons|2|55–59|0.826|0.725|0.895
Relative|Bone cancer|2015–2019|Persons|2|60–64|0.791|0.686|0.865
Relative|Bone cancer|2015–2019|Persons|2|65–69|0.784|0.68|0.86
Relative|Bone cancer|2015–2019|Persons|2|70–74|0.786|0.675|0.867
Relative|Bone cancer|2015–2019|Persons|2|75–79|0.713|0.582|0.817
Relative|Bone cancer|2015–2019|Persons|2|80–84|0.562|0.394|0.711
Relative|Bone cancer|2015–2019|Persons|2|85+|||
Relative|Bone cancer|2015–2019|Persons|2|All ages combined|0.816|0.792|0.837
Relative|Bone cancer|2015–2019|Persons|3|00–04|||
Relative|Bone cancer|2015–2019|Persons|3|05–09|0.919|0.799|0.969
Relative|Bone cancer|2015–2019|Persons|3|10–14|0.807|0.716|0.871
Relative|Bone cancer|2015–2019|Persons|3|15–19|0.746|0.665|0.811
Relative|Bone cancer|2015–2019|Persons|3|20–24|0.835|0.722|0.906
Relative|Bone cancer|2015–2019|Persons|3|25–29|0.853|0.715|0.928
Relative|Bone cancer|2015–2019|Persons|3|30–34|0.825|0.704|0.9
Relative|Bone cancer|2015–2019|Persons|3|35–39|0.832|0.7|0.91
Relative|Bone cancer|2015–2019|Persons|3|40–44|0.837|0.722|0.908
Relative|Bone cancer|2015–2019|Persons|3|45–49|0.792|0.66|0.878
Relative|Bone cancer|2015–2019|Persons|3|50–54|0.798|0.683|0.876
Relative|Bone cancer|2015–2019|Persons|3|55–59|0.804|0.698|0.878
Relative|Bone cancer|2015–2019|Persons|3|60–64|0.773|0.666|0.852
Relative|Bone cancer|2015–2019|Persons|3|65–69|0.721|0.611|0.808
Relative|Bone cancer|2015–2019|Persons|3|70–74|0.706|0.585|0.802
Relative|Bone cancer|2015–2019|Persons|3|75–79|0.688|0.548|0.801
Relative|Bone cancer|2015–2019|Persons|3|80–84|0.493|0.323|0.656
Relative|Bone cancer|2015–2019|Persons|3|85+|||
Relative|Bone cancer|2015–2019|Persons|3|All ages combined|0.77|0.744|0.794
Relative|Bone cancer|2015–2019|Persons|4|00–04|||
Relative|Bone cancer|2015–2019|Persons|4|05–09|0.919|0.799|0.969
Relative|Bone cancer|2015–2019|Persons|4|10–14|0.747|0.65|0.82
Relative|Bone cancer|2015–2019|Persons|4|15–19|0.643|0.554|0.718
Relative|Bone cancer|2015–2019|Persons|4|20–24|0.786|0.665|0.868
Relative|Bone cancer|2015–2019|Persons|4|25–29|0.854|0.715|0.929
Relative|Bone cancer|2015–2019|Persons|4|30–34|0.806|0.68|0.887
Relative|Bone cancer|2015–2019|Persons|4|35–39|0.729|0.59|0.828
Relative|Bone cancer|2015–2019|Persons|4|40–44|0.823|0.705|0.897
Relative|Bone cancer|2015–2019|Persons|4|45–49|0.778|0.645|0.868
Relative|Bone cancer|2015–2019|Persons|4|50–54|0.783|0.665|0.866
Relative|Bone cancer|2015–2019|Persons|4|55–59|0.794|0.685|0.872
Relative|Bone cancer|2015–2019|Persons|4|60–64|0.766|0.657|0.848
Relative|Bone cancer|2015–2019|Persons|4|65–69|0.691|0.576|0.784
Relative|Bone cancer|2015–2019|Persons|4|70–74|0.708|0.583|0.808
Relative|Bone cancer|2015–2019|Persons|4|75–79|0.638|0.49|0.765
Relative|Bone cancer|2015–2019|Persons|4|80–84|||
Relative|Bone cancer|2015–2019|Persons|4|85+|||
Relative|Bone cancer|2015–2019|Persons|4|All ages combined|0.736|0.709|0.762
Relative|Bone cancer|2015–2019|Persons|5|00–04|||
Relative|Bone cancer|2015–2019|Persons|5|05–09|0.893|0.759|0.955
Relative|Bone cancer|2015–2019|Persons|5|10–14|0.736|0.639|0.811
Relative|Bone cancer|2015–2019|Persons|5|15–19|0.579|0.488|0.66
Relative|Bone cancer|2015–2019|Persons|5|20–24|0.741|0.616|0.831
Relative|Bone cancer|2015–2019|Persons|5|25–29|0.815|0.673|0.901
Relative|Bone cancer|2015–2019|Persons|5|30–34|0.785|0.654|0.871
Relative|Bone cancer|2015–2019|Persons|5|35–39|0.73|0.591|0.829
Relative|Bone cancer|2015–2019|Persons|5|40–44|0.824|0.707|0.899
Relative|Bone cancer|2015–2019|Persons|5|45–49|0.752|0.619|0.846
Relative|Bone cancer|2015–2019|Persons|5|50–54|0.786|0.668|0.869
Relative|Bone cancer|2015–2019|Persons|5|55–59|0.784|0.672|0.865
Relative|Bone cancer|2015–2019|Persons|5|60–64|0.742|0.627|0.83
Relative|Bone cancer|2015–2019|Persons|5|65–69|0.639|0.518|0.741
Relative|Bone cancer|2015–2019|Persons|5|70–74|0.606|0.472|0.723
Relative|Bone cancer|2015–2019|Persons|5|75–79|0.62|0.464|0.759
Relative|Bone cancer|2015–2019|Persons|5|80–84|||
Relative|Bone cancer|2015–2019|Persons|5|85+|||
Relative|Bone cancer|2015–2019|Persons|5|All ages combined|0.707|0.678|0.734
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|00–04|0.769|0.684|0.834
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|05–09|0.791|0.702|0.855
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|10–14|0.913|0.834|0.956
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|15–19|0.923|0.845|0.962
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|20–24|0.97|0.911|0.99
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|25–29|0.928|0.874|0.959
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|30–34|0.923|0.875|0.953
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|35–39|0.916|0.869|0.947
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|40–44|0.836|0.783|0.877
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|45–49|0.76|0.708|0.804
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|50–54|0.689|0.642|0.731
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|55–59|0.609|0.568|0.648
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|60–64|0.559|0.52|0.596
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|65–69|0.467|0.43|0.503
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|70–74|0.369|0.334|0.405
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|75–79|0.256|0.221|0.292
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|80–84|0.159|0.126|0.196
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|85+|0.044|0.029|0.064
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|All ages combined|0.548|0.534|0.56
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|00–04|0.674|0.584|0.749
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|05–09|0.643|0.548|0.724
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|10–14|0.814|0.713|0.882
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|15–19|0.868|0.779|0.923
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|20–24|0.927|0.853|0.965
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|25–29|0.872|0.809|0.916
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|30–34|0.819|0.756|0.867
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|35–39|0.746|0.679|0.801
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|40–44|0.637|0.575|0.693
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|45–49|0.461|0.404|0.516
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|50–54|0.434|0.385|0.481
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|55–59|0.334|0.295|0.373
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|60–64|0.271|0.237|0.306
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|65–69|0.207|0.177|0.238
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|70–74|0.141|0.116|0.169
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|75–79|0.096|0.073|0.123
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|80–84|0.058|0.037|0.085
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|85+|0.011|0.004|0.026
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|All ages combined|0.349|0.336|0.361
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|00–04|0.667|0.577|0.742
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|05–09|0.575|0.48|0.66
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|10–14|0.786|0.681|0.86
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|15–19|0.833|0.738|0.896
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|20–24|0.856|0.765|0.914
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|25–29|0.813|0.742|0.866
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|30–34|0.764|0.696|0.819
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|35–39|0.656|0.586|0.718
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|40–44|0.533|0.469|0.592
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|45–49|0.378|0.324|0.431
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|50–54|0.328|0.283|0.374
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|55–59|0.24|0.205|0.277
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|60–64|0.193|0.163|0.225
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|65–69|0.144|0.118|0.172
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|70–74|0.092|0.071|0.117
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|75–79|0.061|0.043|0.084
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|80–84|0.053|0.033|0.081
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|85+|0.011|0.004|0.026
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|All ages combined|0.288|0.276|0.3
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|00–04|0.638|0.547|0.715
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|05–09|0.551|0.456|0.637
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|10–14|0.786|0.681|0.86
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|15–19|0.793|0.692|0.865
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|20–24|0.796|0.696|0.867
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|25–29|0.767|0.691|0.826
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|30–34|0.698|0.625|0.76
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|35–39|0.595|0.523|0.659
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|40–44|0.477|0.414|0.538
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|45–49|0.335|0.283|0.388
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|50–54|0.3|0.256|0.345
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|55–59|0.187|0.155|0.221
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|60–64|0.152|0.125|0.182
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|65–69|0.12|0.096|0.146
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|70–74|0.077|0.057|0.1
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|75–79|0.048|0.032|0.069
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|80–84|0.036|0.018|0.064
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|85+|0.01|0.003|0.023
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|All ages combined|0.257|0.245|0.268
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|00–04|0.608|0.518|0.687
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|05–09|0.544|0.448|0.629
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|10–14|0.786|0.681|0.86
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|15–19|0.766|0.66|0.843
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|20–24|0.774|0.672|0.848
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|25–29|0.747|0.67|0.808
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|30–34|0.656|0.581|0.721
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|35–39|0.562|0.491|0.627
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|40–44|0.451|0.388|0.512
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|45–49|0.308|0.258|0.359
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|50–54|0.265|0.223|0.309
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|55–59|0.162|0.132|0.195
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|60–64|0.131|0.106|0.16
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|65–69|0.105|0.082|0.131
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|70–74|0.065|0.046|0.088
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|75–79|0.034|0.02|0.053
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|80–84|||
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|85+|0.008|0.003|0.02
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|All ages combined|0.238|0.227|0.249
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|00–04|0.77|0.684|0.835
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|05–09|0.791|0.702|0.855
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|10–14|0.914|0.835|0.956
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|15–19|0.923|0.845|0.963
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|20–24|0.971|0.911|0.991
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|25–29|0.929|0.874|0.96
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|30–34|0.924|0.876|0.954
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|35–39|0.917|0.87|0.948
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|40–44|0.837|0.784|0.878
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|45–49|0.762|0.71|0.806
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|50–54|0.691|0.644|0.733
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|55–59|0.613|0.571|0.652
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|60–64|0.563|0.524|0.6
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|65–69|0.473|0.436|0.509
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|70–74|0.377|0.34|0.413
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|75–79|0.265|0.229|0.302
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|80–84|0.169|0.134|0.208
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|85+|0.051|0.033|0.074
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|1|All ages combined|0.557|0.544|0.57
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|00–04|0.675|0.585|0.75
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|05–09|0.644|0.548|0.724
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|10–14|0.814|0.714|0.882
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|15–19|0.869|0.78|0.924
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|20–24|0.928|0.854|0.966
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|25–29|0.874|0.81|0.917
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|30–34|0.821|0.758|0.869
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|35–39|0.748|0.681|0.803
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|40–44|0.639|0.577|0.695
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|45–49|0.463|0.406|0.519
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|50–54|0.437|0.388|0.485
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|55–59|0.338|0.298|0.377
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|60–64|0.275|0.241|0.311
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|65–69|0.212|0.182|0.244
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|70–74|0.147|0.12|0.177
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|75–79|0.103|0.078|0.132
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|80–84|0.066|0.042|0.097
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|85+|0.015|0.005|0.033
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|2|All ages combined|0.358|0.345|0.371
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|00–04|0.668|0.577|0.743
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|05–09|0.576|0.48|0.66
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|10–14|0.786|0.681|0.86
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|15–19|0.834|0.739|0.897
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|20–24|0.858|0.766|0.916
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|25–29|0.815|0.744|0.868
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|30–34|0.766|0.698|0.821
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|35–39|0.659|0.588|0.72
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|40–44|0.535|0.472|0.595
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|45–49|0.38|0.326|0.435
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|50–54|0.332|0.286|0.378
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|55–59|0.244|0.209|0.281
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|60–64|0.198|0.167|0.231
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|65–69|0.15|0.123|0.178
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|70–74|0.098|0.075|0.124
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|75–79|0.069|0.048|0.094
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|80–84|0.065|0.041|0.099
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|85+|0.017|0.006|0.038
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|3|All ages combined|0.297|0.285|0.309
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|00–04|0.639|0.548|0.716
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|05–09|0.551|0.456|0.637
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|10–14|0.787|0.682|0.861
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|15–19|0.795|0.693|0.866
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|20–24|0.798|0.698|0.869
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|25–29|0.769|0.693|0.828
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|30–34|0.701|0.628|0.762
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|35–39|0.598|0.526|0.662
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|40–44|0.481|0.417|0.542
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|45–49|0.339|0.286|0.392
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|50–54|0.305|0.26|0.351
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|55–59|0.191|0.159|0.226
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|60–64|0.157|0.129|0.188
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|65–69|0.127|0.102|0.155
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|70–74|0.084|0.062|0.11
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|75–79|0.056|0.037|0.081
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|80–84|0.048|0.024|0.085
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|85+|0.017|0.006|0.041
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|4|All ages combined|0.266|0.255|0.279
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|00–04|0.609|0.518|0.688
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|05–09|0.544|0.449|0.629
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|10–14|0.787|0.682|0.861
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|15–19|0.768|0.662|0.845
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|20–24|0.777|0.674|0.851
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|25–29|0.75|0.673|0.811
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|30–34|0.659|0.584|0.724
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|35–39|0.566|0.494|0.631
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|40–44|0.456|0.392|0.517
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|45–49|0.312|0.261|0.364
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|50–54|0.271|0.227|0.316
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|55–59|0.167|0.136|0.201
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|60–64|0.138|0.111|0.168
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|65–69|0.113|0.088|0.14
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|70–74|0.073|0.052|0.099
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|75–79|0.042|0.025|0.065
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|80–84|||
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|85+|0.017|0.006|0.043
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Males|5|All ages combined|0.248|0.237|0.26
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|00–04|0.798|0.712|0.861
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|05–09|0.808|0.702|0.88
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|10–14|0.896|0.782|0.952
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|15–19|0.964|0.864|0.991
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|20–24|0.963|0.891|0.988
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|25–29|0.947|0.878|0.978
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|30–34|0.939|0.882|0.969
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|35–39|0.897|0.832|0.937
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|40–44|0.838|0.771|0.886
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|45–49|0.827|0.767|0.872
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|50–54|0.756|0.704|0.801
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|55–59|0.656|0.604|0.702
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|60–64|0.61|0.561|0.656
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|65–69|0.538|0.491|0.582
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|70–74|0.411|0.365|0.457
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|75–79|0.275|0.23|0.322
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|80–84|0.145|0.111|0.184
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|85+|0.066|0.044|0.093
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|All ages combined|0.575|0.559|0.59
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|00–04|0.691|0.597|0.767
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|05–09|0.706|0.592|0.794
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|10–14|0.81|0.684|0.89
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|15–19|0.964|0.864|0.991
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|20–24|0.88|0.789|0.934
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|25–29|0.916|0.838|0.957
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|30–34|0.8|0.72|0.859
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|35–39|0.762|0.678|0.826
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|40–44|0.673|0.595|0.739
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|45–49|0.656|0.585|0.717
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|50–54|0.527|0.469|0.582
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|55–59|0.404|0.352|0.455
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|60–64|0.361|0.313|0.409
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|65–69|0.279|0.237|0.322
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|70–74|0.212|0.174|0.252
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|75–79|0.116|0.085|0.152
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|80–84|0.057|0.035|0.087
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|85+|0.059|0.038|0.085
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|All ages combined|0.405|0.389|0.42
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|00–04|0.63|0.535|0.712
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|05–09|0.679|0.564|0.771
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|10–14|0.741|0.607|0.835
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|15–19|0.921|0.802|0.97
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|20–24|0.84|0.74|0.904
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|25–29|0.863|0.776|0.918
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|30–34|0.766|0.682|0.83
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|35–39|0.722|0.636|0.791
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|40–44|0.589|0.51|0.66
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|45–49|0.522|0.45|0.59
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|50–54|0.404|0.347|0.459
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|55–59|0.299|0.252|0.348
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|60–64|0.244|0.202|0.288
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|65–69|0.221|0.182|0.262
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|70–74|0.12|0.09|0.155
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|75–79|0.079|0.053|0.111
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|80–84|0.041|0.022|0.068
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|85+|0.046|0.027|0.073
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|All ages combined|0.334|0.319|0.349
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|00–04|0.612|0.516|0.694
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|05–09|0.667|0.55|0.759
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|10–14|0.741|0.607|0.835
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|15–19|0.896|0.766|0.956
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|20–24|0.81|0.703|0.881
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|25–29|0.817|0.725|0.88
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|30–34|0.733|0.646|0.801
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|35–39|0.659|0.57|0.734
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|40–44|0.521|0.442|0.595
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|45–49|0.464|0.393|0.532
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|50–54|0.355|0.299|0.41
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|55–59|0.254|0.21|0.3
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|60–64|0.196|0.157|0.238
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|65–69|0.185|0.148|0.225
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|70–74|0.089|0.063|0.12
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|75–79|0.063|0.039|0.093
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|80–84|0.03|0.014|0.054
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|85+|0.035|0.018|0.062
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|All ages combined|0.299|0.284|0.314
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|00–04|0.602|0.506|0.686
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|05–09|0.637|0.519|0.734
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|10–14|0.741|0.607|0.835
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|15–19|0.896|0.766|0.956
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|20–24|0.743|0.624|0.829
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|25–29|0.777|0.682|0.847
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|30–34|0.668|0.578|0.743
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|35–39|0.637|0.548|0.713
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|40–44|0.51|0.431|0.583
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|45–49|0.444|0.374|0.512
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|50–54|0.331|0.276|0.386
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|55–59|0.222|0.18|0.266
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|60–64|0.178|0.141|0.219
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|65–69|0.169|0.133|0.208
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|70–74|0.083|0.058|0.114
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|75–79|0.058|0.036|0.089
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|80–84|||
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|85+|||
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|All ages combined|0.28|0.266|0.295
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|00–04|0.798|0.712|0.861
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|05–09|0.808|0.703|0.88
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|10–14|0.896|0.783|0.952
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|15–19|0.964|0.864|0.991
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|20–24|0.964|0.891|0.988
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|25–29|0.947|0.878|0.978
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|30–34|0.939|0.882|0.969
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|35–39|0.897|0.832|0.938
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|40–44|0.838|0.771|0.887
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|45–49|0.828|0.768|0.874
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|50–54|0.758|0.705|0.802
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|55–59|0.658|0.606|0.704
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|60–64|0.613|0.564|0.659
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|65–69|0.542|0.494|0.587
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|70–74|0.416|0.369|0.463
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|75–79|0.281|0.235|0.329
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|80–84|0.151|0.115|0.191
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|85+|0.073|0.049|0.104
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|1|All ages combined|0.583|0.567|0.598
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|00–04|0.691|0.597|0.768
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|05–09|0.706|0.592|0.794
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|10–14|0.81|0.684|0.89
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|15–19|0.964|0.864|0.991
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|20–24|0.881|0.789|0.934
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|25–29|0.916|0.839|0.957
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|30–34|0.8|0.721|0.86
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|35–39|0.763|0.679|0.827
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|40–44|0.674|0.596|0.741
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|45–49|0.658|0.586|0.719
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|50–54|0.529|0.471|0.584
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|55–59|0.407|0.355|0.458
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|60–64|0.364|0.316|0.413
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|65–69|0.283|0.241|0.327
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|70–74|0.217|0.178|0.259
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|75–79|0.121|0.089|0.159
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|80–84|0.063|0.039|0.095
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|85+|0.076|0.049|0.11
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|2|All ages combined|0.413|0.397|0.429
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|00–04|0.631|0.535|0.712
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|05–09|0.679|0.564|0.771
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|10–14|0.741|0.607|0.835
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|15–19|0.922|0.803|0.97
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|20–24|0.841|0.741|0.905
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|25–29|0.864|0.776|0.919
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|30–34|0.767|0.683|0.831
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|35–39|0.723|0.637|0.792
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|40–44|0.591|0.511|0.662
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|45–49|0.525|0.452|0.593
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|50–54|0.406|0.349|0.463
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|55–59|0.303|0.255|0.351
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|60–64|0.248|0.205|0.293
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|65–69|0.226|0.186|0.268
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|70–74|0.125|0.093|0.161
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|75–79|0.085|0.057|0.119
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|80–84|0.047|0.026|0.079
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|85+|0.07|0.041|0.109
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|3|All ages combined|0.342|0.327|0.358
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|00–04|0.612|0.516|0.695
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|05–09|0.667|0.55|0.759
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|10–14|0.741|0.608|0.835
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|15–19|0.897|0.766|0.957
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|20–24|0.81|0.704|0.882
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|25–29|0.818|0.726|0.881
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|30–34|0.734|0.648|0.803
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|35–39|0.661|0.572|0.736
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|40–44|0.524|0.444|0.597
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|45–49|0.467|0.395|0.535
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|50–54|0.358|0.302|0.414
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|55–59|0.258|0.213|0.305
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|60–64|0.2|0.16|0.243
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|65–69|0.191|0.153|0.232
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|70–74|0.094|0.067|0.127
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|75–79|0.069|0.043|0.103
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|80–84|0.036|0.017|0.066
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|85+|0.062|0.032|0.109
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|4|All ages combined|0.308|0.293|0.323
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|00–04|0.603|0.507|0.686
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|05–09|0.637|0.519|0.734
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|10–14|0.741|0.608|0.835
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|15–19|0.897|0.767|0.957
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|20–24|0.744|0.625|0.83
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|25–29|0.779|0.683|0.849
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|30–34|0.669|0.58|0.745
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|35–39|0.639|0.55|0.716
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|40–44|0.513|0.433|0.586
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|45–49|0.448|0.377|0.517
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|50–54|0.335|0.28|0.391
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|55–59|0.226|0.184|0.271
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|60–64|0.183|0.145|0.225
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|65–69|0.176|0.139|0.217
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|70–74|0.09|0.063|0.123
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|75–79|0.067|0.041|0.102
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|80–84|||
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|85+|||
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Females|5|All ages combined|0.29|0.275|0.305
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|00–04|0.783|0.725|0.83
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|05–09|0.798|0.733|0.849
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|10–14|0.907|0.848|0.944
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|15–19|0.939|0.885|0.968
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|20–24|0.967|0.928|0.985
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|25–29|0.935|0.896|0.96
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|30–34|0.929|0.896|0.952
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|35–39|0.908|0.872|0.935
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|40–44|0.836|0.797|0.869
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|45–49|0.787|0.749|0.82
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|50–54|0.717|0.683|0.749
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|55–59|0.627|0.595|0.657
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|60–64|0.578|0.548|0.607
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|65–69|0.494|0.465|0.522
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|70–74|0.386|0.357|0.414
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|75–79|0.263|0.236|0.292
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|80–84|0.153|0.128|0.179
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|85+|0.054|0.041|0.07
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|All ages combined|0.559|0.548|0.568
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|00–04|0.682|0.619|0.737
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|05–09|0.669|0.597|0.731
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|10–14|0.813|0.739|0.868
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|15–19|0.903|0.841|0.941
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|20–24|0.905|0.851|0.94
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|25–29|0.889|0.843|0.922
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|30–34|0.811|0.763|0.85
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|35–39|0.752|0.701|0.795
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|40–44|0.651|0.603|0.695
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|45–49|0.538|0.493|0.58
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|50–54|0.473|0.436|0.509
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|55–59|0.361|0.33|0.392
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|60–64|0.305|0.277|0.333
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|65–69|0.234|0.21|0.26
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|70–74|0.169|0.147|0.192
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|75–79|0.104|0.085|0.125
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|80–84|0.058|0.042|0.077
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|85+|0.033|0.022|0.047
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|All ages combined|0.371|0.362|0.381
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|00–04|0.651|0.587|0.707
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|05–09|0.617|0.544|0.681
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|10–14|0.767|0.687|0.828
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|15–19|0.865|0.796|0.911
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|20–24|0.849|0.785|0.894
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|25–29|0.832|0.779|0.873
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|30–34|0.764|0.713|0.807
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|35–39|0.681|0.628|0.729
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|40–44|0.555|0.506|0.601
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|45–49|0.435|0.391|0.478
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|50–54|0.36|0.324|0.396
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|55–59|0.263|0.235|0.292
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|60–64|0.212|0.187|0.238
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|65–69|0.173|0.151|0.196
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|70–74|0.103|0.085|0.123
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|75–79|0.068|0.053|0.087
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|80–84|0.047|0.032|0.066
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|85+|0.028|0.018|0.042
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|All ages combined|0.306|0.297|0.316
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|00–04|0.626|0.562|0.684
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|05–09|0.597|0.524|0.662
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|10–14|0.767|0.687|0.828
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|15–19|0.83|0.755|0.884
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|20–24|0.802|0.732|0.855
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|25–29|0.786|0.73|0.831
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|30–34|0.712|0.658|0.759
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|35–39|0.619|0.565|0.669
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|40–44|0.495|0.446|0.542
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|45–49|0.386|0.344|0.428
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|50–54|0.323|0.289|0.359
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|55–59|0.214|0.188|0.241
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|60–64|0.168|0.146|0.193
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|65–69|0.145|0.124|0.167
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|70–74|0.081|0.065|0.1
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|75–79|0.054|0.04|0.071
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|80–84|0.033|0.02|0.05
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|85+|0.023|0.014|0.036
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|All ages combined|0.274|0.265|0.283
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|00–04|0.606|0.541|0.664
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|05–09|0.582|0.509|0.648
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|10–14|0.767|0.687|0.828
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|15–19|0.811|0.733|0.869
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|20–24|0.762|0.688|0.82
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|25–29|0.758|0.7|0.806
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|30–34|0.66|0.604|0.71
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|35–39|0.591|0.536|0.642
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|40–44|0.475|0.426|0.522
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|45–49|0.361|0.32|0.403
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|50–54|0.293|0.259|0.327
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|55–59|0.186|0.161|0.212
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|60–64|0.149|0.127|0.172
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|65–69|0.129|0.109|0.151
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|70–74|0.072|0.057|0.09
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|75–79|0.043|0.03|0.059
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|80–84|0.025|0.013|0.043
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|85+|0.013|0.006|0.025
Observed|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|All ages combined|0.255|0.246|0.264
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|00–04|0.784|0.725|0.831
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|05–09|0.798|0.733|0.849
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|10–14|0.907|0.848|0.944
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|15–19|0.939|0.886|0.968
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|20–24|0.968|0.929|0.986
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|25–29|0.936|0.897|0.96
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|30–34|0.93|0.896|0.953
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|35–39|0.909|0.873|0.936
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|40–44|0.838|0.798|0.87
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|45–49|0.788|0.75|0.822
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|50–54|0.719|0.685|0.751
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|55–59|0.63|0.598|0.66
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|60–64|0.582|0.552|0.611
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|65–69|0.499|0.47|0.528
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|70–74|0.392|0.363|0.421
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|75–79|0.271|0.243|0.3
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|80–84|0.161|0.135|0.189
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|85+|0.061|0.046|0.079
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|1|All ages combined|0.567|0.557|0.577
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|00–04|0.683|0.619|0.738
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|05–09|0.669|0.597|0.731
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|10–14|0.813|0.739|0.868
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|15–19|0.903|0.841|0.942
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|20–24|0.906|0.852|0.941
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|25–29|0.89|0.844|0.923
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|30–34|0.812|0.765|0.851
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|35–39|0.753|0.703|0.797
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|40–44|0.653|0.605|0.697
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|45–49|0.54|0.495|0.583
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|50–54|0.476|0.438|0.512
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|55–59|0.364|0.333|0.396
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|60–64|0.309|0.281|0.338
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|65–69|0.239|0.214|0.265
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|70–74|0.175|0.152|0.199
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|75–79|0.111|0.09|0.133
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|80–84|0.064|0.047|0.086
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|85+|0.042|0.028|0.061
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|2|All ages combined|0.38|0.37|0.39
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|00–04|0.651|0.587|0.708
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|05–09|0.617|0.544|0.682
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|10–14|0.767|0.688|0.829
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|15–19|0.866|0.797|0.912
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|20–24|0.85|0.786|0.896
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|25–29|0.833|0.781|0.874
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|30–34|0.766|0.715|0.809
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|35–39|0.684|0.63|0.731
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|40–44|0.557|0.508|0.604
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|45–49|0.438|0.394|0.481
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|50–54|0.363|0.327|0.399
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|55–59|0.267|0.238|0.296
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|60–64|0.217|0.192|0.243
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|65–69|0.179|0.156|0.203
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|70–74|0.109|0.09|0.13
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|75–79|0.075|0.058|0.095
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|80–84|0.056|0.038|0.078
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|85+|0.042|0.027|0.063
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|3|All ages combined|0.315|0.306|0.325
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|00–04|0.627|0.562|0.685
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|05–09|0.597|0.524|0.663
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|10–14|0.767|0.688|0.829
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|15–19|0.831|0.756|0.885
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|20–24|0.803|0.733|0.856
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|25–29|0.787|0.731|0.833
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|30–34|0.714|0.66|0.762
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|35–39|0.622|0.567|0.672
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|40–44|0.498|0.448|0.545
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|45–49|0.389|0.347|0.432
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|50–54|0.328|0.293|0.363
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|55–59|0.218|0.191|0.246
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|60–64|0.173|0.15|0.198
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|65–69|0.151|0.13|0.175
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|70–74|0.088|0.07|0.108
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|75–79|0.062|0.045|0.081
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|80–84|0.042|0.026|0.064
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|85+|0.04|0.024|0.064
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|4|All ages combined|0.283|0.274|0.293
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|00–04|0.606|0.541|0.665
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|05–09|0.582|0.509|0.648
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|10–14|0.767|0.688|0.829
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|15–19|0.813|0.734|0.871
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|20–24|0.763|0.69|0.822
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|25–29|0.76|0.702|0.809
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|30–34|0.663|0.606|0.713
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|35–39|0.594|0.539|0.645
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|40–44|0.479|0.429|0.526
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|45–49|0.365|0.323|0.407
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|50–54|0.298|0.263|0.333
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|55–59|0.191|0.165|0.218
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|60–64|0.155|0.132|0.179
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|65–69|0.137|0.116|0.16
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|70–74|0.08|0.063|0.1
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|75–79|0.051|0.036|0.07
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|80–84|0.034|0.018|0.06
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|85+|0.027|0.012|0.053
Relative|Brain and other central nervous system (cancer of the)|2015–2019|Persons|5|All ages combined|0.265|0.256|0.275
Observed|Brain cancer|2015–2019|Males|1|00–04|0.756|0.661|0.828
Observed|Brain cancer|2015–2019|Males|1|05–09|0.758|0.659|0.832
Observed|Brain cancer|2015–2019|Males|1|10–14|0.902|0.805|0.952
Observed|Brain cancer|2015–2019|Males|1|15–19|0.913|0.817|0.96
Observed|Brain cancer|2015–2019|Males|1|20–24|0.977|0.91|0.994
Observed|Brain cancer|2015–2019|Males|1|25–29|0.943|0.89|0.971
Observed|Brain cancer|2015–2019|Males|1|30–34|0.927|0.878|0.957
Observed|Brain cancer|2015–2019|Males|1|35–39|0.915|0.866|0.947
Observed|Brain cancer|2015–2019|Males|1|40–44|0.827|0.771|0.871
Observed|Brain cancer|2015–2019|Males|1|45–49|0.747|0.692|0.793
Observed|Brain cancer|2015–2019|Males|1|50–54|0.678|0.629|0.722
Observed|Brain cancer|2015–2019|Males|1|55–59|0.592|0.55|0.632
Observed|Brain cancer|2015–2019|Males|1|60–64|0.553|0.514|0.59
Observed|Brain cancer|2015–2019|Males|1|65–69|0.457|0.42|0.493
Observed|Brain cancer|2015–2019|Males|1|70–74|0.36|0.324|0.396
Observed|Brain cancer|2015–2019|Males|1|75–79|0.247|0.212|0.283
Observed|Brain cancer|2015–2019|Males|1|80–84|0.154|0.121|0.191
Observed|Brain cancer|2015–2019|Males|1|85+|0.044|0.028|0.064
Observed|Brain cancer|2015–2019|Males|1|All ages combined|0.531|0.518|0.544
Observed|Brain cancer|2015–2019|Males|2|00–04|0.658|0.558|0.741
Observed|Brain cancer|2015–2019|Males|2|05–09|0.578|0.473|0.67
Observed|Brain cancer|2015–2019|Males|2|10–14|0.789|0.669|0.87
Observed|Brain cancer|2015–2019|Males|2|15–19|0.867|0.76|0.929
Observed|Brain cancer|2015–2019|Males|2|20–24|0.94|0.862|0.975
Observed|Brain cancer|2015–2019|Males|2|25–29|0.889|0.825|0.93
Observed|Brain cancer|2015–2019|Males|2|30–34|0.823|0.758|0.872
Observed|Brain cancer|2015–2019|Males|2|35–39|0.75|0.681|0.807
Observed|Brain cancer|2015–2019|Males|2|40–44|0.623|0.558|0.681
Observed|Brain cancer|2015–2019|Males|2|45–49|0.425|0.367|0.481
Observed|Brain cancer|2015–2019|Males|2|50–54|0.415|0.366|0.463
Observed|Brain cancer|2015–2019|Males|2|55–59|0.303|0.264|0.343
Observed|Brain cancer|2015–2019|Males|2|60–64|0.257|0.223|0.292
Observed|Brain cancer|2015–2019|Males|2|65–69|0.191|0.162|0.222
Observed|Brain cancer|2015–2019|Males|2|70–74|0.127|0.103|0.155
Observed|Brain cancer|2015–2019|Males|2|75–79|0.087|0.065|0.113
Observed|Brain cancer|2015–2019|Males|2|80–84|0.056|0.035|0.084
Observed|Brain cancer|2015–2019|Males|2|85+|0.01|0.003|0.024
Observed|Brain cancer|2015–2019|Males|2|All ages combined|0.325|0.313|0.338
Observed|Brain cancer|2015–2019|Males|3|00–04|0.649|0.549|0.733
Observed|Brain cancer|2015–2019|Males|3|05–09|0.506|0.402|0.601
Observed|Brain cancer|2015–2019|Males|3|10–14|0.753|0.628|0.841
Observed|Brain cancer|2015–2019|Males|3|15–19|0.82|0.704|0.893
Observed|Brain cancer|2015–2019|Males|3|20–24|0.862|0.764|0.921
Observed|Brain cancer|2015–2019|Males|3|25–29|0.824|0.751|0.877
Observed|Brain cancer|2015–2019|Males|3|30–34|0.764|0.694|0.821
Observed|Brain cancer|2015–2019|Males|3|35–39|0.655|0.582|0.718
Observed|Brain cancer|2015–2019|Males|3|40–44|0.518|0.453|0.579
Observed|Brain cancer|2015–2019|Males|3|45–49|0.338|0.284|0.393
Observed|Brain cancer|2015–2019|Males|3|50–54|0.303|0.257|0.349
Observed|Brain cancer|2015–2019|Males|3|55–59|0.208|0.174|0.244
Observed|Brain cancer|2015–2019|Males|3|60–64|0.18|0.151|0.212
Observed|Brain cancer|2015–2019|Males|3|65–69|0.126|0.102|0.154
Observed|Brain cancer|2015–2019|Males|3|70–74|0.078|0.058|0.102
Observed|Brain cancer|2015–2019|Males|3|75–79|0.054|0.037|0.076
Observed|Brain cancer|2015–2019|Males|3|80–84|0.056|0.035|0.084
Observed|Brain cancer|2015–2019|Males|3|85+|||
Observed|Brain cancer|2015–2019|Males|3|All ages combined|0.263|0.251|0.275
Observed|Brain cancer|2015–2019|Males|4|00–04|0.613|0.512|0.699
Observed|Brain cancer|2015–2019|Males|4|05–09|0.475|0.372|0.57
Observed|Brain cancer|2015–2019|Males|4|10–14|0.753|0.628|0.841
Observed|Brain cancer|2015–2019|Males|4|15–19|0.764|0.638|0.851
Observed|Brain cancer|2015–2019|Males|4|20–24|0.794|0.685|0.868
Observed|Brain cancer|2015–2019|Males|4|25–29|0.773|0.694|0.834
Observed|Brain cancer|2015–2019|Males|4|30–34|0.695|0.62|0.759
Observed|Brain cancer|2015–2019|Males|4|35–39|0.589|0.515|0.655
Observed|Brain cancer|2015–2019|Males|4|40–44|0.46|0.396|0.523
Observed|Brain cancer|2015–2019|Males|4|45–49|0.297|0.246|0.35
Observed|Brain cancer|2015–2019|Males|4|50–54|0.272|0.228|0.317
Observed|Brain cancer|2015–2019|Males|4|55–59|0.154|0.125|0.186
Observed|Brain cancer|2015–2019|Males|4|60–64|0.136|0.109|0.165
Observed|Brain cancer|2015–2019|Males|4|65–69|0.101|0.079|0.127
Observed|Brain cancer|2015–2019|Males|4|70–74|0.061|0.043|0.084
Observed|Brain cancer|2015–2019|Males|4|75–79|0.042|0.026|0.062
Observed|Brain cancer|2015–2019|Males|4|80–84|0.04|0.019|0.071
Observed|Brain cancer|2015–2019|Males|4|85+|||
Observed|Brain cancer|2015–2019|Males|4|All ages combined|0.23|0.219|0.242
Observed|Brain cancer|2015–2019|Males|5|00–04|0.585|0.484|0.672
Observed|Brain cancer|2015–2019|Males|5|05–09|0.465|0.363|0.561
Observed|Brain cancer|2015–2019|Males|5|10–14|0.753|0.628|0.841
Observed|Brain cancer|2015–2019|Males|5|15–19|0.726|0.594|0.821
Observed|Brain cancer|2015–2019|Males|5|20–24|0.769|0.659|0.848
Observed|Brain cancer|2015–2019|Males|5|25–29|0.751|0.671|0.814
Observed|Brain cancer|2015–2019|Males|5|30–34|0.651|0.573|0.718
Observed|Brain cancer|2015–2019|Males|5|35–39|0.554|0.48|0.621
Observed|Brain cancer|2015–2019|Males|5|40–44|0.437|0.372|0.499
Observed|Brain cancer|2015–2019|Males|5|45–49|0.271|0.222|0.323
Observed|Brain cancer|2015–2019|Males|5|50–54|0.232|0.19|0.276
Observed|Brain cancer|2015–2019|Males|5|55–59|0.131|0.103|0.162
Observed|Brain cancer|2015–2019|Males|5|60–64|0.115|0.09|0.143
Observed|Brain cancer|2015–2019|Males|5|65–69|0.085|0.064|0.11
Observed|Brain cancer|2015–2019|Males|5|70–74|0.05|0.033|0.072
Observed|Brain cancer|2015–2019|Males|5|75–79|0.027|0.015|0.046
Observed|Brain cancer|2015–2019|Males|5|80–84|||
Observed|Brain cancer|2015–2019|Males|5|85+|||
Observed|Brain cancer|2015–2019|Males|5|All ages combined|0.211|0.2|0.222
Relative|Brain cancer|2015–2019|Males|1|00–04|0.756|0.661|0.828
Relative|Brain cancer|2015–2019|Males|1|05–09|0.758|0.659|0.832
Relative|Brain cancer|2015–2019|Males|1|10–14|0.902|0.805|0.952
Relative|Brain cancer|2015–2019|Males|1|15–19|0.914|0.818|0.96
Relative|Brain cancer|2015–2019|Males|1|20–24|0.977|0.91|0.995
Relative|Brain cancer|2015–2019|Males|1|25–29|0.944|0.89|0.972
Relative|Brain cancer|2015–2019|Males|1|30–34|0.928|0.879|0.958
Relative|Brain cancer|2015–2019|Males|1|35–39|0.917|0.867|0.948
Relative|Brain cancer|2015–2019|Males|1|40–44|0.829|0.773|0.872
Relative|Brain cancer|2015–2019|Males|1|45–49|0.748|0.694|0.794
Relative|Brain cancer|2015–2019|Males|1|50–54|0.68|0.631|0.724
Relative|Brain cancer|2015–2019|Males|1|55–59|0.595|0.553|0.635
Relative|Brain cancer|2015–2019|Males|1|60–64|0.558|0.518|0.595
Relative|Brain cancer|2015–2019|Males|1|65–69|0.462|0.425|0.499
Relative|Brain cancer|2015–2019|Males|1|70–74|0.367|0.331|0.404
Relative|Brain cancer|2015–2019|Males|1|75–79|0.255|0.22|0.292
Relative|Brain cancer|2015–2019|Males|1|80–84|0.164|0.128|0.203
Relative|Brain cancer|2015–2019|Males|1|85+|0.05|0.032|0.074
Relative|Brain cancer|2015–2019|Males|1|All ages combined|0.541|0.527|0.554
Relative|Brain cancer|2015–2019|Males|2|00–04|0.659|0.558|0.742
Relative|Brain cancer|2015–2019|Males|2|05–09|0.578|0.473|0.67
Relative|Brain cancer|2015–2019|Males|2|10–14|0.789|0.669|0.87
Relative|Brain cancer|2015–2019|Males|2|15–19|0.868|0.761|0.929
Relative|Brain cancer|2015–2019|Males|2|20–24|0.941|0.863|0.976
Relative|Brain cancer|2015–2019|Males|2|25–29|0.89|0.826|0.932
Relative|Brain cancer|2015–2019|Males|2|30–34|0.824|0.759|0.874
Relative|Brain cancer|2015–2019|Males|2|35–39|0.752|0.683|0.809
Relative|Brain cancer|2015–2019|Males|2|40–44|0.625|0.56|0.684
Relative|Brain cancer|2015–2019|Males|2|45–49|0.427|0.369|0.484
Relative|Brain cancer|2015–2019|Males|2|50–54|0.418|0.368|0.467
Relative|Brain cancer|2015–2019|Males|2|55–59|0.306|0.267|0.346
Relative|Brain cancer|2015–2019|Males|2|60–64|0.261|0.227|0.296
Relative|Brain cancer|2015–2019|Males|2|65–69|0.196|0.166|0.227
Relative|Brain cancer|2015–2019|Males|2|70–74|0.133|0.107|0.161
Relative|Brain cancer|2015–2019|Males|2|75–79|0.093|0.069|0.121
Relative|Brain cancer|2015–2019|Males|2|80–84|0.064|0.04|0.095
Relative|Brain cancer|2015–2019|Males|2|85+|0.013|0.004|0.031
Relative|Brain cancer|2015–2019|Males|2|All ages combined|0.334|0.321|0.347
Relative|Brain cancer|2015–2019|Males|3|00–04|0.65|0.549|0.733
Relative|Brain cancer|2015–2019|Males|3|05–09|0.506|0.402|0.601
Relative|Brain cancer|2015–2019|Males|3|10–14|0.753|0.628|0.842
Relative|Brain cancer|2015–2019|Males|3|15–19|0.821|0.705|0.895
Relative|Brain cancer|2015–2019|Males|3|20–24|0.863|0.765|0.923
Relative|Brain cancer|2015–2019|Males|3|25–29|0.826|0.752|0.879
Relative|Brain cancer|2015–2019|Males|3|30–34|0.766|0.696|0.823
Relative|Brain cancer|2015–2019|Males|3|35–39|0.657|0.584|0.721
Relative|Brain cancer|2015–2019|Males|3|40–44|0.521|0.455|0.582
Relative|Brain cancer|2015–2019|Males|3|45–49|0.341|0.286|0.396
Relative|Brain cancer|2015–2019|Males|3|50–54|0.306|0.26|0.353
Relative|Brain cancer|2015–2019|Males|3|55–59|0.212|0.177|0.248
Relative|Brain cancer|2015–2019|Males|3|60–64|0.185|0.155|0.218
Relative|Brain cancer|2015–2019|Males|3|65–69|0.132|0.106|0.16
Relative|Brain cancer|2015–2019|Males|3|70–74|0.083|0.062|0.108
Relative|Brain cancer|2015–2019|Males|3|75–79|0.06|0.041|0.085
Relative|Brain cancer|2015–2019|Males|3|80–84|0.069|0.043|0.103
Relative|Brain cancer|2015–2019|Males|3|85+|||
Relative|Brain cancer|2015–2019|Males|3|All ages combined|0.271|0.259|0.284
Relative|Brain cancer|2015–2019|Males|4|00–04|0.613|0.513|0.699
Relative|Brain cancer|2015–2019|Males|4|05–09|0.475|0.372|0.57
Relative|Brain cancer|2015–2019|Males|4|10–14|0.754|0.628|0.842
Relative|Brain cancer|2015–2019|Males|4|15–19|0.766|0.64|0.853
Relative|Brain cancer|2015–2019|Males|4|20–24|0.796|0.687|0.871
Relative|Brain cancer|2015–2019|Males|4|25–29|0.775|0.696|0.836
Relative|Brain cancer|2015–2019|Males|4|30–34|0.698|0.622|0.761
Relative|Brain cancer|2015–2019|Males|4|35–39|0.592|0.518|0.659
Relative|Brain cancer|2015–2019|Males|4|40–44|0.464|0.398|0.526
Relative|Brain cancer|2015–2019|Males|4|45–49|0.3|0.248|0.353
Relative|Brain cancer|2015–2019|Males|4|50–54|0.276|0.231|0.322
Relative|Brain cancer|2015–2019|Males|4|55–59|0.158|0.128|0.191
Relative|Brain cancer|2015–2019|Males|4|60–64|0.141|0.113|0.171
Relative|Brain cancer|2015–2019|Males|4|65–69|0.107|0.083|0.134
Relative|Brain cancer|2015–2019|Males|4|70–74|0.067|0.047|0.091
Relative|Brain cancer|2015–2019|Males|4|75–79|0.049|0.031|0.073
Relative|Brain cancer|2015–2019|Males|4|80–84|0.053|0.026|0.095
Relative|Brain cancer|2015–2019|Males|4|85+|||
Relative|Brain cancer|2015–2019|Males|4|All ages combined|0.239|0.227|0.251
Relative|Brain cancer|2015–2019|Males|5|00–04|0.585|0.485|0.673
Relative|Brain cancer|2015–2019|Males|5|05–09|0.465|0.363|0.561
Relative|Brain cancer|2015–2019|Males|5|10–14|0.754|0.628|0.842
Relative|Brain cancer|2015–2019|Males|5|15–19|0.727|0.595|0.823
Relative|Brain cancer|2015–2019|Males|5|20–24|0.772|0.661|0.851
Relative|Brain cancer|2015–2019|Males|5|25–29|0.754|0.673|0.818
Relative|Brain cancer|2015–2019|Males|5|30–34|0.654|0.576|0.721
Relative|Brain cancer|2015–2019|Males|5|35–39|0.558|0.483|0.625
Relative|Brain cancer|2015–2019|Males|5|40–44|0.441|0.376|0.504
Relative|Brain cancer|2015–2019|Males|5|45–49|0.275|0.226|0.327
Relative|Brain cancer|2015–2019|Males|5|50–54|0.237|0.194|0.282
Relative|Brain cancer|2015–2019|Males|5|55–59|0.135|0.107|0.167
Relative|Brain cancer|2015–2019|Males|5|60–64|0.12|0.094|0.15
Relative|Brain cancer|2015–2019|Males|5|65–69|0.091|0.068|0.118
Relative|Brain cancer|2015–2019|Males|5|70–74|0.056|0.037|0.081
Relative|Brain cancer|2015–2019|Males|5|75–79|0.034|0.018|0.057
Relative|Brain cancer|2015–2019|Males|5|80–84|||
Relative|Brain cancer|2015–2019|Males|5|85+|||
Relative|Brain cancer|2015–2019|Males|5|All ages combined|0.22|0.209|0.232
Observed|Brain cancer|2015–2019|Females|1|00–04|0.765|0.664|0.84
Observed|Brain cancer|2015–2019|Females|1|05–09|0.801|0.688|0.877
Observed|Brain cancer|2015–2019|Females|1|10–14|0.921|0.802|0.969
Observed|Brain cancer|2015–2019|Females|1|15–19|0.979|0.863|0.997
Observed|Brain cancer|2015–2019|Females|1|20–24|0.959|0.877|0.986
Observed|Brain cancer|2015–2019|Females|1|25–29|0.954|0.881|0.982
Observed|Brain cancer|2015–2019|Females|1|30–34|0.934|0.872|0.966
Observed|Brain cancer|2015–2019|Females|1|35–39|0.884|0.812|0.93
Observed|Brain cancer|2015–2019|Females|1|40–44|0.839|0.77|0.889
Observed|Brain cancer|2015–2019|Females|1|45–49|0.819|0.756|0.867
Observed|Brain cancer|2015–2019|Females|1|50–54|0.738|0.682|0.786
Observed|Brain cancer|2015–2019|Females|1|55–59|0.638|0.585|0.687
Observed|Brain cancer|2015–2019|Females|1|60–64|0.583|0.532|0.631
Observed|Brain cancer|2015–2019|Females|1|65–69|0.515|0.467|0.562
Observed|Brain cancer|2015–2019|Females|1|70–74|0.384|0.337|0.431
Observed|Brain cancer|2015–2019|Females|1|75–79|0.253|0.209|0.299
Observed|Brain cancer|2015–2019|Females|1|80–84|0.124|0.092|0.161
Observed|Brain cancer|2015–2019|Females|1|85+|0.047|0.03|0.071
Observed|Brain cancer|2015–2019|Females|1|All ages combined|0.552|0.535|0.568
Observed|Brain cancer|2015–2019|Females|2|00–04|0.64|0.531|0.73
Observed|Brain cancer|2015–2019|Females|2|05–09|0.684|0.561|0.779
Observed|Brain cancer|2015–2019|Females|2|10–14|0.822|0.686|0.903
Observed|Brain cancer|2015–2019|Females|2|15–19|0.979|0.863|0.997
Observed|Brain cancer|2015–2019|Females|2|20–24|0.865|0.764|0.925
Observed|Brain cancer|2015–2019|Females|2|25–29|0.918|0.836|0.96
Observed|Brain cancer|2015–2019|Females|2|30–34|0.783|0.698|0.847
Observed|Brain cancer|2015–2019|Females|2|35–39|0.733|0.642|0.804
Observed|Brain cancer|2015–2019|Females|2|40–44|0.672|0.59|0.741
Observed|Brain cancer|2015–2019|Females|2|45–49|0.635|0.56|0.7
Observed|Brain cancer|2015–2019|Females|2|50–54|0.496|0.436|0.554
Observed|Brain cancer|2015–2019|Females|2|55–59|0.366|0.313|0.418
Observed|Brain cancer|2015–2019|Females|2|60–64|0.324|0.276|0.373
Observed|Brain cancer|2015–2019|Females|2|65–69|0.246|0.205|0.29
Observed|Brain cancer|2015–2019|Females|2|70–74|0.172|0.137|0.211
Observed|Brain cancer|2015–2019|Females|2|75–79|0.094|0.066|0.128
Observed|Brain cancer|2015–2019|Females|2|80–84|0.048|0.028|0.077
Observed|Brain cancer|2015–2019|Females|2|85+|0.039|0.022|0.062
Observed|Brain cancer|2015–2019|Females|2|All ages combined|0.372|0.356|0.388
Observed|Brain cancer|2015–2019|Females|3|00–04|0.574|0.465|0.668
Observed|Brain cancer|2015–2019|Females|3|05–09|0.653|0.528|0.752
Observed|Brain cancer|2015–2019|Females|3|10–14|0.738|0.591|0.839
Observed|Brain cancer|2015–2019|Females|3|15–19|0.93|0.798|0.977
Observed|Brain cancer|2015–2019|Females|3|20–24|0.819|0.708|0.891
Observed|Brain cancer|2015–2019|Females|3|25–29|0.872|0.78|0.927
Observed|Brain cancer|2015–2019|Females|3|30–34|0.747|0.658|0.816
Observed|Brain cancer|2015–2019|Females|3|35–39|0.688|0.594|0.764
Observed|Brain cancer|2015–2019|Females|3|40–44|0.587|0.504|0.661
Observed|Brain cancer|2015–2019|Females|3|45–49|0.484|0.408|0.556
Observed|Brain cancer|2015–2019|Females|3|50–54|0.364|0.306|0.421
Observed|Brain cancer|2015–2019|Females|3|55–59|0.256|0.21|0.305
Observed|Brain cancer|2015–2019|Females|3|60–64|0.205|0.164|0.249
Observed|Brain cancer|2015–2019|Females|3|65–69|0.184|0.147|0.225
Observed|Brain cancer|2015–2019|Females|3|70–74|0.086|0.06|0.117
Observed|Brain cancer|2015–2019|Females|3|75–79|0.054|0.032|0.083
Observed|Brain cancer|2015–2019|Females|3|80–84|0.032|0.016|0.058
Observed|Brain cancer|2015–2019|Females|3|85+|0.033|0.017|0.057
Observed|Brain cancer|2015–2019|Females|3|All ages combined|0.299|0.284|0.314
Observed|Brain cancer|2015–2019|Females|4|00–04|0.548|0.438|0.645
Observed|Brain cancer|2015–2019|Females|4|05–09|0.638|0.513|0.739
Observed|Brain cancer|2015–2019|Females|4|10–14|0.738|0.591|0.839
Observed|Brain cancer|2015–2019|Females|4|15–19|0.902|0.757|0.962
Observed|Brain cancer|2015–2019|Females|4|20–24|0.785|0.667|0.865
Observed|Brain cancer|2015–2019|Females|4|25–29|0.819|0.722|0.885
Observed|Brain cancer|2015–2019|Females|4|30–34|0.712|0.62|0.785
Observed|Brain cancer|2015–2019|Females|4|35–39|0.635|0.539|0.715
Observed|Brain cancer|2015–2019|Females|4|40–44|0.512|0.43|0.589
Observed|Brain cancer|2015–2019|Females|4|45–49|0.417|0.344|0.489
Observed|Brain cancer|2015–2019|Females|4|50–54|0.308|0.253|0.365
Observed|Brain cancer|2015–2019|Females|4|55–59|0.204|0.162|0.249
Observed|Brain cancer|2015–2019|Females|4|60–64|0.164|0.127|0.205
Observed|Brain cancer|2015–2019|Females|4|65–69|0.141|0.106|0.18
Observed|Brain cancer|2015–2019|Females|4|70–74|0.059|0.038|0.086
Observed|Brain cancer|2015–2019|Females|4|75–79|0.036|0.018|0.063
Observed|Brain cancer|2015–2019|Females|4|80–84|0.02|0.008|0.043
Observed|Brain cancer|2015–2019|Females|4|85+|||
Observed|Brain cancer|2015–2019|Females|4|All ages combined|0.263|0.248|0.278
Observed|Brain cancer|2015–2019|Females|5|00–04|0.548|0.438|0.645
Observed|Brain cancer|2015–2019|Females|5|05–09|0.621|0.495|0.724
Observed|Brain cancer|2015–2019|Females|5|10–14|0.738|0.591|0.839
Observed|Brain cancer|2015–2019|Females|5|15–19|0.902|0.757|0.962
Observed|Brain cancer|2015–2019|Females|5|20–24|0.712|0.583|0.807
Observed|Brain cancer|2015–2019|Females|5|25–29|0.774|0.672|0.848
Observed|Brain cancer|2015–2019|Females|5|30–34|0.65|0.556|0.729
Observed|Brain cancer|2015–2019|Females|5|35–39|0.609|0.514|0.692
Observed|Brain cancer|2015–2019|Females|5|40–44|0.499|0.417|0.576
Observed|Brain cancer|2015–2019|Females|5|45–49|0.401|0.329|0.472
Observed|Brain cancer|2015–2019|Females|5|50–54|0.282|0.228|0.338
Observed|Brain cancer|2015–2019|Females|5|55–59|0.176|0.136|0.219
Observed|Brain cancer|2015–2019|Females|5|60–64|0.148|0.112|0.188
Observed|Brain cancer|2015–2019|Females|5|65–69|0.124|0.091|0.163
Observed|Brain cancer|2015–2019|Females|5|70–74|0.056|0.035|0.083
Observed|Brain cancer|2015–2019|Females|5|75–79|0.03|0.014|0.057
Observed|Brain cancer|2015–2019|Females|5|80–84|||
Observed|Brain cancer|2015–2019|Females|5|85+|||
Observed|Brain cancer|2015–2019|Females|5|All ages combined|0.245|0.231|0.26
Relative|Brain cancer|2015–2019|Females|1|00–04|0.766|0.664|0.841
Relative|Brain cancer|2015–2019|Females|1|05–09|0.801|0.688|0.877
Relative|Brain cancer|2015–2019|Females|1|10–14|0.921|0.802|0.97
Relative|Brain cancer|2015–2019|Females|1|15–19|0.98|0.863|0.997
Relative|Brain cancer|2015–2019|Females|1|20–24|0.959|0.877|0.987
Relative|Brain cancer|2015–2019|Females|1|25–29|0.954|0.881|0.983
Relative|Brain cancer|2015–2019|Females|1|30–34|0.934|0.872|0.967
Relative|Brain cancer|2015–2019|Females|1|35–39|0.885|0.813|0.93
Relative|Brain cancer|2015–2019|Females|1|40–44|0.84|0.77|0.89
Relative|Brain cancer|2015–2019|Females|1|45–49|0.82|0.757|0.868
Relative|Brain cancer|2015–2019|Females|1|50–54|0.74|0.683|0.787
Relative|Brain cancer|2015–2019|Females|1|55–59|0.641|0.586|0.69
Relative|Brain cancer|2015–2019|Females|1|60–64|0.586|0.534|0.634
Relative|Brain cancer|2015–2019|Females|1|65–69|0.519|0.47|0.566
Relative|Brain cancer|2015–2019|Females|1|70–74|0.389|0.341|0.436
Relative|Brain cancer|2015–2019|Females|1|75–79|0.259|0.214|0.306
Relative|Brain cancer|2015–2019|Females|1|80–84|0.129|0.096|0.168
Relative|Brain cancer|2015–2019|Females|1|85+|0.053|0.033|0.079
Relative|Brain cancer|2015–2019|Females|1|All ages combined|0.56|0.543|0.576
Relative|Brain cancer|2015–2019|Females|2|00–04|0.641|0.532|0.731
Relative|Brain cancer|2015–2019|Females|2|05–09|0.684|0.561|0.779
Relative|Brain cancer|2015–2019|Females|2|10–14|0.822|0.686|0.903
Relative|Brain cancer|2015–2019|Females|2|15–19|0.98|0.863|0.997
Relative|Brain cancer|2015–2019|Females|2|20–24|0.865|0.764|0.925
Relative|Brain cancer|2015–2019|Females|2|25–29|0.919|0.837|0.961
Relative|Brain cancer|2015–2019|Females|2|30–34|0.784|0.699|0.848
Relative|Brain cancer|2015–2019|Females|2|35–39|0.734|0.643|0.805
Relative|Brain cancer|2015–2019|Females|2|40–44|0.673|0.591|0.742
Relative|Brain cancer|2015–2019|Females|2|45–49|0.636|0.562|0.702
Relative|Brain cancer|2015–2019|Females|2|50–54|0.498|0.437|0.556
Relative|Brain cancer|2015–2019|Females|2|55–59|0.368|0.316|0.421
Relative|Brain cancer|2015–2019|Females|2|60–64|0.327|0.279|0.376
Relative|Brain cancer|2015–2019|Females|2|65–69|0.25|0.208|0.294
Relative|Brain cancer|2015–2019|Females|2|70–74|0.176|0.14|0.216
Relative|Brain cancer|2015–2019|Females|2|75–79|0.098|0.069|0.134
Relative|Brain cancer|2015–2019|Females|2|80–84|0.053|0.031|0.083
Relative|Brain cancer|2015–2019|Females|2|85+|0.05|0.029|0.08
Relative|Brain cancer|2015–2019|Females|2|All ages combined|0.38|0.363|0.396
Relative|Brain cancer|2015–2019|Females|3|00–04|0.574|0.465|0.669
Relative|Brain cancer|2015–2019|Females|3|05–09|0.653|0.528|0.752
Relative|Brain cancer|2015–2019|Females|3|10–14|0.738|0.591|0.839
Relative|Brain cancer|2015–2019|Females|3|15–19|0.931|0.799|0.978
Relative|Brain cancer|2015–2019|Females|3|20–24|0.82|0.709|0.891
Relative|Brain cancer|2015–2019|Females|3|25–29|0.873|0.781|0.928
Relative|Brain cancer|2015–2019|Females|3|30–34|0.748|0.659|0.817
Relative|Brain cancer|2015–2019|Females|3|35–39|0.689|0.595|0.765
Relative|Brain cancer|2015–2019|Females|3|40–44|0.589|0.505|0.663
Relative|Brain cancer|2015–2019|Females|3|45–49|0.486|0.41|0.558
Relative|Brain cancer|2015–2019|Females|3|50–54|0.366|0.308|0.424
Relative|Brain cancer|2015–2019|Females|3|55–59|0.259|0.212|0.308
Relative|Brain cancer|2015–2019|Females|3|60–64|0.208|0.167|0.252
Relative|Brain cancer|2015–2019|Females|3|65–69|0.189|0.15|0.231
Relative|Brain cancer|2015–2019|Females|3|70–74|0.089|0.063|0.122
Relative|Brain cancer|2015–2019|Females|3|75–79|0.058|0.035|0.089
Relative|Brain cancer|2015–2019|Females|3|80–84|0.037|0.019|0.066
Relative|Brain cancer|2015–2019|Females|3|85+|0.05|0.026|0.087
Relative|Brain cancer|2015–2019|Females|3|All ages combined|0.306|0.29|0.322
Relative|Brain cancer|2015–2019|Females|4|00–04|0.548|0.439|0.645
Relative|Brain cancer|2015–2019|Females|4|05–09|0.638|0.513|0.739
Relative|Brain cancer|2015–2019|Females|4|10–14|0.738|0.591|0.839
Relative|Brain cancer|2015–2019|Females|4|15–19|0.902|0.757|0.963
Relative|Brain cancer|2015–2019|Females|4|20–24|0.785|0.668|0.866
Relative|Brain cancer|2015–2019|Females|4|25–29|0.82|0.723|0.886
Relative|Brain cancer|2015–2019|Females|4|30–34|0.713|0.622|0.786
Relative|Brain cancer|2015–2019|Females|4|35–39|0.636|0.541|0.717
Relative|Brain cancer|2015–2019|Females|4|40–44|0.514|0.432|0.591
Relative|Brain cancer|2015–2019|Females|4|45–49|0.42|0.346|0.492
Relative|Brain cancer|2015–2019|Females|4|50–54|0.311|0.255|0.369
Relative|Brain cancer|2015–2019|Females|4|55–59|0.207|0.164|0.253
Relative|Brain cancer|2015–2019|Females|4|60–64|0.168|0.13|0.21
Relative|Brain cancer|2015–2019|Females|4|65–69|0.146|0.11|0.186
Relative|Brain cancer|2015–2019|Females|4|70–74|0.062|0.04|0.092
Relative|Brain cancer|2015–2019|Females|4|75–79|0.04|0.02|0.07
Relative|Brain cancer|2015–2019|Females|4|80–84|0.024|0.01|0.052
Relative|Brain cancer|2015–2019|Females|4|85+|||
Relative|Brain cancer|2015–2019|Females|4|All ages combined|0.27|0.255|0.286
Relative|Brain cancer|2015–2019|Females|5|00–04|0.549|0.439|0.645
Relative|Brain cancer|2015–2019|Females|5|05–09|0.621|0.495|0.725
Relative|Brain cancer|2015–2019|Females|5|10–14|0.738|0.592|0.839
Relative|Brain cancer|2015–2019|Females|5|15–19|0.903|0.757|0.963
Relative|Brain cancer|2015–2019|Females|5|20–24|0.713|0.584|0.808
Relative|Brain cancer|2015–2019|Females|5|25–29|0.776|0.674|0.849
Relative|Brain cancer|2015–2019|Females|5|30–34|0.652|0.558|0.731
Relative|Brain cancer|2015–2019|Females|5|35–39|0.612|0.516|0.694
Relative|Brain cancer|2015–2019|Females|5|40–44|0.502|0.419|0.579
Relative|Brain cancer|2015–2019|Females|5|45–49|0.405|0.332|0.476
Relative|Brain cancer|2015–2019|Females|5|50–54|0.285|0.231|0.342
Relative|Brain cancer|2015–2019|Females|5|55–59|0.179|0.139|0.223
Relative|Brain cancer|2015–2019|Females|5|60–64|0.152|0.116|0.193
Relative|Brain cancer|2015–2019|Females|5|65–69|0.13|0.095|0.17
Relative|Brain cancer|2015–2019|Females|5|70–74|0.06|0.038|0.089
Relative|Brain cancer|2015–2019|Females|5|75–79|0.035|0.016|0.066
Relative|Brain cancer|2015–2019|Females|5|80–84|||
Relative|Brain cancer|2015–2019|Females|5|85+|||
Relative|Brain cancer|2015–2019|Females|5|All ages combined|0.253|0.238|0.268
Observed|Brain cancer|2015–2019|Persons|1|00–04|0.76|0.693|0.814
Observed|Brain cancer|2015–2019|Persons|1|05–09|0.776|0.705|0.832
Observed|Brain cancer|2015–2019|Persons|1|10–14|0.91|0.843|0.949
Observed|Brain cancer|2015–2019|Persons|1|15–19|0.941|0.879|0.971
Observed|Brain cancer|2015–2019|Persons|1|20–24|0.968|0.926|0.987
Observed|Brain cancer|2015–2019|Persons|1|25–29|0.947|0.909|0.97
Observed|Brain cancer|2015–2019|Persons|1|30–34|0.93|0.895|0.954
Observed|Brain cancer|2015–2019|Persons|1|35–39|0.903|0.865|0.931
Observed|Brain cancer|2015–2019|Persons|1|40–44|0.832|0.79|0.866
Observed|Brain cancer|2015–2019|Persons|1|45–49|0.775|0.735|0.81
Observed|Brain cancer|2015–2019|Persons|1|50–54|0.703|0.667|0.736
Observed|Brain cancer|2015–2019|Persons|1|55–59|0.61|0.577|0.641
Observed|Brain cancer|2015–2019|Persons|1|60–64|0.564|0.533|0.594
Observed|Brain cancer|2015–2019|Persons|1|65–69|0.479|0.449|0.508
Observed|Brain cancer|2015–2019|Persons|1|70–74|0.369|0.341|0.398
Observed|Brain cancer|2015–2019|Persons|1|75–79|0.249|0.222|0.277
Observed|Brain cancer|2015–2019|Persons|1|80–84|0.14|0.117|0.166
Observed|Brain cancer|2015–2019|Persons|1|85+|0.045|0.033|0.06
Observed|Brain cancer|2015–2019|Persons|1|All ages combined|0.539|0.529|0.55
Observed|Brain cancer|2015–2019|Persons|2|00–04|0.65|0.578|0.713
Observed|Brain cancer|2015–2019|Persons|2|05–09|0.623|0.544|0.692
Observed|Brain cancer|2015–2019|Persons|2|10–14|0.803|0.719|0.865
Observed|Brain cancer|2015–2019|Persons|2|15–19|0.912|0.843|0.952
Observed|Brain cancer|2015–2019|Persons|2|20–24|0.905|0.847|0.941
Observed|Brain cancer|2015–2019|Persons|2|25–29|0.9|0.853|0.932
Observed|Brain cancer|2015–2019|Persons|2|30–34|0.807|0.757|0.847
Observed|Brain cancer|2015–2019|Persons|2|35–39|0.744|0.69|0.789
Observed|Brain cancer|2015–2019|Persons|2|40–44|0.642|0.592|0.687
Observed|Brain cancer|2015–2019|Persons|2|45–49|0.507|0.461|0.551
Observed|Brain cancer|2015–2019|Persons|2|50–54|0.449|0.41|0.486
Observed|Brain cancer|2015–2019|Persons|2|55–59|0.327|0.296|0.358
Observed|Brain cancer|2015–2019|Persons|2|60–64|0.281|0.254|0.31
Observed|Brain cancer|2015–2019|Persons|2|65–69|0.212|0.188|0.237
Observed|Brain cancer|2015–2019|Persons|2|70–74|0.145|0.124|0.167
Observed|Brain cancer|2015–2019|Persons|2|75–79|0.09|0.072|0.11
Observed|Brain cancer|2015–2019|Persons|2|80–84|0.053|0.037|0.072
Observed|Brain cancer|2015–2019|Persons|2|85+|0.022|0.013|0.034
Observed|Brain cancer|2015–2019|Persons|2|All ages combined|0.344|0.334|0.354
Observed|Brain cancer|2015–2019|Persons|3|00–04|0.615|0.542|0.679
Observed|Brain cancer|2015–2019|Persons|3|05–09|0.566|0.487|0.638
Observed|Brain cancer|2015–2019|Persons|3|10–14|0.745|0.654|0.816
Observed|Brain cancer|2015–2019|Persons|3|15–19|0.864|0.784|0.916
Observed|Brain cancer|2015–2019|Persons|3|20–24|0.841|0.772|0.891
Observed|Brain cancer|2015–2019|Persons|3|25–29|0.842|0.788|0.883
Observed|Brain cancer|2015–2019|Persons|3|30–34|0.757|0.703|0.802
Observed|Brain cancer|2015–2019|Persons|3|35–39|0.667|0.61|0.717
Observed|Brain cancer|2015–2019|Persons|3|40–44|0.545|0.494|0.593
Observed|Brain cancer|2015–2019|Persons|3|45–49|0.396|0.351|0.44
Observed|Brain cancer|2015–2019|Persons|3|50–54|0.328|0.292|0.364
Observed|Brain cancer|2015–2019|Persons|3|55–59|0.226|0.199|0.255
Observed|Brain cancer|2015–2019|Persons|3|60–64|0.189|0.165|0.214
Observed|Brain cancer|2015–2019|Persons|3|65–69|0.148|0.127|0.171
Observed|Brain cancer|2015–2019|Persons|3|70–74|0.081|0.065|0.1
Observed|Brain cancer|2015–2019|Persons|3|75–79|0.054|0.04|0.071
Observed|Brain cancer|2015–2019|Persons|3|80–84|0.043|0.029|0.062
Observed|Brain cancer|2015–2019|Persons|3|85+|0.019|0.011|0.032
Observed|Brain cancer|2015–2019|Persons|3|All ages combined|0.277|0.268|0.286
Observed|Brain cancer|2015–2019|Persons|4|00–04|0.583|0.51|0.649
Observed|Brain cancer|2015–2019|Persons|4|05–09|0.542|0.463|0.615
Observed|Brain cancer|2015–2019|Persons|4|10–14|0.745|0.654|0.816
Observed|Brain cancer|2015–2019|Persons|4|15–19|0.819|0.73|0.881
Observed|Brain cancer|2015–2019|Persons|4|20–24|0.788|0.712|0.846
Observed|Brain cancer|2015–2019|Persons|4|25–29|0.79|0.732|0.838
Observed|Brain cancer|2015–2019|Persons|4|30–34|0.702|0.645|0.751
Observed|Brain cancer|2015–2019|Persons|4|35–39|0.605|0.548|0.658
Observed|Brain cancer|2015–2019|Persons|4|40–44|0.48|0.43|0.529
Observed|Brain cancer|2015–2019|Persons|4|45–49|0.345|0.302|0.388
Observed|Brain cancer|2015–2019|Persons|4|50–54|0.287|0.252|0.323
Observed|Brain cancer|2015–2019|Persons|4|55–59|0.173|0.149|0.199
Observed|Brain cancer|2015–2019|Persons|4|60–64|0.146|0.124|0.17
Observed|Brain cancer|2015–2019|Persons|4|65–69|0.116|0.096|0.137
Observed|Brain cancer|2015–2019|Persons|4|70–74|0.06|0.045|0.077
Observed|Brain cancer|2015–2019|Persons|4|75–79|0.04|0.028|0.055
Observed|Brain cancer|2015–2019|Persons|4|80–84|0.029|0.016|0.047
Observed|Brain cancer|2015–2019|Persons|4|85+|0.017|0.009|0.03
Observed|Brain cancer|2015–2019|Persons|4|All ages combined|0.243|0.234|0.252
Observed|Brain cancer|2015–2019|Persons|5|00–04|0.566|0.493|0.633
Observed|Brain cancer|2015–2019|Persons|5|05–09|0.53|0.45|0.603
Observed|Brain cancer|2015–2019|Persons|5|10–14|0.745|0.654|0.816
Observed|Brain cancer|2015–2019|Persons|5|15–19|0.794|0.7|0.862
Observed|Brain cancer|2015–2019|Persons|5|20–24|0.744|0.664|0.808
Observed|Brain cancer|2015–2019|Persons|5|25–29|0.76|0.699|0.81
Observed|Brain cancer|2015–2019|Persons|5|30–34|0.65|0.591|0.702
Observed|Brain cancer|2015–2019|Persons|5|35–39|0.574|0.516|0.627
Observed|Brain cancer|2015–2019|Persons|5|40–44|0.462|0.411|0.511
Observed|Brain cancer|2015–2019|Persons|5|45–49|0.322|0.28|0.364
Observed|Brain cancer|2015–2019|Persons|5|50–54|0.253|0.219|0.288
Observed|Brain cancer|2015–2019|Persons|5|55–59|0.148|0.125|0.173
Observed|Brain cancer|2015–2019|Persons|5|60–64|0.127|0.106|0.15
Observed|Brain cancer|2015–2019|Persons|5|65–69|0.099|0.081|0.12
Observed|Brain cancer|2015–2019|Persons|5|70–74|0.052|0.039|0.069
Observed|Brain cancer|2015–2019|Persons|5|75–79|0.028|0.018|0.043
Observed|Brain cancer|2015–2019|Persons|5|80–84|||
Observed|Brain cancer|2015–2019|Persons|5|85+|||
Observed|Brain cancer|2015–2019|Persons|5|All ages combined|0.225|0.216|0.234
Relative|Brain cancer|2015–2019|Persons|1|00–04|0.761|0.694|0.815
Relative|Brain cancer|2015–2019|Persons|1|05–09|0.776|0.705|0.832
Relative|Brain cancer|2015–2019|Persons|1|10–14|0.91|0.843|0.949
Relative|Brain cancer|2015–2019|Persons|1|15–19|0.941|0.88|0.972
Relative|Brain cancer|2015–2019|Persons|1|20–24|0.969|0.926|0.987
Relative|Brain cancer|2015–2019|Persons|1|25–29|0.948|0.909|0.97
Relative|Brain cancer|2015–2019|Persons|1|30–34|0.931|0.895|0.954
Relative|Brain cancer|2015–2019|Persons|1|35–39|0.904|0.865|0.932
Relative|Brain cancer|2015–2019|Persons|1|40–44|0.833|0.791|0.867
Relative|Brain cancer|2015–2019|Persons|1|45–49|0.777|0.736|0.811
Relative|Brain cancer|2015–2019|Persons|1|50–54|0.705|0.669|0.738
Relative|Brain cancer|2015–2019|Persons|1|55–59|0.612|0.579|0.644
Relative|Brain cancer|2015–2019|Persons|1|60–64|0.568|0.537|0.598
Relative|Brain cancer|2015–2019|Persons|1|65–69|0.484|0.454|0.513
Relative|Brain cancer|2015–2019|Persons|1|70–74|0.375|0.346|0.404
Relative|Brain cancer|2015–2019|Persons|1|75–79|0.256|0.228|0.286
Relative|Brain cancer|2015–2019|Persons|1|80–84|0.148|0.123|0.175
Relative|Brain cancer|2015–2019|Persons|1|85+|0.051|0.038|0.068
Relative|Brain cancer|2015–2019|Persons|1|All ages combined|0.548|0.538|0.559
Relative|Brain cancer|2015–2019|Persons|2|00–04|0.65|0.578|0.713
Relative|Brain cancer|2015–2019|Persons|2|05–09|0.623|0.544|0.692
Relative|Brain cancer|2015–2019|Persons|2|10–14|0.804|0.719|0.865
Relative|Brain cancer|2015–2019|Persons|2|15–19|0.913|0.844|0.953
Relative|Brain cancer|2015–2019|Persons|2|20–24|0.905|0.847|0.942
Relative|Brain cancer|2015–2019|Persons|2|25–29|0.901|0.854|0.933
Relative|Brain cancer|2015–2019|Persons|2|30–34|0.808|0.758|0.849
Relative|Brain cancer|2015–2019|Persons|2|35–39|0.745|0.691|0.791
Relative|Brain cancer|2015–2019|Persons|2|40–44|0.644|0.593|0.689
Relative|Brain cancer|2015–2019|Persons|2|45–49|0.509|0.462|0.553
Relative|Brain cancer|2015–2019|Persons|2|50–54|0.451|0.413|0.489
Relative|Brain cancer|2015–2019|Persons|2|55–59|0.33|0.298|0.362
Relative|Brain cancer|2015–2019|Persons|2|60–64|0.285|0.257|0.314
Relative|Brain cancer|2015–2019|Persons|2|65–69|0.216|0.192|0.242
Relative|Brain cancer|2015–2019|Persons|2|70–74|0.15|0.128|0.173
Relative|Brain cancer|2015–2019|Persons|2|75–79|0.095|0.076|0.117
Relative|Brain cancer|2015–2019|Persons|2|80–84|0.059|0.042|0.08
Relative|Brain cancer|2015–2019|Persons|2|85+|0.028|0.016|0.045
Relative|Brain cancer|2015–2019|Persons|2|All ages combined|0.352|0.342|0.362
Relative|Brain cancer|2015–2019|Persons|3|00–04|0.615|0.543|0.68
Relative|Brain cancer|2015–2019|Persons|3|05–09|0.567|0.487|0.638
Relative|Brain cancer|2015–2019|Persons|3|10–14|0.745|0.654|0.816
Relative|Brain cancer|2015–2019|Persons|3|15–19|0.865|0.785|0.917
Relative|Brain cancer|2015–2019|Persons|3|20–24|0.842|0.773|0.892
Relative|Brain cancer|2015–2019|Persons|3|25–29|0.843|0.789|0.885
Relative|Brain cancer|2015–2019|Persons|3|30–34|0.758|0.705|0.804
Relative|Brain cancer|2015–2019|Persons|3|35–39|0.669|0.612|0.719
Relative|Brain cancer|2015–2019|Persons|3|40–44|0.547|0.496|0.595
Relative|Brain cancer|2015–2019|Persons|3|45–49|0.398|0.354|0.443
Relative|Brain cancer|2015–2019|Persons|3|50–54|0.331|0.295|0.368
Relative|Brain cancer|2015–2019|Persons|3|55–59|0.23|0.202|0.259
Relative|Brain cancer|2015–2019|Persons|3|60–64|0.193|0.168|0.219
Relative|Brain cancer|2015–2019|Persons|3|65–69|0.153|0.131|0.176
Relative|Brain cancer|2015–2019|Persons|3|70–74|0.086|0.068|0.105
Relative|Brain cancer|2015–2019|Persons|3|75–79|0.06|0.044|0.078
Relative|Brain cancer|2015–2019|Persons|3|80–84|0.051|0.034|0.073
Relative|Brain cancer|2015–2019|Persons|3|85+|0.029|0.016|0.048
Relative|Brain cancer|2015–2019|Persons|3|All ages combined|0.285|0.276|0.295
Relative|Brain cancer|2015–2019|Persons|4|00–04|0.584|0.511|0.65
Relative|Brain cancer|2015–2019|Persons|4|05–09|0.542|0.463|0.615
Relative|Brain cancer|2015–2019|Persons|4|10–14|0.746|0.654|0.816
Relative|Brain cancer|2015–2019|Persons|4|15–19|0.82|0.731|0.883
Relative|Brain cancer|2015–2019|Persons|4|20–24|0.79|0.713|0.848
Relative|Brain cancer|2015–2019|Persons|4|25–29|0.792|0.733|0.839
Relative|Brain cancer|2015–2019|Persons|4|30–34|0.704|0.647|0.753
Relative|Brain cancer|2015–2019|Persons|4|35–39|0.608|0.55|0.661
Relative|Brain cancer|2015–2019|Persons|4|40–44|0.483|0.432|0.533
Relative|Brain cancer|2015–2019|Persons|4|45–49|0.348|0.305|0.391
Relative|Brain cancer|2015–2019|Persons|4|50–54|0.291|0.256|0.327
Relative|Brain cancer|2015–2019|Persons|4|55–59|0.177|0.152|0.203
Relative|Brain cancer|2015–2019|Persons|4|60–64|0.15|0.128|0.175
Relative|Brain cancer|2015–2019|Persons|4|65–69|0.121|0.101|0.144
Relative|Brain cancer|2015–2019|Persons|4|70–74|0.064|0.049|0.083
Relative|Brain cancer|2015–2019|Persons|4|75–79|0.046|0.032|0.064
Relative|Brain cancer|2015–2019|Persons|4|80–84|0.036|0.021|0.059
Relative|Brain cancer|2015–2019|Persons|4|85+|0.03|0.015|0.052
Relative|Brain cancer|2015–2019|Persons|4|All ages combined|0.251|0.242|0.261
Relative|Brain cancer|2015–2019|Persons|5|00–04|0.567|0.493|0.633
Relative|Brain cancer|2015–2019|Persons|5|05–09|0.53|0.451|0.603
Relative|Brain cancer|2015–2019|Persons|5|10–14|0.746|0.654|0.816
Relative|Brain cancer|2015–2019|Persons|5|15–19|0.796|0.702|0.863
Relative|Brain cancer|2015–2019|Persons|5|20–24|0.746|0.666|0.81
Relative|Brain cancer|2015–2019|Persons|5|25–29|0.762|0.701|0.812
Relative|Brain cancer|2015–2019|Persons|5|30–34|0.653|0.594|0.705
Relative|Brain cancer|2015–2019|Persons|5|35–39|0.577|0.519|0.631
Relative|Brain cancer|2015–2019|Persons|5|40–44|0.465|0.414|0.514
Relative|Brain cancer|2015–2019|Persons|5|45–49|0.326|0.284|0.368
Relative|Brain cancer|2015–2019|Persons|5|50–54|0.257|0.223|0.292
Relative|Brain cancer|2015–2019|Persons|5|55–59|0.152|0.128|0.178
Relative|Brain cancer|2015–2019|Persons|5|60–64|0.132|0.11|0.156
Relative|Brain cancer|2015–2019|Persons|5|65–69|0.106|0.086|0.128
Relative|Brain cancer|2015–2019|Persons|5|70–74|0.058|0.043|0.076
Relative|Brain cancer|2015–2019|Persons|5|75–79|0.034|0.021|0.052
Relative|Brain cancer|2015–2019|Persons|5|80–84|||
Relative|Brain cancer|2015–2019|Persons|5|85+|||
Relative|Brain cancer|2015–2019|Persons|5|All ages combined|0.233|0.224|0.243
Observed|Breast cancer|2015–2019|Males|1|00–04|||
Observed|Breast cancer|2015–2019|Males|1|05–09|||
Observed|Breast cancer|2015–2019|Males|1|10–14|||
Observed|Breast cancer|2015–2019|Males|1|15–19|||
Observed|Breast cancer|2015–2019|Males|1|20–24|||
Observed|Breast cancer|2015–2019|Males|1|25–29|||
Observed|Breast cancer|2015–2019|Males|1|30–34|||
Observed|Breast cancer|2015–2019|Males|1|35–39|||
Observed|Breast cancer|2015–2019|Males|1|40–44|||
Observed|Breast cancer|2015–2019|Males|1|45–49|0.969|0.802|0.996
Observed|Breast cancer|2015–2019|Males|1|50–54|0.907|0.738|0.969
Observed|Breast cancer|2015–2019|Males|1|55–59|0.98|0.865|0.997
Observed|Breast cancer|2015–2019|Males|1|60–64|0.956|0.887|0.983
Observed|Breast cancer|2015–2019|Males|1|65–69|0.961|0.91|0.984
Observed|Breast cancer|2015–2019|Males|1|70–74|0.942|0.888|0.971
Observed|Breast cancer|2015–2019|Males|1|75–79|0.965|0.908|0.987
Observed|Breast cancer|2015–2019|Males|1|80–84|0.901|0.811|0.949
Observed|Breast cancer|2015–2019|Males|1|85+|0.794|0.682|0.87
Observed|Breast cancer|2015–2019|Males|1|All ages combined|0.932|0.912|0.948
Observed|Breast cancer|2015–2019|Males|2|00–04|||
Observed|Breast cancer|2015–2019|Males|2|05–09|||
Observed|Breast cancer|2015–2019|Males|2|10–14|||
Observed|Breast cancer|2015–2019|Males|2|15–19|||
Observed|Breast cancer|2015–2019|Males|2|20–24|||
Observed|Breast cancer|2015–2019|Males|2|25–29|||
Observed|Breast cancer|2015–2019|Males|2|30–34|||
Observed|Breast cancer|2015–2019|Males|2|35–39|||
Observed|Breast cancer|2015–2019|Males|2|40–44|||
Observed|Breast cancer|2015–2019|Males|2|45–49|0.969|0.802|0.996
Observed|Breast cancer|2015–2019|Males|2|50–54|0.907|0.738|0.969
Observed|Breast cancer|2015–2019|Males|2|55–59|0.962|0.855|0.99
Observed|Breast cancer|2015–2019|Males|2|60–64|0.935|0.861|0.97
Observed|Breast cancer|2015–2019|Males|2|65–69|0.922|0.86|0.957
Observed|Breast cancer|2015–2019|Males|2|70–74|0.893|0.825|0.935
Observed|Breast cancer|2015–2019|Males|2|75–79|0.899|0.825|0.943
Observed|Breast cancer|2015–2019|Males|2|80–84|0.794|0.685|0.868
Observed|Breast cancer|2015–2019|Males|2|85+|0.595|0.473|0.698
Observed|Breast cancer|2015–2019|Males|2|All ages combined|0.873|0.847|0.895
Observed|Breast cancer|2015–2019|Males|3|00–04|||
Observed|Breast cancer|2015–2019|Males|3|05–09|||
Observed|Breast cancer|2015–2019|Males|3|10–14|||
Observed|Breast cancer|2015–2019|Males|3|15–19|||
Observed|Breast cancer|2015–2019|Males|3|20–24|||
Observed|Breast cancer|2015–2019|Males|3|25–29|||
Observed|Breast cancer|2015–2019|Males|3|30–34|||
Observed|Breast cancer|2015–2019|Males|3|35–39|||
Observed|Breast cancer|2015–2019|Males|3|40–44|||
Observed|Breast cancer|2015–2019|Males|3|45–49|0.969|0.802|0.996
Observed|Breast cancer|2015–2019|Males|3|50–54|0.907|0.738|0.969
Observed|Breast cancer|2015–2019|Males|3|55–59|0.945|0.838|0.982
Observed|Breast cancer|2015–2019|Males|3|60–64|0.905|0.825|0.949
Observed|Breast cancer|2015–2019|Males|3|65–69|0.865|0.791|0.914
Observed|Breast cancer|2015–2019|Males|3|70–74|0.864|0.79|0.914
Observed|Breast cancer|2015–2019|Males|3|75–79|0.826|0.738|0.887
Observed|Breast cancer|2015–2019|Males|3|80–84|0.767|0.655|0.846
Observed|Breast cancer|2015–2019|Males|3|85+|0.458|0.335|0.573
Observed|Breast cancer|2015–2019|Males|3|All ages combined|0.828|0.799|0.853
Observed|Breast cancer|2015–2019|Males|4|00–04|||
Observed|Breast cancer|2015–2019|Males|4|05–09|||
Observed|Breast cancer|2015–2019|Males|4|10–14|||
Observed|Breast cancer|2015–2019|Males|4|15–19|||
Observed|Breast cancer|2015–2019|Males|4|20–24|||
Observed|Breast cancer|2015–2019|Males|4|25–29|||
Observed|Breast cancer|2015–2019|Males|4|30–34|||
Observed|Breast cancer|2015–2019|Males|4|35–39|||
Observed|Breast cancer|2015–2019|Males|4|40–44|||
Observed|Breast cancer|2015–2019|Males|4|45–49|||
Observed|Breast cancer|2015–2019|Males|4|50–54|0.833|0.666|0.922
Observed|Breast cancer|2015–2019|Males|4|55–59|0.929|0.822|0.973
Observed|Breast cancer|2015–2019|Males|4|60–64|0.905|0.825|0.949
Observed|Breast cancer|2015–2019|Males|4|65–69|0.81|0.731|0.869
Observed|Breast cancer|2015–2019|Males|4|70–74|0.797|0.709|0.862
Observed|Breast cancer|2015–2019|Males|4|75–79|0.788|0.692|0.857
Observed|Breast cancer|2015–2019|Males|4|80–84|0.636|0.515|0.735
Observed|Breast cancer|2015–2019|Males|4|85+|0.395|0.272|0.515
Observed|Breast cancer|2015–2019|Males|4|All ages combined|0.779|0.747|0.807
Observed|Breast cancer|2015–2019|Males|5|00–04|||
Observed|Breast cancer|2015–2019|Males|5|05–09|||
Observed|Breast cancer|2015–2019|Males|5|10–14|||
Observed|Breast cancer|2015–2019|Males|5|15–19|||
Observed|Breast cancer|2015–2019|Males|5|20–24|||
Observed|Breast cancer|2015–2019|Males|5|25–29|||
Observed|Breast cancer|2015–2019|Males|5|30–34|||
Observed|Breast cancer|2015–2019|Males|5|35–39|||
Observed|Breast cancer|2015–2019|Males|5|40–44|||
Observed|Breast cancer|2015–2019|Males|5|45–49|||
Observed|Breast cancer|2015–2019|Males|5|50–54|0.833|0.666|0.922
Observed|Breast cancer|2015–2019|Males|5|55–59|0.914|0.805|0.963
Observed|Breast cancer|2015–2019|Males|5|60–64|0.894|0.812|0.942
Observed|Breast cancer|2015–2019|Males|5|65–69|0.776|0.692|0.84
Observed|Breast cancer|2015–2019|Males|5|70–74|0.761|0.665|0.832
Observed|Breast cancer|2015–2019|Males|5|75–79|0.727|0.619|0.809
Observed|Breast cancer|2015–2019|Males|5|80–84|0.54|0.416|0.649
Observed|Breast cancer|2015–2019|Males|5|85+|0.373|0.251|0.494
Observed|Breast cancer|2015–2019|Males|5|All ages combined|0.744|0.71|0.775
Relative|Breast cancer|2015–2019|Males|1|00–04|||
Relative|Breast cancer|2015–2019|Males|1|05–09|||
Relative|Breast cancer|2015–2019|Males|1|10–14|||
Relative|Breast cancer|2015–2019|Males|1|15–19|||
Relative|Breast cancer|2015–2019|Males|1|20–24|||
Relative|Breast cancer|2015–2019|Males|1|25–29|||
Relative|Breast cancer|2015–2019|Males|1|30–34|||
Relative|Breast cancer|2015–2019|Males|1|35–39|||
Relative|Breast cancer|2015–2019|Males|1|40–44|||
Relative|Breast cancer|2015–2019|Males|1|45–49|0.972|0.804|0.998
Relative|Breast cancer|2015–2019|Males|1|50–54|0.91|0.741|0.972
Relative|Breast cancer|2015–2019|Males|1|55–59|0.985|0.87|1.002
Relative|Breast cancer|2015–2019|Males|1|60–64|0.964|0.894|0.991
Relative|Breast cancer|2015–2019|Males|1|65–69|0.973|0.921|0.996
Relative|Breast cancer|2015–2019|Males|1|70–74|0.961|0.905|0.99
Relative|Breast cancer|2015–2019|Males|1|75–79|0.997|0.939|1.02
Relative|Breast cancer|2015–2019|Males|1|80–84|0.959|0.863|1.01
Relative|Breast cancer|2015–2019|Males|1|85+|0.923|0.793|1.012
Relative|Breast cancer|2015–2019|Males|1|All ages combined|0.962|0.941|0.979
Relative|Breast cancer|2015–2019|Males|2|00–04|||
Relative|Breast cancer|2015–2019|Males|2|05–09|||
Relative|Breast cancer|2015–2019|Males|2|10–14|||
Relative|Breast cancer|2015–2019|Males|2|15–19|||
Relative|Breast cancer|2015–2019|Males|2|20–24|||
Relative|Breast cancer|2015–2019|Males|2|25–29|||
Relative|Breast cancer|2015–2019|Males|2|30–34|||
Relative|Breast cancer|2015–2019|Males|2|35–39|||
Relative|Breast cancer|2015–2019|Males|2|40–44|||
Relative|Breast cancer|2015–2019|Males|2|45–49|0.974|0.806|1.001
Relative|Breast cancer|2015–2019|Males|2|50–54|0.913|0.743|0.976
Relative|Breast cancer|2015–2019|Males|2|55–59|0.972|0.865|1.001
Relative|Breast cancer|2015–2019|Males|2|60–64|0.951|0.875|0.987
Relative|Breast cancer|2015–2019|Males|2|65–69|0.946|0.882|0.982
Relative|Breast cancer|2015–2019|Males|2|70–74|0.93|0.86|0.974
Relative|Breast cancer|2015–2019|Males|2|75–79|0.965|0.885|1.012
Relative|Breast cancer|2015–2019|Males|2|80–84|0.907|0.783|0.992
Relative|Breast cancer|2015–2019|Males|2|85+|0.813|0.646|0.954
Relative|Breast cancer|2015–2019|Males|2|All ages combined|0.932|0.904|0.955
Relative|Breast cancer|2015–2019|Males|3|00–04|||
Relative|Breast cancer|2015–2019|Males|3|05–09|||
Relative|Breast cancer|2015–2019|Males|3|10–14|||
Relative|Breast cancer|2015–2019|Males|3|15–19|||
Relative|Breast cancer|2015–2019|Males|3|20–24|||
Relative|Breast cancer|2015–2019|Males|3|25–29|||
Relative|Breast cancer|2015–2019|Males|3|30–34|||
Relative|Breast cancer|2015–2019|Males|3|35–39|||
Relative|Breast cancer|2015–2019|Males|3|40–44|||
Relative|Breast cancer|2015–2019|Males|3|45–49|0.977|0.808|1.003
Relative|Breast cancer|2015–2019|Males|3|50–54|0.917|0.746|0.98
Relative|Breast cancer|2015–2019|Males|3|55–59|0.961|0.853|0.999
Relative|Breast cancer|2015–2019|Males|3|60–64|0.928|0.846|0.974
Relative|Breast cancer|2015–2019|Males|3|65–69|0.9|0.824|0.951
Relative|Breast cancer|2015–2019|Males|3|70–74|0.922|0.843|0.975
Relative|Breast cancer|2015–2019|Males|3|75–79|0.925|0.826|0.993
Relative|Breast cancer|2015–2019|Males|3|80–84|0.948|0.81|1.046
Relative|Breast cancer|2015–2019|Males|3|85+|0.746|0.545|0.932
Relative|Breast cancer|2015–2019|Males|3|All ages combined|0.911|0.879|0.939
Relative|Breast cancer|2015–2019|Males|4|00–04|||
Relative|Breast cancer|2015–2019|Males|4|05–09|||
Relative|Breast cancer|2015–2019|Males|4|10–14|||
Relative|Breast cancer|2015–2019|Males|4|15–19|||
Relative|Breast cancer|2015–2019|Males|4|20–24|||
Relative|Breast cancer|2015–2019|Males|4|25–29|||
Relative|Breast cancer|2015–2019|Males|4|30–34|||
Relative|Breast cancer|2015–2019|Males|4|35–39|||
Relative|Breast cancer|2015–2019|Males|4|40–44|||
Relative|Breast cancer|2015–2019|Males|4|45–49|||
Relative|Breast cancer|2015–2019|Males|4|50–54|0.847|0.677|0.936
Relative|Breast cancer|2015–2019|Males|4|55–59|0.952|0.842|0.996
Relative|Breast cancer|2015–2019|Males|4|60–64|0.938|0.855|0.984
Relative|Breast cancer|2015–2019|Males|4|65–69|0.857|0.773|0.919
Relative|Breast cancer|2015–2019|Males|4|70–74|0.873|0.776|0.944
Relative|Breast cancer|2015–2019|Males|4|75–79|0.925|0.812|1.006
Relative|Breast cancer|2015–2019|Males|4|80–84|0.86|0.696|0.994
Relative|Breast cancer|2015–2019|Males|4|85+|0.772|0.532|1.007
Relative|Breast cancer|2015–2019|Males|4|All ages combined|0.883|0.847|0.916
Relative|Breast cancer|2015–2019|Males|5|00–04|||
Relative|Breast cancer|2015–2019|Males|5|05–09|||
Relative|Breast cancer|2015–2019|Males|5|10–14|||
Relative|Breast cancer|2015–2019|Males|5|15–19|||
Relative|Breast cancer|2015–2019|Males|5|20–24|||
Relative|Breast cancer|2015–2019|Males|5|25–29|||
Relative|Breast cancer|2015–2019|Males|5|30–34|||
Relative|Breast cancer|2015–2019|Males|5|35–39|||
Relative|Breast cancer|2015–2019|Males|5|40–44|||
Relative|Breast cancer|2015–2019|Males|5|45–49|||
Relative|Breast cancer|2015–2019|Males|5|50–54|0.851|0.68|0.941
Relative|Breast cancer|2015–2019|Males|5|55–59|0.943|0.83|0.994
Relative|Breast cancer|2015–2019|Males|5|60–64|0.937|0.851|0.987
Relative|Breast cancer|2015–2019|Males|5|65–69|0.835|0.745|0.904
Relative|Breast cancer|2015–2019|Males|5|70–74|0.857|0.75|0.938
Relative|Breast cancer|2015–2019|Males|5|75–79|0.899|0.766|1.001
Relative|Breast cancer|2015–2019|Males|5|80–84|0.807|0.621|0.969
Relative|Breast cancer|2015–2019|Males|5|85+|0.889|0.599|1.179
Relative|Breast cancer|2015–2019|Males|5|All ages combined|0.87|0.831|0.906
Observed|Breast cancer|2015–2019|Females|1|00–04|||
Observed|Breast cancer|2015–2019|Females|1|05–09|||
Observed|Breast cancer|2015–2019|Females|1|10–14|||
Observed|Breast cancer|2015–2019|Females|1|15–19|||
Observed|Breast cancer|2015–2019|Females|1|20–24|0.977|0.848|0.997
Observed|Breast cancer|2015–2019|Females|1|25–29|0.993|0.978|0.998
Observed|Breast cancer|2015–2019|Females|1|30–34|0.986|0.978|0.991
Observed|Breast cancer|2015–2019|Females|1|35–39|0.988|0.983|0.992
Observed|Breast cancer|2015–2019|Females|1|40–44|0.99|0.987|0.992
Observed|Breast cancer|2015–2019|Females|1|45–49|0.992|0.99|0.994
Observed|Breast cancer|2015–2019|Females|1|50–54|0.99|0.988|0.992
Observed|Breast cancer|2015–2019|Females|1|55–59|0.985|0.983|0.987
Observed|Breast cancer|2015–2019|Females|1|60–64|0.984|0.981|0.986
Observed|Breast cancer|2015–2019|Females|1|65–69|0.981|0.978|0.983
Observed|Breast cancer|2015–2019|Females|1|70–74|0.974|0.971|0.977
Observed|Breast cancer|2015–2019|Females|1|75–79|0.95|0.944|0.955
Observed|Breast cancer|2015–2019|Females|1|80–84|0.912|0.903|0.92
Observed|Breast cancer|2015–2019|Females|1|85+|0.823|0.812|0.834
Observed|Breast cancer|2015–2019|Females|1|All ages combined|0.97|0.969|0.971
Observed|Breast cancer|2015–2019|Females|2|00–04|||
Observed|Breast cancer|2015–2019|Females|2|05–09|||
Observed|Breast cancer|2015–2019|Females|2|10–14|||
Observed|Breast cancer|2015–2019|Females|2|15–19|||
Observed|Breast cancer|2015–2019|Females|2|20–24|0.905|0.766|0.963
Observed|Breast cancer|2015–2019|Females|2|25–29|0.956|0.931|0.973
Observed|Breast cancer|2015–2019|Females|2|30–34|0.957|0.945|0.967
Observed|Breast cancer|2015–2019|Females|2|35–39|0.968|0.96|0.974
Observed|Breast cancer|2015–2019|Females|2|40–44|0.976|0.971|0.979
Observed|Breast cancer|2015–2019|Females|2|45–49|0.979|0.976|0.982
Observed|Breast cancer|2015–2019|Females|2|50–54|0.975|0.972|0.978
Observed|Breast cancer|2015–2019|Females|2|55–59|0.968|0.964|0.971
Observed|Breast cancer|2015–2019|Females|2|60–64|0.97|0.967|0.973
Observed|Breast cancer|2015–2019|Females|2|65–69|0.962|0.958|0.965
Observed|Breast cancer|2015–2019|Females|2|70–74|0.95|0.946|0.954
Observed|Breast cancer|2015–2019|Females|2|75–79|0.902|0.895|0.909
Observed|Breast cancer|2015–2019|Females|2|80–84|0.844|0.833|0.854
Observed|Breast cancer|2015–2019|Females|2|85+|0.696|0.682|0.709
Observed|Breast cancer|2015–2019|Females|2|All ages combined|0.942|0.941|0.944
Observed|Breast cancer|2015–2019|Females|3|00–04|||
Observed|Breast cancer|2015–2019|Females|3|05–09|||
Observed|Breast cancer|2015–2019|Females|3|10–14|||
Observed|Breast cancer|2015–2019|Females|3|15–19|||
Observed|Breast cancer|2015–2019|Females|3|20–24|0.881|0.737|0.949
Observed|Breast cancer|2015–2019|Females|3|25–29|0.936|0.907|0.956
Observed|Breast cancer|2015–2019|Females|3|30–34|0.928|0.912|0.941
Observed|Breast cancer|2015–2019|Females|3|35–39|0.949|0.94|0.957
Observed|Breast cancer|2015–2019|Females|3|40–44|0.959|0.953|0.964
Observed|Breast cancer|2015–2019|Females|3|45–49|0.967|0.963|0.971
Observed|Breast cancer|2015–2019|Females|3|50–54|0.959|0.955|0.963
Observed|Breast cancer|2015–2019|Females|3|55–59|0.95|0.945|0.954
Observed|Breast cancer|2015–2019|Females|3|60–64|0.953|0.949|0.957
Observed|Breast cancer|2015–2019|Females|3|65–69|0.941|0.936|0.945
Observed|Breast cancer|2015–2019|Females|3|70–74|0.921|0.916|0.927
Observed|Breast cancer|2015–2019|Females|3|75–79|0.853|0.843|0.861
Observed|Breast cancer|2015–2019|Females|3|80–84|0.772|0.759|0.784
Observed|Breast cancer|2015–2019|Females|3|85+|0.578|0.563|0.592
Observed|Breast cancer|2015–2019|Females|3|All ages combined|0.914|0.912|0.916
Observed|Breast cancer|2015–2019|Females|4|00–04|||
Observed|Breast cancer|2015–2019|Females|4|05–09|||
Observed|Breast cancer|2015–2019|Females|4|10–14|||
Observed|Breast cancer|2015–2019|Females|4|15–19|||
Observed|Breast cancer|2015–2019|Females|4|20–24|0.881|0.737|0.949
Observed|Breast cancer|2015–2019|Females|4|25–29|0.91|0.877|0.935
Observed|Breast cancer|2015–2019|Females|4|30–34|0.901|0.883|0.917
Observed|Breast cancer|2015–2019|Females|4|35–39|0.924|0.913|0.934
Observed|Breast cancer|2015–2019|Females|4|40–44|0.941|0.934|0.947
Observed|Breast cancer|2015–2019|Females|4|45–49|0.951|0.946|0.956
Observed|Breast cancer|2015–2019|Females|4|50–54|0.943|0.938|0.947
Observed|Breast cancer|2015–2019|Females|4|55–59|0.935|0.93|0.939
Observed|Breast cancer|2015–2019|Females|4|60–64|0.936|0.931|0.94
Observed|Breast cancer|2015–2019|Females|4|65–69|0.921|0.916|0.926
Observed|Breast cancer|2015–2019|Females|4|70–74|0.893|0.886|0.899
Observed|Breast cancer|2015–2019|Females|4|75–79|0.808|0.798|0.818
Observed|Breast cancer|2015–2019|Females|4|80–84|0.694|0.68|0.708
Observed|Breast cancer|2015–2019|Females|4|85+|0.472|0.457|0.487
Observed|Breast cancer|2015–2019|Females|4|All ages combined|0.885|0.883|0.888
Observed|Breast cancer|2015–2019|Females|5|00–04|||
Observed|Breast cancer|2015–2019|Females|5|05–09|||
Observed|Breast cancer|2015–2019|Females|5|10–14|||
Observed|Breast cancer|2015–2019|Females|5|15–19|||
Observed|Breast cancer|2015–2019|Females|5|20–24|0.881|0.737|0.949
Observed|Breast cancer|2015–2019|Females|5|25–29|0.894|0.859|0.921
Observed|Breast cancer|2015–2019|Females|5|30–34|0.882|0.863|0.899
Observed|Breast cancer|2015–2019|Females|5|35–39|0.901|0.888|0.912
Observed|Breast cancer|2015–2019|Females|5|40–44|0.925|0.918|0.932
Observed|Breast cancer|2015–2019|Females|5|45–49|0.939|0.933|0.944
Observed|Breast cancer|2015–2019|Females|5|50–54|0.928|0.923|0.933
Observed|Breast cancer|2015–2019|Females|5|55–59|0.92|0.914|0.925
Observed|Breast cancer|2015–2019|Females|5|60–64|0.917|0.911|0.922
Observed|Breast cancer|2015–2019|Females|5|65–69|0.902|0.896|0.907
Observed|Breast cancer|2015–2019|Females|5|70–74|0.862|0.855|0.87
Observed|Breast cancer|2015–2019|Females|5|75–79|0.761|0.75|0.772
Observed|Breast cancer|2015–2019|Females|5|80–84|0.618|0.603|0.633
Observed|Breast cancer|2015–2019|Females|5|85+|0.383|0.368|0.397
Observed|Breast cancer|2015–2019|Females|5|All ages combined|0.859|0.856|0.861
Relative|Breast cancer|2015–2019|Females|1|00–04|||
Relative|Breast cancer|2015–2019|Females|1|05–09|||
Relative|Breast cancer|2015–2019|Females|1|10–14|||
Relative|Breast cancer|2015–2019|Females|1|15–19|||
Relative|Breast cancer|2015–2019|Females|1|20–24|0.977|0.849|0.997
Relative|Breast cancer|2015–2019|Females|1|25–29|0.993|0.978|0.998
Relative|Breast cancer|2015–2019|Females|1|30–34|0.987|0.979|0.992
Relative|Breast cancer|2015–2019|Females|1|35–39|0.989|0.984|0.993
Relative|Breast cancer|2015–2019|Females|1|40–44|0.991|0.988|0.993
Relative|Breast cancer|2015–2019|Females|1|45–49|0.993|0.991|0.995
Relative|Breast cancer|2015–2019|Females|1|50–54|0.992|0.99|0.994
Relative|Breast cancer|2015–2019|Females|1|55–59|0.988|0.986|0.99
Relative|Breast cancer|2015–2019|Females|1|60–64|0.988|0.986|0.991
Relative|Breast cancer|2015–2019|Females|1|65–69|0.988|0.985|0.99
Relative|Breast cancer|2015–2019|Females|1|70–74|0.986|0.983|0.989
Relative|Breast cancer|2015–2019|Females|1|75–79|0.97|0.964|0.976
Relative|Breast cancer|2015–2019|Females|1|80–84|0.951|0.941|0.959
Relative|Breast cancer|2015–2019|Females|1|85+|0.923|0.91|0.935
Relative|Breast cancer|2015–2019|Females|1|All ages combined|0.983|0.982|0.984
Relative|Breast cancer|2015–2019|Females|2|00–04|||
Relative|Breast cancer|2015–2019|Females|2|05–09|||
Relative|Breast cancer|2015–2019|Females|2|10–14|||
Relative|Breast cancer|2015–2019|Females|2|15–19|||
Relative|Breast cancer|2015–2019|Females|2|20–24|0.905|0.766|0.964
Relative|Breast cancer|2015–2019|Females|2|25–29|0.957|0.931|0.973
Relative|Breast cancer|2015–2019|Females|2|30–34|0.958|0.946|0.968
Relative|Breast cancer|2015–2019|Females|2|35–39|0.969|0.961|0.975
Relative|Breast cancer|2015–2019|Females|2|40–44|0.978|0.973|0.981
Relative|Breast cancer|2015–2019|Females|2|45–49|0.982|0.979|0.985
Relative|Breast cancer|2015–2019|Females|2|50–54|0.979|0.976|0.982
Relative|Breast cancer|2015–2019|Females|2|55–59|0.974|0.971|0.977
Relative|Breast cancer|2015–2019|Females|2|60–64|0.98|0.976|0.983
Relative|Breast cancer|2015–2019|Females|2|65–69|0.977|0.973|0.98
Relative|Breast cancer|2015–2019|Females|2|70–74|0.975|0.97|0.979
Relative|Breast cancer|2015–2019|Females|2|75–79|0.945|0.937|0.952
Relative|Breast cancer|2015–2019|Females|2|80–84|0.922|0.91|0.933
Relative|Breast cancer|2015–2019|Females|2|85+|0.883|0.865|0.9
Relative|Breast cancer|2015–2019|Females|2|All ages combined|0.968|0.966|0.969
Relative|Breast cancer|2015–2019|Females|3|00–04|||
Relative|Breast cancer|2015–2019|Females|3|05–09|||
Relative|Breast cancer|2015–2019|Females|3|10–14|||
Relative|Breast cancer|2015–2019|Females|3|15–19|||
Relative|Breast cancer|2015–2019|Females|3|20–24|0.881|0.737|0.949
Relative|Breast cancer|2015–2019|Females|3|25–29|0.937|0.907|0.957
Relative|Breast cancer|2015–2019|Females|3|30–34|0.929|0.913|0.942
Relative|Breast cancer|2015–2019|Females|3|35–39|0.951|0.942|0.959
Relative|Breast cancer|2015–2019|Females|3|40–44|0.962|0.956|0.967
Relative|Breast cancer|2015–2019|Females|3|45–49|0.971|0.967|0.975
Relative|Breast cancer|2015–2019|Females|3|50–54|0.966|0.962|0.97
Relative|Breast cancer|2015–2019|Females|3|55–59|0.959|0.955|0.964
Relative|Breast cancer|2015–2019|Females|3|60–64|0.968|0.964|0.972
Relative|Breast cancer|2015–2019|Females|3|65–69|0.964|0.959|0.968
Relative|Breast cancer|2015–2019|Females|3|70–74|0.96|0.954|0.965
Relative|Breast cancer|2015–2019|Females|3|75–79|0.918|0.908|0.927
Relative|Breast cancer|2015–2019|Females|3|80–84|0.891|0.876|0.905
Relative|Breast cancer|2015–2019|Females|3|85+|0.841|0.819|0.862
Relative|Breast cancer|2015–2019|Females|3|All ages combined|0.951|0.949|0.953
Relative|Breast cancer|2015–2019|Females|4|00–04|||
Relative|Breast cancer|2015–2019|Females|4|05–09|||
Relative|Breast cancer|2015–2019|Females|4|10–14|||
Relative|Breast cancer|2015–2019|Females|4|15–19|||
Relative|Breast cancer|2015–2019|Females|4|20–24|0.882|0.737|0.949
Relative|Breast cancer|2015–2019|Females|4|25–29|0.911|0.878|0.936
Relative|Breast cancer|2015–2019|Females|4|30–34|0.903|0.885|0.918
Relative|Breast cancer|2015–2019|Females|4|35–39|0.927|0.915|0.936
Relative|Breast cancer|2015–2019|Females|4|40–44|0.945|0.938|0.951
Relative|Breast cancer|2015–2019|Females|4|45–49|0.957|0.952|0.962
Relative|Breast cancer|2015–2019|Females|4|50–54|0.952|0.947|0.957
Relative|Breast cancer|2015–2019|Females|4|55–59|0.948|0.943|0.953
Relative|Breast cancer|2015–2019|Females|4|60–64|0.956|0.951|0.96
Relative|Breast cancer|2015–2019|Females|4|65–69|0.953|0.947|0.958
Relative|Breast cancer|2015–2019|Females|4|70–74|0.946|0.939|0.953
Relative|Breast cancer|2015–2019|Females|4|75–79|0.897|0.886|0.908
Relative|Breast cancer|2015–2019|Females|4|80–84|0.854|0.836|0.871
Relative|Breast cancer|2015–2019|Females|4|85+|0.799|0.774|0.824
Relative|Breast cancer|2015–2019|Females|4|All ages combined|0.935|0.933|0.937
Relative|Breast cancer|2015–2019|Females|5|00–04|||
Relative|Breast cancer|2015–2019|Females|5|05–09|||
Relative|Breast cancer|2015–2019|Females|5|10–14|||
Relative|Breast cancer|2015–2019|Females|5|15–19|||
Relative|Breast cancer|2015–2019|Females|5|20–24|0.882|0.738|0.95
Relative|Breast cancer|2015–2019|Females|5|25–29|0.896|0.861|0.923
Relative|Breast cancer|2015–2019|Females|5|30–34|0.884|0.865|0.901
Relative|Breast cancer|2015–2019|Females|5|35–39|0.904|0.891|0.915
Relative|Breast cancer|2015–2019|Females|5|40–44|0.93|0.923|0.937
Relative|Breast cancer|2015–2019|Females|5|45–49|0.946|0.941|0.951
Relative|Breast cancer|2015–2019|Females|5|50–54|0.94|0.935|0.945
Relative|Breast cancer|2015–2019|Females|5|55–59|0.937|0.931|0.942
Relative|Breast cancer|2015–2019|Females|5|60–64|0.942|0.937|0.948
Relative|Breast cancer|2015–2019|Females|5|65–69|0.943|0.937|0.949
Relative|Breast cancer|2015–2019|Females|5|70–74|0.932|0.923|0.939
Relative|Breast cancer|2015–2019|Females|5|75–79|0.876|0.863|0.888
Relative|Breast cancer|2015–2019|Females|5|80–84|0.817|0.797|0.836
Relative|Breast cancer|2015–2019|Females|5|85+|0.766|0.737|0.795
Relative|Breast cancer|2015–2019|Females|5|All ages combined|0.92|0.918|0.923
Observed|Breast cancer|2015–2019|Persons|1|00–04|||
Observed|Breast cancer|2015–2019|Persons|1|05–09|||
Observed|Breast cancer|2015–2019|Persons|1|10–14|||
Observed|Breast cancer|2015–2019|Persons|1|15–19|||
Observed|Breast cancer|2015–2019|Persons|1|20–24|0.978|0.855|0.997
Observed|Breast cancer|2015–2019|Persons|1|25–29|0.993|0.978|0.998
Observed|Breast cancer|2015–2019|Persons|1|30–34|0.986|0.978|0.991
Observed|Breast cancer|2015–2019|Persons|1|35–39|0.988|0.983|0.991
Observed|Breast cancer|2015–2019|Persons|1|40–44|0.99|0.987|0.992
Observed|Breast cancer|2015–2019|Persons|1|45–49|0.992|0.99|0.994
Observed|Breast cancer|2015–2019|Persons|1|50–54|0.99|0.987|0.991
Observed|Breast cancer|2015–2019|Persons|1|55–59|0.985|0.983|0.987
Observed|Breast cancer|2015–2019|Persons|1|60–64|0.984|0.981|0.986
Observed|Breast cancer|2015–2019|Persons|1|65–69|0.98|0.978|0.983
Observed|Breast cancer|2015–2019|Persons|1|70–74|0.974|0.97|0.977
Observed|Breast cancer|2015–2019|Persons|1|75–79|0.95|0.944|0.955
Observed|Breast cancer|2015–2019|Persons|1|80–84|0.912|0.903|0.92
Observed|Breast cancer|2015–2019|Persons|1|85+|0.823|0.811|0.834
Observed|Breast cancer|2015–2019|Persons|1|All ages combined|0.97|0.969|0.971
Observed|Breast cancer|2015–2019|Persons|2|00–04|||
Observed|Breast cancer|2015–2019|Persons|2|05–09|||
Observed|Breast cancer|2015–2019|Persons|2|10–14|||
Observed|Breast cancer|2015–2019|Persons|2|15–19|||
Observed|Breast cancer|2015–2019|Persons|2|20–24|0.908|0.773|0.964
Observed|Breast cancer|2015–2019|Persons|2|25–29|0.957|0.931|0.973
Observed|Breast cancer|2015–2019|Persons|2|30–34|0.957|0.945|0.967
Observed|Breast cancer|2015–2019|Persons|2|35–39|0.967|0.959|0.973
Observed|Breast cancer|2015–2019|Persons|2|40–44|0.975|0.971|0.979
Observed|Breast cancer|2015–2019|Persons|2|45–49|0.979|0.976|0.982
Observed|Breast cancer|2015–2019|Persons|2|50–54|0.975|0.972|0.978
Observed|Breast cancer|2015–2019|Persons|2|55–59|0.968|0.964|0.971
Observed|Breast cancer|2015–2019|Persons|2|60–64|0.97|0.967|0.973
Observed|Breast cancer|2015–2019|Persons|2|65–69|0.961|0.958|0.965
Observed|Breast cancer|2015–2019|Persons|2|70–74|0.95|0.945|0.954
Observed|Breast cancer|2015–2019|Persons|2|75–79|0.902|0.895|0.909
Observed|Breast cancer|2015–2019|Persons|2|80–84|0.843|0.832|0.853
Observed|Breast cancer|2015–2019|Persons|2|85+|0.694|0.68|0.707
Observed|Breast cancer|2015–2019|Persons|2|All ages combined|0.942|0.94|0.943
Observed|Breast cancer|2015–2019|Persons|3|00–04|||
Observed|Breast cancer|2015–2019|Persons|3|05–09|||
Observed|Breast cancer|2015–2019|Persons|3|10–14|||
Observed|Breast cancer|2015–2019|Persons|3|15–19|||
Observed|Breast cancer|2015–2019|Persons|3|20–24|0.884|0.744|0.95
Observed|Breast cancer|2015–2019|Persons|3|25–29|0.936|0.907|0.957
Observed|Breast cancer|2015–2019|Persons|3|30–34|0.928|0.912|0.941
Observed|Breast cancer|2015–2019|Persons|3|35–39|0.949|0.939|0.957
Observed|Breast cancer|2015–2019|Persons|3|40–44|0.959|0.953|0.964
Observed|Breast cancer|2015–2019|Persons|3|45–49|0.967|0.963|0.971
Observed|Breast cancer|2015–2019|Persons|3|50–54|0.959|0.955|0.963
Observed|Breast cancer|2015–2019|Persons|3|55–59|0.95|0.945|0.954
Observed|Breast cancer|2015–2019|Persons|3|60–64|0.953|0.949|0.957
Observed|Breast cancer|2015–2019|Persons|3|65–69|0.94|0.936|0.944
Observed|Breast cancer|2015–2019|Persons|3|70–74|0.921|0.915|0.926
Observed|Breast cancer|2015–2019|Persons|3|75–79|0.852|0.843|0.861
Observed|Breast cancer|2015–2019|Persons|3|80–84|0.772|0.759|0.784
Observed|Breast cancer|2015–2019|Persons|3|85+|0.576|0.562|0.59
Observed|Breast cancer|2015–2019|Persons|3|All ages combined|0.913|0.911|0.915
Observed|Breast cancer|2015–2019|Persons|4|00–04|||
Observed|Breast cancer|2015–2019|Persons|4|05–09|||
Observed|Breast cancer|2015–2019|Persons|4|10–14|||
Observed|Breast cancer|2015–2019|Persons|4|15–19|||
Observed|Breast cancer|2015–2019|Persons|4|20–24|0.884|0.744|0.95
Observed|Breast cancer|2015–2019|Persons|4|25–29|0.91|0.877|0.935
Observed|Breast cancer|2015–2019|Persons|4|30–34|0.901|0.883|0.917
Observed|Breast cancer|2015–2019|Persons|4|35–39|0.923|0.912|0.933
Observed|Breast cancer|2015–2019|Persons|4|40–44|0.94|0.934|0.946
Observed|Breast cancer|2015–2019|Persons|4|45–49|0.951|0.946|0.956
Observed|Breast cancer|2015–2019|Persons|4|50–54|0.943|0.938|0.947
Observed|Breast cancer|2015–2019|Persons|4|55–59|0.935|0.93|0.939
Observed|Breast cancer|2015–2019|Persons|4|60–64|0.935|0.931|0.94
Observed|Breast cancer|2015–2019|Persons|4|65–69|0.92|0.915|0.924
Observed|Breast cancer|2015–2019|Persons|4|70–74|0.892|0.885|0.898
Observed|Breast cancer|2015–2019|Persons|4|75–79|0.808|0.798|0.818
Observed|Breast cancer|2015–2019|Persons|4|80–84|0.694|0.68|0.707
Observed|Breast cancer|2015–2019|Persons|4|85+|0.471|0.456|0.485
Observed|Breast cancer|2015–2019|Persons|4|All ages combined|0.885|0.882|0.887
Observed|Breast cancer|2015–2019|Persons|5|00–04|||
Observed|Breast cancer|2015–2019|Persons|5|05–09|||
Observed|Breast cancer|2015–2019|Persons|5|10–14|||
Observed|Breast cancer|2015–2019|Persons|5|15–19|||
Observed|Breast cancer|2015–2019|Persons|5|20–24|0.884|0.744|0.95
Observed|Breast cancer|2015–2019|Persons|5|25–29|0.895|0.86|0.921
Observed|Breast cancer|2015–2019|Persons|5|30–34|0.883|0.863|0.899
Observed|Breast cancer|2015–2019|Persons|5|35–39|0.9|0.887|0.911
Observed|Breast cancer|2015–2019|Persons|5|40–44|0.925|0.917|0.931
Observed|Breast cancer|2015–2019|Persons|5|45–49|0.938|0.933|0.943
Observed|Breast cancer|2015–2019|Persons|5|50–54|0.928|0.923|0.933
Observed|Breast cancer|2015–2019|Persons|5|55–59|0.92|0.914|0.925
Observed|Breast cancer|2015–2019|Persons|5|60–64|0.916|0.911|0.921
Observed|Breast cancer|2015–2019|Persons|5|65–69|0.901|0.895|0.906
Observed|Breast cancer|2015–2019|Persons|5|70–74|0.861|0.854|0.868
Observed|Breast cancer|2015–2019|Persons|5|75–79|0.761|0.75|0.772
Observed|Breast cancer|2015–2019|Persons|5|80–84|0.617|0.602|0.631
Observed|Breast cancer|2015–2019|Persons|5|85+|0.382|0.368|0.397
Observed|Breast cancer|2015–2019|Persons|5|All ages combined|0.858|0.855|0.86
Relative|Breast cancer|2015–2019|Persons|1|00–04|||
Relative|Breast cancer|2015–2019|Persons|1|05–09|||
Relative|Breast cancer|2015–2019|Persons|1|10–14|||
Relative|Breast cancer|2015–2019|Persons|1|15–19|||
Relative|Breast cancer|2015–2019|Persons|1|20–24|0.978|0.855|0.997
Relative|Breast cancer|2015–2019|Persons|1|25–29|0.993|0.978|0.998
Relative|Breast cancer|2015–2019|Persons|1|30–34|0.987|0.979|0.992
Relative|Breast cancer|2015–2019|Persons|1|35–39|0.988|0.983|0.992
Relative|Breast cancer|2015–2019|Persons|1|40–44|0.991|0.988|0.993
Relative|Breast cancer|2015–2019|Persons|1|45–49|0.993|0.991|0.995
Relative|Breast cancer|2015–2019|Persons|1|50–54|0.992|0.99|0.993
Relative|Breast cancer|2015–2019|Persons|1|55–59|0.988|0.986|0.99
Relative|Breast cancer|2015–2019|Persons|1|60–64|0.988|0.986|0.99
Relative|Breast cancer|2015–2019|Persons|1|65–69|0.987|0.985|0.99
Relative|Breast cancer|2015–2019|Persons|1|70–74|0.986|0.982|0.988
Relative|Breast cancer|2015–2019|Persons|1|75–79|0.971|0.965|0.976
Relative|Breast cancer|2015–2019|Persons|1|80–84|0.951|0.942|0.959
Relative|Breast cancer|2015–2019|Persons|1|85+|0.923|0.91|0.935
Relative|Breast cancer|2015–2019|Persons|1|All ages combined|0.983|0.982|0.984
Relative|Breast cancer|2015–2019|Persons|2|00–04|||
Relative|Breast cancer|2015–2019|Persons|2|05–09|||
Relative|Breast cancer|2015–2019|Persons|2|10–14|||
Relative|Breast cancer|2015–2019|Persons|2|15–19|||
Relative|Breast cancer|2015–2019|Persons|2|20–24|0.908|0.773|0.965
Relative|Breast cancer|2015–2019|Persons|2|25–29|0.957|0.932|0.973
Relative|Breast cancer|2015–2019|Persons|2|30–34|0.958|0.946|0.968
Relative|Breast cancer|2015–2019|Persons|2|35–39|0.968|0.961|0.975
Relative|Breast cancer|2015–2019|Persons|2|40–44|0.977|0.973|0.981
Relative|Breast cancer|2015–2019|Persons|2|45–49|0.982|0.979|0.985
Relative|Breast cancer|2015–2019|Persons|2|50–54|0.979|0.976|0.982
Relative|Breast cancer|2015–2019|Persons|2|55–59|0.974|0.971|0.977
Relative|Breast cancer|2015–2019|Persons|2|60–64|0.979|0.976|0.982
Relative|Breast cancer|2015–2019|Persons|2|65–69|0.976|0.973|0.98
Relative|Breast cancer|2015–2019|Persons|2|70–74|0.974|0.97|0.979
Relative|Breast cancer|2015–2019|Persons|2|75–79|0.945|0.937|0.953
Relative|Breast cancer|2015–2019|Persons|2|80–84|0.922|0.91|0.933
Relative|Breast cancer|2015–2019|Persons|2|85+|0.882|0.864|0.898
Relative|Breast cancer|2015–2019|Persons|2|All ages combined|0.967|0.966|0.969
Relative|Breast cancer|2015–2019|Persons|3|00–04|||
Relative|Breast cancer|2015–2019|Persons|3|05–09|||
Relative|Breast cancer|2015–2019|Persons|3|10–14|||
Relative|Breast cancer|2015–2019|Persons|3|15–19|||
Relative|Breast cancer|2015–2019|Persons|3|20–24|0.885|0.745|0.951
Relative|Breast cancer|2015–2019|Persons|3|25–29|0.937|0.908|0.957
Relative|Breast cancer|2015–2019|Persons|3|30–34|0.929|0.914|0.942
Relative|Breast cancer|2015–2019|Persons|3|35–39|0.951|0.941|0.959
Relative|Breast cancer|2015–2019|Persons|3|40–44|0.962|0.956|0.967
Relative|Breast cancer|2015–2019|Persons|3|45–49|0.971|0.967|0.975
Relative|Breast cancer|2015–2019|Persons|3|50–54|0.966|0.962|0.969
Relative|Breast cancer|2015–2019|Persons|3|55–59|0.959|0.955|0.964
Relative|Breast cancer|2015–2019|Persons|3|60–64|0.968|0.964|0.972
Relative|Breast cancer|2015–2019|Persons|3|65–69|0.963|0.959|0.967
Relative|Breast cancer|2015–2019|Persons|3|70–74|0.959|0.954|0.965
Relative|Breast cancer|2015–2019|Persons|3|75–79|0.918|0.908|0.927
Relative|Breast cancer|2015–2019|Persons|3|80–84|0.892|0.877|0.906
Relative|Breast cancer|2015–2019|Persons|3|85+|0.839|0.818|0.86
Relative|Breast cancer|2015–2019|Persons|3|All ages combined|0.951|0.949|0.953
Relative|Breast cancer|2015–2019|Persons|4|00–04|||
Relative|Breast cancer|2015–2019|Persons|4|05–09|||
Relative|Breast cancer|2015–2019|Persons|4|10–14|||
Relative|Breast cancer|2015–2019|Persons|4|15–19|||
Relative|Breast cancer|2015–2019|Persons|4|20–24|0.885|0.745|0.951
Relative|Breast cancer|2015–2019|Persons|4|25–29|0.912|0.878|0.936
Relative|Breast cancer|2015–2019|Persons|4|30–34|0.903|0.885|0.918
Relative|Breast cancer|2015–2019|Persons|4|35–39|0.926|0.914|0.936
Relative|Breast cancer|2015–2019|Persons|4|40–44|0.944|0.938|0.95
Relative|Breast cancer|2015–2019|Persons|4|45–49|0.957|0.953|0.962
Relative|Breast cancer|2015–2019|Persons|4|50–54|0.952|0.947|0.956
Relative|Breast cancer|2015–2019|Persons|4|55–59|0.948|0.943|0.953
Relative|Breast cancer|2015–2019|Persons|4|60–64|0.956|0.951|0.96
Relative|Breast cancer|2015–2019|Persons|4|65–69|0.952|0.946|0.957
Relative|Breast cancer|2015–2019|Persons|4|70–74|0.945|0.938|0.952
Relative|Breast cancer|2015–2019|Persons|4|75–79|0.898|0.887|0.909
Relative|Breast cancer|2015–2019|Persons|4|80–84|0.854|0.837|0.871
Relative|Breast cancer|2015–2019|Persons|4|85+|0.798|0.773|0.823
Relative|Breast cancer|2015–2019|Persons|4|All ages combined|0.934|0.932|0.937
Relative|Breast cancer|2015–2019|Persons|5|00–04|||
Relative|Breast cancer|2015–2019|Persons|5|05–09|||
Relative|Breast cancer|2015–2019|Persons|5|10–14|||
Relative|Breast cancer|2015–2019|Persons|5|15–19|||
Relative|Breast cancer|2015–2019|Persons|5|20–24|0.886|0.745|0.951
Relative|Breast cancer|2015–2019|Persons|5|25–29|0.896|0.861|0.923
Relative|Breast cancer|2015–2019|Persons|5|30–34|0.885|0.865|0.902
Relative|Breast cancer|2015–2019|Persons|5|35–39|0.903|0.89|0.914
Relative|Breast cancer|2015–2019|Persons|5|40–44|0.93|0.922|0.937
Relative|Breast cancer|2015–2019|Persons|5|45–49|0.946|0.941|0.951
Relative|Breast cancer|2015–2019|Persons|5|50–54|0.94|0.934|0.944
Relative|Breast cancer|2015–2019|Persons|5|55–59|0.937|0.932|0.942
Relative|Breast cancer|2015–2019|Persons|5|60–64|0.942|0.937|0.947
Relative|Breast cancer|2015–2019|Persons|5|65–69|0.942|0.936|0.948
Relative|Breast cancer|2015–2019|Persons|5|70–74|0.931|0.923|0.938
Relative|Breast cancer|2015–2019|Persons|5|75–79|0.876|0.864|0.889
Relative|Breast cancer|2015–2019|Persons|5|80–84|0.817|0.797|0.836
Relative|Breast cancer|2015–2019|Persons|5|85+|0.767|0.738|0.796
Relative|Breast cancer|2015–2019|Persons|5|All ages combined|0.92|0.917|0.922
Observed|Cervical cancer|2015–2019|Females|1|00–04|||
Observed|Cervical cancer|2015–2019|Females|1|05–09|||
Observed|Cervical cancer|2015–2019|Females|1|10–14|||
Observed|Cervical cancer|2015–2019|Females|1|15–19|||
Observed|Cervical cancer|2015–2019|Females|1|20–24|1|0.925|1
Observed|Cervical cancer|2015–2019|Females|1|25–29|0.977|0.949|0.99
Observed|Cervical cancer|2015–2019|Females|1|30–34|0.984|0.97|0.992
Observed|Cervical cancer|2015–2019|Females|1|35–39|0.963|0.944|0.976
Observed|Cervical cancer|2015–2019|Females|1|40–44|0.944|0.922|0.96
Observed|Cervical cancer|2015–2019|Females|1|45–49|0.937|0.913|0.955
Observed|Cervical cancer|2015–2019|Females|1|50–54|0.889|0.852|0.918
Observed|Cervical cancer|2015–2019|Females|1|55–59|0.879|0.838|0.91
Observed|Cervical cancer|2015–2019|Females|1|60–64|0.867|0.822|0.901
Observed|Cervical cancer|2015–2019|Females|1|65–69|0.811|0.757|0.854
Observed|Cervical cancer|2015–2019|Females|1|70–74|0.759|0.691|0.813
Observed|Cervical cancer|2015–2019|Females|1|75–79|0.724|0.645|0.788
Observed|Cervical cancer|2015–2019|Females|1|80–84|0.571|0.477|0.654
Observed|Cervical cancer|2015–2019|Females|1|85+|0.406|0.318|0.493
Observed|Cervical cancer|2015–2019|Females|1|All ages combined|0.892|0.882|0.901
Observed|Cervical cancer|2015–2019|Females|2|00–04|||
Observed|Cervical cancer|2015–2019|Females|2|05–09|||
Observed|Cervical cancer|2015–2019|Females|2|10–14|||
Observed|Cervical cancer|2015–2019|Females|2|15–19|||
Observed|Cervical cancer|2015–2019|Females|2|20–24|0.953|0.826|0.988
Observed|Cervical cancer|2015–2019|Females|2|25–29|0.929|0.891|0.953
Observed|Cervical cancer|2015–2019|Females|2|30–34|0.953|0.931|0.968
Observed|Cervical cancer|2015–2019|Females|2|35–39|0.929|0.905|0.947
Observed|Cervical cancer|2015–2019|Females|2|40–44|0.883|0.854|0.907
Observed|Cervical cancer|2015–2019|Females|2|45–49|0.875|0.843|0.901
Observed|Cervical cancer|2015–2019|Females|2|50–54|0.809|0.764|0.846
Observed|Cervical cancer|2015–2019|Females|2|55–59|0.775|0.724|0.817
Observed|Cervical cancer|2015–2019|Females|2|60–64|0.771|0.719|0.815
Observed|Cervical cancer|2015–2019|Females|2|65–69|0.74|0.681|0.79
Observed|Cervical cancer|2015–2019|Females|2|70–74|0.633|0.56|0.698
Observed|Cervical cancer|2015–2019|Females|2|75–79|0.498|0.416|0.575
Observed|Cervical cancer|2015–2019|Females|2|80–84|0.435|0.345|0.521
Observed|Cervical cancer|2015–2019|Females|2|85+|0.249|0.177|0.328
Observed|Cervical cancer|2015–2019|Females|2|All ages combined|0.818|0.806|0.829
Observed|Cervical cancer|2015–2019|Females|3|00–04|||
Observed|Cervical cancer|2015–2019|Females|3|05–09|||
Observed|Cervical cancer|2015–2019|Females|3|10–14|||
Observed|Cervical cancer|2015–2019|Females|3|15–19|||
Observed|Cervical cancer|2015–2019|Females|3|20–24|0.917|0.793|0.968
Observed|Cervical cancer|2015–2019|Females|3|25–29|0.916|0.878|0.943
Observed|Cervical cancer|2015–2019|Females|3|30–34|0.938|0.914|0.955
Observed|Cervical cancer|2015–2019|Females|3|35–39|0.907|0.88|0.928
Observed|Cervical cancer|2015–2019|Females|3|40–44|0.844|0.812|0.872
Observed|Cervical cancer|2015–2019|Females|3|45–49|0.826|0.79|0.857
Observed|Cervical cancer|2015–2019|Females|3|50–54|0.761|0.713|0.802
Observed|Cervical cancer|2015–2019|Females|3|55–59|0.714|0.66|0.762
Observed|Cervical cancer|2015–2019|Females|3|60–64|0.74|0.685|0.786
Observed|Cervical cancer|2015–2019|Females|3|65–69|0.673|0.611|0.727
Observed|Cervical cancer|2015–2019|Females|3|70–74|0.54|0.465|0.609
Observed|Cervical cancer|2015–2019|Females|3|75–79|0.436|0.355|0.514
Observed|Cervical cancer|2015–2019|Females|3|80–84|0.315|0.234|0.399
Observed|Cervical cancer|2015–2019|Females|3|85+|0.175|0.116|0.244
Observed|Cervical cancer|2015–2019|Females|3|All ages combined|0.775|0.762|0.787
Observed|Cervical cancer|2015–2019|Females|4|00–04|||
Observed|Cervical cancer|2015–2019|Females|4|05–09|||
Observed|Cervical cancer|2015–2019|Females|4|10–14|||
Observed|Cervical cancer|2015–2019|Females|4|15–19|||
Observed|Cervical cancer|2015–2019|Females|4|20–24|0.901|0.777|0.958
Observed|Cervical cancer|2015–2019|Females|4|25–29|0.911|0.872|0.938
Observed|Cervical cancer|2015–2019|Females|4|30–34|0.92|0.894|0.94
Observed|Cervical cancer|2015–2019|Females|4|35–39|0.887|0.857|0.91
Observed|Cervical cancer|2015–2019|Females|4|40–44|0.825|0.791|0.854
Observed|Cervical cancer|2015–2019|Females|4|45–49|0.794|0.755|0.828
Observed|Cervical cancer|2015–2019|Females|4|50–54|0.726|0.677|0.77
Observed|Cervical cancer|2015–2019|Females|4|55–59|0.671|0.615|0.72
Observed|Cervical cancer|2015–2019|Females|4|60–64|0.709|0.652|0.757
Observed|Cervical cancer|2015–2019|Females|4|65–69|0.626|0.562|0.683
Observed|Cervical cancer|2015–2019|Females|4|70–74|0.49|0.416|0.56
Observed|Cervical cancer|2015–2019|Females|4|75–79|0.33|0.256|0.406
Observed|Cervical cancer|2015–2019|Females|4|80–84|0.298|0.218|0.381
Observed|Cervical cancer|2015–2019|Females|4|85+|0.163|0.106|0.23
Observed|Cervical cancer|2015–2019|Females|4|All ages combined|0.746|0.733|0.759
Observed|Cervical cancer|2015–2019|Females|5|00–04|||
Observed|Cervical cancer|2015–2019|Females|5|05–09|||
Observed|Cervical cancer|2015–2019|Females|5|10–14|||
Observed|Cervical cancer|2015–2019|Females|5|15–19|||
Observed|Cervical cancer|2015–2019|Females|5|20–24|0.901|0.777|0.958
Observed|Cervical cancer|2015–2019|Females|5|25–29|0.908|0.868|0.936
Observed|Cervical cancer|2015–2019|Females|5|30–34|0.916|0.889|0.937
Observed|Cervical cancer|2015–2019|Females|5|35–39|0.871|0.84|0.896
Observed|Cervical cancer|2015–2019|Females|5|40–44|0.817|0.783|0.847
Observed|Cervical cancer|2015–2019|Females|5|45–49|0.777|0.737|0.812
Observed|Cervical cancer|2015–2019|Females|5|50–54|0.71|0.66|0.754
Observed|Cervical cancer|2015–2019|Females|5|55–59|0.642|0.585|0.693
Observed|Cervical cancer|2015–2019|Females|5|60–64|0.688|0.63|0.738
Observed|Cervical cancer|2015–2019|Females|5|65–69|0.598|0.534|0.656
Observed|Cervical cancer|2015–2019|Females|5|70–74|0.464|0.391|0.534
Observed|Cervical cancer|2015–2019|Females|5|75–79|0.317|0.244|0.392
Observed|Cervical cancer|2015–2019|Females|5|80–84|0.241|0.168|0.322
Observed|Cervical cancer|2015–2019|Females|5|85+|0.13|0.081|0.192
Observed|Cervical cancer|2015–2019|Females|5|All ages combined|0.73|0.716|0.743
Relative|Cervical cancer|2015–2019|Females|1|00–04|||
Relative|Cervical cancer|2015–2019|Females|1|05–09|||
Relative|Cervical cancer|2015–2019|Females|1|10–14|||
Relative|Cervical cancer|2015–2019|Females|1|15–19|||
Relative|Cervical cancer|2015–2019|Females|1|20–24|1|0.925|1
Relative|Cervical cancer|2015–2019|Females|1|25–29|0.977|0.95|0.99
Relative|Cervical cancer|2015–2019|Females|1|30–34|0.984|0.97|0.992
Relative|Cervical cancer|2015–2019|Females|1|35–39|0.964|0.945|0.976
Relative|Cervical cancer|2015–2019|Females|1|40–44|0.945|0.923|0.961
Relative|Cervical cancer|2015–2019|Females|1|45–49|0.938|0.914|0.956
Relative|Cervical cancer|2015–2019|Females|1|50–54|0.891|0.854|0.92
Relative|Cervical cancer|2015–2019|Females|1|55–59|0.882|0.841|0.913
Relative|Cervical cancer|2015–2019|Females|1|60–64|0.871|0.826|0.905
Relative|Cervical cancer|2015–2019|Females|1|65–69|0.817|0.762|0.861
Relative|Cervical cancer|2015–2019|Females|1|70–74|0.768|0.7|0.823
Relative|Cervical cancer|2015–2019|Females|1|75–79|0.74|0.659|0.806
Relative|Cervical cancer|2015–2019|Females|1|80–84|0.595|0.497|0.681
Relative|Cervical cancer|2015–2019|Females|1|85+|0.454|0.355|0.55
Relative|Cervical cancer|2015–2019|Females|1|All ages combined|0.898|0.888|0.907
Relative|Cervical cancer|2015–2019|Females|2|00–04|||
Relative|Cervical cancer|2015–2019|Females|2|05–09|||
Relative|Cervical cancer|2015–2019|Females|2|10–14|||
Relative|Cervical cancer|2015–2019|Females|2|15–19|||
Relative|Cervical cancer|2015–2019|Females|2|20–24|0.954|0.826|0.989
Relative|Cervical cancer|2015–2019|Females|2|25–29|0.929|0.892|0.954
Relative|Cervical cancer|2015–2019|Females|2|30–34|0.954|0.932|0.968
Relative|Cervical cancer|2015–2019|Females|2|35–39|0.93|0.906|0.949
Relative|Cervical cancer|2015–2019|Females|2|40–44|0.885|0.856|0.909
Relative|Cervical cancer|2015–2019|Females|2|45–49|0.878|0.846|0.904
Relative|Cervical cancer|2015–2019|Females|2|50–54|0.812|0.767|0.85
Relative|Cervical cancer|2015–2019|Females|2|55–59|0.78|0.729|0.823
Relative|Cervical cancer|2015–2019|Females|2|60–64|0.779|0.726|0.823
Relative|Cervical cancer|2015–2019|Females|2|65–69|0.752|0.692|0.802
Relative|Cervical cancer|2015–2019|Females|2|70–74|0.65|0.574|0.717
Relative|Cervical cancer|2015–2019|Females|2|75–79|0.522|0.435|0.603
Relative|Cervical cancer|2015–2019|Females|2|80–84|0.475|0.377|0.57
Relative|Cervical cancer|2015–2019|Females|2|85+|0.313|0.222|0.411
Relative|Cervical cancer|2015–2019|Females|2|All ages combined|0.828|0.816|0.839
Relative|Cervical cancer|2015–2019|Females|3|00–04|||
Relative|Cervical cancer|2015–2019|Females|3|05–09|||
Relative|Cervical cancer|2015–2019|Females|3|10–14|||
Relative|Cervical cancer|2015–2019|Females|3|15–19|||
Relative|Cervical cancer|2015–2019|Females|3|20–24|0.918|0.794|0.969
Relative|Cervical cancer|2015–2019|Females|3|25–29|0.917|0.879|0.944
Relative|Cervical cancer|2015–2019|Females|3|30–34|0.939|0.915|0.956
Relative|Cervical cancer|2015–2019|Females|3|35–39|0.909|0.882|0.93
Relative|Cervical cancer|2015–2019|Females|3|40–44|0.847|0.814|0.874
Relative|Cervical cancer|2015–2019|Females|3|45–49|0.83|0.794|0.861
Relative|Cervical cancer|2015–2019|Females|3|50–54|0.766|0.718|0.807
Relative|Cervical cancer|2015–2019|Females|3|55–59|0.722|0.667|0.769
Relative|Cervical cancer|2015–2019|Females|3|60–64|0.751|0.696|0.798
Relative|Cervical cancer|2015–2019|Females|3|65–69|0.689|0.626|0.745
Relative|Cervical cancer|2015–2019|Females|3|70–74|0.562|0.484|0.634
Relative|Cervical cancer|2015–2019|Females|3|75–79|0.469|0.382|0.553
Relative|Cervical cancer|2015–2019|Females|3|80–84|0.364|0.27|0.462
Relative|Cervical cancer|2015–2019|Females|3|85+|0.253|0.167|0.353
Relative|Cervical cancer|2015–2019|Females|3|All ages combined|0.788|0.775|0.801
Relative|Cervical cancer|2015–2019|Females|4|00–04|||
Relative|Cervical cancer|2015–2019|Females|4|05–09|||
Relative|Cervical cancer|2015–2019|Females|4|10–14|||
Relative|Cervical cancer|2015–2019|Females|4|15–19|||
Relative|Cervical cancer|2015–2019|Females|4|20–24|0.902|0.777|0.959
Relative|Cervical cancer|2015–2019|Females|4|25–29|0.912|0.873|0.94
Relative|Cervical cancer|2015–2019|Females|4|30–34|0.922|0.895|0.942
Relative|Cervical cancer|2015–2019|Females|4|35–39|0.889|0.86|0.913
Relative|Cervical cancer|2015–2019|Females|4|40–44|0.828|0.794|0.857
Relative|Cervical cancer|2015–2019|Females|4|45–49|0.799|0.76|0.833
Relative|Cervical cancer|2015–2019|Females|4|50–54|0.733|0.683|0.777
Relative|Cervical cancer|2015–2019|Females|4|55–59|0.68|0.623|0.73
Relative|Cervical cancer|2015–2019|Females|4|60–64|0.724|0.666|0.774
Relative|Cervical cancer|2015–2019|Females|4|65–69|0.647|0.582|0.706
Relative|Cervical cancer|2015–2019|Females|4|70–74|0.519|0.441|0.593
Relative|Cervical cancer|2015–2019|Females|4|75–79|0.368|0.285|0.452
Relative|Cervical cancer|2015–2019|Females|4|80–84|0.366|0.268|0.469
Relative|Cervical cancer|2015–2019|Females|4|85+|0.276|0.18|0.39
Relative|Cervical cancer|2015–2019|Females|4|All ages combined|0.763|0.749|0.776
Relative|Cervical cancer|2015–2019|Females|5|00–04|||
Relative|Cervical cancer|2015–2019|Females|5|05–09|||
Relative|Cervical cancer|2015–2019|Females|5|10–14|||
Relative|Cervical cancer|2015–2019|Females|5|15–19|||
Relative|Cervical cancer|2015–2019|Females|5|20–24|0.902|0.778|0.959
Relative|Cervical cancer|2015–2019|Females|5|25–29|0.909|0.87|0.937
Relative|Cervical cancer|2015–2019|Females|5|30–34|0.918|0.891|0.939
Relative|Cervical cancer|2015–2019|Females|5|35–39|0.874|0.843|0.899
Relative|Cervical cancer|2015–2019|Females|5|40–44|0.822|0.788|0.852
Relative|Cervical cancer|2015–2019|Females|5|45–49|0.784|0.743|0.819
Relative|Cervical cancer|2015–2019|Females|5|50–54|0.719|0.668|0.763
Relative|Cervical cancer|2015–2019|Females|5|55–59|0.654|0.596|0.705
Relative|Cervical cancer|2015–2019|Females|5|60–64|0.707|0.648|0.759
Relative|Cervical cancer|2015–2019|Females|5|65–69|0.625|0.558|0.686
Relative|Cervical cancer|2015–2019|Females|5|70–74|0.501|0.422|0.577
Relative|Cervical cancer|2015–2019|Females|5|75–79|0.366|0.281|0.452
Relative|Cervical cancer|2015–2019|Females|5|80–84|0.32|0.222|0.427
Relative|Cervical cancer|2015–2019|Females|5|85+|0.264|0.164|0.389
Relative|Cervical cancer|2015–2019|Females|5|All ages combined|0.75|0.736|0.763
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|35–39|1|0.913|1
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|40–44|1|0.962|1
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|45–49|0.988|0.953|0.997
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|50–54|0.991|0.972|0.997
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|55–59|0.984|0.968|0.992
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|60–64|0.983|0.969|0.99
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|65–69|0.96|0.946|0.971
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|70–74|0.956|0.942|0.967
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|75–79|0.922|0.901|0.938
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|80–84|0.859|0.828|0.884
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|85+|0.727|0.687|0.763
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|1|All ages combined|0.93|0.923|0.937
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|35–39|1|0.91|1
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|40–44|1|0.96|1
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|45–49|0.97|0.929|0.987
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|50–54|0.972|0.948|0.986
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|55–59|0.964|0.943|0.977
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|60–64|0.953|0.934|0.966
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|65–69|0.929|0.911|0.943
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|70–74|0.917|0.897|0.932
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|75–79|0.849|0.822|0.872
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|80–84|0.767|0.731|0.8
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|85+|0.603|0.56|0.643
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|2|All ages combined|0.88|0.871|0.888
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|35–39|0.925|0.733|0.981
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|40–44|0.986|0.906|0.998
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|45–49|0.952|0.906|0.976
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|50–54|0.96|0.931|0.976
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|55–59|0.937|0.912|0.956
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|60–64|0.936|0.915|0.952
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|65–69|0.897|0.876|0.915
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|70–74|0.872|0.849|0.892
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|75–79|0.78|0.749|0.808
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|80–84|0.676|0.636|0.714
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|85+|0.479|0.436|0.522
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|3|All ages combined|0.83|0.82|0.84
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|35–39|0.925|0.733|0.981
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|40–44|0.973|0.897|0.993
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|45–49|0.952|0.906|0.976
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|50–54|0.943|0.91|0.963
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|55–59|0.935|0.909|0.954
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|60–64|0.909|0.885|0.929
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|65–69|0.86|0.836|0.881
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|70–74|0.82|0.793|0.844
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|75–79|0.709|0.675|0.741
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|80–84|0.58|0.536|0.621
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|85+|0.35|0.308|0.392
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|4|All ages combined|0.779|0.768|0.79
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|35–39|0.925|0.733|0.981
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|40–44|0.96|0.882|0.987
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|45–49|0.952|0.906|0.976
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|50–54|0.936|0.902|0.958
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|55–59|0.912|0.882|0.934
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|60–64|0.87|0.842|0.894
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|65–69|0.822|0.795|0.846
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|70–74|0.764|0.733|0.792
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|75–79|0.653|0.616|0.687
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|80–84|0.488|0.443|0.531
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|85+|0.252|0.213|0.293
Observed|Chronic lymphocytic leukaemia|2015–2019|Males|5|All ages combined|0.732|0.719|0.744
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|35–39|1.001|0.914|1.001
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|40–44|1.002|0.963|1.002
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|45–49|0.99|0.955|0.999
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|50–54|0.994|0.976|1.001
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|55–59|0.989|0.974|0.997
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|60–64|0.99|0.977|0.998
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|65–69|0.972|0.958|0.983
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|70–74|0.975|0.96|0.986
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|75–79|0.953|0.932|0.97
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|80–84|0.913|0.88|0.94
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|85+|0.839|0.793|0.88
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|1|All ages combined|0.96|0.952|0.966
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|35–39|1.002|0.912|1.002
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|40–44|1.003|0.963|1.003
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|45–49|0.975|0.934|0.992
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|50–54|0.98|0.955|0.993
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|55–59|0.974|0.954|0.988
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|60–64|0.969|0.95|0.983
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|65–69|0.953|0.934|0.968
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|70–74|0.955|0.935|0.971
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|75–79|0.911|0.882|0.936
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|80–84|0.873|0.832|0.91
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|85+|0.811|0.754|0.865
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|2|All ages combined|0.935|0.926|0.944
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|35–39|0.929|0.736|0.984
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|40–44|0.991|0.911|1.003
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|45–49|0.959|0.913|0.983
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|50–54|0.971|0.942|0.988
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|55–59|0.954|0.928|0.973
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|60–64|0.961|0.94|0.978
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|65–69|0.934|0.912|0.952
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|70–74|0.931|0.906|0.952
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|75–79|0.874|0.839|0.905
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|80–84|0.832|0.782|0.877
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|85+|0.76|0.692|0.827
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|3|All ages combined|0.91|0.899|0.921
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|35–39|0.93|0.737|0.986
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|40–44|0.981|0.904|1.001
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|45–49|0.962|0.915|0.986
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|50–54|0.958|0.925|0.979
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|55–59|0.958|0.931|0.977
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|60–64|0.943|0.918|0.963
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|65–69|0.91|0.884|0.932
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|70–74|0.899|0.868|0.925
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|75–79|0.833|0.792|0.87
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|80–84|0.778|0.72|0.833
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|85+|0.665|0.585|0.745
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|4|All ages combined|0.882|0.869|0.895
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|35–39|0.931|0.738|0.987
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|40–44|0.969|0.89|0.997
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|45–49|0.965|0.918|0.989
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|50–54|0.955|0.921|0.978
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|55–59|0.941|0.91|0.964
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|60–64|0.913|0.883|0.937
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|65–69|0.885|0.856|0.91
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|70–74|0.862|0.827|0.894
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|75–79|0.809|0.763|0.851
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|80–84|0.723|0.657|0.787
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|85+|0.582|0.492|0.676
Relative|Chronic lymphocytic leukaemia|2015–2019|Males|5|All ages combined|0.854|0.84|0.868
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|35–39|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|40–44|0.975|0.838|0.996
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|45–49|1|0.968|1
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|50–54|0.994|0.957|0.999
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|55–59|0.985|0.96|0.994
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|60–64|0.992|0.976|0.997
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|65–69|0.975|0.958|0.986
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|70–74|0.962|0.943|0.975
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|75–79|0.952|0.93|0.968
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|80–84|0.885|0.851|0.912
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|85+|0.749|0.707|0.786
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|1|All ages combined|0.933|0.924|0.941
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|35–39|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|40–44|0.975|0.838|0.996
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|45–49|0.988|0.921|0.998
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|50–54|0.982|0.944|0.994
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|55–59|0.965|0.934|0.982
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|60–64|0.979|0.958|0.989
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|65–69|0.953|0.931|0.968
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|70–74|0.929|0.905|0.948
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|75–79|0.91|0.882|0.932
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|80–84|0.801|0.759|0.837
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|85+|0.594|0.548|0.637
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|2|All ages combined|0.882|0.871|0.892
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|35–39|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|40–44|0.975|0.838|0.996
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|45–49|0.988|0.921|0.998
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|50–54|0.982|0.944|0.994
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|55–59|0.945|0.909|0.967
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|60–64|0.965|0.94|0.979
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|65–69|0.927|0.9|0.947
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|70–74|0.909|0.882|0.93
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|75–79|0.875|0.842|0.902
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|80–84|0.698|0.65|0.741
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|85+|0.484|0.437|0.529
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|3|All ages combined|0.839|0.826|0.851
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|35–39|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|40–44|0.975|0.838|0.996
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|45–49|0.988|0.921|0.998
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|50–54|0.968|0.925|0.987
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|55–59|0.928|0.887|0.954
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|60–64|0.953|0.926|0.971
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|65–69|0.91|0.881|0.933
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|70–74|0.885|0.854|0.909
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|75–79|0.829|0.79|0.861
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|80–84|0.605|0.554|0.653
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|85+|0.394|0.348|0.44
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|4|All ages combined|0.799|0.785|0.813
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|35–39|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|40–44|0.947|0.804|0.987
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|45–49|0.988|0.921|0.998
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|50–54|0.968|0.925|0.987
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|55–59|0.923|0.882|0.95
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|60–64|0.947|0.918|0.966
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|65–69|0.875|0.84|0.903
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|70–74|0.848|0.813|0.877
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|75–79|0.767|0.723|0.805
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|80–84|0.56|0.508|0.609
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|85+|0.286|0.242|0.33
Observed|Chronic lymphocytic leukaemia|2015–2019|Females|5|All ages combined|0.759|0.743|0.774
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|35–39|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|40–44|0.976|0.839|0.997
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|45–49|1.001|0.97|1.001
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|50–54|0.996|0.96|1.001
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|55–59|0.988|0.963|0.997
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|60–64|0.997|0.98|1.002
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|65–69|0.982|0.965|0.993
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|70–74|0.974|0.954|0.987
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|75–79|0.973|0.951|0.989
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|80–84|0.923|0.887|0.951
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|85+|0.845|0.798|0.887
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|1|All ages combined|0.959|0.95|0.967
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|35–39|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|40–44|0.977|0.839|0.998
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|45–49|0.991|0.923|1.001
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|50–54|0.986|0.948|0.999
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|55–59|0.972|0.94|0.988
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|60–64|0.988|0.967|0.999
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|65–69|0.968|0.945|0.983
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|70–74|0.953|0.928|0.972
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|75–79|0.953|0.923|0.976
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|80–84|0.875|0.83|0.914
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|85+|0.759|0.7|0.814
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|2|All ages combined|0.932|0.92|0.943
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|35–39|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|40–44|0.978|0.84|1
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|45–49|0.993|0.925|1.003
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|50–54|0.989|0.951|1.001
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|55–59|0.955|0.918|0.977
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|60–64|0.98|0.954|0.994
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|65–69|0.95|0.922|0.97
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|70–74|0.947|0.918|0.969
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|75–79|0.942|0.907|0.971
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|80–84|0.806|0.75|0.856
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|85+|0.708|0.64|0.774
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|3|All ages combined|0.91|0.896|0.923
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|35–39|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|40–44|0.98|0.841|1.001
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|45–49|0.995|0.927|1.005
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|50–54|0.978|0.935|0.996
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|55–59|0.941|0.9|0.968
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|60–64|0.974|0.946|0.992
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|65–69|0.942|0.911|0.965
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|70–74|0.937|0.904|0.963
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|75–79|0.921|0.879|0.957
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|80–84|0.744|0.681|0.802
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|85+|0.668|0.59|0.746
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|4|All ages combined|0.891|0.875|0.906
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|35–39|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|40–44|0.953|0.809|0.992
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|45–49|0.997|0.928|1.007
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|50–54|0.981|0.937|0.999
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|55–59|0.94|0.898|0.968
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|60–64|0.974|0.944|0.993
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|65–69|0.915|0.879|0.944
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|70–74|0.916|0.878|0.947
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|75–79|0.885|0.834|0.929
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|80–84|0.741|0.672|0.805
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|85+|0.573|0.486|0.663
Relative|Chronic lymphocytic leukaemia|2015–2019|Females|5|All ages combined|0.871|0.853|0.888
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|35–39|1|0.938|1
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|40–44|0.991|0.941|0.999
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|45–49|0.992|0.97|0.998
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|50–54|0.992|0.979|0.997
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|55–59|0.984|0.973|0.991
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|60–64|0.986|0.977|0.991
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|65–69|0.965|0.955|0.974
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|70–74|0.958|0.947|0.967
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|75–79|0.934|0.919|0.946
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|80–84|0.87|0.847|0.889
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|85+|0.738|0.709|0.764
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|1|All ages combined|0.931|0.926|0.936
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|35–39|1|0.937|1
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|40–44|0.991|0.941|0.999
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|45–49|0.976|0.948|0.989
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|50–54|0.975|0.957|0.986
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|55–59|0.964|0.948|0.975
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|60–64|0.962|0.948|0.972
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|65–69|0.937|0.924|0.948
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|70–74|0.921|0.907|0.934
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|75–79|0.873|0.853|0.89
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|80–84|0.781|0.754|0.806
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|85+|0.599|0.568|0.628
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|2|All ages combined|0.88|0.874|0.887
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|35–39|0.926|0.789|0.976
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|40–44|0.982|0.931|0.996
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|45–49|0.964|0.932|0.981
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|50–54|0.967|0.947|0.98
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|55–59|0.94|0.92|0.955
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|60–64|0.946|0.931|0.959
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|65–69|0.907|0.891|0.921
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|70–74|0.886|0.869|0.901
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|75–79|0.817|0.794|0.838
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|80–84|0.686|0.655|0.714
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|85+|0.482|0.45|0.513
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|3|All ages combined|0.833|0.825|0.841
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|35–39|0.926|0.789|0.976
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|40–44|0.974|0.92|0.991
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|45–49|0.964|0.932|0.981
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|50–54|0.951|0.927|0.967
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|55–59|0.932|0.912|0.949
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|60–64|0.925|0.907|0.939
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|65–69|0.877|0.859|0.893
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|70–74|0.844|0.824|0.862
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|75–79|0.755|0.729|0.779
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|80–84|0.591|0.558|0.622
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|85+|0.37|0.339|0.401
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|4|All ages combined|0.787|0.778|0.795
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|00–04|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|05–09|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|10–14|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|15–19|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|20–24|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|25–29|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|30–34|||
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|35–39|0.926|0.789|0.976
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|40–44|0.956|0.897|0.981
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|45–49|0.964|0.932|0.981
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|50–54|0.947|0.922|0.964
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|55–59|0.915|0.892|0.934
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|60–64|0.897|0.877|0.914
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|65–69|0.84|0.819|0.859
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|70–74|0.796|0.773|0.817
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|75–79|0.696|0.668|0.723
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|80–84|0.52|0.486|0.552
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|85+|0.267|0.238|0.298
Observed|Chronic lymphocytic leukaemia|2015–2019|Persons|5|All ages combined|0.742|0.732|0.751
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|35–39|1.001|0.939|1.001
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|40–44|0.993|0.942|1
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|45–49|0.994|0.972|1
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|50–54|0.995|0.982|1
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|55–59|0.989|0.977|0.996
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|60–64|0.993|0.983|0.998
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|65–69|0.976|0.965|0.984
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|70–74|0.975|0.963|0.983
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|75–79|0.961|0.946|0.974
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|80–84|0.917|0.894|0.937
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|85+|0.842|0.81|0.872
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|1|All ages combined|0.959|0.954|0.964
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|35–39|1.002|0.939|1.002
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|40–44|0.994|0.944|1.002
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|45–49|0.981|0.952|0.994
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|50–54|0.982|0.963|0.992
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|55–59|0.974|0.957|0.985
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|60–64|0.976|0.962|0.986
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|65–69|0.958|0.944|0.969
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|70–74|0.954|0.939|0.967
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|75–79|0.928|0.907|0.946
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|80–84|0.874|0.844|0.902
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|85+|0.786|0.745|0.825
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|2|All ages combined|0.934|0.927|0.941
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|35–39|0.929|0.791|0.979
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|40–44|0.987|0.936|1
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|45–49|0.971|0.939|0.988
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|50–54|0.977|0.956|0.99
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|55–59|0.954|0.934|0.969
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|60–64|0.968|0.952|0.98
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|65–69|0.939|0.922|0.954
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|70–74|0.937|0.919|0.953
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|75–79|0.901|0.875|0.923
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|80–84|0.821|0.784|0.855
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|85+|0.735|0.687|0.783
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|3|All ages combined|0.91|0.902|0.919
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|35–39|0.93|0.792|0.98
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|40–44|0.98|0.926|0.998
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|45–49|0.973|0.941|0.99
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|50–54|0.965|0.941|0.981
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|55–59|0.952|0.931|0.969
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|60–64|0.954|0.936|0.969
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|65–69|0.921|0.901|0.938
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|70–74|0.913|0.891|0.933
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|75–79|0.867|0.838|0.894
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|80–84|0.764|0.721|0.804
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|85+|0.666|0.61|0.723
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|4|All ages combined|0.886|0.876|0.895
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|00–04|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|05–09|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|10–14|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|15–19|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|20–24|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|25–29|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|30–34|||
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|35–39|0.932|0.793|0.981
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|40–44|0.964|0.904|0.99
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|45–49|0.976|0.944|0.993
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|50–54|0.964|0.939|0.981
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|55–59|0.94|0.917|0.959
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|60–64|0.934|0.913|0.952
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|65–69|0.895|0.873|0.915
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|70–74|0.883|0.857|0.906
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|75–79|0.838|0.805|0.87
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|80–84|0.733|0.686|0.779
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|85+|0.577|0.514|0.642
Relative|Chronic lymphocytic leukaemia|2015–2019|Persons|5|All ages combined|0.86|0.849|0.871
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|20–24|1|0.867|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|25–29|1|0.905|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|30–34|1|0.934|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|35–39|1|0.947|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|40–44|0.986|0.903|0.998
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|45–49|1|0.956|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|50–54|0.978|0.913|0.994
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|55–59|0.964|0.891|0.988
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|60–64|0.976|0.907|0.994
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|65–69|0.939|0.876|0.97
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|70–74|0.892|0.808|0.94
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|75–79|0.85|0.739|0.916
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|80–84|0.752|0.636|0.835
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|85+|0.54|0.422|0.643
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|All ages combined|0.911|0.891|0.927
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|20–24|0.915|0.701|0.978
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|25–29|0.933|0.757|0.983
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|30–34|0.978|0.854|0.997
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|35–39|0.96|0.848|0.99
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|40–44|0.986|0.903|0.998
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|45–49|0.971|0.888|0.993
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|50–54|0.978|0.913|0.994
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|55–59|0.915|0.83|0.959
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|60–64|0.952|0.876|0.982
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|65–69|0.904|0.833|0.945
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|70–74|0.821|0.724|0.886
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|75–79|0.789|0.67|0.869
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|80–84|0.616|0.491|0.718
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|85+|0.428|0.319|0.533
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|All ages combined|0.861|0.837|0.881
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|20–24|0.915|0.701|0.978
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|25–29|0.933|0.757|0.983
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|30–34|0.978|0.854|0.997
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|35–39|0.96|0.848|0.99
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|40–44|0.931|0.843|0.971
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|45–49|0.957|0.873|0.986
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|50–54|0.966|0.897|0.989
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|55–59|0.882|0.791|0.934
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|60–64|0.952|0.876|0.982
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|65–69|0.883|0.807|0.931
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|70–74|0.808|0.709|0.876
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|75–79|0.644|0.514|0.747
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|80–84|0.471|0.344|0.588
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|85+|0.288|0.196|0.385
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|All ages combined|0.816|0.791|0.839
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|20–24|0.915|0.701|0.978
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|25–29|0.933|0.757|0.983
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|30–34|0.978|0.854|0.997
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|35–39|0.94|0.826|0.98
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|40–44|0.904|0.809|0.953
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|45–49|0.957|0.873|0.986
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|50–54|0.966|0.897|0.989
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|55–59|0.851|0.758|0.911
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|60–64|0.909|0.826|0.954
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|65–69|0.85|0.766|0.906
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|70–74|0.795|0.695|0.866
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|75–79|0.628|0.497|0.733
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|80–84|0.355|0.239|0.473
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|85+|0.224|0.144|0.315
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|All ages combined|0.788|0.761|0.812
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|20–24|0.915|0.701|0.978
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|25–29|0.933|0.757|0.983
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|30–34|0.978|0.854|0.997
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|35–39|0.94|0.826|0.98
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|40–44|0.891|0.793|0.944
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|45–49|0.957|0.873|0.986
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|50–54|0.966|0.897|0.989
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|55–59|0.841|0.746|0.903
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|60–64|0.899|0.815|0.946
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|65–69|0.828|0.74|0.889
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|70–74|0.768|0.663|0.844
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|75–79|0.545|0.415|0.658
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|80–84|0.244|0.143|0.359
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|85+|0.147|0.083|0.228
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|All ages combined|0.762|0.734|0.787
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|20–24|1.001|0.868|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|25–29|1.001|0.905|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|30–34|1.001|0.935|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|35–39|1.001|0.948|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|40–44|0.987|0.904|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|45–49|1.002|0.958|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|50–54|0.981|0.917|0.998
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|55–59|0.969|0.896|0.993
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|60–64|0.984|0.914|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|65–69|0.951|0.887|0.982
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|70–74|0.909|0.824|0.959
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|75–79|0.879|0.764|0.947
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|80–84|0.799|0.675|0.888
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|85+|0.625|0.488|0.745
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|1|All ages combined|0.931|0.911|0.947
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|20–24|0.916|0.701|0.979
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|25–29|0.934|0.758|0.984
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|30–34|0.98|0.856|0.999
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|35–39|0.962|0.85|0.992
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|40–44|0.989|0.906|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|45–49|0.975|0.892|0.997
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|50–54|0.985|0.92|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|55–59|0.925|0.839|0.969
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|60–64|0.968|0.891|0.998
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|65–69|0.927|0.854|0.97
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|70–74|0.855|0.754|0.924
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|75–79|0.846|0.719|0.933
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|80–84|0.701|0.559|0.817
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|85+|0.578|0.431|0.719
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|2|All ages combined|0.896|0.872|0.918
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|20–24|0.917|0.702|0.98
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|25–29|0.935|0.759|0.985
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|30–34|0.981|0.857|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|35–39|0.963|0.851|0.993
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|40–44|0.936|0.847|0.976
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|45–49|0.964|0.879|0.994
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|50–54|0.977|0.907|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|55–59|0.897|0.805|0.951
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|60–64|0.977|0.899|1.007
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|65–69|0.92|0.84|0.969
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|70–74|0.863|0.757|0.936
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|75–79|0.72|0.574|0.835
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|80–84|0.579|0.423|0.723
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|85+|0.459|0.314|0.615
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|3|All ages combined|0.867|0.839|0.891
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|20–24|0.917|0.702|0.98
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|25–29|0.935|0.759|0.986
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|30–34|0.982|0.858|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|35–39|0.945|0.83|0.985
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|40–44|0.91|0.815|0.96
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|45–49|0.967|0.882|0.997
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|50–54|0.981|0.911|1.005
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|55–59|0.872|0.776|0.933
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|60–64|0.942|0.857|0.988
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|65–69|0.899|0.81|0.958
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|70–74|0.873|0.762|0.951
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|75–79|0.735|0.582|0.858
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|80–84|0.476|0.321|0.634
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|85+|0.428|0.275|0.602
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|4|All ages combined|0.851|0.822|0.877
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|20–24|0.918|0.703|0.981
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|25–29|0.936|0.76|0.986
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|30–34|0.983|0.859|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|35–39|0.946|0.831|0.987
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|40–44|0.899|0.801|0.953
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|45–49|0.97|0.885|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|50–54|0.986|0.916|1.009
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|55–59|0.867|0.77|0.931
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|60–64|0.942|0.854|0.992
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|65–69|0.892|0.797|0.957
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|70–74|0.869|0.75|0.955
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|75–79|0.673|0.512|0.812
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|80–84|0.361|0.212|0.531
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|85+|0.336|0.19|0.521
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Males|5|All ages combined|0.836|0.805|0.864
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|20–24|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|25–29|1|0.887|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|30–34|1|0.906|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|35–39|1|0.923|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|40–44|1|0.939|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|45–49|0.982|0.881|0.997
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|50–54|1|0.95|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|55–59|0.965|0.896|0.989
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|60–64|0.989|0.927|0.999
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|65–69|1|0.962|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|70–74|0.892|0.795|0.944
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|75–79|0.878|0.761|0.94
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|80–84|0.877|0.729|0.947
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|85+|0.502|0.373|0.618
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|All ages combined|0.928|0.908|0.945
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|20–24|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|25–29|1|0.88|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|30–34|1|0.905|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|35–39|1|0.924|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|40–44|1|0.936|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|45–49|0.982|0.881|0.997
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|50–54|0.984|0.894|0.998
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|55–59|0.941|0.863|0.975
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|60–64|0.944|0.871|0.976
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|65–69|1|0.96|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|70–74|0.863|0.76|0.924
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|75–79|0.766|0.631|0.857
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|80–84|0.824|0.665|0.912
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|85+|0.29|0.19|0.398
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|All ages combined|0.884|0.859|0.905
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|20–24|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|25–29|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|30–34|1|0.903|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|35–39|0.976|0.843|0.997
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|40–44|1|0.934|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|45–49|0.946|0.843|0.982
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|50–54|0.956|0.87|0.986
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|55–59|0.929|0.848|0.967
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|60–64|0.932|0.855|0.969
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|65–69|0.969|0.88|0.992
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|70–74|0.848|0.742|0.913
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|75–79|0.732|0.595|0.829
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|80–84|0.67|0.5|0.793
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|85+|0.227|0.14|0.325
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|All ages combined|0.85|0.823|0.874
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|20–24|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|25–29|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|30–34|1|0.901|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|35–39|0.976|0.843|0.997
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|40–44|1|0.933|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|45–49|0.929|0.822|0.973
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|50–54|0.956|0.87|0.986
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|55–59|0.916|0.832|0.959
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|60–64|0.882|0.792|0.935
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|65–69|0.918|0.814|0.965
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|70–74|0.806|0.694|0.88
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|75–79|0.732|0.595|0.829
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|80–84|0.499|0.338|0.64
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|85+|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|All ages combined|0.82|0.791|0.846
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|20–24|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|25–29|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|30–34|1|0.898|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|35–39|0.976|0.843|0.997
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|40–44|1|0.933|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|45–49|0.929|0.822|0.973
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|50–54|0.942|0.854|0.978
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|55–59|0.891|0.802|0.942
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|60–64|0.882|0.792|0.935
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|65–69|0.864|0.747|0.93
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|70–74|0.766|0.651|0.848
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|75–79|0.691|0.55|0.795
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|80–84|0.431|0.279|0.575
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|85+|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|All ages combined|0.788|0.756|0.815
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|20–24|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|25–29|1|0.887|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|30–34|1|0.907|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|35–39|1.001|0.923|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|40–44|1.001|0.94|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|45–49|0.984|0.882|0.999
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|50–54|1.002|0.952|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|55–59|0.968|0.899|0.992
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|60–64|0.994|0.932|1.003
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|65–69|1.007|0.969|1.007
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|70–74|0.903|0.805|0.956
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|75–79|0.897|0.777|0.96
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|80–84|0.915|0.761|0.988
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|85+|0.569|0.423|0.7
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|1|All ages combined|0.945|0.924|0.961
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|20–24|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|25–29|1.001|0.88|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|30–34|1.001|0.906|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|35–39|1.001|0.925|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|40–44|1.002|0.938|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|45–49|0.985|0.884|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|50–54|0.989|0.898|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|55–59|0.947|0.869|0.981
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|60–64|0.953|0.879|0.986
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|65–69|1.015|0.975|1.015
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|70–74|0.885|0.779|0.948
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|75–79|0.802|0.661|0.897
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|80–84|0.901|0.728|0.998
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|85+|0.374|0.245|0.513
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|2|All ages combined|0.912|0.886|0.933
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|20–24|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|25–29|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|30–34|1.001|0.904|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|35–39|0.978|0.844|0.999
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|40–44|1.003|0.937|1.003
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|45–49|0.951|0.847|0.987
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|50–54|0.963|0.876|0.993
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|55–59|0.938|0.857|0.977
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|60–64|0.947|0.868|0.984
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|65–69|0.991|0.901|1.015
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|70–74|0.883|0.773|0.951
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|75–79|0.788|0.64|0.892
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|80–84|0.773|0.577|0.916
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|85+|0.336|0.208|0.482
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|3|All ages combined|0.889|0.86|0.914
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|20–24|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|25–29|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|30–34|1.002|0.903|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|35–39|0.979|0.845|0.999
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|40–44|1.004|0.937|1.004
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|45–49|0.935|0.827|0.979
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|50–54|0.965|0.878|0.995
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|55–59|0.929|0.844|0.973
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|60–64|0.901|0.809|0.955
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|65–69|0.948|0.841|0.997
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|70–74|0.854|0.735|0.933
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|75–79|0.813|0.661|0.921
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|80–84|0.614|0.415|0.788
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|85+|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|4|All ages combined|0.869|0.838|0.897
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|20–24|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|25–29|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|30–34|1.002|0.901|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|35–39|0.98|0.846|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|40–44|1.006|0.938|1.006
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|45–49|0.937|0.828|0.981
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|50–54|0.954|0.864|0.99
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|55–59|0.908|0.816|0.96
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|60–64|0.907|0.814|0.961
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|65–69|0.903|0.78|0.971
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|70–74|0.827|0.703|0.915
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|75–79|0.796|0.633|0.916
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|80–84|0.569|0.368|0.758
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|85+|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Females|5|All ages combined|0.846|0.813|0.876
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|20–24|1|0.914|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|25–29|1|0.947|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|30–34|1|0.961|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|35–39|1|0.968|1
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|40–44|0.991|0.941|0.999
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|45–49|0.992|0.943|0.999
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|50–54|0.986|0.947|0.997
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|55–59|0.964|0.923|0.984
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|60–64|0.983|0.949|0.995
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|65–69|0.964|0.925|0.982
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|70–74|0.892|0.834|0.93
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|75–79|0.863|0.788|0.912
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|80–84|0.797|0.71|0.86
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|85+|0.523|0.437|0.602
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|All ages combined|0.918|0.904|0.93
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|20–24|0.94|0.78|0.985
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|25–29|0.961|0.853|0.99
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|30–34|0.987|0.909|0.998
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|35–39|0.977|0.912|0.994
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|40–44|0.991|0.941|0.999
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|45–49|0.976|0.927|0.992
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|50–54|0.98|0.938|0.993
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|55–59|0.928|0.876|0.958
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|60–64|0.948|0.902|0.973
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|65–69|0.942|0.897|0.967
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|70–74|0.839|0.773|0.888
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|75–79|0.779|0.694|0.843
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|80–84|0.691|0.595|0.768
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|85+|0.365|0.289|0.442
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|All ages combined|0.871|0.854|0.886
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|20–24|0.911|0.749|0.97
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|25–29|0.961|0.853|0.99
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|30–34|0.987|0.909|0.998
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|35–39|0.966|0.898|0.989
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|40–44|0.956|0.898|0.982
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|45–49|0.953|0.898|0.978
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|50–54|0.96|0.913|0.982
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|55–59|0.905|0.849|0.94
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|60–64|0.942|0.895|0.968
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|65–69|0.917|0.866|0.949
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|70–74|0.826|0.758|0.876
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|75–79|0.687|0.596|0.761
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|80–84|0.544|0.443|0.635
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|85+|0.261|0.197|0.331
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|All ages combined|0.831|0.813|0.848
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|20–24|0.911|0.749|0.97
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|25–29|0.961|0.853|0.99
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|30–34|0.987|0.909|0.998
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|35–39|0.955|0.885|0.983
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|40–44|0.939|0.876|0.97
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|45–49|0.945|0.888|0.973
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|50–54|0.96|0.913|0.982
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|55–59|0.882|0.824|0.922
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|60–64|0.896|0.84|0.933
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|65–69|0.877|0.817|0.918
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|70–74|0.799|0.728|0.854
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|75–79|0.678|0.587|0.753
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|80–84|0.408|0.313|0.501
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|85+|0.212|0.154|0.277
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|All ages combined|0.802|0.782|0.82
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|00–04|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|05–09|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|10–14|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|15–19|||
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|20–24|0.911|0.749|0.97
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|25–29|0.961|0.853|0.99
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|30–34|0.987|0.909|0.998
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|35–39|0.955|0.885|0.983
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|40–44|0.93|0.866|0.965
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|45–49|0.945|0.888|0.973
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|50–54|0.954|0.906|0.978
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|55–59|0.865|0.805|0.908
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|60–64|0.89|0.833|0.929
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|65–69|0.843|0.777|0.891
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|70–74|0.766|0.691|0.825
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|75–79|0.614|0.52|0.695
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|80–84|0.319|0.232|0.41
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|85+|0.123|0.08|0.175
Observed|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|All ages combined|0.773|0.753|0.792
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|20–24|1|0.915|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|25–29|1.001|0.947|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|30–34|1.001|0.961|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|35–39|1.001|0.969|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|40–44|0.993|0.942|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|45–49|0.994|0.945|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|50–54|0.989|0.95|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|55–59|0.968|0.926|0.988
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|60–64|0.989|0.954|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|65–69|0.974|0.935|0.993
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|70–74|0.906|0.847|0.946
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|75–79|0.887|0.811|0.938
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|80–84|0.841|0.75|0.907
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|85+|0.599|0.5|0.69
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|1|All ages combined|0.937|0.923|0.949
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|20–24|0.941|0.781|0.986
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|25–29|0.962|0.854|0.991
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|30–34|0.988|0.911|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|35–39|0.979|0.913|0.996
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|40–44|0.994|0.944|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|45–49|0.98|0.931|0.996
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|50–54|0.986|0.944|0.999
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|55–59|0.936|0.884|0.967
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|60–64|0.96|0.914|0.985
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|65–69|0.962|0.917|0.988
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|70–74|0.869|0.8|0.919
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|75–79|0.826|0.736|0.894
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|80–84|0.774|0.666|0.861
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|85+|0.482|0.382|0.583
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|2|All ages combined|0.903|0.886|0.919
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|20–24|0.912|0.75|0.972
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|25–29|0.963|0.855|0.992
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|30–34|0.989|0.911|1
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|35–39|0.969|0.901|0.992
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|40–44|0.961|0.902|0.986
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|45–49|0.959|0.903|0.985
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|50–54|0.969|0.922|0.991
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|55–59|0.917|0.861|0.953
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|60–64|0.962|0.914|0.988
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|65–69|0.948|0.896|0.982
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|70–74|0.872|0.8|0.925
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|75–79|0.754|0.655|0.836
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|80–84|0.652|0.531|0.76
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|85+|0.404|0.304|0.511
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|3|All ages combined|0.877|0.857|0.894
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|20–24|0.913|0.75|0.972
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|25–29|0.963|0.855|0.992
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|30–34|0.99|0.912|1.001
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|35–39|0.959|0.889|0.987
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|40–44|0.945|0.881|0.976
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|45–49|0.953|0.896|0.982
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|50–54|0.973|0.925|0.995
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|55–59|0.899|0.839|0.94
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|60–64|0.922|0.865|0.96
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|65–69|0.919|0.856|0.962
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|70–74|0.863|0.786|0.922
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|75–79|0.774|0.67|0.86
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|80–84|0.526|0.404|0.646
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|85+|0.385|0.279|0.502
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|4|All ages combined|0.859|0.838|0.879
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|00–04|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|05–09|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|10–14|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|15–19|||
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|20–24|0.913|0.751|0.973
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|25–29|0.964|0.856|0.993
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|30–34|0.991|0.913|1.002
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|35–39|0.96|0.89|0.988
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|40–44|0.938|0.873|0.972
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|45–49|0.956|0.898|0.985
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|50–54|0.97|0.921|0.995
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|55–59|0.887|0.825|0.931
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|60–64|0.925|0.866|0.964
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|65–69|0.897|0.827|0.947
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|70–74|0.847|0.765|0.912
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|75–79|0.733|0.621|0.83
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|80–84|0.447|0.324|0.574
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|85+|0.263|0.171|0.376
Relative|Chronic myeloid leukaemia (CML)|2015–2019|Persons|5|All ages combined|0.841|0.818|0.862
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|55–59|0.787|0.587|0.898
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|60–64|0.859|0.746|0.924
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|65–69|0.844|0.764|0.898
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|70–74|0.795|0.73|0.846
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|75–79|0.753|0.692|0.803
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|80–84|0.688|0.623|0.744
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|85+|0.578|0.511|0.64
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|All ages combined|0.732|0.705|0.757
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|60–64|0.723|0.592|0.818
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|65–69|0.726|0.635|0.797
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|70–74|0.709|0.637|0.769
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|75–79|0.589|0.523|0.649
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|80–84|0.546|0.478|0.609
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|85+|0.41|0.346|0.472
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|All ages combined|0.589|0.559|0.617
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|60–64|0.627|0.495|0.735
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|65–69|0.624|0.53|0.705
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|70–74|0.623|0.546|0.69
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|75–79|0.464|0.397|0.527
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|80–84|0.401|0.336|0.465
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|85+|0.288|0.23|0.348
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|All ages combined|0.472|0.442|0.502
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|60–64|0.556|0.426|0.668
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|65–69|0.543|0.448|0.629
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|70–74|0.536|0.459|0.608
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|75–79|0.37|0.306|0.435
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|80–84|0.318|0.256|0.381
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|85+|0.181|0.133|0.234
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|All ages combined|0.386|0.356|0.415
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|60–64|0.472|0.345|0.589
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|65–69|0.468|0.374|0.556
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|70–74|0.422|0.347|0.495
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|75–79|0.28|0.221|0.343
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|80–84|0.213|0.159|0.271
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|85+|0.149|0.105|0.201
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|All ages combined|0.308|0.28|0.336
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|55–59|0.791|0.59|0.903
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|60–64|0.866|0.752|0.931
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|65–69|0.854|0.773|0.91
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|70–74|0.811|0.744|0.863
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|75–79|0.779|0.716|0.831
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|80–84|0.731|0.662|0.791
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|85+|0.665|0.588|0.736
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|1|All ages combined|0.771|0.742|0.797
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|60–64|0.735|0.602|0.832
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|65–69|0.745|0.652|0.818
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|70–74|0.738|0.663|0.801
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|75–79|0.633|0.562|0.697
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|80–84|0.621|0.544|0.693
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|85+|0.545|0.46|0.628
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|2|All ages combined|0.651|0.618|0.682
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|60–64|0.645|0.508|0.754
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|65–69|0.651|0.553|0.734
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|70–74|0.664|0.583|0.736
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|75–79|0.52|0.446|0.591
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|80–84|0.493|0.413|0.572
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|85+|0.447|0.358|0.541
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|3|All ages combined|0.55|0.515|0.584
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|60–64|0.577|0.442|0.693
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|65–69|0.575|0.475|0.666
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|70–74|0.588|0.503|0.666
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|75–79|0.436|0.36|0.511
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|80–84|0.425|0.343|0.51
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|85+|0.333|0.245|0.433
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|4|All ages combined|0.474|0.438|0.509
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|60–64|0.496|0.362|0.618
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|65–69|0.504|0.403|0.6
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|70–74|0.476|0.391|0.558
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|75–79|0.349|0.275|0.426
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|80–84|0.314|0.236|0.4
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|85+|0.333|0.235|0.448
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Males|5|All ages combined|0.399|0.363|0.435
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|60–64|0.96|0.746|0.994
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|65–69|0.856|0.707|0.932
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|70–74|0.716|0.6|0.805
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|75–79|0.759|0.646|0.841
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|80–84|0.734|0.628|0.815
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|85+|0.499|0.414|0.579
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|All ages combined|0.696|0.652|0.735
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|60–64|0.884|0.683|0.961
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|65–69|0.789|0.634|0.884
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|70–74|0.499|0.381|0.605
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|75–79|0.632|0.514|0.729
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|80–84|0.65|0.542|0.739
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|85+|0.37|0.292|0.447
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|All ages combined|0.573|0.528|0.615
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|60–64|0.767|0.553|0.888
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|65–69|0.676|0.516|0.793
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|70–74|0.42|0.307|0.528
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|75–79|0.581|0.463|0.682
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|80–84|0.548|0.441|0.643
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|85+|0.278|0.209|0.351
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|All ages combined|0.487|0.442|0.53
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|60–64|0.672|0.465|0.813
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|65–69|0.619|0.462|0.742
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|70–74|0.368|0.263|0.473
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|75–79|0.43|0.321|0.534
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|80–84|0.394|0.297|0.489
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|85+|0.197|0.138|0.264
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|All ages combined|0.391|0.349|0.433
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|60–64|0.672|0.465|0.813
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|65–69|0.564|0.411|0.691
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|70–74|0.33|0.231|0.432
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|75–79|0.399|0.294|0.502
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|80–84|0.317|0.229|0.409
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|85+|0.133|0.083|0.195
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|All ages combined|0.344|0.303|0.384
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|60–64|0.964|0.75|0.999
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|65–69|0.862|0.712|0.939
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|70–74|0.726|0.607|0.815
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|75–79|0.776|0.66|0.859
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|80–84|0.766|0.656|0.85
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|85+|0.56|0.464|0.649
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|1|All ages combined|0.728|0.683|0.77
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|60–64|0.893|0.689|0.971
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|65–69|0.801|0.644|0.898
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|70–74|0.512|0.391|0.622
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|75–79|0.662|0.538|0.763
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|80–84|0.712|0.594|0.809
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|85+|0.467|0.369|0.564
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|2|All ages combined|0.625|0.576|0.672
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|60–64|0.779|0.561|0.902
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|65–69|0.692|0.528|0.813
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|70–74|0.438|0.321|0.551
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|75–79|0.626|0.499|0.735
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|80–84|0.635|0.511|0.745
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|85+|0.401|0.302|0.507
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|3|All ages combined|0.555|0.504|0.605
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|60–64|0.686|0.475|0.831
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|65–69|0.64|0.477|0.768
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|70–74|0.392|0.28|0.504
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|75–79|0.478|0.357|0.594
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|80–84|0.487|0.368|0.605
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|85+|0.325|0.227|0.436
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|4|All ages combined|0.466|0.416|0.516
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|60–64|0.691|0.478|0.836
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|65–69|0.59|0.43|0.723
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|70–74|0.358|0.251|0.469
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|75–79|0.46|0.339|0.579
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|80–84|0.422|0.305|0.545
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|85+|0.256|0.16|0.375
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Females|5|All ages combined|0.427|0.377|0.478
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|00–04|0.873|0.656|0.957
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|55–59|0.771|0.606|0.873
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|60–64|0.887|0.8|0.937
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|65–69|0.847|0.78|0.895
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|70–74|0.773|0.717|0.819
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|75–79|0.755|0.702|0.799
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|80–84|0.701|0.647|0.748
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|85+|0.548|0.496|0.598
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|All ages combined|0.721|0.699|0.743
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|55–59|0.575|0.409|0.709
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|60–64|0.77|0.667|0.845
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|65–69|0.743|0.668|0.804
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|70–74|0.647|0.585|0.702
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|75–79|0.6|0.543|0.652
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|80–84|0.577|0.52|0.629
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|85+|0.395|0.346|0.444
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|All ages combined|0.584|0.56|0.608
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|55–59|0.479|0.321|0.621
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|60–64|0.668|0.559|0.756
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|65–69|0.639|0.559|0.707
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|70–74|0.562|0.498|0.621
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|75–79|0.494|0.437|0.549
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|80–84|0.446|0.39|0.5
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|85+|0.285|0.241|0.332
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|All ages combined|0.478|0.453|0.502
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|60–64|0.59|0.482|0.683
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|65–69|0.565|0.485|0.638
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|70–74|0.487|0.424|0.547
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|75–79|0.384|0.329|0.439
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|80–84|0.34|0.288|0.392
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|85+|0.188|0.15|0.23
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|All ages combined|0.388|0.364|0.412
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|00–04|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|05–09|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|10–14|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|15–19|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|20–24|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|25–29|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|30–34|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|35–39|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|40–44|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|45–49|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|50–54|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|55–59|||
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|60–64|0.534|0.427|0.63
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|65–69|0.497|0.418|0.571
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|70–74|0.399|0.339|0.459
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|75–79|0.316|0.263|0.369
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|80–84|0.246|0.2|0.295
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|85+|0.144|0.11|0.183
Observed|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|All ages combined|0.321|0.298|0.344
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|00–04|0.875|0.658|0.959
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|55–59|0.775|0.609|0.878
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|60–64|0.893|0.806|0.944
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|65–69|0.856|0.789|0.904
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|70–74|0.786|0.73|0.833
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|75–79|0.778|0.724|0.824
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|80–84|0.741|0.684|0.791
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|85+|0.625|0.565|0.681
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|1|All ages combined|0.758|0.734|0.781
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|55–59|0.58|0.413|0.717
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|60–64|0.782|0.677|0.858
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|65–69|0.76|0.684|0.822
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|70–74|0.671|0.607|0.729
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|75–79|0.64|0.579|0.696
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|80–84|0.648|0.585|0.707
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|85+|0.515|0.451|0.579
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|2|All ages combined|0.644|0.617|0.67
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|55–59|0.487|0.326|0.631
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|60–64|0.684|0.572|0.774
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|65–69|0.662|0.58|0.733
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|70–74|0.596|0.529|0.659
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|75–79|0.548|0.485|0.609
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|80–84|0.537|0.47|0.603
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|85+|0.431|0.363|0.501
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|3|All ages combined|0.553|0.524|0.581
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|60–64|0.609|0.498|0.705
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|65–69|0.595|0.511|0.67
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|70–74|0.529|0.46|0.595
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|75–79|0.445|0.381|0.509
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|80–84|0.443|0.375|0.511
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|85+|0.333|0.265|0.407
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|4|All ages combined|0.472|0.442|0.501
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|00–04|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|05–09|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|10–14|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|15–19|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|20–24|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|25–29|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|30–34|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|35–39|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|40–44|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|45–49|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|50–54|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|55–59|||
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|60–64|0.557|0.445|0.657
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|65–69|0.531|0.447|0.61
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|70–74|0.446|0.378|0.512
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|75–79|0.383|0.32|0.448
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|80–84|0.35|0.284|0.42
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|85+|0.303|0.231|0.385
Relative|Chronic myelomonocytic leukaemia (including juvenile)|2015–2019|Persons|5|All ages combined|0.41|0.381|0.44
Observed|Colon cancer|2015–2019|Males|1|00–04|||
Observed|Colon cancer|2015–2019|Males|1|05–09|||
Observed|Colon cancer|2015–2019|Males|1|10–14|1|0.915|1
Observed|Colon cancer|2015–2019|Males|1|15–19|1|0.966|1
Observed|Colon cancer|2015–2019|Males|1|20–24|0.991|0.937|0.999
Observed|Colon cancer|2015–2019|Males|1|25–29|0.921|0.867|0.953
Observed|Colon cancer|2015–2019|Males|1|30–34|0.881|0.837|0.913
Observed|Colon cancer|2015–2019|Males|1|35–39|0.898|0.858|0.927
Observed|Colon cancer|2015–2019|Males|1|40–44|0.909|0.88|0.931
Observed|Colon cancer|2015–2019|Males|1|45–49|0.913|0.891|0.931
Observed|Colon cancer|2015–2019|Males|1|50–54|0.919|0.903|0.932
Observed|Colon cancer|2015–2019|Males|1|55–59|0.896|0.881|0.91
Observed|Colon cancer|2015–2019|Males|1|60–64|0.903|0.892|0.914
Observed|Colon cancer|2015–2019|Males|1|65–69|0.89|0.879|0.899
Observed|Colon cancer|2015–2019|Males|1|70–74|0.875|0.865|0.885
Observed|Colon cancer|2015–2019|Males|1|75–79|0.816|0.803|0.828
Observed|Colon cancer|2015–2019|Males|1|80–84|0.758|0.743|0.773
Observed|Colon cancer|2015–2019|Males|1|85+|0.598|0.58|0.617
Observed|Colon cancer|2015–2019|Males|1|All ages combined|0.836|0.831|0.84
Observed|Colon cancer|2015–2019|Males|2|00–04|||
Observed|Colon cancer|2015–2019|Males|2|05–09|||
Observed|Colon cancer|2015–2019|Males|2|10–14|0.97|0.806|0.996
Observed|Colon cancer|2015–2019|Males|2|15–19|0.986|0.907|0.998
Observed|Colon cancer|2015–2019|Males|2|20–24|0.951|0.886|0.979
Observed|Colon cancer|2015–2019|Males|2|25–29|0.866|0.803|0.909
Observed|Colon cancer|2015–2019|Males|2|30–34|0.816|0.766|0.857
Observed|Colon cancer|2015–2019|Males|2|35–39|0.844|0.797|0.88
Observed|Colon cancer|2015–2019|Males|2|40–44|0.823|0.786|0.854
Observed|Colon cancer|2015–2019|Males|2|45–49|0.833|0.804|0.857
Observed|Colon cancer|2015–2019|Males|2|50–54|0.859|0.839|0.877
Observed|Colon cancer|2015–2019|Males|2|55–59|0.827|0.808|0.844
Observed|Colon cancer|2015–2019|Males|2|60–64|0.83|0.815|0.843
Observed|Colon cancer|2015–2019|Males|2|65–69|0.817|0.804|0.829
Observed|Colon cancer|2015–2019|Males|2|70–74|0.804|0.791|0.815
Observed|Colon cancer|2015–2019|Males|2|75–79|0.728|0.714|0.742
Observed|Colon cancer|2015–2019|Males|2|80–84|0.654|0.637|0.67
Observed|Colon cancer|2015–2019|Males|2|85+|0.467|0.448|0.485
Observed|Colon cancer|2015–2019|Males|2|All ages combined|0.751|0.746|0.756
Observed|Colon cancer|2015–2019|Males|3|00–04|||
Observed|Colon cancer|2015–2019|Males|3|05–09|||
Observed|Colon cancer|2015–2019|Males|3|10–14|0.97|0.806|0.996
Observed|Colon cancer|2015–2019|Males|3|15–19|0.972|0.892|0.993
Observed|Colon cancer|2015–2019|Males|3|20–24|0.951|0.886|0.979
Observed|Colon cancer|2015–2019|Males|3|25–29|0.82|0.752|0.871
Observed|Colon cancer|2015–2019|Males|3|30–34|0.781|0.727|0.825
Observed|Colon cancer|2015–2019|Males|3|35–39|0.802|0.752|0.843
Observed|Colon cancer|2015–2019|Males|3|40–44|0.781|0.742|0.815
Observed|Colon cancer|2015–2019|Males|3|45–49|0.785|0.755|0.813
Observed|Colon cancer|2015–2019|Males|3|50–54|0.803|0.78|0.823
Observed|Colon cancer|2015–2019|Males|3|55–59|0.772|0.752|0.79
Observed|Colon cancer|2015–2019|Males|3|60–64|0.774|0.758|0.79
Observed|Colon cancer|2015–2019|Males|3|65–69|0.762|0.748|0.775
Observed|Colon cancer|2015–2019|Males|3|70–74|0.741|0.727|0.754
Observed|Colon cancer|2015–2019|Males|3|75–79|0.659|0.644|0.673
Observed|Colon cancer|2015–2019|Males|3|80–84|0.574|0.557|0.591
Observed|Colon cancer|2015–2019|Males|3|85+|0.377|0.359|0.395
Observed|Colon cancer|2015–2019|Males|3|All ages combined|0.687|0.681|0.692
Observed|Colon cancer|2015–2019|Males|4|00–04|||
Observed|Colon cancer|2015–2019|Males|4|05–09|||
Observed|Colon cancer|2015–2019|Males|4|10–14|0.97|0.806|0.996
Observed|Colon cancer|2015–2019|Males|4|15–19|0.972|0.892|0.993
Observed|Colon cancer|2015–2019|Males|4|20–24|0.94|0.87|0.972
Observed|Colon cancer|2015–2019|Males|4|25–29|0.782|0.709|0.838
Observed|Colon cancer|2015–2019|Males|4|30–34|0.759|0.703|0.805
Observed|Colon cancer|2015–2019|Males|4|35–39|0.778|0.726|0.821
Observed|Colon cancer|2015–2019|Males|4|40–44|0.737|0.696|0.774
Observed|Colon cancer|2015–2019|Males|4|45–49|0.741|0.708|0.77
Observed|Colon cancer|2015–2019|Males|4|50–54|0.77|0.746|0.793
Observed|Colon cancer|2015–2019|Males|4|55–59|0.734|0.713|0.753
Observed|Colon cancer|2015–2019|Males|4|60–64|0.731|0.714|0.747
Observed|Colon cancer|2015–2019|Males|4|65–69|0.722|0.707|0.736
Observed|Colon cancer|2015–2019|Males|4|70–74|0.689|0.675|0.703
Observed|Colon cancer|2015–2019|Males|4|75–79|0.601|0.585|0.616
Observed|Colon cancer|2015–2019|Males|4|80–84|0.503|0.485|0.52
Observed|Colon cancer|2015–2019|Males|4|85+|0.3|0.283|0.317
Observed|Colon cancer|2015–2019|Males|4|All ages combined|0.634|0.628|0.64
Observed|Colon cancer|2015–2019|Males|5|00–04|||
Observed|Colon cancer|2015–2019|Males|5|05–09|||
Observed|Colon cancer|2015–2019|Males|5|10–14|0.97|0.806|0.996
Observed|Colon cancer|2015–2019|Males|5|15–19|0.972|0.892|0.993
Observed|Colon cancer|2015–2019|Males|5|20–24|0.94|0.87|0.972
Observed|Colon cancer|2015–2019|Males|5|25–29|0.768|0.694|0.826
Observed|Colon cancer|2015–2019|Males|5|30–34|0.743|0.686|0.792
Observed|Colon cancer|2015–2019|Males|5|35–39|0.77|0.718|0.814
Observed|Colon cancer|2015–2019|Males|5|40–44|0.711|0.668|0.749
Observed|Colon cancer|2015–2019|Males|5|45–49|0.709|0.675|0.74
Observed|Colon cancer|2015–2019|Males|5|50–54|0.75|0.726|0.773
Observed|Colon cancer|2015–2019|Males|5|55–59|0.705|0.683|0.725
Observed|Colon cancer|2015–2019|Males|5|60–64|0.701|0.683|0.717
Observed|Colon cancer|2015–2019|Males|5|65–69|0.681|0.666|0.696
Observed|Colon cancer|2015–2019|Males|5|70–74|0.652|0.637|0.666
Observed|Colon cancer|2015–2019|Males|5|75–79|0.545|0.53|0.561
Observed|Colon cancer|2015–2019|Males|5|80–84|0.44|0.423|0.457
Observed|Colon cancer|2015–2019|Males|5|85+|0.243|0.227|0.259
Observed|Colon cancer|2015–2019|Males|5|All ages combined|0.592|0.586|0.598
Relative|Colon cancer|2015–2019|Males|1|00–04|||
Relative|Colon cancer|2015–2019|Males|1|05–09|||
Relative|Colon cancer|2015–2019|Males|1|10–14|1|0.915|1
Relative|Colon cancer|2015–2019|Males|1|15–19|1|0.966|1
Relative|Colon cancer|2015–2019|Males|1|20–24|0.991|0.937|0.999
Relative|Colon cancer|2015–2019|Males|1|25–29|0.921|0.868|0.954
Relative|Colon cancer|2015–2019|Males|1|30–34|0.882|0.838|0.914
Relative|Colon cancer|2015–2019|Males|1|35–39|0.899|0.859|0.928
Relative|Colon cancer|2015–2019|Males|1|40–44|0.911|0.882|0.933
Relative|Colon cancer|2015–2019|Males|1|45–49|0.915|0.893|0.933
Relative|Colon cancer|2015–2019|Males|1|50–54|0.922|0.906|0.936
Relative|Colon cancer|2015–2019|Males|1|55–59|0.901|0.886|0.915
Relative|Colon cancer|2015–2019|Males|1|60–64|0.91|0.899|0.921
Relative|Colon cancer|2015–2019|Males|1|65–69|0.9|0.889|0.91
Relative|Colon cancer|2015–2019|Males|1|70–74|0.893|0.882|0.902
Relative|Colon cancer|2015–2019|Males|1|75–79|0.844|0.831|0.856
Relative|Colon cancer|2015–2019|Males|1|80–84|0.806|0.79|0.821
Relative|Colon cancer|2015–2019|Males|1|85+|0.686|0.664|0.707
Relative|Colon cancer|2015–2019|Males|1|All ages combined|0.863|0.859|0.868
Relative|Colon cancer|2015–2019|Males|2|00–04|||
Relative|Colon cancer|2015–2019|Males|2|05–09|||
Relative|Colon cancer|2015–2019|Males|2|10–14|0.97|0.806|0.996
Relative|Colon cancer|2015–2019|Males|2|15–19|0.987|0.908|0.999
Relative|Colon cancer|2015–2019|Males|2|20–24|0.952|0.887|0.98
Relative|Colon cancer|2015–2019|Males|2|25–29|0.867|0.804|0.911
Relative|Colon cancer|2015–2019|Males|2|30–34|0.818|0.767|0.858
Relative|Colon cancer|2015–2019|Males|2|35–39|0.846|0.799|0.882
Relative|Colon cancer|2015–2019|Males|2|40–44|0.826|0.789|0.857
Relative|Colon cancer|2015–2019|Males|2|45–49|0.837|0.808|0.861
Relative|Colon cancer|2015–2019|Males|2|50–54|0.865|0.845|0.883
Relative|Colon cancer|2015–2019|Males|2|55–59|0.836|0.817|0.853
Relative|Colon cancer|2015–2019|Males|2|60–64|0.844|0.829|0.857
Relative|Colon cancer|2015–2019|Males|2|65–69|0.838|0.824|0.85
Relative|Colon cancer|2015–2019|Males|2|70–74|0.837|0.825|0.85
Relative|Colon cancer|2015–2019|Males|2|75–79|0.782|0.767|0.797
Relative|Colon cancer|2015–2019|Males|2|80–84|0.744|0.725|0.762
Relative|Colon cancer|2015–2019|Males|2|85+|0.618|0.593|0.643
Relative|Colon cancer|2015–2019|Males|2|All ages combined|0.801|0.795|0.806
Relative|Colon cancer|2015–2019|Males|3|00–04|||
Relative|Colon cancer|2015–2019|Males|3|05–09|||
Relative|Colon cancer|2015–2019|Males|3|10–14|0.971|0.806|0.996
Relative|Colon cancer|2015–2019|Males|3|15–19|0.973|0.893|0.994
Relative|Colon cancer|2015–2019|Males|3|20–24|0.953|0.888|0.981
Relative|Colon cancer|2015–2019|Males|3|25–29|0.822|0.753|0.873
Relative|Colon cancer|2015–2019|Males|3|30–34|0.783|0.729|0.827
Relative|Colon cancer|2015–2019|Males|3|35–39|0.805|0.755|0.846
Relative|Colon cancer|2015–2019|Males|3|40–44|0.785|0.746|0.819
Relative|Colon cancer|2015–2019|Males|3|45–49|0.791|0.76|0.819
Relative|Colon cancer|2015–2019|Males|3|50–54|0.812|0.789|0.833
Relative|Colon cancer|2015–2019|Males|3|55–59|0.785|0.765|0.804
Relative|Colon cancer|2015–2019|Males|3|60–64|0.795|0.778|0.81
Relative|Colon cancer|2015–2019|Males|3|65–69|0.792|0.778|0.806
Relative|Colon cancer|2015–2019|Males|3|70–74|0.791|0.777|0.805
Relative|Colon cancer|2015–2019|Males|3|75–79|0.738|0.722|0.755
Relative|Colon cancer|2015–2019|Males|3|80–84|0.705|0.684|0.726
Relative|Colon cancer|2015–2019|Males|3|85+|0.586|0.558|0.614
Relative|Colon cancer|2015–2019|Males|3|All ages combined|0.757|0.75|0.763
Relative|Colon cancer|2015–2019|Males|4|00–04|||
Relative|Colon cancer|2015–2019|Males|4|05–09|||
Relative|Colon cancer|2015–2019|Males|4|10–14|0.971|0.806|0.997
Relative|Colon cancer|2015–2019|Males|4|15–19|0.974|0.894|0.995
Relative|Colon cancer|2015–2019|Males|4|20–24|0.942|0.872|0.975
Relative|Colon cancer|2015–2019|Males|4|25–29|0.784|0.711|0.841
Relative|Colon cancer|2015–2019|Males|4|30–34|0.762|0.706|0.809
Relative|Colon cancer|2015–2019|Males|4|35–39|0.782|0.73|0.825
Relative|Colon cancer|2015–2019|Males|4|40–44|0.743|0.701|0.779
Relative|Colon cancer|2015–2019|Males|4|45–49|0.748|0.715|0.779
Relative|Colon cancer|2015–2019|Males|4|50–54|0.783|0.758|0.805
Relative|Colon cancer|2015–2019|Males|4|55–59|0.751|0.73|0.772
Relative|Colon cancer|2015–2019|Males|4|60–64|0.758|0.74|0.775
Relative|Colon cancer|2015–2019|Males|4|65–69|0.763|0.747|0.778
Relative|Colon cancer|2015–2019|Males|4|70–74|0.756|0.741|0.771
Relative|Colon cancer|2015–2019|Males|4|75–79|0.706|0.688|0.723
Relative|Colon cancer|2015–2019|Males|4|80–84|0.674|0.651|0.697
Relative|Colon cancer|2015–2019|Males|4|85+|0.555|0.524|0.587
Relative|Colon cancer|2015–2019|Males|4|All ages combined|0.724|0.717|0.731
Relative|Colon cancer|2015–2019|Males|5|00–04|||
Relative|Colon cancer|2015–2019|Males|5|05–09|||
Relative|Colon cancer|2015–2019|Males|5|10–14|0.971|0.807|0.997
Relative|Colon cancer|2015–2019|Males|5|15–19|0.974|0.894|0.995
Relative|Colon cancer|2015–2019|Males|5|20–24|0.943|0.873|0.976
Relative|Colon cancer|2015–2019|Males|5|25–29|0.771|0.696|0.829
Relative|Colon cancer|2015–2019|Males|5|30–34|0.747|0.689|0.796
Relative|Colon cancer|2015–2019|Males|5|35–39|0.775|0.723|0.82
Relative|Colon cancer|2015–2019|Males|5|40–44|0.718|0.675|0.756
Relative|Colon cancer|2015–2019|Males|5|45–49|0.719|0.684|0.75
Relative|Colon cancer|2015–2019|Males|5|50–54|0.766|0.741|0.789
Relative|Colon cancer|2015–2019|Males|5|55–59|0.727|0.705|0.748
Relative|Colon cancer|2015–2019|Males|5|60–64|0.735|0.716|0.752
Relative|Colon cancer|2015–2019|Males|5|65–69|0.732|0.716|0.748
Relative|Colon cancer|2015–2019|Males|5|70–74|0.737|0.721|0.754
Relative|Colon cancer|2015–2019|Males|5|75–79|0.676|0.657|0.695
Relative|Colon cancer|2015–2019|Males|5|80–84|0.652|0.627|0.677
Relative|Colon cancer|2015–2019|Males|5|85+|0.543|0.508|0.579
Relative|Colon cancer|2015–2019|Males|5|All ages combined|0.701|0.694|0.708
Observed|Colon cancer|2015–2019|Females|1|00–04|||
Observed|Colon cancer|2015–2019|Females|1|05–09|||
Observed|Colon cancer|2015–2019|Females|1|10–14|1|0.955|1
Observed|Colon cancer|2015–2019|Females|1|15–19|1|0.978|1
Observed|Colon cancer|2015–2019|Females|1|20–24|0.988|0.951|0.997
Observed|Colon cancer|2015–2019|Females|1|25–29|0.954|0.916|0.975
Observed|Colon cancer|2015–2019|Females|1|30–34|0.926|0.893|0.948
Observed|Colon cancer|2015–2019|Females|1|35–39|0.958|0.932|0.974
Observed|Colon cancer|2015–2019|Females|1|40–44|0.935|0.91|0.953
Observed|Colon cancer|2015–2019|Females|1|45–49|0.935|0.915|0.95
Observed|Colon cancer|2015–2019|Females|1|50–54|0.934|0.918|0.946
Observed|Colon cancer|2015–2019|Females|1|55–59|0.926|0.912|0.938
Observed|Colon cancer|2015–2019|Females|1|60–64|0.915|0.902|0.926
Observed|Colon cancer|2015–2019|Females|1|65–69|0.9|0.889|0.911
Observed|Colon cancer|2015–2019|Females|1|70–74|0.879|0.868|0.889
Observed|Colon cancer|2015–2019|Females|1|75–79|0.834|0.821|0.846
Observed|Colon cancer|2015–2019|Females|1|80–84|0.775|0.761|0.788
Observed|Colon cancer|2015–2019|Females|1|85+|0.606|0.59|0.621
Observed|Colon cancer|2015–2019|Females|1|All ages combined|0.833|0.829|0.838
Observed|Colon cancer|2015–2019|Females|2|00–04|||
Observed|Colon cancer|2015–2019|Females|2|05–09|||
Observed|Colon cancer|2015–2019|Females|2|10–14|1|0.955|1
Observed|Colon cancer|2015–2019|Females|2|15–19|1|0.978|1
Observed|Colon cancer|2015–2019|Females|2|20–24|0.988|0.951|0.997
Observed|Colon cancer|2015–2019|Females|2|25–29|0.884|0.833|0.92
Observed|Colon cancer|2015–2019|Females|2|30–34|0.857|0.816|0.89
Observed|Colon cancer|2015–2019|Females|2|35–39|0.898|0.862|0.926
Observed|Colon cancer|2015–2019|Females|2|40–44|0.863|0.829|0.89
Observed|Colon cancer|2015–2019|Females|2|45–49|0.842|0.815|0.866
Observed|Colon cancer|2015–2019|Females|2|50–54|0.854|0.833|0.873
Observed|Colon cancer|2015–2019|Females|2|55–59|0.856|0.837|0.873
Observed|Colon cancer|2015–2019|Females|2|60–64|0.845|0.829|0.86
Observed|Colon cancer|2015–2019|Females|2|65–69|0.838|0.824|0.851
Observed|Colon cancer|2015–2019|Females|2|70–74|0.808|0.795|0.821
Observed|Colon cancer|2015–2019|Females|2|75–79|0.756|0.742|0.77
Observed|Colon cancer|2015–2019|Females|2|80–84|0.683|0.668|0.698
Observed|Colon cancer|2015–2019|Females|2|85+|0.503|0.488|0.519
Observed|Colon cancer|2015–2019|Females|2|All ages combined|0.754|0.749|0.76
Observed|Colon cancer|2015–2019|Females|3|00–04|||
Observed|Colon cancer|2015–2019|Females|3|05–09|||
Observed|Colon cancer|2015–2019|Females|3|10–14|1|0.955|1
Observed|Colon cancer|2015–2019|Females|3|15–19|0.992|0.945|0.999
Observed|Colon cancer|2015–2019|Females|3|20–24|0.988|0.951|0.997
Observed|Colon cancer|2015–2019|Females|3|25–29|0.852|0.797|0.893
Observed|Colon cancer|2015–2019|Females|3|30–34|0.822|0.777|0.859
Observed|Colon cancer|2015–2019|Females|3|35–39|0.85|0.806|0.884
Observed|Colon cancer|2015–2019|Females|3|40–44|0.813|0.775|0.845
Observed|Colon cancer|2015–2019|Females|3|45–49|0.787|0.756|0.814
Observed|Colon cancer|2015–2019|Females|3|50–54|0.816|0.792|0.837
Observed|Colon cancer|2015–2019|Females|3|55–59|0.818|0.798|0.837
Observed|Colon cancer|2015–2019|Females|3|60–64|0.789|0.771|0.806
Observed|Colon cancer|2015–2019|Females|3|65–69|0.788|0.772|0.802
Observed|Colon cancer|2015–2019|Females|3|70–74|0.762|0.748|0.775
Observed|Colon cancer|2015–2019|Females|3|75–79|0.703|0.688|0.717
Observed|Colon cancer|2015–2019|Females|3|80–84|0.624|0.608|0.64
Observed|Colon cancer|2015–2019|Females|3|85+|0.425|0.409|0.44
Observed|Colon cancer|2015–2019|Females|3|All ages combined|0.7|0.694|0.705
Observed|Colon cancer|2015–2019|Females|4|00–04|||
Observed|Colon cancer|2015–2019|Females|4|05–09|||
Observed|Colon cancer|2015–2019|Females|4|10–14|1|0.955|1
Observed|Colon cancer|2015–2019|Females|4|15–19|0.992|0.945|0.999
Observed|Colon cancer|2015–2019|Females|4|20–24|0.988|0.951|0.997
Observed|Colon cancer|2015–2019|Females|4|25–29|0.833|0.776|0.877
Observed|Colon cancer|2015–2019|Females|4|30–34|0.818|0.772|0.856
Observed|Colon cancer|2015–2019|Females|4|35–39|0.809|0.761|0.849
Observed|Colon cancer|2015–2019|Females|4|40–44|0.774|0.734|0.809
Observed|Colon cancer|2015–2019|Females|4|45–49|0.741|0.709|0.771
Observed|Colon cancer|2015–2019|Females|4|50–54|0.791|0.767|0.814
Observed|Colon cancer|2015–2019|Females|4|55–59|0.79|0.769|0.81
Observed|Colon cancer|2015–2019|Females|4|60–64|0.756|0.737|0.773
Observed|Colon cancer|2015–2019|Females|4|65–69|0.757|0.741|0.772
Observed|Colon cancer|2015–2019|Females|4|70–74|0.727|0.712|0.742
Observed|Colon cancer|2015–2019|Females|4|75–79|0.658|0.642|0.673
Observed|Colon cancer|2015–2019|Females|4|80–84|0.566|0.55|0.583
Observed|Colon cancer|2015–2019|Females|4|85+|0.358|0.344|0.373
Observed|Colon cancer|2015–2019|Females|4|All ages combined|0.656|0.65|0.662
Observed|Colon cancer|2015–2019|Females|5|00–04|||
Observed|Colon cancer|2015–2019|Females|5|05–09|||
Observed|Colon cancer|2015–2019|Females|5|10–14|1|0.954|1
Observed|Colon cancer|2015–2019|Females|5|15–19|0.992|0.945|0.999
Observed|Colon cancer|2015–2019|Females|5|20–24|0.988|0.951|0.997
Observed|Colon cancer|2015–2019|Females|5|25–29|0.817|0.759|0.863
Observed|Colon cancer|2015–2019|Females|5|30–34|0.809|0.762|0.848
Observed|Colon cancer|2015–2019|Females|5|35–39|0.784|0.733|0.826
Observed|Colon cancer|2015–2019|Females|5|40–44|0.748|0.706|0.785
Observed|Colon cancer|2015–2019|Females|5|45–49|0.708|0.674|0.739
Observed|Colon cancer|2015–2019|Females|5|50–54|0.769|0.743|0.792
Observed|Colon cancer|2015–2019|Females|5|55–59|0.755|0.733|0.776
Observed|Colon cancer|2015–2019|Females|5|60–64|0.727|0.707|0.746
Observed|Colon cancer|2015–2019|Females|5|65–69|0.735|0.718|0.751
Observed|Colon cancer|2015–2019|Females|5|70–74|0.691|0.675|0.706
Observed|Colon cancer|2015–2019|Females|5|75–79|0.614|0.598|0.63
Observed|Colon cancer|2015–2019|Females|5|80–84|0.522|0.505|0.538
Observed|Colon cancer|2015–2019|Females|5|85+|0.307|0.293|0.322
Observed|Colon cancer|2015–2019|Females|5|All ages combined|0.62|0.614|0.626
Relative|Colon cancer|2015–2019|Females|1|00–04|||
Relative|Colon cancer|2015–2019|Females|1|05–09|||
Relative|Colon cancer|2015–2019|Females|1|10–14|1|0.955|1
Relative|Colon cancer|2015–2019|Females|1|15–19|1|0.979|1
Relative|Colon cancer|2015–2019|Females|1|20–24|0.988|0.952|0.997
Relative|Colon cancer|2015–2019|Females|1|25–29|0.954|0.916|0.975
Relative|Colon cancer|2015–2019|Females|1|30–34|0.926|0.894|0.949
Relative|Colon cancer|2015–2019|Females|1|35–39|0.959|0.933|0.975
Relative|Colon cancer|2015–2019|Females|1|40–44|0.936|0.911|0.954
Relative|Colon cancer|2015–2019|Females|1|45–49|0.936|0.916|0.951
Relative|Colon cancer|2015–2019|Females|1|50–54|0.936|0.92|0.948
Relative|Colon cancer|2015–2019|Females|1|55–59|0.929|0.915|0.941
Relative|Colon cancer|2015–2019|Females|1|60–64|0.919|0.906|0.93
Relative|Colon cancer|2015–2019|Females|1|65–69|0.907|0.895|0.917
Relative|Colon cancer|2015–2019|Females|1|70–74|0.89|0.879|0.9
Relative|Colon cancer|2015–2019|Females|1|75–79|0.853|0.84|0.865
Relative|Colon cancer|2015–2019|Females|1|80–84|0.808|0.793|0.822
Relative|Colon cancer|2015–2019|Females|1|85+|0.678|0.66|0.695
Relative|Colon cancer|2015–2019|Females|1|All ages combined|0.858|0.853|0.863
Relative|Colon cancer|2015–2019|Females|2|00–04|||
Relative|Colon cancer|2015–2019|Females|2|05–09|||
Relative|Colon cancer|2015–2019|Females|2|10–14|1|0.955|1
Relative|Colon cancer|2015–2019|Females|2|15–19|1|0.979|1
Relative|Colon cancer|2015–2019|Females|2|20–24|0.988|0.952|0.997
Relative|Colon cancer|2015–2019|Females|2|25–29|0.884|0.833|0.92
Relative|Colon cancer|2015–2019|Females|2|30–34|0.858|0.816|0.89
Relative|Colon cancer|2015–2019|Females|2|35–39|0.9|0.863|0.927
Relative|Colon cancer|2015–2019|Females|2|40–44|0.864|0.831|0.892
Relative|Colon cancer|2015–2019|Females|2|45–49|0.844|0.817|0.868
Relative|Colon cancer|2015–2019|Females|2|50–54|0.858|0.836|0.877
Relative|Colon cancer|2015–2019|Females|2|55–59|0.862|0.843|0.878
Relative|Colon cancer|2015–2019|Females|2|60–64|0.853|0.837|0.868
Relative|Colon cancer|2015–2019|Females|2|65–69|0.85|0.836|0.864
Relative|Colon cancer|2015–2019|Females|2|70–74|0.83|0.816|0.843
Relative|Colon cancer|2015–2019|Females|2|75–79|0.793|0.778|0.807
Relative|Colon cancer|2015–2019|Females|2|80–84|0.748|0.73|0.764
Relative|Colon cancer|2015–2019|Females|2|85+|0.634|0.614|0.653
Relative|Colon cancer|2015–2019|Females|2|All ages combined|0.799|0.793|0.804
Relative|Colon cancer|2015–2019|Females|3|00–04|||
Relative|Colon cancer|2015–2019|Females|3|05–09|||
Relative|Colon cancer|2015–2019|Females|3|10–14|1|0.956|1
Relative|Colon cancer|2015–2019|Females|3|15–19|0.993|0.946|1
Relative|Colon cancer|2015–2019|Females|3|20–24|0.988|0.952|0.998
Relative|Colon cancer|2015–2019|Females|3|25–29|0.853|0.798|0.894
Relative|Colon cancer|2015–2019|Females|3|30–34|0.823|0.778|0.86
Relative|Colon cancer|2015–2019|Females|3|35–39|0.852|0.808|0.886
Relative|Colon cancer|2015–2019|Females|3|40–44|0.815|0.777|0.847
Relative|Colon cancer|2015–2019|Females|3|45–49|0.791|0.76|0.818
Relative|Colon cancer|2015–2019|Females|3|50–54|0.821|0.798|0.843
Relative|Colon cancer|2015–2019|Females|3|55–59|0.827|0.806|0.845
Relative|Colon cancer|2015–2019|Females|3|60–64|0.802|0.783|0.819
Relative|Colon cancer|2015–2019|Females|3|65–69|0.807|0.791|0.822
Relative|Colon cancer|2015–2019|Females|3|70–74|0.794|0.779|0.808
Relative|Colon cancer|2015–2019|Females|3|75–79|0.758|0.741|0.773
Relative|Colon cancer|2015–2019|Females|3|80–84|0.722|0.703|0.74
Relative|Colon cancer|2015–2019|Females|3|85+|0.609|0.587|0.63
Relative|Colon cancer|2015–2019|Females|3|All ages combined|0.763|0.757|0.769
Relative|Colon cancer|2015–2019|Females|4|00–04|||
Relative|Colon cancer|2015–2019|Females|4|05–09|||
Relative|Colon cancer|2015–2019|Females|4|10–14|1.001|0.955|1.001
Relative|Colon cancer|2015–2019|Females|4|15–19|0.993|0.946|1
Relative|Colon cancer|2015–2019|Females|4|20–24|0.989|0.952|0.998
Relative|Colon cancer|2015–2019|Females|4|25–29|0.834|0.777|0.878
Relative|Colon cancer|2015–2019|Females|4|30–34|0.82|0.773|0.857
Relative|Colon cancer|2015–2019|Females|4|35–39|0.812|0.763|0.851
Relative|Colon cancer|2015–2019|Females|4|40–44|0.778|0.737|0.813
Relative|Colon cancer|2015–2019|Females|4|45–49|0.746|0.714|0.776
Relative|Colon cancer|2015–2019|Females|4|50–54|0.799|0.774|0.822
Relative|Colon cancer|2015–2019|Females|4|55–59|0.802|0.78|0.821
Relative|Colon cancer|2015–2019|Females|4|60–64|0.772|0.753|0.79
Relative|Colon cancer|2015–2019|Females|4|65–69|0.783|0.766|0.799
Relative|Colon cancer|2015–2019|Females|4|70–74|0.772|0.756|0.787
Relative|Colon cancer|2015–2019|Females|4|75–79|0.732|0.714|0.749
Relative|Colon cancer|2015–2019|Females|4|80–84|0.698|0.677|0.718
Relative|Colon cancer|2015–2019|Females|4|85+|0.593|0.569|0.617
Relative|Colon cancer|2015–2019|Females|4|All ages combined|0.739|0.732|0.745
Relative|Colon cancer|2015–2019|Females|5|00–04|||
Relative|Colon cancer|2015–2019|Females|5|05–09|||
Relative|Colon cancer|2015–2019|Females|5|10–14|1.001|0.954|1.001
Relative|Colon cancer|2015–2019|Females|5|15–19|0.993|0.946|1
Relative|Colon cancer|2015–2019|Females|5|20–24|0.989|0.953|0.998
Relative|Colon cancer|2015–2019|Females|5|25–29|0.819|0.76|0.865
Relative|Colon cancer|2015–2019|Females|5|30–34|0.811|0.763|0.85
Relative|Colon cancer|2015–2019|Females|5|35–39|0.787|0.736|0.829
Relative|Colon cancer|2015–2019|Females|5|40–44|0.752|0.71|0.789
Relative|Colon cancer|2015–2019|Females|5|45–49|0.714|0.68|0.745
Relative|Colon cancer|2015–2019|Females|5|50–54|0.779|0.753|0.802
Relative|Colon cancer|2015–2019|Females|5|55–59|0.769|0.746|0.79
Relative|Colon cancer|2015–2019|Females|5|60–64|0.748|0.728|0.767
Relative|Colon cancer|2015–2019|Females|5|65–69|0.768|0.751|0.785
Relative|Colon cancer|2015–2019|Females|5|70–74|0.748|0.731|0.764
Relative|Colon cancer|2015–2019|Females|5|75–79|0.709|0.69|0.727
Relative|Colon cancer|2015–2019|Females|5|80–84|0.692|0.67|0.714
Relative|Colon cancer|2015–2019|Females|5|85+|0.597|0.569|0.624
Relative|Colon cancer|2015–2019|Females|5|All ages combined|0.721|0.714|0.728
Observed|Colon cancer|2015–2019|Persons|1|00–04|||
Observed|Colon cancer|2015–2019|Persons|1|05–09|||
Observed|Colon cancer|2015–2019|Persons|1|10–14|1|0.97|1
Observed|Colon cancer|2015–2019|Persons|1|15–19|1|0.987|1
Observed|Colon cancer|2015–2019|Persons|1|20–24|0.989|0.966|0.996
Observed|Colon cancer|2015–2019|Persons|1|25–29|0.94|0.91|0.959
Observed|Colon cancer|2015–2019|Persons|1|30–34|0.906|0.881|0.926
Observed|Colon cancer|2015–2019|Persons|1|35–39|0.931|0.91|0.948
Observed|Colon cancer|2015–2019|Persons|1|40–44|0.922|0.904|0.937
Observed|Colon cancer|2015–2019|Persons|1|45–49|0.924|0.91|0.936
Observed|Colon cancer|2015–2019|Persons|1|50–54|0.926|0.915|0.935
Observed|Colon cancer|2015–2019|Persons|1|55–59|0.91|0.9|0.919
Observed|Colon cancer|2015–2019|Persons|1|60–64|0.908|0.9|0.916
Observed|Colon cancer|2015–2019|Persons|1|65–69|0.894|0.887|0.902
Observed|Colon cancer|2015–2019|Persons|1|70–74|0.877|0.87|0.884
Observed|Colon cancer|2015–2019|Persons|1|75–79|0.825|0.816|0.833
Observed|Colon cancer|2015–2019|Persons|1|80–84|0.767|0.757|0.777
Observed|Colon cancer|2015–2019|Persons|1|85+|0.603|0.591|0.614
Observed|Colon cancer|2015–2019|Persons|1|All ages combined|0.835|0.831|0.838
Observed|Colon cancer|2015–2019|Persons|2|00–04|||
Observed|Colon cancer|2015–2019|Persons|2|05–09|||
Observed|Colon cancer|2015–2019|Persons|2|10–14|0.99|0.93|0.999
Observed|Colon cancer|2015–2019|Persons|2|15–19|0.995|0.966|0.999
Observed|Colon cancer|2015–2019|Persons|2|20–24|0.973|0.945|0.987
Observed|Colon cancer|2015–2019|Persons|2|25–29|0.876|0.838|0.905
Observed|Colon cancer|2015–2019|Persons|2|30–34|0.839|0.808|0.866
Observed|Colon cancer|2015–2019|Persons|2|35–39|0.874|0.846|0.897
Observed|Colon cancer|2015–2019|Persons|2|40–44|0.843|0.819|0.864
Observed|Colon cancer|2015–2019|Persons|2|45–49|0.837|0.818|0.855
Observed|Colon cancer|2015–2019|Persons|2|50–54|0.857|0.842|0.87
Observed|Colon cancer|2015–2019|Persons|2|55–59|0.84|0.827|0.852
Observed|Colon cancer|2015–2019|Persons|2|60–64|0.836|0.826|0.846
Observed|Colon cancer|2015–2019|Persons|2|65–69|0.826|0.817|0.835
Observed|Colon cancer|2015–2019|Persons|2|70–74|0.806|0.797|0.814
Observed|Colon cancer|2015–2019|Persons|2|75–79|0.742|0.732|0.751
Observed|Colon cancer|2015–2019|Persons|2|80–84|0.669|0.658|0.68
Observed|Colon cancer|2015–2019|Persons|2|85+|0.488|0.477|0.5
Observed|Colon cancer|2015–2019|Persons|2|All ages combined|0.753|0.749|0.756
Observed|Colon cancer|2015–2019|Persons|3|00–04|||
Observed|Colon cancer|2015–2019|Persons|3|05–09|||
Observed|Colon cancer|2015–2019|Persons|3|10–14|0.99|0.93|0.999
Observed|Colon cancer|2015–2019|Persons|3|15–19|0.985|0.954|0.995
Observed|Colon cancer|2015–2019|Persons|3|20–24|0.973|0.945|0.987
Observed|Colon cancer|2015–2019|Persons|3|25–29|0.839|0.797|0.872
Observed|Colon cancer|2015–2019|Persons|3|30–34|0.804|0.77|0.833
Observed|Colon cancer|2015–2019|Persons|3|35–39|0.829|0.797|0.856
Observed|Colon cancer|2015–2019|Persons|3|40–44|0.797|0.771|0.821
Observed|Colon cancer|2015–2019|Persons|3|45–49|0.786|0.765|0.806
Observed|Colon cancer|2015–2019|Persons|3|50–54|0.809|0.793|0.824
Observed|Colon cancer|2015–2019|Persons|3|55–59|0.793|0.779|0.807
Observed|Colon cancer|2015–2019|Persons|3|60–64|0.781|0.769|0.792
Observed|Colon cancer|2015–2019|Persons|3|65–69|0.773|0.763|0.783
Observed|Colon cancer|2015–2019|Persons|3|70–74|0.751|0.741|0.76
Observed|Colon cancer|2015–2019|Persons|3|75–79|0.68|0.669|0.69
Observed|Colon cancer|2015–2019|Persons|3|80–84|0.6|0.588|0.611
Observed|Colon cancer|2015–2019|Persons|3|85+|0.405|0.394|0.417
Observed|Colon cancer|2015–2019|Persons|3|All ages combined|0.693|0.689|0.697
Observed|Colon cancer|2015–2019|Persons|4|00–04|||
Observed|Colon cancer|2015–2019|Persons|4|05–09|||
Observed|Colon cancer|2015–2019|Persons|4|10–14|0.99|0.93|0.999
Observed|Colon cancer|2015–2019|Persons|4|15–19|0.985|0.954|0.995
Observed|Colon cancer|2015–2019|Persons|4|20–24|0.969|0.94|0.985
Observed|Colon cancer|2015–2019|Persons|4|25–29|0.811|0.768|0.847
Observed|Colon cancer|2015–2019|Persons|4|30–34|0.791|0.756|0.822
Observed|Colon cancer|2015–2019|Persons|4|35–39|0.797|0.763|0.826
Observed|Colon cancer|2015–2019|Persons|4|40–44|0.756|0.728|0.782
Observed|Colon cancer|2015–2019|Persons|4|45–49|0.741|0.718|0.762
Observed|Colon cancer|2015–2019|Persons|4|50–54|0.78|0.763|0.796
Observed|Colon cancer|2015–2019|Persons|4|55–59|0.759|0.745|0.774
Observed|Colon cancer|2015–2019|Persons|4|60–64|0.741|0.729|0.754
Observed|Colon cancer|2015–2019|Persons|4|65–69|0.737|0.726|0.748
Observed|Colon cancer|2015–2019|Persons|4|70–74|0.707|0.696|0.717
Observed|Colon cancer|2015–2019|Persons|4|75–79|0.628|0.617|0.638
Observed|Colon cancer|2015–2019|Persons|4|80–84|0.535|0.523|0.547
Observed|Colon cancer|2015–2019|Persons|4|85+|0.335|0.324|0.346
Observed|Colon cancer|2015–2019|Persons|4|All ages combined|0.645|0.641|0.649
Observed|Colon cancer|2015–2019|Persons|5|00–04|||
Observed|Colon cancer|2015–2019|Persons|5|05–09|||
Observed|Colon cancer|2015–2019|Persons|5|10–14|0.99|0.93|0.999
Observed|Colon cancer|2015–2019|Persons|5|15–19|0.985|0.954|0.995
Observed|Colon cancer|2015–2019|Persons|5|20–24|0.969|0.94|0.985
Observed|Colon cancer|2015–2019|Persons|5|25–29|0.796|0.752|0.834
Observed|Colon cancer|2015–2019|Persons|5|30–34|0.779|0.743|0.811
Observed|Colon cancer|2015–2019|Persons|5|35–39|0.78|0.745|0.811
Observed|Colon cancer|2015–2019|Persons|5|40–44|0.73|0.7|0.757
Observed|Colon cancer|2015–2019|Persons|5|45–49|0.708|0.684|0.73
Observed|Colon cancer|2015–2019|Persons|5|50–54|0.759|0.742|0.776
Observed|Colon cancer|2015–2019|Persons|5|55–59|0.728|0.712|0.743
Observed|Colon cancer|2015–2019|Persons|5|60–64|0.712|0.699|0.725
Observed|Colon cancer|2015–2019|Persons|5|65–69|0.705|0.693|0.716
Observed|Colon cancer|2015–2019|Persons|5|70–74|0.67|0.659|0.68
Observed|Colon cancer|2015–2019|Persons|5|75–79|0.578|0.567|0.589
Observed|Colon cancer|2015–2019|Persons|5|80–84|0.482|0.47|0.494
Observed|Colon cancer|2015–2019|Persons|5|85+|0.281|0.27|0.292
Observed|Colon cancer|2015–2019|Persons|5|All ages combined|0.605|0.601|0.61
Relative|Colon cancer|2015–2019|Persons|1|00–04|||
Relative|Colon cancer|2015–2019|Persons|1|05–09|||
Relative|Colon cancer|2015–2019|Persons|1|10–14|1|0.97|1
Relative|Colon cancer|2015–2019|Persons|1|15–19|1|0.987|1
Relative|Colon cancer|2015–2019|Persons|1|20–24|0.989|0.966|0.997
Relative|Colon cancer|2015–2019|Persons|1|25–29|0.94|0.911|0.96
Relative|Colon cancer|2015–2019|Persons|1|30–34|0.906|0.881|0.927
Relative|Colon cancer|2015–2019|Persons|1|35–39|0.932|0.911|0.949
Relative|Colon cancer|2015–2019|Persons|1|40–44|0.923|0.905|0.938
Relative|Colon cancer|2015–2019|Persons|1|45–49|0.926|0.911|0.938
Relative|Colon cancer|2015–2019|Persons|1|50–54|0.928|0.918|0.938
Relative|Colon cancer|2015–2019|Persons|1|55–59|0.914|0.904|0.923
Relative|Colon cancer|2015–2019|Persons|1|60–64|0.914|0.906|0.922
Relative|Colon cancer|2015–2019|Persons|1|65–69|0.903|0.895|0.911
Relative|Colon cancer|2015–2019|Persons|1|70–74|0.892|0.884|0.899
Relative|Colon cancer|2015–2019|Persons|1|75–79|0.848|0.839|0.857
Relative|Colon cancer|2015–2019|Persons|1|80–84|0.807|0.796|0.817
Relative|Colon cancer|2015–2019|Persons|1|85+|0.681|0.668|0.694
Relative|Colon cancer|2015–2019|Persons|1|All ages combined|0.861|0.857|0.864
Relative|Colon cancer|2015–2019|Persons|2|00–04|||
Relative|Colon cancer|2015–2019|Persons|2|05–09|||
Relative|Colon cancer|2015–2019|Persons|2|10–14|0.99|0.93|0.999
Relative|Colon cancer|2015–2019|Persons|2|15–19|0.996|0.967|1
Relative|Colon cancer|2015–2019|Persons|2|20–24|0.974|0.946|0.988
Relative|Colon cancer|2015–2019|Persons|2|25–29|0.877|0.839|0.906
Relative|Colon cancer|2015–2019|Persons|2|30–34|0.84|0.809|0.867
Relative|Colon cancer|2015–2019|Persons|2|35–39|0.876|0.848|0.899
Relative|Colon cancer|2015–2019|Persons|2|40–44|0.845|0.821|0.866
Relative|Colon cancer|2015–2019|Persons|2|45–49|0.841|0.821|0.858
Relative|Colon cancer|2015–2019|Persons|2|50–54|0.862|0.847|0.875
Relative|Colon cancer|2015–2019|Persons|2|55–59|0.848|0.835|0.86
Relative|Colon cancer|2015–2019|Persons|2|60–64|0.848|0.837|0.858
Relative|Colon cancer|2015–2019|Persons|2|65–69|0.843|0.834|0.853
Relative|Colon cancer|2015–2019|Persons|2|70–74|0.834|0.825|0.843
Relative|Colon cancer|2015–2019|Persons|2|75–79|0.787|0.777|0.798
Relative|Colon cancer|2015–2019|Persons|2|80–84|0.746|0.733|0.758
Relative|Colon cancer|2015–2019|Persons|2|85+|0.628|0.612|0.643
Relative|Colon cancer|2015–2019|Persons|2|All ages combined|0.8|0.796|0.804
Relative|Colon cancer|2015–2019|Persons|3|00–04|||
Relative|Colon cancer|2015–2019|Persons|3|05–09|||
Relative|Colon cancer|2015–2019|Persons|3|10–14|0.99|0.931|0.999
Relative|Colon cancer|2015–2019|Persons|3|15–19|0.986|0.955|0.996
Relative|Colon cancer|2015–2019|Persons|3|20–24|0.975|0.946|0.988
Relative|Colon cancer|2015–2019|Persons|3|25–29|0.84|0.799|0.873
Relative|Colon cancer|2015–2019|Persons|3|30–34|0.805|0.772|0.835
Relative|Colon cancer|2015–2019|Persons|3|35–39|0.831|0.799|0.859
Relative|Colon cancer|2015–2019|Persons|3|40–44|0.801|0.774|0.824
Relative|Colon cancer|2015–2019|Persons|3|45–49|0.791|0.77|0.811
Relative|Colon cancer|2015–2019|Persons|3|50–54|0.816|0.8|0.832
Relative|Colon cancer|2015–2019|Persons|3|55–59|0.804|0.79|0.818
Relative|Colon cancer|2015–2019|Persons|3|60–64|0.798|0.786|0.809
Relative|Colon cancer|2015–2019|Persons|3|65–69|0.799|0.788|0.809
Relative|Colon cancer|2015–2019|Persons|3|70–74|0.793|0.782|0.803
Relative|Colon cancer|2015–2019|Persons|3|75–79|0.748|0.736|0.759
Relative|Colon cancer|2015–2019|Persons|3|80–84|0.714|0.7|0.728
Relative|Colon cancer|2015–2019|Persons|3|85+|0.6|0.582|0.617
Relative|Colon cancer|2015–2019|Persons|3|All ages combined|0.76|0.755|0.764
Relative|Colon cancer|2015–2019|Persons|4|00–04|||
Relative|Colon cancer|2015–2019|Persons|4|05–09|||
Relative|Colon cancer|2015–2019|Persons|4|10–14|0.99|0.931|0.999
Relative|Colon cancer|2015–2019|Persons|4|15–19|0.986|0.955|0.996
Relative|Colon cancer|2015–2019|Persons|4|20–24|0.971|0.941|0.986
Relative|Colon cancer|2015–2019|Persons|4|25–29|0.813|0.769|0.849
Relative|Colon cancer|2015–2019|Persons|4|30–34|0.793|0.758|0.824
Relative|Colon cancer|2015–2019|Persons|4|35–39|0.8|0.766|0.83
Relative|Colon cancer|2015–2019|Persons|4|40–44|0.76|0.732|0.786
Relative|Colon cancer|2015–2019|Persons|4|45–49|0.747|0.724|0.769
Relative|Colon cancer|2015–2019|Persons|4|50–54|0.79|0.773|0.807
Relative|Colon cancer|2015–2019|Persons|4|55–59|0.774|0.759|0.789
Relative|Colon cancer|2015–2019|Persons|4|60–64|0.764|0.751|0.776
Relative|Colon cancer|2015–2019|Persons|4|65–69|0.772|0.76|0.783
Relative|Colon cancer|2015–2019|Persons|4|70–74|0.763|0.752|0.774
Relative|Colon cancer|2015–2019|Persons|4|75–79|0.718|0.706|0.731
Relative|Colon cancer|2015–2019|Persons|4|80–84|0.687|0.671|0.702
Relative|Colon cancer|2015–2019|Persons|4|85+|0.578|0.559|0.598
Relative|Colon cancer|2015–2019|Persons|4|All ages combined|0.731|0.726|0.736
Relative|Colon cancer|2015–2019|Persons|5|00–04|||
Relative|Colon cancer|2015–2019|Persons|5|05–09|||
Relative|Colon cancer|2015–2019|Persons|5|10–14|0.991|0.931|0.999
Relative|Colon cancer|2015–2019|Persons|5|15–19|0.987|0.956|0.997
Relative|Colon cancer|2015–2019|Persons|5|20–24|0.971|0.942|0.987
Relative|Colon cancer|2015–2019|Persons|5|25–29|0.798|0.754|0.836
Relative|Colon cancer|2015–2019|Persons|5|30–34|0.782|0.746|0.814
Relative|Colon cancer|2015–2019|Persons|5|35–39|0.784|0.749|0.815
Relative|Colon cancer|2015–2019|Persons|5|40–44|0.735|0.706|0.762
Relative|Colon cancer|2015–2019|Persons|5|45–49|0.716|0.692|0.738
Relative|Colon cancer|2015–2019|Persons|5|50–54|0.772|0.754|0.789
Relative|Colon cancer|2015–2019|Persons|5|55–59|0.746|0.73|0.761
Relative|Colon cancer|2015–2019|Persons|5|60–64|0.74|0.727|0.753
Relative|Colon cancer|2015–2019|Persons|5|65–69|0.748|0.736|0.76
Relative|Colon cancer|2015–2019|Persons|5|70–74|0.742|0.73|0.754
Relative|Colon cancer|2015–2019|Persons|5|75–79|0.692|0.679|0.705
Relative|Colon cancer|2015–2019|Persons|5|80–84|0.674|0.657|0.69
Relative|Colon cancer|2015–2019|Persons|5|85+|0.576|0.554|0.598
Relative|Colon cancer|2015–2019|Persons|5|All ages combined|0.711|0.706|0.716
Observed|Colorectal cancer|2015–2019|Males|1|00–04|||
Observed|Colorectal cancer|2015–2019|Males|1|05–09|||
Observed|Colorectal cancer|2015–2019|Males|1|10–14|1|0.92|1
Observed|Colorectal cancer|2015–2019|Males|1|15–19|1|0.967|1
Observed|Colorectal cancer|2015–2019|Males|1|20–24|0.984|0.937|0.996
Observed|Colorectal cancer|2015–2019|Males|1|25–29|0.911|0.867|0.941
Observed|Colorectal cancer|2015–2019|Males|1|30–34|0.907|0.878|0.93
Observed|Colorectal cancer|2015–2019|Males|1|35–39|0.912|0.885|0.932
Observed|Colorectal cancer|2015–2019|Males|1|40–44|0.923|0.903|0.939
Observed|Colorectal cancer|2015–2019|Males|1|45–49|0.93|0.916|0.942
Observed|Colorectal cancer|2015–2019|Males|1|50–54|0.925|0.914|0.935
Observed|Colorectal cancer|2015–2019|Males|1|55–59|0.91|0.899|0.919
Observed|Colorectal cancer|2015–2019|Males|1|60–64|0.915|0.906|0.922
Observed|Colorectal cancer|2015–2019|Males|1|65–69|0.892|0.884|0.9
Observed|Colorectal cancer|2015–2019|Males|1|70–74|0.876|0.867|0.883
Observed|Colorectal cancer|2015–2019|Males|1|75–79|0.818|0.807|0.827
Observed|Colorectal cancer|2015–2019|Males|1|80–84|0.759|0.746|0.771
Observed|Colorectal cancer|2015–2019|Males|1|85+|0.589|0.573|0.604
Observed|Colorectal cancer|2015–2019|Males|1|All ages combined|0.847|0.843|0.85
Observed|Colorectal cancer|2015–2019|Males|2|00–04|||
Observed|Colorectal cancer|2015–2019|Males|2|05–09|||
Observed|Colorectal cancer|2015–2019|Males|2|10–14|0.915|0.759|0.972
Observed|Colorectal cancer|2015–2019|Males|2|15–19|0.987|0.913|0.998
Observed|Colorectal cancer|2015–2019|Males|2|20–24|0.949|0.889|0.977
Observed|Colorectal cancer|2015–2019|Males|2|25–29|0.848|0.796|0.888
Observed|Colorectal cancer|2015–2019|Males|2|30–34|0.844|0.808|0.874
Observed|Colorectal cancer|2015–2019|Males|2|35–39|0.865|0.833|0.891
Observed|Colorectal cancer|2015–2019|Males|2|40–44|0.849|0.823|0.871
Observed|Colorectal cancer|2015–2019|Males|2|45–49|0.851|0.832|0.869
Observed|Colorectal cancer|2015–2019|Males|2|50–54|0.867|0.853|0.88
Observed|Colorectal cancer|2015–2019|Males|2|55–59|0.843|0.83|0.855
Observed|Colorectal cancer|2015–2019|Males|2|60–64|0.843|0.832|0.853
Observed|Colorectal cancer|2015–2019|Males|2|65–69|0.818|0.808|0.828
Observed|Colorectal cancer|2015–2019|Males|2|70–74|0.802|0.792|0.811
Observed|Colorectal cancer|2015–2019|Males|2|75–79|0.725|0.713|0.736
Observed|Colorectal cancer|2015–2019|Males|2|80–84|0.651|0.637|0.665
Observed|Colorectal cancer|2015–2019|Males|2|85+|0.454|0.438|0.469
Observed|Colorectal cancer|2015–2019|Males|2|All ages combined|0.762|0.758|0.766
Observed|Colorectal cancer|2015–2019|Males|3|00–04|||
Observed|Colorectal cancer|2015–2019|Males|3|05–09|||
Observed|Colorectal cancer|2015–2019|Males|3|10–14|0.915|0.759|0.972
Observed|Colorectal cancer|2015–2019|Males|3|15–19|0.974|0.899|0.993
Observed|Colorectal cancer|2015–2019|Males|3|20–24|0.939|0.877|0.971
Observed|Colorectal cancer|2015–2019|Males|3|25–29|0.797|0.74|0.843
Observed|Colorectal cancer|2015–2019|Males|3|30–34|0.797|0.756|0.831
Observed|Colorectal cancer|2015–2019|Males|3|35–39|0.824|0.789|0.854
Observed|Colorectal cancer|2015–2019|Males|3|40–44|0.805|0.778|0.83
Observed|Colorectal cancer|2015–2019|Males|3|45–49|0.797|0.775|0.817
Observed|Colorectal cancer|2015–2019|Males|3|50–54|0.805|0.789|0.82
Observed|Colorectal cancer|2015–2019|Males|3|55–59|0.787|0.773|0.801
Observed|Colorectal cancer|2015–2019|Males|3|60–64|0.787|0.775|0.798
Observed|Colorectal cancer|2015–2019|Males|3|65–69|0.763|0.752|0.774
Observed|Colorectal cancer|2015–2019|Males|3|70–74|0.737|0.726|0.748
Observed|Colorectal cancer|2015–2019|Males|3|75–79|0.653|0.64|0.665
Observed|Colorectal cancer|2015–2019|Males|3|80–84|0.565|0.551|0.58
Observed|Colorectal cancer|2015–2019|Males|3|85+|0.362|0.347|0.377
Observed|Colorectal cancer|2015–2019|Males|3|All ages combined|0.696|0.692|0.701
Observed|Colorectal cancer|2015–2019|Males|4|00–04|||
Observed|Colorectal cancer|2015–2019|Males|4|05–09|||
Observed|Colorectal cancer|2015–2019|Males|4|10–14|0.915|0.759|0.972
Observed|Colorectal cancer|2015–2019|Males|4|15–19|0.974|0.899|0.993
Observed|Colorectal cancer|2015–2019|Males|4|20–24|0.93|0.864|0.964
Observed|Colorectal cancer|2015–2019|Males|4|25–29|0.763|0.704|0.812
Observed|Colorectal cancer|2015–2019|Males|4|30–34|0.769|0.727|0.806
Observed|Colorectal cancer|2015–2019|Males|4|35–39|0.793|0.756|0.826
Observed|Colorectal cancer|2015–2019|Males|4|40–44|0.759|0.729|0.786
Observed|Colorectal cancer|2015–2019|Males|4|45–49|0.753|0.729|0.775
Observed|Colorectal cancer|2015–2019|Males|4|50–54|0.771|0.754|0.787
Observed|Colorectal cancer|2015–2019|Males|4|55–59|0.748|0.733|0.762
Observed|Colorectal cancer|2015–2019|Males|4|60–64|0.741|0.729|0.753
Observed|Colorectal cancer|2015–2019|Males|4|65–69|0.721|0.71|0.733
Observed|Colorectal cancer|2015–2019|Males|4|70–74|0.683|0.671|0.694
Observed|Colorectal cancer|2015–2019|Males|4|75–79|0.592|0.579|0.604
Observed|Colorectal cancer|2015–2019|Males|4|80–84|0.494|0.479|0.508
Observed|Colorectal cancer|2015–2019|Males|4|85+|0.288|0.273|0.302
Observed|Colorectal cancer|2015–2019|Males|4|All ages combined|0.644|0.639|0.648
Observed|Colorectal cancer|2015–2019|Males|5|00–04|||
Observed|Colorectal cancer|2015–2019|Males|5|05–09|||
Observed|Colorectal cancer|2015–2019|Males|5|10–14|0.915|0.759|0.972
Observed|Colorectal cancer|2015–2019|Males|5|15–19|0.974|0.899|0.993
Observed|Colorectal cancer|2015–2019|Males|5|20–24|0.919|0.85|0.957
Observed|Colorectal cancer|2015–2019|Males|5|25–29|0.749|0.688|0.8
Observed|Colorectal cancer|2015–2019|Males|5|30–34|0.744|0.7|0.784
Observed|Colorectal cancer|2015–2019|Males|5|35–39|0.778|0.739|0.811
Observed|Colorectal cancer|2015–2019|Males|5|40–44|0.731|0.7|0.759
Observed|Colorectal cancer|2015–2019|Males|5|45–49|0.722|0.698|0.745
Observed|Colorectal cancer|2015–2019|Males|5|50–54|0.743|0.725|0.76
Observed|Colorectal cancer|2015–2019|Males|5|55–59|0.716|0.7|0.731
Observed|Colorectal cancer|2015–2019|Males|5|60–64|0.707|0.694|0.72
Observed|Colorectal cancer|2015–2019|Males|5|65–69|0.681|0.669|0.692
Observed|Colorectal cancer|2015–2019|Males|5|70–74|0.644|0.632|0.655
Observed|Colorectal cancer|2015–2019|Males|5|75–79|0.541|0.528|0.553
Observed|Colorectal cancer|2015–2019|Males|5|80–84|0.43|0.416|0.444
Observed|Colorectal cancer|2015–2019|Males|5|85+|0.231|0.218|0.244
Observed|Colorectal cancer|2015–2019|Males|5|All ages combined|0.601|0.596|0.606
Relative|Colorectal cancer|2015–2019|Males|1|00–04|||
Relative|Colorectal cancer|2015–2019|Males|1|05–09|||
Relative|Colorectal cancer|2015–2019|Males|1|10–14|1|0.92|1
Relative|Colorectal cancer|2015–2019|Males|1|15–19|1|0.968|1
Relative|Colorectal cancer|2015–2019|Males|1|20–24|0.984|0.937|0.997
Relative|Colorectal cancer|2015–2019|Males|1|25–29|0.912|0.868|0.942
Relative|Colorectal cancer|2015–2019|Males|1|30–34|0.908|0.878|0.931
Relative|Colorectal cancer|2015–2019|Males|1|35–39|0.913|0.886|0.934
Relative|Colorectal cancer|2015–2019|Males|1|40–44|0.925|0.905|0.941
Relative|Colorectal cancer|2015–2019|Males|1|45–49|0.932|0.918|0.944
Relative|Colorectal cancer|2015–2019|Males|1|50–54|0.928|0.917|0.938
Relative|Colorectal cancer|2015–2019|Males|1|55–59|0.915|0.904|0.924
Relative|Colorectal cancer|2015–2019|Males|1|60–64|0.922|0.914|0.929
Relative|Colorectal cancer|2015–2019|Males|1|65–69|0.903|0.895|0.911
Relative|Colorectal cancer|2015–2019|Males|1|70–74|0.893|0.885|0.901
Relative|Colorectal cancer|2015–2019|Males|1|75–79|0.846|0.835|0.856
Relative|Colorectal cancer|2015–2019|Males|1|80–84|0.806|0.792|0.819
Relative|Colorectal cancer|2015–2019|Males|1|85+|0.675|0.657|0.693
Relative|Colorectal cancer|2015–2019|Males|1|All ages combined|0.872|0.868|0.876
Relative|Colorectal cancer|2015–2019|Males|2|00–04|||
Relative|Colorectal cancer|2015–2019|Males|2|05–09|||
Relative|Colorectal cancer|2015–2019|Males|2|10–14|0.915|0.76|0.972
Relative|Colorectal cancer|2015–2019|Males|2|15–19|0.988|0.913|0.999
Relative|Colorectal cancer|2015–2019|Males|2|20–24|0.95|0.89|0.978
Relative|Colorectal cancer|2015–2019|Males|2|25–29|0.849|0.797|0.889
Relative|Colorectal cancer|2015–2019|Males|2|30–34|0.845|0.809|0.875
Relative|Colorectal cancer|2015–2019|Males|2|35–39|0.867|0.835|0.893
Relative|Colorectal cancer|2015–2019|Males|2|40–44|0.852|0.826|0.874
Relative|Colorectal cancer|2015–2019|Males|2|45–49|0.856|0.836|0.873
Relative|Colorectal cancer|2015–2019|Males|2|50–54|0.873|0.859|0.886
Relative|Colorectal cancer|2015–2019|Males|2|55–59|0.852|0.839|0.864
Relative|Colorectal cancer|2015–2019|Males|2|60–64|0.857|0.846|0.867
Relative|Colorectal cancer|2015–2019|Males|2|65–69|0.839|0.828|0.849
Relative|Colorectal cancer|2015–2019|Males|2|70–74|0.836|0.826|0.846
Relative|Colorectal cancer|2015–2019|Males|2|75–79|0.779|0.766|0.791
Relative|Colorectal cancer|2015–2019|Males|2|80–84|0.741|0.725|0.757
Relative|Colorectal cancer|2015–2019|Males|2|85+|0.601|0.58|0.622
Relative|Colorectal cancer|2015–2019|Males|2|All ages combined|0.808|0.804|0.812
Relative|Colorectal cancer|2015–2019|Males|3|00–04|||
Relative|Colorectal cancer|2015–2019|Males|3|05–09|||
Relative|Colorectal cancer|2015–2019|Males|3|10–14|0.916|0.76|0.972
Relative|Colorectal cancer|2015–2019|Males|3|15–19|0.975|0.9|0.995
Relative|Colorectal cancer|2015–2019|Males|3|20–24|0.941|0.879|0.972
Relative|Colorectal cancer|2015–2019|Males|3|25–29|0.799|0.742|0.845
Relative|Colorectal cancer|2015–2019|Males|3|30–34|0.799|0.759|0.833
Relative|Colorectal cancer|2015–2019|Males|3|35–39|0.827|0.792|0.857
Relative|Colorectal cancer|2015–2019|Males|3|40–44|0.81|0.782|0.835
Relative|Colorectal cancer|2015–2019|Males|3|45–49|0.803|0.781|0.823
Relative|Colorectal cancer|2015–2019|Males|3|50–54|0.814|0.798|0.83
Relative|Colorectal cancer|2015–2019|Males|3|55–59|0.801|0.786|0.815
Relative|Colorectal cancer|2015–2019|Males|3|60–64|0.807|0.795|0.819
Relative|Colorectal cancer|2015–2019|Males|3|65–69|0.794|0.783|0.805
Relative|Colorectal cancer|2015–2019|Males|3|70–74|0.787|0.775|0.798
Relative|Colorectal cancer|2015–2019|Males|3|75–79|0.732|0.718|0.745
Relative|Colorectal cancer|2015–2019|Males|3|80–84|0.695|0.677|0.712
Relative|Colorectal cancer|2015–2019|Males|3|85+|0.562|0.539|0.586
Relative|Colorectal cancer|2015–2019|Males|3|All ages combined|0.761|0.756|0.765
Relative|Colorectal cancer|2015–2019|Males|4|00–04|||
Relative|Colorectal cancer|2015–2019|Males|4|05–09|||
Relative|Colorectal cancer|2015–2019|Males|4|10–14|0.916|0.76|0.973
Relative|Colorectal cancer|2015–2019|Males|4|15–19|0.976|0.9|0.995
Relative|Colorectal cancer|2015–2019|Males|4|20–24|0.932|0.866|0.967
Relative|Colorectal cancer|2015–2019|Males|4|25–29|0.765|0.706|0.815
Relative|Colorectal cancer|2015–2019|Males|4|30–34|0.772|0.729|0.809
Relative|Colorectal cancer|2015–2019|Males|4|35–39|0.797|0.76|0.83
Relative|Colorectal cancer|2015–2019|Males|4|40–44|0.765|0.735|0.792
Relative|Colorectal cancer|2015–2019|Males|4|45–49|0.761|0.737|0.783
Relative|Colorectal cancer|2015–2019|Males|4|50–54|0.783|0.766|0.8
Relative|Colorectal cancer|2015–2019|Males|4|55–59|0.766|0.75|0.781
Relative|Colorectal cancer|2015–2019|Males|4|60–64|0.769|0.756|0.781
Relative|Colorectal cancer|2015–2019|Males|4|65–69|0.762|0.75|0.774
Relative|Colorectal cancer|2015–2019|Males|4|70–74|0.749|0.737|0.762
Relative|Colorectal cancer|2015–2019|Males|4|75–79|0.696|0.68|0.71
Relative|Colorectal cancer|2015–2019|Males|4|80–84|0.662|0.643|0.682
Relative|Colorectal cancer|2015–2019|Males|4|85+|0.532|0.505|0.558
Relative|Colorectal cancer|2015–2019|Males|4|All ages combined|0.726|0.721|0.731
Relative|Colorectal cancer|2015–2019|Males|5|00–04|||
Relative|Colorectal cancer|2015–2019|Males|5|05–09|||
Relative|Colorectal cancer|2015–2019|Males|5|10–14|0.916|0.76|0.973
Relative|Colorectal cancer|2015–2019|Males|5|15–19|0.976|0.901|0.996
Relative|Colorectal cancer|2015–2019|Males|5|20–24|0.922|0.853|0.96
Relative|Colorectal cancer|2015–2019|Males|5|25–29|0.752|0.691|0.803
Relative|Colorectal cancer|2015–2019|Males|5|30–34|0.748|0.703|0.787
Relative|Colorectal cancer|2015–2019|Males|5|35–39|0.783|0.744|0.817
Relative|Colorectal cancer|2015–2019|Males|5|40–44|0.738|0.706|0.766
Relative|Colorectal cancer|2015–2019|Males|5|45–49|0.733|0.708|0.756
Relative|Colorectal cancer|2015–2019|Males|5|50–54|0.758|0.74|0.775
Relative|Colorectal cancer|2015–2019|Males|5|55–59|0.738|0.722|0.754
Relative|Colorectal cancer|2015–2019|Males|5|60–64|0.742|0.728|0.755
Relative|Colorectal cancer|2015–2019|Males|5|65–69|0.731|0.718|0.744
Relative|Colorectal cancer|2015–2019|Males|5|70–74|0.728|0.714|0.741
Relative|Colorectal cancer|2015–2019|Males|5|75–79|0.67|0.654|0.686
Relative|Colorectal cancer|2015–2019|Males|5|80–84|0.637|0.615|0.658
Relative|Colorectal cancer|2015–2019|Males|5|85+|0.518|0.488|0.548
Relative|Colorectal cancer|2015–2019|Males|5|All ages combined|0.701|0.695|0.706
Observed|Colorectal cancer|2015–2019|Females|1|00–04|||
Observed|Colorectal cancer|2015–2019|Females|1|05–09|||
Observed|Colorectal cancer|2015–2019|Females|1|10–14|1|0.955|1
Observed|Colorectal cancer|2015–2019|Females|1|15–19|1|0.979|1
Observed|Colorectal cancer|2015–2019|Females|1|20–24|0.983|0.948|0.994
Observed|Colorectal cancer|2015–2019|Females|1|25–29|0.947|0.914|0.968
Observed|Colorectal cancer|2015–2019|Females|1|30–34|0.941|0.916|0.958
Observed|Colorectal cancer|2015–2019|Females|1|35–39|0.958|0.939|0.972
Observed|Colorectal cancer|2015–2019|Females|1|40–44|0.947|0.93|0.96
Observed|Colorectal cancer|2015–2019|Females|1|45–49|0.936|0.921|0.948
Observed|Colorectal cancer|2015–2019|Females|1|50–54|0.939|0.927|0.949
Observed|Colorectal cancer|2015–2019|Females|1|55–59|0.93|0.919|0.94
Observed|Colorectal cancer|2015–2019|Females|1|60–64|0.921|0.911|0.93
Observed|Colorectal cancer|2015–2019|Females|1|65–69|0.905|0.895|0.914
Observed|Colorectal cancer|2015–2019|Females|1|70–74|0.881|0.872|0.89
Observed|Colorectal cancer|2015–2019|Females|1|75–79|0.828|0.817|0.839
Observed|Colorectal cancer|2015–2019|Females|1|80–84|0.768|0.755|0.78
Observed|Colorectal cancer|2015–2019|Females|1|85+|0.602|0.588|0.616
Observed|Colorectal cancer|2015–2019|Females|1|All ages combined|0.841|0.837|0.845
Observed|Colorectal cancer|2015–2019|Females|2|00–04|||
Observed|Colorectal cancer|2015–2019|Females|2|05–09|||
Observed|Colorectal cancer|2015–2019|Females|2|10–14|1|0.955|1
Observed|Colorectal cancer|2015–2019|Females|2|15–19|0.993|0.95|0.999
Observed|Colorectal cancer|2015–2019|Females|2|20–24|0.977|0.94|0.991
Observed|Colorectal cancer|2015–2019|Females|2|25–29|0.879|0.835|0.912
Observed|Colorectal cancer|2015–2019|Females|2|30–34|0.864|0.83|0.892
Observed|Colorectal cancer|2015–2019|Females|2|35–39|0.901|0.872|0.923
Observed|Colorectal cancer|2015–2019|Females|2|40–44|0.887|0.863|0.907
Observed|Colorectal cancer|2015–2019|Females|2|45–49|0.858|0.838|0.876
Observed|Colorectal cancer|2015–2019|Females|2|50–54|0.87|0.854|0.884
Observed|Colorectal cancer|2015–2019|Females|2|55–59|0.867|0.852|0.88
Observed|Colorectal cancer|2015–2019|Females|2|60–64|0.86|0.847|0.871
Observed|Colorectal cancer|2015–2019|Females|2|65–69|0.838|0.826|0.849
Observed|Colorectal cancer|2015–2019|Females|2|70–74|0.811|0.8|0.822
Observed|Colorectal cancer|2015–2019|Females|2|75–79|0.75|0.737|0.762
Observed|Colorectal cancer|2015–2019|Females|2|80–84|0.672|0.658|0.686
Observed|Colorectal cancer|2015–2019|Females|2|85+|0.493|0.479|0.507
Observed|Colorectal cancer|2015–2019|Females|2|All ages combined|0.763|0.759|0.768
Observed|Colorectal cancer|2015–2019|Females|3|00–04|||
Observed|Colorectal cancer|2015–2019|Females|3|05–09|||
Observed|Colorectal cancer|2015–2019|Females|3|10–14|1|0.955|1
Observed|Colorectal cancer|2015–2019|Females|3|15–19|0.985|0.942|0.996
Observed|Colorectal cancer|2015–2019|Females|3|20–24|0.977|0.94|0.991
Observed|Colorectal cancer|2015–2019|Females|3|25–29|0.84|0.792|0.878
Observed|Colorectal cancer|2015–2019|Females|3|30–34|0.832|0.795|0.863
Observed|Colorectal cancer|2015–2019|Females|3|35–39|0.85|0.815|0.878
Observed|Colorectal cancer|2015–2019|Females|3|40–44|0.83|0.803|0.854
Observed|Colorectal cancer|2015–2019|Females|3|45–49|0.804|0.781|0.824
Observed|Colorectal cancer|2015–2019|Females|3|50–54|0.823|0.805|0.839
Observed|Colorectal cancer|2015–2019|Females|3|55–59|0.828|0.812|0.842
Observed|Colorectal cancer|2015–2019|Females|3|60–64|0.807|0.793|0.821
Observed|Colorectal cancer|2015–2019|Females|3|65–69|0.79|0.777|0.802
Observed|Colorectal cancer|2015–2019|Females|3|70–74|0.762|0.75|0.774
Observed|Colorectal cancer|2015–2019|Females|3|75–79|0.695|0.682|0.708
Observed|Colorectal cancer|2015–2019|Females|3|80–84|0.613|0.598|0.627
Observed|Colorectal cancer|2015–2019|Females|3|85+|0.411|0.398|0.425
Observed|Colorectal cancer|2015–2019|Females|3|All ages combined|0.708|0.703|0.713
Observed|Colorectal cancer|2015–2019|Females|4|00–04|||
Observed|Colorectal cancer|2015–2019|Females|4|05–09|||
Observed|Colorectal cancer|2015–2019|Females|4|10–14|1|0.955|1
Observed|Colorectal cancer|2015–2019|Females|4|15–19|0.985|0.942|0.996
Observed|Colorectal cancer|2015–2019|Females|4|20–24|0.971|0.933|0.988
Observed|Colorectal cancer|2015–2019|Females|4|25–29|0.808|0.757|0.85
Observed|Colorectal cancer|2015–2019|Females|4|30–34|0.821|0.783|0.853
Observed|Colorectal cancer|2015–2019|Females|4|35–39|0.81|0.772|0.843
Observed|Colorectal cancer|2015–2019|Females|4|40–44|0.797|0.768|0.823
Observed|Colorectal cancer|2015–2019|Females|4|45–49|0.759|0.735|0.781
Observed|Colorectal cancer|2015–2019|Females|4|50–54|0.797|0.778|0.814
Observed|Colorectal cancer|2015–2019|Females|4|55–59|0.795|0.778|0.81
Observed|Colorectal cancer|2015–2019|Females|4|60–64|0.771|0.756|0.785
Observed|Colorectal cancer|2015–2019|Females|4|65–69|0.757|0.743|0.77
Observed|Colorectal cancer|2015–2019|Females|4|70–74|0.726|0.713|0.739
Observed|Colorectal cancer|2015–2019|Females|4|75–79|0.65|0.636|0.663
Observed|Colorectal cancer|2015–2019|Females|4|80–84|0.555|0.54|0.57
Observed|Colorectal cancer|2015–2019|Females|4|85+|0.346|0.333|0.359
Observed|Colorectal cancer|2015–2019|Females|4|All ages combined|0.664|0.659|0.669
Observed|Colorectal cancer|2015–2019|Females|5|00–04|||
Observed|Colorectal cancer|2015–2019|Females|5|05–09|||
Observed|Colorectal cancer|2015–2019|Females|5|10–14|1|0.954|1
Observed|Colorectal cancer|2015–2019|Females|5|15–19|0.985|0.942|0.996
Observed|Colorectal cancer|2015–2019|Females|5|20–24|0.971|0.933|0.988
Observed|Colorectal cancer|2015–2019|Females|5|25–29|0.793|0.74|0.836
Observed|Colorectal cancer|2015–2019|Females|5|30–34|0.802|0.761|0.836
Observed|Colorectal cancer|2015–2019|Females|5|35–39|0.783|0.743|0.818
Observed|Colorectal cancer|2015–2019|Females|5|40–44|0.771|0.74|0.799
Observed|Colorectal cancer|2015–2019|Females|5|45–49|0.73|0.705|0.753
Observed|Colorectal cancer|2015–2019|Females|5|50–54|0.777|0.757|0.795
Observed|Colorectal cancer|2015–2019|Females|5|55–59|0.764|0.747|0.781
Observed|Colorectal cancer|2015–2019|Females|5|60–64|0.74|0.725|0.755
Observed|Colorectal cancer|2015–2019|Females|5|65–69|0.728|0.714|0.742
Observed|Colorectal cancer|2015–2019|Females|5|70–74|0.688|0.674|0.701
Observed|Colorectal cancer|2015–2019|Females|5|75–79|0.605|0.591|0.619
Observed|Colorectal cancer|2015–2019|Females|5|80–84|0.51|0.495|0.525
Observed|Colorectal cancer|2015–2019|Females|5|85+|0.293|0.281|0.306
Observed|Colorectal cancer|2015–2019|Females|5|All ages combined|0.627|0.622|0.632
Relative|Colorectal cancer|2015–2019|Females|1|00–04|||
Relative|Colorectal cancer|2015–2019|Females|1|05–09|||
Relative|Colorectal cancer|2015–2019|Females|1|10–14|1|0.955|1
Relative|Colorectal cancer|2015–2019|Females|1|15–19|1|0.979|1
Relative|Colorectal cancer|2015–2019|Females|1|20–24|0.983|0.948|0.995
Relative|Colorectal cancer|2015–2019|Females|1|25–29|0.948|0.914|0.968
Relative|Colorectal cancer|2015–2019|Females|1|30–34|0.941|0.916|0.958
Relative|Colorectal cancer|2015–2019|Females|1|35–39|0.959|0.939|0.973
Relative|Colorectal cancer|2015–2019|Females|1|40–44|0.948|0.931|0.961
Relative|Colorectal cancer|2015–2019|Females|1|45–49|0.937|0.922|0.949
Relative|Colorectal cancer|2015–2019|Females|1|50–54|0.941|0.929|0.951
Relative|Colorectal cancer|2015–2019|Females|1|55–59|0.933|0.922|0.943
Relative|Colorectal cancer|2015–2019|Females|1|60–64|0.925|0.915|0.934
Relative|Colorectal cancer|2015–2019|Females|1|65–69|0.911|0.902|0.92
Relative|Colorectal cancer|2015–2019|Females|1|70–74|0.892|0.883|0.901
Relative|Colorectal cancer|2015–2019|Females|1|75–79|0.847|0.835|0.858
Relative|Colorectal cancer|2015–2019|Females|1|80–84|0.801|0.787|0.813
Relative|Colorectal cancer|2015–2019|Females|1|85+|0.675|0.659|0.69
Relative|Colorectal cancer|2015–2019|Females|1|All ages combined|0.865|0.86|0.868
Relative|Colorectal cancer|2015–2019|Females|2|00–04|||
Relative|Colorectal cancer|2015–2019|Females|2|05–09|||
Relative|Colorectal cancer|2015–2019|Females|2|10–14|1|0.955|1
Relative|Colorectal cancer|2015–2019|Females|2|15–19|0.993|0.951|0.999
Relative|Colorectal cancer|2015–2019|Females|2|20–24|0.978|0.941|0.992
Relative|Colorectal cancer|2015–2019|Females|2|25–29|0.879|0.835|0.912
Relative|Colorectal cancer|2015–2019|Females|2|30–34|0.865|0.831|0.892
Relative|Colorectal cancer|2015–2019|Females|2|35–39|0.902|0.873|0.924
Relative|Colorectal cancer|2015–2019|Females|2|40–44|0.889|0.865|0.908
Relative|Colorectal cancer|2015–2019|Females|2|45–49|0.861|0.841|0.878
Relative|Colorectal cancer|2015–2019|Females|2|50–54|0.874|0.858|0.888
Relative|Colorectal cancer|2015–2019|Females|2|55–59|0.872|0.858|0.885
Relative|Colorectal cancer|2015–2019|Females|2|60–64|0.868|0.855|0.88
Relative|Colorectal cancer|2015–2019|Females|2|65–69|0.851|0.839|0.862
Relative|Colorectal cancer|2015–2019|Females|2|70–74|0.833|0.821|0.844
Relative|Colorectal cancer|2015–2019|Females|2|75–79|0.786|0.772|0.799
Relative|Colorectal cancer|2015–2019|Females|2|80–84|0.735|0.72|0.75
Relative|Colorectal cancer|2015–2019|Females|2|85+|0.622|0.605|0.64
Relative|Colorectal cancer|2015–2019|Females|2|All ages combined|0.804|0.799|0.809
Relative|Colorectal cancer|2015–2019|Females|3|00–04|||
Relative|Colorectal cancer|2015–2019|Females|3|05–09|||
Relative|Colorectal cancer|2015–2019|Females|3|10–14|1|0.956|1
Relative|Colorectal cancer|2015–2019|Females|3|15–19|0.986|0.942|0.997
Relative|Colorectal cancer|2015–2019|Females|3|20–24|0.978|0.941|0.992
Relative|Colorectal cancer|2015–2019|Females|3|25–29|0.841|0.793|0.879
Relative|Colorectal cancer|2015–2019|Females|3|30–34|0.833|0.796|0.864
Relative|Colorectal cancer|2015–2019|Females|3|35–39|0.851|0.817|0.88
Relative|Colorectal cancer|2015–2019|Females|3|40–44|0.833|0.805|0.857
Relative|Colorectal cancer|2015–2019|Females|3|45–49|0.808|0.785|0.828
Relative|Colorectal cancer|2015–2019|Females|3|50–54|0.828|0.81|0.845
Relative|Colorectal cancer|2015–2019|Females|3|55–59|0.836|0.82|0.851
Relative|Colorectal cancer|2015–2019|Females|3|60–64|0.82|0.805|0.833
Relative|Colorectal cancer|2015–2019|Females|3|65–69|0.809|0.795|0.821
Relative|Colorectal cancer|2015–2019|Females|3|70–74|0.795|0.782|0.807
Relative|Colorectal cancer|2015–2019|Females|3|75–79|0.749|0.735|0.763
Relative|Colorectal cancer|2015–2019|Females|3|80–84|0.709|0.692|0.725
Relative|Colorectal cancer|2015–2019|Females|3|85+|0.591|0.571|0.61
Relative|Colorectal cancer|2015–2019|Females|3|All ages combined|0.766|0.761|0.771
Relative|Colorectal cancer|2015–2019|Females|4|00–04|||
Relative|Colorectal cancer|2015–2019|Females|4|05–09|||
Relative|Colorectal cancer|2015–2019|Females|4|10–14|1.001|0.955|1.001
Relative|Colorectal cancer|2015–2019|Females|4|15–19|0.986|0.943|0.997
Relative|Colorectal cancer|2015–2019|Females|4|20–24|0.972|0.934|0.989
Relative|Colorectal cancer|2015–2019|Females|4|25–29|0.809|0.758|0.851
Relative|Colorectal cancer|2015–2019|Females|4|30–34|0.823|0.784|0.855
Relative|Colorectal cancer|2015–2019|Females|4|35–39|0.813|0.775|0.845
Relative|Colorectal cancer|2015–2019|Females|4|40–44|0.801|0.771|0.827
Relative|Colorectal cancer|2015–2019|Females|4|45–49|0.764|0.74|0.786
Relative|Colorectal cancer|2015–2019|Females|4|50–54|0.804|0.785|0.822
Relative|Colorectal cancer|2015–2019|Females|4|55–59|0.806|0.789|0.822
Relative|Colorectal cancer|2015–2019|Females|4|60–64|0.787|0.772|0.802
Relative|Colorectal cancer|2015–2019|Females|4|65–69|0.782|0.768|0.796
Relative|Colorectal cancer|2015–2019|Females|4|70–74|0.77|0.756|0.783
Relative|Colorectal cancer|2015–2019|Females|4|75–79|0.723|0.707|0.738
Relative|Colorectal cancer|2015–2019|Females|4|80–84|0.684|0.666|0.702
Relative|Colorectal cancer|2015–2019|Females|4|85+|0.574|0.552|0.595
Relative|Colorectal cancer|2015–2019|Females|4|All ages combined|0.74|0.734|0.745
Relative|Colorectal cancer|2015–2019|Females|5|00–04|||
Relative|Colorectal cancer|2015–2019|Females|5|05–09|||
Relative|Colorectal cancer|2015–2019|Females|5|10–14|1.001|0.954|1.001
Relative|Colorectal cancer|2015–2019|Females|5|15–19|0.986|0.943|0.997
Relative|Colorectal cancer|2015–2019|Females|5|20–24|0.973|0.934|0.989
Relative|Colorectal cancer|2015–2019|Females|5|25–29|0.794|0.742|0.837
Relative|Colorectal cancer|2015–2019|Females|5|30–34|0.804|0.763|0.838
Relative|Colorectal cancer|2015–2019|Females|5|35–39|0.786|0.746|0.821
Relative|Colorectal cancer|2015–2019|Females|5|40–44|0.776|0.744|0.804
Relative|Colorectal cancer|2015–2019|Females|5|45–49|0.736|0.711|0.76
Relative|Colorectal cancer|2015–2019|Females|5|50–54|0.786|0.767|0.805
Relative|Colorectal cancer|2015–2019|Females|5|55–59|0.778|0.761|0.795
Relative|Colorectal cancer|2015–2019|Females|5|60–64|0.761|0.745|0.776
Relative|Colorectal cancer|2015–2019|Females|5|65–69|0.761|0.747|0.775
Relative|Colorectal cancer|2015–2019|Females|5|70–74|0.744|0.729|0.758
Relative|Colorectal cancer|2015–2019|Females|5|75–79|0.698|0.682|0.714
Relative|Colorectal cancer|2015–2019|Females|5|80–84|0.677|0.657|0.696
Relative|Colorectal cancer|2015–2019|Females|5|85+|0.57|0.546|0.595
Relative|Colorectal cancer|2015–2019|Females|5|All ages combined|0.72|0.714|0.726
Observed|Colorectal cancer|2015–2019|Persons|1|00–04|||
Observed|Colorectal cancer|2015–2019|Persons|1|05–09|||
Observed|Colorectal cancer|2015–2019|Persons|1|10–14|1|0.971|1
Observed|Colorectal cancer|2015–2019|Persons|1|15–19|1|0.987|1
Observed|Colorectal cancer|2015–2019|Persons|1|20–24|0.983|0.96|0.993
Observed|Colorectal cancer|2015–2019|Persons|1|25–29|0.931|0.906|0.95
Observed|Colorectal cancer|2015–2019|Persons|1|30–34|0.924|0.906|0.939
Observed|Colorectal cancer|2015–2019|Persons|1|35–39|0.936|0.92|0.948
Observed|Colorectal cancer|2015–2019|Persons|1|40–44|0.935|0.922|0.946
Observed|Colorectal cancer|2015–2019|Persons|1|45–49|0.933|0.923|0.942
Observed|Colorectal cancer|2015–2019|Persons|1|50–54|0.931|0.923|0.938
Observed|Colorectal cancer|2015–2019|Persons|1|55–59|0.918|0.911|0.925
Observed|Colorectal cancer|2015–2019|Persons|1|60–64|0.917|0.911|0.923
Observed|Colorectal cancer|2015–2019|Persons|1|65–69|0.897|0.891|0.903
Observed|Colorectal cancer|2015–2019|Persons|1|70–74|0.878|0.872|0.884
Observed|Colorectal cancer|2015–2019|Persons|1|75–79|0.822|0.815|0.83
Observed|Colorectal cancer|2015–2019|Persons|1|80–84|0.763|0.754|0.772
Observed|Colorectal cancer|2015–2019|Persons|1|85+|0.596|0.586|0.607
Observed|Colorectal cancer|2015–2019|Persons|1|All ages combined|0.844|0.842|0.847
Observed|Colorectal cancer|2015–2019|Persons|2|00–04|||
Observed|Colorectal cancer|2015–2019|Persons|2|05–09|||
Observed|Colorectal cancer|2015–2019|Persons|2|10–14|0.97|0.91|0.99
Observed|Colorectal cancer|2015–2019|Persons|2|15–19|0.991|0.964|0.998
Observed|Colorectal cancer|2015–2019|Persons|2|20–24|0.966|0.938|0.982
Observed|Colorectal cancer|2015–2019|Persons|2|25–29|0.865|0.832|0.892
Observed|Colorectal cancer|2015–2019|Persons|2|30–34|0.854|0.83|0.875
Observed|Colorectal cancer|2015–2019|Persons|2|35–39|0.883|0.862|0.901
Observed|Colorectal cancer|2015–2019|Persons|2|40–44|0.867|0.85|0.883
Observed|Colorectal cancer|2015–2019|Persons|2|45–49|0.855|0.841|0.867
Observed|Colorectal cancer|2015–2019|Persons|2|50–54|0.868|0.858|0.878
Observed|Colorectal cancer|2015–2019|Persons|2|55–59|0.853|0.843|0.862
Observed|Colorectal cancer|2015–2019|Persons|2|60–64|0.85|0.842|0.857
Observed|Colorectal cancer|2015–2019|Persons|2|65–69|0.826|0.818|0.833
Observed|Colorectal cancer|2015–2019|Persons|2|70–74|0.806|0.798|0.813
Observed|Colorectal cancer|2015–2019|Persons|2|75–79|0.736|0.727|0.744
Observed|Colorectal cancer|2015–2019|Persons|2|80–84|0.661|0.651|0.671
Observed|Colorectal cancer|2015–2019|Persons|2|85+|0.476|0.466|0.487
Observed|Colorectal cancer|2015–2019|Persons|2|All ages combined|0.763|0.76|0.766
Observed|Colorectal cancer|2015–2019|Persons|3|00–04|||
Observed|Colorectal cancer|2015–2019|Persons|3|05–09|||
Observed|Colorectal cancer|2015–2019|Persons|3|10–14|0.97|0.91|0.99
Observed|Colorectal cancer|2015–2019|Persons|3|15–19|0.981|0.95|0.993
Observed|Colorectal cancer|2015–2019|Persons|3|20–24|0.962|0.933|0.979
Observed|Colorectal cancer|2015–2019|Persons|3|25–29|0.821|0.785|0.851
Observed|Colorectal cancer|2015–2019|Persons|3|30–34|0.815|0.788|0.839
Observed|Colorectal cancer|2015–2019|Persons|3|35–39|0.838|0.814|0.859
Observed|Colorectal cancer|2015–2019|Persons|3|40–44|0.818|0.798|0.835
Observed|Colorectal cancer|2015–2019|Persons|3|45–49|0.8|0.785|0.815
Observed|Colorectal cancer|2015–2019|Persons|3|50–54|0.813|0.801|0.824
Observed|Colorectal cancer|2015–2019|Persons|3|55–59|0.804|0.794|0.814
Observed|Colorectal cancer|2015–2019|Persons|3|60–64|0.795|0.786|0.803
Observed|Colorectal cancer|2015–2019|Persons|3|65–69|0.774|0.766|0.782
Observed|Colorectal cancer|2015–2019|Persons|3|70–74|0.748|0.74|0.756
Observed|Colorectal cancer|2015–2019|Persons|3|75–79|0.672|0.663|0.681
Observed|Colorectal cancer|2015–2019|Persons|3|80–84|0.588|0.578|0.598
Observed|Colorectal cancer|2015–2019|Persons|3|85+|0.39|0.38|0.4
Observed|Colorectal cancer|2015–2019|Persons|3|All ages combined|0.702|0.698|0.705
Observed|Colorectal cancer|2015–2019|Persons|4|00–04|||
Observed|Colorectal cancer|2015–2019|Persons|4|05–09|||
Observed|Colorectal cancer|2015–2019|Persons|4|10–14|0.97|0.91|0.99
Observed|Colorectal cancer|2015–2019|Persons|4|15–19|0.981|0.95|0.993
Observed|Colorectal cancer|2015–2019|Persons|4|20–24|0.955|0.924|0.974
Observed|Colorectal cancer|2015–2019|Persons|4|25–29|0.788|0.75|0.821
Observed|Colorectal cancer|2015–2019|Persons|4|30–34|0.796|0.767|0.821
Observed|Colorectal cancer|2015–2019|Persons|4|35–39|0.803|0.777|0.826
Observed|Colorectal cancer|2015–2019|Persons|4|40–44|0.778|0.757|0.797
Observed|Colorectal cancer|2015–2019|Persons|4|45–49|0.756|0.739|0.772
Observed|Colorectal cancer|2015–2019|Persons|4|50–54|0.782|0.77|0.794
Observed|Colorectal cancer|2015–2019|Persons|4|55–59|0.767|0.756|0.778
Observed|Colorectal cancer|2015–2019|Persons|4|60–64|0.753|0.743|0.762
Observed|Colorectal cancer|2015–2019|Persons|4|65–69|0.735|0.727|0.744
Observed|Colorectal cancer|2015–2019|Persons|4|70–74|0.701|0.693|0.71
Observed|Colorectal cancer|2015–2019|Persons|4|75–79|0.617|0.608|0.627
Observed|Colorectal cancer|2015–2019|Persons|4|80–84|0.523|0.513|0.534
Observed|Colorectal cancer|2015–2019|Persons|4|85+|0.321|0.311|0.33
Observed|Colorectal cancer|2015–2019|Persons|4|All ages combined|0.653|0.65|0.656
Observed|Colorectal cancer|2015–2019|Persons|5|00–04|||
Observed|Colorectal cancer|2015–2019|Persons|5|05–09|||
Observed|Colorectal cancer|2015–2019|Persons|5|10–14|0.97|0.91|0.99
Observed|Colorectal cancer|2015–2019|Persons|5|15–19|0.981|0.95|0.993
Observed|Colorectal cancer|2015–2019|Persons|5|20–24|0.951|0.919|0.971
Observed|Colorectal cancer|2015–2019|Persons|5|25–29|0.773|0.734|0.807
Observed|Colorectal cancer|2015–2019|Persons|5|30–34|0.773|0.744|0.8
Observed|Colorectal cancer|2015–2019|Persons|5|35–39|0.781|0.754|0.806
Observed|Colorectal cancer|2015–2019|Persons|5|40–44|0.75|0.729|0.771
Observed|Colorectal cancer|2015–2019|Persons|5|45–49|0.726|0.709|0.743
Observed|Colorectal cancer|2015–2019|Persons|5|50–54|0.758|0.745|0.77
Observed|Colorectal cancer|2015–2019|Persons|5|55–59|0.736|0.725|0.747
Observed|Colorectal cancer|2015–2019|Persons|5|60–64|0.72|0.71|0.73
Observed|Colorectal cancer|2015–2019|Persons|5|65–69|0.7|0.691|0.708
Observed|Colorectal cancer|2015–2019|Persons|5|70–74|0.662|0.653|0.671
Observed|Colorectal cancer|2015–2019|Persons|5|75–79|0.569|0.56|0.579
Observed|Colorectal cancer|2015–2019|Persons|5|80–84|0.469|0.458|0.479
Observed|Colorectal cancer|2015–2019|Persons|5|85+|0.266|0.257|0.275
Observed|Colorectal cancer|2015–2019|Persons|5|All ages combined|0.613|0.609|0.616
Relative|Colorectal cancer|2015–2019|Persons|1|00–04|||
Relative|Colorectal cancer|2015–2019|Persons|1|05–09|||
Relative|Colorectal cancer|2015–2019|Persons|1|10–14|1|0.971|1
Relative|Colorectal cancer|2015–2019|Persons|1|15–19|1|0.988|1
Relative|Colorectal cancer|2015–2019|Persons|1|20–24|0.984|0.961|0.993
Relative|Colorectal cancer|2015–2019|Persons|1|25–29|0.931|0.906|0.95
Relative|Colorectal cancer|2015–2019|Persons|1|30–34|0.925|0.907|0.94
Relative|Colorectal cancer|2015–2019|Persons|1|35–39|0.936|0.92|0.949
Relative|Colorectal cancer|2015–2019|Persons|1|40–44|0.936|0.923|0.947
Relative|Colorectal cancer|2015–2019|Persons|1|45–49|0.935|0.925|0.943
Relative|Colorectal cancer|2015–2019|Persons|1|50–54|0.934|0.926|0.941
Relative|Colorectal cancer|2015–2019|Persons|1|55–59|0.922|0.915|0.929
Relative|Colorectal cancer|2015–2019|Persons|1|60–64|0.923|0.917|0.929
Relative|Colorectal cancer|2015–2019|Persons|1|65–69|0.907|0.9|0.912
Relative|Colorectal cancer|2015–2019|Persons|1|70–74|0.893|0.886|0.899
Relative|Colorectal cancer|2015–2019|Persons|1|75–79|0.846|0.838|0.854
Relative|Colorectal cancer|2015–2019|Persons|1|80–84|0.803|0.794|0.812
Relative|Colorectal cancer|2015–2019|Persons|1|85+|0.675|0.663|0.686
Relative|Colorectal cancer|2015–2019|Persons|1|All ages combined|0.869|0.866|0.871
Relative|Colorectal cancer|2015–2019|Persons|2|00–04|||
Relative|Colorectal cancer|2015–2019|Persons|2|05–09|||
Relative|Colorectal cancer|2015–2019|Persons|2|10–14|0.97|0.911|0.991
Relative|Colorectal cancer|2015–2019|Persons|2|15–19|0.991|0.964|0.998
Relative|Colorectal cancer|2015–2019|Persons|2|20–24|0.967|0.938|0.982
Relative|Colorectal cancer|2015–2019|Persons|2|25–29|0.866|0.833|0.892
Relative|Colorectal cancer|2015–2019|Persons|2|30–34|0.856|0.831|0.876
Relative|Colorectal cancer|2015–2019|Persons|2|35–39|0.885|0.864|0.903
Relative|Colorectal cancer|2015–2019|Persons|2|40–44|0.87|0.853|0.885
Relative|Colorectal cancer|2015–2019|Persons|2|45–49|0.858|0.844|0.871
Relative|Colorectal cancer|2015–2019|Persons|2|50–54|0.873|0.863|0.883
Relative|Colorectal cancer|2015–2019|Persons|2|55–59|0.86|0.851|0.87
Relative|Colorectal cancer|2015–2019|Persons|2|60–64|0.861|0.853|0.869
Relative|Colorectal cancer|2015–2019|Persons|2|65–69|0.844|0.836|0.851
Relative|Colorectal cancer|2015–2019|Persons|2|70–74|0.834|0.827|0.842
Relative|Colorectal cancer|2015–2019|Persons|2|75–79|0.782|0.773|0.791
Relative|Colorectal cancer|2015–2019|Persons|2|80–84|0.738|0.727|0.749
Relative|Colorectal cancer|2015–2019|Persons|2|85+|0.614|0.6|0.627
Relative|Colorectal cancer|2015–2019|Persons|2|All ages combined|0.806|0.803|0.81
Relative|Colorectal cancer|2015–2019|Persons|3|00–04|||
Relative|Colorectal cancer|2015–2019|Persons|3|05–09|||
Relative|Colorectal cancer|2015–2019|Persons|3|10–14|0.971|0.911|0.991
Relative|Colorectal cancer|2015–2019|Persons|3|15–19|0.982|0.951|0.994
Relative|Colorectal cancer|2015–2019|Persons|3|20–24|0.964|0.934|0.98
Relative|Colorectal cancer|2015–2019|Persons|3|25–29|0.822|0.786|0.852
Relative|Colorectal cancer|2015–2019|Persons|3|30–34|0.817|0.79|0.84
Relative|Colorectal cancer|2015–2019|Persons|3|35–39|0.84|0.816|0.861
Relative|Colorectal cancer|2015–2019|Persons|3|40–44|0.821|0.802|0.839
Relative|Colorectal cancer|2015–2019|Persons|3|45–49|0.805|0.79|0.82
Relative|Colorectal cancer|2015–2019|Persons|3|50–54|0.821|0.808|0.832
Relative|Colorectal cancer|2015–2019|Persons|3|55–59|0.816|0.805|0.826
Relative|Colorectal cancer|2015–2019|Persons|3|60–64|0.812|0.803|0.821
Relative|Colorectal cancer|2015–2019|Persons|3|65–69|0.8|0.791|0.808
Relative|Colorectal cancer|2015–2019|Persons|3|70–74|0.79|0.782|0.799
Relative|Colorectal cancer|2015–2019|Persons|3|75–79|0.74|0.73|0.749
Relative|Colorectal cancer|2015–2019|Persons|3|80–84|0.702|0.689|0.714
Relative|Colorectal cancer|2015–2019|Persons|3|85+|0.579|0.564|0.594
Relative|Colorectal cancer|2015–2019|Persons|3|All ages combined|0.763|0.76|0.767
Relative|Colorectal cancer|2015–2019|Persons|4|00–04|||
Relative|Colorectal cancer|2015–2019|Persons|4|05–09|||
Relative|Colorectal cancer|2015–2019|Persons|4|10–14|0.971|0.911|0.991
Relative|Colorectal cancer|2015–2019|Persons|4|15–19|0.982|0.951|0.994
Relative|Colorectal cancer|2015–2019|Persons|4|20–24|0.957|0.925|0.975
Relative|Colorectal cancer|2015–2019|Persons|4|25–29|0.789|0.752|0.822
Relative|Colorectal cancer|2015–2019|Persons|4|30–34|0.798|0.77|0.823
Relative|Colorectal cancer|2015–2019|Persons|4|35–39|0.806|0.78|0.829
Relative|Colorectal cancer|2015–2019|Persons|4|40–44|0.782|0.761|0.802
Relative|Colorectal cancer|2015–2019|Persons|4|45–49|0.762|0.746|0.778
Relative|Colorectal cancer|2015–2019|Persons|4|50–54|0.792|0.78|0.805
Relative|Colorectal cancer|2015–2019|Persons|4|55–59|0.783|0.771|0.794
Relative|Colorectal cancer|2015–2019|Persons|4|60–64|0.776|0.766|0.786
Relative|Colorectal cancer|2015–2019|Persons|4|65–69|0.77|0.761|0.779
Relative|Colorectal cancer|2015–2019|Persons|4|70–74|0.758|0.749|0.767
Relative|Colorectal cancer|2015–2019|Persons|4|75–79|0.708|0.697|0.718
Relative|Colorectal cancer|2015–2019|Persons|4|80–84|0.673|0.66|0.686
Relative|Colorectal cancer|2015–2019|Persons|4|85+|0.556|0.539|0.573
Relative|Colorectal cancer|2015–2019|Persons|4|All ages combined|0.732|0.728|0.736
Relative|Colorectal cancer|2015–2019|Persons|5|00–04|||
Relative|Colorectal cancer|2015–2019|Persons|5|05–09|||
Relative|Colorectal cancer|2015–2019|Persons|5|10–14|0.971|0.911|0.991
Relative|Colorectal cancer|2015–2019|Persons|5|15–19|0.983|0.952|0.994
Relative|Colorectal cancer|2015–2019|Persons|5|20–24|0.953|0.921|0.973
Relative|Colorectal cancer|2015–2019|Persons|5|25–29|0.775|0.736|0.809
Relative|Colorectal cancer|2015–2019|Persons|5|30–34|0.776|0.746|0.803
Relative|Colorectal cancer|2015–2019|Persons|5|35–39|0.785|0.758|0.81
Relative|Colorectal cancer|2015–2019|Persons|5|40–44|0.756|0.734|0.776
Relative|Colorectal cancer|2015–2019|Persons|5|45–49|0.734|0.717|0.751
Relative|Colorectal cancer|2015–2019|Persons|5|50–54|0.771|0.757|0.783
Relative|Colorectal cancer|2015–2019|Persons|5|55–59|0.755|0.743|0.767
Relative|Colorectal cancer|2015–2019|Persons|5|60–64|0.75|0.739|0.76
Relative|Colorectal cancer|2015–2019|Persons|5|65–69|0.743|0.734|0.753
Relative|Colorectal cancer|2015–2019|Persons|5|70–74|0.735|0.725|0.745
Relative|Colorectal cancer|2015–2019|Persons|5|75–79|0.683|0.671|0.694
Relative|Colorectal cancer|2015–2019|Persons|5|80–84|0.657|0.642|0.671
Relative|Colorectal cancer|2015–2019|Persons|5|85+|0.548|0.53|0.568
Relative|Colorectal cancer|2015–2019|Persons|5|All ages combined|0.709|0.705|0.713
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|00–04|0.862|0.701|0.94
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|05–09|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|10–14|1|0.865|1
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|15–19|0.938|0.82|0.98
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|20–24|0.896|0.745|0.959
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|25–29|0.962|0.856|0.99
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|30–34|0.938|0.821|0.98
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|35–39|0.927|0.833|0.969
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|40–44|0.93|0.839|0.97
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|45–49|0.899|0.82|0.944
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|50–54|0.956|0.904|0.98
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|55–59|0.823|0.753|0.875
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|60–64|0.842|0.787|0.884
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|65–69|0.786|0.728|0.832
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|70–74|0.788|0.73|0.835
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|75–79|0.778|0.717|0.828
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|80–84|0.771|0.705|0.825
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|85+|0.638|0.568|0.7
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|All ages combined|0.822|0.805|0.838
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|00–04|0.74|0.559|0.856
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|05–09|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|10–14|0.957|0.731|0.994
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|15–19|0.79|0.633|0.885
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|20–24|0.766|0.599|0.871
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|25–29|0.86|0.728|0.931
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|30–34|0.852|0.714|0.926
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|35–39|0.866|0.758|0.928
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|40–44|0.902|0.806|0.952
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|45–49|0.851|0.765|0.907
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|50–54|0.868|0.799|0.915
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|55–59|0.786|0.713|0.843
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|60–64|0.759|0.697|0.81
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|65–69|0.685|0.622|0.74
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|70–74|0.7|0.635|0.755
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|75–79|0.679|0.612|0.737
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|80–84|0.654|0.582|0.716
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|85+|0.464|0.394|0.53
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|All ages combined|0.728|0.708|0.747
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|00–04|0.74|0.559|0.856
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|05–09|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|10–14|0.843|0.634|0.938
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|15–19|0.763|0.602|0.865
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|20–24|0.745|0.578|0.853
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|25–29|0.783|0.642|0.873
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|30–34|0.81|0.666|0.896
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|35–39|0.837|0.724|0.906
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|40–44|0.83|0.72|0.9
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|45–49|0.796|0.704|0.862
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|50–54|0.832|0.759|0.885
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|55–59|0.768|0.693|0.826
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|60–64|0.712|0.647|0.767
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|65–69|0.624|0.559|0.683
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|70–74|0.635|0.568|0.695
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|75–79|0.583|0.514|0.646
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|80–84|0.56|0.487|0.628
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|85+|0.336|0.272|0.4
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|All ages combined|0.663|0.642|0.683
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|00–04|0.71|0.528|0.833
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|05–09|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|10–14|0.807|0.597|0.915
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|15–19|0.733|0.568|0.844
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|20–24|0.687|0.523|0.804
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|25–29|0.783|0.642|0.873
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|30–34|0.767|0.619|0.864
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|35–39|0.805|0.687|0.882
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|40–44|0.761|0.645|0.844
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|45–49|0.739|0.645|0.811
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|50–54|0.812|0.736|0.868
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|55–59|0.737|0.661|0.799
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|60–64|0.689|0.623|0.746
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|65–69|0.588|0.522|0.648
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|70–74|0.589|0.52|0.652
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|75–79|0.521|0.451|0.586
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|80–84|0.439|0.366|0.509
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|85+|0.263|0.203|0.327
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|All ages combined|0.615|0.594|0.636
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|00–04|0.684|0.502|0.811
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|05–09|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|10–14|0.807|0.597|0.915
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|15–19|0.669|0.494|0.795
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|20–24|0.687|0.523|0.804
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|25–29|0.762|0.62|0.857
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|30–34|0.767|0.619|0.864
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|35–39|0.805|0.687|0.882
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|40–44|0.695|0.575|0.787
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|45–49|0.715|0.621|0.79
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|50–54|0.797|0.72|0.855
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|55–59|0.731|0.654|0.793
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|60–64|0.663|0.596|0.721
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|65–69|0.569|0.503|0.63
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|70–74|0.562|0.492|0.626
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|75–79|0.471|0.401|0.538
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|80–84|0.358|0.289|0.428
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|85+|0.192|0.137|0.254
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|All ages combined|0.584|0.562|0.605
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|00–04|0.864|0.702|0.942
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|05–09|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|10–14|1|0.865|1
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|15–19|0.938|0.82|0.98
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|20–24|0.896|0.746|0.96
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|25–29|0.963|0.857|0.991
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|30–34|0.939|0.821|0.98
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|35–39|0.928|0.834|0.97
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|40–44|0.931|0.841|0.972
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|45–49|0.901|0.822|0.946
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|50–54|0.959|0.907|0.983
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|55–59|0.828|0.757|0.88
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|60–64|0.849|0.793|0.891
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|65–69|0.795|0.737|0.843
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|70–74|0.803|0.744|0.852
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|75–79|0.804|0.741|0.856
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|80–84|0.819|0.749|0.876
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|85+|0.736|0.655|0.808
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|1|All ages combined|0.845|0.828|0.861
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|00–04|0.741|0.56|0.857
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|05–09|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|10–14|0.957|0.731|0.994
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|15–19|0.79|0.634|0.886
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|20–24|0.767|0.6|0.872
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|25–29|0.861|0.729|0.932
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|30–34|0.853|0.715|0.928
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|35–39|0.868|0.76|0.93
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|40–44|0.905|0.809|0.955
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|45–49|0.855|0.768|0.912
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|50–54|0.875|0.805|0.922
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|55–59|0.795|0.721|0.852
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|60–64|0.772|0.709|0.824
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|65–69|0.703|0.638|0.759
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|70–74|0.729|0.662|0.786
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|75–79|0.729|0.657|0.791
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|80–84|0.743|0.662|0.815
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|85+|0.625|0.531|0.714
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|2|All ages combined|0.768|0.747|0.788
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|00–04|0.741|0.56|0.857
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|05–09|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|10–14|0.843|0.634|0.938
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|15–19|0.764|0.603|0.866
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|20–24|0.746|0.579|0.855
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|25–29|0.785|0.644|0.875
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|30–34|0.812|0.668|0.899
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|35–39|0.84|0.727|0.909
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|40–44|0.834|0.724|0.904
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|45–49|0.802|0.71|0.868
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|50–54|0.842|0.767|0.895
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|55–59|0.781|0.705|0.841
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|60–64|0.731|0.664|0.788
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|65–69|0.65|0.582|0.71
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|70–74|0.678|0.606|0.742
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|75–79|0.653|0.575|0.723
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|80–84|0.689|0.598|0.772
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|85+|0.536|0.434|0.639
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|3|All ages combined|0.718|0.695|0.739
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|00–04|0.712|0.529|0.835
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|05–09|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|10–14|0.807|0.597|0.915
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|15–19|0.735|0.569|0.845
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|20–24|0.688|0.524|0.806
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|25–29|0.785|0.644|0.876
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|30–34|0.77|0.622|0.867
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|35–39|0.809|0.691|0.886
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|40–44|0.767|0.649|0.851
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|45–49|0.747|0.652|0.82
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|50–54|0.825|0.748|0.882
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|55–59|0.755|0.676|0.818
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|60–64|0.715|0.646|0.774
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|65–69|0.622|0.552|0.685
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|70–74|0.646|0.57|0.714
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|75–79|0.611|0.529|0.688
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|80–84|0.589|0.491|0.683
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|85+|0.508|0.392|0.631
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|4|All ages combined|0.682|0.658|0.705
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|00–04|0.685|0.503|0.813
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|05–09|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|10–14|0.808|0.598|0.915
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|15–19|0.671|0.496|0.797
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|20–24|0.689|0.525|0.807
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|25–29|0.765|0.622|0.861
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|30–34|0.771|0.622|0.868
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|35–39|0.81|0.692|0.887
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|40–44|0.702|0.58|0.795
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|45–49|0.726|0.63|0.801
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|50–54|0.814|0.735|0.873
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|55–59|0.754|0.674|0.818
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|60–64|0.695|0.625|0.756
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|65–69|0.613|0.542|0.678
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|70–74|0.635|0.556|0.707
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|75–79|0.583|0.497|0.666
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|80–84|0.532|0.429|0.635
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|85+|0.455|0.325|0.603
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Males|5|All ages combined|0.662|0.638|0.686
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|00–04|0.968|0.793|0.995
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|05–09|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|10–14|0.879|0.67|0.959
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|15–19|0.925|0.785|0.975
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|20–24|0.93|0.797|0.977
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|25–29|0.965|0.775|0.995
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|30–34|0.979|0.859|0.997
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|35–39|0.951|0.857|0.984
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|40–44|0.987|0.911|0.998
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|45–49|0.946|0.875|0.977
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|50–54|0.961|0.91|0.984
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|55–59|0.899|0.836|0.939
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|60–64|0.908|0.848|0.946
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|65–69|0.845|0.772|0.896
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|70–74|0.785|0.708|0.845
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|75–79|0.777|0.69|0.842
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|80–84|0.635|0.541|0.715
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|85+|0.576|0.486|0.655
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|All ages combined|0.848|0.829|0.865
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|00–04|0.968|0.793|0.995
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|05–09|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|10–14|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|15–19|0.866|0.706|0.942
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|20–24|0.8|0.638|0.894
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|25–29|0.903|0.729|0.968
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|30–34|0.937|0.816|0.979
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|35–39|0.92|0.818|0.966
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|40–44|0.945|0.861|0.979
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|45–49|0.877|0.788|0.93
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|50–54|0.892|0.825|0.935
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|55–59|0.802|0.726|0.858
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|60–64|0.839|0.768|0.89
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|65–69|0.776|0.696|0.838
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|70–74|0.723|0.641|0.789
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|75–79|0.66|0.567|0.737
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|80–84|0.521|0.427|0.607
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|85+|0.451|0.365|0.533
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|All ages combined|0.768|0.746|0.789
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|00–04|0.968|0.793|0.995
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|05–09|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|10–14|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|15–19|0.779|0.604|0.883
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|20–24|0.735|0.572|0.843
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|25–29|0.903|0.729|0.968
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|30–34|0.9|0.776|0.957
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|35–39|0.869|0.755|0.932
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|40–44|0.945|0.861|0.979
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|45–49|0.828|0.73|0.893
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|50–54|0.84|0.765|0.892
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|55–59|0.758|0.679|0.821
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|60–64|0.81|0.735|0.866
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|65–69|0.726|0.642|0.793
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|70–74|0.679|0.595|0.749
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|75–79|0.582|0.489|0.664
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|80–84|0.454|0.36|0.542
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|85+|0.33|0.254|0.408
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|All ages combined|0.714|0.69|0.736
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|00–04|0.968|0.793|0.995
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|05–09|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|10–14|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|15–19|0.748|0.57|0.861
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|20–24|0.711|0.548|0.825
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|25–29|0.903|0.729|0.968
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|30–34|0.859|0.726|0.93
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|35–39|0.85|0.732|0.919
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|40–44|0.901|0.804|0.952
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|45–49|0.781|0.678|0.854
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|50–54|0.81|0.732|0.867
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|55–59|0.737|0.656|0.802
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|60–64|0.762|0.682|0.825
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|65–69|0.696|0.611|0.766
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|70–74|0.609|0.523|0.684
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|75–79|0.538|0.446|0.621
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|80–84|0.433|0.34|0.523
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|85+|0.245|0.179|0.317
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|All ages combined|0.672|0.648|0.695
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|00–04|0.968|0.793|0.995
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|05–09|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|10–14|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|15–19|||
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|20–24|0.64|0.476|0.765
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|25–29|0.824|0.649|0.917
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|30–34|0.836|0.699|0.915
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|35–39|0.797|0.669|0.879
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|40–44|0.811|0.696|0.886
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|45–49|0.755|0.649|0.833
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|50–54|0.81|0.732|0.867
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|55–59|0.689|0.605|0.76
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|60–64|0.739|0.657|0.805
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|65–69|0.653|0.566|0.728
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|70–74|0.566|0.48|0.643
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|75–79|0.491|0.401|0.576
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|80–84|0.352|0.263|0.442
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|85+|0.178|0.121|0.245
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|All ages combined|0.627|0.602|0.652
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|00–04|0.969|0.795|0.997
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|05–09|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|10–14|0.879|0.67|0.959
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|15–19|0.925|0.785|0.975
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|20–24|0.93|0.797|0.977
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|25–29|0.965|0.775|0.995
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|30–34|0.979|0.859|0.997
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|35–39|0.952|0.858|0.985
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|40–44|0.988|0.912|0.999
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|45–49|0.947|0.877|0.979
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|50–54|0.964|0.912|0.986
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|55–59|0.902|0.839|0.942
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|60–64|0.913|0.851|0.95
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|65–69|0.851|0.778|0.902
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|70–74|0.795|0.717|0.855
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|75–79|0.795|0.706|0.861
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|80–84|0.663|0.565|0.746
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|85+|0.643|0.543|0.732
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|1|All ages combined|0.862|0.843|0.88
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|00–04|0.97|0.795|0.997
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|05–09|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|10–14|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|15–19|0.866|0.706|0.942
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|20–24|0.8|0.639|0.895
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|25–29|0.904|0.729|0.968
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|30–34|0.937|0.817|0.98
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|35–39|0.921|0.819|0.967
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|40–44|0.947|0.862|0.981
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|45–49|0.879|0.79|0.932
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|50–54|0.896|0.829|0.939
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|55–59|0.807|0.731|0.864
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|60–64|0.848|0.776|0.899
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|65–69|0.788|0.706|0.851
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|70–74|0.742|0.659|0.81
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|75–79|0.692|0.594|0.773
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|80–84|0.571|0.467|0.665
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|85+|0.568|0.459|0.671
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|2|All ages combined|0.793|0.77|0.814
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|00–04|0.97|0.795|0.997
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|05–09|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|10–14|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|15–19|0.779|0.605|0.884
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|20–24|0.735|0.573|0.844
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|25–29|0.904|0.729|0.969
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|30–34|0.901|0.777|0.958
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|35–39|0.87|0.756|0.934
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|40–44|0.948|0.863|0.982
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|45–49|0.832|0.734|0.897
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|50–54|0.846|0.77|0.899
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|55–59|0.766|0.686|0.829
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|60–64|0.822|0.746|0.879
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|65–69|0.744|0.658|0.813
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|70–74|0.708|0.62|0.781
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|75–79|0.628|0.528|0.717
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|80–84|0.526|0.417|0.628
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|85+|0.476|0.367|0.588
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|3|All ages combined|0.748|0.724|0.772
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|00–04|0.97|0.795|0.997
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|05–09|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|10–14|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|15–19|0.749|0.571|0.861
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|20–24|0.712|0.549|0.825
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|25–29|0.904|0.729|0.969
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|30–34|0.86|0.728|0.932
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|35–39|0.853|0.734|0.922
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|40–44|0.905|0.807|0.956
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|45–49|0.786|0.682|0.86
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|50–54|0.818|0.739|0.876
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|55–59|0.747|0.665|0.813
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|60–64|0.778|0.696|0.842
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|65–69|0.72|0.632|0.793
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|70–74|0.646|0.555|0.725
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|75–79|0.6|0.498|0.693
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|80–84|0.536|0.421|0.647
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|85+|0.41|0.299|0.531
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|4|All ages combined|0.716|0.69|0.74
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|00–04|0.97|0.795|0.997
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|05–09|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|10–14|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|15–19|||
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|20–24|0.641|0.477|0.766
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|25–29|0.825|0.651|0.918
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|30–34|0.838|0.7|0.917
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|35–39|0.799|0.671|0.882
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|40–44|0.815|0.7|0.891
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|45–49|0.762|0.655|0.84
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|50–54|0.82|0.741|0.878
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|55–59|0.703|0.616|0.774
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|60–64|0.76|0.675|0.827
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|65–69|0.684|0.592|0.761
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|70–74|0.612|0.519|0.695
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|75–79|0.569|0.465|0.667
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|80–84|0.469|0.351|0.589
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|85+|0.349|0.236|0.48
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Females|5|All ages combined|0.679|0.652|0.705
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|00–04|0.911|0.813|0.959
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|05–09|0.886|0.687|0.962
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|10–14|0.934|0.809|0.978
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|15–19|0.932|0.855|0.969
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|20–24|0.913|0.827|0.958
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|25–29|0.963|0.889|0.988
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|30–34|0.958|0.893|0.984
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|35–39|0.938|0.881|0.969
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|40–44|0.959|0.912|0.982
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|45–49|0.922|0.874|0.952
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|50–54|0.959|0.926|0.977
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|55–59|0.859|0.814|0.894
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|60–64|0.868|0.829|0.899
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|65–69|0.807|0.763|0.844
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|70–74|0.787|0.742|0.825
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|75–79|0.778|0.729|0.818
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|80–84|0.719|0.665|0.766
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|85+|0.614|0.559|0.664
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|All ages combined|0.833|0.82|0.845
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|00–04|0.849|0.737|0.916
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|05–09|0.886|0.687|0.962
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|10–14|0.87|0.733|0.939
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|15–19|0.824|0.72|0.892
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|20–24|0.784|0.675|0.86
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|25–29|0.877|0.783|0.932
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|30–34|0.894|0.812|0.942
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|35–39|0.892|0.824|0.935
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|40–44|0.925|0.868|0.958
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|45–49|0.864|0.806|0.905
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|50–54|0.88|0.835|0.914
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|55–59|0.794|0.743|0.836
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|60–64|0.791|0.745|0.829
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|65–69|0.718|0.669|0.76
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|70–74|0.709|0.66|0.753
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|75–79|0.672|0.619|0.72
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|80–84|0.603|0.546|0.655
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|85+|0.459|0.405|0.511
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|All ages combined|0.745|0.73|0.759
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|00–04|0.849|0.737|0.916
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|05–09|0.848|0.644|0.94
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|10–14|0.79|0.645|0.881
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|15–19|0.769|0.657|0.848
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|20–24|0.74|0.63|0.822
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|25–29|0.829|0.728|0.895
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|30–34|0.855|0.768|0.911
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|35–39|0.852|0.778|0.903
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|40–44|0.889|0.825|0.931
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|45–49|0.811|0.748|0.86
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|50–54|0.836|0.786|0.875
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|55–59|0.764|0.711|0.808
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|60–64|0.751|0.703|0.792
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|65–69|0.661|0.611|0.707
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|70–74|0.653|0.602|0.7
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|75–79|0.583|0.528|0.634
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|80–84|0.52|0.462|0.575
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|85+|0.334|0.285|0.383
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|All ages combined|0.685|0.669|0.7
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|00–04|0.833|0.718|0.904
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|05–09|0.848|0.644|0.94
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|10–14|0.73|0.581|0.833
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|15–19|0.739|0.624|0.824
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|20–24|0.698|0.587|0.785
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|25–29|0.829|0.728|0.895
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|30–34|0.813|0.72|0.878
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|35–39|0.827|0.749|0.882
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|40–44|0.832|0.76|0.884
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|45–49|0.758|0.692|0.812
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|50–54|0.811|0.759|0.853
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|55–59|0.737|0.684|0.784
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|60–64|0.718|0.669|0.762
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|65–69|0.627|0.576|0.674
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|70–74|0.597|0.544|0.646
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|75–79|0.528|0.473|0.58
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|80–84|0.435|0.378|0.491
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|85+|0.255|0.21|0.303
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|All ages combined|0.639|0.623|0.655
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|00–04|0.816|0.698|0.891
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|05–09|0.848|0.644|0.94
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|10–14|0.73|0.581|0.833
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|15–19|0.685|0.562|0.78
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|20–24|0.665|0.553|0.755
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|25–29|0.783|0.678|0.857
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|30–34|0.803|0.709|0.87
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|35–39|0.801|0.72|0.861
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|40–44|0.754|0.674|0.817
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|45–49|0.734|0.666|0.79
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|50–54|0.803|0.75|0.846
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|55–59|0.713|0.657|0.761
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|60–64|0.693|0.642|0.738
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|65–69|0.6|0.548|0.648
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|70–74|0.563|0.509|0.613
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|75–79|0.48|0.425|0.532
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|80–84|0.355|0.3|0.41
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|85+|0.186|0.145|0.23
Observed|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|All ages combined|0.602|0.586|0.618
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|00–04|0.912|0.814|0.961
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|05–09|0.886|0.687|0.962
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|10–14|0.934|0.809|0.978
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|15–19|0.932|0.855|0.969
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|20–24|0.914|0.827|0.958
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|25–29|0.963|0.89|0.988
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|30–34|0.959|0.893|0.985
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|35–39|0.939|0.882|0.97
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|40–44|0.961|0.913|0.983
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|45–49|0.923|0.875|0.954
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|50–54|0.961|0.929|0.98
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|55–59|0.863|0.818|0.898
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|60–64|0.874|0.834|0.905
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|65–69|0.815|0.771|0.852
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|70–74|0.8|0.754|0.839
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|75–79|0.801|0.751|0.843
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|80–84|0.759|0.702|0.809
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|85+|0.699|0.637|0.756
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|1|All ages combined|0.852|0.839|0.864
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|00–04|0.85|0.738|0.917
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|05–09|0.886|0.687|0.962
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|10–14|0.87|0.734|0.94
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|15–19|0.825|0.721|0.893
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|20–24|0.784|0.676|0.86
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|25–29|0.878|0.784|0.933
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|30–34|0.895|0.813|0.943
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|35–39|0.894|0.826|0.936
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|40–44|0.927|0.871|0.96
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|45–49|0.867|0.81|0.909
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|50–54|0.885|0.84|0.919
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|55–59|0.801|0.75|0.843
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|60–64|0.802|0.756|0.841
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|65–69|0.733|0.684|0.777
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|70–74|0.735|0.684|0.78
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|75–79|0.716|0.659|0.766
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|80–84|0.677|0.613|0.736
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|85+|0.603|0.532|0.671
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|2|All ages combined|0.779|0.763|0.793
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|00–04|0.85|0.738|0.917
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|05–09|0.848|0.644|0.94
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|10–14|0.79|0.645|0.881
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|15–19|0.769|0.658|0.849
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|20–24|0.741|0.631|0.823
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|25–29|0.83|0.73|0.896
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|30–34|0.857|0.769|0.913
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|35–39|0.855|0.781|0.906
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|40–44|0.893|0.829|0.934
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|45–49|0.816|0.753|0.866
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|50–54|0.844|0.793|0.883
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|55–59|0.775|0.721|0.82
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|60–64|0.767|0.718|0.809
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|65–69|0.684|0.632|0.731
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|70–74|0.69|0.636|0.74
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|75–79|0.644|0.584|0.7
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|80–84|0.626|0.557|0.692
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|85+|0.512|0.437|0.588
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|3|All ages combined|0.731|0.714|0.747
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|00–04|0.834|0.719|0.905
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|05–09|0.848|0.644|0.94
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|10–14|0.73|0.582|0.834
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|15–19|0.74|0.625|0.825
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|20–24|0.699|0.588|0.786
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|25–29|0.831|0.73|0.897
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|30–34|0.816|0.722|0.88
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|35–39|0.83|0.752|0.886
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|40–44|0.837|0.765|0.889
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|45–49|0.765|0.698|0.82
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|50–54|0.821|0.769|0.864
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|55–59|0.752|0.697|0.799
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|60–64|0.74|0.689|0.785
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|65–69|0.658|0.604|0.707
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|70–74|0.645|0.588|0.698
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|75–79|0.608|0.545|0.668
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|80–84|0.568|0.493|0.641
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|85+|0.464|0.382|0.55
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|4|All ages combined|0.696|0.679|0.713
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|00–04|0.817|0.699|0.893
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|05–09|0.848|0.644|0.94
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|10–14|0.731|0.582|0.834
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|15–19|0.687|0.563|0.782
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|20–24|0.666|0.555|0.756
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|25–29|0.785|0.68|0.86
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|30–34|0.806|0.711|0.873
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|35–39|0.805|0.723|0.866
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|40–44|0.76|0.68|0.823
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|45–49|0.743|0.674|0.799
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|50–54|0.817|0.763|0.86
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|55–59|0.731|0.674|0.78
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|60–64|0.721|0.668|0.768
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|65–69|0.639|0.583|0.69
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|70–74|0.625|0.565|0.68
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|75–79|0.579|0.513|0.643
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|80–84|0.507|0.429|0.586
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|85+|0.405|0.316|0.503
Relative|Connective, subcutaneous and other soft tissues (cancer of)|2015–2019|Persons|5|All ages combined|0.669|0.651|0.687
Observed|Endometrial cancer|2015–2019|Females|1|00–04|||
Observed|Endometrial cancer|2015–2019|Females|1|05–09|||
Observed|Endometrial cancer|2015–2019|Females|1|10–14|||
Observed|Endometrial cancer|2015–2019|Females|1|15–19|||
Observed|Endometrial cancer|2015–2019|Females|1|20–24|||
Observed|Endometrial cancer|2015–2019|Females|1|25–29|1|0.939|1
Observed|Endometrial cancer|2015–2019|Females|1|30–34|0.991|0.94|0.999
Observed|Endometrial cancer|2015–2019|Females|1|35–39|0.981|0.951|0.993
Observed|Endometrial cancer|2015–2019|Females|1|40–44|0.977|0.955|0.988
Observed|Endometrial cancer|2015–2019|Females|1|45–49|0.964|0.946|0.976
Observed|Endometrial cancer|2015–2019|Females|1|50–54|0.966|0.954|0.976
Observed|Endometrial cancer|2015–2019|Females|1|55–59|0.967|0.958|0.975
Observed|Endometrial cancer|2015–2019|Females|1|60–64|0.957|0.948|0.965
Observed|Endometrial cancer|2015–2019|Females|1|65–69|0.947|0.937|0.956
Observed|Endometrial cancer|2015–2019|Females|1|70–74|0.934|0.921|0.945
Observed|Endometrial cancer|2015–2019|Females|1|75–79|0.886|0.867|0.903
Observed|Endometrial cancer|2015–2019|Females|1|80–84|0.864|0.837|0.886
Observed|Endometrial cancer|2015–2019|Females|1|85+|0.72|0.682|0.754
Observed|Endometrial cancer|2015–2019|Females|1|All ages combined|0.933|0.928|0.937
Observed|Endometrial cancer|2015–2019|Females|2|00–04|||
Observed|Endometrial cancer|2015–2019|Females|2|05–09|||
Observed|Endometrial cancer|2015–2019|Females|2|10–14|||
Observed|Endometrial cancer|2015–2019|Females|2|15–19|||
Observed|Endometrial cancer|2015–2019|Females|2|20–24|||
Observed|Endometrial cancer|2015–2019|Females|2|25–29|1|0.937|1
Observed|Endometrial cancer|2015–2019|Females|2|30–34|0.991|0.94|0.999
Observed|Endometrial cancer|2015–2019|Females|2|35–39|0.971|0.937|0.987
Observed|Endometrial cancer|2015–2019|Females|2|40–44|0.956|0.928|0.973
Observed|Endometrial cancer|2015–2019|Females|2|45–49|0.944|0.922|0.959
Observed|Endometrial cancer|2015–2019|Females|2|50–54|0.946|0.93|0.958
Observed|Endometrial cancer|2015–2019|Females|2|55–59|0.941|0.929|0.951
Observed|Endometrial cancer|2015–2019|Females|2|60–64|0.926|0.913|0.936
Observed|Endometrial cancer|2015–2019|Females|2|65–69|0.895|0.881|0.907
Observed|Endometrial cancer|2015–2019|Females|2|70–74|0.867|0.85|0.883
Observed|Endometrial cancer|2015–2019|Females|2|75–79|0.797|0.773|0.819
Observed|Endometrial cancer|2015–2019|Females|2|80–84|0.767|0.735|0.795
Observed|Endometrial cancer|2015–2019|Females|2|85+|0.555|0.514|0.594
Observed|Endometrial cancer|2015–2019|Females|2|All ages combined|0.881|0.875|0.886
Observed|Endometrial cancer|2015–2019|Females|3|00–04|||
Observed|Endometrial cancer|2015–2019|Females|3|05–09|||
Observed|Endometrial cancer|2015–2019|Females|3|10–14|||
Observed|Endometrial cancer|2015–2019|Females|3|15–19|||
Observed|Endometrial cancer|2015–2019|Females|3|20–24|||
Observed|Endometrial cancer|2015–2019|Females|3|25–29|1|0.934|1
Observed|Endometrial cancer|2015–2019|Females|3|30–34|0.973|0.917|0.991
Observed|Endometrial cancer|2015–2019|Females|3|35–39|0.971|0.937|0.987
Observed|Endometrial cancer|2015–2019|Females|3|40–44|0.95|0.92|0.968
Observed|Endometrial cancer|2015–2019|Females|3|45–49|0.928|0.904|0.946
Observed|Endometrial cancer|2015–2019|Females|3|50–54|0.929|0.911|0.943
Observed|Endometrial cancer|2015–2019|Females|3|55–59|0.915|0.901|0.927
Observed|Endometrial cancer|2015–2019|Females|3|60–64|0.892|0.878|0.905
Observed|Endometrial cancer|2015–2019|Females|3|65–69|0.857|0.842|0.871
Observed|Endometrial cancer|2015–2019|Females|3|70–74|0.819|0.799|0.837
Observed|Endometrial cancer|2015–2019|Females|3|75–79|0.74|0.714|0.765
Observed|Endometrial cancer|2015–2019|Females|3|80–84|0.681|0.646|0.713
Observed|Endometrial cancer|2015–2019|Females|3|85+|0.452|0.411|0.492
Observed|Endometrial cancer|2015–2019|Females|3|All ages combined|0.841|0.834|0.847
Observed|Endometrial cancer|2015–2019|Females|4|00–04|||
Observed|Endometrial cancer|2015–2019|Females|4|05–09|||
Observed|Endometrial cancer|2015–2019|Females|4|10–14|||
Observed|Endometrial cancer|2015–2019|Females|4|15–19|||
Observed|Endometrial cancer|2015–2019|Females|4|20–24|||
Observed|Endometrial cancer|2015–2019|Females|4|25–29|1|0.932|1
Observed|Endometrial cancer|2015–2019|Females|4|30–34|0.952|0.889|0.98
Observed|Endometrial cancer|2015–2019|Females|4|35–39|0.971|0.937|0.987
Observed|Endometrial cancer|2015–2019|Females|4|40–44|0.937|0.904|0.958
Observed|Endometrial cancer|2015–2019|Females|4|45–49|0.906|0.88|0.927
Observed|Endometrial cancer|2015–2019|Females|4|50–54|0.909|0.89|0.925
Observed|Endometrial cancer|2015–2019|Females|4|55–59|0.901|0.886|0.914
Observed|Endometrial cancer|2015–2019|Females|4|60–64|0.872|0.856|0.886
Observed|Endometrial cancer|2015–2019|Females|4|65–69|0.83|0.813|0.845
Observed|Endometrial cancer|2015–2019|Females|4|70–74|0.776|0.754|0.796
Observed|Endometrial cancer|2015–2019|Females|4|75–79|0.685|0.656|0.711
Observed|Endometrial cancer|2015–2019|Females|4|80–84|0.615|0.579|0.649
Observed|Endometrial cancer|2015–2019|Females|4|85+|0.37|0.331|0.409
Observed|Endometrial cancer|2015–2019|Females|4|All ages combined|0.809|0.802|0.816
Observed|Endometrial cancer|2015–2019|Females|5|00–04|||
Observed|Endometrial cancer|2015–2019|Females|5|05–09|||
Observed|Endometrial cancer|2015–2019|Females|5|10–14|||
Observed|Endometrial cancer|2015–2019|Females|5|15–19|||
Observed|Endometrial cancer|2015–2019|Females|5|20–24|||
Observed|Endometrial cancer|2015–2019|Females|5|25–29|1|0.927|1
Observed|Endometrial cancer|2015–2019|Females|5|30–34|0.952|0.889|0.98
Observed|Endometrial cancer|2015–2019|Females|5|35–39|0.965|0.928|0.983
Observed|Endometrial cancer|2015–2019|Females|5|40–44|0.933|0.9|0.955
Observed|Endometrial cancer|2015–2019|Females|5|45–49|0.899|0.871|0.921
Observed|Endometrial cancer|2015–2019|Females|5|50–54|0.901|0.882|0.918
Observed|Endometrial cancer|2015–2019|Females|5|55–59|0.89|0.875|0.904
Observed|Endometrial cancer|2015–2019|Females|5|60–64|0.855|0.839|0.87
Observed|Endometrial cancer|2015–2019|Females|5|65–69|0.804|0.787|0.821
Observed|Endometrial cancer|2015–2019|Females|5|70–74|0.743|0.72|0.765
Observed|Endometrial cancer|2015–2019|Females|5|75–79|0.649|0.62|0.676
Observed|Endometrial cancer|2015–2019|Females|5|80–84|0.566|0.529|0.601
Observed|Endometrial cancer|2015–2019|Females|5|85+|0.307|0.27|0.345
Observed|Endometrial cancer|2015–2019|Females|5|All ages combined|0.786|0.778|0.793
Relative|Endometrial cancer|2015–2019|Females|1|00–04|||
Relative|Endometrial cancer|2015–2019|Females|1|05–09|||
Relative|Endometrial cancer|2015–2019|Females|1|10–14|||
Relative|Endometrial cancer|2015–2019|Females|1|15–19|||
Relative|Endometrial cancer|2015–2019|Females|1|20–24|||
Relative|Endometrial cancer|2015–2019|Females|1|25–29|1|0.939|1
Relative|Endometrial cancer|2015–2019|Females|1|30–34|0.992|0.941|0.999
Relative|Endometrial cancer|2015–2019|Females|1|35–39|0.982|0.952|0.994
Relative|Endometrial cancer|2015–2019|Females|1|40–44|0.978|0.955|0.989
Relative|Endometrial cancer|2015–2019|Females|1|45–49|0.965|0.947|0.978
Relative|Endometrial cancer|2015–2019|Females|1|50–54|0.968|0.956|0.978
Relative|Endometrial cancer|2015–2019|Females|1|55–59|0.97|0.961|0.978
Relative|Endometrial cancer|2015–2019|Females|1|60–64|0.962|0.952|0.97
Relative|Endometrial cancer|2015–2019|Females|1|65–69|0.954|0.944|0.963
Relative|Endometrial cancer|2015–2019|Females|1|70–74|0.945|0.932|0.956
Relative|Endometrial cancer|2015–2019|Females|1|75–79|0.906|0.886|0.923
Relative|Endometrial cancer|2015–2019|Females|1|80–84|0.899|0.872|0.923
Relative|Endometrial cancer|2015–2019|Females|1|85+|0.803|0.761|0.841
Relative|Endometrial cancer|2015–2019|Females|1|All ages combined|0.946|0.941|0.95
Relative|Endometrial cancer|2015–2019|Females|2|00–04|||
Relative|Endometrial cancer|2015–2019|Females|2|05–09|||
Relative|Endometrial cancer|2015–2019|Females|2|10–14|||
Relative|Endometrial cancer|2015–2019|Females|2|15–19|||
Relative|Endometrial cancer|2015–2019|Females|2|20–24|||
Relative|Endometrial cancer|2015–2019|Females|2|25–29|1.001|0.937|1.001
Relative|Endometrial cancer|2015–2019|Females|2|30–34|0.992|0.941|1
Relative|Endometrial cancer|2015–2019|Females|2|35–39|0.973|0.938|0.988
Relative|Endometrial cancer|2015–2019|Females|2|40–44|0.958|0.93|0.975
Relative|Endometrial cancer|2015–2019|Females|2|45–49|0.946|0.925|0.962
Relative|Endometrial cancer|2015–2019|Females|2|50–54|0.95|0.934|0.962
Relative|Endometrial cancer|2015–2019|Females|2|55–59|0.947|0.935|0.957
Relative|Endometrial cancer|2015–2019|Females|2|60–64|0.935|0.922|0.945
Relative|Endometrial cancer|2015–2019|Females|2|65–69|0.908|0.894|0.921
Relative|Endometrial cancer|2015–2019|Females|2|70–74|0.89|0.872|0.906
Relative|Endometrial cancer|2015–2019|Females|2|75–79|0.834|0.809|0.857
Relative|Endometrial cancer|2015–2019|Females|2|80–84|0.837|0.802|0.867
Relative|Endometrial cancer|2015–2019|Females|2|85+|0.694|0.643|0.743
Relative|Endometrial cancer|2015–2019|Females|2|All ages combined|0.905|0.899|0.911
Relative|Endometrial cancer|2015–2019|Females|3|00–04|||
Relative|Endometrial cancer|2015–2019|Females|3|05–09|||
Relative|Endometrial cancer|2015–2019|Females|3|10–14|||
Relative|Endometrial cancer|2015–2019|Females|3|15–19|||
Relative|Endometrial cancer|2015–2019|Females|3|20–24|||
Relative|Endometrial cancer|2015–2019|Females|3|25–29|1.001|0.935|1.001
Relative|Endometrial cancer|2015–2019|Females|3|30–34|0.974|0.918|0.992
Relative|Endometrial cancer|2015–2019|Females|3|35–39|0.973|0.939|0.989
Relative|Endometrial cancer|2015–2019|Females|3|40–44|0.953|0.923|0.971
Relative|Endometrial cancer|2015–2019|Females|3|45–49|0.932|0.908|0.95
Relative|Endometrial cancer|2015–2019|Females|3|50–54|0.935|0.918|0.949
Relative|Endometrial cancer|2015–2019|Females|3|55–59|0.925|0.911|0.937
Relative|Endometrial cancer|2015–2019|Females|3|60–64|0.906|0.891|0.919
Relative|Endometrial cancer|2015–2019|Females|3|65–69|0.878|0.862|0.893
Relative|Endometrial cancer|2015–2019|Females|3|70–74|0.853|0.832|0.872
Relative|Endometrial cancer|2015–2019|Females|3|75–79|0.796|0.768|0.822
Relative|Endometrial cancer|2015–2019|Females|3|80–84|0.783|0.744|0.82
Relative|Endometrial cancer|2015–2019|Females|3|85+|0.643|0.585|0.699
Relative|Endometrial cancer|2015–2019|Females|3|All ages combined|0.876|0.869|0.883
Relative|Endometrial cancer|2015–2019|Females|4|00–04|||
Relative|Endometrial cancer|2015–2019|Females|4|05–09|||
Relative|Endometrial cancer|2015–2019|Females|4|10–14|||
Relative|Endometrial cancer|2015–2019|Females|4|15–19|||
Relative|Endometrial cancer|2015–2019|Females|4|20–24|||
Relative|Endometrial cancer|2015–2019|Females|4|25–29|1.001|0.933|1.001
Relative|Endometrial cancer|2015–2019|Females|4|30–34|0.954|0.891|0.982
Relative|Endometrial cancer|2015–2019|Females|4|35–39|0.974|0.94|0.99
Relative|Endometrial cancer|2015–2019|Females|4|40–44|0.941|0.908|0.962
Relative|Endometrial cancer|2015–2019|Females|4|45–49|0.912|0.885|0.933
Relative|Endometrial cancer|2015–2019|Females|4|50–54|0.918|0.899|0.934
Relative|Endometrial cancer|2015–2019|Females|4|55–59|0.914|0.899|0.928
Relative|Endometrial cancer|2015–2019|Females|4|60–64|0.89|0.875|0.905
Relative|Endometrial cancer|2015–2019|Females|4|65–69|0.858|0.841|0.874
Relative|Endometrial cancer|2015–2019|Females|4|70–74|0.822|0.799|0.843
Relative|Endometrial cancer|2015–2019|Females|4|75–79|0.76|0.728|0.789
Relative|Endometrial cancer|2015–2019|Females|4|80–84|0.753|0.709|0.794
Relative|Endometrial cancer|2015–2019|Females|4|85+|0.607|0.543|0.671
Relative|Endometrial cancer|2015–2019|Females|4|All ages combined|0.856|0.848|0.863
Relative|Endometrial cancer|2015–2019|Females|5|00–04|||
Relative|Endometrial cancer|2015–2019|Females|5|05–09|||
Relative|Endometrial cancer|2015–2019|Females|5|10–14|||
Relative|Endometrial cancer|2015–2019|Females|5|15–19|||
Relative|Endometrial cancer|2015–2019|Females|5|20–24|||
Relative|Endometrial cancer|2015–2019|Females|5|25–29|1.002|0.928|1.002
Relative|Endometrial cancer|2015–2019|Females|5|30–34|0.955|0.891|0.982
Relative|Endometrial cancer|2015–2019|Females|5|35–39|0.969|0.931|0.987
Relative|Endometrial cancer|2015–2019|Females|5|40–44|0.938|0.905|0.961
Relative|Endometrial cancer|2015–2019|Females|5|45–49|0.907|0.879|0.929
Relative|Endometrial cancer|2015–2019|Females|5|50–54|0.913|0.893|0.93
Relative|Endometrial cancer|2015–2019|Females|5|55–59|0.907|0.891|0.921
Relative|Endometrial cancer|2015–2019|Females|5|60–64|0.88|0.863|0.895
Relative|Endometrial cancer|2015–2019|Females|5|65–69|0.841|0.822|0.858
Relative|Endometrial cancer|2015–2019|Females|5|70–74|0.802|0.778|0.825
Relative|Endometrial cancer|2015–2019|Females|5|75–79|0.746|0.713|0.778
Relative|Endometrial cancer|2015–2019|Females|5|80–84|0.743|0.695|0.79
Relative|Endometrial cancer|2015–2019|Females|5|85+|0.589|0.518|0.661
Relative|Endometrial cancer|2015–2019|Females|5|All ages combined|0.844|0.836|0.852
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|50–54|0.645|0.463|0.78
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|55–59|0.744|0.622|0.832
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|60–64|0.619|0.514|0.708
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|65–69|0.588|0.505|0.661
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|70–74|0.534|0.453|0.608
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|75–79|0.514|0.434|0.587
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|80–84|0.474|0.391|0.553
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|85+|0.178|0.12|0.245
Observed|Extrahepatic bile duct cancer|2015–2019|Males|1|All ages combined|0.517|0.485|0.548
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|50–54|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|55–59|0.579|0.448|0.689
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|60–64|0.487|0.383|0.583
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|65–69|0.413|0.334|0.49
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|70–74|0.346|0.273|0.419
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|75–79|0.33|0.257|0.404
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|80–84|0.199|0.139|0.268
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|85+|0.046|0.021|0.086
Observed|Extrahepatic bile duct cancer|2015–2019|Males|2|All ages combined|0.332|0.302|0.362
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|50–54|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|55–59|0.415|0.289|0.536
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|60–64|0.395|0.297|0.491
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|65–69|0.298|0.226|0.373
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|70–74|0.251|0.186|0.321
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|75–79|0.233|0.17|0.303
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|80–84|0.117|0.067|0.181
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|85+|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|3|All ages combined|0.245|0.218|0.273
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|50–54|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|55–59|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|60–64|0.315|0.221|0.413
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|65–69|0.251|0.184|0.325
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|70–74|0.211|0.151|0.278
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|75–79|0.215|0.153|0.285
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|80–84|0.084|0.041|0.145
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|85+|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|4|All ages combined|0.206|0.18|0.233
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|50–54|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|55–59|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|60–64|0.204|0.122|0.301
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|65–69|0.214|0.15|0.287
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|70–74|0.177|0.122|0.241
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|75–79|0.169|0.109|0.24
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|80–84|0.073|0.034|0.132
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|85+|||
Observed|Extrahepatic bile duct cancer|2015–2019|Males|5|All ages combined|0.167|0.142|0.193
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|50–54|0.648|0.464|0.783
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|55–59|0.748|0.625|0.837
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|60–64|0.624|0.519|0.713
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|65–69|0.595|0.511|0.669
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|70–74|0.544|0.463|0.62
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|75–79|0.531|0.449|0.608
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|80–84|0.504|0.415|0.587
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|85+|0.205|0.139|0.282
Relative|Extrahepatic bile duct cancer|2015–2019|Males|1|All ages combined|0.536|0.503|0.568
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|50–54|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|55–59|0.585|0.453|0.697
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|60–64|0.496|0.39|0.593
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|65–69|0.424|0.343|0.503
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|70–74|0.36|0.285|0.437
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|75–79|0.354|0.276|0.434
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|80–84|0.226|0.158|0.304
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|85+|0.063|0.028|0.118
Relative|Extrahepatic bile duct cancer|2015–2019|Males|2|All ages combined|0.355|0.323|0.387
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|50–54|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|55–59|0.422|0.294|0.545
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|60–64|0.406|0.305|0.504
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|65–69|0.31|0.235|0.388
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|70–74|0.268|0.199|0.343
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|75–79|0.261|0.19|0.34
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|80–84|0.143|0.082|0.222
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|85+|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|3|All ages combined|0.269|0.239|0.299
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|50–54|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|55–59|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|60–64|0.327|0.23|0.428
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|65–69|0.266|0.194|0.343
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|70–74|0.232|0.166|0.305
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|75–79|0.253|0.18|0.335
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|80–84|0.112|0.055|0.194
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|85+|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|4|All ages combined|0.231|0.202|0.262
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|50–54|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|55–59|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|60–64|0.214|0.128|0.315
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|65–69|0.231|0.161|0.309
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|70–74|0.2|0.137|0.272
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|75–79|0.209|0.135|0.297
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|80–84|0.108|0.05|0.196
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|85+|||
Relative|Extrahepatic bile duct cancer|2015–2019|Males|5|All ages combined|0.193|0.165|0.223
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|50–54|0.433|0.273|0.583
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|55–59|0.485|0.34|0.616
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|60–64|0.502|0.363|0.625
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|65–69|0.52|0.413|0.617
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|70–74|0.449|0.353|0.54
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|75–79|0.408|0.316|0.497
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|80–84|0.326|0.243|0.412
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|85+|0.111|0.069|0.165
Observed|Extrahepatic bile duct cancer|2015–2019|Females|1|All ages combined|0.379|0.344|0.415
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|50–54|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|55–59|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|60–64|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|65–69|0.275|0.184|0.373
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|70–74|0.304|0.22|0.393
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|75–79|0.237|0.158|0.324
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|80–84|0.142|0.085|0.213
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|85+|0.032|0.012|0.069
Observed|Extrahepatic bile duct cancer|2015–2019|Females|2|All ages combined|0.212|0.182|0.243
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|50–54|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|55–59|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|60–64|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|65–69|0.185|0.109|0.275
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|70–74|0.241|0.163|0.327
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|75–79|0.123|0.065|0.2
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|80–84|0.09|0.047|0.151
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|85+|0.015|0.004|0.041
Observed|Extrahepatic bile duct cancer|2015–2019|Females|3|All ages combined|0.146|0.12|0.174
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|50–54|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|55–59|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|60–64|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|65–69|0.145|0.075|0.237
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|70–74|0.143|0.081|0.222
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|75–79|0.084|0.038|0.155
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|80–84|0.04|0.015|0.084
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|85+|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|4|All ages combined|0.101|0.079|0.126
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|50–54|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|55–59|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|60–64|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|65–69|0.145|0.075|0.237
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|70–74|0.131|0.072|0.208
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|75–79|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|80–84|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|85+|||
Observed|Extrahepatic bile duct cancer|2015–2019|Females|5|All ages combined|0.094|0.072|0.118
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|50–54|0.434|0.274|0.584
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|55–59|0.487|0.341|0.618
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|60–64|0.504|0.365|0.628
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|65–69|0.524|0.416|0.622
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|70–74|0.454|0.357|0.546
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|75–79|0.417|0.322|0.508
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|80–84|0.34|0.254|0.429
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|85+|0.125|0.077|0.185
Relative|Extrahepatic bile duct cancer|2015–2019|Females|1|All ages combined|0.392|0.354|0.428
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|50–54|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|55–59|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|60–64|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|65–69|0.279|0.187|0.378
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|70–74|0.312|0.226|0.403
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|75–79|0.248|0.166|0.34
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|80–84|0.155|0.093|0.233
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|85+|0.041|0.015|0.087
Relative|Extrahepatic bile duct cancer|2015–2019|Females|2|All ages combined|0.223|0.192|0.257
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|50–54|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|55–59|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|60–64|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|65–69|0.189|0.112|0.282
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|70–74|0.251|0.17|0.34
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|75–79|0.132|0.07|0.216
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|80–84|0.104|0.054|0.174
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|85+|0.022|0.006|0.06
Relative|Extrahepatic bile duct cancer|2015–2019|Females|3|All ages combined|0.158|0.13|0.188
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|50–54|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|55–59|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|60–64|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|65–69|0.15|0.078|0.245
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|70–74|0.152|0.086|0.235
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|75–79|0.094|0.042|0.172
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|80–84|0.049|0.019|0.102
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|85+|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|4|All ages combined|0.112|0.087|0.139
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|50–54|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|55–59|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|60–64|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|65–69|0.152|0.079|0.248
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|70–74|0.142|0.078|0.225
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|75–79|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|80–84|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|85+|||
Relative|Extrahepatic bile duct cancer|2015–2019|Females|5|All ages combined|0.105|0.081|0.133
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|50–54|0.536|0.414|0.643
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|55–59|0.637|0.542|0.717
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|60–64|0.577|0.494|0.651
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|65–69|0.562|0.498|0.622
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|70–74|0.5|0.438|0.558
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|75–79|0.471|0.411|0.529
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|80–84|0.409|0.349|0.468
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|85+|0.144|0.107|0.186
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|1|All ages combined|0.46|0.436|0.484
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|50–54|0.394|0.279|0.508
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|55–59|0.478|0.382|0.568
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|60–64|0.404|0.325|0.482
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|65–69|0.364|0.303|0.425
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|70–74|0.329|0.274|0.386
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|75–79|0.293|0.239|0.35
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|80–84|0.174|0.131|0.223
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|85+|0.039|0.021|0.064
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|2|All ages combined|0.282|0.261|0.304
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|50–54|0.331|0.222|0.444
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|55–59|0.352|0.259|0.445
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|60–64|0.325|0.252|0.401
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|65–69|0.258|0.203|0.316
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|70–74|0.247|0.196|0.3
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|75–79|0.192|0.145|0.244
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|80–84|0.106|0.07|0.149
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|85+|0.021|0.009|0.041
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|3|All ages combined|0.204|0.184|0.224
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|50–54|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|55–59|0.299|0.209|0.393
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|60–64|0.277|0.207|0.352
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|65–69|0.215|0.163|0.271
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|70–74|0.187|0.141|0.237
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|75–79|0.165|0.12|0.215
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|80–84|0.06|0.034|0.096
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|85+|0.017|0.007|0.036
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|4|All ages combined|0.162|0.144|0.181
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|00–04|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|05–09|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|10–14|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|15–19|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|20–24|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|25–29|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|30–34|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|35–39|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|40–44|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|45–49|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|50–54|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|55–59|0.269|0.181|0.364
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|60–64|0.205|0.141|0.278
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|65–69|0.189|0.139|0.245
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|70–74|0.16|0.118|0.209
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|75–79|0.136|0.093|0.187
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|80–84|0.055|0.03|0.09
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|85+|||
Observed|Extrahepatic bile duct cancer|2015–2019|Persons|5|All ages combined|0.136|0.119|0.155
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|50–54|0.537|0.415|0.645
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|55–59|0.639|0.544|0.72
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|60–64|0.581|0.498|0.656
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|65–69|0.568|0.503|0.629
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|70–74|0.508|0.446|0.568
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|75–79|0.485|0.423|0.545
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|80–84|0.431|0.367|0.493
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|85+|0.164|0.121|0.212
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|1|All ages combined|0.476|0.451|0.5
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|50–54|0.397|0.28|0.511
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|55–59|0.483|0.385|0.574
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|60–64|0.41|0.329|0.489
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|65–69|0.372|0.31|0.435
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|70–74|0.341|0.284|0.4
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|75–79|0.312|0.254|0.373
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|80–84|0.194|0.146|0.249
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|85+|0.051|0.028|0.085
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|2|All ages combined|0.3|0.277|0.324
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|50–54|0.334|0.224|0.448
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|55–59|0.357|0.263|0.452
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|60–64|0.333|0.257|0.41
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|65–69|0.267|0.21|0.327
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|70–74|0.261|0.207|0.318
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|75–79|0.212|0.16|0.269
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|80–84|0.126|0.084|0.178
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|85+|0.033|0.015|0.065
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|3|All ages combined|0.222|0.201|0.244
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|50–54|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|55–59|0.305|0.214|0.402
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|60–64|0.286|0.213|0.363
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|65–69|0.225|0.171|0.285
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|70–74|0.202|0.153|0.257
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|75–79|0.19|0.139|0.248
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|80–84|0.077|0.044|0.123
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|85+|0.033|0.013|0.068
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|4|All ages combined|0.181|0.161|0.202
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|00–04|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|05–09|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|10–14|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|15–19|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|20–24|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|25–29|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|30–34|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|35–39|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|40–44|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|45–49|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|50–54|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|55–59|0.277|0.186|0.374
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|60–64|0.214|0.147|0.289
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|65–69|0.202|0.149|0.262
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|70–74|0.178|0.131|0.232
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|75–79|0.165|0.113|0.226
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|80–84|0.077|0.042|0.126
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|85+|||
Relative|Extrahepatic bile duct cancer|2015–2019|Persons|5|All ages combined|0.156|0.137|0.177
Observed|Eye cancer|2015–2019|Males|1|00–04|1|0.924|1
Observed|Eye cancer|2015–2019|Males|1|05–09|||
Observed|Eye cancer|2015–2019|Males|1|10–14|||
Observed|Eye cancer|2015–2019|Males|1|15–19|||
Observed|Eye cancer|2015–2019|Males|1|20–24|||
Observed|Eye cancer|2015–2019|Males|1|25–29|||
Observed|Eye cancer|2015–2019|Males|1|30–34|||
Observed|Eye cancer|2015–2019|Males|1|35–39|||
Observed|Eye cancer|2015–2019|Males|1|40–44|1|0.885|1
Observed|Eye cancer|2015–2019|Males|1|45–49|1|0.942|1
Observed|Eye cancer|2015–2019|Males|1|50–54|0.984|0.89|0.998
Observed|Eye cancer|2015–2019|Males|1|55–59|0.97|0.91|0.99
Observed|Eye cancer|2015–2019|Males|1|60–64|0.94|0.871|0.972
Observed|Eye cancer|2015–2019|Males|1|65–69|0.957|0.907|0.981
Observed|Eye cancer|2015–2019|Males|1|70–74|0.95|0.893|0.977
Observed|Eye cancer|2015–2019|Males|1|75–79|0.933|0.857|0.969
Observed|Eye cancer|2015–2019|Males|1|80–84|0.881|0.776|0.939
Observed|Eye cancer|2015–2019|Males|1|85+|0.75|0.634|0.834
Observed|Eye cancer|2015–2019|Males|1|All ages combined|0.94|0.923|0.954
Observed|Eye cancer|2015–2019|Males|2|00–04|0.973|0.823|0.996
Observed|Eye cancer|2015–2019|Males|2|05–09|||
Observed|Eye cancer|2015–2019|Males|2|10–14|||
Observed|Eye cancer|2015–2019|Males|2|15–19|||
Observed|Eye cancer|2015–2019|Males|2|20–24|||
Observed|Eye cancer|2015–2019|Males|2|25–29|||
Observed|Eye cancer|2015–2019|Males|2|30–34|||
Observed|Eye cancer|2015–2019|Males|2|35–39|||
Observed|Eye cancer|2015–2019|Males|2|40–44|0.961|0.752|0.994
Observed|Eye cancer|2015–2019|Males|2|45–49|0.98|0.866|0.997
Observed|Eye cancer|2015–2019|Males|2|50–54|0.967|0.876|0.992
Observed|Eye cancer|2015–2019|Males|2|55–59|0.898|0.818|0.944
Observed|Eye cancer|2015–2019|Males|2|60–64|0.903|0.827|0.947
Observed|Eye cancer|2015–2019|Males|2|65–69|0.891|0.826|0.933
Observed|Eye cancer|2015–2019|Males|2|70–74|0.902|0.833|0.943
Observed|Eye cancer|2015–2019|Males|2|75–79|0.826|0.729|0.892
Observed|Eye cancer|2015–2019|Males|2|80–84|0.744|0.621|0.832
Observed|Eye cancer|2015–2019|Males|2|85+|0.62|0.496|0.721
Observed|Eye cancer|2015–2019|Males|2|All ages combined|0.876|0.853|0.896
Observed|Eye cancer|2015–2019|Males|3|00–04|0.973|0.823|0.996
Observed|Eye cancer|2015–2019|Males|3|05–09|||
Observed|Eye cancer|2015–2019|Males|3|10–14|||
Observed|Eye cancer|2015–2019|Males|3|15–19|||
Observed|Eye cancer|2015–2019|Males|3|20–24|||
Observed|Eye cancer|2015–2019|Males|3|25–29|||
Observed|Eye cancer|2015–2019|Males|3|30–34|||
Observed|Eye cancer|2015–2019|Males|3|35–39|||
Observed|Eye cancer|2015–2019|Males|3|40–44|0.883|0.681|0.961
Observed|Eye cancer|2015–2019|Males|3|45–49|0.94|0.826|0.98
Observed|Eye cancer|2015–2019|Males|3|50–54|0.932|0.829|0.974
Observed|Eye cancer|2015–2019|Males|3|55–59|0.854|0.765|0.911
Observed|Eye cancer|2015–2019|Males|3|60–64|0.861|0.781|0.914
Observed|Eye cancer|2015–2019|Males|3|65–69|0.814|0.736|0.87
Observed|Eye cancer|2015–2019|Males|3|70–74|0.828|0.748|0.884
Observed|Eye cancer|2015–2019|Males|3|75–79|0.707|0.594|0.794
Observed|Eye cancer|2015–2019|Males|3|80–84|0.63|0.5|0.735
Observed|Eye cancer|2015–2019|Males|3|85+|0.467|0.343|0.582
Observed|Eye cancer|2015–2019|Males|3|All ages combined|0.811|0.784|0.834
Observed|Eye cancer|2015–2019|Males|4|00–04|0.973|0.823|0.996
Observed|Eye cancer|2015–2019|Males|4|05–09|||
Observed|Eye cancer|2015–2019|Males|4|10–14|||
Observed|Eye cancer|2015–2019|Males|4|15–19|||
Observed|Eye cancer|2015–2019|Males|4|20–24|||
Observed|Eye cancer|2015–2019|Males|4|25–29|||
Observed|Eye cancer|2015–2019|Males|4|30–34|||
Observed|Eye cancer|2015–2019|Males|4|35–39|||
Observed|Eye cancer|2015–2019|Males|4|40–44|0.804|0.591|0.913
Observed|Eye cancer|2015–2019|Males|4|45–49|0.899|0.775|0.957
Observed|Eye cancer|2015–2019|Males|4|50–54|0.865|0.749|0.93
Observed|Eye cancer|2015–2019|Males|4|55–59|0.817|0.721|0.882
Observed|Eye cancer|2015–2019|Males|4|60–64|0.793|0.707|0.856
Observed|Eye cancer|2015–2019|Males|4|65–69|0.759|0.675|0.825
Observed|Eye cancer|2015–2019|Males|4|70–74|0.75|0.664|0.817
Observed|Eye cancer|2015–2019|Males|4|75–79|0.605|0.485|0.704
Observed|Eye cancer|2015–2019|Males|4|80–84|0.563|0.433|0.675
Observed|Eye cancer|2015–2019|Males|4|85+|0.289|0.182|0.405
Observed|Eye cancer|2015–2019|Males|4|All ages combined|0.744|0.714|0.771
Observed|Eye cancer|2015–2019|Males|5|00–04|0.973|0.823|0.996
Observed|Eye cancer|2015–2019|Males|5|05–09|||
Observed|Eye cancer|2015–2019|Males|5|10–14|||
Observed|Eye cancer|2015–2019|Males|5|15–19|||
Observed|Eye cancer|2015–2019|Males|5|20–24|||
Observed|Eye cancer|2015–2019|Males|5|25–29|||
Observed|Eye cancer|2015–2019|Males|5|30–34|||
Observed|Eye cancer|2015–2019|Males|5|35–39|||
Observed|Eye cancer|2015–2019|Males|5|40–44|0.768|0.556|0.889
Observed|Eye cancer|2015–2019|Males|5|45–49|0.832|0.691|0.912
Observed|Eye cancer|2015–2019|Males|5|50–54|0.818|0.696|0.895
Observed|Eye cancer|2015–2019|Males|5|55–59|0.789|0.688|0.861
Observed|Eye cancer|2015–2019|Males|5|60–64|0.738|0.649|0.807
Observed|Eye cancer|2015–2019|Males|5|65–69|0.709|0.618|0.782
Observed|Eye cancer|2015–2019|Males|5|70–74|0.678|0.587|0.754
Observed|Eye cancer|2015–2019|Males|5|75–79|0.589|0.469|0.69
Observed|Eye cancer|2015–2019|Males|5|80–84|0.453|0.325|0.573
Observed|Eye cancer|2015–2019|Males|5|85+|0.215|0.124|0.323
Observed|Eye cancer|2015–2019|Males|5|All ages combined|0.695|0.663|0.724
Relative|Eye cancer|2015–2019|Males|1|00–04|1.002|0.926|1.002
Relative|Eye cancer|2015–2019|Males|1|05–09|||
Relative|Eye cancer|2015–2019|Males|1|10–14|||
Relative|Eye cancer|2015–2019|Males|1|15–19|||
Relative|Eye cancer|2015–2019|Males|1|20–24|||
Relative|Eye cancer|2015–2019|Males|1|25–29|||
Relative|Eye cancer|2015–2019|Males|1|30–34|||
Relative|Eye cancer|2015–2019|Males|1|35–39|||
Relative|Eye cancer|2015–2019|Males|1|40–44|1.002|0.886|1.002
Relative|Eye cancer|2015–2019|Males|1|45–49|1.002|0.944|1.002
Relative|Eye cancer|2015–2019|Males|1|50–54|0.987|0.893|1.001
Relative|Eye cancer|2015–2019|Males|1|55–59|0.975|0.915|0.995
Relative|Eye cancer|2015–2019|Males|1|60–64|0.947|0.878|0.98
Relative|Eye cancer|2015–2019|Males|1|65–69|0.969|0.918|0.992
Relative|Eye cancer|2015–2019|Males|1|70–74|0.969|0.91|0.996
Relative|Eye cancer|2015–2019|Males|1|75–79|0.966|0.887|1.003
Relative|Eye cancer|2015–2019|Males|1|80–84|0.937|0.826|0.998
Relative|Eye cancer|2015–2019|Males|1|85+|0.872|0.736|0.969
Relative|Eye cancer|2015–2019|Males|1|All ages combined|0.965|0.947|0.978
Relative|Eye cancer|2015–2019|Males|2|00–04|0.975|0.825|0.998
Relative|Eye cancer|2015–2019|Males|2|05–09|||
Relative|Eye cancer|2015–2019|Males|2|10–14|||
Relative|Eye cancer|2015–2019|Males|2|15–19|||
Relative|Eye cancer|2015–2019|Males|2|20–24|||
Relative|Eye cancer|2015–2019|Males|2|25–29|||
Relative|Eye cancer|2015–2019|Males|2|30–34|||
Relative|Eye cancer|2015–2019|Males|2|35–39|||
Relative|Eye cancer|2015–2019|Males|2|40–44|0.964|0.754|0.998
Relative|Eye cancer|2015–2019|Males|2|45–49|0.985|0.871|1.002
Relative|Eye cancer|2015–2019|Males|2|50–54|0.975|0.882|0.999
Relative|Eye cancer|2015–2019|Males|2|55–59|0.908|0.827|0.954
Relative|Eye cancer|2015–2019|Males|2|60–64|0.919|0.842|0.963
Relative|Eye cancer|2015–2019|Males|2|65–69|0.914|0.847|0.957
Relative|Eye cancer|2015–2019|Males|2|70–74|0.939|0.868|0.982
Relative|Eye cancer|2015–2019|Males|2|75–79|0.889|0.784|0.959
Relative|Eye cancer|2015–2019|Males|2|80–84|0.849|0.708|0.949
Relative|Eye cancer|2015–2019|Males|2|85+|0.846|0.678|0.985
Relative|Eye cancer|2015–2019|Males|2|All ages combined|0.921|0.897|0.942
Relative|Eye cancer|2015–2019|Males|3|00–04|0.975|0.825|0.998
Relative|Eye cancer|2015–2019|Males|3|05–09|||
Relative|Eye cancer|2015–2019|Males|3|10–14|||
Relative|Eye cancer|2015–2019|Males|3|15–19|||
Relative|Eye cancer|2015–2019|Males|3|20–24|||
Relative|Eye cancer|2015–2019|Males|3|25–29|||
Relative|Eye cancer|2015–2019|Males|3|30–34|||
Relative|Eye cancer|2015–2019|Males|3|35–39|||
Relative|Eye cancer|2015–2019|Males|3|40–44|0.888|0.684|0.966
Relative|Eye cancer|2015–2019|Males|3|45–49|0.947|0.832|0.988
Relative|Eye cancer|2015–2019|Males|3|50–54|0.943|0.839|0.985
Relative|Eye cancer|2015–2019|Males|3|55–59|0.869|0.779|0.927
Relative|Eye cancer|2015–2019|Males|3|60–64|0.885|0.802|0.939
Relative|Eye cancer|2015–2019|Males|3|65–69|0.846|0.766|0.905
Relative|Eye cancer|2015–2019|Males|3|70–74|0.882|0.798|0.942
Relative|Eye cancer|2015–2019|Males|3|75–79|0.794|0.667|0.891
Relative|Eye cancer|2015–2019|Males|3|80–84|0.777|0.617|0.906
Relative|Eye cancer|2015–2019|Males|3|85+|0.765|0.561|0.953
Relative|Eye cancer|2015–2019|Males|3|All ages combined|0.872|0.843|0.898
Relative|Eye cancer|2015–2019|Males|4|00–04|0.975|0.825|0.998
Relative|Eye cancer|2015–2019|Males|4|05–09|||
Relative|Eye cancer|2015–2019|Males|4|10–14|||
Relative|Eye cancer|2015–2019|Males|4|15–19|||
Relative|Eye cancer|2015–2019|Males|4|20–24|||
Relative|Eye cancer|2015–2019|Males|4|25–29|||
Relative|Eye cancer|2015–2019|Males|4|30–34|||
Relative|Eye cancer|2015–2019|Males|4|35–39|||
Relative|Eye cancer|2015–2019|Males|4|40–44|0.809|0.595|0.92
Relative|Eye cancer|2015–2019|Males|4|45–49|0.909|0.784|0.967
Relative|Eye cancer|2015–2019|Males|4|50–54|0.879|0.761|0.945
Relative|Eye cancer|2015–2019|Males|4|55–59|0.837|0.739|0.904
Relative|Eye cancer|2015–2019|Males|4|60–64|0.823|0.734|0.888
Relative|Eye cancer|2015–2019|Males|4|65–69|0.803|0.713|0.872
Relative|Eye cancer|2015–2019|Males|4|70–74|0.82|0.726|0.893
Relative|Eye cancer|2015–2019|Males|4|75–79|0.712|0.572|0.83
Relative|Eye cancer|2015–2019|Males|4|80–84|0.757|0.582|0.907
Relative|Eye cancer|2015–2019|Males|4|85+|0.577|0.362|0.809
Relative|Eye cancer|2015–2019|Males|4|All ages combined|0.82|0.787|0.85
Relative|Eye cancer|2015–2019|Males|5|00–04|0.975|0.825|0.998
Relative|Eye cancer|2015–2019|Males|5|05–09|||
Relative|Eye cancer|2015–2019|Males|5|10–14|||
Relative|Eye cancer|2015–2019|Males|5|15–19|||
Relative|Eye cancer|2015–2019|Males|5|20–24|||
Relative|Eye cancer|2015–2019|Males|5|25–29|||
Relative|Eye cancer|2015–2019|Males|5|30–34|||
Relative|Eye cancer|2015–2019|Males|5|35–39|||
Relative|Eye cancer|2015–2019|Males|5|40–44|0.776|0.561|0.897
Relative|Eye cancer|2015–2019|Males|5|45–49|0.843|0.7|0.925
Relative|Eye cancer|2015–2019|Males|5|50–54|0.836|0.711|0.914
Relative|Eye cancer|2015–2019|Males|5|55–59|0.814|0.71|0.888
Relative|Eye cancer|2015–2019|Males|5|60–64|0.774|0.681|0.847
Relative|Eye cancer|2015–2019|Males|5|65–69|0.762|0.665|0.841
Relative|Eye cancer|2015–2019|Males|5|70–74|0.763|0.66|0.848
Relative|Eye cancer|2015–2019|Males|5|75–79|0.731|0.582|0.857
Relative|Eye cancer|2015–2019|Males|5|80–84|0.671|0.481|0.848
Relative|Eye cancer|2015–2019|Males|5|85+|0.527|0.304|0.791
Relative|Eye cancer|2015–2019|Males|5|All ages combined|0.783|0.748|0.816
Observed|Eye cancer|2015–2019|Females|1|00–04|1|0.951|1
Observed|Eye cancer|2015–2019|Females|1|05–09|||
Observed|Eye cancer|2015–2019|Females|1|10–14|||
Observed|Eye cancer|2015–2019|Females|1|15–19|||
Observed|Eye cancer|2015–2019|Females|1|20–24|||
Observed|Eye cancer|2015–2019|Females|1|25–29|||
Observed|Eye cancer|2015–2019|Females|1|30–34|||
Observed|Eye cancer|2015–2019|Females|1|35–39|||
Observed|Eye cancer|2015–2019|Females|1|40–44|0.972|0.819|0.996
Observed|Eye cancer|2015–2019|Females|1|45–49|0.972|0.816|0.996
Observed|Eye cancer|2015–2019|Females|1|50–54|0.98|0.868|0.997
Observed|Eye cancer|2015–2019|Females|1|55–59|0.987|0.909|0.998
Observed|Eye cancer|2015–2019|Females|1|60–64|0.976|0.909|0.994
Observed|Eye cancer|2015–2019|Females|1|65–69|0.965|0.896|0.989
Observed|Eye cancer|2015–2019|Females|1|70–74|0.972|0.892|0.993
Observed|Eye cancer|2015–2019|Females|1|75–79|0.946|0.863|0.979
Observed|Eye cancer|2015–2019|Females|1|80–84|0.907|0.806|0.957
Observed|Eye cancer|2015–2019|Females|1|85+|0.89|0.782|0.946
Observed|Eye cancer|2015–2019|Females|1|All ages combined|0.961|0.945|0.973
Observed|Eye cancer|2015–2019|Females|2|00–04|0.983|0.886|0.998
Observed|Eye cancer|2015–2019|Females|2|05–09|||
Observed|Eye cancer|2015–2019|Females|2|10–14|||
Observed|Eye cancer|2015–2019|Females|2|15–19|||
Observed|Eye cancer|2015–2019|Females|2|20–24|||
Observed|Eye cancer|2015–2019|Females|2|25–29|||
Observed|Eye cancer|2015–2019|Females|2|30–34|||
Observed|Eye cancer|2015–2019|Females|2|35–39|||
Observed|Eye cancer|2015–2019|Females|2|40–44|0.972|0.819|0.996
Observed|Eye cancer|2015–2019|Females|2|45–49|0.92|0.773|0.974
Observed|Eye cancer|2015–2019|Females|2|50–54|0.945|0.838|0.982
Observed|Eye cancer|2015–2019|Females|2|55–59|0.947|0.865|0.98
Observed|Eye cancer|2015–2019|Females|2|60–64|0.915|0.829|0.958
Observed|Eye cancer|2015–2019|Females|2|65–69|0.965|0.896|0.989
Observed|Eye cancer|2015–2019|Females|2|70–74|0.944|0.858|0.979
Observed|Eye cancer|2015–2019|Females|2|75–79|0.847|0.746|0.91
Observed|Eye cancer|2015–2019|Females|2|80–84|0.843|0.727|0.912
Observed|Eye cancer|2015–2019|Females|2|85+|0.736|0.611|0.827
Observed|Eye cancer|2015–2019|Females|2|All ages combined|0.911|0.888|0.929
Observed|Eye cancer|2015–2019|Females|3|00–04|0.983|0.886|0.998
Observed|Eye cancer|2015–2019|Females|3|05–09|||
Observed|Eye cancer|2015–2019|Females|3|10–14|||
Observed|Eye cancer|2015–2019|Females|3|15–19|||
Observed|Eye cancer|2015–2019|Females|3|20–24|||
Observed|Eye cancer|2015–2019|Females|3|25–29|||
Observed|Eye cancer|2015–2019|Females|3|30–34|||
Observed|Eye cancer|2015–2019|Females|3|35–39|||
Observed|Eye cancer|2015–2019|Females|3|40–44|0.945|0.798|0.986
Observed|Eye cancer|2015–2019|Females|3|45–49|0.868|0.711|0.943
Observed|Eye cancer|2015–2019|Females|3|50–54|0.927|0.817|0.972
Observed|Eye cancer|2015–2019|Females|3|55–59|0.919|0.829|0.963
Observed|Eye cancer|2015–2019|Females|3|60–64|0.839|0.738|0.903
Observed|Eye cancer|2015–2019|Females|3|65–69|0.925|0.84|0.966
Observed|Eye cancer|2015–2019|Females|3|70–74|0.874|0.772|0.932
Observed|Eye cancer|2015–2019|Females|3|75–79|0.776|0.669|0.853
Observed|Eye cancer|2015–2019|Females|3|80–84|0.711|0.58|0.807
Observed|Eye cancer|2015–2019|Females|3|85+|0.565|0.436|0.676
Observed|Eye cancer|2015–2019|Females|3|All ages combined|0.849|0.821|0.873
Observed|Eye cancer|2015–2019|Females|4|00–04|0.965|0.867|0.991
Observed|Eye cancer|2015–2019|Females|4|05–09|||
Observed|Eye cancer|2015–2019|Females|4|10–14|||
Observed|Eye cancer|2015–2019|Females|4|15–19|||
Observed|Eye cancer|2015–2019|Females|4|20–24|||
Observed|Eye cancer|2015–2019|Females|4|25–29|||
Observed|Eye cancer|2015–2019|Females|4|30–34|||
Observed|Eye cancer|2015–2019|Females|4|35–39|||
Observed|Eye cancer|2015–2019|Females|4|40–44|0.945|0.798|0.986
Observed|Eye cancer|2015–2019|Females|4|45–49|0.868|0.711|0.943
Observed|Eye cancer|2015–2019|Females|4|50–54|0.91|0.796|0.961
Observed|Eye cancer|2015–2019|Females|4|55–59|0.857|0.75|0.921
Observed|Eye cancer|2015–2019|Females|4|60–64|0.788|0.682|0.863
Observed|Eye cancer|2015–2019|Females|4|65–69|0.816|0.702|0.889
Observed|Eye cancer|2015–2019|Females|4|70–74|0.86|0.755|0.922
Observed|Eye cancer|2015–2019|Females|4|75–79|0.648|0.532|0.741
Observed|Eye cancer|2015–2019|Females|4|80–84|0.545|0.404|0.666
Observed|Eye cancer|2015–2019|Females|4|85+|0.473|0.348|0.588
Observed|Eye cancer|2015–2019|Females|4|All ages combined|0.788|0.756|0.816
Observed|Eye cancer|2015–2019|Females|5|00–04|0.965|0.867|0.991
Observed|Eye cancer|2015–2019|Females|5|05–09|||
Observed|Eye cancer|2015–2019|Females|5|10–14|||
Observed|Eye cancer|2015–2019|Females|5|15–19|||
Observed|Eye cancer|2015–2019|Females|5|20–24|||
Observed|Eye cancer|2015–2019|Females|5|25–29|||
Observed|Eye cancer|2015–2019|Females|5|30–34|||
Observed|Eye cancer|2015–2019|Females|5|35–39|||
Observed|Eye cancer|2015–2019|Females|5|40–44|0.945|0.798|0.986
Observed|Eye cancer|2015–2019|Females|5|45–49|0.816|0.653|0.908
Observed|Eye cancer|2015–2019|Females|5|50–54|0.891|0.773|0.949
Observed|Eye cancer|2015–2019|Females|5|55–59|0.841|0.73|0.909
Observed|Eye cancer|2015–2019|Females|5|60–64|0.735|0.623|0.819
Observed|Eye cancer|2015–2019|Females|5|65–69|0.745|0.619|0.834
Observed|Eye cancer|2015–2019|Females|5|70–74|0.812|0.698|0.886
Observed|Eye cancer|2015–2019|Females|5|75–79|0.593|0.476|0.693
Observed|Eye cancer|2015–2019|Females|5|80–84|0.427|0.296|0.551
Observed|Eye cancer|2015–2019|Females|5|85+|0.309|0.2|0.424
Observed|Eye cancer|2015–2019|Females|5|All ages combined|0.731|0.696|0.762
Relative|Eye cancer|2015–2019|Females|1|00–04|1.001|0.952|1.001
Relative|Eye cancer|2015–2019|Females|1|05–09|||
Relative|Eye cancer|2015–2019|Females|1|10–14|||
Relative|Eye cancer|2015–2019|Females|1|15–19|||
Relative|Eye cancer|2015–2019|Females|1|20–24|||
Relative|Eye cancer|2015–2019|Females|1|25–29|||
Relative|Eye cancer|2015–2019|Females|1|30–34|||
Relative|Eye cancer|2015–2019|Females|1|35–39|||
Relative|Eye cancer|2015–2019|Females|1|40–44|0.973|0.82|0.997
Relative|Eye cancer|2015–2019|Females|1|45–49|0.973|0.818|0.997
Relative|Eye cancer|2015–2019|Females|1|50–54|0.982|0.869|0.999
Relative|Eye cancer|2015–2019|Females|1|55–59|0.99|0.912|1.001
Relative|Eye cancer|2015–2019|Females|1|60–64|0.981|0.913|0.999
Relative|Eye cancer|2015–2019|Females|1|65–69|0.972|0.903|0.996
Relative|Eye cancer|2015–2019|Females|1|70–74|0.984|0.903|1.005
Relative|Eye cancer|2015–2019|Females|1|75–79|0.967|0.881|1.001
Relative|Eye cancer|2015–2019|Females|1|80–84|0.946|0.84|0.998
Relative|Eye cancer|2015–2019|Females|1|85+|1.006|0.884|1.069
Relative|Eye cancer|2015–2019|Females|1|All ages combined|0.979|0.962|0.991
Relative|Eye cancer|2015–2019|Females|2|00–04|0.985|0.888|0.999
Relative|Eye cancer|2015–2019|Females|2|05–09|||
Relative|Eye cancer|2015–2019|Females|2|10–14|||
Relative|Eye cancer|2015–2019|Females|2|15–19|||
Relative|Eye cancer|2015–2019|Females|2|20–24|||
Relative|Eye cancer|2015–2019|Females|2|25–29|||
Relative|Eye cancer|2015–2019|Females|2|30–34|||
Relative|Eye cancer|2015–2019|Females|2|35–39|||
Relative|Eye cancer|2015–2019|Females|2|40–44|0.974|0.821|0.998
Relative|Eye cancer|2015–2019|Females|2|45–49|0.923|0.775|0.976
Relative|Eye cancer|2015–2019|Females|2|50–54|0.949|0.842|0.986
Relative|Eye cancer|2015–2019|Females|2|55–59|0.953|0.871|0.986
Relative|Eye cancer|2015–2019|Females|2|60–64|0.923|0.837|0.968
Relative|Eye cancer|2015–2019|Females|2|65–69|0.98|0.91|1.004
Relative|Eye cancer|2015–2019|Females|2|70–74|0.968|0.88|1.004
Relative|Eye cancer|2015–2019|Females|2|75–79|0.887|0.781|0.953
Relative|Eye cancer|2015–2019|Females|2|80–84|0.922|0.795|0.998
Relative|Eye cancer|2015–2019|Females|2|85+|0.95|0.788|1.067
Relative|Eye cancer|2015–2019|Females|2|All ages combined|0.946|0.922|0.965
Relative|Eye cancer|2015–2019|Females|3|00–04|0.985|0.888|0.999
Relative|Eye cancer|2015–2019|Females|3|05–09|||
Relative|Eye cancer|2015–2019|Females|3|10–14|||
Relative|Eye cancer|2015–2019|Females|3|15–19|||
Relative|Eye cancer|2015–2019|Females|3|20–24|||
Relative|Eye cancer|2015–2019|Females|3|25–29|||
Relative|Eye cancer|2015–2019|Females|3|30–34|||
Relative|Eye cancer|2015–2019|Females|3|35–39|||
Relative|Eye cancer|2015–2019|Females|3|40–44|0.948|0.8|0.989
Relative|Eye cancer|2015–2019|Females|3|45–49|0.872|0.714|0.947
Relative|Eye cancer|2015–2019|Females|3|50–54|0.934|0.823|0.979
Relative|Eye cancer|2015–2019|Females|3|55–59|0.929|0.837|0.973
Relative|Eye cancer|2015–2019|Females|3|60–64|0.851|0.75|0.917
Relative|Eye cancer|2015–2019|Females|3|65–69|0.948|0.86|0.99
Relative|Eye cancer|2015–2019|Females|3|70–74|0.91|0.804|0.971
Relative|Eye cancer|2015–2019|Females|3|75–79|0.836|0.72|0.918
Relative|Eye cancer|2015–2019|Females|3|80–84|0.823|0.672|0.934
Relative|Eye cancer|2015–2019|Females|3|85+|0.841|0.649|1.005
Relative|Eye cancer|2015–2019|Females|3|All ages combined|0.9|0.87|0.925
Relative|Eye cancer|2015–2019|Females|4|00–04|0.967|0.868|0.993
Relative|Eye cancer|2015–2019|Females|4|05–09|||
Relative|Eye cancer|2015–2019|Females|4|10–14|||
Relative|Eye cancer|2015–2019|Females|4|15–19|||
Relative|Eye cancer|2015–2019|Females|4|20–24|||
Relative|Eye cancer|2015–2019|Females|4|25–29|||
Relative|Eye cancer|2015–2019|Females|4|30–34|||
Relative|Eye cancer|2015–2019|Females|4|35–39|||
Relative|Eye cancer|2015–2019|Females|4|40–44|0.949|0.801|0.99
Relative|Eye cancer|2015–2019|Females|4|45–49|0.873|0.715|0.949
Relative|Eye cancer|2015–2019|Females|4|50–54|0.918|0.804|0.971
Relative|Eye cancer|2015–2019|Females|4|55–59|0.869|0.761|0.934
Relative|Eye cancer|2015–2019|Females|4|60–64|0.805|0.696|0.881
Relative|Eye cancer|2015–2019|Females|4|65–69|0.844|0.727|0.92
Relative|Eye cancer|2015–2019|Females|4|70–74|0.911|0.8|0.977
Relative|Eye cancer|2015–2019|Females|4|75–79|0.72|0.592|0.825
Relative|Eye cancer|2015–2019|Females|4|80–84|0.674|0.499|0.823
Relative|Eye cancer|2015–2019|Females|4|85+|0.828|0.609|1.029
Relative|Eye cancer|2015–2019|Females|4|All ages combined|0.853|0.818|0.883
Relative|Eye cancer|2015–2019|Females|5|00–04|0.967|0.868|0.993
Relative|Eye cancer|2015–2019|Females|5|05–09|||
Relative|Eye cancer|2015–2019|Females|5|10–14|||
Relative|Eye cancer|2015–2019|Females|5|15–19|||
Relative|Eye cancer|2015–2019|Females|5|20–24|||
Relative|Eye cancer|2015–2019|Females|5|25–29|||
Relative|Eye cancer|2015–2019|Females|5|30–34|||
Relative|Eye cancer|2015–2019|Females|5|35–39|||
Relative|Eye cancer|2015–2019|Females|5|40–44|0.95|0.802|0.992
Relative|Eye cancer|2015–2019|Females|5|45–49|0.823|0.658|0.915
Relative|Eye cancer|2015–2019|Females|5|50–54|0.902|0.782|0.961
Relative|Eye cancer|2015–2019|Females|5|55–59|0.856|0.744|0.926
Relative|Eye cancer|2015–2019|Females|5|60–64|0.756|0.64|0.842
Relative|Eye cancer|2015–2019|Females|5|65–69|0.779|0.648|0.873
Relative|Eye cancer|2015–2019|Females|5|70–74|0.877|0.754|0.958
Relative|Eye cancer|2015–2019|Females|5|75–79|0.685|0.55|0.8
Relative|Eye cancer|2015–2019|Females|5|80–84|0.569|0.396|0.735
Relative|Eye cancer|2015–2019|Females|5|85+|0.653|0.424|0.896
Relative|Eye cancer|2015–2019|Females|5|All ages combined|0.809|0.77|0.843
Observed|Eye cancer|2015–2019|Persons|1|00–04|1|0.97|1
Observed|Eye cancer|2015–2019|Persons|1|05–09|||
Observed|Eye cancer|2015–2019|Persons|1|10–14|||
Observed|Eye cancer|2015–2019|Persons|1|15–19|||
Observed|Eye cancer|2015–2019|Persons|1|20–24|||
Observed|Eye cancer|2015–2019|Persons|1|25–29|1|0.871|1
Observed|Eye cancer|2015–2019|Persons|1|30–34|1|0.895|1
Observed|Eye cancer|2015–2019|Persons|1|35–39|0.931|0.751|0.982
Observed|Eye cancer|2015–2019|Persons|1|40–44|0.984|0.889|0.998
Observed|Eye cancer|2015–2019|Persons|1|45–49|0.988|0.92|0.998
Observed|Eye cancer|2015–2019|Persons|1|50–54|0.982|0.931|0.996
Observed|Eye cancer|2015–2019|Persons|1|55–59|0.977|0.94|0.991
Observed|Eye cancer|2015–2019|Persons|1|60–64|0.957|0.915|0.978
Observed|Eye cancer|2015–2019|Persons|1|65–69|0.96|0.925|0.979
Observed|Eye cancer|2015–2019|Persons|1|70–74|0.958|0.918|0.979
Observed|Eye cancer|2015–2019|Persons|1|75–79|0.939|0.889|0.967
Observed|Eye cancer|2015–2019|Persons|1|80–84|0.894|0.828|0.936
Observed|Eye cancer|2015–2019|Persons|1|85+|0.815|0.739|0.871
Observed|Eye cancer|2015–2019|Persons|1|All ages combined|0.95|0.938|0.959
Observed|Eye cancer|2015–2019|Persons|2|00–04|0.979|0.92|0.995
Observed|Eye cancer|2015–2019|Persons|2|05–09|||
Observed|Eye cancer|2015–2019|Persons|2|10–14|||
Observed|Eye cancer|2015–2019|Persons|2|15–19|||
Observed|Eye cancer|2015–2019|Persons|2|20–24|||
Observed|Eye cancer|2015–2019|Persons|2|25–29|||
Observed|Eye cancer|2015–2019|Persons|2|30–34|1|0.895|1
Observed|Eye cancer|2015–2019|Persons|2|35–39|0.869|0.687|0.949
Observed|Eye cancer|2015–2019|Persons|2|40–44|0.968|0.876|0.992
Observed|Eye cancer|2015–2019|Persons|2|45–49|0.954|0.883|0.983
Observed|Eye cancer|2015–2019|Persons|2|50–54|0.957|0.899|0.982
Observed|Eye cancer|2015–2019|Persons|2|55–59|0.919|0.867|0.951
Observed|Eye cancer|2015–2019|Persons|2|60–64|0.909|0.858|0.943
Observed|Eye cancer|2015–2019|Persons|2|65–69|0.918|0.874|0.948
Observed|Eye cancer|2015–2019|Persons|2|70–74|0.917|0.868|0.948
Observed|Eye cancer|2015–2019|Persons|2|75–79|0.836|0.77|0.884
Observed|Eye cancer|2015–2019|Persons|2|80–84|0.792|0.711|0.852
Observed|Eye cancer|2015–2019|Persons|2|85+|0.674|0.588|0.746
Observed|Eye cancer|2015–2019|Persons|2|All ages combined|0.892|0.876|0.906
Observed|Eye cancer|2015–2019|Persons|3|00–04|0.979|0.92|0.995
Observed|Eye cancer|2015–2019|Persons|3|05–09|||
Observed|Eye cancer|2015–2019|Persons|3|10–14|||
Observed|Eye cancer|2015–2019|Persons|3|15–19|||
Observed|Eye cancer|2015–2019|Persons|3|20–24|||
Observed|Eye cancer|2015–2019|Persons|3|25–29|||
Observed|Eye cancer|2015–2019|Persons|3|30–34|1|0.892|1
Observed|Eye cancer|2015–2019|Persons|3|35–39|0.869|0.687|0.949
Observed|Eye cancer|2015–2019|Persons|3|40–44|0.92|0.818|0.966
Observed|Eye cancer|2015–2019|Persons|3|45–49|0.909|0.826|0.953
Observed|Eye cancer|2015–2019|Persons|3|50–54|0.93|0.865|0.964
Observed|Eye cancer|2015–2019|Persons|3|55–59|0.882|0.823|0.922
Observed|Eye cancer|2015–2019|Persons|3|60–64|0.854|0.795|0.897
Observed|Eye cancer|2015–2019|Persons|3|65–69|0.854|0.799|0.895
Observed|Eye cancer|2015–2019|Persons|3|70–74|0.845|0.786|0.889
Observed|Eye cancer|2015–2019|Persons|3|75–79|0.743|0.668|0.803
Observed|Eye cancer|2015–2019|Persons|3|80–84|0.669|0.58|0.744
Observed|Eye cancer|2015–2019|Persons|3|85+|0.513|0.425|0.595
Observed|Eye cancer|2015–2019|Persons|3|All ages combined|0.828|0.809|0.845
Observed|Eye cancer|2015–2019|Persons|4|00–04|0.969|0.907|0.99
Observed|Eye cancer|2015–2019|Persons|4|05–09|||
Observed|Eye cancer|2015–2019|Persons|4|10–14|||
Observed|Eye cancer|2015–2019|Persons|4|15–19|||
Observed|Eye cancer|2015–2019|Persons|4|20–24|||
Observed|Eye cancer|2015–2019|Persons|4|25–29|||
Observed|Eye cancer|2015–2019|Persons|4|30–34|1|0.888|1
Observed|Eye cancer|2015–2019|Persons|4|35–39|0.837|0.651|0.928
Observed|Eye cancer|2015–2019|Persons|4|40–44|0.884|0.772|0.943
Observed|Eye cancer|2015–2019|Persons|4|45–49|0.885|0.797|0.937
Observed|Eye cancer|2015–2019|Persons|4|50–54|0.887|0.814|0.933
Observed|Eye cancer|2015–2019|Persons|4|55–59|0.834|0.767|0.883
Observed|Eye cancer|2015–2019|Persons|4|60–64|0.792|0.728|0.842
Observed|Eye cancer|2015–2019|Persons|4|65–69|0.78|0.715|0.832
Observed|Eye cancer|2015–2019|Persons|4|70–74|0.789|0.725|0.84
Observed|Eye cancer|2015–2019|Persons|4|75–79|0.626|0.545|0.697
Observed|Eye cancer|2015–2019|Persons|4|80–84|0.558|0.464|0.642
Observed|Eye cancer|2015–2019|Persons|4|85+|0.383|0.299|0.466
Observed|Eye cancer|2015–2019|Persons|4|All ages combined|0.764|0.742|0.783
Observed|Eye cancer|2015–2019|Persons|5|00–04|0.969|0.907|0.99
Observed|Eye cancer|2015–2019|Persons|5|05–09|||
Observed|Eye cancer|2015–2019|Persons|5|10–14|||
Observed|Eye cancer|2015–2019|Persons|5|15–19|||
Observed|Eye cancer|2015–2019|Persons|5|20–24|||
Observed|Eye cancer|2015–2019|Persons|5|25–29|||
Observed|Eye cancer|2015–2019|Persons|5|30–34|1|0.884|1
Observed|Eye cancer|2015–2019|Persons|5|35–39|0.837|0.651|0.928
Observed|Eye cancer|2015–2019|Persons|5|40–44|0.866|0.749|0.931
Observed|Eye cancer|2015–2019|Persons|5|45–49|0.825|0.726|0.891
Observed|Eye cancer|2015–2019|Persons|5|50–54|0.853|0.774|0.906
Observed|Eye cancer|2015–2019|Persons|5|55–59|0.812|0.741|0.865
Observed|Eye cancer|2015–2019|Persons|5|60–64|0.738|0.671|0.793
Observed|Eye cancer|2015–2019|Persons|5|65–69|0.722|0.651|0.781
Observed|Eye cancer|2015–2019|Persons|5|70–74|0.726|0.657|0.784
Observed|Eye cancer|2015–2019|Persons|5|75–79|0.59|0.508|0.663
Observed|Eye cancer|2015–2019|Persons|5|80–84|0.443|0.351|0.53
Observed|Eye cancer|2015–2019|Persons|5|85+|0.264|0.191|0.343
Observed|Eye cancer|2015–2019|Persons|5|All ages combined|0.711|0.688|0.733
Relative|Eye cancer|2015–2019|Persons|1|00–04|1.001|0.971|1.001
Relative|Eye cancer|2015–2019|Persons|1|05–09|||
Relative|Eye cancer|2015–2019|Persons|1|10–14|||
Relative|Eye cancer|2015–2019|Persons|1|15–19|||
Relative|Eye cancer|2015–2019|Persons|1|20–24|||
Relative|Eye cancer|2015–2019|Persons|1|25–29|1|0.871|1
Relative|Eye cancer|2015–2019|Persons|1|30–34|1.001|0.896|1.001
Relative|Eye cancer|2015–2019|Persons|1|35–39|0.932|0.751|0.983
Relative|Eye cancer|2015–2019|Persons|1|40–44|0.985|0.89|0.999
Relative|Eye cancer|2015–2019|Persons|1|45–49|0.99|0.922|1
Relative|Eye cancer|2015–2019|Persons|1|50–54|0.985|0.933|0.998
Relative|Eye cancer|2015–2019|Persons|1|55–59|0.981|0.944|0.996
Relative|Eye cancer|2015–2019|Persons|1|60–64|0.963|0.921|0.984
Relative|Eye cancer|2015–2019|Persons|1|65–69|0.97|0.934|0.989
Relative|Eye cancer|2015–2019|Persons|1|70–74|0.974|0.934|0.995
Relative|Eye cancer|2015–2019|Persons|1|75–79|0.966|0.915|0.994
Relative|Eye cancer|2015–2019|Persons|1|80–84|0.941|0.872|0.985
Relative|Eye cancer|2015–2019|Persons|1|85+|0.935|0.848|1
Relative|Eye cancer|2015–2019|Persons|1|All ages combined|0.971|0.959|0.981
Relative|Eye cancer|2015–2019|Persons|2|00–04|0.981|0.921|0.996
Relative|Eye cancer|2015–2019|Persons|2|05–09|||
Relative|Eye cancer|2015–2019|Persons|2|10–14|||
Relative|Eye cancer|2015–2019|Persons|2|15–19|||
Relative|Eye cancer|2015–2019|Persons|2|20–24|||
Relative|Eye cancer|2015–2019|Persons|2|25–29|||
Relative|Eye cancer|2015–2019|Persons|2|30–34|1.001|0.897|1.001
Relative|Eye cancer|2015–2019|Persons|2|35–39|0.87|0.688|0.95
Relative|Eye cancer|2015–2019|Persons|2|40–44|0.97|0.879|0.994
Relative|Eye cancer|2015–2019|Persons|2|45–49|0.958|0.887|0.987
Relative|Eye cancer|2015–2019|Persons|2|50–54|0.962|0.904|0.988
Relative|Eye cancer|2015–2019|Persons|2|55–59|0.928|0.875|0.96
Relative|Eye cancer|2015–2019|Persons|2|60–64|0.922|0.87|0.956
Relative|Eye cancer|2015–2019|Persons|2|65–69|0.938|0.893|0.968
Relative|Eye cancer|2015–2019|Persons|2|70–74|0.95|0.899|0.982
Relative|Eye cancer|2015–2019|Persons|2|75–79|0.887|0.817|0.939
Relative|Eye cancer|2015–2019|Persons|2|80–84|0.885|0.795|0.953
Relative|Eye cancer|2015–2019|Persons|2|85+|0.896|0.782|0.991
Relative|Eye cancer|2015–2019|Persons|2|All ages combined|0.932|0.915|0.947
Relative|Eye cancer|2015–2019|Persons|3|00–04|0.981|0.921|0.996
Relative|Eye cancer|2015–2019|Persons|3|05–09|||
Relative|Eye cancer|2015–2019|Persons|3|10–14|||
Relative|Eye cancer|2015–2019|Persons|3|15–19|||
Relative|Eye cancer|2015–2019|Persons|3|20–24|||
Relative|Eye cancer|2015–2019|Persons|3|25–29|||
Relative|Eye cancer|2015–2019|Persons|3|30–34|1.002|0.894|1.002
Relative|Eye cancer|2015–2019|Persons|3|35–39|0.871|0.689|0.951
Relative|Eye cancer|2015–2019|Persons|3|40–44|0.923|0.821|0.97
Relative|Eye cancer|2015–2019|Persons|3|45–49|0.915|0.832|0.96
Relative|Eye cancer|2015–2019|Persons|3|50–54|0.939|0.873|0.973
Relative|Eye cancer|2015–2019|Persons|3|55–59|0.895|0.835|0.936
Relative|Eye cancer|2015–2019|Persons|3|60–64|0.873|0.813|0.916
Relative|Eye cancer|2015–2019|Persons|3|65–69|0.884|0.827|0.926
Relative|Eye cancer|2015–2019|Persons|3|70–74|0.893|0.83|0.939
Relative|Eye cancer|2015–2019|Persons|3|75–79|0.816|0.734|0.883
Relative|Eye cancer|2015–2019|Persons|3|80–84|0.8|0.693|0.889
Relative|Eye cancer|2015–2019|Persons|3|85+|0.8|0.661|0.927
Relative|Eye cancer|2015–2019|Persons|3|All ages combined|0.885|0.864|0.903
Relative|Eye cancer|2015–2019|Persons|4|00–04|0.971|0.909|0.992
Relative|Eye cancer|2015–2019|Persons|4|05–09|||
Relative|Eye cancer|2015–2019|Persons|4|10–14|||
Relative|Eye cancer|2015–2019|Persons|4|15–19|||
Relative|Eye cancer|2015–2019|Persons|4|20–24|||
Relative|Eye cancer|2015–2019|Persons|4|25–29|||
Relative|Eye cancer|2015–2019|Persons|4|30–34|1.003|0.891|1.003
Relative|Eye cancer|2015–2019|Persons|4|35–39|0.84|0.654|0.932
Relative|Eye cancer|2015–2019|Persons|4|40–44|0.889|0.776|0.948
Relative|Eye cancer|2015–2019|Persons|4|45–49|0.893|0.804|0.945
Relative|Eye cancer|2015–2019|Persons|4|50–54|0.899|0.824|0.945
Relative|Eye cancer|2015–2019|Persons|4|55–59|0.851|0.782|0.901
Relative|Eye cancer|2015–2019|Persons|4|60–64|0.816|0.751|0.868
Relative|Eye cancer|2015–2019|Persons|4|65–69|0.818|0.75|0.872
Relative|Eye cancer|2015–2019|Persons|4|70–74|0.853|0.784|0.908
Relative|Eye cancer|2015–2019|Persons|4|75–79|0.716|0.624|0.797
Relative|Eye cancer|2015–2019|Persons|4|80–84|0.719|0.598|0.827
Relative|Eye cancer|2015–2019|Persons|4|85+|0.712|0.555|0.867
Relative|Eye cancer|2015–2019|Persons|4|All ages combined|0.835|0.811|0.856
Relative|Eye cancer|2015–2019|Persons|5|00–04|0.971|0.909|0.992
Relative|Eye cancer|2015–2019|Persons|5|05–09|||
Relative|Eye cancer|2015–2019|Persons|5|10–14|||
Relative|Eye cancer|2015–2019|Persons|5|15–19|||
Relative|Eye cancer|2015–2019|Persons|5|20–24|||
Relative|Eye cancer|2015–2019|Persons|5|25–29|||
Relative|Eye cancer|2015–2019|Persons|5|30–34|1.004|0.888|1.004
Relative|Eye cancer|2015–2019|Persons|5|35–39|0.841|0.655|0.934
Relative|Eye cancer|2015–2019|Persons|5|40–44|0.872|0.755|0.938
Relative|Eye cancer|2015–2019|Persons|5|45–49|0.835|0.735|0.901
Relative|Eye cancer|2015–2019|Persons|5|50–54|0.868|0.788|0.921
Relative|Eye cancer|2015–2019|Persons|5|55–59|0.833|0.76|0.887
Relative|Eye cancer|2015–2019|Persons|5|60–64|0.768|0.698|0.825
Relative|Eye cancer|2015–2019|Persons|5|65–69|0.768|0.693|0.831
Relative|Eye cancer|2015–2019|Persons|5|70–74|0.805|0.728|0.869
Relative|Eye cancer|2015–2019|Persons|5|75–79|0.706|0.607|0.793
Relative|Eye cancer|2015–2019|Persons|5|80–84|0.622|0.494|0.745
Relative|Eye cancer|2015–2019|Persons|5|85+|0.597|0.432|0.775
Relative|Eye cancer|2015–2019|Persons|5|All ages combined|0.795|0.769|0.819
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|45–49|0.647|0.492|0.766
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|50–54|0.656|0.551|0.742
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|55–59|0.711|0.637|0.772
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|60–64|0.603|0.538|0.661
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|65–69|0.542|0.491|0.59
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|70–74|0.516|0.467|0.563
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|75–79|0.448|0.4|0.494
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|80–84|0.407|0.356|0.457
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|85+|0.234|0.189|0.282
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|All ages combined|0.494|0.474|0.513
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|45–49|0.475|0.322|0.613
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|50–54|0.481|0.375|0.579
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|55–59|0.545|0.467|0.617
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|60–64|0.45|0.386|0.512
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|65–69|0.415|0.366|0.464
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|70–74|0.345|0.3|0.391
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|75–79|0.296|0.253|0.34
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|80–84|0.22|0.178|0.265
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|85+|0.094|0.066|0.127
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|All ages combined|0.335|0.317|0.354
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|45–49|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|50–54|0.424|0.321|0.524
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|55–59|0.45|0.372|0.525
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|60–64|0.366|0.305|0.427
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|65–69|0.313|0.267|0.36
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|70–74|0.267|0.225|0.311
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|75–79|0.222|0.183|0.263
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|80–84|0.122|0.09|0.161
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|85+|0.056|0.035|0.083
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|All ages combined|0.256|0.239|0.274
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|45–49|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|50–54|0.379|0.279|0.478
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|55–59|0.409|0.331|0.485
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|60–64|0.304|0.246|0.364
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|65–69|0.266|0.222|0.312
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|70–74|0.22|0.181|0.262
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|75–79|0.183|0.146|0.223
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|80–84|0.102|0.072|0.137
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|85+|0.035|0.019|0.058
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|All ages combined|0.214|0.198|0.231
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|45–49|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|50–54|0.354|0.257|0.453
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|55–59|0.383|0.305|0.46
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|60–64|0.264|0.209|0.323
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|65–69|0.232|0.19|0.277
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|70–74|0.194|0.156|0.235
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|75–79|0.146|0.111|0.185
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|80–84|0.084|0.057|0.117
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|85+|0.029|0.015|0.051
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|All ages combined|0.186|0.171|0.203
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|45–49|0.649|0.493|0.768
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|50–54|0.658|0.553|0.745
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|55–59|0.715|0.641|0.776
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|60–64|0.608|0.543|0.667
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|65–69|0.549|0.497|0.597
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|70–74|0.526|0.476|0.574
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|75–79|0.463|0.414|0.511
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|80–84|0.432|0.378|0.485
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|85+|0.27|0.218|0.326
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|1|All ages combined|0.512|0.491|0.532
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|45–49|0.477|0.323|0.616
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|50–54|0.484|0.377|0.583
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|55–59|0.551|0.472|0.624
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|60–64|0.458|0.392|0.521
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|65–69|0.426|0.375|0.476
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|70–74|0.36|0.312|0.407
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|75–79|0.318|0.272|0.365
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|80–84|0.25|0.203|0.301
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|85+|0.127|0.089|0.172
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|2|All ages combined|0.358|0.339|0.379
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|45–49|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|50–54|0.429|0.325|0.53
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|55–59|0.458|0.378|0.534
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|60–64|0.375|0.313|0.438
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|65–69|0.326|0.278|0.375
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|70–74|0.285|0.24|0.332
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|75–79|0.248|0.205|0.294
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|80–84|0.15|0.11|0.198
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|85+|0.089|0.056|0.132
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|3|All ages combined|0.282|0.263|0.301
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|45–49|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|50–54|0.385|0.284|0.486
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|55–59|0.419|0.339|0.497
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|60–64|0.316|0.255|0.378
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|65–69|0.281|0.234|0.33
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|70–74|0.241|0.198|0.287
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|75–79|0.215|0.172|0.262
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|80–84|0.136|0.096|0.184
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|85+|0.067|0.037|0.11
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|4|All ages combined|0.243|0.224|0.262
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|45–49|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|50–54|0.362|0.262|0.463
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|55–59|0.396|0.315|0.475
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|60–64|0.277|0.219|0.339
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|65–69|0.25|0.204|0.299
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|70–74|0.219|0.177|0.265
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|75–79|0.18|0.137|0.229
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|80–84|0.124|0.085|0.173
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|85+|0.067|0.034|0.117
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Males|5|All ages combined|0.218|0.199|0.237
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|45–49|0.543|0.396|0.669
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|50–54|0.589|0.496|0.67
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|55–59|0.578|0.499|0.648
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|60–64|0.497|0.434|0.557
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|65–69|0.548|0.495|0.598
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|70–74|0.468|0.418|0.516
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|75–79|0.449|0.4|0.497
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|80–84|0.315|0.269|0.362
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|85+|0.191|0.159|0.225
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|All ages combined|0.424|0.405|0.442
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|45–49|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|50–54|0.457|0.366|0.542
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|55–59|0.432|0.355|0.506
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|60–64|0.32|0.264|0.378
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|65–69|0.385|0.334|0.436
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|70–74|0.334|0.288|0.381
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|75–79|0.285|0.242|0.33
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|80–84|0.173|0.137|0.213
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|85+|0.102|0.079|0.128
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|All ages combined|0.28|0.263|0.297
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|45–49|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|50–54|0.408|0.32|0.495
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|55–59|0.388|0.312|0.463
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|60–64|0.275|0.221|0.331
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|65–69|0.281|0.235|0.33
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|70–74|0.263|0.219|0.309
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|75–79|0.211|0.172|0.253
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|80–84|0.127|0.096|0.162
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|85+|0.059|0.042|0.079
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|All ages combined|0.216|0.2|0.232
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|45–49|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|50–54|0.351|0.263|0.44
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|55–59|0.355|0.279|0.43
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|60–64|0.266|0.213|0.322
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|65–69|0.231|0.187|0.277
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|70–74|0.206|0.166|0.25
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|75–79|0.181|0.144|0.221
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|80–84|0.089|0.064|0.119
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|85+|0.039|0.026|0.055
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|All ages combined|0.178|0.164|0.193
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|45–49|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|50–54|0.339|0.251|0.428
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|55–59|0.355|0.279|0.43
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|60–64|0.246|0.194|0.302
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|65–69|0.209|0.167|0.255
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|70–74|0.189|0.15|0.232
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|75–79|0.15|0.115|0.19
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|80–84|0.074|0.051|0.102
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|85+|0.033|0.021|0.049
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|All ages combined|0.163|0.149|0.177
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|45–49|0.544|0.396|0.67
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|50–54|0.59|0.497|0.672
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|55–59|0.579|0.501|0.65
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|60–64|0.499|0.436|0.559
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|65–69|0.552|0.499|0.602
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|70–74|0.474|0.423|0.522
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|75–79|0.459|0.409|0.508
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|80–84|0.328|0.281|0.377
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|85+|0.214|0.178|0.252
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|1|All ages combined|0.437|0.418|0.457
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|45–49|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|50–54|0.459|0.368|0.545
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|55–59|0.435|0.357|0.509
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|60–64|0.323|0.266|0.382
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|65–69|0.391|0.339|0.443
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|70–74|0.343|0.295|0.391
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|75–79|0.299|0.254|0.346
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|80–84|0.189|0.15|0.233
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|85+|0.13|0.101|0.163
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|2|All ages combined|0.296|0.279|0.315
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|45–49|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|50–54|0.411|0.322|0.499
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|55–59|0.392|0.315|0.468
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|60–64|0.279|0.224|0.336
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|65–69|0.288|0.24|0.338
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|70–74|0.274|0.228|0.321
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|75–79|0.228|0.186|0.273
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|80–84|0.147|0.111|0.187
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|85+|0.086|0.062|0.115
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|3|All ages combined|0.235|0.218|0.252
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|45–49|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|50–54|0.354|0.265|0.444
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|55–59|0.36|0.283|0.437
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|60–64|0.271|0.217|0.329
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|65–69|0.238|0.193|0.286
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|70–74|0.218|0.176|0.264
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|75–79|0.201|0.16|0.246
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|80–84|0.11|0.079|0.147
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|85+|0.066|0.044|0.094
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|4|All ages combined|0.2|0.183|0.217
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|45–49|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|50–54|0.343|0.255|0.434
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|55–59|0.361|0.285|0.439
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|60–64|0.253|0.2|0.31
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|65–69|0.219|0.175|0.266
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|70–74|0.204|0.162|0.25
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|75–79|0.173|0.133|0.219
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|80–84|0.099|0.068|0.136
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|85+|0.067|0.043|0.099
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Females|5|All ages combined|0.187|0.171|0.204
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|35–39|0.665|0.469|0.803
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|40–44|0.627|0.461|0.755
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|45–49|0.593|0.488|0.684
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|50–54|0.618|0.55|0.679
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|55–59|0.646|0.593|0.694
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|60–64|0.549|0.504|0.591
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|65–69|0.545|0.508|0.58
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|70–74|0.493|0.458|0.526
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|75–79|0.448|0.414|0.482
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|80–84|0.36|0.325|0.394
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|85+|0.207|0.18|0.234
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|All ages combined|0.458|0.444|0.471
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|40–44|0.52|0.362|0.656
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|45–49|0.397|0.296|0.495
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|50–54|0.468|0.399|0.533
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|55–59|0.49|0.435|0.542
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|60–64|0.383|0.34|0.426
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|65–69|0.401|0.366|0.437
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|70–74|0.34|0.307|0.372
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|75–79|0.291|0.26|0.322
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|80–84|0.196|0.168|0.226
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|85+|0.099|0.081|0.119
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|All ages combined|0.307|0.294|0.319
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|40–44|0.457|0.307|0.595
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|45–49|0.335|0.24|0.434
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|50–54|0.416|0.348|0.482
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|55–59|0.419|0.365|0.473
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|60–64|0.319|0.278|0.36
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|65–69|0.298|0.265|0.332
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|70–74|0.265|0.234|0.296
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|75–79|0.216|0.189|0.246
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|80–84|0.127|0.104|0.153
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|85+|0.058|0.044|0.073
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|All ages combined|0.235|0.223|0.247
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|45–49|0.262|0.176|0.355
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|50–54|0.364|0.298|0.431
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|55–59|0.382|0.328|0.436
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|60–64|0.284|0.244|0.325
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|65–69|0.249|0.218|0.282
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|70–74|0.213|0.185|0.243
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|75–79|0.182|0.156|0.21
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|80–84|0.096|0.076|0.119
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|85+|0.037|0.027|0.05
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|All ages combined|0.196|0.185|0.207
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|00–04|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|05–09|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|10–14|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|15–19|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|20–24|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|25–29|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|30–34|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|35–39|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|40–44|||
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|45–49|0.231|0.151|0.321
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|50–54|0.346|0.281|0.413
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|55–59|0.369|0.315|0.424
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|60–64|0.255|0.216|0.295
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|65–69|0.221|0.191|0.253
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|70–74|0.192|0.164|0.221
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|75–79|0.148|0.123|0.176
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|80–84|0.08|0.061|0.101
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|85+|0.032|0.022|0.044
Observed|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|All ages combined|0.174|0.164|0.185
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|35–39|0.666|0.469|0.804
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|40–44|0.628|0.462|0.756
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|45–49|0.595|0.489|0.685
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|50–54|0.62|0.551|0.681
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|55–59|0.649|0.595|0.697
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|60–64|0.552|0.507|0.595
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|65–69|0.55|0.513|0.585
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|70–74|0.501|0.465|0.535
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|75–79|0.461|0.426|0.495
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|80–84|0.378|0.342|0.415
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|85+|0.234|0.204|0.266
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|1|All ages combined|0.473|0.459|0.487
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|40–44|0.521|0.363|0.658
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|45–49|0.398|0.297|0.497
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|50–54|0.47|0.402|0.536
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|55–59|0.494|0.439|0.547
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|60–64|0.388|0.345|0.432
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|65–69|0.41|0.374|0.446
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|70–74|0.351|0.318|0.385
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|75–79|0.309|0.276|0.342
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|80–84|0.219|0.188|0.252
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|85+|0.129|0.106|0.156
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|2|All ages combined|0.326|0.313|0.34
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|40–44|0.459|0.308|0.598
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|45–49|0.338|0.241|0.436
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|50–54|0.42|0.352|0.486
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|55–59|0.425|0.37|0.48
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|60–64|0.325|0.284|0.368
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|65–69|0.308|0.274|0.343
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|70–74|0.28|0.247|0.313
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|75–79|0.238|0.207|0.27
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|80–84|0.151|0.124|0.182
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|85+|0.087|0.067|0.111
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|3|All ages combined|0.257|0.245|0.27
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|45–49|0.264|0.178|0.358
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|50–54|0.369|0.302|0.436
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|55–59|0.39|0.334|0.445
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|60–64|0.293|0.252|0.335
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|65–69|0.261|0.228|0.295
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|70–74|0.23|0.199|0.263
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|75–79|0.208|0.178|0.24
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|80–84|0.124|0.098|0.153
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|85+|0.066|0.048|0.089
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|4|All ages combined|0.22|0.208|0.233
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|00–04|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|05–09|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|10–14|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|15–19|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|20–24|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|25–29|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|30–34|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|35–39|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|40–44|||
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|45–49|0.233|0.153|0.325
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|50–54|0.352|0.285|0.42
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|55–59|0.379|0.323|0.435
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|60–64|0.265|0.225|0.306
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|65–69|0.235|0.203|0.269
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|70–74|0.212|0.182|0.244
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|75–79|0.177|0.147|0.21
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|80–84|0.112|0.086|0.142
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|85+|0.067|0.047|0.093
Relative|Gallbladder and extrahepatic bile duct cancer|2015–2019|Persons|5|All ages combined|0.202|0.189|0.214
Observed|Gallbladder cancer|2015–2019|Males|1|00–04|||
Observed|Gallbladder cancer|2015–2019|Males|1|05–09|||
Observed|Gallbladder cancer|2015–2019|Males|1|10–14|||
Observed|Gallbladder cancer|2015–2019|Males|1|15–19|||
Observed|Gallbladder cancer|2015–2019|Males|1|20–24|||
Observed|Gallbladder cancer|2015–2019|Males|1|25–29|||
Observed|Gallbladder cancer|2015–2019|Males|1|30–34|||
Observed|Gallbladder cancer|2015–2019|Males|1|35–39|||
Observed|Gallbladder cancer|2015–2019|Males|1|40–44|||
Observed|Gallbladder cancer|2015–2019|Males|1|45–49|||
Observed|Gallbladder cancer|2015–2019|Males|1|50–54|||
Observed|Gallbladder cancer|2015–2019|Males|1|55–59|0.502|0.339|0.644
Observed|Gallbladder cancer|2015–2019|Males|1|60–64|0.517|0.385|0.634
Observed|Gallbladder cancer|2015–2019|Males|1|65–69|0.459|0.358|0.554
Observed|Gallbladder cancer|2015–2019|Males|1|70–74|0.464|0.363|0.558
Observed|Gallbladder cancer|2015–2019|Males|1|75–79|0.308|0.225|0.394
Observed|Gallbladder cancer|2015–2019|Males|1|80–84|0.33|0.241|0.421
Observed|Gallbladder cancer|2015–2019|Males|1|85+|0.215|0.13|0.314
Observed|Gallbladder cancer|2015–2019|Males|1|All ages combined|0.404|0.366|0.443
Observed|Gallbladder cancer|2015–2019|Males|2|00–04|||
Observed|Gallbladder cancer|2015–2019|Males|2|05–09|||
Observed|Gallbladder cancer|2015–2019|Males|2|10–14|||
Observed|Gallbladder cancer|2015–2019|Males|2|15–19|||
Observed|Gallbladder cancer|2015–2019|Males|2|20–24|||
Observed|Gallbladder cancer|2015–2019|Males|2|25–29|||
Observed|Gallbladder cancer|2015–2019|Males|2|30–34|||
Observed|Gallbladder cancer|2015–2019|Males|2|35–39|||
Observed|Gallbladder cancer|2015–2019|Males|2|40–44|||
Observed|Gallbladder cancer|2015–2019|Males|2|45–49|||
Observed|Gallbladder cancer|2015–2019|Males|2|50–54|||
Observed|Gallbladder cancer|2015–2019|Males|2|55–59|||
Observed|Gallbladder cancer|2015–2019|Males|2|60–64|0.323|0.209|0.443
Observed|Gallbladder cancer|2015–2019|Males|2|65–69|0.332|0.24|0.426
Observed|Gallbladder cancer|2015–2019|Males|2|70–74|0.296|0.21|0.387
Observed|Gallbladder cancer|2015–2019|Males|2|75–79|0.185|0.119|0.262
Observed|Gallbladder cancer|2015–2019|Males|2|80–84|0.234|0.157|0.321
Observed|Gallbladder cancer|2015–2019|Males|2|85+|||
Observed|Gallbladder cancer|2015–2019|Males|2|All ages combined|0.27|0.235|0.305
Observed|Gallbladder cancer|2015–2019|Males|3|00–04|||
Observed|Gallbladder cancer|2015–2019|Males|3|05–09|||
Observed|Gallbladder cancer|2015–2019|Males|3|10–14|||
Observed|Gallbladder cancer|2015–2019|Males|3|15–19|||
Observed|Gallbladder cancer|2015–2019|Males|3|20–24|||
Observed|Gallbladder cancer|2015–2019|Males|3|25–29|||
Observed|Gallbladder cancer|2015–2019|Males|3|30–34|||
Observed|Gallbladder cancer|2015–2019|Males|3|35–39|||
Observed|Gallbladder cancer|2015–2019|Males|3|40–44|||
Observed|Gallbladder cancer|2015–2019|Males|3|45–49|||
Observed|Gallbladder cancer|2015–2019|Males|3|50–54|||
Observed|Gallbladder cancer|2015–2019|Males|3|55–59|||
Observed|Gallbladder cancer|2015–2019|Males|3|60–64|||
Observed|Gallbladder cancer|2015–2019|Males|3|65–69|0.231|0.152|0.32
Observed|Gallbladder cancer|2015–2019|Males|3|70–74|0.248|0.169|0.335
Observed|Gallbladder cancer|2015–2019|Males|3|75–79|0.158|0.097|0.232
Observed|Gallbladder cancer|2015–2019|Males|3|80–84|0.118|0.065|0.188
Observed|Gallbladder cancer|2015–2019|Males|3|85+|||
Observed|Gallbladder cancer|2015–2019|Males|3|All ages combined|0.204|0.174|0.237
Observed|Gallbladder cancer|2015–2019|Males|4|00–04|||
Observed|Gallbladder cancer|2015–2019|Males|4|05–09|||
Observed|Gallbladder cancer|2015–2019|Males|4|10–14|||
Observed|Gallbladder cancer|2015–2019|Males|4|15–19|||
Observed|Gallbladder cancer|2015–2019|Males|4|20–24|||
Observed|Gallbladder cancer|2015–2019|Males|4|25–29|||
Observed|Gallbladder cancer|2015–2019|Males|4|30–34|||
Observed|Gallbladder cancer|2015–2019|Males|4|35–39|||
Observed|Gallbladder cancer|2015–2019|Males|4|40–44|||
Observed|Gallbladder cancer|2015–2019|Males|4|45–49|||
Observed|Gallbladder cancer|2015–2019|Males|4|50–54|||
Observed|Gallbladder cancer|2015–2019|Males|4|55–59|||
Observed|Gallbladder cancer|2015–2019|Males|4|60–64|||
Observed|Gallbladder cancer|2015–2019|Males|4|65–69|0.185|0.113|0.27
Observed|Gallbladder cancer|2015–2019|Males|4|70–74|0.217|0.142|0.301
Observed|Gallbladder cancer|2015–2019|Males|4|75–79|0.114|0.062|0.183
Observed|Gallbladder cancer|2015–2019|Males|4|80–84|0.118|0.065|0.188
Observed|Gallbladder cancer|2015–2019|Males|4|85+|||
Observed|Gallbladder cancer|2015–2019|Males|4|All ages combined|0.164|0.136|0.194
Observed|Gallbladder cancer|2015–2019|Males|5|00–04|||
Observed|Gallbladder cancer|2015–2019|Males|5|05–09|||
Observed|Gallbladder cancer|2015–2019|Males|5|10–14|||
Observed|Gallbladder cancer|2015–2019|Males|5|15–19|||
Observed|Gallbladder cancer|2015–2019|Males|5|20–24|||
Observed|Gallbladder cancer|2015–2019|Males|5|25–29|||
Observed|Gallbladder cancer|2015–2019|Males|5|30–34|||
Observed|Gallbladder cancer|2015–2019|Males|5|35–39|||
Observed|Gallbladder cancer|2015–2019|Males|5|40–44|||
Observed|Gallbladder cancer|2015–2019|Males|5|45–49|||
Observed|Gallbladder cancer|2015–2019|Males|5|50–54|||
Observed|Gallbladder cancer|2015–2019|Males|5|55–59|||
Observed|Gallbladder cancer|2015–2019|Males|5|60–64|||
Observed|Gallbladder cancer|2015–2019|Males|5|65–69|0.15|0.086|0.231
Observed|Gallbladder cancer|2015–2019|Males|5|70–74|0.185|0.116|0.267
Observed|Gallbladder cancer|2015–2019|Males|5|75–79|0.103|0.053|0.171
Observed|Gallbladder cancer|2015–2019|Males|5|80–84|0.1|0.052|0.166
Observed|Gallbladder cancer|2015–2019|Males|5|85+|||
Observed|Gallbladder cancer|2015–2019|Males|5|All ages combined|0.145|0.118|0.174
Relative|Gallbladder cancer|2015–2019|Males|1|00–04|||
Relative|Gallbladder cancer|2015–2019|Males|1|05–09|||
Relative|Gallbladder cancer|2015–2019|Males|1|10–14|||
Relative|Gallbladder cancer|2015–2019|Males|1|15–19|||
Relative|Gallbladder cancer|2015–2019|Males|1|20–24|||
Relative|Gallbladder cancer|2015–2019|Males|1|25–29|||
Relative|Gallbladder cancer|2015–2019|Males|1|30–34|||
Relative|Gallbladder cancer|2015–2019|Males|1|35–39|||
Relative|Gallbladder cancer|2015–2019|Males|1|40–44|||
Relative|Gallbladder cancer|2015–2019|Males|1|45–49|||
Relative|Gallbladder cancer|2015–2019|Males|1|50–54|||
Relative|Gallbladder cancer|2015–2019|Males|1|55–59|0.504|0.341|0.647
Relative|Gallbladder cancer|2015–2019|Males|1|60–64|0.521|0.388|0.639
Relative|Gallbladder cancer|2015–2019|Males|1|65–69|0.465|0.363|0.561
Relative|Gallbladder cancer|2015–2019|Males|1|70–74|0.473|0.37|0.57
Relative|Gallbladder cancer|2015–2019|Males|1|75–79|0.318|0.233|0.407
Relative|Gallbladder cancer|2015–2019|Males|1|80–84|0.35|0.256|0.447
Relative|Gallbladder cancer|2015–2019|Males|1|85+|0.248|0.15|0.362
Relative|Gallbladder cancer|2015–2019|Males|1|All ages combined|0.419|0.379|0.459
Relative|Gallbladder cancer|2015–2019|Males|2|00–04|||
Relative|Gallbladder cancer|2015–2019|Males|2|05–09|||
Relative|Gallbladder cancer|2015–2019|Males|2|10–14|||
Relative|Gallbladder cancer|2015–2019|Males|2|15–19|||
Relative|Gallbladder cancer|2015–2019|Males|2|20–24|||
Relative|Gallbladder cancer|2015–2019|Males|2|25–29|||
Relative|Gallbladder cancer|2015–2019|Males|2|30–34|||
Relative|Gallbladder cancer|2015–2019|Males|2|35–39|||
Relative|Gallbladder cancer|2015–2019|Males|2|40–44|||
Relative|Gallbladder cancer|2015–2019|Males|2|45–49|||
Relative|Gallbladder cancer|2015–2019|Males|2|50–54|||
Relative|Gallbladder cancer|2015–2019|Males|2|55–59|||
Relative|Gallbladder cancer|2015–2019|Males|2|60–64|0.329|0.212|0.45
Relative|Gallbladder cancer|2015–2019|Males|2|65–69|0.34|0.246|0.437
Relative|Gallbladder cancer|2015–2019|Males|2|70–74|0.309|0.219|0.403
Relative|Gallbladder cancer|2015–2019|Males|2|75–79|0.199|0.128|0.282
Relative|Gallbladder cancer|2015–2019|Males|2|80–84|0.267|0.178|0.366
Relative|Gallbladder cancer|2015–2019|Males|2|85+|||
Relative|Gallbladder cancer|2015–2019|Males|2|All ages combined|0.288|0.252|0.326
Relative|Gallbladder cancer|2015–2019|Males|3|00–04|||
Relative|Gallbladder cancer|2015–2019|Males|3|05–09|||
Relative|Gallbladder cancer|2015–2019|Males|3|10–14|||
Relative|Gallbladder cancer|2015–2019|Males|3|15–19|||
Relative|Gallbladder cancer|2015–2019|Males|3|20–24|||
Relative|Gallbladder cancer|2015–2019|Males|3|25–29|||
Relative|Gallbladder cancer|2015–2019|Males|3|30–34|||
Relative|Gallbladder cancer|2015–2019|Males|3|35–39|||
Relative|Gallbladder cancer|2015–2019|Males|3|40–44|||
Relative|Gallbladder cancer|2015–2019|Males|3|45–49|||
Relative|Gallbladder cancer|2015–2019|Males|3|50–54|||
Relative|Gallbladder cancer|2015–2019|Males|3|55–59|||
Relative|Gallbladder cancer|2015–2019|Males|3|60–64|||
Relative|Gallbladder cancer|2015–2019|Males|3|65–69|0.241|0.158|0.333
Relative|Gallbladder cancer|2015–2019|Males|3|70–74|0.265|0.18|0.358
Relative|Gallbladder cancer|2015–2019|Males|3|75–79|0.177|0.109|0.26
Relative|Gallbladder cancer|2015–2019|Males|3|80–84|0.145|0.08|0.231
Relative|Gallbladder cancer|2015–2019|Males|3|85+|||
Relative|Gallbladder cancer|2015–2019|Males|3|All ages combined|0.226|0.192|0.262
Relative|Gallbladder cancer|2015–2019|Males|4|00–04|||
Relative|Gallbladder cancer|2015–2019|Males|4|05–09|||
Relative|Gallbladder cancer|2015–2019|Males|4|10–14|||
Relative|Gallbladder cancer|2015–2019|Males|4|15–19|||
Relative|Gallbladder cancer|2015–2019|Males|4|20–24|||
Relative|Gallbladder cancer|2015–2019|Males|4|25–29|||
Relative|Gallbladder cancer|2015–2019|Males|4|30–34|||
Relative|Gallbladder cancer|2015–2019|Males|4|35–39|||
Relative|Gallbladder cancer|2015–2019|Males|4|40–44|||
Relative|Gallbladder cancer|2015–2019|Males|4|45–49|||
Relative|Gallbladder cancer|2015–2019|Males|4|50–54|||
Relative|Gallbladder cancer|2015–2019|Males|4|55–59|||
Relative|Gallbladder cancer|2015–2019|Males|4|60–64|||
Relative|Gallbladder cancer|2015–2019|Males|4|65–69|0.195|0.12|0.286
Relative|Gallbladder cancer|2015–2019|Males|4|70–74|0.238|0.156|0.331
Relative|Gallbladder cancer|2015–2019|Males|4|75–79|0.134|0.073|0.216
Relative|Gallbladder cancer|2015–2019|Males|4|80–84|0.158|0.087|0.253
Relative|Gallbladder cancer|2015–2019|Males|4|85+|||
Relative|Gallbladder cancer|2015–2019|Males|4|All ages combined|0.189|0.156|0.223
Relative|Gallbladder cancer|2015–2019|Males|5|00–04|||
Relative|Gallbladder cancer|2015–2019|Males|5|05–09|||
Relative|Gallbladder cancer|2015–2019|Males|5|10–14|||
Relative|Gallbladder cancer|2015–2019|Males|5|15–19|||
Relative|Gallbladder cancer|2015–2019|Males|5|20–24|||
Relative|Gallbladder cancer|2015–2019|Males|5|25–29|||
Relative|Gallbladder cancer|2015–2019|Males|5|30–34|||
Relative|Gallbladder cancer|2015–2019|Males|5|35–39|||
Relative|Gallbladder cancer|2015–2019|Males|5|40–44|||
Relative|Gallbladder cancer|2015–2019|Males|5|45–49|||
Relative|Gallbladder cancer|2015–2019|Males|5|50–54|||
Relative|Gallbladder cancer|2015–2019|Males|5|55–59|||
Relative|Gallbladder cancer|2015–2019|Males|5|60–64|||
Relative|Gallbladder cancer|2015–2019|Males|5|65–69|0.161|0.092|0.249
Relative|Gallbladder cancer|2015–2019|Males|5|70–74|0.21|0.132|0.303
Relative|Gallbladder cancer|2015–2019|Males|5|75–79|0.128|0.066|0.212
Relative|Gallbladder cancer|2015–2019|Males|5|80–84|0.149|0.078|0.248
Relative|Gallbladder cancer|2015–2019|Males|5|85+|||
Relative|Gallbladder cancer|2015–2019|Males|5|All ages combined|0.172|0.141|0.206
Observed|Gallbladder cancer|2015–2019|Females|1|00–04|||
Observed|Gallbladder cancer|2015–2019|Females|1|05–09|||
Observed|Gallbladder cancer|2015–2019|Females|1|10–14|||
Observed|Gallbladder cancer|2015–2019|Females|1|15–19|||
Observed|Gallbladder cancer|2015–2019|Females|1|20–24|||
Observed|Gallbladder cancer|2015–2019|Females|1|25–29|||
Observed|Gallbladder cancer|2015–2019|Females|1|30–34|||
Observed|Gallbladder cancer|2015–2019|Females|1|35–39|||
Observed|Gallbladder cancer|2015–2019|Females|1|40–44|||
Observed|Gallbladder cancer|2015–2019|Females|1|45–49|0.564|0.373|0.717
Observed|Gallbladder cancer|2015–2019|Females|1|50–54|0.64|0.483|0.761
Observed|Gallbladder cancer|2015–2019|Females|1|55–59|0.602|0.484|0.701
Observed|Gallbladder cancer|2015–2019|Females|1|60–64|0.46|0.368|0.547
Observed|Gallbladder cancer|2015–2019|Females|1|65–69|0.532|0.455|0.603
Observed|Gallbladder cancer|2015–2019|Females|1|70–74|0.422|0.349|0.494
Observed|Gallbladder cancer|2015–2019|Females|1|75–79|0.43|0.355|0.503
Observed|Gallbladder cancer|2015–2019|Females|1|80–84|0.293|0.225|0.364
Observed|Gallbladder cancer|2015–2019|Females|1|85+|0.199|0.152|0.25
Observed|Gallbladder cancer|2015–2019|Females|1|All ages combined|0.409|0.381|0.437
Observed|Gallbladder cancer|2015–2019|Females|2|00–04|||
Observed|Gallbladder cancer|2015–2019|Females|2|05–09|||
Observed|Gallbladder cancer|2015–2019|Females|2|10–14|||
Observed|Gallbladder cancer|2015–2019|Females|2|15–19|||
Observed|Gallbladder cancer|2015–2019|Females|2|20–24|||
Observed|Gallbladder cancer|2015–2019|Females|2|25–29|||
Observed|Gallbladder cancer|2015–2019|Females|2|30–34|||
Observed|Gallbladder cancer|2015–2019|Females|2|35–39|||
Observed|Gallbladder cancer|2015–2019|Females|2|40–44|||
Observed|Gallbladder cancer|2015–2019|Females|2|45–49|||
Observed|Gallbladder cancer|2015–2019|Females|2|50–54|0.573|0.417|0.702
Observed|Gallbladder cancer|2015–2019|Females|2|55–59|0.454|0.339|0.561
Observed|Gallbladder cancer|2015–2019|Females|2|60–64|0.334|0.25|0.419
Observed|Gallbladder cancer|2015–2019|Females|2|65–69|0.368|0.296|0.44
Observed|Gallbladder cancer|2015–2019|Females|2|70–74|0.295|0.23|0.363
Observed|Gallbladder cancer|2015–2019|Females|2|75–79|0.265|0.201|0.333
Observed|Gallbladder cancer|2015–2019|Females|2|80–84|0.189|0.133|0.252
Observed|Gallbladder cancer|2015–2019|Females|2|85+|0.124|0.089|0.165
Observed|Gallbladder cancer|2015–2019|Females|2|All ages combined|0.284|0.259|0.309
Observed|Gallbladder cancer|2015–2019|Females|3|00–04|||
Observed|Gallbladder cancer|2015–2019|Females|3|05–09|||
Observed|Gallbladder cancer|2015–2019|Females|3|10–14|||
Observed|Gallbladder cancer|2015–2019|Females|3|15–19|||
Observed|Gallbladder cancer|2015–2019|Females|3|20–24|||
Observed|Gallbladder cancer|2015–2019|Females|3|25–29|||
Observed|Gallbladder cancer|2015–2019|Females|3|30–34|||
Observed|Gallbladder cancer|2015–2019|Females|3|35–39|||
Observed|Gallbladder cancer|2015–2019|Females|3|40–44|||
Observed|Gallbladder cancer|2015–2019|Females|3|45–49|||
Observed|Gallbladder cancer|2015–2019|Females|3|50–54|0.548|0.391|0.68
Observed|Gallbladder cancer|2015–2019|Females|3|55–59|0.39|0.278|0.499
Observed|Gallbladder cancer|2015–2019|Females|3|60–64|0.3|0.221|0.384
Observed|Gallbladder cancer|2015–2019|Females|3|65–69|0.273|0.208|0.343
Observed|Gallbladder cancer|2015–2019|Females|3|70–74|0.226|0.167|0.29
Observed|Gallbladder cancer|2015–2019|Females|3|75–79|0.223|0.163|0.288
Observed|Gallbladder cancer|2015–2019|Females|3|80–84|0.141|0.093|0.198
Observed|Gallbladder cancer|2015–2019|Females|3|85+|0.08|0.053|0.114
Observed|Gallbladder cancer|2015–2019|Females|3|All ages combined|0.227|0.204|0.251
Observed|Gallbladder cancer|2015–2019|Females|4|00–04|||
Observed|Gallbladder cancer|2015–2019|Females|4|05–09|||
Observed|Gallbladder cancer|2015–2019|Females|4|10–14|||
Observed|Gallbladder cancer|2015–2019|Females|4|15–19|||
Observed|Gallbladder cancer|2015–2019|Females|4|20–24|||
Observed|Gallbladder cancer|2015–2019|Females|4|25–29|||
Observed|Gallbladder cancer|2015–2019|Females|4|30–34|||
Observed|Gallbladder cancer|2015–2019|Females|4|35–39|||
Observed|Gallbladder cancer|2015–2019|Females|4|40–44|||
Observed|Gallbladder cancer|2015–2019|Females|4|45–49|||
Observed|Gallbladder cancer|2015–2019|Females|4|50–54|||
Observed|Gallbladder cancer|2015–2019|Females|4|55–59|0.355|0.246|0.466
Observed|Gallbladder cancer|2015–2019|Females|4|60–64|0.292|0.213|0.375
Observed|Gallbladder cancer|2015–2019|Females|4|65–69|0.22|0.16|0.285
Observed|Gallbladder cancer|2015–2019|Females|4|70–74|0.186|0.132|0.248
Observed|Gallbladder cancer|2015–2019|Females|4|75–79|0.191|0.136|0.254
Observed|Gallbladder cancer|2015–2019|Females|4|80–84|0.109|0.067|0.162
Observed|Gallbladder cancer|2015–2019|Females|4|85+|0.06|0.037|0.09
Observed|Gallbladder cancer|2015–2019|Females|4|All ages combined|0.194|0.172|0.217
Observed|Gallbladder cancer|2015–2019|Females|5|00–04|||
Observed|Gallbladder cancer|2015–2019|Females|5|05–09|||
Observed|Gallbladder cancer|2015–2019|Females|5|10–14|||
Observed|Gallbladder cancer|2015–2019|Females|5|15–19|||
Observed|Gallbladder cancer|2015–2019|Females|5|20–24|||
Observed|Gallbladder cancer|2015–2019|Females|5|25–29|||
Observed|Gallbladder cancer|2015–2019|Females|5|30–34|||
Observed|Gallbladder cancer|2015–2019|Females|5|35–39|||
Observed|Gallbladder cancer|2015–2019|Females|5|40–44|||
Observed|Gallbladder cancer|2015–2019|Females|5|45–49|||
Observed|Gallbladder cancer|2015–2019|Females|5|50–54|||
Observed|Gallbladder cancer|2015–2019|Females|5|55–59|0.355|0.246|0.466
Observed|Gallbladder cancer|2015–2019|Females|5|60–64|0.259|0.183|0.342
Observed|Gallbladder cancer|2015–2019|Females|5|65–69|0.192|0.136|0.256
Observed|Gallbladder cancer|2015–2019|Females|5|70–74|0.167|0.115|0.227
Observed|Gallbladder cancer|2015–2019|Females|5|75–79|0.146|0.096|0.206
Observed|Gallbladder cancer|2015–2019|Females|5|80–84|0.091|0.053|0.141
Observed|Gallbladder cancer|2015–2019|Females|5|85+|0.056|0.034|0.086
Observed|Gallbladder cancer|2015–2019|Females|5|All ages combined|0.174|0.153|0.196
Relative|Gallbladder cancer|2015–2019|Females|1|00–04|||
Relative|Gallbladder cancer|2015–2019|Females|1|05–09|||
Relative|Gallbladder cancer|2015–2019|Females|1|10–14|||
Relative|Gallbladder cancer|2015–2019|Females|1|15–19|||
Relative|Gallbladder cancer|2015–2019|Females|1|20–24|||
Relative|Gallbladder cancer|2015–2019|Females|1|25–29|||
Relative|Gallbladder cancer|2015–2019|Females|1|30–34|||
Relative|Gallbladder cancer|2015–2019|Females|1|35–39|||
Relative|Gallbladder cancer|2015–2019|Females|1|40–44|||
Relative|Gallbladder cancer|2015–2019|Females|1|45–49|0.565|0.374|0.718
Relative|Gallbladder cancer|2015–2019|Females|1|50–54|0.641|0.484|0.762
Relative|Gallbladder cancer|2015–2019|Females|1|55–59|0.604|0.485|0.703
Relative|Gallbladder cancer|2015–2019|Females|1|60–64|0.462|0.369|0.55
Relative|Gallbladder cancer|2015–2019|Females|1|65–69|0.536|0.458|0.608
Relative|Gallbladder cancer|2015–2019|Females|1|70–74|0.428|0.353|0.5
Relative|Gallbladder cancer|2015–2019|Females|1|75–79|0.44|0.363|0.515
Relative|Gallbladder cancer|2015–2019|Females|1|80–84|0.306|0.235|0.379
Relative|Gallbladder cancer|2015–2019|Females|1|85+|0.223|0.171|0.28
Relative|Gallbladder cancer|2015–2019|Females|1|All ages combined|0.423|0.394|0.451
Relative|Gallbladder cancer|2015–2019|Females|2|00–04|||
Relative|Gallbladder cancer|2015–2019|Females|2|05–09|||
Relative|Gallbladder cancer|2015–2019|Females|2|10–14|||
Relative|Gallbladder cancer|2015–2019|Females|2|15–19|||
Relative|Gallbladder cancer|2015–2019|Females|2|20–24|||
Relative|Gallbladder cancer|2015–2019|Females|2|25–29|||
Relative|Gallbladder cancer|2015–2019|Females|2|30–34|||
Relative|Gallbladder cancer|2015–2019|Females|2|35–39|||
Relative|Gallbladder cancer|2015–2019|Females|2|40–44|||
Relative|Gallbladder cancer|2015–2019|Females|2|45–49|||
Relative|Gallbladder cancer|2015–2019|Females|2|50–54|0.576|0.419|0.705
Relative|Gallbladder cancer|2015–2019|Females|2|55–59|0.457|0.342|0.564
Relative|Gallbladder cancer|2015–2019|Females|2|60–64|0.337|0.253|0.423
Relative|Gallbladder cancer|2015–2019|Females|2|65–69|0.373|0.3|0.447
Relative|Gallbladder cancer|2015–2019|Females|2|70–74|0.303|0.236|0.373
Relative|Gallbladder cancer|2015–2019|Females|2|75–79|0.278|0.211|0.349
Relative|Gallbladder cancer|2015–2019|Females|2|80–84|0.207|0.146|0.276
Relative|Gallbladder cancer|2015–2019|Females|2|85+|0.156|0.112|0.208
Relative|Gallbladder cancer|2015–2019|Females|2|All ages combined|0.301|0.274|0.328
Relative|Gallbladder cancer|2015–2019|Females|3|00–04|||
Relative|Gallbladder cancer|2015–2019|Females|3|05–09|||
Relative|Gallbladder cancer|2015–2019|Females|3|10–14|||
Relative|Gallbladder cancer|2015–2019|Females|3|15–19|||
Relative|Gallbladder cancer|2015–2019|Females|3|20–24|||
Relative|Gallbladder cancer|2015–2019|Females|3|25–29|||
Relative|Gallbladder cancer|2015–2019|Females|3|30–34|||
Relative|Gallbladder cancer|2015–2019|Females|3|35–39|||
Relative|Gallbladder cancer|2015–2019|Females|3|40–44|||
Relative|Gallbladder cancer|2015–2019|Females|3|45–49|||
Relative|Gallbladder cancer|2015–2019|Females|3|50–54|0.552|0.394|0.684
Relative|Gallbladder cancer|2015–2019|Females|3|55–59|0.394|0.281|0.505
Relative|Gallbladder cancer|2015–2019|Females|3|60–64|0.305|0.224|0.39
Relative|Gallbladder cancer|2015–2019|Females|3|65–69|0.28|0.213|0.351
Relative|Gallbladder cancer|2015–2019|Females|3|70–74|0.235|0.174|0.302
Relative|Gallbladder cancer|2015–2019|Females|3|75–79|0.24|0.176|0.31
Relative|Gallbladder cancer|2015–2019|Females|3|80–84|0.163|0.108|0.23
Relative|Gallbladder cancer|2015–2019|Females|3|85+|0.115|0.077|0.164
Relative|Gallbladder cancer|2015–2019|Females|3|All ages combined|0.248|0.223|0.274
Relative|Gallbladder cancer|2015–2019|Females|4|00–04|||
Relative|Gallbladder cancer|2015–2019|Females|4|05–09|||
Relative|Gallbladder cancer|2015–2019|Females|4|10–14|||
Relative|Gallbladder cancer|2015–2019|Females|4|15–19|||
Relative|Gallbladder cancer|2015–2019|Females|4|20–24|||
Relative|Gallbladder cancer|2015–2019|Females|4|25–29|||
Relative|Gallbladder cancer|2015–2019|Females|4|30–34|||
Relative|Gallbladder cancer|2015–2019|Females|4|35–39|||
Relative|Gallbladder cancer|2015–2019|Females|4|40–44|||
Relative|Gallbladder cancer|2015–2019|Females|4|45–49|||
Relative|Gallbladder cancer|2015–2019|Females|4|50–54|||
Relative|Gallbladder cancer|2015–2019|Females|4|55–59|0.361|0.249|0.473
Relative|Gallbladder cancer|2015–2019|Females|4|60–64|0.298|0.217|0.383
Relative|Gallbladder cancer|2015–2019|Females|4|65–69|0.227|0.166|0.295
Relative|Gallbladder cancer|2015–2019|Females|4|70–74|0.197|0.14|0.263
Relative|Gallbladder cancer|2015–2019|Females|4|75–79|0.213|0.151|0.283
Relative|Gallbladder cancer|2015–2019|Females|4|80–84|0.136|0.084|0.202
Relative|Gallbladder cancer|2015–2019|Females|4|85+|0.101|0.063|0.151
Relative|Gallbladder cancer|2015–2019|Females|4|All ages combined|0.218|0.194|0.244
Relative|Gallbladder cancer|2015–2019|Females|5|00–04|||
Relative|Gallbladder cancer|2015–2019|Females|5|05–09|||
Relative|Gallbladder cancer|2015–2019|Females|5|10–14|||
Relative|Gallbladder cancer|2015–2019|Females|5|15–19|||
Relative|Gallbladder cancer|2015–2019|Females|5|20–24|||
Relative|Gallbladder cancer|2015–2019|Females|5|25–29|||
Relative|Gallbladder cancer|2015–2019|Females|5|30–34|||
Relative|Gallbladder cancer|2015–2019|Females|5|35–39|||
Relative|Gallbladder cancer|2015–2019|Females|5|40–44|||
Relative|Gallbladder cancer|2015–2019|Females|5|45–49|||
Relative|Gallbladder cancer|2015–2019|Females|5|50–54|||
Relative|Gallbladder cancer|2015–2019|Females|5|55–59|0.362|0.251|0.475
Relative|Gallbladder cancer|2015–2019|Females|5|60–64|0.266|0.188|0.352
Relative|Gallbladder cancer|2015–2019|Females|5|65–69|0.201|0.142|0.268
Relative|Gallbladder cancer|2015–2019|Females|5|70–74|0.18|0.124|0.245
Relative|Gallbladder cancer|2015–2019|Females|5|75–79|0.169|0.111|0.238
Relative|Gallbladder cancer|2015–2019|Females|5|80–84|0.122|0.071|0.189
Relative|Gallbladder cancer|2015–2019|Females|5|85+|0.113|0.069|0.172
Relative|Gallbladder cancer|2015–2019|Females|5|All ages combined|0.201|0.177|0.227
Observed|Gallbladder cancer|2015–2019|Persons|1|00–04|||
Observed|Gallbladder cancer|2015–2019|Persons|1|05–09|||
Observed|Gallbladder cancer|2015–2019|Persons|1|10–14|||
Observed|Gallbladder cancer|2015–2019|Persons|1|15–19|||
Observed|Gallbladder cancer|2015–2019|Persons|1|20–24|||
Observed|Gallbladder cancer|2015–2019|Persons|1|25–29|||
Observed|Gallbladder cancer|2015–2019|Persons|1|30–34|||
Observed|Gallbladder cancer|2015–2019|Persons|1|35–39|||
Observed|Gallbladder cancer|2015–2019|Persons|1|40–44|||
Observed|Gallbladder cancer|2015–2019|Persons|1|45–49|0.52|0.363|0.656
Observed|Gallbladder cancer|2015–2019|Persons|1|50–54|0.625|0.496|0.73
Observed|Gallbladder cancer|2015–2019|Persons|1|55–59|0.568|0.473|0.652
Observed|Gallbladder cancer|2015–2019|Persons|1|60–64|0.479|0.404|0.551
Observed|Gallbladder cancer|2015–2019|Persons|1|65–69|0.506|0.445|0.564
Observed|Gallbladder cancer|2015–2019|Persons|1|70–74|0.437|0.378|0.495
Observed|Gallbladder cancer|2015–2019|Persons|1|75–79|0.382|0.325|0.439
Observed|Gallbladder cancer|2015–2019|Persons|1|80–84|0.307|0.253|0.363
Observed|Gallbladder cancer|2015–2019|Persons|1|85+|0.202|0.161|0.247
Observed|Gallbladder cancer|2015–2019|Persons|1|All ages combined|0.408|0.385|0.43
Observed|Gallbladder cancer|2015–2019|Persons|2|00–04|||
Observed|Gallbladder cancer|2015–2019|Persons|2|05–09|||
Observed|Gallbladder cancer|2015–2019|Persons|2|10–14|||
Observed|Gallbladder cancer|2015–2019|Persons|2|15–19|||
Observed|Gallbladder cancer|2015–2019|Persons|2|20–24|||
Observed|Gallbladder cancer|2015–2019|Persons|2|25–29|||
Observed|Gallbladder cancer|2015–2019|Persons|2|30–34|||
Observed|Gallbladder cancer|2015–2019|Persons|2|35–39|||
Observed|Gallbladder cancer|2015–2019|Persons|2|40–44|||
Observed|Gallbladder cancer|2015–2019|Persons|2|45–49|||
Observed|Gallbladder cancer|2015–2019|Persons|2|50–54|0.513|0.385|0.627
Observed|Gallbladder cancer|2015–2019|Persons|2|55–59|0.403|0.314|0.491
Observed|Gallbladder cancer|2015–2019|Persons|2|60–64|0.331|0.263|0.4
Observed|Gallbladder cancer|2015–2019|Persons|2|65–69|0.355|0.298|0.412
Observed|Gallbladder cancer|2015–2019|Persons|2|70–74|0.296|0.243|0.35
Observed|Gallbladder cancer|2015–2019|Persons|2|75–79|0.234|0.186|0.284
Observed|Gallbladder cancer|2015–2019|Persons|2|80–84|0.206|0.16|0.257
Observed|Gallbladder cancer|2015–2019|Persons|2|85+|0.128|0.096|0.164
Observed|Gallbladder cancer|2015–2019|Persons|2|All ages combined|0.279|0.259|0.3
Observed|Gallbladder cancer|2015–2019|Persons|3|00–04|||
Observed|Gallbladder cancer|2015–2019|Persons|3|05–09|||
Observed|Gallbladder cancer|2015–2019|Persons|3|10–14|||
Observed|Gallbladder cancer|2015–2019|Persons|3|15–19|||
Observed|Gallbladder cancer|2015–2019|Persons|3|20–24|||
Observed|Gallbladder cancer|2015–2019|Persons|3|25–29|||
Observed|Gallbladder cancer|2015–2019|Persons|3|30–34|||
Observed|Gallbladder cancer|2015–2019|Persons|3|35–39|||
Observed|Gallbladder cancer|2015–2019|Persons|3|40–44|||
Observed|Gallbladder cancer|2015–2019|Persons|3|45–49|||
Observed|Gallbladder cancer|2015–2019|Persons|3|50–54|0.477|0.35|0.593
Observed|Gallbladder cancer|2015–2019|Persons|3|55–59|0.363|0.276|0.451
Observed|Gallbladder cancer|2015–2019|Persons|3|60–64|0.288|0.223|0.355
Observed|Gallbladder cancer|2015–2019|Persons|3|65–69|0.258|0.207|0.313
Observed|Gallbladder cancer|2015–2019|Persons|3|70–74|0.234|0.186|0.285
Observed|Gallbladder cancer|2015–2019|Persons|3|75–79|0.197|0.153|0.246
Observed|Gallbladder cancer|2015–2019|Persons|3|80–84|0.132|0.094|0.175
Observed|Gallbladder cancer|2015–2019|Persons|3|85+|0.079|0.055|0.108
Observed|Gallbladder cancer|2015–2019|Persons|3|All ages combined|0.219|0.201|0.238
Observed|Gallbladder cancer|2015–2019|Persons|4|00–04|||
Observed|Gallbladder cancer|2015–2019|Persons|4|05–09|||
Observed|Gallbladder cancer|2015–2019|Persons|4|10–14|||
Observed|Gallbladder cancer|2015–2019|Persons|4|15–19|||
Observed|Gallbladder cancer|2015–2019|Persons|4|20–24|||
Observed|Gallbladder cancer|2015–2019|Persons|4|25–29|||
Observed|Gallbladder cancer|2015–2019|Persons|4|30–34|||
Observed|Gallbladder cancer|2015–2019|Persons|4|35–39|||
Observed|Gallbladder cancer|2015–2019|Persons|4|40–44|||
Observed|Gallbladder cancer|2015–2019|Persons|4|45–49|||
Observed|Gallbladder cancer|2015–2019|Persons|4|50–54|0.435|0.308|0.555
Observed|Gallbladder cancer|2015–2019|Persons|4|55–59|0.331|0.245|0.419
Observed|Gallbladder cancer|2015–2019|Persons|4|60–64|0.259|0.197|0.325
Observed|Gallbladder cancer|2015–2019|Persons|4|65–69|0.207|0.16|0.258
Observed|Gallbladder cancer|2015–2019|Persons|4|70–74|0.198|0.153|0.247
Observed|Gallbladder cancer|2015–2019|Persons|4|75–79|0.162|0.121|0.208
Observed|Gallbladder cancer|2015–2019|Persons|4|80–84|0.113|0.078|0.154
Observed|Gallbladder cancer|2015–2019|Persons|4|85+|0.052|0.033|0.076
Observed|Gallbladder cancer|2015–2019|Persons|4|All ages combined|0.184|0.166|0.202
Observed|Gallbladder cancer|2015–2019|Persons|5|00–04|||
Observed|Gallbladder cancer|2015–2019|Persons|5|05–09|||
Observed|Gallbladder cancer|2015–2019|Persons|5|10–14|||
Observed|Gallbladder cancer|2015–2019|Persons|5|15–19|||
Observed|Gallbladder cancer|2015–2019|Persons|5|20–24|||
Observed|Gallbladder cancer|2015–2019|Persons|5|25–29|||
Observed|Gallbladder cancer|2015–2019|Persons|5|30–34|||
Observed|Gallbladder cancer|2015–2019|Persons|5|35–39|||
Observed|Gallbladder cancer|2015–2019|Persons|5|40–44|||
Observed|Gallbladder cancer|2015–2019|Persons|5|45–49|||
Observed|Gallbladder cancer|2015–2019|Persons|5|50–54|||
Observed|Gallbladder cancer|2015–2019|Persons|5|55–59|0.331|0.245|0.419
Observed|Gallbladder cancer|2015–2019|Persons|5|60–64|0.234|0.174|0.299
Observed|Gallbladder cancer|2015–2019|Persons|5|65–69|0.177|0.133|0.226
Observed|Gallbladder cancer|2015–2019|Persons|5|70–74|0.174|0.131|0.221
Observed|Gallbladder cancer|2015–2019|Persons|5|75–79|0.13|0.092|0.174
Observed|Gallbladder cancer|2015–2019|Persons|5|80–84|0.095|0.063|0.133
Observed|Gallbladder cancer|2015–2019|Persons|5|85+|0.049|0.031|0.073
Observed|Gallbladder cancer|2015–2019|Persons|5|All ages combined|0.164|0.147|0.181
Relative|Gallbladder cancer|2015–2019|Persons|1|00–04|||
Relative|Gallbladder cancer|2015–2019|Persons|1|05–09|||
Relative|Gallbladder cancer|2015–2019|Persons|1|10–14|||
Relative|Gallbladder cancer|2015–2019|Persons|1|15–19|||
Relative|Gallbladder cancer|2015–2019|Persons|1|20–24|||
Relative|Gallbladder cancer|2015–2019|Persons|1|25–29|||
Relative|Gallbladder cancer|2015–2019|Persons|1|30–34|||
Relative|Gallbladder cancer|2015–2019|Persons|1|35–39|||
Relative|Gallbladder cancer|2015–2019|Persons|1|40–44|||
Relative|Gallbladder cancer|2015–2019|Persons|1|45–49|0.521|0.363|0.657
Relative|Gallbladder cancer|2015–2019|Persons|1|50–54|0.627|0.498|0.732
Relative|Gallbladder cancer|2015–2019|Persons|1|55–59|0.57|0.475|0.655
Relative|Gallbladder cancer|2015–2019|Persons|1|60–64|0.482|0.406|0.554
Relative|Gallbladder cancer|2015–2019|Persons|1|65–69|0.51|0.449|0.569
Relative|Gallbladder cancer|2015–2019|Persons|1|70–74|0.444|0.383|0.503
Relative|Gallbladder cancer|2015–2019|Persons|1|75–79|0.392|0.334|0.45
Relative|Gallbladder cancer|2015–2019|Persons|1|80–84|0.323|0.266|0.382
Relative|Gallbladder cancer|2015–2019|Persons|1|85+|0.228|0.181|0.279
Relative|Gallbladder cancer|2015–2019|Persons|1|All ages combined|0.421|0.398|0.445
Relative|Gallbladder cancer|2015–2019|Persons|2|00–04|||
Relative|Gallbladder cancer|2015–2019|Persons|2|05–09|||
Relative|Gallbladder cancer|2015–2019|Persons|2|10–14|||
Relative|Gallbladder cancer|2015–2019|Persons|2|15–19|||
Relative|Gallbladder cancer|2015–2019|Persons|2|20–24|||
Relative|Gallbladder cancer|2015–2019|Persons|2|25–29|||
Relative|Gallbladder cancer|2015–2019|Persons|2|30–34|||
Relative|Gallbladder cancer|2015–2019|Persons|2|35–39|||
Relative|Gallbladder cancer|2015–2019|Persons|2|40–44|||
Relative|Gallbladder cancer|2015–2019|Persons|2|45–49|||
Relative|Gallbladder cancer|2015–2019|Persons|2|50–54|0.515|0.387|0.63
Relative|Gallbladder cancer|2015–2019|Persons|2|55–59|0.406|0.316|0.495
Relative|Gallbladder cancer|2015–2019|Persons|2|60–64|0.335|0.266|0.405
Relative|Gallbladder cancer|2015–2019|Persons|2|65–69|0.362|0.303|0.42
Relative|Gallbladder cancer|2015–2019|Persons|2|70–74|0.305|0.251|0.361
Relative|Gallbladder cancer|2015–2019|Persons|2|75–79|0.247|0.197|0.301
Relative|Gallbladder cancer|2015–2019|Persons|2|80–84|0.229|0.178|0.286
Relative|Gallbladder cancer|2015–2019|Persons|2|85+|0.162|0.122|0.209
Relative|Gallbladder cancer|2015–2019|Persons|2|All ages combined|0.297|0.275|0.318
Relative|Gallbladder cancer|2015–2019|Persons|3|00–04|||
Relative|Gallbladder cancer|2015–2019|Persons|3|05–09|||
Relative|Gallbladder cancer|2015–2019|Persons|3|10–14|||
Relative|Gallbladder cancer|2015–2019|Persons|3|15–19|||
Relative|Gallbladder cancer|2015–2019|Persons|3|20–24|||
Relative|Gallbladder cancer|2015–2019|Persons|3|25–29|||
Relative|Gallbladder cancer|2015–2019|Persons|3|30–34|||
Relative|Gallbladder cancer|2015–2019|Persons|3|35–39|||
Relative|Gallbladder cancer|2015–2019|Persons|3|40–44|||
Relative|Gallbladder cancer|2015–2019|Persons|3|45–49|||
Relative|Gallbladder cancer|2015–2019|Persons|3|50–54|0.481|0.353|0.598
Relative|Gallbladder cancer|2015–2019|Persons|3|55–59|0.368|0.28|0.457
Relative|Gallbladder cancer|2015–2019|Persons|3|60–64|0.293|0.228|0.362
Relative|Gallbladder cancer|2015–2019|Persons|3|65–69|0.266|0.213|0.322
Relative|Gallbladder cancer|2015–2019|Persons|3|70–74|0.246|0.196|0.3
Relative|Gallbladder cancer|2015–2019|Persons|3|75–79|0.215|0.167|0.268
Relative|Gallbladder cancer|2015–2019|Persons|3|80–84|0.157|0.112|0.208
Relative|Gallbladder cancer|2015–2019|Persons|3|85+|0.115|0.08|0.158
Relative|Gallbladder cancer|2015–2019|Persons|3|All ages combined|0.241|0.22|0.262
Relative|Gallbladder cancer|2015–2019|Persons|4|00–04|||
Relative|Gallbladder cancer|2015–2019|Persons|4|05–09|||
Relative|Gallbladder cancer|2015–2019|Persons|4|10–14|||
Relative|Gallbladder cancer|2015–2019|Persons|4|15–19|||
Relative|Gallbladder cancer|2015–2019|Persons|4|20–24|||
Relative|Gallbladder cancer|2015–2019|Persons|4|25–29|||
Relative|Gallbladder cancer|2015–2019|Persons|4|30–34|||
Relative|Gallbladder cancer|2015–2019|Persons|4|35–39|||
Relative|Gallbladder cancer|2015–2019|Persons|4|40–44|||
Relative|Gallbladder cancer|2015–2019|Persons|4|45–49|||
Relative|Gallbladder cancer|2015–2019|Persons|4|50–54|0.44|0.311|0.561
Relative|Gallbladder cancer|2015–2019|Persons|4|55–59|0.337|0.25|0.427
Relative|Gallbladder cancer|2015–2019|Persons|4|60–64|0.266|0.203|0.334
Relative|Gallbladder cancer|2015–2019|Persons|4|65–69|0.216|0.167|0.269
Relative|Gallbladder cancer|2015–2019|Persons|4|70–74|0.213|0.164|0.265
Relative|Gallbladder cancer|2015–2019|Persons|4|75–79|0.183|0.137|0.235
Relative|Gallbladder cancer|2015–2019|Persons|4|80–84|0.145|0.1|0.198
Relative|Gallbladder cancer|2015–2019|Persons|4|85+|0.089|0.057|0.13
Relative|Gallbladder cancer|2015–2019|Persons|4|All ages combined|0.208|0.188|0.229
Relative|Gallbladder cancer|2015–2019|Persons|5|00–04|||
Relative|Gallbladder cancer|2015–2019|Persons|5|05–09|||
Relative|Gallbladder cancer|2015–2019|Persons|5|10–14|||
Relative|Gallbladder cancer|2015–2019|Persons|5|15–19|||
Relative|Gallbladder cancer|2015–2019|Persons|5|20–24|||
Relative|Gallbladder cancer|2015–2019|Persons|5|25–29|||
Relative|Gallbladder cancer|2015–2019|Persons|5|30–34|||
Relative|Gallbladder cancer|2015–2019|Persons|5|35–39|||
Relative|Gallbladder cancer|2015–2019|Persons|5|40–44|||
Relative|Gallbladder cancer|2015–2019|Persons|5|45–49|||
Relative|Gallbladder cancer|2015–2019|Persons|5|50–54|||
Relative|Gallbladder cancer|2015–2019|Persons|5|55–59|0.339|0.251|0.429
Relative|Gallbladder cancer|2015–2019|Persons|5|60–64|0.242|0.181|0.309
Relative|Gallbladder cancer|2015–2019|Persons|5|65–69|0.187|0.14|0.239
Relative|Gallbladder cancer|2015–2019|Persons|5|70–74|0.191|0.144|0.244
Relative|Gallbladder cancer|2015–2019|Persons|5|75–79|0.153|0.109|0.205
Relative|Gallbladder cancer|2015–2019|Persons|5|80–84|0.133|0.089|0.187
Relative|Gallbladder cancer|2015–2019|Persons|5|85+|0.1|0.063|0.15
Relative|Gallbladder cancer|2015–2019|Persons|5|All ages combined|0.191|0.172|0.212
Observed|Gynaecological cancers|2015–2019|Females|1|00–04|||
Observed|Gynaecological cancers|2015–2019|Females|1|05–09|||
Observed|Gynaecological cancers|2015–2019|Females|1|10–14|1|0.891|1
Observed|Gynaecological cancers|2015–2019|Females|1|15–19|0.94|0.825|0.98
Observed|Gynaecological cancers|2015–2019|Females|1|20–24|0.956|0.905|0.98
Observed|Gynaecological cancers|2015–2019|Females|1|25–29|0.981|0.962|0.99
Observed|Gynaecological cancers|2015–2019|Females|1|30–34|0.977|0.965|0.985
Observed|Gynaecological cancers|2015–2019|Females|1|35–39|0.963|0.95|0.973
Observed|Gynaecological cancers|2015–2019|Females|1|40–44|0.951|0.939|0.962
Observed|Gynaecological cancers|2015–2019|Females|1|45–49|0.947|0.936|0.956
Observed|Gynaecological cancers|2015–2019|Females|1|50–54|0.932|0.921|0.941
Observed|Gynaecological cancers|2015–2019|Females|1|55–59|0.935|0.926|0.943
Observed|Gynaecological cancers|2015–2019|Females|1|60–64|0.922|0.913|0.93
Observed|Gynaecological cancers|2015–2019|Females|1|65–69|0.908|0.899|0.916
Observed|Gynaecological cancers|2015–2019|Females|1|70–74|0.871|0.86|0.882
Observed|Gynaecological cancers|2015–2019|Females|1|75–79|0.807|0.792|0.822
Observed|Gynaecological cancers|2015–2019|Females|1|80–84|0.694|0.672|0.714
Observed|Gynaecological cancers|2015–2019|Females|1|85+|0.49|0.467|0.512
Observed|Gynaecological cancers|2015–2019|Females|1|All ages combined|0.872|0.868|0.876
Observed|Gynaecological cancers|2015–2019|Females|2|00–04|||
Observed|Gynaecological cancers|2015–2019|Females|2|05–09|||
Observed|Gynaecological cancers|2015–2019|Females|2|10–14|1|0.904|1
Observed|Gynaecological cancers|2015–2019|Females|2|15–19|0.94|0.825|0.98
Observed|Gynaecological cancers|2015–2019|Females|2|20–24|0.942|0.888|0.971
Observed|Gynaecological cancers|2015–2019|Females|2|25–29|0.938|0.911|0.957
Observed|Gynaecological cancers|2015–2019|Females|2|30–34|0.937|0.918|0.951
Observed|Gynaecological cancers|2015–2019|Females|2|35–39|0.934|0.917|0.947
Observed|Gynaecological cancers|2015–2019|Females|2|40–44|0.897|0.879|0.912
Observed|Gynaecological cancers|2015–2019|Females|2|45–49|0.902|0.887|0.915
Observed|Gynaecological cancers|2015–2019|Females|2|50–54|0.882|0.868|0.894
Observed|Gynaecological cancers|2015–2019|Females|2|55–59|0.875|0.864|0.886
Observed|Gynaecological cancers|2015–2019|Females|2|60–64|0.861|0.849|0.871
Observed|Gynaecological cancers|2015–2019|Females|2|65–69|0.829|0.817|0.84
Observed|Gynaecological cancers|2015–2019|Females|2|70–74|0.77|0.755|0.784
Observed|Gynaecological cancers|2015–2019|Females|2|75–79|0.683|0.664|0.701
Observed|Gynaecological cancers|2015–2019|Females|2|80–84|0.558|0.535|0.581
Observed|Gynaecological cancers|2015–2019|Females|2|85+|0.342|0.321|0.363
Observed|Gynaecological cancers|2015–2019|Females|2|All ages combined|0.792|0.787|0.796
Observed|Gynaecological cancers|2015–2019|Females|3|00–04|||
Observed|Gynaecological cancers|2015–2019|Females|3|05–09|||
Observed|Gynaecological cancers|2015–2019|Females|3|10–14|1|0.907|1
Observed|Gynaecological cancers|2015–2019|Females|3|15–19|0.94|0.825|0.98
Observed|Gynaecological cancers|2015–2019|Females|3|20–24|0.91|0.851|0.947
Observed|Gynaecological cancers|2015–2019|Females|3|25–29|0.924|0.895|0.945
Observed|Gynaecological cancers|2015–2019|Females|3|30–34|0.918|0.898|0.935
Observed|Gynaecological cancers|2015–2019|Females|3|35–39|0.914|0.895|0.93
Observed|Gynaecological cancers|2015–2019|Females|3|40–44|0.862|0.842|0.879
Observed|Gynaecological cancers|2015–2019|Females|3|45–49|0.857|0.84|0.873
Observed|Gynaecological cancers|2015–2019|Females|3|50–54|0.844|0.829|0.858
Observed|Gynaecological cancers|2015–2019|Females|3|55–59|0.824|0.811|0.837
Observed|Gynaecological cancers|2015–2019|Females|3|60–64|0.807|0.794|0.82
Observed|Gynaecological cancers|2015–2019|Females|3|65–69|0.767|0.754|0.78
Observed|Gynaecological cancers|2015–2019|Females|3|70–74|0.697|0.681|0.713
Observed|Gynaecological cancers|2015–2019|Females|3|75–79|0.603|0.583|0.622
Observed|Gynaecological cancers|2015–2019|Females|3|80–84|0.463|0.44|0.486
Observed|Gynaecological cancers|2015–2019|Females|3|85+|0.263|0.244|0.283
Observed|Gynaecological cancers|2015–2019|Females|3|All ages combined|0.734|0.729|0.739
Observed|Gynaecological cancers|2015–2019|Females|4|00–04|||
Observed|Gynaecological cancers|2015–2019|Females|4|05–09|||
Observed|Gynaecological cancers|2015–2019|Females|4|10–14|1|0.905|1
Observed|Gynaecological cancers|2015–2019|Females|4|15–19|0.918|0.795|0.968
Observed|Gynaecological cancers|2015–2019|Females|4|20–24|0.904|0.844|0.942
Observed|Gynaecological cancers|2015–2019|Females|4|25–29|0.916|0.886|0.938
Observed|Gynaecological cancers|2015–2019|Females|4|30–34|0.9|0.877|0.918
Observed|Gynaecological cancers|2015–2019|Females|4|35–39|0.892|0.871|0.909
Observed|Gynaecological cancers|2015–2019|Females|4|40–44|0.839|0.818|0.858
Observed|Gynaecological cancers|2015–2019|Females|4|45–49|0.814|0.795|0.832
Observed|Gynaecological cancers|2015–2019|Females|4|50–54|0.808|0.791|0.823
Observed|Gynaecological cancers|2015–2019|Females|4|55–59|0.789|0.774|0.803
Observed|Gynaecological cancers|2015–2019|Females|4|60–64|0.766|0.752|0.78
Observed|Gynaecological cancers|2015–2019|Females|4|65–69|0.716|0.702|0.73
Observed|Gynaecological cancers|2015–2019|Females|4|70–74|0.64|0.622|0.656
Observed|Gynaecological cancers|2015–2019|Females|4|75–79|0.53|0.51|0.55
Observed|Gynaecological cancers|2015–2019|Females|4|80–84|0.407|0.384|0.429
Observed|Gynaecological cancers|2015–2019|Females|4|85+|0.213|0.195|0.231
Observed|Gynaecological cancers|2015–2019|Females|4|All ages combined|0.69|0.684|0.695
Observed|Gynaecological cancers|2015–2019|Females|5|00–04|||
Observed|Gynaecological cancers|2015–2019|Females|5|05–09|||
Observed|Gynaecological cancers|2015–2019|Females|5|10–14|1|0.906|1
Observed|Gynaecological cancers|2015–2019|Females|5|15–19|0.918|0.795|0.968
Observed|Gynaecological cancers|2015–2019|Females|5|20–24|0.898|0.837|0.938
Observed|Gynaecological cancers|2015–2019|Females|5|25–29|0.914|0.884|0.936
Observed|Gynaecological cancers|2015–2019|Females|5|30–34|0.893|0.87|0.912
Observed|Gynaecological cancers|2015–2019|Females|5|35–39|0.878|0.856|0.897
Observed|Gynaecological cancers|2015–2019|Females|5|40–44|0.827|0.805|0.846
Observed|Gynaecological cancers|2015–2019|Females|5|45–49|0.792|0.772|0.81
Observed|Gynaecological cancers|2015–2019|Females|5|50–54|0.789|0.772|0.805
Observed|Gynaecological cancers|2015–2019|Females|5|55–59|0.763|0.748|0.778
Observed|Gynaecological cancers|2015–2019|Females|5|60–64|0.739|0.724|0.753
Observed|Gynaecological cancers|2015–2019|Females|5|65–69|0.677|0.662|0.692
Observed|Gynaecological cancers|2015–2019|Females|5|70–74|0.599|0.581|0.616
Observed|Gynaecological cancers|2015–2019|Females|5|75–79|0.487|0.467|0.507
Observed|Gynaecological cancers|2015–2019|Females|5|80–84|0.354|0.332|0.376
Observed|Gynaecological cancers|2015–2019|Females|5|85+|0.173|0.156|0.19
Observed|Gynaecological cancers|2015–2019|Females|5|All ages combined|0.659|0.654|0.665
Relative|Gynaecological cancers|2015–2019|Females|1|00–04|||
Relative|Gynaecological cancers|2015–2019|Females|1|05–09|||
Relative|Gynaecological cancers|2015–2019|Females|1|10–14|1|0.891|1
Relative|Gynaecological cancers|2015–2019|Females|1|15–19|0.94|0.826|0.98
Relative|Gynaecological cancers|2015–2019|Females|1|20–24|0.956|0.905|0.98
Relative|Gynaecological cancers|2015–2019|Females|1|25–29|0.981|0.962|0.991
Relative|Gynaecological cancers|2015–2019|Females|1|30–34|0.977|0.965|0.985
Relative|Gynaecological cancers|2015–2019|Females|1|35–39|0.964|0.951|0.974
Relative|Gynaecological cancers|2015–2019|Females|1|40–44|0.952|0.939|0.963
Relative|Gynaecological cancers|2015–2019|Females|1|45–49|0.949|0.937|0.958
Relative|Gynaecological cancers|2015–2019|Females|1|50–54|0.934|0.923|0.944
Relative|Gynaecological cancers|2015–2019|Females|1|55–59|0.938|0.929|0.946
Relative|Gynaecological cancers|2015–2019|Females|1|60–64|0.926|0.917|0.934
Relative|Gynaecological cancers|2015–2019|Females|1|65–69|0.914|0.905|0.923
Relative|Gynaecological cancers|2015–2019|Females|1|70–74|0.882|0.87|0.893
Relative|Gynaecological cancers|2015–2019|Females|1|75–79|0.825|0.809|0.84
Relative|Gynaecological cancers|2015–2019|Females|1|80–84|0.723|0.7|0.744
Relative|Gynaecological cancers|2015–2019|Females|1|85+|0.549|0.523|0.574
Relative|Gynaecological cancers|2015–2019|Females|1|All ages combined|0.885|0.881|0.889
Relative|Gynaecological cancers|2015–2019|Females|2|00–04|||
Relative|Gynaecological cancers|2015–2019|Females|2|05–09|||
Relative|Gynaecological cancers|2015–2019|Females|2|10–14|1|0.904|1
Relative|Gynaecological cancers|2015–2019|Females|2|15–19|0.94|0.826|0.981
Relative|Gynaecological cancers|2015–2019|Females|2|20–24|0.943|0.888|0.971
Relative|Gynaecological cancers|2015–2019|Females|2|25–29|0.939|0.912|0.958
Relative|Gynaecological cancers|2015–2019|Females|2|30–34|0.937|0.919|0.952
Relative|Gynaecological cancers|2015–2019|Females|2|35–39|0.935|0.918|0.948
Relative|Gynaecological cancers|2015–2019|Females|2|40–44|0.899|0.881|0.914
Relative|Gynaecological cancers|2015–2019|Females|2|45–49|0.904|0.89|0.917
Relative|Gynaecological cancers|2015–2019|Females|2|50–54|0.885|0.872|0.898
Relative|Gynaecological cancers|2015–2019|Females|2|55–59|0.881|0.869|0.892
Relative|Gynaecological cancers|2015–2019|Females|2|60–64|0.869|0.857|0.88
Relative|Gynaecological cancers|2015–2019|Females|2|65–69|0.842|0.829|0.853
Relative|Gynaecological cancers|2015–2019|Females|2|70–74|0.79|0.775|0.804
Relative|Gynaecological cancers|2015–2019|Females|2|75–79|0.715|0.696|0.734
Relative|Gynaecological cancers|2015–2019|Females|2|80–84|0.61|0.585|0.634
Relative|Gynaecological cancers|2015–2019|Females|2|85+|0.432|0.405|0.458
Relative|Gynaecological cancers|2015–2019|Females|2|All ages combined|0.814|0.809|0.819
Relative|Gynaecological cancers|2015–2019|Females|3|00–04|||
Relative|Gynaecological cancers|2015–2019|Females|3|05–09|||
Relative|Gynaecological cancers|2015–2019|Females|3|10–14|1|0.908|1
Relative|Gynaecological cancers|2015–2019|Females|3|15–19|0.941|0.826|0.981
Relative|Gynaecological cancers|2015–2019|Females|3|20–24|0.911|0.851|0.948
Relative|Gynaecological cancers|2015–2019|Females|3|25–29|0.925|0.896|0.946
Relative|Gynaecological cancers|2015–2019|Females|3|30–34|0.92|0.899|0.936
Relative|Gynaecological cancers|2015–2019|Females|3|35–39|0.916|0.897|0.931
Relative|Gynaecological cancers|2015–2019|Females|3|40–44|0.865|0.845|0.882
Relative|Gynaecological cancers|2015–2019|Females|3|45–49|0.861|0.844|0.877
Relative|Gynaecological cancers|2015–2019|Females|3|50–54|0.85|0.835|0.864
Relative|Gynaecological cancers|2015–2019|Females|3|55–59|0.833|0.819|0.846
Relative|Gynaecological cancers|2015–2019|Females|3|60–64|0.82|0.806|0.832
Relative|Gynaecological cancers|2015–2019|Females|3|65–69|0.786|0.772|0.799
Relative|Gynaecological cancers|2015–2019|Females|3|70–74|0.726|0.709|0.742
Relative|Gynaecological cancers|2015–2019|Females|3|75–79|0.648|0.627|0.669
Relative|Gynaecological cancers|2015–2019|Females|3|80–84|0.534|0.507|0.56
Relative|Gynaecological cancers|2015–2019|Females|3|85+|0.379|0.352|0.408
Relative|Gynaecological cancers|2015–2019|Females|3|All ages combined|0.765|0.759|0.77
Relative|Gynaecological cancers|2015–2019|Females|4|00–04|||
Relative|Gynaecological cancers|2015–2019|Females|4|05–09|||
Relative|Gynaecological cancers|2015–2019|Females|4|10–14|1.001|0.906|1.001
Relative|Gynaecological cancers|2015–2019|Females|4|15–19|0.918|0.796|0.969
Relative|Gynaecological cancers|2015–2019|Females|4|20–24|0.905|0.845|0.943
Relative|Gynaecological cancers|2015–2019|Females|4|25–29|0.917|0.887|0.939
Relative|Gynaecological cancers|2015–2019|Females|4|30–34|0.901|0.879|0.92
Relative|Gynaecological cancers|2015–2019|Females|4|35–39|0.894|0.873|0.912
Relative|Gynaecological cancers|2015–2019|Females|4|40–44|0.842|0.821|0.861
Relative|Gynaecological cancers|2015–2019|Females|4|45–49|0.82|0.8|0.837
Relative|Gynaecological cancers|2015–2019|Females|4|50–54|0.816|0.799|0.831
Relative|Gynaecological cancers|2015–2019|Females|4|55–59|0.8|0.785|0.814
Relative|Gynaecological cancers|2015–2019|Females|4|60–64|0.783|0.768|0.796
Relative|Gynaecological cancers|2015–2019|Females|4|65–69|0.741|0.726|0.755
Relative|Gynaecological cancers|2015–2019|Females|4|70–74|0.678|0.659|0.695
Relative|Gynaecological cancers|2015–2019|Females|4|75–79|0.589|0.566|0.611
Relative|Gynaecological cancers|2015–2019|Females|4|80–84|0.498|0.471|0.526
Relative|Gynaecological cancers|2015–2019|Females|4|85+|0.356|0.326|0.386
Relative|Gynaecological cancers|2015–2019|Females|4|All ages combined|0.728|0.722|0.734
Relative|Gynaecological cancers|2015–2019|Females|5|00–04|||
Relative|Gynaecological cancers|2015–2019|Females|5|05–09|||
Relative|Gynaecological cancers|2015–2019|Females|5|10–14|1.001|0.907|1.001
Relative|Gynaecological cancers|2015–2019|Females|5|15–19|0.919|0.796|0.969
Relative|Gynaecological cancers|2015–2019|Females|5|20–24|0.9|0.838|0.939
Relative|Gynaecological cancers|2015–2019|Females|5|25–29|0.915|0.885|0.938
Relative|Gynaecological cancers|2015–2019|Females|5|30–34|0.895|0.872|0.914
Relative|Gynaecological cancers|2015–2019|Females|5|35–39|0.881|0.859|0.9
Relative|Gynaecological cancers|2015–2019|Females|5|40–44|0.831|0.809|0.851
Relative|Gynaecological cancers|2015–2019|Females|5|45–49|0.799|0.778|0.817
Relative|Gynaecological cancers|2015–2019|Females|5|50–54|0.799|0.782|0.815
Relative|Gynaecological cancers|2015–2019|Females|5|55–59|0.778|0.762|0.792
Relative|Gynaecological cancers|2015–2019|Females|5|60–64|0.76|0.745|0.774
Relative|Gynaecological cancers|2015–2019|Females|5|65–69|0.708|0.692|0.723
Relative|Gynaecological cancers|2015–2019|Females|5|70–74|0.647|0.628|0.666
Relative|Gynaecological cancers|2015–2019|Females|5|75–79|0.56|0.537|0.583
Relative|Gynaecological cancers|2015–2019|Females|5|80–84|0.466|0.437|0.495
Relative|Gynaecological cancers|2015–2019|Females|5|85+|0.34|0.308|0.373
Relative|Gynaecological cancers|2015–2019|Females|5|All ages combined|0.705|0.699|0.711
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|10–14|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|15–19|0.954|0.714|0.993
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|20–24|0.875|0.725|0.946
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|25–29|0.939|0.844|0.976
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|30–34|0.96|0.897|0.985
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|35–39|0.942|0.892|0.97
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|40–44|0.939|0.907|0.96
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|45–49|0.932|0.912|0.948
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|50–54|0.919|0.903|0.932
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|55–59|0.895|0.881|0.908
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|60–64|0.87|0.856|0.883
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|65–69|0.829|0.812|0.843
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|70–74|0.807|0.787|0.824
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|75–79|0.735|0.709|0.759
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|80–84|0.691|0.658|0.721
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|85+|0.526|0.486|0.565
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|1|All ages combined|0.835|0.828|0.841
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|10–14|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|15–19|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|20–24|0.794|0.629|0.891
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|25–29|0.857|0.743|0.923
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|30–34|0.91|0.835|0.952
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|35–39|0.884|0.82|0.926
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|40–44|0.88|0.841|0.91
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|45–49|0.854|0.827|0.877
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|50–54|0.851|0.831|0.869
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|55–59|0.826|0.809|0.841
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|60–64|0.785|0.767|0.801
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|65–69|0.734|0.715|0.752
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|70–74|0.689|0.666|0.71
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|75–79|0.618|0.59|0.645
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|80–84|0.545|0.509|0.578
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|85+|0.396|0.357|0.434
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|2|All ages combined|0.741|0.734|0.749
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|10–14|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|15–19|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|20–24|0.766|0.598|0.871
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|25–29|0.839|0.722|0.91
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|30–34|0.872|0.789|0.923
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|35–39|0.862|0.793|0.909
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|40–44|0.85|0.808|0.884
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|45–49|0.812|0.782|0.837
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|50–54|0.804|0.782|0.824
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|55–59|0.769|0.75|0.786
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|60–64|0.726|0.707|0.744
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|65–69|0.674|0.654|0.694
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|70–74|0.62|0.596|0.643
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|75–79|0.544|0.515|0.572
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|80–84|0.455|0.42|0.489
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|85+|0.32|0.284|0.357
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|3|All ages combined|0.682|0.674|0.69
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|10–14|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|15–19|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|20–24|0.733|0.559|0.847
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|25–29|0.82|0.698|0.897
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|30–34|0.831|0.743|0.892
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|35–39|0.839|0.768|0.89
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|40–44|0.831|0.788|0.867
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|45–49|0.775|0.744|0.803
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|50–54|0.769|0.746|0.79
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|55–59|0.727|0.707|0.746
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|60–64|0.683|0.663|0.702
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|65–69|0.624|0.603|0.644
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|70–74|0.552|0.527|0.576
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|75–79|0.482|0.453|0.511
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|80–84|0.382|0.348|0.416
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|85+|0.269|0.234|0.304
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|4|All ages combined|0.634|0.625|0.642
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|10–14|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|15–19|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|20–24|0.733|0.559|0.847
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|25–29|0.782|0.653|0.868
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|30–34|0.821|0.732|0.884
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|35–39|0.805|0.731|0.861
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|40–44|0.807|0.762|0.845
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|45–49|0.762|0.73|0.79
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|50–54|0.752|0.729|0.774
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|55–59|0.694|0.673|0.714
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|60–64|0.649|0.629|0.669
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|65–69|0.592|0.57|0.612
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|70–74|0.502|0.477|0.527
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|75–79|0.432|0.402|0.461
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|80–84|0.323|0.291|0.356
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|85+|0.215|0.183|0.249
Observed|Head and neck cancer (excluding lip)|2015–2019|Males|5|All ages combined|0.599|0.59|0.607
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|10–14|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|15–19|0.954|0.714|0.994
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|20–24|0.875|0.725|0.946
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|25–29|0.939|0.845|0.977
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|30–34|0.961|0.898|0.986
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|35–39|0.944|0.893|0.971
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|40–44|0.941|0.909|0.962
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|45–49|0.934|0.914|0.95
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|50–54|0.922|0.906|0.935
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|55–59|0.9|0.886|0.913
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|60–64|0.877|0.863|0.89
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|65–69|0.839|0.822|0.854
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|70–74|0.822|0.803|0.84
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|75–79|0.76|0.733|0.785
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|80–84|0.733|0.698|0.766
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|85+|0.605|0.559|0.65
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|1|All ages combined|0.851|0.844|0.857
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|10–14|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|15–19|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|20–24|0.795|0.63|0.892
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|25–29|0.858|0.744|0.924
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|30–34|0.912|0.837|0.954
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|35–39|0.886|0.822|0.929
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|40–44|0.883|0.844|0.913
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|45–49|0.858|0.831|0.881
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|50–54|0.857|0.838|0.875
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|55–59|0.835|0.818|0.851
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|60–64|0.798|0.78|0.814
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|65–69|0.753|0.733|0.771
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|70–74|0.717|0.694|0.739
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|75–79|0.663|0.632|0.692
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|80–84|0.619|0.579|0.657
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|85+|0.529|0.477|0.58
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|2|All ages combined|0.769|0.761|0.777
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|10–14|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|15–19|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|20–24|0.767|0.599|0.872
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|25–29|0.841|0.723|0.912
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|30–34|0.874|0.791|0.926
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|35–39|0.865|0.796|0.912
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|40–44|0.855|0.813|0.888
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|45–49|0.818|0.788|0.844
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|50–54|0.813|0.791|0.833
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|55–59|0.782|0.763|0.8
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|60–64|0.745|0.726|0.764
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|65–69|0.702|0.681|0.721
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|70–74|0.661|0.636|0.686
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|75–79|0.608|0.575|0.639
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|80–84|0.558|0.515|0.6
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|85+|0.504|0.447|0.562
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|3|All ages combined|0.72|0.712|0.728
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|10–14|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|15–19|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|20–24|0.735|0.56|0.85
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|25–29|0.823|0.7|0.899
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|30–34|0.834|0.745|0.895
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|35–39|0.844|0.772|0.895
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|40–44|0.838|0.794|0.873
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|45–49|0.784|0.752|0.812
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|50–54|0.782|0.758|0.803
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|55–59|0.745|0.724|0.764
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|60–64|0.708|0.687|0.728
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|65–69|0.659|0.637|0.68
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|70–74|0.604|0.577|0.631
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|75–79|0.564|0.53|0.598
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|80–84|0.511|0.465|0.556
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|85+|0.505|0.44|0.572
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|4|All ages combined|0.682|0.673|0.691
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|10–14|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|15–19|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|20–24|0.736|0.561|0.85
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|25–29|0.785|0.656|0.871
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|30–34|0.825|0.735|0.888
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|35–39|0.811|0.735|0.867
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|40–44|0.815|0.77|0.853
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|45–49|0.773|0.74|0.801
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|50–54|0.768|0.744|0.79
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|55–59|0.716|0.695|0.737
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|60–64|0.681|0.659|0.701
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|65–69|0.636|0.613|0.658
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|70–74|0.566|0.538|0.594
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|75–79|0.532|0.496|0.568
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|80–84|0.477|0.429|0.526
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|85+|0.49|0.417|0.567
Relative|Head and neck cancer (excluding lip)|2015–2019|Males|5|All ages combined|0.657|0.648|0.666
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|10–14|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|15–19|1|0.909|1
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|20–24|0.927|0.791|0.976
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|25–29|0.929|0.822|0.973
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|30–34|0.951|0.875|0.981
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|35–39|0.954|0.893|0.981
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|40–44|0.944|0.895|0.97
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|45–49|0.942|0.909|0.964
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|50–54|0.927|0.899|0.947
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|55–59|0.899|0.872|0.921
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|60–64|0.9|0.874|0.921
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|65–69|0.874|0.847|0.898
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|70–74|0.832|0.8|0.86
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|75–79|0.808|0.769|0.841
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|80–84|0.694|0.646|0.737
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|85+|0.514|0.469|0.557
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|1|All ages combined|0.837|0.827|0.847
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|10–14|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|15–19|1|0.904|1
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|20–24|0.9|0.755|0.961
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|25–29|0.892|0.776|0.95
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|30–34|0.928|0.847|0.967
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|35–39|0.901|0.828|0.944
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|40–44|0.886|0.828|0.926
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|45–49|0.914|0.875|0.941
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|50–54|0.871|0.836|0.899
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|55–59|0.829|0.796|0.857
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|60–64|0.808|0.775|0.837
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|65–69|0.804|0.771|0.833
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|70–74|0.729|0.692|0.763
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|75–79|0.728|0.684|0.767
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|80–84|0.556|0.505|0.604
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|85+|0.392|0.349|0.434
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|2|All ages combined|0.756|0.744|0.767
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|10–14|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|15–19|1|0.898|1
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|20–24|0.9|0.755|0.961
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|25–29|0.892|0.776|0.95
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|30–34|0.928|0.847|0.967
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|35–39|0.866|0.787|0.917
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|40–44|0.871|0.811|0.913
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|45–49|0.859|0.814|0.894
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|50–54|0.838|0.801|0.869
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|55–59|0.786|0.75|0.817
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|60–64|0.761|0.726|0.793
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|65–69|0.756|0.721|0.788
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|70–74|0.675|0.636|0.712
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|75–79|0.637|0.59|0.68
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|80–84|0.472|0.422|0.521
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|85+|0.321|0.281|0.363
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|3|All ages combined|0.704|0.691|0.717
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|10–14|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|15–19|1|0.893|1
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|20–24|0.847|0.69|0.928
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|25–29|0.873|0.752|0.937
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|30–34|0.928|0.847|0.967
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|35–39|0.857|0.777|0.91
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|40–44|0.836|0.772|0.883
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|45–49|0.836|0.788|0.873
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|50–54|0.802|0.763|0.836
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|55–59|0.762|0.725|0.794
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|60–64|0.723|0.686|0.756
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|65–69|0.731|0.694|0.764
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|70–74|0.644|0.604|0.682
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|75–79|0.591|0.543|0.635
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|80–84|0.418|0.368|0.467
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|85+|0.252|0.215|0.292
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|4|All ages combined|0.668|0.655|0.681
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|10–14|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|15–19|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|20–24|0.847|0.69|0.928
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|25–29|0.873|0.752|0.937
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|30–34|0.915|0.831|0.959
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|35–39|0.849|0.768|0.903
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|40–44|0.836|0.772|0.883
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|45–49|0.818|0.769|0.858
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|50–54|0.772|0.731|0.808
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|55–59|0.754|0.716|0.787
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|60–64|0.709|0.672|0.743
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|65–69|0.688|0.649|0.724
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|70–74|0.596|0.554|0.635
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|75–79|0.543|0.495|0.589
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|80–84|0.357|0.309|0.405
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|85+|0.201|0.166|0.238
Observed|Head and neck cancer (excluding lip)|2015–2019|Females|5|All ages combined|0.637|0.623|0.65
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|10–14|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|15–19|1|0.909|1
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|20–24|0.927|0.791|0.976
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|25–29|0.929|0.822|0.973
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|30–34|0.951|0.875|0.982
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|35–39|0.955|0.894|0.981
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|40–44|0.945|0.895|0.971
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|45–49|0.944|0.91|0.965
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|50–54|0.929|0.901|0.949
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|55–59|0.902|0.875|0.923
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|60–64|0.904|0.878|0.925
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|65–69|0.881|0.853|0.904
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|70–74|0.842|0.81|0.87
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|75–79|0.826|0.786|0.86
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|80–84|0.724|0.674|0.768
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|85+|0.579|0.528|0.627
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|1|All ages combined|0.853|0.843|0.863
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|10–14|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|15–19|1|0.904|1
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|20–24|0.9|0.755|0.962
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|25–29|0.893|0.777|0.951
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|30–34|0.929|0.848|0.968
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|35–39|0.902|0.829|0.945
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|40–44|0.888|0.829|0.928
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|45–49|0.917|0.878|0.944
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|50–54|0.875|0.84|0.903
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|55–59|0.834|0.801|0.862
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|60–64|0.816|0.782|0.845
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|65–69|0.817|0.783|0.846
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|70–74|0.749|0.71|0.783
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|75–79|0.762|0.716|0.803
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|80–84|0.608|0.553|0.66
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|85+|0.499|0.445|0.554
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|2|All ages combined|0.783|0.771|0.795
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|10–14|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|15–19|1.001|0.899|1.001
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|20–24|0.901|0.755|0.962
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|25–29|0.893|0.777|0.951
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|30–34|0.929|0.848|0.968
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|35–39|0.867|0.789|0.919
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|40–44|0.874|0.813|0.916
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|45–49|0.863|0.817|0.898
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|50–54|0.844|0.806|0.875
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|55–59|0.794|0.758|0.825
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|60–64|0.773|0.737|0.805
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|65–69|0.774|0.738|0.807
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|70–74|0.704|0.662|0.742
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|75–79|0.686|0.635|0.732
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|80–84|0.546|0.487|0.603
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|85+|0.471|0.412|0.532
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|3|All ages combined|0.742|0.729|0.755
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|10–14|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|15–19|1.001|0.894|1.001
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|20–24|0.848|0.691|0.929
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|25–29|0.874|0.753|0.939
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|30–34|0.93|0.849|0.969
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|35–39|0.859|0.779|0.912
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|40–44|0.839|0.776|0.887
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|45–49|0.841|0.793|0.879
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|50–54|0.81|0.77|0.845
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|55–59|0.773|0.735|0.806
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|60–64|0.738|0.701|0.772
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|65–69|0.756|0.718|0.79
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|70–74|0.683|0.64|0.723
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|75–79|0.656|0.603|0.706
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|80–84|0.515|0.454|0.576
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|85+|0.433|0.368|0.5
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|4|All ages combined|0.716|0.702|0.73
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|10–14|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|15–19|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|20–24|0.848|0.691|0.93
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|25–29|0.874|0.753|0.939
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|30–34|0.918|0.833|0.961
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|35–39|0.852|0.771|0.906
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|40–44|0.84|0.777|0.888
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|45–49|0.825|0.775|0.865
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|50–54|0.782|0.74|0.819
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|55–59|0.768|0.73|0.802
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|60–64|0.729|0.691|0.764
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|65–69|0.72|0.679|0.757
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|70–74|0.644|0.599|0.686
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|75–79|0.626|0.57|0.679
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|80–84|0.473|0.409|0.537
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|85+|0.411|0.34|0.486
Relative|Head and neck cancer (excluding lip)|2015–2019|Females|5|All ages combined|0.695|0.68|0.709
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|10–14|1|0.866|1
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|15–19|0.981|0.873|0.997
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|20–24|0.901|0.812|0.949
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|25–29|0.934|0.873|0.967
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|30–34|0.956|0.914|0.978
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|35–39|0.947|0.912|0.968
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|40–44|0.941|0.916|0.958
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|45–49|0.935|0.918|0.948
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|50–54|0.921|0.907|0.932
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|55–59|0.896|0.884|0.907
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|60–64|0.876|0.864|0.888
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|65–69|0.839|0.825|0.852
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|70–74|0.813|0.797|0.828
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|75–79|0.755|0.734|0.775
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|80–84|0.692|0.665|0.717
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|85+|0.521|0.491|0.55
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|1|All ages combined|0.835|0.83|0.84
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|10–14|1|0.872|1
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|15–19|0.981|0.873|0.997
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|20–24|0.847|0.746|0.91
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|25–29|0.874|0.799|0.922
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|30–34|0.919|0.869|0.95
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|35–39|0.891|0.846|0.924
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|40–44|0.882|0.851|0.907
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|45–49|0.87|0.848|0.889
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|50–54|0.856|0.839|0.871
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|55–59|0.826|0.811|0.84
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|60–64|0.789|0.774|0.804
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|65–69|0.75|0.733|0.765
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|70–74|0.699|0.68|0.718
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|75–79|0.648|0.624|0.671
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|80–84|0.548|0.52|0.576
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|85+|0.394|0.365|0.423
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|2|All ages combined|0.745|0.739|0.751
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|10–14|1|0.876|1
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|15–19|0.956|0.835|0.989
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|20–24|0.833|0.73|0.9
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|25–29|0.865|0.789|0.915
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|30–34|0.898|0.844|0.933
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|35–39|0.863|0.814|0.9
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|40–44|0.857|0.824|0.885
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|45–49|0.824|0.8|0.846
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|50–54|0.812|0.794|0.829
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|55–59|0.772|0.756|0.788
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|60–64|0.734|0.717|0.75
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|65–69|0.693|0.675|0.709
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|70–74|0.634|0.614|0.654
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|75–79|0.569|0.545|0.593
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|80–84|0.461|0.432|0.489
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|85+|0.321|0.293|0.348
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|3|All ages combined|0.688|0.681|0.694
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|10–14|0.962|0.757|0.995
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|15–19|0.956|0.835|0.989
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|20–24|0.79|0.679|0.866
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|25–29|0.845|0.766|0.9
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|30–34|0.876|0.819|0.916
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|35–39|0.847|0.796|0.886
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|40–44|0.833|0.798|0.862
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|45–49|0.792|0.766|0.815
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|50–54|0.777|0.758|0.796
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|55–59|0.735|0.717|0.752
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|60–64|0.692|0.674|0.709
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|65–69|0.647|0.629|0.665
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|70–74|0.577|0.556|0.597
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|75–79|0.512|0.487|0.536
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|80–84|0.394|0.365|0.422
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|85+|0.262|0.236|0.288
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|4|All ages combined|0.643|0.636|0.65
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|00–04|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|05–09|||
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|10–14|0.962|0.757|0.995
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|15–19|0.956|0.835|0.989
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|20–24|0.79|0.679|0.866
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|25–29|0.826|0.743|0.884
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|30–34|0.865|0.807|0.907
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|35–39|0.825|0.772|0.866
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|40–44|0.817|0.782|0.848
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|45–49|0.777|0.751|0.801
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|50–54|0.757|0.737|0.776
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|55–59|0.708|0.69|0.725
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|60–64|0.663|0.645|0.68
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|65–69|0.613|0.594|0.631
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|70–74|0.528|0.506|0.549
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|75–79|0.462|0.437|0.487
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|80–84|0.334|0.307|0.362
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|85+|0.209|0.185|0.234
Observed|Head and neck cancer (excluding lip)|2015–2019|Persons|5|All ages combined|0.609|0.602|0.616
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|10–14|1|0.866|1
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|15–19|0.981|0.873|0.998
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|20–24|0.902|0.813|0.95
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|25–29|0.935|0.873|0.967
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|30–34|0.957|0.915|0.978
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|35–39|0.948|0.913|0.969
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|40–44|0.942|0.917|0.96
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|45–49|0.937|0.92|0.95
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|50–54|0.924|0.91|0.935
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|55–59|0.901|0.888|0.911
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|60–64|0.883|0.87|0.894
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|65–69|0.848|0.834|0.861
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|70–74|0.828|0.811|0.843
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|75–79|0.778|0.756|0.799
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|80–84|0.73|0.702|0.757
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|85+|0.593|0.559|0.626
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|1|All ages combined|0.851|0.846|0.857
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|10–14|1|0.873|1
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|15–19|0.982|0.874|0.998
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|20–24|0.848|0.747|0.911
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|25–29|0.875|0.8|0.923
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|30–34|0.92|0.87|0.952
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|35–39|0.893|0.848|0.925
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|40–44|0.885|0.853|0.91
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|45–49|0.874|0.852|0.893
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|50–54|0.862|0.845|0.877
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|55–59|0.835|0.82|0.849
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|60–64|0.801|0.786|0.816
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|65–69|0.767|0.75|0.783
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|70–74|0.725|0.705|0.744
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|75–79|0.69|0.665|0.714
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|80–84|0.615|0.583|0.646
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|85+|0.516|0.478|0.553
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|2|All ages combined|0.773|0.766|0.779
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|10–14|1|0.876|1
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|15–19|0.957|0.836|0.99
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|20–24|0.834|0.731|0.901
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|25–29|0.866|0.79|0.916
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|30–34|0.9|0.846|0.935
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|35–39|0.865|0.817|0.902
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|40–44|0.861|0.828|0.889
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|45–49|0.83|0.806|0.852
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|50–54|0.821|0.802|0.838
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|55–59|0.785|0.768|0.801
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|60–64|0.751|0.734|0.768
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|65–69|0.718|0.7|0.735
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|70–74|0.672|0.651|0.693
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|75–79|0.629|0.602|0.656
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|80–84|0.554|0.519|0.588
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|85+|0.489|0.448|0.531
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|3|All ages combined|0.726|0.719|0.733
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|10–14|0.962|0.758|0.995
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|15–19|0.958|0.836|0.99
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|20–24|0.791|0.68|0.867
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|25–29|0.847|0.767|0.902
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|30–34|0.878|0.822|0.918
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|35–39|0.85|0.8|0.889
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|40–44|0.838|0.803|0.868
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|45–49|0.799|0.773|0.823
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|50–54|0.789|0.769|0.807
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|55–59|0.751|0.733|0.768
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|60–64|0.715|0.697|0.732
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|65–69|0.681|0.662|0.699
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|70–74|0.626|0.603|0.648
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|75–79|0.59|0.561|0.618
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|80–84|0.512|0.476|0.549
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|85+|0.472|0.426|0.519
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|4|All ages combined|0.691|0.684|0.699
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|00–04|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|05–09|||
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|10–14|0.963|0.758|0.995
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|15–19|0.958|0.836|0.991
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|20–24|0.791|0.681|0.868
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|25–29|0.828|0.745|0.887
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|30–34|0.868|0.81|0.91
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|35–39|0.829|0.776|0.871
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|40–44|0.824|0.788|0.855
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|45–49|0.787|0.76|0.811
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|50–54|0.772|0.751|0.791
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|55–59|0.728|0.709|0.746
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|60–64|0.692|0.673|0.71
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|65–69|0.655|0.635|0.674
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|70–74|0.588|0.564|0.611
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|75–79|0.558|0.528|0.588
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|80–84|0.476|0.437|0.515
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|85+|0.453|0.401|0.507
Relative|Head and neck cancer (excluding lip)|2015–2019|Persons|5|All ages combined|0.667|0.66|0.675
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|10–14|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|15–19|0.954|0.714|0.993
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|20–24|0.893|0.762|0.954
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|25–29|0.954|0.883|0.983
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|30–34|0.975|0.935|0.991
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|35–39|0.967|0.937|0.982
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|40–44|0.96|0.939|0.974
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|45–49|0.948|0.932|0.96
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|50–54|0.932|0.919|0.943
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|55–59|0.908|0.895|0.918
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|60–64|0.885|0.872|0.896
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|65–69|0.849|0.835|0.862
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|70–74|0.833|0.816|0.848
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|75–79|0.778|0.756|0.799
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|80–84|0.745|0.717|0.771
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|85+|0.609|0.575|0.642
Observed|Head and neck cancer (including lip)|2015–2019|Males|1|All ages combined|0.859|0.854|0.864
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|10–14|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|15–19|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|20–24|0.821|0.673|0.906
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|25–29|0.9|0.817|0.947
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|30–34|0.94|0.892|0.967
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|35–39|0.931|0.892|0.956
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|40–44|0.917|0.891|0.937
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|45–49|0.885|0.864|0.903
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|50–54|0.876|0.86|0.891
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|55–59|0.843|0.828|0.857
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|60–64|0.807|0.791|0.822
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|65–69|0.763|0.746|0.779
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|70–74|0.728|0.709|0.747
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|75–79|0.677|0.653|0.7
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|80–84|0.611|0.581|0.641
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|85+|0.475|0.441|0.509
Observed|Head and neck cancer (including lip)|2015–2019|Males|2|All ages combined|0.776|0.77|0.783
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|10–14|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|15–19|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|20–24|0.796|0.644|0.889
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|25–29|0.89|0.805|0.939
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|30–34|0.908|0.854|0.943
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|35–39|0.92|0.88|0.947
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|40–44|0.898|0.87|0.921
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|45–49|0.851|0.828|0.872
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|50–54|0.833|0.815|0.85
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|55–59|0.792|0.775|0.808
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|60–64|0.756|0.739|0.772
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|65–69|0.709|0.691|0.726
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|70–74|0.662|0.641|0.682
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|75–79|0.602|0.576|0.626
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|80–84|0.526|0.495|0.557
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|85+|0.379|0.346|0.412
Observed|Head and neck cancer (including lip)|2015–2019|Males|3|All ages combined|0.721|0.714|0.728
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|10–14|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|15–19|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|20–24|0.77|0.614|0.87
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|25–29|0.859|0.769|0.915
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|30–34|0.886|0.83|0.925
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|35–39|0.91|0.868|0.938
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|40–44|0.885|0.855|0.909
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|45–49|0.824|0.799|0.846
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|50–54|0.803|0.783|0.821
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|55–59|0.756|0.738|0.772
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|60–64|0.717|0.699|0.734
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|65–69|0.663|0.644|0.681
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|70–74|0.602|0.58|0.623
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|75–79|0.545|0.519|0.571
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|80–84|0.453|0.422|0.483
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|85+|0.308|0.277|0.339
Observed|Head and neck cancer (including lip)|2015–2019|Males|4|All ages combined|0.677|0.67|0.684
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|10–14|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|15–19|||
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|20–24|0.77|0.614|0.87
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|25–29|0.839|0.748|0.9
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|30–34|0.881|0.824|0.921
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|35–39|0.891|0.847|0.922
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|40–44|0.865|0.834|0.891
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|45–49|0.813|0.788|0.835
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|50–54|0.787|0.767|0.805
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|55–59|0.729|0.71|0.746
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|60–64|0.688|0.669|0.706
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|65–69|0.632|0.613|0.65
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|70–74|0.554|0.531|0.576
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|75–79|0.496|0.469|0.521
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|80–84|0.389|0.359|0.419
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|85+|0.249|0.22|0.28
Observed|Head and neck cancer (including lip)|2015–2019|Males|5|All ages combined|0.645|0.637|0.652
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|10–14|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|15–19|0.954|0.714|0.994
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|20–24|0.894|0.763|0.955
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|25–29|0.955|0.883|0.983
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|30–34|0.976|0.935|0.991
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|35–39|0.968|0.938|0.984
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|40–44|0.961|0.941|0.975
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|45–49|0.95|0.935|0.962
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|50–54|0.935|0.922|0.946
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|55–59|0.912|0.9|0.923
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|60–64|0.892|0.879|0.903
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|65–69|0.86|0.845|0.873
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|70–74|0.849|0.832|0.865
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|75–79|0.805|0.782|0.826
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|80–84|0.791|0.762|0.818
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|85+|0.701|0.662|0.739
Relative|Head and neck cancer (including lip)|2015–2019|Males|1|All ages combined|0.876|0.871|0.881
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|10–14|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|15–19|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|20–24|0.822|0.673|0.907
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|25–29|0.902|0.819|0.948
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|30–34|0.942|0.893|0.969
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|35–39|0.933|0.894|0.958
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|40–44|0.92|0.894|0.941
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|45–49|0.889|0.868|0.907
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|50–54|0.883|0.866|0.897
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|55–59|0.853|0.837|0.867
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|60–64|0.82|0.805|0.835
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|65–69|0.782|0.765|0.799
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|70–74|0.759|0.738|0.778
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|75–79|0.726|0.7|0.751
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|80–84|0.695|0.66|0.728
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|85+|0.637|0.591|0.683
Relative|Head and neck cancer (including lip)|2015–2019|Males|2|All ages combined|0.807|0.8|0.813
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|10–14|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|15–19|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|20–24|0.798|0.645|0.89
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|25–29|0.892|0.807|0.941
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|30–34|0.911|0.857|0.945
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|35–39|0.923|0.883|0.951
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|40–44|0.903|0.875|0.926
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|45–49|0.858|0.835|0.878
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|50–54|0.843|0.824|0.86
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|55–59|0.806|0.789|0.822
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|60–64|0.776|0.759|0.792
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|65–69|0.737|0.718|0.755
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|70–74|0.706|0.683|0.728
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|75–79|0.673|0.644|0.7
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|80–84|0.646|0.607|0.683
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|85+|0.601|0.549|0.654
Relative|Head and neck cancer (including lip)|2015–2019|Males|3|All ages combined|0.764|0.757|0.771
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|10–14|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|15–19|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|20–24|0.772|0.616|0.872
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|25–29|0.861|0.772|0.918
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|30–34|0.89|0.833|0.929
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|35–39|0.914|0.873|0.943
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|40–44|0.891|0.862|0.915
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|45–49|0.833|0.808|0.855
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|50–54|0.815|0.796|0.834
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|55–59|0.774|0.756|0.791
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|60–64|0.743|0.725|0.761
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|65–69|0.701|0.681|0.72
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|70–74|0.659|0.635|0.683
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|75–79|0.639|0.608|0.668
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|80–84|0.606|0.564|0.647
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|85+|0.585|0.526|0.645
Relative|Head and neck cancer (including lip)|2015–2019|Males|4|All ages combined|0.732|0.724|0.739
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|10–14|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|15–19|||
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|20–24|0.773|0.616|0.873
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|25–29|0.843|0.751|0.903
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|30–34|0.886|0.828|0.925
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|35–39|0.897|0.853|0.928
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|40–44|0.873|0.842|0.899
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|45–49|0.824|0.799|0.847
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|50–54|0.803|0.783|0.822
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|55–59|0.752|0.733|0.77
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|60–64|0.721|0.702|0.74
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|65–69|0.68|0.659|0.7
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|70–74|0.625|0.599|0.65
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|75–79|0.612|0.579|0.643
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|80–84|0.575|0.53|0.619
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|85+|0.576|0.509|0.646
Relative|Head and neck cancer (including lip)|2015–2019|Males|5|All ages combined|0.711|0.703|0.719
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|10–14|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|15–19|1|0.909|1
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|20–24|0.929|0.795|0.976
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|25–29|0.934|0.833|0.975
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|30–34|0.956|0.887|0.983
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|35–39|0.96|0.906|0.983
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|40–44|0.954|0.914|0.976
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|45–49|0.95|0.921|0.969
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|50–54|0.936|0.911|0.954
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|55–59|0.912|0.888|0.931
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|60–64|0.914|0.891|0.932
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|65–69|0.893|0.869|0.912
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|70–74|0.857|0.83|0.88
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|75–79|0.845|0.814|0.872
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|80–84|0.751|0.711|0.787
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|85+|0.605|0.567|0.641
Observed|Head and neck cancer (including lip)|2015–2019|Females|1|All ages combined|0.858|0.849|0.867
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|10–14|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|15–19|1|0.904|1
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|20–24|0.903|0.76|0.962
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|25–29|0.9|0.792|0.954
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|30–34|0.937|0.864|0.971
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|35–39|0.914|0.85|0.952
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|40–44|0.908|0.86|0.941
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|45–49|0.926|0.892|0.949
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|50–54|0.888|0.858|0.912
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|55–59|0.852|0.823|0.877
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|60–64|0.834|0.805|0.859
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|65–69|0.832|0.803|0.857
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|70–74|0.766|0.733|0.795
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|75–79|0.776|0.74|0.808
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|80–84|0.636|0.593|0.676
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|85+|0.476|0.438|0.512
Observed|Head and neck cancer (including lip)|2015–2019|Females|2|All ages combined|0.784|0.774|0.794
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|10–14|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|15–19|1|0.898|1
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|20–24|0.903|0.76|0.962
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|25–29|0.9|0.792|0.954
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|30–34|0.937|0.864|0.971
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|35–39|0.886|0.819|0.93
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|40–44|0.896|0.846|0.93
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|45–49|0.879|0.84|0.91
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|50–54|0.855|0.823|0.883
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|55–59|0.816|0.785|0.843
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|60–64|0.794|0.763|0.822
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|65–69|0.788|0.757|0.815
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|70–74|0.722|0.688|0.753
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|75–79|0.702|0.663|0.738
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|80–84|0.561|0.517|0.603
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|85+|0.4|0.364|0.437
Observed|Head and neck cancer (including lip)|2015–2019|Females|3|All ages combined|0.737|0.726|0.748
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|10–14|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|15–19|1|0.893|1
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|20–24|0.852|0.7|0.931
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|25–29|0.884|0.772|0.943
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|30–34|0.937|0.864|0.971
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|35–39|0.88|0.811|0.925
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|40–44|0.868|0.816|0.906
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|45–49|0.86|0.818|0.892
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|50–54|0.822|0.787|0.852
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|55–59|0.796|0.764|0.824
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|60–64|0.762|0.729|0.791
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|65–69|0.763|0.731|0.791
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|70–74|0.693|0.657|0.725
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|75–79|0.664|0.624|0.701
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|80–84|0.502|0.458|0.544
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|85+|0.309|0.275|0.344
Observed|Head and neck cancer (including lip)|2015–2019|Females|4|All ages combined|0.699|0.688|0.711
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|10–14|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|15–19|||
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|20–24|0.852|0.7|0.931
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|25–29|0.884|0.772|0.943
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|30–34|0.926|0.852|0.964
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|35–39|0.868|0.798|0.914
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|40–44|0.868|0.816|0.906
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|45–49|0.845|0.803|0.88
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|50–54|0.798|0.761|0.829
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|55–59|0.789|0.757|0.818
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|60–64|0.748|0.715|0.778
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|65–69|0.726|0.693|0.757
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|70–74|0.646|0.61|0.68
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|75–79|0.611|0.57|0.649
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|80–84|0.429|0.386|0.47
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|85+|0.235|0.205|0.267
Observed|Head and neck cancer (including lip)|2015–2019|Females|5|All ages combined|0.664|0.652|0.675
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|10–14|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|15–19|1|0.909|1
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|20–24|0.929|0.796|0.977
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|25–29|0.934|0.833|0.975
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|30–34|0.957|0.888|0.984
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|35–39|0.96|0.907|0.984
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|40–44|0.955|0.915|0.977
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|45–49|0.952|0.923|0.97
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|50–54|0.938|0.913|0.956
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|55–59|0.915|0.891|0.933
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|60–64|0.918|0.895|0.936
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|65–69|0.899|0.875|0.919
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|70–74|0.867|0.84|0.891
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|75–79|0.864|0.831|0.891
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|80–84|0.783|0.742|0.82
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|85+|0.683|0.641|0.723
Relative|Head and neck cancer (including lip)|2015–2019|Females|1|All ages combined|0.877|0.868|0.885
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|10–14|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|15–19|1|0.904|1
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|20–24|0.903|0.761|0.963
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|25–29|0.901|0.792|0.955
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|30–34|0.937|0.865|0.972
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|35–39|0.915|0.852|0.953
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|40–44|0.91|0.862|0.942
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|45–49|0.929|0.895|0.952
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|50–54|0.892|0.862|0.916
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|55–59|0.858|0.829|0.882
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|60–64|0.842|0.812|0.867
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|65–69|0.845|0.816|0.87
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|70–74|0.786|0.753|0.816
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|75–79|0.813|0.775|0.846
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|80–84|0.696|0.648|0.74
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|85+|0.612|0.564|0.66
Relative|Head and neck cancer (including lip)|2015–2019|Females|2|All ages combined|0.817|0.806|0.827
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|10–14|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|15–19|1.001|0.899|1.001
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|20–24|0.903|0.761|0.963
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|25–29|0.901|0.793|0.955
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|30–34|0.938|0.865|0.972
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|35–39|0.888|0.82|0.932
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|40–44|0.899|0.849|0.933
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|45–49|0.883|0.844|0.914
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|50–54|0.862|0.828|0.889
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|55–59|0.824|0.793|0.852
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|60–64|0.806|0.775|0.834
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|65–69|0.807|0.775|0.835
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|70–74|0.753|0.717|0.785
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|75–79|0.756|0.714|0.794
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|80–84|0.649|0.598|0.697
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|85+|0.596|0.542|0.65
Relative|Head and neck cancer (including lip)|2015–2019|Females|3|All ages combined|0.783|0.771|0.795
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|10–14|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|15–19|1.001|0.894|1.001
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|20–24|0.853|0.701|0.932
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|25–29|0.885|0.773|0.944
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|30–34|0.938|0.866|0.973
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|35–39|0.882|0.814|0.927
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|40–44|0.872|0.819|0.91
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|45–49|0.865|0.824|0.898
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|50–54|0.83|0.795|0.861
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|55–59|0.807|0.775|0.836
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|60–64|0.778|0.745|0.808
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|65–69|0.789|0.756|0.819
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|70–74|0.734|0.697|0.769
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|75–79|0.738|0.693|0.779
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|80–84|0.619|0.565|0.671
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|85+|0.542|0.483|0.603
Relative|Head and neck cancer (including lip)|2015–2019|Females|4|All ages combined|0.76|0.747|0.772
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|10–14|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|15–19|||
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|20–24|0.853|0.701|0.932
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|25–29|0.886|0.774|0.945
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|30–34|0.929|0.854|0.967
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|35–39|0.871|0.801|0.918
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|40–44|0.873|0.82|0.911
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|45–49|0.853|0.81|0.887
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|50–54|0.808|0.771|0.84
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|55–59|0.804|0.771|0.834
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|60–64|0.769|0.735|0.8
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|65–69|0.759|0.724|0.792
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|70–74|0.699|0.659|0.735
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|75–79|0.704|0.657|0.748
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|80–84|0.57|0.513|0.625
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|85+|0.492|0.428|0.559
Relative|Head and neck cancer (including lip)|2015–2019|Females|5|All ages combined|0.737|0.723|0.75
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|10–14|1|0.866|1
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|15–19|0.981|0.873|0.997
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|20–24|0.91|0.828|0.954
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|25–29|0.946|0.895|0.973
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|30–34|0.968|0.937|0.984
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|35–39|0.964|0.941|0.979
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|40–44|0.958|0.941|0.971
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|45–49|0.948|0.935|0.959
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|50–54|0.933|0.922|0.943
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|55–59|0.909|0.898|0.918
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|60–64|0.891|0.88|0.901
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|65–69|0.859|0.847|0.87
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|70–74|0.839|0.825|0.852
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|75–79|0.798|0.78|0.814
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|80–84|0.747|0.725|0.768
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|85+|0.607|0.582|0.632
Observed|Head and neck cancer (including lip)|2015–2019|Persons|1|All ages combined|0.859|0.854|0.863
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|10–14|1|0.872|1
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|15–19|0.981|0.873|0.997
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|20–24|0.86|0.766|0.918
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|25–29|0.9|0.84|0.939
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|30–34|0.939|0.902|0.962
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|35–39|0.925|0.894|0.947
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|40–44|0.915|0.892|0.933
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|45–49|0.895|0.877|0.91
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|50–54|0.879|0.865|0.892
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|55–59|0.845|0.832|0.858
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|60–64|0.813|0.799|0.826
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|65–69|0.778|0.764|0.792
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|70–74|0.738|0.721|0.754
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|75–79|0.705|0.685|0.724
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|80–84|0.62|0.595|0.644
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|85+|0.475|0.45|0.5
Observed|Head and neck cancer (including lip)|2015–2019|Persons|2|All ages combined|0.778|0.773|0.784
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|10–14|1|0.876|1
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|15–19|0.957|0.837|0.989
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|20–24|0.847|0.75|0.908
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|25–29|0.894|0.832|0.933
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|30–34|0.918|0.879|0.945
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|35–39|0.909|0.875|0.933
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|40–44|0.898|0.874|0.917
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|45–49|0.858|0.838|0.875
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|50–54|0.839|0.823|0.853
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|55–59|0.797|0.783|0.811
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|60–64|0.765|0.75|0.779
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|65–69|0.727|0.711|0.741
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|70–74|0.678|0.66|0.695
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|75–79|0.63|0.609|0.651
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|80–84|0.538|0.513|0.563
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|85+|0.389|0.364|0.413
Observed|Head and neck cancer (including lip)|2015–2019|Persons|3|All ages combined|0.725|0.719|0.731
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|10–14|0.962|0.757|0.995
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|15–19|0.932|0.802|0.978
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|20–24|0.809|0.706|0.878
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|25–29|0.868|0.804|0.913
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|30–34|0.904|0.863|0.934
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|35–39|0.9|0.866|0.925
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|40–44|0.88|0.855|0.901
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|45–49|0.833|0.812|0.851
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|50–54|0.807|0.79|0.823
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|55–59|0.765|0.749|0.779
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|60–64|0.727|0.711|0.742
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|65–69|0.686|0.669|0.701
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|70–74|0.627|0.608|0.645
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|75–79|0.579|0.557|0.6
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|80–84|0.47|0.444|0.494
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|85+|0.308|0.285|0.332
Observed|Head and neck cancer (including lip)|2015–2019|Persons|4|All ages combined|0.683|0.677|0.689
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|00–04|||
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|05–09|||
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|10–14|0.962|0.757|0.995
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|15–19|0.932|0.802|0.978
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|20–24|0.809|0.706|0.878
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|25–29|0.856|0.79|0.903
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|30–34|0.897|0.855|0.928
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|35–39|0.883|0.848|0.91
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|40–44|0.866|0.84|0.888
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|45–49|0.821|0.799|0.84
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|50–54|0.789|0.772|0.806
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|55–59|0.742|0.726|0.757
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|60–64|0.701|0.685|0.717
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|65–69|0.653|0.637|0.669
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|70–74|0.579|0.56|0.598
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|75–79|0.529|0.507|0.55
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|80–84|0.403|0.378|0.427
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|85+|0.242|0.221|0.264
Observed|Head and neck cancer (including lip)|2015–2019|Persons|5|All ages combined|0.65|0.644|0.656
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|10–14|1|0.866|1
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|15–19|0.981|0.873|0.998
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|20–24|0.91|0.829|0.954
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|25–29|0.946|0.895|0.973
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|30–34|0.969|0.938|0.985
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|35–39|0.965|0.941|0.98
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|40–44|0.96|0.942|0.972
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|45–49|0.95|0.937|0.961
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|50–54|0.936|0.925|0.946
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|55–59|0.913|0.902|0.923
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|60–64|0.897|0.886|0.907
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|65–69|0.869|0.856|0.88
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|70–74|0.854|0.84|0.867
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|75–79|0.822|0.803|0.839
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|80–84|0.789|0.765|0.811
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|85+|0.693|0.664|0.721
Relative|Head and neck cancer (including lip)|2015–2019|Persons|1|All ages combined|0.876|0.872|0.881
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|10–14|1|0.873|1
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|15–19|0.982|0.874|0.998
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|20–24|0.86|0.766|0.919
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|25–29|0.901|0.841|0.94
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|30–34|0.94|0.904|0.964
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|35–39|0.927|0.896|0.949
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|40–44|0.917|0.895|0.935
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|45–49|0.899|0.881|0.914
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|50–54|0.885|0.87|0.898
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|55–59|0.854|0.841|0.866
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|60–64|0.825|0.811|0.838
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|65–69|0.797|0.782|0.81
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|70–74|0.766|0.748|0.782
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|75–79|0.751|0.729|0.771
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|80–84|0.695|0.667|0.722
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|85+|0.626|0.592|0.659
Relative|Head and neck cancer (including lip)|2015–2019|Persons|2|All ages combined|0.809|0.804|0.815
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|10–14|1|0.876|1
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|15–19|0.958|0.838|0.99
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|20–24|0.848|0.751|0.909
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|25–29|0.895|0.834|0.935
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|30–34|0.92|0.881|0.948
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|35–39|0.911|0.878|0.936
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|40–44|0.902|0.878|0.922
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|45–49|0.864|0.844|0.882
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|50–54|0.847|0.831|0.862
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|55–59|0.81|0.795|0.824
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|60–64|0.783|0.768|0.797
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|65–69|0.753|0.737|0.768
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|70–74|0.719|0.7|0.737
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|75–79|0.697|0.673|0.719
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|80–84|0.647|0.616|0.676
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|85+|0.599|0.561|0.637
Relative|Head and neck cancer (including lip)|2015–2019|Persons|3|All ages combined|0.769|0.763|0.775
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|10–14|0.962|0.758|0.995
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|15–19|0.933|0.803|0.979
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|20–24|0.81|0.708|0.88
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|25–29|0.87|0.805|0.915
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|30–34|0.907|0.865|0.937
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|35–39|0.903|0.869|0.929
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|40–44|0.886|0.861|0.907
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|45–49|0.841|0.82|0.86
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|50–54|0.819|0.802|0.835
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|55–59|0.781|0.766|0.797
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|60–64|0.751|0.735|0.766
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|65–69|0.721|0.704|0.737
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|70–74|0.68|0.66|0.7
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|75–79|0.667|0.642|0.692
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|80–84|0.611|0.578|0.643
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|85+|0.565|0.523|0.607
Relative|Head and neck cancer (including lip)|2015–2019|Persons|4|All ages combined|0.739|0.733|0.746
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|00–04|||
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|05–09|||
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|10–14|0.963|0.758|0.995
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|15–19|0.934|0.804|0.979
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|20–24|0.811|0.708|0.88
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|25–29|0.859|0.792|0.905
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|30–34|0.901|0.858|0.932
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|35–39|0.888|0.852|0.916
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|40–44|0.873|0.847|0.896
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|45–49|0.831|0.809|0.85
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|50–54|0.804|0.787|0.821
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|55–59|0.764|0.747|0.779
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|60–64|0.732|0.715|0.748
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|65–69|0.698|0.68|0.715
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|70–74|0.645|0.624|0.666
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|75–79|0.639|0.612|0.665
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|80–84|0.572|0.537|0.607
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|85+|0.535|0.488|0.583
Relative|Head and neck cancer (including lip)|2015–2019|Persons|5|All ages combined|0.718|0.711|0.725
Observed|Hodgkin lymphoma|2015–2019|Males|1|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Males|1|05–09|1|0.891|1
Observed|Hodgkin lymphoma|2015–2019|Males|1|10–14|1|0.94|1
Observed|Hodgkin lymphoma|2015–2019|Males|1|15–19|1|0.979|1
Observed|Hodgkin lymphoma|2015–2019|Males|1|20–24|1|0.984|1
Observed|Hodgkin lymphoma|2015–2019|Males|1|25–29|0.994|0.959|0.999
Observed|Hodgkin lymphoma|2015–2019|Males|1|30–34|1|0.982|1
Observed|Hodgkin lymphoma|2015–2019|Males|1|35–39|0.992|0.944|0.999
Observed|Hodgkin lymphoma|2015–2019|Males|1|40–44|0.95|0.891|0.977
Observed|Hodgkin lymphoma|2015–2019|Males|1|45–49|0.966|0.912|0.987
Observed|Hodgkin lymphoma|2015–2019|Males|1|50–54|0.973|0.918|0.991
Observed|Hodgkin lymphoma|2015–2019|Males|1|55–59|0.938|0.875|0.97
Observed|Hodgkin lymphoma|2015–2019|Males|1|60–64|0.89|0.814|0.936
Observed|Hodgkin lymphoma|2015–2019|Males|1|65–69|0.897|0.826|0.94
Observed|Hodgkin lymphoma|2015–2019|Males|1|70–74|0.825|0.742|0.883
Observed|Hodgkin lymphoma|2015–2019|Males|1|75–79|0.632|0.517|0.727
Observed|Hodgkin lymphoma|2015–2019|Males|1|80–84|0.677|0.561|0.768
Observed|Hodgkin lymphoma|2015–2019|Males|1|85+|0.447|0.309|0.576
Observed|Hodgkin lymphoma|2015–2019|Males|1|All ages combined|0.921|0.908|0.932
Observed|Hodgkin lymphoma|2015–2019|Males|2|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Males|2|05–09|1|0.891|1
Observed|Hodgkin lymphoma|2015–2019|Males|2|10–14|1|0.944|1
Observed|Hodgkin lymphoma|2015–2019|Males|2|15–19|0.992|0.947|0.999
Observed|Hodgkin lymphoma|2015–2019|Males|2|20–24|1|0.985|1
Observed|Hodgkin lymphoma|2015–2019|Males|2|25–29|0.988|0.954|0.997
Observed|Hodgkin lymphoma|2015–2019|Males|2|30–34|0.987|0.95|0.997
Observed|Hodgkin lymphoma|2015–2019|Males|2|35–39|0.992|0.944|0.999
Observed|Hodgkin lymphoma|2015–2019|Males|2|40–44|0.95|0.891|0.977
Observed|Hodgkin lymphoma|2015–2019|Males|2|45–49|0.966|0.912|0.987
Observed|Hodgkin lymphoma|2015–2019|Males|2|50–54|0.964|0.908|0.987
Observed|Hodgkin lymphoma|2015–2019|Males|2|55–59|0.91|0.839|0.951
Observed|Hodgkin lymphoma|2015–2019|Males|2|60–64|0.88|0.802|0.928
Observed|Hodgkin lymphoma|2015–2019|Males|2|65–69|0.798|0.712|0.861
Observed|Hodgkin lymphoma|2015–2019|Males|2|70–74|0.744|0.653|0.814
Observed|Hodgkin lymphoma|2015–2019|Males|2|75–79|0.537|0.421|0.64
Observed|Hodgkin lymphoma|2015–2019|Males|2|80–84|0.515|0.4|0.618
Observed|Hodgkin lymphoma|2015–2019|Males|2|85+|||
Observed|Hodgkin lymphoma|2015–2019|Males|2|All ages combined|0.89|0.874|0.903
Observed|Hodgkin lymphoma|2015–2019|Males|3|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Males|3|05–09|1|0.888|1
Observed|Hodgkin lymphoma|2015–2019|Males|3|10–14|1|0.946|1
Observed|Hodgkin lymphoma|2015–2019|Males|3|15–19|0.985|0.941|0.996
Observed|Hodgkin lymphoma|2015–2019|Males|3|20–24|1|0.985|1
Observed|Hodgkin lymphoma|2015–2019|Males|3|25–29|0.988|0.954|0.997
Observed|Hodgkin lymphoma|2015–2019|Males|3|30–34|0.987|0.95|0.997
Observed|Hodgkin lymphoma|2015–2019|Males|3|35–39|0.976|0.928|0.992
Observed|Hodgkin lymphoma|2015–2019|Males|3|40–44|0.928|0.861|0.964
Observed|Hodgkin lymphoma|2015–2019|Males|3|45–49|0.956|0.897|0.981
Observed|Hodgkin lymphoma|2015–2019|Males|3|50–54|0.948|0.889|0.976
Observed|Hodgkin lymphoma|2015–2019|Males|3|55–59|0.9|0.827|0.944
Observed|Hodgkin lymphoma|2015–2019|Males|3|60–64|0.821|0.733|0.882
Observed|Hodgkin lymphoma|2015–2019|Males|3|65–69|0.747|0.656|0.816
Observed|Hodgkin lymphoma|2015–2019|Males|3|70–74|0.704|0.609|0.78
Observed|Hodgkin lymphoma|2015–2019|Males|3|75–79|0.485|0.371|0.59
Observed|Hodgkin lymphoma|2015–2019|Males|3|80–84|0.502|0.388|0.606
Observed|Hodgkin lymphoma|2015–2019|Males|3|85+|||
Observed|Hodgkin lymphoma|2015–2019|Males|3|All ages combined|0.871|0.855|0.885
Observed|Hodgkin lymphoma|2015–2019|Males|4|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Males|4|05–09|1|0.887|1
Observed|Hodgkin lymphoma|2015–2019|Males|4|10–14|1|0.949|1
Observed|Hodgkin lymphoma|2015–2019|Males|4|15–19|0.985|0.941|0.996
Observed|Hodgkin lymphoma|2015–2019|Males|4|20–24|0.995|0.963|0.999
Observed|Hodgkin lymphoma|2015–2019|Males|4|25–29|0.977|0.941|0.991
Observed|Hodgkin lymphoma|2015–2019|Males|4|30–34|0.987|0.95|0.997
Observed|Hodgkin lymphoma|2015–2019|Males|4|35–39|0.969|0.919|0.988
Observed|Hodgkin lymphoma|2015–2019|Males|4|40–44|0.928|0.861|0.964
Observed|Hodgkin lymphoma|2015–2019|Males|4|45–49|0.946|0.883|0.975
Observed|Hodgkin lymphoma|2015–2019|Males|4|50–54|0.94|0.878|0.971
Observed|Hodgkin lymphoma|2015–2019|Males|4|55–59|0.86|0.779|0.914
Observed|Hodgkin lymphoma|2015–2019|Males|4|60–64|0.811|0.722|0.874
Observed|Hodgkin lymphoma|2015–2019|Males|4|65–69|0.729|0.637|0.801
Observed|Hodgkin lymphoma|2015–2019|Males|4|70–74|0.66|0.561|0.741
Observed|Hodgkin lymphoma|2015–2019|Males|4|75–79|0.473|0.359|0.578
Observed|Hodgkin lymphoma|2015–2019|Males|4|80–84|0.441|0.328|0.549
Observed|Hodgkin lymphoma|2015–2019|Males|4|85+|||
Observed|Hodgkin lymphoma|2015–2019|Males|4|All ages combined|0.857|0.84|0.872
Observed|Hodgkin lymphoma|2015–2019|Males|5|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Males|5|05–09|1|0.887|1
Observed|Hodgkin lymphoma|2015–2019|Males|5|10–14|1|0.95|1
Observed|Hodgkin lymphoma|2015–2019|Males|5|15–19|0.985|0.941|0.996
Observed|Hodgkin lymphoma|2015–2019|Males|5|20–24|0.989|0.958|0.997
Observed|Hodgkin lymphoma|2015–2019|Males|5|25–29|0.966|0.926|0.985
Observed|Hodgkin lymphoma|2015–2019|Males|5|30–34|0.98|0.939|0.993
Observed|Hodgkin lymphoma|2015–2019|Males|5|35–39|0.962|0.91|0.984
Observed|Hodgkin lymphoma|2015–2019|Males|5|40–44|0.917|0.846|0.956
Observed|Hodgkin lymphoma|2015–2019|Males|5|45–49|0.918|0.849|0.957
Observed|Hodgkin lymphoma|2015–2019|Males|5|50–54|0.903|0.832|0.945
Observed|Hodgkin lymphoma|2015–2019|Males|5|55–59|0.841|0.756|0.898
Observed|Hodgkin lymphoma|2015–2019|Males|5|60–64|0.791|0.699|0.857
Observed|Hodgkin lymphoma|2015–2019|Males|5|65–69|0.694|0.601|0.77
Observed|Hodgkin lymphoma|2015–2019|Males|5|70–74|0.586|0.482|0.676
Observed|Hodgkin lymphoma|2015–2019|Males|5|75–79|0.447|0.335|0.553
Observed|Hodgkin lymphoma|2015–2019|Males|5|80–84|0.334|0.225|0.447
Observed|Hodgkin lymphoma|2015–2019|Males|5|85+|||
Observed|Hodgkin lymphoma|2015–2019|Males|5|All ages combined|0.837|0.819|0.853
Relative|Hodgkin lymphoma|2015–2019|Males|1|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Males|1|05–09|1|0.892|1
Relative|Hodgkin lymphoma|2015–2019|Males|1|10–14|1|0.94|1
Relative|Hodgkin lymphoma|2015–2019|Males|1|15–19|1|0.979|1
Relative|Hodgkin lymphoma|2015–2019|Males|1|20–24|1.001|0.985|1.001
Relative|Hodgkin lymphoma|2015–2019|Males|1|25–29|0.995|0.959|1
Relative|Hodgkin lymphoma|2015–2019|Males|1|30–34|1.001|0.982|1.001
Relative|Hodgkin lymphoma|2015–2019|Males|1|35–39|0.993|0.945|1
Relative|Hodgkin lymphoma|2015–2019|Males|1|40–44|0.951|0.893|0.979
Relative|Hodgkin lymphoma|2015–2019|Males|1|45–49|0.968|0.914|0.989
Relative|Hodgkin lymphoma|2015–2019|Males|1|50–54|0.976|0.921|0.995
Relative|Hodgkin lymphoma|2015–2019|Males|1|55–59|0.943|0.88|0.975
Relative|Hodgkin lymphoma|2015–2019|Males|1|60–64|0.897|0.82|0.943
Relative|Hodgkin lymphoma|2015–2019|Males|1|65–69|0.908|0.836|0.952
Relative|Hodgkin lymphoma|2015–2019|Males|1|70–74|0.841|0.757|0.901
Relative|Hodgkin lymphoma|2015–2019|Males|1|75–79|0.653|0.534|0.751
Relative|Hodgkin lymphoma|2015–2019|Males|1|80–84|0.719|0.596|0.816
Relative|Hodgkin lymphoma|2015–2019|Males|1|85+|0.503|0.348|0.647
Relative|Hodgkin lymphoma|2015–2019|Males|1|All ages combined|0.93|0.917|0.941
Relative|Hodgkin lymphoma|2015–2019|Males|2|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Males|2|05–09|1|0.891|1
Relative|Hodgkin lymphoma|2015–2019|Males|2|10–14|1|0.944|1
Relative|Hodgkin lymphoma|2015–2019|Males|2|15–19|0.993|0.948|1
Relative|Hodgkin lymphoma|2015–2019|Males|2|20–24|1.001|0.986|1.001
Relative|Hodgkin lymphoma|2015–2019|Males|2|25–29|0.99|0.955|0.998
Relative|Hodgkin lymphoma|2015–2019|Males|2|30–34|0.989|0.951|0.999
Relative|Hodgkin lymphoma|2015–2019|Males|2|35–39|0.994|0.946|1.001
Relative|Hodgkin lymphoma|2015–2019|Males|2|40–44|0.953|0.894|0.98
Relative|Hodgkin lymphoma|2015–2019|Males|2|45–49|0.971|0.916|0.992
Relative|Hodgkin lymphoma|2015–2019|Males|2|50–54|0.971|0.915|0.994
Relative|Hodgkin lymphoma|2015–2019|Males|2|55–59|0.92|0.848|0.961
Relative|Hodgkin lymphoma|2015–2019|Males|2|60–64|0.895|0.816|0.944
Relative|Hodgkin lymphoma|2015–2019|Males|2|65–69|0.819|0.731|0.884
Relative|Hodgkin lymphoma|2015–2019|Males|2|70–74|0.775|0.68|0.848
Relative|Hodgkin lymphoma|2015–2019|Males|2|75–79|0.575|0.45|0.685
Relative|Hodgkin lymphoma|2015–2019|Males|2|80–84|0.584|0.454|0.701
Relative|Hodgkin lymphoma|2015–2019|Males|2|85+|||
Relative|Hodgkin lymphoma|2015–2019|Males|2|All ages combined|0.906|0.89|0.919
Relative|Hodgkin lymphoma|2015–2019|Males|3|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Males|3|05–09|1|0.888|1
Relative|Hodgkin lymphoma|2015–2019|Males|3|10–14|1.001|0.947|1.001
Relative|Hodgkin lymphoma|2015–2019|Males|3|15–19|0.986|0.942|0.998
Relative|Hodgkin lymphoma|2015–2019|Males|3|20–24|1.002|0.987|1.002
Relative|Hodgkin lymphoma|2015–2019|Males|3|25–29|0.99|0.956|0.999
Relative|Hodgkin lymphoma|2015–2019|Males|3|30–34|0.99|0.952|0.999
Relative|Hodgkin lymphoma|2015–2019|Males|3|35–39|0.98|0.932|0.996
Relative|Hodgkin lymphoma|2015–2019|Males|3|40–44|0.933|0.866|0.969
Relative|Hodgkin lymphoma|2015–2019|Males|3|45–49|0.963|0.903|0.989
Relative|Hodgkin lymphoma|2015–2019|Males|3|50–54|0.959|0.899|0.988
Relative|Hodgkin lymphoma|2015–2019|Males|3|55–59|0.916|0.842|0.96
Relative|Hodgkin lymphoma|2015–2019|Males|3|60–64|0.842|0.752|0.905
Relative|Hodgkin lymphoma|2015–2019|Males|3|65–69|0.777|0.683|0.85
Relative|Hodgkin lymphoma|2015–2019|Males|3|70–74|0.751|0.65|0.832
Relative|Hodgkin lymphoma|2015–2019|Males|3|75–79|0.54|0.413|0.657
Relative|Hodgkin lymphoma|2015–2019|Males|3|80–84|0.613|0.474|0.74
Relative|Hodgkin lymphoma|2015–2019|Males|3|85+|||
Relative|Hodgkin lymphoma|2015–2019|Males|3|All ages combined|0.893|0.877|0.908
Relative|Hodgkin lymphoma|2015–2019|Males|4|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Males|4|05–09|1|0.887|1
Relative|Hodgkin lymphoma|2015–2019|Males|4|10–14|1.001|0.95|1.001
Relative|Hodgkin lymphoma|2015–2019|Males|4|15–19|0.987|0.943|0.998
Relative|Hodgkin lymphoma|2015–2019|Males|4|20–24|0.997|0.965|1.002
Relative|Hodgkin lymphoma|2015–2019|Males|4|25–29|0.98|0.943|0.994
Relative|Hodgkin lymphoma|2015–2019|Males|4|30–34|0.991|0.953|1
Relative|Hodgkin lymphoma|2015–2019|Males|4|35–39|0.974|0.924|0.993
Relative|Hodgkin lymphoma|2015–2019|Males|4|40–44|0.935|0.867|0.971
Relative|Hodgkin lymphoma|2015–2019|Males|4|45–49|0.956|0.893|0.986
Relative|Hodgkin lymphoma|2015–2019|Males|4|50–54|0.955|0.892|0.986
Relative|Hodgkin lymphoma|2015–2019|Males|4|55–59|0.881|0.798|0.936
Relative|Hodgkin lymphoma|2015–2019|Males|4|60–64|0.841|0.749|0.906
Relative|Hodgkin lymphoma|2015–2019|Males|4|65–69|0.771|0.674|0.847
Relative|Hodgkin lymphoma|2015–2019|Males|4|70–74|0.723|0.615|0.812
Relative|Hodgkin lymphoma|2015–2019|Males|4|75–79|0.551|0.418|0.674
Relative|Hodgkin lymphoma|2015–2019|Males|4|80–84|0.585|0.435|0.727
Relative|Hodgkin lymphoma|2015–2019|Males|4|85+|||
Relative|Hodgkin lymphoma|2015–2019|Males|4|All ages combined|0.886|0.868|0.901
Relative|Hodgkin lymphoma|2015–2019|Males|5|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Males|5|05–09|1|0.888|1
Relative|Hodgkin lymphoma|2015–2019|Males|5|10–14|1.001|0.951|1.001
Relative|Hodgkin lymphoma|2015–2019|Males|5|15–19|0.987|0.943|0.999
Relative|Hodgkin lymphoma|2015–2019|Males|5|20–24|0.992|0.961|1
Relative|Hodgkin lymphoma|2015–2019|Males|5|25–29|0.97|0.929|0.988
Relative|Hodgkin lymphoma|2015–2019|Males|5|30–34|0.985|0.943|0.998
Relative|Hodgkin lymphoma|2015–2019|Males|5|35–39|0.968|0.916|0.99
Relative|Hodgkin lymphoma|2015–2019|Males|5|40–44|0.926|0.854|0.965
Relative|Hodgkin lymphoma|2015–2019|Males|5|45–49|0.931|0.86|0.97
Relative|Hodgkin lymphoma|2015–2019|Males|5|50–54|0.922|0.849|0.965
Relative|Hodgkin lymphoma|2015–2019|Males|5|55–59|0.868|0.781|0.927
Relative|Hodgkin lymphoma|2015–2019|Males|5|60–64|0.829|0.733|0.898
Relative|Hodgkin lymphoma|2015–2019|Males|5|65–69|0.747|0.647|0.829
Relative|Hodgkin lymphoma|2015–2019|Males|5|70–74|0.662|0.545|0.763
Relative|Hodgkin lymphoma|2015–2019|Males|5|75–79|0.548|0.41|0.677
Relative|Hodgkin lymphoma|2015–2019|Males|5|80–84|0.485|0.327|0.648
Relative|Hodgkin lymphoma|2015–2019|Males|5|85+|||
Relative|Hodgkin lymphoma|2015–2019|Males|5|All ages combined|0.871|0.853|0.888
Observed|Hodgkin lymphoma|2015–2019|Females|1|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Females|1|05–09|||
Observed|Hodgkin lymphoma|2015–2019|Females|1|10–14|1|0.939|1
Observed|Hodgkin lymphoma|2015–2019|Females|1|15–19|1|0.981|1
Observed|Hodgkin lymphoma|2015–2019|Females|1|20–24|0.995|0.963|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|1|25–29|1|0.984|1
Observed|Hodgkin lymphoma|2015–2019|Females|1|30–34|1|0.981|1
Observed|Hodgkin lymphoma|2015–2019|Females|1|35–39|1|0.979|1
Observed|Hodgkin lymphoma|2015–2019|Females|1|40–44|1|0.956|1
Observed|Hodgkin lymphoma|2015–2019|Females|1|45–49|0.981|0.871|0.997
Observed|Hodgkin lymphoma|2015–2019|Females|1|50–54|1|0.959|1
Observed|Hodgkin lymphoma|2015–2019|Females|1|55–59|0.966|0.869|0.991
Observed|Hodgkin lymphoma|2015–2019|Females|1|60–64|0.926|0.831|0.968
Observed|Hodgkin lymphoma|2015–2019|Females|1|65–69|0.96|0.882|0.987
Observed|Hodgkin lymphoma|2015–2019|Females|1|70–74|0.742|0.622|0.828
Observed|Hodgkin lymphoma|2015–2019|Females|1|75–79|0.694|0.567|0.79
Observed|Hodgkin lymphoma|2015–2019|Females|1|80–84|0.629|0.479|0.746
Observed|Hodgkin lymphoma|2015–2019|Females|1|85+|0.534|0.382|0.664
Observed|Hodgkin lymphoma|2015–2019|Females|1|All ages combined|0.941|0.928|0.952
Observed|Hodgkin lymphoma|2015–2019|Females|2|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Females|2|05–09|||
Observed|Hodgkin lymphoma|2015–2019|Females|2|10–14|1|0.937|1
Observed|Hodgkin lymphoma|2015–2019|Females|2|15–19|0.994|0.958|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|2|20–24|0.995|0.963|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|2|25–29|0.994|0.96|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|2|30–34|0.994|0.956|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|2|35–39|1|0.978|1
Observed|Hodgkin lymphoma|2015–2019|Females|2|40–44|0.987|0.91|0.998
Observed|Hodgkin lymphoma|2015–2019|Females|2|45–49|0.965|0.866|0.991
Observed|Hodgkin lymphoma|2015–2019|Females|2|50–54|0.987|0.911|0.998
Observed|Hodgkin lymphoma|2015–2019|Females|2|55–59|0.931|0.826|0.974
Observed|Hodgkin lymphoma|2015–2019|Females|2|60–64|0.926|0.831|0.968
Observed|Hodgkin lymphoma|2015–2019|Females|2|65–69|0.947|0.865|0.98
Observed|Hodgkin lymphoma|2015–2019|Females|2|70–74|0.698|0.575|0.791
Observed|Hodgkin lymphoma|2015–2019|Females|2|75–79|0.623|0.491|0.729
Observed|Hodgkin lymphoma|2015–2019|Females|2|80–84|0.524|0.377|0.653
Observed|Hodgkin lymphoma|2015–2019|Females|2|85+|||
Observed|Hodgkin lymphoma|2015–2019|Females|2|All ages combined|0.921|0.906|0.933
Observed|Hodgkin lymphoma|2015–2019|Females|3|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Females|3|05–09|||
Observed|Hodgkin lymphoma|2015–2019|Females|3|10–14|1|0.934|1
Observed|Hodgkin lymphoma|2015–2019|Females|3|15–19|0.982|0.946|0.994
Observed|Hodgkin lymphoma|2015–2019|Females|3|20–24|0.989|0.957|0.997
Observed|Hodgkin lymphoma|2015–2019|Females|3|25–29|0.994|0.96|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|3|30–34|0.974|0.933|0.99
Observed|Hodgkin lymphoma|2015–2019|Females|3|35–39|0.992|0.945|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|3|40–44|0.975|0.904|0.994
Observed|Hodgkin lymphoma|2015–2019|Females|3|45–49|0.965|0.866|0.991
Observed|Hodgkin lymphoma|2015–2019|Females|3|50–54|0.987|0.911|0.998
Observed|Hodgkin lymphoma|2015–2019|Females|3|55–59|0.883|0.771|0.942
Observed|Hodgkin lymphoma|2015–2019|Females|3|60–64|0.926|0.831|0.968
Observed|Hodgkin lymphoma|2015–2019|Females|3|65–69|0.933|0.845|0.971
Observed|Hodgkin lymphoma|2015–2019|Females|3|70–74|0.638|0.513|0.739
Observed|Hodgkin lymphoma|2015–2019|Females|3|75–79|0.623|0.491|0.729
Observed|Hodgkin lymphoma|2015–2019|Females|3|80–84|0.463|0.32|0.595
Observed|Hodgkin lymphoma|2015–2019|Females|3|85+|||
Observed|Hodgkin lymphoma|2015–2019|Females|3|All ages combined|0.906|0.89|0.92
Observed|Hodgkin lymphoma|2015–2019|Females|4|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Females|4|05–09|||
Observed|Hodgkin lymphoma|2015–2019|Females|4|10–14|0.971|0.809|0.996
Observed|Hodgkin lymphoma|2015–2019|Females|4|15–19|0.976|0.938|0.991
Observed|Hodgkin lymphoma|2015–2019|Females|4|20–24|0.983|0.949|0.995
Observed|Hodgkin lymphoma|2015–2019|Females|4|25–29|0.994|0.96|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|4|30–34|0.974|0.933|0.99
Observed|Hodgkin lymphoma|2015–2019|Females|4|35–39|0.992|0.945|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|4|40–44|0.975|0.904|0.994
Observed|Hodgkin lymphoma|2015–2019|Females|4|45–49|0.922|0.821|0.967
Observed|Hodgkin lymphoma|2015–2019|Females|4|50–54|0.974|0.898|0.993
Observed|Hodgkin lymphoma|2015–2019|Females|4|55–59|0.853|0.737|0.921
Observed|Hodgkin lymphoma|2015–2019|Females|4|60–64|0.909|0.808|0.958
Observed|Hodgkin lymphoma|2015–2019|Females|4|65–69|0.854|0.745|0.919
Observed|Hodgkin lymphoma|2015–2019|Females|4|70–74|0.594|0.469|0.699
Observed|Hodgkin lymphoma|2015–2019|Females|4|75–79|0.537|0.401|0.656
Observed|Hodgkin lymphoma|2015–2019|Females|4|80–84|||
Observed|Hodgkin lymphoma|2015–2019|Females|4|85+|||
Observed|Hodgkin lymphoma|2015–2019|Females|4|All ages combined|0.889|0.871|0.904
Observed|Hodgkin lymphoma|2015–2019|Females|5|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Females|5|05–09|||
Observed|Hodgkin lymphoma|2015–2019|Females|5|10–14|0.971|0.809|0.996
Observed|Hodgkin lymphoma|2015–2019|Females|5|15–19|0.976|0.938|0.991
Observed|Hodgkin lymphoma|2015–2019|Females|5|20–24|0.983|0.949|0.995
Observed|Hodgkin lymphoma|2015–2019|Females|5|25–29|0.994|0.96|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|5|30–34|0.974|0.933|0.99
Observed|Hodgkin lymphoma|2015–2019|Females|5|35–39|0.992|0.945|0.999
Observed|Hodgkin lymphoma|2015–2019|Females|5|40–44|0.975|0.904|0.994
Observed|Hodgkin lymphoma|2015–2019|Females|5|45–49|0.922|0.821|0.967
Observed|Hodgkin lymphoma|2015–2019|Females|5|50–54|0.974|0.898|0.993
Observed|Hodgkin lymphoma|2015–2019|Females|5|55–59|0.807|0.685|0.885
Observed|Hodgkin lymphoma|2015–2019|Females|5|60–64|0.909|0.808|0.958
Observed|Hodgkin lymphoma|2015–2019|Females|5|65–69|0.838|0.725|0.907
Observed|Hodgkin lymphoma|2015–2019|Females|5|70–74|0.579|0.454|0.685
Observed|Hodgkin lymphoma|2015–2019|Females|5|75–79|0.537|0.401|0.656
Observed|Hodgkin lymphoma|2015–2019|Females|5|80–84|||
Observed|Hodgkin lymphoma|2015–2019|Females|5|85+|||
Observed|Hodgkin lymphoma|2015–2019|Females|5|All ages combined|0.883|0.865|0.898
Relative|Hodgkin lymphoma|2015–2019|Females|1|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Females|1|05–09|||
Relative|Hodgkin lymphoma|2015–2019|Females|1|10–14|1|0.939|1
Relative|Hodgkin lymphoma|2015–2019|Females|1|15–19|1|0.981|1
Relative|Hodgkin lymphoma|2015–2019|Females|1|20–24|0.995|0.963|0.999
Relative|Hodgkin lymphoma|2015–2019|Females|1|25–29|1|0.984|1
Relative|Hodgkin lymphoma|2015–2019|Females|1|30–34|1|0.982|1
Relative|Hodgkin lymphoma|2015–2019|Females|1|35–39|1.001|0.979|1.001
Relative|Hodgkin lymphoma|2015–2019|Females|1|40–44|1.001|0.957|1.001
Relative|Hodgkin lymphoma|2015–2019|Females|1|45–49|0.982|0.872|0.999
Relative|Hodgkin lymphoma|2015–2019|Females|1|50–54|1.002|0.961|1.002
Relative|Hodgkin lymphoma|2015–2019|Females|1|55–59|0.969|0.872|0.994
Relative|Hodgkin lymphoma|2015–2019|Females|1|60–64|0.93|0.835|0.973
Relative|Hodgkin lymphoma|2015–2019|Females|1|65–69|0.967|0.888|0.994
Relative|Hodgkin lymphoma|2015–2019|Females|1|70–74|0.751|0.63|0.839
Relative|Hodgkin lymphoma|2015–2019|Females|1|75–79|0.709|0.58|0.807
Relative|Hodgkin lymphoma|2015–2019|Females|1|80–84|0.655|0.499|0.778
Relative|Hodgkin lymphoma|2015–2019|Females|1|85+|0.587|0.42|0.731
Relative|Hodgkin lymphoma|2015–2019|Females|1|All ages combined|0.947|0.934|0.958
Relative|Hodgkin lymphoma|2015–2019|Females|2|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Females|2|05–09|||
Relative|Hodgkin lymphoma|2015–2019|Females|2|10–14|1|0.937|1
Relative|Hodgkin lymphoma|2015–2019|Females|2|15–19|0.994|0.958|1
Relative|Hodgkin lymphoma|2015–2019|Females|2|20–24|0.995|0.963|1
Relative|Hodgkin lymphoma|2015–2019|Females|2|25–29|0.995|0.96|1
Relative|Hodgkin lymphoma|2015–2019|Females|2|30–34|0.995|0.957|1
Relative|Hodgkin lymphoma|2015–2019|Females|2|35–39|1.001|0.979|1.001
Relative|Hodgkin lymphoma|2015–2019|Females|2|40–44|0.989|0.912|1
Relative|Hodgkin lymphoma|2015–2019|Females|2|45–49|0.968|0.868|0.994
Relative|Hodgkin lymphoma|2015–2019|Females|2|50–54|0.991|0.915|1.003
Relative|Hodgkin lymphoma|2015–2019|Females|2|55–59|0.937|0.832|0.98
Relative|Hodgkin lymphoma|2015–2019|Females|2|60–64|0.935|0.84|0.978
Relative|Hodgkin lymphoma|2015–2019|Females|2|65–69|0.961|0.878|0.995
Relative|Hodgkin lymphoma|2015–2019|Females|2|70–74|0.716|0.59|0.812
Relative|Hodgkin lymphoma|2015–2019|Females|2|75–79|0.652|0.515|0.764
Relative|Hodgkin lymphoma|2015–2019|Females|2|80–84|0.573|0.412|0.713
Relative|Hodgkin lymphoma|2015–2019|Females|2|85+|||
Relative|Hodgkin lymphoma|2015–2019|Females|2|All ages combined|0.931|0.916|0.944
Relative|Hodgkin lymphoma|2015–2019|Females|3|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Females|3|05–09|||
Relative|Hodgkin lymphoma|2015–2019|Females|3|10–14|1|0.934|1
Relative|Hodgkin lymphoma|2015–2019|Females|3|15–19|0.983|0.946|0.995
Relative|Hodgkin lymphoma|2015–2019|Females|3|20–24|0.99|0.957|0.998
Relative|Hodgkin lymphoma|2015–2019|Females|3|25–29|0.995|0.96|1
Relative|Hodgkin lymphoma|2015–2019|Females|3|30–34|0.976|0.935|0.992
Relative|Hodgkin lymphoma|2015–2019|Females|3|35–39|0.994|0.947|1.001
Relative|Hodgkin lymphoma|2015–2019|Females|3|40–44|0.978|0.907|0.997
Relative|Hodgkin lymphoma|2015–2019|Females|3|45–49|0.969|0.87|0.996
Relative|Hodgkin lymphoma|2015–2019|Females|3|50–54|0.994|0.917|1.005
Relative|Hodgkin lymphoma|2015–2019|Females|3|55–59|0.892|0.778|0.952
Relative|Hodgkin lymphoma|2015–2019|Females|3|60–64|0.941|0.844|0.984
Relative|Hodgkin lymphoma|2015–2019|Females|3|65–69|0.955|0.866|0.995
Relative|Hodgkin lymphoma|2015–2019|Females|3|70–74|0.665|0.535|0.77
Relative|Hodgkin lymphoma|2015–2019|Females|3|75–79|0.671|0.529|0.786
Relative|Hodgkin lymphoma|2015–2019|Females|3|80–84|0.534|0.369|0.685
Relative|Hodgkin lymphoma|2015–2019|Females|3|85+|||
Relative|Hodgkin lymphoma|2015–2019|Females|3|All ages combined|0.92|0.904|0.934
Relative|Hodgkin lymphoma|2015–2019|Females|4|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Females|4|05–09|||
Relative|Hodgkin lymphoma|2015–2019|Females|4|10–14|0.971|0.81|0.996
Relative|Hodgkin lymphoma|2015–2019|Females|4|15–19|0.977|0.939|0.992
Relative|Hodgkin lymphoma|2015–2019|Females|4|20–24|0.984|0.95|0.996
Relative|Hodgkin lymphoma|2015–2019|Females|4|25–29|0.995|0.961|1
Relative|Hodgkin lymphoma|2015–2019|Females|4|30–34|0.976|0.935|0.992
Relative|Hodgkin lymphoma|2015–2019|Females|4|35–39|0.995|0.948|1.002
Relative|Hodgkin lymphoma|2015–2019|Females|4|40–44|0.979|0.908|0.998
Relative|Hodgkin lymphoma|2015–2019|Females|4|45–49|0.928|0.826|0.973
Relative|Hodgkin lymphoma|2015–2019|Females|4|50–54|0.983|0.907|1.003
Relative|Hodgkin lymphoma|2015–2019|Females|4|55–59|0.865|0.747|0.934
Relative|Hodgkin lymphoma|2015–2019|Females|4|60–64|0.929|0.826|0.979
Relative|Hodgkin lymphoma|2015–2019|Females|4|65–69|0.884|0.771|0.951
Relative|Hodgkin lymphoma|2015–2019|Females|4|70–74|0.63|0.497|0.741
Relative|Hodgkin lymphoma|2015–2019|Females|4|75–79|0.597|0.445|0.729
Relative|Hodgkin lymphoma|2015–2019|Females|4|80–84|||
Relative|Hodgkin lymphoma|2015–2019|Females|4|85+|||
Relative|Hodgkin lymphoma|2015–2019|Females|4|All ages combined|0.907|0.889|0.922
Relative|Hodgkin lymphoma|2015–2019|Females|5|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Females|5|05–09|||
Relative|Hodgkin lymphoma|2015–2019|Females|5|10–14|0.971|0.81|0.997
Relative|Hodgkin lymphoma|2015–2019|Females|5|15–19|0.977|0.939|0.992
Relative|Hodgkin lymphoma|2015–2019|Females|5|20–24|0.985|0.95|0.996
Relative|Hodgkin lymphoma|2015–2019|Females|5|25–29|0.996|0.961|1.001
Relative|Hodgkin lymphoma|2015–2019|Females|5|30–34|0.977|0.936|0.993
Relative|Hodgkin lymphoma|2015–2019|Females|5|35–39|0.996|0.948|1.002
Relative|Hodgkin lymphoma|2015–2019|Females|5|40–44|0.981|0.909|0.999
Relative|Hodgkin lymphoma|2015–2019|Females|5|45–49|0.929|0.828|0.975
Relative|Hodgkin lymphoma|2015–2019|Females|5|50–54|0.986|0.91|1.006
Relative|Hodgkin lymphoma|2015–2019|Females|5|55–59|0.822|0.698|0.901
Relative|Hodgkin lymphoma|2015–2019|Females|5|60–64|0.935|0.832|0.986
Relative|Hodgkin lymphoma|2015–2019|Females|5|65–69|0.876|0.758|0.949
Relative|Hodgkin lymphoma|2015–2019|Females|5|70–74|0.625|0.49|0.74
Relative|Hodgkin lymphoma|2015–2019|Females|5|75–79|0.619|0.462|0.756
Relative|Hodgkin lymphoma|2015–2019|Females|5|80–84|||
Relative|Hodgkin lymphoma|2015–2019|Females|5|85+|||
Relative|Hodgkin lymphoma|2015–2019|Females|5|All ages combined|0.905|0.887|0.921
Observed|Hodgkin lymphoma|2015–2019|Persons|1|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Persons|1|05–09|1|0.918|1
Observed|Hodgkin lymphoma|2015–2019|Persons|1|10–14|1|0.969|1
Observed|Hodgkin lymphoma|2015–2019|Persons|1|15–19|1|0.99|1
Observed|Hodgkin lymphoma|2015–2019|Persons|1|20–24|0.997|0.981|1
Observed|Hodgkin lymphoma|2015–2019|Persons|1|25–29|0.997|0.98|1
Observed|Hodgkin lymphoma|2015–2019|Persons|1|30–34|1|0.991|1
Observed|Hodgkin lymphoma|2015–2019|Persons|1|35–39|0.996|0.973|0.999
Observed|Hodgkin lymphoma|2015–2019|Persons|1|40–44|0.968|0.93|0.985
Observed|Hodgkin lymphoma|2015–2019|Persons|1|45–49|0.97|0.931|0.988
Observed|Hodgkin lymphoma|2015–2019|Persons|1|50–54|0.983|0.949|0.995
Observed|Hodgkin lymphoma|2015–2019|Persons|1|55–59|0.948|0.902|0.972
Observed|Hodgkin lymphoma|2015–2019|Persons|1|60–64|0.904|0.849|0.939
Observed|Hodgkin lymphoma|2015–2019|Persons|1|65–69|0.922|0.874|0.952
Observed|Hodgkin lymphoma|2015–2019|Persons|1|70–74|0.793|0.728|0.845
Observed|Hodgkin lymphoma|2015–2019|Persons|1|75–79|0.66|0.577|0.731
Observed|Hodgkin lymphoma|2015–2019|Persons|1|80–84|0.658|0.569|0.733
Observed|Hodgkin lymphoma|2015–2019|Persons|1|85+|0.488|0.386|0.583
Observed|Hodgkin lymphoma|2015–2019|Persons|1|All ages combined|0.93|0.921|0.938
Observed|Hodgkin lymphoma|2015–2019|Persons|2|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Persons|2|05–09|1|0.914|1
Observed|Hodgkin lymphoma|2015–2019|Persons|2|10–14|1|0.97|1
Observed|Hodgkin lymphoma|2015–2019|Persons|2|15–19|0.993|0.973|0.998
Observed|Hodgkin lymphoma|2015–2019|Persons|2|20–24|0.997|0.981|1
Observed|Hodgkin lymphoma|2015–2019|Persons|2|25–29|0.991|0.973|0.997
Observed|Hodgkin lymphoma|2015–2019|Persons|2|30–34|0.99|0.971|0.997
Observed|Hodgkin lymphoma|2015–2019|Persons|2|35–39|0.996|0.973|0.999
Observed|Hodgkin lymphoma|2015–2019|Persons|2|40–44|0.962|0.923|0.982
Observed|Hodgkin lymphoma|2015–2019|Persons|2|45–49|0.965|0.923|0.984
Observed|Hodgkin lymphoma|2015–2019|Persons|2|50–54|0.973|0.937|0.989
Observed|Hodgkin lymphoma|2015–2019|Persons|2|55–59|0.917|0.864|0.95
Observed|Hodgkin lymphoma|2015–2019|Persons|2|60–64|0.898|0.843|0.934
Observed|Hodgkin lymphoma|2015–2019|Persons|2|65–69|0.857|0.799|0.9
Observed|Hodgkin lymphoma|2015–2019|Persons|2|70–74|0.726|0.655|0.785
Observed|Hodgkin lymphoma|2015–2019|Persons|2|75–79|0.575|0.489|0.652
Observed|Hodgkin lymphoma|2015–2019|Persons|2|80–84|0.518|0.428|0.6
Observed|Hodgkin lymphoma|2015–2019|Persons|2|85+|0.281|0.194|0.375
Observed|Hodgkin lymphoma|2015–2019|Persons|2|All ages combined|0.903|0.893|0.913
Observed|Hodgkin lymphoma|2015–2019|Persons|3|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Persons|3|05–09|1|0.91|1
Observed|Hodgkin lymphoma|2015–2019|Persons|3|10–14|1|0.97|1
Observed|Hodgkin lymphoma|2015–2019|Persons|3|15–19|0.983|0.96|0.993
Observed|Hodgkin lymphoma|2015–2019|Persons|3|20–24|0.995|0.979|0.999
Observed|Hodgkin lymphoma|2015–2019|Persons|3|25–29|0.991|0.973|0.997
Observed|Hodgkin lymphoma|2015–2019|Persons|3|30–34|0.981|0.957|0.991
Observed|Hodgkin lymphoma|2015–2019|Persons|3|35–39|0.984|0.959|0.994
Observed|Hodgkin lymphoma|2015–2019|Persons|3|40–44|0.946|0.902|0.97
Observed|Hodgkin lymphoma|2015–2019|Persons|3|45–49|0.959|0.915|0.98
Observed|Hodgkin lymphoma|2015–2019|Persons|3|50–54|0.963|0.925|0.982
Observed|Hodgkin lymphoma|2015–2019|Persons|3|55–59|0.893|0.836|0.931
Observed|Hodgkin lymphoma|2015–2019|Persons|3|60–64|0.862|0.802|0.906
Observed|Hodgkin lymphoma|2015–2019|Persons|3|65–69|0.82|0.757|0.868
Observed|Hodgkin lymphoma|2015–2019|Persons|3|70–74|0.679|0.605|0.741
Observed|Hodgkin lymphoma|2015–2019|Persons|3|75–79|0.544|0.458|0.622
Observed|Hodgkin lymphoma|2015–2019|Persons|3|80–84|0.487|0.398|0.57
Observed|Hodgkin lymphoma|2015–2019|Persons|3|85+|0.198|0.123|0.286
Observed|Hodgkin lymphoma|2015–2019|Persons|3|All ages combined|0.886|0.875|0.897
Observed|Hodgkin lymphoma|2015–2019|Persons|4|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Persons|4|05–09|1|0.909|1
Observed|Hodgkin lymphoma|2015–2019|Persons|4|10–14|0.99|0.931|0.999
Observed|Hodgkin lymphoma|2015–2019|Persons|4|15–19|0.98|0.956|0.991
Observed|Hodgkin lymphoma|2015–2019|Persons|4|20–24|0.989|0.971|0.996
Observed|Hodgkin lymphoma|2015–2019|Persons|4|25–29|0.986|0.966|0.994
Observed|Hodgkin lymphoma|2015–2019|Persons|4|30–34|0.981|0.957|0.991
Observed|Hodgkin lymphoma|2015–2019|Persons|4|35–39|0.98|0.953|0.992
Observed|Hodgkin lymphoma|2015–2019|Persons|4|40–44|0.946|0.902|0.97
Observed|Hodgkin lymphoma|2015–2019|Persons|4|45–49|0.935|0.886|0.964
Observed|Hodgkin lymphoma|2015–2019|Persons|4|50–54|0.953|0.911|0.975
Observed|Hodgkin lymphoma|2015–2019|Persons|4|55–59|0.857|0.795|0.902
Observed|Hodgkin lymphoma|2015–2019|Persons|4|60–64|0.85|0.787|0.895
Observed|Hodgkin lymphoma|2015–2019|Persons|4|65–69|0.779|0.712|0.833
Observed|Hodgkin lymphoma|2015–2019|Persons|4|70–74|0.634|0.558|0.701
Observed|Hodgkin lymphoma|2015–2019|Persons|4|75–79|0.504|0.418|0.584
Observed|Hodgkin lymphoma|2015–2019|Persons|4|80–84|0.423|0.335|0.508
Observed|Hodgkin lymphoma|2015–2019|Persons|4|85+|0.16|0.093|0.245
Observed|Hodgkin lymphoma|2015–2019|Persons|4|All ages combined|0.871|0.859|0.882
Observed|Hodgkin lymphoma|2015–2019|Persons|5|00–04|||
Observed|Hodgkin lymphoma|2015–2019|Persons|5|05–09|1|0.909|1
Observed|Hodgkin lymphoma|2015–2019|Persons|5|10–14|0.99|0.931|0.999
Observed|Hodgkin lymphoma|2015–2019|Persons|5|15–19|0.98|0.956|0.991
Observed|Hodgkin lymphoma|2015–2019|Persons|5|20–24|0.986|0.967|0.994
Observed|Hodgkin lymphoma|2015–2019|Persons|5|25–29|0.98|0.958|0.99
Observed|Hodgkin lymphoma|2015–2019|Persons|5|30–34|0.977|0.952|0.989
Observed|Hodgkin lymphoma|2015–2019|Persons|5|35–39|0.976|0.948|0.989
Observed|Hodgkin lymphoma|2015–2019|Persons|5|40–44|0.94|0.895|0.967
Observed|Hodgkin lymphoma|2015–2019|Persons|5|45–49|0.919|0.867|0.951
Observed|Hodgkin lymphoma|2015–2019|Persons|5|50–54|0.931|0.884|0.959
Observed|Hodgkin lymphoma|2015–2019|Persons|5|55–59|0.827|0.761|0.877
Observed|Hodgkin lymphoma|2015–2019|Persons|5|60–64|0.837|0.773|0.885
Observed|Hodgkin lymphoma|2015–2019|Persons|5|65–69|0.751|0.682|0.807
Observed|Hodgkin lymphoma|2015–2019|Persons|5|70–74|0.586|0.508|0.656
Observed|Hodgkin lymphoma|2015–2019|Persons|5|75–79|0.487|0.401|0.568
Observed|Hodgkin lymphoma|2015–2019|Persons|5|80–84|0.339|0.255|0.424
Observed|Hodgkin lymphoma|2015–2019|Persons|5|85+|0.16|0.093|0.245
Observed|Hodgkin lymphoma|2015–2019|Persons|5|All ages combined|0.858|0.845|0.869
Relative|Hodgkin lymphoma|2015–2019|Persons|1|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Persons|1|05–09|1|0.918|1
Relative|Hodgkin lymphoma|2015–2019|Persons|1|10–14|1|0.969|1
Relative|Hodgkin lymphoma|2015–2019|Persons|1|15–19|1|0.99|1
Relative|Hodgkin lymphoma|2015–2019|Persons|1|20–24|0.998|0.982|1
Relative|Hodgkin lymphoma|2015–2019|Persons|1|25–29|0.998|0.981|1
Relative|Hodgkin lymphoma|2015–2019|Persons|1|30–34|1.001|0.991|1.001
Relative|Hodgkin lymphoma|2015–2019|Persons|1|35–39|0.997|0.974|1
Relative|Hodgkin lymphoma|2015–2019|Persons|1|40–44|0.969|0.931|0.987
Relative|Hodgkin lymphoma|2015–2019|Persons|1|45–49|0.972|0.932|0.99
Relative|Hodgkin lymphoma|2015–2019|Persons|1|50–54|0.986|0.952|0.998
Relative|Hodgkin lymphoma|2015–2019|Persons|1|55–59|0.952|0.906|0.977
Relative|Hodgkin lymphoma|2015–2019|Persons|1|60–64|0.91|0.855|0.945
Relative|Hodgkin lymphoma|2015–2019|Persons|1|65–69|0.931|0.883|0.962
Relative|Hodgkin lymphoma|2015–2019|Persons|1|70–74|0.807|0.74|0.859
Relative|Hodgkin lymphoma|2015–2019|Persons|1|75–79|0.679|0.593|0.751
Relative|Hodgkin lymphoma|2015–2019|Persons|1|80–84|0.694|0.6|0.773
Relative|Hodgkin lymphoma|2015–2019|Persons|1|85+|0.543|0.43|0.648
Relative|Hodgkin lymphoma|2015–2019|Persons|1|All ages combined|0.938|0.928|0.946
Relative|Hodgkin lymphoma|2015–2019|Persons|2|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Persons|2|05–09|1|0.914|1
Relative|Hodgkin lymphoma|2015–2019|Persons|2|10–14|1|0.97|1
Relative|Hodgkin lymphoma|2015–2019|Persons|2|15–19|0.994|0.974|0.999
Relative|Hodgkin lymphoma|2015–2019|Persons|2|20–24|0.998|0.982|1
Relative|Hodgkin lymphoma|2015–2019|Persons|2|25–29|0.992|0.974|0.998
Relative|Hodgkin lymphoma|2015–2019|Persons|2|30–34|0.992|0.972|0.998
Relative|Hodgkin lymphoma|2015–2019|Persons|2|35–39|0.998|0.975|1.001
Relative|Hodgkin lymphoma|2015–2019|Persons|2|40–44|0.965|0.925|0.985
Relative|Hodgkin lymphoma|2015–2019|Persons|2|45–49|0.969|0.927|0.988
Relative|Hodgkin lymphoma|2015–2019|Persons|2|50–54|0.979|0.943|0.995
Relative|Hodgkin lymphoma|2015–2019|Persons|2|55–59|0.926|0.872|0.959
Relative|Hodgkin lymphoma|2015–2019|Persons|2|60–64|0.91|0.855|0.948
Relative|Hodgkin lymphoma|2015–2019|Persons|2|65–69|0.876|0.816|0.92
Relative|Hodgkin lymphoma|2015–2019|Persons|2|70–74|0.753|0.679|0.813
Relative|Hodgkin lymphoma|2015–2019|Persons|2|75–79|0.61|0.519|0.691
Relative|Hodgkin lymphoma|2015–2019|Persons|2|80–84|0.579|0.479|0.671
Relative|Hodgkin lymphoma|2015–2019|Persons|2|85+|0.351|0.242|0.469
Relative|Hodgkin lymphoma|2015–2019|Persons|2|All ages combined|0.917|0.907|0.927
Relative|Hodgkin lymphoma|2015–2019|Persons|3|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Persons|3|05–09|1|0.91|1
Relative|Hodgkin lymphoma|2015–2019|Persons|3|10–14|1|0.97|1
Relative|Hodgkin lymphoma|2015–2019|Persons|3|15–19|0.984|0.961|0.994
Relative|Hodgkin lymphoma|2015–2019|Persons|3|20–24|0.996|0.98|1
Relative|Hodgkin lymphoma|2015–2019|Persons|3|25–29|0.993|0.975|0.999
Relative|Hodgkin lymphoma|2015–2019|Persons|3|30–34|0.983|0.959|0.993
Relative|Hodgkin lymphoma|2015–2019|Persons|3|35–39|0.987|0.962|0.997
Relative|Hodgkin lymphoma|2015–2019|Persons|3|40–44|0.95|0.905|0.975
Relative|Hodgkin lymphoma|2015–2019|Persons|3|45–49|0.965|0.921|0.986
Relative|Hodgkin lymphoma|2015–2019|Persons|3|50–54|0.973|0.933|0.992
Relative|Hodgkin lymphoma|2015–2019|Persons|3|55–59|0.906|0.848|0.945
Relative|Hodgkin lymphoma|2015–2019|Persons|3|60–64|0.881|0.819|0.926
Relative|Hodgkin lymphoma|2015–2019|Persons|3|65–69|0.848|0.783|0.897
Relative|Hodgkin lymphoma|2015–2019|Persons|3|70–74|0.718|0.64|0.784
Relative|Hodgkin lymphoma|2015–2019|Persons|3|75–79|0.597|0.502|0.683
Relative|Hodgkin lymphoma|2015–2019|Persons|3|80–84|0.581|0.475|0.68
Relative|Hodgkin lymphoma|2015–2019|Persons|3|85+|0.28|0.174|0.404
Relative|Hodgkin lymphoma|2015–2019|Persons|3|All ages combined|0.905|0.894|0.916
Relative|Hodgkin lymphoma|2015–2019|Persons|4|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Persons|4|05–09|1|0.909|1
Relative|Hodgkin lymphoma|2015–2019|Persons|4|10–14|0.991|0.932|0.999
Relative|Hodgkin lymphoma|2015–2019|Persons|4|15–19|0.981|0.958|0.992
Relative|Hodgkin lymphoma|2015–2019|Persons|4|20–24|0.991|0.973|0.998
Relative|Hodgkin lymphoma|2015–2019|Persons|4|25–29|0.988|0.968|0.996
Relative|Hodgkin lymphoma|2015–2019|Persons|4|30–34|0.983|0.96|0.994
Relative|Hodgkin lymphoma|2015–2019|Persons|4|35–39|0.984|0.957|0.996
Relative|Hodgkin lymphoma|2015–2019|Persons|4|40–44|0.951|0.907|0.976
Relative|Hodgkin lymphoma|2015–2019|Persons|4|45–49|0.944|0.894|0.972
Relative|Hodgkin lymphoma|2015–2019|Persons|4|50–54|0.966|0.924|0.988
Relative|Hodgkin lymphoma|2015–2019|Persons|4|55–59|0.875|0.811|0.92
Relative|Hodgkin lymphoma|2015–2019|Persons|4|60–64|0.876|0.812|0.923
Relative|Hodgkin lymphoma|2015–2019|Persons|4|65–69|0.817|0.747|0.873
Relative|Hodgkin lymphoma|2015–2019|Persons|4|70–74|0.686|0.604|0.758
Relative|Hodgkin lymphoma|2015–2019|Persons|4|75–79|0.575|0.477|0.667
Relative|Hodgkin lymphoma|2015–2019|Persons|4|80–84|0.544|0.431|0.653
Relative|Hodgkin lymphoma|2015–2019|Persons|4|85+|0.26|0.15|0.396
Relative|Hodgkin lymphoma|2015–2019|Persons|4|All ages combined|0.895|0.883|0.906
Relative|Hodgkin lymphoma|2015–2019|Persons|5|00–04|||
Relative|Hodgkin lymphoma|2015–2019|Persons|5|05–09|1|0.909|1
Relative|Hodgkin lymphoma|2015–2019|Persons|5|10–14|0.991|0.932|1
Relative|Hodgkin lymphoma|2015–2019|Persons|5|15–19|0.982|0.958|0.993
Relative|Hodgkin lymphoma|2015–2019|Persons|5|20–24|0.989|0.97|0.997
Relative|Hodgkin lymphoma|2015–2019|Persons|5|25–29|0.982|0.96|0.993
Relative|Hodgkin lymphoma|2015–2019|Persons|5|30–34|0.98|0.955|0.992
Relative|Hodgkin lymphoma|2015–2019|Persons|5|35–39|0.981|0.953|0.994
Relative|Hodgkin lymphoma|2015–2019|Persons|5|40–44|0.947|0.902|0.974
Relative|Hodgkin lymphoma|2015–2019|Persons|5|45–49|0.93|0.878|0.963
Relative|Hodgkin lymphoma|2015–2019|Persons|5|50–54|0.947|0.899|0.976
Relative|Hodgkin lymphoma|2015–2019|Persons|5|55–59|0.85|0.782|0.9
Relative|Hodgkin lymphoma|2015–2019|Persons|5|60–64|0.871|0.804|0.92
Relative|Hodgkin lymphoma|2015–2019|Persons|5|65–69|0.799|0.725|0.859
Relative|Hodgkin lymphoma|2015–2019|Persons|5|70–74|0.651|0.564|0.728
Relative|Hodgkin lymphoma|2015–2019|Persons|5|75–79|0.581|0.478|0.678
Relative|Hodgkin lymphoma|2015–2019|Persons|5|80–84|0.473|0.356|0.592
Relative|Hodgkin lymphoma|2015–2019|Persons|5|85+|0.304|0.175|0.463
Relative|Hodgkin lymphoma|2015–2019|Persons|5|All ages combined|0.886|0.874|0.898
Observed|Hypopharyngeal cancer|2015–2019|Males|1|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|50–54|0.785|0.646|0.875
Observed|Hypopharyngeal cancer|2015–2019|Males|1|55–59|0.756|0.653|0.832
Observed|Hypopharyngeal cancer|2015–2019|Males|1|60–64|0.787|0.703|0.849
Observed|Hypopharyngeal cancer|2015–2019|Males|1|65–69|0.703|0.625|0.768
Observed|Hypopharyngeal cancer|2015–2019|Males|1|70–74|0.66|0.572|0.734
Observed|Hypopharyngeal cancer|2015–2019|Males|1|75–79|0.567|0.464|0.657
Observed|Hypopharyngeal cancer|2015–2019|Males|1|80–84|0.597|0.436|0.726
Observed|Hypopharyngeal cancer|2015–2019|Males|1|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Males|1|All ages combined|0.689|0.654|0.721
Observed|Hypopharyngeal cancer|2015–2019|Males|2|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|50–54|0.679|0.536|0.786
Observed|Hypopharyngeal cancer|2015–2019|Males|2|55–59|0.606|0.499|0.697
Observed|Hypopharyngeal cancer|2015–2019|Males|2|60–64|0.698|0.607|0.772
Observed|Hypopharyngeal cancer|2015–2019|Males|2|65–69|0.553|0.472|0.626
Observed|Hypopharyngeal cancer|2015–2019|Males|2|70–74|0.533|0.442|0.616
Observed|Hypopharyngeal cancer|2015–2019|Males|2|75–79|0.428|0.332|0.521
Observed|Hypopharyngeal cancer|2015–2019|Males|2|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Males|2|All ages combined|0.55|0.514|0.585
Observed|Hypopharyngeal cancer|2015–2019|Males|3|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|50–54|0.602|0.458|0.719
Observed|Hypopharyngeal cancer|2015–2019|Males|3|55–59|0.501|0.391|0.601
Observed|Hypopharyngeal cancer|2015–2019|Males|3|60–64|0.597|0.501|0.68
Observed|Hypopharyngeal cancer|2015–2019|Males|3|65–69|0.479|0.399|0.554
Observed|Hypopharyngeal cancer|2015–2019|Males|3|70–74|0.454|0.364|0.539
Observed|Hypopharyngeal cancer|2015–2019|Males|3|75–79|0.355|0.263|0.447
Observed|Hypopharyngeal cancer|2015–2019|Males|3|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Males|3|All ages combined|0.465|0.429|0.5
Observed|Hypopharyngeal cancer|2015–2019|Males|4|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|50–54|0.558|0.413|0.681
Observed|Hypopharyngeal cancer|2015–2019|Males|4|55–59|0.454|0.344|0.558
Observed|Hypopharyngeal cancer|2015–2019|Males|4|60–64|0.549|0.452|0.635
Observed|Hypopharyngeal cancer|2015–2019|Males|4|65–69|0.419|0.342|0.495
Observed|Hypopharyngeal cancer|2015–2019|Males|4|70–74|0.351|0.267|0.436
Observed|Hypopharyngeal cancer|2015–2019|Males|4|75–79|0.318|0.228|0.411
Observed|Hypopharyngeal cancer|2015–2019|Males|4|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Males|4|All ages combined|0.41|0.374|0.446
Observed|Hypopharyngeal cancer|2015–2019|Males|5|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|50–54|0.534|0.389|0.66
Observed|Hypopharyngeal cancer|2015–2019|Males|5|55–59|0.396|0.288|0.501
Observed|Hypopharyngeal cancer|2015–2019|Males|5|60–64|0.506|0.409|0.595
Observed|Hypopharyngeal cancer|2015–2019|Males|5|65–69|0.396|0.319|0.472
Observed|Hypopharyngeal cancer|2015–2019|Males|5|70–74|0.314|0.233|0.398
Observed|Hypopharyngeal cancer|2015–2019|Males|5|75–79|0.252|0.169|0.345
Observed|Hypopharyngeal cancer|2015–2019|Males|5|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Males|5|All ages combined|0.374|0.339|0.41
Relative|Hypopharyngeal cancer|2015–2019|Males|1|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|50–54|0.788|0.648|0.878
Relative|Hypopharyngeal cancer|2015–2019|Males|1|55–59|0.76|0.657|0.836
Relative|Hypopharyngeal cancer|2015–2019|Males|1|60–64|0.793|0.709|0.856
Relative|Hypopharyngeal cancer|2015–2019|Males|1|65–69|0.711|0.632|0.777
Relative|Hypopharyngeal cancer|2015–2019|Males|1|70–74|0.673|0.583|0.748
Relative|Hypopharyngeal cancer|2015–2019|Males|1|75–79|0.586|0.48|0.68
Relative|Hypopharyngeal cancer|2015–2019|Males|1|80–84|0.633|0.462|0.769
Relative|Hypopharyngeal cancer|2015–2019|Males|1|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Males|1|All ages combined|0.703|0.668|0.736
Relative|Hypopharyngeal cancer|2015–2019|Males|2|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|50–54|0.684|0.54|0.792
Relative|Hypopharyngeal cancer|2015–2019|Males|2|55–59|0.613|0.504|0.705
Relative|Hypopharyngeal cancer|2015–2019|Males|2|60–64|0.71|0.617|0.785
Relative|Hypopharyngeal cancer|2015–2019|Males|2|65–69|0.567|0.484|0.642
Relative|Hypopharyngeal cancer|2015–2019|Males|2|70–74|0.555|0.461|0.641
Relative|Hypopharyngeal cancer|2015–2019|Males|2|75–79|0.46|0.356|0.559
Relative|Hypopharyngeal cancer|2015–2019|Males|2|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Males|2|All ages combined|0.573|0.535|0.609
Relative|Hypopharyngeal cancer|2015–2019|Males|3|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|50–54|0.609|0.463|0.727
Relative|Hypopharyngeal cancer|2015–2019|Males|3|55–59|0.509|0.398|0.611
Relative|Hypopharyngeal cancer|2015–2019|Males|3|60–64|0.612|0.514|0.698
Relative|Hypopharyngeal cancer|2015–2019|Males|3|65–69|0.498|0.415|0.576
Relative|Hypopharyngeal cancer|2015–2019|Males|3|70–74|0.484|0.389|0.575
Relative|Hypopharyngeal cancer|2015–2019|Males|3|75–79|0.396|0.294|0.5
Relative|Hypopharyngeal cancer|2015–2019|Males|3|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Males|3|All ages combined|0.494|0.455|0.532
Relative|Hypopharyngeal cancer|2015–2019|Males|4|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|50–54|0.567|0.42|0.692
Relative|Hypopharyngeal cancer|2015–2019|Males|4|55–59|0.466|0.353|0.572
Relative|Hypopharyngeal cancer|2015–2019|Males|4|60–64|0.569|0.469|0.658
Relative|Hypopharyngeal cancer|2015–2019|Males|4|65–69|0.443|0.361|0.523
Relative|Hypopharyngeal cancer|2015–2019|Males|4|70–74|0.385|0.293|0.477
Relative|Hypopharyngeal cancer|2015–2019|Males|4|75–79|0.371|0.267|0.48
Relative|Hypopharyngeal cancer|2015–2019|Males|4|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Males|4|All ages combined|0.445|0.406|0.484
Relative|Hypopharyngeal cancer|2015–2019|Males|5|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|50–54|0.546|0.397|0.674
Relative|Hypopharyngeal cancer|2015–2019|Males|5|55–59|0.408|0.297|0.518
Relative|Hypopharyngeal cancer|2015–2019|Males|5|60–64|0.531|0.429|0.624
Relative|Hypopharyngeal cancer|2015–2019|Males|5|65–69|0.426|0.343|0.508
Relative|Hypopharyngeal cancer|2015–2019|Males|5|70–74|0.354|0.262|0.449
Relative|Hypopharyngeal cancer|2015–2019|Males|5|75–79|0.31|0.207|0.424
Relative|Hypopharyngeal cancer|2015–2019|Males|5|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Males|5|All ages combined|0.415|0.376|0.455
Observed|Hypopharyngeal cancer|2015–2019|Females|1|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|50–54|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|55–59|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|60–64|0.84|0.658|0.93
Observed|Hypopharyngeal cancer|2015–2019|Females|1|65–69|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|70–74|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|75–79|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Females|1|All ages combined|0.566|0.48|0.644
Observed|Hypopharyngeal cancer|2015–2019|Females|2|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|50–54|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|55–59|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|60–64|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|65–69|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|70–74|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|75–79|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Females|2|All ages combined|0.415|0.333|0.495
Observed|Hypopharyngeal cancer|2015–2019|Females|3|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|50–54|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|55–59|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|60–64|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|65–69|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|70–74|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|75–79|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Females|3|All ages combined|0.371|0.292|0.449
Observed|Hypopharyngeal cancer|2015–2019|Females|4|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|50–54|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|55–59|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|60–64|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|65–69|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|70–74|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|75–79|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Females|4|All ages combined|0.334|0.259|0.411
Observed|Hypopharyngeal cancer|2015–2019|Females|5|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|50–54|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|55–59|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|60–64|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|65–69|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|70–74|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|75–79|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Females|5|All ages combined|0.291|0.221|0.365
Relative|Hypopharyngeal cancer|2015–2019|Females|1|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|50–54|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|55–59|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|60–64|0.844|0.661|0.935
Relative|Hypopharyngeal cancer|2015–2019|Females|1|65–69|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|70–74|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|75–79|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Females|1|All ages combined|0.576|0.488|0.654
Relative|Hypopharyngeal cancer|2015–2019|Females|2|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|50–54|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|55–59|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|60–64|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|65–69|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|70–74|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|75–79|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Females|2|All ages combined|0.428|0.343|0.511
Relative|Hypopharyngeal cancer|2015–2019|Females|3|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|50–54|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|55–59|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|60–64|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|65–69|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|70–74|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|75–79|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Females|3|All ages combined|0.387|0.305|0.469
Relative|Hypopharyngeal cancer|2015–2019|Females|4|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|50–54|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|55–59|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|60–64|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|65–69|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|70–74|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|75–79|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Females|4|All ages combined|0.353|0.274|0.434
Relative|Hypopharyngeal cancer|2015–2019|Females|5|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|50–54|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|55–59|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|60–64|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|65–69|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|70–74|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|75–79|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Females|5|All ages combined|0.313|0.238|0.392
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|45–49|0.786|0.562|0.905
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|50–54|0.766|0.638|0.854
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|55–59|0.721|0.628|0.795
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|60–64|0.798|0.725|0.853
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|65–69|0.677|0.602|0.74
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|70–74|0.637|0.554|0.709
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|75–79|0.554|0.456|0.64
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|80–84|0.571|0.437|0.685
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|1|All ages combined|0.67|0.637|0.699
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|50–54|0.674|0.543|0.776
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|55–59|0.587|0.49|0.671
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|60–64|0.669|0.586|0.738
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|65–69|0.537|0.461|0.607
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|70–74|0.515|0.43|0.592
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|75–79|0.417|0.326|0.504
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|80–84|0.3|0.19|0.417
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|2|All ages combined|0.529|0.496|0.561
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|50–54|0.611|0.478|0.719
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|55–59|0.493|0.395|0.583
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|60–64|0.581|0.496|0.657
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|65–69|0.465|0.391|0.536
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|70–74|0.441|0.358|0.52
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|75–79|0.347|0.262|0.433
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|3|All ages combined|0.451|0.418|0.483
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|50–54|0.574|0.441|0.687
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|55–59|0.444|0.346|0.537
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|60–64|0.528|0.443|0.606
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|65–69|0.414|0.341|0.485
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|70–74|0.346|0.269|0.425
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|75–79|0.308|0.226|0.394
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|4|All ages combined|0.399|0.366|0.431
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|00–04|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|05–09|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|10–14|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|15–19|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|20–24|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|25–29|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|30–34|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|35–39|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|40–44|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|45–49|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|50–54|0.52|0.387|0.637
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|55–59|0.396|0.3|0.492
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|60–64|0.485|0.4|0.566
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|65–69|0.382|0.31|0.453
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|70–74|0.308|0.234|0.386
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|75–79|0.248|0.172|0.332
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|80–84|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|85+|||
Observed|Hypopharyngeal cancer|2015–2019|Persons|5|All ages combined|0.361|0.329|0.393
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|45–49|0.788|0.563|0.907
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|50–54|0.769|0.64|0.857
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|55–59|0.725|0.631|0.799
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|60–64|0.803|0.73|0.859
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|65–69|0.684|0.609|0.749
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|70–74|0.649|0.565|0.722
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|75–79|0.572|0.471|0.661
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|80–84|0.603|0.461|0.723
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|1|All ages combined|0.683|0.65|0.714
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|50–54|0.679|0.546|0.781
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|55–59|0.593|0.495|0.678
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|60–64|0.679|0.595|0.75
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|65–69|0.55|0.472|0.622
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|70–74|0.535|0.447|0.616
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|75–79|0.446|0.349|0.54
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|80–84|0.336|0.214|0.468
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|2|All ages combined|0.55|0.515|0.583
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|50–54|0.617|0.483|0.727
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|55–59|0.501|0.401|0.593
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|60–64|0.595|0.508|0.672
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|65–69|0.483|0.406|0.557
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|70–74|0.469|0.381|0.553
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|75–79|0.386|0.291|0.482
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|3|All ages combined|0.478|0.443|0.512
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|50–54|0.583|0.448|0.697
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|55–59|0.454|0.353|0.55
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|60–64|0.546|0.458|0.627
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|65–69|0.437|0.36|0.512
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|70–74|0.378|0.293|0.463
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|75–79|0.358|0.262|0.457
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|4|All ages combined|0.431|0.396|0.466
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|00–04|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|05–09|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|10–14|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|15–19|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|20–24|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|25–29|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|30–34|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|35–39|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|40–44|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|45–49|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|50–54|0.53|0.394|0.649
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|55–59|0.408|0.308|0.506
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|60–64|0.507|0.417|0.591
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|65–69|0.409|0.332|0.486
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|70–74|0.345|0.262|0.432
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|75–79|0.302|0.209|0.404
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|80–84|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|85+|||
Relative|Hypopharyngeal cancer|2015–2019|Persons|5|All ages combined|0.398|0.363|0.434
Observed|Immunoproliferative cancers|2015–2019|Males|1|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Males|1|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Males|1|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Males|1|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Males|1|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Males|1|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Males|1|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Males|1|35–39|1|0.881|1
Observed|Immunoproliferative cancers|2015–2019|Males|1|40–44|||
Observed|Immunoproliferative cancers|2015–2019|Males|1|45–49|1|0.884|1
Observed|Immunoproliferative cancers|2015–2019|Males|1|50–54|1|0.949|1
Observed|Immunoproliferative cancers|2015–2019|Males|1|55–59|0.972|0.892|0.993
Observed|Immunoproliferative cancers|2015–2019|Males|1|60–64|0.988|0.916|0.998
Observed|Immunoproliferative cancers|2015–2019|Males|1|65–69|0.954|0.9|0.979
Observed|Immunoproliferative cancers|2015–2019|Males|1|70–74|0.974|0.932|0.99
Observed|Immunoproliferative cancers|2015–2019|Males|1|75–79|0.945|0.893|0.972
Observed|Immunoproliferative cancers|2015–2019|Males|1|80–84|0.809|0.72|0.872
Observed|Immunoproliferative cancers|2015–2019|Males|1|85+|0.78|0.681|0.852
Observed|Immunoproliferative cancers|2015–2019|Males|1|All ages combined|0.934|0.916|0.948
Observed|Immunoproliferative cancers|2015–2019|Males|2|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Males|2|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Males|2|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Males|2|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Males|2|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Males|2|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Males|2|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Males|2|35–39|1|0.878|1
Observed|Immunoproliferative cancers|2015–2019|Males|2|40–44|||
Observed|Immunoproliferative cancers|2015–2019|Males|2|45–49|1|0.896|1
Observed|Immunoproliferative cancers|2015–2019|Males|2|50–54|1|0.948|1
Observed|Immunoproliferative cancers|2015–2019|Males|2|55–59|0.957|0.873|0.986
Observed|Immunoproliferative cancers|2015–2019|Males|2|60–64|0.947|0.866|0.98
Observed|Immunoproliferative cancers|2015–2019|Males|2|65–69|0.946|0.89|0.974
Observed|Immunoproliferative cancers|2015–2019|Males|2|70–74|0.966|0.92|0.986
Observed|Immunoproliferative cancers|2015–2019|Males|2|75–79|0.891|0.825|0.933
Observed|Immunoproliferative cancers|2015–2019|Males|2|80–84|0.696|0.594|0.777
Observed|Immunoproliferative cancers|2015–2019|Males|2|85+|0.606|0.497|0.699
Observed|Immunoproliferative cancers|2015–2019|Males|2|All ages combined|0.889|0.867|0.908
Observed|Immunoproliferative cancers|2015–2019|Males|3|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Males|3|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Males|3|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Males|3|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Males|3|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Males|3|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Males|3|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Males|3|35–39|||
Observed|Immunoproliferative cancers|2015–2019|Males|3|40–44|||
Observed|Immunoproliferative cancers|2015–2019|Males|3|45–49|1|0.906|1
Observed|Immunoproliferative cancers|2015–2019|Males|3|50–54|1|0.947|1
Observed|Immunoproliferative cancers|2015–2019|Males|3|55–59|0.957|0.873|0.986
Observed|Immunoproliferative cancers|2015–2019|Males|3|60–64|0.896|0.802|0.946
Observed|Immunoproliferative cancers|2015–2019|Males|3|65–69|0.937|0.879|0.968
Observed|Immunoproliferative cancers|2015–2019|Males|3|70–74|0.929|0.868|0.963
Observed|Immunoproliferative cancers|2015–2019|Males|3|75–79|0.828|0.75|0.884
Observed|Immunoproliferative cancers|2015–2019|Males|3|80–84|0.605|0.498|0.695
Observed|Immunoproliferative cancers|2015–2019|Males|3|85+|0.511|0.4|0.612
Observed|Immunoproliferative cancers|2015–2019|Males|3|All ages combined|0.85|0.824|0.872
Observed|Immunoproliferative cancers|2015–2019|Males|4|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Males|4|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Males|4|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Males|4|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Males|4|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Males|4|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Males|4|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Males|4|35–39|||
Observed|Immunoproliferative cancers|2015–2019|Males|4|40–44|||
Observed|Immunoproliferative cancers|2015–2019|Males|4|45–49|1|0.913|1
Observed|Immunoproliferative cancers|2015–2019|Males|4|50–54|1|0.945|1
Observed|Immunoproliferative cancers|2015–2019|Males|4|55–59|0.957|0.873|0.986
Observed|Immunoproliferative cancers|2015–2019|Males|4|60–64|0.871|0.774|0.929
Observed|Immunoproliferative cancers|2015–2019|Males|4|65–69|0.919|0.854|0.956
Observed|Immunoproliferative cancers|2015–2019|Males|4|70–74|0.901|0.831|0.943
Observed|Immunoproliferative cancers|2015–2019|Males|4|75–79|0.743|0.651|0.814
Observed|Immunoproliferative cancers|2015–2019|Males|4|80–84|0.511|0.404|0.608
Observed|Immunoproliferative cancers|2015–2019|Males|4|85+|0.392|0.283|0.499
Observed|Immunoproliferative cancers|2015–2019|Males|4|All ages combined|0.809|0.78|0.834
Observed|Immunoproliferative cancers|2015–2019|Males|5|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Males|5|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Males|5|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Males|5|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Males|5|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Males|5|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Males|5|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Males|5|35–39|||
Observed|Immunoproliferative cancers|2015–2019|Males|5|40–44|||
Observed|Immunoproliferative cancers|2015–2019|Males|5|45–49|1|0.915|1
Observed|Immunoproliferative cancers|2015–2019|Males|5|50–54|1|0.944|1
Observed|Immunoproliferative cancers|2015–2019|Males|5|55–59|0.923|0.825|0.968
Observed|Immunoproliferative cancers|2015–2019|Males|5|60–64|0.861|0.763|0.92
Observed|Immunoproliferative cancers|2015–2019|Males|5|65–69|0.871|0.794|0.92
Observed|Immunoproliferative cancers|2015–2019|Males|5|70–74|0.838|0.753|0.896
Observed|Immunoproliferative cancers|2015–2019|Males|5|75–79|0.722|0.628|0.797
Observed|Immunoproliferative cancers|2015–2019|Males|5|80–84|0.448|0.343|0.548
Observed|Immunoproliferative cancers|2015–2019|Males|5|85+|0.269|0.17|0.378
Observed|Immunoproliferative cancers|2015–2019|Males|5|All ages combined|0.771|0.74|0.798
Relative|Immunoproliferative cancers|2015–2019|Males|1|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Males|1|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Males|1|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Males|1|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Males|1|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Males|1|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Males|1|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Males|1|35–39|1.001|0.882|1.001
Relative|Immunoproliferative cancers|2015–2019|Males|1|40–44|||
Relative|Immunoproliferative cancers|2015–2019|Males|1|45–49|1.002|0.887|1.002
Relative|Immunoproliferative cancers|2015–2019|Males|1|50–54|1.004|0.953|1.004
Relative|Immunoproliferative cancers|2015–2019|Males|1|55–59|0.977|0.897|0.998
Relative|Immunoproliferative cancers|2015–2019|Males|1|60–64|0.996|0.924|1.006
Relative|Immunoproliferative cancers|2015–2019|Males|1|65–69|0.966|0.911|0.991
Relative|Immunoproliferative cancers|2015–2019|Males|1|70–74|0.993|0.95|1.009
Relative|Immunoproliferative cancers|2015–2019|Males|1|75–79|0.976|0.922|1.004
Relative|Immunoproliferative cancers|2015–2019|Males|1|80–84|0.861|0.766|0.928
Relative|Immunoproliferative cancers|2015–2019|Males|1|85+|0.892|0.778|0.974
Relative|Immunoproliferative cancers|2015–2019|Males|1|All ages combined|0.963|0.945|0.978
Relative|Immunoproliferative cancers|2015–2019|Males|2|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Males|2|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Males|2|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Males|2|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Males|2|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Males|2|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Males|2|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Males|2|35–39|1.002|0.88|1.002
Relative|Immunoproliferative cancers|2015–2019|Males|2|40–44|||
Relative|Immunoproliferative cancers|2015–2019|Males|2|45–49|1.005|0.9|1.005
Relative|Immunoproliferative cancers|2015–2019|Males|2|50–54|1.007|0.955|1.007
Relative|Immunoproliferative cancers|2015–2019|Males|2|55–59|0.968|0.883|0.997
Relative|Immunoproliferative cancers|2015–2019|Males|2|60–64|0.963|0.881|0.997
Relative|Immunoproliferative cancers|2015–2019|Males|2|65–69|0.97|0.913|0.999
Relative|Immunoproliferative cancers|2015–2019|Males|2|70–74|1.006|0.958|1.026
Relative|Immunoproliferative cancers|2015–2019|Males|2|75–79|0.954|0.884|0.999
Relative|Immunoproliferative cancers|2015–2019|Males|2|80–84|0.796|0.679|0.889
Relative|Immunoproliferative cancers|2015–2019|Males|2|85+|0.807|0.662|0.931
Relative|Immunoproliferative cancers|2015–2019|Males|2|All ages combined|0.946|0.922|0.966
Relative|Immunoproliferative cancers|2015–2019|Males|3|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Males|3|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Males|3|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Males|3|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Males|3|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Males|3|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Males|3|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Males|3|35–39|||
Relative|Immunoproliferative cancers|2015–2019|Males|3|40–44|||
Relative|Immunoproliferative cancers|2015–2019|Males|3|45–49|1.008|0.913|1.008
Relative|Immunoproliferative cancers|2015–2019|Males|3|50–54|1.011|0.957|1.011
Relative|Immunoproliferative cancers|2015–2019|Males|3|55–59|0.974|0.889|1.003
Relative|Immunoproliferative cancers|2015–2019|Males|3|60–64|0.92|0.824|0.972
Relative|Immunoproliferative cancers|2015–2019|Males|3|65–69|0.976|0.914|1.008
Relative|Immunoproliferative cancers|2015–2019|Males|3|70–74|0.991|0.925|1.027
Relative|Immunoproliferative cancers|2015–2019|Males|3|75–79|0.925|0.838|0.987
Relative|Immunoproliferative cancers|2015–2019|Males|3|80–84|0.75|0.618|0.862
Relative|Immunoproliferative cancers|2015–2019|Males|3|85+|0.805|0.629|0.964
Relative|Immunoproliferative cancers|2015–2019|Males|3|All ages combined|0.933|0.904|0.957
Relative|Immunoproliferative cancers|2015–2019|Males|4|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Males|4|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Males|4|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Males|4|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Males|4|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Males|4|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Males|4|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Males|4|35–39|||
Relative|Immunoproliferative cancers|2015–2019|Males|4|40–44|||
Relative|Immunoproliferative cancers|2015–2019|Males|4|45–49|1.011|0.922|1.011
Relative|Immunoproliferative cancers|2015–2019|Males|4|50–54|1.016|0.96|1.016
Relative|Immunoproliferative cancers|2015–2019|Males|4|55–59|0.981|0.895|1.01
Relative|Immunoproliferative cancers|2015–2019|Males|4|60–64|0.904|0.803|0.963
Relative|Immunoproliferative cancers|2015–2019|Males|4|65–69|0.972|0.903|1.01
Relative|Immunoproliferative cancers|2015–2019|Males|4|70–74|0.986|0.909|1.032
Relative|Immunoproliferative cancers|2015–2019|Males|4|75–79|0.872|0.763|0.955
Relative|Immunoproliferative cancers|2015–2019|Males|4|80–84|0.695|0.55|0.826
Relative|Immunoproliferative cancers|2015–2019|Males|4|85+|0.736|0.531|0.937
Relative|Immunoproliferative cancers|2015–2019|Males|4|All ages combined|0.915|0.883|0.944
Relative|Immunoproliferative cancers|2015–2019|Males|5|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Males|5|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Males|5|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Males|5|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Males|5|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Males|5|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Males|5|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Males|5|35–39|||
Relative|Immunoproliferative cancers|2015–2019|Males|5|40–44|||
Relative|Immunoproliferative cancers|2015–2019|Males|5|45–49|1.014|0.928|1.014
Relative|Immunoproliferative cancers|2015–2019|Males|5|50–54|1.021|0.964|1.021
Relative|Immunoproliferative cancers|2015–2019|Males|5|55–59|0.953|0.852|0.999
Relative|Immunoproliferative cancers|2015–2019|Males|5|60–64|0.903|0.8|0.965
Relative|Immunoproliferative cancers|2015–2019|Males|5|65–69|0.937|0.854|0.99
Relative|Immunoproliferative cancers|2015–2019|Males|5|70–74|0.945|0.849|1.009
Relative|Immunoproliferative cancers|2015–2019|Males|5|75–79|0.895|0.778|0.987
Relative|Immunoproliferative cancers|2015–2019|Males|5|80–84|0.674|0.515|0.824
Relative|Immunoproliferative cancers|2015–2019|Males|5|85+|0.61|0.385|0.858
Relative|Immunoproliferative cancers|2015–2019|Males|5|All ages combined|0.899|0.863|0.931
Observed|Immunoproliferative cancers|2015–2019|Females|1|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Females|1|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Females|1|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Females|1|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Females|1|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Females|1|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Females|1|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Females|1|35–39|||
Observed|Immunoproliferative cancers|2015–2019|Females|1|40–44|1|0.882|1
Observed|Immunoproliferative cancers|2015–2019|Females|1|45–49|1|0.929|1
Observed|Immunoproliferative cancers|2015–2019|Females|1|50–54|1|0.937|1
Observed|Immunoproliferative cancers|2015–2019|Females|1|55–59|0.988|0.919|0.998
Observed|Immunoproliferative cancers|2015–2019|Females|1|60–64|0.989|0.924|0.998
Observed|Immunoproliferative cancers|2015–2019|Females|1|65–69|0.991|0.938|0.999
Observed|Immunoproliferative cancers|2015–2019|Females|1|70–74|0.984|0.937|0.996
Observed|Immunoproliferative cancers|2015–2019|Females|1|75–79|0.973|0.919|0.991
Observed|Immunoproliferative cancers|2015–2019|Females|1|80–84|0.935|0.852|0.973
Observed|Immunoproliferative cancers|2015–2019|Females|1|85+|0.803|0.696|0.876
Observed|Immunoproliferative cancers|2015–2019|Females|1|All ages combined|0.966|0.951|0.976
Observed|Immunoproliferative cancers|2015–2019|Females|2|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Females|2|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Females|2|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Females|2|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Females|2|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Females|2|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Females|2|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Females|2|35–39|||
Observed|Immunoproliferative cancers|2015–2019|Females|2|40–44|1|0.882|1
Observed|Immunoproliferative cancers|2015–2019|Females|2|45–49|1|0.929|1
Observed|Immunoproliferative cancers|2015–2019|Females|2|50–54|0.958|0.842|0.989
Observed|Immunoproliferative cancers|2015–2019|Females|2|55–59|0.988|0.919|0.998
Observed|Immunoproliferative cancers|2015–2019|Females|2|60–64|0.966|0.899|0.989
Observed|Immunoproliferative cancers|2015–2019|Females|2|65–69|0.97|0.911|0.99
Observed|Immunoproliferative cancers|2015–2019|Females|2|70–74|0.975|0.925|0.992
Observed|Immunoproliferative cancers|2015–2019|Females|2|75–79|0.945|0.881|0.975
Observed|Immunoproliferative cancers|2015–2019|Females|2|80–84|0.867|0.768|0.926
Observed|Immunoproliferative cancers|2015–2019|Females|2|85+|0.696|0.579|0.787
Observed|Immunoproliferative cancers|2015–2019|Females|2|All ages combined|0.936|0.917|0.951
Observed|Immunoproliferative cancers|2015–2019|Females|3|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Females|3|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Females|3|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Females|3|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Females|3|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Females|3|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Females|3|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Females|3|35–39|||
Observed|Immunoproliferative cancers|2015–2019|Females|3|40–44|1|0.885|1
Observed|Immunoproliferative cancers|2015–2019|Females|3|45–49|0.949|0.813|0.987
Observed|Immunoproliferative cancers|2015–2019|Females|3|50–54|0.958|0.842|0.989
Observed|Immunoproliferative cancers|2015–2019|Females|3|55–59|0.988|0.919|0.998
Observed|Immunoproliferative cancers|2015–2019|Females|3|60–64|0.954|0.883|0.983
Observed|Immunoproliferative cancers|2015–2019|Females|3|65–69|0.97|0.911|0.99
Observed|Immunoproliferative cancers|2015–2019|Females|3|70–74|0.954|0.893|0.981
Observed|Immunoproliferative cancers|2015–2019|Females|3|75–79|0.886|0.808|0.934
Observed|Immunoproliferative cancers|2015–2019|Females|3|80–84|0.807|0.696|0.881
Observed|Immunoproliferative cancers|2015–2019|Females|3|85+|0.58|0.459|0.683
Observed|Immunoproliferative cancers|2015–2019|Females|3|All ages combined|0.904|0.881|0.923
Observed|Immunoproliferative cancers|2015–2019|Females|4|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Females|4|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Females|4|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Females|4|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Females|4|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Females|4|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Females|4|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Females|4|35–39|||
Observed|Immunoproliferative cancers|2015–2019|Females|4|40–44|1|0.886|1
Observed|Immunoproliferative cancers|2015–2019|Females|4|45–49|0.949|0.813|0.987
Observed|Immunoproliferative cancers|2015–2019|Females|4|50–54|0.958|0.842|0.989
Observed|Immunoproliferative cancers|2015–2019|Females|4|55–59|0.973|0.895|0.993
Observed|Immunoproliferative cancers|2015–2019|Females|4|60–64|0.943|0.869|0.976
Observed|Immunoproliferative cancers|2015–2019|Females|4|65–69|0.97|0.911|0.99
Observed|Immunoproliferative cancers|2015–2019|Females|4|70–74|0.916|0.838|0.958
Observed|Immunoproliferative cancers|2015–2019|Females|4|75–79|0.853|0.768|0.909
Observed|Immunoproliferative cancers|2015–2019|Females|4|80–84|0.79|0.675|0.868
Observed|Immunoproliferative cancers|2015–2019|Females|4|85+|0.5|0.378|0.61
Observed|Immunoproliferative cancers|2015–2019|Females|4|All ages combined|0.883|0.858|0.904
Observed|Immunoproliferative cancers|2015–2019|Females|5|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Females|5|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Females|5|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Females|5|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Females|5|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Females|5|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Females|5|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Females|5|35–39|||
Observed|Immunoproliferative cancers|2015–2019|Females|5|40–44|1|0.886|1
Observed|Immunoproliferative cancers|2015–2019|Females|5|45–49|0.949|0.813|0.987
Observed|Immunoproliferative cancers|2015–2019|Females|5|50–54|0.958|0.842|0.989
Observed|Immunoproliferative cancers|2015–2019|Females|5|55–59|0.973|0.895|0.993
Observed|Immunoproliferative cancers|2015–2019|Females|5|60–64|0.932|0.856|0.969
Observed|Immunoproliferative cancers|2015–2019|Females|5|65–69|0.915|0.827|0.959
Observed|Immunoproliferative cancers|2015–2019|Females|5|70–74|0.89|0.803|0.94
Observed|Immunoproliferative cancers|2015–2019|Females|5|75–79|0.819|0.728|0.882
Observed|Immunoproliferative cancers|2015–2019|Females|5|80–84|0.701|0.574|0.798
Observed|Immunoproliferative cancers|2015–2019|Females|5|85+|0.467|0.346|0.579
Observed|Immunoproliferative cancers|2015–2019|Females|5|All ages combined|0.857|0.829|0.88
Relative|Immunoproliferative cancers|2015–2019|Females|1|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Females|1|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Females|1|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Females|1|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Females|1|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Females|1|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Females|1|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Females|1|35–39|||
Relative|Immunoproliferative cancers|2015–2019|Females|1|40–44|1.001|0.882|1.001
Relative|Immunoproliferative cancers|2015–2019|Females|1|45–49|1.001|0.93|1.001
Relative|Immunoproliferative cancers|2015–2019|Females|1|50–54|1.002|0.939|1.002
Relative|Immunoproliferative cancers|2015–2019|Females|1|55–59|0.991|0.922|1.001
Relative|Immunoproliferative cancers|2015–2019|Females|1|60–64|0.994|0.928|1.003
Relative|Immunoproliferative cancers|2015–2019|Females|1|65–69|0.998|0.944|1.006
Relative|Immunoproliferative cancers|2015–2019|Females|1|70–74|0.996|0.949|1.008
Relative|Immunoproliferative cancers|2015–2019|Females|1|75–79|0.995|0.939|1.013
Relative|Immunoproliferative cancers|2015–2019|Females|1|80–84|0.976|0.889|1.015
Relative|Immunoproliferative cancers|2015–2019|Females|1|85+|0.891|0.771|0.972
Relative|Immunoproliferative cancers|2015–2019|Females|1|All ages combined|0.986|0.971|0.996
Relative|Immunoproliferative cancers|2015–2019|Females|2|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Females|2|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Females|2|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Females|2|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Females|2|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Females|2|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Females|2|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Females|2|35–39|||
Relative|Immunoproliferative cancers|2015–2019|Females|2|40–44|1.002|0.884|1.002
Relative|Immunoproliferative cancers|2015–2019|Females|2|45–49|1.003|0.932|1.003
Relative|Immunoproliferative cancers|2015–2019|Females|2|50–54|0.962|0.845|0.994
Relative|Immunoproliferative cancers|2015–2019|Females|2|55–59|0.995|0.925|1.005
Relative|Immunoproliferative cancers|2015–2019|Females|2|60–64|0.976|0.907|0.999
Relative|Immunoproliferative cancers|2015–2019|Females|2|65–69|0.985|0.925|1.006
Relative|Immunoproliferative cancers|2015–2019|Females|2|70–74|1.001|0.949|1.018
Relative|Immunoproliferative cancers|2015–2019|Females|2|75–79|0.99|0.923|1.021
Relative|Immunoproliferative cancers|2015–2019|Females|2|80–84|0.95|0.841|1.015
Relative|Immunoproliferative cancers|2015–2019|Females|2|85+|0.867|0.721|0.979
Relative|Immunoproliferative cancers|2015–2019|Females|2|All ages combined|0.975|0.955|0.991
Relative|Immunoproliferative cancers|2015–2019|Females|3|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Females|3|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Females|3|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Females|3|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Females|3|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Females|3|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Females|3|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Females|3|35–39|||
Relative|Immunoproliferative cancers|2015–2019|Females|3|40–44|1.003|0.888|1.003
Relative|Immunoproliferative cancers|2015–2019|Females|3|45–49|0.954|0.817|0.992
Relative|Immunoproliferative cancers|2015–2019|Females|3|50–54|0.964|0.847|0.996
Relative|Immunoproliferative cancers|2015–2019|Females|3|55–59|0.998|0.928|1.009
Relative|Immunoproliferative cancers|2015–2019|Females|3|60–64|0.969|0.896|0.998
Relative|Immunoproliferative cancers|2015–2019|Females|3|65–69|0.994|0.933|1.014
Relative|Immunoproliferative cancers|2015–2019|Females|3|70–74|0.995|0.931|1.023
Relative|Immunoproliferative cancers|2015–2019|Females|3|75–79|0.955|0.871|1.006
Relative|Immunoproliferative cancers|2015–2019|Females|3|80–84|0.935|0.806|1.021
Relative|Immunoproliferative cancers|2015–2019|Females|3|85+|0.818|0.646|0.963
Relative|Immunoproliferative cancers|2015–2019|Females|3|All ages combined|0.962|0.938|0.982
Relative|Immunoproliferative cancers|2015–2019|Females|4|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Females|4|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Females|4|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Females|4|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Females|4|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Females|4|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Females|4|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Females|4|35–39|||
Relative|Immunoproliferative cancers|2015–2019|Females|4|40–44|1.004|0.89|1.004
Relative|Immunoproliferative cancers|2015–2019|Females|4|45–49|0.956|0.818|0.993
Relative|Immunoproliferative cancers|2015–2019|Females|4|50–54|0.967|0.85|0.999
Relative|Immunoproliferative cancers|2015–2019|Females|4|55–59|0.987|0.908|1.007
Relative|Immunoproliferative cancers|2015–2019|Females|4|60–64|0.964|0.888|0.997
Relative|Immunoproliferative cancers|2015–2019|Females|4|65–69|1.004|0.942|1.024
Relative|Immunoproliferative cancers|2015–2019|Females|4|70–74|0.972|0.889|1.016
Relative|Immunoproliferative cancers|2015–2019|Females|4|75–79|0.948|0.853|1.01
Relative|Immunoproliferative cancers|2015–2019|Females|4|80–84|0.978|0.835|1.075
Relative|Immunoproliferative cancers|2015–2019|Females|4|85+|0.804|0.608|0.981
Relative|Immunoproliferative cancers|2015–2019|Females|4|All ages combined|0.961|0.933|0.984
Relative|Immunoproliferative cancers|2015–2019|Females|5|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Females|5|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Females|5|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Females|5|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Females|5|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Females|5|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Females|5|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Females|5|35–39|||
Relative|Immunoproliferative cancers|2015–2019|Females|5|40–44|1.006|0.891|1.006
Relative|Immunoproliferative cancers|2015–2019|Females|5|45–49|0.957|0.82|0.995
Relative|Immunoproliferative cancers|2015–2019|Females|5|50–54|0.97|0.852|1.002
Relative|Immunoproliferative cancers|2015–2019|Females|5|55–59|0.991|0.912|1.012
Relative|Immunoproliferative cancers|2015–2019|Females|5|60–64|0.959|0.88|0.997
Relative|Immunoproliferative cancers|2015–2019|Females|5|65–69|0.956|0.865|1.003
Relative|Immunoproliferative cancers|2015–2019|Females|5|70–74|0.962|0.868|1.017
Relative|Immunoproliferative cancers|2015–2019|Females|5|75–79|0.943|0.838|1.016
Relative|Immunoproliferative cancers|2015–2019|Females|5|80–84|0.937|0.766|1.065
Relative|Immunoproliferative cancers|2015–2019|Females|5|85+|0.872|0.646|1.082
Relative|Immunoproliferative cancers|2015–2019|Females|5|All ages combined|0.954|0.923|0.98
Observed|Immunoproliferative cancers|2015–2019|Persons|1|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Persons|1|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Persons|1|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Persons|1|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Persons|1|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Persons|1|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Persons|1|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Persons|1|35–39|1|0.925|1
Observed|Immunoproliferative cancers|2015–2019|Persons|1|40–44|1|0.934|1
Observed|Immunoproliferative cancers|2015–2019|Persons|1|45–49|1|0.955|1
Observed|Immunoproliferative cancers|2015–2019|Persons|1|50–54|1|0.971|1
Observed|Immunoproliferative cancers|2015–2019|Persons|1|55–59|0.981|0.942|0.994
Observed|Immunoproliferative cancers|2015–2019|Persons|1|60–64|0.988|0.954|0.997
Observed|Immunoproliferative cancers|2015–2019|Persons|1|65–69|0.971|0.94|0.986
Observed|Immunoproliferative cancers|2015–2019|Persons|1|70–74|0.978|0.953|0.99
Observed|Immunoproliferative cancers|2015–2019|Persons|1|75–79|0.957|0.924|0.976
Observed|Immunoproliferative cancers|2015–2019|Persons|1|80–84|0.863|0.804|0.905
Observed|Immunoproliferative cancers|2015–2019|Persons|1|85+|0.791|0.721|0.845
Observed|Immunoproliferative cancers|2015–2019|Persons|1|All ages combined|0.949|0.938|0.958
Observed|Immunoproliferative cancers|2015–2019|Persons|2|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Persons|2|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Persons|2|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Persons|2|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Persons|2|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Persons|2|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Persons|2|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Persons|2|35–39|1|0.921|1
Observed|Immunoproliferative cancers|2015–2019|Persons|2|40–44|1|0.934|1
Observed|Immunoproliferative cancers|2015–2019|Persons|2|45–49|1|0.957|1
Observed|Immunoproliferative cancers|2015–2019|Persons|2|50–54|0.98|0.924|0.995
Observed|Immunoproliferative cancers|2015–2019|Persons|2|55–59|0.974|0.931|0.99
Observed|Immunoproliferative cancers|2015–2019|Persons|2|60–64|0.958|0.913|0.98
Observed|Immunoproliferative cancers|2015–2019|Persons|2|65–69|0.957|0.922|0.977
Observed|Immunoproliferative cancers|2015–2019|Persons|2|70–74|0.97|0.941|0.985
Observed|Immunoproliferative cancers|2015–2019|Persons|2|75–79|0.915|0.872|0.944
Observed|Immunoproliferative cancers|2015–2019|Persons|2|80–84|0.771|0.7|0.826
Observed|Immunoproliferative cancers|2015–2019|Persons|2|85+|0.648|0.57|0.715
Observed|Immunoproliferative cancers|2015–2019|Persons|2|All ages combined|0.911|0.897|0.924
Observed|Immunoproliferative cancers|2015–2019|Persons|3|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Persons|3|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Persons|3|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Persons|3|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Persons|3|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Persons|3|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Persons|3|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Persons|3|35–39|1|0.916|1
Observed|Immunoproliferative cancers|2015–2019|Persons|3|40–44|1|0.935|1
Observed|Immunoproliferative cancers|2015–2019|Persons|3|45–49|0.974|0.899|0.993
Observed|Immunoproliferative cancers|2015–2019|Persons|3|50–54|0.98|0.924|0.995
Observed|Immunoproliferative cancers|2015–2019|Persons|3|55–59|0.974|0.931|0.99
Observed|Immunoproliferative cancers|2015–2019|Persons|3|60–64|0.927|0.874|0.958
Observed|Immunoproliferative cancers|2015–2019|Persons|3|65–69|0.953|0.916|0.973
Observed|Immunoproliferative cancers|2015–2019|Persons|3|70–74|0.941|0.902|0.965
Observed|Immunoproliferative cancers|2015–2019|Persons|3|75–79|0.854|0.802|0.894
Observed|Immunoproliferative cancers|2015–2019|Persons|3|80–84|0.693|0.616|0.757
Observed|Immunoproliferative cancers|2015–2019|Persons|3|85+|0.543|0.462|0.617
Observed|Immunoproliferative cancers|2015–2019|Persons|3|All ages combined|0.876|0.859|0.891
Observed|Immunoproliferative cancers|2015–2019|Persons|4|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Persons|4|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Persons|4|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Persons|4|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Persons|4|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Persons|4|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Persons|4|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Persons|4|35–39|1|0.912|1
Observed|Immunoproliferative cancers|2015–2019|Persons|4|40–44|1|0.935|1
Observed|Immunoproliferative cancers|2015–2019|Persons|4|45–49|0.974|0.899|0.993
Observed|Immunoproliferative cancers|2015–2019|Persons|4|50–54|0.98|0.924|0.995
Observed|Immunoproliferative cancers|2015–2019|Persons|4|55–59|0.966|0.919|0.986
Observed|Immunoproliferative cancers|2015–2019|Persons|4|60–64|0.909|0.854|0.944
Observed|Immunoproliferative cancers|2015–2019|Persons|4|65–69|0.942|0.902|0.966
Observed|Immunoproliferative cancers|2015–2019|Persons|4|70–74|0.908|0.86|0.94
Observed|Immunoproliferative cancers|2015–2019|Persons|4|75–79|0.795|0.734|0.843
Observed|Immunoproliferative cancers|2015–2019|Persons|4|80–84|0.629|0.55|0.699
Observed|Immunoproliferative cancers|2015–2019|Persons|4|85+|0.443|0.361|0.521
Observed|Immunoproliferative cancers|2015–2019|Persons|4|All ages combined|0.844|0.825|0.861
Observed|Immunoproliferative cancers|2015–2019|Persons|5|00–04|||
Observed|Immunoproliferative cancers|2015–2019|Persons|5|05–09|||
Observed|Immunoproliferative cancers|2015–2019|Persons|5|10–14|||
Observed|Immunoproliferative cancers|2015–2019|Persons|5|15–19|||
Observed|Immunoproliferative cancers|2015–2019|Persons|5|20–24|||
Observed|Immunoproliferative cancers|2015–2019|Persons|5|25–29|||
Observed|Immunoproliferative cancers|2015–2019|Persons|5|30–34|||
Observed|Immunoproliferative cancers|2015–2019|Persons|5|35–39|1|0.907|1
Observed|Immunoproliferative cancers|2015–2019|Persons|5|40–44|1|0.936|1
Observed|Immunoproliferative cancers|2015–2019|Persons|5|45–49|0.974|0.899|0.993
Observed|Immunoproliferative cancers|2015–2019|Persons|5|50–54|0.98|0.924|0.995
Observed|Immunoproliferative cancers|2015–2019|Persons|5|55–59|0.948|0.894|0.975
Observed|Immunoproliferative cancers|2015–2019|Persons|5|60–64|0.898|0.842|0.936
Observed|Immunoproliferative cancers|2015–2019|Persons|5|65–69|0.891|0.838|0.927
Observed|Immunoproliferative cancers|2015–2019|Persons|5|70–74|0.861|0.804|0.903
Observed|Immunoproliferative cancers|2015–2019|Persons|5|75–79|0.768|0.704|0.819
Observed|Immunoproliferative cancers|2015–2019|Persons|5|80–84|0.555|0.473|0.63
Observed|Immunoproliferative cancers|2015–2019|Persons|5|85+|0.367|0.287|0.446
Observed|Immunoproliferative cancers|2015–2019|Persons|5|All ages combined|0.811|0.791|0.83
Relative|Immunoproliferative cancers|2015–2019|Persons|1|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Persons|1|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Persons|1|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Persons|1|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Persons|1|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Persons|1|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Persons|1|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Persons|1|35–39|1.001|0.925|1.001
Relative|Immunoproliferative cancers|2015–2019|Persons|1|40–44|1.001|0.935|1.001
Relative|Immunoproliferative cancers|2015–2019|Persons|1|45–49|1.002|0.957|1.002
Relative|Immunoproliferative cancers|2015–2019|Persons|1|50–54|1.003|0.974|1.003
Relative|Immunoproliferative cancers|2015–2019|Persons|1|55–59|0.985|0.945|0.998
Relative|Immunoproliferative cancers|2015–2019|Persons|1|60–64|0.995|0.96|1.003
Relative|Immunoproliferative cancers|2015–2019|Persons|1|65–69|0.981|0.949|0.996
Relative|Immunoproliferative cancers|2015–2019|Persons|1|70–74|0.994|0.968|1.006
Relative|Immunoproliferative cancers|2015–2019|Persons|1|75–79|0.984|0.95|1.004
Relative|Immunoproliferative cancers|2015–2019|Persons|1|80–84|0.91|0.848|0.955
Relative|Immunoproliferative cancers|2015–2019|Persons|1|85+|0.891|0.813|0.952
Relative|Immunoproliferative cancers|2015–2019|Persons|1|All ages combined|0.974|0.962|0.984
Relative|Immunoproliferative cancers|2015–2019|Persons|2|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Persons|2|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Persons|2|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Persons|2|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Persons|2|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Persons|2|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Persons|2|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Persons|2|35–39|1.002|0.922|1.002
Relative|Immunoproliferative cancers|2015–2019|Persons|2|40–44|1.003|0.937|1.003
Relative|Immunoproliferative cancers|2015–2019|Persons|2|45–49|1.004|0.961|1.004
Relative|Immunoproliferative cancers|2015–2019|Persons|2|50–54|0.986|0.93|1.001
Relative|Immunoproliferative cancers|2015–2019|Persons|2|55–59|0.982|0.939|0.999
Relative|Immunoproliferative cancers|2015–2019|Persons|2|60–64|0.97|0.925|0.992
Relative|Immunoproliferative cancers|2015–2019|Persons|2|65–69|0.977|0.942|0.997
Relative|Immunoproliferative cancers|2015–2019|Persons|2|70–74|1.003|0.973|1.019
Relative|Immunoproliferative cancers|2015–2019|Persons|2|75–79|0.97|0.925|1.001
Relative|Immunoproliferative cancers|2015–2019|Persons|2|80–84|0.864|0.785|0.927
Relative|Immunoproliferative cancers|2015–2019|Persons|2|85+|0.835|0.734|0.922
Relative|Immunoproliferative cancers|2015–2019|Persons|2|All ages combined|0.96|0.944|0.973
Relative|Immunoproliferative cancers|2015–2019|Persons|3|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Persons|3|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Persons|3|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Persons|3|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Persons|3|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Persons|3|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Persons|3|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Persons|3|35–39|1.003|0.919|1.003
Relative|Immunoproliferative cancers|2015–2019|Persons|3|40–44|1.004|0.939|1.004
Relative|Immunoproliferative cancers|2015–2019|Persons|3|45–49|0.98|0.905|0.999
Relative|Immunoproliferative cancers|2015–2019|Persons|3|50–54|0.99|0.933|1.004
Relative|Immunoproliferative cancers|2015–2019|Persons|3|55–59|0.987|0.944|1.004
Relative|Immunoproliferative cancers|2015–2019|Persons|3|60–64|0.946|0.892|0.977
Relative|Immunoproliferative cancers|2015–2019|Persons|3|65–69|0.984|0.946|1.006
Relative|Immunoproliferative cancers|2015–2019|Persons|3|70–74|0.993|0.951|1.018
Relative|Immunoproliferative cancers|2015–2019|Persons|3|75–79|0.938|0.88|0.981
Relative|Immunoproliferative cancers|2015–2019|Persons|3|80–84|0.832|0.74|0.909
Relative|Immunoproliferative cancers|2015–2019|Persons|3|85+|0.809|0.688|0.92
Relative|Immunoproliferative cancers|2015–2019|Persons|3|All ages combined|0.947|0.928|0.963
Relative|Immunoproliferative cancers|2015–2019|Persons|4|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Persons|4|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Persons|4|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Persons|4|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Persons|4|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Persons|4|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Persons|4|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Persons|4|35–39|1.004|0.916|1.004
Relative|Immunoproliferative cancers|2015–2019|Persons|4|40–44|1.006|0.941|1.006
Relative|Immunoproliferative cancers|2015–2019|Persons|4|45–49|0.982|0.907|1.002
Relative|Immunoproliferative cancers|2015–2019|Persons|4|50–54|0.993|0.936|1.008
Relative|Immunoproliferative cancers|2015–2019|Persons|4|55–59|0.984|0.936|1.004
Relative|Immunoproliferative cancers|2015–2019|Persons|4|60–64|0.935|0.879|0.972
Relative|Immunoproliferative cancers|2015–2019|Persons|4|65–69|0.986|0.944|1.011
Relative|Immunoproliferative cancers|2015–2019|Persons|4|70–74|0.98|0.929|1.015
Relative|Immunoproliferative cancers|2015–2019|Persons|4|75–79|0.908|0.839|0.963
Relative|Immunoproliferative cancers|2015–2019|Persons|4|80–84|0.819|0.715|0.909
Relative|Immunoproliferative cancers|2015–2019|Persons|4|85+|0.77|0.628|0.906
Relative|Immunoproliferative cancers|2015–2019|Persons|4|All ages combined|0.937|0.916|0.956
Relative|Immunoproliferative cancers|2015–2019|Persons|5|00–04|||
Relative|Immunoproliferative cancers|2015–2019|Persons|5|05–09|||
Relative|Immunoproliferative cancers|2015–2019|Persons|5|10–14|||
Relative|Immunoproliferative cancers|2015–2019|Persons|5|15–19|||
Relative|Immunoproliferative cancers|2015–2019|Persons|5|20–24|||
Relative|Immunoproliferative cancers|2015–2019|Persons|5|25–29|||
Relative|Immunoproliferative cancers|2015–2019|Persons|5|30–34|||
Relative|Immunoproliferative cancers|2015–2019|Persons|5|35–39|1.005|0.912|1.005
Relative|Immunoproliferative cancers|2015–2019|Persons|5|40–44|1.007|0.943|1.007
Relative|Immunoproliferative cancers|2015–2019|Persons|5|45–49|0.984|0.909|1.004
Relative|Immunoproliferative cancers|2015–2019|Persons|5|50–54|0.997|0.94|1.012
Relative|Immunoproliferative cancers|2015–2019|Persons|5|55–59|0.972|0.917|1
Relative|Immunoproliferative cancers|2015–2019|Persons|5|60–64|0.933|0.874|0.971
Relative|Immunoproliferative cancers|2015–2019|Persons|5|65–69|0.946|0.89|0.985
Relative|Immunoproliferative cancers|2015–2019|Persons|5|70–74|0.953|0.89|0.999
Relative|Immunoproliferative cancers|2015–2019|Persons|5|75–79|0.918|0.842|0.979
Relative|Immunoproliferative cancers|2015–2019|Persons|5|80–84|0.789|0.672|0.895
Relative|Immunoproliferative cancers|2015–2019|Persons|5|85+|0.754|0.59|0.918
Relative|Immunoproliferative cancers|2015–2019|Persons|5|All ages combined|0.925|0.902|0.946
Observed|Kaposi sarcoma|2015–2019|Males|1|00–04|||
Observed|Kaposi sarcoma|2015–2019|Males|1|05–09|||
Observed|Kaposi sarcoma|2015–2019|Males|1|10–14|||
Observed|Kaposi sarcoma|2015–2019|Males|1|15–19|||
Observed|Kaposi sarcoma|2015–2019|Males|1|20–24|||
Observed|Kaposi sarcoma|2015–2019|Males|1|25–29|||
Observed|Kaposi sarcoma|2015–2019|Males|1|30–34|||
Observed|Kaposi sarcoma|2015–2019|Males|1|35–39|||
Observed|Kaposi sarcoma|2015–2019|Males|1|40–44|||
Observed|Kaposi sarcoma|2015–2019|Males|1|45–49|0.871|0.652|0.956
Observed|Kaposi sarcoma|2015–2019|Males|1|50–54|||
Observed|Kaposi sarcoma|2015–2019|Males|1|55–59|0.911|0.689|0.977
Observed|Kaposi sarcoma|2015–2019|Males|1|60–64|||
Observed|Kaposi sarcoma|2015–2019|Males|1|65–69|0.961|0.755|0.994
Observed|Kaposi sarcoma|2015–2019|Males|1|70–74|1|0.874|1
Observed|Kaposi sarcoma|2015–2019|Males|1|75–79|||
Observed|Kaposi sarcoma|2015–2019|Males|1|80–84|0.876|0.663|0.958
Observed|Kaposi sarcoma|2015–2019|Males|1|85+|||
Observed|Kaposi sarcoma|2015–2019|Males|1|All ages combined|0.922|0.878|0.951
Observed|Kaposi sarcoma|2015–2019|Males|2|00–04|||
Observed|Kaposi sarcoma|2015–2019|Males|2|05–09|||
Observed|Kaposi sarcoma|2015–2019|Males|2|10–14|||
Observed|Kaposi sarcoma|2015–2019|Males|2|15–19|||
Observed|Kaposi sarcoma|2015–2019|Males|2|20–24|||
Observed|Kaposi sarcoma|2015–2019|Males|2|25–29|||
Observed|Kaposi sarcoma|2015–2019|Males|2|30–34|||
Observed|Kaposi sarcoma|2015–2019|Males|2|35–39|||
Observed|Kaposi sarcoma|2015–2019|Males|2|40–44|||
Observed|Kaposi sarcoma|2015–2019|Males|2|45–49|||
Observed|Kaposi sarcoma|2015–2019|Males|2|50–54|||
Observed|Kaposi sarcoma|2015–2019|Males|2|55–59|||
Observed|Kaposi sarcoma|2015–2019|Males|2|60–64|||
Observed|Kaposi sarcoma|2015–2019|Males|2|65–69|||
Observed|Kaposi sarcoma|2015–2019|Males|2|70–74|0.959|0.742|0.994
Observed|Kaposi sarcoma|2015–2019|Males|2|75–79|||
Observed|Kaposi sarcoma|2015–2019|Males|2|80–84|0.797|0.58|0.91
Observed|Kaposi sarcoma|2015–2019|Males|2|85+|||
Observed|Kaposi sarcoma|2015–2019|Males|2|All ages combined|0.896|0.847|0.929
Observed|Kaposi sarcoma|2015–2019|Males|3|00–04|||
Observed|Kaposi sarcoma|2015–2019|Males|3|05–09|||
Observed|Kaposi sarcoma|2015–2019|Males|3|10–14|||
Observed|Kaposi sarcoma|2015–2019|Males|3|15–19|||
Observed|Kaposi sarcoma|2015–2019|Males|3|20–24|||
Observed|Kaposi sarcoma|2015–2019|Males|3|25–29|||
Observed|Kaposi sarcoma|2015–2019|Males|3|30–34|||
Observed|Kaposi sarcoma|2015–2019|Males|3|35–39|||
Observed|Kaposi sarcoma|2015–2019|Males|3|40–44|||
Observed|Kaposi sarcoma|2015–2019|Males|3|45–49|||
Observed|Kaposi sarcoma|2015–2019|Males|3|50–54|||
Observed|Kaposi sarcoma|2015–2019|Males|3|55–59|||
Observed|Kaposi sarcoma|2015–2019|Males|3|60–64|||
Observed|Kaposi sarcoma|2015–2019|Males|3|65–69|||
Observed|Kaposi sarcoma|2015–2019|Males|3|70–74|0.959|0.742|0.994
Observed|Kaposi sarcoma|2015–2019|Males|3|75–79|||
Observed|Kaposi sarcoma|2015–2019|Males|3|80–84|||
Observed|Kaposi sarcoma|2015–2019|Males|3|85+|||
Observed|Kaposi sarcoma|2015–2019|Males|3|All ages combined|0.852|0.799|0.893
Observed|Kaposi sarcoma|2015–2019|Males|4|00–04|||
Observed|Kaposi sarcoma|2015–2019|Males|4|05–09|||
Observed|Kaposi sarcoma|2015–2019|Males|4|10–14|||
Observed|Kaposi sarcoma|2015–2019|Males|4|15–19|||
Observed|Kaposi sarcoma|2015–2019|Males|4|20–24|||
Observed|Kaposi sarcoma|2015–2019|Males|4|25–29|||
Observed|Kaposi sarcoma|2015–2019|Males|4|30–34|||
Observed|Kaposi sarcoma|2015–2019|Males|4|35–39|||
Observed|Kaposi sarcoma|2015–2019|Males|4|40–44|||
Observed|Kaposi sarcoma|2015–2019|Males|4|45–49|||
Observed|Kaposi sarcoma|2015–2019|Males|4|50–54|||
Observed|Kaposi sarcoma|2015–2019|Males|4|55–59|||
Observed|Kaposi sarcoma|2015–2019|Males|4|60–64|||
Observed|Kaposi sarcoma|2015–2019|Males|4|65–69|||
Observed|Kaposi sarcoma|2015–2019|Males|4|70–74|0.92|0.715|0.979
Observed|Kaposi sarcoma|2015–2019|Males|4|75–79|||
Observed|Kaposi sarcoma|2015–2019|Males|4|80–84|||
Observed|Kaposi sarcoma|2015–2019|Males|4|85+|||
Observed|Kaposi sarcoma|2015–2019|Males|4|All ages combined|0.815|0.759|0.86
Observed|Kaposi sarcoma|2015–2019|Males|5|00–04|||
Observed|Kaposi sarcoma|2015–2019|Males|5|05–09|||
Observed|Kaposi sarcoma|2015–2019|Males|5|10–14|||
Observed|Kaposi sarcoma|2015–2019|Males|5|15–19|||
Observed|Kaposi sarcoma|2015–2019|Males|5|20–24|||
Observed|Kaposi sarcoma|2015–2019|Males|5|25–29|||
Observed|Kaposi sarcoma|2015–2019|Males|5|30–34|||
Observed|Kaposi sarcoma|2015–2019|Males|5|35–39|||
Observed|Kaposi sarcoma|2015–2019|Males|5|40–44|||
Observed|Kaposi sarcoma|2015–2019|Males|5|45–49|||
Observed|Kaposi sarcoma|2015–2019|Males|5|50–54|||
Observed|Kaposi sarcoma|2015–2019|Males|5|55–59|||
Observed|Kaposi sarcoma|2015–2019|Males|5|60–64|||
Observed|Kaposi sarcoma|2015–2019|Males|5|65–69|||
Observed|Kaposi sarcoma|2015–2019|Males|5|70–74|0.883|0.681|0.961
Observed|Kaposi sarcoma|2015–2019|Males|5|75–79|||
Observed|Kaposi sarcoma|2015–2019|Males|5|80–84|||
Observed|Kaposi sarcoma|2015–2019|Males|5|85+|||
Observed|Kaposi sarcoma|2015–2019|Males|5|All ages combined|0.796|0.738|0.842
Relative|Kaposi sarcoma|2015–2019|Males|1|00–04|||
Relative|Kaposi sarcoma|2015–2019|Males|1|05–09|||
Relative|Kaposi sarcoma|2015–2019|Males|1|10–14|||
Relative|Kaposi sarcoma|2015–2019|Males|1|15–19|||
Relative|Kaposi sarcoma|2015–2019|Males|1|20–24|||
Relative|Kaposi sarcoma|2015–2019|Males|1|25–29|||
Relative|Kaposi sarcoma|2015–2019|Males|1|30–34|||
Relative|Kaposi sarcoma|2015–2019|Males|1|35–39|||
Relative|Kaposi sarcoma|2015–2019|Males|1|40–44|||
Relative|Kaposi sarcoma|2015–2019|Males|1|45–49|0.873|0.653|0.959
Relative|Kaposi sarcoma|2015–2019|Males|1|50–54|||
Relative|Kaposi sarcoma|2015–2019|Males|1|55–59|0.916|0.693|0.982
Relative|Kaposi sarcoma|2015–2019|Males|1|60–64|||
Relative|Kaposi sarcoma|2015–2019|Males|1|65–69|0.973|0.764|1.007
Relative|Kaposi sarcoma|2015–2019|Males|1|70–74|1.02|0.891|1.02
Relative|Kaposi sarcoma|2015–2019|Males|1|75–79|||
Relative|Kaposi sarcoma|2015–2019|Males|1|80–84|0.929|0.703|1.016
Relative|Kaposi sarcoma|2015–2019|Males|1|85+|||
Relative|Kaposi sarcoma|2015–2019|Males|1|All ages combined|0.947|0.901|0.976
Relative|Kaposi sarcoma|2015–2019|Males|2|00–04|||
Relative|Kaposi sarcoma|2015–2019|Males|2|05–09|||
Relative|Kaposi sarcoma|2015–2019|Males|2|10–14|||
Relative|Kaposi sarcoma|2015–2019|Males|2|15–19|||
Relative|Kaposi sarcoma|2015–2019|Males|2|20–24|||
Relative|Kaposi sarcoma|2015–2019|Males|2|25–29|||
Relative|Kaposi sarcoma|2015–2019|Males|2|30–34|||
Relative|Kaposi sarcoma|2015–2019|Males|2|35–39|||
Relative|Kaposi sarcoma|2015–2019|Males|2|40–44|||
Relative|Kaposi sarcoma|2015–2019|Males|2|45–49|||
Relative|Kaposi sarcoma|2015–2019|Males|2|50–54|||
Relative|Kaposi sarcoma|2015–2019|Males|2|55–59|||
Relative|Kaposi sarcoma|2015–2019|Males|2|60–64|||
Relative|Kaposi sarcoma|2015–2019|Males|2|65–69|||
Relative|Kaposi sarcoma|2015–2019|Males|2|70–74|0.999|0.774|1.036
Relative|Kaposi sarcoma|2015–2019|Males|2|75–79|||
Relative|Kaposi sarcoma|2015–2019|Males|2|80–84|0.904|0.658|1.032
Relative|Kaposi sarcoma|2015–2019|Males|2|85+|||
Relative|Kaposi sarcoma|2015–2019|Males|2|All ages combined|0.944|0.893|0.98
Relative|Kaposi sarcoma|2015–2019|Males|3|00–04|||
Relative|Kaposi sarcoma|2015–2019|Males|3|05–09|||
Relative|Kaposi sarcoma|2015–2019|Males|3|10–14|||
Relative|Kaposi sarcoma|2015–2019|Males|3|15–19|||
Relative|Kaposi sarcoma|2015–2019|Males|3|20–24|||
Relative|Kaposi sarcoma|2015–2019|Males|3|25–29|||
Relative|Kaposi sarcoma|2015–2019|Males|3|30–34|||
Relative|Kaposi sarcoma|2015–2019|Males|3|35–39|||
Relative|Kaposi sarcoma|2015–2019|Males|3|40–44|||
Relative|Kaposi sarcoma|2015–2019|Males|3|45–49|||
Relative|Kaposi sarcoma|2015–2019|Males|3|50–54|||
Relative|Kaposi sarcoma|2015–2019|Males|3|55–59|||
Relative|Kaposi sarcoma|2015–2019|Males|3|60–64|||
Relative|Kaposi sarcoma|2015–2019|Males|3|65–69|||
Relative|Kaposi sarcoma|2015–2019|Males|3|70–74|1.024|0.793|1.061
Relative|Kaposi sarcoma|2015–2019|Males|3|75–79|||
Relative|Kaposi sarcoma|2015–2019|Males|3|80–84|||
Relative|Kaposi sarcoma|2015–2019|Males|3|85+|||
Relative|Kaposi sarcoma|2015–2019|Males|3|All ages combined|0.925|0.867|0.969
Relative|Kaposi sarcoma|2015–2019|Males|4|00–04|||
Relative|Kaposi sarcoma|2015–2019|Males|4|05–09|||
Relative|Kaposi sarcoma|2015–2019|Males|4|10–14|||
Relative|Kaposi sarcoma|2015–2019|Males|4|15–19|||
Relative|Kaposi sarcoma|2015–2019|Males|4|20–24|||
Relative|Kaposi sarcoma|2015–2019|Males|4|25–29|||
Relative|Kaposi sarcoma|2015–2019|Males|4|30–34|||
Relative|Kaposi sarcoma|2015–2019|Males|4|35–39|||
Relative|Kaposi sarcoma|2015–2019|Males|4|40–44|||
Relative|Kaposi sarcoma|2015–2019|Males|4|45–49|||
Relative|Kaposi sarcoma|2015–2019|Males|4|50–54|||
Relative|Kaposi sarcoma|2015–2019|Males|4|55–59|||
Relative|Kaposi sarcoma|2015–2019|Males|4|60–64|||
Relative|Kaposi sarcoma|2015–2019|Males|4|65–69|||
Relative|Kaposi sarcoma|2015–2019|Males|4|70–74|1.009|0.785|1.074
Relative|Kaposi sarcoma|2015–2019|Males|4|75–79|||
Relative|Kaposi sarcoma|2015–2019|Males|4|80–84|||
Relative|Kaposi sarcoma|2015–2019|Males|4|85+|||
Relative|Kaposi sarcoma|2015–2019|Males|4|All ages combined|0.908|0.845|0.958
Relative|Kaposi sarcoma|2015–2019|Males|5|00–04|||
Relative|Kaposi sarcoma|2015–2019|Males|5|05–09|||
Relative|Kaposi sarcoma|2015–2019|Males|5|10–14|||
Relative|Kaposi sarcoma|2015–2019|Males|5|15–19|||
Relative|Kaposi sarcoma|2015–2019|Males|5|20–24|||
Relative|Kaposi sarcoma|2015–2019|Males|5|25–29|||
Relative|Kaposi sarcoma|2015–2019|Males|5|30–34|||
Relative|Kaposi sarcoma|2015–2019|Males|5|35–39|||
Relative|Kaposi sarcoma|2015–2019|Males|5|40–44|||
Relative|Kaposi sarcoma|2015–2019|Males|5|45–49|||
Relative|Kaposi sarcoma|2015–2019|Males|5|50–54|||
Relative|Kaposi sarcoma|2015–2019|Males|5|55–59|||
Relative|Kaposi sarcoma|2015–2019|Males|5|60–64|||
Relative|Kaposi sarcoma|2015–2019|Males|5|65–69|||
Relative|Kaposi sarcoma|2015–2019|Males|5|70–74|0.998|0.769|1.086
Relative|Kaposi sarcoma|2015–2019|Males|5|75–79|||
Relative|Kaposi sarcoma|2015–2019|Males|5|80–84|||
Relative|Kaposi sarcoma|2015–2019|Males|5|85+|||
Relative|Kaposi sarcoma|2015–2019|Males|5|All ages combined|0.909|0.843|0.962
Observed|Kaposi sarcoma|2015–2019|Females|1|00–04|||
Observed|Kaposi sarcoma|2015–2019|Females|1|05–09|||
Observed|Kaposi sarcoma|2015–2019|Females|1|10–14|||
Observed|Kaposi sarcoma|2015–2019|Females|1|15–19|||
Observed|Kaposi sarcoma|2015–2019|Females|1|20–24|||
Observed|Kaposi sarcoma|2015–2019|Females|1|25–29|||
Observed|Kaposi sarcoma|2015–2019|Females|1|30–34|||
Observed|Kaposi sarcoma|2015–2019|Females|1|35–39|||
Observed|Kaposi sarcoma|2015–2019|Females|1|40–44|||
Observed|Kaposi sarcoma|2015–2019|Females|1|45–49|||
Observed|Kaposi sarcoma|2015–2019|Females|1|50–54|||
Observed|Kaposi sarcoma|2015–2019|Females|1|55–59|||
Observed|Kaposi sarcoma|2015–2019|Females|1|60–64|||
Observed|Kaposi sarcoma|2015–2019|Females|1|65–69|||
Observed|Kaposi sarcoma|2015–2019|Females|1|70–74|||
Observed|Kaposi sarcoma|2015–2019|Females|1|75–79|||
Observed|Kaposi sarcoma|2015–2019|Females|1|80–84|||
Observed|Kaposi sarcoma|2015–2019|Females|1|85+|||
Observed|Kaposi sarcoma|2015–2019|Females|1|All ages combined|0.894|0.764|0.954
Observed|Kaposi sarcoma|2015–2019|Females|2|00–04|||
Observed|Kaposi sarcoma|2015–2019|Females|2|05–09|||
Observed|Kaposi sarcoma|2015–2019|Females|2|10–14|||
Observed|Kaposi sarcoma|2015–2019|Females|2|15–19|||
Observed|Kaposi sarcoma|2015–2019|Females|2|20–24|||
Observed|Kaposi sarcoma|2015–2019|Females|2|25–29|||
Observed|Kaposi sarcoma|2015–2019|Females|2|30–34|||
Observed|Kaposi sarcoma|2015–2019|Females|2|35–39|||
Observed|Kaposi sarcoma|2015–2019|Females|2|40–44|||
Observed|Kaposi sarcoma|2015–2019|Females|2|45–49|||
Observed|Kaposi sarcoma|2015–2019|Females|2|50–54|||
Observed|Kaposi sarcoma|2015–2019|Females|2|55–59|||
Observed|Kaposi sarcoma|2015–2019|Females|2|60–64|||
Observed|Kaposi sarcoma|2015–2019|Females|2|65–69|||
Observed|Kaposi sarcoma|2015–2019|Females|2|70–74|||
Observed|Kaposi sarcoma|2015–2019|Females|2|75–79|||
Observed|Kaposi sarcoma|2015–2019|Females|2|80–84|||
Observed|Kaposi sarcoma|2015–2019|Females|2|85+|||
Observed|Kaposi sarcoma|2015–2019|Females|2|All ages combined|0.785|0.646|0.875
Observed|Kaposi sarcoma|2015–2019|Females|3|00–04|||
Observed|Kaposi sarcoma|2015–2019|Females|3|05–09|||
Observed|Kaposi sarcoma|2015–2019|Females|3|10–14|||
Observed|Kaposi sarcoma|2015–2019|Females|3|15–19|||
Observed|Kaposi sarcoma|2015–2019|Females|3|20–24|||
Observed|Kaposi sarcoma|2015–2019|Females|3|25–29|||
Observed|Kaposi sarcoma|2015–2019|Females|3|30–34|||
Observed|Kaposi sarcoma|2015–2019|Females|3|35–39|||
Observed|Kaposi sarcoma|2015–2019|Females|3|40–44|||
Observed|Kaposi sarcoma|2015–2019|Females|3|45–49|||
Observed|Kaposi sarcoma|2015–2019|Females|3|50–54|||
Observed|Kaposi sarcoma|2015–2019|Females|3|55–59|||
Observed|Kaposi sarcoma|2015–2019|Females|3|60–64|||
Observed|Kaposi sarcoma|2015–2019|Females|3|65–69|||
Observed|Kaposi sarcoma|2015–2019|Females|3|70–74|||
Observed|Kaposi sarcoma|2015–2019|Females|3|75–79|||
Observed|Kaposi sarcoma|2015–2019|Females|3|80–84|||
Observed|Kaposi sarcoma|2015–2019|Females|3|85+|||
Observed|Kaposi sarcoma|2015–2019|Females|3|All ages combined|0.717|0.575|0.818
Observed|Kaposi sarcoma|2015–2019|Females|4|00–04|||
Observed|Kaposi sarcoma|2015–2019|Females|4|05–09|||
Observed|Kaposi sarcoma|2015–2019|Females|4|10–14|||
Observed|Kaposi sarcoma|2015–2019|Females|4|15–19|||
Observed|Kaposi sarcoma|2015–2019|Females|4|20–24|||
Observed|Kaposi sarcoma|2015–2019|Females|4|25–29|||
Observed|Kaposi sarcoma|2015–2019|Females|4|30–34|||
Observed|Kaposi sarcoma|2015–2019|Females|4|35–39|||
Observed|Kaposi sarcoma|2015–2019|Females|4|40–44|||
Observed|Kaposi sarcoma|2015–2019|Females|4|45–49|||
Observed|Kaposi sarcoma|2015–2019|Females|4|50–54|||
Observed|Kaposi sarcoma|2015–2019|Females|4|55–59|||
Observed|Kaposi sarcoma|2015–2019|Females|4|60–64|||
Observed|Kaposi sarcoma|2015–2019|Females|4|65–69|||
Observed|Kaposi sarcoma|2015–2019|Females|4|70–74|||
Observed|Kaposi sarcoma|2015–2019|Females|4|75–79|||
Observed|Kaposi sarcoma|2015–2019|Females|4|80–84|||
Observed|Kaposi sarcoma|2015–2019|Females|4|85+|||
Observed|Kaposi sarcoma|2015–2019|Females|4|All ages combined|0.597|0.457|0.713
Observed|Kaposi sarcoma|2015–2019|Females|5|00–04|||
Observed|Kaposi sarcoma|2015–2019|Females|5|05–09|||
Observed|Kaposi sarcoma|2015–2019|Females|5|10–14|||
Observed|Kaposi sarcoma|2015–2019|Females|5|15–19|||
Observed|Kaposi sarcoma|2015–2019|Females|5|20–24|||
Observed|Kaposi sarcoma|2015–2019|Females|5|25–29|||
Observed|Kaposi sarcoma|2015–2019|Females|5|30–34|||
Observed|Kaposi sarcoma|2015–2019|Females|5|35–39|||
Observed|Kaposi sarcoma|2015–2019|Females|5|40–44|||
Observed|Kaposi sarcoma|2015–2019|Females|5|45–49|||
Observed|Kaposi sarcoma|2015–2019|Females|5|50–54|||
Observed|Kaposi sarcoma|2015–2019|Females|5|55–59|||
Observed|Kaposi sarcoma|2015–2019|Females|5|60–64|||
Observed|Kaposi sarcoma|2015–2019|Females|5|65–69|||
Observed|Kaposi sarcoma|2015–2019|Females|5|70–74|||
Observed|Kaposi sarcoma|2015–2019|Females|5|75–79|||
Observed|Kaposi sarcoma|2015–2019|Females|5|80–84|||
Observed|Kaposi sarcoma|2015–2019|Females|5|85+|||
Observed|Kaposi sarcoma|2015–2019|Females|5|All ages combined|0.566|0.427|0.683
Relative|Kaposi sarcoma|2015–2019|Females|1|00–04|||
Relative|Kaposi sarcoma|2015–2019|Females|1|05–09|||
Relative|Kaposi sarcoma|2015–2019|Females|1|10–14|||
Relative|Kaposi sarcoma|2015–2019|Females|1|15–19|||
Relative|Kaposi sarcoma|2015–2019|Females|1|20–24|||
Relative|Kaposi sarcoma|2015–2019|Females|1|25–29|||
Relative|Kaposi sarcoma|2015–2019|Females|1|30–34|||
Relative|Kaposi sarcoma|2015–2019|Females|1|35–39|||
Relative|Kaposi sarcoma|2015–2019|Females|1|40–44|||
Relative|Kaposi sarcoma|2015–2019|Females|1|45–49|||
Relative|Kaposi sarcoma|2015–2019|Females|1|50–54|||
Relative|Kaposi sarcoma|2015–2019|Females|1|55–59|||
Relative|Kaposi sarcoma|2015–2019|Females|1|60–64|||
Relative|Kaposi sarcoma|2015–2019|Females|1|65–69|||
Relative|Kaposi sarcoma|2015–2019|Females|1|70–74|||
Relative|Kaposi sarcoma|2015–2019|Females|1|75–79|||
Relative|Kaposi sarcoma|2015–2019|Females|1|80–84|||
Relative|Kaposi sarcoma|2015–2019|Females|1|85+|||
Relative|Kaposi sarcoma|2015–2019|Females|1|All ages combined|0.935|0.799|0.999
Relative|Kaposi sarcoma|2015–2019|Females|2|00–04|||
Relative|Kaposi sarcoma|2015–2019|Females|2|05–09|||
Relative|Kaposi sarcoma|2015–2019|Females|2|10–14|||
Relative|Kaposi sarcoma|2015–2019|Females|2|15–19|||
Relative|Kaposi sarcoma|2015–2019|Females|2|20–24|||
Relative|Kaposi sarcoma|2015–2019|Females|2|25–29|||
Relative|Kaposi sarcoma|2015–2019|Females|2|30–34|||
Relative|Kaposi sarcoma|2015–2019|Females|2|35–39|||
Relative|Kaposi sarcoma|2015–2019|Females|2|40–44|||
Relative|Kaposi sarcoma|2015–2019|Females|2|45–49|||
Relative|Kaposi sarcoma|2015–2019|Females|2|50–54|||
Relative|Kaposi sarcoma|2015–2019|Females|2|55–59|||
Relative|Kaposi sarcoma|2015–2019|Females|2|60–64|||
Relative|Kaposi sarcoma|2015–2019|Females|2|65–69|||
Relative|Kaposi sarcoma|2015–2019|Females|2|70–74|||
Relative|Kaposi sarcoma|2015–2019|Females|2|75–79|||
Relative|Kaposi sarcoma|2015–2019|Females|2|80–84|||
Relative|Kaposi sarcoma|2015–2019|Females|2|85+|||
Relative|Kaposi sarcoma|2015–2019|Females|2|All ages combined|0.862|0.709|0.961
Relative|Kaposi sarcoma|2015–2019|Females|3|00–04|||
Relative|Kaposi sarcoma|2015–2019|Females|3|05–09|||
Relative|Kaposi sarcoma|2015–2019|Females|3|10–14|||
Relative|Kaposi sarcoma|2015–2019|Females|3|15–19|||
Relative|Kaposi sarcoma|2015–2019|Females|3|20–24|||
Relative|Kaposi sarcoma|2015–2019|Females|3|25–29|||
Relative|Kaposi sarcoma|2015–2019|Females|3|30–34|||
Relative|Kaposi sarcoma|2015–2019|Females|3|35–39|||
Relative|Kaposi sarcoma|2015–2019|Females|3|40–44|||
Relative|Kaposi sarcoma|2015–2019|Females|3|45–49|||
Relative|Kaposi sarcoma|2015–2019|Females|3|50–54|||
Relative|Kaposi sarcoma|2015–2019|Females|3|55–59|||
Relative|Kaposi sarcoma|2015–2019|Females|3|60–64|||
Relative|Kaposi sarcoma|2015–2019|Females|3|65–69|||
Relative|Kaposi sarcoma|2015–2019|Females|3|70–74|||
Relative|Kaposi sarcoma|2015–2019|Females|3|75–79|||
Relative|Kaposi sarcoma|2015–2019|Females|3|80–84|||
Relative|Kaposi sarcoma|2015–2019|Females|3|85+|||
Relative|Kaposi sarcoma|2015–2019|Females|3|All ages combined|0.822|0.66|0.938
Relative|Kaposi sarcoma|2015–2019|Females|4|00–04|||
Relative|Kaposi sarcoma|2015–2019|Females|4|05–09|||
Relative|Kaposi sarcoma|2015–2019|Females|4|10–14|||
Relative|Kaposi sarcoma|2015–2019|Females|4|15–19|||
Relative|Kaposi sarcoma|2015–2019|Females|4|20–24|||
Relative|Kaposi sarcoma|2015–2019|Females|4|25–29|||
Relative|Kaposi sarcoma|2015–2019|Females|4|30–34|||
Relative|Kaposi sarcoma|2015–2019|Females|4|35–39|||
Relative|Kaposi sarcoma|2015–2019|Females|4|40–44|||
Relative|Kaposi sarcoma|2015–2019|Females|4|45–49|||
Relative|Kaposi sarcoma|2015–2019|Females|4|50–54|||
Relative|Kaposi sarcoma|2015–2019|Females|4|55–59|||
Relative|Kaposi sarcoma|2015–2019|Females|4|60–64|||
Relative|Kaposi sarcoma|2015–2019|Females|4|65–69|||
Relative|Kaposi sarcoma|2015–2019|Females|4|70–74|||
Relative|Kaposi sarcoma|2015–2019|Females|4|75–79|||
Relative|Kaposi sarcoma|2015–2019|Females|4|80–84|||
Relative|Kaposi sarcoma|2015–2019|Females|4|85+|||
Relative|Kaposi sarcoma|2015–2019|Females|4|All ages combined|0.722|0.552|0.862
Relative|Kaposi sarcoma|2015–2019|Females|5|00–04|||
Relative|Kaposi sarcoma|2015–2019|Females|5|05–09|||
Relative|Kaposi sarcoma|2015–2019|Females|5|10–14|||
Relative|Kaposi sarcoma|2015–2019|Females|5|15–19|||
Relative|Kaposi sarcoma|2015–2019|Females|5|20–24|||
Relative|Kaposi sarcoma|2015–2019|Females|5|25–29|||
Relative|Kaposi sarcoma|2015–2019|Females|5|30–34|||
Relative|Kaposi sarcoma|2015–2019|Females|5|35–39|||
Relative|Kaposi sarcoma|2015–2019|Females|5|40–44|||
Relative|Kaposi sarcoma|2015–2019|Females|5|45–49|||
Relative|Kaposi sarcoma|2015–2019|Females|5|50–54|||
Relative|Kaposi sarcoma|2015–2019|Females|5|55–59|||
Relative|Kaposi sarcoma|2015–2019|Females|5|60–64|||
Relative|Kaposi sarcoma|2015–2019|Females|5|65–69|||
Relative|Kaposi sarcoma|2015–2019|Females|5|70–74|||
Relative|Kaposi sarcoma|2015–2019|Females|5|75–79|||
Relative|Kaposi sarcoma|2015–2019|Females|5|80–84|||
Relative|Kaposi sarcoma|2015–2019|Females|5|85+|||
Relative|Kaposi sarcoma|2015–2019|Females|5|All ages combined|0.714|0.539|0.862
Observed|Kaposi sarcoma|2015–2019|Persons|1|00–04|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|05–09|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|10–14|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|15–19|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|20–24|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|25–29|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|30–34|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|35–39|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|40–44|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|45–49|0.876|0.664|0.958
Observed|Kaposi sarcoma|2015–2019|Persons|1|50–54|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|55–59|0.918|0.709|0.979
Observed|Kaposi sarcoma|2015–2019|Persons|1|60–64|||
Observed|Kaposi sarcoma|2015–2019|Persons|1|65–69|0.963|0.763|0.995
Observed|Kaposi sarcoma|2015–2019|Persons|1|70–74|0.966|0.785|0.995
Observed|Kaposi sarcoma|2015–2019|Persons|1|75–79|0.889|0.695|0.963
Observed|Kaposi sarcoma|2015–2019|Persons|1|80–84|0.878|0.706|0.952
Observed|Kaposi sarcoma|2015–2019|Persons|1|85+|0.832|0.665|0.921
Observed|Kaposi sarcoma|2015–2019|Persons|1|All ages combined|0.917|0.877|0.945
Observed|Kaposi sarcoma|2015–2019|Persons|2|00–04|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|05–09|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|10–14|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|15–19|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|20–24|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|25–29|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|30–34|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|35–39|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|40–44|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|45–49|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|50–54|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|55–59|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|60–64|||
Observed|Kaposi sarcoma|2015–2019|Persons|2|65–69|0.963|0.763|0.995
Observed|Kaposi sarcoma|2015–2019|Persons|2|70–74|0.906|0.737|0.969
Observed|Kaposi sarcoma|2015–2019|Persons|2|75–79|0.889|0.695|0.963
Observed|Kaposi sarcoma|2015–2019|Persons|2|80–84|0.821|0.645|0.915
Observed|Kaposi sarcoma|2015–2019|Persons|2|85+|0.699|0.524|0.82
Observed|Kaposi sarcoma|2015–2019|Persons|2|All ages combined|0.874|0.829|0.909
Observed|Kaposi sarcoma|2015–2019|Persons|3|00–04|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|05–09|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|10–14|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|15–19|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|20–24|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|25–29|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|30–34|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|35–39|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|40–44|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|45–49|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|50–54|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|55–59|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|60–64|||
Observed|Kaposi sarcoma|2015–2019|Persons|3|65–69|0.963|0.763|0.995
Observed|Kaposi sarcoma|2015–2019|Persons|3|70–74|0.876|0.702|0.951
Observed|Kaposi sarcoma|2015–2019|Persons|3|75–79|0.83|0.638|0.925
Observed|Kaposi sarcoma|2015–2019|Persons|3|80–84|0.721|0.531|0.844
Observed|Kaposi sarcoma|2015–2019|Persons|3|85+|0.568|0.395|0.708
Observed|Kaposi sarcoma|2015–2019|Persons|3|All ages combined|0.826|0.776|0.866
Observed|Kaposi sarcoma|2015–2019|Persons|4|00–04|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|05–09|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|10–14|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|15–19|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|20–24|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|25–29|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|30–34|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|35–39|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|40–44|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|45–49|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|50–54|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|55–59|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|60–64|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|65–69|0.963|0.763|0.995
Observed|Kaposi sarcoma|2015–2019|Persons|4|70–74|0.847|0.671|0.933
Observed|Kaposi sarcoma|2015–2019|Persons|4|75–79|0.83|0.638|0.925
Observed|Kaposi sarcoma|2015–2019|Persons|4|80–84|0.656|0.464|0.793
Observed|Kaposi sarcoma|2015–2019|Persons|4|85+|||
Observed|Kaposi sarcoma|2015–2019|Persons|4|All ages combined|0.773|0.72|0.818
Observed|Kaposi sarcoma|2015–2019|Persons|5|00–04|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|05–09|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|10–14|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|15–19|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|20–24|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|25–29|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|30–34|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|35–39|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|40–44|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|45–49|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|50–54|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|55–59|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|60–64|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|65–69|0.963|0.763|0.995
Observed|Kaposi sarcoma|2015–2019|Persons|5|70–74|0.821|0.644|0.915
Observed|Kaposi sarcoma|2015–2019|Persons|5|75–79|0.766|0.571|0.881
Observed|Kaposi sarcoma|2015–2019|Persons|5|80–84|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|85+|||
Observed|Kaposi sarcoma|2015–2019|Persons|5|All ages combined|0.751|0.697|0.797
Relative|Kaposi sarcoma|2015–2019|Persons|1|00–04|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|05–09|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|10–14|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|15–19|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|20–24|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|25–29|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|30–34|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|35–39|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|40–44|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|45–49|0.878|0.666|0.961
Relative|Kaposi sarcoma|2015–2019|Persons|1|50–54|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|55–59|0.922|0.713|0.984
Relative|Kaposi sarcoma|2015–2019|Persons|1|60–64|||
Relative|Kaposi sarcoma|2015–2019|Persons|1|65–69|0.974|0.772|1.007
Relative|Kaposi sarcoma|2015–2019|Persons|1|70–74|0.984|0.799|1.013
Relative|Kaposi sarcoma|2015–2019|Persons|1|75–79|0.918|0.717|0.994
Relative|Kaposi sarcoma|2015–2019|Persons|1|80–84|0.926|0.745|1.005
Relative|Kaposi sarcoma|2015–2019|Persons|1|85+|0.931|0.744|1.03
Relative|Kaposi sarcoma|2015–2019|Persons|1|All ages combined|0.945|0.904|0.973
Relative|Kaposi sarcoma|2015–2019|Persons|2|00–04|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|05–09|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|10–14|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|15–19|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|20–24|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|25–29|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|30–34|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|35–39|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|40–44|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|45–49|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|50–54|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|55–59|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|60–64|||
Relative|Kaposi sarcoma|2015–2019|Persons|2|65–69|0.987|0.782|1.02
Relative|Kaposi sarcoma|2015–2019|Persons|2|70–74|0.941|0.765|1.006
Relative|Kaposi sarcoma|2015–2019|Persons|2|75–79|0.951|0.744|1.03
Relative|Kaposi sarcoma|2015–2019|Persons|2|80–84|0.923|0.725|1.028
Relative|Kaposi sarcoma|2015–2019|Persons|2|85+|0.889|0.666|1.044
Relative|Kaposi sarcoma|2015–2019|Persons|2|All ages combined|0.929|0.881|0.965
Relative|Kaposi sarcoma|2015–2019|Persons|3|00–04|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|05–09|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|10–14|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|15–19|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|20–24|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|25–29|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|30–34|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|35–39|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|40–44|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|45–49|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|50–54|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|55–59|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|60–64|||
Relative|Kaposi sarcoma|2015–2019|Persons|3|65–69|1.001|0.793|1.034
Relative|Kaposi sarcoma|2015–2019|Persons|3|70–74|0.93|0.746|1.01
Relative|Kaposi sarcoma|2015–2019|Persons|3|75–79|0.923|0.71|1.029
Relative|Kaposi sarcoma|2015–2019|Persons|3|80–84|0.871|0.641|1.02
Relative|Kaposi sarcoma|2015–2019|Persons|3|85+|0.836|0.582|1.042
Relative|Kaposi sarcoma|2015–2019|Persons|3|All ages combined|0.906|0.851|0.949
Relative|Kaposi sarcoma|2015–2019|Persons|4|00–04|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|05–09|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|10–14|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|15–19|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|20–24|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|25–29|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|30–34|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|35–39|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|40–44|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|45–49|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|50–54|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|55–59|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|60–64|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|65–69|1.017|0.806|1.051
Relative|Kaposi sarcoma|2015–2019|Persons|4|70–74|0.922|0.73|1.016
Relative|Kaposi sarcoma|2015–2019|Persons|4|75–79|0.966|0.743|1.077
Relative|Kaposi sarcoma|2015–2019|Persons|4|80–84|0.86|0.608|1.04
Relative|Kaposi sarcoma|2015–2019|Persons|4|85+|||
Relative|Kaposi sarcoma|2015–2019|Persons|4|All ages combined|0.874|0.814|0.924
Relative|Kaposi sarcoma|2015–2019|Persons|5|00–04|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|05–09|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|10–14|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|15–19|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|20–24|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|25–29|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|30–34|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|35–39|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|40–44|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|45–49|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|50–54|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|55–59|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|60–64|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|65–69|1.034|0.819|1.068
Relative|Kaposi sarcoma|2015–2019|Persons|5|70–74|0.918|0.721|1.024
Relative|Kaposi sarcoma|2015–2019|Persons|5|75–79|0.939|0.7|1.081
Relative|Kaposi sarcoma|2015–2019|Persons|5|80–84|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|85+|||
Relative|Kaposi sarcoma|2015–2019|Persons|5|All ages combined|0.873|0.81|0.927
Observed|Kidney cancer|2015–2019|Males|1|00–04|0.976|0.906|0.994
Observed|Kidney cancer|2015–2019|Males|1|05–09|||
Observed|Kidney cancer|2015–2019|Males|1|10–14|||
Observed|Kidney cancer|2015–2019|Males|1|15–19|||
Observed|Kidney cancer|2015–2019|Males|1|20–24|||
Observed|Kidney cancer|2015–2019|Males|1|25–29|0.964|0.864|0.991
Observed|Kidney cancer|2015–2019|Males|1|30–34|0.947|0.886|0.976
Observed|Kidney cancer|2015–2019|Males|1|35–39|0.972|0.942|0.986
Observed|Kidney cancer|2015–2019|Males|1|40–44|0.947|0.923|0.964
Observed|Kidney cancer|2015–2019|Males|1|45–49|0.935|0.913|0.951
Observed|Kidney cancer|2015–2019|Males|1|50–54|0.929|0.912|0.943
Observed|Kidney cancer|2015–2019|Males|1|55–59|0.925|0.911|0.938
Observed|Kidney cancer|2015–2019|Males|1|60–64|0.919|0.905|0.93
Observed|Kidney cancer|2015–2019|Males|1|65–69|0.918|0.905|0.929
Observed|Kidney cancer|2015–2019|Males|1|70–74|0.893|0.878|0.907
Observed|Kidney cancer|2015–2019|Males|1|75–79|0.853|0.831|0.872
Observed|Kidney cancer|2015–2019|Males|1|80–84|0.772|0.74|0.8
Observed|Kidney cancer|2015–2019|Males|1|85+|0.504|0.459|0.546
Observed|Kidney cancer|2015–2019|Males|1|All ages combined|0.888|0.883|0.894
Observed|Kidney cancer|2015–2019|Males|2|00–04|0.952|0.878|0.982
Observed|Kidney cancer|2015–2019|Males|2|05–09|||
Observed|Kidney cancer|2015–2019|Males|2|10–14|||
Observed|Kidney cancer|2015–2019|Males|2|15–19|||
Observed|Kidney cancer|2015–2019|Males|2|20–24|||
Observed|Kidney cancer|2015–2019|Males|2|25–29|0.964|0.864|0.991
Observed|Kidney cancer|2015–2019|Males|2|30–34|0.929|0.863|0.964
Observed|Kidney cancer|2015–2019|Males|2|35–39|0.959|0.925|0.978
Observed|Kidney cancer|2015–2019|Males|2|40–44|0.928|0.901|0.948
Observed|Kidney cancer|2015–2019|Males|2|45–49|0.899|0.874|0.92
Observed|Kidney cancer|2015–2019|Males|2|50–54|0.894|0.875|0.911
Observed|Kidney cancer|2015–2019|Males|2|55–59|0.889|0.871|0.904
Observed|Kidney cancer|2015–2019|Males|2|60–64|0.888|0.872|0.902
Observed|Kidney cancer|2015–2019|Males|2|65–69|0.868|0.851|0.882
Observed|Kidney cancer|2015–2019|Males|2|70–74|0.837|0.818|0.854
Observed|Kidney cancer|2015–2019|Males|2|75–79|0.774|0.749|0.797
Observed|Kidney cancer|2015–2019|Males|2|80–84|0.679|0.644|0.711
Observed|Kidney cancer|2015–2019|Males|2|85+|0.405|0.363|0.447
Observed|Kidney cancer|2015–2019|Males|2|All ages combined|0.839|0.832|0.846
Observed|Kidney cancer|2015–2019|Males|3|00–04|0.952|0.878|0.982
Observed|Kidney cancer|2015–2019|Males|3|05–09|||
Observed|Kidney cancer|2015–2019|Males|3|10–14|||
Observed|Kidney cancer|2015–2019|Males|3|15–19|||
Observed|Kidney cancer|2015–2019|Males|3|20–24|||
Observed|Kidney cancer|2015–2019|Males|3|25–29|0.941|0.827|0.981
Observed|Kidney cancer|2015–2019|Males|3|30–34|0.929|0.863|0.964
Observed|Kidney cancer|2015–2019|Males|3|35–39|0.959|0.925|0.978
Observed|Kidney cancer|2015–2019|Males|3|40–44|0.918|0.889|0.939
Observed|Kidney cancer|2015–2019|Males|3|45–49|0.887|0.861|0.909
Observed|Kidney cancer|2015–2019|Males|3|50–54|0.867|0.846|0.886
Observed|Kidney cancer|2015–2019|Males|3|55–59|0.869|0.85|0.885
Observed|Kidney cancer|2015–2019|Males|3|60–64|0.859|0.842|0.875
Observed|Kidney cancer|2015–2019|Males|3|65–69|0.822|0.804|0.839
Observed|Kidney cancer|2015–2019|Males|3|70–74|0.802|0.781|0.82
Observed|Kidney cancer|2015–2019|Males|3|75–79|0.717|0.69|0.743
Observed|Kidney cancer|2015–2019|Males|3|80–84|0.603|0.567|0.637
Observed|Kidney cancer|2015–2019|Males|3|85+|0.321|0.282|0.361
Observed|Kidney cancer|2015–2019|Males|3|All ages combined|0.802|0.795|0.81
Observed|Kidney cancer|2015–2019|Males|4|00–04|0.952|0.878|0.982
Observed|Kidney cancer|2015–2019|Males|4|05–09|||
Observed|Kidney cancer|2015–2019|Males|4|10–14|||
Observed|Kidney cancer|2015–2019|Males|4|15–19|||
Observed|Kidney cancer|2015–2019|Males|4|20–24|||
Observed|Kidney cancer|2015–2019|Males|4|25–29|0.941|0.827|0.981
Observed|Kidney cancer|2015–2019|Males|4|30–34|0.929|0.863|0.964
Observed|Kidney cancer|2015–2019|Males|4|35–39|0.946|0.909|0.968
Observed|Kidney cancer|2015–2019|Males|4|40–44|0.898|0.867|0.922
Observed|Kidney cancer|2015–2019|Males|4|45–49|0.879|0.852|0.902
Observed|Kidney cancer|2015–2019|Males|4|50–54|0.85|0.827|0.869
Observed|Kidney cancer|2015–2019|Males|4|55–59|0.842|0.822|0.861
Observed|Kidney cancer|2015–2019|Males|4|60–64|0.828|0.808|0.845
Observed|Kidney cancer|2015–2019|Males|4|65–69|0.789|0.769|0.807
Observed|Kidney cancer|2015–2019|Males|4|70–74|0.762|0.739|0.782
Observed|Kidney cancer|2015–2019|Males|4|75–79|0.669|0.64|0.696
Observed|Kidney cancer|2015–2019|Males|4|80–84|0.54|0.503|0.576
Observed|Kidney cancer|2015–2019|Males|4|85+|0.271|0.234|0.309
Observed|Kidney cancer|2015–2019|Males|4|All ages combined|0.77|0.762|0.778
Observed|Kidney cancer|2015–2019|Males|5|00–04|0.952|0.878|0.982
Observed|Kidney cancer|2015–2019|Males|5|05–09|||
Observed|Kidney cancer|2015–2019|Males|5|10–14|||
Observed|Kidney cancer|2015–2019|Males|5|15–19|||
Observed|Kidney cancer|2015–2019|Males|5|20–24|||
Observed|Kidney cancer|2015–2019|Males|5|25–29|0.941|0.827|0.981
Observed|Kidney cancer|2015–2019|Males|5|30–34|0.929|0.863|0.964
Observed|Kidney cancer|2015–2019|Males|5|35–39|0.933|0.893|0.958
Observed|Kidney cancer|2015–2019|Males|5|40–44|0.889|0.856|0.914
Observed|Kidney cancer|2015–2019|Males|5|45–49|0.861|0.833|0.885
Observed|Kidney cancer|2015–2019|Males|5|50–54|0.827|0.803|0.848
Observed|Kidney cancer|2015–2019|Males|5|55–59|0.819|0.797|0.838
Observed|Kidney cancer|2015–2019|Males|5|60–64|0.802|0.782|0.821
Observed|Kidney cancer|2015–2019|Males|5|65–69|0.76|0.739|0.78
Observed|Kidney cancer|2015–2019|Males|5|70–74|0.719|0.696|0.742
Observed|Kidney cancer|2015–2019|Males|5|75–79|0.621|0.591|0.65
Observed|Kidney cancer|2015–2019|Males|5|80–84|0.452|0.415|0.489
Observed|Kidney cancer|2015–2019|Males|5|85+|0.201|0.168|0.235
Observed|Kidney cancer|2015–2019|Males|5|All ages combined|0.736|0.728|0.744
Relative|Kidney cancer|2015–2019|Males|1|00–04|0.977|0.907|0.995
Relative|Kidney cancer|2015–2019|Males|1|05–09|||
Relative|Kidney cancer|2015–2019|Males|1|10–14|||
Relative|Kidney cancer|2015–2019|Males|1|15–19|||
Relative|Kidney cancer|2015–2019|Males|1|20–24|||
Relative|Kidney cancer|2015–2019|Males|1|25–29|0.965|0.865|0.992
Relative|Kidney cancer|2015–2019|Males|1|30–34|0.948|0.887|0.977
Relative|Kidney cancer|2015–2019|Males|1|35–39|0.973|0.943|0.988
Relative|Kidney cancer|2015–2019|Males|1|40–44|0.949|0.924|0.966
Relative|Kidney cancer|2015–2019|Males|1|45–49|0.937|0.916|0.953
Relative|Kidney cancer|2015–2019|Males|1|50–54|0.932|0.916|0.946
Relative|Kidney cancer|2015–2019|Males|1|55–59|0.93|0.915|0.943
Relative|Kidney cancer|2015–2019|Males|1|60–64|0.926|0.912|0.938
Relative|Kidney cancer|2015–2019|Males|1|65–69|0.929|0.916|0.941
Relative|Kidney cancer|2015–2019|Males|1|70–74|0.911|0.895|0.925
Relative|Kidney cancer|2015–2019|Males|1|75–79|0.881|0.859|0.901
Relative|Kidney cancer|2015–2019|Males|1|80–84|0.82|0.786|0.85
Relative|Kidney cancer|2015–2019|Males|1|85+|0.579|0.528|0.628
Relative|Kidney cancer|2015–2019|Males|1|All ages combined|0.906|0.9|0.911
Relative|Kidney cancer|2015–2019|Males|2|00–04|0.953|0.879|0.983
Relative|Kidney cancer|2015–2019|Males|2|05–09|||
Relative|Kidney cancer|2015–2019|Males|2|10–14|||
Relative|Kidney cancer|2015–2019|Males|2|15–19|||
Relative|Kidney cancer|2015–2019|Males|2|20–24|||
Relative|Kidney cancer|2015–2019|Males|2|25–29|0.965|0.865|0.992
Relative|Kidney cancer|2015–2019|Males|2|30–34|0.93|0.864|0.965
Relative|Kidney cancer|2015–2019|Males|2|35–39|0.962|0.928|0.98
Relative|Kidney cancer|2015–2019|Males|2|40–44|0.932|0.904|0.952
Relative|Kidney cancer|2015–2019|Males|2|45–49|0.904|0.879|0.924
Relative|Kidney cancer|2015–2019|Males|2|50–54|0.901|0.881|0.918
Relative|Kidney cancer|2015–2019|Males|2|55–59|0.899|0.881|0.914
Relative|Kidney cancer|2015–2019|Males|2|60–64|0.903|0.886|0.917
Relative|Kidney cancer|2015–2019|Males|2|65–69|0.89|0.873|0.905
Relative|Kidney cancer|2015–2019|Males|2|70–74|0.872|0.852|0.89
Relative|Kidney cancer|2015–2019|Males|2|75–79|0.83|0.803|0.855
Relative|Kidney cancer|2015–2019|Males|2|80–84|0.772|0.732|0.809
Relative|Kidney cancer|2015–2019|Males|2|85+|0.538|0.482|0.593
Relative|Kidney cancer|2015–2019|Males|2|All ages combined|0.871|0.864|0.878
Relative|Kidney cancer|2015–2019|Males|3|00–04|0.954|0.879|0.983
Relative|Kidney cancer|2015–2019|Males|3|05–09|||
Relative|Kidney cancer|2015–2019|Males|3|10–14|||
Relative|Kidney cancer|2015–2019|Males|3|15–19|||
Relative|Kidney cancer|2015–2019|Males|3|20–24|||
Relative|Kidney cancer|2015–2019|Males|3|25–29|0.943|0.829|0.983
Relative|Kidney cancer|2015–2019|Males|3|30–34|0.931|0.865|0.966
Relative|Kidney cancer|2015–2019|Males|3|35–39|0.963|0.929|0.982
Relative|Kidney cancer|2015–2019|Males|3|40–44|0.923|0.894|0.944
Relative|Kidney cancer|2015–2019|Males|3|45–49|0.894|0.868|0.916
Relative|Kidney cancer|2015–2019|Males|3|50–54|0.877|0.856|0.896
Relative|Kidney cancer|2015–2019|Males|3|55–59|0.884|0.865|0.901
Relative|Kidney cancer|2015–2019|Males|3|60–64|0.882|0.864|0.898
Relative|Kidney cancer|2015–2019|Males|3|65–69|0.855|0.836|0.873
Relative|Kidney cancer|2015–2019|Males|3|70–74|0.855|0.833|0.875
Relative|Kidney cancer|2015–2019|Males|3|75–79|0.802|0.771|0.83
Relative|Kidney cancer|2015–2019|Males|3|80–84|0.741|0.697|0.783
Relative|Kidney cancer|2015–2019|Males|3|85+|0.498|0.437|0.559
Relative|Kidney cancer|2015–2019|Males|3|All ages combined|0.85|0.842|0.857
Relative|Kidney cancer|2015–2019|Males|4|00–04|0.954|0.879|0.983
Relative|Kidney cancer|2015–2019|Males|4|05–09|||
Relative|Kidney cancer|2015–2019|Males|4|10–14|||
Relative|Kidney cancer|2015–2019|Males|4|15–19|||
Relative|Kidney cancer|2015–2019|Males|4|20–24|||
Relative|Kidney cancer|2015–2019|Males|4|25–29|0.944|0.829|0.984
Relative|Kidney cancer|2015–2019|Males|4|30–34|0.932|0.866|0.967
Relative|Kidney cancer|2015–2019|Males|4|35–39|0.951|0.914|0.973
Relative|Kidney cancer|2015–2019|Males|4|40–44|0.905|0.873|0.929
Relative|Kidney cancer|2015–2019|Males|4|45–49|0.889|0.861|0.911
Relative|Kidney cancer|2015–2019|Males|4|50–54|0.863|0.84|0.883
Relative|Kidney cancer|2015–2019|Males|4|55–59|0.863|0.842|0.882
Relative|Kidney cancer|2015–2019|Males|4|60–64|0.858|0.838|0.876
Relative|Kidney cancer|2015–2019|Males|4|65–69|0.834|0.813|0.854
Relative|Kidney cancer|2015–2019|Males|4|70–74|0.834|0.81|0.857
Relative|Kidney cancer|2015–2019|Males|4|75–79|0.783|0.75|0.815
Relative|Kidney cancer|2015–2019|Males|4|80–84|0.724|0.675|0.772
Relative|Kidney cancer|2015–2019|Males|4|85+|0.497|0.43|0.567
Relative|Kidney cancer|2015–2019|Males|4|All ages combined|0.832|0.824|0.84
Relative|Kidney cancer|2015–2019|Males|5|00–04|0.954|0.879|0.983
Relative|Kidney cancer|2015–2019|Males|5|05–09|||
Relative|Kidney cancer|2015–2019|Males|5|10–14|||
Relative|Kidney cancer|2015–2019|Males|5|15–19|||
Relative|Kidney cancer|2015–2019|Males|5|20–24|||
Relative|Kidney cancer|2015–2019|Males|5|25–29|0.945|0.83|0.985
Relative|Kidney cancer|2015–2019|Males|5|30–34|0.933|0.867|0.969
Relative|Kidney cancer|2015–2019|Males|5|35–39|0.939|0.899|0.965
Relative|Kidney cancer|2015–2019|Males|5|40–44|0.897|0.864|0.923
Relative|Kidney cancer|2015–2019|Males|5|45–49|0.873|0.844|0.898
Relative|Kidney cancer|2015–2019|Males|5|50–54|0.844|0.82|0.866
Relative|Kidney cancer|2015–2019|Males|5|55–59|0.845|0.823|0.865
Relative|Kidney cancer|2015–2019|Males|5|60–64|0.841|0.819|0.86
Relative|Kidney cancer|2015–2019|Males|5|65–69|0.818|0.796|0.839
Relative|Kidney cancer|2015–2019|Males|5|70–74|0.812|0.785|0.837
Relative|Kidney cancer|2015–2019|Males|5|75–79|0.767|0.73|0.803
Relative|Kidney cancer|2015–2019|Males|5|80–84|0.67|0.614|0.725
Relative|Kidney cancer|2015–2019|Males|5|85+|0.441|0.37|0.517
Relative|Kidney cancer|2015–2019|Males|5|All ages combined|0.813|0.804|0.822
Observed|Kidney cancer|2015–2019|Females|1|00–04|0.976|0.909|0.994
Observed|Kidney cancer|2015–2019|Females|1|05–09|||
Observed|Kidney cancer|2015–2019|Females|1|10–14|||
Observed|Kidney cancer|2015–2019|Females|1|15–19|||
Observed|Kidney cancer|2015–2019|Females|1|20–24|||
Observed|Kidney cancer|2015–2019|Females|1|25–29|0.968|0.795|0.995
Observed|Kidney cancer|2015–2019|Females|1|30–34|0.949|0.869|0.98
Observed|Kidney cancer|2015–2019|Females|1|35–39|0.967|0.914|0.987
Observed|Kidney cancer|2015–2019|Females|1|40–44|0.963|0.927|0.981
Observed|Kidney cancer|2015–2019|Females|1|45–49|0.966|0.941|0.98
Observed|Kidney cancer|2015–2019|Females|1|50–54|0.96|0.94|0.974
Observed|Kidney cancer|2015–2019|Females|1|55–59|0.943|0.922|0.959
Observed|Kidney cancer|2015–2019|Females|1|60–64|0.931|0.911|0.947
Observed|Kidney cancer|2015–2019|Females|1|65–69|0.938|0.921|0.952
Observed|Kidney cancer|2015–2019|Females|1|70–74|0.913|0.891|0.93
Observed|Kidney cancer|2015–2019|Females|1|75–79|0.875|0.846|0.899
Observed|Kidney cancer|2015–2019|Females|1|80–84|0.802|0.761|0.836
Observed|Kidney cancer|2015–2019|Females|1|85+|0.514|0.463|0.563
Observed|Kidney cancer|2015–2019|Females|1|All ages combined|0.898|0.89|0.905
Observed|Kidney cancer|2015–2019|Females|2|00–04|0.976|0.909|0.994
Observed|Kidney cancer|2015–2019|Females|2|05–09|||
Observed|Kidney cancer|2015–2019|Females|2|10–14|||
Observed|Kidney cancer|2015–2019|Females|2|15–19|||
Observed|Kidney cancer|2015–2019|Females|2|20–24|||
Observed|Kidney cancer|2015–2019|Females|2|25–29|0.968|0.795|0.995
Observed|Kidney cancer|2015–2019|Females|2|30–34|0.923|0.836|0.964
Observed|Kidney cancer|2015–2019|Females|2|35–39|0.959|0.904|0.983
Observed|Kidney cancer|2015–2019|Females|2|40–44|0.945|0.905|0.968
Observed|Kidney cancer|2015–2019|Females|2|45–49|0.946|0.917|0.965
Observed|Kidney cancer|2015–2019|Females|2|50–54|0.931|0.906|0.95
Observed|Kidney cancer|2015–2019|Females|2|55–59|0.922|0.899|0.941
Observed|Kidney cancer|2015–2019|Females|2|60–64|0.896|0.873|0.915
Observed|Kidney cancer|2015–2019|Females|2|65–69|0.902|0.881|0.92
Observed|Kidney cancer|2015–2019|Females|2|70–74|0.848|0.821|0.871
Observed|Kidney cancer|2015–2019|Females|2|75–79|0.815|0.782|0.844
Observed|Kidney cancer|2015–2019|Females|2|80–84|0.709|0.664|0.749
Observed|Kidney cancer|2015–2019|Females|2|85+|0.401|0.352|0.449
Observed|Kidney cancer|2015–2019|Females|2|All ages combined|0.852|0.842|0.86
Observed|Kidney cancer|2015–2019|Females|3|00–04|0.976|0.909|0.994
Observed|Kidney cancer|2015–2019|Females|3|05–09|||
Observed|Kidney cancer|2015–2019|Females|3|10–14|||
Observed|Kidney cancer|2015–2019|Females|3|15–19|||
Observed|Kidney cancer|2015–2019|Females|3|20–24|||
Observed|Kidney cancer|2015–2019|Females|3|25–29|0.968|0.795|0.995
Observed|Kidney cancer|2015–2019|Females|3|30–34|0.923|0.836|0.964
Observed|Kidney cancer|2015–2019|Females|3|35–39|0.934|0.872|0.966
Observed|Kidney cancer|2015–2019|Females|3|40–44|0.923|0.879|0.951
Observed|Kidney cancer|2015–2019|Females|3|45–49|0.935|0.903|0.956
Observed|Kidney cancer|2015–2019|Females|3|50–54|0.915|0.888|0.936
Observed|Kidney cancer|2015–2019|Females|3|55–59|0.911|0.885|0.931
Observed|Kidney cancer|2015–2019|Females|3|60–64|0.869|0.844|0.891
Observed|Kidney cancer|2015–2019|Females|3|65–69|0.874|0.85|0.895
Observed|Kidney cancer|2015–2019|Females|3|70–74|0.811|0.781|0.837
Observed|Kidney cancer|2015–2019|Females|3|75–79|0.764|0.728|0.797
Observed|Kidney cancer|2015–2019|Females|3|80–84|0.623|0.576|0.667
Observed|Kidney cancer|2015–2019|Females|3|85+|0.318|0.273|0.364
Observed|Kidney cancer|2015–2019|Females|3|All ages combined|0.817|0.807|0.827
Observed|Kidney cancer|2015–2019|Females|4|00–04|0.976|0.909|0.994
Observed|Kidney cancer|2015–2019|Females|4|05–09|||
Observed|Kidney cancer|2015–2019|Females|4|10–14|||
Observed|Kidney cancer|2015–2019|Females|4|15–19|||
Observed|Kidney cancer|2015–2019|Females|4|20–24|||
Observed|Kidney cancer|2015–2019|Females|4|25–29|0.968|0.795|0.995
Observed|Kidney cancer|2015–2019|Females|4|30–34|0.909|0.818|0.955
Observed|Kidney cancer|2015–2019|Females|4|35–39|0.934|0.872|0.966
Observed|Kidney cancer|2015–2019|Females|4|40–44|0.918|0.873|0.948
Observed|Kidney cancer|2015–2019|Females|4|45–49|0.911|0.876|0.937
Observed|Kidney cancer|2015–2019|Females|4|50–54|0.905|0.876|0.927
Observed|Kidney cancer|2015–2019|Females|4|55–59|0.895|0.869|0.917
Observed|Kidney cancer|2015–2019|Females|4|60–64|0.853|0.827|0.876
Observed|Kidney cancer|2015–2019|Females|4|65–69|0.85|0.824|0.872
Observed|Kidney cancer|2015–2019|Females|4|70–74|0.778|0.747|0.806
Observed|Kidney cancer|2015–2019|Females|4|75–79|0.725|0.687|0.759
Observed|Kidney cancer|2015–2019|Females|4|80–84|0.56|0.512|0.606
Observed|Kidney cancer|2015–2019|Females|4|85+|0.267|0.225|0.311
Observed|Kidney cancer|2015–2019|Females|4|All ages combined|0.79|0.78|0.801
Observed|Kidney cancer|2015–2019|Females|5|00–04|0.976|0.909|0.994
Observed|Kidney cancer|2015–2019|Females|5|05–09|||
Observed|Kidney cancer|2015–2019|Females|5|10–14|||
Observed|Kidney cancer|2015–2019|Females|5|15–19|||
Observed|Kidney cancer|2015–2019|Females|5|20–24|||
Observed|Kidney cancer|2015–2019|Females|5|25–29|0.968|0.795|0.995
Observed|Kidney cancer|2015–2019|Females|5|30–34|0.893|0.797|0.945
Observed|Kidney cancer|2015–2019|Females|5|35–39|0.934|0.872|0.966
Observed|Kidney cancer|2015–2019|Females|5|40–44|0.909|0.862|0.94
Observed|Kidney cancer|2015–2019|Females|5|45–49|0.899|0.862|0.926
Observed|Kidney cancer|2015–2019|Females|5|50–54|0.896|0.866|0.92
Observed|Kidney cancer|2015–2019|Females|5|55–59|0.886|0.858|0.909
Observed|Kidney cancer|2015–2019|Females|5|60–64|0.833|0.804|0.857
Observed|Kidney cancer|2015–2019|Females|5|65–69|0.824|0.796|0.848
Observed|Kidney cancer|2015–2019|Females|5|70–74|0.742|0.708|0.772
Observed|Kidney cancer|2015–2019|Females|5|75–79|0.666|0.625|0.703
Observed|Kidney cancer|2015–2019|Females|5|80–84|0.509|0.461|0.555
Observed|Kidney cancer|2015–2019|Females|5|85+|0.213|0.174|0.254
Observed|Kidney cancer|2015–2019|Females|5|All ages combined|0.762|0.751|0.773
Relative|Kidney cancer|2015–2019|Females|1|00–04|0.977|0.909|0.995
Relative|Kidney cancer|2015–2019|Females|1|05–09|||
Relative|Kidney cancer|2015–2019|Females|1|10–14|||
Relative|Kidney cancer|2015–2019|Females|1|15–19|||
Relative|Kidney cancer|2015–2019|Females|1|20–24|||
Relative|Kidney cancer|2015–2019|Females|1|25–29|0.969|0.796|0.996
Relative|Kidney cancer|2015–2019|Females|1|30–34|0.949|0.869|0.981
Relative|Kidney cancer|2015–2019|Females|1|35–39|0.968|0.915|0.988
Relative|Kidney cancer|2015–2019|Females|1|40–44|0.964|0.928|0.982
Relative|Kidney cancer|2015–2019|Females|1|45–49|0.967|0.942|0.982
Relative|Kidney cancer|2015–2019|Females|1|50–54|0.962|0.942|0.976
Relative|Kidney cancer|2015–2019|Females|1|55–59|0.946|0.925|0.962
Relative|Kidney cancer|2015–2019|Females|1|60–64|0.935|0.915|0.951
Relative|Kidney cancer|2015–2019|Females|1|65–69|0.945|0.927|0.959
Relative|Kidney cancer|2015–2019|Females|1|70–74|0.924|0.902|0.942
Relative|Kidney cancer|2015–2019|Females|1|75–79|0.894|0.864|0.918
Relative|Kidney cancer|2015–2019|Females|1|80–84|0.835|0.793|0.871
Relative|Kidney cancer|2015–2019|Females|1|85+|0.577|0.519|0.631
Relative|Kidney cancer|2015–2019|Females|1|All ages combined|0.912|0.904|0.92
Relative|Kidney cancer|2015–2019|Females|2|00–04|0.977|0.909|0.995
Relative|Kidney cancer|2015–2019|Females|2|05–09|||
Relative|Kidney cancer|2015–2019|Females|2|10–14|||
Relative|Kidney cancer|2015–2019|Females|2|15–19|||
Relative|Kidney cancer|2015–2019|Females|2|20–24|||
Relative|Kidney cancer|2015–2019|Females|2|25–29|0.969|0.796|0.996
Relative|Kidney cancer|2015–2019|Females|2|30–34|0.923|0.837|0.965
Relative|Kidney cancer|2015–2019|Females|2|35–39|0.96|0.905|0.984
Relative|Kidney cancer|2015–2019|Females|2|40–44|0.947|0.907|0.97
Relative|Kidney cancer|2015–2019|Females|2|45–49|0.949|0.92|0.968
Relative|Kidney cancer|2015–2019|Females|2|50–54|0.935|0.91|0.954
Relative|Kidney cancer|2015–2019|Females|2|55–59|0.929|0.905|0.947
Relative|Kidney cancer|2015–2019|Females|2|60–64|0.905|0.881|0.924
Relative|Kidney cancer|2015–2019|Females|2|65–69|0.916|0.894|0.934
Relative|Kidney cancer|2015–2019|Females|2|70–74|0.87|0.842|0.894
Relative|Kidney cancer|2015–2019|Females|2|75–79|0.853|0.818|0.883
Relative|Kidney cancer|2015–2019|Females|2|80–84|0.774|0.725|0.818
Relative|Kidney cancer|2015–2019|Females|2|85+|0.506|0.445|0.567
Relative|Kidney cancer|2015–2019|Females|2|All ages combined|0.878|0.868|0.887
Relative|Kidney cancer|2015–2019|Females|3|00–04|0.977|0.91|0.995
Relative|Kidney cancer|2015–2019|Females|3|05–09|||
Relative|Kidney cancer|2015–2019|Females|3|10–14|||
Relative|Kidney cancer|2015–2019|Females|3|15–19|||
Relative|Kidney cancer|2015–2019|Females|3|20–24|||
Relative|Kidney cancer|2015–2019|Females|3|25–29|0.969|0.796|0.996
Relative|Kidney cancer|2015–2019|Females|3|30–34|0.924|0.837|0.966
Relative|Kidney cancer|2015–2019|Females|3|35–39|0.935|0.873|0.968
Relative|Kidney cancer|2015–2019|Females|3|40–44|0.926|0.882|0.954
Relative|Kidney cancer|2015–2019|Females|3|45–49|0.939|0.908|0.961
Relative|Kidney cancer|2015–2019|Females|3|50–54|0.922|0.894|0.943
Relative|Kidney cancer|2015–2019|Females|3|55–59|0.92|0.895|0.94
Relative|Kidney cancer|2015–2019|Females|3|60–64|0.883|0.857|0.905
Relative|Kidney cancer|2015–2019|Females|3|65–69|0.896|0.871|0.916
Relative|Kidney cancer|2015–2019|Females|3|70–74|0.845|0.814|0.872
Relative|Kidney cancer|2015–2019|Females|3|75–79|0.822|0.783|0.857
Relative|Kidney cancer|2015–2019|Females|3|80–84|0.718|0.663|0.768
Relative|Kidney cancer|2015–2019|Females|3|85+|0.457|0.392|0.523
Relative|Kidney cancer|2015–2019|Females|3|All ages combined|0.855|0.844|0.865
Relative|Kidney cancer|2015–2019|Females|4|00–04|0.977|0.91|0.995
Relative|Kidney cancer|2015–2019|Females|4|05–09|||
Relative|Kidney cancer|2015–2019|Females|4|10–14|||
Relative|Kidney cancer|2015–2019|Females|4|15–19|||
Relative|Kidney cancer|2015–2019|Females|4|20–24|||
Relative|Kidney cancer|2015–2019|Females|4|25–29|0.97|0.796|0.997
Relative|Kidney cancer|2015–2019|Females|4|30–34|0.91|0.819|0.957
Relative|Kidney cancer|2015–2019|Females|4|35–39|0.936|0.874|0.969
Relative|Kidney cancer|2015–2019|Females|4|40–44|0.922|0.877|0.952
Relative|Kidney cancer|2015–2019|Females|4|45–49|0.917|0.881|0.943
Relative|Kidney cancer|2015–2019|Females|4|50–54|0.914|0.885|0.936
Relative|Kidney cancer|2015–2019|Females|4|55–59|0.908|0.881|0.93
Relative|Kidney cancer|2015–2019|Females|4|60–64|0.872|0.844|0.895
Relative|Kidney cancer|2015–2019|Females|4|65–69|0.879|0.852|0.903
Relative|Kidney cancer|2015–2019|Females|4|70–74|0.825|0.791|0.854
Relative|Kidney cancer|2015–2019|Females|4|75–79|0.804|0.762|0.842
Relative|Kidney cancer|2015–2019|Females|4|80–84|0.686|0.628|0.742
Relative|Kidney cancer|2015–2019|Females|4|85+|0.442|0.372|0.515
Relative|Kidney cancer|2015–2019|Females|4|All ages combined|0.84|0.829|0.851
Relative|Kidney cancer|2015–2019|Females|5|00–04|0.977|0.91|0.995
Relative|Kidney cancer|2015–2019|Females|5|05–09|||
Relative|Kidney cancer|2015–2019|Females|5|10–14|||
Relative|Kidney cancer|2015–2019|Females|5|15–19|||
Relative|Kidney cancer|2015–2019|Females|5|20–24|||
Relative|Kidney cancer|2015–2019|Females|5|25–29|0.97|0.797|0.997
Relative|Kidney cancer|2015–2019|Females|5|30–34|0.895|0.799|0.948
Relative|Kidney cancer|2015–2019|Females|5|35–39|0.937|0.875|0.97
Relative|Kidney cancer|2015–2019|Females|5|40–44|0.914|0.867|0.945
Relative|Kidney cancer|2015–2019|Females|5|45–49|0.906|0.869|0.934
Relative|Kidney cancer|2015–2019|Females|5|50–54|0.908|0.877|0.931
Relative|Kidney cancer|2015–2019|Females|5|55–59|0.903|0.875|0.926
Relative|Kidney cancer|2015–2019|Females|5|60–64|0.856|0.827|0.881
Relative|Kidney cancer|2015–2019|Females|5|65–69|0.862|0.832|0.888
Relative|Kidney cancer|2015–2019|Females|5|70–74|0.801|0.765|0.834
Relative|Kidney cancer|2015–2019|Females|5|75–79|0.765|0.719|0.808
Relative|Kidney cancer|2015–2019|Females|5|80–84|0.669|0.606|0.729
Relative|Kidney cancer|2015–2019|Females|5|85+|0.413|0.338|0.494
Relative|Kidney cancer|2015–2019|Females|5|All ages combined|0.824|0.812|0.836
Observed|Kidney cancer|2015–2019|Persons|1|00–04|0.976|0.937|0.991
Observed|Kidney cancer|2015–2019|Persons|1|05–09|0.948|0.808|0.987
Observed|Kidney cancer|2015–2019|Persons|1|10–14|||
Observed|Kidney cancer|2015–2019|Persons|1|15–19|||
Observed|Kidney cancer|2015–2019|Persons|1|20–24|0.97|0.806|0.996
Observed|Kidney cancer|2015–2019|Persons|1|25–29|0.966|0.897|0.989
Observed|Kidney cancer|2015–2019|Persons|1|30–34|0.948|0.905|0.972
Observed|Kidney cancer|2015–2019|Persons|1|35–39|0.97|0.947|0.983
Observed|Kidney cancer|2015–2019|Persons|1|40–44|0.952|0.933|0.966
Observed|Kidney cancer|2015–2019|Persons|1|45–49|0.945|0.93|0.957
Observed|Kidney cancer|2015–2019|Persons|1|50–54|0.939|0.926|0.95
Observed|Kidney cancer|2015–2019|Persons|1|55–59|0.931|0.919|0.941
Observed|Kidney cancer|2015–2019|Persons|1|60–64|0.922|0.911|0.932
Observed|Kidney cancer|2015–2019|Persons|1|65–69|0.925|0.914|0.934
Observed|Kidney cancer|2015–2019|Persons|1|70–74|0.9|0.887|0.911
Observed|Kidney cancer|2015–2019|Persons|1|75–79|0.86|0.843|0.875
Observed|Kidney cancer|2015–2019|Persons|1|80–84|0.783|0.758|0.805
Observed|Kidney cancer|2015–2019|Persons|1|85+|0.508|0.475|0.54
Observed|Kidney cancer|2015–2019|Persons|1|All ages combined|0.891|0.887|0.896
Observed|Kidney cancer|2015–2019|Persons|2|00–04|0.964|0.922|0.984
Observed|Kidney cancer|2015–2019|Persons|2|05–09|0.948|0.808|0.987
Observed|Kidney cancer|2015–2019|Persons|2|10–14|||
Observed|Kidney cancer|2015–2019|Persons|2|15–19|||
Observed|Kidney cancer|2015–2019|Persons|2|20–24|0.97|0.806|0.996
Observed|Kidney cancer|2015–2019|Persons|2|25–29|0.966|0.897|0.989
Observed|Kidney cancer|2015–2019|Persons|2|30–34|0.926|0.879|0.956
Observed|Kidney cancer|2015–2019|Persons|2|35–39|0.959|0.933|0.975
Observed|Kidney cancer|2015–2019|Persons|2|40–44|0.934|0.912|0.95
Observed|Kidney cancer|2015–2019|Persons|2|45–49|0.915|0.897|0.931
Observed|Kidney cancer|2015–2019|Persons|2|50–54|0.906|0.891|0.919
Observed|Kidney cancer|2015–2019|Persons|2|55–59|0.899|0.885|0.912
Observed|Kidney cancer|2015–2019|Persons|2|60–64|0.89|0.877|0.902
Observed|Kidney cancer|2015–2019|Persons|2|65–69|0.879|0.866|0.891
Observed|Kidney cancer|2015–2019|Persons|2|70–74|0.84|0.825|0.854
Observed|Kidney cancer|2015–2019|Persons|2|75–79|0.788|0.768|0.807
Observed|Kidney cancer|2015–2019|Persons|2|80–84|0.69|0.663|0.715
Observed|Kidney cancer|2015–2019|Persons|2|85+|0.403|0.372|0.435
Observed|Kidney cancer|2015–2019|Persons|2|All ages combined|0.843|0.838|0.849
Observed|Kidney cancer|2015–2019|Persons|3|00–04|0.964|0.922|0.984
Observed|Kidney cancer|2015–2019|Persons|3|05–09|0.948|0.808|0.987
Observed|Kidney cancer|2015–2019|Persons|3|10–14|||
Observed|Kidney cancer|2015–2019|Persons|3|15–19|||
Observed|Kidney cancer|2015–2019|Persons|3|20–24|0.97|0.806|0.996
Observed|Kidney cancer|2015–2019|Persons|3|25–29|0.954|0.882|0.983
Observed|Kidney cancer|2015–2019|Persons|3|30–34|0.926|0.879|0.956
Observed|Kidney cancer|2015–2019|Persons|3|35–39|0.95|0.922|0.968
Observed|Kidney cancer|2015–2019|Persons|3|40–44|0.919|0.896|0.937
Observed|Kidney cancer|2015–2019|Persons|3|45–49|0.903|0.884|0.92
Observed|Kidney cancer|2015–2019|Persons|3|50–54|0.883|0.866|0.897
Observed|Kidney cancer|2015–2019|Persons|3|55–59|0.882|0.867|0.895
Observed|Kidney cancer|2015–2019|Persons|3|60–64|0.862|0.848|0.875
Observed|Kidney cancer|2015–2019|Persons|3|65–69|0.839|0.824|0.852
Observed|Kidney cancer|2015–2019|Persons|3|70–74|0.804|0.788|0.82
Observed|Kidney cancer|2015–2019|Persons|3|75–79|0.734|0.712|0.754
Observed|Kidney cancer|2015–2019|Persons|3|80–84|0.61|0.582|0.638
Observed|Kidney cancer|2015–2019|Persons|3|85+|0.32|0.29|0.35
Observed|Kidney cancer|2015–2019|Persons|3|All ages combined|0.807|0.801|0.813
Observed|Kidney cancer|2015–2019|Persons|4|00–04|0.964|0.922|0.984
Observed|Kidney cancer|2015–2019|Persons|4|05–09|0.948|0.808|0.987
Observed|Kidney cancer|2015–2019|Persons|4|10–14|||
Observed|Kidney cancer|2015–2019|Persons|4|15–19|||
Observed|Kidney cancer|2015–2019|Persons|4|20–24|0.97|0.806|0.996
Observed|Kidney cancer|2015–2019|Persons|4|25–29|0.954|0.882|0.983
Observed|Kidney cancer|2015–2019|Persons|4|30–34|0.92|0.871|0.951
Observed|Kidney cancer|2015–2019|Persons|4|35–39|0.942|0.912|0.962
Observed|Kidney cancer|2015–2019|Persons|4|40–44|0.904|0.88|0.924
Observed|Kidney cancer|2015–2019|Persons|4|45–49|0.89|0.869|0.908
Observed|Kidney cancer|2015–2019|Persons|4|50–54|0.867|0.85|0.883
Observed|Kidney cancer|2015–2019|Persons|4|55–59|0.859|0.843|0.873
Observed|Kidney cancer|2015–2019|Persons|4|60–64|0.836|0.821|0.85
Observed|Kidney cancer|2015–2019|Persons|4|65–69|0.808|0.793|0.823
Observed|Kidney cancer|2015–2019|Persons|4|70–74|0.767|0.749|0.784
Observed|Kidney cancer|2015–2019|Persons|4|75–79|0.688|0.665|0.71
Observed|Kidney cancer|2015–2019|Persons|4|80–84|0.548|0.518|0.576
Observed|Kidney cancer|2015–2019|Persons|4|85+|0.269|0.242|0.298
Observed|Kidney cancer|2015–2019|Persons|4|All ages combined|0.777|0.771|0.783
Observed|Kidney cancer|2015–2019|Persons|5|00–04|0.964|0.922|0.984
Observed|Kidney cancer|2015–2019|Persons|5|05–09|0.948|0.808|0.987
Observed|Kidney cancer|2015–2019|Persons|5|10–14|||
Observed|Kidney cancer|2015–2019|Persons|5|15–19|||
Observed|Kidney cancer|2015–2019|Persons|5|20–24|0.97|0.806|0.996
Observed|Kidney cancer|2015–2019|Persons|5|25–29|0.954|0.882|0.983
Observed|Kidney cancer|2015–2019|Persons|5|30–34|0.914|0.862|0.946
Observed|Kidney cancer|2015–2019|Persons|5|35–39|0.933|0.901|0.955
Observed|Kidney cancer|2015–2019|Persons|5|40–44|0.895|0.869|0.916
Observed|Kidney cancer|2015–2019|Persons|5|45–49|0.874|0.852|0.893
Observed|Kidney cancer|2015–2019|Persons|5|50–54|0.849|0.83|0.865
Observed|Kidney cancer|2015–2019|Persons|5|55–59|0.84|0.823|0.855
Observed|Kidney cancer|2015–2019|Persons|5|60–64|0.812|0.796|0.827
Observed|Kidney cancer|2015–2019|Persons|5|65–69|0.78|0.764|0.796
Observed|Kidney cancer|2015–2019|Persons|5|70–74|0.727|0.708|0.745
Observed|Kidney cancer|2015–2019|Persons|5|75–79|0.637|0.613|0.66
Observed|Kidney cancer|2015–2019|Persons|5|80–84|0.475|0.446|0.504
Observed|Kidney cancer|2015–2019|Persons|5|85+|0.205|0.18|0.232
Observed|Kidney cancer|2015–2019|Persons|5|All ages combined|0.745|0.738|0.752
Relative|Kidney cancer|2015–2019|Persons|1|00–04|0.977|0.938|0.992
Relative|Kidney cancer|2015–2019|Persons|1|05–09|0.948|0.808|0.987
Relative|Kidney cancer|2015–2019|Persons|1|10–14|||
Relative|Kidney cancer|2015–2019|Persons|1|15–19|||
Relative|Kidney cancer|2015–2019|Persons|1|20–24|0.97|0.806|0.996
Relative|Kidney cancer|2015–2019|Persons|1|25–29|0.966|0.898|0.989
Relative|Kidney cancer|2015–2019|Persons|1|30–34|0.948|0.906|0.972
Relative|Kidney cancer|2015–2019|Persons|1|35–39|0.971|0.948|0.984
Relative|Kidney cancer|2015–2019|Persons|1|40–44|0.954|0.935|0.967
Relative|Kidney cancer|2015–2019|Persons|1|45–49|0.947|0.931|0.959
Relative|Kidney cancer|2015–2019|Persons|1|50–54|0.942|0.929|0.953
Relative|Kidney cancer|2015–2019|Persons|1|55–59|0.935|0.923|0.946
Relative|Kidney cancer|2015–2019|Persons|1|60–64|0.929|0.918|0.939
Relative|Kidney cancer|2015–2019|Persons|1|65–69|0.934|0.924|0.944
Relative|Kidney cancer|2015–2019|Persons|1|70–74|0.915|0.902|0.926
Relative|Kidney cancer|2015–2019|Persons|1|75–79|0.886|0.868|0.901
Relative|Kidney cancer|2015–2019|Persons|1|80–84|0.825|0.8|0.849
Relative|Kidney cancer|2015–2019|Persons|1|85+|0.578|0.54|0.615
Relative|Kidney cancer|2015–2019|Persons|1|All ages combined|0.908|0.903|0.913
Relative|Kidney cancer|2015–2019|Persons|2|00–04|0.965|0.923|0.985
Relative|Kidney cancer|2015–2019|Persons|2|05–09|0.948|0.808|0.987
Relative|Kidney cancer|2015–2019|Persons|2|10–14|||
Relative|Kidney cancer|2015–2019|Persons|2|15–19|||
Relative|Kidney cancer|2015–2019|Persons|2|20–24|0.971|0.806|0.997
Relative|Kidney cancer|2015–2019|Persons|2|25–29|0.967|0.898|0.99
Relative|Kidney cancer|2015–2019|Persons|2|30–34|0.927|0.88|0.957
Relative|Kidney cancer|2015–2019|Persons|2|35–39|0.961|0.935|0.977
Relative|Kidney cancer|2015–2019|Persons|2|40–44|0.936|0.915|0.953
Relative|Kidney cancer|2015–2019|Persons|2|45–49|0.919|0.9|0.935
Relative|Kidney cancer|2015–2019|Persons|2|50–54|0.912|0.897|0.925
Relative|Kidney cancer|2015–2019|Persons|2|55–59|0.908|0.894|0.92
Relative|Kidney cancer|2015–2019|Persons|2|60–64|0.903|0.89|0.915
Relative|Kidney cancer|2015–2019|Persons|2|65–69|0.899|0.885|0.91
Relative|Kidney cancer|2015–2019|Persons|2|70–74|0.871|0.856|0.886
Relative|Kidney cancer|2015–2019|Persons|2|75–79|0.838|0.817|0.858
Relative|Kidney cancer|2015–2019|Persons|2|80–84|0.773|0.742|0.801
Relative|Kidney cancer|2015–2019|Persons|2|85+|0.524|0.483|0.565
Relative|Kidney cancer|2015–2019|Persons|2|All ages combined|0.874|0.868|0.879
Relative|Kidney cancer|2015–2019|Persons|3|00–04|0.965|0.923|0.985
Relative|Kidney cancer|2015–2019|Persons|3|05–09|0.948|0.808|0.987
Relative|Kidney cancer|2015–2019|Persons|3|10–14|||
Relative|Kidney cancer|2015–2019|Persons|3|15–19|||
Relative|Kidney cancer|2015–2019|Persons|3|20–24|0.971|0.807|0.997
Relative|Kidney cancer|2015–2019|Persons|3|25–29|0.956|0.884|0.984
Relative|Kidney cancer|2015–2019|Persons|3|30–34|0.928|0.88|0.958
Relative|Kidney cancer|2015–2019|Persons|3|35–39|0.953|0.925|0.972
Relative|Kidney cancer|2015–2019|Persons|3|40–44|0.923|0.9|0.942
Relative|Kidney cancer|2015–2019|Persons|3|45–49|0.909|0.89|0.926
Relative|Kidney cancer|2015–2019|Persons|3|50–54|0.891|0.875|0.906
Relative|Kidney cancer|2015–2019|Persons|3|55–59|0.895|0.88|0.909
Relative|Kidney cancer|2015–2019|Persons|3|60–64|0.882|0.868|0.895
Relative|Kidney cancer|2015–2019|Persons|3|65–69|0.868|0.853|0.882
Relative|Kidney cancer|2015–2019|Persons|3|70–74|0.852|0.834|0.868
Relative|Kidney cancer|2015–2019|Persons|3|75–79|0.809|0.785|0.831
Relative|Kidney cancer|2015–2019|Persons|3|80–84|0.732|0.698|0.764
Relative|Kidney cancer|2015–2019|Persons|3|85+|0.48|0.435|0.525
Relative|Kidney cancer|2015–2019|Persons|3|All ages combined|0.851|0.845|0.857
Relative|Kidney cancer|2015–2019|Persons|4|00–04|0.965|0.923|0.985
Relative|Kidney cancer|2015–2019|Persons|4|05–09|0.948|0.808|0.987
Relative|Kidney cancer|2015–2019|Persons|4|10–14|||
Relative|Kidney cancer|2015–2019|Persons|4|15–19|||
Relative|Kidney cancer|2015–2019|Persons|4|20–24|0.972|0.807|0.997
Relative|Kidney cancer|2015–2019|Persons|4|25–29|0.956|0.884|0.985
Relative|Kidney cancer|2015–2019|Persons|4|30–34|0.923|0.874|0.954
Relative|Kidney cancer|2015–2019|Persons|4|35–39|0.946|0.916|0.966
Relative|Kidney cancer|2015–2019|Persons|4|40–44|0.91|0.885|0.93
Relative|Kidney cancer|2015–2019|Persons|4|45–49|0.898|0.877|0.916
Relative|Kidney cancer|2015–2019|Persons|4|50–54|0.879|0.862|0.895
Relative|Kidney cancer|2015–2019|Persons|4|55–59|0.877|0.861|0.892
Relative|Kidney cancer|2015–2019|Persons|4|60–64|0.862|0.847|0.877
Relative|Kidney cancer|2015–2019|Persons|4|65–69|0.849|0.832|0.864
Relative|Kidney cancer|2015–2019|Persons|4|70–74|0.831|0.812|0.849
Relative|Kidney cancer|2015–2019|Persons|4|75–79|0.791|0.765|0.816
Relative|Kidney cancer|2015–2019|Persons|4|80–84|0.709|0.671|0.745
Relative|Kidney cancer|2015–2019|Persons|4|85+|0.473|0.424|0.523
Relative|Kidney cancer|2015–2019|Persons|4|All ages combined|0.835|0.828|0.841
Relative|Kidney cancer|2015–2019|Persons|5|00–04|0.965|0.923|0.985
Relative|Kidney cancer|2015–2019|Persons|5|05–09|0.948|0.808|0.987
Relative|Kidney cancer|2015–2019|Persons|5|10–14|||
Relative|Kidney cancer|2015–2019|Persons|5|15–19|||
Relative|Kidney cancer|2015–2019|Persons|5|20–24|0.972|0.807|0.998
Relative|Kidney cancer|2015–2019|Persons|5|25–29|0.957|0.885|0.985
Relative|Kidney cancer|2015–2019|Persons|5|30–34|0.917|0.866|0.95
Relative|Kidney cancer|2015–2019|Persons|5|35–39|0.938|0.907|0.96
Relative|Kidney cancer|2015–2019|Persons|5|40–44|0.902|0.877|0.923
Relative|Kidney cancer|2015–2019|Persons|5|45–49|0.885|0.862|0.904
Relative|Kidney cancer|2015–2019|Persons|5|50–54|0.864|0.845|0.881
Relative|Kidney cancer|2015–2019|Persons|5|55–59|0.863|0.846|0.879
Relative|Kidney cancer|2015–2019|Persons|5|60–64|0.846|0.829|0.862
Relative|Kidney cancer|2015–2019|Persons|5|65–69|0.832|0.814|0.849
Relative|Kidney cancer|2015–2019|Persons|5|70–74|0.808|0.787|0.828
Relative|Kidney cancer|2015–2019|Persons|5|75–79|0.766|0.737|0.793
Relative|Kidney cancer|2015–2019|Persons|5|80–84|0.671|0.629|0.712
Relative|Kidney cancer|2015–2019|Persons|5|85+|0.429|0.376|0.484
Relative|Kidney cancer|2015–2019|Persons|5|All ages combined|0.817|0.809|0.824
Observed|Laryngeal cancer|2015–2019|Males|1|00–04|||
Observed|Laryngeal cancer|2015–2019|Males|1|05–09|||
Observed|Laryngeal cancer|2015–2019|Males|1|10–14|||
Observed|Laryngeal cancer|2015–2019|Males|1|15–19|||
Observed|Laryngeal cancer|2015–2019|Males|1|20–24|||
Observed|Laryngeal cancer|2015–2019|Males|1|25–29|||
Observed|Laryngeal cancer|2015–2019|Males|1|30–34|||
Observed|Laryngeal cancer|2015–2019|Males|1|35–39|||
Observed|Laryngeal cancer|2015–2019|Males|1|40–44|||
Observed|Laryngeal cancer|2015–2019|Males|1|45–49|0.893|0.776|0.95
Observed|Laryngeal cancer|2015–2019|Males|1|50–54|0.888|0.83|0.927
Observed|Laryngeal cancer|2015–2019|Males|1|55–59|0.885|0.844|0.915
Observed|Laryngeal cancer|2015–2019|Males|1|60–64|0.854|0.815|0.886
Observed|Laryngeal cancer|2015–2019|Males|1|65–69|0.876|0.841|0.903
Observed|Laryngeal cancer|2015–2019|Males|1|70–74|0.842|0.804|0.873
Observed|Laryngeal cancer|2015–2019|Males|1|75–79|0.808|0.761|0.846
Observed|Laryngeal cancer|2015–2019|Males|1|80–84|0.788|0.729|0.836
Observed|Laryngeal cancer|2015–2019|Males|1|85+|0.564|0.49|0.632
Observed|Laryngeal cancer|2015–2019|Males|1|All ages combined|0.831|0.816|0.845
Observed|Laryngeal cancer|2015–2019|Males|2|00–04|||
Observed|Laryngeal cancer|2015–2019|Males|2|05–09|||
Observed|Laryngeal cancer|2015–2019|Males|2|10–14|||
Observed|Laryngeal cancer|2015–2019|Males|2|15–19|||
Observed|Laryngeal cancer|2015–2019|Males|2|20–24|||
Observed|Laryngeal cancer|2015–2019|Males|2|25–29|||
Observed|Laryngeal cancer|2015–2019|Males|2|30–34|||
Observed|Laryngeal cancer|2015–2019|Males|2|35–39|||
Observed|Laryngeal cancer|2015–2019|Males|2|40–44|||
Observed|Laryngeal cancer|2015–2019|Males|2|45–49|0.765|0.636|0.853
Observed|Laryngeal cancer|2015–2019|Males|2|50–54|0.813|0.746|0.864
Observed|Laryngeal cancer|2015–2019|Males|2|55–59|0.806|0.758|0.846
Observed|Laryngeal cancer|2015–2019|Males|2|60–64|0.755|0.709|0.795
Observed|Laryngeal cancer|2015–2019|Males|2|65–69|0.764|0.722|0.801
Observed|Laryngeal cancer|2015–2019|Males|2|70–74|0.736|0.692|0.775
Observed|Laryngeal cancer|2015–2019|Males|2|75–79|0.698|0.646|0.744
Observed|Laryngeal cancer|2015–2019|Males|2|80–84|0.63|0.563|0.69
Observed|Laryngeal cancer|2015–2019|Males|2|85+|0.436|0.364|0.505
Observed|Laryngeal cancer|2015–2019|Males|2|All ages combined|0.723|0.706|0.74
Observed|Laryngeal cancer|2015–2019|Males|3|00–04|||
Observed|Laryngeal cancer|2015–2019|Males|3|05–09|||
Observed|Laryngeal cancer|2015–2019|Males|3|10–14|||
Observed|Laryngeal cancer|2015–2019|Males|3|15–19|||
Observed|Laryngeal cancer|2015–2019|Males|3|20–24|||
Observed|Laryngeal cancer|2015–2019|Males|3|25–29|||
Observed|Laryngeal cancer|2015–2019|Males|3|30–34|||
Observed|Laryngeal cancer|2015–2019|Males|3|35–39|||
Observed|Laryngeal cancer|2015–2019|Males|3|40–44|||
Observed|Laryngeal cancer|2015–2019|Males|3|45–49|0.74|0.611|0.832
Observed|Laryngeal cancer|2015–2019|Males|3|50–54|0.762|0.691|0.819
Observed|Laryngeal cancer|2015–2019|Males|3|55–59|0.753|0.701|0.797
Observed|Laryngeal cancer|2015–2019|Males|3|60–64|0.689|0.641|0.732
Observed|Laryngeal cancer|2015–2019|Males|3|65–69|0.716|0.671|0.755
Observed|Laryngeal cancer|2015–2019|Males|3|70–74|0.657|0.61|0.7
Observed|Laryngeal cancer|2015–2019|Males|3|75–79|0.633|0.579|0.682
Observed|Laryngeal cancer|2015–2019|Males|3|80–84|0.516|0.448|0.58
Observed|Laryngeal cancer|2015–2019|Males|3|85+|0.357|0.288|0.427
Observed|Laryngeal cancer|2015–2019|Males|3|All ages combined|0.659|0.64|0.676
Observed|Laryngeal cancer|2015–2019|Males|4|00–04|||
Observed|Laryngeal cancer|2015–2019|Males|4|05–09|||
Observed|Laryngeal cancer|2015–2019|Males|4|10–14|||
Observed|Laryngeal cancer|2015–2019|Males|4|15–19|||
Observed|Laryngeal cancer|2015–2019|Males|4|20–24|||
Observed|Laryngeal cancer|2015–2019|Males|4|25–29|||
Observed|Laryngeal cancer|2015–2019|Males|4|30–34|||
Observed|Laryngeal cancer|2015–2019|Males|4|35–39|||
Observed|Laryngeal cancer|2015–2019|Males|4|40–44|||
Observed|Laryngeal cancer|2015–2019|Males|4|45–49|0.694|0.568|0.791
Observed|Laryngeal cancer|2015–2019|Males|4|50–54|0.724|0.652|0.784
Observed|Laryngeal cancer|2015–2019|Males|4|55–59|0.719|0.665|0.766
Observed|Laryngeal cancer|2015–2019|Males|4|60–64|0.646|0.597|0.69
Observed|Laryngeal cancer|2015–2019|Males|4|65–69|0.662|0.616|0.704
Observed|Laryngeal cancer|2015–2019|Males|4|70–74|0.593|0.544|0.639
Observed|Laryngeal cancer|2015–2019|Males|4|75–79|0.547|0.493|0.599
Observed|Laryngeal cancer|2015–2019|Males|4|80–84|0.464|0.396|0.529
Observed|Laryngeal cancer|2015–2019|Males|4|85+|0.296|0.231|0.363
Observed|Laryngeal cancer|2015–2019|Males|4|All ages combined|0.606|0.587|0.624
Observed|Laryngeal cancer|2015–2019|Males|5|00–04|||
Observed|Laryngeal cancer|2015–2019|Males|5|05–09|||
Observed|Laryngeal cancer|2015–2019|Males|5|10–14|||
Observed|Laryngeal cancer|2015–2019|Males|5|15–19|||
Observed|Laryngeal cancer|2015–2019|Males|5|20–24|||
Observed|Laryngeal cancer|2015–2019|Males|5|25–29|||
Observed|Laryngeal cancer|2015–2019|Males|5|30–34|||
Observed|Laryngeal cancer|2015–2019|Males|5|35–39|||
Observed|Laryngeal cancer|2015–2019|Males|5|40–44|||
Observed|Laryngeal cancer|2015–2019|Males|5|45–49|0.673|0.547|0.771
Observed|Laryngeal cancer|2015–2019|Males|5|50–54|0.707|0.634|0.769
Observed|Laryngeal cancer|2015–2019|Males|5|55–59|0.68|0.624|0.729
Observed|Laryngeal cancer|2015–2019|Males|5|60–64|0.611|0.562|0.656
Observed|Laryngeal cancer|2015–2019|Males|5|65–69|0.625|0.578|0.668
Observed|Laryngeal cancer|2015–2019|Males|5|70–74|0.554|0.504|0.601
Observed|Laryngeal cancer|2015–2019|Males|5|75–79|0.504|0.45|0.557
Observed|Laryngeal cancer|2015–2019|Males|5|80–84|0.395|0.33|0.459
Observed|Laryngeal cancer|2015–2019|Males|5|85+|0.22|0.163|0.284
Observed|Laryngeal cancer|2015–2019|Males|5|All ages combined|0.565|0.545|0.583
Relative|Laryngeal cancer|2015–2019|Males|1|00–04|||
Relative|Laryngeal cancer|2015–2019|Males|1|05–09|||
Relative|Laryngeal cancer|2015–2019|Males|1|10–14|||
Relative|Laryngeal cancer|2015–2019|Males|1|15–19|||
Relative|Laryngeal cancer|2015–2019|Males|1|20–24|||
Relative|Laryngeal cancer|2015–2019|Males|1|25–29|||
Relative|Laryngeal cancer|2015–2019|Males|1|30–34|||
Relative|Laryngeal cancer|2015–2019|Males|1|35–39|||
Relative|Laryngeal cancer|2015–2019|Males|1|40–44|||
Relative|Laryngeal cancer|2015–2019|Males|1|45–49|0.895|0.778|0.953
Relative|Laryngeal cancer|2015–2019|Males|1|50–54|0.891|0.833|0.93
Relative|Laryngeal cancer|2015–2019|Males|1|55–59|0.889|0.848|0.92
Relative|Laryngeal cancer|2015–2019|Males|1|60–64|0.861|0.821|0.893
Relative|Laryngeal cancer|2015–2019|Males|1|65–69|0.886|0.851|0.914
Relative|Laryngeal cancer|2015–2019|Males|1|70–74|0.858|0.819|0.89
Relative|Laryngeal cancer|2015–2019|Males|1|75–79|0.835|0.787|0.875
Relative|Laryngeal cancer|2015–2019|Males|1|80–84|0.837|0.774|0.888
Relative|Laryngeal cancer|2015–2019|Males|1|85+|0.647|0.562|0.724
Relative|Laryngeal cancer|2015–2019|Males|1|All ages combined|0.853|0.838|0.868
Relative|Laryngeal cancer|2015–2019|Males|2|00–04|||
Relative|Laryngeal cancer|2015–2019|Males|2|05–09|||
Relative|Laryngeal cancer|2015–2019|Males|2|10–14|||
Relative|Laryngeal cancer|2015–2019|Males|2|15–19|||
Relative|Laryngeal cancer|2015–2019|Males|2|20–24|||
Relative|Laryngeal cancer|2015–2019|Males|2|25–29|||
Relative|Laryngeal cancer|2015–2019|Males|2|30–34|||
Relative|Laryngeal cancer|2015–2019|Males|2|35–39|||
Relative|Laryngeal cancer|2015–2019|Males|2|40–44|||
Relative|Laryngeal cancer|2015–2019|Males|2|45–49|0.769|0.64|0.858
Relative|Laryngeal cancer|2015–2019|Males|2|50–54|0.819|0.752|0.87
Relative|Laryngeal cancer|2015–2019|Males|2|55–59|0.815|0.766|0.856
Relative|Laryngeal cancer|2015–2019|Males|2|60–64|0.768|0.721|0.808
Relative|Laryngeal cancer|2015–2019|Males|2|65–69|0.783|0.74|0.821
Relative|Laryngeal cancer|2015–2019|Males|2|70–74|0.767|0.72|0.807
Relative|Laryngeal cancer|2015–2019|Males|2|75–79|0.749|0.693|0.798
Relative|Laryngeal cancer|2015–2019|Males|2|80–84|0.716|0.64|0.784
Relative|Laryngeal cancer|2015–2019|Males|2|85+|0.576|0.481|0.668
Relative|Laryngeal cancer|2015–2019|Males|2|All ages combined|0.761|0.743|0.779
Relative|Laryngeal cancer|2015–2019|Males|3|00–04|||
Relative|Laryngeal cancer|2015–2019|Males|3|05–09|||
Relative|Laryngeal cancer|2015–2019|Males|3|10–14|||
Relative|Laryngeal cancer|2015–2019|Males|3|15–19|||
Relative|Laryngeal cancer|2015–2019|Males|3|20–24|||
Relative|Laryngeal cancer|2015–2019|Males|3|25–29|||
Relative|Laryngeal cancer|2015–2019|Males|3|30–34|||
Relative|Laryngeal cancer|2015–2019|Males|3|35–39|||
Relative|Laryngeal cancer|2015–2019|Males|3|40–44|||
Relative|Laryngeal cancer|2015–2019|Males|3|45–49|0.746|0.616|0.838
Relative|Laryngeal cancer|2015–2019|Males|3|50–54|0.771|0.699|0.828
Relative|Laryngeal cancer|2015–2019|Males|3|55–59|0.766|0.713|0.811
Relative|Laryngeal cancer|2015–2019|Males|3|60–64|0.707|0.658|0.751
Relative|Laryngeal cancer|2015–2019|Males|3|65–69|0.745|0.698|0.786
Relative|Laryngeal cancer|2015–2019|Males|3|70–74|0.701|0.65|0.747
Relative|Laryngeal cancer|2015–2019|Males|3|75–79|0.708|0.648|0.762
Relative|Laryngeal cancer|2015–2019|Males|3|80–84|0.633|0.55|0.712
Relative|Laryngeal cancer|2015–2019|Males|3|85+|0.551|0.444|0.659
Relative|Laryngeal cancer|2015–2019|Males|3|All ages combined|0.711|0.691|0.73
Relative|Laryngeal cancer|2015–2019|Males|4|00–04|||
Relative|Laryngeal cancer|2015–2019|Males|4|05–09|||
Relative|Laryngeal cancer|2015–2019|Males|4|10–14|||
Relative|Laryngeal cancer|2015–2019|Males|4|15–19|||
Relative|Laryngeal cancer|2015–2019|Males|4|20–24|||
Relative|Laryngeal cancer|2015–2019|Males|4|25–29|||
Relative|Laryngeal cancer|2015–2019|Males|4|30–34|||
Relative|Laryngeal cancer|2015–2019|Males|4|35–39|||
Relative|Laryngeal cancer|2015–2019|Males|4|40–44|||
Relative|Laryngeal cancer|2015–2019|Males|4|45–49|0.702|0.574|0.799
Relative|Laryngeal cancer|2015–2019|Males|4|50–54|0.736|0.662|0.797
Relative|Laryngeal cancer|2015–2019|Males|4|55–59|0.737|0.682|0.785
Relative|Laryngeal cancer|2015–2019|Males|4|60–64|0.67|0.62|0.716
Relative|Laryngeal cancer|2015–2019|Males|4|65–69|0.7|0.651|0.744
Relative|Laryngeal cancer|2015–2019|Males|4|70–74|0.649|0.596|0.7
Relative|Laryngeal cancer|2015–2019|Males|4|75–79|0.641|0.577|0.702
Relative|Laryngeal cancer|2015–2019|Males|4|80–84|0.62|0.53|0.706
Relative|Laryngeal cancer|2015–2019|Males|4|85+|0.54|0.422|0.663
Relative|Laryngeal cancer|2015–2019|Males|4|All ages combined|0.671|0.65|0.692
Relative|Laryngeal cancer|2015–2019|Males|5|00–04|||
Relative|Laryngeal cancer|2015–2019|Males|5|05–09|||
Relative|Laryngeal cancer|2015–2019|Males|5|10–14|||
Relative|Laryngeal cancer|2015–2019|Males|5|15–19|||
Relative|Laryngeal cancer|2015–2019|Males|5|20–24|||
Relative|Laryngeal cancer|2015–2019|Males|5|25–29|||
Relative|Laryngeal cancer|2015–2019|Males|5|30–34|||
Relative|Laryngeal cancer|2015–2019|Males|5|35–39|||
Relative|Laryngeal cancer|2015–2019|Males|5|40–44|||
Relative|Laryngeal cancer|2015–2019|Males|5|45–49|0.682|0.555|0.782
Relative|Laryngeal cancer|2015–2019|Males|5|50–54|0.722|0.647|0.785
Relative|Laryngeal cancer|2015–2019|Males|5|55–59|0.702|0.644|0.752
Relative|Laryngeal cancer|2015–2019|Males|5|60–64|0.641|0.589|0.688
Relative|Laryngeal cancer|2015–2019|Males|5|65–69|0.672|0.622|0.719
Relative|Laryngeal cancer|2015–2019|Males|5|70–74|0.624|0.568|0.678
Relative|Laryngeal cancer|2015–2019|Males|5|75–79|0.623|0.555|0.687
Relative|Laryngeal cancer|2015–2019|Males|5|80–84|0.582|0.486|0.677
Relative|Laryngeal cancer|2015–2019|Males|5|85+|0.482|0.356|0.621
Relative|Laryngeal cancer|2015–2019|Males|5|All ages combined|0.644|0.622|0.665
Observed|Laryngeal cancer|2015–2019|Females|1|00–04|||
Observed|Laryngeal cancer|2015–2019|Females|1|05–09|||
Observed|Laryngeal cancer|2015–2019|Females|1|10–14|||
Observed|Laryngeal cancer|2015–2019|Females|1|15–19|||
Observed|Laryngeal cancer|2015–2019|Females|1|20–24|||
Observed|Laryngeal cancer|2015–2019|Females|1|25–29|||
Observed|Laryngeal cancer|2015–2019|Females|1|30–34|||
Observed|Laryngeal cancer|2015–2019|Females|1|35–39|||
Observed|Laryngeal cancer|2015–2019|Females|1|40–44|||
Observed|Laryngeal cancer|2015–2019|Females|1|45–49|||
Observed|Laryngeal cancer|2015–2019|Females|1|50–54|0.886|0.687|0.962
Observed|Laryngeal cancer|2015–2019|Females|1|55–59|0.843|0.684|0.926
Observed|Laryngeal cancer|2015–2019|Females|1|60–64|0.825|0.69|0.905
Observed|Laryngeal cancer|2015–2019|Females|1|65–69|0.778|0.649|0.864
Observed|Laryngeal cancer|2015–2019|Females|1|70–74|0.876|0.744|0.942
Observed|Laryngeal cancer|2015–2019|Females|1|75–79|0.809|0.641|0.904
Observed|Laryngeal cancer|2015–2019|Females|1|80–84|0.841|0.63|0.937
Observed|Laryngeal cancer|2015–2019|Females|1|85+|||
Observed|Laryngeal cancer|2015–2019|Females|1|All ages combined|0.826|0.78|0.863
Observed|Laryngeal cancer|2015–2019|Females|2|00–04|||
Observed|Laryngeal cancer|2015–2019|Females|2|05–09|||
Observed|Laryngeal cancer|2015–2019|Females|2|10–14|||
Observed|Laryngeal cancer|2015–2019|Females|2|15–19|||
Observed|Laryngeal cancer|2015–2019|Females|2|20–24|||
Observed|Laryngeal cancer|2015–2019|Females|2|25–29|||
Observed|Laryngeal cancer|2015–2019|Females|2|30–34|||
Observed|Laryngeal cancer|2015–2019|Females|2|35–39|||
Observed|Laryngeal cancer|2015–2019|Females|2|40–44|||
Observed|Laryngeal cancer|2015–2019|Females|2|45–49|||
Observed|Laryngeal cancer|2015–2019|Females|2|50–54|0.817|0.616|0.919
Observed|Laryngeal cancer|2015–2019|Females|2|55–59|0.759|0.588|0.867
Observed|Laryngeal cancer|2015–2019|Females|2|60–64|0.736|0.588|0.838
Observed|Laryngeal cancer|2015–2019|Females|2|65–69|0.683|0.549|0.784
Observed|Laryngeal cancer|2015–2019|Females|2|70–74|0.698|0.544|0.809
Observed|Laryngeal cancer|2015–2019|Females|2|75–79|0.74|0.557|0.856
Observed|Laryngeal cancer|2015–2019|Females|2|80–84|0.629|0.422|0.779
Observed|Laryngeal cancer|2015–2019|Females|2|85+|||
Observed|Laryngeal cancer|2015–2019|Females|2|All ages combined|0.714|0.661|0.76
Observed|Laryngeal cancer|2015–2019|Females|3|00–04|||
Observed|Laryngeal cancer|2015–2019|Females|3|05–09|||
Observed|Laryngeal cancer|2015–2019|Females|3|10–14|||
Observed|Laryngeal cancer|2015–2019|Females|3|15–19|||
Observed|Laryngeal cancer|2015–2019|Females|3|20–24|||
Observed|Laryngeal cancer|2015–2019|Females|3|25–29|||
Observed|Laryngeal cancer|2015–2019|Females|3|30–34|||
Observed|Laryngeal cancer|2015–2019|Females|3|35–39|||
Observed|Laryngeal cancer|2015–2019|Females|3|40–44|||
Observed|Laryngeal cancer|2015–2019|Females|3|45–49|||
Observed|Laryngeal cancer|2015–2019|Females|3|50–54|0.785|0.583|0.897
Observed|Laryngeal cancer|2015–2019|Females|3|55–59|0.711|0.54|0.828
Observed|Laryngeal cancer|2015–2019|Females|3|60–64|0.635|0.485|0.753
Observed|Laryngeal cancer|2015–2019|Females|3|65–69|0.633|0.499|0.74
Observed|Laryngeal cancer|2015–2019|Females|3|70–74|0.657|0.503|0.774
Observed|Laryngeal cancer|2015–2019|Females|3|75–79|0.672|0.483|0.805
Observed|Laryngeal cancer|2015–2019|Females|3|80–84|||
Observed|Laryngeal cancer|2015–2019|Females|3|85+|||
Observed|Laryngeal cancer|2015–2019|Females|3|All ages combined|0.652|0.598|0.701
Observed|Laryngeal cancer|2015–2019|Females|4|00–04|||
Observed|Laryngeal cancer|2015–2019|Females|4|05–09|||
Observed|Laryngeal cancer|2015–2019|Females|4|10–14|||
Observed|Laryngeal cancer|2015–2019|Females|4|15–19|||
Observed|Laryngeal cancer|2015–2019|Females|4|20–24|||
Observed|Laryngeal cancer|2015–2019|Females|4|25–29|||
Observed|Laryngeal cancer|2015–2019|Females|4|30–34|||
Observed|Laryngeal cancer|2015–2019|Females|4|35–39|||
Observed|Laryngeal cancer|2015–2019|Females|4|40–44|||
Observed|Laryngeal cancer|2015–2019|Females|4|45–49|||
Observed|Laryngeal cancer|2015–2019|Females|4|50–54|0.752|0.549|0.873
Observed|Laryngeal cancer|2015–2019|Females|4|55–59|0.711|0.54|0.828
Observed|Laryngeal cancer|2015–2019|Females|4|60–64|0.615|0.465|0.735
Observed|Laryngeal cancer|2015–2019|Females|4|65–69|0.578|0.442|0.692
Observed|Laryngeal cancer|2015–2019|Females|4|70–74|0.579|0.427|0.704
Observed|Laryngeal cancer|2015–2019|Females|4|75–79|0.672|0.483|0.805
Observed|Laryngeal cancer|2015–2019|Females|4|80–84|||
Observed|Laryngeal cancer|2015–2019|Females|4|85+|||
Observed|Laryngeal cancer|2015–2019|Females|4|All ages combined|0.613|0.558|0.663
Observed|Laryngeal cancer|2015–2019|Females|5|00–04|||
Observed|Laryngeal cancer|2015–2019|Females|5|05–09|||
Observed|Laryngeal cancer|2015–2019|Females|5|10–14|||
Observed|Laryngeal cancer|2015–2019|Females|5|15–19|||
Observed|Laryngeal cancer|2015–2019|Females|5|20–24|||
Observed|Laryngeal cancer|2015–2019|Females|5|25–29|||
Observed|Laryngeal cancer|2015–2019|Females|5|30–34|||
Observed|Laryngeal cancer|2015–2019|Females|5|35–39|||
Observed|Laryngeal cancer|2015–2019|Females|5|40–44|||
Observed|Laryngeal cancer|2015–2019|Females|5|45–49|||
Observed|Laryngeal cancer|2015–2019|Females|5|50–54|||
Observed|Laryngeal cancer|2015–2019|Females|5|55–59|0.711|0.54|0.828
Observed|Laryngeal cancer|2015–2019|Females|5|60–64|0.595|0.446|0.717
Observed|Laryngeal cancer|2015–2019|Females|5|65–69|0.578|0.442|0.692
Observed|Laryngeal cancer|2015–2019|Females|5|70–74|0.579|0.427|0.704
Observed|Laryngeal cancer|2015–2019|Females|5|75–79|||
Observed|Laryngeal cancer|2015–2019|Females|5|80–84|||
Observed|Laryngeal cancer|2015–2019|Females|5|85+|||
Observed|Laryngeal cancer|2015–2019|Females|5|All ages combined|0.584|0.528|0.635
Relative|Laryngeal cancer|2015–2019|Females|1|00–04|||
Relative|Laryngeal cancer|2015–2019|Females|1|05–09|||
Relative|Laryngeal cancer|2015–2019|Females|1|10–14|||
Relative|Laryngeal cancer|2015–2019|Females|1|15–19|||
Relative|Laryngeal cancer|2015–2019|Females|1|20–24|||
Relative|Laryngeal cancer|2015–2019|Females|1|25–29|||
Relative|Laryngeal cancer|2015–2019|Females|1|30–34|||
Relative|Laryngeal cancer|2015–2019|Females|1|35–39|||
Relative|Laryngeal cancer|2015–2019|Females|1|40–44|||
Relative|Laryngeal cancer|2015–2019|Females|1|45–49|||
Relative|Laryngeal cancer|2015–2019|Females|1|50–54|0.888|0.688|0.964
Relative|Laryngeal cancer|2015–2019|Females|1|55–59|0.846|0.686|0.929
Relative|Laryngeal cancer|2015–2019|Females|1|60–64|0.828|0.694|0.909
Relative|Laryngeal cancer|2015–2019|Females|1|65–69|0.784|0.654|0.871
Relative|Laryngeal cancer|2015–2019|Females|1|70–74|0.887|0.754|0.954
Relative|Laryngeal cancer|2015–2019|Females|1|75–79|0.826|0.654|0.923
Relative|Laryngeal cancer|2015–2019|Females|1|80–84|0.877|0.657|0.977
Relative|Laryngeal cancer|2015–2019|Females|1|85+|||
Relative|Laryngeal cancer|2015–2019|Females|1|All ages combined|0.838|0.792|0.876
Relative|Laryngeal cancer|2015–2019|Females|2|00–04|||
Relative|Laryngeal cancer|2015–2019|Females|2|05–09|||
Relative|Laryngeal cancer|2015–2019|Females|2|10–14|||
Relative|Laryngeal cancer|2015–2019|Females|2|15–19|||
Relative|Laryngeal cancer|2015–2019|Females|2|20–24|||
Relative|Laryngeal cancer|2015–2019|Females|2|25–29|||
Relative|Laryngeal cancer|2015–2019|Females|2|30–34|||
Relative|Laryngeal cancer|2015–2019|Females|2|35–39|||
Relative|Laryngeal cancer|2015–2019|Females|2|40–44|||
Relative|Laryngeal cancer|2015–2019|Females|2|45–49|||
Relative|Laryngeal cancer|2015–2019|Females|2|50–54|0.821|0.619|0.924
Relative|Laryngeal cancer|2015–2019|Females|2|55–59|0.764|0.592|0.873
Relative|Laryngeal cancer|2015–2019|Females|2|60–64|0.743|0.594|0.846
Relative|Laryngeal cancer|2015–2019|Females|2|65–69|0.693|0.558|0.796
Relative|Laryngeal cancer|2015–2019|Females|2|70–74|0.717|0.558|0.83
Relative|Laryngeal cancer|2015–2019|Females|2|75–79|0.773|0.582|0.895
Relative|Laryngeal cancer|2015–2019|Females|2|80–84|0.687|0.461|0.852
Relative|Laryngeal cancer|2015–2019|Females|2|85+|||
Relative|Laryngeal cancer|2015–2019|Females|2|All ages combined|0.737|0.682|0.784
Relative|Laryngeal cancer|2015–2019|Females|3|00–04|||
Relative|Laryngeal cancer|2015–2019|Females|3|05–09|||
Relative|Laryngeal cancer|2015–2019|Females|3|10–14|||
Relative|Laryngeal cancer|2015–2019|Females|3|15–19|||
Relative|Laryngeal cancer|2015–2019|Females|3|20–24|||
Relative|Laryngeal cancer|2015–2019|Females|3|25–29|||
Relative|Laryngeal cancer|2015–2019|Females|3|30–34|||
Relative|Laryngeal cancer|2015–2019|Females|3|35–39|||
Relative|Laryngeal cancer|2015–2019|Females|3|40–44|||
Relative|Laryngeal cancer|2015–2019|Females|3|45–49|||
Relative|Laryngeal cancer|2015–2019|Females|3|50–54|0.791|0.588|0.904
Relative|Laryngeal cancer|2015–2019|Females|3|55–59|0.718|0.545|0.837
Relative|Laryngeal cancer|2015–2019|Females|3|60–64|0.645|0.492|0.764
Relative|Laryngeal cancer|2015–2019|Females|3|65–69|0.648|0.511|0.758
Relative|Laryngeal cancer|2015–2019|Females|3|70–74|0.685|0.524|0.807
Relative|Laryngeal cancer|2015–2019|Females|3|75–79|0.721|0.519|0.864
Relative|Laryngeal cancer|2015–2019|Females|3|80–84|||
Relative|Laryngeal cancer|2015–2019|Females|3|85+|||
Relative|Laryngeal cancer|2015–2019|Females|3|All ages combined|0.684|0.627|0.735
Relative|Laryngeal cancer|2015–2019|Females|4|00–04|||
Relative|Laryngeal cancer|2015–2019|Females|4|05–09|||
Relative|Laryngeal cancer|2015–2019|Females|4|10–14|||
Relative|Laryngeal cancer|2015–2019|Females|4|15–19|||
Relative|Laryngeal cancer|2015–2019|Females|4|20–24|||
Relative|Laryngeal cancer|2015–2019|Females|4|25–29|||
Relative|Laryngeal cancer|2015–2019|Females|4|30–34|||
Relative|Laryngeal cancer|2015–2019|Females|4|35–39|||
Relative|Laryngeal cancer|2015–2019|Females|4|40–44|||
Relative|Laryngeal cancer|2015–2019|Females|4|45–49|||
Relative|Laryngeal cancer|2015–2019|Females|4|50–54|0.759|0.555|0.882
Relative|Laryngeal cancer|2015–2019|Females|4|55–59|0.721|0.547|0.84
Relative|Laryngeal cancer|2015–2019|Females|4|60–64|0.629|0.475|0.751
Relative|Laryngeal cancer|2015–2019|Females|4|65–69|0.598|0.458|0.716
Relative|Laryngeal cancer|2015–2019|Females|4|70–74|0.614|0.453|0.747
Relative|Laryngeal cancer|2015–2019|Females|4|75–79|0.745|0.535|0.892
Relative|Laryngeal cancer|2015–2019|Females|4|80–84|||
Relative|Laryngeal cancer|2015–2019|Females|4|85+|||
Relative|Laryngeal cancer|2015–2019|Females|4|All ages combined|0.654|0.596|0.708
Relative|Laryngeal cancer|2015–2019|Females|5|00–04|||
Relative|Laryngeal cancer|2015–2019|Females|5|05–09|||
Relative|Laryngeal cancer|2015–2019|Females|5|10–14|||
Relative|Laryngeal cancer|2015–2019|Females|5|15–19|||
Relative|Laryngeal cancer|2015–2019|Females|5|20–24|||
Relative|Laryngeal cancer|2015–2019|Females|5|25–29|||
Relative|Laryngeal cancer|2015–2019|Females|5|30–34|||
Relative|Laryngeal cancer|2015–2019|Females|5|35–39|||
Relative|Laryngeal cancer|2015–2019|Females|5|40–44|||
Relative|Laryngeal cancer|2015–2019|Females|5|45–49|||
Relative|Laryngeal cancer|2015–2019|Females|5|50–54|||
Relative|Laryngeal cancer|2015–2019|Females|5|55–59|0.724|0.549|0.843
Relative|Laryngeal cancer|2015–2019|Females|5|60–64|0.612|0.458|0.737
Relative|Laryngeal cancer|2015–2019|Females|5|65–69|0.604|0.462|0.723
Relative|Laryngeal cancer|2015–2019|Females|5|70–74|0.626|0.462|0.761
Relative|Laryngeal cancer|2015–2019|Females|5|75–79|||
Relative|Laryngeal cancer|2015–2019|Females|5|80–84|||
Relative|Laryngeal cancer|2015–2019|Females|5|85+|||
Relative|Laryngeal cancer|2015–2019|Females|5|All ages combined|0.634|0.574|0.689
Observed|Laryngeal cancer|2015–2019|Persons|1|00–04|||
Observed|Laryngeal cancer|2015–2019|Persons|1|05–09|||
Observed|Laryngeal cancer|2015–2019|Persons|1|10–14|||
Observed|Laryngeal cancer|2015–2019|Persons|1|15–19|||
Observed|Laryngeal cancer|2015–2019|Persons|1|20–24|||
Observed|Laryngeal cancer|2015–2019|Persons|1|25–29|||
Observed|Laryngeal cancer|2015–2019|Persons|1|30–34|||
Observed|Laryngeal cancer|2015–2019|Persons|1|35–39|||
Observed|Laryngeal cancer|2015–2019|Persons|1|40–44|0.958|0.737|0.994
Observed|Laryngeal cancer|2015–2019|Persons|1|45–49|0.892|0.786|0.947
Observed|Laryngeal cancer|2015–2019|Persons|1|50–54|0.888|0.834|0.924
Observed|Laryngeal cancer|2015–2019|Persons|1|55–59|0.88|0.841|0.91
Observed|Laryngeal cancer|2015–2019|Persons|1|60–64|0.851|0.814|0.881
Observed|Laryngeal cancer|2015–2019|Persons|1|65–69|0.864|0.831|0.891
Observed|Laryngeal cancer|2015–2019|Persons|1|70–74|0.845|0.81|0.875
Observed|Laryngeal cancer|2015–2019|Persons|1|75–79|0.808|0.764|0.845
Observed|Laryngeal cancer|2015–2019|Persons|1|80–84|0.794|0.738|0.839
Observed|Laryngeal cancer|2015–2019|Persons|1|85+|0.577|0.506|0.641
Observed|Laryngeal cancer|2015–2019|Persons|1|All ages combined|0.831|0.817|0.844
Observed|Laryngeal cancer|2015–2019|Persons|2|00–04|||
Observed|Laryngeal cancer|2015–2019|Persons|2|05–09|||
Observed|Laryngeal cancer|2015–2019|Persons|2|10–14|||
Observed|Laryngeal cancer|2015–2019|Persons|2|15–19|||
Observed|Laryngeal cancer|2015–2019|Persons|2|20–24|||
Observed|Laryngeal cancer|2015–2019|Persons|2|25–29|||
Observed|Laryngeal cancer|2015–2019|Persons|2|30–34|||
Observed|Laryngeal cancer|2015–2019|Persons|2|35–39|||
Observed|Laryngeal cancer|2015–2019|Persons|2|40–44|0.894|0.704|0.965
Observed|Laryngeal cancer|2015–2019|Persons|2|45–49|0.768|0.65|0.851
Observed|Laryngeal cancer|2015–2019|Persons|2|50–54|0.814|0.752|0.861
Observed|Laryngeal cancer|2015–2019|Persons|2|55–59|0.801|0.755|0.839
Observed|Laryngeal cancer|2015–2019|Persons|2|60–64|0.753|0.71|0.791
Observed|Laryngeal cancer|2015–2019|Persons|2|65–69|0.754|0.714|0.79
Observed|Laryngeal cancer|2015–2019|Persons|2|70–74|0.733|0.69|0.77
Observed|Laryngeal cancer|2015–2019|Persons|2|75–79|0.701|0.652|0.745
Observed|Laryngeal cancer|2015–2019|Persons|2|80–84|0.629|0.566|0.686
Observed|Laryngeal cancer|2015–2019|Persons|2|85+|0.443|0.375|0.509
Observed|Laryngeal cancer|2015–2019|Persons|2|All ages combined|0.722|0.706|0.738
Observed|Laryngeal cancer|2015–2019|Persons|3|00–04|||
Observed|Laryngeal cancer|2015–2019|Persons|3|05–09|||
Observed|Laryngeal cancer|2015–2019|Persons|3|10–14|||
Observed|Laryngeal cancer|2015–2019|Persons|3|15–19|||
Observed|Laryngeal cancer|2015–2019|Persons|3|20–24|||
Observed|Laryngeal cancer|2015–2019|Persons|3|25–29|||
Observed|Laryngeal cancer|2015–2019|Persons|3|30–34|||
Observed|Laryngeal cancer|2015–2019|Persons|3|35–39|||
Observed|Laryngeal cancer|2015–2019|Persons|3|40–44|0.868|0.683|0.949
Observed|Laryngeal cancer|2015–2019|Persons|3|45–49|0.735|0.616|0.821
Observed|Laryngeal cancer|2015–2019|Persons|3|50–54|0.765|0.7|0.818
Observed|Laryngeal cancer|2015–2019|Persons|3|55–59|0.748|0.699|0.791
Observed|Laryngeal cancer|2015–2019|Persons|3|60–64|0.683|0.637|0.724
Observed|Laryngeal cancer|2015–2019|Persons|3|65–69|0.706|0.664|0.743
Observed|Laryngeal cancer|2015–2019|Persons|3|70–74|0.658|0.613|0.699
Observed|Laryngeal cancer|2015–2019|Persons|3|75–79|0.636|0.585|0.682
Observed|Laryngeal cancer|2015–2019|Persons|3|80–84|0.514|0.45|0.574
Observed|Laryngeal cancer|2015–2019|Persons|3|85+|0.368|0.302|0.434
Observed|Laryngeal cancer|2015–2019|Persons|3|All ages combined|0.658|0.64|0.675
Observed|Laryngeal cancer|2015–2019|Persons|4|00–04|||
Observed|Laryngeal cancer|2015–2019|Persons|4|05–09|||
Observed|Laryngeal cancer|2015–2019|Persons|4|10–14|||
Observed|Laryngeal cancer|2015–2019|Persons|4|15–19|||
Observed|Laryngeal cancer|2015–2019|Persons|4|20–24|||
Observed|Laryngeal cancer|2015–2019|Persons|4|25–29|||
Observed|Laryngeal cancer|2015–2019|Persons|4|30–34|||
Observed|Laryngeal cancer|2015–2019|Persons|4|35–39|||
Observed|Laryngeal cancer|2015–2019|Persons|4|40–44|0.868|0.683|0.949
Observed|Laryngeal cancer|2015–2019|Persons|4|45–49|0.695|0.578|0.785
Observed|Laryngeal cancer|2015–2019|Persons|4|50–54|0.728|0.662|0.784
Observed|Laryngeal cancer|2015–2019|Persons|4|55–59|0.719|0.668|0.763
Observed|Laryngeal cancer|2015–2019|Persons|4|60–64|0.642|0.596|0.685
Observed|Laryngeal cancer|2015–2019|Persons|4|65–69|0.652|0.609|0.692
Observed|Laryngeal cancer|2015–2019|Persons|4|70–74|0.592|0.545|0.635
Observed|Laryngeal cancer|2015–2019|Persons|4|75–79|0.558|0.506|0.607
Observed|Laryngeal cancer|2015–2019|Persons|4|80–84|0.461|0.398|0.521
Observed|Laryngeal cancer|2015–2019|Persons|4|85+|0.3|0.237|0.364
Observed|Laryngeal cancer|2015–2019|Persons|4|All ages combined|0.606|0.589|0.624
Observed|Laryngeal cancer|2015–2019|Persons|5|00–04|||
Observed|Laryngeal cancer|2015–2019|Persons|5|05–09|||
Observed|Laryngeal cancer|2015–2019|Persons|5|10–14|||
Observed|Laryngeal cancer|2015–2019|Persons|5|15–19|||
Observed|Laryngeal cancer|2015–2019|Persons|5|20–24|||
Observed|Laryngeal cancer|2015–2019|Persons|5|25–29|||
Observed|Laryngeal cancer|2015–2019|Persons|5|30–34|||
Observed|Laryngeal cancer|2015–2019|Persons|5|35–39|||
Observed|Laryngeal cancer|2015–2019|Persons|5|40–44|0.868|0.683|0.949
Observed|Laryngeal cancer|2015–2019|Persons|5|45–49|0.667|0.551|0.759
Observed|Laryngeal cancer|2015–2019|Persons|5|50–54|0.709|0.641|0.766
Observed|Laryngeal cancer|2015–2019|Persons|5|55–59|0.684|0.632|0.73
Observed|Laryngeal cancer|2015–2019|Persons|5|60–64|0.609|0.562|0.651
Observed|Laryngeal cancer|2015–2019|Persons|5|65–69|0.619|0.575|0.66
Observed|Laryngeal cancer|2015–2019|Persons|5|70–74|0.558|0.511|0.602
Observed|Laryngeal cancer|2015–2019|Persons|5|75–79|0.516|0.463|0.565
Observed|Laryngeal cancer|2015–2019|Persons|5|80–84|0.377|0.317|0.437
Observed|Laryngeal cancer|2015–2019|Persons|5|85+|0.229|0.173|0.29
Observed|Laryngeal cancer|2015–2019|Persons|5|All ages combined|0.567|0.549|0.584
Relative|Laryngeal cancer|2015–2019|Persons|1|00–04|||
Relative|Laryngeal cancer|2015–2019|Persons|1|05–09|||
Relative|Laryngeal cancer|2015–2019|Persons|1|10–14|||
Relative|Laryngeal cancer|2015–2019|Persons|1|15–19|||
Relative|Laryngeal cancer|2015–2019|Persons|1|20–24|||
Relative|Laryngeal cancer|2015–2019|Persons|1|25–29|||
Relative|Laryngeal cancer|2015–2019|Persons|1|30–34|||
Relative|Laryngeal cancer|2015–2019|Persons|1|35–39|||
Relative|Laryngeal cancer|2015–2019|Persons|1|40–44|0.959|0.738|0.995
Relative|Laryngeal cancer|2015–2019|Persons|1|45–49|0.894|0.788|0.949
Relative|Laryngeal cancer|2015–2019|Persons|1|50–54|0.891|0.837|0.928
Relative|Laryngeal cancer|2015–2019|Persons|1|55–59|0.885|0.846|0.915
Relative|Laryngeal cancer|2015–2019|Persons|1|60–64|0.857|0.82|0.888
Relative|Laryngeal cancer|2015–2019|Persons|1|65–69|0.874|0.84|0.902
Relative|Laryngeal cancer|2015–2019|Persons|1|70–74|0.861|0.825|0.891
Relative|Laryngeal cancer|2015–2019|Persons|1|75–79|0.834|0.789|0.872
Relative|Laryngeal cancer|2015–2019|Persons|1|80–84|0.841|0.782|0.889
Relative|Laryngeal cancer|2015–2019|Persons|1|85+|0.657|0.577|0.73
Relative|Laryngeal cancer|2015–2019|Persons|1|All ages combined|0.852|0.837|0.865
Relative|Laryngeal cancer|2015–2019|Persons|2|00–04|||
Relative|Laryngeal cancer|2015–2019|Persons|2|05–09|||
Relative|Laryngeal cancer|2015–2019|Persons|2|10–14|||
Relative|Laryngeal cancer|2015–2019|Persons|2|15–19|||
Relative|Laryngeal cancer|2015–2019|Persons|2|20–24|||
Relative|Laryngeal cancer|2015–2019|Persons|2|25–29|||
Relative|Laryngeal cancer|2015–2019|Persons|2|30–34|||
Relative|Laryngeal cancer|2015–2019|Persons|2|35–39|||
Relative|Laryngeal cancer|2015–2019|Persons|2|40–44|0.897|0.707|0.968
Relative|Laryngeal cancer|2015–2019|Persons|2|45–49|0.771|0.653|0.855
Relative|Laryngeal cancer|2015–2019|Persons|2|50–54|0.819|0.757|0.867
Relative|Laryngeal cancer|2015–2019|Persons|2|55–59|0.81|0.763|0.848
Relative|Laryngeal cancer|2015–2019|Persons|2|60–64|0.765|0.721|0.803
Relative|Laryngeal cancer|2015–2019|Persons|2|65–69|0.773|0.732|0.809
Relative|Laryngeal cancer|2015–2019|Persons|2|70–74|0.762|0.718|0.801
Relative|Laryngeal cancer|2015–2019|Persons|2|75–79|0.751|0.698|0.797
Relative|Laryngeal cancer|2015–2019|Persons|2|80–84|0.712|0.641|0.776
Relative|Laryngeal cancer|2015–2019|Persons|2|85+|0.579|0.49|0.666
Relative|Laryngeal cancer|2015–2019|Persons|2|All ages combined|0.758|0.741|0.775
Relative|Laryngeal cancer|2015–2019|Persons|3|00–04|||
Relative|Laryngeal cancer|2015–2019|Persons|3|05–09|||
Relative|Laryngeal cancer|2015–2019|Persons|3|10–14|||
Relative|Laryngeal cancer|2015–2019|Persons|3|15–19|||
Relative|Laryngeal cancer|2015–2019|Persons|3|20–24|||
Relative|Laryngeal cancer|2015–2019|Persons|3|25–29|||
Relative|Laryngeal cancer|2015–2019|Persons|3|30–34|||
Relative|Laryngeal cancer|2015–2019|Persons|3|35–39|||
Relative|Laryngeal cancer|2015–2019|Persons|3|40–44|0.872|0.686|0.953
Relative|Laryngeal cancer|2015–2019|Persons|3|45–49|0.74|0.621|0.828
Relative|Laryngeal cancer|2015–2019|Persons|3|50–54|0.774|0.708|0.827
Relative|Laryngeal cancer|2015–2019|Persons|3|55–59|0.761|0.711|0.804
Relative|Laryngeal cancer|2015–2019|Persons|3|60–64|0.7|0.654|0.742
Relative|Laryngeal cancer|2015–2019|Persons|3|65–69|0.733|0.69|0.772
Relative|Laryngeal cancer|2015–2019|Persons|3|70–74|0.7|0.652|0.743
Relative|Laryngeal cancer|2015–2019|Persons|3|75–79|0.709|0.652|0.761
Relative|Laryngeal cancer|2015–2019|Persons|3|80–84|0.626|0.548|0.699
Relative|Laryngeal cancer|2015–2019|Persons|3|85+|0.559|0.459|0.66
Relative|Laryngeal cancer|2015–2019|Persons|3|All ages combined|0.708|0.689|0.726
Relative|Laryngeal cancer|2015–2019|Persons|4|00–04|||
Relative|Laryngeal cancer|2015–2019|Persons|4|05–09|||
Relative|Laryngeal cancer|2015–2019|Persons|4|10–14|||
Relative|Laryngeal cancer|2015–2019|Persons|4|15–19|||
Relative|Laryngeal cancer|2015–2019|Persons|4|20–24|||
Relative|Laryngeal cancer|2015–2019|Persons|4|25–29|||
Relative|Laryngeal cancer|2015–2019|Persons|4|30–34|||
Relative|Laryngeal cancer|2015–2019|Persons|4|35–39|||
Relative|Laryngeal cancer|2015–2019|Persons|4|40–44|0.874|0.688|0.955
Relative|Laryngeal cancer|2015–2019|Persons|4|45–49|0.702|0.584|0.794
Relative|Laryngeal cancer|2015–2019|Persons|4|50–54|0.74|0.672|0.796
Relative|Laryngeal cancer|2015–2019|Persons|4|55–59|0.736|0.684|0.781
Relative|Laryngeal cancer|2015–2019|Persons|4|60–64|0.665|0.618|0.709
Relative|Laryngeal cancer|2015–2019|Persons|4|65–69|0.688|0.642|0.73
Relative|Laryngeal cancer|2015–2019|Persons|4|70–74|0.646|0.595|0.693
Relative|Laryngeal cancer|2015–2019|Persons|4|75–79|0.65|0.589|0.708
Relative|Laryngeal cancer|2015–2019|Persons|4|80–84|0.61|0.526|0.69
Relative|Laryngeal cancer|2015–2019|Persons|4|85+|0.536|0.425|0.652
Relative|Laryngeal cancer|2015–2019|Persons|4|All ages combined|0.669|0.65|0.689
Relative|Laryngeal cancer|2015–2019|Persons|5|00–04|||
Relative|Laryngeal cancer|2015–2019|Persons|5|05–09|||
Relative|Laryngeal cancer|2015–2019|Persons|5|10–14|||
Relative|Laryngeal cancer|2015–2019|Persons|5|15–19|||
Relative|Laryngeal cancer|2015–2019|Persons|5|20–24|||
Relative|Laryngeal cancer|2015–2019|Persons|5|25–29|||
Relative|Laryngeal cancer|2015–2019|Persons|5|30–34|||
Relative|Laryngeal cancer|2015–2019|Persons|5|35–39|||
Relative|Laryngeal cancer|2015–2019|Persons|5|40–44|0.875|0.689|0.957
Relative|Laryngeal cancer|2015–2019|Persons|5|45–49|0.676|0.559|0.77
Relative|Laryngeal cancer|2015–2019|Persons|5|50–54|0.723|0.654|0.781
Relative|Laryngeal cancer|2015–2019|Persons|5|55–59|0.705|0.652|0.753
Relative|Laryngeal cancer|2015–2019|Persons|5|60–64|0.637|0.589|0.682
Relative|Laryngeal cancer|2015–2019|Persons|5|65–69|0.664|0.617|0.708
Relative|Laryngeal cancer|2015–2019|Persons|5|70–74|0.626|0.573|0.676
Relative|Laryngeal cancer|2015–2019|Persons|5|75–79|0.632|0.568|0.693
Relative|Laryngeal cancer|2015–2019|Persons|5|80–84|0.549|0.461|0.636
Relative|Laryngeal cancer|2015–2019|Persons|5|85+|0.49|0.37|0.621
Relative|Laryngeal cancer|2015–2019|Persons|5|All ages combined|0.643|0.622|0.663
Observed|Leukaemia|2015–2019|Males|1|00–04|0.93|0.898|0.953
Observed|Leukaemia|2015–2019|Males|1|05–09|0.978|0.942|0.992
Observed|Leukaemia|2015–2019|Males|1|10–14|0.933|0.875|0.964
Observed|Leukaemia|2015–2019|Males|1|15–19|0.922|0.859|0.957
Observed|Leukaemia|2015–2019|Males|1|20–24|0.883|0.813|0.928
Observed|Leukaemia|2015–2019|Males|1|25–29|0.931|0.867|0.965
Observed|Leukaemia|2015–2019|Males|1|30–34|0.935|0.879|0.966
Observed|Leukaemia|2015–2019|Males|1|35–39|0.907|0.861|0.938
Observed|Leukaemia|2015–2019|Males|1|40–44|0.93|0.895|0.954
Observed|Leukaemia|2015–2019|Males|1|45–49|0.92|0.89|0.943
Observed|Leukaemia|2015–2019|Males|1|50–54|0.907|0.883|0.926
Observed|Leukaemia|2015–2019|Males|1|55–59|0.893|0.871|0.911
Observed|Leukaemia|2015–2019|Males|1|60–64|0.885|0.865|0.902
Observed|Leukaemia|2015–2019|Males|1|65–69|0.843|0.824|0.859
Observed|Leukaemia|2015–2019|Males|1|70–74|0.789|0.769|0.807
Observed|Leukaemia|2015–2019|Males|1|75–79|0.708|0.685|0.73
Observed|Leukaemia|2015–2019|Males|1|80–84|0.613|0.586|0.639
Observed|Leukaemia|2015–2019|Males|1|85+|0.454|0.426|0.481
Observed|Leukaemia|2015–2019|Males|1|All ages combined|0.782|0.775|0.789
Observed|Leukaemia|2015–2019|Males|2|00–04|0.91|0.874|0.936
Observed|Leukaemia|2015–2019|Males|2|05–09|0.967|0.928|0.985
Observed|Leukaemia|2015–2019|Males|2|10–14|0.881|0.812|0.925
Observed|Leukaemia|2015–2019|Males|2|15–19|0.869|0.798|0.917
Observed|Leukaemia|2015–2019|Males|2|20–24|0.808|0.729|0.866
Observed|Leukaemia|2015–2019|Males|2|25–29|0.894|0.821|0.939
Observed|Leukaemia|2015–2019|Males|2|30–34|0.888|0.823|0.93
Observed|Leukaemia|2015–2019|Males|2|35–39|0.869|0.818|0.907
Observed|Leukaemia|2015–2019|Males|2|40–44|0.87|0.826|0.903
Observed|Leukaemia|2015–2019|Males|2|45–49|0.873|0.836|0.901
Observed|Leukaemia|2015–2019|Males|2|50–54|0.856|0.827|0.88
Observed|Leukaemia|2015–2019|Males|2|55–59|0.833|0.807|0.855
Observed|Leukaemia|2015–2019|Males|2|60–64|0.81|0.787|0.832
Observed|Leukaemia|2015–2019|Males|2|65–69|0.771|0.75|0.79
Observed|Leukaemia|2015–2019|Males|2|70–74|0.717|0.696|0.738
Observed|Leukaemia|2015–2019|Males|2|75–79|0.602|0.578|0.626
Observed|Leukaemia|2015–2019|Males|2|80–84|0.508|0.481|0.535
Observed|Leukaemia|2015–2019|Males|2|85+|0.346|0.32|0.371
Observed|Leukaemia|2015–2019|Males|2|All ages combined|0.704|0.696|0.712
Observed|Leukaemia|2015–2019|Males|3|00–04|0.904|0.868|0.931
Observed|Leukaemia|2015–2019|Males|3|05–09|0.956|0.914|0.978
Observed|Leukaemia|2015–2019|Males|3|10–14|0.843|0.77|0.895
Observed|Leukaemia|2015–2019|Males|3|15–19|0.825|0.749|0.88
Observed|Leukaemia|2015–2019|Males|3|20–24|0.8|0.721|0.859
Observed|Leukaemia|2015–2019|Males|3|25–29|0.876|0.799|0.924
Observed|Leukaemia|2015–2019|Males|3|30–34|0.839|0.768|0.89
Observed|Leukaemia|2015–2019|Males|3|35–39|0.841|0.786|0.883
Observed|Leukaemia|2015–2019|Males|3|40–44|0.843|0.797|0.88
Observed|Leukaemia|2015–2019|Males|3|45–49|0.853|0.814|0.884
Observed|Leukaemia|2015–2019|Males|3|50–54|0.823|0.792|0.85
Observed|Leukaemia|2015–2019|Males|3|55–59|0.789|0.761|0.814
Observed|Leukaemia|2015–2019|Males|3|60–64|0.782|0.758|0.805
Observed|Leukaemia|2015–2019|Males|3|65–69|0.725|0.703|0.745
Observed|Leukaemia|2015–2019|Males|3|70–74|0.658|0.635|0.68
Observed|Leukaemia|2015–2019|Males|3|75–79|0.52|0.495|0.544
Observed|Leukaemia|2015–2019|Males|3|80–84|0.421|0.394|0.448
Observed|Leukaemia|2015–2019|Males|3|85+|0.256|0.233|0.28
Observed|Leukaemia|2015–2019|Males|3|All ages combined|0.65|0.641|0.658
Observed|Leukaemia|2015–2019|Males|4|00–04|0.899|0.862|0.926
Observed|Leukaemia|2015–2019|Males|4|05–09|0.951|0.907|0.974
Observed|Leukaemia|2015–2019|Males|4|10–14|0.828|0.753|0.882
Observed|Leukaemia|2015–2019|Males|4|15–19|0.795|0.716|0.855
Observed|Leukaemia|2015–2019|Males|4|20–24|0.793|0.713|0.853
Observed|Leukaemia|2015–2019|Males|4|25–29|0.876|0.799|0.924
Observed|Leukaemia|2015–2019|Males|4|30–34|0.812|0.738|0.867
Observed|Leukaemia|2015–2019|Males|4|35–39|0.832|0.775|0.875
Observed|Leukaemia|2015–2019|Males|4|40–44|0.814|0.765|0.854
Observed|Leukaemia|2015–2019|Males|4|45–49|0.84|0.8|0.872
Observed|Leukaemia|2015–2019|Males|4|50–54|0.807|0.775|0.834
Observed|Leukaemia|2015–2019|Males|4|55–59|0.773|0.744|0.799
Observed|Leukaemia|2015–2019|Males|4|60–64|0.747|0.721|0.77
Observed|Leukaemia|2015–2019|Males|4|65–69|0.68|0.657|0.702
Observed|Leukaemia|2015–2019|Males|4|70–74|0.606|0.582|0.629
Observed|Leukaemia|2015–2019|Males|4|75–79|0.462|0.436|0.487
Observed|Leukaemia|2015–2019|Males|4|80–84|0.349|0.323|0.376
Observed|Leukaemia|2015–2019|Males|4|85+|0.182|0.162|0.204
Observed|Leukaemia|2015–2019|Males|4|All ages combined|0.607|0.599|0.616
Observed|Leukaemia|2015–2019|Males|5|00–04|0.891|0.853|0.919
Observed|Leukaemia|2015–2019|Males|5|05–09|0.945|0.9|0.97
Observed|Leukaemia|2015–2019|Males|5|10–14|0.813|0.736|0.87
Observed|Leukaemia|2015–2019|Males|5|15–19|0.795|0.716|0.855
Observed|Leukaemia|2015–2019|Males|5|20–24|0.773|0.692|0.835
Observed|Leukaemia|2015–2019|Males|5|25–29|0.866|0.787|0.917
Observed|Leukaemia|2015–2019|Males|5|30–34|0.812|0.738|0.867
Observed|Leukaemia|2015–2019|Males|5|35–39|0.827|0.77|0.871
Observed|Leukaemia|2015–2019|Males|5|40–44|0.808|0.759|0.848
Observed|Leukaemia|2015–2019|Males|5|45–49|0.837|0.797|0.87
Observed|Leukaemia|2015–2019|Males|5|50–54|0.799|0.767|0.827
Observed|Leukaemia|2015–2019|Males|5|55–59|0.75|0.721|0.777
Observed|Leukaemia|2015–2019|Males|5|60–64|0.713|0.686|0.738
Observed|Leukaemia|2015–2019|Males|5|65–69|0.642|0.618|0.665
Observed|Leukaemia|2015–2019|Males|5|70–74|0.556|0.532|0.58
Observed|Leukaemia|2015–2019|Males|5|75–79|0.41|0.385|0.435
Observed|Leukaemia|2015–2019|Males|5|80–84|0.284|0.259|0.31
Observed|Leukaemia|2015–2019|Males|5|85+|0.132|0.114|0.151
Observed|Leukaemia|2015–2019|Males|5|All ages combined|0.573|0.564|0.581
Relative|Leukaemia|2015–2019|Males|1|00–04|0.931|0.898|0.953
Relative|Leukaemia|2015–2019|Males|1|05–09|0.978|0.942|0.992
Relative|Leukaemia|2015–2019|Males|1|10–14|0.933|0.875|0.965
Relative|Leukaemia|2015–2019|Males|1|15–19|0.922|0.86|0.957
Relative|Leukaemia|2015–2019|Males|1|20–24|0.884|0.814|0.928
Relative|Leukaemia|2015–2019|Males|1|25–29|0.932|0.867|0.966
Relative|Leukaemia|2015–2019|Males|1|30–34|0.936|0.88|0.967
Relative|Leukaemia|2015–2019|Males|1|35–39|0.908|0.862|0.939
Relative|Leukaemia|2015–2019|Males|1|40–44|0.931|0.896|0.955
Relative|Leukaemia|2015–2019|Males|1|45–49|0.922|0.892|0.945
Relative|Leukaemia|2015–2019|Males|1|50–54|0.91|0.886|0.93
Relative|Leukaemia|2015–2019|Males|1|55–59|0.897|0.876|0.916
Relative|Leukaemia|2015–2019|Males|1|60–64|0.892|0.872|0.909
Relative|Leukaemia|2015–2019|Males|1|65–69|0.853|0.834|0.869
Relative|Leukaemia|2015–2019|Males|1|70–74|0.805|0.785|0.823
Relative|Leukaemia|2015–2019|Males|1|75–79|0.732|0.708|0.755
Relative|Leukaemia|2015–2019|Males|1|80–84|0.651|0.623|0.679
Relative|Leukaemia|2015–2019|Males|1|85+|0.524|0.492|0.555
Relative|Leukaemia|2015–2019|Males|1|All ages combined|0.806|0.798|0.813
Relative|Leukaemia|2015–2019|Males|2|00–04|0.91|0.875|0.936
Relative|Leukaemia|2015–2019|Males|2|05–09|0.967|0.928|0.985
Relative|Leukaemia|2015–2019|Males|2|10–14|0.881|0.813|0.925
Relative|Leukaemia|2015–2019|Males|2|15–19|0.87|0.799|0.917
Relative|Leukaemia|2015–2019|Males|2|20–24|0.809|0.73|0.867
Relative|Leukaemia|2015–2019|Males|2|25–29|0.895|0.822|0.94
Relative|Leukaemia|2015–2019|Males|2|30–34|0.889|0.824|0.931
Relative|Leukaemia|2015–2019|Males|2|35–39|0.871|0.819|0.91
Relative|Leukaemia|2015–2019|Males|2|40–44|0.873|0.829|0.906
Relative|Leukaemia|2015–2019|Males|2|45–49|0.877|0.84|0.906
Relative|Leukaemia|2015–2019|Males|2|50–54|0.862|0.834|0.887
Relative|Leukaemia|2015–2019|Males|2|55–59|0.842|0.816|0.865
Relative|Leukaemia|2015–2019|Males|2|60–64|0.824|0.8|0.846
Relative|Leukaemia|2015–2019|Males|2|65–69|0.791|0.77|0.811
Relative|Leukaemia|2015–2019|Males|2|70–74|0.747|0.725|0.769
Relative|Leukaemia|2015–2019|Males|2|75–79|0.647|0.62|0.672
Relative|Leukaemia|2015–2019|Males|2|80–84|0.578|0.547|0.609
Relative|Leukaemia|2015–2019|Males|2|85+|0.464|0.43|0.499
Relative|Leukaemia|2015–2019|Males|2|All ages combined|0.744|0.736|0.753
Relative|Leukaemia|2015–2019|Males|3|00–04|0.905|0.868|0.931
Relative|Leukaemia|2015–2019|Males|3|05–09|0.956|0.914|0.978
Relative|Leukaemia|2015–2019|Males|3|10–14|0.844|0.771|0.895
Relative|Leukaemia|2015–2019|Males|3|15–19|0.826|0.75|0.881
Relative|Leukaemia|2015–2019|Males|3|20–24|0.802|0.722|0.861
Relative|Leukaemia|2015–2019|Males|3|25–29|0.877|0.801|0.926
Relative|Leukaemia|2015–2019|Males|3|30–34|0.841|0.77|0.892
Relative|Leukaemia|2015–2019|Males|3|35–39|0.844|0.789|0.887
Relative|Leukaemia|2015–2019|Males|3|40–44|0.848|0.801|0.884
Relative|Leukaemia|2015–2019|Males|3|45–49|0.859|0.82|0.89
Relative|Leukaemia|2015–2019|Males|3|50–54|0.833|0.802|0.86
Relative|Leukaemia|2015–2019|Males|3|55–59|0.803|0.774|0.828
Relative|Leukaemia|2015–2019|Males|3|60–64|0.803|0.778|0.826
Relative|Leukaemia|2015–2019|Males|3|65–69|0.754|0.732|0.776
Relative|Leukaemia|2015–2019|Males|3|70–74|0.702|0.678|0.725
Relative|Leukaemia|2015–2019|Males|3|75–79|0.582|0.554|0.609
Relative|Leukaemia|2015–2019|Males|3|80–84|0.517|0.484|0.55
Relative|Leukaemia|2015–2019|Males|3|85+|0.405|0.369|0.443
Relative|Leukaemia|2015–2019|Males|3|All ages combined|0.704|0.695|0.714
Relative|Leukaemia|2015–2019|Males|4|00–04|0.899|0.862|0.927
Relative|Leukaemia|2015–2019|Males|4|05–09|0.951|0.907|0.974
Relative|Leukaemia|2015–2019|Males|4|10–14|0.829|0.753|0.883
Relative|Leukaemia|2015–2019|Males|4|15–19|0.797|0.717|0.856
Relative|Leukaemia|2015–2019|Males|4|20–24|0.795|0.715|0.855
Relative|Leukaemia|2015–2019|Males|4|25–29|0.878|0.801|0.927
Relative|Leukaemia|2015–2019|Males|4|30–34|0.815|0.741|0.87
Relative|Leukaemia|2015–2019|Males|4|35–39|0.836|0.779|0.88
Relative|Leukaemia|2015–2019|Males|4|40–44|0.82|0.771|0.86
Relative|Leukaemia|2015–2019|Males|4|45–49|0.849|0.809|0.881
Relative|Leukaemia|2015–2019|Males|4|50–54|0.82|0.787|0.848
Relative|Leukaemia|2015–2019|Males|4|55–59|0.792|0.762|0.818
Relative|Leukaemia|2015–2019|Males|4|60–64|0.774|0.747|0.799
Relative|Leukaemia|2015–2019|Males|4|65–69|0.72|0.695|0.743
Relative|Leukaemia|2015–2019|Males|4|70–74|0.664|0.638|0.689
Relative|Leukaemia|2015–2019|Males|4|75–79|0.542|0.512|0.571
Relative|Leukaemia|2015–2019|Males|4|80–84|0.469|0.433|0.504
Relative|Leukaemia|2015–2019|Males|4|85+|0.345|0.306|0.385
Relative|Leukaemia|2015–2019|Males|4|All ages combined|0.675|0.665|0.685
Relative|Leukaemia|2015–2019|Males|5|00–04|0.891|0.853|0.92
Relative|Leukaemia|2015–2019|Males|5|05–09|0.946|0.901|0.971
Relative|Leukaemia|2015–2019|Males|5|10–14|0.814|0.737|0.871
Relative|Leukaemia|2015–2019|Males|5|15–19|0.797|0.718|0.857
Relative|Leukaemia|2015–2019|Males|5|20–24|0.776|0.694|0.838
Relative|Leukaemia|2015–2019|Males|5|25–29|0.869|0.79|0.92
Relative|Leukaemia|2015–2019|Males|5|30–34|0.816|0.742|0.871
Relative|Leukaemia|2015–2019|Males|5|35–39|0.832|0.775|0.877
Relative|Leukaemia|2015–2019|Males|5|40–44|0.816|0.766|0.856
Relative|Leukaemia|2015–2019|Males|5|45–49|0.849|0.808|0.882
Relative|Leukaemia|2015–2019|Males|5|50–54|0.816|0.783|0.845
Relative|Leukaemia|2015–2019|Males|5|55–59|0.774|0.744|0.802
Relative|Leukaemia|2015–2019|Males|5|60–64|0.748|0.72|0.774
Relative|Leukaemia|2015–2019|Males|5|65–69|0.691|0.665|0.716
Relative|Leukaemia|2015–2019|Males|5|70–74|0.628|0.6|0.655
Relative|Leukaemia|2015–2019|Males|5|75–79|0.508|0.477|0.539
Relative|Leukaemia|2015–2019|Males|5|80–84|0.421|0.384|0.459
Relative|Leukaemia|2015–2019|Males|5|85+|0.303|0.261|0.347
Relative|Leukaemia|2015–2019|Males|5|All ages combined|0.652|0.642|0.662
Observed|Leukaemia|2015–2019|Females|1|00–04|0.951|0.92|0.97
Observed|Leukaemia|2015–2019|Females|1|05–09|0.969|0.926|0.987
Observed|Leukaemia|2015–2019|Females|1|10–14|0.93|0.851|0.968
Observed|Leukaemia|2015–2019|Females|1|15–19|0.88|0.788|0.933
Observed|Leukaemia|2015–2019|Females|1|20–24|0.943|0.856|0.978
Observed|Leukaemia|2015–2019|Females|1|25–29|0.949|0.87|0.981
Observed|Leukaemia|2015–2019|Females|1|30–34|0.939|0.882|0.969
Observed|Leukaemia|2015–2019|Females|1|35–39|0.897|0.838|0.936
Observed|Leukaemia|2015–2019|Females|1|40–44|0.894|0.845|0.928
Observed|Leukaemia|2015–2019|Females|1|45–49|0.858|0.814|0.892
Observed|Leukaemia|2015–2019|Females|1|50–54|0.859|0.822|0.888
Observed|Leukaemia|2015–2019|Females|1|55–59|0.868|0.838|0.892
Observed|Leukaemia|2015–2019|Females|1|60–64|0.882|0.857|0.903
Observed|Leukaemia|2015–2019|Females|1|65–69|0.863|0.839|0.883
Observed|Leukaemia|2015–2019|Females|1|70–74|0.781|0.754|0.805
Observed|Leukaemia|2015–2019|Females|1|75–79|0.712|0.682|0.739
Observed|Leukaemia|2015–2019|Females|1|80–84|0.64|0.605|0.672
Observed|Leukaemia|2015–2019|Females|1|85+|0.434|0.403|0.464
Observed|Leukaemia|2015–2019|Females|1|All ages combined|0.773|0.763|0.782
Observed|Leukaemia|2015–2019|Females|2|00–04|0.928|0.893|0.952
Observed|Leukaemia|2015–2019|Females|2|05–09|0.949|0.902|0.974
Observed|Leukaemia|2015–2019|Females|2|10–14|0.861|0.769|0.919
Observed|Leukaemia|2015–2019|Females|2|15–19|0.803|0.703|0.873
Observed|Leukaemia|2015–2019|Females|2|20–24|0.9|0.802|0.951
Observed|Leukaemia|2015–2019|Females|2|25–29|0.923|0.837|0.965
Observed|Leukaemia|2015–2019|Females|2|30–34|0.861|0.788|0.91
Observed|Leukaemia|2015–2019|Females|2|35–39|0.826|0.757|0.877
Observed|Leukaemia|2015–2019|Females|2|40–44|0.855|0.8|0.896
Observed|Leukaemia|2015–2019|Females|2|45–49|0.813|0.765|0.852
Observed|Leukaemia|2015–2019|Females|2|50–54|0.795|0.753|0.83
Observed|Leukaemia|2015–2019|Females|2|55–59|0.817|0.784|0.846
Observed|Leukaemia|2015–2019|Females|2|60–64|0.819|0.789|0.845
Observed|Leukaemia|2015–2019|Females|2|65–69|0.797|0.77|0.822
Observed|Leukaemia|2015–2019|Females|2|70–74|0.692|0.662|0.719
Observed|Leukaemia|2015–2019|Females|2|75–79|0.631|0.599|0.66
Observed|Leukaemia|2015–2019|Females|2|80–84|0.536|0.501|0.569
Observed|Leukaemia|2015–2019|Females|2|85+|0.324|0.296|0.352
Observed|Leukaemia|2015–2019|Females|2|All ages combined|0.696|0.686|0.706
Observed|Leukaemia|2015–2019|Females|3|00–04|0.915|0.877|0.941
Observed|Leukaemia|2015–2019|Females|3|05–09|0.937|0.886|0.965
Observed|Leukaemia|2015–2019|Females|3|10–14|0.85|0.756|0.91
Observed|Leukaemia|2015–2019|Females|3|15–19|0.757|0.653|0.834
Observed|Leukaemia|2015–2019|Females|3|20–24|0.859|0.753|0.921
Observed|Leukaemia|2015–2019|Females|3|25–29|0.895|0.802|0.946
Observed|Leukaemia|2015–2019|Females|3|30–34|0.845|0.769|0.897
Observed|Leukaemia|2015–2019|Females|3|35–39|0.801|0.729|0.855
Observed|Leukaemia|2015–2019|Females|3|40–44|0.829|0.771|0.874
Observed|Leukaemia|2015–2019|Females|3|45–49|0.79|0.74|0.831
Observed|Leukaemia|2015–2019|Females|3|50–54|0.774|0.731|0.811
Observed|Leukaemia|2015–2019|Females|3|55–59|0.788|0.753|0.819
Observed|Leukaemia|2015–2019|Females|3|60–64|0.785|0.753|0.813
Observed|Leukaemia|2015–2019|Females|3|65–69|0.73|0.699|0.757
Observed|Leukaemia|2015–2019|Females|3|70–74|0.653|0.622|0.681
Observed|Leukaemia|2015–2019|Females|3|75–79|0.595|0.564|0.626
Observed|Leukaemia|2015–2019|Females|3|80–84|0.457|0.422|0.491
Observed|Leukaemia|2015–2019|Females|3|85+|0.254|0.229|0.28
Observed|Leukaemia|2015–2019|Females|3|All ages combined|0.651|0.641|0.661
Observed|Leukaemia|2015–2019|Females|4|00–04|0.911|0.873|0.938
Observed|Leukaemia|2015–2019|Females|4|05–09|0.937|0.886|0.965
Observed|Leukaemia|2015–2019|Females|4|10–14|0.85|0.756|0.91
Observed|Leukaemia|2015–2019|Females|4|15–19|0.734|0.628|0.815
Observed|Leukaemia|2015–2019|Females|4|20–24|0.834|0.727|0.902
Observed|Leukaemia|2015–2019|Females|4|25–29|0.868|0.768|0.927
Observed|Leukaemia|2015–2019|Females|4|30–34|0.836|0.76|0.89
Observed|Leukaemia|2015–2019|Females|4|35–39|0.788|0.715|0.844
Observed|Leukaemia|2015–2019|Females|4|40–44|0.808|0.748|0.856
Observed|Leukaemia|2015–2019|Females|4|45–49|0.776|0.725|0.818
Observed|Leukaemia|2015–2019|Females|4|50–54|0.76|0.717|0.798
Observed|Leukaemia|2015–2019|Females|4|55–59|0.767|0.73|0.799
Observed|Leukaemia|2015–2019|Females|4|60–64|0.749|0.716|0.779
Observed|Leukaemia|2015–2019|Females|4|65–69|0.7|0.669|0.729
Observed|Leukaemia|2015–2019|Females|4|70–74|0.618|0.586|0.647
Observed|Leukaemia|2015–2019|Females|4|75–79|0.546|0.514|0.578
Observed|Leukaemia|2015–2019|Females|4|80–84|0.379|0.345|0.412
Observed|Leukaemia|2015–2019|Females|4|85+|0.205|0.181|0.23
Observed|Leukaemia|2015–2019|Females|4|All ages combined|0.615|0.604|0.626
Observed|Leukaemia|2015–2019|Females|5|00–04|0.911|0.873|0.938
Observed|Leukaemia|2015–2019|Females|5|05–09|0.937|0.886|0.965
Observed|Leukaemia|2015–2019|Females|5|10–14|0.85|0.756|0.91
Observed|Leukaemia|2015–2019|Females|5|15–19|0.723|0.616|0.805
Observed|Leukaemia|2015–2019|Females|5|20–24|0.822|0.713|0.892
Observed|Leukaemia|2015–2019|Females|5|25–29|0.841|0.737|0.907
Observed|Leukaemia|2015–2019|Females|5|30–34|0.818|0.739|0.875
Observed|Leukaemia|2015–2019|Females|5|35–39|0.775|0.701|0.833
Observed|Leukaemia|2015–2019|Females|5|40–44|0.793|0.731|0.842
Observed|Leukaemia|2015–2019|Females|5|45–49|0.762|0.71|0.806
Observed|Leukaemia|2015–2019|Females|5|50–54|0.748|0.704|0.787
Observed|Leukaemia|2015–2019|Females|5|55–59|0.751|0.713|0.784
Observed|Leukaemia|2015–2019|Females|5|60–64|0.74|0.706|0.771
Observed|Leukaemia|2015–2019|Females|5|65–69|0.672|0.639|0.702
Observed|Leukaemia|2015–2019|Females|5|70–74|0.576|0.544|0.607
Observed|Leukaemia|2015–2019|Females|5|75–79|0.5|0.467|0.532
Observed|Leukaemia|2015–2019|Females|5|80–84|0.34|0.307|0.372
Observed|Leukaemia|2015–2019|Females|5|85+|0.139|0.119|0.161
Observed|Leukaemia|2015–2019|Females|5|All ages combined|0.585|0.574|0.595
Relative|Leukaemia|2015–2019|Females|1|00–04|0.951|0.92|0.971
Relative|Leukaemia|2015–2019|Females|1|05–09|0.969|0.926|0.987
Relative|Leukaemia|2015–2019|Females|1|10–14|0.93|0.851|0.968
Relative|Leukaemia|2015–2019|Females|1|15–19|0.88|0.788|0.934
Relative|Leukaemia|2015–2019|Females|1|20–24|0.943|0.856|0.979
Relative|Leukaemia|2015–2019|Females|1|25–29|0.949|0.871|0.981
Relative|Leukaemia|2015–2019|Females|1|30–34|0.94|0.883|0.97
Relative|Leukaemia|2015–2019|Females|1|35–39|0.898|0.838|0.936
Relative|Leukaemia|2015–2019|Females|1|40–44|0.895|0.846|0.929
Relative|Leukaemia|2015–2019|Females|1|45–49|0.859|0.815|0.894
Relative|Leukaemia|2015–2019|Females|1|50–54|0.86|0.823|0.89
Relative|Leukaemia|2015–2019|Females|1|55–59|0.87|0.841|0.895
Relative|Leukaemia|2015–2019|Females|1|60–64|0.886|0.861|0.908
Relative|Leukaemia|2015–2019|Females|1|65–69|0.869|0.845|0.89
Relative|Leukaemia|2015–2019|Females|1|70–74|0.79|0.764|0.815
Relative|Leukaemia|2015–2019|Females|1|75–79|0.727|0.697|0.755
Relative|Leukaemia|2015–2019|Females|1|80–84|0.667|0.631|0.701
Relative|Leukaemia|2015–2019|Females|1|85+|0.489|0.454|0.523
Relative|Leukaemia|2015–2019|Females|1|All ages combined|0.791|0.782|0.801
Relative|Leukaemia|2015–2019|Females|2|00–04|0.929|0.893|0.953
Relative|Leukaemia|2015–2019|Females|2|05–09|0.95|0.902|0.975
Relative|Leukaemia|2015–2019|Females|2|10–14|0.861|0.769|0.919
Relative|Leukaemia|2015–2019|Females|2|15–19|0.803|0.703|0.873
Relative|Leukaemia|2015–2019|Females|2|20–24|0.9|0.802|0.951
Relative|Leukaemia|2015–2019|Females|2|25–29|0.924|0.837|0.965
Relative|Leukaemia|2015–2019|Females|2|30–34|0.861|0.788|0.911
Relative|Leukaemia|2015–2019|Females|2|35–39|0.827|0.758|0.879
Relative|Leukaemia|2015–2019|Females|2|40–44|0.857|0.802|0.898
Relative|Leukaemia|2015–2019|Females|2|45–49|0.815|0.767|0.855
Relative|Leukaemia|2015–2019|Females|2|50–54|0.799|0.757|0.834
Relative|Leukaemia|2015–2019|Females|2|55–59|0.823|0.789|0.852
Relative|Leukaemia|2015–2019|Females|2|60–64|0.827|0.796|0.853
Relative|Leukaemia|2015–2019|Females|2|65–69|0.809|0.782|0.834
Relative|Leukaemia|2015–2019|Females|2|70–74|0.71|0.679|0.738
Relative|Leukaemia|2015–2019|Females|2|75–79|0.66|0.628|0.691
Relative|Leukaemia|2015–2019|Females|2|80–84|0.586|0.548|0.623
Relative|Leukaemia|2015–2019|Females|2|85+|0.412|0.377|0.448
Relative|Leukaemia|2015–2019|Females|2|All ages combined|0.727|0.717|0.738
Relative|Leukaemia|2015–2019|Females|3|00–04|0.915|0.878|0.942
Relative|Leukaemia|2015–2019|Females|3|05–09|0.937|0.886|0.966
Relative|Leukaemia|2015–2019|Females|3|10–14|0.85|0.756|0.91
Relative|Leukaemia|2015–2019|Females|3|15–19|0.758|0.653|0.835
Relative|Leukaemia|2015–2019|Females|3|20–24|0.859|0.754|0.922
Relative|Leukaemia|2015–2019|Females|3|25–29|0.896|0.802|0.947
Relative|Leukaemia|2015–2019|Females|3|30–34|0.846|0.77|0.898
Relative|Leukaemia|2015–2019|Females|3|35–39|0.802|0.73|0.857
Relative|Leukaemia|2015–2019|Females|3|40–44|0.832|0.773|0.876
Relative|Leukaemia|2015–2019|Females|3|45–49|0.793|0.743|0.835
Relative|Leukaemia|2015–2019|Females|3|50–54|0.779|0.736|0.817
Relative|Leukaemia|2015–2019|Females|3|55–59|0.796|0.76|0.828
Relative|Leukaemia|2015–2019|Females|3|60–64|0.797|0.765|0.825
Relative|Leukaemia|2015–2019|Females|3|65–69|0.748|0.717|0.776
Relative|Leukaemia|2015–2019|Females|3|70–74|0.68|0.648|0.71
Relative|Leukaemia|2015–2019|Females|3|75–79|0.641|0.607|0.674
Relative|Leukaemia|2015–2019|Females|3|80–84|0.528|0.488|0.567
Relative|Leukaemia|2015–2019|Females|3|85+|0.371|0.334|0.409
Relative|Leukaemia|2015–2019|Females|3|All ages combined|0.694|0.683|0.705
Relative|Leukaemia|2015–2019|Females|4|00–04|0.912|0.874|0.939
Relative|Leukaemia|2015–2019|Females|4|05–09|0.937|0.886|0.966
Relative|Leukaemia|2015–2019|Females|4|10–14|0.85|0.756|0.91
Relative|Leukaemia|2015–2019|Females|4|15–19|0.735|0.629|0.815
Relative|Leukaemia|2015–2019|Females|4|20–24|0.835|0.728|0.903
Relative|Leukaemia|2015–2019|Females|4|25–29|0.869|0.769|0.928
Relative|Leukaemia|2015–2019|Females|4|30–34|0.838|0.762|0.892
Relative|Leukaemia|2015–2019|Females|4|35–39|0.79|0.717|0.846
Relative|Leukaemia|2015–2019|Females|4|40–44|0.812|0.751|0.859
Relative|Leukaemia|2015–2019|Females|4|45–49|0.781|0.729|0.824
Relative|Leukaemia|2015–2019|Females|4|50–54|0.768|0.724|0.806
Relative|Leukaemia|2015–2019|Females|4|55–59|0.778|0.741|0.811
Relative|Leukaemia|2015–2019|Females|4|60–64|0.765|0.731|0.796
Relative|Leukaemia|2015–2019|Females|4|65–69|0.725|0.692|0.755
Relative|Leukaemia|2015–2019|Females|4|70–74|0.654|0.621|0.686
Relative|Leukaemia|2015–2019|Females|4|75–79|0.607|0.571|0.642
Relative|Leukaemia|2015–2019|Females|4|80–84|0.466|0.425|0.507
Relative|Leukaemia|2015–2019|Females|4|85+|0.345|0.306|0.387
Relative|Leukaemia|2015–2019|Females|4|All ages combined|0.669|0.657|0.68
Relative|Leukaemia|2015–2019|Females|5|00–04|0.912|0.874|0.939
Relative|Leukaemia|2015–2019|Females|5|05–09|0.937|0.886|0.966
Relative|Leukaemia|2015–2019|Females|5|10–14|0.851|0.756|0.911
Relative|Leukaemia|2015–2019|Females|5|15–19|0.724|0.617|0.806
Relative|Leukaemia|2015–2019|Females|5|20–24|0.823|0.714|0.893
Relative|Leukaemia|2015–2019|Females|5|25–29|0.843|0.738|0.908
Relative|Leukaemia|2015–2019|Females|5|30–34|0.82|0.74|0.877
Relative|Leukaemia|2015–2019|Females|5|35–39|0.778|0.703|0.836
Relative|Leukaemia|2015–2019|Females|5|40–44|0.798|0.735|0.847
Relative|Leukaemia|2015–2019|Females|5|45–49|0.768|0.716|0.812
Relative|Leukaemia|2015–2019|Females|5|50–54|0.758|0.713|0.797
Relative|Leukaemia|2015–2019|Females|5|55–59|0.765|0.726|0.799
Relative|Leukaemia|2015–2019|Females|5|60–64|0.761|0.726|0.792
Relative|Leukaemia|2015–2019|Females|5|65–69|0.702|0.668|0.734
Relative|Leukaemia|2015–2019|Females|5|70–74|0.622|0.588|0.655
Relative|Leukaemia|2015–2019|Females|5|75–79|0.576|0.538|0.614
Relative|Leukaemia|2015–2019|Females|5|80–84|0.449|0.406|0.493
Relative|Leukaemia|2015–2019|Females|5|85+|0.277|0.237|0.32
Relative|Leukaemia|2015–2019|Females|5|All ages combined|0.648|0.636|0.66
Observed|Leukaemia|2015–2019|Persons|1|00–04|0.94|0.919|0.956
Observed|Leukaemia|2015–2019|Persons|1|05–09|0.974|0.95|0.986
Observed|Leukaemia|2015–2019|Persons|1|10–14|0.932|0.889|0.958
Observed|Leukaemia|2015–2019|Persons|1|15–19|0.905|0.857|0.938
Observed|Leukaemia|2015–2019|Persons|1|20–24|0.904|0.854|0.938
Observed|Leukaemia|2015–2019|Persons|1|25–29|0.938|0.894|0.965
Observed|Leukaemia|2015–2019|Persons|1|30–34|0.937|0.901|0.961
Observed|Leukaemia|2015–2019|Persons|1|35–39|0.903|0.869|0.929
Observed|Leukaemia|2015–2019|Persons|1|40–44|0.915|0.887|0.936
Observed|Leukaemia|2015–2019|Persons|1|45–49|0.893|0.869|0.914
Observed|Leukaemia|2015–2019|Persons|1|50–54|0.889|0.869|0.906
Observed|Leukaemia|2015–2019|Persons|1|55–59|0.883|0.866|0.898
Observed|Leukaemia|2015–2019|Persons|1|60–64|0.884|0.869|0.897
Observed|Leukaemia|2015–2019|Persons|1|65–69|0.85|0.836|0.863
Observed|Leukaemia|2015–2019|Persons|1|70–74|0.786|0.77|0.801
Observed|Leukaemia|2015–2019|Persons|1|75–79|0.71|0.692|0.727
Observed|Leukaemia|2015–2019|Persons|1|80–84|0.623|0.602|0.643
Observed|Leukaemia|2015–2019|Persons|1|85+|0.445|0.424|0.465
Observed|Leukaemia|2015–2019|Persons|1|All ages combined|0.778|0.773|0.784
Observed|Leukaemia|2015–2019|Persons|2|00–04|0.918|0.894|0.937
Observed|Leukaemia|2015–2019|Persons|2|05–09|0.959|0.931|0.975
Observed|Leukaemia|2015–2019|Persons|2|10–14|0.873|0.821|0.91
Observed|Leukaemia|2015–2019|Persons|2|15–19|0.843|0.787|0.885
Observed|Leukaemia|2015–2019|Persons|2|20–24|0.84|0.781|0.884
Observed|Leukaemia|2015–2019|Persons|2|25–29|0.906|0.855|0.94
Observed|Leukaemia|2015–2019|Persons|2|30–34|0.875|0.83|0.909
Observed|Leukaemia|2015–2019|Persons|2|35–39|0.851|0.811|0.884
Observed|Leukaemia|2015–2019|Persons|2|40–44|0.863|0.83|0.89
Observed|Leukaemia|2015–2019|Persons|2|45–49|0.847|0.819|0.871
Observed|Leukaemia|2015–2019|Persons|2|50–54|0.833|0.809|0.853
Observed|Leukaemia|2015–2019|Persons|2|55–59|0.826|0.806|0.845
Observed|Leukaemia|2015–2019|Persons|2|60–64|0.814|0.795|0.83
Observed|Leukaemia|2015–2019|Persons|2|65–69|0.78|0.764|0.796
Observed|Leukaemia|2015–2019|Persons|2|70–74|0.708|0.691|0.724
Observed|Leukaemia|2015–2019|Persons|2|75–79|0.613|0.594|0.632
Observed|Leukaemia|2015–2019|Persons|2|80–84|0.519|0.497|0.54
Observed|Leukaemia|2015–2019|Persons|2|85+|0.336|0.317|0.355
Observed|Leukaemia|2015–2019|Persons|2|All ages combined|0.701|0.695|0.707
Observed|Leukaemia|2015–2019|Persons|3|00–04|0.909|0.884|0.929
Observed|Leukaemia|2015–2019|Persons|3|05–09|0.947|0.917|0.966
Observed|Leukaemia|2015–2019|Persons|3|10–14|0.846|0.791|0.887
Observed|Leukaemia|2015–2019|Persons|3|15–19|0.798|0.738|0.845
Observed|Leukaemia|2015–2019|Persons|3|20–24|0.821|0.761|0.867
Observed|Leukaemia|2015–2019|Persons|3|25–29|0.884|0.829|0.922
Observed|Leukaemia|2015–2019|Persons|3|30–34|0.842|0.793|0.88
Observed|Leukaemia|2015–2019|Persons|3|35–39|0.824|0.782|0.859
Observed|Leukaemia|2015–2019|Persons|3|40–44|0.837|0.802|0.866
Observed|Leukaemia|2015–2019|Persons|3|45–49|0.826|0.796|0.851
Observed|Leukaemia|2015–2019|Persons|3|50–54|0.804|0.78|0.827
Observed|Leukaemia|2015–2019|Persons|3|55–59|0.788|0.767|0.808
Observed|Leukaemia|2015–2019|Persons|3|60–64|0.783|0.764|0.801
Observed|Leukaemia|2015–2019|Persons|3|65–69|0.727|0.709|0.744
Observed|Leukaemia|2015–2019|Persons|3|70–74|0.656|0.638|0.674
Observed|Leukaemia|2015–2019|Persons|3|75–79|0.548|0.528|0.567
Observed|Leukaemia|2015–2019|Persons|3|80–84|0.435|0.413|0.456
Observed|Leukaemia|2015–2019|Persons|3|85+|0.256|0.238|0.273
Observed|Leukaemia|2015–2019|Persons|3|All ages combined|0.65|0.644|0.657
Observed|Leukaemia|2015–2019|Persons|4|00–04|0.905|0.879|0.925
Observed|Leukaemia|2015–2019|Persons|4|05–09|0.944|0.914|0.964
Observed|Leukaemia|2015–2019|Persons|4|10–14|0.837|0.781|0.88
Observed|Leukaemia|2015–2019|Persons|4|15–19|0.771|0.709|0.821
Observed|Leukaemia|2015–2019|Persons|4|20–24|0.808|0.746|0.855
Observed|Leukaemia|2015–2019|Persons|4|25–29|0.872|0.816|0.913
Observed|Leukaemia|2015–2019|Persons|4|30–34|0.823|0.772|0.864
Observed|Leukaemia|2015–2019|Persons|4|35–39|0.813|0.77|0.849
Observed|Leukaemia|2015–2019|Persons|4|40–44|0.811|0.774|0.843
Observed|Leukaemia|2015–2019|Persons|4|45–49|0.812|0.782|0.839
Observed|Leukaemia|2015–2019|Persons|4|50–54|0.789|0.764|0.812
Observed|Leukaemia|2015–2019|Persons|4|55–59|0.77|0.748|0.791
Observed|Leukaemia|2015–2019|Persons|4|60–64|0.748|0.727|0.766
Observed|Leukaemia|2015–2019|Persons|4|65–69|0.688|0.669|0.705
Observed|Leukaemia|2015–2019|Persons|4|70–74|0.611|0.592|0.629
Observed|Leukaemia|2015–2019|Persons|4|75–79|0.493|0.473|0.513
Observed|Leukaemia|2015–2019|Persons|4|80–84|0.361|0.34|0.381
Observed|Leukaemia|2015–2019|Persons|4|85+|0.193|0.177|0.209
Observed|Leukaemia|2015–2019|Persons|4|All ages combined|0.61|0.604|0.617
Observed|Leukaemia|2015–2019|Persons|5|00–04|0.9|0.874|0.921
Observed|Leukaemia|2015–2019|Persons|5|05–09|0.941|0.91|0.962
Observed|Leukaemia|2015–2019|Persons|5|10–14|0.828|0.771|0.872
Observed|Leukaemia|2015–2019|Persons|5|15–19|0.767|0.705|0.817
Observed|Leukaemia|2015–2019|Persons|5|20–24|0.79|0.728|0.84
Observed|Leukaemia|2015–2019|Persons|5|25–29|0.856|0.796|0.899
Observed|Leukaemia|2015–2019|Persons|5|30–34|0.815|0.764|0.857
Observed|Leukaemia|2015–2019|Persons|5|35–39|0.805|0.761|0.842
Observed|Leukaemia|2015–2019|Persons|5|40–44|0.801|0.764|0.834
Observed|Leukaemia|2015–2019|Persons|5|45–49|0.805|0.774|0.832
Observed|Leukaemia|2015–2019|Persons|5|50–54|0.78|0.754|0.803
Observed|Leukaemia|2015–2019|Persons|5|55–59|0.75|0.727|0.771
Observed|Leukaemia|2015–2019|Persons|5|60–64|0.723|0.702|0.743
Observed|Leukaemia|2015–2019|Persons|5|65–69|0.652|0.633|0.671
Observed|Leukaemia|2015–2019|Persons|5|70–74|0.564|0.545|0.583
Observed|Leukaemia|2015–2019|Persons|5|75–79|0.444|0.424|0.464
Observed|Leukaemia|2015–2019|Persons|5|80–84|0.307|0.287|0.327
Observed|Leukaemia|2015–2019|Persons|5|85+|0.135|0.121|0.149
Observed|Leukaemia|2015–2019|Persons|5|All ages combined|0.577|0.57|0.584
Relative|Leukaemia|2015–2019|Persons|1|00–04|0.94|0.919|0.956
Relative|Leukaemia|2015–2019|Persons|1|05–09|0.974|0.95|0.986
Relative|Leukaemia|2015–2019|Persons|1|10–14|0.932|0.889|0.958
Relative|Leukaemia|2015–2019|Persons|1|15–19|0.905|0.857|0.938
Relative|Leukaemia|2015–2019|Persons|1|20–24|0.905|0.855|0.938
Relative|Leukaemia|2015–2019|Persons|1|25–29|0.939|0.895|0.965
Relative|Leukaemia|2015–2019|Persons|1|30–34|0.938|0.902|0.961
Relative|Leukaemia|2015–2019|Persons|1|35–39|0.904|0.87|0.93
Relative|Leukaemia|2015–2019|Persons|1|40–44|0.916|0.889|0.937
Relative|Leukaemia|2015–2019|Persons|1|45–49|0.895|0.87|0.916
Relative|Leukaemia|2015–2019|Persons|1|50–54|0.891|0.871|0.908
Relative|Leukaemia|2015–2019|Persons|1|55–59|0.887|0.87|0.902
Relative|Leukaemia|2015–2019|Persons|1|60–64|0.89|0.874|0.903
Relative|Leukaemia|2015–2019|Persons|1|65–69|0.859|0.844|0.872
Relative|Leukaemia|2015–2019|Persons|1|70–74|0.799|0.784|0.814
Relative|Leukaemia|2015–2019|Persons|1|75–79|0.73|0.712|0.748
Relative|Leukaemia|2015–2019|Persons|1|80–84|0.657|0.635|0.679
Relative|Leukaemia|2015–2019|Persons|1|85+|0.508|0.484|0.531
Relative|Leukaemia|2015–2019|Persons|1|All ages combined|0.8|0.794|0.806
Relative|Leukaemia|2015–2019|Persons|2|00–04|0.919|0.895|0.938
Relative|Leukaemia|2015–2019|Persons|2|05–09|0.959|0.932|0.976
Relative|Leukaemia|2015–2019|Persons|2|10–14|0.873|0.822|0.911
Relative|Leukaemia|2015–2019|Persons|2|15–19|0.843|0.788|0.886
Relative|Leukaemia|2015–2019|Persons|2|20–24|0.841|0.782|0.885
Relative|Leukaemia|2015–2019|Persons|2|25–29|0.907|0.856|0.941
Relative|Leukaemia|2015–2019|Persons|2|30–34|0.876|0.831|0.91
Relative|Leukaemia|2015–2019|Persons|2|35–39|0.853|0.813|0.885
Relative|Leukaemia|2015–2019|Persons|2|40–44|0.866|0.833|0.893
Relative|Leukaemia|2015–2019|Persons|2|45–49|0.85|0.822|0.875
Relative|Leukaemia|2015–2019|Persons|2|50–54|0.838|0.814|0.859
Relative|Leukaemia|2015–2019|Persons|2|55–59|0.834|0.814|0.853
Relative|Leukaemia|2015–2019|Persons|2|60–64|0.825|0.807|0.842
Relative|Leukaemia|2015–2019|Persons|2|65–69|0.797|0.781|0.813
Relative|Leukaemia|2015–2019|Persons|2|70–74|0.733|0.716|0.751
Relative|Leukaemia|2015–2019|Persons|2|75–79|0.652|0.631|0.672
Relative|Leukaemia|2015–2019|Persons|2|80–84|0.581|0.557|0.605
Relative|Leukaemia|2015–2019|Persons|2|85+|0.44|0.415|0.465
Relative|Leukaemia|2015–2019|Persons|2|All ages combined|0.738|0.731|0.744
Relative|Leukaemia|2015–2019|Persons|3|00–04|0.91|0.885|0.93
Relative|Leukaemia|2015–2019|Persons|3|05–09|0.947|0.917|0.967
Relative|Leukaemia|2015–2019|Persons|3|10–14|0.846|0.792|0.888
Relative|Leukaemia|2015–2019|Persons|3|15–19|0.799|0.739|0.846
Relative|Leukaemia|2015–2019|Persons|3|20–24|0.822|0.762|0.869
Relative|Leukaemia|2015–2019|Persons|3|25–29|0.885|0.83|0.923
Relative|Leukaemia|2015–2019|Persons|3|30–34|0.843|0.794|0.882
Relative|Leukaemia|2015–2019|Persons|3|35–39|0.827|0.784|0.862
Relative|Leukaemia|2015–2019|Persons|3|40–44|0.841|0.805|0.87
Relative|Leukaemia|2015–2019|Persons|3|45–49|0.831|0.801|0.857
Relative|Leukaemia|2015–2019|Persons|3|50–54|0.812|0.788|0.835
Relative|Leukaemia|2015–2019|Persons|3|55–59|0.8|0.778|0.82
Relative|Leukaemia|2015–2019|Persons|3|60–64|0.801|0.781|0.819
Relative|Leukaemia|2015–2019|Persons|3|65–69|0.752|0.734|0.77
Relative|Leukaemia|2015–2019|Persons|3|70–74|0.694|0.675|0.713
Relative|Leukaemia|2015–2019|Persons|3|75–79|0.604|0.583|0.626
Relative|Leukaemia|2015–2019|Persons|3|80–84|0.521|0.496|0.547
Relative|Leukaemia|2015–2019|Persons|3|85+|0.39|0.363|0.416
Relative|Leukaemia|2015–2019|Persons|3|All ages combined|0.7|0.693|0.707
Relative|Leukaemia|2015–2019|Persons|4|00–04|0.905|0.88|0.926
Relative|Leukaemia|2015–2019|Persons|4|05–09|0.944|0.914|0.964
Relative|Leukaemia|2015–2019|Persons|4|10–14|0.838|0.782|0.88
Relative|Leukaemia|2015–2019|Persons|4|15–19|0.772|0.711|0.822
Relative|Leukaemia|2015–2019|Persons|4|20–24|0.809|0.748|0.857
Relative|Leukaemia|2015–2019|Persons|4|25–29|0.874|0.817|0.915
Relative|Leukaemia|2015–2019|Persons|4|30–34|0.826|0.775|0.866
Relative|Leukaemia|2015–2019|Persons|4|35–39|0.817|0.773|0.853
Relative|Leukaemia|2015–2019|Persons|4|40–44|0.816|0.779|0.848
Relative|Leukaemia|2015–2019|Persons|4|45–49|0.82|0.789|0.847
Relative|Leukaemia|2015–2019|Persons|4|50–54|0.8|0.774|0.823
Relative|Leukaemia|2015–2019|Persons|4|55–59|0.786|0.763|0.807
Relative|Leukaemia|2015–2019|Persons|4|60–64|0.771|0.75|0.79
Relative|Leukaemia|2015–2019|Persons|4|65–69|0.721|0.702|0.74
Relative|Leukaemia|2015–2019|Persons|4|70–74|0.661|0.64|0.681
Relative|Leukaemia|2015–2019|Persons|4|75–79|0.567|0.544|0.589
Relative|Leukaemia|2015–2019|Persons|4|80–84|0.467|0.44|0.494
Relative|Leukaemia|2015–2019|Persons|4|85+|0.346|0.318|0.375
Relative|Leukaemia|2015–2019|Persons|4|All ages combined|0.673|0.665|0.68
Relative|Leukaemia|2015–2019|Persons|5|00–04|0.901|0.875|0.922
Relative|Leukaemia|2015–2019|Persons|5|05–09|0.942|0.911|0.962
Relative|Leukaemia|2015–2019|Persons|5|10–14|0.829|0.772|0.872
Relative|Leukaemia|2015–2019|Persons|5|15–19|0.768|0.706|0.819
Relative|Leukaemia|2015–2019|Persons|5|20–24|0.792|0.729|0.842
Relative|Leukaemia|2015–2019|Persons|5|25–29|0.858|0.799|0.901
Relative|Leukaemia|2015–2019|Persons|5|30–34|0.818|0.767|0.86
Relative|Leukaemia|2015–2019|Persons|5|35–39|0.809|0.765|0.846
Relative|Leukaemia|2015–2019|Persons|5|40–44|0.808|0.77|0.84
Relative|Leukaemia|2015–2019|Persons|5|45–49|0.814|0.783|0.842
Relative|Leukaemia|2015–2019|Persons|5|50–54|0.794|0.768|0.817
Relative|Leukaemia|2015–2019|Persons|5|55–59|0.77|0.747|0.792
Relative|Leukaemia|2015–2019|Persons|5|60–64|0.753|0.731|0.773
Relative|Leukaemia|2015–2019|Persons|5|65–69|0.695|0.675|0.715
Relative|Leukaemia|2015–2019|Persons|5|70–74|0.626|0.605|0.647
Relative|Leukaemia|2015–2019|Persons|5|75–79|0.534|0.51|0.558
Relative|Leukaemia|2015–2019|Persons|5|80–84|0.434|0.405|0.462
Relative|Leukaemia|2015–2019|Persons|5|85+|0.29|0.261|0.321
Relative|Leukaemia|2015–2019|Persons|5|All ages combined|0.65|0.643|0.658
Observed|Lip cancer|2015–2019|Males|1|00–04|||
Observed|Lip cancer|2015–2019|Males|1|05–09|||
Observed|Lip cancer|2015–2019|Males|1|10–14|||
Observed|Lip cancer|2015–2019|Males|1|15–19|||
Observed|Lip cancer|2015–2019|Males|1|20–24|||
Observed|Lip cancer|2015–2019|Males|1|25–29|1|0.875|1
Observed|Lip cancer|2015–2019|Males|1|30–34|1|0.951|1
Observed|Lip cancer|2015–2019|Males|1|35–39|1|0.974|1
Observed|Lip cancer|2015–2019|Males|1|40–44|0.995|0.964|0.999
Observed|Lip cancer|2015–2019|Males|1|45–49|0.996|0.973|0.999
Observed|Lip cancer|2015–2019|Males|1|50–54|0.993|0.973|0.998
Observed|Lip cancer|2015–2019|Males|1|55–59|0.985|0.964|0.994
Observed|Lip cancer|2015–2019|Males|1|60–64|0.983|0.962|0.992
Observed|Lip cancer|2015–2019|Males|1|65–69|0.98|0.959|0.991
Observed|Lip cancer|2015–2019|Males|1|70–74|0.965|0.94|0.98
Observed|Lip cancer|2015–2019|Males|1|75–79|0.955|0.924|0.974
Observed|Lip cancer|2015–2019|Males|1|80–84|0.941|0.901|0.966
Observed|Lip cancer|2015–2019|Males|1|85+|0.86|0.804|0.901
Observed|Lip cancer|2015–2019|Males|1|All ages combined|0.971|0.965|0.977
Observed|Lip cancer|2015–2019|Males|2|00–04|||
Observed|Lip cancer|2015–2019|Males|2|05–09|||
Observed|Lip cancer|2015–2019|Males|2|10–14|||
Observed|Lip cancer|2015–2019|Males|2|15–19|||
Observed|Lip cancer|2015–2019|Males|2|20–24|||
Observed|Lip cancer|2015–2019|Males|2|25–29|1|0.894|1
Observed|Lip cancer|2015–2019|Males|2|30–34|0.986|0.905|0.998
Observed|Lip cancer|2015–2019|Males|2|35–39|0.991|0.939|0.999
Observed|Lip cancer|2015–2019|Males|2|40–44|0.98|0.948|0.993
Observed|Lip cancer|2015–2019|Males|2|45–49|0.977|0.949|0.99
Observed|Lip cancer|2015–2019|Males|2|50–54|0.99|0.97|0.997
Observed|Lip cancer|2015–2019|Males|2|55–59|0.953|0.924|0.971
Observed|Lip cancer|2015–2019|Males|2|60–64|0.952|0.925|0.97
Observed|Lip cancer|2015–2019|Males|2|65–69|0.942|0.913|0.962
Observed|Lip cancer|2015–2019|Males|2|70–74|0.929|0.896|0.952
Observed|Lip cancer|2015–2019|Males|2|75–79|0.92|0.882|0.946
Observed|Lip cancer|2015–2019|Males|2|80–84|0.856|0.802|0.897
Observed|Lip cancer|2015–2019|Males|2|85+|0.714|0.647|0.771
Observed|Lip cancer|2015–2019|Males|2|All ages combined|0.933|0.924|0.942
Observed|Lip cancer|2015–2019|Males|3|00–04|||
Observed|Lip cancer|2015–2019|Males|3|05–09|||
Observed|Lip cancer|2015–2019|Males|3|10–14|||
Observed|Lip cancer|2015–2019|Males|3|15–19|||
Observed|Lip cancer|2015–2019|Males|3|20–24|||
Observed|Lip cancer|2015–2019|Males|3|25–29|1|0.904|1
Observed|Lip cancer|2015–2019|Males|3|30–34|0.962|0.887|0.988
Observed|Lip cancer|2015–2019|Males|3|35–39|0.991|0.939|0.999
Observed|Lip cancer|2015–2019|Males|3|40–44|0.98|0.948|0.993
Observed|Lip cancer|2015–2019|Males|3|45–49|0.969|0.94|0.985
Observed|Lip cancer|2015–2019|Males|3|50–54|0.967|0.94|0.981
Observed|Lip cancer|2015–2019|Males|3|55–59|0.931|0.898|0.953
Observed|Lip cancer|2015–2019|Males|3|60–64|0.942|0.912|0.962
Observed|Lip cancer|2015–2019|Males|3|65–69|0.914|0.881|0.939
Observed|Lip cancer|2015–2019|Males|3|70–74|0.868|0.827|0.9
Observed|Lip cancer|2015–2019|Males|3|75–79|0.837|0.79|0.875
Observed|Lip cancer|2015–2019|Males|3|80–84|0.785|0.724|0.834
Observed|Lip cancer|2015–2019|Males|3|85+|0.559|0.49|0.623
Observed|Lip cancer|2015–2019|Males|3|All ages combined|0.894|0.882|0.904
Observed|Lip cancer|2015–2019|Males|4|00–04|||
Observed|Lip cancer|2015–2019|Males|4|05–09|||
Observed|Lip cancer|2015–2019|Males|4|10–14|||
Observed|Lip cancer|2015–2019|Males|4|15–19|||
Observed|Lip cancer|2015–2019|Males|4|20–24|||
Observed|Lip cancer|2015–2019|Males|4|25–29|0.953|0.824|0.988
Observed|Lip cancer|2015–2019|Males|4|30–34|0.962|0.887|0.988
Observed|Lip cancer|2015–2019|Males|4|35–39|0.991|0.939|0.999
Observed|Lip cancer|2015–2019|Males|4|40–44|0.976|0.943|0.99
Observed|Lip cancer|2015–2019|Males|4|45–49|0.966|0.936|0.982
Observed|Lip cancer|2015–2019|Males|4|50–54|0.949|0.92|0.968
Observed|Lip cancer|2015–2019|Males|4|55–59|0.918|0.884|0.942
Observed|Lip cancer|2015–2019|Males|4|60–64|0.921|0.889|0.945
Observed|Lip cancer|2015–2019|Males|4|65–69|0.89|0.855|0.918
Observed|Lip cancer|2015–2019|Males|4|70–74|0.837|0.794|0.872
Observed|Lip cancer|2015–2019|Males|4|75–79|0.795|0.745|0.837
Observed|Lip cancer|2015–2019|Males|4|80–84|0.708|0.642|0.763
Observed|Lip cancer|2015–2019|Males|4|85+|0.43|0.364|0.494
Observed|Lip cancer|2015–2019|Males|4|All ages combined|0.864|0.851|0.875
Observed|Lip cancer|2015–2019|Males|5|00–04|||
Observed|Lip cancer|2015–2019|Males|5|05–09|||
Observed|Lip cancer|2015–2019|Males|5|10–14|||
Observed|Lip cancer|2015–2019|Males|5|15–19|||
Observed|Lip cancer|2015–2019|Males|5|20–24|||
Observed|Lip cancer|2015–2019|Males|5|25–29|0.953|0.824|0.988
Observed|Lip cancer|2015–2019|Males|5|30–34|0.962|0.887|0.988
Observed|Lip cancer|2015–2019|Males|5|35–39|0.985|0.94|0.996
Observed|Lip cancer|2015–2019|Males|5|40–44|0.963|0.927|0.981
Observed|Lip cancer|2015–2019|Males|5|45–49|0.959|0.928|0.977
Observed|Lip cancer|2015–2019|Males|5|50–54|0.938|0.907|0.959
Observed|Lip cancer|2015–2019|Males|5|55–59|0.915|0.881|0.94
Observed|Lip cancer|2015–2019|Males|5|60–64|0.912|0.878|0.936
Observed|Lip cancer|2015–2019|Males|5|65–69|0.862|0.823|0.892
Observed|Lip cancer|2015–2019|Males|5|70–74|0.792|0.745|0.831
Observed|Lip cancer|2015–2019|Males|5|75–79|0.744|0.691|0.789
Observed|Lip cancer|2015–2019|Males|5|80–84|0.625|0.557|0.685
Observed|Lip cancer|2015–2019|Males|5|85+|0.354|0.291|0.418
Observed|Lip cancer|2015–2019|Males|5|All ages combined|0.837|0.824|0.85
Relative|Lip cancer|2015–2019|Males|1|00–04|||
Relative|Lip cancer|2015–2019|Males|1|05–09|||
Relative|Lip cancer|2015–2019|Males|1|10–14|||
Relative|Lip cancer|2015–2019|Males|1|15–19|||
Relative|Lip cancer|2015–2019|Males|1|20–24|||
Relative|Lip cancer|2015–2019|Males|1|25–29|1.001|0.876|1.001
Relative|Lip cancer|2015–2019|Males|1|30–34|1.001|0.951|1.001
Relative|Lip cancer|2015–2019|Males|1|35–39|1.001|0.975|1.001
Relative|Lip cancer|2015–2019|Males|1|40–44|0.996|0.966|1.001
Relative|Lip cancer|2015–2019|Males|1|45–49|0.998|0.975|1.002
Relative|Lip cancer|2015–2019|Males|1|50–54|0.997|0.977|1.002
Relative|Lip cancer|2015–2019|Males|1|55–59|0.99|0.969|0.999
Relative|Lip cancer|2015–2019|Males|1|60–64|0.991|0.97|1
Relative|Lip cancer|2015–2019|Males|1|65–69|0.993|0.971|1.003
Relative|Lip cancer|2015–2019|Males|1|70–74|0.984|0.959|1
Relative|Lip cancer|2015–2019|Males|1|75–79|0.988|0.956|1.007
Relative|Lip cancer|2015–2019|Males|1|80–84|1|0.957|1.025
Relative|Lip cancer|2015–2019|Males|1|85+|0.993|0.928|1.04
Relative|Lip cancer|2015–2019|Males|1|All ages combined|0.993|0.986|0.998
Relative|Lip cancer|2015–2019|Males|2|00–04|||
Relative|Lip cancer|2015–2019|Males|2|05–09|||
Relative|Lip cancer|2015–2019|Males|2|10–14|||
Relative|Lip cancer|2015–2019|Males|2|15–19|||
Relative|Lip cancer|2015–2019|Males|2|20–24|||
Relative|Lip cancer|2015–2019|Males|2|25–29|1.001|0.896|1.001
Relative|Lip cancer|2015–2019|Males|2|30–34|0.988|0.906|1
Relative|Lip cancer|2015–2019|Males|2|35–39|0.994|0.941|1.001
Relative|Lip cancer|2015–2019|Males|2|40–44|0.984|0.951|0.996
Relative|Lip cancer|2015–2019|Males|2|45–49|0.982|0.954|0.994
Relative|Lip cancer|2015–2019|Males|2|50–54|0.997|0.977|1.004
Relative|Lip cancer|2015–2019|Males|2|55–59|0.963|0.935|0.982
Relative|Lip cancer|2015–2019|Males|2|60–64|0.968|0.94|0.986
Relative|Lip cancer|2015–2019|Males|2|65–69|0.967|0.937|0.987
Relative|Lip cancer|2015–2019|Males|2|70–74|0.968|0.933|0.992
Relative|Lip cancer|2015–2019|Males|2|75–79|0.988|0.947|1.016
Relative|Lip cancer|2015–2019|Males|2|80–84|0.973|0.911|1.019
Relative|Lip cancer|2015–2019|Males|2|85+|0.967|0.876|1.044
Relative|Lip cancer|2015–2019|Males|2|All ages combined|0.976|0.967|0.985
Relative|Lip cancer|2015–2019|Males|3|00–04|||
Relative|Lip cancer|2015–2019|Males|3|05–09|||
Relative|Lip cancer|2015–2019|Males|3|10–14|||
Relative|Lip cancer|2015–2019|Males|3|15–19|||
Relative|Lip cancer|2015–2019|Males|3|20–24|||
Relative|Lip cancer|2015–2019|Males|3|25–29|1.002|0.906|1.002
Relative|Lip cancer|2015–2019|Males|3|30–34|0.965|0.889|0.99
Relative|Lip cancer|2015–2019|Males|3|35–39|0.995|0.943|1.003
Relative|Lip cancer|2015–2019|Males|3|40–44|0.985|0.953|0.998
Relative|Lip cancer|2015–2019|Males|3|45–49|0.977|0.947|0.992
Relative|Lip cancer|2015–2019|Males|3|50–54|0.977|0.951|0.992
Relative|Lip cancer|2015–2019|Males|3|55–59|0.947|0.914|0.969
Relative|Lip cancer|2015–2019|Males|3|60–64|0.967|0.936|0.987
Relative|Lip cancer|2015–2019|Males|3|65–69|0.952|0.918|0.978
Relative|Lip cancer|2015–2019|Males|3|70–74|0.927|0.884|0.961
Relative|Lip cancer|2015–2019|Males|3|75–79|0.938|0.885|0.98
Relative|Lip cancer|2015–2019|Males|3|80–84|0.964|0.889|1.024
Relative|Lip cancer|2015–2019|Males|3|85+|0.899|0.788|1.001
Relative|Lip cancer|2015–2019|Males|3|All ages combined|0.957|0.945|0.968
Relative|Lip cancer|2015–2019|Males|4|00–04|||
Relative|Lip cancer|2015–2019|Males|4|05–09|||
Relative|Lip cancer|2015–2019|Males|4|10–14|||
Relative|Lip cancer|2015–2019|Males|4|15–19|||
Relative|Lip cancer|2015–2019|Males|4|20–24|||
Relative|Lip cancer|2015–2019|Males|4|25–29|0.956|0.827|0.991
Relative|Lip cancer|2015–2019|Males|4|30–34|0.966|0.89|0.991
Relative|Lip cancer|2015–2019|Males|4|35–39|0.996|0.944|1.004
Relative|Lip cancer|2015–2019|Males|4|40–44|0.983|0.95|0.997
Relative|Lip cancer|2015–2019|Males|4|45–49|0.976|0.946|0.993
Relative|Lip cancer|2015–2019|Males|4|50–54|0.965|0.935|0.984
Relative|Lip cancer|2015–2019|Males|4|55–59|0.94|0.905|0.965
Relative|Lip cancer|2015–2019|Males|4|60–64|0.955|0.922|0.979
Relative|Lip cancer|2015–2019|Males|4|65–69|0.942|0.905|0.971
Relative|Lip cancer|2015–2019|Males|4|70–74|0.919|0.871|0.957
Relative|Lip cancer|2015–2019|Males|4|75–79|0.933|0.874|0.982
Relative|Lip cancer|2015–2019|Males|4|80–84|0.947|0.86|1.021
Relative|Lip cancer|2015–2019|Males|4|85+|0.834|0.706|0.959
Relative|Lip cancer|2015–2019|Males|4|All ages combined|0.946|0.933|0.959
Relative|Lip cancer|2015–2019|Males|5|00–04|||
Relative|Lip cancer|2015–2019|Males|5|05–09|||
Relative|Lip cancer|2015–2019|Males|5|10–14|||
Relative|Lip cancer|2015–2019|Males|5|15–19|||
Relative|Lip cancer|2015–2019|Males|5|20–24|||
Relative|Lip cancer|2015–2019|Males|5|25–29|0.956|0.827|0.992
Relative|Lip cancer|2015–2019|Males|5|30–34|0.967|0.891|0.992
Relative|Lip cancer|2015–2019|Males|5|35–39|0.992|0.947|1.003
Relative|Lip cancer|2015–2019|Males|5|40–44|0.972|0.936|0.991
Relative|Lip cancer|2015–2019|Males|5|45–49|0.973|0.941|0.991
Relative|Lip cancer|2015–2019|Males|5|50–54|0.958|0.926|0.979
Relative|Lip cancer|2015–2019|Males|5|55–59|0.944|0.909|0.97
Relative|Lip cancer|2015–2019|Males|5|60–64|0.956|0.92|0.982
Relative|Lip cancer|2015–2019|Males|5|65–69|0.928|0.887|0.961
Relative|Lip cancer|2015–2019|Males|5|70–74|0.896|0.843|0.94
Relative|Lip cancer|2015–2019|Males|5|75–79|0.921|0.855|0.977
Relative|Lip cancer|2015–2019|Males|5|80–84|0.923|0.823|1.013
Relative|Lip cancer|2015–2019|Males|5|85+|0.84|0.691|0.991
Relative|Lip cancer|2015–2019|Males|5|All ages combined|0.939|0.924|0.952
Observed|Lip cancer|2015–2019|Females|1|00–04|||
Observed|Lip cancer|2015–2019|Females|1|05–09|||
Observed|Lip cancer|2015–2019|Females|1|10–14|||
Observed|Lip cancer|2015–2019|Females|1|15–19|||
Observed|Lip cancer|2015–2019|Females|1|20–24|||
Observed|Lip cancer|2015–2019|Females|1|25–29|||
Observed|Lip cancer|2015–2019|Females|1|30–34|||
Observed|Lip cancer|2015–2019|Females|1|35–39|||
Observed|Lip cancer|2015–2019|Females|1|40–44|1|0.923|1
Observed|Lip cancer|2015–2019|Females|1|45–49|1|0.939|1
Observed|Lip cancer|2015–2019|Females|1|50–54|0.987|0.913|0.998
Observed|Lip cancer|2015–2019|Females|1|55–59|0.99|0.93|0.999
Observed|Lip cancer|2015–2019|Females|1|60–64|1|0.971|1
Observed|Lip cancer|2015–2019|Females|1|65–69|0.992|0.942|0.999
Observed|Lip cancer|2015–2019|Females|1|70–74|0.97|0.922|0.989
Observed|Lip cancer|2015–2019|Females|1|75–79|0.971|0.924|0.989
Observed|Lip cancer|2015–2019|Females|1|80–84|0.955|0.895|0.981
Observed|Lip cancer|2015–2019|Females|1|85+|0.838|0.778|0.883
Observed|Lip cancer|2015–2019|Females|1|All ages combined|0.957|0.943|0.967
Observed|Lip cancer|2015–2019|Females|2|00–04|||
Observed|Lip cancer|2015–2019|Females|2|05–09|||
Observed|Lip cancer|2015–2019|Females|2|10–14|||
Observed|Lip cancer|2015–2019|Females|2|15–19|||
Observed|Lip cancer|2015–2019|Females|2|20–24|||
Observed|Lip cancer|2015–2019|Females|2|25–29|||
Observed|Lip cancer|2015–2019|Females|2|30–34|||
Observed|Lip cancer|2015–2019|Females|2|35–39|||
Observed|Lip cancer|2015–2019|Females|2|40–44|1|0.928|1
Observed|Lip cancer|2015–2019|Females|2|45–49|1|0.937|1
Observed|Lip cancer|2015–2019|Females|2|50–54|0.987|0.913|0.998
Observed|Lip cancer|2015–2019|Females|2|55–59|0.99|0.93|0.999
Observed|Lip cancer|2015–2019|Females|2|60–64|0.99|0.933|0.999
Observed|Lip cancer|2015–2019|Females|2|65–69|0.976|0.928|0.992
Observed|Lip cancer|2015–2019|Females|2|70–74|0.926|0.867|0.96
Observed|Lip cancer|2015–2019|Females|2|75–79|0.934|0.877|0.965
Observed|Lip cancer|2015–2019|Females|2|80–84|0.907|0.838|0.947
Observed|Lip cancer|2015–2019|Females|2|85+|0.69|0.62|0.75
Observed|Lip cancer|2015–2019|Females|2|All ages combined|0.914|0.895|0.929
Observed|Lip cancer|2015–2019|Females|3|00–04|||
Observed|Lip cancer|2015–2019|Females|3|05–09|||
Observed|Lip cancer|2015–2019|Females|3|10–14|||
Observed|Lip cancer|2015–2019|Females|3|15–19|||
Observed|Lip cancer|2015–2019|Females|3|20–24|||
Observed|Lip cancer|2015–2019|Females|3|25–29|||
Observed|Lip cancer|2015–2019|Females|3|30–34|||
Observed|Lip cancer|2015–2019|Females|3|35–39|||
Observed|Lip cancer|2015–2019|Females|3|40–44|1|0.93|1
Observed|Lip cancer|2015–2019|Females|3|45–49|1|0.94|1
Observed|Lip cancer|2015–2019|Females|3|50–54|0.954|0.881|0.982
Observed|Lip cancer|2015–2019|Females|3|55–59|0.99|0.93|0.999
Observed|Lip cancer|2015–2019|Females|3|60–64|0.99|0.933|0.999
Observed|Lip cancer|2015–2019|Females|3|65–69|0.948|0.894|0.975
Observed|Lip cancer|2015–2019|Females|3|70–74|0.919|0.859|0.955
Observed|Lip cancer|2015–2019|Females|3|75–79|0.907|0.845|0.945
Observed|Lip cancer|2015–2019|Females|3|80–84|0.844|0.768|0.896
Observed|Lip cancer|2015–2019|Females|3|85+|0.602|0.53|0.666
Observed|Lip cancer|2015–2019|Females|3|All ages combined|0.882|0.862|0.9
Observed|Lip cancer|2015–2019|Females|4|00–04|||
Observed|Lip cancer|2015–2019|Females|4|05–09|||
Observed|Lip cancer|2015–2019|Females|4|10–14|||
Observed|Lip cancer|2015–2019|Females|4|15–19|||
Observed|Lip cancer|2015–2019|Females|4|20–24|||
Observed|Lip cancer|2015–2019|Females|4|25–29|||
Observed|Lip cancer|2015–2019|Females|4|30–34|||
Observed|Lip cancer|2015–2019|Females|4|35–39|||
Observed|Lip cancer|2015–2019|Females|4|40–44|1|0.935|1
Observed|Lip cancer|2015–2019|Females|4|45–49|1|0.943|1
Observed|Lip cancer|2015–2019|Females|4|50–54|0.932|0.855|0.969
Observed|Lip cancer|2015–2019|Females|4|55–59|0.99|0.93|0.999
Observed|Lip cancer|2015–2019|Females|4|60–64|0.99|0.933|0.999
Observed|Lip cancer|2015–2019|Females|4|65–69|0.921|0.862|0.956
Observed|Lip cancer|2015–2019|Females|4|70–74|0.893|0.829|0.934
Observed|Lip cancer|2015–2019|Females|4|75–79|0.888|0.823|0.93
Observed|Lip cancer|2015–2019|Females|4|80–84|0.766|0.685|0.828
Observed|Lip cancer|2015–2019|Females|4|85+|0.456|0.387|0.523
Observed|Lip cancer|2015–2019|Females|4|All ages combined|0.84|0.818|0.859
Observed|Lip cancer|2015–2019|Females|5|00–04|||
Observed|Lip cancer|2015–2019|Females|5|05–09|||
Observed|Lip cancer|2015–2019|Females|5|10–14|||
Observed|Lip cancer|2015–2019|Females|5|15–19|||
Observed|Lip cancer|2015–2019|Females|5|20–24|||
Observed|Lip cancer|2015–2019|Females|5|25–29|||
Observed|Lip cancer|2015–2019|Females|5|30–34|||
Observed|Lip cancer|2015–2019|Females|5|35–39|||
Observed|Lip cancer|2015–2019|Females|5|40–44|1|0.938|1
Observed|Lip cancer|2015–2019|Females|5|45–49|1|0.945|1
Observed|Lip cancer|2015–2019|Females|5|50–54|0.932|0.855|0.969
Observed|Lip cancer|2015–2019|Females|5|55–59|0.99|0.93|0.999
Observed|Lip cancer|2015–2019|Females|5|60–64|0.972|0.917|0.991
Observed|Lip cancer|2015–2019|Females|5|65–69|0.907|0.845|0.945
Observed|Lip cancer|2015–2019|Females|5|70–74|0.853|0.784|0.902
Observed|Lip cancer|2015–2019|Females|5|75–79|0.818|0.747|0.872
Observed|Lip cancer|2015–2019|Females|5|80–84|0.655|0.573|0.725
Observed|Lip cancer|2015–2019|Females|5|85+|0.329|0.268|0.392
Observed|Lip cancer|2015–2019|Females|5|All ages combined|0.787|0.763|0.808
Relative|Lip cancer|2015–2019|Females|1|00–04|||
Relative|Lip cancer|2015–2019|Females|1|05–09|||
Relative|Lip cancer|2015–2019|Females|1|10–14|||
Relative|Lip cancer|2015–2019|Females|1|15–19|||
Relative|Lip cancer|2015–2019|Females|1|20–24|||
Relative|Lip cancer|2015–2019|Females|1|25–29|||
Relative|Lip cancer|2015–2019|Females|1|30–34|||
Relative|Lip cancer|2015–2019|Females|1|35–39|||
Relative|Lip cancer|2015–2019|Females|1|40–44|1.001|0.924|1.001
Relative|Lip cancer|2015–2019|Females|1|45–49|1.001|0.94|1.001
Relative|Lip cancer|2015–2019|Females|1|50–54|0.989|0.915|1
Relative|Lip cancer|2015–2019|Females|1|55–59|0.993|0.933|1.002
Relative|Lip cancer|2015–2019|Females|1|60–64|1.005|0.976|1.005
Relative|Lip cancer|2015–2019|Females|1|65–69|0.999|0.949|1.006
Relative|Lip cancer|2015–2019|Females|1|70–74|0.982|0.934|1.001
Relative|Lip cancer|2015–2019|Females|1|75–79|0.992|0.944|1.011
Relative|Lip cancer|2015–2019|Females|1|80–84|0.996|0.934|1.023
Relative|Lip cancer|2015–2019|Females|1|85+|0.955|0.886|1.006
Relative|Lip cancer|2015–2019|Females|1|All ages combined|0.988|0.973|0.999
Relative|Lip cancer|2015–2019|Females|2|00–04|||
Relative|Lip cancer|2015–2019|Females|2|05–09|||
Relative|Lip cancer|2015–2019|Females|2|10–14|||
Relative|Lip cancer|2015–2019|Females|2|15–19|||
Relative|Lip cancer|2015–2019|Females|2|20–24|||
Relative|Lip cancer|2015–2019|Females|2|25–29|||
Relative|Lip cancer|2015–2019|Females|2|30–34|||
Relative|Lip cancer|2015–2019|Females|2|35–39|||
Relative|Lip cancer|2015–2019|Females|2|40–44|1.002|0.93|1.002
Relative|Lip cancer|2015–2019|Females|2|45–49|1.003|0.94|1.003
Relative|Lip cancer|2015–2019|Females|2|50–54|0.992|0.917|1.003
Relative|Lip cancer|2015–2019|Females|2|55–59|0.996|0.936|1.005
Relative|Lip cancer|2015–2019|Females|2|60–64|1|0.942|1.008
Relative|Lip cancer|2015–2019|Females|2|65–69|0.991|0.942|1.008
Relative|Lip cancer|2015–2019|Females|2|70–74|0.951|0.89|0.985
Relative|Lip cancer|2015–2019|Females|2|75–79|0.978|0.919|1.011
Relative|Lip cancer|2015–2019|Females|2|80–84|0.993|0.917|1.037
Relative|Lip cancer|2015–2019|Females|2|85+|0.906|0.814|0.984
Relative|Lip cancer|2015–2019|Females|2|All ages combined|0.973|0.954|0.989
Relative|Lip cancer|2015–2019|Females|3|00–04|||
Relative|Lip cancer|2015–2019|Females|3|05–09|||
Relative|Lip cancer|2015–2019|Females|3|10–14|||
Relative|Lip cancer|2015–2019|Females|3|15–19|||
Relative|Lip cancer|2015–2019|Females|3|20–24|||
Relative|Lip cancer|2015–2019|Females|3|25–29|||
Relative|Lip cancer|2015–2019|Females|3|30–34|||
Relative|Lip cancer|2015–2019|Females|3|35–39|||
Relative|Lip cancer|2015–2019|Females|3|40–44|1.003|0.933|1.003
Relative|Lip cancer|2015–2019|Females|3|45–49|1.005|0.944|1.005
Relative|Lip cancer|2015–2019|Females|3|50–54|0.96|0.887|0.989
Relative|Lip cancer|2015–2019|Females|3|55–59|1|0.939|1.009
Relative|Lip cancer|2015–2019|Females|3|60–64|1.005|0.947|1.014
Relative|Lip cancer|2015–2019|Females|3|65–69|0.972|0.916|0.999
Relative|Lip cancer|2015–2019|Females|3|70–74|0.959|0.897|0.996
Relative|Lip cancer|2015–2019|Females|3|75–79|0.977|0.91|1.018
Relative|Lip cancer|2015–2019|Females|3|80–84|0.978|0.891|1.039
Relative|Lip cancer|2015–2019|Females|3|85+|0.92|0.81|1.019
Relative|Lip cancer|2015–2019|Females|3|All ages combined|0.97|0.948|0.989
Relative|Lip cancer|2015–2019|Females|4|00–04|||
Relative|Lip cancer|2015–2019|Females|4|05–09|||
Relative|Lip cancer|2015–2019|Females|4|10–14|||
Relative|Lip cancer|2015–2019|Females|4|15–19|||
Relative|Lip cancer|2015–2019|Females|4|20–24|||
Relative|Lip cancer|2015–2019|Females|4|25–29|||
Relative|Lip cancer|2015–2019|Females|4|30–34|||
Relative|Lip cancer|2015–2019|Females|4|35–39|||
Relative|Lip cancer|2015–2019|Females|4|40–44|1.004|0.938|1.004
Relative|Lip cancer|2015–2019|Females|4|45–49|1.006|0.949|1.006
Relative|Lip cancer|2015–2019|Females|4|50–54|0.941|0.863|0.978
Relative|Lip cancer|2015–2019|Females|4|55–59|1.004|0.943|1.013
Relative|Lip cancer|2015–2019|Females|4|60–64|1.011|0.953|1.02
Relative|Lip cancer|2015–2019|Females|4|65–69|0.953|0.892|0.989
Relative|Lip cancer|2015–2019|Females|4|70–74|0.949|0.881|0.992
Relative|Lip cancer|2015–2019|Females|4|75–79|0.987|0.915|1.034
Relative|Lip cancer|2015–2019|Females|4|80–84|0.948|0.848|1.025
Relative|Lip cancer|2015–2019|Females|4|85+|0.827|0.701|0.947
Relative|Lip cancer|2015–2019|Females|4|All ages combined|0.955|0.93|0.977
Relative|Lip cancer|2015–2019|Females|5|00–04|||
Relative|Lip cancer|2015–2019|Females|5|05–09|||
Relative|Lip cancer|2015–2019|Females|5|10–14|||
Relative|Lip cancer|2015–2019|Females|5|15–19|||
Relative|Lip cancer|2015–2019|Females|5|20–24|||
Relative|Lip cancer|2015–2019|Females|5|25–29|||
Relative|Lip cancer|2015–2019|Females|5|30–34|||
Relative|Lip cancer|2015–2019|Females|5|35–39|||
Relative|Lip cancer|2015–2019|Females|5|40–44|1.006|0.943|1.006
Relative|Lip cancer|2015–2019|Females|5|45–49|1.008|0.953|1.008
Relative|Lip cancer|2015–2019|Females|5|50–54|0.944|0.865|0.981
Relative|Lip cancer|2015–2019|Females|5|55–59|1.008|0.947|1.017
Relative|Lip cancer|2015–2019|Females|5|60–64|1|0.942|1.019
Relative|Lip cancer|2015–2019|Females|5|65–69|0.949|0.884|0.988
Relative|Lip cancer|2015–2019|Females|5|70–74|0.924|0.849|0.976
Relative|Lip cancer|2015–2019|Females|5|75–79|0.944|0.861|1.005
Relative|Lip cancer|2015–2019|Females|5|80–84|0.874|0.764|0.967
Relative|Lip cancer|2015–2019|Females|5|85+|0.716|0.582|0.852
Relative|Lip cancer|2015–2019|Females|5|All ages combined|0.925|0.897|0.951
Observed|Lip cancer|2015–2019|Persons|1|00–04|||
Observed|Lip cancer|2015–2019|Persons|1|05–09|||
Observed|Lip cancer|2015–2019|Persons|1|10–14|||
Observed|Lip cancer|2015–2019|Persons|1|15–19|||
Observed|Lip cancer|2015–2019|Persons|1|20–24|||
Observed|Lip cancer|2015–2019|Persons|1|25–29|1|0.892|1
Observed|Lip cancer|2015–2019|Persons|1|30–34|1|0.957|1
Observed|Lip cancer|2015–2019|Persons|1|35–39|1|0.977|1
Observed|Lip cancer|2015–2019|Persons|1|40–44|0.996|0.97|0.999
Observed|Lip cancer|2015–2019|Persons|1|45–49|0.997|0.977|1
Observed|Lip cancer|2015–2019|Persons|1|50–54|0.992|0.975|0.997
Observed|Lip cancer|2015–2019|Persons|1|55–59|0.986|0.969|0.994
Observed|Lip cancer|2015–2019|Persons|1|60–64|0.987|0.971|0.994
Observed|Lip cancer|2015–2019|Persons|1|65–69|0.983|0.967|0.992
Observed|Lip cancer|2015–2019|Persons|1|70–74|0.967|0.946|0.98
Observed|Lip cancer|2015–2019|Persons|1|75–79|0.96|0.937|0.975
Observed|Lip cancer|2015–2019|Persons|1|80–84|0.946|0.916|0.966
Observed|Lip cancer|2015–2019|Persons|1|85+|0.85|0.81|0.881
Observed|Lip cancer|2015–2019|Persons|1|All ages combined|0.967|0.962|0.972
Observed|Lip cancer|2015–2019|Persons|2|00–04|||
Observed|Lip cancer|2015–2019|Persons|2|05–09|||
Observed|Lip cancer|2015–2019|Persons|2|10–14|||
Observed|Lip cancer|2015–2019|Persons|2|15–19|||
Observed|Lip cancer|2015–2019|Persons|2|20–24|||
Observed|Lip cancer|2015–2019|Persons|2|25–29|1|0.909|1
Observed|Lip cancer|2015–2019|Persons|2|30–34|0.988|0.92|0.998
Observed|Lip cancer|2015–2019|Persons|2|35–39|0.992|0.948|0.999
Observed|Lip cancer|2015–2019|Persons|2|40–44|0.984|0.957|0.994
Observed|Lip cancer|2015–2019|Persons|2|45–49|0.98|0.957|0.991
Observed|Lip cancer|2015–2019|Persons|2|50–54|0.989|0.972|0.996
Observed|Lip cancer|2015–2019|Persons|2|55–59|0.961|0.939|0.976
Observed|Lip cancer|2015–2019|Persons|2|60–64|0.961|0.939|0.975
Observed|Lip cancer|2015–2019|Persons|2|65–69|0.951|0.928|0.967
Observed|Lip cancer|2015–2019|Persons|2|70–74|0.928|0.901|0.948
Observed|Lip cancer|2015–2019|Persons|2|75–79|0.925|0.895|0.946
Observed|Lip cancer|2015–2019|Persons|2|80–84|0.874|0.834|0.905
Observed|Lip cancer|2015–2019|Persons|2|85+|0.703|0.655|0.745
Observed|Lip cancer|2015–2019|Persons|2|All ages combined|0.928|0.92|0.936
Observed|Lip cancer|2015–2019|Persons|3|00–04|||
Observed|Lip cancer|2015–2019|Persons|3|05–09|||
Observed|Lip cancer|2015–2019|Persons|3|10–14|||
Observed|Lip cancer|2015–2019|Persons|3|15–19|||
Observed|Lip cancer|2015–2019|Persons|3|20–24|||
Observed|Lip cancer|2015–2019|Persons|3|25–29|1|0.918|1
Observed|Lip cancer|2015–2019|Persons|3|30–34|0.968|0.905|0.99
Observed|Lip cancer|2015–2019|Persons|3|35–39|0.992|0.948|0.999
Observed|Lip cancer|2015–2019|Persons|3|40–44|0.984|0.957|0.994
Observed|Lip cancer|2015–2019|Persons|3|45–49|0.974|0.949|0.987
Observed|Lip cancer|2015–2019|Persons|3|50–54|0.964|0.941|0.978
Observed|Lip cancer|2015–2019|Persons|3|55–59|0.944|0.918|0.962
Observed|Lip cancer|2015–2019|Persons|3|60–64|0.953|0.929|0.969
Observed|Lip cancer|2015–2019|Persons|3|65–69|0.923|0.896|0.943
Observed|Lip cancer|2015–2019|Persons|3|70–74|0.884|0.852|0.909
Observed|Lip cancer|2015–2019|Persons|3|75–79|0.86|0.824|0.889
Observed|Lip cancer|2015–2019|Persons|3|80–84|0.807|0.761|0.844
Observed|Lip cancer|2015–2019|Persons|3|85+|0.579|0.53|0.625
Observed|Lip cancer|2015–2019|Persons|3|All ages combined|0.891|0.881|0.9
Observed|Lip cancer|2015–2019|Persons|4|00–04|||
Observed|Lip cancer|2015–2019|Persons|4|05–09|||
Observed|Lip cancer|2015–2019|Persons|4|10–14|||
Observed|Lip cancer|2015–2019|Persons|4|15–19|||
Observed|Lip cancer|2015–2019|Persons|4|20–24|||
Observed|Lip cancer|2015–2019|Persons|4|25–29|0.961|0.854|0.99
Observed|Lip cancer|2015–2019|Persons|4|30–34|0.968|0.905|0.99
Observed|Lip cancer|2015–2019|Persons|4|35–39|0.992|0.948|0.999
Observed|Lip cancer|2015–2019|Persons|4|40–44|0.98|0.953|0.992
Observed|Lip cancer|2015–2019|Persons|4|45–49|0.971|0.945|0.985
Observed|Lip cancer|2015–2019|Persons|4|50–54|0.946|0.92|0.964
Observed|Lip cancer|2015–2019|Persons|4|55–59|0.934|0.907|0.953
Observed|Lip cancer|2015–2019|Persons|4|60–64|0.937|0.911|0.955
Observed|Lip cancer|2015–2019|Persons|4|65–69|0.898|0.869|0.921
Observed|Lip cancer|2015–2019|Persons|4|70–74|0.854|0.82|0.883
Observed|Lip cancer|2015–2019|Persons|4|75–79|0.825|0.787|0.858
Observed|Lip cancer|2015–2019|Persons|4|80–84|0.729|0.68|0.772
Observed|Lip cancer|2015–2019|Persons|4|85+|0.442|0.394|0.489
Observed|Lip cancer|2015–2019|Persons|4|All ages combined|0.857|0.847|0.867
Observed|Lip cancer|2015–2019|Persons|5|00–04|||
Observed|Lip cancer|2015–2019|Persons|5|05–09|||
Observed|Lip cancer|2015–2019|Persons|5|10–14|||
Observed|Lip cancer|2015–2019|Persons|5|15–19|||
Observed|Lip cancer|2015–2019|Persons|5|20–24|||
Observed|Lip cancer|2015–2019|Persons|5|25–29|0.961|0.854|0.99
Observed|Lip cancer|2015–2019|Persons|5|30–34|0.968|0.905|0.99
Observed|Lip cancer|2015–2019|Persons|5|35–39|0.983|0.946|0.994
Observed|Lip cancer|2015–2019|Persons|5|40–44|0.97|0.94|0.985
Observed|Lip cancer|2015–2019|Persons|5|45–49|0.966|0.939|0.981
Observed|Lip cancer|2015–2019|Persons|5|50–54|0.937|0.909|0.956
Observed|Lip cancer|2015–2019|Persons|5|55–59|0.932|0.904|0.952
Observed|Lip cancer|2015–2019|Persons|5|60–64|0.925|0.898|0.946
Observed|Lip cancer|2015–2019|Persons|5|65–69|0.873|0.842|0.899
Observed|Lip cancer|2015–2019|Persons|5|70–74|0.81|0.773|0.842
Observed|Lip cancer|2015–2019|Persons|5|75–79|0.768|0.727|0.805
Observed|Lip cancer|2015–2019|Persons|5|80–84|0.635|0.583|0.682
Observed|Lip cancer|2015–2019|Persons|5|85+|0.34|0.295|0.384
Observed|Lip cancer|2015–2019|Persons|5|All ages combined|0.824|0.812|0.834
Relative|Lip cancer|2015–2019|Persons|1|00–04|||
Relative|Lip cancer|2015–2019|Persons|1|05–09|||
Relative|Lip cancer|2015–2019|Persons|1|10–14|||
Relative|Lip cancer|2015–2019|Persons|1|15–19|||
Relative|Lip cancer|2015–2019|Persons|1|20–24|||
Relative|Lip cancer|2015–2019|Persons|1|25–29|1.001|0.893|1.001
Relative|Lip cancer|2015–2019|Persons|1|30–34|1.001|0.958|1.001
Relative|Lip cancer|2015–2019|Persons|1|35–39|1.001|0.978|1.001
Relative|Lip cancer|2015–2019|Persons|1|40–44|0.997|0.971|1.001
Relative|Lip cancer|2015–2019|Persons|1|45–49|0.999|0.979|1.002
Relative|Lip cancer|2015–2019|Persons|1|50–54|0.995|0.979|1.001
Relative|Lip cancer|2015–2019|Persons|1|55–59|0.991|0.974|0.998
Relative|Lip cancer|2015–2019|Persons|1|60–64|0.994|0.978|1.001
Relative|Lip cancer|2015–2019|Persons|1|65–69|0.994|0.978|1.003
Relative|Lip cancer|2015–2019|Persons|1|70–74|0.984|0.963|0.997
Relative|Lip cancer|2015–2019|Persons|1|75–79|0.989|0.965|1.005
Relative|Lip cancer|2015–2019|Persons|1|80–84|0.999|0.967|1.019
Relative|Lip cancer|2015–2019|Persons|1|85+|0.974|0.929|1.011
Relative|Lip cancer|2015–2019|Persons|1|All ages combined|0.992|0.986|0.997
Relative|Lip cancer|2015–2019|Persons|2|00–04|||
Relative|Lip cancer|2015–2019|Persons|2|05–09|||
Relative|Lip cancer|2015–2019|Persons|2|10–14|||
Relative|Lip cancer|2015–2019|Persons|2|15–19|||
Relative|Lip cancer|2015–2019|Persons|2|20–24|||
Relative|Lip cancer|2015–2019|Persons|2|25–29|1.001|0.911|1.001
Relative|Lip cancer|2015–2019|Persons|2|30–34|0.99|0.922|1
Relative|Lip cancer|2015–2019|Persons|2|35–39|0.995|0.95|1.001
Relative|Lip cancer|2015–2019|Persons|2|40–44|0.987|0.96|0.997
Relative|Lip cancer|2015–2019|Persons|2|45–49|0.985|0.961|0.996
Relative|Lip cancer|2015–2019|Persons|2|50–54|0.996|0.979|1.003
Relative|Lip cancer|2015–2019|Persons|2|55–59|0.971|0.948|0.986
Relative|Lip cancer|2015–2019|Persons|2|60–64|0.975|0.953|0.99
Relative|Lip cancer|2015–2019|Persons|2|65–69|0.973|0.949|0.989
Relative|Lip cancer|2015–2019|Persons|2|70–74|0.963|0.935|0.984
Relative|Lip cancer|2015–2019|Persons|2|75–79|0.985|0.953|1.008
Relative|Lip cancer|2015–2019|Persons|2|80–84|0.981|0.935|1.016
Relative|Lip cancer|2015–2019|Persons|2|85+|0.937|0.874|0.993
Relative|Lip cancer|2015–2019|Persons|2|All ages combined|0.976|0.967|0.983
Relative|Lip cancer|2015–2019|Persons|3|00–04|||
Relative|Lip cancer|2015–2019|Persons|3|05–09|||
Relative|Lip cancer|2015–2019|Persons|3|10–14|||
Relative|Lip cancer|2015–2019|Persons|3|15–19|||
Relative|Lip cancer|2015–2019|Persons|3|20–24|||
Relative|Lip cancer|2015–2019|Persons|3|25–29|1.002|0.92|1.002
Relative|Lip cancer|2015–2019|Persons|3|30–34|0.971|0.908|0.992
Relative|Lip cancer|2015–2019|Persons|3|35–39|0.996|0.951|1.002
Relative|Lip cancer|2015–2019|Persons|3|40–44|0.988|0.962|0.999
Relative|Lip cancer|2015–2019|Persons|3|45–49|0.981|0.956|0.994
Relative|Lip cancer|2015–2019|Persons|3|50–54|0.974|0.95|0.988
Relative|Lip cancer|2015–2019|Persons|3|55–59|0.959|0.933|0.977
Relative|Lip cancer|2015–2019|Persons|3|60–64|0.975|0.951|0.992
Relative|Lip cancer|2015–2019|Persons|3|65–69|0.957|0.929|0.978
Relative|Lip cancer|2015–2019|Persons|3|70–74|0.937|0.903|0.965
Relative|Lip cancer|2015–2019|Persons|3|75–79|0.951|0.911|0.983
Relative|Lip cancer|2015–2019|Persons|3|80–84|0.969|0.914|1.015
Relative|Lip cancer|2015–2019|Persons|3|85+|0.909|0.831|0.981
Relative|Lip cancer|2015–2019|Persons|3|All ages combined|0.96|0.95|0.97
Relative|Lip cancer|2015–2019|Persons|4|00–04|||
Relative|Lip cancer|2015–2019|Persons|4|05–09|||
Relative|Lip cancer|2015–2019|Persons|4|10–14|||
Relative|Lip cancer|2015–2019|Persons|4|15–19|||
Relative|Lip cancer|2015–2019|Persons|4|20–24|||
Relative|Lip cancer|2015–2019|Persons|4|25–29|0.964|0.856|0.993
Relative|Lip cancer|2015–2019|Persons|4|30–34|0.972|0.908|0.993
Relative|Lip cancer|2015–2019|Persons|4|35–39|0.997|0.952|1.004
Relative|Lip cancer|2015–2019|Persons|4|40–44|0.987|0.959|0.998
Relative|Lip cancer|2015–2019|Persons|4|45–49|0.981|0.955|0.995
Relative|Lip cancer|2015–2019|Persons|4|50–54|0.96|0.933|0.978
Relative|Lip cancer|2015–2019|Persons|4|55–59|0.954|0.927|0.974
Relative|Lip cancer|2015–2019|Persons|4|60–64|0.968|0.941|0.987
Relative|Lip cancer|2015–2019|Persons|4|65–69|0.945|0.914|0.969
Relative|Lip cancer|2015–2019|Persons|4|70–74|0.928|0.891|0.959
Relative|Lip cancer|2015–2019|Persons|4|75–79|0.952|0.907|0.989
Relative|Lip cancer|2015–2019|Persons|4|80–84|0.947|0.883|1.003
Relative|Lip cancer|2015–2019|Persons|4|85+|0.83|0.74|0.917
Relative|Lip cancer|2015–2019|Persons|4|All ages combined|0.949|0.937|0.96
Relative|Lip cancer|2015–2019|Persons|5|00–04|||
Relative|Lip cancer|2015–2019|Persons|5|05–09|||
Relative|Lip cancer|2015–2019|Persons|5|10–14|||
Relative|Lip cancer|2015–2019|Persons|5|15–19|||
Relative|Lip cancer|2015–2019|Persons|5|20–24|||
Relative|Lip cancer|2015–2019|Persons|5|25–29|0.965|0.857|0.994
Relative|Lip cancer|2015–2019|Persons|5|30–34|0.973|0.909|0.994
Relative|Lip cancer|2015–2019|Persons|5|35–39|0.989|0.952|1.001
Relative|Lip cancer|2015–2019|Persons|5|40–44|0.978|0.948|0.993
Relative|Lip cancer|2015–2019|Persons|5|45–49|0.978|0.951|0.994
Relative|Lip cancer|2015–2019|Persons|5|50–54|0.955|0.927|0.975
Relative|Lip cancer|2015–2019|Persons|5|55–59|0.959|0.931|0.979
Relative|Lip cancer|2015–2019|Persons|5|60–64|0.966|0.937|0.987
Relative|Lip cancer|2015–2019|Persons|5|65–69|0.933|0.9|0.961
Relative|Lip cancer|2015–2019|Persons|5|70–74|0.905|0.863|0.94
Relative|Lip cancer|2015–2019|Persons|5|75–79|0.929|0.878|0.972
Relative|Lip cancer|2015–2019|Persons|5|80–84|0.9|0.827|0.966
Relative|Lip cancer|2015–2019|Persons|5|85+|0.771|0.671|0.873
Relative|Lip cancer|2015–2019|Persons|5|All ages combined|0.935|0.922|0.947
Observed|Liver cancer|2015–2019|Males|1|00–04|0.957|0.733|0.994
Observed|Liver cancer|2015–2019|Males|1|05–09|||
Observed|Liver cancer|2015–2019|Males|1|10–14|||
Observed|Liver cancer|2015–2019|Males|1|15–19|||
Observed|Liver cancer|2015–2019|Males|1|20–24|||
Observed|Liver cancer|2015–2019|Males|1|25–29|||
Observed|Liver cancer|2015–2019|Males|1|30–34|0.642|0.427|0.794
Observed|Liver cancer|2015–2019|Males|1|35–39|0.709|0.552|0.819
Observed|Liver cancer|2015–2019|Males|1|40–44|0.638|0.519|0.735
Observed|Liver cancer|2015–2019|Males|1|45–49|0.578|0.513|0.638
Observed|Liver cancer|2015–2019|Males|1|50–54|0.572|0.532|0.61
Observed|Liver cancer|2015–2019|Males|1|55–59|0.577|0.549|0.605
Observed|Liver cancer|2015–2019|Males|1|60–64|0.551|0.524|0.577
Observed|Liver cancer|2015–2019|Males|1|65–69|0.54|0.512|0.568
Observed|Liver cancer|2015–2019|Males|1|70–74|0.492|0.461|0.521
Observed|Liver cancer|2015–2019|Males|1|75–79|0.469|0.435|0.502
Observed|Liver cancer|2015–2019|Males|1|80–84|0.352|0.315|0.39
Observed|Liver cancer|2015–2019|Males|1|85+|0.192|0.16|0.226
Observed|Liver cancer|2015–2019|Males|1|All ages combined|0.506|0.494|0.517
Observed|Liver cancer|2015–2019|Males|2|00–04|0.92|0.717|0.98
Observed|Liver cancer|2015–2019|Males|2|05–09|||
Observed|Liver cancer|2015–2019|Males|2|10–14|||
Observed|Liver cancer|2015–2019|Males|2|15–19|||
Observed|Liver cancer|2015–2019|Males|2|20–24|||
Observed|Liver cancer|2015–2019|Males|2|25–29|||
Observed|Liver cancer|2015–2019|Males|2|30–34|||
Observed|Liver cancer|2015–2019|Males|2|35–39|0.615|0.456|0.74
Observed|Liver cancer|2015–2019|Males|2|40–44|0.53|0.414|0.633
Observed|Liver cancer|2015–2019|Males|2|45–49|0.466|0.402|0.526
Observed|Liver cancer|2015–2019|Males|2|50–54|0.455|0.416|0.493
Observed|Liver cancer|2015–2019|Males|2|55–59|0.445|0.417|0.473
Observed|Liver cancer|2015–2019|Males|2|60–64|0.43|0.403|0.456
Observed|Liver cancer|2015–2019|Males|2|65–69|0.398|0.371|0.426
Observed|Liver cancer|2015–2019|Males|2|70–74|0.354|0.325|0.383
Observed|Liver cancer|2015–2019|Males|2|75–79|0.319|0.288|0.35
Observed|Liver cancer|2015–2019|Males|2|80–84|0.204|0.174|0.235
Observed|Liver cancer|2015–2019|Males|2|85+|0.095|0.072|0.121
Observed|Liver cancer|2015–2019|Males|2|All ages combined|0.374|0.364|0.385
Observed|Liver cancer|2015–2019|Males|3|00–04|0.849|0.647|0.941
Observed|Liver cancer|2015–2019|Males|3|05–09|||
Observed|Liver cancer|2015–2019|Males|3|10–14|||
Observed|Liver cancer|2015–2019|Males|3|15–19|||
Observed|Liver cancer|2015–2019|Males|3|20–24|||
Observed|Liver cancer|2015–2019|Males|3|25–29|||
Observed|Liver cancer|2015–2019|Males|3|30–34|||
Observed|Liver cancer|2015–2019|Males|3|35–39|0.561|0.4|0.694
Observed|Liver cancer|2015–2019|Males|3|40–44|0.453|0.343|0.557
Observed|Liver cancer|2015–2019|Males|3|45–49|0.373|0.314|0.433
Observed|Liver cancer|2015–2019|Males|3|50–54|0.385|0.348|0.423
Observed|Liver cancer|2015–2019|Males|3|55–59|0.368|0.341|0.395
Observed|Liver cancer|2015–2019|Males|3|60–64|0.338|0.312|0.363
Observed|Liver cancer|2015–2019|Males|3|65–69|0.312|0.285|0.339
Observed|Liver cancer|2015–2019|Males|3|70–74|0.267|0.241|0.295
Observed|Liver cancer|2015–2019|Males|3|75–79|0.231|0.203|0.261
Observed|Liver cancer|2015–2019|Males|3|80–84|0.145|0.12|0.174
Observed|Liver cancer|2015–2019|Males|3|85+|0.06|0.042|0.081
Observed|Liver cancer|2015–2019|Males|3|All ages combined|0.296|0.285|0.306
Observed|Liver cancer|2015–2019|Males|4|00–04|0.817|0.615|0.919
Observed|Liver cancer|2015–2019|Males|4|05–09|||
Observed|Liver cancer|2015–2019|Males|4|10–14|||
Observed|Liver cancer|2015–2019|Males|4|15–19|||
Observed|Liver cancer|2015–2019|Males|4|20–24|||
Observed|Liver cancer|2015–2019|Males|4|25–29|||
Observed|Liver cancer|2015–2019|Males|4|30–34|||
Observed|Liver cancer|2015–2019|Males|4|35–39|||
Observed|Liver cancer|2015–2019|Males|4|40–44|0.397|0.292|0.5
Observed|Liver cancer|2015–2019|Males|4|45–49|0.334|0.277|0.393
Observed|Liver cancer|2015–2019|Males|4|50–54|0.329|0.294|0.365
Observed|Liver cancer|2015–2019|Males|4|55–59|0.315|0.29|0.342
Observed|Liver cancer|2015–2019|Males|4|60–64|0.28|0.254|0.305
Observed|Liver cancer|2015–2019|Males|4|65–69|0.266|0.24|0.293
Observed|Liver cancer|2015–2019|Males|4|70–74|0.209|0.184|0.235
Observed|Liver cancer|2015–2019|Males|4|75–79|0.173|0.147|0.2
Observed|Liver cancer|2015–2019|Males|4|80–84|0.096|0.074|0.12
Observed|Liver cancer|2015–2019|Males|4|85+|0.047|0.031|0.067
Observed|Liver cancer|2015–2019|Males|4|All ages combined|0.246|0.236|0.255
Observed|Liver cancer|2015–2019|Males|5|00–04|0.817|0.615|0.919
Observed|Liver cancer|2015–2019|Males|5|05–09|||
Observed|Liver cancer|2015–2019|Males|5|10–14|||
Observed|Liver cancer|2015–2019|Males|5|15–19|||
Observed|Liver cancer|2015–2019|Males|5|20–24|||
Observed|Liver cancer|2015–2019|Males|5|25–29|||
Observed|Liver cancer|2015–2019|Males|5|30–34|||
Observed|Liver cancer|2015–2019|Males|5|35–39|||
Observed|Liver cancer|2015–2019|Males|5|40–44|0.387|0.284|0.49
Observed|Liver cancer|2015–2019|Males|5|45–49|0.301|0.245|0.357
Observed|Liver cancer|2015–2019|Males|5|50–54|0.296|0.262|0.331
Observed|Liver cancer|2015–2019|Males|5|55–59|0.283|0.258|0.309
Observed|Liver cancer|2015–2019|Males|5|60–64|0.243|0.218|0.268
Observed|Liver cancer|2015–2019|Males|5|65–69|0.213|0.188|0.24
Observed|Liver cancer|2015–2019|Males|5|70–74|0.162|0.139|0.187
Observed|Liver cancer|2015–2019|Males|5|75–79|0.14|0.116|0.166
Observed|Liver cancer|2015–2019|Males|5|80–84|0.068|0.05|0.091
Observed|Liver cancer|2015–2019|Males|5|85+|0.034|0.021|0.053
Observed|Liver cancer|2015–2019|Males|5|All ages combined|0.211|0.202|0.221
Relative|Liver cancer|2015–2019|Males|1|00–04|0.958|0.734|0.995
Relative|Liver cancer|2015–2019|Males|1|05–09|||
Relative|Liver cancer|2015–2019|Males|1|10–14|||
Relative|Liver cancer|2015–2019|Males|1|15–19|||
Relative|Liver cancer|2015–2019|Males|1|20–24|||
Relative|Liver cancer|2015–2019|Males|1|25–29|||
Relative|Liver cancer|2015–2019|Males|1|30–34|0.643|0.428|0.795
Relative|Liver cancer|2015–2019|Males|1|35–39|0.709|0.553|0.82
Relative|Liver cancer|2015–2019|Males|1|40–44|0.639|0.52|0.736
Relative|Liver cancer|2015–2019|Males|1|45–49|0.58|0.514|0.64
Relative|Liver cancer|2015–2019|Males|1|50–54|0.574|0.534|0.612
Relative|Liver cancer|2015–2019|Males|1|55–59|0.58|0.552|0.608
Relative|Liver cancer|2015–2019|Males|1|60–64|0.556|0.529|0.582
Relative|Liver cancer|2015–2019|Males|1|65–69|0.547|0.518|0.575
Relative|Liver cancer|2015–2019|Males|1|70–74|0.501|0.47|0.532
Relative|Liver cancer|2015–2019|Males|1|75–79|0.485|0.45|0.519
Relative|Liver cancer|2015–2019|Males|1|80–84|0.374|0.335|0.413
Relative|Liver cancer|2015–2019|Males|1|85+|0.22|0.184|0.259
Relative|Liver cancer|2015–2019|Males|1|All ages combined|0.517|0.506|0.528
Relative|Liver cancer|2015–2019|Males|2|00–04|0.921|0.718|0.981
Relative|Liver cancer|2015–2019|Males|2|05–09|||
Relative|Liver cancer|2015–2019|Males|2|10–14|||
Relative|Liver cancer|2015–2019|Males|2|15–19|||
Relative|Liver cancer|2015–2019|Males|2|20–24|||
Relative|Liver cancer|2015–2019|Males|2|25–29|||
Relative|Liver cancer|2015–2019|Males|2|30–34|||
Relative|Liver cancer|2015–2019|Males|2|35–39|0.616|0.457|0.742
Relative|Liver cancer|2015–2019|Males|2|40–44|0.532|0.416|0.635
Relative|Liver cancer|2015–2019|Males|2|45–49|0.468|0.404|0.529
Relative|Liver cancer|2015–2019|Males|2|50–54|0.459|0.419|0.497
Relative|Liver cancer|2015–2019|Males|2|55–59|0.45|0.422|0.478
Relative|Liver cancer|2015–2019|Males|2|60–64|0.437|0.41|0.464
Relative|Liver cancer|2015–2019|Males|2|65–69|0.409|0.38|0.437
Relative|Liver cancer|2015–2019|Males|2|70–74|0.369|0.339|0.399
Relative|Liver cancer|2015–2019|Males|2|75–79|0.342|0.309|0.376
Relative|Liver cancer|2015–2019|Males|2|80–84|0.231|0.197|0.267
Relative|Liver cancer|2015–2019|Males|2|85+|0.125|0.095|0.16
Relative|Liver cancer|2015–2019|Males|2|All ages combined|0.39|0.379|0.401
Relative|Liver cancer|2015–2019|Males|3|00–04|0.85|0.648|0.942
Relative|Liver cancer|2015–2019|Males|3|05–09|||
Relative|Liver cancer|2015–2019|Males|3|10–14|||
Relative|Liver cancer|2015–2019|Males|3|15–19|||
Relative|Liver cancer|2015–2019|Males|3|20–24|||
Relative|Liver cancer|2015–2019|Males|3|25–29|||
Relative|Liver cancer|2015–2019|Males|3|30–34|||
Relative|Liver cancer|2015–2019|Males|3|35–39|0.563|0.401|0.696
Relative|Liver cancer|2015–2019|Males|3|40–44|0.455|0.345|0.56
Relative|Liver cancer|2015–2019|Males|3|45–49|0.376|0.316|0.436
Relative|Liver cancer|2015–2019|Males|3|50–54|0.39|0.352|0.428
Relative|Liver cancer|2015–2019|Males|3|55–59|0.375|0.347|0.402
Relative|Liver cancer|2015–2019|Males|3|60–64|0.346|0.32|0.373
Relative|Liver cancer|2015–2019|Males|3|65–69|0.324|0.297|0.352
Relative|Liver cancer|2015–2019|Males|3|70–74|0.285|0.257|0.314
Relative|Liver cancer|2015–2019|Males|3|75–79|0.259|0.227|0.291
Relative|Liver cancer|2015–2019|Males|3|80–84|0.178|0.146|0.212
Relative|Liver cancer|2015–2019|Males|3|85+|0.091|0.064|0.124
Relative|Liver cancer|2015–2019|Males|3|All ages combined|0.314|0.303|0.324
Relative|Liver cancer|2015–2019|Males|4|00–04|0.818|0.616|0.921
Relative|Liver cancer|2015–2019|Males|4|05–09|||
Relative|Liver cancer|2015–2019|Males|4|10–14|||
Relative|Liver cancer|2015–2019|Males|4|15–19|||
Relative|Liver cancer|2015–2019|Males|4|20–24|||
Relative|Liver cancer|2015–2019|Males|4|25–29|||
Relative|Liver cancer|2015–2019|Males|4|30–34|||
Relative|Liver cancer|2015–2019|Males|4|35–39|||
Relative|Liver cancer|2015–2019|Males|4|40–44|0.4|0.295|0.504
Relative|Liver cancer|2015–2019|Males|4|45–49|0.338|0.28|0.397
Relative|Liver cancer|2015–2019|Males|4|50–54|0.335|0.299|0.371
Relative|Liver cancer|2015–2019|Males|4|55–59|0.323|0.297|0.35
Relative|Liver cancer|2015–2019|Males|4|60–64|0.29|0.264|0.316
Relative|Liver cancer|2015–2019|Males|4|65–69|0.281|0.254|0.309
Relative|Liver cancer|2015–2019|Males|4|70–74|0.229|0.202|0.258
Relative|Liver cancer|2015–2019|Males|4|75–79|0.202|0.172|0.235
Relative|Liver cancer|2015–2019|Males|4|80–84|0.128|0.099|0.16
Relative|Liver cancer|2015–2019|Males|4|85+|0.084|0.056|0.121
Relative|Liver cancer|2015–2019|Males|4|All ages combined|0.266|0.255|0.276
Relative|Liver cancer|2015–2019|Males|5|00–04|0.818|0.616|0.921
Relative|Liver cancer|2015–2019|Males|5|05–09|||
Relative|Liver cancer|2015–2019|Males|5|10–14|||
Relative|Liver cancer|2015–2019|Males|5|15–19|||
Relative|Liver cancer|2015–2019|Males|5|20–24|||
Relative|Liver cancer|2015–2019|Males|5|25–29|||
Relative|Liver cancer|2015–2019|Males|5|30–34|||
Relative|Liver cancer|2015–2019|Males|5|35–39|||
Relative|Liver cancer|2015–2019|Males|5|40–44|0.391|0.286|0.494
Relative|Liver cancer|2015–2019|Males|5|45–49|0.305|0.249|0.363
Relative|Liver cancer|2015–2019|Males|5|50–54|0.303|0.268|0.338
Relative|Liver cancer|2015–2019|Males|5|55–59|0.292|0.266|0.319
Relative|Liver cancer|2015–2019|Males|5|60–64|0.254|0.228|0.281
Relative|Liver cancer|2015–2019|Males|5|65–69|0.229|0.202|0.258
Relative|Liver cancer|2015–2019|Males|5|70–74|0.183|0.157|0.211
Relative|Liver cancer|2015–2019|Males|5|75–79|0.173|0.143|0.206
Relative|Liver cancer|2015–2019|Males|5|80–84|0.101|0.074|0.133
Relative|Liver cancer|2015–2019|Males|5|85+|0.074|0.045|0.114
Relative|Liver cancer|2015–2019|Males|5|All ages combined|0.233|0.223|0.243
Observed|Liver cancer|2015–2019|Females|1|00–04|||
Observed|Liver cancer|2015–2019|Females|1|05–09|||
Observed|Liver cancer|2015–2019|Females|1|10–14|||
Observed|Liver cancer|2015–2019|Females|1|15–19|||
Observed|Liver cancer|2015–2019|Females|1|20–24|||
Observed|Liver cancer|2015–2019|Females|1|25–29|||
Observed|Liver cancer|2015–2019|Females|1|30–34|||
Observed|Liver cancer|2015–2019|Females|1|35–39|||
Observed|Liver cancer|2015–2019|Females|1|40–44|0.536|0.391|0.661
Observed|Liver cancer|2015–2019|Females|1|45–49|0.651|0.539|0.742
Observed|Liver cancer|2015–2019|Females|1|50–54|0.585|0.505|0.656
Observed|Liver cancer|2015–2019|Females|1|55–59|0.648|0.592|0.698
Observed|Liver cancer|2015–2019|Females|1|60–64|0.59|0.536|0.639
Observed|Liver cancer|2015–2019|Females|1|65–69|0.504|0.451|0.554
Observed|Liver cancer|2015–2019|Females|1|70–74|0.525|0.471|0.576
Observed|Liver cancer|2015–2019|Females|1|75–79|0.402|0.354|0.45
Observed|Liver cancer|2015–2019|Females|1|80–84|0.304|0.256|0.352
Observed|Liver cancer|2015–2019|Females|1|85+|0.191|0.155|0.229
Observed|Liver cancer|2015–2019|Females|1|All ages combined|0.47|0.451|0.488
Observed|Liver cancer|2015–2019|Females|2|00–04|||
Observed|Liver cancer|2015–2019|Females|2|05–09|||
Observed|Liver cancer|2015–2019|Females|2|10–14|||
Observed|Liver cancer|2015–2019|Females|2|15–19|||
Observed|Liver cancer|2015–2019|Females|2|20–24|||
Observed|Liver cancer|2015–2019|Females|2|25–29|||
Observed|Liver cancer|2015–2019|Females|2|30–34|||
Observed|Liver cancer|2015–2019|Females|2|35–39|||
Observed|Liver cancer|2015–2019|Females|2|40–44|0.431|0.293|0.562
Observed|Liver cancer|2015–2019|Females|2|45–49|0.494|0.379|0.6
Observed|Liver cancer|2015–2019|Females|2|50–54|0.439|0.363|0.513
Observed|Liver cancer|2015–2019|Females|2|55–59|0.49|0.433|0.544
Observed|Liver cancer|2015–2019|Females|2|60–64|0.47|0.417|0.522
Observed|Liver cancer|2015–2019|Females|2|65–69|0.371|0.32|0.422
Observed|Liver cancer|2015–2019|Females|2|70–74|0.4|0.349|0.451
Observed|Liver cancer|2015–2019|Females|2|75–79|0.253|0.212|0.297
Observed|Liver cancer|2015–2019|Females|2|80–84|0.2|0.16|0.243
Observed|Liver cancer|2015–2019|Females|2|85+|0.097|0.072|0.126
Observed|Liver cancer|2015–2019|Females|2|All ages combined|0.341|0.323|0.358
Observed|Liver cancer|2015–2019|Females|3|00–04|||
Observed|Liver cancer|2015–2019|Females|3|05–09|||
Observed|Liver cancer|2015–2019|Females|3|10–14|||
Observed|Liver cancer|2015–2019|Females|3|15–19|||
Observed|Liver cancer|2015–2019|Females|3|20–24|||
Observed|Liver cancer|2015–2019|Females|3|25–29|||
Observed|Liver cancer|2015–2019|Females|3|30–34|||
Observed|Liver cancer|2015–2019|Females|3|35–39|||
Observed|Liver cancer|2015–2019|Females|3|40–44|||
Observed|Liver cancer|2015–2019|Females|3|45–49|0.418|0.305|0.527
Observed|Liver cancer|2015–2019|Females|3|50–54|0.38|0.306|0.452
Observed|Liver cancer|2015–2019|Females|3|55–59|0.376|0.319|0.432
Observed|Liver cancer|2015–2019|Females|3|60–64|0.356|0.304|0.408
Observed|Liver cancer|2015–2019|Females|3|65–69|0.274|0.227|0.323
Observed|Liver cancer|2015–2019|Females|3|70–74|0.289|0.241|0.338
Observed|Liver cancer|2015–2019|Females|3|75–79|0.189|0.152|0.23
Observed|Liver cancer|2015–2019|Females|3|80–84|0.147|0.112|0.186
Observed|Liver cancer|2015–2019|Females|3|85+|0.071|0.05|0.098
Observed|Liver cancer|2015–2019|Females|3|All ages combined|0.263|0.247|0.28
Observed|Liver cancer|2015–2019|Females|4|00–04|||
Observed|Liver cancer|2015–2019|Females|4|05–09|||
Observed|Liver cancer|2015–2019|Females|4|10–14|||
Observed|Liver cancer|2015–2019|Females|4|15–19|||
Observed|Liver cancer|2015–2019|Females|4|20–24|||
Observed|Liver cancer|2015–2019|Females|4|25–29|||
Observed|Liver cancer|2015–2019|Females|4|30–34|||
Observed|Liver cancer|2015–2019|Females|4|35–39|||
Observed|Liver cancer|2015–2019|Females|4|40–44|||
Observed|Liver cancer|2015–2019|Females|4|45–49|0.387|0.276|0.497
Observed|Liver cancer|2015–2019|Females|4|50–54|0.32|0.25|0.392
Observed|Liver cancer|2015–2019|Females|4|55–59|0.332|0.275|0.389
Observed|Liver cancer|2015–2019|Females|4|60–64|0.325|0.273|0.377
Observed|Liver cancer|2015–2019|Females|4|65–69|0.239|0.194|0.287
Observed|Liver cancer|2015–2019|Females|4|70–74|0.23|0.185|0.278
Observed|Liver cancer|2015–2019|Females|4|75–79|0.129|0.097|0.166
Observed|Liver cancer|2015–2019|Females|4|80–84|0.111|0.08|0.147
Observed|Liver cancer|2015–2019|Females|4|85+|0.035|0.019|0.056
Observed|Liver cancer|2015–2019|Females|4|All ages combined|0.219|0.203|0.235
Observed|Liver cancer|2015–2019|Females|5|00–04|||
Observed|Liver cancer|2015–2019|Females|5|05–09|||
Observed|Liver cancer|2015–2019|Females|5|10–14|||
Observed|Liver cancer|2015–2019|Females|5|15–19|||
Observed|Liver cancer|2015–2019|Females|5|20–24|||
Observed|Liver cancer|2015–2019|Females|5|25–29|||
Observed|Liver cancer|2015–2019|Females|5|30–34|||
Observed|Liver cancer|2015–2019|Females|5|35–39|||
Observed|Liver cancer|2015–2019|Females|5|40–44|||
Observed|Liver cancer|2015–2019|Females|5|45–49|0.387|0.276|0.497
Observed|Liver cancer|2015–2019|Females|5|50–54|0.292|0.224|0.364
Observed|Liver cancer|2015–2019|Females|5|55–59|0.292|0.237|0.35
Observed|Liver cancer|2015–2019|Females|5|60–64|0.293|0.242|0.345
Observed|Liver cancer|2015–2019|Females|5|65–69|0.223|0.178|0.27
Observed|Liver cancer|2015–2019|Females|5|70–74|0.193|0.151|0.239
Observed|Liver cancer|2015–2019|Females|5|75–79|0.112|0.082|0.148
Observed|Liver cancer|2015–2019|Females|5|80–84|0.1|0.07|0.135
Observed|Liver cancer|2015–2019|Females|5|85+|0.027|0.014|0.047
Observed|Liver cancer|2015–2019|Females|5|All ages combined|0.197|0.182|0.213
Relative|Liver cancer|2015–2019|Females|1|00–04|||
Relative|Liver cancer|2015–2019|Females|1|05–09|||
Relative|Liver cancer|2015–2019|Females|1|10–14|||
Relative|Liver cancer|2015–2019|Females|1|15–19|||
Relative|Liver cancer|2015–2019|Females|1|20–24|||
Relative|Liver cancer|2015–2019|Females|1|25–29|||
Relative|Liver cancer|2015–2019|Females|1|30–34|||
Relative|Liver cancer|2015–2019|Females|1|35–39|||
Relative|Liver cancer|2015–2019|Females|1|40–44|0.537|0.392|0.661
Relative|Liver cancer|2015–2019|Females|1|45–49|0.652|0.54|0.743
Relative|Liver cancer|2015–2019|Females|1|50–54|0.586|0.506|0.657
Relative|Liver cancer|2015–2019|Females|1|55–59|0.65|0.594|0.7
Relative|Liver cancer|2015–2019|Females|1|60–64|0.592|0.538|0.642
Relative|Liver cancer|2015–2019|Females|1|65–69|0.507|0.454|0.558
Relative|Liver cancer|2015–2019|Females|1|70–74|0.531|0.477|0.583
Relative|Liver cancer|2015–2019|Females|1|75–79|0.411|0.361|0.46
Relative|Liver cancer|2015–2019|Females|1|80–84|0.317|0.267|0.367
Relative|Liver cancer|2015–2019|Females|1|85+|0.213|0.173|0.256
Relative|Liver cancer|2015–2019|Females|1|All ages combined|0.482|0.463|0.5
Relative|Liver cancer|2015–2019|Females|2|00–04|||
Relative|Liver cancer|2015–2019|Females|2|05–09|||
Relative|Liver cancer|2015–2019|Females|2|10–14|||
Relative|Liver cancer|2015–2019|Females|2|15–19|||
Relative|Liver cancer|2015–2019|Females|2|20–24|||
Relative|Liver cancer|2015–2019|Females|2|25–29|||
Relative|Liver cancer|2015–2019|Females|2|30–34|||
Relative|Liver cancer|2015–2019|Females|2|35–39|||
Relative|Liver cancer|2015–2019|Females|2|40–44|0.432|0.293|0.563
Relative|Liver cancer|2015–2019|Females|2|45–49|0.496|0.38|0.601
Relative|Liver cancer|2015–2019|Females|2|50–54|0.441|0.365|0.515
Relative|Liver cancer|2015–2019|Females|2|55–59|0.493|0.435|0.548
Relative|Liver cancer|2015–2019|Females|2|60–64|0.475|0.421|0.527
Relative|Liver cancer|2015–2019|Females|2|65–69|0.377|0.325|0.428
Relative|Liver cancer|2015–2019|Females|2|70–74|0.411|0.358|0.463
Relative|Liver cancer|2015–2019|Females|2|75–79|0.266|0.222|0.312
Relative|Liver cancer|2015–2019|Females|2|80–84|0.219|0.175|0.266
Relative|Liver cancer|2015–2019|Females|2|85+|0.121|0.09|0.158
Relative|Liver cancer|2015–2019|Females|2|All ages combined|0.356|0.338|0.374
Relative|Liver cancer|2015–2019|Females|3|00–04|||
Relative|Liver cancer|2015–2019|Females|3|05–09|||
Relative|Liver cancer|2015–2019|Females|3|10–14|||
Relative|Liver cancer|2015–2019|Females|3|15–19|||
Relative|Liver cancer|2015–2019|Females|3|20–24|||
Relative|Liver cancer|2015–2019|Females|3|25–29|||
Relative|Liver cancer|2015–2019|Females|3|30–34|||
Relative|Liver cancer|2015–2019|Females|3|35–39|||
Relative|Liver cancer|2015–2019|Females|3|40–44|||
Relative|Liver cancer|2015–2019|Females|3|45–49|0.42|0.306|0.53
Relative|Liver cancer|2015–2019|Females|3|50–54|0.382|0.308|0.456
Relative|Liver cancer|2015–2019|Females|3|55–59|0.38|0.323|0.437
Relative|Liver cancer|2015–2019|Females|3|60–64|0.362|0.309|0.414
Relative|Liver cancer|2015–2019|Females|3|65–69|0.281|0.233|0.331
Relative|Liver cancer|2015–2019|Females|3|70–74|0.301|0.251|0.352
Relative|Liver cancer|2015–2019|Females|3|75–79|0.204|0.163|0.248
Relative|Liver cancer|2015–2019|Females|3|80–84|0.17|0.13|0.215
Relative|Liver cancer|2015–2019|Females|3|85+|0.101|0.071|0.139
Relative|Liver cancer|2015–2019|Females|3|All ages combined|0.28|0.262|0.297
Relative|Liver cancer|2015–2019|Females|4|00–04|||
Relative|Liver cancer|2015–2019|Females|4|05–09|||
Relative|Liver cancer|2015–2019|Females|4|10–14|||
Relative|Liver cancer|2015–2019|Females|4|15–19|||
Relative|Liver cancer|2015–2019|Females|4|20–24|||
Relative|Liver cancer|2015–2019|Females|4|25–29|||
Relative|Liver cancer|2015–2019|Females|4|30–34|||
Relative|Liver cancer|2015–2019|Females|4|35–39|||
Relative|Liver cancer|2015–2019|Females|4|40–44|||
Relative|Liver cancer|2015–2019|Females|4|45–49|0.389|0.277|0.5
Relative|Liver cancer|2015–2019|Females|4|50–54|0.324|0.253|0.396
Relative|Liver cancer|2015–2019|Females|4|55–59|0.336|0.279|0.394
Relative|Liver cancer|2015–2019|Females|4|60–64|0.331|0.279|0.385
Relative|Liver cancer|2015–2019|Females|4|65–69|0.247|0.201|0.297
Relative|Liver cancer|2015–2019|Females|4|70–74|0.244|0.197|0.295
Relative|Liver cancer|2015–2019|Females|4|75–79|0.144|0.108|0.184
Relative|Liver cancer|2015–2019|Females|4|80–84|0.137|0.099|0.181
Relative|Liver cancer|2015–2019|Females|4|85+|0.057|0.032|0.093
Relative|Liver cancer|2015–2019|Females|4|All ages combined|0.237|0.22|0.255
Relative|Liver cancer|2015–2019|Females|5|00–04|||
Relative|Liver cancer|2015–2019|Females|5|05–09|||
Relative|Liver cancer|2015–2019|Females|5|10–14|||
Relative|Liver cancer|2015–2019|Females|5|15–19|||
Relative|Liver cancer|2015–2019|Females|5|20–24|||
Relative|Liver cancer|2015–2019|Females|5|25–29|||
Relative|Liver cancer|2015–2019|Females|5|30–34|||
Relative|Liver cancer|2015–2019|Females|5|35–39|||
Relative|Liver cancer|2015–2019|Females|5|40–44|||
Relative|Liver cancer|2015–2019|Females|5|45–49|0.39|0.278|0.501
Relative|Liver cancer|2015–2019|Females|5|50–54|0.296|0.227|0.368
Relative|Liver cancer|2015–2019|Females|5|55–59|0.298|0.241|0.357
Relative|Liver cancer|2015–2019|Females|5|60–64|0.301|0.249|0.355
Relative|Liver cancer|2015–2019|Females|5|65–69|0.233|0.186|0.282
Relative|Liver cancer|2015–2019|Females|5|70–74|0.209|0.163|0.259
Relative|Liver cancer|2015–2019|Females|5|75–79|0.129|0.094|0.17
Relative|Liver cancer|2015–2019|Females|5|80–84|0.132|0.093|0.178
Relative|Liver cancer|2015–2019|Females|5|85+|0.054|0.028|0.094
Relative|Liver cancer|2015–2019|Females|5|All ages combined|0.217|0.2|0.234
Observed|Liver cancer|2015–2019|Persons|1|00–04|0.941|0.786|0.985
Observed|Liver cancer|2015–2019|Persons|1|05–09|||
Observed|Liver cancer|2015–2019|Persons|1|10–14|||
Observed|Liver cancer|2015–2019|Persons|1|15–19|||
Observed|Liver cancer|2015–2019|Persons|1|20–24|||
Observed|Liver cancer|2015–2019|Persons|1|25–29|||
Observed|Liver cancer|2015–2019|Persons|1|30–34|0.655|0.489|0.778
Observed|Liver cancer|2015–2019|Persons|1|35–39|0.657|0.531|0.756
Observed|Liver cancer|2015–2019|Persons|1|40–44|0.597|0.507|0.677
Observed|Liver cancer|2015–2019|Persons|1|45–49|0.597|0.542|0.649
Observed|Liver cancer|2015–2019|Persons|1|50–54|0.575|0.539|0.609
Observed|Liver cancer|2015–2019|Persons|1|55–59|0.592|0.567|0.616
Observed|Liver cancer|2015–2019|Persons|1|60–64|0.559|0.535|0.582
Observed|Liver cancer|2015–2019|Persons|1|65–69|0.532|0.507|0.556
Observed|Liver cancer|2015–2019|Persons|1|70–74|0.5|0.473|0.526
Observed|Liver cancer|2015–2019|Persons|1|75–79|0.448|0.42|0.475
Observed|Liver cancer|2015–2019|Persons|1|80–84|0.335|0.306|0.365
Observed|Liver cancer|2015–2019|Persons|1|85+|0.191|0.167|0.217
Observed|Liver cancer|2015–2019|Persons|1|All ages combined|0.496|0.487|0.506
Observed|Liver cancer|2015–2019|Persons|2|00–04|0.916|0.762|0.972
Observed|Liver cancer|2015–2019|Persons|2|05–09|||
Observed|Liver cancer|2015–2019|Persons|2|10–14|||
Observed|Liver cancer|2015–2019|Persons|2|15–19|||
Observed|Liver cancer|2015–2019|Persons|2|20–24|||
Observed|Liver cancer|2015–2019|Persons|2|25–29|||
Observed|Liver cancer|2015–2019|Persons|2|30–34|0.572|0.404|0.708
Observed|Liver cancer|2015–2019|Persons|2|35–39|0.545|0.418|0.656
Observed|Liver cancer|2015–2019|Persons|2|40–44|0.491|0.402|0.574
Observed|Liver cancer|2015–2019|Persons|2|45–49|0.475|0.42|0.528
Observed|Liver cancer|2015–2019|Persons|2|50–54|0.452|0.417|0.486
Observed|Liver cancer|2015–2019|Persons|2|55–59|0.455|0.43|0.479
Observed|Liver cancer|2015–2019|Persons|2|60–64|0.438|0.414|0.462
Observed|Liver cancer|2015–2019|Persons|2|65–69|0.392|0.368|0.416
Observed|Liver cancer|2015–2019|Persons|2|70–74|0.365|0.34|0.39
Observed|Liver cancer|2015–2019|Persons|2|75–79|0.298|0.273|0.324
Observed|Liver cancer|2015–2019|Persons|2|80–84|0.202|0.178|0.227
Observed|Liver cancer|2015–2019|Persons|2|85+|0.096|0.078|0.115
Observed|Liver cancer|2015–2019|Persons|2|All ages combined|0.366|0.356|0.375
Observed|Liver cancer|2015–2019|Persons|3|00–04|0.87|0.714|0.944
Observed|Liver cancer|2015–2019|Persons|3|05–09|||
Observed|Liver cancer|2015–2019|Persons|3|10–14|||
Observed|Liver cancer|2015–2019|Persons|3|15–19|||
Observed|Liver cancer|2015–2019|Persons|3|20–24|||
Observed|Liver cancer|2015–2019|Persons|3|25–29|||
Observed|Liver cancer|2015–2019|Persons|3|30–34|||
Observed|Liver cancer|2015–2019|Persons|3|35–39|0.514|0.387|0.626
Observed|Liver cancer|2015–2019|Persons|3|40–44|0.425|0.339|0.508
Observed|Liver cancer|2015–2019|Persons|3|45–49|0.385|0.332|0.438
Observed|Liver cancer|2015–2019|Persons|3|50–54|0.384|0.351|0.417
Observed|Liver cancer|2015–2019|Persons|3|55–59|0.371|0.347|0.395
Observed|Liver cancer|2015–2019|Persons|3|60–64|0.341|0.318|0.364
Observed|Liver cancer|2015–2019|Persons|3|65–69|0.303|0.28|0.327
Observed|Liver cancer|2015–2019|Persons|3|70–74|0.273|0.249|0.296
Observed|Liver cancer|2015–2019|Persons|3|75–79|0.218|0.195|0.242
Observed|Liver cancer|2015–2019|Persons|3|80–84|0.146|0.125|0.168
Observed|Liver cancer|2015–2019|Persons|3|85+|0.064|0.05|0.081
Observed|Liver cancer|2015–2019|Persons|3|All ages combined|0.287|0.279|0.296
Observed|Liver cancer|2015–2019|Persons|4|00–04|0.848|0.692|0.929
Observed|Liver cancer|2015–2019|Persons|4|05–09|||
Observed|Liver cancer|2015–2019|Persons|4|10–14|||
Observed|Liver cancer|2015–2019|Persons|4|15–19|||
Observed|Liver cancer|2015–2019|Persons|4|20–24|||
Observed|Liver cancer|2015–2019|Persons|4|25–29|||
Observed|Liver cancer|2015–2019|Persons|4|30–34|||
Observed|Liver cancer|2015–2019|Persons|4|35–39|0.498|0.373|0.612
Observed|Liver cancer|2015–2019|Persons|4|40–44|0.366|0.285|0.448
Observed|Liver cancer|2015–2019|Persons|4|45–49|0.347|0.296|0.399
Observed|Liver cancer|2015–2019|Persons|4|50–54|0.328|0.296|0.36
Observed|Liver cancer|2015–2019|Persons|4|55–59|0.32|0.296|0.343
Observed|Liver cancer|2015–2019|Persons|4|60–64|0.289|0.266|0.312
Observed|Liver cancer|2015–2019|Persons|4|65–69|0.26|0.237|0.283
Observed|Liver cancer|2015–2019|Persons|4|70–74|0.214|0.192|0.237
Observed|Liver cancer|2015–2019|Persons|4|75–79|0.159|0.138|0.181
Observed|Liver cancer|2015–2019|Persons|4|80–84|0.101|0.083|0.121
Observed|Liver cancer|2015–2019|Persons|4|85+|0.042|0.03|0.056
Observed|Liver cancer|2015–2019|Persons|4|All ages combined|0.239|0.231|0.247
Observed|Liver cancer|2015–2019|Persons|5|00–04|0.848|0.692|0.929
Observed|Liver cancer|2015–2019|Persons|5|05–09|||
Observed|Liver cancer|2015–2019|Persons|5|10–14|||
Observed|Liver cancer|2015–2019|Persons|5|15–19|||
Observed|Liver cancer|2015–2019|Persons|5|20–24|||
Observed|Liver cancer|2015–2019|Persons|5|25–29|||
Observed|Liver cancer|2015–2019|Persons|5|30–34|||
Observed|Liver cancer|2015–2019|Persons|5|35–39|0.465|0.34|0.58
Observed|Liver cancer|2015–2019|Persons|5|40–44|0.353|0.273|0.434
Observed|Liver cancer|2015–2019|Persons|5|45–49|0.32|0.27|0.371
Observed|Liver cancer|2015–2019|Persons|5|50–54|0.296|0.265|0.327
Observed|Liver cancer|2015–2019|Persons|5|55–59|0.286|0.263|0.309
Observed|Liver cancer|2015–2019|Persons|5|60–64|0.253|0.23|0.276
Observed|Liver cancer|2015–2019|Persons|5|65–69|0.217|0.194|0.24
Observed|Liver cancer|2015–2019|Persons|5|70–74|0.17|0.15|0.192
Observed|Liver cancer|2015–2019|Persons|5|75–79|0.131|0.112|0.152
Observed|Liver cancer|2015–2019|Persons|5|80–84|0.079|0.063|0.098
Observed|Liver cancer|2015–2019|Persons|5|85+|0.031|0.021|0.044
Observed|Liver cancer|2015–2019|Persons|5|All ages combined|0.208|0.2|0.216
Relative|Liver cancer|2015–2019|Persons|1|00–04|0.942|0.786|0.986
Relative|Liver cancer|2015–2019|Persons|1|05–09|||
Relative|Liver cancer|2015–2019|Persons|1|10–14|||
Relative|Liver cancer|2015–2019|Persons|1|15–19|||
Relative|Liver cancer|2015–2019|Persons|1|20–24|||
Relative|Liver cancer|2015–2019|Persons|1|25–29|||
Relative|Liver cancer|2015–2019|Persons|1|30–34|0.655|0.489|0.779
Relative|Liver cancer|2015–2019|Persons|1|35–39|0.658|0.532|0.757
Relative|Liver cancer|2015–2019|Persons|1|40–44|0.598|0.507|0.678
Relative|Liver cancer|2015–2019|Persons|1|45–49|0.599|0.543|0.65
Relative|Liver cancer|2015–2019|Persons|1|50–54|0.577|0.541|0.611
Relative|Liver cancer|2015–2019|Persons|1|55–59|0.595|0.569|0.619
Relative|Liver cancer|2015–2019|Persons|1|60–64|0.563|0.539|0.586
Relative|Liver cancer|2015–2019|Persons|1|65–69|0.538|0.513|0.562
Relative|Liver cancer|2015–2019|Persons|1|70–74|0.509|0.482|0.535
Relative|Liver cancer|2015–2019|Persons|1|75–79|0.461|0.433|0.49
Relative|Liver cancer|2015–2019|Persons|1|80–84|0.353|0.323|0.385
Relative|Liver cancer|2015–2019|Persons|1|85+|0.217|0.19|0.246
Relative|Liver cancer|2015–2019|Persons|1|All ages combined|0.508|0.498|0.517
Relative|Liver cancer|2015–2019|Persons|2|00–04|0.917|0.763|0.973
Relative|Liver cancer|2015–2019|Persons|2|05–09|||
Relative|Liver cancer|2015–2019|Persons|2|10–14|||
Relative|Liver cancer|2015–2019|Persons|2|15–19|||
Relative|Liver cancer|2015–2019|Persons|2|20–24|||
Relative|Liver cancer|2015–2019|Persons|2|25–29|||
Relative|Liver cancer|2015–2019|Persons|2|30–34|0.572|0.405|0.709
Relative|Liver cancer|2015–2019|Persons|2|35–39|0.547|0.419|0.657
Relative|Liver cancer|2015–2019|Persons|2|40–44|0.492|0.403|0.575
Relative|Liver cancer|2015–2019|Persons|2|45–49|0.477|0.422|0.53
Relative|Liver cancer|2015–2019|Persons|2|50–54|0.455|0.42|0.489
Relative|Liver cancer|2015–2019|Persons|2|55–59|0.459|0.434|0.484
Relative|Liver cancer|2015–2019|Persons|2|60–64|0.445|0.421|0.469
Relative|Liver cancer|2015–2019|Persons|2|65–69|0.401|0.377|0.426
Relative|Liver cancer|2015–2019|Persons|2|70–74|0.379|0.353|0.405
Relative|Liver cancer|2015–2019|Persons|2|75–79|0.318|0.291|0.345
Relative|Liver cancer|2015–2019|Persons|2|80–84|0.226|0.199|0.255
Relative|Liver cancer|2015–2019|Persons|2|85+|0.123|0.101|0.148
Relative|Liver cancer|2015–2019|Persons|2|All ages combined|0.381|0.372|0.391
Relative|Liver cancer|2015–2019|Persons|3|00–04|0.871|0.715|0.945
Relative|Liver cancer|2015–2019|Persons|3|05–09|||
Relative|Liver cancer|2015–2019|Persons|3|10–14|||
Relative|Liver cancer|2015–2019|Persons|3|15–19|||
Relative|Liver cancer|2015–2019|Persons|3|20–24|||
Relative|Liver cancer|2015–2019|Persons|3|25–29|||
Relative|Liver cancer|2015–2019|Persons|3|30–34|||
Relative|Liver cancer|2015–2019|Persons|3|35–39|0.515|0.389|0.628
Relative|Liver cancer|2015–2019|Persons|3|40–44|0.427|0.341|0.51
Relative|Liver cancer|2015–2019|Persons|3|45–49|0.388|0.335|0.441
Relative|Liver cancer|2015–2019|Persons|3|50–54|0.388|0.355|0.422
Relative|Liver cancer|2015–2019|Persons|3|55–59|0.377|0.353|0.402
Relative|Liver cancer|2015–2019|Persons|3|60–64|0.349|0.326|0.373
Relative|Liver cancer|2015–2019|Persons|3|65–69|0.314|0.29|0.339
Relative|Liver cancer|2015–2019|Persons|3|70–74|0.289|0.265|0.314
Relative|Liver cancer|2015–2019|Persons|3|75–79|0.241|0.216|0.268
Relative|Liver cancer|2015–2019|Persons|3|80–84|0.175|0.15|0.202
Relative|Liver cancer|2015–2019|Persons|3|85+|0.095|0.074|0.12
Relative|Liver cancer|2015–2019|Persons|3|All ages combined|0.305|0.296|0.314
Relative|Liver cancer|2015–2019|Persons|4|00–04|0.849|0.693|0.93
Relative|Liver cancer|2015–2019|Persons|4|05–09|||
Relative|Liver cancer|2015–2019|Persons|4|10–14|||
Relative|Liver cancer|2015–2019|Persons|4|15–19|||
Relative|Liver cancer|2015–2019|Persons|4|20–24|||
Relative|Liver cancer|2015–2019|Persons|4|25–29|||
Relative|Liver cancer|2015–2019|Persons|4|30–34|||
Relative|Liver cancer|2015–2019|Persons|4|35–39|0.5|0.374|0.614
Relative|Liver cancer|2015–2019|Persons|4|40–44|0.369|0.287|0.451
Relative|Liver cancer|2015–2019|Persons|4|45–49|0.351|0.299|0.403
Relative|Liver cancer|2015–2019|Persons|4|50–54|0.333|0.3|0.365
Relative|Liver cancer|2015–2019|Persons|4|55–59|0.327|0.303|0.351
Relative|Liver cancer|2015–2019|Persons|4|60–64|0.298|0.275|0.322
Relative|Liver cancer|2015–2019|Persons|4|65–69|0.274|0.25|0.298
Relative|Liver cancer|2015–2019|Persons|4|70–74|0.233|0.209|0.258
Relative|Liver cancer|2015–2019|Persons|4|75–79|0.183|0.16|0.209
Relative|Liver cancer|2015–2019|Persons|4|80–84|0.131|0.108|0.157
Relative|Liver cancer|2015–2019|Persons|4|85+|0.073|0.052|0.097
Relative|Liver cancer|2015–2019|Persons|4|All ages combined|0.258|0.249|0.267
Relative|Liver cancer|2015–2019|Persons|5|00–04|0.849|0.693|0.93
Relative|Liver cancer|2015–2019|Persons|5|05–09|||
Relative|Liver cancer|2015–2019|Persons|5|10–14|||
Relative|Liver cancer|2015–2019|Persons|5|15–19|||
Relative|Liver cancer|2015–2019|Persons|5|20–24|||
Relative|Liver cancer|2015–2019|Persons|5|25–29|||
Relative|Liver cancer|2015–2019|Persons|5|30–34|||
Relative|Liver cancer|2015–2019|Persons|5|35–39|0.467|0.342|0.583
Relative|Liver cancer|2015–2019|Persons|5|40–44|0.356|0.275|0.438
Relative|Liver cancer|2015–2019|Persons|5|45–49|0.324|0.274|0.376
Relative|Liver cancer|2015–2019|Persons|5|50–54|0.301|0.27|0.333
Relative|Liver cancer|2015–2019|Persons|5|55–59|0.294|0.271|0.319
Relative|Liver cancer|2015–2019|Persons|5|60–64|0.264|0.24|0.288
Relative|Liver cancer|2015–2019|Persons|5|65–69|0.231|0.208|0.256
Relative|Liver cancer|2015–2019|Persons|5|70–74|0.19|0.167|0.214
Relative|Liver cancer|2015–2019|Persons|5|75–79|0.159|0.136|0.184
Relative|Liver cancer|2015–2019|Persons|5|80–84|0.112|0.089|0.138
Relative|Liver cancer|2015–2019|Persons|5|85+|0.065|0.044|0.093
Relative|Liver cancer|2015–2019|Persons|5|All ages combined|0.229|0.22|0.238
Observed|Lung cancer|2015–2019|Males|1|00–04|||
Observed|Lung cancer|2015–2019|Males|1|05–09|||
Observed|Lung cancer|2015–2019|Males|1|10–14|||
Observed|Lung cancer|2015–2019|Males|1|15–19|||
Observed|Lung cancer|2015–2019|Males|1|20–24|||
Observed|Lung cancer|2015–2019|Males|1|25–29|0.806|0.595|0.914
Observed|Lung cancer|2015–2019|Males|1|30–34|0.662|0.504|0.78
Observed|Lung cancer|2015–2019|Males|1|35–39|0.649|0.554|0.729
Observed|Lung cancer|2015–2019|Males|1|40–44|0.522|0.463|0.578
Observed|Lung cancer|2015–2019|Males|1|45–49|0.526|0.484|0.565
Observed|Lung cancer|2015–2019|Males|1|50–54|0.497|0.469|0.524
Observed|Lung cancer|2015–2019|Males|1|55–59|0.517|0.497|0.536
Observed|Lung cancer|2015–2019|Males|1|60–64|0.5|0.484|0.515
Observed|Lung cancer|2015–2019|Males|1|65–69|0.493|0.48|0.507
Observed|Lung cancer|2015–2019|Males|1|70–74|0.477|0.465|0.489
Observed|Lung cancer|2015–2019|Males|1|75–79|0.44|0.428|0.453
Observed|Lung cancer|2015–2019|Males|1|80–84|0.348|0.334|0.362
Observed|Lung cancer|2015–2019|Males|1|85+|0.198|0.186|0.21
Observed|Lung cancer|2015–2019|Males|1|All ages combined|0.437|0.432|0.442
Observed|Lung cancer|2015–2019|Males|2|00–04|||
Observed|Lung cancer|2015–2019|Males|2|05–09|||
Observed|Lung cancer|2015–2019|Males|2|10–14|||
Observed|Lung cancer|2015–2019|Males|2|15–19|||
Observed|Lung cancer|2015–2019|Males|2|20–24|||
Observed|Lung cancer|2015–2019|Males|2|25–29|||
Observed|Lung cancer|2015–2019|Males|2|30–34|0.638|0.48|0.76
Observed|Lung cancer|2015–2019|Males|2|35–39|0.525|0.429|0.612
Observed|Lung cancer|2015–2019|Males|2|40–44|0.373|0.318|0.428
Observed|Lung cancer|2015–2019|Males|2|45–49|0.379|0.339|0.418
Observed|Lung cancer|2015–2019|Males|2|50–54|0.34|0.314|0.366
Observed|Lung cancer|2015–2019|Males|2|55–59|0.375|0.356|0.394
Observed|Lung cancer|2015–2019|Males|2|60–64|0.346|0.332|0.361
Observed|Lung cancer|2015–2019|Males|2|65–69|0.348|0.335|0.361
Observed|Lung cancer|2015–2019|Males|2|70–74|0.337|0.325|0.349
Observed|Lung cancer|2015–2019|Males|2|75–79|0.295|0.283|0.306
Observed|Lung cancer|2015–2019|Males|2|80–84|0.218|0.207|0.231
Observed|Lung cancer|2015–2019|Males|2|85+|0.104|0.095|0.114
Observed|Lung cancer|2015–2019|Males|2|All ages combined|0.298|0.293|0.303
Observed|Lung cancer|2015–2019|Males|3|00–04|||
Observed|Lung cancer|2015–2019|Males|3|05–09|||
Observed|Lung cancer|2015–2019|Males|3|10–14|||
Observed|Lung cancer|2015–2019|Males|3|15–19|||
Observed|Lung cancer|2015–2019|Males|3|20–24|||
Observed|Lung cancer|2015–2019|Males|3|25–29|||
Observed|Lung cancer|2015–2019|Males|3|30–34|0.588|0.428|0.717
Observed|Lung cancer|2015–2019|Males|3|35–39|0.487|0.392|0.576
Observed|Lung cancer|2015–2019|Males|3|40–44|0.318|0.265|0.372
Observed|Lung cancer|2015–2019|Males|3|45–49|0.298|0.261|0.336
Observed|Lung cancer|2015–2019|Males|3|50–54|0.273|0.248|0.297
Observed|Lung cancer|2015–2019|Males|3|55–59|0.307|0.289|0.326
Observed|Lung cancer|2015–2019|Males|3|60–64|0.281|0.266|0.295
Observed|Lung cancer|2015–2019|Males|3|65–69|0.281|0.269|0.293
Observed|Lung cancer|2015–2019|Males|3|70–74|0.265|0.254|0.276
Observed|Lung cancer|2015–2019|Males|3|75–79|0.221|0.21|0.232
Observed|Lung cancer|2015–2019|Males|3|80–84|0.156|0.145|0.166
Observed|Lung cancer|2015–2019|Males|3|85+|0.059|0.053|0.067
Observed|Lung cancer|2015–2019|Males|3|All ages combined|0.232|0.227|0.236
Observed|Lung cancer|2015–2019|Males|4|00–04|||
Observed|Lung cancer|2015–2019|Males|4|05–09|||
Observed|Lung cancer|2015–2019|Males|4|10–14|||
Observed|Lung cancer|2015–2019|Males|4|15–19|||
Observed|Lung cancer|2015–2019|Males|4|20–24|||
Observed|Lung cancer|2015–2019|Males|4|25–29|||
Observed|Lung cancer|2015–2019|Males|4|30–34|||
Observed|Lung cancer|2015–2019|Males|4|35–39|0.477|0.381|0.566
Observed|Lung cancer|2015–2019|Males|4|40–44|0.268|0.218|0.32
Observed|Lung cancer|2015–2019|Males|4|45–49|0.281|0.244|0.318
Observed|Lung cancer|2015–2019|Males|4|50–54|0.233|0.211|0.257
Observed|Lung cancer|2015–2019|Males|4|55–59|0.269|0.252|0.287
Observed|Lung cancer|2015–2019|Males|4|60–64|0.237|0.224|0.251
Observed|Lung cancer|2015–2019|Males|4|65–69|0.242|0.231|0.254
Observed|Lung cancer|2015–2019|Males|4|70–74|0.218|0.208|0.229
Observed|Lung cancer|2015–2019|Males|4|75–79|0.179|0.169|0.189
Observed|Lung cancer|2015–2019|Males|4|80–84|0.117|0.108|0.127
Observed|Lung cancer|2015–2019|Males|4|85+|0.036|0.031|0.043
Observed|Lung cancer|2015–2019|Males|4|All ages combined|0.193|0.188|0.197
Observed|Lung cancer|2015–2019|Males|5|00–04|||
Observed|Lung cancer|2015–2019|Males|5|05–09|||
Observed|Lung cancer|2015–2019|Males|5|10–14|||
Observed|Lung cancer|2015–2019|Males|5|15–19|||
Observed|Lung cancer|2015–2019|Males|5|20–24|||
Observed|Lung cancer|2015–2019|Males|5|25–29|||
Observed|Lung cancer|2015–2019|Males|5|30–34|||
Observed|Lung cancer|2015–2019|Males|5|35–39|0.453|0.357|0.543
Observed|Lung cancer|2015–2019|Males|5|40–44|0.25|0.202|0.302
Observed|Lung cancer|2015–2019|Males|5|45–49|0.26|0.225|0.297
Observed|Lung cancer|2015–2019|Males|5|50–54|0.213|0.191|0.236
Observed|Lung cancer|2015–2019|Males|5|55–59|0.244|0.227|0.262
Observed|Lung cancer|2015–2019|Males|5|60–64|0.212|0.199|0.225
Observed|Lung cancer|2015–2019|Males|5|65–69|0.214|0.203|0.225
Observed|Lung cancer|2015–2019|Males|5|70–74|0.188|0.178|0.199
Observed|Lung cancer|2015–2019|Males|5|75–79|0.149|0.14|0.159
Observed|Lung cancer|2015–2019|Males|5|80–84|0.091|0.082|0.1
Observed|Lung cancer|2015–2019|Males|5|85+|0.026|0.022|0.032
Observed|Lung cancer|2015–2019|Males|5|All ages combined|0.167|0.163|0.171
Relative|Lung cancer|2015–2019|Males|1|00–04|||
Relative|Lung cancer|2015–2019|Males|1|05–09|||
Relative|Lung cancer|2015–2019|Males|1|10–14|||
Relative|Lung cancer|2015–2019|Males|1|15–19|||
Relative|Lung cancer|2015–2019|Males|1|20–24|||
Relative|Lung cancer|2015–2019|Males|1|25–29|0.806|0.596|0.915
Relative|Lung cancer|2015–2019|Males|1|30–34|0.662|0.504|0.78
Relative|Lung cancer|2015–2019|Males|1|35–39|0.65|0.554|0.73
Relative|Lung cancer|2015–2019|Males|1|40–44|0.523|0.464|0.579
Relative|Lung cancer|2015–2019|Males|1|45–49|0.527|0.486|0.566
Relative|Lung cancer|2015–2019|Males|1|50–54|0.499|0.471|0.526
Relative|Lung cancer|2015–2019|Males|1|55–59|0.519|0.5|0.539
Relative|Lung cancer|2015–2019|Males|1|60–64|0.504|0.488|0.52
Relative|Lung cancer|2015–2019|Males|1|65–69|0.499|0.486|0.513
Relative|Lung cancer|2015–2019|Males|1|70–74|0.487|0.474|0.499
Relative|Lung cancer|2015–2019|Males|1|75–79|0.455|0.442|0.469
Relative|Lung cancer|2015–2019|Males|1|80–84|0.37|0.355|0.385
Relative|Lung cancer|2015–2019|Males|1|85+|0.226|0.213|0.241
Relative|Lung cancer|2015–2019|Males|1|All ages combined|0.452|0.446|0.457
Relative|Lung cancer|2015–2019|Males|2|00–04|||
Relative|Lung cancer|2015–2019|Males|2|05–09|||
Relative|Lung cancer|2015–2019|Males|2|10–14|||
Relative|Lung cancer|2015–2019|Males|2|15–19|||
Relative|Lung cancer|2015–2019|Males|2|20–24|||
Relative|Lung cancer|2015–2019|Males|2|25–29|||
Relative|Lung cancer|2015–2019|Males|2|30–34|0.639|0.481|0.761
Relative|Lung cancer|2015–2019|Males|2|35–39|0.526|0.43|0.614
Relative|Lung cancer|2015–2019|Males|2|40–44|0.374|0.319|0.43
Relative|Lung cancer|2015–2019|Males|2|45–49|0.381|0.341|0.42
Relative|Lung cancer|2015–2019|Males|2|50–54|0.343|0.317|0.369
Relative|Lung cancer|2015–2019|Males|2|55–59|0.379|0.36|0.398
Relative|Lung cancer|2015–2019|Males|2|60–64|0.352|0.337|0.367
Relative|Lung cancer|2015–2019|Males|2|65–69|0.357|0.344|0.37
Relative|Lung cancer|2015–2019|Males|2|70–74|0.351|0.339|0.363
Relative|Lung cancer|2015–2019|Males|2|75–79|0.316|0.303|0.329
Relative|Lung cancer|2015–2019|Males|2|80–84|0.248|0.235|0.262
Relative|Lung cancer|2015–2019|Males|2|85+|0.137|0.125|0.15
Relative|Lung cancer|2015–2019|Males|2|All ages combined|0.317|0.312|0.322
Relative|Lung cancer|2015–2019|Males|3|00–04|||
Relative|Lung cancer|2015–2019|Males|3|05–09|||
Relative|Lung cancer|2015–2019|Males|3|10–14|||
Relative|Lung cancer|2015–2019|Males|3|15–19|||
Relative|Lung cancer|2015–2019|Males|3|20–24|||
Relative|Lung cancer|2015–2019|Males|3|25–29|||
Relative|Lung cancer|2015–2019|Males|3|30–34|0.589|0.43|0.719
Relative|Lung cancer|2015–2019|Males|3|35–39|0.489|0.394|0.578
Relative|Lung cancer|2015–2019|Males|3|40–44|0.319|0.266|0.374
Relative|Lung cancer|2015–2019|Males|3|45–49|0.3|0.263|0.338
Relative|Lung cancer|2015–2019|Males|3|50–54|0.276|0.251|0.301
Relative|Lung cancer|2015–2019|Males|3|55–59|0.313|0.294|0.332
Relative|Lung cancer|2015–2019|Males|3|60–64|0.288|0.274|0.303
Relative|Lung cancer|2015–2019|Males|3|65–69|0.293|0.28|0.305
Relative|Lung cancer|2015–2019|Males|3|70–74|0.283|0.271|0.294
Relative|Lung cancer|2015–2019|Males|3|75–79|0.247|0.235|0.259
Relative|Lung cancer|2015–2019|Males|3|80–84|0.191|0.178|0.204
Relative|Lung cancer|2015–2019|Males|3|85+|0.091|0.081|0.103
Relative|Lung cancer|2015–2019|Males|3|All ages combined|0.254|0.249|0.259
Relative|Lung cancer|2015–2019|Males|4|00–04|||
Relative|Lung cancer|2015–2019|Males|4|05–09|||
Relative|Lung cancer|2015–2019|Males|4|10–14|||
Relative|Lung cancer|2015–2019|Males|4|15–19|||
Relative|Lung cancer|2015–2019|Males|4|20–24|||
Relative|Lung cancer|2015–2019|Males|4|25–29|||
Relative|Lung cancer|2015–2019|Males|4|30–34|||
Relative|Lung cancer|2015–2019|Males|4|35–39|0.479|0.383|0.569
Relative|Lung cancer|2015–2019|Males|4|40–44|0.27|0.22|0.322
Relative|Lung cancer|2015–2019|Males|4|45–49|0.284|0.247|0.322
Relative|Lung cancer|2015–2019|Males|4|50–54|0.237|0.214|0.261
Relative|Lung cancer|2015–2019|Males|4|55–59|0.276|0.258|0.294
Relative|Lung cancer|2015–2019|Males|4|60–64|0.246|0.232|0.261
Relative|Lung cancer|2015–2019|Males|4|65–69|0.256|0.244|0.269
Relative|Lung cancer|2015–2019|Males|4|70–74|0.239|0.228|0.251
Relative|Lung cancer|2015–2019|Males|4|75–79|0.209|0.198|0.222
Relative|Lung cancer|2015–2019|Males|4|80–84|0.156|0.144|0.169
Relative|Lung cancer|2015–2019|Males|4|85+|0.066|0.056|0.078
Relative|Lung cancer|2015–2019|Males|4|All ages combined|0.218|0.213|0.222
Relative|Lung cancer|2015–2019|Males|5|00–04|||
Relative|Lung cancer|2015–2019|Males|5|05–09|||
Relative|Lung cancer|2015–2019|Males|5|10–14|||
Relative|Lung cancer|2015–2019|Males|5|15–19|||
Relative|Lung cancer|2015–2019|Males|5|20–24|||
Relative|Lung cancer|2015–2019|Males|5|25–29|||
Relative|Lung cancer|2015–2019|Males|5|30–34|||
Relative|Lung cancer|2015–2019|Males|5|35–39|0.456|0.359|0.547
Relative|Lung cancer|2015–2019|Males|5|40–44|0.253|0.204|0.304
Relative|Lung cancer|2015–2019|Males|5|45–49|0.264|0.228|0.301
Relative|Lung cancer|2015–2019|Males|5|50–54|0.218|0.195|0.241
Relative|Lung cancer|2015–2019|Males|5|55–59|0.252|0.234|0.27
Relative|Lung cancer|2015–2019|Males|5|60–64|0.222|0.209|0.236
Relative|Lung cancer|2015–2019|Males|5|65–69|0.23|0.218|0.242
Relative|Lung cancer|2015–2019|Males|5|70–74|0.213|0.201|0.224
Relative|Lung cancer|2015–2019|Males|5|75–79|0.184|0.173|0.197
Relative|Lung cancer|2015–2019|Males|5|80–84|0.134|0.121|0.147
Relative|Lung cancer|2015–2019|Males|5|85+|0.058|0.047|0.069
Relative|Lung cancer|2015–2019|Males|5|All ages combined|0.195|0.19|0.2
Observed|Lung cancer|2015–2019|Females|1|00–04|||
Observed|Lung cancer|2015–2019|Females|1|05–09|||
Observed|Lung cancer|2015–2019|Females|1|10–14|||
Observed|Lung cancer|2015–2019|Females|1|15–19|||
Observed|Lung cancer|2015–2019|Females|1|20–24|||
Observed|Lung cancer|2015–2019|Females|1|25–29|0.873|0.721|0.945
Observed|Lung cancer|2015–2019|Females|1|30–34|0.785|0.669|0.864
Observed|Lung cancer|2015–2019|Females|1|35–39|0.708|0.617|0.781
Observed|Lung cancer|2015–2019|Females|1|40–44|0.751|0.693|0.799
Observed|Lung cancer|2015–2019|Females|1|45–49|0.671|0.63|0.708
Observed|Lung cancer|2015–2019|Females|1|50–54|0.642|0.615|0.668
Observed|Lung cancer|2015–2019|Females|1|55–59|0.647|0.627|0.666
Observed|Lung cancer|2015–2019|Females|1|60–64|0.632|0.616|0.649
Observed|Lung cancer|2015–2019|Females|1|65–69|0.615|0.601|0.63
Observed|Lung cancer|2015–2019|Females|1|70–74|0.584|0.57|0.598
Observed|Lung cancer|2015–2019|Females|1|75–79|0.522|0.506|0.537
Observed|Lung cancer|2015–2019|Females|1|80–84|0.423|0.405|0.441
Observed|Lung cancer|2015–2019|Females|1|85+|0.24|0.224|0.256
Observed|Lung cancer|2015–2019|Females|1|All ages combined|0.551|0.545|0.557
Observed|Lung cancer|2015–2019|Females|2|00–04|||
Observed|Lung cancer|2015–2019|Females|2|05–09|||
Observed|Lung cancer|2015–2019|Females|2|10–14|||
Observed|Lung cancer|2015–2019|Females|2|15–19|||
Observed|Lung cancer|2015–2019|Females|2|20–24|||
Observed|Lung cancer|2015–2019|Females|2|25–29|0.873|0.721|0.945
Observed|Lung cancer|2015–2019|Females|2|30–34|0.659|0.533|0.759
Observed|Lung cancer|2015–2019|Females|2|35–39|0.605|0.51|0.687
Observed|Lung cancer|2015–2019|Females|2|40–44|0.6|0.537|0.657
Observed|Lung cancer|2015–2019|Females|2|45–49|0.502|0.459|0.543
Observed|Lung cancer|2015–2019|Females|2|50–54|0.484|0.456|0.512
Observed|Lung cancer|2015–2019|Females|2|55–59|0.48|0.459|0.5
Observed|Lung cancer|2015–2019|Females|2|60–64|0.489|0.471|0.506
Observed|Lung cancer|2015–2019|Females|2|65–69|0.475|0.46|0.49
Observed|Lung cancer|2015–2019|Females|2|70–74|0.439|0.425|0.453
Observed|Lung cancer|2015–2019|Females|2|75–79|0.385|0.37|0.4
Observed|Lung cancer|2015–2019|Females|2|80–84|0.284|0.267|0.3
Observed|Lung cancer|2015–2019|Females|2|85+|0.145|0.132|0.159
Observed|Lung cancer|2015–2019|Females|2|All ages combined|0.41|0.403|0.416
Observed|Lung cancer|2015–2019|Females|3|00–04|||
Observed|Lung cancer|2015–2019|Females|3|05–09|||
Observed|Lung cancer|2015–2019|Females|3|10–14|||
Observed|Lung cancer|2015–2019|Females|3|15–19|||
Observed|Lung cancer|2015–2019|Females|3|20–24|||
Observed|Lung cancer|2015–2019|Females|3|25–29|0.834|0.663|0.923
Observed|Lung cancer|2015–2019|Females|3|30–34|0.613|0.486|0.718
Observed|Lung cancer|2015–2019|Females|3|35–39|0.511|0.417|0.597
Observed|Lung cancer|2015–2019|Females|3|40–44|0.509|0.445|0.569
Observed|Lung cancer|2015–2019|Females|3|45–49|0.413|0.371|0.454
Observed|Lung cancer|2015–2019|Females|3|50–54|0.404|0.377|0.432
Observed|Lung cancer|2015–2019|Females|3|55–59|0.404|0.383|0.424
Observed|Lung cancer|2015–2019|Females|3|60–64|0.415|0.398|0.433
Observed|Lung cancer|2015–2019|Females|3|65–69|0.395|0.381|0.41
Observed|Lung cancer|2015–2019|Females|3|70–74|0.374|0.36|0.388
Observed|Lung cancer|2015–2019|Females|3|75–79|0.313|0.298|0.328
Observed|Lung cancer|2015–2019|Females|3|80–84|0.215|0.2|0.23
Observed|Lung cancer|2015–2019|Females|3|85+|0.099|0.088|0.111
Observed|Lung cancer|2015–2019|Females|3|All ages combined|0.338|0.332|0.344
Observed|Lung cancer|2015–2019|Females|4|00–04|||
Observed|Lung cancer|2015–2019|Females|4|05–09|||
Observed|Lung cancer|2015–2019|Females|4|10–14|||
Observed|Lung cancer|2015–2019|Females|4|15–19|||
Observed|Lung cancer|2015–2019|Females|4|20–24|||
Observed|Lung cancer|2015–2019|Females|4|25–29|||
Observed|Lung cancer|2015–2019|Females|4|30–34|0.596|0.468|0.703
Observed|Lung cancer|2015–2019|Females|4|35–39|0.465|0.372|0.552
Observed|Lung cancer|2015–2019|Females|4|40–44|0.461|0.397|0.522
Observed|Lung cancer|2015–2019|Females|4|45–49|0.367|0.326|0.407
Observed|Lung cancer|2015–2019|Females|4|50–54|0.37|0.343|0.397
Observed|Lung cancer|2015–2019|Females|4|55–59|0.355|0.334|0.375
Observed|Lung cancer|2015–2019|Females|4|60–64|0.362|0.345|0.38
Observed|Lung cancer|2015–2019|Females|4|65–69|0.353|0.338|0.368
Observed|Lung cancer|2015–2019|Females|4|70–74|0.325|0.311|0.339
Observed|Lung cancer|2015–2019|Females|4|75–79|0.269|0.255|0.284
Observed|Lung cancer|2015–2019|Females|4|80–84|0.172|0.158|0.186
Observed|Lung cancer|2015–2019|Females|4|85+|0.066|0.057|0.076
Observed|Lung cancer|2015–2019|Females|4|All ages combined|0.293|0.288|0.299
Observed|Lung cancer|2015–2019|Females|5|00–04|||
Observed|Lung cancer|2015–2019|Females|5|05–09|||
Observed|Lung cancer|2015–2019|Females|5|10–14|||
Observed|Lung cancer|2015–2019|Females|5|15–19|||
Observed|Lung cancer|2015–2019|Females|5|20–24|||
Observed|Lung cancer|2015–2019|Females|5|25–29|||
Observed|Lung cancer|2015–2019|Females|5|30–34|0.564|0.436|0.674
Observed|Lung cancer|2015–2019|Females|5|35–39|0.448|0.356|0.536
Observed|Lung cancer|2015–2019|Females|5|40–44|0.4|0.336|0.463
Observed|Lung cancer|2015–2019|Females|5|45–49|0.347|0.307|0.388
Observed|Lung cancer|2015–2019|Females|5|50–54|0.346|0.319|0.373
Observed|Lung cancer|2015–2019|Females|5|55–59|0.328|0.308|0.348
Observed|Lung cancer|2015–2019|Females|5|60–64|0.328|0.311|0.345
Observed|Lung cancer|2015–2019|Females|5|65–69|0.318|0.303|0.332
Observed|Lung cancer|2015–2019|Females|5|70–74|0.29|0.276|0.305
Observed|Lung cancer|2015–2019|Females|5|75–79|0.229|0.215|0.243
Observed|Lung cancer|2015–2019|Females|5|80–84|0.14|0.127|0.154
Observed|Lung cancer|2015–2019|Females|5|85+|0.049|0.041|0.059
Observed|Lung cancer|2015–2019|Females|5|All ages combined|0.262|0.256|0.267
Relative|Lung cancer|2015–2019|Females|1|00–04|||
Relative|Lung cancer|2015–2019|Females|1|05–09|||
Relative|Lung cancer|2015–2019|Females|1|10–14|||
Relative|Lung cancer|2015–2019|Females|1|15–19|||
Relative|Lung cancer|2015–2019|Females|1|20–24|||
Relative|Lung cancer|2015–2019|Females|1|25–29|0.873|0.722|0.945
Relative|Lung cancer|2015–2019|Females|1|30–34|0.785|0.669|0.864
Relative|Lung cancer|2015–2019|Females|1|35–39|0.708|0.617|0.782
Relative|Lung cancer|2015–2019|Females|1|40–44|0.751|0.693|0.8
Relative|Lung cancer|2015–2019|Females|1|45–49|0.672|0.631|0.709
Relative|Lung cancer|2015–2019|Females|1|50–54|0.644|0.616|0.67
Relative|Lung cancer|2015–2019|Females|1|55–59|0.649|0.629|0.668
Relative|Lung cancer|2015–2019|Females|1|60–64|0.635|0.618|0.652
Relative|Lung cancer|2015–2019|Females|1|65–69|0.62|0.605|0.634
Relative|Lung cancer|2015–2019|Females|1|70–74|0.591|0.577|0.605
Relative|Lung cancer|2015–2019|Females|1|75–79|0.533|0.517|0.548
Relative|Lung cancer|2015–2019|Females|1|80–84|0.441|0.422|0.46
Relative|Lung cancer|2015–2019|Females|1|85+|0.267|0.25|0.286
Relative|Lung cancer|2015–2019|Females|1|All ages combined|0.562|0.556|0.569
Relative|Lung cancer|2015–2019|Females|2|00–04|||
Relative|Lung cancer|2015–2019|Females|2|05–09|||
Relative|Lung cancer|2015–2019|Females|2|10–14|||
Relative|Lung cancer|2015–2019|Females|2|15–19|||
Relative|Lung cancer|2015–2019|Females|2|20–24|||
Relative|Lung cancer|2015–2019|Females|2|25–29|0.873|0.722|0.946
Relative|Lung cancer|2015–2019|Females|2|30–34|0.66|0.533|0.76
Relative|Lung cancer|2015–2019|Females|2|35–39|0.606|0.511|0.688
Relative|Lung cancer|2015–2019|Females|2|40–44|0.601|0.538|0.658
Relative|Lung cancer|2015–2019|Females|2|45–49|0.503|0.46|0.544
Relative|Lung cancer|2015–2019|Females|2|50–54|0.486|0.458|0.514
Relative|Lung cancer|2015–2019|Females|2|55–59|0.483|0.462|0.503
Relative|Lung cancer|2015–2019|Females|2|60–64|0.494|0.476|0.511
Relative|Lung cancer|2015–2019|Females|2|65–69|0.483|0.467|0.498
Relative|Lung cancer|2015–2019|Females|2|70–74|0.451|0.436|0.465
Relative|Lung cancer|2015–2019|Females|2|75–79|0.403|0.387|0.419
Relative|Lung cancer|2015–2019|Females|2|80–84|0.31|0.292|0.328
Relative|Lung cancer|2015–2019|Females|2|85+|0.181|0.165|0.198
Relative|Lung cancer|2015–2019|Females|2|All ages combined|0.426|0.42|0.432
Relative|Lung cancer|2015–2019|Females|3|00–04|||
Relative|Lung cancer|2015–2019|Females|3|05–09|||
Relative|Lung cancer|2015–2019|Females|3|10–14|||
Relative|Lung cancer|2015–2019|Females|3|15–19|||
Relative|Lung cancer|2015–2019|Females|3|20–24|||
Relative|Lung cancer|2015–2019|Females|3|25–29|0.835|0.663|0.924
Relative|Lung cancer|2015–2019|Females|3|30–34|0.614|0.487|0.719
Relative|Lung cancer|2015–2019|Females|3|35–39|0.512|0.418|0.598
Relative|Lung cancer|2015–2019|Females|3|40–44|0.51|0.446|0.571
Relative|Lung cancer|2015–2019|Females|3|45–49|0.415|0.373|0.456
Relative|Lung cancer|2015–2019|Females|3|50–54|0.407|0.379|0.435
Relative|Lung cancer|2015–2019|Females|3|55–59|0.408|0.387|0.429
Relative|Lung cancer|2015–2019|Females|3|60–64|0.422|0.404|0.44
Relative|Lung cancer|2015–2019|Females|3|65–69|0.405|0.39|0.42
Relative|Lung cancer|2015–2019|Females|3|70–74|0.39|0.375|0.404
Relative|Lung cancer|2015–2019|Females|3|75–79|0.337|0.321|0.352
Relative|Lung cancer|2015–2019|Females|3|80–84|0.248|0.23|0.266
Relative|Lung cancer|2015–2019|Females|3|85+|0.14|0.125|0.156
Relative|Lung cancer|2015–2019|Females|3|All ages combined|0.358|0.352|0.364
Relative|Lung cancer|2015–2019|Females|4|00–04|||
Relative|Lung cancer|2015–2019|Females|4|05–09|||
Relative|Lung cancer|2015–2019|Females|4|10–14|||
Relative|Lung cancer|2015–2019|Females|4|15–19|||
Relative|Lung cancer|2015–2019|Females|4|20–24|||
Relative|Lung cancer|2015–2019|Females|4|25–29|||
Relative|Lung cancer|2015–2019|Females|4|30–34|0.597|0.469|0.704
Relative|Lung cancer|2015–2019|Females|4|35–39|0.466|0.373|0.554
Relative|Lung cancer|2015–2019|Females|4|40–44|0.463|0.399|0.525
Relative|Lung cancer|2015–2019|Females|4|45–49|0.369|0.328|0.41
Relative|Lung cancer|2015–2019|Females|4|50–54|0.373|0.346|0.401
Relative|Lung cancer|2015–2019|Females|4|55–59|0.36|0.339|0.381
Relative|Lung cancer|2015–2019|Females|4|60–64|0.37|0.352|0.388
Relative|Lung cancer|2015–2019|Females|4|65–69|0.365|0.35|0.38
Relative|Lung cancer|2015–2019|Females|4|70–74|0.345|0.33|0.36
Relative|Lung cancer|2015–2019|Females|4|75–79|0.299|0.283|0.315
Relative|Lung cancer|2015–2019|Females|4|80–84|0.211|0.194|0.229
Relative|Lung cancer|2015–2019|Females|4|85+|0.107|0.092|0.123
Relative|Lung cancer|2015–2019|Females|4|All ages combined|0.317|0.311|0.323
Relative|Lung cancer|2015–2019|Females|5|00–04|||
Relative|Lung cancer|2015–2019|Females|5|05–09|||
Relative|Lung cancer|2015–2019|Females|5|10–14|||
Relative|Lung cancer|2015–2019|Females|5|15–19|||
Relative|Lung cancer|2015–2019|Females|5|20–24|||
Relative|Lung cancer|2015–2019|Females|5|25–29|||
Relative|Lung cancer|2015–2019|Females|5|30–34|0.566|0.437|0.676
Relative|Lung cancer|2015–2019|Females|5|35–39|0.45|0.357|0.538
Relative|Lung cancer|2015–2019|Females|5|40–44|0.402|0.338|0.466
Relative|Lung cancer|2015–2019|Females|5|45–49|0.35|0.31|0.391
Relative|Lung cancer|2015–2019|Females|5|50–54|0.35|0.323|0.378
Relative|Lung cancer|2015–2019|Females|5|55–59|0.334|0.313|0.355
Relative|Lung cancer|2015–2019|Females|5|60–64|0.337|0.319|0.355
Relative|Lung cancer|2015–2019|Females|5|65–69|0.332|0.317|0.348
Relative|Lung cancer|2015–2019|Females|5|70–74|0.314|0.298|0.329
Relative|Lung cancer|2015–2019|Females|5|75–79|0.263|0.247|0.28
Relative|Lung cancer|2015–2019|Females|5|80–84|0.185|0.167|0.203
Relative|Lung cancer|2015–2019|Females|5|85+|0.093|0.078|0.11
Relative|Lung cancer|2015–2019|Females|5|All ages combined|0.288|0.282|0.295
Observed|Lung cancer|2015–2019|Persons|1|00–04|||
Observed|Lung cancer|2015–2019|Persons|1|05–09|||
Observed|Lung cancer|2015–2019|Persons|1|10–14|||
Observed|Lung cancer|2015–2019|Persons|1|15–19|||
Observed|Lung cancer|2015–2019|Persons|1|20–24|0.965|0.774|0.995
Observed|Lung cancer|2015–2019|Persons|1|25–29|0.846|0.733|0.914
Observed|Lung cancer|2015–2019|Persons|1|30–34|0.737|0.646|0.808
Observed|Lung cancer|2015–2019|Persons|1|35–39|0.679|0.615|0.735
Observed|Lung cancer|2015–2019|Persons|1|40–44|0.63|0.588|0.669
Observed|Lung cancer|2015–2019|Persons|1|45–49|0.596|0.567|0.624
Observed|Lung cancer|2015–2019|Persons|1|50–54|0.569|0.549|0.588
Observed|Lung cancer|2015–2019|Persons|1|55–59|0.58|0.565|0.593
Observed|Lung cancer|2015–2019|Persons|1|60–64|0.56|0.548|0.571
Observed|Lung cancer|2015–2019|Persons|1|65–69|0.548|0.538|0.558
Observed|Lung cancer|2015–2019|Persons|1|70–74|0.524|0.514|0.533
Observed|Lung cancer|2015–2019|Persons|1|75–79|0.474|0.465|0.484
Observed|Lung cancer|2015–2019|Persons|1|80–84|0.378|0.367|0.389
Observed|Lung cancer|2015–2019|Persons|1|85+|0.215|0.205|0.225
Observed|Lung cancer|2015–2019|Persons|1|All ages combined|0.487|0.483|0.491
Observed|Lung cancer|2015–2019|Persons|2|00–04|||
Observed|Lung cancer|2015–2019|Persons|2|05–09|||
Observed|Lung cancer|2015–2019|Persons|2|10–14|||
Observed|Lung cancer|2015–2019|Persons|2|15–19|||
Observed|Lung cancer|2015–2019|Persons|2|20–24|0.934|0.76|0.983
Observed|Lung cancer|2015–2019|Persons|2|25–29|0.828|0.711|0.901
Observed|Lung cancer|2015–2019|Persons|2|30–34|0.652|0.556|0.732
Observed|Lung cancer|2015–2019|Persons|2|35–39|0.566|0.499|0.627
Observed|Lung cancer|2015–2019|Persons|2|40–44|0.48|0.437|0.521
Observed|Lung cancer|2015–2019|Persons|2|45–49|0.439|0.41|0.468
Observed|Lung cancer|2015–2019|Persons|2|50–54|0.411|0.392|0.43
Observed|Lung cancer|2015–2019|Persons|2|55–59|0.426|0.411|0.44
Observed|Lung cancer|2015–2019|Persons|2|60–64|0.41|0.399|0.422
Observed|Lung cancer|2015–2019|Persons|2|65–69|0.404|0.395|0.414
Observed|Lung cancer|2015–2019|Persons|2|70–74|0.381|0.372|0.39
Observed|Lung cancer|2015–2019|Persons|2|75–79|0.332|0.323|0.342
Observed|Lung cancer|2015–2019|Persons|2|80–84|0.244|0.234|0.254
Observed|Lung cancer|2015–2019|Persons|2|85+|0.121|0.113|0.128
Observed|Lung cancer|2015–2019|Persons|2|All ages combined|0.346|0.343|0.35
Observed|Lung cancer|2015–2019|Persons|3|00–04|||
Observed|Lung cancer|2015–2019|Persons|3|05–09|||
Observed|Lung cancer|2015–2019|Persons|3|10–14|||
Observed|Lung cancer|2015–2019|Persons|3|15–19|||
Observed|Lung cancer|2015–2019|Persons|3|20–24|0.934|0.76|0.983
Observed|Lung cancer|2015–2019|Persons|3|25–29|0.787|0.659|0.871
Observed|Lung cancer|2015–2019|Persons|3|30–34|0.604|0.507|0.689
Observed|Lung cancer|2015–2019|Persons|3|35–39|0.499|0.432|0.561
Observed|Lung cancer|2015–2019|Persons|3|40–44|0.408|0.366|0.449
Observed|Lung cancer|2015–2019|Persons|3|45–49|0.354|0.326|0.382
Observed|Lung cancer|2015–2019|Persons|3|50–54|0.337|0.319|0.356
Observed|Lung cancer|2015–2019|Persons|3|55–59|0.354|0.34|0.368
Observed|Lung cancer|2015–2019|Persons|3|60–64|0.34|0.329|0.352
Observed|Lung cancer|2015–2019|Persons|3|65–69|0.332|0.322|0.341
Observed|Lung cancer|2015–2019|Persons|3|70–74|0.311|0.302|0.32
Observed|Lung cancer|2015–2019|Persons|3|75–79|0.259|0.25|0.268
Observed|Lung cancer|2015–2019|Persons|3|80–84|0.179|0.17|0.188
Observed|Lung cancer|2015–2019|Persons|3|85+|0.075|0.069|0.082
Observed|Lung cancer|2015–2019|Persons|3|All ages combined|0.278|0.274|0.281
Observed|Lung cancer|2015–2019|Persons|4|00–04|||
Observed|Lung cancer|2015–2019|Persons|4|05–09|||
Observed|Lung cancer|2015–2019|Persons|4|10–14|||
Observed|Lung cancer|2015–2019|Persons|4|15–19|||
Observed|Lung cancer|2015–2019|Persons|4|20–24|0.934|0.76|0.983
Observed|Lung cancer|2015–2019|Persons|4|25–29|0.766|0.634|0.855
Observed|Lung cancer|2015–2019|Persons|4|30–34|0.583|0.484|0.669
Observed|Lung cancer|2015–2019|Persons|4|35–39|0.469|0.403|0.533
Observed|Lung cancer|2015–2019|Persons|4|40–44|0.358|0.317|0.399
Observed|Lung cancer|2015–2019|Persons|4|45–49|0.323|0.296|0.351
Observed|Lung cancer|2015–2019|Persons|4|50–54|0.3|0.282|0.318
Observed|Lung cancer|2015–2019|Persons|4|55–59|0.31|0.297|0.324
Observed|Lung cancer|2015–2019|Persons|4|60–64|0.293|0.282|0.304
Observed|Lung cancer|2015–2019|Persons|4|65–69|0.291|0.282|0.3
Observed|Lung cancer|2015–2019|Persons|4|70–74|0.263|0.254|0.272
Observed|Lung cancer|2015–2019|Persons|4|75–79|0.216|0.207|0.225
Observed|Lung cancer|2015–2019|Persons|4|80–84|0.138|0.13|0.146
Observed|Lung cancer|2015–2019|Persons|4|85+|0.048|0.043|0.054
Observed|Lung cancer|2015–2019|Persons|4|All ages combined|0.236|0.232|0.239
Observed|Lung cancer|2015–2019|Persons|5|00–04|||
Observed|Lung cancer|2015–2019|Persons|5|05–09|||
Observed|Lung cancer|2015–2019|Persons|5|10–14|||
Observed|Lung cancer|2015–2019|Persons|5|15–19|||
Observed|Lung cancer|2015–2019|Persons|5|20–24|0.934|0.76|0.983
Observed|Lung cancer|2015–2019|Persons|5|25–29|0.766|0.634|0.855
Observed|Lung cancer|2015–2019|Persons|5|30–34|0.56|0.461|0.648
Observed|Lung cancer|2015–2019|Persons|5|35–39|0.449|0.383|0.513
Observed|Lung cancer|2015–2019|Persons|5|40–44|0.322|0.282|0.362
Observed|Lung cancer|2015–2019|Persons|5|45–49|0.303|0.276|0.331
Observed|Lung cancer|2015–2019|Persons|5|50–54|0.278|0.26|0.296
Observed|Lung cancer|2015–2019|Persons|5|55–59|0.284|0.271|0.298
Observed|Lung cancer|2015–2019|Persons|5|60–64|0.263|0.252|0.274
Observed|Lung cancer|2015–2019|Persons|5|65–69|0.259|0.25|0.268
Observed|Lung cancer|2015–2019|Persons|5|70–74|0.231|0.222|0.239
Observed|Lung cancer|2015–2019|Persons|5|75–79|0.182|0.174|0.19
Observed|Lung cancer|2015–2019|Persons|5|80–84|0.11|0.103|0.118
Observed|Lung cancer|2015–2019|Persons|5|85+|0.035|0.031|0.04
Observed|Lung cancer|2015–2019|Persons|5|All ages combined|0.208|0.204|0.211
Relative|Lung cancer|2015–2019|Persons|1|00–04|||
Relative|Lung cancer|2015–2019|Persons|1|05–09|||
Relative|Lung cancer|2015–2019|Persons|1|10–14|||
Relative|Lung cancer|2015–2019|Persons|1|15–19|||
Relative|Lung cancer|2015–2019|Persons|1|20–24|0.965|0.774|0.995
Relative|Lung cancer|2015–2019|Persons|1|25–29|0.847|0.734|0.915
Relative|Lung cancer|2015–2019|Persons|1|30–34|0.737|0.646|0.808
Relative|Lung cancer|2015–2019|Persons|1|35–39|0.68|0.615|0.736
Relative|Lung cancer|2015–2019|Persons|1|40–44|0.631|0.589|0.67
Relative|Lung cancer|2015–2019|Persons|1|45–49|0.598|0.569|0.625
Relative|Lung cancer|2015–2019|Persons|1|50–54|0.57|0.551|0.59
Relative|Lung cancer|2015–2019|Persons|1|55–59|0.582|0.568|0.596
Relative|Lung cancer|2015–2019|Persons|1|60–64|0.563|0.552|0.575
Relative|Lung cancer|2015–2019|Persons|1|65–69|0.553|0.543|0.563
Relative|Lung cancer|2015–2019|Persons|1|70–74|0.532|0.523|0.542
Relative|Lung cancer|2015–2019|Persons|1|75–79|0.488|0.478|0.498
Relative|Lung cancer|2015–2019|Persons|1|80–84|0.398|0.387|0.41
Relative|Lung cancer|2015–2019|Persons|1|85+|0.243|0.232|0.255
Relative|Lung cancer|2015–2019|Persons|1|All ages combined|0.5|0.496|0.504
Relative|Lung cancer|2015–2019|Persons|2|00–04|||
Relative|Lung cancer|2015–2019|Persons|2|05–09|||
Relative|Lung cancer|2015–2019|Persons|2|10–14|||
Relative|Lung cancer|2015–2019|Persons|2|15–19|||
Relative|Lung cancer|2015–2019|Persons|2|20–24|0.934|0.76|0.984
Relative|Lung cancer|2015–2019|Persons|2|25–29|0.829|0.712|0.902
Relative|Lung cancer|2015–2019|Persons|2|30–34|0.653|0.557|0.733
Relative|Lung cancer|2015–2019|Persons|2|35–39|0.567|0.5|0.628
Relative|Lung cancer|2015–2019|Persons|2|40–44|0.481|0.439|0.522
Relative|Lung cancer|2015–2019|Persons|2|45–49|0.441|0.411|0.47
Relative|Lung cancer|2015–2019|Persons|2|50–54|0.414|0.394|0.433
Relative|Lung cancer|2015–2019|Persons|2|55–59|0.429|0.415|0.444
Relative|Lung cancer|2015–2019|Persons|2|60–64|0.416|0.404|0.427
Relative|Lung cancer|2015–2019|Persons|2|65–69|0.413|0.403|0.423
Relative|Lung cancer|2015–2019|Persons|2|70–74|0.394|0.385|0.404
Relative|Lung cancer|2015–2019|Persons|2|75–79|0.352|0.342|0.363
Relative|Lung cancer|2015–2019|Persons|2|80–84|0.273|0.262|0.284
Relative|Lung cancer|2015–2019|Persons|2|85+|0.155|0.146|0.165
Relative|Lung cancer|2015–2019|Persons|2|All ages combined|0.365|0.361|0.369
Relative|Lung cancer|2015–2019|Persons|3|00–04|||
Relative|Lung cancer|2015–2019|Persons|3|05–09|||
Relative|Lung cancer|2015–2019|Persons|3|10–14|||
Relative|Lung cancer|2015–2019|Persons|3|15–19|||
Relative|Lung cancer|2015–2019|Persons|3|20–24|0.935|0.761|0.984
Relative|Lung cancer|2015–2019|Persons|3|25–29|0.788|0.66|0.872
Relative|Lung cancer|2015–2019|Persons|3|30–34|0.606|0.508|0.69
Relative|Lung cancer|2015–2019|Persons|3|35–39|0.5|0.433|0.563
Relative|Lung cancer|2015–2019|Persons|3|40–44|0.409|0.367|0.451
Relative|Lung cancer|2015–2019|Persons|3|45–49|0.356|0.328|0.385
Relative|Lung cancer|2015–2019|Persons|3|50–54|0.34|0.322|0.359
Relative|Lung cancer|2015–2019|Persons|3|55–59|0.359|0.345|0.373
Relative|Lung cancer|2015–2019|Persons|3|60–64|0.348|0.336|0.359
Relative|Lung cancer|2015–2019|Persons|3|65–69|0.343|0.333|0.353
Relative|Lung cancer|2015–2019|Persons|3|70–74|0.328|0.319|0.338
Relative|Lung cancer|2015–2019|Persons|3|75–79|0.284|0.274|0.294
Relative|Lung cancer|2015–2019|Persons|3|80–84|0.213|0.203|0.224
Relative|Lung cancer|2015–2019|Persons|3|85+|0.111|0.102|0.121
Relative|Lung cancer|2015–2019|Persons|3|All ages combined|0.299|0.296|0.303
Relative|Lung cancer|2015–2019|Persons|4|00–04|||
Relative|Lung cancer|2015–2019|Persons|4|05–09|||
Relative|Lung cancer|2015–2019|Persons|4|10–14|||
Relative|Lung cancer|2015–2019|Persons|4|15–19|||
Relative|Lung cancer|2015–2019|Persons|4|20–24|0.935|0.761|0.985
Relative|Lung cancer|2015–2019|Persons|4|25–29|0.767|0.636|0.857
Relative|Lung cancer|2015–2019|Persons|4|30–34|0.584|0.485|0.67
Relative|Lung cancer|2015–2019|Persons|4|35–39|0.471|0.404|0.535
Relative|Lung cancer|2015–2019|Persons|4|40–44|0.36|0.319|0.401
Relative|Lung cancer|2015–2019|Persons|4|45–49|0.326|0.298|0.354
Relative|Lung cancer|2015–2019|Persons|4|50–54|0.304|0.286|0.323
Relative|Lung cancer|2015–2019|Persons|4|55–59|0.316|0.303|0.33
Relative|Lung cancer|2015–2019|Persons|4|60–64|0.301|0.29|0.313
Relative|Lung cancer|2015–2019|Persons|4|65–69|0.305|0.295|0.314
Relative|Lung cancer|2015–2019|Persons|4|70–74|0.284|0.274|0.293
Relative|Lung cancer|2015–2019|Persons|4|75–79|0.247|0.237|0.256
Relative|Lung cancer|2015–2019|Persons|4|80–84|0.178|0.168|0.188
Relative|Lung cancer|2015–2019|Persons|4|85+|0.083|0.075|0.092
Relative|Lung cancer|2015–2019|Persons|4|All ages combined|0.261|0.257|0.265
Relative|Lung cancer|2015–2019|Persons|5|00–04|||
Relative|Lung cancer|2015–2019|Persons|5|05–09|||
Relative|Lung cancer|2015–2019|Persons|5|10–14|||
Relative|Lung cancer|2015–2019|Persons|5|15–19|||
Relative|Lung cancer|2015–2019|Persons|5|20–24|0.936|0.761|0.985
Relative|Lung cancer|2015–2019|Persons|5|25–29|0.768|0.636|0.858
Relative|Lung cancer|2015–2019|Persons|5|30–34|0.562|0.462|0.65
Relative|Lung cancer|2015–2019|Persons|5|35–39|0.452|0.385|0.516
Relative|Lung cancer|2015–2019|Persons|5|40–44|0.324|0.284|0.365
Relative|Lung cancer|2015–2019|Persons|5|45–49|0.307|0.279|0.334
Relative|Lung cancer|2015–2019|Persons|5|50–54|0.283|0.265|0.301
Relative|Lung cancer|2015–2019|Persons|5|55–59|0.291|0.278|0.305
Relative|Lung cancer|2015–2019|Persons|5|60–64|0.273|0.262|0.284
Relative|Lung cancer|2015–2019|Persons|5|65–69|0.275|0.266|0.285
Relative|Lung cancer|2015–2019|Persons|5|70–74|0.255|0.246|0.265
Relative|Lung cancer|2015–2019|Persons|5|75–79|0.217|0.207|0.227
Relative|Lung cancer|2015–2019|Persons|5|80–84|0.154|0.144|0.165
Relative|Lung cancer|2015–2019|Persons|5|85+|0.072|0.063|0.082
Relative|Lung cancer|2015–2019|Persons|5|All ages combined|0.235|0.232|0.239
Observed|Lymphoma|2015–2019|Males|1|00–04|1|0.901|1
Observed|Lymphoma|2015–2019|Males|1|05–09|0.975|0.903|0.994
Observed|Lymphoma|2015–2019|Males|1|10–14|0.99|0.933|0.999
Observed|Lymphoma|2015–2019|Males|1|15–19|0.972|0.939|0.987
Observed|Lymphoma|2015–2019|Males|1|20–24|0.982|0.958|0.993
Observed|Lymphoma|2015–2019|Males|1|25–29|0.979|0.955|0.991
Observed|Lymphoma|2015–2019|Males|1|30–34|0.983|0.961|0.992
Observed|Lymphoma|2015–2019|Males|1|35–39|0.952|0.927|0.968
Observed|Lymphoma|2015–2019|Males|1|40–44|0.962|0.941|0.975
Observed|Lymphoma|2015–2019|Males|1|45–49|0.942|0.922|0.956
Observed|Lymphoma|2015–2019|Males|1|50–54|0.938|0.922|0.951
Observed|Lymphoma|2015–2019|Males|1|55–59|0.921|0.906|0.934
Observed|Lymphoma|2015–2019|Males|1|60–64|0.916|0.902|0.928
Observed|Lymphoma|2015–2019|Males|1|65–69|0.88|0.866|0.893
Observed|Lymphoma|2015–2019|Males|1|70–74|0.866|0.852|0.879
Observed|Lymphoma|2015–2019|Males|1|75–79|0.799|0.781|0.816
Observed|Lymphoma|2015–2019|Males|1|80–84|0.723|0.701|0.744
Observed|Lymphoma|2015–2019|Males|1|85+|0.537|0.51|0.563
Observed|Lymphoma|2015–2019|Males|1|All ages combined|0.853|0.847|0.858
Observed|Lymphoma|2015–2019|Males|2|00–04|0.964|0.769|0.995
Observed|Lymphoma|2015–2019|Males|2|05–09|0.975|0.903|0.994
Observed|Lymphoma|2015–2019|Males|2|10–14|0.981|0.925|0.995
Observed|Lymphoma|2015–2019|Males|2|15–19|0.963|0.927|0.981
Observed|Lymphoma|2015–2019|Males|2|20–24|0.975|0.949|0.988
Observed|Lymphoma|2015–2019|Males|2|25–29|0.969|0.942|0.984
Observed|Lymphoma|2015–2019|Males|2|30–34|0.964|0.938|0.979
Observed|Lymphoma|2015–2019|Males|2|35–39|0.932|0.904|0.952
Observed|Lymphoma|2015–2019|Males|2|40–44|0.939|0.915|0.956
Observed|Lymphoma|2015–2019|Males|2|45–49|0.917|0.895|0.935
Observed|Lymphoma|2015–2019|Males|2|50–54|0.912|0.893|0.928
Observed|Lymphoma|2015–2019|Males|2|55–59|0.874|0.855|0.89
Observed|Lymphoma|2015–2019|Males|2|60–64|0.87|0.853|0.884
Observed|Lymphoma|2015–2019|Males|2|65–69|0.83|0.814|0.845
Observed|Lymphoma|2015–2019|Males|2|70–74|0.792|0.775|0.808
Observed|Lymphoma|2015–2019|Males|2|75–79|0.716|0.696|0.735
Observed|Lymphoma|2015–2019|Males|2|80–84|0.623|0.599|0.646
Observed|Lymphoma|2015–2019|Males|2|85+|0.422|0.396|0.448
Observed|Lymphoma|2015–2019|Males|2|All ages combined|0.793|0.787|0.799
Observed|Lymphoma|2015–2019|Males|3|00–04|0.964|0.769|0.995
Observed|Lymphoma|2015–2019|Males|3|05–09|0.962|0.885|0.987
Observed|Lymphoma|2015–2019|Males|3|10–14|0.981|0.925|0.995
Observed|Lymphoma|2015–2019|Males|3|15–19|0.958|0.921|0.978
Observed|Lymphoma|2015–2019|Males|3|20–24|0.969|0.94|0.983
Observed|Lymphoma|2015–2019|Males|3|25–29|0.956|0.926|0.974
Observed|Lymphoma|2015–2019|Males|3|30–34|0.952|0.923|0.97
Observed|Lymphoma|2015–2019|Males|3|35–39|0.918|0.888|0.94
Observed|Lymphoma|2015–2019|Males|3|40–44|0.922|0.896|0.942
Observed|Lymphoma|2015–2019|Males|3|45–49|0.908|0.884|0.926
Observed|Lymphoma|2015–2019|Males|3|50–54|0.887|0.867|0.905
Observed|Lymphoma|2015–2019|Males|3|55–59|0.853|0.833|0.87
Observed|Lymphoma|2015–2019|Males|3|60–64|0.834|0.816|0.85
Observed|Lymphoma|2015–2019|Males|3|65–69|0.794|0.777|0.811
Observed|Lymphoma|2015–2019|Males|3|70–74|0.741|0.722|0.758
Observed|Lymphoma|2015–2019|Males|3|75–79|0.648|0.626|0.669
Observed|Lymphoma|2015–2019|Males|3|80–84|0.547|0.522|0.572
Observed|Lymphoma|2015–2019|Males|3|85+|0.337|0.312|0.362
Observed|Lymphoma|2015–2019|Males|3|All ages combined|0.751|0.744|0.757
Observed|Lymphoma|2015–2019|Males|4|00–04|0.964|0.769|0.995
Observed|Lymphoma|2015–2019|Males|4|05–09|0.962|0.885|0.987
Observed|Lymphoma|2015–2019|Males|4|10–14|0.981|0.925|0.995
Observed|Lymphoma|2015–2019|Males|4|15–19|0.949|0.91|0.971
Observed|Lymphoma|2015–2019|Males|4|20–24|0.965|0.936|0.981
Observed|Lymphoma|2015–2019|Males|4|25–29|0.95|0.918|0.97
Observed|Lymphoma|2015–2019|Males|4|30–34|0.949|0.919|0.968
Observed|Lymphoma|2015–2019|Males|4|35–39|0.911|0.881|0.934
Observed|Lymphoma|2015–2019|Males|4|40–44|0.922|0.896|0.942
Observed|Lymphoma|2015–2019|Males|4|45–49|0.893|0.868|0.913
Observed|Lymphoma|2015–2019|Males|4|50–54|0.873|0.851|0.892
Observed|Lymphoma|2015–2019|Males|4|55–59|0.827|0.806|0.846
Observed|Lymphoma|2015–2019|Males|4|60–64|0.811|0.792|0.828
Observed|Lymphoma|2015–2019|Males|4|65–69|0.762|0.744|0.779
Observed|Lymphoma|2015–2019|Males|4|70–74|0.682|0.662|0.702
Observed|Lymphoma|2015–2019|Males|4|75–79|0.586|0.563|0.608
Observed|Lymphoma|2015–2019|Males|4|80–84|0.471|0.446|0.496
Observed|Lymphoma|2015–2019|Males|4|85+|0.264|0.24|0.288
Observed|Lymphoma|2015–2019|Males|4|All ages combined|0.713|0.706|0.72
Observed|Lymphoma|2015–2019|Males|5|00–04|0.964|0.769|0.995
Observed|Lymphoma|2015–2019|Males|5|05–09|0.962|0.885|0.987
Observed|Lymphoma|2015–2019|Males|5|10–14|0.981|0.925|0.995
Observed|Lymphoma|2015–2019|Males|5|15–19|0.949|0.91|0.971
Observed|Lymphoma|2015–2019|Males|5|20–24|0.961|0.931|0.978
Observed|Lymphoma|2015–2019|Males|5|25–29|0.937|0.904|0.96
Observed|Lymphoma|2015–2019|Males|5|30–34|0.936|0.904|0.958
Observed|Lymphoma|2015–2019|Males|5|35–39|0.905|0.873|0.929
Observed|Lymphoma|2015–2019|Males|5|40–44|0.913|0.885|0.934
Observed|Lymphoma|2015–2019|Males|5|45–49|0.876|0.85|0.898
Observed|Lymphoma|2015–2019|Males|5|50–54|0.854|0.83|0.874
Observed|Lymphoma|2015–2019|Males|5|55–59|0.807|0.785|0.827
Observed|Lymphoma|2015–2019|Males|5|60–64|0.788|0.768|0.806
Observed|Lymphoma|2015–2019|Males|5|65–69|0.735|0.716|0.753
Observed|Lymphoma|2015–2019|Males|5|70–74|0.644|0.623|0.664
Observed|Lymphoma|2015–2019|Males|5|75–79|0.54|0.517|0.563
Observed|Lymphoma|2015–2019|Males|5|80–84|0.401|0.376|0.426
Observed|Lymphoma|2015–2019|Males|5|85+|0.211|0.189|0.235
Observed|Lymphoma|2015–2019|Males|5|All ages combined|0.683|0.676|0.69
Relative|Lymphoma|2015–2019|Males|1|00–04|1|0.902|1
Relative|Lymphoma|2015–2019|Males|1|05–09|0.975|0.903|0.994
Relative|Lymphoma|2015–2019|Males|1|10–14|0.99|0.933|0.999
Relative|Lymphoma|2015–2019|Males|1|15–19|0.972|0.939|0.988
Relative|Lymphoma|2015–2019|Males|1|20–24|0.983|0.958|0.993
Relative|Lymphoma|2015–2019|Males|1|25–29|0.98|0.955|0.991
Relative|Lymphoma|2015–2019|Males|1|30–34|0.983|0.962|0.993
Relative|Lymphoma|2015–2019|Males|1|35–39|0.953|0.928|0.97
Relative|Lymphoma|2015–2019|Males|1|40–44|0.963|0.943|0.977
Relative|Lymphoma|2015–2019|Males|1|45–49|0.944|0.925|0.959
Relative|Lymphoma|2015–2019|Males|1|50–54|0.942|0.925|0.955
Relative|Lymphoma|2015–2019|Males|1|55–59|0.926|0.911|0.939
Relative|Lymphoma|2015–2019|Males|1|60–64|0.923|0.91|0.935
Relative|Lymphoma|2015–2019|Males|1|65–69|0.891|0.877|0.904
Relative|Lymphoma|2015–2019|Males|1|70–74|0.883|0.869|0.896
Relative|Lymphoma|2015–2019|Males|1|75–79|0.826|0.807|0.844
Relative|Lymphoma|2015–2019|Males|1|80–84|0.768|0.745|0.791
Relative|Lymphoma|2015–2019|Males|1|85+|0.616|0.585|0.645
Relative|Lymphoma|2015–2019|Males|1|All ages combined|0.875|0.869|0.88
Relative|Lymphoma|2015–2019|Males|2|00–04|0.964|0.77|0.995
Relative|Lymphoma|2015–2019|Males|2|05–09|0.975|0.903|0.994
Relative|Lymphoma|2015–2019|Males|2|10–14|0.981|0.926|0.995
Relative|Lymphoma|2015–2019|Males|2|15–19|0.963|0.927|0.982
Relative|Lymphoma|2015–2019|Males|2|20–24|0.977|0.95|0.989
Relative|Lymphoma|2015–2019|Males|2|25–29|0.971|0.943|0.985
Relative|Lymphoma|2015–2019|Males|2|30–34|0.966|0.939|0.981
Relative|Lymphoma|2015–2019|Males|2|35–39|0.934|0.906|0.954
Relative|Lymphoma|2015–2019|Males|2|40–44|0.942|0.918|0.96
Relative|Lymphoma|2015–2019|Males|2|45–49|0.922|0.9|0.94
Relative|Lymphoma|2015–2019|Males|2|50–54|0.919|0.9|0.935
Relative|Lymphoma|2015–2019|Males|2|55–59|0.883|0.865|0.9
Relative|Lymphoma|2015–2019|Males|2|60–64|0.884|0.868|0.899
Relative|Lymphoma|2015–2019|Males|2|65–69|0.852|0.835|0.867
Relative|Lymphoma|2015–2019|Males|2|70–74|0.825|0.807|0.842
Relative|Lymphoma|2015–2019|Males|2|75–79|0.769|0.747|0.789
Relative|Lymphoma|2015–2019|Males|2|80–84|0.708|0.681|0.734
Relative|Lymphoma|2015–2019|Males|2|85+|0.559|0.525|0.594
Relative|Lymphoma|2015–2019|Males|2|All ages combined|0.833|0.827|0.839
Relative|Lymphoma|2015–2019|Males|3|00–04|0.964|0.77|0.995
Relative|Lymphoma|2015–2019|Males|3|05–09|0.962|0.886|0.988
Relative|Lymphoma|2015–2019|Males|3|10–14|0.981|0.926|0.996
Relative|Lymphoma|2015–2019|Males|3|15–19|0.959|0.922|0.979
Relative|Lymphoma|2015–2019|Males|3|20–24|0.97|0.942|0.985
Relative|Lymphoma|2015–2019|Males|3|25–29|0.958|0.928|0.976
Relative|Lymphoma|2015–2019|Males|3|30–34|0.954|0.925|0.973
Relative|Lymphoma|2015–2019|Males|3|35–39|0.921|0.891|0.944
Relative|Lymphoma|2015–2019|Males|3|40–44|0.927|0.9|0.947
Relative|Lymphoma|2015–2019|Males|3|45–49|0.915|0.891|0.933
Relative|Lymphoma|2015–2019|Males|3|50–54|0.898|0.876|0.916
Relative|Lymphoma|2015–2019|Males|3|55–59|0.868|0.847|0.885
Relative|Lymphoma|2015–2019|Males|3|60–64|0.856|0.837|0.872
Relative|Lymphoma|2015–2019|Males|3|65–69|0.827|0.809|0.844
Relative|Lymphoma|2015–2019|Males|3|70–74|0.791|0.771|0.809
Relative|Lymphoma|2015–2019|Males|3|75–79|0.725|0.701|0.748
Relative|Lymphoma|2015–2019|Males|3|80–84|0.672|0.641|0.702
Relative|Lymphoma|2015–2019|Males|3|85+|0.522|0.483|0.561
Relative|Lymphoma|2015–2019|Males|3|All ages combined|0.807|0.8|0.814
Relative|Lymphoma|2015–2019|Males|4|00–04|0.964|0.77|0.995
Relative|Lymphoma|2015–2019|Males|4|05–09|0.962|0.886|0.988
Relative|Lymphoma|2015–2019|Males|4|10–14|0.982|0.926|0.996
Relative|Lymphoma|2015–2019|Males|4|15–19|0.951|0.912|0.973
Relative|Lymphoma|2015–2019|Males|4|20–24|0.967|0.938|0.983
Relative|Lymphoma|2015–2019|Males|4|25–29|0.953|0.921|0.972
Relative|Lymphoma|2015–2019|Males|4|30–34|0.952|0.922|0.971
Relative|Lymphoma|2015–2019|Males|4|35–39|0.916|0.885|0.939
Relative|Lymphoma|2015–2019|Males|4|40–44|0.929|0.902|0.949
Relative|Lymphoma|2015–2019|Males|4|45–49|0.903|0.878|0.923
Relative|Lymphoma|2015–2019|Males|4|50–54|0.887|0.865|0.906
Relative|Lymphoma|2015–2019|Males|4|55–59|0.848|0.826|0.867
Relative|Lymphoma|2015–2019|Males|4|60–64|0.841|0.822|0.859
Relative|Lymphoma|2015–2019|Males|4|65–69|0.806|0.787|0.824
Relative|Lymphoma|2015–2019|Males|4|70–74|0.748|0.726|0.769
Relative|Lymphoma|2015–2019|Males|4|75–79|0.688|0.662|0.714
Relative|Lymphoma|2015–2019|Males|4|80–84|0.631|0.597|0.664
Relative|Lymphoma|2015–2019|Males|4|85+|0.486|0.442|0.531
Relative|Lymphoma|2015–2019|Males|4|All ages combined|0.785|0.777|0.793
Relative|Lymphoma|2015–2019|Males|5|00–04|0.964|0.77|0.996
Relative|Lymphoma|2015–2019|Males|5|05–09|0.962|0.886|0.988
Relative|Lymphoma|2015–2019|Males|5|10–14|0.982|0.926|0.996
Relative|Lymphoma|2015–2019|Males|5|15–19|0.951|0.912|0.974
Relative|Lymphoma|2015–2019|Males|5|20–24|0.964|0.934|0.982
Relative|Lymphoma|2015–2019|Males|5|25–29|0.941|0.907|0.963
Relative|Lymphoma|2015–2019|Males|5|30–34|0.941|0.908|0.963
Relative|Lymphoma|2015–2019|Males|5|35–39|0.911|0.879|0.935
Relative|Lymphoma|2015–2019|Males|5|40–44|0.921|0.894|0.943
Relative|Lymphoma|2015–2019|Males|5|45–49|0.888|0.862|0.91
Relative|Lymphoma|2015–2019|Males|5|50–54|0.871|0.848|0.892
Relative|Lymphoma|2015–2019|Males|5|55–59|0.832|0.81|0.853
Relative|Lymphoma|2015–2019|Males|5|60–64|0.826|0.805|0.845
Relative|Lymphoma|2015–2019|Males|5|65–69|0.791|0.77|0.81
Relative|Lymphoma|2015–2019|Males|5|70–74|0.727|0.704|0.75
Relative|Lymphoma|2015–2019|Males|5|75–79|0.669|0.641|0.697
Relative|Lymphoma|2015–2019|Males|5|80–84|0.593|0.556|0.63
Relative|Lymphoma|2015–2019|Males|5|85+|0.469|0.419|0.521
Relative|Lymphoma|2015–2019|Males|5|All ages combined|0.769|0.761|0.777
Observed|Lymphoma|2015–2019|Females|1|00–04|||
Observed|Lymphoma|2015–2019|Females|1|05–09|0.953|0.712|0.993
Observed|Lymphoma|2015–2019|Females|1|10–14|0.97|0.885|0.992
Observed|Lymphoma|2015–2019|Females|1|15–19|0.989|0.958|0.997
Observed|Lymphoma|2015–2019|Females|1|20–24|0.985|0.959|0.994
Observed|Lymphoma|2015–2019|Females|1|25–29|0.99|0.968|0.997
Observed|Lymphoma|2015–2019|Females|1|30–34|0.98|0.955|0.991
Observed|Lymphoma|2015–2019|Females|1|35–39|0.984|0.962|0.993
Observed|Lymphoma|2015–2019|Females|1|40–44|0.972|0.949|0.985
Observed|Lymphoma|2015–2019|Females|1|45–49|0.958|0.937|0.972
Observed|Lymphoma|2015–2019|Females|1|50–54|0.958|0.942|0.97
Observed|Lymphoma|2015–2019|Females|1|55–59|0.956|0.942|0.967
Observed|Lymphoma|2015–2019|Females|1|60–64|0.924|0.909|0.937
Observed|Lymphoma|2015–2019|Females|1|65–69|0.914|0.9|0.926
Observed|Lymphoma|2015–2019|Females|1|70–74|0.883|0.867|0.898
Observed|Lymphoma|2015–2019|Females|1|75–79|0.822|0.802|0.841
Observed|Lymphoma|2015–2019|Females|1|80–84|0.731|0.706|0.755
Observed|Lymphoma|2015–2019|Females|1|85+|0.536|0.509|0.563
Observed|Lymphoma|2015–2019|Females|1|All ages combined|0.862|0.856|0.868
Observed|Lymphoma|2015–2019|Females|2|00–04|||
Observed|Lymphoma|2015–2019|Females|2|05–09|||
Observed|Lymphoma|2015–2019|Females|2|10–14|0.954|0.864|0.985
Observed|Lymphoma|2015–2019|Females|2|15–19|0.979|0.945|0.992
Observed|Lymphoma|2015–2019|Females|2|20–24|0.985|0.959|0.994
Observed|Lymphoma|2015–2019|Females|2|25–29|0.979|0.953|0.99
Observed|Lymphoma|2015–2019|Females|2|30–34|0.959|0.928|0.976
Observed|Lymphoma|2015–2019|Females|2|35–39|0.975|0.95|0.987
Observed|Lymphoma|2015–2019|Females|2|40–44|0.951|0.923|0.969
Observed|Lymphoma|2015–2019|Females|2|45–49|0.935|0.91|0.953
Observed|Lymphoma|2015–2019|Females|2|50–54|0.944|0.926|0.958
Observed|Lymphoma|2015–2019|Females|2|55–59|0.925|0.907|0.94
Observed|Lymphoma|2015–2019|Females|2|60–64|0.894|0.876|0.909
Observed|Lymphoma|2015–2019|Females|2|65–69|0.874|0.857|0.889
Observed|Lymphoma|2015–2019|Females|2|70–74|0.838|0.819|0.855
Observed|Lymphoma|2015–2019|Females|2|75–79|0.753|0.73|0.775
Observed|Lymphoma|2015–2019|Females|2|80–84|0.645|0.617|0.67
Observed|Lymphoma|2015–2019|Females|2|85+|0.415|0.389|0.442
Observed|Lymphoma|2015–2019|Females|2|All ages combined|0.813|0.806|0.82
Observed|Lymphoma|2015–2019|Females|3|00–04|||
Observed|Lymphoma|2015–2019|Females|3|05–09|||
Observed|Lymphoma|2015–2019|Females|3|10–14|0.954|0.864|0.985
Observed|Lymphoma|2015–2019|Females|3|15–19|0.964|0.927|0.983
Observed|Lymphoma|2015–2019|Females|3|20–24|0.976|0.948|0.989
Observed|Lymphoma|2015–2019|Females|3|25–29|0.979|0.953|0.99
Observed|Lymphoma|2015–2019|Females|3|30–34|0.944|0.911|0.966
Observed|Lymphoma|2015–2019|Females|3|35–39|0.962|0.934|0.978
Observed|Lymphoma|2015–2019|Females|3|40–44|0.933|0.902|0.954
Observed|Lymphoma|2015–2019|Females|3|45–49|0.922|0.896|0.942
Observed|Lymphoma|2015–2019|Females|3|50–54|0.929|0.908|0.945
Observed|Lymphoma|2015–2019|Females|3|55–59|0.899|0.879|0.916
Observed|Lymphoma|2015–2019|Females|3|60–64|0.87|0.851|0.887
Observed|Lymphoma|2015–2019|Females|3|65–69|0.85|0.832|0.866
Observed|Lymphoma|2015–2019|Females|3|70–74|0.797|0.777|0.816
Observed|Lymphoma|2015–2019|Females|3|75–79|0.706|0.681|0.729
Observed|Lymphoma|2015–2019|Females|3|80–84|0.581|0.553|0.608
Observed|Lymphoma|2015–2019|Females|3|85+|0.338|0.313|0.364
Observed|Lymphoma|2015–2019|Females|3|All ages combined|0.778|0.77|0.785
Observed|Lymphoma|2015–2019|Females|4|00–04|||
Observed|Lymphoma|2015–2019|Females|4|05–09|||
Observed|Lymphoma|2015–2019|Females|4|10–14|0.936|0.838|0.976
Observed|Lymphoma|2015–2019|Females|4|15–19|0.96|0.921|0.98
Observed|Lymphoma|2015–2019|Females|4|20–24|0.972|0.943|0.987
Observed|Lymphoma|2015–2019|Females|4|25–29|0.979|0.953|0.99
Observed|Lymphoma|2015–2019|Females|4|30–34|0.944|0.911|0.966
Observed|Lymphoma|2015–2019|Females|4|35–39|0.962|0.934|0.978
Observed|Lymphoma|2015–2019|Females|4|40–44|0.933|0.902|0.954
Observed|Lymphoma|2015–2019|Females|4|45–49|0.906|0.877|0.928
Observed|Lymphoma|2015–2019|Females|4|50–54|0.914|0.892|0.931
Observed|Lymphoma|2015–2019|Females|4|55–59|0.888|0.867|0.906
Observed|Lymphoma|2015–2019|Females|4|60–64|0.852|0.831|0.87
Observed|Lymphoma|2015–2019|Females|4|65–69|0.826|0.807|0.844
Observed|Lymphoma|2015–2019|Females|4|70–74|0.768|0.747|0.788
Observed|Lymphoma|2015–2019|Females|4|75–79|0.662|0.637|0.686
Observed|Lymphoma|2015–2019|Females|4|80–84|0.528|0.499|0.555
Observed|Lymphoma|2015–2019|Females|4|85+|0.288|0.263|0.313
Observed|Lymphoma|2015–2019|Females|4|All ages combined|0.752|0.744|0.759
Observed|Lymphoma|2015–2019|Females|5|00–04|||
Observed|Lymphoma|2015–2019|Females|5|05–09|||
Observed|Lymphoma|2015–2019|Females|5|10–14|0.936|0.838|0.976
Observed|Lymphoma|2015–2019|Females|5|15–19|0.96|0.921|0.98
Observed|Lymphoma|2015–2019|Females|5|20–24|0.972|0.943|0.987
Observed|Lymphoma|2015–2019|Females|5|25–29|0.979|0.953|0.99
Observed|Lymphoma|2015–2019|Females|5|30–34|0.944|0.911|0.966
Observed|Lymphoma|2015–2019|Females|5|35–39|0.962|0.934|0.978
Observed|Lymphoma|2015–2019|Females|5|40–44|0.93|0.9|0.952
Observed|Lymphoma|2015–2019|Females|5|45–49|0.897|0.868|0.92
Observed|Lymphoma|2015–2019|Females|5|50–54|0.9|0.877|0.92
Observed|Lymphoma|2015–2019|Females|5|55–59|0.874|0.852|0.893
Observed|Lymphoma|2015–2019|Females|5|60–64|0.832|0.81|0.851
Observed|Lymphoma|2015–2019|Females|5|65–69|0.804|0.784|0.823
Observed|Lymphoma|2015–2019|Females|5|70–74|0.733|0.71|0.755
Observed|Lymphoma|2015–2019|Females|5|75–79|0.614|0.588|0.639
Observed|Lymphoma|2015–2019|Females|5|80–84|0.463|0.434|0.491
Observed|Lymphoma|2015–2019|Females|5|85+|0.237|0.214|0.261
Observed|Lymphoma|2015–2019|Females|5|All ages combined|0.724|0.716|0.732
Relative|Lymphoma|2015–2019|Females|1|00–04|||
Relative|Lymphoma|2015–2019|Females|1|05–09|0.953|0.712|0.993
Relative|Lymphoma|2015–2019|Females|1|10–14|0.97|0.885|0.992
Relative|Lymphoma|2015–2019|Females|1|15–19|0.989|0.958|0.998
Relative|Lymphoma|2015–2019|Females|1|20–24|0.985|0.96|0.994
Relative|Lymphoma|2015–2019|Females|1|25–29|0.99|0.968|0.997
Relative|Lymphoma|2015–2019|Females|1|30–34|0.98|0.956|0.991
Relative|Lymphoma|2015–2019|Females|1|35–39|0.985|0.963|0.994
Relative|Lymphoma|2015–2019|Females|1|40–44|0.973|0.95|0.986
Relative|Lymphoma|2015–2019|Females|1|45–49|0.959|0.938|0.973
Relative|Lymphoma|2015–2019|Females|1|50–54|0.96|0.944|0.972
Relative|Lymphoma|2015–2019|Females|1|55–59|0.959|0.945|0.97
Relative|Lymphoma|2015–2019|Females|1|60–64|0.929|0.913|0.942
Relative|Lymphoma|2015–2019|Females|1|65–69|0.921|0.906|0.933
Relative|Lymphoma|2015–2019|Females|1|70–74|0.894|0.877|0.909
Relative|Lymphoma|2015–2019|Females|1|75–79|0.84|0.819|0.859
Relative|Lymphoma|2015–2019|Females|1|80–84|0.762|0.736|0.787
Relative|Lymphoma|2015–2019|Females|1|85+|0.601|0.571|0.631
Relative|Lymphoma|2015–2019|Females|1|All ages combined|0.881|0.874|0.887
Relative|Lymphoma|2015–2019|Females|2|00–04|||
Relative|Lymphoma|2015–2019|Females|2|05–09|||
Relative|Lymphoma|2015–2019|Females|2|10–14|0.954|0.864|0.985
Relative|Lymphoma|2015–2019|Females|2|15–19|0.98|0.946|0.993
Relative|Lymphoma|2015–2019|Females|2|20–24|0.985|0.96|0.995
Relative|Lymphoma|2015–2019|Females|2|25–29|0.979|0.954|0.991
Relative|Lymphoma|2015–2019|Females|2|30–34|0.96|0.929|0.977
Relative|Lymphoma|2015–2019|Females|2|35–39|0.976|0.951|0.988
Relative|Lymphoma|2015–2019|Females|2|40–44|0.953|0.925|0.971
Relative|Lymphoma|2015–2019|Females|2|45–49|0.938|0.913|0.956
Relative|Lymphoma|2015–2019|Females|2|50–54|0.949|0.93|0.963
Relative|Lymphoma|2015–2019|Females|2|55–59|0.931|0.913|0.946
Relative|Lymphoma|2015–2019|Females|2|60–64|0.903|0.885|0.918
Relative|Lymphoma|2015–2019|Females|2|65–69|0.887|0.87|0.903
Relative|Lymphoma|2015–2019|Females|2|70–74|0.86|0.841|0.877
Relative|Lymphoma|2015–2019|Females|2|75–79|0.789|0.765|0.811
Relative|Lymphoma|2015–2019|Females|2|80–84|0.705|0.675|0.733
Relative|Lymphoma|2015–2019|Females|2|85+|0.526|0.493|0.56
Relative|Lymphoma|2015–2019|Females|2|All ages combined|0.846|0.838|0.852
Relative|Lymphoma|2015–2019|Females|3|00–04|||
Relative|Lymphoma|2015–2019|Females|3|05–09|||
Relative|Lymphoma|2015–2019|Females|3|10–14|0.954|0.864|0.985
Relative|Lymphoma|2015–2019|Females|3|15–19|0.965|0.927|0.983
Relative|Lymphoma|2015–2019|Females|3|20–24|0.977|0.949|0.99
Relative|Lymphoma|2015–2019|Females|3|25–29|0.98|0.954|0.991
Relative|Lymphoma|2015–2019|Females|3|30–34|0.946|0.912|0.967
Relative|Lymphoma|2015–2019|Females|3|35–39|0.964|0.936|0.98
Relative|Lymphoma|2015–2019|Females|3|40–44|0.936|0.905|0.957
Relative|Lymphoma|2015–2019|Females|3|45–49|0.926|0.9|0.946
Relative|Lymphoma|2015–2019|Females|3|50–54|0.935|0.915|0.952
Relative|Lymphoma|2015–2019|Females|3|55–59|0.909|0.888|0.926
Relative|Lymphoma|2015–2019|Females|3|60–64|0.884|0.864|0.901
Relative|Lymphoma|2015–2019|Females|3|65–69|0.871|0.852|0.887
Relative|Lymphoma|2015–2019|Females|3|70–74|0.831|0.809|0.85
Relative|Lymphoma|2015–2019|Females|3|75–79|0.76|0.734|0.785
Relative|Lymphoma|2015–2019|Females|3|80–84|0.67|0.638|0.701
Relative|Lymphoma|2015–2019|Females|3|85+|0.491|0.454|0.528
Relative|Lymphoma|2015–2019|Females|3|All ages combined|0.824|0.816|0.831
Relative|Lymphoma|2015–2019|Females|4|00–04|||
Relative|Lymphoma|2015–2019|Females|4|05–09|||
Relative|Lymphoma|2015–2019|Females|4|10–14|0.936|0.838|0.976
Relative|Lymphoma|2015–2019|Females|4|15–19|0.96|0.921|0.98
Relative|Lymphoma|2015–2019|Females|4|20–24|0.973|0.944|0.988
Relative|Lymphoma|2015–2019|Females|4|25–29|0.98|0.955|0.992
Relative|Lymphoma|2015–2019|Females|4|30–34|0.946|0.912|0.967
Relative|Lymphoma|2015–2019|Females|4|35–39|0.964|0.936|0.981
Relative|Lymphoma|2015–2019|Females|4|40–44|0.937|0.906|0.958
Relative|Lymphoma|2015–2019|Females|4|45–49|0.912|0.883|0.934
Relative|Lymphoma|2015–2019|Females|4|50–54|0.923|0.9|0.94
Relative|Lymphoma|2015–2019|Females|4|55–59|0.901|0.88|0.919
Relative|Lymphoma|2015–2019|Females|4|60–64|0.87|0.849|0.889
Relative|Lymphoma|2015–2019|Females|4|65–69|0.855|0.835|0.873
Relative|Lymphoma|2015–2019|Females|4|70–74|0.814|0.791|0.836
Relative|Lymphoma|2015–2019|Females|4|75–79|0.736|0.708|0.763
Relative|Lymphoma|2015–2019|Females|4|80–84|0.648|0.613|0.682
Relative|Lymphoma|2015–2019|Females|4|85+|0.485|0.443|0.527
Relative|Lymphoma|2015–2019|Females|4|All ages combined|0.811|0.803|0.819
Relative|Lymphoma|2015–2019|Females|5|00–04|||
Relative|Lymphoma|2015–2019|Females|5|05–09|||
Relative|Lymphoma|2015–2019|Females|5|10–14|0.937|0.838|0.976
Relative|Lymphoma|2015–2019|Females|5|15–19|0.961|0.922|0.981
Relative|Lymphoma|2015–2019|Females|5|20–24|0.974|0.944|0.988
Relative|Lymphoma|2015–2019|Females|5|25–29|0.98|0.955|0.992
Relative|Lymphoma|2015–2019|Females|5|30–34|0.947|0.913|0.968
Relative|Lymphoma|2015–2019|Females|5|35–39|0.965|0.937|0.982
Relative|Lymphoma|2015–2019|Females|5|40–44|0.936|0.905|0.957
Relative|Lymphoma|2015–2019|Females|5|45–49|0.904|0.875|0.928
Relative|Lymphoma|2015–2019|Females|5|50–54|0.912|0.888|0.931
Relative|Lymphoma|2015–2019|Females|5|55–59|0.89|0.868|0.91
Relative|Lymphoma|2015–2019|Females|5|60–64|0.855|0.833|0.875
Relative|Lymphoma|2015–2019|Females|5|65–69|0.842|0.82|0.861
Relative|Lymphoma|2015–2019|Females|5|70–74|0.792|0.767|0.816
Relative|Lymphoma|2015–2019|Females|5|75–79|0.708|0.678|0.737
Relative|Lymphoma|2015–2019|Females|5|80–84|0.611|0.573|0.648
Relative|Lymphoma|2015–2019|Females|5|85+|0.468|0.422|0.515
Relative|Lymphoma|2015–2019|Females|5|All ages combined|0.796|0.787|0.805
Observed|Lymphoma|2015–2019|Persons|1|00–04|0.903|0.762|0.962
Observed|Lymphoma|2015–2019|Persons|1|05–09|0.97|0.91|0.99
Observed|Lymphoma|2015–2019|Persons|1|10–14|0.982|0.946|0.994
Observed|Lymphoma|2015–2019|Persons|1|15–19|0.98|0.961|0.99
Observed|Lymphoma|2015–2019|Persons|1|20–24|0.983|0.968|0.991
Observed|Lymphoma|2015–2019|Persons|1|25–29|0.984|0.97|0.992
Observed|Lymphoma|2015–2019|Persons|1|30–34|0.981|0.967|0.989
Observed|Lymphoma|2015–2019|Persons|1|35–39|0.965|0.95|0.976
Observed|Lymphoma|2015–2019|Persons|1|40–44|0.966|0.952|0.976
Observed|Lymphoma|2015–2019|Persons|1|45–49|0.948|0.935|0.959
Observed|Lymphoma|2015–2019|Persons|1|50–54|0.947|0.935|0.956
Observed|Lymphoma|2015–2019|Persons|1|55–59|0.936|0.926|0.945
Observed|Lymphoma|2015–2019|Persons|1|60–64|0.919|0.909|0.928
Observed|Lymphoma|2015–2019|Persons|1|65–69|0.895|0.885|0.904
Observed|Lymphoma|2015–2019|Persons|1|70–74|0.873|0.862|0.883
Observed|Lymphoma|2015–2019|Persons|1|75–79|0.809|0.795|0.822
Observed|Lymphoma|2015–2019|Persons|1|80–84|0.727|0.71|0.743
Observed|Lymphoma|2015–2019|Persons|1|85+|0.537|0.518|0.556
Observed|Lymphoma|2015–2019|Persons|1|All ages combined|0.857|0.853|0.861
Observed|Lymphoma|2015–2019|Persons|2|00–04|0.879|0.734|0.948
Observed|Lymphoma|2015–2019|Persons|2|05–09|0.97|0.91|0.99
Observed|Lymphoma|2015–2019|Persons|2|10–14|0.97|0.93|0.988
Observed|Lymphoma|2015–2019|Persons|2|15–19|0.97|0.948|0.983
Observed|Lymphoma|2015–2019|Persons|2|20–24|0.98|0.964|0.989
Observed|Lymphoma|2015–2019|Persons|2|25–29|0.974|0.957|0.984
Observed|Lymphoma|2015–2019|Persons|2|30–34|0.962|0.943|0.974
Observed|Lymphoma|2015–2019|Persons|2|35–39|0.95|0.931|0.963
Observed|Lymphoma|2015–2019|Persons|2|40–44|0.944|0.926|0.957
Observed|Lymphoma|2015–2019|Persons|2|45–49|0.925|0.909|0.938
Observed|Lymphoma|2015–2019|Persons|2|50–54|0.926|0.913|0.937
Observed|Lymphoma|2015–2019|Persons|2|55–59|0.896|0.883|0.907
Observed|Lymphoma|2015–2019|Persons|2|60–64|0.88|0.868|0.891
Observed|Lymphoma|2015–2019|Persons|2|65–69|0.849|0.837|0.859
Observed|Lymphoma|2015–2019|Persons|2|70–74|0.811|0.799|0.823
Observed|Lymphoma|2015–2019|Persons|2|75–79|0.732|0.717|0.746
Observed|Lymphoma|2015–2019|Persons|2|80–84|0.632|0.615|0.65
Observed|Lymphoma|2015–2019|Persons|2|85+|0.419|0.4|0.437
Observed|Lymphoma|2015–2019|Persons|2|All ages combined|0.802|0.797|0.806
Observed|Lymphoma|2015–2019|Persons|3|00–04|0.879|0.734|0.948
Observed|Lymphoma|2015–2019|Persons|3|05–09|0.96|0.896|0.985
Observed|Lymphoma|2015–2019|Persons|3|10–14|0.97|0.93|0.988
Observed|Lymphoma|2015–2019|Persons|3|15–19|0.961|0.937|0.976
Observed|Lymphoma|2015–2019|Persons|3|20–24|0.972|0.954|0.983
Observed|Lymphoma|2015–2019|Persons|3|25–29|0.967|0.949|0.979
Observed|Lymphoma|2015–2019|Persons|3|30–34|0.948|0.928|0.963
Observed|Lymphoma|2015–2019|Persons|3|35–39|0.936|0.916|0.952
Observed|Lymphoma|2015–2019|Persons|3|40–44|0.927|0.907|0.942
Observed|Lymphoma|2015–2019|Persons|3|45–49|0.913|0.897|0.928
Observed|Lymphoma|2015–2019|Persons|3|50–54|0.905|0.891|0.918
Observed|Lymphoma|2015–2019|Persons|3|55–59|0.873|0.859|0.885
Observed|Lymphoma|2015–2019|Persons|3|60–64|0.849|0.836|0.861
Observed|Lymphoma|2015–2019|Persons|3|65–69|0.818|0.805|0.83
Observed|Lymphoma|2015–2019|Persons|3|70–74|0.764|0.751|0.777
Observed|Lymphoma|2015–2019|Persons|3|75–79|0.672|0.656|0.688
Observed|Lymphoma|2015–2019|Persons|3|80–84|0.562|0.544|0.58
Observed|Lymphoma|2015–2019|Persons|3|85+|0.338|0.32|0.356
Observed|Lymphoma|2015–2019|Persons|3|All ages combined|0.762|0.757|0.767
Observed|Lymphoma|2015–2019|Persons|4|00–04|0.879|0.734|0.948
Observed|Lymphoma|2015–2019|Persons|4|05–09|0.96|0.896|0.985
Observed|Lymphoma|2015–2019|Persons|4|10–14|0.964|0.923|0.984
Observed|Lymphoma|2015–2019|Persons|4|15–19|0.954|0.928|0.97
Observed|Lymphoma|2015–2019|Persons|4|20–24|0.968|0.95|0.98
Observed|Lymphoma|2015–2019|Persons|4|25–29|0.964|0.945|0.976
Observed|Lymphoma|2015–2019|Persons|4|30–34|0.947|0.926|0.962
Observed|Lymphoma|2015–2019|Persons|4|35–39|0.932|0.912|0.948
Observed|Lymphoma|2015–2019|Persons|4|40–44|0.927|0.907|0.942
Observed|Lymphoma|2015–2019|Persons|4|45–49|0.898|0.88|0.914
Observed|Lymphoma|2015–2019|Persons|4|50–54|0.89|0.875|0.904
Observed|Lymphoma|2015–2019|Persons|4|55–59|0.853|0.839|0.867
Observed|Lymphoma|2015–2019|Persons|4|60–64|0.828|0.814|0.841
Observed|Lymphoma|2015–2019|Persons|4|65–69|0.789|0.776|0.802
Observed|Lymphoma|2015–2019|Persons|4|70–74|0.718|0.704|0.732
Observed|Lymphoma|2015–2019|Persons|4|75–79|0.619|0.602|0.635
Observed|Lymphoma|2015–2019|Persons|4|80–84|0.496|0.477|0.515
Observed|Lymphoma|2015–2019|Persons|4|85+|0.276|0.259|0.293
Observed|Lymphoma|2015–2019|Persons|4|All ages combined|0.73|0.725|0.735
Observed|Lymphoma|2015–2019|Persons|5|00–04|0.879|0.734|0.948
Observed|Lymphoma|2015–2019|Persons|5|05–09|0.96|0.896|0.985
Observed|Lymphoma|2015–2019|Persons|5|10–14|0.964|0.923|0.984
Observed|Lymphoma|2015–2019|Persons|5|15–19|0.954|0.928|0.97
Observed|Lymphoma|2015–2019|Persons|5|20–24|0.967|0.947|0.979
Observed|Lymphoma|2015–2019|Persons|5|25–29|0.957|0.937|0.971
Observed|Lymphoma|2015–2019|Persons|5|30–34|0.939|0.917|0.956
Observed|Lymphoma|2015–2019|Persons|5|35–39|0.928|0.908|0.945
Observed|Lymphoma|2015–2019|Persons|5|40–44|0.92|0.9|0.936
Observed|Lymphoma|2015–2019|Persons|5|45–49|0.885|0.866|0.901
Observed|Lymphoma|2015–2019|Persons|5|50–54|0.874|0.857|0.888
Observed|Lymphoma|2015–2019|Persons|5|55–59|0.835|0.82|0.85
Observed|Lymphoma|2015–2019|Persons|5|60–64|0.806|0.792|0.819
Observed|Lymphoma|2015–2019|Persons|5|65–69|0.764|0.75|0.777
Observed|Lymphoma|2015–2019|Persons|5|70–74|0.681|0.666|0.696
Observed|Lymphoma|2015–2019|Persons|5|75–79|0.572|0.555|0.589
Observed|Lymphoma|2015–2019|Persons|5|80–84|0.429|0.41|0.448
Observed|Lymphoma|2015–2019|Persons|5|85+|0.224|0.208|0.241
Observed|Lymphoma|2015–2019|Persons|5|All ages combined|0.701|0.695|0.706
Relative|Lymphoma|2015–2019|Persons|1|00–04|0.903|0.763|0.963
Relative|Lymphoma|2015–2019|Persons|1|05–09|0.97|0.91|0.99
Relative|Lymphoma|2015–2019|Persons|1|10–14|0.982|0.946|0.994
Relative|Lymphoma|2015–2019|Persons|1|15–19|0.98|0.961|0.99
Relative|Lymphoma|2015–2019|Persons|1|20–24|0.984|0.969|0.992
Relative|Lymphoma|2015–2019|Persons|1|25–29|0.985|0.971|0.992
Relative|Lymphoma|2015–2019|Persons|1|30–34|0.982|0.968|0.99
Relative|Lymphoma|2015–2019|Persons|1|35–39|0.966|0.951|0.977
Relative|Lymphoma|2015–2019|Persons|1|40–44|0.967|0.953|0.977
Relative|Lymphoma|2015–2019|Persons|1|45–49|0.95|0.936|0.961
Relative|Lymphoma|2015–2019|Persons|1|50–54|0.95|0.938|0.959
Relative|Lymphoma|2015–2019|Persons|1|55–59|0.94|0.93|0.949
Relative|Lymphoma|2015–2019|Persons|1|60–64|0.925|0.915|0.934
Relative|Lymphoma|2015–2019|Persons|1|65–69|0.904|0.894|0.913
Relative|Lymphoma|2015–2019|Persons|1|70–74|0.888|0.877|0.898
Relative|Lymphoma|2015–2019|Persons|1|75–79|0.832|0.818|0.845
Relative|Lymphoma|2015–2019|Persons|1|80–84|0.766|0.748|0.782
Relative|Lymphoma|2015–2019|Persons|1|85+|0.609|0.587|0.63
Relative|Lymphoma|2015–2019|Persons|1|All ages combined|0.877|0.873|0.881
Relative|Lymphoma|2015–2019|Persons|2|00–04|0.88|0.735|0.948
Relative|Lymphoma|2015–2019|Persons|2|05–09|0.97|0.91|0.99
Relative|Lymphoma|2015–2019|Persons|2|10–14|0.971|0.93|0.988
Relative|Lymphoma|2015–2019|Persons|2|15–19|0.971|0.949|0.984
Relative|Lymphoma|2015–2019|Persons|2|20–24|0.981|0.964|0.99
Relative|Lymphoma|2015–2019|Persons|2|25–29|0.975|0.958|0.985
Relative|Lymphoma|2015–2019|Persons|2|30–34|0.963|0.945|0.975
Relative|Lymphoma|2015–2019|Persons|2|35–39|0.951|0.933|0.965
Relative|Lymphoma|2015–2019|Persons|2|40–44|0.946|0.929|0.96
Relative|Lymphoma|2015–2019|Persons|2|45–49|0.928|0.913|0.942
Relative|Lymphoma|2015–2019|Persons|2|50–54|0.932|0.919|0.943
Relative|Lymphoma|2015–2019|Persons|2|55–59|0.904|0.891|0.915
Relative|Lymphoma|2015–2019|Persons|2|60–64|0.892|0.88|0.903
Relative|Lymphoma|2015–2019|Persons|2|65–69|0.867|0.855|0.878
Relative|Lymphoma|2015–2019|Persons|2|70–74|0.84|0.827|0.852
Relative|Lymphoma|2015–2019|Persons|2|75–79|0.777|0.761|0.793
Relative|Lymphoma|2015–2019|Persons|2|80–84|0.707|0.687|0.726
Relative|Lymphoma|2015–2019|Persons|2|85+|0.543|0.519|0.567
Relative|Lymphoma|2015–2019|Persons|2|All ages combined|0.838|0.834|0.843
Relative|Lymphoma|2015–2019|Persons|3|00–04|0.88|0.735|0.948
Relative|Lymphoma|2015–2019|Persons|3|05–09|0.96|0.896|0.985
Relative|Lymphoma|2015–2019|Persons|3|10–14|0.971|0.931|0.988
Relative|Lymphoma|2015–2019|Persons|3|15–19|0.962|0.938|0.977
Relative|Lymphoma|2015–2019|Persons|3|20–24|0.974|0.956|0.985
Relative|Lymphoma|2015–2019|Persons|3|25–29|0.969|0.95|0.98
Relative|Lymphoma|2015–2019|Persons|3|30–34|0.95|0.93|0.965
Relative|Lymphoma|2015–2019|Persons|3|35–39|0.939|0.919|0.954
Relative|Lymphoma|2015–2019|Persons|3|40–44|0.931|0.911|0.946
Relative|Lymphoma|2015–2019|Persons|3|45–49|0.919|0.902|0.934
Relative|Lymphoma|2015–2019|Persons|3|50–54|0.914|0.899|0.927
Relative|Lymphoma|2015–2019|Persons|3|55–59|0.885|0.871|0.898
Relative|Lymphoma|2015–2019|Persons|3|60–64|0.867|0.854|0.88
Relative|Lymphoma|2015–2019|Persons|3|65–69|0.846|0.833|0.858
Relative|Lymphoma|2015–2019|Persons|3|70–74|0.807|0.793|0.821
Relative|Lymphoma|2015–2019|Persons|3|75–79|0.74|0.722|0.757
Relative|Lymphoma|2015–2019|Persons|3|80–84|0.671|0.649|0.693
Relative|Lymphoma|2015–2019|Persons|3|85+|0.507|0.48|0.534
Relative|Lymphoma|2015–2019|Persons|3|All ages combined|0.814|0.809|0.82
Relative|Lymphoma|2015–2019|Persons|4|00–04|0.88|0.735|0.948
Relative|Lymphoma|2015–2019|Persons|4|05–09|0.96|0.896|0.985
Relative|Lymphoma|2015–2019|Persons|4|10–14|0.965|0.923|0.985
Relative|Lymphoma|2015–2019|Persons|4|15–19|0.955|0.93|0.972
Relative|Lymphoma|2015–2019|Persons|4|20–24|0.97|0.951|0.982
Relative|Lymphoma|2015–2019|Persons|4|25–29|0.966|0.947|0.978
Relative|Lymphoma|2015–2019|Persons|4|30–34|0.949|0.928|0.965
Relative|Lymphoma|2015–2019|Persons|4|35–39|0.936|0.916|0.952
Relative|Lymphoma|2015–2019|Persons|4|40–44|0.932|0.913|0.948
Relative|Lymphoma|2015–2019|Persons|4|45–49|0.906|0.888|0.922
Relative|Lymphoma|2015–2019|Persons|4|50–54|0.902|0.887|0.916
Relative|Lymphoma|2015–2019|Persons|4|55–59|0.87|0.855|0.884
Relative|Lymphoma|2015–2019|Persons|4|60–64|0.853|0.839|0.867
Relative|Lymphoma|2015–2019|Persons|4|65–69|0.827|0.813|0.84
Relative|Lymphoma|2015–2019|Persons|4|70–74|0.776|0.76|0.791
Relative|Lymphoma|2015–2019|Persons|4|75–79|0.709|0.69|0.728
Relative|Lymphoma|2015–2019|Persons|4|80–84|0.639|0.615|0.663
Relative|Lymphoma|2015–2019|Persons|4|85+|0.486|0.456|0.517
Relative|Lymphoma|2015–2019|Persons|4|All ages combined|0.796|0.791|0.802
Relative|Lymphoma|2015–2019|Persons|5|00–04|0.88|0.735|0.949
Relative|Lymphoma|2015–2019|Persons|5|05–09|0.96|0.896|0.985
Relative|Lymphoma|2015–2019|Persons|5|10–14|0.965|0.923|0.985
Relative|Lymphoma|2015–2019|Persons|5|15–19|0.956|0.93|0.972
Relative|Lymphoma|2015–2019|Persons|5|20–24|0.969|0.95|0.981
Relative|Lymphoma|2015–2019|Persons|5|25–29|0.959|0.939|0.973
Relative|Lymphoma|2015–2019|Persons|5|30–34|0.943|0.921|0.959
Relative|Lymphoma|2015–2019|Persons|5|35–39|0.933|0.912|0.95
Relative|Lymphoma|2015–2019|Persons|5|40–44|0.927|0.907|0.943
Relative|Lymphoma|2015–2019|Persons|5|45–49|0.895|0.876|0.912
Relative|Lymphoma|2015–2019|Persons|5|50–54|0.889|0.872|0.904
Relative|Lymphoma|2015–2019|Persons|5|55–59|0.857|0.841|0.872
Relative|Lymphoma|2015–2019|Persons|5|60–64|0.838|0.823|0.852
Relative|Lymphoma|2015–2019|Persons|5|65–69|0.812|0.798|0.826
Relative|Lymphoma|2015–2019|Persons|5|70–74|0.755|0.738|0.771
Relative|Lymphoma|2015–2019|Persons|5|75–79|0.686|0.665|0.706
Relative|Lymphoma|2015–2019|Persons|5|80–84|0.601|0.575|0.628
Relative|Lymphoma|2015–2019|Persons|5|85+|0.469|0.435|0.504
Relative|Lymphoma|2015–2019|Persons|5|All ages combined|0.781|0.775|0.787
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|20–24|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|25–29|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|30–34|1|0.872|1
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|35–39|0.962|0.761|0.995
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|40–44|0.929|0.746|0.982
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|45–49|1|0.922|1
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|50–54|0.947|0.845|0.983
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|55–59|0.943|0.855|0.978
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|60–64|0.897|0.816|0.943
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|65–69|0.943|0.883|0.972
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|70–74|0.932|0.862|0.967
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|75–79|0.769|0.674|0.84
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|80–84|0.679|0.575|0.763
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|85+|0.606|0.497|0.698
Observed|Major salivary glands (cancer of the)|2015–2019|Males|1|All ages combined|0.861|0.836|0.882
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|20–24|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|25–29|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|30–34|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|35–39|0.962|0.761|0.995
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|40–44|0.899|0.718|0.966
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|45–49|0.943|0.791|0.985
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|50–54|0.894|0.779|0.951
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|55–59|0.902|0.805|0.952
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|60–64|0.864|0.777|0.919
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|65–69|0.819|0.741|0.876
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|70–74|0.818|0.729|0.879
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|75–79|0.615|0.514|0.702
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|80–84|0.531|0.428|0.624
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|85+|0.502|0.397|0.598
Observed|Major salivary glands (cancer of the)|2015–2019|Males|2|All ages combined|0.77|0.741|0.796
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|20–24|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|25–29|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|30–34|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|35–39|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|40–44|0.868|0.686|0.948
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|45–49|0.91|0.746|0.97
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|50–54|0.833|0.704|0.91
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|55–59|0.827|0.715|0.898
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|60–64|0.83|0.738|0.892
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|65–69|0.77|0.686|0.834
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|70–74|0.747|0.653|0.819
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|75–79|0.55|0.45|0.64
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|80–84|0.476|0.375|0.57
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|85+|0.403|0.305|0.5
Observed|Major salivary glands (cancer of the)|2015–2019|Males|3|All ages combined|0.712|0.681|0.741
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|20–24|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|25–29|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|30–34|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|35–39|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|40–44|0.868|0.686|0.948
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|45–49|0.91|0.746|0.97
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|50–54|0.811|0.676|0.894
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|55–59|0.794|0.676|0.873
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|60–64|0.806|0.71|0.873
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|65–69|0.718|0.629|0.789
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|70–74|0.652|0.553|0.734
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|75–79|0.504|0.404|0.595
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|80–84|0.348|0.259|0.438
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|85+|0.361|0.266|0.456
Observed|Major salivary glands (cancer of the)|2015–2019|Males|4|All ages combined|0.658|0.625|0.688
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|20–24|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|25–29|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|30–34|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|35–39|||
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|40–44|0.868|0.686|0.948
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|45–49|0.91|0.746|0.97
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|50–54|0.772|0.632|0.864
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|55–59|0.747|0.624|0.835
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|60–64|0.78|0.679|0.853
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|65–69|0.66|0.567|0.738
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|70–74|0.572|0.471|0.66
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|75–79|0.463|0.365|0.556
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|80–84|0.313|0.228|0.401
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|85+|0.291|0.2|0.388
Observed|Major salivary glands (cancer of the)|2015–2019|Males|5|All ages combined|0.616|0.582|0.647
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|20–24|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|25–29|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|30–34|1.001|0.873|1.001
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|35–39|0.963|0.762|0.996
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|40–44|0.931|0.747|0.983
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|45–49|1.002|0.924|1.002
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|50–54|0.951|0.848|0.986
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|55–59|0.948|0.86|0.983
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|60–64|0.904|0.823|0.951
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|65–69|0.954|0.894|0.984
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|70–74|0.95|0.88|0.986
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|75–79|0.795|0.697|0.868
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|80–84|0.723|0.612|0.813
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|85+|0.707|0.58|0.814
Relative|Major salivary glands (cancer of the)|2015–2019|Males|1|All ages combined|0.887|0.862|0.909
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|20–24|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|25–29|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|30–34|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|35–39|0.965|0.763|0.997
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|40–44|0.902|0.721|0.97
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|45–49|0.948|0.794|0.99
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|50–54|0.9|0.785|0.958
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|55–59|0.911|0.813|0.962
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|60–64|0.879|0.79|0.934
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|65–69|0.84|0.76|0.898
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|70–74|0.853|0.76|0.917
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|75–79|0.66|0.551|0.753
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|80–84|0.609|0.49|0.715
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|85+|0.686|0.542|0.818
Relative|Major salivary glands (cancer of the)|2015–2019|Males|2|All ages combined|0.816|0.785|0.844
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|20–24|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|25–29|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|30–34|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|35–39|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|40–44|0.873|0.689|0.953
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|45–49|0.917|0.752|0.978
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|50–54|0.843|0.712|0.921
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|55–59|0.841|0.727|0.913
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|60–64|0.852|0.757|0.916
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|65–69|0.801|0.714|0.868
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|70–74|0.798|0.698|0.875
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|75–79|0.616|0.503|0.716
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|80–84|0.591|0.467|0.708
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|85+|0.654|0.494|0.81
Relative|Major salivary glands (cancer of the)|2015–2019|Males|3|All ages combined|0.778|0.744|0.809
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|20–24|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|25–29|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|30–34|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|35–39|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|40–44|0.874|0.691|0.955
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|45–49|0.92|0.754|0.981
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|50–54|0.824|0.687|0.909
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|55–59|0.813|0.692|0.894
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|60–64|0.836|0.736|0.906
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|65–69|0.759|0.665|0.833
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|70–74|0.716|0.607|0.806
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|75–79|0.59|0.474|0.697
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|80–84|0.473|0.352|0.595
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|85+|0.705|0.519|0.892
Relative|Major salivary glands (cancer of the)|2015–2019|Males|4|All ages combined|0.741|0.704|0.775
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|20–24|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|25–29|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|30–34|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|35–39|||
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|40–44|0.876|0.692|0.957
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|45–49|0.923|0.756|0.984
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|50–54|0.788|0.646|0.882
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|55–59|0.771|0.644|0.861
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|60–64|0.818|0.712|0.894
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|65–69|0.71|0.61|0.793
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|70–74|0.647|0.534|0.747
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|75–79|0.573|0.452|0.687
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|80–84|0.471|0.343|0.604
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|85+|0.691|0.475|0.92
Relative|Major salivary glands (cancer of the)|2015–2019|Males|5|All ages combined|0.714|0.675|0.75
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|20–24|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|25–29|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|30–34|1|0.896|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|35–39|1|0.902|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|40–44|1|0.91|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|45–49|0.938|0.819|0.979
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|50–54|1|0.954|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|55–59|1|0.952|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|60–64|1|0.953|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|65–69|0.981|0.87|0.997
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|70–74|0.959|0.877|0.986
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|75–79|0.926|0.815|0.972
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|80–84|0.814|0.663|0.902
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|85+|0.585|0.455|0.694
Observed|Major salivary glands (cancer of the)|2015–2019|Females|1|All ages combined|0.932|0.91|0.949
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|20–24|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|25–29|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|30–34|1|0.904|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|35–39|1|0.904|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|40–44|1|0.916|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|45–49|0.938|0.819|0.979
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|50–54|0.938|0.844|0.976
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|55–59|0.984|0.894|0.998
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|60–64|0.983|0.883|0.998
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|65–69|0.961|0.852|0.99
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|70–74|0.912|0.813|0.959
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|75–79|0.889|0.769|0.948
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|80–84|0.683|0.525|0.798
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|85+|0.412|0.291|0.528
Observed|Major salivary glands (cancer of the)|2015–2019|Females|2|All ages combined|0.889|0.862|0.91
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|20–24|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|25–29|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|30–34|1|0.905|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|35–39|0.972|0.82|0.996
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|40–44|0.978|0.853|0.997
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|45–49|0.917|0.794|0.968
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|50–54|0.938|0.844|0.976
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|55–59|0.97|0.886|0.992
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|60–64|0.951|0.855|0.984
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|65–69|0.86|0.729|0.931
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|70–74|0.828|0.711|0.901
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|75–79|0.807|0.67|0.891
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|80–84|0.558|0.398|0.691
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|85+|0.327|0.218|0.44
Observed|Major salivary glands (cancer of the)|2015–2019|Females|3|All ages combined|0.843|0.813|0.868
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|20–24|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|25–29|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|30–34|1|0.904|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|35–39|0.972|0.82|0.996
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|40–44|0.955|0.832|0.989
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|45–49|0.917|0.794|0.968
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|50–54|0.921|0.82|0.966
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|55–59|0.956|0.869|0.986
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|60–64|0.877|0.769|0.936
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|65–69|0.822|0.687|0.903
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|70–74|0.811|0.691|0.889
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|75–79|0.765|0.622|0.859
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|80–84|0.532|0.372|0.668
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|85+|0.299|0.194|0.41
Observed|Major salivary glands (cancer of the)|2015–2019|Females|4|All ages combined|0.819|0.787|0.846
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|20–24|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|25–29|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|30–34|1|0.903|1
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|35–39|0.972|0.82|0.996
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|40–44|0.955|0.832|0.989
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|45–49|0.917|0.794|0.968
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|50–54|0.904|0.798|0.956
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|55–59|0.956|0.869|0.986
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|60–64|0.864|0.754|0.927
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|65–69|0.782|0.64|0.873
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|70–74|0.794|0.672|0.876
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|75–79|0.674|0.522|0.787
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|80–84|0.464|0.31|0.604
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|85+|||
Observed|Major salivary glands (cancer of the)|2015–2019|Females|5|All ages combined|0.79|0.757|0.819
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|20–24|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|25–29|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|30–34|1|0.896|1
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|35–39|1.001|0.902|1.001
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|40–44|1.001|0.911|1.001
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|45–49|0.939|0.82|0.981
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|50–54|1.002|0.956|1.002
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|55–59|1.003|0.955|1.003
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|60–64|1.005|0.957|1.005
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|65–69|0.988|0.876|1.005
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|70–74|0.97|0.888|0.998
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|75–79|0.947|0.833|0.993
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|80–84|0.85|0.692|0.942
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|85+|0.672|0.522|0.797
Relative|Major salivary glands (cancer of the)|2015–2019|Females|1|All ages combined|0.95|0.928|0.967
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|20–24|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|25–29|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|30–34|1.001|0.905|1.001
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|35–39|1.001|0.906|1.001
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|40–44|1.002|0.918|1.002
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|45–49|0.94|0.821|0.982
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|50–54|0.943|0.848|0.981
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|55–59|0.991|0.9|1.004
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|60–64|0.992|0.891|1.007
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|65–69|0.976|0.866|1.005
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|70–74|0.935|0.834|0.984
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|75–79|0.931|0.805|0.994
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|80–84|0.749|0.576|0.875
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|85+|0.54|0.382|0.693
Relative|Major salivary glands (cancer of the)|2015–2019|Females|2|All ages combined|0.92|0.893|0.942
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|20–24|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|25–29|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|30–34|1.001|0.907|1.001
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|35–39|0.974|0.822|0.998
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|40–44|0.981|0.855|1
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|45–49|0.921|0.798|0.972
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|50–54|0.945|0.85|0.983
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|55–59|0.98|0.895|1.003
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|60–64|0.966|0.869|0.999
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|65–69|0.881|0.747|0.954
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|70–74|0.863|0.74|0.939
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|75–79|0.87|0.723|0.961
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|80–84|0.648|0.462|0.803
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|85+|0.499|0.333|0.672
Relative|Major salivary glands (cancer of the)|2015–2019|Females|3|All ages combined|0.886|0.854|0.912
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|20–24|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|25–29|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|30–34|1.002|0.906|1.002
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|35–39|0.975|0.823|0.999
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|40–44|0.959|0.836|0.993
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|45–49|0.923|0.799|0.974
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|50–54|0.93|0.828|0.976
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|55–59|0.97|0.882|1
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|60–64|0.896|0.786|0.957
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|65–69|0.851|0.711|0.935
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|70–74|0.859|0.732|0.941
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|75–79|0.851|0.693|0.957
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|80–84|0.661|0.462|0.83
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|85+|0.527|0.343|0.724
Relative|Major salivary glands (cancer of the)|2015–2019|Females|4|All ages combined|0.873|0.84|0.902
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|20–24|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|25–29|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|30–34|1.002|0.905|1.002
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|35–39|0.976|0.823|1
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|40–44|0.96|0.837|0.994
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|45–49|0.925|0.801|0.976
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|50–54|0.915|0.808|0.968
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|55–59|0.974|0.886|1.004
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|60–64|0.888|0.776|0.953
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|65–69|0.818|0.67|0.913
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|70–74|0.858|0.725|0.946
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|75–79|0.778|0.603|0.909
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|80–84|0.622|0.416|0.809
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|85+|||
Relative|Major salivary glands (cancer of the)|2015–2019|Females|5|All ages combined|0.856|0.82|0.887
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|15–19|1|0.897|1
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|20–24|0.969|0.802|0.996
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|25–29|0.972|0.819|0.996
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|30–34|1|0.941|1
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|35–39|0.982|0.879|0.997
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|40–44|0.967|0.874|0.992
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|45–49|0.965|0.895|0.988
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|50–54|0.975|0.925|0.992
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|55–59|0.97|0.921|0.988
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|60–64|0.937|0.886|0.966
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|65–69|0.954|0.91|0.977
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|70–74|0.943|0.896|0.969
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|75–79|0.824|0.755|0.876
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|80–84|0.721|0.638|0.788
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|85+|0.597|0.516|0.67
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|1|All ages combined|0.891|0.875|0.906
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|15–19|1|0.888|1
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|20–24|0.969|0.802|0.996
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|25–29|0.943|0.791|0.985
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|30–34|1|0.942|1
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|35–39|0.982|0.879|0.997
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|40–44|0.952|0.859|0.984
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|45–49|0.94|0.862|0.975
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|50–54|0.917|0.852|0.955
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|55–59|0.94|0.884|0.97
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|60–64|0.91|0.853|0.946
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|65–69|0.86|0.8|0.903
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|70–74|0.854|0.792|0.899
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|75–79|0.71|0.631|0.774
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|80–84|0.579|0.493|0.655
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|85+|0.466|0.386|0.541
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|2|All ages combined|0.82|0.801|0.839
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|20–24|0.969|0.802|0.996
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|25–29|0.943|0.791|0.985
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|30–34|0.98|0.865|0.997
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|35–39|0.964|0.864|0.991
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|40–44|0.927|0.832|0.969
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|45–49|0.915|0.83|0.959
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|50–54|0.89|0.818|0.935
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|55–59|0.897|0.832|0.938
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|60–64|0.877|0.814|0.92
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|65–69|0.795|0.728|0.848
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|70–74|0.778|0.709|0.834
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|75–79|0.639|0.558|0.709
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|80–84|0.504|0.419|0.582
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|85+|0.373|0.299|0.447
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|3|All ages combined|0.768|0.746|0.788
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|20–24|0.969|0.802|0.996
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|25–29|0.943|0.791|0.985
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|30–34|0.98|0.865|0.997
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|35–39|0.947|0.844|0.982
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|40–44|0.914|0.818|0.96
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|45–49|0.915|0.83|0.959
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|50–54|0.87|0.793|0.92
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|55–59|0.874|0.805|0.92
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|60–64|0.831|0.762|0.882
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|65–69|0.748|0.677|0.806
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|70–74|0.711|0.636|0.773
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|75–79|0.592|0.511|0.665
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|80–84|0.399|0.32|0.477
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|85+|0.336|0.264|0.409
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|4|All ages combined|0.727|0.704|0.748
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|00–04|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|05–09|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|10–14|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|15–19|||
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|20–24|0.969|0.802|0.996
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|25–29|0.943|0.791|0.985
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|30–34|0.98|0.865|0.997
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|35–39|0.947|0.844|0.982
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|40–44|0.914|0.818|0.96
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|45–49|0.915|0.83|0.959
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|50–54|0.843|0.762|0.898
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|55–59|0.851|0.779|0.901
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|60–64|0.812|0.74|0.865
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|65–69|0.696|0.62|0.759
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|70–74|0.655|0.577|0.721
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|75–79|0.536|0.453|0.611
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|80–84|0.355|0.279|0.432
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|85+|0.25|0.184|0.32
Observed|Major salivary glands (cancer of the)|2015–2019|Persons|5|All ages combined|0.691|0.667|0.713
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|15–19|1|0.898|1
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|20–24|0.97|0.802|0.996
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|25–29|0.973|0.819|0.997
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|30–34|1.001|0.941|1.001
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|35–39|0.983|0.879|0.998
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|40–44|0.968|0.875|0.993
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|45–49|0.966|0.896|0.99
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|50–54|0.978|0.927|0.995
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|55–59|0.974|0.925|0.993
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|60–64|0.943|0.892|0.972
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|65–69|0.964|0.919|0.987
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|70–74|0.959|0.912|0.985
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|75–79|0.849|0.777|0.902
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|80–84|0.764|0.676|0.835
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|85+|0.692|0.597|0.776
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|1|All ages combined|0.914|0.897|0.929
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|15–19|1.001|0.889|1.001
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|20–24|0.97|0.803|0.996
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|25–29|0.944|0.792|0.986
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|30–34|1.001|0.943|1.001
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|35–39|0.984|0.88|0.999
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|40–44|0.955|0.862|0.987
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|45–49|0.944|0.865|0.978
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|50–54|0.923|0.857|0.96
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|55–59|0.949|0.892|0.978
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|60–64|0.923|0.865|0.959
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|65–69|0.879|0.817|0.923
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|70–74|0.885|0.82|0.931
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|75–79|0.755|0.671|0.823
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|80–84|0.654|0.557|0.74
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|85+|0.626|0.519|0.728
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|2|All ages combined|0.861|0.84|0.88
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|20–24|0.971|0.803|0.997
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|25–29|0.945|0.792|0.987
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|30–34|0.982|0.866|0.999
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|35–39|0.967|0.866|0.994
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|40–44|0.93|0.836|0.973
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|45–49|0.92|0.835|0.964
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|50–54|0.898|0.825|0.943
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|55–59|0.909|0.843|0.95
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|60–64|0.896|0.832|0.94
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|65–69|0.823|0.754|0.878
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|70–74|0.824|0.75|0.882
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|75–79|0.704|0.615|0.781
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|80–84|0.613|0.51|0.708
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|85+|0.59|0.473|0.707
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|3|All ages combined|0.824|0.801|0.846
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|20–24|0.971|0.803|0.997
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|25–29|0.945|0.793|0.987
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|30–34|0.982|0.867|1
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|35–39|0.95|0.847|0.986
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|40–44|0.919|0.822|0.966
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|45–49|0.922|0.836|0.966
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|50–54|0.881|0.803|0.931
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|55–59|0.891|0.821|0.937
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|60–64|0.856|0.785|0.908
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|65–69|0.785|0.71|0.846
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|70–74|0.77|0.689|0.838
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|75–79|0.681|0.587|0.764
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|80–84|0.527|0.423|0.63
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|85+|0.63|0.496|0.767
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|4|All ages combined|0.798|0.773|0.822
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|00–04|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|05–09|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|10–14|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|15–19|||
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|20–24|0.971|0.804|0.998
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|25–29|0.946|0.793|0.988
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|30–34|0.983|0.868|1
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|35–39|0.951|0.848|0.987
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|40–44|0.92|0.823|0.967
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|45–49|0.925|0.838|0.969
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|50–54|0.857|0.774|0.913
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|55–59|0.872|0.798|0.924
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|60–64|0.844|0.769|0.899
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|65–69|0.741|0.661|0.809
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|70–74|0.728|0.642|0.802
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|75–79|0.645|0.546|0.736
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|80–84|0.514|0.404|0.625
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|85+|0.559|0.413|0.717
Relative|Major salivary glands (cancer of the)|2015–2019|Persons|5|All ages combined|0.776|0.75|0.801
Observed|Melanoma of the skin|2015–2019|Males|1|00–04|||
Observed|Melanoma of the skin|2015–2019|Males|1|05–09|||
Observed|Melanoma of the skin|2015–2019|Males|1|10–14|||
Observed|Melanoma of the skin|2015–2019|Males|1|15–19|1|0.956|1
Observed|Melanoma of the skin|2015–2019|Males|1|20–24|0.986|0.957|0.995
Observed|Melanoma of the skin|2015–2019|Males|1|25–29|0.989|0.973|0.995
Observed|Melanoma of the skin|2015–2019|Males|1|30–34|0.993|0.984|0.997
Observed|Melanoma of the skin|2015–2019|Males|1|35–39|0.989|0.981|0.994
Observed|Melanoma of the skin|2015–2019|Males|1|40–44|0.986|0.979|0.991
Observed|Melanoma of the skin|2015–2019|Males|1|45–49|0.988|0.982|0.991
Observed|Melanoma of the skin|2015–2019|Males|1|50–54|0.985|0.98|0.989
Observed|Melanoma of the skin|2015–2019|Males|1|55–59|0.977|0.972|0.981
Observed|Melanoma of the skin|2015–2019|Males|1|60–64|0.975|0.97|0.979
Observed|Melanoma of the skin|2015–2019|Males|1|65–69|0.97|0.966|0.974
Observed|Melanoma of the skin|2015–2019|Males|1|70–74|0.966|0.961|0.97
Observed|Melanoma of the skin|2015–2019|Males|1|75–79|0.943|0.936|0.949
Observed|Melanoma of the skin|2015–2019|Males|1|80–84|0.913|0.904|0.922
Observed|Melanoma of the skin|2015–2019|Males|1|85+|0.826|0.813|0.838
Observed|Melanoma of the skin|2015–2019|Males|1|All ages combined|0.955|0.953|0.957
Observed|Melanoma of the skin|2015–2019|Males|2|00–04|||
Observed|Melanoma of the skin|2015–2019|Males|2|05–09|||
Observed|Melanoma of the skin|2015–2019|Males|2|10–14|||
Observed|Melanoma of the skin|2015–2019|Males|2|15–19|1|0.956|1
Observed|Melanoma of the skin|2015–2019|Males|2|20–24|0.986|0.957|0.995
Observed|Melanoma of the skin|2015–2019|Males|2|25–29|0.978|0.959|0.988
Observed|Melanoma of the skin|2015–2019|Males|2|30–34|0.984|0.972|0.991
Observed|Melanoma of the skin|2015–2019|Males|2|35–39|0.978|0.967|0.985
Observed|Melanoma of the skin|2015–2019|Males|2|40–44|0.975|0.966|0.981
Observed|Melanoma of the skin|2015–2019|Males|2|45–49|0.972|0.965|0.978
Observed|Melanoma of the skin|2015–2019|Males|2|50–54|0.971|0.965|0.977
Observed|Melanoma of the skin|2015–2019|Males|2|55–59|0.959|0.952|0.964
Observed|Melanoma of the skin|2015–2019|Males|2|60–64|0.954|0.948|0.96
Observed|Melanoma of the skin|2015–2019|Males|2|65–69|0.942|0.936|0.948
Observed|Melanoma of the skin|2015–2019|Males|2|70–74|0.929|0.922|0.935
Observed|Melanoma of the skin|2015–2019|Males|2|75–79|0.887|0.878|0.896
Observed|Melanoma of the skin|2015–2019|Males|2|80–84|0.827|0.815|0.839
Observed|Melanoma of the skin|2015–2019|Males|2|85+|0.676|0.66|0.692
Observed|Melanoma of the skin|2015–2019|Males|2|All ages combined|0.913|0.91|0.915
Observed|Melanoma of the skin|2015–2019|Males|3|00–04|||
Observed|Melanoma of the skin|2015–2019|Males|3|05–09|||
Observed|Melanoma of the skin|2015–2019|Males|3|10–14|||
Observed|Melanoma of the skin|2015–2019|Males|3|15–19|0.985|0.896|0.998
Observed|Melanoma of the skin|2015–2019|Males|3|20–24|0.981|0.951|0.993
Observed|Melanoma of the skin|2015–2019|Males|3|25–29|0.971|0.951|0.983
Observed|Melanoma of the skin|2015–2019|Males|3|30–34|0.971|0.957|0.981
Observed|Melanoma of the skin|2015–2019|Males|3|35–39|0.968|0.955|0.977
Observed|Melanoma of the skin|2015–2019|Males|3|40–44|0.967|0.957|0.974
Observed|Melanoma of the skin|2015–2019|Males|3|45–49|0.959|0.95|0.967
Observed|Melanoma of the skin|2015–2019|Males|3|50–54|0.957|0.949|0.964
Observed|Melanoma of the skin|2015–2019|Males|3|55–59|0.944|0.936|0.95
Observed|Melanoma of the skin|2015–2019|Males|3|60–64|0.933|0.926|0.94
Observed|Melanoma of the skin|2015–2019|Males|3|65–69|0.919|0.912|0.926
Observed|Melanoma of the skin|2015–2019|Males|3|70–74|0.896|0.888|0.904
Observed|Melanoma of the skin|2015–2019|Males|3|75–79|0.836|0.825|0.846
Observed|Melanoma of the skin|2015–2019|Males|3|80–84|0.737|0.723|0.752
Observed|Melanoma of the skin|2015–2019|Males|3|85+|0.54|0.523|0.557
Observed|Melanoma of the skin|2015–2019|Males|3|All ages combined|0.874|0.871|0.878
Observed|Melanoma of the skin|2015–2019|Males|4|00–04|||
Observed|Melanoma of the skin|2015–2019|Males|4|05–09|||
Observed|Melanoma of the skin|2015–2019|Males|4|10–14|||
Observed|Melanoma of the skin|2015–2019|Males|4|15–19|0.97|0.886|0.992
Observed|Melanoma of the skin|2015–2019|Males|4|20–24|0.972|0.939|0.987
Observed|Melanoma of the skin|2015–2019|Males|4|25–29|0.969|0.948|0.981
Observed|Melanoma of the skin|2015–2019|Males|4|30–34|0.967|0.951|0.978
Observed|Melanoma of the skin|2015–2019|Males|4|35–39|0.958|0.944|0.969
Observed|Melanoma of the skin|2015–2019|Males|4|40–44|0.955|0.944|0.964
Observed|Melanoma of the skin|2015–2019|Males|4|45–49|0.945|0.935|0.954
Observed|Melanoma of the skin|2015–2019|Males|4|50–54|0.949|0.94|0.956
Observed|Melanoma of the skin|2015–2019|Males|4|55–59|0.931|0.923|0.939
Observed|Melanoma of the skin|2015–2019|Males|4|60–64|0.914|0.906|0.922
Observed|Melanoma of the skin|2015–2019|Males|4|65–69|0.893|0.884|0.901
Observed|Melanoma of the skin|2015–2019|Males|4|70–74|0.857|0.848|0.867
Observed|Melanoma of the skin|2015–2019|Males|4|75–79|0.783|0.77|0.794
Observed|Melanoma of the skin|2015–2019|Males|4|80–84|0.659|0.643|0.674
Observed|Melanoma of the skin|2015–2019|Males|4|85+|0.425|0.407|0.442
Observed|Melanoma of the skin|2015–2019|Males|4|All ages combined|0.839|0.835|0.842
Observed|Melanoma of the skin|2015–2019|Males|5|00–04|||
Observed|Melanoma of the skin|2015–2019|Males|5|05–09|||
Observed|Melanoma of the skin|2015–2019|Males|5|10–14|||
Observed|Melanoma of the skin|2015–2019|Males|5|15–19|0.97|0.886|0.992
Observed|Melanoma of the skin|2015–2019|Males|5|20–24|0.963|0.927|0.981
Observed|Melanoma of the skin|2015–2019|Males|5|25–29|0.965|0.943|0.978
Observed|Melanoma of the skin|2015–2019|Males|5|30–34|0.966|0.95|0.977
Observed|Melanoma of the skin|2015–2019|Males|5|35–39|0.948|0.933|0.96
Observed|Melanoma of the skin|2015–2019|Males|5|40–44|0.951|0.939|0.96
Observed|Melanoma of the skin|2015–2019|Males|5|45–49|0.938|0.927|0.947
Observed|Melanoma of the skin|2015–2019|Males|5|50–54|0.937|0.928|0.946
Observed|Melanoma of the skin|2015–2019|Males|5|55–59|0.917|0.908|0.925
Observed|Melanoma of the skin|2015–2019|Males|5|60–64|0.9|0.892|0.909
Observed|Melanoma of the skin|2015–2019|Males|5|65–69|0.869|0.86|0.878
Observed|Melanoma of the skin|2015–2019|Males|5|70–74|0.824|0.813|0.834
Observed|Melanoma of the skin|2015–2019|Males|5|75–79|0.734|0.72|0.747
Observed|Melanoma of the skin|2015–2019|Males|5|80–84|0.577|0.56|0.594
Observed|Melanoma of the skin|2015–2019|Males|5|85+|0.328|0.311|0.345
Observed|Melanoma of the skin|2015–2019|Males|5|All ages combined|0.807|0.803|0.811
Relative|Melanoma of the skin|2015–2019|Males|1|00–04|||
Relative|Melanoma of the skin|2015–2019|Males|1|05–09|||
Relative|Melanoma of the skin|2015–2019|Males|1|10–14|||
Relative|Melanoma of the skin|2015–2019|Males|1|15–19|1|0.957|1
Relative|Melanoma of the skin|2015–2019|Males|1|20–24|0.987|0.958|0.996
Relative|Melanoma of the skin|2015–2019|Males|1|25–29|0.989|0.974|0.996
Relative|Melanoma of the skin|2015–2019|Males|1|30–34|0.994|0.985|0.998
Relative|Melanoma of the skin|2015–2019|Males|1|35–39|0.991|0.982|0.995
Relative|Melanoma of the skin|2015–2019|Males|1|40–44|0.988|0.981|0.993
Relative|Melanoma of the skin|2015–2019|Males|1|45–49|0.99|0.984|0.994
Relative|Melanoma of the skin|2015–2019|Males|1|50–54|0.989|0.984|0.992
Relative|Melanoma of the skin|2015–2019|Males|1|55–59|0.982|0.977|0.986
Relative|Melanoma of the skin|2015–2019|Males|1|60–64|0.983|0.978|0.987
Relative|Melanoma of the skin|2015–2019|Males|1|65–69|0.982|0.977|0.986
Relative|Melanoma of the skin|2015–2019|Males|1|70–74|0.985|0.98|0.989
Relative|Melanoma of the skin|2015–2019|Males|1|75–79|0.975|0.968|0.981
Relative|Melanoma of the skin|2015–2019|Males|1|80–84|0.97|0.96|0.98
Relative|Melanoma of the skin|2015–2019|Males|1|85+|0.951|0.936|0.965
Relative|Melanoma of the skin|2015–2019|Males|1|All ages combined|0.98|0.978|0.982
Relative|Melanoma of the skin|2015–2019|Males|2|00–04|||
Relative|Melanoma of the skin|2015–2019|Males|2|05–09|||
Relative|Melanoma of the skin|2015–2019|Males|2|10–14|||
Relative|Melanoma of the skin|2015–2019|Males|2|15–19|1.001|0.957|1.001
Relative|Melanoma of the skin|2015–2019|Males|2|20–24|0.987|0.959|0.997
Relative|Melanoma of the skin|2015–2019|Males|2|25–29|0.979|0.961|0.989
Relative|Melanoma of the skin|2015–2019|Males|2|30–34|0.986|0.973|0.993
Relative|Melanoma of the skin|2015–2019|Males|2|35–39|0.98|0.969|0.988
Relative|Melanoma of the skin|2015–2019|Males|2|40–44|0.978|0.969|0.985
Relative|Melanoma of the skin|2015–2019|Males|2|45–49|0.977|0.969|0.983
Relative|Melanoma of the skin|2015–2019|Males|2|50–54|0.978|0.972|0.984
Relative|Melanoma of the skin|2015–2019|Males|2|55–59|0.969|0.963|0.975
Relative|Melanoma of the skin|2015–2019|Males|2|60–64|0.97|0.964|0.976
Relative|Melanoma of the skin|2015–2019|Males|2|65–69|0.967|0.96|0.972
Relative|Melanoma of the skin|2015–2019|Males|2|70–74|0.968|0.96|0.974
Relative|Melanoma of the skin|2015–2019|Males|2|75–79|0.952|0.942|0.961
Relative|Melanoma of the skin|2015–2019|Males|2|80–84|0.941|0.927|0.955
Relative|Melanoma of the skin|2015–2019|Males|2|85+|0.908|0.886|0.929
Relative|Melanoma of the skin|2015–2019|Males|2|All ages combined|0.962|0.96|0.965
Relative|Melanoma of the skin|2015–2019|Males|3|00–04|||
Relative|Melanoma of the skin|2015–2019|Males|3|05–09|||
Relative|Melanoma of the skin|2015–2019|Males|3|10–14|||
Relative|Melanoma of the skin|2015–2019|Males|3|15–19|0.986|0.897|0.999
Relative|Melanoma of the skin|2015–2019|Males|3|20–24|0.983|0.953|0.995
Relative|Melanoma of the skin|2015–2019|Males|3|25–29|0.973|0.953|0.985
Relative|Melanoma of the skin|2015–2019|Males|3|30–34|0.974|0.959|0.984
Relative|Melanoma of the skin|2015–2019|Males|3|35–39|0.972|0.959|0.981
Relative|Melanoma of the skin|2015–2019|Males|3|40–44|0.972|0.962|0.979
Relative|Melanoma of the skin|2015–2019|Males|3|45–49|0.967|0.957|0.974
Relative|Melanoma of the skin|2015–2019|Males|3|50–54|0.968|0.96|0.975
Relative|Melanoma of the skin|2015–2019|Males|3|55–59|0.96|0.952|0.967
Relative|Melanoma of the skin|2015–2019|Males|3|60–64|0.958|0.95|0.965
Relative|Melanoma of the skin|2015–2019|Males|3|65–69|0.957|0.949|0.964
Relative|Melanoma of the skin|2015–2019|Males|3|70–74|0.956|0.947|0.964
Relative|Melanoma of the skin|2015–2019|Males|3|75–79|0.936|0.923|0.947
Relative|Melanoma of the skin|2015–2019|Males|3|80–84|0.907|0.889|0.924
Relative|Melanoma of the skin|2015–2019|Males|3|85+|0.856|0.829|0.883
Relative|Melanoma of the skin|2015–2019|Males|3|All ages combined|0.947|0.944|0.951
Relative|Melanoma of the skin|2015–2019|Males|4|00–04|||
Relative|Melanoma of the skin|2015–2019|Males|4|05–09|||
Relative|Melanoma of the skin|2015–2019|Males|4|10–14|||
Relative|Melanoma of the skin|2015–2019|Males|4|15–19|0.972|0.887|0.994
Relative|Melanoma of the skin|2015–2019|Males|4|20–24|0.975|0.941|0.99
Relative|Melanoma of the skin|2015–2019|Males|4|25–29|0.972|0.951|0.984
Relative|Melanoma of the skin|2015–2019|Males|4|30–34|0.971|0.955|0.982
Relative|Melanoma of the skin|2015–2019|Males|4|35–39|0.963|0.949|0.974
Relative|Melanoma of the skin|2015–2019|Males|4|40–44|0.962|0.951|0.971
Relative|Melanoma of the skin|2015–2019|Males|4|45–49|0.956|0.945|0.964
Relative|Melanoma of the skin|2015–2019|Males|4|50–54|0.964|0.955|0.971
Relative|Melanoma of the skin|2015–2019|Males|4|55–59|0.954|0.946|0.962
Relative|Melanoma of the skin|2015–2019|Males|4|60–64|0.948|0.939|0.956
Relative|Melanoma of the skin|2015–2019|Males|4|65–69|0.944|0.936|0.953
Relative|Melanoma of the skin|2015–2019|Males|4|70–74|0.94|0.929|0.95
Relative|Melanoma of the skin|2015–2019|Males|4|75–79|0.918|0.904|0.932
Relative|Melanoma of the skin|2015–2019|Males|4|80–84|0.884|0.863|0.905
Relative|Melanoma of the skin|2015–2019|Males|4|85+|0.804|0.771|0.837
Relative|Melanoma of the skin|2015–2019|Males|4|All ages combined|0.934|0.93|0.938
Relative|Melanoma of the skin|2015–2019|Males|5|00–04|||
Relative|Melanoma of the skin|2015–2019|Males|5|05–09|||
Relative|Melanoma of the skin|2015–2019|Males|5|10–14|||
Relative|Melanoma of the skin|2015–2019|Males|5|15–19|0.973|0.888|0.995
Relative|Melanoma of the skin|2015–2019|Males|5|20–24|0.966|0.93|0.984
Relative|Melanoma of the skin|2015–2019|Males|5|25–29|0.968|0.946|0.982
Relative|Melanoma of the skin|2015–2019|Males|5|30–34|0.97|0.954|0.981
Relative|Melanoma of the skin|2015–2019|Males|5|35–39|0.954|0.939|0.966
Relative|Melanoma of the skin|2015–2019|Males|5|40–44|0.96|0.948|0.969
Relative|Melanoma of the skin|2015–2019|Males|5|45–49|0.951|0.94|0.96
Relative|Melanoma of the skin|2015–2019|Males|5|50–54|0.957|0.947|0.965
Relative|Melanoma of the skin|2015–2019|Males|5|55–59|0.946|0.937|0.955
Relative|Melanoma of the skin|2015–2019|Males|5|60–64|0.944|0.935|0.953
Relative|Melanoma of the skin|2015–2019|Males|5|65–69|0.936|0.926|0.945
Relative|Melanoma of the skin|2015–2019|Males|5|70–74|0.931|0.918|0.942
Relative|Melanoma of the skin|2015–2019|Males|5|75–79|0.908|0.892|0.924
Relative|Melanoma of the skin|2015–2019|Males|5|80–84|0.855|0.83|0.88
Relative|Melanoma of the skin|2015–2019|Males|5|85+|0.753|0.715|0.792
Relative|Melanoma of the skin|2015–2019|Males|5|All ages combined|0.924|0.919|0.928
Observed|Melanoma of the skin|2015–2019|Females|1|00–04|||
Observed|Melanoma of the skin|2015–2019|Females|1|05–09|||
Observed|Melanoma of the skin|2015–2019|Females|1|10–14|||
Observed|Melanoma of the skin|2015–2019|Females|1|15–19|0.978|0.916|0.995
Observed|Melanoma of the skin|2015–2019|Females|1|20–24|1|0.99|1
Observed|Melanoma of the skin|2015–2019|Females|1|25–29|1|0.995|1
Observed|Melanoma of the skin|2015–2019|Females|1|30–34|0.996|0.99|0.999
Observed|Melanoma of the skin|2015–2019|Females|1|35–39|0.998|0.993|0.999
Observed|Melanoma of the skin|2015–2019|Females|1|40–44|0.993|0.987|0.996
Observed|Melanoma of the skin|2015–2019|Females|1|45–49|0.992|0.987|0.995
Observed|Melanoma of the skin|2015–2019|Females|1|50–54|0.991|0.987|0.994
Observed|Melanoma of the skin|2015–2019|Females|1|55–59|0.991|0.987|0.994
Observed|Melanoma of the skin|2015–2019|Females|1|60–64|0.984|0.979|0.987
Observed|Melanoma of the skin|2015–2019|Females|1|65–69|0.986|0.982|0.989
Observed|Melanoma of the skin|2015–2019|Females|1|70–74|0.974|0.968|0.979
Observed|Melanoma of the skin|2015–2019|Females|1|75–79|0.966|0.959|0.972
Observed|Melanoma of the skin|2015–2019|Females|1|80–84|0.937|0.926|0.947
Observed|Melanoma of the skin|2015–2019|Females|1|85+|0.859|0.845|0.872
Observed|Melanoma of the skin|2015–2019|Females|1|All ages combined|0.972|0.97|0.974
Observed|Melanoma of the skin|2015–2019|Females|2|00–04|||
Observed|Melanoma of the skin|2015–2019|Females|2|05–09|||
Observed|Melanoma of the skin|2015–2019|Females|2|10–14|||
Observed|Melanoma of the skin|2015–2019|Females|2|15–19|0.967|0.902|0.989
Observed|Melanoma of the skin|2015–2019|Females|2|20–24|0.993|0.973|0.998
Observed|Melanoma of the skin|2015–2019|Females|2|25–29|0.995|0.985|0.998
Observed|Melanoma of the skin|2015–2019|Females|2|30–34|0.989|0.981|0.994
Observed|Melanoma of the skin|2015–2019|Females|2|35–39|0.991|0.984|0.995
Observed|Melanoma of the skin|2015–2019|Females|2|40–44|0.988|0.982|0.992
Observed|Melanoma of the skin|2015–2019|Females|2|45–49|0.987|0.982|0.991
Observed|Melanoma of the skin|2015–2019|Females|2|50–54|0.983|0.978|0.988
Observed|Melanoma of the skin|2015–2019|Females|2|55–59|0.985|0.98|0.989
Observed|Melanoma of the skin|2015–2019|Females|2|60–64|0.972|0.966|0.977
Observed|Melanoma of the skin|2015–2019|Females|2|65–69|0.967|0.96|0.972
Observed|Melanoma of the skin|2015–2019|Females|2|70–74|0.949|0.941|0.956
Observed|Melanoma of the skin|2015–2019|Females|2|75–79|0.923|0.912|0.933
Observed|Melanoma of the skin|2015–2019|Females|2|80–84|0.876|0.861|0.89
Observed|Melanoma of the skin|2015–2019|Females|2|85+|0.725|0.707|0.742
Observed|Melanoma of the skin|2015–2019|Females|2|All ages combined|0.944|0.941|0.946
Observed|Melanoma of the skin|2015–2019|Females|3|00–04|||
Observed|Melanoma of the skin|2015–2019|Females|3|05–09|||
Observed|Melanoma of the skin|2015–2019|Females|3|10–14|||
Observed|Melanoma of the skin|2015–2019|Females|3|15–19|0.967|0.902|0.989
Observed|Melanoma of the skin|2015–2019|Females|3|20–24|0.993|0.973|0.998
Observed|Melanoma of the skin|2015–2019|Females|3|25–29|0.991|0.98|0.996
Observed|Melanoma of the skin|2015–2019|Females|3|30–34|0.982|0.972|0.989
Observed|Melanoma of the skin|2015–2019|Females|3|35–39|0.982|0.973|0.988
Observed|Melanoma of the skin|2015–2019|Females|3|40–44|0.983|0.975|0.988
Observed|Melanoma of the skin|2015–2019|Females|3|45–49|0.981|0.975|0.986
Observed|Melanoma of the skin|2015–2019|Females|3|50–54|0.976|0.97|0.981
Observed|Melanoma of the skin|2015–2019|Females|3|55–59|0.974|0.968|0.98
Observed|Melanoma of the skin|2015–2019|Females|3|60–64|0.961|0.954|0.968
Observed|Melanoma of the skin|2015–2019|Females|3|65–69|0.949|0.941|0.956
Observed|Melanoma of the skin|2015–2019|Females|3|70–74|0.922|0.912|0.931
Observed|Melanoma of the skin|2015–2019|Females|3|75–79|0.886|0.873|0.898
Observed|Melanoma of the skin|2015–2019|Females|3|80–84|0.81|0.792|0.827
Observed|Melanoma of the skin|2015–2019|Females|3|85+|0.611|0.592|0.63
Observed|Melanoma of the skin|2015–2019|Females|3|All ages combined|0.917|0.914|0.92
Observed|Melanoma of the skin|2015–2019|Females|4|00–04|||
Observed|Melanoma of the skin|2015–2019|Females|4|05–09|||
Observed|Melanoma of the skin|2015–2019|Females|4|10–14|||
Observed|Melanoma of the skin|2015–2019|Females|4|15–19|0.967|0.902|0.989
Observed|Melanoma of the skin|2015–2019|Females|4|20–24|0.986|0.964|0.995
Observed|Melanoma of the skin|2015–2019|Females|4|25–29|0.986|0.974|0.993
Observed|Melanoma of the skin|2015–2019|Females|4|30–34|0.975|0.963|0.983
Observed|Melanoma of the skin|2015–2019|Females|4|35–39|0.976|0.965|0.983
Observed|Melanoma of the skin|2015–2019|Females|4|40–44|0.977|0.969|0.983
Observed|Melanoma of the skin|2015–2019|Females|4|45–49|0.974|0.966|0.98
Observed|Melanoma of the skin|2015–2019|Females|4|50–54|0.97|0.963|0.976
Observed|Melanoma of the skin|2015–2019|Females|4|55–59|0.962|0.954|0.968
Observed|Melanoma of the skin|2015–2019|Females|4|60–64|0.95|0.942|0.957
Observed|Melanoma of the skin|2015–2019|Females|4|65–69|0.935|0.926|0.943
Observed|Melanoma of the skin|2015–2019|Females|4|70–74|0.898|0.886|0.909
Observed|Melanoma of the skin|2015–2019|Females|4|75–79|0.851|0.836|0.864
Observed|Melanoma of the skin|2015–2019|Females|4|80–84|0.741|0.72|0.76
Observed|Melanoma of the skin|2015–2019|Females|4|85+|0.505|0.484|0.524
Observed|Melanoma of the skin|2015–2019|Females|4|All ages combined|0.892|0.889|0.896
Observed|Melanoma of the skin|2015–2019|Females|5|00–04|||
Observed|Melanoma of the skin|2015–2019|Females|5|05–09|||
Observed|Melanoma of the skin|2015–2019|Females|5|10–14|||
Observed|Melanoma of the skin|2015–2019|Females|5|15–19|0.957|0.889|0.984
Observed|Melanoma of the skin|2015–2019|Females|5|20–24|0.983|0.96|0.993
Observed|Melanoma of the skin|2015–2019|Females|5|25–29|0.981|0.968|0.989
Observed|Melanoma of the skin|2015–2019|Females|5|30–34|0.97|0.957|0.979
Observed|Melanoma of the skin|2015–2019|Females|5|35–39|0.971|0.96|0.979
Observed|Melanoma of the skin|2015–2019|Females|5|40–44|0.97|0.961|0.977
Observed|Melanoma of the skin|2015–2019|Females|5|45–49|0.968|0.959|0.974
Observed|Melanoma of the skin|2015–2019|Females|5|50–54|0.965|0.957|0.971
Observed|Melanoma of the skin|2015–2019|Females|5|55–59|0.953|0.944|0.961
Observed|Melanoma of the skin|2015–2019|Females|5|60–64|0.94|0.931|0.948
Observed|Melanoma of the skin|2015–2019|Females|5|65–69|0.923|0.913|0.931
Observed|Melanoma of the skin|2015–2019|Females|5|70–74|0.872|0.859|0.884
Observed|Melanoma of the skin|2015–2019|Females|5|75–79|0.818|0.802|0.833
Observed|Melanoma of the skin|2015–2019|Females|5|80–84|0.673|0.651|0.694
Observed|Melanoma of the skin|2015–2019|Females|5|85+|0.417|0.397|0.437
Observed|Melanoma of the skin|2015–2019|Females|5|All ages combined|0.87|0.866|0.874
Relative|Melanoma of the skin|2015–2019|Females|1|00–04|||
Relative|Melanoma of the skin|2015–2019|Females|1|05–09|||
Relative|Melanoma of the skin|2015–2019|Females|1|10–14|||
Relative|Melanoma of the skin|2015–2019|Females|1|15–19|0.978|0.916|0.995
Relative|Melanoma of the skin|2015–2019|Females|1|20–24|1|0.99|1
Relative|Melanoma of the skin|2015–2019|Females|1|25–29|1|0.996|1
Relative|Melanoma of the skin|2015–2019|Females|1|30–34|0.997|0.99|0.999
Relative|Melanoma of the skin|2015–2019|Females|1|35–39|0.998|0.993|1
Relative|Melanoma of the skin|2015–2019|Females|1|40–44|0.994|0.988|0.997
Relative|Melanoma of the skin|2015–2019|Females|1|45–49|0.993|0.989|0.996
Relative|Melanoma of the skin|2015–2019|Females|1|50–54|0.993|0.989|0.996
Relative|Melanoma of the skin|2015–2019|Females|1|55–59|0.994|0.99|0.997
Relative|Melanoma of the skin|2015–2019|Females|1|60–64|0.988|0.983|0.992
Relative|Melanoma of the skin|2015–2019|Females|1|65–69|0.993|0.989|0.997
Relative|Melanoma of the skin|2015–2019|Females|1|70–74|0.986|0.98|0.991
Relative|Melanoma of the skin|2015–2019|Females|1|75–79|0.987|0.98|0.994
Relative|Melanoma of the skin|2015–2019|Females|1|80–84|0.977|0.965|0.987
Relative|Melanoma of the skin|2015–2019|Females|1|85+|0.97|0.954|0.984
Relative|Melanoma of the skin|2015–2019|Females|1|All ages combined|0.989|0.987|0.991
Relative|Melanoma of the skin|2015–2019|Females|2|00–04|||
Relative|Melanoma of the skin|2015–2019|Females|2|05–09|||
Relative|Melanoma of the skin|2015–2019|Females|2|10–14|||
Relative|Melanoma of the skin|2015–2019|Females|2|15–19|0.968|0.902|0.99
Relative|Melanoma of the skin|2015–2019|Females|2|20–24|0.994|0.974|0.999
Relative|Melanoma of the skin|2015–2019|Females|2|25–29|0.996|0.986|0.999
Relative|Melanoma of the skin|2015–2019|Females|2|30–34|0.99|0.981|0.995
Relative|Melanoma of the skin|2015–2019|Females|2|35–39|0.992|0.985|0.996
Relative|Melanoma of the skin|2015–2019|Females|2|40–44|0.99|0.984|0.994
Relative|Melanoma of the skin|2015–2019|Females|2|45–49|0.99|0.985|0.994
Relative|Melanoma of the skin|2015–2019|Females|2|50–54|0.988|0.982|0.992
Relative|Melanoma of the skin|2015–2019|Females|2|55–59|0.992|0.986|0.995
Relative|Melanoma of the skin|2015–2019|Females|2|60–64|0.981|0.975|0.987
Relative|Melanoma of the skin|2015–2019|Females|2|65–69|0.982|0.975|0.987
Relative|Melanoma of the skin|2015–2019|Females|2|70–74|0.974|0.965|0.981
Relative|Melanoma of the skin|2015–2019|Females|2|75–79|0.967|0.955|0.977
Relative|Melanoma of the skin|2015–2019|Females|2|80–84|0.958|0.941|0.973
Relative|Melanoma of the skin|2015–2019|Females|2|85+|0.933|0.91|0.955
Relative|Melanoma of the skin|2015–2019|Females|2|All ages combined|0.978|0.975|0.981
Relative|Melanoma of the skin|2015–2019|Females|3|00–04|||
Relative|Melanoma of the skin|2015–2019|Females|3|05–09|||
Relative|Melanoma of the skin|2015–2019|Females|3|10–14|||
Relative|Melanoma of the skin|2015–2019|Females|3|15–19|0.968|0.902|0.99
Relative|Melanoma of the skin|2015–2019|Females|3|20–24|0.994|0.974|0.999
Relative|Melanoma of the skin|2015–2019|Females|3|25–29|0.992|0.98|0.997
Relative|Melanoma of the skin|2015–2019|Females|3|30–34|0.983|0.973|0.99
Relative|Melanoma of the skin|2015–2019|Females|3|35–39|0.984|0.975|0.99
Relative|Melanoma of the skin|2015–2019|Females|3|40–44|0.986|0.978|0.991
Relative|Melanoma of the skin|2015–2019|Females|3|45–49|0.986|0.979|0.991
Relative|Melanoma of the skin|2015–2019|Females|3|50–54|0.983|0.976|0.988
Relative|Melanoma of the skin|2015–2019|Females|3|55–59|0.984|0.978|0.99
Relative|Melanoma of the skin|2015–2019|Females|3|60–64|0.976|0.969|0.982
Relative|Melanoma of the skin|2015–2019|Females|3|65–69|0.972|0.964|0.979
Relative|Melanoma of the skin|2015–2019|Females|3|70–74|0.96|0.95|0.97
Relative|Melanoma of the skin|2015–2019|Females|3|75–79|0.954|0.94|0.966
Relative|Melanoma of the skin|2015–2019|Females|3|80–84|0.936|0.915|0.956
Relative|Melanoma of the skin|2015–2019|Females|3|85+|0.906|0.878|0.934
Relative|Melanoma of the skin|2015–2019|Females|3|All ages combined|0.968|0.965|0.972
Relative|Melanoma of the skin|2015–2019|Females|4|00–04|||
Relative|Melanoma of the skin|2015–2019|Females|4|05–09|||
Relative|Melanoma of the skin|2015–2019|Females|4|10–14|||
Relative|Melanoma of the skin|2015–2019|Females|4|15–19|0.968|0.903|0.99
Relative|Melanoma of the skin|2015–2019|Females|4|20–24|0.987|0.965|0.996
Relative|Melanoma of the skin|2015–2019|Females|4|25–29|0.987|0.975|0.994
Relative|Melanoma of the skin|2015–2019|Females|4|30–34|0.976|0.964|0.985
Relative|Melanoma of the skin|2015–2019|Females|4|35–39|0.978|0.968|0.986
Relative|Melanoma of the skin|2015–2019|Females|4|40–44|0.981|0.973|0.987
Relative|Melanoma of the skin|2015–2019|Females|4|45–49|0.98|0.973|0.986
Relative|Melanoma of the skin|2015–2019|Females|4|50–54|0.98|0.972|0.986
Relative|Melanoma of the skin|2015–2019|Females|4|55–59|0.975|0.967|0.982
Relative|Melanoma of the skin|2015–2019|Females|4|60–64|0.97|0.962|0.978
Relative|Melanoma of the skin|2015–2019|Females|4|65–69|0.967|0.958|0.975
Relative|Melanoma of the skin|2015–2019|Females|4|70–74|0.951|0.939|0.963
Relative|Melanoma of the skin|2015–2019|Females|4|75–79|0.945|0.928|0.96
Relative|Melanoma of the skin|2015–2019|Females|4|80–84|0.912|0.887|0.936
Relative|Melanoma of the skin|2015–2019|Females|4|85+|0.873|0.838|0.907
Relative|Melanoma of the skin|2015–2019|Females|4|All ages combined|0.96|0.956|0.963
Relative|Melanoma of the skin|2015–2019|Females|5|00–04|||
Relative|Melanoma of the skin|2015–2019|Females|5|05–09|||
Relative|Melanoma of the skin|2015–2019|Females|5|10–14|||
Relative|Melanoma of the skin|2015–2019|Females|5|15–19|0.958|0.89|0.985
Relative|Melanoma of the skin|2015–2019|Females|5|20–24|0.984|0.961|0.994
Relative|Melanoma of the skin|2015–2019|Females|5|25–29|0.983|0.969|0.991
Relative|Melanoma of the skin|2015–2019|Females|5|30–34|0.972|0.959|0.981
Relative|Melanoma of the skin|2015–2019|Females|5|35–39|0.974|0.963|0.982
Relative|Melanoma of the skin|2015–2019|Females|5|40–44|0.975|0.966|0.982
Relative|Melanoma of the skin|2015–2019|Females|5|45–49|0.976|0.967|0.983
Relative|Melanoma of the skin|2015–2019|Females|5|50–54|0.977|0.969|0.984
Relative|Melanoma of the skin|2015–2019|Females|5|55–59|0.971|0.962|0.979
Relative|Melanoma of the skin|2015–2019|Females|5|60–64|0.967|0.957|0.975
Relative|Melanoma of the skin|2015–2019|Females|5|65–69|0.965|0.955|0.974
Relative|Melanoma of the skin|2015–2019|Females|5|70–74|0.942|0.927|0.955
Relative|Melanoma of the skin|2015–2019|Females|5|75–79|0.942|0.923|0.959
Relative|Melanoma of the skin|2015–2019|Females|5|80–84|0.891|0.862|0.919
Relative|Melanoma of the skin|2015–2019|Females|5|85+|0.855|0.814|0.896
Relative|Melanoma of the skin|2015–2019|Females|5|All ages combined|0.954|0.949|0.958
Observed|Melanoma of the skin|2015–2019|Persons|1|00–04|||
Observed|Melanoma of the skin|2015–2019|Persons|1|05–09|||
Observed|Melanoma of the skin|2015–2019|Persons|1|10–14|1|0.871|1
Observed|Melanoma of the skin|2015–2019|Persons|1|15–19|0.987|0.951|0.997
Observed|Melanoma of the skin|2015–2019|Persons|1|20–24|0.994|0.982|0.998
Observed|Melanoma of the skin|2015–2019|Persons|1|25–29|0.995|0.989|0.998
Observed|Melanoma of the skin|2015–2019|Persons|1|30–34|0.995|0.99|0.997
Observed|Melanoma of the skin|2015–2019|Persons|1|35–39|0.994|0.99|0.996
Observed|Melanoma of the skin|2015–2019|Persons|1|40–44|0.99|0.986|0.993
Observed|Melanoma of the skin|2015–2019|Persons|1|45–49|0.99|0.986|0.992
Observed|Melanoma of the skin|2015–2019|Persons|1|50–54|0.988|0.985|0.99
Observed|Melanoma of the skin|2015–2019|Persons|1|55–59|0.983|0.979|0.985
Observed|Melanoma of the skin|2015–2019|Persons|1|60–64|0.978|0.975|0.981
Observed|Melanoma of the skin|2015–2019|Persons|1|65–69|0.976|0.973|0.979
Observed|Melanoma of the skin|2015–2019|Persons|1|70–74|0.969|0.965|0.972
Observed|Melanoma of the skin|2015–2019|Persons|1|75–79|0.951|0.946|0.956
Observed|Melanoma of the skin|2015–2019|Persons|1|80–84|0.922|0.915|0.929
Observed|Melanoma of the skin|2015–2019|Persons|1|85+|0.84|0.831|0.849
Observed|Melanoma of the skin|2015–2019|Persons|1|All ages combined|0.962|0.96|0.963
Observed|Melanoma of the skin|2015–2019|Persons|2|00–04|||
Observed|Melanoma of the skin|2015–2019|Persons|2|05–09|||
Observed|Melanoma of the skin|2015–2019|Persons|2|10–14|||
Observed|Melanoma of the skin|2015–2019|Persons|2|15–19|0.981|0.942|0.994
Observed|Melanoma of the skin|2015–2019|Persons|2|20–24|0.99|0.977|0.996
Observed|Melanoma of the skin|2015–2019|Persons|2|25–29|0.988|0.98|0.993
Observed|Melanoma of the skin|2015–2019|Persons|2|30–34|0.987|0.98|0.991
Observed|Melanoma of the skin|2015–2019|Persons|2|35–39|0.985|0.979|0.989
Observed|Melanoma of the skin|2015–2019|Persons|2|40–44|0.982|0.977|0.986
Observed|Melanoma of the skin|2015–2019|Persons|2|45–49|0.98|0.975|0.984
Observed|Melanoma of the skin|2015–2019|Persons|2|50–54|0.977|0.973|0.98
Observed|Melanoma of the skin|2015–2019|Persons|2|55–59|0.97|0.965|0.973
Observed|Melanoma of the skin|2015–2019|Persons|2|60–64|0.961|0.957|0.965
Observed|Melanoma of the skin|2015–2019|Persons|2|65–69|0.951|0.947|0.956
Observed|Melanoma of the skin|2015–2019|Persons|2|70–74|0.936|0.931|0.941
Observed|Melanoma of the skin|2015–2019|Persons|2|75–79|0.9|0.893|0.906
Observed|Melanoma of the skin|2015–2019|Persons|2|80–84|0.844|0.834|0.853
Observed|Melanoma of the skin|2015–2019|Persons|2|85+|0.697|0.685|0.709
Observed|Melanoma of the skin|2015–2019|Persons|2|All ages combined|0.926|0.924|0.928
Observed|Melanoma of the skin|2015–2019|Persons|3|00–04|||
Observed|Melanoma of the skin|2015–2019|Persons|3|05–09|||
Observed|Melanoma of the skin|2015–2019|Persons|3|10–14|||
Observed|Melanoma of the skin|2015–2019|Persons|3|15–19|0.975|0.934|0.99
Observed|Melanoma of the skin|2015–2019|Persons|3|20–24|0.988|0.974|0.995
Observed|Melanoma of the skin|2015–2019|Persons|3|25–29|0.983|0.973|0.989
Observed|Melanoma of the skin|2015–2019|Persons|3|30–34|0.978|0.969|0.984
Observed|Melanoma of the skin|2015–2019|Persons|3|35–39|0.976|0.969|0.981
Observed|Melanoma of the skin|2015–2019|Persons|3|40–44|0.975|0.969|0.98
Observed|Melanoma of the skin|2015–2019|Persons|3|45–49|0.97|0.965|0.975
Observed|Melanoma of the skin|2015–2019|Persons|3|50–54|0.966|0.961|0.97
Observed|Melanoma of the skin|2015–2019|Persons|3|55–59|0.956|0.951|0.961
Observed|Melanoma of the skin|2015–2019|Persons|3|60–64|0.944|0.939|0.949
Observed|Melanoma of the skin|2015–2019|Persons|3|65–69|0.93|0.925|0.935
Observed|Melanoma of the skin|2015–2019|Persons|3|70–74|0.905|0.899|0.911
Observed|Melanoma of the skin|2015–2019|Persons|3|75–79|0.854|0.845|0.862
Observed|Melanoma of the skin|2015–2019|Persons|3|80–84|0.763|0.751|0.774
Observed|Melanoma of the skin|2015–2019|Persons|3|85+|0.571|0.558|0.584
Observed|Melanoma of the skin|2015–2019|Persons|3|All ages combined|0.892|0.89|0.894
Observed|Melanoma of the skin|2015–2019|Persons|4|00–04|||
Observed|Melanoma of the skin|2015–2019|Persons|4|05–09|||
Observed|Melanoma of the skin|2015–2019|Persons|4|10–14|||
Observed|Melanoma of the skin|2015–2019|Persons|4|15–19|0.969|0.926|0.987
Observed|Melanoma of the skin|2015–2019|Persons|4|20–24|0.98|0.964|0.989
Observed|Melanoma of the skin|2015–2019|Persons|4|25–29|0.979|0.969|0.986
Observed|Melanoma of the skin|2015–2019|Persons|4|30–34|0.971|0.962|0.978
Observed|Melanoma of the skin|2015–2019|Persons|4|35–39|0.968|0.96|0.974
Observed|Melanoma of the skin|2015–2019|Persons|4|40–44|0.967|0.96|0.972
Observed|Melanoma of the skin|2015–2019|Persons|4|45–49|0.96|0.953|0.965
Observed|Melanoma of the skin|2015–2019|Persons|4|50–54|0.959|0.953|0.964
Observed|Melanoma of the skin|2015–2019|Persons|4|55–59|0.944|0.938|0.949
Observed|Melanoma of the skin|2015–2019|Persons|4|60–64|0.928|0.922|0.933
Observed|Melanoma of the skin|2015–2019|Persons|4|65–69|0.909|0.902|0.914
Observed|Melanoma of the skin|2015–2019|Persons|4|70–74|0.872|0.864|0.879
Observed|Melanoma of the skin|2015–2019|Persons|4|75–79|0.807|0.797|0.816
Observed|Melanoma of the skin|2015–2019|Persons|4|80–84|0.688|0.675|0.7
Observed|Melanoma of the skin|2015–2019|Persons|4|85+|0.459|0.446|0.472
Observed|Melanoma of the skin|2015–2019|Persons|4|All ages combined|0.861|0.858|0.863
Observed|Melanoma of the skin|2015–2019|Persons|5|00–04|||
Observed|Melanoma of the skin|2015–2019|Persons|5|05–09|||
Observed|Melanoma of the skin|2015–2019|Persons|5|10–14|||
Observed|Melanoma of the skin|2015–2019|Persons|5|15–19|0.963|0.919|0.983
Observed|Melanoma of the skin|2015–2019|Persons|5|20–24|0.975|0.957|0.985
Observed|Melanoma of the skin|2015–2019|Persons|5|25–29|0.975|0.963|0.982
Observed|Melanoma of the skin|2015–2019|Persons|5|30–34|0.968|0.959|0.976
Observed|Melanoma of the skin|2015–2019|Persons|5|35–39|0.96|0.952|0.968
Observed|Melanoma of the skin|2015–2019|Persons|5|40–44|0.961|0.954|0.967
Observed|Melanoma of the skin|2015–2019|Persons|5|45–49|0.953|0.946|0.959
Observed|Melanoma of the skin|2015–2019|Persons|5|50–54|0.95|0.944|0.956
Observed|Melanoma of the skin|2015–2019|Persons|5|55–59|0.932|0.925|0.938
Observed|Melanoma of the skin|2015–2019|Persons|5|60–64|0.916|0.909|0.922
Observed|Melanoma of the skin|2015–2019|Persons|5|65–69|0.889|0.882|0.896
Observed|Melanoma of the skin|2015–2019|Persons|5|70–74|0.841|0.832|0.849
Observed|Melanoma of the skin|2015–2019|Persons|5|75–79|0.764|0.753|0.774
Observed|Melanoma of the skin|2015–2019|Persons|5|80–84|0.611|0.598|0.624
Observed|Melanoma of the skin|2015–2019|Persons|5|85+|0.367|0.354|0.38
Observed|Melanoma of the skin|2015–2019|Persons|5|All ages combined|0.833|0.83|0.836
Relative|Melanoma of the skin|2015–2019|Persons|1|00–04|||
Relative|Melanoma of the skin|2015–2019|Persons|1|05–09|||
Relative|Melanoma of the skin|2015–2019|Persons|1|10–14|1|0.871|1
Relative|Melanoma of the skin|2015–2019|Persons|1|15–19|0.988|0.951|0.997
Relative|Melanoma of the skin|2015–2019|Persons|1|20–24|0.995|0.982|0.998
Relative|Melanoma of the skin|2015–2019|Persons|1|25–29|0.996|0.989|0.999
Relative|Melanoma of the skin|2015–2019|Persons|1|30–34|0.996|0.991|0.998
Relative|Melanoma of the skin|2015–2019|Persons|1|35–39|0.995|0.991|0.997
Relative|Melanoma of the skin|2015–2019|Persons|1|40–44|0.991|0.987|0.994
Relative|Melanoma of the skin|2015–2019|Persons|1|45–49|0.992|0.988|0.994
Relative|Melanoma of the skin|2015–2019|Persons|1|50–54|0.991|0.988|0.993
Relative|Melanoma of the skin|2015–2019|Persons|1|55–59|0.987|0.983|0.99
Relative|Melanoma of the skin|2015–2019|Persons|1|60–64|0.985|0.982|0.988
Relative|Melanoma of the skin|2015–2019|Persons|1|65–69|0.986|0.983|0.989
Relative|Melanoma of the skin|2015–2019|Persons|1|70–74|0.985|0.981|0.989
Relative|Melanoma of the skin|2015–2019|Persons|1|75–79|0.979|0.974|0.984
Relative|Melanoma of the skin|2015–2019|Persons|1|80–84|0.973|0.965|0.98
Relative|Melanoma of the skin|2015–2019|Persons|1|85+|0.959|0.948|0.969
Relative|Melanoma of the skin|2015–2019|Persons|1|All ages combined|0.984|0.982|0.985
Relative|Melanoma of the skin|2015–2019|Persons|2|00–04|||
Relative|Melanoma of the skin|2015–2019|Persons|2|05–09|||
Relative|Melanoma of the skin|2015–2019|Persons|2|10–14|||
Relative|Melanoma of the skin|2015–2019|Persons|2|15–19|0.982|0.943|0.994
Relative|Melanoma of the skin|2015–2019|Persons|2|20–24|0.991|0.977|0.997
Relative|Melanoma of the skin|2015–2019|Persons|2|25–29|0.989|0.981|0.994
Relative|Melanoma of the skin|2015–2019|Persons|2|30–34|0.988|0.982|0.993
Relative|Melanoma of the skin|2015–2019|Persons|2|35–39|0.987|0.981|0.991
Relative|Melanoma of the skin|2015–2019|Persons|2|40–44|0.984|0.979|0.988
Relative|Melanoma of the skin|2015–2019|Persons|2|45–49|0.984|0.979|0.987
Relative|Melanoma of the skin|2015–2019|Persons|2|50–54|0.983|0.978|0.986
Relative|Melanoma of the skin|2015–2019|Persons|2|55–59|0.979|0.974|0.982
Relative|Melanoma of the skin|2015–2019|Persons|2|60–64|0.975|0.97|0.979
Relative|Melanoma of the skin|2015–2019|Persons|2|65–69|0.972|0.968|0.976
Relative|Melanoma of the skin|2015–2019|Persons|2|70–74|0.97|0.964|0.975
Relative|Melanoma of the skin|2015–2019|Persons|2|75–79|0.957|0.95|0.964
Relative|Melanoma of the skin|2015–2019|Persons|2|80–84|0.947|0.936|0.958
Relative|Melanoma of the skin|2015–2019|Persons|2|85+|0.919|0.903|0.934
Relative|Melanoma of the skin|2015–2019|Persons|2|All ages combined|0.969|0.967|0.971
Relative|Melanoma of the skin|2015–2019|Persons|3|00–04|||
Relative|Melanoma of the skin|2015–2019|Persons|3|05–09|||
Relative|Melanoma of the skin|2015–2019|Persons|3|10–14|||
Relative|Melanoma of the skin|2015–2019|Persons|3|15–19|0.976|0.935|0.991
Relative|Melanoma of the skin|2015–2019|Persons|3|20–24|0.989|0.975|0.996
Relative|Melanoma of the skin|2015–2019|Persons|3|25–29|0.984|0.974|0.99
Relative|Melanoma of the skin|2015–2019|Persons|3|30–34|0.979|0.971|0.985
Relative|Melanoma of the skin|2015–2019|Persons|3|35–39|0.979|0.971|0.984
Relative|Melanoma of the skin|2015–2019|Persons|3|40–44|0.979|0.973|0.984
Relative|Melanoma of the skin|2015–2019|Persons|3|45–49|0.976|0.971|0.981
Relative|Melanoma of the skin|2015–2019|Persons|3|50–54|0.975|0.97|0.98
Relative|Melanoma of the skin|2015–2019|Persons|3|55–59|0.97|0.965|0.975
Relative|Melanoma of the skin|2015–2019|Persons|3|60–64|0.965|0.96|0.97
Relative|Melanoma of the skin|2015–2019|Persons|3|65–69|0.963|0.957|0.968
Relative|Melanoma of the skin|2015–2019|Persons|3|70–74|0.957|0.951|0.964
Relative|Melanoma of the skin|2015–2019|Persons|3|75–79|0.942|0.933|0.951
Relative|Melanoma of the skin|2015–2019|Persons|3|80–84|0.917|0.903|0.931
Relative|Melanoma of the skin|2015–2019|Persons|3|85+|0.878|0.859|0.898
Relative|Melanoma of the skin|2015–2019|Persons|3|All ages combined|0.956|0.954|0.959
Relative|Melanoma of the skin|2015–2019|Persons|4|00–04|||
Relative|Melanoma of the skin|2015–2019|Persons|4|05–09|||
Relative|Melanoma of the skin|2015–2019|Persons|4|10–14|||
Relative|Melanoma of the skin|2015–2019|Persons|4|15–19|0.97|0.928|0.988
Relative|Melanoma of the skin|2015–2019|Persons|4|20–24|0.982|0.965|0.991
Relative|Melanoma of the skin|2015–2019|Persons|4|25–29|0.981|0.971|0.988
Relative|Melanoma of the skin|2015–2019|Persons|4|30–34|0.974|0.965|0.981
Relative|Melanoma of the skin|2015–2019|Persons|4|35–39|0.971|0.963|0.978
Relative|Melanoma of the skin|2015–2019|Persons|4|40–44|0.972|0.966|0.978
Relative|Melanoma of the skin|2015–2019|Persons|4|45–49|0.968|0.962|0.973
Relative|Melanoma of the skin|2015–2019|Persons|4|50–54|0.971|0.966|0.976
Relative|Melanoma of the skin|2015–2019|Persons|4|55–59|0.963|0.957|0.968
Relative|Melanoma of the skin|2015–2019|Persons|4|60–64|0.957|0.95|0.962
Relative|Melanoma of the skin|2015–2019|Persons|4|65–69|0.953|0.947|0.959
Relative|Melanoma of the skin|2015–2019|Persons|4|70–74|0.944|0.936|0.951
Relative|Melanoma of the skin|2015–2019|Persons|4|75–79|0.928|0.917|0.938
Relative|Melanoma of the skin|2015–2019|Persons|4|80–84|0.894|0.878|0.91
Relative|Melanoma of the skin|2015–2019|Persons|4|85+|0.835|0.811|0.859
Relative|Melanoma of the skin|2015–2019|Persons|4|All ages combined|0.945|0.942|0.947
Relative|Melanoma of the skin|2015–2019|Persons|5|00–04|||
Relative|Melanoma of the skin|2015–2019|Persons|5|05–09|||
Relative|Melanoma of the skin|2015–2019|Persons|5|10–14|||
Relative|Melanoma of the skin|2015–2019|Persons|5|15–19|0.964|0.921|0.985
Relative|Melanoma of the skin|2015–2019|Persons|5|20–24|0.977|0.959|0.987
Relative|Melanoma of the skin|2015–2019|Persons|5|25–29|0.977|0.966|0.985
Relative|Melanoma of the skin|2015–2019|Persons|5|30–34|0.972|0.962|0.979
Relative|Melanoma of the skin|2015–2019|Persons|5|35–39|0.965|0.956|0.973
Relative|Melanoma of the skin|2015–2019|Persons|5|40–44|0.968|0.961|0.974
Relative|Melanoma of the skin|2015–2019|Persons|5|45–49|0.963|0.956|0.969
Relative|Melanoma of the skin|2015–2019|Persons|5|50–54|0.966|0.96|0.972
Relative|Melanoma of the skin|2015–2019|Persons|5|55–59|0.956|0.95|0.963
Relative|Melanoma of the skin|2015–2019|Persons|5|60–64|0.953|0.946|0.959
Relative|Melanoma of the skin|2015–2019|Persons|5|65–69|0.947|0.94|0.954
Relative|Melanoma of the skin|2015–2019|Persons|5|70–74|0.934|0.925|0.943
Relative|Melanoma of the skin|2015–2019|Persons|5|75–79|0.92|0.908|0.933
Relative|Melanoma of the skin|2015–2019|Persons|5|80–84|0.868|0.849|0.887
Relative|Melanoma of the skin|2015–2019|Persons|5|85+|0.8|0.771|0.828
Relative|Melanoma of the skin|2015–2019|Persons|5|All ages combined|0.936|0.933|0.939
Observed|Mesothelioma|2015–2019|Males|1|00–04|||
Observed|Mesothelioma|2015–2019|Males|1|05–09|||
Observed|Mesothelioma|2015–2019|Males|1|10–14|||
Observed|Mesothelioma|2015–2019|Males|1|15–19|||
Observed|Mesothelioma|2015–2019|Males|1|20–24|||
Observed|Mesothelioma|2015–2019|Males|1|25–29|||
Observed|Mesothelioma|2015–2019|Males|1|30–34|||
Observed|Mesothelioma|2015–2019|Males|1|35–39|||
Observed|Mesothelioma|2015–2019|Males|1|40–44|||
Observed|Mesothelioma|2015–2019|Males|1|45–49|||
Observed|Mesothelioma|2015–2019|Males|1|50–54|0.609|0.44|0.742
Observed|Mesothelioma|2015–2019|Males|1|55–59|0.669|0.572|0.748
Observed|Mesothelioma|2015–2019|Males|1|60–64|0.608|0.539|0.67
Observed|Mesothelioma|2015–2019|Males|1|65–69|0.611|0.564|0.655
Observed|Mesothelioma|2015–2019|Males|1|70–74|0.56|0.521|0.598
Observed|Mesothelioma|2015–2019|Males|1|75–79|0.434|0.397|0.471
Observed|Mesothelioma|2015–2019|Males|1|80–84|0.319|0.282|0.357
Observed|Mesothelioma|2015–2019|Males|1|85+|0.215|0.183|0.248
Observed|Mesothelioma|2015–2019|Males|1|All ages combined|0.448|0.431|0.465
Observed|Mesothelioma|2015–2019|Males|2|00–04|||
Observed|Mesothelioma|2015–2019|Males|2|05–09|||
Observed|Mesothelioma|2015–2019|Males|2|10–14|||
Observed|Mesothelioma|2015–2019|Males|2|15–19|||
Observed|Mesothelioma|2015–2019|Males|2|20–24|||
Observed|Mesothelioma|2015–2019|Males|2|25–29|||
Observed|Mesothelioma|2015–2019|Males|2|30–34|||
Observed|Mesothelioma|2015–2019|Males|2|35–39|||
Observed|Mesothelioma|2015–2019|Males|2|40–44|||
Observed|Mesothelioma|2015–2019|Males|2|45–49|||
Observed|Mesothelioma|2015–2019|Males|2|50–54|0.416|0.264|0.56
Observed|Mesothelioma|2015–2019|Males|2|55–59|0.376|0.285|0.467
Observed|Mesothelioma|2015–2019|Males|2|60–64|0.305|0.246|0.365
Observed|Mesothelioma|2015–2019|Males|2|65–69|0.274|0.233|0.316
Observed|Mesothelioma|2015–2019|Males|2|70–74|0.3|0.263|0.337
Observed|Mesothelioma|2015–2019|Males|2|75–79|0.194|0.164|0.227
Observed|Mesothelioma|2015–2019|Males|2|80–84|0.122|0.096|0.15
Observed|Mesothelioma|2015–2019|Males|2|85+|0.066|0.047|0.088
Observed|Mesothelioma|2015–2019|Males|2|All ages combined|0.209|0.195|0.223
Observed|Mesothelioma|2015–2019|Males|3|00–04|||
Observed|Mesothelioma|2015–2019|Males|3|05–09|||
Observed|Mesothelioma|2015–2019|Males|3|10–14|||
Observed|Mesothelioma|2015–2019|Males|3|15–19|||
Observed|Mesothelioma|2015–2019|Males|3|20–24|||
Observed|Mesothelioma|2015–2019|Males|3|25–29|||
Observed|Mesothelioma|2015–2019|Males|3|30–34|||
Observed|Mesothelioma|2015–2019|Males|3|35–39|||
Observed|Mesothelioma|2015–2019|Males|3|40–44|||
Observed|Mesothelioma|2015–2019|Males|3|45–49|||
Observed|Mesothelioma|2015–2019|Males|3|50–54|||
Observed|Mesothelioma|2015–2019|Males|3|55–59|0.234|0.157|0.319
Observed|Mesothelioma|2015–2019|Males|3|60–64|0.176|0.13|0.227
Observed|Mesothelioma|2015–2019|Males|3|65–69|0.149|0.117|0.184
Observed|Mesothelioma|2015–2019|Males|3|70–74|0.163|0.132|0.196
Observed|Mesothelioma|2015–2019|Males|3|75–79|0.086|0.065|0.11
Observed|Mesothelioma|2015–2019|Males|3|80–84|0.06|0.042|0.084
Observed|Mesothelioma|2015–2019|Males|3|85+|0.023|0.013|0.038
Observed|Mesothelioma|2015–2019|Males|3|All ages combined|0.11|0.099|0.122
Observed|Mesothelioma|2015–2019|Males|4|00–04|||
Observed|Mesothelioma|2015–2019|Males|4|05–09|||
Observed|Mesothelioma|2015–2019|Males|4|10–14|||
Observed|Mesothelioma|2015–2019|Males|4|15–19|||
Observed|Mesothelioma|2015–2019|Males|4|20–24|||
Observed|Mesothelioma|2015–2019|Males|4|25–29|||
Observed|Mesothelioma|2015–2019|Males|4|30–34|||
Observed|Mesothelioma|2015–2019|Males|4|35–39|||
Observed|Mesothelioma|2015–2019|Males|4|40–44|||
Observed|Mesothelioma|2015–2019|Males|4|45–49|||
Observed|Mesothelioma|2015–2019|Males|4|50–54|||
Observed|Mesothelioma|2015–2019|Males|4|55–59|0.132|0.075|0.205
Observed|Mesothelioma|2015–2019|Males|4|60–64|0.132|0.093|0.179
Observed|Mesothelioma|2015–2019|Males|4|65–69|0.093|0.068|0.123
Observed|Mesothelioma|2015–2019|Males|4|70–74|0.104|0.079|0.132
Observed|Mesothelioma|2015–2019|Males|4|75–79|0.049|0.033|0.07
Observed|Mesothelioma|2015–2019|Males|4|80–84|0.038|0.023|0.06
Observed|Mesothelioma|2015–2019|Males|4|85+|0.014|0.007|0.027
Observed|Mesothelioma|2015–2019|Males|4|All ages combined|0.071|0.062|0.08
Observed|Mesothelioma|2015–2019|Males|5|00–04|||
Observed|Mesothelioma|2015–2019|Males|5|05–09|||
Observed|Mesothelioma|2015–2019|Males|5|10–14|||
Observed|Mesothelioma|2015–2019|Males|5|15–19|||
Observed|Mesothelioma|2015–2019|Males|5|20–24|||
Observed|Mesothelioma|2015–2019|Males|5|25–29|||
Observed|Mesothelioma|2015–2019|Males|5|30–34|||
Observed|Mesothelioma|2015–2019|Males|5|35–39|||
Observed|Mesothelioma|2015–2019|Males|5|40–44|||
Observed|Mesothelioma|2015–2019|Males|5|45–49|||
Observed|Mesothelioma|2015–2019|Males|5|50–54|||
Observed|Mesothelioma|2015–2019|Males|5|55–59|0.103|0.054|0.171
Observed|Mesothelioma|2015–2019|Males|5|60–64|0.093|0.06|0.136
Observed|Mesothelioma|2015–2019|Males|5|65–69|0.065|0.044|0.092
Observed|Mesothelioma|2015–2019|Males|5|70–74|0.065|0.045|0.089
Observed|Mesothelioma|2015–2019|Males|5|75–79|0.025|0.013|0.043
Observed|Mesothelioma|2015–2019|Males|5|80–84|0.027|0.014|0.048
Observed|Mesothelioma|2015–2019|Males|5|85+|0.01|0.004|0.022
Observed|Mesothelioma|2015–2019|Males|5|All ages combined|0.048|0.04|0.056
Relative|Mesothelioma|2015–2019|Males|1|00–04|||
Relative|Mesothelioma|2015–2019|Males|1|05–09|||
Relative|Mesothelioma|2015–2019|Males|1|10–14|||
Relative|Mesothelioma|2015–2019|Males|1|15–19|||
Relative|Mesothelioma|2015–2019|Males|1|20–24|||
Relative|Mesothelioma|2015–2019|Males|1|25–29|||
Relative|Mesothelioma|2015–2019|Males|1|30–34|||
Relative|Mesothelioma|2015–2019|Males|1|35–39|||
Relative|Mesothelioma|2015–2019|Males|1|40–44|||
Relative|Mesothelioma|2015–2019|Males|1|45–49|||
Relative|Mesothelioma|2015–2019|Males|1|50–54|0.612|0.441|0.745
Relative|Mesothelioma|2015–2019|Males|1|55–59|0.672|0.576|0.752
Relative|Mesothelioma|2015–2019|Males|1|60–64|0.613|0.543|0.675
Relative|Mesothelioma|2015–2019|Males|1|65–69|0.619|0.571|0.663
Relative|Mesothelioma|2015–2019|Males|1|70–74|0.571|0.531|0.61
Relative|Mesothelioma|2015–2019|Males|1|75–79|0.449|0.41|0.487
Relative|Mesothelioma|2015–2019|Males|1|80–84|0.339|0.299|0.379
Relative|Mesothelioma|2015–2019|Males|1|85+|0.246|0.21|0.284
Relative|Mesothelioma|2015–2019|Males|1|All ages combined|0.469|0.451|0.487
Relative|Mesothelioma|2015–2019|Males|2|00–04|||
Relative|Mesothelioma|2015–2019|Males|2|05–09|||
Relative|Mesothelioma|2015–2019|Males|2|10–14|||
Relative|Mesothelioma|2015–2019|Males|2|15–19|||
Relative|Mesothelioma|2015–2019|Males|2|20–24|||
Relative|Mesothelioma|2015–2019|Males|2|25–29|||
Relative|Mesothelioma|2015–2019|Males|2|30–34|||
Relative|Mesothelioma|2015–2019|Males|2|35–39|||
Relative|Mesothelioma|2015–2019|Males|2|40–44|||
Relative|Mesothelioma|2015–2019|Males|2|45–49|||
Relative|Mesothelioma|2015–2019|Males|2|50–54|0.419|0.266|0.564
Relative|Mesothelioma|2015–2019|Males|2|55–59|0.38|0.288|0.472
Relative|Mesothelioma|2015–2019|Males|2|60–64|0.31|0.251|0.372
Relative|Mesothelioma|2015–2019|Males|2|65–69|0.281|0.239|0.324
Relative|Mesothelioma|2015–2019|Males|2|70–74|0.312|0.274|0.351
Relative|Mesothelioma|2015–2019|Males|2|75–79|0.209|0.176|0.243
Relative|Mesothelioma|2015–2019|Males|2|80–84|0.139|0.11|0.171
Relative|Mesothelioma|2015–2019|Males|2|85+|0.087|0.063|0.117
Relative|Mesothelioma|2015–2019|Males|2|All ages combined|0.226|0.211|0.242
Relative|Mesothelioma|2015–2019|Males|3|00–04|||
Relative|Mesothelioma|2015–2019|Males|3|05–09|||
Relative|Mesothelioma|2015–2019|Males|3|10–14|||
Relative|Mesothelioma|2015–2019|Males|3|15–19|||
Relative|Mesothelioma|2015–2019|Males|3|20–24|||
Relative|Mesothelioma|2015–2019|Males|3|25–29|||
Relative|Mesothelioma|2015–2019|Males|3|30–34|||
Relative|Mesothelioma|2015–2019|Males|3|35–39|||
Relative|Mesothelioma|2015–2019|Males|3|40–44|||
Relative|Mesothelioma|2015–2019|Males|3|45–49|||
Relative|Mesothelioma|2015–2019|Males|3|50–54|||
Relative|Mesothelioma|2015–2019|Males|3|55–59|0.238|0.16|0.324
Relative|Mesothelioma|2015–2019|Males|3|60–64|0.181|0.134|0.233
Relative|Mesothelioma|2015–2019|Males|3|65–69|0.155|0.122|0.192
Relative|Mesothelioma|2015–2019|Males|3|70–74|0.174|0.141|0.209
Relative|Mesothelioma|2015–2019|Males|3|75–79|0.096|0.073|0.123
Relative|Mesothelioma|2015–2019|Males|3|80–84|0.075|0.052|0.104
Relative|Mesothelioma|2015–2019|Males|3|85+|0.036|0.02|0.059
Relative|Mesothelioma|2015–2019|Males|3|All ages combined|0.124|0.111|0.136
Relative|Mesothelioma|2015–2019|Males|4|00–04|||
Relative|Mesothelioma|2015–2019|Males|4|05–09|||
Relative|Mesothelioma|2015–2019|Males|4|10–14|||
Relative|Mesothelioma|2015–2019|Males|4|15–19|||
Relative|Mesothelioma|2015–2019|Males|4|20–24|||
Relative|Mesothelioma|2015–2019|Males|4|25–29|||
Relative|Mesothelioma|2015–2019|Males|4|30–34|||
Relative|Mesothelioma|2015–2019|Males|4|35–39|||
Relative|Mesothelioma|2015–2019|Males|4|40–44|||
Relative|Mesothelioma|2015–2019|Males|4|45–49|||
Relative|Mesothelioma|2015–2019|Males|4|50–54|||
Relative|Mesothelioma|2015–2019|Males|4|55–59|0.135|0.077|0.21
Relative|Mesothelioma|2015–2019|Males|4|60–64|0.137|0.096|0.186
Relative|Mesothelioma|2015–2019|Males|4|65–69|0.099|0.072|0.131
Relative|Mesothelioma|2015–2019|Males|4|70–74|0.114|0.087|0.145
Relative|Mesothelioma|2015–2019|Males|4|75–79|0.057|0.038|0.082
Relative|Mesothelioma|2015–2019|Males|4|80–84|0.052|0.031|0.081
Relative|Mesothelioma|2015–2019|Males|4|85+|0.027|0.013|0.05
Relative|Mesothelioma|2015–2019|Males|4|All ages combined|0.082|0.071|0.093
Relative|Mesothelioma|2015–2019|Males|5|00–04|||
Relative|Mesothelioma|2015–2019|Males|5|05–09|||
Relative|Mesothelioma|2015–2019|Males|5|10–14|||
Relative|Mesothelioma|2015–2019|Males|5|15–19|||
Relative|Mesothelioma|2015–2019|Males|5|20–24|||
Relative|Mesothelioma|2015–2019|Males|5|25–29|||
Relative|Mesothelioma|2015–2019|Males|5|30–34|||
Relative|Mesothelioma|2015–2019|Males|5|35–39|||
Relative|Mesothelioma|2015–2019|Males|5|40–44|||
Relative|Mesothelioma|2015–2019|Males|5|45–49|||
Relative|Mesothelioma|2015–2019|Males|5|50–54|||
Relative|Mesothelioma|2015–2019|Males|5|55–59|0.107|0.056|0.176
Relative|Mesothelioma|2015–2019|Males|5|60–64|0.098|0.062|0.142
Relative|Mesothelioma|2015–2019|Males|5|65–69|0.07|0.048|0.099
Relative|Mesothelioma|2015–2019|Males|5|70–74|0.073|0.051|0.101
Relative|Mesothelioma|2015–2019|Males|5|75–79|0.031|0.016|0.053
Relative|Mesothelioma|2015–2019|Males|5|80–84|0.04|0.02|0.072
Relative|Mesothelioma|2015–2019|Males|5|85+|0.024|0.01|0.05
Relative|Mesothelioma|2015–2019|Males|5|All ages combined|0.057|0.048|0.067
Observed|Mesothelioma|2015–2019|Females|1|00–04|||
Observed|Mesothelioma|2015–2019|Females|1|05–09|||
Observed|Mesothelioma|2015–2019|Females|1|10–14|||
Observed|Mesothelioma|2015–2019|Females|1|15–19|||
Observed|Mesothelioma|2015–2019|Females|1|20–24|||
Observed|Mesothelioma|2015–2019|Females|1|25–29|||
Observed|Mesothelioma|2015–2019|Females|1|30–34|||
Observed|Mesothelioma|2015–2019|Females|1|35–39|||
Observed|Mesothelioma|2015–2019|Females|1|40–44|||
Observed|Mesothelioma|2015–2019|Females|1|45–49|||
Observed|Mesothelioma|2015–2019|Females|1|50–54|0.913|0.694|0.977
Observed|Mesothelioma|2015–2019|Females|1|55–59|0.668|0.512|0.784
Observed|Mesothelioma|2015–2019|Females|1|60–64|0.724|0.599|0.816
Observed|Mesothelioma|2015–2019|Females|1|65–69|0.577|0.481|0.662
Observed|Mesothelioma|2015–2019|Females|1|70–74|0.59|0.504|0.665
Observed|Mesothelioma|2015–2019|Females|1|75–79|0.555|0.466|0.635
Observed|Mesothelioma|2015–2019|Females|1|80–84|0.358|0.271|0.446
Observed|Mesothelioma|2015–2019|Females|1|85+|0.32|0.245|0.397
Observed|Mesothelioma|2015–2019|Females|1|All ages combined|0.533|0.498|0.568
Observed|Mesothelioma|2015–2019|Females|2|00–04|||
Observed|Mesothelioma|2015–2019|Females|2|05–09|||
Observed|Mesothelioma|2015–2019|Females|2|10–14|||
Observed|Mesothelioma|2015–2019|Females|2|15–19|||
Observed|Mesothelioma|2015–2019|Females|2|20–24|||
Observed|Mesothelioma|2015–2019|Females|2|25–29|||
Observed|Mesothelioma|2015–2019|Females|2|30–34|||
Observed|Mesothelioma|2015–2019|Females|2|35–39|||
Observed|Mesothelioma|2015–2019|Females|2|40–44|||
Observed|Mesothelioma|2015–2019|Females|2|45–49|||
Observed|Mesothelioma|2015–2019|Females|2|50–54|||
Observed|Mesothelioma|2015–2019|Females|2|55–59|0.431|0.291|0.563
Observed|Mesothelioma|2015–2019|Females|2|60–64|0.429|0.304|0.548
Observed|Mesothelioma|2015–2019|Females|2|65–69|0.368|0.28|0.456
Observed|Mesothelioma|2015–2019|Females|2|70–74|0.31|0.236|0.387
Observed|Mesothelioma|2015–2019|Females|2|75–79|0.26|0.187|0.339
Observed|Mesothelioma|2015–2019|Females|2|80–84|0.196|0.129|0.273
Observed|Mesothelioma|2015–2019|Females|2|85+|0.175|0.114|0.246
Observed|Mesothelioma|2015–2019|Females|2|All ages combined|0.306|0.274|0.339
Observed|Mesothelioma|2015–2019|Females|3|00–04|||
Observed|Mesothelioma|2015–2019|Females|3|05–09|||
Observed|Mesothelioma|2015–2019|Females|3|10–14|||
Observed|Mesothelioma|2015–2019|Females|3|15–19|||
Observed|Mesothelioma|2015–2019|Females|3|20–24|||
Observed|Mesothelioma|2015–2019|Females|3|25–29|||
Observed|Mesothelioma|2015–2019|Females|3|30–34|||
Observed|Mesothelioma|2015–2019|Females|3|35–39|||
Observed|Mesothelioma|2015–2019|Females|3|40–44|||
Observed|Mesothelioma|2015–2019|Females|3|45–49|||
Observed|Mesothelioma|2015–2019|Females|3|50–54|||
Observed|Mesothelioma|2015–2019|Females|3|55–59|0.319|0.198|0.448
Observed|Mesothelioma|2015–2019|Females|3|60–64|0.33|0.216|0.448
Observed|Mesothelioma|2015–2019|Females|3|65–69|0.229|0.155|0.312
Observed|Mesothelioma|2015–2019|Females|3|70–74|0.171|0.112|0.241
Observed|Mesothelioma|2015–2019|Females|3|75–79|0.15|0.093|0.22
Observed|Mesothelioma|2015–2019|Females|3|80–84|0.11|0.059|0.179
Observed|Mesothelioma|2015–2019|Females|3|85+|0.126|0.072|0.196
Observed|Mesothelioma|2015–2019|Females|3|All ages combined|0.206|0.177|0.235
Observed|Mesothelioma|2015–2019|Females|4|00–04|||
Observed|Mesothelioma|2015–2019|Females|4|05–09|||
Observed|Mesothelioma|2015–2019|Females|4|10–14|||
Observed|Mesothelioma|2015–2019|Females|4|15–19|||
Observed|Mesothelioma|2015–2019|Females|4|20–24|||
Observed|Mesothelioma|2015–2019|Females|4|25–29|||
Observed|Mesothelioma|2015–2019|Females|4|30–34|||
Observed|Mesothelioma|2015–2019|Females|4|35–39|||
Observed|Mesothelioma|2015–2019|Females|4|40–44|||
Observed|Mesothelioma|2015–2019|Females|4|45–49|||
Observed|Mesothelioma|2015–2019|Females|4|50–54|||
Observed|Mesothelioma|2015–2019|Females|4|55–59|||
Observed|Mesothelioma|2015–2019|Females|4|60–64|||
Observed|Mesothelioma|2015–2019|Females|4|65–69|0.143|0.079|0.224
Observed|Mesothelioma|2015–2019|Females|4|70–74|0.135|0.082|0.202
Observed|Mesothelioma|2015–2019|Females|4|75–79|0.091|0.045|0.156
Observed|Mesothelioma|2015–2019|Females|4|80–84|0.11|0.059|0.179
Observed|Mesothelioma|2015–2019|Females|4|85+|0.058|0.023|0.116
Observed|Mesothelioma|2015–2019|Females|4|All ages combined|0.154|0.129|0.182
Observed|Mesothelioma|2015–2019|Females|5|00–04|||
Observed|Mesothelioma|2015–2019|Females|5|05–09|||
Observed|Mesothelioma|2015–2019|Females|5|10–14|||
Observed|Mesothelioma|2015–2019|Females|5|15–19|||
Observed|Mesothelioma|2015–2019|Females|5|20–24|||
Observed|Mesothelioma|2015–2019|Females|5|25–29|||
Observed|Mesothelioma|2015–2019|Females|5|30–34|||
Observed|Mesothelioma|2015–2019|Females|5|35–39|||
Observed|Mesothelioma|2015–2019|Females|5|40–44|||
Observed|Mesothelioma|2015–2019|Females|5|45–49|||
Observed|Mesothelioma|2015–2019|Females|5|50–54|||
Observed|Mesothelioma|2015–2019|Females|5|55–59|||
Observed|Mesothelioma|2015–2019|Females|5|60–64|||
Observed|Mesothelioma|2015–2019|Females|5|65–69|0.094|0.044|0.167
Observed|Mesothelioma|2015–2019|Females|5|70–74|0.076|0.037|0.134
Observed|Mesothelioma|2015–2019|Females|5|75–79|0.091|0.045|0.156
Observed|Mesothelioma|2015–2019|Females|5|80–84|||
Observed|Mesothelioma|2015–2019|Females|5|85+|||
Observed|Mesothelioma|2015–2019|Females|5|All ages combined|0.119|0.096|0.145
Relative|Mesothelioma|2015–2019|Females|1|00–04|||
Relative|Mesothelioma|2015–2019|Females|1|05–09|||
Relative|Mesothelioma|2015–2019|Females|1|10–14|||
Relative|Mesothelioma|2015–2019|Females|1|15–19|||
Relative|Mesothelioma|2015–2019|Females|1|20–24|||
Relative|Mesothelioma|2015–2019|Females|1|25–29|||
Relative|Mesothelioma|2015–2019|Females|1|30–34|||
Relative|Mesothelioma|2015–2019|Females|1|35–39|||
Relative|Mesothelioma|2015–2019|Females|1|40–44|||
Relative|Mesothelioma|2015–2019|Females|1|45–49|||
Relative|Mesothelioma|2015–2019|Females|1|50–54|0.915|0.695|0.98
Relative|Mesothelioma|2015–2019|Females|1|55–59|0.67|0.514|0.787
Relative|Mesothelioma|2015–2019|Females|1|60–64|0.727|0.602|0.82
Relative|Mesothelioma|2015–2019|Females|1|65–69|0.582|0.485|0.667
Relative|Mesothelioma|2015–2019|Females|1|70–74|0.597|0.51|0.674
Relative|Mesothelioma|2015–2019|Females|1|75–79|0.567|0.476|0.649
Relative|Mesothelioma|2015–2019|Females|1|80–84|0.374|0.282|0.466
Relative|Mesothelioma|2015–2019|Females|1|85+|0.357|0.273|0.444
Relative|Mesothelioma|2015–2019|Females|1|All ages combined|0.55|0.514|0.585
Relative|Mesothelioma|2015–2019|Females|2|00–04|||
Relative|Mesothelioma|2015–2019|Females|2|05–09|||
Relative|Mesothelioma|2015–2019|Females|2|10–14|||
Relative|Mesothelioma|2015–2019|Females|2|15–19|||
Relative|Mesothelioma|2015–2019|Females|2|20–24|||
Relative|Mesothelioma|2015–2019|Females|2|25–29|||
Relative|Mesothelioma|2015–2019|Females|2|30–34|||
Relative|Mesothelioma|2015–2019|Females|2|35–39|||
Relative|Mesothelioma|2015–2019|Females|2|40–44|||
Relative|Mesothelioma|2015–2019|Females|2|45–49|||
Relative|Mesothelioma|2015–2019|Females|2|50–54|||
Relative|Mesothelioma|2015–2019|Females|2|55–59|0.434|0.293|0.566
Relative|Mesothelioma|2015–2019|Females|2|60–64|0.433|0.307|0.554
Relative|Mesothelioma|2015–2019|Females|2|65–69|0.374|0.284|0.463
Relative|Mesothelioma|2015–2019|Females|2|70–74|0.318|0.242|0.397
Relative|Mesothelioma|2015–2019|Females|2|75–79|0.272|0.196|0.354
Relative|Mesothelioma|2015–2019|Females|2|80–84|0.214|0.141|0.299
Relative|Mesothelioma|2015–2019|Females|2|85+|0.22|0.143|0.31
Relative|Mesothelioma|2015–2019|Females|2|All ages combined|0.323|0.289|0.357
Relative|Mesothelioma|2015–2019|Females|3|00–04|||
Relative|Mesothelioma|2015–2019|Females|3|05–09|||
Relative|Mesothelioma|2015–2019|Females|3|10–14|||
Relative|Mesothelioma|2015–2019|Females|3|15–19|||
Relative|Mesothelioma|2015–2019|Females|3|20–24|||
Relative|Mesothelioma|2015–2019|Females|3|25–29|||
Relative|Mesothelioma|2015–2019|Females|3|30–34|||
Relative|Mesothelioma|2015–2019|Females|3|35–39|||
Relative|Mesothelioma|2015–2019|Females|3|40–44|||
Relative|Mesothelioma|2015–2019|Females|3|45–49|||
Relative|Mesothelioma|2015–2019|Females|3|50–54|||
Relative|Mesothelioma|2015–2019|Females|3|55–59|0.323|0.2|0.453
Relative|Mesothelioma|2015–2019|Females|3|60–64|0.335|0.22|0.455
Relative|Mesothelioma|2015–2019|Females|3|65–69|0.235|0.159|0.32
Relative|Mesothelioma|2015–2019|Females|3|70–74|0.178|0.116|0.251
Relative|Mesothelioma|2015–2019|Females|3|75–79|0.162|0.1|0.237
Relative|Mesothelioma|2015–2019|Females|3|80–84|0.127|0.068|0.206
Relative|Mesothelioma|2015–2019|Females|3|85+|0.179|0.102|0.279
Relative|Mesothelioma|2015–2019|Females|3|All ages combined|0.222|0.192|0.254
Relative|Mesothelioma|2015–2019|Females|4|00–04|||
Relative|Mesothelioma|2015–2019|Females|4|05–09|||
Relative|Mesothelioma|2015–2019|Females|4|10–14|||
Relative|Mesothelioma|2015–2019|Females|4|15–19|||
Relative|Mesothelioma|2015–2019|Females|4|20–24|||
Relative|Mesothelioma|2015–2019|Females|4|25–29|||
Relative|Mesothelioma|2015–2019|Females|4|30–34|||
Relative|Mesothelioma|2015–2019|Females|4|35–39|||
Relative|Mesothelioma|2015–2019|Females|4|40–44|||
Relative|Mesothelioma|2015–2019|Females|4|45–49|||
Relative|Mesothelioma|2015–2019|Females|4|50–54|||
Relative|Mesothelioma|2015–2019|Females|4|55–59|||
Relative|Mesothelioma|2015–2019|Females|4|60–64|||
Relative|Mesothelioma|2015–2019|Females|4|65–69|0.148|0.082|0.232
Relative|Mesothelioma|2015–2019|Females|4|70–74|0.143|0.087|0.214
Relative|Mesothelioma|2015–2019|Females|4|75–79|0.101|0.05|0.173
Relative|Mesothelioma|2015–2019|Females|4|80–84|0.134|0.072|0.218
Relative|Mesothelioma|2015–2019|Females|4|85+|0.095|0.038|0.19
Relative|Mesothelioma|2015–2019|Females|4|All ages combined|0.17|0.142|0.201
Relative|Mesothelioma|2015–2019|Females|5|00–04|||
Relative|Mesothelioma|2015–2019|Females|5|05–09|||
Relative|Mesothelioma|2015–2019|Females|5|10–14|||
Relative|Mesothelioma|2015–2019|Females|5|15–19|||
Relative|Mesothelioma|2015–2019|Females|5|20–24|||
Relative|Mesothelioma|2015–2019|Females|5|25–29|||
Relative|Mesothelioma|2015–2019|Females|5|30–34|||
Relative|Mesothelioma|2015–2019|Females|5|35–39|||
Relative|Mesothelioma|2015–2019|Females|5|40–44|||
Relative|Mesothelioma|2015–2019|Females|5|45–49|||
Relative|Mesothelioma|2015–2019|Females|5|50–54|||
Relative|Mesothelioma|2015–2019|Females|5|55–59|||
Relative|Mesothelioma|2015–2019|Females|5|60–64|||
Relative|Mesothelioma|2015–2019|Females|5|65–69|0.098|0.046|0.174
Relative|Mesothelioma|2015–2019|Females|5|70–74|0.082|0.04|0.145
Relative|Mesothelioma|2015–2019|Females|5|75–79|0.105|0.052|0.18
Relative|Mesothelioma|2015–2019|Females|5|80–84|||
Relative|Mesothelioma|2015–2019|Females|5|85+|||
Relative|Mesothelioma|2015–2019|Females|5|All ages combined|0.135|0.108|0.164
Observed|Mesothelioma|2015–2019|Persons|1|00–04|||
Observed|Mesothelioma|2015–2019|Persons|1|05–09|||
Observed|Mesothelioma|2015–2019|Persons|1|10–14|||
Observed|Mesothelioma|2015–2019|Persons|1|15–19|||
Observed|Mesothelioma|2015–2019|Persons|1|20–24|||
Observed|Mesothelioma|2015–2019|Persons|1|25–29|||
Observed|Mesothelioma|2015–2019|Persons|1|30–34|||
Observed|Mesothelioma|2015–2019|Persons|1|35–39|||
Observed|Mesothelioma|2015–2019|Persons|1|40–44|||
Observed|Mesothelioma|2015–2019|Persons|1|45–49|||
Observed|Mesothelioma|2015–2019|Persons|1|50–54|0.722|0.592|0.817
Observed|Mesothelioma|2015–2019|Persons|1|55–59|0.669|0.589|0.736
Observed|Mesothelioma|2015–2019|Persons|1|60–64|0.635|0.576|0.689
Observed|Mesothelioma|2015–2019|Persons|1|65–69|0.604|0.562|0.644
Observed|Mesothelioma|2015–2019|Persons|1|70–74|0.566|0.53|0.6
Observed|Mesothelioma|2015–2019|Persons|1|75–79|0.454|0.42|0.488
Observed|Mesothelioma|2015–2019|Persons|1|80–84|0.325|0.291|0.36
Observed|Mesothelioma|2015–2019|Persons|1|85+|0.235|0.206|0.266
Observed|Mesothelioma|2015–2019|Persons|1|All ages combined|0.465|0.45|0.48
Observed|Mesothelioma|2015–2019|Persons|2|00–04|||
Observed|Mesothelioma|2015–2019|Persons|2|05–09|||
Observed|Mesothelioma|2015–2019|Persons|2|10–14|||
Observed|Mesothelioma|2015–2019|Persons|2|15–19|||
Observed|Mesothelioma|2015–2019|Persons|2|20–24|||
Observed|Mesothelioma|2015–2019|Persons|2|25–29|||
Observed|Mesothelioma|2015–2019|Persons|2|30–34|||
Observed|Mesothelioma|2015–2019|Persons|2|35–39|||
Observed|Mesothelioma|2015–2019|Persons|2|40–44|||
Observed|Mesothelioma|2015–2019|Persons|2|45–49|||
Observed|Mesothelioma|2015–2019|Persons|2|50–54|0.486|0.361|0.6
Observed|Mesothelioma|2015–2019|Persons|2|55–59|0.394|0.317|0.469
Observed|Mesothelioma|2015–2019|Persons|2|60–64|0.332|0.278|0.387
Observed|Mesothelioma|2015–2019|Persons|2|65–69|0.293|0.255|0.331
Observed|Mesothelioma|2015–2019|Persons|2|70–74|0.301|0.269|0.335
Observed|Mesothelioma|2015–2019|Persons|2|75–79|0.205|0.177|0.235
Observed|Mesothelioma|2015–2019|Persons|2|80–84|0.134|0.11|0.161
Observed|Mesothelioma|2015–2019|Persons|2|85+|0.086|0.066|0.108
Observed|Mesothelioma|2015–2019|Persons|2|All ages combined|0.228|0.215|0.242
Observed|Mesothelioma|2015–2019|Persons|3|00–04|||
Observed|Mesothelioma|2015–2019|Persons|3|05–09|||
Observed|Mesothelioma|2015–2019|Persons|3|10–14|||
Observed|Mesothelioma|2015–2019|Persons|3|15–19|||
Observed|Mesothelioma|2015–2019|Persons|3|20–24|||
Observed|Mesothelioma|2015–2019|Persons|3|25–29|||
Observed|Mesothelioma|2015–2019|Persons|3|30–34|||
Observed|Mesothelioma|2015–2019|Persons|3|35–39|||
Observed|Mesothelioma|2015–2019|Persons|3|40–44|||
Observed|Mesothelioma|2015–2019|Persons|3|45–49|||
Observed|Mesothelioma|2015–2019|Persons|3|50–54|0.37|0.256|0.484
Observed|Mesothelioma|2015–2019|Persons|3|55–59|0.263|0.197|0.334
Observed|Mesothelioma|2015–2019|Persons|3|60–64|0.209|0.164|0.257
Observed|Mesothelioma|2015–2019|Persons|3|65–69|0.165|0.135|0.197
Observed|Mesothelioma|2015–2019|Persons|3|70–74|0.164|0.137|0.194
Observed|Mesothelioma|2015–2019|Persons|3|75–79|0.096|0.076|0.119
Observed|Mesothelioma|2015–2019|Persons|3|80–84|0.069|0.051|0.091
Observed|Mesothelioma|2015–2019|Persons|3|85+|0.039|0.026|0.056
Observed|Mesothelioma|2015–2019|Persons|3|All ages combined|0.129|0.119|0.14
Observed|Mesothelioma|2015–2019|Persons|4|00–04|||
Observed|Mesothelioma|2015–2019|Persons|4|05–09|||
Observed|Mesothelioma|2015–2019|Persons|4|10–14|||
Observed|Mesothelioma|2015–2019|Persons|4|15–19|||
Observed|Mesothelioma|2015–2019|Persons|4|20–24|||
Observed|Mesothelioma|2015–2019|Persons|4|25–29|||
Observed|Mesothelioma|2015–2019|Persons|4|30–34|||
Observed|Mesothelioma|2015–2019|Persons|4|35–39|||
Observed|Mesothelioma|2015–2019|Persons|4|40–44|||
Observed|Mesothelioma|2015–2019|Persons|4|45–49|||
Observed|Mesothelioma|2015–2019|Persons|4|50–54|0.261|0.163|0.37
Observed|Mesothelioma|2015–2019|Persons|4|55–59|0.173|0.119|0.237
Observed|Mesothelioma|2015–2019|Persons|4|60–64|0.163|0.123|0.208
Observed|Mesothelioma|2015–2019|Persons|4|65–69|0.103|0.079|0.132
Observed|Mesothelioma|2015–2019|Persons|4|70–74|0.11|0.087|0.135
Observed|Mesothelioma|2015–2019|Persons|4|75–79|0.056|0.039|0.076
Observed|Mesothelioma|2015–2019|Persons|4|80–84|0.051|0.035|0.073
Observed|Mesothelioma|2015–2019|Persons|4|85+|0.021|0.012|0.035
Observed|Mesothelioma|2015–2019|Persons|4|All ages combined|0.087|0.078|0.096
Observed|Mesothelioma|2015–2019|Persons|5|00–04|||
Observed|Mesothelioma|2015–2019|Persons|5|05–09|||
Observed|Mesothelioma|2015–2019|Persons|5|10–14|||
Observed|Mesothelioma|2015–2019|Persons|5|15–19|||
Observed|Mesothelioma|2015–2019|Persons|5|20–24|||
Observed|Mesothelioma|2015–2019|Persons|5|25–29|||
Observed|Mesothelioma|2015–2019|Persons|5|30–34|||
Observed|Mesothelioma|2015–2019|Persons|5|35–39|||
Observed|Mesothelioma|2015–2019|Persons|5|40–44|||
Observed|Mesothelioma|2015–2019|Persons|5|45–49|||
Observed|Mesothelioma|2015–2019|Persons|5|50–54|||
Observed|Mesothelioma|2015–2019|Persons|5|55–59|0.137|0.088|0.197
Observed|Mesothelioma|2015–2019|Persons|5|60–64|0.124|0.089|0.166
Observed|Mesothelioma|2015–2019|Persons|5|65–69|0.071|0.051|0.096
Observed|Mesothelioma|2015–2019|Persons|5|70–74|0.067|0.049|0.089
Observed|Mesothelioma|2015–2019|Persons|5|75–79|0.036|0.022|0.054
Observed|Mesothelioma|2015–2019|Persons|5|80–84|0.032|0.018|0.052
Observed|Mesothelioma|2015–2019|Persons|5|85+|0.017|0.009|0.03
Observed|Mesothelioma|2015–2019|Persons|5|All ages combined|0.062|0.054|0.07
Relative|Mesothelioma|2015–2019|Persons|1|00–04|||
Relative|Mesothelioma|2015–2019|Persons|1|05–09|||
Relative|Mesothelioma|2015–2019|Persons|1|10–14|||
Relative|Mesothelioma|2015–2019|Persons|1|15–19|||
Relative|Mesothelioma|2015–2019|Persons|1|20–24|||
Relative|Mesothelioma|2015–2019|Persons|1|25–29|||
Relative|Mesothelioma|2015–2019|Persons|1|30–34|||
Relative|Mesothelioma|2015–2019|Persons|1|35–39|||
Relative|Mesothelioma|2015–2019|Persons|1|40–44|||
Relative|Mesothelioma|2015–2019|Persons|1|45–49|||
Relative|Mesothelioma|2015–2019|Persons|1|50–54|0.724|0.594|0.819
Relative|Mesothelioma|2015–2019|Persons|1|55–59|0.672|0.591|0.74
Relative|Mesothelioma|2015–2019|Persons|1|60–64|0.64|0.58|0.694
Relative|Mesothelioma|2015–2019|Persons|1|65–69|0.611|0.569|0.651
Relative|Mesothelioma|2015–2019|Persons|1|70–74|0.576|0.54|0.611
Relative|Mesothelioma|2015–2019|Persons|1|75–79|0.469|0.433|0.504
Relative|Mesothelioma|2015–2019|Persons|1|80–84|0.345|0.308|0.381
Relative|Mesothelioma|2015–2019|Persons|1|85+|0.268|0.234|0.303
Relative|Mesothelioma|2015–2019|Persons|1|All ages combined|0.485|0.469|0.501
Relative|Mesothelioma|2015–2019|Persons|2|00–04|||
Relative|Mesothelioma|2015–2019|Persons|2|05–09|||
Relative|Mesothelioma|2015–2019|Persons|2|10–14|||
Relative|Mesothelioma|2015–2019|Persons|2|15–19|||
Relative|Mesothelioma|2015–2019|Persons|2|20–24|||
Relative|Mesothelioma|2015–2019|Persons|2|25–29|||
Relative|Mesothelioma|2015–2019|Persons|2|30–34|||
Relative|Mesothelioma|2015–2019|Persons|2|35–39|||
Relative|Mesothelioma|2015–2019|Persons|2|40–44|||
Relative|Mesothelioma|2015–2019|Persons|2|45–49|||
Relative|Mesothelioma|2015–2019|Persons|2|50–54|0.489|0.364|0.603
Relative|Mesothelioma|2015–2019|Persons|2|55–59|0.398|0.32|0.474
Relative|Mesothelioma|2015–2019|Persons|2|60–64|0.337|0.283|0.393
Relative|Mesothelioma|2015–2019|Persons|2|65–69|0.3|0.262|0.339
Relative|Mesothelioma|2015–2019|Persons|2|70–74|0.313|0.279|0.348
Relative|Mesothelioma|2015–2019|Persons|2|75–79|0.219|0.189|0.251
Relative|Mesothelioma|2015–2019|Persons|2|80–84|0.152|0.124|0.183
Relative|Mesothelioma|2015–2019|Persons|2|85+|0.112|0.087|0.142
Relative|Mesothelioma|2015–2019|Persons|2|All ages combined|0.246|0.232|0.26
Relative|Mesothelioma|2015–2019|Persons|3|00–04|||
Relative|Mesothelioma|2015–2019|Persons|3|05–09|||
Relative|Mesothelioma|2015–2019|Persons|3|10–14|||
Relative|Mesothelioma|2015–2019|Persons|3|15–19|||
Relative|Mesothelioma|2015–2019|Persons|3|20–24|||
Relative|Mesothelioma|2015–2019|Persons|3|25–29|||
Relative|Mesothelioma|2015–2019|Persons|3|30–34|||
Relative|Mesothelioma|2015–2019|Persons|3|35–39|||
Relative|Mesothelioma|2015–2019|Persons|3|40–44|||
Relative|Mesothelioma|2015–2019|Persons|3|45–49|||
Relative|Mesothelioma|2015–2019|Persons|3|50–54|0.374|0.259|0.488
Relative|Mesothelioma|2015–2019|Persons|3|55–59|0.267|0.2|0.339
Relative|Mesothelioma|2015–2019|Persons|3|60–64|0.214|0.168|0.263
Relative|Mesothelioma|2015–2019|Persons|3|65–69|0.171|0.14|0.205
Relative|Mesothelioma|2015–2019|Persons|3|70–74|0.174|0.145|0.206
Relative|Mesothelioma|2015–2019|Persons|3|75–79|0.107|0.085|0.132
Relative|Mesothelioma|2015–2019|Persons|3|80–84|0.084|0.062|0.111
Relative|Mesothelioma|2015–2019|Persons|3|85+|0.059|0.039|0.085
Relative|Mesothelioma|2015–2019|Persons|3|All ages combined|0.144|0.132|0.156
Relative|Mesothelioma|2015–2019|Persons|4|00–04|||
Relative|Mesothelioma|2015–2019|Persons|4|05–09|||
Relative|Mesothelioma|2015–2019|Persons|4|10–14|||
Relative|Mesothelioma|2015–2019|Persons|4|15–19|||
Relative|Mesothelioma|2015–2019|Persons|4|20–24|||
Relative|Mesothelioma|2015–2019|Persons|4|25–29|||
Relative|Mesothelioma|2015–2019|Persons|4|30–34|||
Relative|Mesothelioma|2015–2019|Persons|4|35–39|||
Relative|Mesothelioma|2015–2019|Persons|4|40–44|||
Relative|Mesothelioma|2015–2019|Persons|4|45–49|||
Relative|Mesothelioma|2015–2019|Persons|4|50–54|0.264|0.165|0.375
Relative|Mesothelioma|2015–2019|Persons|4|55–59|0.177|0.121|0.242
Relative|Mesothelioma|2015–2019|Persons|4|60–64|0.168|0.127|0.215
Relative|Mesothelioma|2015–2019|Persons|4|65–69|0.109|0.083|0.139
Relative|Mesothelioma|2015–2019|Persons|4|70–74|0.12|0.095|0.148
Relative|Mesothelioma|2015–2019|Persons|4|75–79|0.064|0.046|0.087
Relative|Mesothelioma|2015–2019|Persons|4|80–84|0.068|0.046|0.096
Relative|Mesothelioma|2015–2019|Persons|4|85+|0.038|0.022|0.062
Relative|Mesothelioma|2015–2019|Persons|4|All ages combined|0.099|0.089|0.11
Relative|Mesothelioma|2015–2019|Persons|5|00–04|||
Relative|Mesothelioma|2015–2019|Persons|5|05–09|||
Relative|Mesothelioma|2015–2019|Persons|5|10–14|||
Relative|Mesothelioma|2015–2019|Persons|5|15–19|||
Relative|Mesothelioma|2015–2019|Persons|5|20–24|||
Relative|Mesothelioma|2015–2019|Persons|5|25–29|||
Relative|Mesothelioma|2015–2019|Persons|5|30–34|||
Relative|Mesothelioma|2015–2019|Persons|5|35–39|||
Relative|Mesothelioma|2015–2019|Persons|5|40–44|||
Relative|Mesothelioma|2015–2019|Persons|5|45–49|||
Relative|Mesothelioma|2015–2019|Persons|5|50–54|||
Relative|Mesothelioma|2015–2019|Persons|5|55–59|0.141|0.091|0.202
Relative|Mesothelioma|2015–2019|Persons|5|60–64|0.13|0.093|0.173
Relative|Mesothelioma|2015–2019|Persons|5|65–69|0.076|0.054|0.103
Relative|Mesothelioma|2015–2019|Persons|5|70–74|0.075|0.054|0.1
Relative|Mesothelioma|2015–2019|Persons|5|75–79|0.043|0.027|0.065
Relative|Mesothelioma|2015–2019|Persons|5|80–84|0.046|0.026|0.075
Relative|Mesothelioma|2015–2019|Persons|5|85+|0.036|0.019|0.065
Relative|Mesothelioma|2015–2019|Persons|5|All ages combined|0.072|0.063|0.082
Observed|Middle ear cancer|2015–2019|Males|1|00–04|||
Observed|Middle ear cancer|2015–2019|Males|1|05–09|||
Observed|Middle ear cancer|2015–2019|Males|1|10–14|||
Observed|Middle ear cancer|2015–2019|Males|1|15–19|||
Observed|Middle ear cancer|2015–2019|Males|1|20–24|||
Observed|Middle ear cancer|2015–2019|Males|1|25–29|||
Observed|Middle ear cancer|2015–2019|Males|1|30–34|||
Observed|Middle ear cancer|2015–2019|Males|1|35–39|||
Observed|Middle ear cancer|2015–2019|Males|1|40–44|||
Observed|Middle ear cancer|2015–2019|Males|1|45–49|||
Observed|Middle ear cancer|2015–2019|Males|1|50–54|||
Observed|Middle ear cancer|2015–2019|Males|1|55–59|||
Observed|Middle ear cancer|2015–2019|Males|1|60–64|||
Observed|Middle ear cancer|2015–2019|Males|1|65–69|||
Observed|Middle ear cancer|2015–2019|Males|1|70–74|||
Observed|Middle ear cancer|2015–2019|Males|1|75–79|||
Observed|Middle ear cancer|2015–2019|Males|1|80–84|||
Observed|Middle ear cancer|2015–2019|Males|1|85+|||
Observed|Middle ear cancer|2015–2019|Males|1|All ages combined|||
Observed|Middle ear cancer|2015–2019|Males|2|00–04|||
Observed|Middle ear cancer|2015–2019|Males|2|05–09|||
Observed|Middle ear cancer|2015–2019|Males|2|10–14|||
Observed|Middle ear cancer|2015–2019|Males|2|15–19|||
Observed|Middle ear cancer|2015–2019|Males|2|20–24|||
Observed|Middle ear cancer|2015–2019|Males|2|25–29|||
Observed|Middle ear cancer|2015–2019|Males|2|30–34|||
Observed|Middle ear cancer|2015–2019|Males|2|35–39|||
Observed|Middle ear cancer|2015–2019|Males|2|40–44|||
Observed|Middle ear cancer|2015–2019|Males|2|45–49|||
Observed|Middle ear cancer|2015–2019|Males|2|50–54|||
Observed|Middle ear cancer|2015–2019|Males|2|55–59|||
Observed|Middle ear cancer|2015–2019|Males|2|60–64|||
Observed|Middle ear cancer|2015–2019|Males|2|65–69|||
Observed|Middle ear cancer|2015–2019|Males|2|70–74|||
Observed|Middle ear cancer|2015–2019|Males|2|75–79|||
Observed|Middle ear cancer|2015–2019|Males|2|80–84|||
Observed|Middle ear cancer|2015–2019|Males|2|85+|||
Observed|Middle ear cancer|2015–2019|Males|2|All ages combined|||
Observed|Middle ear cancer|2015–2019|Males|3|00–04|||
Observed|Middle ear cancer|2015–2019|Males|3|05–09|||
Observed|Middle ear cancer|2015–2019|Males|3|10–14|||
Observed|Middle ear cancer|2015–2019|Males|3|15–19|||
Observed|Middle ear cancer|2015–2019|Males|3|20–24|||
Observed|Middle ear cancer|2015–2019|Males|3|25–29|||
Observed|Middle ear cancer|2015–2019|Males|3|30–34|||
Observed|Middle ear cancer|2015–2019|Males|3|35–39|||
Observed|Middle ear cancer|2015–2019|Males|3|40–44|||
Observed|Middle ear cancer|2015–2019|Males|3|45–49|||
Observed|Middle ear cancer|2015–2019|Males|3|50–54|||
Observed|Middle ear cancer|2015–2019|Males|3|55–59|||
Observed|Middle ear cancer|2015–2019|Males|3|60–64|||
Observed|Middle ear cancer|2015–2019|Males|3|65–69|||
Observed|Middle ear cancer|2015–2019|Males|3|70–74|||
Observed|Middle ear cancer|2015–2019|Males|3|75–79|||
Observed|Middle ear cancer|2015–2019|Males|3|80–84|||
Observed|Middle ear cancer|2015–2019|Males|3|85+|||
Observed|Middle ear cancer|2015–2019|Males|3|All ages combined|||
Observed|Middle ear cancer|2015–2019|Males|4|00–04|||
Observed|Middle ear cancer|2015–2019|Males|4|05–09|||
Observed|Middle ear cancer|2015–2019|Males|4|10–14|||
Observed|Middle ear cancer|2015–2019|Males|4|15–19|||
Observed|Middle ear cancer|2015–2019|Males|4|20–24|||
Observed|Middle ear cancer|2015–2019|Males|4|25–29|||
Observed|Middle ear cancer|2015–2019|Males|4|30–34|||
Observed|Middle ear cancer|2015–2019|Males|4|35–39|||
Observed|Middle ear cancer|2015–2019|Males|4|40–44|||
Observed|Middle ear cancer|2015–2019|Males|4|45–49|||
Observed|Middle ear cancer|2015–2019|Males|4|50–54|||
Observed|Middle ear cancer|2015–2019|Males|4|55–59|||
Observed|Middle ear cancer|2015–2019|Males|4|60–64|||
Observed|Middle ear cancer|2015–2019|Males|4|65–69|||
Observed|Middle ear cancer|2015–2019|Males|4|70–74|||
Observed|Middle ear cancer|2015–2019|Males|4|75–79|||
Observed|Middle ear cancer|2015–2019|Males|4|80–84|||
Observed|Middle ear cancer|2015–2019|Males|4|85+|||
Observed|Middle ear cancer|2015–2019|Males|4|All ages combined|||
Observed|Middle ear cancer|2015–2019|Males|5|00–04|||
Observed|Middle ear cancer|2015–2019|Males|5|05–09|||
Observed|Middle ear cancer|2015–2019|Males|5|10–14|||
Observed|Middle ear cancer|2015–2019|Males|5|15–19|||
Observed|Middle ear cancer|2015–2019|Males|5|20–24|||
Observed|Middle ear cancer|2015–2019|Males|5|25–29|||
Observed|Middle ear cancer|2015–2019|Males|5|30–34|||
Observed|Middle ear cancer|2015–2019|Males|5|35–39|||
Observed|Middle ear cancer|2015–2019|Males|5|40–44|||
Observed|Middle ear cancer|2015–2019|Males|5|45–49|||
Observed|Middle ear cancer|2015–2019|Males|5|50–54|||
Observed|Middle ear cancer|2015–2019|Males|5|55–59|||
Observed|Middle ear cancer|2015–2019|Males|5|60–64|||
Observed|Middle ear cancer|2015–2019|Males|5|65–69|||
Observed|Middle ear cancer|2015–2019|Males|5|70–74|||
Observed|Middle ear cancer|2015–2019|Males|5|75–79|||
Observed|Middle ear cancer|2015–2019|Males|5|80–84|||
Observed|Middle ear cancer|2015–2019|Males|5|85+|||
Observed|Middle ear cancer|2015–2019|Males|5|All ages combined|||
Relative|Middle ear cancer|2015–2019|Males|1|00–04|||
Relative|Middle ear cancer|2015–2019|Males|1|05–09|||
Relative|Middle ear cancer|2015–2019|Males|1|10–14|||
Relative|Middle ear cancer|2015–2019|Males|1|15–19|||
Relative|Middle ear cancer|2015–2019|Males|1|20–24|||
Relative|Middle ear cancer|2015–2019|Males|1|25–29|||
Relative|Middle ear cancer|2015–2019|Males|1|30–34|||
Relative|Middle ear cancer|2015–2019|Males|1|35–39|||
Relative|Middle ear cancer|2015–2019|Males|1|40–44|||
Relative|Middle ear cancer|2015–2019|Males|1|45–49|||
Relative|Middle ear cancer|2015–2019|Males|1|50–54|||
Relative|Middle ear cancer|2015–2019|Males|1|55–59|||
Relative|Middle ear cancer|2015–2019|Males|1|60–64|||
Relative|Middle ear cancer|2015–2019|Males|1|65–69|||
Relative|Middle ear cancer|2015–2019|Males|1|70–74|||
Relative|Middle ear cancer|2015–2019|Males|1|75–79|||
Relative|Middle ear cancer|2015–2019|Males|1|80–84|||
Relative|Middle ear cancer|2015–2019|Males|1|85+|||
Relative|Middle ear cancer|2015–2019|Males|1|All ages combined|||
Relative|Middle ear cancer|2015–2019|Males|2|00–04|||
Relative|Middle ear cancer|2015–2019|Males|2|05–09|||
Relative|Middle ear cancer|2015–2019|Males|2|10–14|||
Relative|Middle ear cancer|2015–2019|Males|2|15–19|||
Relative|Middle ear cancer|2015–2019|Males|2|20–24|||
Relative|Middle ear cancer|2015–2019|Males|2|25–29|||
Relative|Middle ear cancer|2015–2019|Males|2|30–34|||
Relative|Middle ear cancer|2015–2019|Males|2|35–39|||
Relative|Middle ear cancer|2015–2019|Males|2|40–44|||
Relative|Middle ear cancer|2015–2019|Males|2|45–49|||
Relative|Middle ear cancer|2015–2019|Males|2|50–54|||
Relative|Middle ear cancer|2015–2019|Males|2|55–59|||
Relative|Middle ear cancer|2015–2019|Males|2|60–64|||
Relative|Middle ear cancer|2015–2019|Males|2|65–69|||
Relative|Middle ear cancer|2015–2019|Males|2|70–74|||
Relative|Middle ear cancer|2015–2019|Males|2|75–79|||
Relative|Middle ear cancer|2015–2019|Males|2|80–84|||
Relative|Middle ear cancer|2015–2019|Males|2|85+|||
Relative|Middle ear cancer|2015–2019|Males|2|All ages combined|||
Relative|Middle ear cancer|2015–2019|Males|3|00–04|||
Relative|Middle ear cancer|2015–2019|Males|3|05–09|||
Relative|Middle ear cancer|2015–2019|Males|3|10–14|||
Relative|Middle ear cancer|2015–2019|Males|3|15–19|||
Relative|Middle ear cancer|2015–2019|Males|3|20–24|||
Relative|Middle ear cancer|2015–2019|Males|3|25–29|||
Relative|Middle ear cancer|2015–2019|Males|3|30–34|||
Relative|Middle ear cancer|2015–2019|Males|3|35–39|||
Relative|Middle ear cancer|2015–2019|Males|3|40–44|||
Relative|Middle ear cancer|2015–2019|Males|3|45–49|||
Relative|Middle ear cancer|2015–2019|Males|3|50–54|||
Relative|Middle ear cancer|2015–2019|Males|3|55–59|||
Relative|Middle ear cancer|2015–2019|Males|3|60–64|||
Relative|Middle ear cancer|2015–2019|Males|3|65–69|||
Relative|Middle ear cancer|2015–2019|Males|3|70–74|||
Relative|Middle ear cancer|2015–2019|Males|3|75–79|||
Relative|Middle ear cancer|2015–2019|Males|3|80–84|||
Relative|Middle ear cancer|2015–2019|Males|3|85+|||
Relative|Middle ear cancer|2015–2019|Males|3|All ages combined|||
Relative|Middle ear cancer|2015–2019|Males|4|00–04|||
Relative|Middle ear cancer|2015–2019|Males|4|05–09|||
Relative|Middle ear cancer|2015–2019|Males|4|10–14|||
Relative|Middle ear cancer|2015–2019|Males|4|15–19|||
Relative|Middle ear cancer|2015–2019|Males|4|20–24|||
Relative|Middle ear cancer|2015–2019|Males|4|25–29|||
Relative|Middle ear cancer|2015–2019|Males|4|30–34|||
Relative|Middle ear cancer|2015–2019|Males|4|35–39|||
Relative|Middle ear cancer|2015–2019|Males|4|40–44|||
Relative|Middle ear cancer|2015–2019|Males|4|45–49|||
Relative|Middle ear cancer|2015–2019|Males|4|50–54|||
Relative|Middle ear cancer|2015–2019|Males|4|55–59|||
Relative|Middle ear cancer|2015–2019|Males|4|60–64|||
Relative|Middle ear cancer|2015–2019|Males|4|65–69|||
Relative|Middle ear cancer|2015–2019|Males|4|70–74|||
Relative|Middle ear cancer|2015–2019|Males|4|75–79|||
Relative|Middle ear cancer|2015–2019|Males|4|80–84|||
Relative|Middle ear cancer|2015–2019|Males|4|85+|||
Relative|Middle ear cancer|2015–2019|Males|4|All ages combined|||
Relative|Middle ear cancer|2015–2019|Males|5|00–04|||
Relative|Middle ear cancer|2015–2019|Males|5|05–09|||
Relative|Middle ear cancer|2015–2019|Males|5|10–14|||
Relative|Middle ear cancer|2015–2019|Males|5|15–19|||
Relative|Middle ear cancer|2015–2019|Males|5|20–24|||
Relative|Middle ear cancer|2015–2019|Males|5|25–29|||
Relative|Middle ear cancer|2015–2019|Males|5|30–34|||
Relative|Middle ear cancer|2015–2019|Males|5|35–39|||
Relative|Middle ear cancer|2015–2019|Males|5|40–44|||
Relative|Middle ear cancer|2015–2019|Males|5|45–49|||
Relative|Middle ear cancer|2015–2019|Males|5|50–54|||
Relative|Middle ear cancer|2015–2019|Males|5|55–59|||
Relative|Middle ear cancer|2015–2019|Males|5|60–64|||
Relative|Middle ear cancer|2015–2019|Males|5|65–69|||
Relative|Middle ear cancer|2015–2019|Males|5|70–74|||
Relative|Middle ear cancer|2015–2019|Males|5|75–79|||
Relative|Middle ear cancer|2015–2019|Males|5|80–84|||
Relative|Middle ear cancer|2015–2019|Males|5|85+|||
Relative|Middle ear cancer|2015–2019|Males|5|All ages combined|||
Observed|Middle ear cancer|2015–2019|Females|1|00–04|||
Observed|Middle ear cancer|2015–2019|Females|1|05–09|||
Observed|Middle ear cancer|2015–2019|Females|1|10–14|||
Observed|Middle ear cancer|2015–2019|Females|1|15–19|||
Observed|Middle ear cancer|2015–2019|Females|1|20–24|||
Observed|Middle ear cancer|2015–2019|Females|1|25–29|||
Observed|Middle ear cancer|2015–2019|Females|1|30–34|||
Observed|Middle ear cancer|2015–2019|Females|1|35–39|||
Observed|Middle ear cancer|2015–2019|Females|1|40–44|||
Observed|Middle ear cancer|2015–2019|Females|1|45–49|||
Observed|Middle ear cancer|2015–2019|Females|1|50–54|||
Observed|Middle ear cancer|2015–2019|Females|1|55–59|||
Observed|Middle ear cancer|2015–2019|Females|1|60–64|||
Observed|Middle ear cancer|2015–2019|Females|1|65–69|||
Observed|Middle ear cancer|2015–2019|Females|1|70–74|||
Observed|Middle ear cancer|2015–2019|Females|1|75–79|||
Observed|Middle ear cancer|2015–2019|Females|1|80–84|||
Observed|Middle ear cancer|2015–2019|Females|1|85+|||
Observed|Middle ear cancer|2015–2019|Females|1|All ages combined|||
Observed|Middle ear cancer|2015–2019|Females|2|00–04|||
Observed|Middle ear cancer|2015–2019|Females|2|05–09|||
Observed|Middle ear cancer|2015–2019|Females|2|10–14|||
Observed|Middle ear cancer|2015–2019|Females|2|15–19|||
Observed|Middle ear cancer|2015–2019|Females|2|20–24|||
Observed|Middle ear cancer|2015–2019|Females|2|25–29|||
Observed|Middle ear cancer|2015–2019|Females|2|30–34|||
Observed|Middle ear cancer|2015–2019|Females|2|35–39|||
Observed|Middle ear cancer|2015–2019|Females|2|40–44|||
Observed|Middle ear cancer|2015–2019|Females|2|45–49|||
Observed|Middle ear cancer|2015–2019|Females|2|50–54|||
Observed|Middle ear cancer|2015–2019|Females|2|55–59|||
Observed|Middle ear cancer|2015–2019|Females|2|60–64|||
Observed|Middle ear cancer|2015–2019|Females|2|65–69|||
Observed|Middle ear cancer|2015–2019|Females|2|70–74|||
Observed|Middle ear cancer|2015–2019|Females|2|75–79|||
Observed|Middle ear cancer|2015–2019|Females|2|80–84|||
Observed|Middle ear cancer|2015–2019|Females|2|85+|||
Observed|Middle ear cancer|2015–2019|Females|2|All ages combined|||
Observed|Middle ear cancer|2015–2019|Females|3|00–04|||
Observed|Middle ear cancer|2015–2019|Females|3|05–09|||
Observed|Middle ear cancer|2015–2019|Females|3|10–14|||
Observed|Middle ear cancer|2015–2019|Females|3|15–19|||
Observed|Middle ear cancer|2015–2019|Females|3|20–24|||
Observed|Middle ear cancer|2015–2019|Females|3|25–29|||
Observed|Middle ear cancer|2015–2019|Females|3|30–34|||
Observed|Middle ear cancer|2015–2019|Females|3|35–39|||
Observed|Middle ear cancer|2015–2019|Females|3|40–44|||
Observed|Middle ear cancer|2015–2019|Females|3|45–49|||
Observed|Middle ear cancer|2015–2019|Females|3|50–54|||
Observed|Middle ear cancer|2015–2019|Females|3|55–59|||
Observed|Middle ear cancer|2015–2019|Females|3|60–64|||
Observed|Middle ear cancer|2015–2019|Females|3|65–69|||
Observed|Middle ear cancer|2015–2019|Females|3|70–74|||
Observed|Middle ear cancer|2015–2019|Females|3|75–79|||
Observed|Middle ear cancer|2015–2019|Females|3|80–84|||
Observed|Middle ear cancer|2015–2019|Females|3|85+|||
Observed|Middle ear cancer|2015–2019|Females|3|All ages combined|||
Observed|Middle ear cancer|2015–2019|Females|4|00–04|||
Observed|Middle ear cancer|2015–2019|Females|4|05–09|||
Observed|Middle ear cancer|2015–2019|Females|4|10–14|||
Observed|Middle ear cancer|2015–2019|Females|4|15–19|||
Observed|Middle ear cancer|2015–2019|Females|4|20–24|||
Observed|Middle ear cancer|2015–2019|Females|4|25–29|||
Observed|Middle ear cancer|2015–2019|Females|4|30–34|||
Observed|Middle ear cancer|2015–2019|Females|4|35–39|||
Observed|Middle ear cancer|2015–2019|Females|4|40–44|||
Observed|Middle ear cancer|2015–2019|Females|4|45–49|||
Observed|Middle ear cancer|2015–2019|Females|4|50–54|||
Observed|Middle ear cancer|2015–2019|Females|4|55–59|||
Observed|Middle ear cancer|2015–2019|Females|4|60–64|||
Observed|Middle ear cancer|2015–2019|Females|4|65–69|||
Observed|Middle ear cancer|2015–2019|Females|4|70–74|||
Observed|Middle ear cancer|2015–2019|Females|4|75–79|||
Observed|Middle ear cancer|2015–2019|Females|4|80–84|||
Observed|Middle ear cancer|2015–2019|Females|4|85+|||
Observed|Middle ear cancer|2015–2019|Females|4|All ages combined|||
Observed|Middle ear cancer|2015–2019|Females|5|00–04|||
Observed|Middle ear cancer|2015–2019|Females|5|05–09|||
Observed|Middle ear cancer|2015–2019|Females|5|10–14|||
Observed|Middle ear cancer|2015–2019|Females|5|15–19|||
Observed|Middle ear cancer|2015–2019|Females|5|20–24|||
Observed|Middle ear cancer|2015–2019|Females|5|25–29|||
Observed|Middle ear cancer|2015–2019|Females|5|30–34|||
Observed|Middle ear cancer|2015–2019|Females|5|35–39|||
Observed|Middle ear cancer|2015–2019|Females|5|40–44|||
Observed|Middle ear cancer|2015–2019|Females|5|45–49|||
Observed|Middle ear cancer|2015–2019|Females|5|50–54|||
Observed|Middle ear cancer|2015–2019|Females|5|55–59|||
Observed|Middle ear cancer|2015–2019|Females|5|60–64|||
Observed|Middle ear cancer|2015–2019|Females|5|65–69|||
Observed|Middle ear cancer|2015–2019|Females|5|70–74|||
Observed|Middle ear cancer|2015–2019|Females|5|75–79|||
Observed|Middle ear cancer|2015–2019|Females|5|80–84|||
Observed|Middle ear cancer|2015–2019|Females|5|85+|||
Observed|Middle ear cancer|2015–2019|Females|5|All ages combined|||
Relative|Middle ear cancer|2015–2019|Females|1|00–04|||
Relative|Middle ear cancer|2015–2019|Females|1|05–09|||
Relative|Middle ear cancer|2015–2019|Females|1|10–14|||
Relative|Middle ear cancer|2015–2019|Females|1|15–19|||
Relative|Middle ear cancer|2015–2019|Females|1|20–24|||
Relative|Middle ear cancer|2015–2019|Females|1|25–29|||
Relative|Middle ear cancer|2015–2019|Females|1|30–34|||
Relative|Middle ear cancer|2015–2019|Females|1|35–39|||
Relative|Middle ear cancer|2015–2019|Females|1|40–44|||
Relative|Middle ear cancer|2015–2019|Females|1|45–49|||
Relative|Middle ear cancer|2015–2019|Females|1|50–54|||
Relative|Middle ear cancer|2015–2019|Females|1|55–59|||
Relative|Middle ear cancer|2015–2019|Females|1|60–64|||
Relative|Middle ear cancer|2015–2019|Females|1|65–69|||
Relative|Middle ear cancer|2015–2019|Females|1|70–74|||
Relative|Middle ear cancer|2015–2019|Females|1|75–79|||
Relative|Middle ear cancer|2015–2019|Females|1|80–84|||
Relative|Middle ear cancer|2015–2019|Females|1|85+|||
Relative|Middle ear cancer|2015–2019|Females|1|All ages combined|||
Relative|Middle ear cancer|2015–2019|Females|2|00–04|||
Relative|Middle ear cancer|2015–2019|Females|2|05–09|||
Relative|Middle ear cancer|2015–2019|Females|2|10–14|||
Relative|Middle ear cancer|2015–2019|Females|2|15–19|||
Relative|Middle ear cancer|2015–2019|Females|2|20–24|||
Relative|Middle ear cancer|2015–2019|Females|2|25–29|||
Relative|Middle ear cancer|2015–2019|Females|2|30–34|||
Relative|Middle ear cancer|2015–2019|Females|2|35–39|||
Relative|Middle ear cancer|2015–2019|Females|2|40–44|||
Relative|Middle ear cancer|2015–2019|Females|2|45–49|||
Relative|Middle ear cancer|2015–2019|Females|2|50–54|||
Relative|Middle ear cancer|2015–2019|Females|2|55–59|||
Relative|Middle ear cancer|2015–2019|Females|2|60–64|||
Relative|Middle ear cancer|2015–2019|Females|2|65–69|||
Relative|Middle ear cancer|2015–2019|Females|2|70–74|||
Relative|Middle ear cancer|2015–2019|Females|2|75–79|||
Relative|Middle ear cancer|2015–2019|Females|2|80–84|||
Relative|Middle ear cancer|2015–2019|Females|2|85+|||
Relative|Middle ear cancer|2015–2019|Females|2|All ages combined|||
Relative|Middle ear cancer|2015–2019|Females|3|00–04|||
Relative|Middle ear cancer|2015–2019|Females|3|05–09|||
Relative|Middle ear cancer|2015–2019|Females|3|10–14|||
Relative|Middle ear cancer|2015–2019|Females|3|15–19|||
Relative|Middle ear cancer|2015–2019|Females|3|20–24|||
Relative|Middle ear cancer|2015–2019|Females|3|25–29|||
Relative|Middle ear cancer|2015–2019|Females|3|30–34|||
Relative|Middle ear cancer|2015–2019|Females|3|35–39|||
Relative|Middle ear cancer|2015–2019|Females|3|40–44|||
Relative|Middle ear cancer|2015–2019|Females|3|45–49|||
Relative|Middle ear cancer|2015–2019|Females|3|50–54|||
Relative|Middle ear cancer|2015–2019|Females|3|55–59|||
Relative|Middle ear cancer|2015–2019|Females|3|60–64|||
Relative|Middle ear cancer|2015–2019|Females|3|65–69|||
Relative|Middle ear cancer|2015–2019|Females|3|70–74|||
Relative|Middle ear cancer|2015–2019|Females|3|75–79|||
Relative|Middle ear cancer|2015–2019|Females|3|80–84|||
Relative|Middle ear cancer|2015–2019|Females|3|85+|||
Relative|Middle ear cancer|2015–2019|Females|3|All ages combined|||
Relative|Middle ear cancer|2015–2019|Females|4|00–04|||
Relative|Middle ear cancer|2015–2019|Females|4|05–09|||
Relative|Middle ear cancer|2015–2019|Females|4|10–14|||
Relative|Middle ear cancer|2015–2019|Females|4|15–19|||
Relative|Middle ear cancer|2015–2019|Females|4|20–24|||
Relative|Middle ear cancer|2015–2019|Females|4|25–29|||
Relative|Middle ear cancer|2015–2019|Females|4|30–34|||
Relative|Middle ear cancer|2015–2019|Females|4|35–39|||
Relative|Middle ear cancer|2015–2019|Females|4|40–44|||
Relative|Middle ear cancer|2015–2019|Females|4|45–49|||
Relative|Middle ear cancer|2015–2019|Females|4|50–54|||
Relative|Middle ear cancer|2015–2019|Females|4|55–59|||
Relative|Middle ear cancer|2015–2019|Females|4|60–64|||
Relative|Middle ear cancer|2015–2019|Females|4|65–69|||
Relative|Middle ear cancer|2015–2019|Females|4|70–74|||
Relative|Middle ear cancer|2015–2019|Females|4|75–79|||
Relative|Middle ear cancer|2015–2019|Females|4|80–84|||
Relative|Middle ear cancer|2015–2019|Females|4|85+|||
Relative|Middle ear cancer|2015–2019|Females|4|All ages combined|||
Relative|Middle ear cancer|2015–2019|Females|5|00–04|||
Relative|Middle ear cancer|2015–2019|Females|5|05–09|||
Relative|Middle ear cancer|2015–2019|Females|5|10–14|||
Relative|Middle ear cancer|2015–2019|Females|5|15–19|||
Relative|Middle ear cancer|2015–2019|Females|5|20–24|||
Relative|Middle ear cancer|2015–2019|Females|5|25–29|||
Relative|Middle ear cancer|2015–2019|Females|5|30–34|||
Relative|Middle ear cancer|2015–2019|Females|5|35–39|||
Relative|Middle ear cancer|2015–2019|Females|5|40–44|||
Relative|Middle ear cancer|2015–2019|Females|5|45–49|||
Relative|Middle ear cancer|2015–2019|Females|5|50–54|||
Relative|Middle ear cancer|2015–2019|Females|5|55–59|||
Relative|Middle ear cancer|2015–2019|Females|5|60–64|||
Relative|Middle ear cancer|2015–2019|Females|5|65–69|||
Relative|Middle ear cancer|2015–2019|Females|5|70–74|||
Relative|Middle ear cancer|2015–2019|Females|5|75–79|||
Relative|Middle ear cancer|2015–2019|Females|5|80–84|||
Relative|Middle ear cancer|2015–2019|Females|5|85+|||
Relative|Middle ear cancer|2015–2019|Females|5|All ages combined|||
Observed|Middle ear cancer|2015–2019|Persons|1|00–04|||
Observed|Middle ear cancer|2015–2019|Persons|1|05–09|||
Observed|Middle ear cancer|2015–2019|Persons|1|10–14|||
Observed|Middle ear cancer|2015–2019|Persons|1|15–19|||
Observed|Middle ear cancer|2015–2019|Persons|1|20–24|||
Observed|Middle ear cancer|2015–2019|Persons|1|25–29|||
Observed|Middle ear cancer|2015–2019|Persons|1|30–34|||
Observed|Middle ear cancer|2015–2019|Persons|1|35–39|||
Observed|Middle ear cancer|2015–2019|Persons|1|40–44|||
Observed|Middle ear cancer|2015–2019|Persons|1|45–49|||
Observed|Middle ear cancer|2015–2019|Persons|1|50–54|||
Observed|Middle ear cancer|2015–2019|Persons|1|55–59|||
Observed|Middle ear cancer|2015–2019|Persons|1|60–64|||
Observed|Middle ear cancer|2015–2019|Persons|1|65–69|||
Observed|Middle ear cancer|2015–2019|Persons|1|70–74|||
Observed|Middle ear cancer|2015–2019|Persons|1|75–79|||
Observed|Middle ear cancer|2015–2019|Persons|1|80–84|||
Observed|Middle ear cancer|2015–2019|Persons|1|85+|||
Observed|Middle ear cancer|2015–2019|Persons|1|All ages combined|0.852|0.652|0.942
Observed|Middle ear cancer|2015–2019|Persons|2|00–04|||
Observed|Middle ear cancer|2015–2019|Persons|2|05–09|||
Observed|Middle ear cancer|2015–2019|Persons|2|10–14|||
Observed|Middle ear cancer|2015–2019|Persons|2|15–19|||
Observed|Middle ear cancer|2015–2019|Persons|2|20–24|||
Observed|Middle ear cancer|2015–2019|Persons|2|25–29|||
Observed|Middle ear cancer|2015–2019|Persons|2|30–34|||
Observed|Middle ear cancer|2015–2019|Persons|2|35–39|||
Observed|Middle ear cancer|2015–2019|Persons|2|40–44|||
Observed|Middle ear cancer|2015–2019|Persons|2|45–49|||
Observed|Middle ear cancer|2015–2019|Persons|2|50–54|||
Observed|Middle ear cancer|2015–2019|Persons|2|55–59|||
Observed|Middle ear cancer|2015–2019|Persons|2|60–64|||
Observed|Middle ear cancer|2015–2019|Persons|2|65–69|||
Observed|Middle ear cancer|2015–2019|Persons|2|70–74|||
Observed|Middle ear cancer|2015–2019|Persons|2|75–79|||
Observed|Middle ear cancer|2015–2019|Persons|2|80–84|||
Observed|Middle ear cancer|2015–2019|Persons|2|85+|||
Observed|Middle ear cancer|2015–2019|Persons|2|All ages combined|0.582|0.385|0.736
Observed|Middle ear cancer|2015–2019|Persons|3|00–04|||
Observed|Middle ear cancer|2015–2019|Persons|3|05–09|||
Observed|Middle ear cancer|2015–2019|Persons|3|10–14|||
Observed|Middle ear cancer|2015–2019|Persons|3|15–19|||
Observed|Middle ear cancer|2015–2019|Persons|3|20–24|||
Observed|Middle ear cancer|2015–2019|Persons|3|25–29|||
Observed|Middle ear cancer|2015–2019|Persons|3|30–34|||
Observed|Middle ear cancer|2015–2019|Persons|3|35–39|||
Observed|Middle ear cancer|2015–2019|Persons|3|40–44|||
Observed|Middle ear cancer|2015–2019|Persons|3|45–49|||
Observed|Middle ear cancer|2015–2019|Persons|3|50–54|||
Observed|Middle ear cancer|2015–2019|Persons|3|55–59|||
Observed|Middle ear cancer|2015–2019|Persons|3|60–64|||
Observed|Middle ear cancer|2015–2019|Persons|3|65–69|||
Observed|Middle ear cancer|2015–2019|Persons|3|70–74|||
Observed|Middle ear cancer|2015–2019|Persons|3|75–79|||
Observed|Middle ear cancer|2015–2019|Persons|3|80–84|||
Observed|Middle ear cancer|2015–2019|Persons|3|85+|||
Observed|Middle ear cancer|2015–2019|Persons|3|All ages combined|0.582|0.385|0.736
Observed|Middle ear cancer|2015–2019|Persons|4|00–04|||
Observed|Middle ear cancer|2015–2019|Persons|4|05–09|||
Observed|Middle ear cancer|2015–2019|Persons|4|10–14|||
Observed|Middle ear cancer|2015–2019|Persons|4|15–19|||
Observed|Middle ear cancer|2015–2019|Persons|4|20–24|||
Observed|Middle ear cancer|2015–2019|Persons|4|25–29|||
Observed|Middle ear cancer|2015–2019|Persons|4|30–34|||
Observed|Middle ear cancer|2015–2019|Persons|4|35–39|||
Observed|Middle ear cancer|2015–2019|Persons|4|40–44|||
Observed|Middle ear cancer|2015–2019|Persons|4|45–49|||
Observed|Middle ear cancer|2015–2019|Persons|4|50–54|||
Observed|Middle ear cancer|2015–2019|Persons|4|55–59|||
Observed|Middle ear cancer|2015–2019|Persons|4|60–64|||
Observed|Middle ear cancer|2015–2019|Persons|4|65–69|||
Observed|Middle ear cancer|2015–2019|Persons|4|70–74|||
Observed|Middle ear cancer|2015–2019|Persons|4|75–79|||
Observed|Middle ear cancer|2015–2019|Persons|4|80–84|||
Observed|Middle ear cancer|2015–2019|Persons|4|85+|||
Observed|Middle ear cancer|2015–2019|Persons|4|All ages combined|||
Observed|Middle ear cancer|2015–2019|Persons|5|00–04|||
Observed|Middle ear cancer|2015–2019|Persons|5|05–09|||
Observed|Middle ear cancer|2015–2019|Persons|5|10–14|||
Observed|Middle ear cancer|2015–2019|Persons|5|15–19|||
Observed|Middle ear cancer|2015–2019|Persons|5|20–24|||
Observed|Middle ear cancer|2015–2019|Persons|5|25–29|||
Observed|Middle ear cancer|2015–2019|Persons|5|30–34|||
Observed|Middle ear cancer|2015–2019|Persons|5|35–39|||
Observed|Middle ear cancer|2015–2019|Persons|5|40–44|||
Observed|Middle ear cancer|2015–2019|Persons|5|45–49|||
Observed|Middle ear cancer|2015–2019|Persons|5|50–54|||
Observed|Middle ear cancer|2015–2019|Persons|5|55–59|||
Observed|Middle ear cancer|2015–2019|Persons|5|60–64|||
Observed|Middle ear cancer|2015–2019|Persons|5|65–69|||
Observed|Middle ear cancer|2015–2019|Persons|5|70–74|||
Observed|Middle ear cancer|2015–2019|Persons|5|75–79|||
Observed|Middle ear cancer|2015–2019|Persons|5|80–84|||
Observed|Middle ear cancer|2015–2019|Persons|5|85+|||
Observed|Middle ear cancer|2015–2019|Persons|5|All ages combined|||
Relative|Middle ear cancer|2015–2019|Persons|1|00–04|||
Relative|Middle ear cancer|2015–2019|Persons|1|05–09|||
Relative|Middle ear cancer|2015–2019|Persons|1|10–14|||
Relative|Middle ear cancer|2015–2019|Persons|1|15–19|||
Relative|Middle ear cancer|2015–2019|Persons|1|20–24|||
Relative|Middle ear cancer|2015–2019|Persons|1|25–29|||
Relative|Middle ear cancer|2015–2019|Persons|1|30–34|||
Relative|Middle ear cancer|2015–2019|Persons|1|35–39|||
Relative|Middle ear cancer|2015–2019|Persons|1|40–44|||
Relative|Middle ear cancer|2015–2019|Persons|1|45–49|||
Relative|Middle ear cancer|2015–2019|Persons|1|50–54|||
Relative|Middle ear cancer|2015–2019|Persons|1|55–59|||
Relative|Middle ear cancer|2015–2019|Persons|1|60–64|||
Relative|Middle ear cancer|2015–2019|Persons|1|65–69|||
Relative|Middle ear cancer|2015–2019|Persons|1|70–74|||
Relative|Middle ear cancer|2015–2019|Persons|1|75–79|||
Relative|Middle ear cancer|2015–2019|Persons|1|80–84|||
Relative|Middle ear cancer|2015–2019|Persons|1|85+|||
Relative|Middle ear cancer|2015–2019|Persons|1|All ages combined|0.892|0.683|0.985
Relative|Middle ear cancer|2015–2019|Persons|2|00–04|||
Relative|Middle ear cancer|2015–2019|Persons|2|05–09|||
Relative|Middle ear cancer|2015–2019|Persons|2|10–14|||
Relative|Middle ear cancer|2015–2019|Persons|2|15–19|||
Relative|Middle ear cancer|2015–2019|Persons|2|20–24|||
Relative|Middle ear cancer|2015–2019|Persons|2|25–29|||
Relative|Middle ear cancer|2015–2019|Persons|2|30–34|||
Relative|Middle ear cancer|2015–2019|Persons|2|35–39|||
Relative|Middle ear cancer|2015–2019|Persons|2|40–44|||
Relative|Middle ear cancer|2015–2019|Persons|2|45–49|||
Relative|Middle ear cancer|2015–2019|Persons|2|50–54|||
Relative|Middle ear cancer|2015–2019|Persons|2|55–59|||
Relative|Middle ear cancer|2015–2019|Persons|2|60–64|||
Relative|Middle ear cancer|2015–2019|Persons|2|65–69|||
Relative|Middle ear cancer|2015–2019|Persons|2|70–74|||
Relative|Middle ear cancer|2015–2019|Persons|2|75–79|||
Relative|Middle ear cancer|2015–2019|Persons|2|80–84|||
Relative|Middle ear cancer|2015–2019|Persons|2|85+|||
Relative|Middle ear cancer|2015–2019|Persons|2|All ages combined|0.625|0.413|0.791
Relative|Middle ear cancer|2015–2019|Persons|3|00–04|||
Relative|Middle ear cancer|2015–2019|Persons|3|05–09|||
Relative|Middle ear cancer|2015–2019|Persons|3|10–14|||
Relative|Middle ear cancer|2015–2019|Persons|3|15–19|||
Relative|Middle ear cancer|2015–2019|Persons|3|20–24|||
Relative|Middle ear cancer|2015–2019|Persons|3|25–29|||
Relative|Middle ear cancer|2015–2019|Persons|3|30–34|||
Relative|Middle ear cancer|2015–2019|Persons|3|35–39|||
Relative|Middle ear cancer|2015–2019|Persons|3|40–44|||
Relative|Middle ear cancer|2015–2019|Persons|3|45–49|||
Relative|Middle ear cancer|2015–2019|Persons|3|50–54|||
Relative|Middle ear cancer|2015–2019|Persons|3|55–59|||
Relative|Middle ear cancer|2015–2019|Persons|3|60–64|||
Relative|Middle ear cancer|2015–2019|Persons|3|65–69|||
Relative|Middle ear cancer|2015–2019|Persons|3|70–74|||
Relative|Middle ear cancer|2015–2019|Persons|3|75–79|||
Relative|Middle ear cancer|2015–2019|Persons|3|80–84|||
Relative|Middle ear cancer|2015–2019|Persons|3|85+|||
Relative|Middle ear cancer|2015–2019|Persons|3|All ages combined|0.654|0.432|0.827
Relative|Middle ear cancer|2015–2019|Persons|4|00–04|||
Relative|Middle ear cancer|2015–2019|Persons|4|05–09|||
Relative|Middle ear cancer|2015–2019|Persons|4|10–14|||
Relative|Middle ear cancer|2015–2019|Persons|4|15–19|||
Relative|Middle ear cancer|2015–2019|Persons|4|20–24|||
Relative|Middle ear cancer|2015–2019|Persons|4|25–29|||
Relative|Middle ear cancer|2015–2019|Persons|4|30–34|||
Relative|Middle ear cancer|2015–2019|Persons|4|35–39|||
Relative|Middle ear cancer|2015–2019|Persons|4|40–44|||
Relative|Middle ear cancer|2015–2019|Persons|4|45–49|||
Relative|Middle ear cancer|2015–2019|Persons|4|50–54|||
Relative|Middle ear cancer|2015–2019|Persons|4|55–59|||
Relative|Middle ear cancer|2015–2019|Persons|4|60–64|||
Relative|Middle ear cancer|2015–2019|Persons|4|65–69|||
Relative|Middle ear cancer|2015–2019|Persons|4|70–74|||
Relative|Middle ear cancer|2015–2019|Persons|4|75–79|||
Relative|Middle ear cancer|2015–2019|Persons|4|80–84|||
Relative|Middle ear cancer|2015–2019|Persons|4|85+|||
Relative|Middle ear cancer|2015–2019|Persons|4|All ages combined|||
Relative|Middle ear cancer|2015–2019|Persons|5|00–04|||
Relative|Middle ear cancer|2015–2019|Persons|5|05–09|||
Relative|Middle ear cancer|2015–2019|Persons|5|10–14|||
Relative|Middle ear cancer|2015–2019|Persons|5|15–19|||
Relative|Middle ear cancer|2015–2019|Persons|5|20–24|||
Relative|Middle ear cancer|2015–2019|Persons|5|25–29|||
Relative|Middle ear cancer|2015–2019|Persons|5|30–34|||
Relative|Middle ear cancer|2015–2019|Persons|5|35–39|||
Relative|Middle ear cancer|2015–2019|Persons|5|40–44|||
Relative|Middle ear cancer|2015–2019|Persons|5|45–49|||
Relative|Middle ear cancer|2015–2019|Persons|5|50–54|||
Relative|Middle ear cancer|2015–2019|Persons|5|55–59|||
Relative|Middle ear cancer|2015–2019|Persons|5|60–64|||
Relative|Middle ear cancer|2015–2019|Persons|5|65–69|||
Relative|Middle ear cancer|2015–2019|Persons|5|70–74|||
Relative|Middle ear cancer|2015–2019|Persons|5|75–79|||
Relative|Middle ear cancer|2015–2019|Persons|5|80–84|||
Relative|Middle ear cancer|2015–2019|Persons|5|85+|||
Relative|Middle ear cancer|2015–2019|Persons|5|All ages combined|||
Observed|Mouth cancer|2015–2019|Males|1|00–04|||
Observed|Mouth cancer|2015–2019|Males|1|05–09|||
Observed|Mouth cancer|2015–2019|Males|1|10–14|||
Observed|Mouth cancer|2015–2019|Males|1|15–19|||
Observed|Mouth cancer|2015–2019|Males|1|20–24|||
Observed|Mouth cancer|2015–2019|Males|1|25–29|||
Observed|Mouth cancer|2015–2019|Males|1|30–34|||
Observed|Mouth cancer|2015–2019|Males|1|35–39|||
Observed|Mouth cancer|2015–2019|Males|1|40–44|0.88|0.736|0.948
Observed|Mouth cancer|2015–2019|Males|1|45–49|0.893|0.815|0.939
Observed|Mouth cancer|2015–2019|Males|1|50–54|0.896|0.842|0.932
Observed|Mouth cancer|2015–2019|Males|1|55–59|0.845|0.795|0.883
Observed|Mouth cancer|2015–2019|Males|1|60–64|0.846|0.801|0.881
Observed|Mouth cancer|2015–2019|Males|1|65–69|0.813|0.764|0.853
Observed|Mouth cancer|2015–2019|Males|1|70–74|0.804|0.749|0.849
Observed|Mouth cancer|2015–2019|Males|1|75–79|0.749|0.671|0.811
Observed|Mouth cancer|2015–2019|Males|1|80–84|0.715|0.631|0.782
Observed|Mouth cancer|2015–2019|Males|1|85+|0.473|0.373|0.566
Observed|Mouth cancer|2015–2019|Males|1|All ages combined|0.81|0.792|0.827
Observed|Mouth cancer|2015–2019|Males|2|00–04|||
Observed|Mouth cancer|2015–2019|Males|2|05–09|||
Observed|Mouth cancer|2015–2019|Males|2|10–14|||
Observed|Mouth cancer|2015–2019|Males|2|15–19|||
Observed|Mouth cancer|2015–2019|Males|2|20–24|||
Observed|Mouth cancer|2015–2019|Males|2|25–29|||
Observed|Mouth cancer|2015–2019|Males|2|30–34|||
Observed|Mouth cancer|2015–2019|Males|2|35–39|||
Observed|Mouth cancer|2015–2019|Males|2|40–44|0.833|0.682|0.917
Observed|Mouth cancer|2015–2019|Males|2|45–49|0.787|0.692|0.856
Observed|Mouth cancer|2015–2019|Males|2|50–54|0.813|0.75|0.862
Observed|Mouth cancer|2015–2019|Males|2|55–59|0.748|0.69|0.796
Observed|Mouth cancer|2015–2019|Males|2|60–64|0.718|0.664|0.764
Observed|Mouth cancer|2015–2019|Males|2|65–69|0.74|0.687|0.787
Observed|Mouth cancer|2015–2019|Males|2|70–74|0.672|0.607|0.729
Observed|Mouth cancer|2015–2019|Males|2|75–79|0.607|0.519|0.684
Observed|Mouth cancer|2015–2019|Males|2|80–84|0.611|0.524|0.687
Observed|Mouth cancer|2015–2019|Males|2|85+|0.359|0.268|0.451
Observed|Mouth cancer|2015–2019|Males|2|All ages combined|0.707|0.685|0.727
Observed|Mouth cancer|2015–2019|Males|3|00–04|||
Observed|Mouth cancer|2015–2019|Males|3|05–09|||
Observed|Mouth cancer|2015–2019|Males|3|10–14|||
Observed|Mouth cancer|2015–2019|Males|3|15–19|||
Observed|Mouth cancer|2015–2019|Males|3|20–24|||
Observed|Mouth cancer|2015–2019|Males|3|25–29|||
Observed|Mouth cancer|2015–2019|Males|3|30–34|||
Observed|Mouth cancer|2015–2019|Males|3|35–39|||
Observed|Mouth cancer|2015–2019|Males|3|40–44|0.809|0.654|0.899
Observed|Mouth cancer|2015–2019|Males|3|45–49|0.711|0.609|0.791
Observed|Mouth cancer|2015–2019|Males|3|50–54|0.761|0.694|0.815
Observed|Mouth cancer|2015–2019|Males|3|55–59|0.683|0.621|0.737
Observed|Mouth cancer|2015–2019|Males|3|60–64|0.657|0.601|0.707
Observed|Mouth cancer|2015–2019|Males|3|65–69|0.656|0.599|0.708
Observed|Mouth cancer|2015–2019|Males|3|70–74|0.61|0.542|0.671
Observed|Mouth cancer|2015–2019|Males|3|75–79|0.539|0.448|0.622
Observed|Mouth cancer|2015–2019|Males|3|80–84|0.52|0.431|0.601
Observed|Mouth cancer|2015–2019|Males|3|85+|0.319|0.231|0.41
Observed|Mouth cancer|2015–2019|Males|3|All ages combined|0.642|0.619|0.663
Observed|Mouth cancer|2015–2019|Males|4|00–04|||
Observed|Mouth cancer|2015–2019|Males|4|05–09|||
Observed|Mouth cancer|2015–2019|Males|4|10–14|||
Observed|Mouth cancer|2015–2019|Males|4|15–19|||
Observed|Mouth cancer|2015–2019|Males|4|20–24|||
Observed|Mouth cancer|2015–2019|Males|4|25–29|||
Observed|Mouth cancer|2015–2019|Males|4|30–34|||
Observed|Mouth cancer|2015–2019|Males|4|35–39|||
Observed|Mouth cancer|2015–2019|Males|4|40–44|0.809|0.654|0.899
Observed|Mouth cancer|2015–2019|Males|4|45–49|0.671|0.565|0.757
Observed|Mouth cancer|2015–2019|Males|4|50–54|0.732|0.664|0.789
Observed|Mouth cancer|2015–2019|Males|4|55–59|0.616|0.552|0.673
Observed|Mouth cancer|2015–2019|Males|4|60–64|0.607|0.55|0.66
Observed|Mouth cancer|2015–2019|Males|4|65–69|0.591|0.531|0.645
Observed|Mouth cancer|2015–2019|Males|4|70–74|0.535|0.465|0.6
Observed|Mouth cancer|2015–2019|Males|4|75–79|0.496|0.405|0.58
Observed|Mouth cancer|2015–2019|Males|4|80–84|0.401|0.314|0.486
Observed|Mouth cancer|2015–2019|Males|4|85+|0.274|0.19|0.363
Observed|Mouth cancer|2015–2019|Males|4|All ages combined|0.585|0.562|0.608
Observed|Mouth cancer|2015–2019|Males|5|00–04|||
Observed|Mouth cancer|2015–2019|Males|5|05–09|||
Observed|Mouth cancer|2015–2019|Males|5|10–14|||
Observed|Mouth cancer|2015–2019|Males|5|15–19|||
Observed|Mouth cancer|2015–2019|Males|5|20–24|||
Observed|Mouth cancer|2015–2019|Males|5|25–29|||
Observed|Mouth cancer|2015–2019|Males|5|30–34|||
Observed|Mouth cancer|2015–2019|Males|5|35–39|||
Observed|Mouth cancer|2015–2019|Males|5|40–44|0.759|0.598|0.863
Observed|Mouth cancer|2015–2019|Males|5|45–49|0.646|0.538|0.735
Observed|Mouth cancer|2015–2019|Males|5|50–54|0.709|0.64|0.767
Observed|Mouth cancer|2015–2019|Males|5|55–59|0.58|0.516|0.64
Observed|Mouth cancer|2015–2019|Males|5|60–64|0.571|0.513|0.625
Observed|Mouth cancer|2015–2019|Males|5|65–69|0.555|0.495|0.611
Observed|Mouth cancer|2015–2019|Males|5|70–74|0.468|0.398|0.535
Observed|Mouth cancer|2015–2019|Males|5|75–79|0.454|0.364|0.539
Observed|Mouth cancer|2015–2019|Males|5|80–84|0.337|0.253|0.422
Observed|Mouth cancer|2015–2019|Males|5|85+|0.234|0.154|0.323
Observed|Mouth cancer|2015–2019|Males|5|All ages combined|0.546|0.522|0.569
Relative|Mouth cancer|2015–2019|Males|1|00–04|||
Relative|Mouth cancer|2015–2019|Males|1|05–09|||
Relative|Mouth cancer|2015–2019|Males|1|10–14|||
Relative|Mouth cancer|2015–2019|Males|1|15–19|||
Relative|Mouth cancer|2015–2019|Males|1|20–24|||
Relative|Mouth cancer|2015–2019|Males|1|25–29|||
Relative|Mouth cancer|2015–2019|Males|1|30–34|||
Relative|Mouth cancer|2015–2019|Males|1|35–39|||
Relative|Mouth cancer|2015–2019|Males|1|40–44|0.882|0.737|0.95
Relative|Mouth cancer|2015–2019|Males|1|45–49|0.895|0.817|0.942
Relative|Mouth cancer|2015–2019|Males|1|50–54|0.899|0.845|0.936
Relative|Mouth cancer|2015–2019|Males|1|55–59|0.849|0.799|0.888
Relative|Mouth cancer|2015–2019|Males|1|60–64|0.852|0.807|0.888
Relative|Mouth cancer|2015–2019|Males|1|65–69|0.823|0.773|0.863
Relative|Mouth cancer|2015–2019|Males|1|70–74|0.82|0.763|0.865
Relative|Mouth cancer|2015–2019|Males|1|75–79|0.774|0.693|0.838
Relative|Mouth cancer|2015–2019|Males|1|80–84|0.759|0.671|0.831
Relative|Mouth cancer|2015–2019|Males|1|85+|0.545|0.43|0.653
Relative|Mouth cancer|2015–2019|Males|1|All ages combined|0.827|0.809|0.845
Relative|Mouth cancer|2015–2019|Males|2|00–04|||
Relative|Mouth cancer|2015–2019|Males|2|05–09|||
Relative|Mouth cancer|2015–2019|Males|2|10–14|||
Relative|Mouth cancer|2015–2019|Males|2|15–19|||
Relative|Mouth cancer|2015–2019|Males|2|20–24|||
Relative|Mouth cancer|2015–2019|Males|2|25–29|||
Relative|Mouth cancer|2015–2019|Males|2|30–34|||
Relative|Mouth cancer|2015–2019|Males|2|35–39|||
Relative|Mouth cancer|2015–2019|Males|2|40–44|0.836|0.684|0.92
Relative|Mouth cancer|2015–2019|Males|2|45–49|0.791|0.696|0.86
Relative|Mouth cancer|2015–2019|Males|2|50–54|0.819|0.755|0.868
Relative|Mouth cancer|2015–2019|Males|2|55–59|0.756|0.697|0.805
Relative|Mouth cancer|2015–2019|Males|2|60–64|0.73|0.676|0.777
Relative|Mouth cancer|2015–2019|Males|2|65–69|0.759|0.704|0.807
Relative|Mouth cancer|2015–2019|Males|2|70–74|0.7|0.632|0.759
Relative|Mouth cancer|2015–2019|Males|2|75–79|0.651|0.556|0.733
Relative|Mouth cancer|2015–2019|Males|2|80–84|0.695|0.596|0.781
Relative|Mouth cancer|2015–2019|Males|2|85+|0.483|0.36|0.607
Relative|Mouth cancer|2015–2019|Males|2|All ages combined|0.736|0.714|0.757
Relative|Mouth cancer|2015–2019|Males|3|00–04|||
Relative|Mouth cancer|2015–2019|Males|3|05–09|||
Relative|Mouth cancer|2015–2019|Males|3|10–14|||
Relative|Mouth cancer|2015–2019|Males|3|15–19|||
Relative|Mouth cancer|2015–2019|Males|3|20–24|||
Relative|Mouth cancer|2015–2019|Males|3|25–29|||
Relative|Mouth cancer|2015–2019|Males|3|30–34|||
Relative|Mouth cancer|2015–2019|Males|3|35–39|||
Relative|Mouth cancer|2015–2019|Males|3|40–44|0.813|0.657|0.904
Relative|Mouth cancer|2015–2019|Males|3|45–49|0.716|0.613|0.797
Relative|Mouth cancer|2015–2019|Males|3|50–54|0.77|0.702|0.824
Relative|Mouth cancer|2015–2019|Males|3|55–59|0.695|0.632|0.75
Relative|Mouth cancer|2015–2019|Males|3|60–64|0.674|0.617|0.726
Relative|Mouth cancer|2015–2019|Males|3|65–69|0.683|0.623|0.737
Relative|Mouth cancer|2015–2019|Males|3|70–74|0.65|0.578|0.715
Relative|Mouth cancer|2015–2019|Males|3|75–79|0.603|0.501|0.696
Relative|Mouth cancer|2015–2019|Males|3|80–84|0.638|0.53|0.738
Relative|Mouth cancer|2015–2019|Males|3|85+|0.508|0.369|0.653
Relative|Mouth cancer|2015–2019|Males|3|All ages combined|0.681|0.657|0.704
Relative|Mouth cancer|2015–2019|Males|4|00–04|||
Relative|Mouth cancer|2015–2019|Males|4|05–09|||
Relative|Mouth cancer|2015–2019|Males|4|10–14|||
Relative|Mouth cancer|2015–2019|Males|4|15–19|||
Relative|Mouth cancer|2015–2019|Males|4|20–24|||
Relative|Mouth cancer|2015–2019|Males|4|25–29|||
Relative|Mouth cancer|2015–2019|Males|4|30–34|||
Relative|Mouth cancer|2015–2019|Males|4|35–39|||
Relative|Mouth cancer|2015–2019|Males|4|40–44|0.815|0.659|0.906
Relative|Mouth cancer|2015–2019|Males|4|45–49|0.678|0.571|0.765
Relative|Mouth cancer|2015–2019|Males|4|50–54|0.744|0.675|0.801
Relative|Mouth cancer|2015–2019|Males|4|55–59|0.631|0.565|0.689
Relative|Mouth cancer|2015–2019|Males|4|60–64|0.629|0.57|0.684
Relative|Mouth cancer|2015–2019|Males|4|65–69|0.624|0.561|0.682
Relative|Mouth cancer|2015–2019|Males|4|70–74|0.585|0.509|0.656
Relative|Mouth cancer|2015–2019|Males|4|75–79|0.581|0.475|0.68
Relative|Mouth cancer|2015–2019|Males|4|80–84|0.536|0.42|0.65
Relative|Mouth cancer|2015–2019|Males|4|85+|0.524|0.364|0.696
Relative|Mouth cancer|2015–2019|Males|4|All ages combined|0.634|0.609|0.659
Relative|Mouth cancer|2015–2019|Males|5|00–04|||
Relative|Mouth cancer|2015–2019|Males|5|05–09|||
Relative|Mouth cancer|2015–2019|Males|5|10–14|||
Relative|Mouth cancer|2015–2019|Males|5|15–19|||
Relative|Mouth cancer|2015–2019|Males|5|20–24|||
Relative|Mouth cancer|2015–2019|Males|5|25–29|||
Relative|Mouth cancer|2015–2019|Males|5|30–34|||
Relative|Mouth cancer|2015–2019|Males|5|35–39|||
Relative|Mouth cancer|2015–2019|Males|5|40–44|0.767|0.604|0.871
Relative|Mouth cancer|2015–2019|Males|5|45–49|0.655|0.546|0.745
Relative|Mouth cancer|2015–2019|Males|5|50–54|0.724|0.653|0.783
Relative|Mouth cancer|2015–2019|Males|5|55–59|0.599|0.532|0.66
Relative|Mouth cancer|2015–2019|Males|5|60–64|0.599|0.538|0.656
Relative|Mouth cancer|2015–2019|Males|5|65–69|0.597|0.533|0.657
Relative|Mouth cancer|2015–2019|Males|5|70–74|0.527|0.448|0.602
Relative|Mouth cancer|2015–2019|Males|5|75–79|0.561|0.45|0.666
Relative|Mouth cancer|2015–2019|Males|5|80–84|0.496|0.373|0.621
Relative|Mouth cancer|2015–2019|Males|5|85+|0.549|0.362|0.759
Relative|Mouth cancer|2015–2019|Males|5|All ages combined|0.604|0.578|0.63
Observed|Mouth cancer|2015–2019|Females|1|00–04|||
Observed|Mouth cancer|2015–2019|Females|1|05–09|||
Observed|Mouth cancer|2015–2019|Females|1|10–14|||
Observed|Mouth cancer|2015–2019|Females|1|15–19|||
Observed|Mouth cancer|2015–2019|Females|1|20–24|||
Observed|Mouth cancer|2015–2019|Females|1|25–29|||
Observed|Mouth cancer|2015–2019|Females|1|30–34|||
Observed|Mouth cancer|2015–2019|Females|1|35–39|||
Observed|Mouth cancer|2015–2019|Females|1|40–44|0.965|0.779|0.995
Observed|Mouth cancer|2015–2019|Females|1|45–49|0.92|0.773|0.974
Observed|Mouth cancer|2015–2019|Females|1|50–54|0.93|0.85|0.968
Observed|Mouth cancer|2015–2019|Females|1|55–59|0.897|0.829|0.939
Observed|Mouth cancer|2015–2019|Females|1|60–64|0.944|0.887|0.973
Observed|Mouth cancer|2015–2019|Females|1|65–69|0.899|0.842|0.936
Observed|Mouth cancer|2015–2019|Females|1|70–74|0.845|0.783|0.89
Observed|Mouth cancer|2015–2019|Females|1|75–79|0.809|0.729|0.868
Observed|Mouth cancer|2015–2019|Females|1|80–84|0.695|0.611|0.764
Observed|Mouth cancer|2015–2019|Females|1|85+|0.546|0.471|0.615
Observed|Mouth cancer|2015–2019|Females|1|All ages combined|0.82|0.797|0.84
Observed|Mouth cancer|2015–2019|Females|2|00–04|||
Observed|Mouth cancer|2015–2019|Females|2|05–09|||
Observed|Mouth cancer|2015–2019|Females|2|10–14|||
Observed|Mouth cancer|2015–2019|Females|2|15–19|||
Observed|Mouth cancer|2015–2019|Females|2|20–24|||
Observed|Mouth cancer|2015–2019|Females|2|25–29|||
Observed|Mouth cancer|2015–2019|Females|2|30–34|||
Observed|Mouth cancer|2015–2019|Females|2|35–39|||
Observed|Mouth cancer|2015–2019|Females|2|40–44|0.868|0.686|0.948
Observed|Mouth cancer|2015–2019|Females|2|45–49|0.896|0.746|0.96
Observed|Mouth cancer|2015–2019|Females|2|50–54|0.87|0.777|0.926
Observed|Mouth cancer|2015–2019|Females|2|55–59|0.831|0.753|0.886
Observed|Mouth cancer|2015–2019|Females|2|60–64|0.852|0.776|0.904
Observed|Mouth cancer|2015–2019|Females|2|65–69|0.8|0.73|0.853
Observed|Mouth cancer|2015–2019|Females|2|70–74|0.753|0.681|0.81
Observed|Mouth cancer|2015–2019|Females|2|75–79|0.713|0.626|0.784
Observed|Mouth cancer|2015–2019|Females|2|80–84|0.584|0.496|0.662
Observed|Mouth cancer|2015–2019|Females|2|85+|0.429|0.356|0.499
Observed|Mouth cancer|2015–2019|Females|2|All ages combined|0.729|0.703|0.753
Observed|Mouth cancer|2015–2019|Females|3|00–04|||
Observed|Mouth cancer|2015–2019|Females|3|05–09|||
Observed|Mouth cancer|2015–2019|Females|3|10–14|||
Observed|Mouth cancer|2015–2019|Females|3|15–19|||
Observed|Mouth cancer|2015–2019|Females|3|20–24|||
Observed|Mouth cancer|2015–2019|Females|3|25–29|||
Observed|Mouth cancer|2015–2019|Females|3|30–34|||
Observed|Mouth cancer|2015–2019|Females|3|35–39|||
Observed|Mouth cancer|2015–2019|Females|3|40–44|0.868|0.686|0.948
Observed|Mouth cancer|2015–2019|Females|3|45–49|0.789|0.634|0.884
Observed|Mouth cancer|2015–2019|Females|3|50–54|0.824|0.725|0.89
Observed|Mouth cancer|2015–2019|Females|3|55–59|0.796|0.713|0.858
Observed|Mouth cancer|2015–2019|Females|3|60–64|0.785|0.7|0.848
Observed|Mouth cancer|2015–2019|Females|3|65–69|0.757|0.684|0.816
Observed|Mouth cancer|2015–2019|Females|3|70–74|0.692|0.617|0.755
Observed|Mouth cancer|2015–2019|Females|3|75–79|0.632|0.541|0.71
Observed|Mouth cancer|2015–2019|Females|3|80–84|0.505|0.415|0.588
Observed|Mouth cancer|2015–2019|Females|3|85+|0.351|0.282|0.42
Observed|Mouth cancer|2015–2019|Females|3|All ages combined|0.669|0.642|0.695
Observed|Mouth cancer|2015–2019|Females|4|00–04|||
Observed|Mouth cancer|2015–2019|Females|4|05–09|||
Observed|Mouth cancer|2015–2019|Females|4|10–14|||
Observed|Mouth cancer|2015–2019|Females|4|15–19|||
Observed|Mouth cancer|2015–2019|Females|4|20–24|||
Observed|Mouth cancer|2015–2019|Females|4|25–29|||
Observed|Mouth cancer|2015–2019|Females|4|30–34|||
Observed|Mouth cancer|2015–2019|Females|4|35–39|||
Observed|Mouth cancer|2015–2019|Females|4|40–44|0.829|0.636|0.925
Observed|Mouth cancer|2015–2019|Females|4|45–49|0.789|0.634|0.884
Observed|Mouth cancer|2015–2019|Females|4|50–54|0.791|0.688|0.862
Observed|Mouth cancer|2015–2019|Females|4|55–59|0.761|0.674|0.828
Observed|Mouth cancer|2015–2019|Females|4|60–64|0.768|0.682|0.834
Observed|Mouth cancer|2015–2019|Females|4|65–69|0.725|0.649|0.787
Observed|Mouth cancer|2015–2019|Females|4|70–74|0.674|0.598|0.739
Observed|Mouth cancer|2015–2019|Females|4|75–79|0.587|0.494|0.668
Observed|Mouth cancer|2015–2019|Females|4|80–84|0.47|0.381|0.554
Observed|Mouth cancer|2015–2019|Females|4|85+|0.266|0.203|0.333
Observed|Mouth cancer|2015–2019|Females|4|All ages combined|0.632|0.604|0.659
Observed|Mouth cancer|2015–2019|Females|5|00–04|||
Observed|Mouth cancer|2015–2019|Females|5|05–09|||
Observed|Mouth cancer|2015–2019|Females|5|10–14|||
Observed|Mouth cancer|2015–2019|Females|5|15–19|||
Observed|Mouth cancer|2015–2019|Females|5|20–24|||
Observed|Mouth cancer|2015–2019|Females|5|25–29|||
Observed|Mouth cancer|2015–2019|Females|5|30–34|||
Observed|Mouth cancer|2015–2019|Females|5|35–39|||
Observed|Mouth cancer|2015–2019|Females|5|40–44|||
Observed|Mouth cancer|2015–2019|Females|5|45–49|0.732|0.577|0.838
Observed|Mouth cancer|2015–2019|Females|5|50–54|0.711|0.603|0.794
Observed|Mouth cancer|2015–2019|Females|5|55–59|0.761|0.674|0.828
Observed|Mouth cancer|2015–2019|Females|5|60–64|0.752|0.665|0.82
Observed|Mouth cancer|2015–2019|Females|5|65–69|0.643|0.563|0.712
Observed|Mouth cancer|2015–2019|Females|5|70–74|0.641|0.563|0.708
Observed|Mouth cancer|2015–2019|Females|5|75–79|0.55|0.457|0.634
Observed|Mouth cancer|2015–2019|Females|5|80–84|0.426|0.338|0.511
Observed|Mouth cancer|2015–2019|Females|5|85+|0.218|0.159|0.283
Observed|Mouth cancer|2015–2019|Females|5|All ages combined|0.592|0.564|0.62
Relative|Mouth cancer|2015–2019|Females|1|00–04|||
Relative|Mouth cancer|2015–2019|Females|1|05–09|||
Relative|Mouth cancer|2015–2019|Females|1|10–14|||
Relative|Mouth cancer|2015–2019|Females|1|15–19|||
Relative|Mouth cancer|2015–2019|Females|1|20–24|||
Relative|Mouth cancer|2015–2019|Females|1|25–29|||
Relative|Mouth cancer|2015–2019|Females|1|30–34|||
Relative|Mouth cancer|2015–2019|Females|1|35–39|||
Relative|Mouth cancer|2015–2019|Females|1|40–44|0.966|0.779|0.996
Relative|Mouth cancer|2015–2019|Females|1|45–49|0.922|0.774|0.975
Relative|Mouth cancer|2015–2019|Females|1|50–54|0.932|0.852|0.97
Relative|Mouth cancer|2015–2019|Females|1|55–59|0.9|0.832|0.942
Relative|Mouth cancer|2015–2019|Females|1|60–64|0.949|0.891|0.978
Relative|Mouth cancer|2015–2019|Females|1|65–69|0.905|0.848|0.943
Relative|Mouth cancer|2015–2019|Females|1|70–74|0.855|0.793|0.901
Relative|Mouth cancer|2015–2019|Females|1|75–79|0.827|0.745|0.887
Relative|Mouth cancer|2015–2019|Females|1|80–84|0.723|0.636|0.795
Relative|Mouth cancer|2015–2019|Females|1|85+|0.615|0.53|0.693
Relative|Mouth cancer|2015–2019|Females|1|All ages combined|0.841|0.818|0.862
Relative|Mouth cancer|2015–2019|Females|2|00–04|||
Relative|Mouth cancer|2015–2019|Females|2|05–09|||
Relative|Mouth cancer|2015–2019|Females|2|10–14|||
Relative|Mouth cancer|2015–2019|Females|2|15–19|||
Relative|Mouth cancer|2015–2019|Females|2|20–24|||
Relative|Mouth cancer|2015–2019|Females|2|25–29|||
Relative|Mouth cancer|2015–2019|Females|2|30–34|||
Relative|Mouth cancer|2015–2019|Females|2|35–39|||
Relative|Mouth cancer|2015–2019|Females|2|40–44|0.87|0.687|0.95
Relative|Mouth cancer|2015–2019|Females|2|45–49|0.899|0.748|0.962
Relative|Mouth cancer|2015–2019|Females|2|50–54|0.873|0.78|0.93
Relative|Mouth cancer|2015–2019|Females|2|55–59|0.837|0.758|0.892
Relative|Mouth cancer|2015–2019|Females|2|60–64|0.861|0.783|0.913
Relative|Mouth cancer|2015–2019|Females|2|65–69|0.812|0.741|0.866
Relative|Mouth cancer|2015–2019|Females|2|70–74|0.772|0.699|0.831
Relative|Mouth cancer|2015–2019|Females|2|75–79|0.746|0.655|0.82
Relative|Mouth cancer|2015–2019|Females|2|80–84|0.637|0.541|0.722
Relative|Mouth cancer|2015–2019|Females|2|85+|0.545|0.452|0.635
Relative|Mouth cancer|2015–2019|Females|2|All ages combined|0.766|0.738|0.791
Relative|Mouth cancer|2015–2019|Females|3|00–04|||
Relative|Mouth cancer|2015–2019|Females|3|05–09|||
Relative|Mouth cancer|2015–2019|Females|3|10–14|||
Relative|Mouth cancer|2015–2019|Females|3|15–19|||
Relative|Mouth cancer|2015–2019|Females|3|20–24|||
Relative|Mouth cancer|2015–2019|Females|3|25–29|||
Relative|Mouth cancer|2015–2019|Females|3|30–34|||
Relative|Mouth cancer|2015–2019|Females|3|35–39|||
Relative|Mouth cancer|2015–2019|Females|3|40–44|0.87|0.688|0.951
Relative|Mouth cancer|2015–2019|Females|3|45–49|0.793|0.637|0.888
Relative|Mouth cancer|2015–2019|Females|3|50–54|0.829|0.73|0.896
Relative|Mouth cancer|2015–2019|Females|3|55–59|0.804|0.721|0.866
Relative|Mouth cancer|2015–2019|Females|3|60–64|0.797|0.711|0.861
Relative|Mouth cancer|2015–2019|Females|3|65–69|0.775|0.7|0.835
Relative|Mouth cancer|2015–2019|Females|3|70–74|0.721|0.642|0.787
Relative|Mouth cancer|2015–2019|Females|3|75–79|0.68|0.582|0.763
Relative|Mouth cancer|2015–2019|Females|3|80–84|0.581|0.478|0.676
Relative|Mouth cancer|2015–2019|Females|3|85+|0.512|0.412|0.614
Relative|Mouth cancer|2015–2019|Females|3|All ages combined|0.719|0.69|0.747
Relative|Mouth cancer|2015–2019|Females|4|00–04|||
Relative|Mouth cancer|2015–2019|Females|4|05–09|||
Relative|Mouth cancer|2015–2019|Females|4|10–14|||
Relative|Mouth cancer|2015–2019|Females|4|15–19|||
Relative|Mouth cancer|2015–2019|Females|4|20–24|||
Relative|Mouth cancer|2015–2019|Females|4|25–29|||
Relative|Mouth cancer|2015–2019|Females|4|30–34|||
Relative|Mouth cancer|2015–2019|Females|4|35–39|||
Relative|Mouth cancer|2015–2019|Females|4|40–44|0.833|0.639|0.929
Relative|Mouth cancer|2015–2019|Females|4|45–49|0.794|0.638|0.89
Relative|Mouth cancer|2015–2019|Females|4|50–54|0.798|0.695|0.871
Relative|Mouth cancer|2015–2019|Females|4|55–59|0.772|0.684|0.839
Relative|Mouth cancer|2015–2019|Females|4|60–64|0.785|0.697|0.852
Relative|Mouth cancer|2015–2019|Females|4|65–69|0.749|0.671|0.813
Relative|Mouth cancer|2015–2019|Females|4|70–74|0.714|0.634|0.783
Relative|Mouth cancer|2015–2019|Females|4|75–79|0.651|0.548|0.741
Relative|Mouth cancer|2015–2019|Females|4|80–84|0.576|0.467|0.679
Relative|Mouth cancer|2015–2019|Females|4|85+|0.458|0.35|0.573
Relative|Mouth cancer|2015–2019|Females|4|All ages combined|0.697|0.666|0.726
Relative|Mouth cancer|2015–2019|Females|5|00–04|||
Relative|Mouth cancer|2015–2019|Females|5|05–09|||
Relative|Mouth cancer|2015–2019|Females|5|10–14|||
Relative|Mouth cancer|2015–2019|Females|5|15–19|||
Relative|Mouth cancer|2015–2019|Females|5|20–24|||
Relative|Mouth cancer|2015–2019|Females|5|25–29|||
Relative|Mouth cancer|2015–2019|Females|5|30–34|||
Relative|Mouth cancer|2015–2019|Females|5|35–39|||
Relative|Mouth cancer|2015–2019|Females|5|40–44|||
Relative|Mouth cancer|2015–2019|Females|5|45–49|0.738|0.582|0.845
Relative|Mouth cancer|2015–2019|Females|5|50–54|0.72|0.61|0.804
Relative|Mouth cancer|2015–2019|Females|5|55–59|0.775|0.687|0.843
Relative|Mouth cancer|2015–2019|Females|5|60–64|0.773|0.684|0.843
Relative|Mouth cancer|2015–2019|Females|5|65–69|0.672|0.588|0.745
Relative|Mouth cancer|2015–2019|Females|5|70–74|0.692|0.608|0.765
Relative|Mouth cancer|2015–2019|Females|5|75–79|0.633|0.526|0.729
Relative|Mouth cancer|2015–2019|Females|5|80–84|0.563|0.447|0.675
Relative|Mouth cancer|2015–2019|Females|5|85+|0.455|0.332|0.591
Relative|Mouth cancer|2015–2019|Females|5|All ages combined|0.668|0.636|0.699
Observed|Mouth cancer|2015–2019|Persons|1|00–04|||
Observed|Mouth cancer|2015–2019|Persons|1|05–09|||
Observed|Mouth cancer|2015–2019|Persons|1|10–14|||
Observed|Mouth cancer|2015–2019|Persons|1|15–19|||
Observed|Mouth cancer|2015–2019|Persons|1|20–24|||
Observed|Mouth cancer|2015–2019|Persons|1|25–29|||
Observed|Mouth cancer|2015–2019|Persons|1|30–34|||
Observed|Mouth cancer|2015–2019|Persons|1|35–39|0.946|0.799|0.986
Observed|Mouth cancer|2015–2019|Persons|1|40–44|0.915|0.821|0.961
Observed|Mouth cancer|2015–2019|Persons|1|45–49|0.9|0.838|0.94
Observed|Mouth cancer|2015–2019|Persons|1|50–54|0.907|0.865|0.936
Observed|Mouth cancer|2015–2019|Persons|1|55–59|0.862|0.823|0.892
Observed|Mouth cancer|2015–2019|Persons|1|60–64|0.874|0.839|0.901
Observed|Mouth cancer|2015–2019|Persons|1|65–69|0.844|0.808|0.874
Observed|Mouth cancer|2015–2019|Persons|1|70–74|0.821|0.781|0.854
Observed|Mouth cancer|2015–2019|Persons|1|75–79|0.777|0.723|0.821
Observed|Mouth cancer|2015–2019|Persons|1|80–84|0.705|0.647|0.755
Observed|Mouth cancer|2015–2019|Persons|1|85+|0.52|0.46|0.577
Observed|Mouth cancer|2015–2019|Persons|1|All ages combined|0.814|0.8|0.827
Observed|Mouth cancer|2015–2019|Persons|2|00–04|||
Observed|Mouth cancer|2015–2019|Persons|2|05–09|||
Observed|Mouth cancer|2015–2019|Persons|2|10–14|||
Observed|Mouth cancer|2015–2019|Persons|2|15–19|||
Observed|Mouth cancer|2015–2019|Persons|2|20–24|||
Observed|Mouth cancer|2015–2019|Persons|2|25–29|||
Observed|Mouth cancer|2015–2019|Persons|2|30–34|||
Observed|Mouth cancer|2015–2019|Persons|2|35–39|0.911|0.747|0.971
Observed|Mouth cancer|2015–2019|Persons|2|40–44|0.847|0.741|0.912
Observed|Mouth cancer|2015–2019|Persons|2|45–49|0.819|0.744|0.874
Observed|Mouth cancer|2015–2019|Persons|2|50–54|0.831|0.781|0.87
Observed|Mouth cancer|2015–2019|Persons|2|55–59|0.775|0.729|0.814
Observed|Mouth cancer|2015–2019|Persons|2|60–64|0.756|0.713|0.794
Observed|Mouth cancer|2015–2019|Persons|2|65–69|0.762|0.72|0.798
Observed|Mouth cancer|2015–2019|Persons|2|70–74|0.707|0.659|0.749
Observed|Mouth cancer|2015–2019|Persons|2|75–79|0.659|0.598|0.713
Observed|Mouth cancer|2015–2019|Persons|2|80–84|0.598|0.537|0.653
Observed|Mouth cancer|2015–2019|Persons|2|85+|0.404|0.346|0.46
Observed|Mouth cancer|2015–2019|Persons|2|All ages combined|0.716|0.699|0.731
Observed|Mouth cancer|2015–2019|Persons|3|00–04|||
Observed|Mouth cancer|2015–2019|Persons|3|05–09|||
Observed|Mouth cancer|2015–2019|Persons|3|10–14|||
Observed|Mouth cancer|2015–2019|Persons|3|15–19|||
Observed|Mouth cancer|2015–2019|Persons|3|20–24|||
Observed|Mouth cancer|2015–2019|Persons|3|25–29|||
Observed|Mouth cancer|2015–2019|Persons|3|30–34|||
Observed|Mouth cancer|2015–2019|Persons|3|35–39|0.911|0.747|0.971
Observed|Mouth cancer|2015–2019|Persons|3|40–44|0.833|0.725|0.901
Observed|Mouth cancer|2015–2019|Persons|3|45–49|0.733|0.651|0.798
Observed|Mouth cancer|2015–2019|Persons|3|50–54|0.78|0.727|0.824
Observed|Mouth cancer|2015–2019|Persons|3|55–59|0.72|0.672|0.763
Observed|Mouth cancer|2015–2019|Persons|3|60–64|0.693|0.647|0.734
Observed|Mouth cancer|2015–2019|Persons|3|65–69|0.693|0.649|0.733
Observed|Mouth cancer|2015–2019|Persons|3|70–74|0.646|0.596|0.691
Observed|Mouth cancer|2015–2019|Persons|3|75–79|0.584|0.521|0.642
Observed|Mouth cancer|2015–2019|Persons|3|80–84|0.512|0.45|0.571
Observed|Mouth cancer|2015–2019|Persons|3|85+|0.339|0.284|0.394
Observed|Mouth cancer|2015–2019|Persons|3|All ages combined|0.653|0.636|0.67
Observed|Mouth cancer|2015–2019|Persons|4|00–04|||
Observed|Mouth cancer|2015–2019|Persons|4|05–09|||
Observed|Mouth cancer|2015–2019|Persons|4|10–14|||
Observed|Mouth cancer|2015–2019|Persons|4|15–19|||
Observed|Mouth cancer|2015–2019|Persons|4|20–24|||
Observed|Mouth cancer|2015–2019|Persons|4|25–29|||
Observed|Mouth cancer|2015–2019|Persons|4|30–34|||
Observed|Mouth cancer|2015–2019|Persons|4|35–39|0.911|0.747|0.971
Observed|Mouth cancer|2015–2019|Persons|4|40–44|0.818|0.708|0.89
Observed|Mouth cancer|2015–2019|Persons|4|45–49|0.71|0.626|0.778
Observed|Mouth cancer|2015–2019|Persons|4|50–54|0.75|0.695|0.797
Observed|Mouth cancer|2015–2019|Persons|4|55–59|0.663|0.612|0.709
Observed|Mouth cancer|2015–2019|Persons|4|60–64|0.653|0.606|0.697
Observed|Mouth cancer|2015–2019|Persons|4|65–69|0.639|0.593|0.682
Observed|Mouth cancer|2015–2019|Persons|4|70–74|0.598|0.547|0.645
Observed|Mouth cancer|2015–2019|Persons|4|75–79|0.54|0.476|0.6
Observed|Mouth cancer|2015–2019|Persons|4|80–84|0.437|0.374|0.497
Observed|Mouth cancer|2015–2019|Persons|4|85+|0.268|0.217|0.322
Observed|Mouth cancer|2015–2019|Persons|4|All ages combined|0.604|0.586|0.622
Observed|Mouth cancer|2015–2019|Persons|5|00–04|||
Observed|Mouth cancer|2015–2019|Persons|5|05–09|||
Observed|Mouth cancer|2015–2019|Persons|5|10–14|||
Observed|Mouth cancer|2015–2019|Persons|5|15–19|||
Observed|Mouth cancer|2015–2019|Persons|5|20–24|||
Observed|Mouth cancer|2015–2019|Persons|5|25–29|||
Observed|Mouth cancer|2015–2019|Persons|5|30–34|||
Observed|Mouth cancer|2015–2019|Persons|5|35–39|0.911|0.747|0.971
Observed|Mouth cancer|2015–2019|Persons|5|40–44|0.784|0.667|0.864
Observed|Mouth cancer|2015–2019|Persons|5|45–49|0.672|0.587|0.744
Observed|Mouth cancer|2015–2019|Persons|5|50–54|0.71|0.654|0.759
Observed|Mouth cancer|2015–2019|Persons|5|55–59|0.64|0.588|0.687
Observed|Mouth cancer|2015–2019|Persons|5|60–64|0.624|0.576|0.668
Observed|Mouth cancer|2015–2019|Persons|5|65–69|0.587|0.54|0.632
Observed|Mouth cancer|2015–2019|Persons|5|70–74|0.546|0.494|0.595
Observed|Mouth cancer|2015–2019|Persons|5|75–79|0.501|0.436|0.561
Observed|Mouth cancer|2015–2019|Persons|5|80–84|0.383|0.322|0.443
Observed|Mouth cancer|2015–2019|Persons|5|85+|0.223|0.175|0.275
Observed|Mouth cancer|2015–2019|Persons|5|All ages combined|0.565|0.546|0.582
Relative|Mouth cancer|2015–2019|Persons|1|00–04|||
Relative|Mouth cancer|2015–2019|Persons|1|05–09|||
Relative|Mouth cancer|2015–2019|Persons|1|10–14|||
Relative|Mouth cancer|2015–2019|Persons|1|15–19|||
Relative|Mouth cancer|2015–2019|Persons|1|20–24|||
Relative|Mouth cancer|2015–2019|Persons|1|25–29|||
Relative|Mouth cancer|2015–2019|Persons|1|30–34|||
Relative|Mouth cancer|2015–2019|Persons|1|35–39|0.946|0.8|0.987
Relative|Mouth cancer|2015–2019|Persons|1|40–44|0.916|0.822|0.962
Relative|Mouth cancer|2015–2019|Persons|1|45–49|0.902|0.839|0.942
Relative|Mouth cancer|2015–2019|Persons|1|50–54|0.909|0.868|0.939
Relative|Mouth cancer|2015–2019|Persons|1|55–59|0.866|0.827|0.896
Relative|Mouth cancer|2015–2019|Persons|1|60–64|0.88|0.845|0.908
Relative|Mouth cancer|2015–2019|Persons|1|65–69|0.853|0.816|0.883
Relative|Mouth cancer|2015–2019|Persons|1|70–74|0.835|0.794|0.868
Relative|Mouth cancer|2015–2019|Persons|1|75–79|0.798|0.743|0.845
Relative|Mouth cancer|2015–2019|Persons|1|80–84|0.741|0.681|0.794
Relative|Mouth cancer|2015–2019|Persons|1|85+|0.591|0.523|0.655
Relative|Mouth cancer|2015–2019|Persons|1|All ages combined|0.833|0.819|0.846
Relative|Mouth cancer|2015–2019|Persons|2|00–04|||
Relative|Mouth cancer|2015–2019|Persons|2|05–09|||
Relative|Mouth cancer|2015–2019|Persons|2|10–14|||
Relative|Mouth cancer|2015–2019|Persons|2|15–19|||
Relative|Mouth cancer|2015–2019|Persons|2|20–24|||
Relative|Mouth cancer|2015–2019|Persons|2|25–29|||
Relative|Mouth cancer|2015–2019|Persons|2|30–34|||
Relative|Mouth cancer|2015–2019|Persons|2|35–39|0.913|0.748|0.973
Relative|Mouth cancer|2015–2019|Persons|2|40–44|0.849|0.743|0.915
Relative|Mouth cancer|2015–2019|Persons|2|45–49|0.823|0.747|0.878
Relative|Mouth cancer|2015–2019|Persons|2|50–54|0.836|0.786|0.876
Relative|Mouth cancer|2015–2019|Persons|2|55–59|0.782|0.736|0.821
Relative|Mouth cancer|2015–2019|Persons|2|60–64|0.767|0.723|0.805
Relative|Mouth cancer|2015–2019|Persons|2|65–69|0.778|0.736|0.815
Relative|Mouth cancer|2015–2019|Persons|2|70–74|0.731|0.682|0.774
Relative|Mouth cancer|2015–2019|Persons|2|75–79|0.698|0.633|0.755
Relative|Mouth cancer|2015–2019|Persons|2|80–84|0.666|0.598|0.728
Relative|Mouth cancer|2015–2019|Persons|2|85+|0.523|0.449|0.596
Relative|Mouth cancer|2015–2019|Persons|2|All ages combined|0.748|0.731|0.764
Relative|Mouth cancer|2015–2019|Persons|3|00–04|||
Relative|Mouth cancer|2015–2019|Persons|3|05–09|||
Relative|Mouth cancer|2015–2019|Persons|3|10–14|||
Relative|Mouth cancer|2015–2019|Persons|3|15–19|||
Relative|Mouth cancer|2015–2019|Persons|3|20–24|||
Relative|Mouth cancer|2015–2019|Persons|3|25–29|||
Relative|Mouth cancer|2015–2019|Persons|3|30–34|||
Relative|Mouth cancer|2015–2019|Persons|3|35–39|0.914|0.749|0.974
Relative|Mouth cancer|2015–2019|Persons|3|40–44|0.837|0.728|0.905
Relative|Mouth cancer|2015–2019|Persons|3|45–49|0.738|0.655|0.804
Relative|Mouth cancer|2015–2019|Persons|3|50–54|0.788|0.734|0.833
Relative|Mouth cancer|2015–2019|Persons|3|55–59|0.731|0.682|0.774
Relative|Mouth cancer|2015–2019|Persons|3|60–64|0.709|0.662|0.751
Relative|Mouth cancer|2015–2019|Persons|3|65–69|0.717|0.671|0.758
Relative|Mouth cancer|2015–2019|Persons|3|70–74|0.681|0.629|0.729
Relative|Mouth cancer|2015–2019|Persons|3|75–79|0.641|0.571|0.704
Relative|Mouth cancer|2015–2019|Persons|3|80–84|0.609|0.535|0.679
Relative|Mouth cancer|2015–2019|Persons|3|85+|0.51|0.428|0.593
Relative|Mouth cancer|2015–2019|Persons|3|All ages combined|0.697|0.678|0.714
Relative|Mouth cancer|2015–2019|Persons|4|00–04|||
Relative|Mouth cancer|2015–2019|Persons|4|05–09|||
Relative|Mouth cancer|2015–2019|Persons|4|10–14|||
Relative|Mouth cancer|2015–2019|Persons|4|15–19|||
Relative|Mouth cancer|2015–2019|Persons|4|20–24|||
Relative|Mouth cancer|2015–2019|Persons|4|25–29|||
Relative|Mouth cancer|2015–2019|Persons|4|30–34|||
Relative|Mouth cancer|2015–2019|Persons|4|35–39|0.915|0.75|0.975
Relative|Mouth cancer|2015–2019|Persons|4|40–44|0.823|0.712|0.896
Relative|Mouth cancer|2015–2019|Persons|4|45–49|0.716|0.632|0.785
Relative|Mouth cancer|2015–2019|Persons|4|50–54|0.761|0.705|0.808
Relative|Mouth cancer|2015–2019|Persons|4|55–59|0.677|0.625|0.724
Relative|Mouth cancer|2015–2019|Persons|4|60–64|0.674|0.625|0.719
Relative|Mouth cancer|2015–2019|Persons|4|65–69|0.67|0.622|0.715
Relative|Mouth cancer|2015–2019|Persons|4|70–74|0.644|0.589|0.695
Relative|Mouth cancer|2015–2019|Persons|4|75–79|0.615|0.542|0.683
Relative|Mouth cancer|2015–2019|Persons|4|80–84|0.559|0.479|0.636
Relative|Mouth cancer|2015–2019|Persons|4|85+|0.479|0.388|0.574
Relative|Mouth cancer|2015–2019|Persons|4|All ages combined|0.659|0.64|0.678
Relative|Mouth cancer|2015–2019|Persons|5|00–04|||
Relative|Mouth cancer|2015–2019|Persons|5|05–09|||
Relative|Mouth cancer|2015–2019|Persons|5|10–14|||
Relative|Mouth cancer|2015–2019|Persons|5|15–19|||
Relative|Mouth cancer|2015–2019|Persons|5|20–24|||
Relative|Mouth cancer|2015–2019|Persons|5|25–29|||
Relative|Mouth cancer|2015–2019|Persons|5|30–34|||
Relative|Mouth cancer|2015–2019|Persons|5|35–39|0.916|0.751|0.976
Relative|Mouth cancer|2015–2019|Persons|5|40–44|0.79|0.672|0.871
Relative|Mouth cancer|2015–2019|Persons|5|45–49|0.68|0.594|0.753
Relative|Mouth cancer|2015–2019|Persons|5|50–54|0.723|0.666|0.773
Relative|Mouth cancer|2015–2019|Persons|5|55–59|0.657|0.604|0.706
Relative|Mouth cancer|2015–2019|Persons|5|60–64|0.65|0.6|0.696
Relative|Mouth cancer|2015–2019|Persons|5|65–69|0.625|0.574|0.672
Relative|Mouth cancer|2015–2019|Persons|5|70–74|0.603|0.545|0.657
Relative|Mouth cancer|2015–2019|Persons|5|75–79|0.595|0.519|0.668
Relative|Mouth cancer|2015–2019|Persons|5|80–84|0.533|0.448|0.618
Relative|Mouth cancer|2015–2019|Persons|5|85+|0.484|0.379|0.598
Relative|Mouth cancer|2015–2019|Persons|5|All ages combined|0.63|0.61|0.65
Observed|Multiple myeloma|2015–2019|Males|1|00–04|||
Observed|Multiple myeloma|2015–2019|Males|1|05–09|||
Observed|Multiple myeloma|2015–2019|Males|1|10–14|||
Observed|Multiple myeloma|2015–2019|Males|1|15–19|||
Observed|Multiple myeloma|2015–2019|Males|1|20–24|||
Observed|Multiple myeloma|2015–2019|Males|1|25–29|||
Observed|Multiple myeloma|2015–2019|Males|1|30–34|||
Observed|Multiple myeloma|2015–2019|Males|1|35–39|0.945|0.796|0.986
Observed|Multiple myeloma|2015–2019|Males|1|40–44|0.95|0.873|0.981
Observed|Multiple myeloma|2015–2019|Males|1|45–49|0.951|0.904|0.975
Observed|Multiple myeloma|2015–2019|Males|1|50–54|0.94|0.906|0.962
Observed|Multiple myeloma|2015–2019|Males|1|55–59|0.939|0.913|0.957
Observed|Multiple myeloma|2015–2019|Males|1|60–64|0.924|0.901|0.942
Observed|Multiple myeloma|2015–2019|Males|1|65–69|0.919|0.898|0.935
Observed|Multiple myeloma|2015–2019|Males|1|70–74|0.868|0.845|0.888
Observed|Multiple myeloma|2015–2019|Males|1|75–79|0.815|0.787|0.839
Observed|Multiple myeloma|2015–2019|Males|1|80–84|0.72|0.684|0.752
Observed|Multiple myeloma|2015–2019|Males|1|85+|0.533|0.492|0.573
Observed|Multiple myeloma|2015–2019|Males|1|All ages combined|0.837|0.827|0.847
Observed|Multiple myeloma|2015–2019|Males|2|00–04|||
Observed|Multiple myeloma|2015–2019|Males|2|05–09|||
Observed|Multiple myeloma|2015–2019|Males|2|10–14|||
Observed|Multiple myeloma|2015–2019|Males|2|15–19|||
Observed|Multiple myeloma|2015–2019|Males|2|20–24|||
Observed|Multiple myeloma|2015–2019|Males|2|25–29|||
Observed|Multiple myeloma|2015–2019|Males|2|30–34|||
Observed|Multiple myeloma|2015–2019|Males|2|35–39|0.945|0.796|0.986
Observed|Multiple myeloma|2015–2019|Males|2|40–44|0.89|0.8|0.941
Observed|Multiple myeloma|2015–2019|Males|2|45–49|0.919|0.864|0.952
Observed|Multiple myeloma|2015–2019|Males|2|50–54|0.892|0.851|0.922
Observed|Multiple myeloma|2015–2019|Males|2|55–59|0.864|0.828|0.892
Observed|Multiple myeloma|2015–2019|Males|2|60–64|0.843|0.814|0.869
Observed|Multiple myeloma|2015–2019|Males|2|65–69|0.847|0.822|0.87
Observed|Multiple myeloma|2015–2019|Males|2|70–74|0.778|0.75|0.803
Observed|Multiple myeloma|2015–2019|Males|2|75–79|0.701|0.669|0.73
Observed|Multiple myeloma|2015–2019|Males|2|80–84|0.564|0.525|0.601
Observed|Multiple myeloma|2015–2019|Males|2|85+|0.364|0.326|0.403
Observed|Multiple myeloma|2015–2019|Males|2|All ages combined|0.737|0.726|0.749
Observed|Multiple myeloma|2015–2019|Males|3|00–04|||
Observed|Multiple myeloma|2015–2019|Males|3|05–09|||
Observed|Multiple myeloma|2015–2019|Males|3|10–14|||
Observed|Multiple myeloma|2015–2019|Males|3|15–19|||
Observed|Multiple myeloma|2015–2019|Males|3|20–24|||
Observed|Multiple myeloma|2015–2019|Males|3|25–29|||
Observed|Multiple myeloma|2015–2019|Males|3|30–34|||
Observed|Multiple myeloma|2015–2019|Males|3|35–39|0.851|0.678|0.935
Observed|Multiple myeloma|2015–2019|Males|3|40–44|0.806|0.702|0.876
Observed|Multiple myeloma|2015–2019|Males|3|45–49|0.892|0.833|0.932
Observed|Multiple myeloma|2015–2019|Males|3|50–54|0.827|0.778|0.866
Observed|Multiple myeloma|2015–2019|Males|3|55–59|0.813|0.774|0.847
Observed|Multiple myeloma|2015–2019|Males|3|60–64|0.774|0.741|0.804
Observed|Multiple myeloma|2015–2019|Males|3|65–69|0.776|0.746|0.802
Observed|Multiple myeloma|2015–2019|Males|3|70–74|0.694|0.663|0.724
Observed|Multiple myeloma|2015–2019|Males|3|75–79|0.595|0.56|0.628
Observed|Multiple myeloma|2015–2019|Males|3|80–84|0.44|0.401|0.478
Observed|Multiple myeloma|2015–2019|Males|3|85+|0.251|0.215|0.288
Observed|Multiple myeloma|2015–2019|Males|3|All ages combined|0.653|0.64|0.666
Observed|Multiple myeloma|2015–2019|Males|4|00–04|||
Observed|Multiple myeloma|2015–2019|Males|4|05–09|||
Observed|Multiple myeloma|2015–2019|Males|4|10–14|||
Observed|Multiple myeloma|2015–2019|Males|4|15–19|||
Observed|Multiple myeloma|2015–2019|Males|4|20–24|||
Observed|Multiple myeloma|2015–2019|Males|4|25–29|||
Observed|Multiple myeloma|2015–2019|Males|4|30–34|||
Observed|Multiple myeloma|2015–2019|Males|4|35–39|0.851|0.678|0.935
Observed|Multiple myeloma|2015–2019|Males|4|40–44|0.768|0.66|0.845
Observed|Multiple myeloma|2015–2019|Males|4|45–49|0.791|0.718|0.848
Observed|Multiple myeloma|2015–2019|Males|4|50–54|0.741|0.685|0.789
Observed|Multiple myeloma|2015–2019|Males|4|55–59|0.752|0.709|0.79
Observed|Multiple myeloma|2015–2019|Males|4|60–64|0.696|0.66|0.729
Observed|Multiple myeloma|2015–2019|Males|4|65–69|0.701|0.668|0.731
Observed|Multiple myeloma|2015–2019|Males|4|70–74|0.591|0.556|0.623
Observed|Multiple myeloma|2015–2019|Males|4|75–79|0.492|0.456|0.527
Observed|Multiple myeloma|2015–2019|Males|4|80–84|0.329|0.292|0.367
Observed|Multiple myeloma|2015–2019|Males|4|85+|0.163|0.132|0.197
Observed|Multiple myeloma|2015–2019|Males|4|All ages combined|0.566|0.552|0.579
Observed|Multiple myeloma|2015–2019|Males|5|00–04|||
Observed|Multiple myeloma|2015–2019|Males|5|05–09|||
Observed|Multiple myeloma|2015–2019|Males|5|10–14|||
Observed|Multiple myeloma|2015–2019|Males|5|15–19|||
Observed|Multiple myeloma|2015–2019|Males|5|20–24|||
Observed|Multiple myeloma|2015–2019|Males|5|25–29|||
Observed|Multiple myeloma|2015–2019|Males|5|30–34|||
Observed|Multiple myeloma|2015–2019|Males|5|35–39|0.778|0.586|0.888
Observed|Multiple myeloma|2015–2019|Males|5|40–44|0.729|0.618|0.813
Observed|Multiple myeloma|2015–2019|Males|5|45–49|0.756|0.679|0.817
Observed|Multiple myeloma|2015–2019|Males|5|50–54|0.686|0.626|0.737
Observed|Multiple myeloma|2015–2019|Males|5|55–59|0.71|0.665|0.75
Observed|Multiple myeloma|2015–2019|Males|5|60–64|0.624|0.585|0.659
Observed|Multiple myeloma|2015–2019|Males|5|65–69|0.635|0.6|0.668
Observed|Multiple myeloma|2015–2019|Males|5|70–74|0.502|0.466|0.537
Observed|Multiple myeloma|2015–2019|Males|5|75–79|0.388|0.352|0.424
Observed|Multiple myeloma|2015–2019|Males|5|80–84|0.26|0.225|0.296
Observed|Multiple myeloma|2015–2019|Males|5|85+|0.109|0.083|0.139
Observed|Multiple myeloma|2015–2019|Males|5|All ages combined|0.497|0.483|0.51
Relative|Multiple myeloma|2015–2019|Males|1|00–04|||
Relative|Multiple myeloma|2015–2019|Males|1|05–09|||
Relative|Multiple myeloma|2015–2019|Males|1|10–14|||
Relative|Multiple myeloma|2015–2019|Males|1|15–19|||
Relative|Multiple myeloma|2015–2019|Males|1|20–24|||
Relative|Multiple myeloma|2015–2019|Males|1|25–29|||
Relative|Multiple myeloma|2015–2019|Males|1|30–34|||
Relative|Multiple myeloma|2015–2019|Males|1|35–39|0.946|0.797|0.987
Relative|Multiple myeloma|2015–2019|Males|1|40–44|0.952|0.874|0.983
Relative|Multiple myeloma|2015–2019|Males|1|45–49|0.953|0.906|0.977
Relative|Multiple myeloma|2015–2019|Males|1|50–54|0.943|0.909|0.965
Relative|Multiple myeloma|2015–2019|Males|1|55–59|0.944|0.917|0.962
Relative|Multiple myeloma|2015–2019|Males|1|60–64|0.931|0.909|0.949
Relative|Multiple myeloma|2015–2019|Males|1|65–69|0.93|0.91|0.946
Relative|Multiple myeloma|2015–2019|Males|1|70–74|0.885|0.862|0.906
Relative|Multiple myeloma|2015–2019|Males|1|75–79|0.843|0.814|0.868
Relative|Multiple myeloma|2015–2019|Males|1|80–84|0.765|0.727|0.799
Relative|Multiple myeloma|2015–2019|Males|1|85+|0.608|0.561|0.653
Relative|Multiple myeloma|2015–2019|Males|1|All ages combined|0.864|0.854|0.874
Relative|Multiple myeloma|2015–2019|Males|2|00–04|||
Relative|Multiple myeloma|2015–2019|Males|2|05–09|||
Relative|Multiple myeloma|2015–2019|Males|2|10–14|||
Relative|Multiple myeloma|2015–2019|Males|2|15–19|||
Relative|Multiple myeloma|2015–2019|Males|2|20–24|||
Relative|Multiple myeloma|2015–2019|Males|2|25–29|||
Relative|Multiple myeloma|2015–2019|Males|2|30–34|||
Relative|Multiple myeloma|2015–2019|Males|2|35–39|0.947|0.798|0.988
Relative|Multiple myeloma|2015–2019|Males|2|40–44|0.893|0.803|0.945
Relative|Multiple myeloma|2015–2019|Males|2|45–49|0.923|0.868|0.957
Relative|Multiple myeloma|2015–2019|Males|2|50–54|0.898|0.857|0.929
Relative|Multiple myeloma|2015–2019|Males|2|55–59|0.873|0.838|0.902
Relative|Multiple myeloma|2015–2019|Males|2|60–64|0.858|0.828|0.883
Relative|Multiple myeloma|2015–2019|Males|2|65–69|0.869|0.843|0.892
Relative|Multiple myeloma|2015–2019|Males|2|70–74|0.811|0.781|0.837
Relative|Multiple myeloma|2015–2019|Males|2|75–79|0.752|0.718|0.784
Relative|Multiple myeloma|2015–2019|Males|2|80–84|0.642|0.598|0.684
Relative|Multiple myeloma|2015–2019|Males|2|85+|0.476|0.426|0.527
Relative|Multiple myeloma|2015–2019|Males|2|All ages combined|0.784|0.771|0.796
Relative|Multiple myeloma|2015–2019|Males|3|00–04|||
Relative|Multiple myeloma|2015–2019|Males|3|05–09|||
Relative|Multiple myeloma|2015–2019|Males|3|10–14|||
Relative|Multiple myeloma|2015–2019|Males|3|15–19|||
Relative|Multiple myeloma|2015–2019|Males|3|20–24|||
Relative|Multiple myeloma|2015–2019|Males|3|25–29|||
Relative|Multiple myeloma|2015–2019|Males|3|30–34|||
Relative|Multiple myeloma|2015–2019|Males|3|35–39|0.855|0.681|0.939
Relative|Multiple myeloma|2015–2019|Males|3|40–44|0.81|0.706|0.881
Relative|Multiple myeloma|2015–2019|Males|3|45–49|0.899|0.839|0.939
Relative|Multiple myeloma|2015–2019|Males|3|50–54|0.837|0.787|0.876
Relative|Multiple myeloma|2015–2019|Males|3|55–59|0.828|0.788|0.862
Relative|Multiple myeloma|2015–2019|Males|3|60–64|0.795|0.761|0.825
Relative|Multiple myeloma|2015–2019|Males|3|65–69|0.807|0.776|0.835
Relative|Multiple myeloma|2015–2019|Males|3|70–74|0.741|0.708|0.772
Relative|Multiple myeloma|2015–2019|Males|3|75–79|0.666|0.627|0.703
Relative|Multiple myeloma|2015–2019|Males|3|80–84|0.54|0.492|0.588
Relative|Multiple myeloma|2015–2019|Males|3|85+|0.381|0.327|0.437
Relative|Multiple myeloma|2015–2019|Males|3|All ages combined|0.714|0.7|0.728
Relative|Multiple myeloma|2015–2019|Males|4|00–04|||
Relative|Multiple myeloma|2015–2019|Males|4|05–09|||
Relative|Multiple myeloma|2015–2019|Males|4|10–14|||
Relative|Multiple myeloma|2015–2019|Males|4|15–19|||
Relative|Multiple myeloma|2015–2019|Males|4|20–24|||
Relative|Multiple myeloma|2015–2019|Males|4|25–29|||
Relative|Multiple myeloma|2015–2019|Males|4|30–34|||
Relative|Multiple myeloma|2015–2019|Males|4|35–39|0.856|0.682|0.94
Relative|Multiple myeloma|2015–2019|Males|4|40–44|0.773|0.665|0.851
Relative|Multiple myeloma|2015–2019|Males|4|45–49|0.8|0.726|0.857
Relative|Multiple myeloma|2015–2019|Males|4|50–54|0.753|0.696|0.802
Relative|Multiple myeloma|2015–2019|Males|4|55–59|0.77|0.726|0.809
Relative|Multiple myeloma|2015–2019|Males|4|60–64|0.722|0.684|0.757
Relative|Multiple myeloma|2015–2019|Males|4|65–69|0.741|0.706|0.773
Relative|Multiple myeloma|2015–2019|Males|4|70–74|0.648|0.61|0.684
Relative|Multiple myeloma|2015–2019|Males|4|75–79|0.577|0.535|0.618
Relative|Multiple myeloma|2015–2019|Males|4|80–84|0.441|0.391|0.491
Relative|Multiple myeloma|2015–2019|Males|4|85+|0.292|0.237|0.353
Relative|Multiple myeloma|2015–2019|Males|4|All ages combined|0.636|0.621|0.651
Relative|Multiple myeloma|2015–2019|Males|5|00–04|||
Relative|Multiple myeloma|2015–2019|Males|5|05–09|||
Relative|Multiple myeloma|2015–2019|Males|5|10–14|||
Relative|Multiple myeloma|2015–2019|Males|5|15–19|||
Relative|Multiple myeloma|2015–2019|Males|5|20–24|||
Relative|Multiple myeloma|2015–2019|Males|5|25–29|||
Relative|Multiple myeloma|2015–2019|Males|5|30–34|||
Relative|Multiple myeloma|2015–2019|Males|5|35–39|0.783|0.59|0.894
Relative|Multiple myeloma|2015–2019|Males|5|40–44|0.736|0.624|0.821
Relative|Multiple myeloma|2015–2019|Males|5|45–49|0.767|0.689|0.828
Relative|Multiple myeloma|2015–2019|Males|5|50–54|0.7|0.64|0.753
Relative|Multiple myeloma|2015–2019|Males|5|55–59|0.733|0.686|0.774
Relative|Multiple myeloma|2015–2019|Males|5|60–64|0.654|0.614|0.692
Relative|Multiple myeloma|2015–2019|Males|5|65–69|0.684|0.646|0.72
Relative|Multiple myeloma|2015–2019|Males|5|70–74|0.568|0.527|0.607
Relative|Multiple myeloma|2015–2019|Males|5|75–79|0.48|0.436|0.525
Relative|Multiple myeloma|2015–2019|Males|5|80–84|0.384|0.333|0.437
Relative|Multiple myeloma|2015–2019|Males|5|85+|0.235|0.179|0.301
Relative|Multiple myeloma|2015–2019|Males|5|All ages combined|0.574|0.558|0.59
Observed|Multiple myeloma|2015–2019|Females|1|00–04|||
Observed|Multiple myeloma|2015–2019|Females|1|05–09|||
Observed|Multiple myeloma|2015–2019|Females|1|10–14|||
Observed|Multiple myeloma|2015–2019|Females|1|15–19|||
Observed|Multiple myeloma|2015–2019|Females|1|20–24|||
Observed|Multiple myeloma|2015–2019|Females|1|25–29|||
Observed|Multiple myeloma|2015–2019|Females|1|30–34|||
Observed|Multiple myeloma|2015–2019|Females|1|35–39|0.914|0.698|0.978
Observed|Multiple myeloma|2015–2019|Females|1|40–44|0.946|0.862|0.979
Observed|Multiple myeloma|2015–2019|Females|1|45–49|0.977|0.929|0.992
Observed|Multiple myeloma|2015–2019|Females|1|50–54|0.942|0.901|0.967
Observed|Multiple myeloma|2015–2019|Females|1|55–59|0.927|0.892|0.951
Observed|Multiple myeloma|2015–2019|Females|1|60–64|0.937|0.911|0.956
Observed|Multiple myeloma|2015–2019|Females|1|65–69|0.906|0.88|0.926
Observed|Multiple myeloma|2015–2019|Females|1|70–74|0.893|0.866|0.914
Observed|Multiple myeloma|2015–2019|Females|1|75–79|0.809|0.775|0.839
Observed|Multiple myeloma|2015–2019|Females|1|80–84|0.729|0.688|0.765
Observed|Multiple myeloma|2015–2019|Females|1|85+|0.5|0.455|0.543
Observed|Multiple myeloma|2015–2019|Females|1|All ages combined|0.83|0.818|0.841
Observed|Multiple myeloma|2015–2019|Females|2|00–04|||
Observed|Multiple myeloma|2015–2019|Females|2|05–09|||
Observed|Multiple myeloma|2015–2019|Females|2|10–14|||
Observed|Multiple myeloma|2015–2019|Females|2|15–19|||
Observed|Multiple myeloma|2015–2019|Females|2|20–24|||
Observed|Multiple myeloma|2015–2019|Females|2|25–29|||
Observed|Multiple myeloma|2015–2019|Females|2|30–34|||
Observed|Multiple myeloma|2015–2019|Females|2|35–39|0.914|0.698|0.978
Observed|Multiple myeloma|2015–2019|Females|2|40–44|0.905|0.811|0.954
Observed|Multiple myeloma|2015–2019|Females|2|45–49|0.944|0.886|0.973
Observed|Multiple myeloma|2015–2019|Females|2|50–54|0.895|0.844|0.929
Observed|Multiple myeloma|2015–2019|Females|2|55–59|0.876|0.835|0.908
Observed|Multiple myeloma|2015–2019|Females|2|60–64|0.885|0.852|0.911
Observed|Multiple myeloma|2015–2019|Females|2|65–69|0.847|0.816|0.873
Observed|Multiple myeloma|2015–2019|Females|2|70–74|0.803|0.769|0.832
Observed|Multiple myeloma|2015–2019|Females|2|75–79|0.69|0.651|0.726
Observed|Multiple myeloma|2015–2019|Females|2|80–84|0.572|0.528|0.613
Observed|Multiple myeloma|2015–2019|Females|2|85+|0.358|0.316|0.4
Observed|Multiple myeloma|2015–2019|Females|2|All ages combined|0.738|0.724|0.751
Observed|Multiple myeloma|2015–2019|Females|3|00–04|||
Observed|Multiple myeloma|2015–2019|Females|3|05–09|||
Observed|Multiple myeloma|2015–2019|Females|3|10–14|||
Observed|Multiple myeloma|2015–2019|Females|3|15–19|||
Observed|Multiple myeloma|2015–2019|Females|3|20–24|||
Observed|Multiple myeloma|2015–2019|Females|3|25–29|||
Observed|Multiple myeloma|2015–2019|Females|3|30–34|||
Observed|Multiple myeloma|2015–2019|Females|3|35–39|0.874|0.658|0.957
Observed|Multiple myeloma|2015–2019|Females|3|40–44|0.85|0.745|0.914
Observed|Multiple myeloma|2015–2019|Females|3|45–49|0.902|0.833|0.943
Observed|Multiple myeloma|2015–2019|Females|3|50–54|0.845|0.787|0.887
Observed|Multiple myeloma|2015–2019|Females|3|55–59|0.825|0.778|0.863
Observed|Multiple myeloma|2015–2019|Females|3|60–64|0.829|0.79|0.861
Observed|Multiple myeloma|2015–2019|Females|3|65–69|0.769|0.733|0.801
Observed|Multiple myeloma|2015–2019|Females|3|70–74|0.705|0.667|0.74
Observed|Multiple myeloma|2015–2019|Females|3|75–79|0.602|0.56|0.641
Observed|Multiple myeloma|2015–2019|Females|3|80–84|0.442|0.398|0.485
Observed|Multiple myeloma|2015–2019|Females|3|85+|0.252|0.214|0.292
Observed|Multiple myeloma|2015–2019|Females|3|All ages combined|0.653|0.638|0.668
Observed|Multiple myeloma|2015–2019|Females|4|00–04|||
Observed|Multiple myeloma|2015–2019|Females|4|05–09|||
Observed|Multiple myeloma|2015–2019|Females|4|10–14|||
Observed|Multiple myeloma|2015–2019|Females|4|15–19|||
Observed|Multiple myeloma|2015–2019|Females|4|20–24|||
Observed|Multiple myeloma|2015–2019|Females|4|25–29|||
Observed|Multiple myeloma|2015–2019|Females|4|30–34|||
Observed|Multiple myeloma|2015–2019|Females|4|35–39|0.874|0.658|0.957
Observed|Multiple myeloma|2015–2019|Females|4|40–44|0.85|0.745|0.914
Observed|Multiple myeloma|2015–2019|Females|4|45–49|0.865|0.79|0.915
Observed|Multiple myeloma|2015–2019|Females|4|50–54|0.795|0.733|0.845
Observed|Multiple myeloma|2015–2019|Females|4|55–59|0.774|0.723|0.816
Observed|Multiple myeloma|2015–2019|Females|4|60–64|0.757|0.713|0.795
Observed|Multiple myeloma|2015–2019|Females|4|65–69|0.72|0.681|0.755
Observed|Multiple myeloma|2015–2019|Females|4|70–74|0.611|0.57|0.65
Observed|Multiple myeloma|2015–2019|Females|4|75–79|0.492|0.45|0.533
Observed|Multiple myeloma|2015–2019|Females|4|80–84|0.352|0.31|0.394
Observed|Multiple myeloma|2015–2019|Females|4|85+|0.196|0.161|0.233
Observed|Multiple myeloma|2015–2019|Females|4|All ages combined|0.582|0.566|0.597
Observed|Multiple myeloma|2015–2019|Females|5|00–04|||
Observed|Multiple myeloma|2015–2019|Females|5|05–09|||
Observed|Multiple myeloma|2015–2019|Females|5|10–14|||
Observed|Multiple myeloma|2015–2019|Females|5|15–19|||
Observed|Multiple myeloma|2015–2019|Females|5|20–24|||
Observed|Multiple myeloma|2015–2019|Females|5|25–29|||
Observed|Multiple myeloma|2015–2019|Females|5|30–34|||
Observed|Multiple myeloma|2015–2019|Females|5|35–39|0.833|0.615|0.934
Observed|Multiple myeloma|2015–2019|Females|5|40–44|0.817|0.704|0.889
Observed|Multiple myeloma|2015–2019|Females|5|45–49|0.795|0.706|0.859
Observed|Multiple myeloma|2015–2019|Females|5|50–54|0.748|0.682|0.802
Observed|Multiple myeloma|2015–2019|Females|5|55–59|0.734|0.681|0.779
Observed|Multiple myeloma|2015–2019|Females|5|60–64|0.704|0.658|0.745
Observed|Multiple myeloma|2015–2019|Females|5|65–69|0.631|0.588|0.671
Observed|Multiple myeloma|2015–2019|Females|5|70–74|0.542|0.499|0.582
Observed|Multiple myeloma|2015–2019|Females|5|75–79|0.423|0.38|0.464
Observed|Multiple myeloma|2015–2019|Females|5|80–84|0.277|0.237|0.317
Observed|Multiple myeloma|2015–2019|Females|5|85+|0.133|0.103|0.167
Observed|Multiple myeloma|2015–2019|Females|5|All ages combined|0.517|0.5|0.533
Relative|Multiple myeloma|2015–2019|Females|1|00–04|||
Relative|Multiple myeloma|2015–2019|Females|1|05–09|||
Relative|Multiple myeloma|2015–2019|Females|1|10–14|||
Relative|Multiple myeloma|2015–2019|Females|1|15–19|||
Relative|Multiple myeloma|2015–2019|Females|1|20–24|||
Relative|Multiple myeloma|2015–2019|Females|1|25–29|||
Relative|Multiple myeloma|2015–2019|Females|1|30–34|||
Relative|Multiple myeloma|2015–2019|Females|1|35–39|0.915|0.698|0.978
Relative|Multiple myeloma|2015–2019|Females|1|40–44|0.947|0.863|0.98
Relative|Multiple myeloma|2015–2019|Females|1|45–49|0.978|0.93|0.994
Relative|Multiple myeloma|2015–2019|Females|1|50–54|0.944|0.903|0.969
Relative|Multiple myeloma|2015–2019|Females|1|55–59|0.93|0.895|0.954
Relative|Multiple myeloma|2015–2019|Females|1|60–64|0.942|0.916|0.961
Relative|Multiple myeloma|2015–2019|Females|1|65–69|0.912|0.886|0.933
Relative|Multiple myeloma|2015–2019|Females|1|70–74|0.904|0.877|0.926
Relative|Multiple myeloma|2015–2019|Females|1|75–79|0.827|0.792|0.857
Relative|Multiple myeloma|2015–2019|Females|1|80–84|0.76|0.718|0.798
Relative|Multiple myeloma|2015–2019|Females|1|85+|0.556|0.506|0.604
Relative|Multiple myeloma|2015–2019|Females|1|All ages combined|0.85|0.838|0.862
Relative|Multiple myeloma|2015–2019|Females|2|00–04|||
Relative|Multiple myeloma|2015–2019|Females|2|05–09|||
Relative|Multiple myeloma|2015–2019|Females|2|10–14|||
Relative|Multiple myeloma|2015–2019|Females|2|15–19|||
Relative|Multiple myeloma|2015–2019|Females|2|20–24|||
Relative|Multiple myeloma|2015–2019|Females|2|25–29|||
Relative|Multiple myeloma|2015–2019|Females|2|30–34|||
Relative|Multiple myeloma|2015–2019|Females|2|35–39|0.915|0.699|0.979
Relative|Multiple myeloma|2015–2019|Females|2|40–44|0.907|0.813|0.955
Relative|Multiple myeloma|2015–2019|Females|2|45–49|0.947|0.888|0.976
Relative|Multiple myeloma|2015–2019|Females|2|50–54|0.899|0.848|0.934
Relative|Multiple myeloma|2015–2019|Females|2|55–59|0.882|0.84|0.914
Relative|Multiple myeloma|2015–2019|Females|2|60–64|0.894|0.86|0.92
Relative|Multiple myeloma|2015–2019|Females|2|65–69|0.86|0.828|0.887
Relative|Multiple myeloma|2015–2019|Females|2|70–74|0.824|0.79|0.854
Relative|Multiple myeloma|2015–2019|Females|2|75–79|0.723|0.682|0.76
Relative|Multiple myeloma|2015–2019|Females|2|80–84|0.626|0.578|0.671
Relative|Multiple myeloma|2015–2019|Females|2|85+|0.445|0.393|0.498
Relative|Multiple myeloma|2015–2019|Females|2|All ages combined|0.773|0.758|0.787
Relative|Multiple myeloma|2015–2019|Females|3|00–04|||
Relative|Multiple myeloma|2015–2019|Females|3|05–09|||
Relative|Multiple myeloma|2015–2019|Females|3|10–14|||
Relative|Multiple myeloma|2015–2019|Females|3|15–19|||
Relative|Multiple myeloma|2015–2019|Females|3|20–24|||
Relative|Multiple myeloma|2015–2019|Females|3|25–29|||
Relative|Multiple myeloma|2015–2019|Females|3|30–34|||
Relative|Multiple myeloma|2015–2019|Females|3|35–39|0.876|0.66|0.959
Relative|Multiple myeloma|2015–2019|Females|3|40–44|0.853|0.748|0.917
Relative|Multiple myeloma|2015–2019|Females|3|45–49|0.906|0.837|0.947
Relative|Multiple myeloma|2015–2019|Females|3|50–54|0.85|0.793|0.894
Relative|Multiple myeloma|2015–2019|Females|3|55–59|0.833|0.786|0.871
Relative|Multiple myeloma|2015–2019|Females|3|60–64|0.841|0.802|0.874
Relative|Multiple myeloma|2015–2019|Females|3|65–69|0.788|0.751|0.821
Relative|Multiple myeloma|2015–2019|Females|3|70–74|0.735|0.695|0.771
Relative|Multiple myeloma|2015–2019|Females|3|75–79|0.648|0.604|0.69
Relative|Multiple myeloma|2015–2019|Females|3|80–84|0.512|0.461|0.561
Relative|Multiple myeloma|2015–2019|Females|3|85+|0.353|0.3|0.409
Relative|Multiple myeloma|2015–2019|Females|3|All ages combined|0.699|0.682|0.714
Relative|Multiple myeloma|2015–2019|Females|4|00–04|||
Relative|Multiple myeloma|2015–2019|Females|4|05–09|||
Relative|Multiple myeloma|2015–2019|Females|4|10–14|||
Relative|Multiple myeloma|2015–2019|Females|4|15–19|||
Relative|Multiple myeloma|2015–2019|Females|4|20–24|||
Relative|Multiple myeloma|2015–2019|Females|4|25–29|||
Relative|Multiple myeloma|2015–2019|Females|4|30–34|||
Relative|Multiple myeloma|2015–2019|Females|4|35–39|0.876|0.66|0.96
Relative|Multiple myeloma|2015–2019|Females|4|40–44|0.854|0.749|0.918
Relative|Multiple myeloma|2015–2019|Females|4|45–49|0.871|0.795|0.922
Relative|Multiple myeloma|2015–2019|Females|4|50–54|0.803|0.741|0.853
Relative|Multiple myeloma|2015–2019|Females|4|55–59|0.785|0.734|0.828
Relative|Multiple myeloma|2015–2019|Females|4|60–64|0.773|0.728|0.812
Relative|Multiple myeloma|2015–2019|Females|4|65–69|0.745|0.705|0.781
Relative|Multiple myeloma|2015–2019|Females|4|70–74|0.648|0.604|0.689
Relative|Multiple myeloma|2015–2019|Females|4|75–79|0.547|0.5|0.593
Relative|Multiple myeloma|2015–2019|Females|4|80–84|0.434|0.382|0.486
Relative|Multiple myeloma|2015–2019|Females|4|85+|0.313|0.258|0.373
Relative|Multiple myeloma|2015–2019|Females|4|All ages combined|0.636|0.618|0.653
Relative|Multiple myeloma|2015–2019|Females|5|00–04|||
Relative|Multiple myeloma|2015–2019|Females|5|05–09|||
Relative|Multiple myeloma|2015–2019|Females|5|10–14|||
Relative|Multiple myeloma|2015–2019|Females|5|15–19|||
Relative|Multiple myeloma|2015–2019|Females|5|20–24|||
Relative|Multiple myeloma|2015–2019|Females|5|25–29|||
Relative|Multiple myeloma|2015–2019|Females|5|30–34|||
Relative|Multiple myeloma|2015–2019|Females|5|35–39|0.836|0.617|0.937
Relative|Multiple myeloma|2015–2019|Females|5|40–44|0.821|0.708|0.894
Relative|Multiple myeloma|2015–2019|Females|5|45–49|0.801|0.712|0.866
Relative|Multiple myeloma|2015–2019|Females|5|50–54|0.758|0.691|0.813
Relative|Multiple myeloma|2015–2019|Females|5|55–59|0.748|0.694|0.794
Relative|Multiple myeloma|2015–2019|Females|5|60–64|0.724|0.676|0.767
Relative|Multiple myeloma|2015–2019|Females|5|65–69|0.66|0.616|0.702
Relative|Multiple myeloma|2015–2019|Females|5|70–74|0.586|0.539|0.63
Relative|Multiple myeloma|2015–2019|Females|5|75–79|0.487|0.438|0.535
Relative|Multiple myeloma|2015–2019|Females|5|80–84|0.367|0.314|0.421
Relative|Multiple myeloma|2015–2019|Females|5|85+|0.245|0.19|0.308
Relative|Multiple myeloma|2015–2019|Females|5|All ages combined|0.577|0.559|0.595
Observed|Multiple myeloma|2015–2019|Persons|1|00–04|||
Observed|Multiple myeloma|2015–2019|Persons|1|05–09|||
Observed|Multiple myeloma|2015–2019|Persons|1|10–14|||
Observed|Multiple myeloma|2015–2019|Persons|1|15–19|||
Observed|Multiple myeloma|2015–2019|Persons|1|20–24|||
Observed|Multiple myeloma|2015–2019|Persons|1|25–29|||
Observed|Multiple myeloma|2015–2019|Persons|1|30–34|0.961|0.754|0.994
Observed|Multiple myeloma|2015–2019|Persons|1|35–39|0.933|0.83|0.974
Observed|Multiple myeloma|2015–2019|Persons|1|40–44|0.948|0.899|0.974
Observed|Multiple myeloma|2015–2019|Persons|1|45–49|0.962|0.933|0.979
Observed|Multiple myeloma|2015–2019|Persons|1|50–54|0.941|0.916|0.958
Observed|Multiple myeloma|2015–2019|Persons|1|55–59|0.934|0.914|0.949
Observed|Multiple myeloma|2015–2019|Persons|1|60–64|0.929|0.913|0.943
Observed|Multiple myeloma|2015–2019|Persons|1|65–69|0.913|0.898|0.926
Observed|Multiple myeloma|2015–2019|Persons|1|70–74|0.878|0.861|0.893
Observed|Multiple myeloma|2015–2019|Persons|1|75–79|0.812|0.791|0.832
Observed|Multiple myeloma|2015–2019|Persons|1|80–84|0.724|0.697|0.748
Observed|Multiple myeloma|2015–2019|Persons|1|85+|0.518|0.488|0.548
Observed|Multiple myeloma|2015–2019|Persons|1|All ages combined|0.834|0.827|0.841
Observed|Multiple myeloma|2015–2019|Persons|2|00–04|||
Observed|Multiple myeloma|2015–2019|Persons|2|05–09|||
Observed|Multiple myeloma|2015–2019|Persons|2|10–14|||
Observed|Multiple myeloma|2015–2019|Persons|2|15–19|||
Observed|Multiple myeloma|2015–2019|Persons|2|20–24|||
Observed|Multiple myeloma|2015–2019|Persons|2|25–29|||
Observed|Multiple myeloma|2015–2019|Persons|2|30–34|0.918|0.709|0.979
Observed|Multiple myeloma|2015–2019|Persons|2|35–39|0.933|0.83|0.974
Observed|Multiple myeloma|2015–2019|Persons|2|40–44|0.897|0.838|0.936
Observed|Multiple myeloma|2015–2019|Persons|2|45–49|0.93|0.893|0.954
Observed|Multiple myeloma|2015–2019|Persons|2|50–54|0.893|0.863|0.917
Observed|Multiple myeloma|2015–2019|Persons|2|55–59|0.869|0.843|0.891
Observed|Multiple myeloma|2015–2019|Persons|2|60–64|0.86|0.838|0.879
Observed|Multiple myeloma|2015–2019|Persons|2|65–69|0.847|0.828|0.865
Observed|Multiple myeloma|2015–2019|Persons|2|70–74|0.788|0.767|0.807
Observed|Multiple myeloma|2015–2019|Persons|2|75–79|0.696|0.672|0.719
Observed|Multiple myeloma|2015–2019|Persons|2|80–84|0.568|0.539|0.595
Observed|Multiple myeloma|2015–2019|Persons|2|85+|0.361|0.333|0.39
Observed|Multiple myeloma|2015–2019|Persons|2|All ages combined|0.738|0.729|0.746
Observed|Multiple myeloma|2015–2019|Persons|3|00–04|||
Observed|Multiple myeloma|2015–2019|Persons|3|05–09|||
Observed|Multiple myeloma|2015–2019|Persons|3|10–14|||
Observed|Multiple myeloma|2015–2019|Persons|3|15–19|||
Observed|Multiple myeloma|2015–2019|Persons|3|20–24|||
Observed|Multiple myeloma|2015–2019|Persons|3|25–29|||
Observed|Multiple myeloma|2015–2019|Persons|3|30–34|0.876|0.662|0.958
Observed|Multiple myeloma|2015–2019|Persons|3|35–39|0.862|0.744|0.929
Observed|Multiple myeloma|2015–2019|Persons|3|40–44|0.826|0.757|0.877
Observed|Multiple myeloma|2015–2019|Persons|3|45–49|0.896|0.854|0.927
Observed|Multiple myeloma|2015–2019|Persons|3|50–54|0.834|0.798|0.864
Observed|Multiple myeloma|2015–2019|Persons|3|55–59|0.818|0.789|0.844
Observed|Multiple myeloma|2015–2019|Persons|3|60–64|0.796|0.771|0.818
Observed|Multiple myeloma|2015–2019|Persons|3|65–69|0.773|0.75|0.794
Observed|Multiple myeloma|2015–2019|Persons|3|70–74|0.699|0.674|0.721
Observed|Multiple myeloma|2015–2019|Persons|3|75–79|0.598|0.571|0.623
Observed|Multiple myeloma|2015–2019|Persons|3|80–84|0.441|0.412|0.47
Observed|Multiple myeloma|2015–2019|Persons|3|85+|0.251|0.225|0.278
Observed|Multiple myeloma|2015–2019|Persons|3|All ages combined|0.653|0.643|0.663
Observed|Multiple myeloma|2015–2019|Persons|4|00–04|||
Observed|Multiple myeloma|2015–2019|Persons|4|05–09|||
Observed|Multiple myeloma|2015–2019|Persons|4|10–14|||
Observed|Multiple myeloma|2015–2019|Persons|4|15–19|||
Observed|Multiple myeloma|2015–2019|Persons|4|20–24|||
Observed|Multiple myeloma|2015–2019|Persons|4|25–29|||
Observed|Multiple myeloma|2015–2019|Persons|4|30–34|||
Observed|Multiple myeloma|2015–2019|Persons|4|35–39|0.862|0.744|0.929
Observed|Multiple myeloma|2015–2019|Persons|4|40–44|0.806|0.734|0.86
Observed|Multiple myeloma|2015–2019|Persons|4|45–49|0.823|0.772|0.864
Observed|Multiple myeloma|2015–2019|Persons|4|50–54|0.765|0.724|0.8
Observed|Multiple myeloma|2015–2019|Persons|4|55–59|0.761|0.729|0.79
Observed|Multiple myeloma|2015–2019|Persons|4|60–64|0.72|0.692|0.745
Observed|Multiple myeloma|2015–2019|Persons|4|65–69|0.709|0.684|0.732
Observed|Multiple myeloma|2015–2019|Persons|4|70–74|0.599|0.573|0.624
Observed|Multiple myeloma|2015–2019|Persons|4|75–79|0.492|0.465|0.519
Observed|Multiple myeloma|2015–2019|Persons|4|80–84|0.339|0.311|0.367
Observed|Multiple myeloma|2015–2019|Persons|4|85+|0.179|0.156|0.204
Observed|Multiple myeloma|2015–2019|Persons|4|All ages combined|0.573|0.562|0.583
Observed|Multiple myeloma|2015–2019|Persons|5|00–04|||
Observed|Multiple myeloma|2015–2019|Persons|5|05–09|||
Observed|Multiple myeloma|2015–2019|Persons|5|10–14|||
Observed|Multiple myeloma|2015–2019|Persons|5|15–19|||
Observed|Multiple myeloma|2015–2019|Persons|5|20–24|||
Observed|Multiple myeloma|2015–2019|Persons|5|25–29|||
Observed|Multiple myeloma|2015–2019|Persons|5|30–34|||
Observed|Multiple myeloma|2015–2019|Persons|5|35–39|0.805|0.674|0.887
Observed|Multiple myeloma|2015–2019|Persons|5|40–44|0.77|0.694|0.829
Observed|Multiple myeloma|2015–2019|Persons|5|45–49|0.773|0.717|0.819
Observed|Multiple myeloma|2015–2019|Persons|5|50–54|0.713|0.67|0.751
Observed|Multiple myeloma|2015–2019|Persons|5|55–59|0.72|0.686|0.751
Observed|Multiple myeloma|2015–2019|Persons|5|60–64|0.655|0.626|0.683
Observed|Multiple myeloma|2015–2019|Persons|5|65–69|0.634|0.607|0.659
Observed|Multiple myeloma|2015–2019|Persons|5|70–74|0.519|0.491|0.546
Observed|Multiple myeloma|2015–2019|Persons|5|75–79|0.403|0.376|0.43
Observed|Multiple myeloma|2015–2019|Persons|5|80–84|0.268|0.241|0.295
Observed|Multiple myeloma|2015–2019|Persons|5|85+|0.121|0.101|0.143
Observed|Multiple myeloma|2015–2019|Persons|5|All ages combined|0.505|0.495|0.516
Relative|Multiple myeloma|2015–2019|Persons|1|00–04|||
Relative|Multiple myeloma|2015–2019|Persons|1|05–09|||
Relative|Multiple myeloma|2015–2019|Persons|1|10–14|||
Relative|Multiple myeloma|2015–2019|Persons|1|15–19|||
Relative|Multiple myeloma|2015–2019|Persons|1|20–24|||
Relative|Multiple myeloma|2015–2019|Persons|1|25–29|||
Relative|Multiple myeloma|2015–2019|Persons|1|30–34|0.962|0.754|0.995
Relative|Multiple myeloma|2015–2019|Persons|1|35–39|0.933|0.831|0.975
Relative|Multiple myeloma|2015–2019|Persons|1|40–44|0.949|0.9|0.975
Relative|Multiple myeloma|2015–2019|Persons|1|45–49|0.964|0.935|0.981
Relative|Multiple myeloma|2015–2019|Persons|1|50–54|0.944|0.919|0.961
Relative|Multiple myeloma|2015–2019|Persons|1|55–59|0.938|0.918|0.954
Relative|Multiple myeloma|2015–2019|Persons|1|60–64|0.936|0.919|0.949
Relative|Multiple myeloma|2015–2019|Persons|1|65–69|0.923|0.907|0.936
Relative|Multiple myeloma|2015–2019|Persons|1|70–74|0.893|0.875|0.908
Relative|Multiple myeloma|2015–2019|Persons|1|75–79|0.836|0.814|0.856
Relative|Multiple myeloma|2015–2019|Persons|1|80–84|0.763|0.735|0.789
Relative|Multiple myeloma|2015–2019|Persons|1|85+|0.584|0.55|0.617
Relative|Multiple myeloma|2015–2019|Persons|1|All ages combined|0.859|0.851|0.866
Relative|Multiple myeloma|2015–2019|Persons|2|00–04|||
Relative|Multiple myeloma|2015–2019|Persons|2|05–09|||
Relative|Multiple myeloma|2015–2019|Persons|2|10–14|||
Relative|Multiple myeloma|2015–2019|Persons|2|15–19|||
Relative|Multiple myeloma|2015–2019|Persons|2|20–24|||
Relative|Multiple myeloma|2015–2019|Persons|2|25–29|||
Relative|Multiple myeloma|2015–2019|Persons|2|30–34|0.919|0.71|0.98
Relative|Multiple myeloma|2015–2019|Persons|2|35–39|0.934|0.832|0.976
Relative|Multiple myeloma|2015–2019|Persons|2|40–44|0.9|0.84|0.938
Relative|Multiple myeloma|2015–2019|Persons|2|45–49|0.934|0.897|0.958
Relative|Multiple myeloma|2015–2019|Persons|2|50–54|0.899|0.868|0.923
Relative|Multiple myeloma|2015–2019|Persons|2|55–59|0.877|0.851|0.899
Relative|Multiple myeloma|2015–2019|Persons|2|60–64|0.872|0.85|0.891
Relative|Multiple myeloma|2015–2019|Persons|2|65–69|0.865|0.846|0.883
Relative|Multiple myeloma|2015–2019|Persons|2|70–74|0.816|0.794|0.836
Relative|Multiple myeloma|2015–2019|Persons|2|75–79|0.74|0.714|0.765
Relative|Multiple myeloma|2015–2019|Persons|2|80–84|0.635|0.603|0.666
Relative|Multiple myeloma|2015–2019|Persons|2|85+|0.462|0.425|0.498
Relative|Multiple myeloma|2015–2019|Persons|2|All ages combined|0.779|0.77|0.788
Relative|Multiple myeloma|2015–2019|Persons|3|00–04|||
Relative|Multiple myeloma|2015–2019|Persons|3|05–09|||
Relative|Multiple myeloma|2015–2019|Persons|3|10–14|||
Relative|Multiple myeloma|2015–2019|Persons|3|15–19|||
Relative|Multiple myeloma|2015–2019|Persons|3|20–24|||
Relative|Multiple myeloma|2015–2019|Persons|3|25–29|||
Relative|Multiple myeloma|2015–2019|Persons|3|30–34|0.878|0.664|0.96
Relative|Multiple myeloma|2015–2019|Persons|3|35–39|0.865|0.746|0.932
Relative|Multiple myeloma|2015–2019|Persons|3|40–44|0.83|0.76|0.881
Relative|Multiple myeloma|2015–2019|Persons|3|45–49|0.902|0.86|0.933
Relative|Multiple myeloma|2015–2019|Persons|3|50–54|0.842|0.806|0.873
Relative|Multiple myeloma|2015–2019|Persons|3|55–59|0.83|0.8|0.856
Relative|Multiple myeloma|2015–2019|Persons|3|60–64|0.813|0.788|0.836
Relative|Multiple myeloma|2015–2019|Persons|3|65–69|0.799|0.776|0.821
Relative|Multiple myeloma|2015–2019|Persons|3|70–74|0.738|0.713|0.762
Relative|Multiple myeloma|2015–2019|Persons|3|75–79|0.659|0.63|0.687
Relative|Multiple myeloma|2015–2019|Persons|3|80–84|0.527|0.493|0.562
Relative|Multiple myeloma|2015–2019|Persons|3|85+|0.368|0.33|0.407
Relative|Multiple myeloma|2015–2019|Persons|3|All ages combined|0.708|0.697|0.718
Relative|Multiple myeloma|2015–2019|Persons|4|00–04|||
Relative|Multiple myeloma|2015–2019|Persons|4|05–09|||
Relative|Multiple myeloma|2015–2019|Persons|4|10–14|||
Relative|Multiple myeloma|2015–2019|Persons|4|15–19|||
Relative|Multiple myeloma|2015–2019|Persons|4|20–24|||
Relative|Multiple myeloma|2015–2019|Persons|4|25–29|||
Relative|Multiple myeloma|2015–2019|Persons|4|30–34|||
Relative|Multiple myeloma|2015–2019|Persons|4|35–39|0.866|0.747|0.933
Relative|Multiple myeloma|2015–2019|Persons|4|40–44|0.811|0.739|0.865
Relative|Multiple myeloma|2015–2019|Persons|4|45–49|0.831|0.779|0.872
Relative|Multiple myeloma|2015–2019|Persons|4|50–54|0.775|0.734|0.811
Relative|Multiple myeloma|2015–2019|Persons|4|55–59|0.777|0.744|0.806
Relative|Multiple myeloma|2015–2019|Persons|4|60–64|0.742|0.714|0.768
Relative|Multiple myeloma|2015–2019|Persons|4|65–69|0.743|0.717|0.767
Relative|Multiple myeloma|2015–2019|Persons|4|70–74|0.648|0.62|0.675
Relative|Multiple myeloma|2015–2019|Persons|4|75–79|0.565|0.533|0.595
Relative|Multiple myeloma|2015–2019|Persons|4|80–84|0.438|0.402|0.474
Relative|Multiple myeloma|2015–2019|Persons|4|85+|0.305|0.265|0.347
Relative|Multiple myeloma|2015–2019|Persons|4|All ages combined|0.636|0.625|0.647
Relative|Multiple myeloma|2015–2019|Persons|5|00–04|||
Relative|Multiple myeloma|2015–2019|Persons|5|05–09|||
Relative|Multiple myeloma|2015–2019|Persons|5|10–14|||
Relative|Multiple myeloma|2015–2019|Persons|5|15–19|||
Relative|Multiple myeloma|2015–2019|Persons|5|20–24|||
Relative|Multiple myeloma|2015–2019|Persons|5|25–29|||
Relative|Multiple myeloma|2015–2019|Persons|5|30–34|||
Relative|Multiple myeloma|2015–2019|Persons|5|35–39|0.809|0.678|0.892
Relative|Multiple myeloma|2015–2019|Persons|5|40–44|0.776|0.699|0.835
Relative|Multiple myeloma|2015–2019|Persons|5|45–49|0.782|0.726|0.829
Relative|Multiple myeloma|2015–2019|Persons|5|50–54|0.725|0.681|0.765
Relative|Multiple myeloma|2015–2019|Persons|5|55–59|0.739|0.705|0.771
Relative|Multiple myeloma|2015–2019|Persons|5|60–64|0.681|0.651|0.71
Relative|Multiple myeloma|2015–2019|Persons|5|65–69|0.674|0.645|0.701
Relative|Multiple myeloma|2015–2019|Persons|5|70–74|0.576|0.545|0.605
Relative|Multiple myeloma|2015–2019|Persons|5|75–79|0.484|0.451|0.517
Relative|Multiple myeloma|2015–2019|Persons|5|80–84|0.376|0.339|0.414
Relative|Multiple myeloma|2015–2019|Persons|5|85+|0.242|0.201|0.286
Relative|Multiple myeloma|2015–2019|Persons|5|All ages combined|0.576|0.564|0.587
Observed|Myelodysplastic syndromes|2015–2019|Males|1|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Males|1|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Males|1|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Males|1|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Males|1|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Males|1|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Males|1|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Males|1|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Males|1|40–44|0.861|0.63|0.953
Observed|Myelodysplastic syndromes|2015–2019|Males|1|45–49|0.764|0.607|0.865
Observed|Myelodysplastic syndromes|2015–2019|Males|1|50–54|0.824|0.704|0.898
Observed|Myelodysplastic syndromes|2015–2019|Males|1|55–59|0.835|0.761|0.888
Observed|Myelodysplastic syndromes|2015–2019|Males|1|60–64|0.799|0.743|0.844
Observed|Myelodysplastic syndromes|2015–2019|Males|1|65–69|0.81|0.772|0.842
Observed|Myelodysplastic syndromes|2015–2019|Males|1|70–74|0.773|0.739|0.803
Observed|Myelodysplastic syndromes|2015–2019|Males|1|75–79|0.764|0.734|0.792
Observed|Myelodysplastic syndromes|2015–2019|Males|1|80–84|0.682|0.65|0.711
Observed|Myelodysplastic syndromes|2015–2019|Males|1|85+|0.532|0.501|0.563
Observed|Myelodysplastic syndromes|2015–2019|Males|1|All ages combined|0.709|0.696|0.722
Observed|Myelodysplastic syndromes|2015–2019|Males|2|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Males|2|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Males|2|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Males|2|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Males|2|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Males|2|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Males|2|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Males|2|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Males|2|40–44|||
Observed|Myelodysplastic syndromes|2015–2019|Males|2|45–49|0.661|0.495|0.784
Observed|Myelodysplastic syndromes|2015–2019|Males|2|50–54|0.711|0.581|0.807
Observed|Myelodysplastic syndromes|2015–2019|Males|2|55–59|0.731|0.644|0.8
Observed|Myelodysplastic syndromes|2015–2019|Males|2|60–64|0.673|0.611|0.728
Observed|Myelodysplastic syndromes|2015–2019|Males|2|65–69|0.639|0.594|0.68
Observed|Myelodysplastic syndromes|2015–2019|Males|2|70–74|0.611|0.573|0.647
Observed|Myelodysplastic syndromes|2015–2019|Males|2|75–79|0.611|0.577|0.643
Observed|Myelodysplastic syndromes|2015–2019|Males|2|80–84|0.485|0.451|0.517
Observed|Myelodysplastic syndromes|2015–2019|Males|2|85+|0.351|0.322|0.381
Observed|Myelodysplastic syndromes|2015–2019|Males|2|All ages combined|0.542|0.527|0.557
Observed|Myelodysplastic syndromes|2015–2019|Males|3|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Males|3|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Males|3|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Males|3|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Males|3|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Males|3|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Males|3|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Males|3|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Males|3|40–44|||
Observed|Myelodysplastic syndromes|2015–2019|Males|3|45–49|0.604|0.435|0.737
Observed|Myelodysplastic syndromes|2015–2019|Males|3|50–54|0.64|0.505|0.746
Observed|Myelodysplastic syndromes|2015–2019|Males|3|55–59|0.665|0.573|0.742
Observed|Myelodysplastic syndromes|2015–2019|Males|3|60–64|0.589|0.525|0.647
Observed|Myelodysplastic syndromes|2015–2019|Males|3|65–69|0.554|0.509|0.597
Observed|Myelodysplastic syndromes|2015–2019|Males|3|70–74|0.494|0.456|0.532
Observed|Myelodysplastic syndromes|2015–2019|Males|3|75–79|0.451|0.416|0.485
Observed|Myelodysplastic syndromes|2015–2019|Males|3|80–84|0.357|0.325|0.389
Observed|Myelodysplastic syndromes|2015–2019|Males|3|85+|0.229|0.204|0.255
Observed|Myelodysplastic syndromes|2015–2019|Males|3|All ages combined|0.423|0.408|0.438
Observed|Myelodysplastic syndromes|2015–2019|Males|4|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Males|4|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Males|4|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Males|4|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Males|4|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Males|4|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Males|4|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Males|4|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Males|4|40–44|||
Observed|Myelodysplastic syndromes|2015–2019|Males|4|45–49|0.58|0.413|0.715
Observed|Myelodysplastic syndromes|2015–2019|Males|4|50–54|0.592|0.459|0.703
Observed|Myelodysplastic syndromes|2015–2019|Males|4|55–59|0.579|0.483|0.663
Observed|Myelodysplastic syndromes|2015–2019|Males|4|60–64|0.519|0.455|0.579
Observed|Myelodysplastic syndromes|2015–2019|Males|4|65–69|0.485|0.44|0.528
Observed|Myelodysplastic syndromes|2015–2019|Males|4|70–74|0.397|0.36|0.435
Observed|Myelodysplastic syndromes|2015–2019|Males|4|75–79|0.35|0.317|0.384
Observed|Myelodysplastic syndromes|2015–2019|Males|4|80–84|0.279|0.25|0.309
Observed|Myelodysplastic syndromes|2015–2019|Males|4|85+|0.145|0.124|0.168
Observed|Myelodysplastic syndromes|2015–2019|Males|4|All ages combined|0.34|0.326|0.354
Observed|Myelodysplastic syndromes|2015–2019|Males|5|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Males|5|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Males|5|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Males|5|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Males|5|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Males|5|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Males|5|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Males|5|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Males|5|40–44|||
Observed|Myelodysplastic syndromes|2015–2019|Males|5|45–49|0.532|0.368|0.671
Observed|Myelodysplastic syndromes|2015–2019|Males|5|50–54|0.55|0.419|0.664
Observed|Myelodysplastic syndromes|2015–2019|Males|5|55–59|0.529|0.433|0.617
Observed|Myelodysplastic syndromes|2015–2019|Males|5|60–64|0.445|0.383|0.505
Observed|Myelodysplastic syndromes|2015–2019|Males|5|65–69|0.422|0.377|0.465
Observed|Myelodysplastic syndromes|2015–2019|Males|5|70–74|0.337|0.3|0.373
Observed|Myelodysplastic syndromes|2015–2019|Males|5|75–79|0.283|0.251|0.316
Observed|Myelodysplastic syndromes|2015–2019|Males|5|80–84|0.213|0.186|0.241
Observed|Myelodysplastic syndromes|2015–2019|Males|5|85+|0.096|0.078|0.116
Observed|Myelodysplastic syndromes|2015–2019|Males|5|All ages combined|0.281|0.267|0.295
Relative|Myelodysplastic syndromes|2015–2019|Males|1|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Males|1|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Males|1|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Males|1|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Males|1|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Males|1|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Males|1|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Males|1|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Males|1|40–44|0.863|0.631|0.955
Relative|Myelodysplastic syndromes|2015–2019|Males|1|45–49|0.766|0.608|0.867
Relative|Myelodysplastic syndromes|2015–2019|Males|1|50–54|0.827|0.707|0.901
Relative|Myelodysplastic syndromes|2015–2019|Males|1|55–59|0.84|0.765|0.893
Relative|Myelodysplastic syndromes|2015–2019|Males|1|60–64|0.805|0.749|0.851
Relative|Myelodysplastic syndromes|2015–2019|Males|1|65–69|0.82|0.782|0.852
Relative|Myelodysplastic syndromes|2015–2019|Males|1|70–74|0.788|0.754|0.819
Relative|Myelodysplastic syndromes|2015–2019|Males|1|75–79|0.791|0.76|0.819
Relative|Myelodysplastic syndromes|2015–2019|Males|1|80–84|0.725|0.692|0.756
Relative|Myelodysplastic syndromes|2015–2019|Males|1|85+|0.616|0.579|0.651
Relative|Myelodysplastic syndromes|2015–2019|Males|1|All ages combined|0.749|0.735|0.763
Relative|Myelodysplastic syndromes|2015–2019|Males|2|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Males|2|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Males|2|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Males|2|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Males|2|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Males|2|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Males|2|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Males|2|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Males|2|40–44|||
Relative|Myelodysplastic syndromes|2015–2019|Males|2|45–49|0.664|0.498|0.787
Relative|Myelodysplastic syndromes|2015–2019|Males|2|50–54|0.716|0.585|0.813
Relative|Myelodysplastic syndromes|2015–2019|Males|2|55–59|0.739|0.651|0.809
Relative|Myelodysplastic syndromes|2015–2019|Males|2|60–64|0.685|0.621|0.741
Relative|Myelodysplastic syndromes|2015–2019|Males|2|65–69|0.656|0.61|0.698
Relative|Myelodysplastic syndromes|2015–2019|Males|2|70–74|0.637|0.597|0.675
Relative|Myelodysplastic syndromes|2015–2019|Males|2|75–79|0.657|0.62|0.692
Relative|Myelodysplastic syndromes|2015–2019|Males|2|80–84|0.552|0.514|0.589
Relative|Myelodysplastic syndromes|2015–2019|Males|2|85+|0.474|0.434|0.514
Relative|Myelodysplastic syndromes|2015–2019|Males|2|All ages combined|0.604|0.587|0.62
Relative|Myelodysplastic syndromes|2015–2019|Males|3|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Males|3|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Males|3|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Males|3|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Males|3|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Males|3|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Males|3|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Males|3|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Males|3|40–44|||
Relative|Myelodysplastic syndromes|2015–2019|Males|3|45–49|0.609|0.439|0.742
Relative|Myelodysplastic syndromes|2015–2019|Males|3|50–54|0.647|0.511|0.755
Relative|Myelodysplastic syndromes|2015–2019|Males|3|55–59|0.677|0.583|0.755
Relative|Myelodysplastic syndromes|2015–2019|Males|3|60–64|0.605|0.539|0.665
Relative|Myelodysplastic syndromes|2015–2019|Males|3|65–69|0.577|0.53|0.622
Relative|Myelodysplastic syndromes|2015–2019|Males|3|70–74|0.528|0.487|0.568
Relative|Myelodysplastic syndromes|2015–2019|Males|3|75–79|0.506|0.467|0.545
Relative|Myelodysplastic syndromes|2015–2019|Males|3|80–84|0.439|0.4|0.478
Relative|Myelodysplastic syndromes|2015–2019|Males|3|85+|0.365|0.325|0.407
Relative|Myelodysplastic syndromes|2015–2019|Males|3|All ages combined|0.497|0.479|0.514
Relative|Myelodysplastic syndromes|2015–2019|Males|4|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Males|4|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Males|4|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Males|4|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Males|4|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Males|4|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Males|4|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Males|4|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Males|4|40–44|||
Relative|Myelodysplastic syndromes|2015–2019|Males|4|45–49|0.586|0.417|0.723
Relative|Myelodysplastic syndromes|2015–2019|Males|4|50–54|0.602|0.466|0.715
Relative|Myelodysplastic syndromes|2015–2019|Males|4|55–59|0.593|0.495|0.679
Relative|Myelodysplastic syndromes|2015–2019|Males|4|60–64|0.538|0.472|0.6
Relative|Myelodysplastic syndromes|2015–2019|Males|4|65–69|0.513|0.466|0.559
Relative|Myelodysplastic syndromes|2015–2019|Males|4|70–74|0.436|0.395|0.477
Relative|Myelodysplastic syndromes|2015–2019|Males|4|75–79|0.413|0.373|0.453
Relative|Myelodysplastic syndromes|2015–2019|Males|4|80–84|0.375|0.335|0.416
Relative|Myelodysplastic syndromes|2015–2019|Males|4|85+|0.277|0.237|0.321
Relative|Myelodysplastic syndromes|2015–2019|Males|4|All ages combined|0.421|0.404|0.439
Relative|Myelodysplastic syndromes|2015–2019|Males|5|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Males|5|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Males|5|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Males|5|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Males|5|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Males|5|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Males|5|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Males|5|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Males|5|40–44|||
Relative|Myelodysplastic syndromes|2015–2019|Males|5|45–49|0.539|0.373|0.681
Relative|Myelodysplastic syndromes|2015–2019|Males|5|50–54|0.562|0.428|0.678
Relative|Myelodysplastic syndromes|2015–2019|Males|5|55–59|0.546|0.447|0.637
Relative|Myelodysplastic syndromes|2015–2019|Males|5|60–64|0.467|0.402|0.53
Relative|Myelodysplastic syndromes|2015–2019|Males|5|65–69|0.455|0.407|0.502
Relative|Myelodysplastic syndromes|2015–2019|Males|5|70–74|0.381|0.339|0.422
Relative|Myelodysplastic syndromes|2015–2019|Males|5|75–79|0.353|0.313|0.394
Relative|Myelodysplastic syndromes|2015–2019|Males|5|80–84|0.316|0.276|0.358
Relative|Myelodysplastic syndromes|2015–2019|Males|5|85+|0.222|0.181|0.268
Relative|Myelodysplastic syndromes|2015–2019|Males|5|All ages combined|0.366|0.349|0.384
Observed|Myelodysplastic syndromes|2015–2019|Females|1|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Females|1|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Females|1|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Females|1|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Females|1|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Females|1|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Females|1|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Females|1|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Females|1|40–44|0.921|0.719|0.98
Observed|Myelodysplastic syndromes|2015–2019|Females|1|45–49|0.911|0.75|0.97
Observed|Myelodysplastic syndromes|2015–2019|Females|1|50–54|0.805|0.677|0.887
Observed|Myelodysplastic syndromes|2015–2019|Females|1|55–59|0.859|0.77|0.916
Observed|Myelodysplastic syndromes|2015–2019|Females|1|60–64|0.818|0.744|0.872
Observed|Myelodysplastic syndromes|2015–2019|Females|1|65–69|0.823|0.773|0.863
Observed|Myelodysplastic syndromes|2015–2019|Females|1|70–74|0.791|0.745|0.829
Observed|Myelodysplastic syndromes|2015–2019|Females|1|75–79|0.787|0.745|0.823
Observed|Myelodysplastic syndromes|2015–2019|Females|1|80–84|0.697|0.653|0.738
Observed|Myelodysplastic syndromes|2015–2019|Females|1|85+|0.553|0.516|0.589
Observed|Myelodysplastic syndromes|2015–2019|Females|1|All ages combined|0.724|0.706|0.741
Observed|Myelodysplastic syndromes|2015–2019|Females|2|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Females|2|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Females|2|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Females|2|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Females|2|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Females|2|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Females|2|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Females|2|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Females|2|40–44|0.85|0.648|0.941
Observed|Myelodysplastic syndromes|2015–2019|Females|2|45–49|0.849|0.674|0.934
Observed|Myelodysplastic syndromes|2015–2019|Females|2|50–54|0.768|0.634|0.858
Observed|Myelodysplastic syndromes|2015–2019|Females|2|55–59|0.748|0.649|0.823
Observed|Myelodysplastic syndromes|2015–2019|Females|2|60–64|0.665|0.581|0.737
Observed|Myelodysplastic syndromes|2015–2019|Females|2|65–69|0.708|0.65|0.758
Observed|Myelodysplastic syndromes|2015–2019|Females|2|70–74|0.646|0.595|0.693
Observed|Myelodysplastic syndromes|2015–2019|Females|2|75–79|0.663|0.616|0.706
Observed|Myelodysplastic syndromes|2015–2019|Females|2|80–84|0.539|0.492|0.584
Observed|Myelodysplastic syndromes|2015–2019|Females|2|85+|0.363|0.329|0.398
Observed|Myelodysplastic syndromes|2015–2019|Females|2|All ages combined|0.576|0.557|0.595
Observed|Myelodysplastic syndromes|2015–2019|Females|3|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Females|3|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Females|3|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Females|3|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Females|3|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Females|3|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Females|3|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Females|3|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Females|3|40–44|0.816|0.613|0.919
Observed|Myelodysplastic syndromes|2015–2019|Females|3|45–49|0.786|0.602|0.892
Observed|Myelodysplastic syndromes|2015–2019|Females|3|50–54|0.679|0.539|0.784
Observed|Myelodysplastic syndromes|2015–2019|Females|3|55–59|0.678|0.576|0.761
Observed|Myelodysplastic syndromes|2015–2019|Females|3|60–64|0.553|0.469|0.63
Observed|Myelodysplastic syndromes|2015–2019|Females|3|65–69|0.596|0.534|0.653
Observed|Myelodysplastic syndromes|2015–2019|Females|3|70–74|0.542|0.489|0.592
Observed|Myelodysplastic syndromes|2015–2019|Females|3|75–79|0.558|0.509|0.604
Observed|Myelodysplastic syndromes|2015–2019|Females|3|80–84|0.453|0.406|0.497
Observed|Myelodysplastic syndromes|2015–2019|Females|3|85+|0.248|0.218|0.28
Observed|Myelodysplastic syndromes|2015–2019|Females|3|All ages combined|0.475|0.455|0.494
Observed|Myelodysplastic syndromes|2015–2019|Females|4|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Females|4|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Females|4|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Females|4|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Females|4|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Females|4|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Females|4|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Females|4|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Females|4|40–44|0.816|0.613|0.919
Observed|Myelodysplastic syndromes|2015–2019|Females|4|45–49|0.753|0.565|0.868
Observed|Myelodysplastic syndromes|2015–2019|Females|4|50–54|0.642|0.502|0.752
Observed|Myelodysplastic syndromes|2015–2019|Females|4|55–59|0.606|0.502|0.696
Observed|Myelodysplastic syndromes|2015–2019|Females|4|60–64|0.501|0.419|0.578
Observed|Myelodysplastic syndromes|2015–2019|Females|4|65–69|0.532|0.467|0.592
Observed|Myelodysplastic syndromes|2015–2019|Females|4|70–74|0.475|0.422|0.526
Observed|Myelodysplastic syndromes|2015–2019|Females|4|75–79|0.479|0.43|0.527
Observed|Myelodysplastic syndromes|2015–2019|Females|4|80–84|0.357|0.314|0.401
Observed|Myelodysplastic syndromes|2015–2019|Females|4|85+|0.17|0.144|0.198
Observed|Myelodysplastic syndromes|2015–2019|Females|4|All ages combined|0.399|0.38|0.418
Observed|Myelodysplastic syndromes|2015–2019|Females|5|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Females|5|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Females|5|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Females|5|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Females|5|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Females|5|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Females|5|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Females|5|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Females|5|40–44|||
Observed|Myelodysplastic syndromes|2015–2019|Females|5|45–49|0.684|0.492|0.817
Observed|Myelodysplastic syndromes|2015–2019|Females|5|50–54|0.588|0.448|0.704
Observed|Myelodysplastic syndromes|2015–2019|Females|5|55–59|0.576|0.472|0.667
Observed|Myelodysplastic syndromes|2015–2019|Females|5|60–64|0.458|0.378|0.534
Observed|Myelodysplastic syndromes|2015–2019|Females|5|65–69|0.47|0.405|0.532
Observed|Myelodysplastic syndromes|2015–2019|Females|5|70–74|0.415|0.363|0.466
Observed|Myelodysplastic syndromes|2015–2019|Females|5|75–79|0.398|0.349|0.446
Observed|Myelodysplastic syndromes|2015–2019|Females|5|80–84|0.276|0.236|0.316
Observed|Myelodysplastic syndromes|2015–2019|Females|5|85+|0.109|0.088|0.132
Observed|Myelodysplastic syndromes|2015–2019|Females|5|All ages combined|0.333|0.315|0.351
Relative|Myelodysplastic syndromes|2015–2019|Females|1|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Females|1|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Females|1|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Females|1|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Females|1|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Females|1|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Females|1|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Females|1|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Females|1|40–44|0.922|0.72|0.981
Relative|Myelodysplastic syndromes|2015–2019|Females|1|45–49|0.913|0.751|0.972
Relative|Myelodysplastic syndromes|2015–2019|Females|1|50–54|0.807|0.678|0.889
Relative|Myelodysplastic syndromes|2015–2019|Females|1|55–59|0.862|0.772|0.918
Relative|Myelodysplastic syndromes|2015–2019|Females|1|60–64|0.821|0.747|0.876
Relative|Myelodysplastic syndromes|2015–2019|Females|1|65–69|0.829|0.778|0.869
Relative|Myelodysplastic syndromes|2015–2019|Females|1|70–74|0.8|0.754|0.839
Relative|Myelodysplastic syndromes|2015–2019|Females|1|75–79|0.804|0.762|0.841
Relative|Myelodysplastic syndromes|2015–2019|Females|1|80–84|0.727|0.681|0.769
Relative|Myelodysplastic syndromes|2015–2019|Females|1|85+|0.627|0.584|0.667
Relative|Myelodysplastic syndromes|2015–2019|Females|1|All ages combined|0.758|0.739|0.775
Relative|Myelodysplastic syndromes|2015–2019|Females|2|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Females|2|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Females|2|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Females|2|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Females|2|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Females|2|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Females|2|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Females|2|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Females|2|40–44|0.851|0.649|0.943
Relative|Myelodysplastic syndromes|2015–2019|Females|2|45–49|0.851|0.676|0.937
Relative|Myelodysplastic syndromes|2015–2019|Females|2|50–54|0.771|0.637|0.862
Relative|Myelodysplastic syndromes|2015–2019|Females|2|55–59|0.753|0.653|0.829
Relative|Myelodysplastic syndromes|2015–2019|Females|2|60–64|0.672|0.586|0.744
Relative|Myelodysplastic syndromes|2015–2019|Females|2|65–69|0.719|0.66|0.77
Relative|Myelodysplastic syndromes|2015–2019|Females|2|70–74|0.663|0.61|0.711
Relative|Myelodysplastic syndromes|2015–2019|Females|2|75–79|0.695|0.645|0.74
Relative|Myelodysplastic syndromes|2015–2019|Females|2|80–84|0.591|0.539|0.639
Relative|Myelodysplastic syndromes|2015–2019|Females|2|85+|0.469|0.424|0.513
Relative|Myelodysplastic syndromes|2015–2019|Females|2|All ages combined|0.63|0.609|0.65
Relative|Myelodysplastic syndromes|2015–2019|Females|3|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Females|3|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Females|3|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Females|3|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Females|3|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Females|3|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Females|3|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Females|3|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Females|3|40–44|0.819|0.615|0.922
Relative|Myelodysplastic syndromes|2015–2019|Females|3|45–49|0.79|0.605|0.896
Relative|Myelodysplastic syndromes|2015–2019|Females|3|50–54|0.683|0.543|0.789
Relative|Myelodysplastic syndromes|2015–2019|Females|3|55–59|0.685|0.582|0.769
Relative|Myelodysplastic syndromes|2015–2019|Females|3|60–64|0.562|0.476|0.64
Relative|Myelodysplastic syndromes|2015–2019|Females|3|65–69|0.611|0.547|0.67
Relative|Myelodysplastic syndromes|2015–2019|Females|3|70–74|0.565|0.51|0.617
Relative|Myelodysplastic syndromes|2015–2019|Females|3|75–79|0.601|0.548|0.651
Relative|Myelodysplastic syndromes|2015–2019|Females|3|80–84|0.524|0.471|0.576
Relative|Myelodysplastic syndromes|2015–2019|Females|3|85+|0.368|0.323|0.415
Relative|Myelodysplastic syndromes|2015–2019|Females|3|All ages combined|0.541|0.519|0.563
Relative|Myelodysplastic syndromes|2015–2019|Females|4|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Females|4|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Females|4|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Females|4|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Females|4|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Females|4|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Females|4|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Females|4|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Females|4|40–44|0.82|0.616|0.923
Relative|Myelodysplastic syndromes|2015–2019|Females|4|45–49|0.758|0.569|0.874
Relative|Myelodysplastic syndromes|2015–2019|Females|4|50–54|0.648|0.507|0.76
Relative|Myelodysplastic syndromes|2015–2019|Females|4|55–59|0.615|0.509|0.706
Relative|Myelodysplastic syndromes|2015–2019|Females|4|60–64|0.512|0.428|0.591
Relative|Myelodysplastic syndromes|2015–2019|Females|4|65–69|0.55|0.484|0.612
Relative|Myelodysplastic syndromes|2015–2019|Females|4|70–74|0.504|0.447|0.558
Relative|Myelodysplastic syndromes|2015–2019|Females|4|75–79|0.533|0.478|0.586
Relative|Myelodysplastic syndromes|2015–2019|Females|4|80–84|0.441|0.388|0.495
Relative|Myelodysplastic syndromes|2015–2019|Females|4|85+|0.294|0.249|0.342
Relative|Myelodysplastic syndromes|2015–2019|Females|4|All ages combined|0.475|0.452|0.497
Relative|Myelodysplastic syndromes|2015–2019|Females|5|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Females|5|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Females|5|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Females|5|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Females|5|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Females|5|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Females|5|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Females|5|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Females|5|40–44|||
Relative|Myelodysplastic syndromes|2015–2019|Females|5|45–49|0.69|0.496|0.824
Relative|Myelodysplastic syndromes|2015–2019|Females|5|50–54|0.596|0.454|0.713
Relative|Myelodysplastic syndromes|2015–2019|Females|5|55–59|0.587|0.481|0.68
Relative|Myelodysplastic syndromes|2015–2019|Females|5|60–64|0.471|0.389|0.55
Relative|Myelodysplastic syndromes|2015–2019|Females|5|65–69|0.492|0.424|0.557
Relative|Myelodysplastic syndromes|2015–2019|Females|5|70–74|0.449|0.393|0.504
Relative|Myelodysplastic syndromes|2015–2019|Females|5|75–79|0.459|0.403|0.515
Relative|Myelodysplastic syndromes|2015–2019|Females|5|80–84|0.366|0.314|0.42
Relative|Myelodysplastic syndromes|2015–2019|Females|5|85+|0.222|0.18|0.27
Relative|Myelodysplastic syndromes|2015–2019|Females|5|All ages combined|0.414|0.391|0.436
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|40–44|0.893|0.763|0.954
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|45–49|0.829|0.724|0.897
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|50–54|0.815|0.733|0.874
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|55–59|0.845|0.791|0.886
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|60–64|0.806|0.763|0.842
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|65–69|0.814|0.785|0.84
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|70–74|0.779|0.753|0.803
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|75–79|0.772|0.748|0.794
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|80–84|0.687|0.662|0.711
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|85+|0.541|0.517|0.564
Observed|Myelodysplastic syndromes|2015–2019|Persons|1|All ages combined|0.715|0.704|0.725
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|40–44|0.784|0.636|0.877
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|45–49|0.745|0.629|0.829
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|50–54|0.737|0.647|0.807
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|55–59|0.738|0.674|0.791
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|60–64|0.671|0.621|0.715
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|65–69|0.663|0.628|0.696
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|70–74|0.624|0.593|0.653
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|75–79|0.628|0.601|0.654
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|80–84|0.503|0.476|0.53
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|85+|0.356|0.334|0.379
Observed|Myelodysplastic syndromes|2015–2019|Persons|2|All ages combined|0.555|0.543|0.567
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|40–44|0.739|0.587|0.843
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|45–49|0.685|0.565|0.779
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|50–54|0.657|0.563|0.735
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|55–59|0.67|0.603|0.728
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|60–64|0.576|0.525|0.623
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|65–69|0.569|0.533|0.604
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|70–74|0.511|0.48|0.542
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|75–79|0.487|0.459|0.515
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|80–84|0.391|0.364|0.417
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|85+|0.237|0.218|0.257
Observed|Myelodysplastic syndromes|2015–2019|Persons|3|All ages combined|0.443|0.431|0.454
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|40–44|0.739|0.587|0.843
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|45–49|0.657|0.536|0.754
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|50–54|0.615|0.52|0.696
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|55–59|0.591|0.522|0.654
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|60–64|0.513|0.463|0.56
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|65–69|0.501|0.465|0.537
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|70–74|0.424|0.393|0.455
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|75–79|0.395|0.367|0.422
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|80–84|0.307|0.282|0.332
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|85+|0.156|0.139|0.174
Observed|Myelodysplastic syndromes|2015–2019|Persons|4|All ages combined|0.362|0.351|0.374
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|00–04|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|05–09|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|10–14|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|15–19|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|20–24|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|25–29|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|30–34|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|35–39|||
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|40–44|0.712|0.554|0.822
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|45–49|0.6|0.478|0.703
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|50–54|0.567|0.473|0.651
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|55–59|0.551|0.481|0.615
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|60–64|0.452|0.403|0.499
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|65–69|0.438|0.402|0.474
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|70–74|0.364|0.334|0.394
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|75–79|0.323|0.296|0.35
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|80–84|0.235|0.213|0.258
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|85+|0.101|0.087|0.116
Observed|Myelodysplastic syndromes|2015–2019|Persons|5|All ages combined|0.301|0.29|0.312
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|40–44|0.895|0.764|0.955
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|45–49|0.831|0.726|0.899
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|50–54|0.817|0.735|0.876
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|55–59|0.849|0.794|0.89
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|60–64|0.811|0.768|0.847
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|65–69|0.823|0.794|0.849
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|70–74|0.793|0.765|0.817
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|75–79|0.796|0.771|0.818
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|80–84|0.726|0.699|0.751
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|85+|0.62|0.593|0.647
Relative|Myelodysplastic syndromes|2015–2019|Persons|1|All ages combined|0.752|0.741|0.763
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|40–44|0.786|0.637|0.88
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|45–49|0.747|0.631|0.832
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|50–54|0.741|0.651|0.812
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|55–59|0.744|0.681|0.798
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|60–64|0.68|0.63|0.725
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|65–69|0.678|0.643|0.712
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|70–74|0.647|0.615|0.677
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|75–79|0.67|0.64|0.698
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|80–84|0.566|0.535|0.595
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|85+|0.471|0.442|0.501
Relative|Myelodysplastic syndromes|2015–2019|Persons|2|All ages combined|0.614|0.601|0.626
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|40–44|0.742|0.589|0.846
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|45–49|0.69|0.568|0.784
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|50–54|0.663|0.568|0.742
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|55–59|0.68|0.612|0.739
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|60–64|0.589|0.537|0.637
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|65–69|0.59|0.552|0.626
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|70–74|0.541|0.508|0.573
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|75–79|0.539|0.508|0.57
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|80–84|0.47|0.439|0.502
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|85+|0.366|0.336|0.397
Relative|Myelodysplastic syndromes|2015–2019|Persons|3|All ages combined|0.514|0.5|0.527
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|40–44|0.744|0.59|0.847
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|45–49|0.663|0.54|0.761
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|50–54|0.623|0.527|0.705
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|55–59|0.603|0.532|0.666
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|60–64|0.529|0.477|0.578
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|65–69|0.527|0.488|0.564
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|70–74|0.46|0.427|0.493
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|75–79|0.456|0.423|0.488
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|80–84|0.399|0.367|0.431
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|85+|0.285|0.255|0.317
Relative|Myelodysplastic syndromes|2015–2019|Persons|4|All ages combined|0.442|0.428|0.456
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|00–04|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|05–09|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|10–14|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|15–19|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|20–24|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|25–29|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|30–34|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|35–39|||
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|40–44|0.717|0.558|0.828
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|45–49|0.607|0.483|0.711
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|50–54|0.577|0.481|0.662
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|55–59|0.565|0.494|0.631
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|60–64|0.47|0.42|0.52
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|65–69|0.468|0.429|0.506
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|70–74|0.405|0.372|0.438
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|75–79|0.391|0.358|0.424
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|80–84|0.334|0.302|0.367
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|85+|0.222|0.191|0.254
Relative|Myelodysplastic syndromes|2015–2019|Persons|5|All ages combined|0.385|0.371|0.399
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|15–19|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|20–24|1|0.922|1
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|25–29|1|0.946|1
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|30–34|1|0.967|1
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|35–39|0.985|0.943|0.996
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|40–44|0.994|0.962|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|45–49|0.991|0.966|0.998
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|50–54|0.974|0.949|0.987
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|55–59|0.968|0.945|0.981
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|60–64|0.959|0.937|0.974
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|65–69|0.957|0.937|0.97
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|70–74|0.915|0.891|0.935
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|75–79|0.861|0.828|0.889
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|80–84|0.784|0.743|0.82
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|85+|0.645|0.597|0.689
Observed|Myeloproliferative neoplasms|2015–2019|Males|1|All ages combined|0.905|0.896|0.913
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|15–19|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|20–24|0.949|0.811|0.987
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|25–29|0.96|0.851|0.99
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|30–34|0.988|0.919|0.998
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|35–39|0.97|0.922|0.989
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|40–44|0.994|0.962|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|45–49|0.978|0.948|0.991
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|50–54|0.964|0.936|0.98
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|55–59|0.942|0.914|0.961
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|60–64|0.923|0.895|0.944
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|65–69|0.908|0.882|0.928
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|70–74|0.826|0.793|0.854
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|75–79|0.754|0.714|0.789
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|80–84|0.649|0.602|0.692
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|85+|0.488|0.439|0.535
Observed|Myeloproliferative neoplasms|2015–2019|Males|2|All ages combined|0.837|0.826|0.847
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|15–19|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|20–24|0.949|0.811|0.987
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|25–29|0.96|0.851|0.99
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|30–34|0.988|0.919|0.998
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|35–39|0.961|0.91|0.984
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|40–44|0.962|0.922|0.982
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|45–49|0.974|0.942|0.988
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|50–54|0.945|0.912|0.966
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|55–59|0.929|0.898|0.95
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|60–64|0.895|0.862|0.92
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|65–69|0.859|0.829|0.885
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|70–74|0.761|0.724|0.794
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|75–79|0.661|0.617|0.701
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|80–84|0.514|0.465|0.56
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|85+|0.332|0.287|0.377
Observed|Myeloproliferative neoplasms|2015–2019|Males|3|All ages combined|0.776|0.763|0.788
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|15–19|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|20–24|0.949|0.811|0.987
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|25–29|0.96|0.851|0.99
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|30–34|0.988|0.919|0.998
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|35–39|0.945|0.887|0.973
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|40–44|0.951|0.908|0.974
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|45–49|0.964|0.929|0.982
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|50–54|0.938|0.904|0.961
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|55–59|0.897|0.861|0.924
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|60–64|0.853|0.817|0.883
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|65–69|0.802|0.766|0.833
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|70–74|0.689|0.649|0.726
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|75–79|0.58|0.534|0.623
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|80–84|0.417|0.369|0.464
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|85+|0.24|0.199|0.283
Observed|Myeloproliferative neoplasms|2015–2019|Males|4|All ages combined|0.724|0.71|0.737
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|15–19|||
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|20–24|0.949|0.811|0.987
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|25–29|0.942|0.832|0.981
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|30–34|0.988|0.919|0.998
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|35–39|0.936|0.875|0.967
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|40–44|0.941|0.895|0.967
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|45–49|0.949|0.91|0.972
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|50–54|0.921|0.883|0.947
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|55–59|0.861|0.82|0.892
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|60–64|0.823|0.784|0.856
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|65–69|0.75|0.711|0.785
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|70–74|0.632|0.59|0.672
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|75–79|0.491|0.444|0.537
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|80–84|0.287|0.243|0.333
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|85+|0.16|0.125|0.198
Observed|Myeloproliferative neoplasms|2015–2019|Males|5|All ages combined|0.673|0.658|0.687
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|15–19|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|20–24|1.001|0.923|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|25–29|1.001|0.946|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|30–34|1.001|0.968|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|35–39|0.987|0.944|0.998
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|40–44|0.996|0.963|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|45–49|0.994|0.968|1
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|50–54|0.978|0.953|0.991
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|55–59|0.973|0.95|0.986
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|60–64|0.967|0.945|0.982
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|65–69|0.968|0.949|0.982
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|70–74|0.933|0.908|0.953
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|75–79|0.891|0.856|0.919
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|80–84|0.833|0.789|0.871
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|85+|0.742|0.686|0.793
Relative|Myeloproliferative neoplasms|2015–2019|Males|1|All ages combined|0.93|0.921|0.938
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|15–19|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|20–24|0.95|0.812|0.988
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|25–29|0.962|0.852|0.991
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|30–34|0.99|0.921|1
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|35–39|0.972|0.924|0.991
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|40–44|0.998|0.965|1.003
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|45–49|0.983|0.953|0.996
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|50–54|0.971|0.943|0.987
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|55–59|0.953|0.924|0.972
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|60–64|0.939|0.91|0.96
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|65–69|0.931|0.905|0.952
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|70–74|0.86|0.826|0.889
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|75–79|0.809|0.766|0.847
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|80–84|0.738|0.685|0.787
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|85+|0.653|0.587|0.716
Relative|Myeloproliferative neoplasms|2015–2019|Males|2|All ages combined|0.882|0.87|0.893
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|15–19|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|20–24|0.951|0.813|0.989
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|25–29|0.962|0.853|0.992
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|30–34|0.991|0.922|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|35–39|0.965|0.913|0.987
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|40–44|0.967|0.927|0.987
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|45–49|0.981|0.949|0.996
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|50–54|0.956|0.923|0.977
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|55–59|0.945|0.914|0.967
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|60–64|0.919|0.885|0.944
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|65–69|0.895|0.863|0.921
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|70–74|0.812|0.773|0.847
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|75–79|0.74|0.691|0.785
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|80–84|0.632|0.572|0.69
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|85+|0.521|0.45|0.593
Relative|Myeloproliferative neoplasms|2015–2019|Males|3|All ages combined|0.839|0.826|0.852
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|15–19|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|20–24|0.951|0.813|0.989
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|25–29|0.963|0.853|0.993
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|30–34|0.992|0.923|1.002
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|35–39|0.949|0.891|0.978
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|40–44|0.958|0.915|0.981
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|45–49|0.974|0.939|0.992
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|50–54|0.953|0.918|0.976
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|55–59|0.919|0.882|0.946
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|60–64|0.885|0.847|0.916
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|65–69|0.848|0.811|0.881
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|70–74|0.755|0.711|0.796
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|75–79|0.681|0.627|0.732
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|80–84|0.56|0.495|0.623
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|85+|0.45|0.373|0.531
Relative|Myeloproliferative neoplasms|2015–2019|Males|4|All ages combined|0.803|0.787|0.817
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|15–19|||
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|20–24|0.952|0.814|0.99
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|25–29|0.946|0.835|0.985
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|30–34|0.993|0.924|1.003
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|35–39|0.942|0.881|0.974
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|40–44|0.95|0.904|0.976
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|45–49|0.962|0.923|0.985
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|50–54|0.94|0.902|0.967
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|55–59|0.888|0.847|0.921
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|60–64|0.863|0.822|0.898
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|65–69|0.808|0.766|0.846
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|70–74|0.714|0.665|0.758
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|75–79|0.609|0.551|0.665
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|80–84|0.426|0.361|0.494
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|85+|0.363|0.283|0.451
Relative|Myeloproliferative neoplasms|2015–2019|Males|5|All ages combined|0.763|0.747|0.779
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|15–19|1|0.867|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|20–24|1|0.931|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|25–29|1|0.964|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|30–34|1|0.972|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|35–39|0.991|0.939|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|40–44|0.994|0.959|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|45–49|0.995|0.965|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|50–54|0.983|0.955|0.994
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|55–59|0.97|0.943|0.984
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|60–64|0.984|0.965|0.993
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|65–69|0.964|0.942|0.978
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|70–74|0.954|0.933|0.969
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|75–79|0.919|0.89|0.941
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|80–84|0.876|0.839|0.904
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|85+|0.667|0.619|0.71
Observed|Myeloproliferative neoplasms|2015–2019|Females|1|All ages combined|0.927|0.919|0.935
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|15–19|1|0.864|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|20–24|1|0.928|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|25–29|1|0.962|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|30–34|1|0.972|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|35–39|0.991|0.939|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|40–44|0.988|0.953|0.997
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|45–49|0.985|0.955|0.995
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|50–54|0.961|0.927|0.98
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|55–59|0.956|0.925|0.974
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|60–64|0.948|0.92|0.967
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|65–69|0.924|0.895|0.945
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|70–74|0.923|0.897|0.943
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|75–79|0.842|0.805|0.872
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|80–84|0.782|0.738|0.819
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|85+|0.52|0.471|0.567
Observed|Myeloproliferative neoplasms|2015–2019|Females|2|All ages combined|0.876|0.866|0.886
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|15–19|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|20–24|0.973|0.823|0.996
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|25–29|1|0.96|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|30–34|1|0.972|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|35–39|0.963|0.904|0.986
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|40–44|0.982|0.944|0.994
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|45–49|0.975|0.941|0.99
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|50–54|0.948|0.91|0.97
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|55–59|0.936|0.901|0.959
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|60–64|0.926|0.893|0.948
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|65–69|0.881|0.845|0.908
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|70–74|0.859|0.825|0.887
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|75–79|0.782|0.74|0.817
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|80–84|0.684|0.636|0.727
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|85+|0.418|0.371|0.464
Observed|Myeloproliferative neoplasms|2015–2019|Females|3|All ages combined|0.827|0.814|0.838
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|15–19|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|20–24|0.973|0.823|0.996
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|25–29|1|0.957|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|30–34|1|0.971|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|35–39|0.963|0.904|0.986
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|40–44|0.975|0.935|0.991
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|45–49|0.96|0.921|0.98
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|50–54|0.94|0.9|0.964
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|55–59|0.924|0.886|0.95
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|60–64|0.885|0.846|0.914
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|65–69|0.854|0.815|0.884
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|70–74|0.791|0.75|0.825
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|75–79|0.72|0.675|0.76
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|80–84|0.591|0.54|0.638
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|85+|0.315|0.272|0.359
Observed|Myeloproliferative neoplasms|2015–2019|Females|4|All ages combined|0.779|0.765|0.792
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|15–19|||
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|20–24|0.973|0.823|0.996
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|25–29|1|0.955|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|30–34|1|0.97|1
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|35–39|0.963|0.904|0.986
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|40–44|0.969|0.927|0.987
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|45–49|0.96|0.921|0.98
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|50–54|0.926|0.884|0.953
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|55–59|0.904|0.861|0.933
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|60–64|0.872|0.832|0.903
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|65–69|0.814|0.771|0.849
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|70–74|0.745|0.701|0.783
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|75–79|0.645|0.596|0.689
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|80–84|0.494|0.443|0.544
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|85+|0.231|0.193|0.271
Observed|Myeloproliferative neoplasms|2015–2019|Females|5|All ages combined|0.736|0.721|0.75
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|15–19|1|0.867|1
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|20–24|1|0.932|1
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|25–29|1|0.964|1
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|30–34|1|0.972|1
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|35–39|0.992|0.94|0.999
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|40–44|0.995|0.96|1
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|45–49|0.996|0.966|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|50–54|0.985|0.957|0.996
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|55–59|0.973|0.946|0.987
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|60–64|0.989|0.97|0.998
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|65–69|0.971|0.949|0.985
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|70–74|0.966|0.945|0.981
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|75–79|0.939|0.91|0.961
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|80–84|0.913|0.876|0.943
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|85+|0.751|0.697|0.8
Relative|Myeloproliferative neoplasms|2015–2019|Females|1|All ages combined|0.948|0.939|0.956
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|15–19|1|0.865|1
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|20–24|1|0.928|1
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|25–29|1.001|0.963|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|30–34|1.001|0.973|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|35–39|0.992|0.94|1
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|40–44|0.99|0.955|0.999
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|45–49|0.988|0.958|0.998
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|50–54|0.966|0.931|0.984
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|55–59|0.962|0.931|0.98
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|60–64|0.958|0.929|0.976
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|65–69|0.938|0.909|0.96
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|70–74|0.947|0.92|0.967
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|75–79|0.881|0.843|0.913
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|80–84|0.855|0.807|0.896
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|85+|0.665|0.603|0.725
Relative|Myeloproliferative neoplasms|2015–2019|Females|2|All ages combined|0.915|0.904|0.926
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|15–19|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|20–24|0.974|0.824|0.997
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|25–29|1.001|0.961|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|30–34|1.001|0.973|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|35–39|0.965|0.905|0.988
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|40–44|0.985|0.947|0.997
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|45–49|0.98|0.946|0.994
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|50–54|0.955|0.917|0.977
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|55–59|0.946|0.91|0.969
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|60–64|0.94|0.907|0.963
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|65–69|0.902|0.866|0.931
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|70–74|0.895|0.859|0.924
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|75–79|0.842|0.797|0.88
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|80–84|0.79|0.735|0.84
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|85+|0.616|0.546|0.684
Relative|Myeloproliferative neoplasms|2015–2019|Females|3|All ages combined|0.883|0.869|0.895
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|15–19|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|20–24|0.974|0.824|0.997
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|25–29|1.001|0.959|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|30–34|1.002|0.973|1.002
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|35–39|0.965|0.906|0.989
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|40–44|0.979|0.939|0.995
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|45–49|0.966|0.927|0.986
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|50–54|0.949|0.909|0.973
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|55–59|0.937|0.899|0.964
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|60–64|0.904|0.865|0.933
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|65–69|0.883|0.844|0.915
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|70–74|0.838|0.796|0.875
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|75–79|0.8|0.75|0.845
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|80–84|0.727|0.665|0.785
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|85+|0.542|0.468|0.618
Relative|Myeloproliferative neoplasms|2015–2019|Females|4|All ages combined|0.851|0.836|0.865
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|15–19|||
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|20–24|0.974|0.824|0.997
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|25–29|1.002|0.957|1.002
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|30–34|1.002|0.972|1.002
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|35–39|0.966|0.907|0.989
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|40–44|0.974|0.932|0.992
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|45–49|0.968|0.929|0.988
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|50–54|0.938|0.895|0.965
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|55–59|0.92|0.877|0.951
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|60–64|0.897|0.856|0.928
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|65–69|0.851|0.807|0.888
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|70–74|0.805|0.758|0.846
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|75–79|0.744|0.688|0.795
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|80–84|0.653|0.585|0.719
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|85+|0.47|0.393|0.552
Relative|Myeloproliferative neoplasms|2015–2019|Females|5|All ages combined|0.822|0.806|0.838
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|15–19|1|0.915|1
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|20–24|1|0.963|1
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|25–29|1|0.978|1
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|30–34|1|0.985|1
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|35–39|0.988|0.963|0.996
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|40–44|0.994|0.977|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|45–49|0.993|0.979|0.998
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|50–54|0.978|0.962|0.987
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|55–59|0.969|0.953|0.979
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|60–64|0.971|0.957|0.98
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|65–69|0.96|0.946|0.97
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|70–74|0.934|0.918|0.946
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|75–79|0.889|0.867|0.907
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|80–84|0.828|0.801|0.852
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|85+|0.656|0.623|0.688
Observed|Myeloproliferative neoplasms|2015–2019|Persons|1|All ages combined|0.915|0.909|0.921
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|15–19|1|0.914|1
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|20–24|0.974|0.9|0.993
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|25–29|0.984|0.938|0.996
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|30–34|0.995|0.964|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|35–39|0.979|0.951|0.991
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|40–44|0.991|0.974|0.997
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|45–49|0.981|0.963|0.991
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|50–54|0.963|0.943|0.976
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|55–59|0.948|0.928|0.962
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|60–64|0.935|0.915|0.95
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|65–69|0.915|0.896|0.93
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|70–74|0.871|0.85|0.889
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|75–79|0.796|0.769|0.82
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|80–84|0.713|0.681|0.742
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|85+|0.504|0.47|0.538
Observed|Myeloproliferative neoplasms|2015–2019|Persons|2|All ages combined|0.855|0.847|0.862
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|15–19|1|0.913|1
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|20–24|0.961|0.885|0.987
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|25–29|0.984|0.938|0.996
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|30–34|0.995|0.964|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|35–39|0.962|0.927|0.98
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|40–44|0.971|0.947|0.984
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|45–49|0.974|0.954|0.986
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|50–54|0.947|0.923|0.963
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|55–59|0.932|0.91|0.949
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|60–64|0.909|0.887|0.927
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|65–69|0.868|0.846|0.888
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|70–74|0.807|0.782|0.829
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|75–79|0.719|0.689|0.746
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|80–84|0.596|0.562|0.629
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|85+|0.376|0.344|0.409
Observed|Myeloproliferative neoplasms|2015–2019|Persons|3|All ages combined|0.8|0.791|0.808
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|15–19|1|0.912|1
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|20–24|0.961|0.885|0.987
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|25–29|0.984|0.938|0.996
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|30–34|0.995|0.964|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|35–39|0.953|0.916|0.974
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|40–44|0.962|0.935|0.978
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|45–49|0.962|0.939|0.977
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|50–54|0.939|0.915|0.956
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|55–59|0.908|0.883|0.928
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|60–64|0.867|0.842|0.889
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|65–69|0.824|0.798|0.846
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|70–74|0.736|0.708|0.762
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|75–79|0.647|0.615|0.677
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|80–84|0.501|0.466|0.535
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|85+|0.279|0.249|0.31
Observed|Myeloproliferative neoplasms|2015–2019|Persons|4|All ages combined|0.75|0.74|0.759
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|00–04|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|05–09|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|10–14|||
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|15–19|1|0.908|1
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|20–24|0.961|0.885|0.987
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|25–29|0.975|0.924|0.992
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|30–34|0.995|0.964|0.999
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|35–39|0.948|0.911|0.97
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|40–44|0.953|0.925|0.971
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|45–49|0.954|0.929|0.971
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|50–54|0.923|0.897|0.943
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|55–59|0.879|0.85|0.902
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|60–64|0.845|0.817|0.868
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|65–69|0.777|0.749|0.803
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|70–74|0.685|0.654|0.713
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|75–79|0.564|0.531|0.597
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|80–84|0.388|0.354|0.423
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|85+|0.198|0.171|0.226
Observed|Myeloproliferative neoplasms|2015–2019|Persons|5|All ages combined|0.702|0.692|0.712
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|15–19|1|0.915|1
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|20–24|1|0.963|1
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|25–29|1|0.978|1
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|30–34|1.001|0.985|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|35–39|0.989|0.964|0.997
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|40–44|0.996|0.979|1
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|45–49|0.995|0.981|1
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|50–54|0.981|0.964|0.99
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|55–59|0.973|0.957|0.984
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|60–64|0.977|0.963|0.986
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|65–69|0.97|0.956|0.98
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|70–74|0.949|0.933|0.962
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|75–79|0.914|0.892|0.933
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|80–84|0.872|0.844|0.897
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|85+|0.747|0.708|0.782
Relative|Myeloproliferative neoplasms|2015–2019|Persons|1|All ages combined|0.938|0.932|0.944
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|15–19|1.001|0.914|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|20–24|0.975|0.901|0.994
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|25–29|0.985|0.939|0.997
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|30–34|0.996|0.965|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|35–39|0.981|0.953|0.993
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|40–44|0.994|0.976|1
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|45–49|0.985|0.967|0.995
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|50–54|0.968|0.948|0.982
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|55–59|0.956|0.937|0.971
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|60–64|0.947|0.928|0.962
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|65–69|0.934|0.915|0.95
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|70–74|0.901|0.879|0.92
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|75–79|0.844|0.815|0.87
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|80–84|0.795|0.76|0.828
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|85+|0.659|0.614|0.702
Relative|Myeloproliferative neoplasms|2015–2019|Persons|2|All ages combined|0.898|0.889|0.905
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|15–19|1.001|0.914|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|20–24|0.963|0.886|0.989
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|25–29|0.985|0.939|0.997
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|30–34|0.997|0.966|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|35–39|0.964|0.93|0.983
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|40–44|0.975|0.951|0.988
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|45–49|0.98|0.96|0.992
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|50–54|0.955|0.932|0.972
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|55–59|0.945|0.923|0.962
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|60–64|0.928|0.906|0.947
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|65–69|0.898|0.875|0.918
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|70–74|0.851|0.824|0.874
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|75–79|0.789|0.756|0.82
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|80–84|0.711|0.67|0.75
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|85+|0.572|0.522|0.621
Relative|Myeloproliferative neoplasms|2015–2019|Persons|3|All ages combined|0.86|0.85|0.869
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|15–19|1.001|0.913|1.001
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|20–24|0.963|0.887|0.989
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|25–29|0.986|0.94|0.998
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|30–34|0.998|0.966|1.002
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|35–39|0.957|0.92|0.978
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|40–44|0.968|0.941|0.984
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|45–49|0.97|0.947|0.985
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|50–54|0.951|0.927|0.969
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|55–59|0.926|0.901|0.947
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|60–64|0.893|0.867|0.916
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|65–69|0.863|0.836|0.887
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|70–74|0.794|0.763|0.822
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|75–79|0.739|0.702|0.774
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|80–84|0.643|0.598|0.687
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|85+|0.5|0.446|0.555
Relative|Myeloproliferative neoplasms|2015–2019|Persons|4|All ages combined|0.825|0.815|0.836
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|00–04|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|05–09|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|10–14|||
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|15–19|1.002|0.91|1.002
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|20–24|0.964|0.887|0.99
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|25–29|0.977|0.926|0.994
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|30–34|0.998|0.967|1.003
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|35–39|0.953|0.916|0.975
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|40–44|0.961|0.932|0.979
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|45–49|0.965|0.94|0.982
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|50–54|0.939|0.912|0.959
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|55–59|0.902|0.873|0.926
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|60–64|0.878|0.85|0.902
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|65–69|0.827|0.796|0.854
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|70–74|0.756|0.723|0.788
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|75–79|0.675|0.634|0.713
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|80–84|0.541|0.493|0.589
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|85+|0.422|0.366|0.481
Relative|Myeloproliferative neoplasms|2015–2019|Persons|5|All ages combined|0.791|0.779|0.802
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|20–24|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|25–29|1|0.88|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|30–34|1|0.936|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|35–39|0.976|0.907|0.994
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|40–44|1|0.974|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|45–49|0.988|0.953|0.997
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|50–54|0.973|0.941|0.988
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|55–59|0.969|0.943|0.983
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|60–64|0.956|0.93|0.972
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|65–69|0.961|0.939|0.974
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|70–74|0.92|0.893|0.94
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|75–79|0.863|0.827|0.892
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|80–84|0.791|0.746|0.829
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|85+|0.669|0.616|0.717
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|All ages combined|0.903|0.893|0.912
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|20–24|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|25–29|1|0.873|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|30–34|1|0.931|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|35–39|0.976|0.907|0.994
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|40–44|1|0.973|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|45–49|0.982|0.944|0.994
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|50–54|0.959|0.922|0.978
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|55–59|0.949|0.919|0.969
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|60–64|0.917|0.884|0.941
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|65–69|0.909|0.88|0.931
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|70–74|0.827|0.791|0.857
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|75–79|0.749|0.705|0.787
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|80–84|0.655|0.604|0.701
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|85+|0.501|0.446|0.553
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|All ages combined|0.83|0.817|0.842
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|20–24|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|25–29|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|30–34|1|0.93|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|35–39|0.962|0.886|0.988
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|40–44|0.982|0.931|0.996
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|45–49|0.982|0.944|0.994
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|50–54|0.937|0.894|0.963
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|55–59|0.942|0.91|0.963
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|60–64|0.881|0.843|0.911
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|65–69|0.854|0.819|0.883
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|70–74|0.753|0.712|0.789
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|75–79|0.664|0.616|0.706
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|80–84|0.522|0.468|0.572
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|85+|0.341|0.29|0.393
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|All ages combined|0.764|0.75|0.778
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|20–24|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|25–29|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|30–34|1|0.93|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|35–39|0.947|0.864|0.98
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|40–44|0.982|0.931|0.996
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|45–49|0.967|0.922|0.986
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|50–54|0.927|0.882|0.955
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|55–59|0.91|0.871|0.938
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|60–64|0.84|0.797|0.874
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|65–69|0.791|0.751|0.826
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|70–74|0.67|0.625|0.711
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|75–79|0.572|0.523|0.619
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|80–84|0.428|0.376|0.479
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|85+|0.241|0.195|0.291
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|All ages combined|0.705|0.689|0.72
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|20–24|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|25–29|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|30–34|1|0.928|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|35–39|0.931|0.84|0.971
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|40–44|0.973|0.92|0.991
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|45–49|0.944|0.89|0.972
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|50–54|0.902|0.852|0.936
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|55–59|0.863|0.816|0.899
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|60–64|0.804|0.758|0.842
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|65–69|0.732|0.687|0.772
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|70–74|0.607|0.56|0.651
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|75–79|0.483|0.432|0.531
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|80–84|0.295|0.247|0.345
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|85+|0.161|0.121|0.206
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|All ages combined|0.644|0.627|0.661
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|20–24|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|25–29|1.001|0.881|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|30–34|1.001|0.936|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|35–39|0.977|0.908|0.995
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|40–44|1.002|0.975|1.002
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|45–49|0.99|0.955|0.999
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|50–54|0.977|0.944|0.991
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|55–59|0.974|0.948|0.988
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|60–64|0.964|0.938|0.98
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|65–69|0.972|0.951|0.986
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|70–74|0.937|0.91|0.958
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|75–79|0.893|0.855|0.923
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|80–84|0.84|0.792|0.881
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|85+|0.768|0.707|0.823
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|1|All ages combined|0.93|0.919|0.939
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|20–24|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|25–29|1.001|0.875|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|30–34|1.002|0.933|1.002
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|35–39|0.978|0.909|0.996
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|40–44|1.003|0.977|1.003
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|45–49|0.986|0.949|0.999
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|50–54|0.966|0.929|0.985
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|55–59|0.96|0.929|0.98
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|60–64|0.933|0.899|0.957
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|65–69|0.932|0.902|0.955
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|70–74|0.861|0.824|0.892
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|75–79|0.804|0.757|0.845
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|80–84|0.746|0.687|0.798
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|85+|0.668|0.595|0.738
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|2|All ages combined|0.878|0.865|0.891
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|20–24|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|25–29|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|30–34|1.003|0.933|1.003
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|35–39|0.965|0.889|0.991
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|40–44|0.987|0.936|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|45–49|0.989|0.951|1.002
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|50–54|0.948|0.904|0.974
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|55–59|0.959|0.926|0.98
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|60–64|0.905|0.865|0.935
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|65–69|0.889|0.853|0.919
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|70–74|0.803|0.76|0.841
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|75–79|0.743|0.69|0.791
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|80–84|0.642|0.576|0.704
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|85+|0.534|0.455|0.615
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|3|All ages combined|0.831|0.815|0.847
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|20–24|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|25–29|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|30–34|1.004|0.933|1.004
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|35–39|0.952|0.868|0.985
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|40–44|0.989|0.938|1.003
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|45–49|0.977|0.931|0.997
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|50–54|0.942|0.896|0.971
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|55–59|0.933|0.892|0.961
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|60–64|0.871|0.827|0.907
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|65–69|0.837|0.795|0.874
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|70–74|0.733|0.684|0.778
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|75–79|0.672|0.614|0.727
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|80–84|0.575|0.505|0.644
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|85+|0.451|0.364|0.543
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|4|All ages combined|0.787|0.77|0.805
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|20–24|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|25–29|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|30–34|1.005|0.932|1.005
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|35–39|0.937|0.846|0.977
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|40–44|0.983|0.929|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|45–49|0.957|0.902|0.985
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|50–54|0.921|0.87|0.955
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|55–59|0.891|0.842|0.928
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|60–64|0.843|0.795|0.883
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|65–69|0.788|0.74|0.831
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|70–74|0.685|0.631|0.734
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|75–79|0.598|0.535|0.659
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|80–84|0.438|0.367|0.512
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|85+|0.367|0.276|0.469
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Males|5|All ages combined|0.739|0.719|0.758
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|20–24|1|0.904|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|25–29|1|0.948|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|30–34|1|0.961|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|35–39|0.987|0.911|0.998
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|40–44|0.992|0.943|0.999
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|45–49|1|0.979|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|50–54|0.977|0.94|0.991
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|55–59|0.972|0.939|0.987
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|60–64|0.983|0.959|0.993
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|65–69|0.957|0.93|0.973
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|70–74|0.964|0.943|0.977
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|75–79|0.925|0.895|0.947
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|80–84|0.876|0.837|0.906
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|85+|0.696|0.645|0.742
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|All ages combined|0.927|0.917|0.936
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|20–24|1|0.901|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|25–29|1|0.947|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|30–34|1|0.962|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|35–39|0.987|0.911|0.998
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|40–44|0.984|0.937|0.996
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|45–49|0.986|0.947|0.997
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|50–54|0.953|0.909|0.976
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|55–59|0.962|0.925|0.981
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|60–64|0.95|0.916|0.97
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|65–69|0.909|0.874|0.934
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|70–74|0.932|0.905|0.952
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|75–79|0.852|0.813|0.883
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|80–84|0.777|0.731|0.817
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|85+|0.565|0.511|0.614
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|All ages combined|0.875|0.862|0.886
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|20–24|1|0.899|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|25–29|1|0.944|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|30–34|1|0.962|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|35–39|0.955|0.867|0.985
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|40–44|0.975|0.924|0.992
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|45–49|0.986|0.947|0.997
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|50–54|0.947|0.9|0.972
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|55–59|0.939|0.895|0.965
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|60–64|0.924|0.885|0.95
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|65–69|0.863|0.822|0.895
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|70–74|0.86|0.822|0.89
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|75–79|0.788|0.744|0.826
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|80–84|0.686|0.635|0.731
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|85+|0.455|0.403|0.506
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|All ages combined|0.821|0.807|0.834
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|20–24|1|0.896|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|25–29|1|0.94|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|30–34|1|0.96|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|35–39|0.955|0.867|0.985
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|40–44|0.966|0.912|0.987
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|45–49|0.972|0.928|0.989
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|50–54|0.934|0.884|0.963
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|55–59|0.927|0.879|0.956
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|60–64|0.885|0.841|0.918
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|65–69|0.84|0.797|0.875
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|70–74|0.786|0.742|0.824
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|75–79|0.717|0.668|0.76
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|80–84|0.603|0.549|0.652
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|85+|0.337|0.289|0.386
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|All ages combined|0.768|0.752|0.783
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|20–24|1|0.893|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|25–29|1|0.937|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|30–34|1|0.958|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|35–39|0.955|0.867|0.985
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|40–44|0.957|0.901|0.982
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|45–49|0.972|0.928|0.989
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|50–54|0.921|0.868|0.953
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|55–59|0.908|0.856|0.942
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|60–64|0.869|0.822|0.904
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|65–69|0.803|0.756|0.842
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|70–74|0.739|0.691|0.781
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|75–79|0.637|0.584|0.685
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|80–84|0.502|0.447|0.554
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|85+|0.26|0.216|0.306
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|All ages combined|0.722|0.705|0.738
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|20–24|1|0.904|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|25–29|1|0.948|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|30–34|1|0.961|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|35–39|0.987|0.911|0.999
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|40–44|0.993|0.944|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|45–49|1.001|0.981|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|50–54|0.979|0.942|0.993
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|55–59|0.975|0.941|0.99
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|60–64|0.987|0.963|0.997
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|65–69|0.964|0.937|0.98
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|70–74|0.976|0.954|0.99
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|75–79|0.945|0.914|0.968
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|80–84|0.913|0.873|0.945
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|85+|0.783|0.725|0.834
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|1|All ages combined|0.949|0.939|0.958
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|20–24|1|0.901|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|25–29|1.001|0.947|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|30–34|1.001|0.962|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|35–39|0.988|0.912|0.999
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|40–44|0.986|0.938|0.998
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|45–49|0.989|0.95|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|50–54|0.957|0.913|0.981
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|55–59|0.968|0.931|0.987
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|60–64|0.959|0.925|0.979
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|65–69|0.923|0.887|0.949
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|70–74|0.957|0.929|0.977
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|75–79|0.892|0.852|0.925
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|80–84|0.85|0.8|0.893
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|85+|0.721|0.653|0.784
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|2|All ages combined|0.916|0.903|0.928
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|20–24|1.001|0.9|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|25–29|1.001|0.945|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|30–34|1.001|0.963|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|35–39|0.957|0.869|0.987
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|40–44|0.978|0.927|0.995
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|45–49|0.991|0.951|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|50–54|0.953|0.907|0.979
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|55–59|0.949|0.904|0.975
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|60–64|0.938|0.899|0.964
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|65–69|0.884|0.842|0.917
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|70–74|0.896|0.857|0.927
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|75–79|0.849|0.802|0.889
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|80–84|0.793|0.734|0.845
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|85+|0.67|0.593|0.744
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|3|All ages combined|0.881|0.866|0.895
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|20–24|1.001|0.897|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|25–29|1.001|0.941|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|30–34|1.002|0.962|1.002
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|35–39|0.958|0.869|0.988
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|40–44|0.97|0.916|0.991
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|45–49|0.979|0.934|0.996
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|50–54|0.943|0.893|0.972
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|55–59|0.94|0.892|0.97
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|60–64|0.904|0.859|0.938
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|65–69|0.87|0.825|0.906
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|70–74|0.834|0.786|0.874
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|75–79|0.798|0.744|0.845
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|80–84|0.742|0.676|0.802
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|85+|0.581|0.498|0.666
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|4|All ages combined|0.846|0.829|0.862
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|20–24|1.001|0.894|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|25–29|1.002|0.938|1.002
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|30–34|1.002|0.96|1.002
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|35–39|0.959|0.87|0.989
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|40–44|0.963|0.906|0.988
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|45–49|0.98|0.935|0.998
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|50–54|0.932|0.878|0.965
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|55–59|0.925|0.872|0.96
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|60–64|0.894|0.845|0.93
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|65–69|0.84|0.791|0.881
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|70–74|0.799|0.746|0.844
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|75–79|0.735|0.674|0.79
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|80–84|0.664|0.591|0.733
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|85+|0.532|0.442|0.626
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Females|5|All ages combined|0.815|0.796|0.834
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|15–19|1|0.874|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|20–24|1|0.936|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|25–29|1|0.963|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|30–34|1|0.975|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|35–39|0.981|0.943|0.994
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|40–44|0.996|0.97|0.999
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|45–49|0.994|0.975|0.998
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|50–54|0.975|0.954|0.986
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|55–59|0.97|0.952|0.982
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|60–64|0.967|0.951|0.978
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|65–69|0.959|0.943|0.97
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|70–74|0.94|0.924|0.953
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|75–79|0.893|0.87|0.912
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|80–84|0.833|0.804|0.858
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|85+|0.683|0.647|0.716
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|All ages combined|0.914|0.907|0.921
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|15–19|1|0.877|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|20–24|1|0.935|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|25–29|1|0.962|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|30–34|1|0.975|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|35–39|0.981|0.943|0.994
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|40–44|0.991|0.966|0.998
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|45–49|0.984|0.961|0.993
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|50–54|0.956|0.93|0.973
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|55–59|0.954|0.933|0.969
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|60–64|0.931|0.909|0.948
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|65–69|0.909|0.887|0.926
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|70–74|0.876|0.854|0.895
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|75–79|0.798|0.769|0.824
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|80–84|0.716|0.682|0.747
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|85+|0.534|0.496|0.57
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|All ages combined|0.851|0.842|0.859
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|15–19|1|0.874|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|20–24|1|0.935|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|25–29|1|0.96|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|30–34|1|0.975|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|35–39|0.959|0.91|0.981
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|40–44|0.978|0.948|0.991
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|45–49|0.984|0.961|0.993
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|50–54|0.942|0.913|0.961
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|55–59|0.941|0.917|0.958
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|60–64|0.9|0.873|0.921
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|65–69|0.858|0.832|0.88
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|70–74|0.803|0.775|0.827
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|75–79|0.723|0.691|0.753
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|80–84|0.604|0.567|0.639
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|85+|0.401|0.364|0.438
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|All ages combined|0.791|0.781|0.801
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|20–24|1|0.936|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|25–29|1|0.958|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|30–34|1|0.974|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|35–39|0.951|0.901|0.977
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|40–44|0.974|0.942|0.988
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|45–49|0.969|0.941|0.984
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|50–54|0.93|0.899|0.952
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|55–59|0.917|0.888|0.939
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|60–64|0.859|0.83|0.884
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|65–69|0.812|0.783|0.838
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|70–74|0.724|0.692|0.753
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|75–79|0.642|0.607|0.674
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|80–84|0.515|0.478|0.552
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|85+|0.292|0.258|0.327
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|All ages combined|0.735|0.724|0.746
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|00–04|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|05–09|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|10–14|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|15–19|||
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|20–24|1|0.935|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|25–29|0.981|0.875|0.997
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|30–34|1|0.973|1
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|35–39|0.944|0.89|0.972
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|40–44|0.965|0.931|0.982
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|45–49|0.958|0.926|0.976
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|50–54|0.91|0.876|0.935
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|55–59|0.882|0.848|0.908
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|60–64|0.832|0.8|0.859
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|65–69|0.763|0.731|0.792
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|70–74|0.668|0.634|0.699
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|75–79|0.556|0.52|0.591
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|80–84|0.399|0.361|0.436
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|85+|0.215|0.185|0.247
Observed|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|All ages combined|0.681|0.669|0.692
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|15–19|1|0.874|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|20–24|1|0.937|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|25–29|1|0.963|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|30–34|1.001|0.976|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|35–39|0.982|0.944|0.995
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|40–44|0.997|0.971|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|45–49|0.995|0.976|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|50–54|0.978|0.956|0.989
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|55–59|0.975|0.956|0.986
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|60–64|0.974|0.957|0.985
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|65–69|0.969|0.953|0.98
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|70–74|0.956|0.939|0.969
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|75–79|0.918|0.894|0.938
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|80–84|0.877|0.847|0.904
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|85+|0.776|0.735|0.814
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|1|All ages combined|0.939|0.931|0.945
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|15–19|1.001|0.877|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|20–24|1.001|0.936|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|25–29|1.001|0.963|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|30–34|1.001|0.976|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|35–39|0.983|0.944|0.996
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|40–44|0.994|0.969|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|45–49|0.988|0.965|0.997
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|50–54|0.962|0.936|0.978
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|55–59|0.963|0.941|0.978
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|60–64|0.944|0.921|0.961
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|65–69|0.928|0.906|0.946
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|70–74|0.906|0.883|0.926
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|75–79|0.846|0.816|0.874
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|80–84|0.799|0.761|0.834
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|85+|0.696|0.646|0.743
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|2|All ages combined|0.896|0.887|0.905
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|15–19|1.001|0.874|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|20–24|1.001|0.937|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|25–29|1.001|0.961|1.001
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|30–34|1.002|0.977|1.002
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|35–39|0.962|0.913|0.984
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|40–44|0.982|0.952|0.995
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|45–49|0.99|0.967|0.999
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|50–54|0.95|0.921|0.97
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|55–59|0.955|0.93|0.972
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|60–64|0.919|0.892|0.941
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|65–69|0.887|0.86|0.91
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|70–74|0.847|0.818|0.872
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|75–79|0.795|0.759|0.827
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|80–84|0.719|0.675|0.761
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|85+|0.607|0.552|0.663
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|3|All ages combined|0.855|0.844|0.865
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|20–24|1.002|0.937|1.002
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|25–29|1.002|0.959|1.002
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|30–34|1.003|0.977|1.003
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|35–39|0.955|0.904|0.981
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|40–44|0.979|0.948|0.994
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|45–49|0.977|0.95|0.992
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|50–54|0.943|0.911|0.965
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|55–59|0.936|0.906|0.958
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|60–64|0.885|0.855|0.911
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|65–69|0.851|0.821|0.878
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|70–74|0.78|0.746|0.811
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|75–79|0.733|0.694|0.771
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|80–84|0.661|0.612|0.707
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|85+|0.522|0.461|0.584
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|4|All ages combined|0.815|0.803|0.827
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|00–04|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|05–09|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|10–14|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|15–19|||
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|20–24|1.002|0.937|1.002
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|25–29|0.984|0.877|1
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|30–34|1.003|0.976|1.003
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|35–39|0.949|0.895|0.977
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|40–44|0.972|0.938|0.99
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|45–49|0.968|0.937|0.987
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|50–54|0.926|0.891|0.951
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|55–59|0.905|0.871|0.933
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|60–64|0.865|0.832|0.893
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|65–69|0.811|0.777|0.842
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|70–74|0.738|0.701|0.772
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|75–79|0.665|0.621|0.707
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|80–84|0.555|0.503|0.607
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|85+|0.46|0.395|0.528
Relative|Myeloproliferative neoplasms (excluding CML)|2015–2019|Persons|5|All ages combined|0.775|0.762|0.789
Observed|Nasal cavity cancer|2015–2019|Males|1|00–04|||
Observed|Nasal cavity cancer|2015–2019|Males|1|05–09|||
Observed|Nasal cavity cancer|2015–2019|Males|1|10–14|||
Observed|Nasal cavity cancer|2015–2019|Males|1|15–19|||
Observed|Nasal cavity cancer|2015–2019|Males|1|20–24|||
Observed|Nasal cavity cancer|2015–2019|Males|1|25–29|||
Observed|Nasal cavity cancer|2015–2019|Males|1|30–34|||
Observed|Nasal cavity cancer|2015–2019|Males|1|35–39|||
Observed|Nasal cavity cancer|2015–2019|Males|1|40–44|||
Observed|Nasal cavity cancer|2015–2019|Males|1|45–49|1|0.876|1
Observed|Nasal cavity cancer|2015–2019|Males|1|50–54|0.929|0.746|0.982
Observed|Nasal cavity cancer|2015–2019|Males|1|55–59|0.98|0.869|0.997
Observed|Nasal cavity cancer|2015–2019|Males|1|60–64|0.911|0.78|0.966
Observed|Nasal cavity cancer|2015–2019|Males|1|65–69|0.846|0.704|0.923
Observed|Nasal cavity cancer|2015–2019|Males|1|70–74|0.841|0.681|0.925
Observed|Nasal cavity cancer|2015–2019|Males|1|75–79|0.706|0.498|0.84
Observed|Nasal cavity cancer|2015–2019|Males|1|80–84|0.832|0.612|0.933
Observed|Nasal cavity cancer|2015–2019|Males|1|85+|0.641|0.448|0.782
Observed|Nasal cavity cancer|2015–2019|Males|1|All ages combined|0.863|0.823|0.895
Observed|Nasal cavity cancer|2015–2019|Males|2|00–04|||
Observed|Nasal cavity cancer|2015–2019|Males|2|05–09|||
Observed|Nasal cavity cancer|2015–2019|Males|2|10–14|||
Observed|Nasal cavity cancer|2015–2019|Males|2|15–19|||
Observed|Nasal cavity cancer|2015–2019|Males|2|20–24|||
Observed|Nasal cavity cancer|2015–2019|Males|2|25–29|||
Observed|Nasal cavity cancer|2015–2019|Males|2|30–34|||
Observed|Nasal cavity cancer|2015–2019|Males|2|35–39|||
Observed|Nasal cavity cancer|2015–2019|Males|2|40–44|||
Observed|Nasal cavity cancer|2015–2019|Males|2|45–49|0.958|0.735|0.994
Observed|Nasal cavity cancer|2015–2019|Males|2|50–54|0.866|0.682|0.948
Observed|Nasal cavity cancer|2015–2019|Males|2|55–59|0.98|0.869|0.997
Observed|Nasal cavity cancer|2015–2019|Males|2|60–64|0.813|0.661|0.902
Observed|Nasal cavity cancer|2015–2019|Males|2|65–69|0.734|0.579|0.839
Observed|Nasal cavity cancer|2015–2019|Males|2|70–74|0.595|0.413|0.738
Observed|Nasal cavity cancer|2015–2019|Males|2|75–79|||
Observed|Nasal cavity cancer|2015–2019|Males|2|80–84|0.717|0.497|0.853
Observed|Nasal cavity cancer|2015–2019|Males|2|85+|||
Observed|Nasal cavity cancer|2015–2019|Males|2|All ages combined|0.753|0.705|0.795
Observed|Nasal cavity cancer|2015–2019|Males|3|00–04|||
Observed|Nasal cavity cancer|2015–2019|Males|3|05–09|||
Observed|Nasal cavity cancer|2015–2019|Males|3|10–14|||
Observed|Nasal cavity cancer|2015–2019|Males|3|15–19|||
Observed|Nasal cavity cancer|2015–2019|Males|3|20–24|||
Observed|Nasal cavity cancer|2015–2019|Males|3|25–29|||
Observed|Nasal cavity cancer|2015–2019|Males|3|30–34|||
Observed|Nasal cavity cancer|2015–2019|Males|3|35–39|||
Observed|Nasal cavity cancer|2015–2019|Males|3|40–44|||
Observed|Nasal cavity cancer|2015–2019|Males|3|45–49|0.958|0.735|0.994
Observed|Nasal cavity cancer|2015–2019|Males|3|50–54|0.805|0.617|0.907
Observed|Nasal cavity cancer|2015–2019|Males|3|55–59|0.98|0.869|0.997
Observed|Nasal cavity cancer|2015–2019|Males|3|60–64|0.763|0.603|0.865
Observed|Nasal cavity cancer|2015–2019|Males|3|65–69|0.712|0.556|0.821
Observed|Nasal cavity cancer|2015–2019|Males|3|70–74|||
Observed|Nasal cavity cancer|2015–2019|Males|3|75–79|||
Observed|Nasal cavity cancer|2015–2019|Males|3|80–84|||
Observed|Nasal cavity cancer|2015–2019|Males|3|85+|||
Observed|Nasal cavity cancer|2015–2019|Males|3|All ages combined|0.722|0.672|0.767
Observed|Nasal cavity cancer|2015–2019|Males|4|00–04|||
Observed|Nasal cavity cancer|2015–2019|Males|4|05–09|||
Observed|Nasal cavity cancer|2015–2019|Males|4|10–14|||
Observed|Nasal cavity cancer|2015–2019|Males|4|15–19|||
Observed|Nasal cavity cancer|2015–2019|Males|4|20–24|||
Observed|Nasal cavity cancer|2015–2019|Males|4|25–29|||
Observed|Nasal cavity cancer|2015–2019|Males|4|30–34|||
Observed|Nasal cavity cancer|2015–2019|Males|4|35–39|||
Observed|Nasal cavity cancer|2015–2019|Males|4|40–44|||
Observed|Nasal cavity cancer|2015–2019|Males|4|45–49|||
Observed|Nasal cavity cancer|2015–2019|Males|4|50–54|0.732|0.534|0.856
Observed|Nasal cavity cancer|2015–2019|Males|4|55–59|0.98|0.869|0.997
Observed|Nasal cavity cancer|2015–2019|Males|4|60–64|0.706|0.538|0.822
Observed|Nasal cavity cancer|2015–2019|Males|4|65–69|0.645|0.488|0.765
Observed|Nasal cavity cancer|2015–2019|Males|4|70–74|||
Observed|Nasal cavity cancer|2015–2019|Males|4|75–79|||
Observed|Nasal cavity cancer|2015–2019|Males|4|80–84|||
Observed|Nasal cavity cancer|2015–2019|Males|4|85+|||
Observed|Nasal cavity cancer|2015–2019|Males|4|All ages combined|0.662|0.609|0.71
Observed|Nasal cavity cancer|2015–2019|Males|5|00–04|||
Observed|Nasal cavity cancer|2015–2019|Males|5|05–09|||
Observed|Nasal cavity cancer|2015–2019|Males|5|10–14|||
Observed|Nasal cavity cancer|2015–2019|Males|5|15–19|||
Observed|Nasal cavity cancer|2015–2019|Males|5|20–24|||
Observed|Nasal cavity cancer|2015–2019|Males|5|25–29|||
Observed|Nasal cavity cancer|2015–2019|Males|5|30–34|||
Observed|Nasal cavity cancer|2015–2019|Males|5|35–39|||
Observed|Nasal cavity cancer|2015–2019|Males|5|40–44|||
Observed|Nasal cavity cancer|2015–2019|Males|5|45–49|||
Observed|Nasal cavity cancer|2015–2019|Males|5|50–54|||
Observed|Nasal cavity cancer|2015–2019|Males|5|55–59|0.944|0.782|0.987
Observed|Nasal cavity cancer|2015–2019|Males|5|60–64|0.677|0.507|0.799
Observed|Nasal cavity cancer|2015–2019|Males|5|65–69|0.645|0.488|0.765
Observed|Nasal cavity cancer|2015–2019|Males|5|70–74|||
Observed|Nasal cavity cancer|2015–2019|Males|5|75–79|||
Observed|Nasal cavity cancer|2015–2019|Males|5|80–84|||
Observed|Nasal cavity cancer|2015–2019|Males|5|85+|||
Observed|Nasal cavity cancer|2015–2019|Males|5|All ages combined|0.626|0.571|0.675
Relative|Nasal cavity cancer|2015–2019|Males|1|00–04|||
Relative|Nasal cavity cancer|2015–2019|Males|1|05–09|||
Relative|Nasal cavity cancer|2015–2019|Males|1|10–14|||
Relative|Nasal cavity cancer|2015–2019|Males|1|15–19|||
Relative|Nasal cavity cancer|2015–2019|Males|1|20–24|||
Relative|Nasal cavity cancer|2015–2019|Males|1|25–29|||
Relative|Nasal cavity cancer|2015–2019|Males|1|30–34|||
Relative|Nasal cavity cancer|2015–2019|Males|1|35–39|||
Relative|Nasal cavity cancer|2015–2019|Males|1|40–44|||
Relative|Nasal cavity cancer|2015–2019|Males|1|45–49|1.002|0.878|1.002
Relative|Nasal cavity cancer|2015–2019|Males|1|50–54|0.933|0.748|0.985
Relative|Nasal cavity cancer|2015–2019|Males|1|55–59|0.986|0.874|1.003
Relative|Nasal cavity cancer|2015–2019|Males|1|60–64|0.918|0.786|0.973
Relative|Nasal cavity cancer|2015–2019|Males|1|65–69|0.857|0.713|0.935
Relative|Nasal cavity cancer|2015–2019|Males|1|70–74|0.857|0.694|0.943
Relative|Nasal cavity cancer|2015–2019|Males|1|75–79|0.73|0.516|0.869
Relative|Nasal cavity cancer|2015–2019|Males|1|80–84|0.88|0.648|0.988
Relative|Nasal cavity cancer|2015–2019|Males|1|85+|0.744|0.52|0.908
Relative|Nasal cavity cancer|2015–2019|Males|1|All ages combined|0.885|0.844|0.918
Relative|Nasal cavity cancer|2015–2019|Males|2|00–04|||
Relative|Nasal cavity cancer|2015–2019|Males|2|05–09|||
Relative|Nasal cavity cancer|2015–2019|Males|2|10–14|||
Relative|Nasal cavity cancer|2015–2019|Males|2|15–19|||
Relative|Nasal cavity cancer|2015–2019|Males|2|20–24|||
Relative|Nasal cavity cancer|2015–2019|Males|2|25–29|||
Relative|Nasal cavity cancer|2015–2019|Males|2|30–34|||
Relative|Nasal cavity cancer|2015–2019|Males|2|35–39|||
Relative|Nasal cavity cancer|2015–2019|Males|2|40–44|||
Relative|Nasal cavity cancer|2015–2019|Males|2|45–49|0.962|0.739|0.999
Relative|Nasal cavity cancer|2015–2019|Males|2|50–54|0.873|0.687|0.955
Relative|Nasal cavity cancer|2015–2019|Males|2|55–59|0.992|0.879|1.009
Relative|Nasal cavity cancer|2015–2019|Males|2|60–64|0.827|0.672|0.918
Relative|Nasal cavity cancer|2015–2019|Males|2|65–69|0.753|0.595|0.861
Relative|Nasal cavity cancer|2015–2019|Males|2|70–74|0.619|0.43|0.767
Relative|Nasal cavity cancer|2015–2019|Males|2|75–79|||
Relative|Nasal cavity cancer|2015–2019|Males|2|80–84|0.81|0.562|0.964
Relative|Nasal cavity cancer|2015–2019|Males|2|85+|||
Relative|Nasal cavity cancer|2015–2019|Males|2|All ages combined|0.793|0.741|0.837
Relative|Nasal cavity cancer|2015–2019|Males|3|00–04|||
Relative|Nasal cavity cancer|2015–2019|Males|3|05–09|||
Relative|Nasal cavity cancer|2015–2019|Males|3|10–14|||
Relative|Nasal cavity cancer|2015–2019|Males|3|15–19|||
Relative|Nasal cavity cancer|2015–2019|Males|3|20–24|||
Relative|Nasal cavity cancer|2015–2019|Males|3|25–29|||
Relative|Nasal cavity cancer|2015–2019|Males|3|30–34|||
Relative|Nasal cavity cancer|2015–2019|Males|3|35–39|||
Relative|Nasal cavity cancer|2015–2019|Males|3|40–44|||
Relative|Nasal cavity cancer|2015–2019|Males|3|45–49|0.965|0.741|1.002
Relative|Nasal cavity cancer|2015–2019|Males|3|50–54|0.814|0.624|0.918
Relative|Nasal cavity cancer|2015–2019|Males|3|55–59|0.998|0.884|1.015
Relative|Nasal cavity cancer|2015–2019|Males|3|60–64|0.783|0.62|0.888
Relative|Nasal cavity cancer|2015–2019|Males|3|65–69|0.742|0.579|0.856
Relative|Nasal cavity cancer|2015–2019|Males|3|70–74|||
Relative|Nasal cavity cancer|2015–2019|Males|3|75–79|||
Relative|Nasal cavity cancer|2015–2019|Males|3|80–84|||
Relative|Nasal cavity cancer|2015–2019|Males|3|85+|||
Relative|Nasal cavity cancer|2015–2019|Males|3|All ages combined|0.78|0.725|0.827
Relative|Nasal cavity cancer|2015–2019|Males|4|00–04|||
Relative|Nasal cavity cancer|2015–2019|Males|4|05–09|||
Relative|Nasal cavity cancer|2015–2019|Males|4|10–14|||
Relative|Nasal cavity cancer|2015–2019|Males|4|15–19|||
Relative|Nasal cavity cancer|2015–2019|Males|4|20–24|||
Relative|Nasal cavity cancer|2015–2019|Males|4|25–29|||
Relative|Nasal cavity cancer|2015–2019|Males|4|30–34|||
Relative|Nasal cavity cancer|2015–2019|Males|4|35–39|||
Relative|Nasal cavity cancer|2015–2019|Males|4|40–44|||
Relative|Nasal cavity cancer|2015–2019|Males|4|45–49|||
Relative|Nasal cavity cancer|2015–2019|Males|4|50–54|0.744|0.542|0.87
Relative|Nasal cavity cancer|2015–2019|Males|4|55–59|1.005|0.891|1.022
Relative|Nasal cavity cancer|2015–2019|Males|4|60–64|0.732|0.558|0.853
Relative|Nasal cavity cancer|2015–2019|Males|4|65–69|0.683|0.516|0.811
Relative|Nasal cavity cancer|2015–2019|Males|4|70–74|||
Relative|Nasal cavity cancer|2015–2019|Males|4|75–79|||
Relative|Nasal cavity cancer|2015–2019|Males|4|80–84|||
Relative|Nasal cavity cancer|2015–2019|Males|4|85+|||
Relative|Nasal cavity cancer|2015–2019|Males|4|All ages combined|0.734|0.675|0.787
Relative|Nasal cavity cancer|2015–2019|Males|5|00–04|||
Relative|Nasal cavity cancer|2015–2019|Males|5|05–09|||
Relative|Nasal cavity cancer|2015–2019|Males|5|10–14|||
Relative|Nasal cavity cancer|2015–2019|Males|5|15–19|||
Relative|Nasal cavity cancer|2015–2019|Males|5|20–24|||
Relative|Nasal cavity cancer|2015–2019|Males|5|25–29|||
Relative|Nasal cavity cancer|2015–2019|Males|5|30–34|||
Relative|Nasal cavity cancer|2015–2019|Males|5|35–39|||
Relative|Nasal cavity cancer|2015–2019|Males|5|40–44|||
Relative|Nasal cavity cancer|2015–2019|Males|5|45–49|||
Relative|Nasal cavity cancer|2015–2019|Males|5|50–54|||
Relative|Nasal cavity cancer|2015–2019|Males|5|55–59|0.975|0.808|1.019
Relative|Nasal cavity cancer|2015–2019|Males|5|60–64|0.71|0.531|0.838
Relative|Nasal cavity cancer|2015–2019|Males|5|65–69|0.695|0.526|0.825
Relative|Nasal cavity cancer|2015–2019|Males|5|70–74|||
Relative|Nasal cavity cancer|2015–2019|Males|5|75–79|||
Relative|Nasal cavity cancer|2015–2019|Males|5|80–84|||
Relative|Nasal cavity cancer|2015–2019|Males|5|85+|||
Relative|Nasal cavity cancer|2015–2019|Males|5|All ages combined|0.712|0.65|0.769
Observed|Nasal cavity cancer|2015–2019|Females|1|00–04|||
Observed|Nasal cavity cancer|2015–2019|Females|1|05–09|||
Observed|Nasal cavity cancer|2015–2019|Females|1|10–14|||
Observed|Nasal cavity cancer|2015–2019|Females|1|15–19|||
Observed|Nasal cavity cancer|2015–2019|Females|1|20–24|||
Observed|Nasal cavity cancer|2015–2019|Females|1|25–29|||
Observed|Nasal cavity cancer|2015–2019|Females|1|30–34|||
Observed|Nasal cavity cancer|2015–2019|Females|1|35–39|||
Observed|Nasal cavity cancer|2015–2019|Females|1|40–44|||
Observed|Nasal cavity cancer|2015–2019|Females|1|45–49|||
Observed|Nasal cavity cancer|2015–2019|Females|1|50–54|||
Observed|Nasal cavity cancer|2015–2019|Females|1|55–59|0.952|0.706|0.993
Observed|Nasal cavity cancer|2015–2019|Females|1|60–64|||
Observed|Nasal cavity cancer|2015–2019|Females|1|65–69|1|0.908|1
Observed|Nasal cavity cancer|2015–2019|Females|1|70–74|0.837|0.653|0.929
Observed|Nasal cavity cancer|2015–2019|Females|1|75–79|||
Observed|Nasal cavity cancer|2015–2019|Females|1|80–84|0.827|0.603|0.931
Observed|Nasal cavity cancer|2015–2019|Females|1|85+|0.585|0.389|0.737
Observed|Nasal cavity cancer|2015–2019|Females|1|All ages combined|0.877|0.829|0.912
Observed|Nasal cavity cancer|2015–2019|Females|2|00–04|||
Observed|Nasal cavity cancer|2015–2019|Females|2|05–09|||
Observed|Nasal cavity cancer|2015–2019|Females|2|10–14|||
Observed|Nasal cavity cancer|2015–2019|Females|2|15–19|||
Observed|Nasal cavity cancer|2015–2019|Females|2|20–24|||
Observed|Nasal cavity cancer|2015–2019|Females|2|25–29|||
Observed|Nasal cavity cancer|2015–2019|Females|2|30–34|||
Observed|Nasal cavity cancer|2015–2019|Females|2|35–39|||
Observed|Nasal cavity cancer|2015–2019|Females|2|40–44|||
Observed|Nasal cavity cancer|2015–2019|Females|2|45–49|||
Observed|Nasal cavity cancer|2015–2019|Females|2|50–54|||
Observed|Nasal cavity cancer|2015–2019|Females|2|55–59|||
Observed|Nasal cavity cancer|2015–2019|Females|2|60–64|||
Observed|Nasal cavity cancer|2015–2019|Females|2|65–69|0.904|0.731|0.968
Observed|Nasal cavity cancer|2015–2019|Females|2|70–74|0.726|0.525|0.853
Observed|Nasal cavity cancer|2015–2019|Females|2|75–79|||
Observed|Nasal cavity cancer|2015–2019|Females|2|80–84|||
Observed|Nasal cavity cancer|2015–2019|Females|2|85+|||
Observed|Nasal cavity cancer|2015–2019|Females|2|All ages combined|0.793|0.736|0.839
Observed|Nasal cavity cancer|2015–2019|Females|3|00–04|||
Observed|Nasal cavity cancer|2015–2019|Females|3|05–09|||
Observed|Nasal cavity cancer|2015–2019|Females|3|10–14|||
Observed|Nasal cavity cancer|2015–2019|Females|3|15–19|||
Observed|Nasal cavity cancer|2015–2019|Females|3|20–24|||
Observed|Nasal cavity cancer|2015–2019|Females|3|25–29|||
Observed|Nasal cavity cancer|2015–2019|Females|3|30–34|||
Observed|Nasal cavity cancer|2015–2019|Females|3|35–39|||
Observed|Nasal cavity cancer|2015–2019|Females|3|40–44|||
Observed|Nasal cavity cancer|2015–2019|Females|3|45–49|||
Observed|Nasal cavity cancer|2015–2019|Females|3|50–54|||
Observed|Nasal cavity cancer|2015–2019|Females|3|55–59|||
Observed|Nasal cavity cancer|2015–2019|Females|3|60–64|||
Observed|Nasal cavity cancer|2015–2019|Females|3|65–69|0.904|0.731|0.968
Observed|Nasal cavity cancer|2015–2019|Females|3|70–74|||
Observed|Nasal cavity cancer|2015–2019|Females|3|75–79|||
Observed|Nasal cavity cancer|2015–2019|Females|3|80–84|||
Observed|Nasal cavity cancer|2015–2019|Females|3|85+|||
Observed|Nasal cavity cancer|2015–2019|Females|3|All ages combined|0.747|0.687|0.798
Observed|Nasal cavity cancer|2015–2019|Females|4|00–04|||
Observed|Nasal cavity cancer|2015–2019|Females|4|05–09|||
Observed|Nasal cavity cancer|2015–2019|Females|4|10–14|||
Observed|Nasal cavity cancer|2015–2019|Females|4|15–19|||
Observed|Nasal cavity cancer|2015–2019|Females|4|20–24|||
Observed|Nasal cavity cancer|2015–2019|Females|4|25–29|||
Observed|Nasal cavity cancer|2015–2019|Females|4|30–34|||
Observed|Nasal cavity cancer|2015–2019|Females|4|35–39|||
Observed|Nasal cavity cancer|2015–2019|Females|4|40–44|||
Observed|Nasal cavity cancer|2015–2019|Females|4|45–49|||
Observed|Nasal cavity cancer|2015–2019|Females|4|50–54|||
Observed|Nasal cavity cancer|2015–2019|Females|4|55–59|||
Observed|Nasal cavity cancer|2015–2019|Females|4|60–64|||
Observed|Nasal cavity cancer|2015–2019|Females|4|65–69|0.904|0.731|0.968
Observed|Nasal cavity cancer|2015–2019|Females|4|70–74|||
Observed|Nasal cavity cancer|2015–2019|Females|4|75–79|||
Observed|Nasal cavity cancer|2015–2019|Females|4|80–84|||
Observed|Nasal cavity cancer|2015–2019|Females|4|85+|||
Observed|Nasal cavity cancer|2015–2019|Females|4|All ages combined|0.701|0.638|0.756
Observed|Nasal cavity cancer|2015–2019|Females|5|00–04|||
Observed|Nasal cavity cancer|2015–2019|Females|5|05–09|||
Observed|Nasal cavity cancer|2015–2019|Females|5|10–14|||
Observed|Nasal cavity cancer|2015–2019|Females|5|15–19|||
Observed|Nasal cavity cancer|2015–2019|Females|5|20–24|||
Observed|Nasal cavity cancer|2015–2019|Females|5|25–29|||
Observed|Nasal cavity cancer|2015–2019|Females|5|30–34|||
Observed|Nasal cavity cancer|2015–2019|Females|5|35–39|||
Observed|Nasal cavity cancer|2015–2019|Females|5|40–44|||
Observed|Nasal cavity cancer|2015–2019|Females|5|45–49|||
Observed|Nasal cavity cancer|2015–2019|Females|5|50–54|||
Observed|Nasal cavity cancer|2015–2019|Females|5|55–59|||
Observed|Nasal cavity cancer|2015–2019|Females|5|60–64|||
Observed|Nasal cavity cancer|2015–2019|Females|5|65–69|0.863|0.673|0.947
Observed|Nasal cavity cancer|2015–2019|Females|5|70–74|||
Observed|Nasal cavity cancer|2015–2019|Females|5|75–79|||
Observed|Nasal cavity cancer|2015–2019|Females|5|80–84|||
Observed|Nasal cavity cancer|2015–2019|Females|5|85+|||
Observed|Nasal cavity cancer|2015–2019|Females|5|All ages combined|0.691|0.627|0.747
Relative|Nasal cavity cancer|2015–2019|Females|1|00–04|||
Relative|Nasal cavity cancer|2015–2019|Females|1|05–09|||
Relative|Nasal cavity cancer|2015–2019|Females|1|10–14|||
Relative|Nasal cavity cancer|2015–2019|Females|1|15–19|||
Relative|Nasal cavity cancer|2015–2019|Females|1|20–24|||
Relative|Nasal cavity cancer|2015–2019|Females|1|25–29|||
Relative|Nasal cavity cancer|2015–2019|Females|1|30–34|||
Relative|Nasal cavity cancer|2015–2019|Females|1|35–39|||
Relative|Nasal cavity cancer|2015–2019|Females|1|40–44|||
Relative|Nasal cavity cancer|2015–2019|Females|1|45–49|||
Relative|Nasal cavity cancer|2015–2019|Females|1|50–54|||
Relative|Nasal cavity cancer|2015–2019|Females|1|55–59|0.955|0.708|0.996
Relative|Nasal cavity cancer|2015–2019|Females|1|60–64|||
Relative|Nasal cavity cancer|2015–2019|Females|1|65–69|1.007|0.914|1.007
Relative|Nasal cavity cancer|2015–2019|Females|1|70–74|0.848|0.661|0.94
Relative|Nasal cavity cancer|2015–2019|Females|1|75–79|||
Relative|Nasal cavity cancer|2015–2019|Females|1|80–84|0.863|0.629|0.971
Relative|Nasal cavity cancer|2015–2019|Females|1|85+|0.657|0.437|0.828
Relative|Nasal cavity cancer|2015–2019|Females|1|All ages combined|0.896|0.847|0.932
Relative|Nasal cavity cancer|2015–2019|Females|2|00–04|||
Relative|Nasal cavity cancer|2015–2019|Females|2|05–09|||
Relative|Nasal cavity cancer|2015–2019|Females|2|10–14|||
Relative|Nasal cavity cancer|2015–2019|Females|2|15–19|||
Relative|Nasal cavity cancer|2015–2019|Females|2|20–24|||
Relative|Nasal cavity cancer|2015–2019|Females|2|25–29|||
Relative|Nasal cavity cancer|2015–2019|Females|2|30–34|||
Relative|Nasal cavity cancer|2015–2019|Females|2|35–39|||
Relative|Nasal cavity cancer|2015–2019|Females|2|40–44|||
Relative|Nasal cavity cancer|2015–2019|Females|2|45–49|||
Relative|Nasal cavity cancer|2015–2019|Females|2|50–54|||
Relative|Nasal cavity cancer|2015–2019|Females|2|55–59|||
Relative|Nasal cavity cancer|2015–2019|Females|2|60–64|||
Relative|Nasal cavity cancer|2015–2019|Females|2|65–69|0.918|0.743|0.983
Relative|Nasal cavity cancer|2015–2019|Females|2|70–74|0.745|0.539|0.876
Relative|Nasal cavity cancer|2015–2019|Females|2|75–79|||
Relative|Nasal cavity cancer|2015–2019|Females|2|80–84|||
Relative|Nasal cavity cancer|2015–2019|Females|2|85+|||
Relative|Nasal cavity cancer|2015–2019|Females|2|All ages combined|0.824|0.765|0.872
Relative|Nasal cavity cancer|2015–2019|Females|3|00–04|||
Relative|Nasal cavity cancer|2015–2019|Females|3|05–09|||
Relative|Nasal cavity cancer|2015–2019|Females|3|10–14|||
Relative|Nasal cavity cancer|2015–2019|Females|3|15–19|||
Relative|Nasal cavity cancer|2015–2019|Females|3|20–24|||
Relative|Nasal cavity cancer|2015–2019|Females|3|25–29|||
Relative|Nasal cavity cancer|2015–2019|Females|3|30–34|||
Relative|Nasal cavity cancer|2015–2019|Females|3|35–39|||
Relative|Nasal cavity cancer|2015–2019|Females|3|40–44|||
Relative|Nasal cavity cancer|2015–2019|Females|3|45–49|||
Relative|Nasal cavity cancer|2015–2019|Females|3|50–54|||
Relative|Nasal cavity cancer|2015–2019|Females|3|55–59|||
Relative|Nasal cavity cancer|2015–2019|Females|3|60–64|||
Relative|Nasal cavity cancer|2015–2019|Females|3|65–69|0.927|0.749|0.992
Relative|Nasal cavity cancer|2015–2019|Females|3|70–74|||
Relative|Nasal cavity cancer|2015–2019|Females|3|75–79|||
Relative|Nasal cavity cancer|2015–2019|Females|3|80–84|||
Relative|Nasal cavity cancer|2015–2019|Females|3|85+|||
Relative|Nasal cavity cancer|2015–2019|Females|3|All ages combined|0.791|0.727|0.845
Relative|Nasal cavity cancer|2015–2019|Females|4|00–04|||
Relative|Nasal cavity cancer|2015–2019|Females|4|05–09|||
Relative|Nasal cavity cancer|2015–2019|Females|4|10–14|||
Relative|Nasal cavity cancer|2015–2019|Females|4|15–19|||
Relative|Nasal cavity cancer|2015–2019|Females|4|20–24|||
Relative|Nasal cavity cancer|2015–2019|Females|4|25–29|||
Relative|Nasal cavity cancer|2015–2019|Females|4|30–34|||
Relative|Nasal cavity cancer|2015–2019|Females|4|35–39|||
Relative|Nasal cavity cancer|2015–2019|Females|4|40–44|||
Relative|Nasal cavity cancer|2015–2019|Females|4|45–49|||
Relative|Nasal cavity cancer|2015–2019|Females|4|50–54|||
Relative|Nasal cavity cancer|2015–2019|Females|4|55–59|||
Relative|Nasal cavity cancer|2015–2019|Females|4|60–64|||
Relative|Nasal cavity cancer|2015–2019|Females|4|65–69|0.936|0.757|1.002
Relative|Nasal cavity cancer|2015–2019|Females|4|70–74|||
Relative|Nasal cavity cancer|2015–2019|Females|4|75–79|||
Relative|Nasal cavity cancer|2015–2019|Females|4|80–84|||
Relative|Nasal cavity cancer|2015–2019|Females|4|85+|||
Relative|Nasal cavity cancer|2015–2019|Females|4|All ages combined|0.755|0.686|0.813
Relative|Nasal cavity cancer|2015–2019|Females|5|00–04|||
Relative|Nasal cavity cancer|2015–2019|Females|5|05–09|||
Relative|Nasal cavity cancer|2015–2019|Females|5|10–14|||
Relative|Nasal cavity cancer|2015–2019|Females|5|15–19|||
Relative|Nasal cavity cancer|2015–2019|Females|5|20–24|||
Relative|Nasal cavity cancer|2015–2019|Females|5|25–29|||
Relative|Nasal cavity cancer|2015–2019|Females|5|30–34|||
Relative|Nasal cavity cancer|2015–2019|Females|5|35–39|||
Relative|Nasal cavity cancer|2015–2019|Females|5|40–44|||
Relative|Nasal cavity cancer|2015–2019|Females|5|45–49|||
Relative|Nasal cavity cancer|2015–2019|Females|5|50–54|||
Relative|Nasal cavity cancer|2015–2019|Females|5|55–59|||
Relative|Nasal cavity cancer|2015–2019|Females|5|60–64|||
Relative|Nasal cavity cancer|2015–2019|Females|5|65–69|0.904|0.705|0.992
Relative|Nasal cavity cancer|2015–2019|Females|5|70–74|||
Relative|Nasal cavity cancer|2015–2019|Females|5|75–79|||
Relative|Nasal cavity cancer|2015–2019|Females|5|80–84|||
Relative|Nasal cavity cancer|2015–2019|Females|5|85+|||
Relative|Nasal cavity cancer|2015–2019|Females|5|All ages combined|0.756|0.686|0.817
Observed|Nasal cavity cancer|2015–2019|Persons|1|00–04|||
Observed|Nasal cavity cancer|2015–2019|Persons|1|05–09|||
Observed|Nasal cavity cancer|2015–2019|Persons|1|10–14|||
Observed|Nasal cavity cancer|2015–2019|Persons|1|15–19|||
Observed|Nasal cavity cancer|2015–2019|Persons|1|20–24|||
Observed|Nasal cavity cancer|2015–2019|Persons|1|25–29|||
Observed|Nasal cavity cancer|2015–2019|Persons|1|30–34|||
Observed|Nasal cavity cancer|2015–2019|Persons|1|35–39|||
Observed|Nasal cavity cancer|2015–2019|Persons|1|40–44|0.913|0.696|0.978
Observed|Nasal cavity cancer|2015–2019|Persons|1|45–49|1|0.93|1
Observed|Nasal cavity cancer|2015–2019|Persons|1|50–54|0.958|0.844|0.989
Observed|Nasal cavity cancer|2015–2019|Persons|1|55–59|0.972|0.893|0.993
Observed|Nasal cavity cancer|2015–2019|Persons|1|60–64|0.893|0.789|0.948
Observed|Nasal cavity cancer|2015–2019|Persons|1|65–69|0.908|0.817|0.955
Observed|Nasal cavity cancer|2015–2019|Persons|1|70–74|0.84|0.729|0.908
Observed|Nasal cavity cancer|2015–2019|Persons|1|75–79|0.766|0.618|0.863
Observed|Nasal cavity cancer|2015–2019|Persons|1|80–84|0.83|0.688|0.911
Observed|Nasal cavity cancer|2015–2019|Persons|1|85+|0.613|0.479|0.723
Observed|Nasal cavity cancer|2015–2019|Persons|1|All ages combined|0.869|0.839|0.894
Observed|Nasal cavity cancer|2015–2019|Persons|2|00–04|||
Observed|Nasal cavity cancer|2015–2019|Persons|2|05–09|||
Observed|Nasal cavity cancer|2015–2019|Persons|2|10–14|||
Observed|Nasal cavity cancer|2015–2019|Persons|2|15–19|||
Observed|Nasal cavity cancer|2015–2019|Persons|2|20–24|||
Observed|Nasal cavity cancer|2015–2019|Persons|2|25–29|||
Observed|Nasal cavity cancer|2015–2019|Persons|2|30–34|||
Observed|Nasal cavity cancer|2015–2019|Persons|2|35–39|||
Observed|Nasal cavity cancer|2015–2019|Persons|2|40–44|0.832|0.613|0.933
Observed|Nasal cavity cancer|2015–2019|Persons|2|45–49|0.951|0.819|0.988
Observed|Nasal cavity cancer|2015–2019|Persons|2|50–54|0.92|0.801|0.969
Observed|Nasal cavity cancer|2015–2019|Persons|2|55–59|0.925|0.829|0.968
Observed|Nasal cavity cancer|2015–2019|Persons|2|60–64|0.8|0.68|0.878
Observed|Nasal cavity cancer|2015–2019|Persons|2|65–69|0.803|0.695|0.876
Observed|Nasal cavity cancer|2015–2019|Persons|2|70–74|0.655|0.524|0.758
Observed|Nasal cavity cancer|2015–2019|Persons|2|75–79|0.65|0.493|0.769
Observed|Nasal cavity cancer|2015–2019|Persons|2|80–84|0.721|0.569|0.828
Observed|Nasal cavity cancer|2015–2019|Persons|2|85+|0.406|0.284|0.524
Observed|Nasal cavity cancer|2015–2019|Persons|2|All ages combined|0.769|0.733|0.801
Observed|Nasal cavity cancer|2015–2019|Persons|3|00–04|||
Observed|Nasal cavity cancer|2015–2019|Persons|3|05–09|||
Observed|Nasal cavity cancer|2015–2019|Persons|3|10–14|||
Observed|Nasal cavity cancer|2015–2019|Persons|3|15–19|||
Observed|Nasal cavity cancer|2015–2019|Persons|3|20–24|||
Observed|Nasal cavity cancer|2015–2019|Persons|3|25–29|||
Observed|Nasal cavity cancer|2015–2019|Persons|3|30–34|||
Observed|Nasal cavity cancer|2015–2019|Persons|3|35–39|||
Observed|Nasal cavity cancer|2015–2019|Persons|3|40–44|0.832|0.613|0.933
Observed|Nasal cavity cancer|2015–2019|Persons|3|45–49|0.951|0.819|0.988
Observed|Nasal cavity cancer|2015–2019|Persons|3|50–54|0.882|0.756|0.945
Observed|Nasal cavity cancer|2015–2019|Persons|3|55–59|0.925|0.829|0.968
Observed|Nasal cavity cancer|2015–2019|Persons|3|60–64|0.767|0.644|0.853
Observed|Nasal cavity cancer|2015–2019|Persons|3|65–69|0.79|0.68|0.865
Observed|Nasal cavity cancer|2015–2019|Persons|3|70–74|0.636|0.504|0.742
Observed|Nasal cavity cancer|2015–2019|Persons|3|75–79|0.553|0.395|0.685
Observed|Nasal cavity cancer|2015–2019|Persons|3|80–84|0.591|0.429|0.721
Observed|Nasal cavity cancer|2015–2019|Persons|3|85+|0.356|0.24|0.474
Observed|Nasal cavity cancer|2015–2019|Persons|3|All ages combined|0.733|0.695|0.767
Observed|Nasal cavity cancer|2015–2019|Persons|4|00–04|||
Observed|Nasal cavity cancer|2015–2019|Persons|4|05–09|||
Observed|Nasal cavity cancer|2015–2019|Persons|4|10–14|||
Observed|Nasal cavity cancer|2015–2019|Persons|4|15–19|||
Observed|Nasal cavity cancer|2015–2019|Persons|4|20–24|||
Observed|Nasal cavity cancer|2015–2019|Persons|4|25–29|||
Observed|Nasal cavity cancer|2015–2019|Persons|4|30–34|||
Observed|Nasal cavity cancer|2015–2019|Persons|4|35–39|||
Observed|Nasal cavity cancer|2015–2019|Persons|4|40–44|||
Observed|Nasal cavity cancer|2015–2019|Persons|4|45–49|0.868|0.711|0.943
Observed|Nasal cavity cancer|2015–2019|Persons|4|50–54|0.816|0.676|0.9
Observed|Nasal cavity cancer|2015–2019|Persons|4|55–59|0.925|0.829|0.968
Observed|Nasal cavity cancer|2015–2019|Persons|4|60–64|0.699|0.569|0.797
Observed|Nasal cavity cancer|2015–2019|Persons|4|65–69|0.747|0.633|0.831
Observed|Nasal cavity cancer|2015–2019|Persons|4|70–74|0.53|0.397|0.646
Observed|Nasal cavity cancer|2015–2019|Persons|4|75–79|0.468|0.318|0.605
Observed|Nasal cavity cancer|2015–2019|Persons|4|80–84|0.535|0.372|0.673
Observed|Nasal cavity cancer|2015–2019|Persons|4|85+|0.309|0.2|0.425
Observed|Nasal cavity cancer|2015–2019|Persons|4|All ages combined|0.678|0.638|0.715
Observed|Nasal cavity cancer|2015–2019|Persons|5|00–04|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|05–09|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|10–14|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|15–19|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|20–24|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|25–29|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|30–34|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|35–39|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|40–44|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|45–49|0.868|0.711|0.943
Observed|Nasal cavity cancer|2015–2019|Persons|5|50–54|0.816|0.676|0.9
Observed|Nasal cavity cancer|2015–2019|Persons|5|55–59|0.903|0.794|0.956
Observed|Nasal cavity cancer|2015–2019|Persons|5|60–64|0.681|0.55|0.782
Observed|Nasal cavity cancer|2015–2019|Persons|5|65–69|0.732|0.616|0.818
Observed|Nasal cavity cancer|2015–2019|Persons|5|70–74|0.479|0.348|0.598
Observed|Nasal cavity cancer|2015–2019|Persons|5|75–79|0.408|0.266|0.544
Observed|Nasal cavity cancer|2015–2019|Persons|5|80–84|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|85+|||
Observed|Nasal cavity cancer|2015–2019|Persons|5|All ages combined|0.652|0.611|0.69
Relative|Nasal cavity cancer|2015–2019|Persons|1|00–04|||
Relative|Nasal cavity cancer|2015–2019|Persons|1|05–09|||
Relative|Nasal cavity cancer|2015–2019|Persons|1|10–14|||
Relative|Nasal cavity cancer|2015–2019|Persons|1|15–19|||
Relative|Nasal cavity cancer|2015–2019|Persons|1|20–24|||
Relative|Nasal cavity cancer|2015–2019|Persons|1|25–29|||
Relative|Nasal cavity cancer|2015–2019|Persons|1|30–34|||
Relative|Nasal cavity cancer|2015–2019|Persons|1|35–39|||
Relative|Nasal cavity cancer|2015–2019|Persons|1|40–44|0.915|0.697|0.979
Relative|Nasal cavity cancer|2015–2019|Persons|1|45–49|1.002|0.931|1.002
Relative|Nasal cavity cancer|2015–2019|Persons|1|50–54|0.961|0.847|0.992
Relative|Nasal cavity cancer|2015–2019|Persons|1|55–59|0.977|0.898|0.998
Relative|Nasal cavity cancer|2015–2019|Persons|1|60–64|0.9|0.795|0.954
Relative|Nasal cavity cancer|2015–2019|Persons|1|65–69|0.918|0.826|0.965
Relative|Nasal cavity cancer|2015–2019|Persons|1|70–74|0.853|0.741|0.922
Relative|Nasal cavity cancer|2015–2019|Persons|1|75–79|0.788|0.636|0.888
Relative|Nasal cavity cancer|2015–2019|Persons|1|80–84|0.872|0.723|0.957
Relative|Nasal cavity cancer|2015–2019|Persons|1|85+|0.701|0.548|0.826
Relative|Nasal cavity cancer|2015–2019|Persons|1|All ages combined|0.89|0.859|0.915
Relative|Nasal cavity cancer|2015–2019|Persons|2|00–04|||
Relative|Nasal cavity cancer|2015–2019|Persons|2|05–09|||
Relative|Nasal cavity cancer|2015–2019|Persons|2|10–14|||
Relative|Nasal cavity cancer|2015–2019|Persons|2|15–19|||
Relative|Nasal cavity cancer|2015–2019|Persons|2|20–24|||
Relative|Nasal cavity cancer|2015–2019|Persons|2|25–29|||
Relative|Nasal cavity cancer|2015–2019|Persons|2|30–34|||
Relative|Nasal cavity cancer|2015–2019|Persons|2|35–39|||
Relative|Nasal cavity cancer|2015–2019|Persons|2|40–44|0.835|0.615|0.936
Relative|Nasal cavity cancer|2015–2019|Persons|2|45–49|0.955|0.822|0.992
Relative|Nasal cavity cancer|2015–2019|Persons|2|50–54|0.926|0.806|0.975
Relative|Nasal cavity cancer|2015–2019|Persons|2|55–59|0.935|0.838|0.978
Relative|Nasal cavity cancer|2015–2019|Persons|2|60–64|0.811|0.69|0.891
Relative|Nasal cavity cancer|2015–2019|Persons|2|65–69|0.821|0.71|0.895
Relative|Nasal cavity cancer|2015–2019|Persons|2|70–74|0.677|0.541|0.783
Relative|Nasal cavity cancer|2015–2019|Persons|2|75–79|0.69|0.524|0.816
Relative|Nasal cavity cancer|2015–2019|Persons|2|80–84|0.805|0.635|0.923
Relative|Nasal cavity cancer|2015–2019|Persons|2|85+|0.538|0.377|0.695
Relative|Nasal cavity cancer|2015–2019|Persons|2|All ages combined|0.806|0.768|0.839
Relative|Nasal cavity cancer|2015–2019|Persons|3|00–04|||
Relative|Nasal cavity cancer|2015–2019|Persons|3|05–09|||
Relative|Nasal cavity cancer|2015–2019|Persons|3|10–14|||
Relative|Nasal cavity cancer|2015–2019|Persons|3|15–19|||
Relative|Nasal cavity cancer|2015–2019|Persons|3|20–24|||
Relative|Nasal cavity cancer|2015–2019|Persons|3|25–29|||
Relative|Nasal cavity cancer|2015–2019|Persons|3|30–34|||
Relative|Nasal cavity cancer|2015–2019|Persons|3|35–39|||
Relative|Nasal cavity cancer|2015–2019|Persons|3|40–44|0.836|0.616|0.938
Relative|Nasal cavity cancer|2015–2019|Persons|3|45–49|0.957|0.824|0.994
Relative|Nasal cavity cancer|2015–2019|Persons|3|50–54|0.89|0.763|0.954
Relative|Nasal cavity cancer|2015–2019|Persons|3|55–59|0.94|0.842|0.983
Relative|Nasal cavity cancer|2015–2019|Persons|3|60–64|0.785|0.659|0.872
Relative|Nasal cavity cancer|2015–2019|Persons|3|65–69|0.817|0.703|0.895
Relative|Nasal cavity cancer|2015–2019|Persons|3|70–74|0.67|0.531|0.782
Relative|Nasal cavity cancer|2015–2019|Persons|3|75–79|0.606|0.433|0.752
Relative|Nasal cavity cancer|2015–2019|Persons|3|80–84|0.704|0.511|0.859
Relative|Nasal cavity cancer|2015–2019|Persons|3|85+|0.555|0.374|0.738
Relative|Nasal cavity cancer|2015–2019|Persons|3|All ages combined|0.784|0.744|0.821
Relative|Nasal cavity cancer|2015–2019|Persons|4|00–04|||
Relative|Nasal cavity cancer|2015–2019|Persons|4|05–09|||
Relative|Nasal cavity cancer|2015–2019|Persons|4|10–14|||
Relative|Nasal cavity cancer|2015–2019|Persons|4|15–19|||
Relative|Nasal cavity cancer|2015–2019|Persons|4|20–24|||
Relative|Nasal cavity cancer|2015–2019|Persons|4|25–29|||
Relative|Nasal cavity cancer|2015–2019|Persons|4|30–34|||
Relative|Nasal cavity cancer|2015–2019|Persons|4|35–39|||
Relative|Nasal cavity cancer|2015–2019|Persons|4|40–44|||
Relative|Nasal cavity cancer|2015–2019|Persons|4|45–49|0.876|0.717|0.951
Relative|Nasal cavity cancer|2015–2019|Persons|4|50–54|0.827|0.685|0.912
Relative|Nasal cavity cancer|2015–2019|Persons|4|55–59|0.945|0.847|0.989
Relative|Nasal cavity cancer|2015–2019|Persons|4|60–64|0.721|0.587|0.822
Relative|Nasal cavity cancer|2015–2019|Persons|4|65–69|0.784|0.663|0.871
Relative|Nasal cavity cancer|2015–2019|Persons|4|70–74|0.57|0.427|0.696
Relative|Nasal cavity cancer|2015–2019|Persons|4|75–79|0.535|0.364|0.69
Relative|Nasal cavity cancer|2015–2019|Persons|4|80–84|0.69|0.481|0.868
Relative|Nasal cavity cancer|2015–2019|Persons|4|85+|0.572|0.369|0.786
Relative|Nasal cavity cancer|2015–2019|Persons|4|All ages combined|0.742|0.698|0.782
Relative|Nasal cavity cancer|2015–2019|Persons|5|00–04|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|05–09|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|10–14|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|15–19|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|20–24|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|25–29|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|30–34|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|35–39|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|40–44|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|45–49|0.878|0.719|0.954
Relative|Nasal cavity cancer|2015–2019|Persons|5|50–54|0.83|0.688|0.916
Relative|Nasal cavity cancer|2015–2019|Persons|5|55–59|0.929|0.816|0.983
Relative|Nasal cavity cancer|2015–2019|Persons|5|60–64|0.71|0.573|0.814
Relative|Nasal cavity cancer|2015–2019|Persons|5|65–69|0.779|0.656|0.871
Relative|Nasal cavity cancer|2015–2019|Persons|5|70–74|0.528|0.384|0.659
Relative|Nasal cavity cancer|2015–2019|Persons|5|75–79|0.486|0.317|0.649
Relative|Nasal cavity cancer|2015–2019|Persons|5|80–84|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|85+|||
Relative|Nasal cavity cancer|2015–2019|Persons|5|All ages combined|0.73|0.684|0.773
Observed|Nasopharyngeal cancer|2015–2019|Males|1|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Males|1|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Males|1|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Males|1|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Males|1|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Males|1|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Males|1|30–34|1|0.864|1
Observed|Nasopharyngeal cancer|2015–2019|Males|1|35–39|1|0.894|1
Observed|Nasopharyngeal cancer|2015–2019|Males|1|40–44|0.962|0.857|0.99
Observed|Nasopharyngeal cancer|2015–2019|Males|1|45–49|1|0.956|1
Observed|Nasopharyngeal cancer|2015–2019|Males|1|50–54|0.891|0.786|0.947
Observed|Nasopharyngeal cancer|2015–2019|Males|1|55–59|0.918|0.826|0.962
Observed|Nasopharyngeal cancer|2015–2019|Males|1|60–64|0.876|0.775|0.933
Observed|Nasopharyngeal cancer|2015–2019|Males|1|65–69|0.85|0.739|0.916
Observed|Nasopharyngeal cancer|2015–2019|Males|1|70–74|0.709|0.537|0.827
Observed|Nasopharyngeal cancer|2015–2019|Males|1|75–79|0.781|0.576|0.895
Observed|Nasopharyngeal cancer|2015–2019|Males|1|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Males|1|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Males|1|All ages combined|0.884|0.854|0.908
Observed|Nasopharyngeal cancer|2015–2019|Males|2|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Males|2|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Males|2|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Males|2|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Males|2|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Males|2|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Males|2|30–34|||
Observed|Nasopharyngeal cancer|2015–2019|Males|2|35–39|0.96|0.751|0.994
Observed|Nasopharyngeal cancer|2015–2019|Males|2|40–44|0.846|0.716|0.92
Observed|Nasopharyngeal cancer|2015–2019|Males|2|45–49|0.901|0.793|0.954
Observed|Nasopharyngeal cancer|2015–2019|Males|2|50–54|0.845|0.731|0.913
Observed|Nasopharyngeal cancer|2015–2019|Males|2|55–59|0.858|0.752|0.921
Observed|Nasopharyngeal cancer|2015–2019|Males|2|60–64|0.841|0.731|0.909
Observed|Nasopharyngeal cancer|2015–2019|Males|2|65–69|0.733|0.606|0.825
Observed|Nasopharyngeal cancer|2015–2019|Males|2|70–74|0.593|0.426|0.727
Observed|Nasopharyngeal cancer|2015–2019|Males|2|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Males|2|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Males|2|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Males|2|All ages combined|0.795|0.758|0.827
Observed|Nasopharyngeal cancer|2015–2019|Males|3|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Males|3|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Males|3|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Males|3|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Males|3|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Males|3|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Males|3|30–34|||
Observed|Nasopharyngeal cancer|2015–2019|Males|3|35–39|0.96|0.751|0.994
Observed|Nasopharyngeal cancer|2015–2019|Males|3|40–44|0.801|0.661|0.888
Observed|Nasopharyngeal cancer|2015–2019|Males|3|45–49|0.836|0.716|0.908
Observed|Nasopharyngeal cancer|2015–2019|Males|3|50–54|0.786|0.666|0.867
Observed|Nasopharyngeal cancer|2015–2019|Males|3|55–59|0.731|0.611|0.819
Observed|Nasopharyngeal cancer|2015–2019|Males|3|60–64|0.745|0.614|0.837
Observed|Nasopharyngeal cancer|2015–2019|Males|3|65–69|0.62|0.484|0.73
Observed|Nasopharyngeal cancer|2015–2019|Males|3|70–74|0.552|0.389|0.688
Observed|Nasopharyngeal cancer|2015–2019|Males|3|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Males|3|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Males|3|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Males|3|All ages combined|0.721|0.681|0.757
Observed|Nasopharyngeal cancer|2015–2019|Males|4|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Males|4|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Males|4|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Males|4|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Males|4|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Males|4|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Males|4|30–34|||
Observed|Nasopharyngeal cancer|2015–2019|Males|4|35–39|0.918|0.71|0.979
Observed|Nasopharyngeal cancer|2015–2019|Males|4|40–44|0.731|0.581|0.835
Observed|Nasopharyngeal cancer|2015–2019|Males|4|45–49|0.733|0.606|0.824
Observed|Nasopharyngeal cancer|2015–2019|Males|4|50–54|0.729|0.606|0.82
Observed|Nasopharyngeal cancer|2015–2019|Males|4|55–59|0.702|0.58|0.794
Observed|Nasopharyngeal cancer|2015–2019|Males|4|60–64|0.707|0.573|0.806
Observed|Nasopharyngeal cancer|2015–2019|Males|4|65–69|0.557|0.417|0.675
Observed|Nasopharyngeal cancer|2015–2019|Males|4|70–74|0.49|0.334|0.629
Observed|Nasopharyngeal cancer|2015–2019|Males|4|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Males|4|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Males|4|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Males|4|All ages combined|0.661|0.619|0.7
Observed|Nasopharyngeal cancer|2015–2019|Males|5|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Males|5|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Males|5|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Males|5|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Males|5|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Males|5|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Males|5|30–34|||
Observed|Nasopharyngeal cancer|2015–2019|Males|5|35–39|0.876|0.663|0.958
Observed|Nasopharyngeal cancer|2015–2019|Males|5|40–44|0.689|0.536|0.8
Observed|Nasopharyngeal cancer|2015–2019|Males|5|45–49|0.703|0.575|0.799
Observed|Nasopharyngeal cancer|2015–2019|Males|5|50–54|0.714|0.59|0.807
Observed|Nasopharyngeal cancer|2015–2019|Males|5|55–59|0.67|0.546|0.767
Observed|Nasopharyngeal cancer|2015–2019|Males|5|60–64|0.655|0.51|0.766
Observed|Nasopharyngeal cancer|2015–2019|Males|5|65–69|0.518|0.379|0.64
Observed|Nasopharyngeal cancer|2015–2019|Males|5|70–74|0.447|0.297|0.587
Observed|Nasopharyngeal cancer|2015–2019|Males|5|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Males|5|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Males|5|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Males|5|All ages combined|0.628|0.585|0.668
Relative|Nasopharyngeal cancer|2015–2019|Males|1|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Males|1|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Males|1|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Males|1|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Males|1|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Males|1|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Males|1|30–34|1.001|0.865|1.001
Relative|Nasopharyngeal cancer|2015–2019|Males|1|35–39|1.001|0.895|1.001
Relative|Nasopharyngeal cancer|2015–2019|Males|1|40–44|0.964|0.858|0.992
Relative|Nasopharyngeal cancer|2015–2019|Males|1|45–49|1.002|0.958|1.002
Relative|Nasopharyngeal cancer|2015–2019|Males|1|50–54|0.895|0.789|0.95
Relative|Nasopharyngeal cancer|2015–2019|Males|1|55–59|0.922|0.83|0.967
Relative|Nasopharyngeal cancer|2015–2019|Males|1|60–64|0.883|0.781|0.941
Relative|Nasopharyngeal cancer|2015–2019|Males|1|65–69|0.86|0.748|0.927
Relative|Nasopharyngeal cancer|2015–2019|Males|1|70–74|0.723|0.548|0.843
Relative|Nasopharyngeal cancer|2015–2019|Males|1|75–79|0.806|0.595|0.923
Relative|Nasopharyngeal cancer|2015–2019|Males|1|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Males|1|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Males|1|All ages combined|0.893|0.863|0.918
Relative|Nasopharyngeal cancer|2015–2019|Males|2|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Males|2|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Males|2|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Males|2|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Males|2|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Males|2|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Males|2|30–34|||
Relative|Nasopharyngeal cancer|2015–2019|Males|2|35–39|0.963|0.753|0.997
Relative|Nasopharyngeal cancer|2015–2019|Males|2|40–44|0.849|0.718|0.923
Relative|Nasopharyngeal cancer|2015–2019|Males|2|45–49|0.906|0.797|0.959
Relative|Nasopharyngeal cancer|2015–2019|Males|2|50–54|0.851|0.737|0.92
Relative|Nasopharyngeal cancer|2015–2019|Males|2|55–59|0.867|0.76|0.931
Relative|Nasopharyngeal cancer|2015–2019|Males|2|60–64|0.855|0.743|0.924
Relative|Nasopharyngeal cancer|2015–2019|Males|2|65–69|0.752|0.621|0.846
Relative|Nasopharyngeal cancer|2015–2019|Males|2|70–74|0.618|0.444|0.757
Relative|Nasopharyngeal cancer|2015–2019|Males|2|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Males|2|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Males|2|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Males|2|All ages combined|0.811|0.773|0.844
Relative|Nasopharyngeal cancer|2015–2019|Males|3|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Males|3|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Males|3|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Males|3|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Males|3|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Males|3|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Males|3|30–34|||
Relative|Nasopharyngeal cancer|2015–2019|Males|3|35–39|0.964|0.754|0.998
Relative|Nasopharyngeal cancer|2015–2019|Males|3|40–44|0.805|0.664|0.893
Relative|Nasopharyngeal cancer|2015–2019|Males|3|45–49|0.842|0.722|0.915
Relative|Nasopharyngeal cancer|2015–2019|Males|3|50–54|0.796|0.674|0.878
Relative|Nasopharyngeal cancer|2015–2019|Males|3|55–59|0.743|0.622|0.833
Relative|Nasopharyngeal cancer|2015–2019|Males|3|60–64|0.765|0.63|0.859
Relative|Nasopharyngeal cancer|2015–2019|Males|3|65–69|0.645|0.503|0.759
Relative|Nasopharyngeal cancer|2015–2019|Males|3|70–74|0.589|0.415|0.734
Relative|Nasopharyngeal cancer|2015–2019|Males|3|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Males|3|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Males|3|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Males|3|All ages combined|0.742|0.7|0.779
Relative|Nasopharyngeal cancer|2015–2019|Males|4|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Males|4|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Males|4|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Males|4|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Males|4|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Males|4|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Males|4|30–34|||
Relative|Nasopharyngeal cancer|2015–2019|Males|4|35–39|0.923|0.714|0.984
Relative|Nasopharyngeal cancer|2015–2019|Males|4|40–44|0.737|0.585|0.841
Relative|Nasopharyngeal cancer|2015–2019|Males|4|45–49|0.741|0.613|0.833
Relative|Nasopharyngeal cancer|2015–2019|Males|4|50–54|0.741|0.615|0.833
Relative|Nasopharyngeal cancer|2015–2019|Males|4|55–59|0.719|0.594|0.813
Relative|Nasopharyngeal cancer|2015–2019|Males|4|60–64|0.734|0.594|0.836
Relative|Nasopharyngeal cancer|2015–2019|Males|4|65–69|0.588|0.441|0.713
Relative|Nasopharyngeal cancer|2015–2019|Males|4|70–74|0.538|0.367|0.69
Relative|Nasopharyngeal cancer|2015–2019|Males|4|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Males|4|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Males|4|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Males|4|All ages combined|0.686|0.642|0.726
Relative|Nasopharyngeal cancer|2015–2019|Males|5|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Males|5|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Males|5|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Males|5|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Males|5|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Males|5|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Males|5|30–34|||
Relative|Nasopharyngeal cancer|2015–2019|Males|5|35–39|0.882|0.667|0.965
Relative|Nasopharyngeal cancer|2015–2019|Males|5|40–44|0.695|0.541|0.808
Relative|Nasopharyngeal cancer|2015–2019|Males|5|45–49|0.713|0.583|0.81
Relative|Nasopharyngeal cancer|2015–2019|Males|5|50–54|0.729|0.602|0.824
Relative|Nasopharyngeal cancer|2015–2019|Males|5|55–59|0.691|0.563|0.791
Relative|Nasopharyngeal cancer|2015–2019|Males|5|60–64|0.687|0.535|0.804
Relative|Nasopharyngeal cancer|2015–2019|Males|5|65–69|0.556|0.407|0.687
Relative|Nasopharyngeal cancer|2015–2019|Males|5|70–74|0.506|0.335|0.663
Relative|Nasopharyngeal cancer|2015–2019|Males|5|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Males|5|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Males|5|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Males|5|All ages combined|0.658|0.613|0.7
Observed|Nasopharyngeal cancer|2015–2019|Females|1|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|30–34|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|35–39|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|40–44|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|45–49|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|50–54|1|0.888|1
Observed|Nasopharyngeal cancer|2015–2019|Females|1|55–59|0.8|0.608|0.905
Observed|Nasopharyngeal cancer|2015–2019|Females|1|60–64|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|65–69|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|70–74|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Females|1|All ages combined|0.84|0.78|0.885
Observed|Nasopharyngeal cancer|2015–2019|Females|2|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|30–34|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|35–39|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|40–44|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|45–49|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|50–54|0.876|0.663|0.958
Observed|Nasopharyngeal cancer|2015–2019|Females|2|55–59|0.698|0.501|0.83
Observed|Nasopharyngeal cancer|2015–2019|Females|2|60–64|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|65–69|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|70–74|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Females|2|All ages combined|0.76|0.691|0.816
Observed|Nasopharyngeal cancer|2015–2019|Females|3|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|30–34|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|35–39|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|40–44|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|45–49|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|50–54|0.771|0.56|0.89
Observed|Nasopharyngeal cancer|2015–2019|Females|3|55–59|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|60–64|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|65–69|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|70–74|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Females|3|All ages combined|0.713|0.641|0.772
Observed|Nasopharyngeal cancer|2015–2019|Females|4|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|30–34|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|35–39|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|40–44|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|45–49|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|50–54|0.734|0.522|0.863
Observed|Nasopharyngeal cancer|2015–2019|Females|4|55–59|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|60–64|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|65–69|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|70–74|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Females|4|All ages combined|0.675|0.603|0.738
Observed|Nasopharyngeal cancer|2015–2019|Females|5|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|30–34|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|35–39|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|40–44|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|45–49|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|50–54|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|55–59|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|60–64|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|65–69|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|70–74|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Females|5|All ages combined|0.665|0.592|0.728
Relative|Nasopharyngeal cancer|2015–2019|Females|1|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|30–34|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|35–39|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|40–44|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|45–49|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|50–54|1.002|0.89|1.002
Relative|Nasopharyngeal cancer|2015–2019|Females|1|55–59|0.802|0.61|0.907
Relative|Nasopharyngeal cancer|2015–2019|Females|1|60–64|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|65–69|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|70–74|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Females|1|All ages combined|0.848|0.787|0.894
Relative|Nasopharyngeal cancer|2015–2019|Females|2|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|30–34|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|35–39|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|40–44|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|45–49|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|50–54|0.88|0.666|0.962
Relative|Nasopharyngeal cancer|2015–2019|Females|2|55–59|0.703|0.504|0.836
Relative|Nasopharyngeal cancer|2015–2019|Females|2|60–64|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|65–69|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|70–74|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Females|2|All ages combined|0.773|0.703|0.829
Relative|Nasopharyngeal cancer|2015–2019|Females|3|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|30–34|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|35–39|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|40–44|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|45–49|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|50–54|0.776|0.564|0.896
Relative|Nasopharyngeal cancer|2015–2019|Females|3|55–59|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|60–64|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|65–69|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|70–74|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Females|3|All ages combined|0.73|0.657|0.791
Relative|Nasopharyngeal cancer|2015–2019|Females|4|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|30–34|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|35–39|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|40–44|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|45–49|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|50–54|0.741|0.527|0.871
Relative|Nasopharyngeal cancer|2015–2019|Females|4|55–59|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|60–64|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|65–69|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|70–74|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Females|4|All ages combined|0.697|0.622|0.762
Relative|Nasopharyngeal cancer|2015–2019|Females|5|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|30–34|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|35–39|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|40–44|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|45–49|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|50–54|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|55–59|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|60–64|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|65–69|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|70–74|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Females|5|All ages combined|0.691|0.615|0.757
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|30–34|0.967|0.787|0.995
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|35–39|0.973|0.824|0.996
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|40–44|0.956|0.869|0.985
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|45–49|1|0.963|1
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|50–54|0.922|0.843|0.962
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|55–59|0.883|0.804|0.932
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|60–64|0.844|0.751|0.905
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|65–69|0.847|0.752|0.908
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|70–74|0.74|0.595|0.84
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|75–79|0.772|0.596|0.879
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|1|All ages combined|0.873|0.846|0.895
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|30–34|0.93|0.747|0.982
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|35–39|0.919|0.77|0.973
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|40–44|0.861|0.751|0.925
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|45–49|0.916|0.822|0.961
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|50–54|0.854|0.762|0.913
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|55–59|0.811|0.719|0.875
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|60–64|0.791|0.688|0.863
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|65–69|0.742|0.632|0.824
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|70–74|0.64|0.492|0.755
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|75–79|0.609|0.432|0.746
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|2|All ages combined|0.786|0.754|0.814
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|30–34|0.862|0.674|0.946
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|35–39|0.864|0.704|0.941
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|40–44|0.813|0.694|0.889
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|45–49|0.835|0.727|0.902
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|50–54|0.782|0.683|0.853
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|55–59|0.709|0.609|0.788
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|60–64|0.722|0.61|0.807
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|65–69|0.654|0.535|0.749
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|70–74|0.602|0.455|0.722
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|3|All ages combined|0.719|0.685|0.751
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|30–34|0.792|0.594|0.901
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|35–39|0.836|0.671|0.923
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|40–44|0.766|0.642|0.852
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|45–49|0.748|0.634|0.831
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|50–54|0.73|0.628|0.809
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|55–59|0.688|0.586|0.769
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|60–64|0.671|0.557|0.762
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|65–69|0.604|0.482|0.706
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|70–74|0.546|0.401|0.67
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|4|All ages combined|0.665|0.629|0.699
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|00–04|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|05–09|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|10–14|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|15–19|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|20–24|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|25–29|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|30–34|0.792|0.594|0.901
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|35–39|0.808|0.638|0.903
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|40–44|0.737|0.611|0.827
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|45–49|0.724|0.609|0.81
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|50–54|0.72|0.616|0.799
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|55–59|0.654|0.55|0.739
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|60–64|0.641|0.524|0.736
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|65–69|0.559|0.437|0.665
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|70–74|0.507|0.364|0.634
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|75–79|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|80–84|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|85+|||
Observed|Nasopharyngeal cancer|2015–2019|Persons|5|All ages combined|0.639|0.602|0.673
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|30–34|0.967|0.787|0.996
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|35–39|0.974|0.824|0.997
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|40–44|0.957|0.87|0.987
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|45–49|1.002|0.965|1.002
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|50–54|0.925|0.846|0.965
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|55–59|0.887|0.807|0.936
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|60–64|0.85|0.757|0.911
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|65–69|0.856|0.76|0.918
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|70–74|0.753|0.606|0.854
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|75–79|0.795|0.614|0.905
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|1|All ages combined|0.882|0.855|0.904
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|30–34|0.931|0.748|0.984
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|35–39|0.921|0.772|0.975
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|40–44|0.864|0.753|0.928
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|45–49|0.92|0.826|0.966
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|50–54|0.86|0.767|0.919
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|55–59|0.818|0.726|0.883
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|60–64|0.803|0.699|0.876
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|65–69|0.759|0.646|0.842
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|70–74|0.664|0.51|0.784
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|75–79|0.647|0.459|0.793
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|2|All ages combined|0.801|0.769|0.83
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|30–34|0.864|0.675|0.948
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|35–39|0.867|0.706|0.944
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|40–44|0.817|0.697|0.894
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|45–49|0.841|0.732|0.909
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|50–54|0.79|0.69|0.862
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|55–59|0.72|0.618|0.8
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|60–64|0.739|0.625|0.826
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|65–69|0.677|0.554|0.775
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|70–74|0.64|0.483|0.766
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|3|All ages combined|0.739|0.703|0.771
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|30–34|0.795|0.596|0.904
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|35–39|0.84|0.674|0.927
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|40–44|0.771|0.646|0.858
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|45–49|0.756|0.641|0.839
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|50–54|0.741|0.637|0.82
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|55–59|0.702|0.599|0.785
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|60–64|0.693|0.575|0.788
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|65–69|0.635|0.507|0.742
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|70–74|0.595|0.437|0.73
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|4|All ages combined|0.689|0.652|0.724
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|00–04|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|05–09|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|10–14|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|15–19|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|20–24|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|25–29|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|30–34|0.795|0.597|0.905
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|35–39|0.812|0.642|0.909
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|40–44|0.743|0.616|0.834
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|45–49|0.733|0.617|0.821
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|50–54|0.733|0.628|0.814
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|55–59|0.672|0.566|0.76
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|60–64|0.668|0.546|0.768
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|65–69|0.597|0.466|0.71
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|70–74|0.569|0.408|0.71
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|75–79|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|80–84|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|85+|||
Relative|Nasopharyngeal cancer|2015–2019|Persons|5|All ages combined|0.668|0.63|0.704
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|10–14|1|0.925|1
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|15–19|1|0.969|1
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|20–24|0.983|0.934|0.996
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|25–29|0.954|0.901|0.979
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|30–34|0.973|0.929|0.99
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|35–39|0.937|0.892|0.964
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|40–44|0.9|0.859|0.93
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|45–49|0.83|0.791|0.863
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|50–54|0.78|0.747|0.809
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|55–59|0.688|0.658|0.715
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|60–64|0.659|0.633|0.684
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|65–69|0.611|0.587|0.634
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|70–74|0.584|0.56|0.606
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|75–79|0.53|0.504|0.555
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|80–84|0.454|0.424|0.483
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|85+|0.393|0.361|0.425
Observed|Neuroendocrine neoplasms|2015–2019|Males|1|All ages combined|0.626|0.617|0.635
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|10–14|1|0.923|1
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|15–19|1|0.967|1
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|20–24|0.983|0.934|0.996
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|25–29|0.938|0.88|0.969
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|30–34|0.965|0.919|0.985
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|35–39|0.909|0.857|0.942
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|40–44|0.862|0.816|0.897
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|45–49|0.733|0.688|0.774
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|50–54|0.69|0.654|0.723
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|55–59|0.581|0.549|0.612
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|60–64|0.534|0.506|0.56
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|65–69|0.461|0.436|0.485
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|70–74|0.45|0.426|0.474
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|75–79|0.396|0.371|0.422
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|80–84|0.321|0.293|0.349
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|85+|0.257|0.229|0.286
Observed|Neuroendocrine neoplasms|2015–2019|Males|2|All ages combined|0.507|0.498|0.516
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|10–14|1|0.92|1
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|15–19|0.987|0.912|0.998
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|20–24|0.983|0.934|0.996
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|25–29|0.93|0.869|0.963
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|30–34|0.95|0.898|0.976
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|35–39|0.891|0.836|0.928
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|40–44|0.841|0.792|0.878
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|45–49|0.71|0.663|0.751
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|50–54|0.641|0.604|0.676
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|55–59|0.543|0.511|0.575
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|60–64|0.488|0.46|0.515
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|65–69|0.418|0.394|0.442
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|70–74|0.393|0.369|0.416
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|75–79|0.332|0.308|0.357
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|80–84|0.26|0.234|0.287
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|85+|0.171|0.147|0.197
Observed|Neuroendocrine neoplasms|2015–2019|Males|3|All ages combined|0.457|0.448|0.467
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|10–14|1|0.916|1
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|15–19|0.987|0.912|0.998
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|20–24|0.983|0.934|0.996
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|25–29|0.904|0.836|0.944
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|30–34|0.942|0.888|0.971
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|35–39|0.885|0.829|0.924
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|40–44|0.833|0.784|0.872
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|45–49|0.699|0.651|0.741
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|50–54|0.624|0.586|0.659
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|55–59|0.531|0.498|0.563
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|60–64|0.463|0.436|0.49
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|65–69|0.396|0.372|0.42
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|70–74|0.353|0.33|0.377
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|75–79|0.293|0.269|0.317
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|80–84|0.222|0.198|0.248
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|85+|0.135|0.113|0.159
Observed|Neuroendocrine neoplasms|2015–2019|Males|4|All ages combined|0.43|0.421|0.44
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|10–14|1|0.914|1
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|15–19|0.987|0.912|0.998
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|20–24|0.983|0.934|0.996
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|25–29|0.904|0.836|0.944
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|30–34|0.933|0.875|0.965
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|35–39|0.878|0.821|0.918
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|40–44|0.82|0.77|0.861
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|45–49|0.693|0.645|0.736
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|50–54|0.608|0.569|0.644
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|55–59|0.515|0.482|0.547
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|60–64|0.446|0.419|0.473
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|65–69|0.373|0.349|0.397
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|70–74|0.334|0.31|0.357
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|75–79|0.266|0.243|0.29
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|80–84|0.19|0.167|0.215
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|85+|0.094|0.075|0.116
Observed|Neuroendocrine neoplasms|2015–2019|Males|5|All ages combined|0.409|0.4|0.418
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|10–14|1|0.925|1
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|15–19|1|0.969|1
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|20–24|0.984|0.934|0.996
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|25–29|0.955|0.902|0.98
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|30–34|0.973|0.929|0.99
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|35–39|0.938|0.893|0.965
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|40–44|0.902|0.86|0.932
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|45–49|0.832|0.793|0.865
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|50–54|0.783|0.75|0.812
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|55–59|0.691|0.661|0.719
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|60–64|0.664|0.638|0.689
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|65–69|0.618|0.594|0.641
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|70–74|0.595|0.571|0.618
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|75–79|0.548|0.521|0.574
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|80–84|0.482|0.45|0.513
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|85+|0.45|0.414|0.487
Relative|Neuroendocrine neoplasms|2015–2019|Males|1|All ages combined|0.643|0.634|0.652
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|10–14|1|0.923|1
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|15–19|1.001|0.968|1.001
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|20–24|0.984|0.935|0.997
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|25–29|0.939|0.881|0.97
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|30–34|0.967|0.921|0.987
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|35–39|0.911|0.859|0.944
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|40–44|0.865|0.819|0.9
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|45–49|0.737|0.691|0.777
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|50–54|0.695|0.658|0.728
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|55–59|0.588|0.555|0.619
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|60–64|0.542|0.515|0.57
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|65–69|0.473|0.448|0.497
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|70–74|0.469|0.444|0.493
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|75–79|0.425|0.398|0.452
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|80–84|0.364|0.333|0.396
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|85+|0.34|0.303|0.379
Relative|Neuroendocrine neoplasms|2015–2019|Males|2|All ages combined|0.533|0.523|0.542
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|10–14|1|0.92|1
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|15–19|0.988|0.913|1
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|20–24|0.985|0.935|0.998
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|25–29|0.932|0.871|0.965
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|30–34|0.953|0.901|0.979
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|35–39|0.894|0.839|0.932
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|40–44|0.845|0.797|0.883
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|45–49|0.715|0.668|0.757
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|50–54|0.649|0.611|0.684
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|55–59|0.553|0.52|0.585
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|60–64|0.501|0.473|0.529
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|65–69|0.435|0.41|0.46
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|70–74|0.419|0.393|0.444
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|75–79|0.372|0.344|0.399
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|80–84|0.319|0.287|0.351
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|85+|0.266|0.228|0.306
Relative|Neuroendocrine neoplasms|2015–2019|Males|3|All ages combined|0.491|0.481|0.501
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|10–14|1.001|0.917|1.001
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|15–19|0.989|0.914|1
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|20–24|0.985|0.936|0.998
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|25–29|0.906|0.839|0.947
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|30–34|0.946|0.891|0.974
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|35–39|0.89|0.833|0.928
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|40–44|0.839|0.79|0.878
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|45–49|0.706|0.658|0.749
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|50–54|0.634|0.595|0.669
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|55–59|0.544|0.51|0.576
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|60–64|0.48|0.452|0.508
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|65–69|0.419|0.393|0.444
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|70–74|0.387|0.361|0.413
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|75–79|0.344|0.316|0.372
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|80–84|0.297|0.264|0.331
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|85+|0.249|0.208|0.294
Relative|Neuroendocrine neoplasms|2015–2019|Males|4|All ages combined|0.473|0.462|0.483
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|10–14|1.001|0.915|1.001
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|15–19|0.99|0.914|1.001
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|20–24|0.986|0.937|0.999
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|25–29|0.907|0.839|0.948
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|30–34|0.938|0.879|0.97
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|35–39|0.884|0.826|0.924
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|40–44|0.828|0.777|0.869
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|45–49|0.703|0.654|0.746
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|50–54|0.62|0.581|0.657
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|55–59|0.531|0.497|0.564
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|60–64|0.468|0.439|0.496
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|65–69|0.401|0.376|0.427
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|70–74|0.376|0.35|0.403
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|75–79|0.329|0.3|0.359
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|80–84|0.28|0.246|0.317
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|85+|0.211|0.168|0.261
Relative|Neuroendocrine neoplasms|2015–2019|Males|5|All ages combined|0.459|0.449|0.47
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|10–14|1|0.957|1
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|15–19|0.987|0.95|0.997
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|20–24|0.994|0.959|0.999
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|25–29|0.99|0.961|0.998
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|30–34|0.968|0.935|0.985
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|35–39|0.949|0.914|0.97
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|40–44|0.94|0.908|0.961
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|45–49|0.877|0.844|0.903
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|50–54|0.823|0.792|0.85
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|55–59|0.785|0.757|0.81
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|60–64|0.746|0.72|0.77
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|65–69|0.708|0.683|0.732
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|70–74|0.653|0.626|0.678
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|75–79|0.593|0.562|0.622
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|80–84|0.522|0.485|0.558
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|85+|0.508|0.47|0.545
Observed|Neuroendocrine neoplasms|2015–2019|Females|1|All ages combined|0.727|0.718|0.736
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|10–14|1|0.956|1
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|15–19|0.987|0.95|0.997
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|20–24|0.982|0.946|0.994
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|25–29|0.98|0.947|0.992
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|30–34|0.944|0.904|0.968
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|35–39|0.899|0.854|0.931
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|40–44|0.891|0.852|0.921
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|45–49|0.815|0.778|0.847
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|50–54|0.743|0.708|0.774
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|55–59|0.652|0.62|0.683
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|60–64|0.642|0.613|0.669
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|65–69|0.58|0.553|0.606
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|70–74|0.526|0.498|0.553
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|75–79|0.467|0.436|0.497
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|80–84|0.411|0.375|0.446
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|85+|0.35|0.314|0.386
Observed|Neuroendocrine neoplasms|2015–2019|Females|2|All ages combined|0.622|0.612|0.632
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|10–14|1|0.957|1
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|15–19|0.987|0.95|0.997
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|20–24|0.976|0.938|0.991
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|25–29|0.969|0.932|0.986
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|30–34|0.924|0.878|0.953
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|35–39|0.881|0.832|0.916
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|40–44|0.87|0.828|0.903
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|45–49|0.784|0.744|0.819
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|50–54|0.705|0.669|0.739
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|55–59|0.596|0.563|0.628
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|60–64|0.591|0.562|0.62
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|65–69|0.524|0.497|0.551
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|70–74|0.485|0.457|0.513
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|75–79|0.416|0.386|0.446
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|80–84|0.354|0.319|0.389
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|85+|0.271|0.238|0.305
Observed|Neuroendocrine neoplasms|2015–2019|Females|3|All ages combined|0.576|0.566|0.586
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|10–14|1|0.957|1
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|15–19|0.987|0.95|0.997
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|20–24|0.976|0.938|0.991
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|25–29|0.962|0.923|0.982
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|30–34|0.907|0.858|0.94
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|35–39|0.865|0.815|0.903
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|40–44|0.844|0.799|0.881
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|45–49|0.764|0.723|0.8
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|50–54|0.692|0.654|0.726
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|55–59|0.578|0.544|0.61
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|60–64|0.567|0.537|0.596
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|65–69|0.498|0.471|0.525
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|70–74|0.461|0.433|0.489
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|75–79|0.372|0.342|0.402
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|80–84|0.308|0.274|0.342
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|85+|0.219|0.188|0.251
Observed|Neuroendocrine neoplasms|2015–2019|Females|4|All ages combined|0.548|0.538|0.558
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|10–14|1|0.956|1
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|15–19|0.987|0.95|0.997
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|20–24|0.969|0.928|0.987
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|25–29|0.962|0.923|0.982
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|30–34|0.894|0.842|0.93
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|35–39|0.856|0.804|0.895
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|40–44|0.84|0.794|0.877
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|45–49|0.742|0.699|0.78
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|50–54|0.686|0.648|0.72
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|55–59|0.561|0.527|0.594
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|60–64|0.541|0.51|0.57
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|65–69|0.476|0.448|0.503
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|70–74|0.443|0.414|0.471
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|75–79|0.347|0.318|0.377
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|80–84|0.27|0.238|0.304
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|85+|0.173|0.145|0.203
Observed|Neuroendocrine neoplasms|2015–2019|Females|5|All ages combined|0.526|0.516|0.537
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|10–14|1|0.957|1
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|15–19|0.988|0.95|0.997
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|20–24|0.994|0.959|0.999
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|25–29|0.99|0.962|0.998
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|30–34|0.969|0.935|0.985
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|35–39|0.95|0.915|0.971
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|40–44|0.94|0.909|0.962
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|45–49|0.878|0.845|0.904
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|50–54|0.825|0.794|0.852
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|55–59|0.788|0.759|0.813
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|60–64|0.75|0.723|0.774
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|65–69|0.713|0.688|0.737
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|70–74|0.661|0.634|0.686
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|75–79|0.606|0.575|0.635
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|80–84|0.545|0.506|0.582
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|85+|0.572|0.528|0.613
Relative|Neuroendocrine neoplasms|2015–2019|Females|1|All ages combined|0.739|0.73|0.748
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|10–14|1|0.957|1
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|15–19|0.988|0.951|0.997
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|20–24|0.983|0.946|0.995
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|25–29|0.98|0.947|0.993
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|30–34|0.945|0.904|0.969
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|35–39|0.9|0.855|0.932
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|40–44|0.893|0.853|0.922
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|45–49|0.818|0.78|0.85
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|50–54|0.746|0.711|0.778
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|55–59|0.657|0.624|0.687
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|60–64|0.648|0.619|0.675
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|65–69|0.589|0.562|0.616
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|70–74|0.54|0.511|0.568
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|75–79|0.489|0.457|0.52
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|80–84|0.449|0.41|0.488
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|85+|0.447|0.401|0.493
Relative|Neuroendocrine neoplasms|2015–2019|Females|2|All ages combined|0.642|0.632|0.652
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|10–14|1|0.957|1
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|15–19|0.988|0.951|0.997
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|20–24|0.977|0.938|0.992
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|25–29|0.97|0.932|0.987
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|30–34|0.925|0.879|0.954
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|35–39|0.882|0.834|0.917
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|40–44|0.873|0.83|0.906
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|45–49|0.788|0.748|0.822
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|50–54|0.71|0.674|0.744
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|55–59|0.602|0.568|0.635
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|60–64|0.6|0.57|0.629
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|65–69|0.537|0.509|0.564
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|70–74|0.505|0.476|0.534
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|75–79|0.448|0.416|0.48
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|80–84|0.409|0.369|0.45
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|85+|0.395|0.346|0.444
Relative|Neuroendocrine neoplasms|2015–2019|Females|3|All ages combined|0.603|0.592|0.613
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|10–14|1.001|0.957|1.001
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|15–19|0.988|0.951|0.998
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|20–24|0.977|0.939|0.992
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|25–29|0.964|0.924|0.983
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|30–34|0.909|0.859|0.941
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|35–39|0.868|0.817|0.905
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|40–44|0.848|0.802|0.884
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|45–49|0.769|0.728|0.805
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|50–54|0.698|0.661|0.733
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|55–59|0.586|0.552|0.619
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|60–64|0.579|0.548|0.608
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|65–69|0.515|0.487|0.543
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|70–74|0.488|0.458|0.518
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|75–79|0.414|0.38|0.447
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|80–84|0.379|0.338|0.421
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|85+|0.368|0.316|0.422
Relative|Neuroendocrine neoplasms|2015–2019|Females|4|All ages combined|0.583|0.572|0.593
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|10–14|1.001|0.956|1.001
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|15–19|0.988|0.951|0.998
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|20–24|0.971|0.929|0.988
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|25–29|0.964|0.924|0.984
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|30–34|0.897|0.844|0.932
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|35–39|0.859|0.807|0.898
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|40–44|0.845|0.798|0.882
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|45–49|0.748|0.705|0.787
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|50–54|0.694|0.657|0.729
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|55–59|0.572|0.537|0.605
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|60–64|0.556|0.525|0.586
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|65–69|0.498|0.469|0.526
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|70–74|0.478|0.447|0.508
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|75–79|0.4|0.366|0.434
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|80–84|0.359|0.316|0.403
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|85+|0.341|0.286|0.401
Relative|Neuroendocrine neoplasms|2015–2019|Females|5|All ages combined|0.568|0.557|0.579
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|10–14|1|0.972|1
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|15–19|0.992|0.969|0.998
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|20–24|0.99|0.968|0.997
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|25–29|0.976|0.953|0.988
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|30–34|0.97|0.946|0.983
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|35–39|0.944|0.918|0.962
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|40–44|0.922|0.897|0.94
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|45–49|0.855|0.83|0.876
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|50–54|0.801|0.779|0.821
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|55–59|0.734|0.714|0.754
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|60–64|0.699|0.681|0.717
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|65–69|0.654|0.637|0.671
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|70–74|0.613|0.596|0.63
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|75–79|0.556|0.537|0.576
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|80–84|0.481|0.458|0.504
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|85+|0.443|0.418|0.468
Observed|Neuroendocrine neoplasms|2015–2019|Persons|1|All ages combined|0.673|0.667|0.68
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|10–14|1|0.972|1
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|15–19|0.992|0.969|0.998
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|20–24|0.982|0.958|0.993
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|25–29|0.963|0.936|0.979
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|30–34|0.953|0.925|0.97
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|35–39|0.903|0.871|0.927
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|40–44|0.878|0.849|0.902
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|45–49|0.778|0.749|0.804
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|50–54|0.716|0.691|0.739
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|55–59|0.615|0.593|0.637
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|60–64|0.584|0.564|0.603
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|65–69|0.514|0.496|0.532
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|70–74|0.483|0.464|0.501
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|75–79|0.426|0.407|0.446
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|80–84|0.357|0.335|0.379
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|85+|0.297|0.275|0.32
Observed|Neuroendocrine neoplasms|2015–2019|Persons|2|All ages combined|0.561|0.554|0.567
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|10–14|1|0.971|1
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|15–19|0.987|0.962|0.996
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|20–24|0.979|0.953|0.99
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|25–29|0.953|0.924|0.972
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|30–34|0.934|0.903|0.956
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|35–39|0.885|0.85|0.912
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|40–44|0.857|0.826|0.882
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|45–49|0.75|0.72|0.777
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|50–54|0.673|0.647|0.697
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|55–59|0.569|0.545|0.591
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|60–64|0.536|0.516|0.556
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|65–69|0.466|0.448|0.484
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|70–74|0.433|0.414|0.451
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|75–79|0.368|0.349|0.387
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|80–84|0.298|0.277|0.319
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|85+|0.215|0.195|0.236
Observed|Neuroendocrine neoplasms|2015–2019|Persons|3|All ages combined|0.512|0.506|0.519
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|10–14|1|0.971|1
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|15–19|0.987|0.962|0.996
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|20–24|0.979|0.953|0.99
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|25–29|0.939|0.906|0.961
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|30–34|0.921|0.887|0.945
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|35–39|0.874|0.838|0.902
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|40–44|0.84|0.808|0.867
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|45–49|0.735|0.704|0.763
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|50–54|0.657|0.631|0.682
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|55–59|0.553|0.53|0.576
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|60–64|0.511|0.491|0.531
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|65–69|0.442|0.424|0.46
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|70–74|0.4|0.382|0.418
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|75–79|0.326|0.308|0.345
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|80–84|0.257|0.236|0.277
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|85+|0.172|0.153|0.191
Observed|Neuroendocrine neoplasms|2015–2019|Persons|4|All ages combined|0.485|0.478|0.492
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|00–04|||
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|05–09|||
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|10–14|1|0.97|1
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|15–19|0.987|0.962|0.996
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|20–24|0.974|0.946|0.988
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|25–29|0.939|0.906|0.961
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|30–34|0.91|0.874|0.936
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|35–39|0.866|0.829|0.895
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|40–44|0.831|0.799|0.86
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|45–49|0.721|0.689|0.749
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|50–54|0.646|0.619|0.671
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|55–59|0.537|0.514|0.56
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|60–64|0.49|0.47|0.51
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|65–69|0.419|0.401|0.437
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|70–74|0.381|0.362|0.399
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|75–79|0.3|0.282|0.319
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|80–84|0.223|0.203|0.242
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|85+|0.13|0.113|0.147
Observed|Neuroendocrine neoplasms|2015–2019|Persons|5|All ages combined|0.464|0.457|0.471
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|10–14|1|0.972|1
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|15–19|0.992|0.969|0.998
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|20–24|0.99|0.968|0.997
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|25–29|0.977|0.953|0.988
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|30–34|0.971|0.947|0.984
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|35–39|0.945|0.919|0.963
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|40–44|0.923|0.898|0.941
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|45–49|0.857|0.832|0.878
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|50–54|0.804|0.781|0.824
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|55–59|0.738|0.717|0.757
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|60–64|0.704|0.685|0.722
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|65–69|0.661|0.643|0.678
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|70–74|0.623|0.605|0.641
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|75–79|0.572|0.552|0.592
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|80–84|0.507|0.483|0.531
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|85+|0.503|0.475|0.531
Relative|Neuroendocrine neoplasms|2015–2019|Persons|1|All ages combined|0.688|0.681|0.694
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|10–14|1|0.972|1
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|15–19|0.993|0.969|0.999
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|20–24|0.983|0.959|0.993
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|25–29|0.964|0.937|0.98
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|30–34|0.954|0.926|0.972
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|35–39|0.905|0.872|0.929
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|40–44|0.88|0.851|0.904
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|45–49|0.781|0.752|0.807
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|50–54|0.72|0.695|0.743
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|55–59|0.621|0.598|0.643
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|60–64|0.591|0.571|0.611
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|65–69|0.525|0.507|0.543
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|70–74|0.499|0.481|0.518
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|75–79|0.452|0.432|0.473
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|80–84|0.399|0.374|0.424
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|85+|0.387|0.358|0.417
Relative|Neuroendocrine neoplasms|2015–2019|Persons|2|All ages combined|0.584|0.577|0.591
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|10–14|1|0.972|1
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|15–19|0.988|0.962|0.997
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|20–24|0.98|0.954|0.991
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|25–29|0.955|0.925|0.973
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|30–34|0.936|0.904|0.958
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|35–39|0.887|0.853|0.914
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|40–44|0.86|0.829|0.886
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|45–49|0.755|0.725|0.782
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|50–54|0.679|0.653|0.704
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|55–59|0.576|0.553|0.599
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|60–64|0.547|0.526|0.567
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|65–69|0.481|0.462|0.5
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|70–74|0.456|0.437|0.476
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|75–79|0.404|0.383|0.426
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|80–84|0.356|0.331|0.381
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|85+|0.323|0.293|0.355
Relative|Neuroendocrine neoplasms|2015–2019|Persons|3|All ages combined|0.544|0.536|0.551
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|10–14|1.001|0.972|1.001
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|15–19|0.989|0.963|0.997
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|20–24|0.98|0.954|0.992
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|25–29|0.941|0.907|0.962
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|30–34|0.924|0.889|0.948
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|35–39|0.877|0.841|0.906
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|40–44|0.845|0.812|0.872
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|45–49|0.741|0.71|0.769
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|50–54|0.665|0.639|0.691
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|55–59|0.564|0.54|0.587
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|60–64|0.526|0.505|0.547
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|65–69|0.462|0.443|0.481
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|70–74|0.431|0.411|0.451
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|75–79|0.373|0.352|0.395
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|80–84|0.331|0.305|0.357
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|85+|0.302|0.269|0.337
Relative|Neuroendocrine neoplasms|2015–2019|Persons|4|All ages combined|0.524|0.517|0.532
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|00–04|||
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|05–09|||
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|10–14|1.001|0.971|1.001
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|15–19|0.989|0.963|0.998
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|20–24|0.976|0.948|0.99
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|25–29|0.941|0.908|0.963
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|30–34|0.913|0.877|0.94
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|35–39|0.87|0.833|0.9
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|40–44|0.838|0.804|0.866
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|45–49|0.728|0.697|0.758
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|50–54|0.657|0.63|0.682
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|55–59|0.551|0.526|0.574
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|60–64|0.509|0.488|0.53
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|65–69|0.445|0.425|0.464
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|70–74|0.421|0.4|0.441
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|75–79|0.359|0.337|0.382
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|80–84|0.312|0.285|0.34
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|85+|0.271|0.236|0.308
Relative|Neuroendocrine neoplasms|2015–2019|Persons|5|All ages combined|0.51|0.503|0.518
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|00–04|1|0.894|1
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|05–09|0.962|0.857|0.99
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|10–14|0.982|0.876|0.997
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|15–19|0.92|0.831|0.963
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|20–24|0.945|0.873|0.977
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|25–29|0.959|0.905|0.983
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|30–34|0.967|0.928|0.985
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|35–39|0.936|0.903|0.958
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|40–44|0.965|0.942|0.979
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|45–49|0.937|0.915|0.954
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|50–54|0.934|0.916|0.948
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|55–59|0.92|0.904|0.933
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|60–64|0.918|0.904|0.929
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|65–69|0.88|0.865|0.892
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|70–74|0.868|0.854|0.882
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|75–79|0.806|0.788|0.823
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|80–84|0.726|0.703|0.747
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|85+|0.541|0.513|0.567
Observed|Non-Hodgkin lymphoma|2015–2019|Males|1|All ages combined|0.844|0.838|0.85
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|00–04|0.961|0.753|0.994
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|05–09|0.962|0.857|0.99
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|10–14|0.962|0.855|0.99
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|15–19|0.908|0.816|0.955
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|20–24|0.923|0.846|0.963
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|25–29|0.943|0.885|0.973
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|30–34|0.943|0.897|0.969
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|35–39|0.908|0.87|0.935
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|40–44|0.937|0.908|0.956
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|45–49|0.909|0.883|0.929
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|50–54|0.906|0.885|0.923
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|55–59|0.871|0.851|0.888
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|60–64|0.869|0.852|0.884
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|65–69|0.832|0.815|0.847
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|70–74|0.794|0.777|0.811
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|75–79|0.723|0.703|0.743
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|80–84|0.629|0.604|0.652
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|85+|0.428|0.402|0.454
Observed|Non-Hodgkin lymphoma|2015–2019|Males|2|All ages combined|0.781|0.774|0.788
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|00–04|0.961|0.753|0.994
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|05–09|0.943|0.834|0.981
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|10–14|0.962|0.855|0.99
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|15–19|0.908|0.816|0.955
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|20–24|0.903|0.822|0.948
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|25–29|0.913|0.848|0.951
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|30–34|0.921|0.87|0.952
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|35–39|0.895|0.855|0.924
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|40–44|0.921|0.89|0.943
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|45–49|0.899|0.873|0.92
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|50–54|0.88|0.857|0.899
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|55–59|0.849|0.828|0.867
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|60–64|0.834|0.816|0.851
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|65–69|0.797|0.779|0.813
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|70–74|0.743|0.724|0.761
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|75–79|0.654|0.632|0.676
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|80–84|0.55|0.524|0.574
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|85+|0.343|0.317|0.369
Observed|Non-Hodgkin lymphoma|2015–2019|Males|3|All ages combined|0.736|0.729|0.743
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|00–04|0.961|0.753|0.994
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|05–09|0.943|0.834|0.981
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|10–14|0.962|0.855|0.99
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|15–19|0.883|0.787|0.937
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|20–24|0.903|0.822|0.948
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|25–29|0.913|0.848|0.951
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|30–34|0.915|0.864|0.948
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|35–39|0.889|0.848|0.919
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|40–44|0.921|0.89|0.943
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|45–49|0.884|0.856|0.906
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|50–54|0.865|0.841|0.885
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|55–59|0.825|0.802|0.844
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|60–64|0.811|0.792|0.829
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|65–69|0.764|0.745|0.781
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|70–74|0.684|0.663|0.703
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|75–79|0.59|0.567|0.613
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|80–84|0.472|0.446|0.498
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|85+|0.27|0.246|0.295
Observed|Non-Hodgkin lymphoma|2015–2019|Males|4|All ages combined|0.695|0.688|0.702
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|00–04|0.961|0.753|0.994
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|05–09|0.943|0.834|0.981
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|10–14|0.962|0.855|0.99
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|15–19|0.883|0.787|0.937
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|20–24|0.903|0.822|0.948
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|25–29|0.899|0.832|0.94
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|30–34|0.899|0.845|0.935
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|35–39|0.882|0.841|0.913
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|40–44|0.912|0.88|0.935
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|45–49|0.868|0.839|0.893
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|50–54|0.847|0.822|0.869
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|55–59|0.804|0.781|0.825
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|60–64|0.788|0.767|0.806
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|65–69|0.737|0.717|0.755
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|70–74|0.647|0.626|0.667
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|75–79|0.544|0.52|0.567
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|80–84|0.404|0.378|0.43
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|85+|0.215|0.192|0.24
Observed|Non-Hodgkin lymphoma|2015–2019|Males|5|All ages combined|0.664|0.656|0.671
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|00–04|1|0.895|1
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|05–09|0.962|0.858|0.991
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|10–14|0.982|0.876|0.997
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|15–19|0.921|0.831|0.964
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|20–24|0.945|0.873|0.977
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|25–29|0.96|0.906|0.984
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|30–34|0.968|0.929|0.986
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|35–39|0.937|0.904|0.96
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|40–44|0.967|0.943|0.981
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|45–49|0.94|0.918|0.956
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|50–54|0.937|0.919|0.952
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|55–59|0.925|0.909|0.938
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|60–64|0.925|0.911|0.937
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|65–69|0.89|0.876|0.903
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|70–74|0.885|0.87|0.899
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|75–79|0.833|0.814|0.851
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|80–84|0.771|0.747|0.794
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|85+|0.62|0.589|0.65
Relative|Non-Hodgkin lymphoma|2015–2019|Males|1|All ages combined|0.868|0.862|0.874
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|00–04|0.961|0.754|0.995
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|05–09|0.962|0.858|0.991
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|10–14|0.962|0.856|0.991
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|15–19|0.908|0.817|0.956
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|20–24|0.924|0.847|0.964
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|25–29|0.945|0.886|0.974
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|30–34|0.945|0.899|0.971
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|35–39|0.91|0.872|0.937
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|40–44|0.94|0.912|0.96
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|45–49|0.913|0.888|0.933
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|50–54|0.913|0.892|0.93
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|55–59|0.88|0.86|0.898
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|60–64|0.884|0.867|0.899
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|65–69|0.853|0.836|0.869
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|70–74|0.828|0.81|0.845
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|75–79|0.777|0.754|0.798
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|80–84|0.715|0.687|0.741
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|85+|0.568|0.533|0.603
Relative|Non-Hodgkin lymphoma|2015–2019|Males|2|All ages combined|0.824|0.817|0.831
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|00–04|0.961|0.754|0.995
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|05–09|0.943|0.834|0.981
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|10–14|0.962|0.856|0.991
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|15–19|0.909|0.817|0.956
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|20–24|0.905|0.823|0.95
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|25–29|0.915|0.85|0.953
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|30–34|0.923|0.873|0.955
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|35–39|0.898|0.859|0.928
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|40–44|0.926|0.895|0.948
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|45–49|0.906|0.879|0.927
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|50–54|0.89|0.867|0.91
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|55–59|0.863|0.842|0.882
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|60–64|0.856|0.838|0.874
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|65–69|0.83|0.811|0.847
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|70–74|0.793|0.772|0.812
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|75–79|0.733|0.708|0.756
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|80–84|0.675|0.643|0.705
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|85+|0.533|0.493|0.573
Relative|Non-Hodgkin lymphoma|2015–2019|Males|3|All ages combined|0.796|0.788|0.804
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|00–04|0.961|0.754|0.995
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|05–09|0.943|0.834|0.982
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|10–14|0.962|0.856|0.991
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|15–19|0.884|0.788|0.939
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|20–24|0.905|0.824|0.951
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|25–29|0.915|0.851|0.953
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|30–34|0.919|0.867|0.952
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|35–39|0.893|0.853|0.923
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|40–44|0.928|0.897|0.95
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|45–49|0.893|0.865|0.916
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|50–54|0.878|0.854|0.899
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|55–59|0.845|0.822|0.865
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|60–64|0.841|0.821|0.86
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|65–69|0.808|0.788|0.826
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|70–74|0.749|0.727|0.771
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|75–79|0.693|0.666|0.72
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|80–84|0.633|0.598|0.667
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|85+|0.498|0.453|0.544
Relative|Non-Hodgkin lymphoma|2015–2019|Males|4|All ages combined|0.772|0.764|0.78
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|00–04|0.962|0.754|0.995
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|05–09|0.943|0.834|0.982
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|10–14|0.963|0.856|0.991
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|15–19|0.885|0.789|0.94
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|20–24|0.906|0.824|0.951
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|25–29|0.902|0.835|0.943
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|30–34|0.903|0.849|0.94
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|35–39|0.888|0.847|0.919
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|40–44|0.921|0.889|0.944
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|45–49|0.881|0.851|0.905
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|50–54|0.865|0.839|0.887
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|55–59|0.829|0.806|0.851
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|60–64|0.826|0.805|0.845
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|65–69|0.793|0.772|0.813
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|70–74|0.731|0.706|0.754
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|75–79|0.674|0.645|0.702
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|80–84|0.598|0.56|0.636
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|85+|0.479|0.427|0.533
Relative|Non-Hodgkin lymphoma|2015–2019|Males|5|All ages combined|0.756|0.747|0.765
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|00–04|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|05–09|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|10–14|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|15–19|0.936|0.766|0.983
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|20–24|0.957|0.873|0.986
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|25–29|0.971|0.914|0.991
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|30–34|0.957|0.906|0.98
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|35–39|0.972|0.933|0.988
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|40–44|0.966|0.938|0.981
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|45–49|0.955|0.932|0.971
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|50–54|0.954|0.936|0.967
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|55–59|0.956|0.941|0.967
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|60–64|0.924|0.908|0.937
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|65–69|0.912|0.897|0.925
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|70–74|0.889|0.873|0.904
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|75–79|0.828|0.808|0.847
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|80–84|0.736|0.71|0.76
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|85+|0.537|0.509|0.564
Observed|Non-Hodgkin lymphoma|2015–2019|Females|1|All ages combined|0.852|0.845|0.858
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|00–04|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|05–09|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|10–14|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|15–19|0.905|0.734|0.968
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|20–24|0.957|0.873|0.986
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|25–29|0.952|0.889|0.98
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|30–34|0.917|0.856|0.953
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|35–39|0.955|0.913|0.977
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|40–44|0.942|0.909|0.964
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|45–49|0.932|0.905|0.951
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|50–54|0.94|0.92|0.955
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|55–59|0.925|0.906|0.94
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|60–64|0.892|0.873|0.908
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|65–69|0.87|0.853|0.886
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|70–74|0.844|0.825|0.861
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|75–79|0.76|0.736|0.781
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|80–84|0.649|0.622|0.676
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|85+|0.419|0.392|0.446
Observed|Non-Hodgkin lymphoma|2015–2019|Females|2|All ages combined|0.798|0.791|0.806
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|00–04|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|05–09|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|10–14|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|15–19|0.875|0.7|0.951
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|20–24|0.944|0.857|0.978
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|25–29|0.952|0.889|0.98
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|30–34|0.909|0.845|0.947
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|35–39|0.939|0.893|0.966
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|40–44|0.923|0.886|0.948
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|45–49|0.917|0.888|0.939
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|50–54|0.923|0.901|0.94
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|55–59|0.901|0.88|0.918
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|60–64|0.867|0.847|0.885
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|65–69|0.846|0.827|0.863
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|70–74|0.804|0.783|0.823
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|75–79|0.71|0.685|0.733
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|80–84|0.586|0.557|0.613
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|85+|0.342|0.316|0.368
Observed|Non-Hodgkin lymphoma|2015–2019|Females|3|All ages combined|0.761|0.753|0.768
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|00–04|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|05–09|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|10–14|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|15–19|0.875|0.7|0.951
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|20–24|0.944|0.857|0.978
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|25–29|0.952|0.889|0.98
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|30–34|0.909|0.845|0.947
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|35–39|0.939|0.893|0.966
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|40–44|0.923|0.886|0.948
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|45–49|0.904|0.874|0.928
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|50–54|0.907|0.883|0.927
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|55–59|0.891|0.869|0.909
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|60–64|0.849|0.827|0.868
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|65–69|0.825|0.805|0.843
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|70–74|0.776|0.754|0.797
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|75–79|0.668|0.642|0.692
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|80–84|0.533|0.504|0.561
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|85+|0.29|0.265|0.315
Observed|Non-Hodgkin lymphoma|2015–2019|Females|4|All ages combined|0.733|0.725|0.741
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|00–04|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|05–09|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|10–14|||
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|15–19|0.875|0.7|0.951
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|20–24|0.944|0.857|0.978
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|25–29|0.952|0.889|0.98
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|30–34|0.909|0.845|0.947
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|35–39|0.939|0.893|0.966
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|40–44|0.919|0.882|0.945
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|45–49|0.894|0.862|0.918
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|50–54|0.893|0.868|0.914
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|55–59|0.879|0.856|0.898
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|60–64|0.827|0.805|0.847
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|65–69|0.803|0.782|0.822
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|70–74|0.74|0.717|0.762
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|75–79|0.618|0.591|0.644
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|80–84|0.468|0.439|0.497
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|85+|0.238|0.214|0.262
Observed|Non-Hodgkin lymphoma|2015–2019|Females|5|All ages combined|0.703|0.694|0.711
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|00–04|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|05–09|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|10–14|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|15–19|0.936|0.766|0.984
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|20–24|0.957|0.873|0.986
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|25–29|0.972|0.914|0.991
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|30–34|0.957|0.907|0.981
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|35–39|0.972|0.934|0.989
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|40–44|0.967|0.938|0.982
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|45–49|0.957|0.933|0.972
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|50–54|0.956|0.938|0.969
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|55–59|0.959|0.944|0.97
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|60–64|0.928|0.912|0.942
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|65–69|0.918|0.903|0.931
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|70–74|0.9|0.884|0.915
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|75–79|0.847|0.825|0.866
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|80–84|0.767|0.74|0.792
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|85+|0.602|0.57|0.632
Relative|Non-Hodgkin lymphoma|2015–2019|Females|1|All ages combined|0.872|0.865|0.878
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|00–04|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|05–09|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|10–14|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|15–19|0.905|0.734|0.969
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|20–24|0.958|0.873|0.986
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|25–29|0.953|0.889|0.98
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|30–34|0.918|0.856|0.954
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|35–39|0.957|0.914|0.979
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|40–44|0.944|0.91|0.966
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|45–49|0.935|0.908|0.954
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|50–54|0.944|0.924|0.96
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|55–59|0.931|0.912|0.946
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|60–64|0.901|0.882|0.917
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|65–69|0.884|0.866|0.9
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|70–74|0.866|0.847|0.884
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|75–79|0.795|0.771|0.818
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|80–84|0.71|0.68|0.738
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|85+|0.531|0.497|0.565
Relative|Non-Hodgkin lymphoma|2015–2019|Females|2|All ages combined|0.834|0.826|0.841
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|00–04|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|05–09|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|10–14|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|15–19|0.875|0.701|0.952
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|20–24|0.944|0.858|0.979
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|25–29|0.953|0.889|0.981
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|30–34|0.91|0.846|0.949
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|35–39|0.941|0.895|0.968
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|40–44|0.926|0.889|0.951
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|45–49|0.921|0.892|0.943
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|50–54|0.929|0.907|0.947
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|55–59|0.91|0.889|0.927
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|60–64|0.88|0.86|0.898
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|65–69|0.867|0.848|0.884
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|70–74|0.838|0.816|0.858
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|75–79|0.764|0.738|0.789
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|80–84|0.676|0.643|0.707
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|85+|0.497|0.459|0.535
Relative|Non-Hodgkin lymphoma|2015–2019|Females|3|All ages combined|0.81|0.802|0.819
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|00–04|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|05–09|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|10–14|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|15–19|0.876|0.701|0.952
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|20–24|0.945|0.858|0.979
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|25–29|0.953|0.89|0.981
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|30–34|0.911|0.847|0.949
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|35–39|0.942|0.896|0.969
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|40–44|0.927|0.89|0.952
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|45–49|0.91|0.88|0.934
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|50–54|0.916|0.892|0.936
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|55–59|0.904|0.882|0.922
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|60–64|0.867|0.845|0.886
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|65–69|0.854|0.833|0.872
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|70–74|0.823|0.799|0.844
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|75–79|0.742|0.713|0.769
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|80–84|0.655|0.619|0.689
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|85+|0.489|0.447|0.532
Relative|Non-Hodgkin lymphoma|2015–2019|Females|4|All ages combined|0.798|0.789|0.807
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|00–04|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|05–09|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|10–14|||
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|15–19|0.876|0.701|0.952
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|20–24|0.945|0.858|0.98
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|25–29|0.954|0.89|0.981
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|30–34|0.911|0.847|0.95
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|35–39|0.943|0.897|0.97
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|40–44|0.925|0.887|0.951
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|45–49|0.901|0.87|0.926
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|50–54|0.904|0.879|0.925
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|55–59|0.895|0.873|0.915
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|60–64|0.851|0.828|0.871
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|65–69|0.84|0.818|0.86
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|70–74|0.8|0.774|0.823
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|75–79|0.712|0.681|0.742
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|80–84|0.618|0.579|0.656
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|85+|0.47|0.423|0.519
Relative|Non-Hodgkin lymphoma|2015–2019|Females|5|All ages combined|0.781|0.771|0.79
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|00–04|0.889|0.731|0.957
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|05–09|0.954|0.865|0.985
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|10–14|0.959|0.879|0.987
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|15–19|0.925|0.855|0.962
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|20–24|0.95|0.903|0.975
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|25–29|0.965|0.931|0.982
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|30–34|0.963|0.935|0.979
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|35–39|0.949|0.926|0.965
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|40–44|0.965|0.949|0.977
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|45–49|0.945|0.93|0.957
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|50–54|0.943|0.93|0.953
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|55–59|0.935|0.924|0.945
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|60–64|0.92|0.91|0.929
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|65–69|0.893|0.883|0.903
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|70–74|0.877|0.866|0.887
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|75–79|0.815|0.802|0.828
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|80–84|0.73|0.713|0.746
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|85+|0.539|0.519|0.558
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|1|All ages combined|0.847|0.843|0.852
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|00–04|0.861|0.698|0.94
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|05–09|0.954|0.865|0.985
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|10–14|0.93|0.839|0.97
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|15–19|0.907|0.834|0.949
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|20–24|0.938|0.888|0.966
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|25–29|0.947|0.909|0.97
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|30–34|0.932|0.898|0.955
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|35–39|0.925|0.898|0.945
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|40–44|0.939|0.919|0.954
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|45–49|0.918|0.901|0.933
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|50–54|0.921|0.906|0.933
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|55–59|0.894|0.881|0.906
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|60–64|0.879|0.866|0.89
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|65–69|0.848|0.836|0.859
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|70–74|0.815|0.802|0.827
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|75–79|0.739|0.723|0.753
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|80–84|0.638|0.619|0.655
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|85+|0.424|0.405|0.442
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|2|All ages combined|0.789|0.784|0.793
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|00–04|0.861|0.698|0.94
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|05–09|0.939|0.846|0.977
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|10–14|0.93|0.839|0.97
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|15–19|0.898|0.824|0.942
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|20–24|0.921|0.868|0.953
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|25–29|0.93|0.889|0.957
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|30–34|0.916|0.878|0.942
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|35–39|0.911|0.882|0.933
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|40–44|0.922|0.899|0.939
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|45–49|0.906|0.888|0.922
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|50–54|0.899|0.883|0.912
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|55–59|0.871|0.857|0.884
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|60–64|0.848|0.835|0.86
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|65–69|0.818|0.805|0.83
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|70–74|0.768|0.754|0.782
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|75–79|0.678|0.661|0.694
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|80–84|0.566|0.547|0.584
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|85+|0.342|0.324|0.361
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|3|All ages combined|0.746|0.741|0.752
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|00–04|0.861|0.698|0.94
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|05–09|0.939|0.846|0.977
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|10–14|0.93|0.839|0.97
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|15–19|0.881|0.803|0.929
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|20–24|0.921|0.868|0.953
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|25–29|0.93|0.889|0.957
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|30–34|0.912|0.875|0.939
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|35–39|0.907|0.878|0.93
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|40–44|0.922|0.899|0.939
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|45–49|0.892|0.872|0.909
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|50–54|0.883|0.867|0.898
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|55–59|0.853|0.838|0.867
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|60–64|0.827|0.813|0.84
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|65–69|0.79|0.776|0.803
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|70–74|0.722|0.707|0.737
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|75–79|0.623|0.606|0.64
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|80–84|0.499|0.48|0.518
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|85+|0.28|0.262|0.298
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|4|All ages combined|0.712|0.706|0.717
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|00–04|0.861|0.698|0.94
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|05–09|0.939|0.846|0.977
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|10–14|0.93|0.839|0.97
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|15–19|0.881|0.803|0.929
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|20–24|0.921|0.868|0.953
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|25–29|0.922|0.879|0.95
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|30–34|0.902|0.863|0.931
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|35–39|0.903|0.874|0.926
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|40–44|0.915|0.892|0.933
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|45–49|0.879|0.859|0.897
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|50–54|0.867|0.849|0.883
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|55–59|0.836|0.82|0.851
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|60–64|0.804|0.789|0.818
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|65–69|0.765|0.75|0.778
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|70–74|0.686|0.67|0.701
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|75–79|0.576|0.558|0.593
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|80–84|0.433|0.414|0.452
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|85+|0.227|0.21|0.244
Observed|Non-Hodgkin lymphoma|2015–2019|Persons|5|All ages combined|0.68|0.675|0.686
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|00–04|0.889|0.731|0.957
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|05–09|0.954|0.865|0.985
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|10–14|0.959|0.879|0.987
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|15–19|0.925|0.855|0.962
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|20–24|0.951|0.903|0.975
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|25–29|0.965|0.931|0.983
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|30–34|0.963|0.936|0.979
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|35–39|0.95|0.926|0.966
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|40–44|0.967|0.95|0.978
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|45–49|0.947|0.932|0.959
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|50–54|0.946|0.933|0.956
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|55–59|0.939|0.929|0.949
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|60–64|0.926|0.916|0.936
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|65–69|0.902|0.892|0.912
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|70–74|0.891|0.881|0.902
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|75–79|0.839|0.825|0.852
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|80–84|0.769|0.751|0.786
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|85+|0.611|0.589|0.633
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|1|All ages combined|0.87|0.865|0.874
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|00–04|0.862|0.699|0.94
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|05–09|0.954|0.865|0.985
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|10–14|0.93|0.84|0.97
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|15–19|0.908|0.834|0.949
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|20–24|0.939|0.889|0.967
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|25–29|0.948|0.91|0.971
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|30–34|0.934|0.899|0.957
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|35–39|0.927|0.9|0.947
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|40–44|0.942|0.921|0.957
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|45–49|0.922|0.904|0.937
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|50–54|0.926|0.912|0.939
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|55–59|0.902|0.889|0.914
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|60–64|0.891|0.878|0.902
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|65–69|0.866|0.854|0.878
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|70–74|0.844|0.831|0.856
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|75–79|0.785|0.768|0.8
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|80–84|0.712|0.692|0.732
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|85+|0.55|0.525|0.574
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|2|All ages combined|0.828|0.823|0.833
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|00–04|0.862|0.699|0.94
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|05–09|0.939|0.846|0.977
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|10–14|0.93|0.84|0.971
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|15–19|0.9|0.825|0.944
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|20–24|0.922|0.869|0.955
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|25–29|0.932|0.89|0.958
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|30–34|0.918|0.88|0.944
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|35–39|0.914|0.885|0.936
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|40–44|0.926|0.903|0.943
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|45–49|0.912|0.893|0.928
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|50–54|0.907|0.891|0.921
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|55–59|0.884|0.869|0.897
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|60–64|0.866|0.853|0.879
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|65–69|0.845|0.832|0.858
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|70–74|0.812|0.797|0.826
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|75–79|0.746|0.728|0.764
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|80–84|0.675|0.653|0.697
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|85+|0.515|0.487|0.542
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|3|All ages combined|0.802|0.797|0.808
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|00–04|0.862|0.699|0.94
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|05–09|0.939|0.846|0.977
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|10–14|0.93|0.84|0.971
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|15–19|0.882|0.805|0.93
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|20–24|0.923|0.869|0.955
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|25–29|0.932|0.891|0.959
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|30–34|0.915|0.877|0.942
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|35–39|0.911|0.882|0.934
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|40–44|0.927|0.905|0.945
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|45–49|0.9|0.88|0.917
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|50–54|0.895|0.878|0.91
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|55–59|0.87|0.855|0.884
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|60–64|0.852|0.837|0.866
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|65–69|0.827|0.813|0.841
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|70–74|0.78|0.764|0.796
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|75–79|0.715|0.695|0.734
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|80–84|0.643|0.618|0.668
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|85+|0.494|0.463|0.525
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|4|All ages combined|0.783|0.777|0.789
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|00–04|0.862|0.699|0.94
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|05–09|0.94|0.846|0.977
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|10–14|0.931|0.84|0.971
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|15–19|0.883|0.805|0.931
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|20–24|0.923|0.87|0.956
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|25–29|0.924|0.881|0.953
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|30–34|0.906|0.866|0.934
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|35–39|0.908|0.878|0.931
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|40–44|0.922|0.899|0.941
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|45–49|0.89|0.869|0.908
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|50–54|0.882|0.864|0.898
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|55–59|0.858|0.841|0.873
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|60–64|0.836|0.821|0.851
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|65–69|0.813|0.798|0.827
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|70–74|0.76|0.742|0.777
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|75–79|0.691|0.669|0.711
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|80–84|0.607|0.58|0.634
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|85+|0.475|0.44|0.511
Relative|Non-Hodgkin lymphoma|2015–2019|Persons|5|All ages combined|0.767|0.76|0.773
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|35–39|0.954|0.716|0.993
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|40–44|1|0.923|1
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|45–49|0.968|0.879|0.992
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|50–54|0.943|0.868|0.976
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|55–59|0.934|0.881|0.964
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|60–64|0.93|0.888|0.956
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|65–69|0.907|0.871|0.933
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|70–74|0.887|0.856|0.912
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|75–79|0.902|0.874|0.925
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|80–84|0.811|0.776|0.841
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|85+|0.721|0.688|0.752
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|All ages combined|0.852|0.839|0.863
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|35–39|0.954|0.716|0.993
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|40–44|0.974|0.831|0.996
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|45–49|0.953|0.862|0.985
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|50–54|0.921|0.841|0.961
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|55–59|0.915|0.857|0.949
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|60–64|0.867|0.815|0.905
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|65–69|0.832|0.788|0.868
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|70–74|0.801|0.761|0.834
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|75–79|0.765|0.726|0.8
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|80–84|0.67|0.628|0.708
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|85+|0.498|0.461|0.535
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|All ages combined|0.73|0.715|0.745
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|35–39|0.954|0.716|0.993
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|40–44|0.974|0.831|0.996
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|45–49|0.953|0.862|0.985
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|50–54|0.91|0.827|0.954
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|55–59|0.888|0.826|0.929
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|60–64|0.832|0.777|0.875
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|65–69|0.775|0.726|0.816
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|70–74|0.717|0.673|0.757
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|75–79|0.692|0.649|0.73
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|80–84|0.545|0.501|0.586
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|85+|0.363|0.327|0.4
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|All ages combined|0.647|0.63|0.664
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|35–39|0.954|0.716|0.993
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|40–44|0.911|0.749|0.971
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|45–49|0.921|0.821|0.966
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|50–54|0.91|0.827|0.954
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|55–59|0.874|0.81|0.918
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|60–64|0.801|0.742|0.847
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|65–69|0.731|0.679|0.776
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|70–74|0.661|0.613|0.704
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|75–79|0.621|0.576|0.663
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|80–84|0.486|0.441|0.529
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|85+|0.282|0.248|0.318
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|All ages combined|0.593|0.575|0.61
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|35–39|0.954|0.716|0.993
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|40–44|0.911|0.749|0.971
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|45–49|0.904|0.797|0.956
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|50–54|0.897|0.812|0.945
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|55–59|0.874|0.81|0.918
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|60–64|0.796|0.737|0.843
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|65–69|0.69|0.635|0.738
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|70–74|0.605|0.554|0.651
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|75–79|0.565|0.517|0.609
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|80–84|0.408|0.363|0.452
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|85+|0.213|0.181|0.248
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|All ages combined|0.545|0.527|0.563
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|35–39|0.955|0.717|0.995
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|40–44|1.002|0.924|1.002
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|45–49|0.97|0.881|0.994
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|50–54|0.946|0.871|0.979
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|55–59|0.939|0.886|0.969
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|60–64|0.937|0.895|0.964
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|65–69|0.918|0.882|0.944
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|70–74|0.905|0.873|0.93
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|75–79|0.933|0.904|0.956
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|80–84|0.861|0.824|0.893
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|85+|0.837|0.798|0.872
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|1|All ages combined|0.897|0.884|0.91
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|35–39|0.956|0.718|0.996
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|40–44|0.978|0.834|1
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|45–49|0.958|0.866|0.99
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|50–54|0.927|0.847|0.968
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|55–59|0.925|0.867|0.96
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|60–64|0.881|0.829|0.92
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|65–69|0.854|0.809|0.89
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|70–74|0.834|0.794|0.869
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|75–79|0.822|0.78|0.859
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|80–84|0.762|0.714|0.805
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|85+|0.679|0.628|0.728
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|2|All ages combined|0.81|0.793|0.827
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|35–39|0.958|0.719|0.997
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|40–44|0.979|0.835|1.002
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|45–49|0.96|0.868|0.992
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|50–54|0.92|0.837|0.965
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|55–59|0.903|0.84|0.945
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|60–64|0.854|0.798|0.898
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|65–69|0.806|0.756|0.849
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|70–74|0.766|0.718|0.808
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|75–79|0.776|0.728|0.819
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|80–84|0.669|0.615|0.72
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|85+|0.589|0.53|0.648
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|3|All ages combined|0.754|0.734|0.773
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|35–39|0.959|0.72|0.999
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|40–44|0.918|0.754|0.978
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|45–49|0.931|0.83|0.977
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|50–54|0.924|0.84|0.969
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|55–59|0.896|0.83|0.941
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|60–64|0.83|0.77|0.878
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|65–69|0.774|0.718|0.821
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|70–74|0.725|0.673|0.772
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|75–79|0.73|0.677|0.78
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|80–84|0.652|0.592|0.71
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|85+|0.552|0.484|0.622
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|4|All ages combined|0.725|0.703|0.746
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|35–39|0.961|0.721|1
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|40–44|0.92|0.756|0.98
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|45–49|0.916|0.809|0.969
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|50–54|0.916|0.828|0.965
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|55–59|0.902|0.836|0.948
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|60–64|0.835|0.773|0.884
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|65–69|0.743|0.684|0.795
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|70–74|0.683|0.626|0.736
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|75–79|0.7|0.642|0.756
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|80–84|0.605|0.539|0.671
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|85+|0.511|0.433|0.594
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Males|5|All ages combined|0.699|0.675|0.722
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|35–39|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|40–44|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|45–49|1|0.92|1
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|50–54|0.985|0.897|0.998
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|55–59|0.971|0.89|0.993
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|60–64|0.966|0.912|0.987
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|65–69|0.954|0.91|0.977
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|70–74|0.949|0.907|0.972
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|75–79|0.905|0.859|0.936
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|80–84|0.849|0.804|0.885
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|85+|0.713|0.672|0.749
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|All ages combined|0.861|0.844|0.877
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|35–39|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|40–44|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|45–49|1|0.919|1
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|50–54|0.985|0.897|0.998
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|55–59|0.942|0.853|0.978
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|60–64|0.928|0.86|0.963
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|65–69|0.89|0.83|0.929
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|70–74|0.896|0.842|0.933
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|75–79|0.817|0.76|0.862
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|80–84|0.725|0.67|0.772
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|85+|0.531|0.486|0.573
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|All ages combined|0.759|0.738|0.779
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|35–39|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|40–44|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|45–49|1|0.92|1
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|50–54|0.985|0.897|0.998
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|55–59|0.942|0.853|0.978
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|60–64|0.88|0.802|0.929
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|65–69|0.834|0.765|0.884
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|70–74|0.849|0.787|0.894
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|75–79|0.727|0.662|0.782
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|80–84|0.629|0.571|0.682
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|85+|0.403|0.359|0.447
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|All ages combined|0.682|0.659|0.703
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|35–39|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|40–44|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|45–49|1|0.919|1
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|50–54|0.962|0.854|0.991
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|55–59|0.942|0.853|0.978
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|60–64|0.852|0.77|0.907
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|65–69|0.802|0.728|0.858
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|70–74|0.824|0.758|0.873
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|75–79|0.66|0.59|0.721
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|80–84|0.529|0.469|0.586
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|85+|0.309|0.266|0.353
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|All ages combined|0.62|0.596|0.644
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|35–39|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|40–44|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|45–49|1|0.918|1
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|50–54|0.895|0.765|0.955
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|55–59|0.942|0.853|0.978
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|60–64|0.832|0.746|0.891
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|65–69|0.774|0.695|0.834
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|70–74|0.811|0.744|0.862
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|75–79|0.617|0.544|0.681
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|80–84|0.471|0.41|0.529
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|85+|0.237|0.196|0.279
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|All ages combined|0.578|0.553|0.602
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|35–39|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|40–44|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|45–49|1.001|0.921|1.001
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|50–54|0.987|0.899|1
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|55–59|0.974|0.892|0.996
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|60–64|0.971|0.917|0.992
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|65–69|0.961|0.916|0.984
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|70–74|0.96|0.918|0.984
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|75–79|0.925|0.878|0.957
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|80–84|0.886|0.839|0.923
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|85+|0.816|0.77|0.858
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|1|All ages combined|0.906|0.888|0.922
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|35–39|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|40–44|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|45–49|1.003|0.921|1.003
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|50–54|0.989|0.901|1.002
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|55–59|0.948|0.859|0.984
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|60–64|0.937|0.869|0.973
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|65–69|0.903|0.843|0.944
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|70–74|0.92|0.864|0.957
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|75–79|0.856|0.796|0.903
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|80–84|0.794|0.734|0.846
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|85+|0.701|0.643|0.757
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|2|All ages combined|0.837|0.814|0.859
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|35–39|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|40–44|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|45–49|1.005|0.924|1.005
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|50–54|0.992|0.903|1.005
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|55–59|0.952|0.862|0.988
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|60–64|0.894|0.814|0.943
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|65–69|0.855|0.784|0.906
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|70–74|0.885|0.82|0.932
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|75–79|0.783|0.713|0.842
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|80–84|0.729|0.662|0.791
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|85+|0.618|0.549|0.685
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|3|All ages combined|0.786|0.759|0.811
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|35–39|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|40–44|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|45–49|1.006|0.925|1.006
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|50–54|0.972|0.863|1
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|55–59|0.956|0.866|0.992
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|60–64|0.871|0.787|0.926
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|65–69|0.83|0.753|0.887
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|70–74|0.873|0.804|0.925
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|75–79|0.734|0.656|0.801
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|80–84|0.655|0.58|0.725
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|85+|0.554|0.476|0.632
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|4|All ages combined|0.747|0.717|0.775
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|35–39|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|40–44|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|45–49|1.008|0.926|1.008
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|50–54|0.907|0.774|0.968
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|55–59|0.96|0.869|0.996
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|60–64|0.855|0.767|0.916
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|65–69|0.809|0.727|0.873
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|70–74|0.877|0.804|0.932
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|75–79|0.711|0.628|0.785
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|80–84|0.627|0.546|0.705
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|85+|0.501|0.416|0.591
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Females|5|All ages combined|0.725|0.694|0.756
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|30–34|0.962|0.757|0.994
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|35–39|0.969|0.799|0.996
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|40–44|0.981|0.876|0.997
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|45–49|0.98|0.921|0.995
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|50–54|0.961|0.915|0.982
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|55–59|0.946|0.907|0.969
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|60–64|0.942|0.912|0.962
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|65–69|0.922|0.896|0.942
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|70–74|0.905|0.88|0.925
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|75–79|0.903|0.88|0.922
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|80–84|0.824|0.797|0.848
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|85+|0.718|0.692|0.741
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|All ages combined|0.855|0.845|0.864
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|30–34|0.962|0.757|0.994
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|35–39|0.969|0.799|0.996
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|40–44|0.946|0.843|0.982
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|45–49|0.97|0.909|0.99
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|50–54|0.947|0.898|0.973
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|55–59|0.923|0.879|0.952
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|60–64|0.887|0.848|0.917
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|65–69|0.851|0.817|0.879
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|70–74|0.828|0.796|0.854
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|75–79|0.781|0.749|0.809
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|80–84|0.689|0.657|0.72
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|85+|0.512|0.483|0.54
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|All ages combined|0.74|0.728|0.752
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|30–34|0.962|0.757|0.994
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|35–39|0.969|0.799|0.996
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|40–44|0.946|0.843|0.982
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|45–49|0.97|0.909|0.99
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|50–54|0.94|0.888|0.969
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|55–59|0.905|0.858|0.937
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|60–64|0.848|0.805|0.883
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|65–69|0.794|0.755|0.827
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|70–74|0.755|0.719|0.787
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|75–79|0.703|0.667|0.735
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|80–84|0.575|0.54|0.608
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|85+|0.38|0.352|0.408
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|All ages combined|0.659|0.646|0.673
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|35–39|0.969|0.799|0.996
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|40–44|0.886|0.764|0.947
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|45–49|0.949|0.882|0.979
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|50–54|0.932|0.878|0.963
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|55–59|0.895|0.847|0.929
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|60–64|0.818|0.772|0.855
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|65–69|0.754|0.712|0.79
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|70–74|0.709|0.67|0.743
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|75–79|0.633|0.595|0.668
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|80–84|0.501|0.465|0.535
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|85+|0.293|0.266|0.321
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|All ages combined|0.602|0.588|0.616
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|00–04|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|05–09|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|10–14|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|15–19|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|20–24|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|25–29|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|30–34|||
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|35–39|0.969|0.799|0.996
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|40–44|0.886|0.764|0.947
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|45–49|0.938|0.868|0.972
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|50–54|0.9|0.837|0.94
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|55–59|0.895|0.847|0.929
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|60–64|0.808|0.762|0.847
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|65–69|0.716|0.672|0.756
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|70–74|0.667|0.627|0.704
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|75–79|0.58|0.541|0.618
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|80–84|0.43|0.394|0.466
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|85+|0.223|0.197|0.25
Observed|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|All ages combined|0.557|0.542|0.571
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|30–34|0.962|0.758|0.995
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|35–39|0.97|0.8|0.997
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|40–44|0.983|0.877|0.999
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|45–49|0.982|0.923|0.997
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|50–54|0.964|0.918|0.985
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|55–59|0.95|0.911|0.973
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|60–64|0.949|0.918|0.969
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|65–69|0.932|0.905|0.952
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|70–74|0.921|0.896|0.941
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|75–79|0.931|0.907|0.95
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|80–84|0.87|0.841|0.895
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|85+|0.828|0.799|0.856
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|1|All ages combined|0.9|0.89|0.91
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|30–34|0.963|0.758|0.996
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|35–39|0.971|0.801|0.998
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|40–44|0.949|0.845|0.985
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|45–49|0.974|0.913|0.994
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|50–54|0.953|0.903|0.979
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|55–59|0.932|0.888|0.961
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|60–64|0.9|0.86|0.93
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|65–69|0.87|0.835|0.899
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|70–74|0.859|0.826|0.887
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|75–79|0.833|0.799|0.863
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|80–84|0.773|0.737|0.807
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|85+|0.689|0.65|0.726
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|2|All ages combined|0.819|0.806|0.833
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|30–34|0.963|0.759|0.996
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|35–39|0.972|0.802|0.999
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|40–44|0.951|0.847|0.987
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|45–49|0.976|0.915|0.997
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|50–54|0.949|0.897|0.978
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|55–59|0.919|0.871|0.951
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|60–64|0.868|0.824|0.903
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|65–69|0.822|0.782|0.857
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|70–74|0.8|0.762|0.834
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|75–79|0.778|0.739|0.814
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|80–84|0.691|0.649|0.731
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|85+|0.601|0.556|0.646
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|3|All ages combined|0.765|0.749|0.781
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|35–39|0.973|0.803|1
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|40–44|0.892|0.769|0.953
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|45–49|0.958|0.891|0.988
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|50–54|0.945|0.89|0.976
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|55–59|0.915|0.865|0.949
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|60–64|0.844|0.797|0.883
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|65–69|0.792|0.748|0.83
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|70–74|0.769|0.727|0.806
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|75–79|0.732|0.688|0.772
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|80–84|0.652|0.606|0.697
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|85+|0.553|0.501|0.605
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|4|All ages combined|0.732|0.715|0.749
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|00–04|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|05–09|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|10–14|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|15–19|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|20–24|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|25–29|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|30–34|||
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|35–39|0.975|0.804|1.001
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|40–44|0.894|0.77|0.955
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|45–49|0.949|0.878|0.983
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|50–54|0.916|0.852|0.956
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|55–59|0.92|0.87|0.955
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|60–64|0.842|0.794|0.882
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|65–69|0.764|0.717|0.806
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|70–74|0.743|0.698|0.784
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|75–79|0.704|0.657|0.749
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|80–84|0.613|0.562|0.663
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|85+|0.506|0.448|0.567
Relative|Non-melanoma skin cancer (rare types)|2015–2019|Persons|5|All ages combined|0.708|0.689|0.727
Observed|Oesophageal cancer|2015–2019|Males|1|00–04|||
Observed|Oesophageal cancer|2015–2019|Males|1|05–09|||
Observed|Oesophageal cancer|2015–2019|Males|1|10–14|||
Observed|Oesophageal cancer|2015–2019|Males|1|15–19|||
Observed|Oesophageal cancer|2015–2019|Males|1|20–24|||
Observed|Oesophageal cancer|2015–2019|Males|1|25–29|||
Observed|Oesophageal cancer|2015–2019|Males|1|30–34|||
Observed|Oesophageal cancer|2015–2019|Males|1|35–39|||
Observed|Oesophageal cancer|2015–2019|Males|1|40–44|0.7|0.579|0.793
Observed|Oesophageal cancer|2015–2019|Males|1|45–49|0.63|0.54|0.707
Observed|Oesophageal cancer|2015–2019|Males|1|50–54|0.526|0.468|0.58
Observed|Oesophageal cancer|2015–2019|Males|1|55–59|0.581|0.538|0.622
Observed|Oesophageal cancer|2015–2019|Males|1|60–64|0.541|0.505|0.576
Observed|Oesophageal cancer|2015–2019|Males|1|65–69|0.576|0.543|0.607
Observed|Oesophageal cancer|2015–2019|Males|1|70–74|0.526|0.494|0.557
Observed|Oesophageal cancer|2015–2019|Males|1|75–79|0.504|0.47|0.538
Observed|Oesophageal cancer|2015–2019|Males|1|80–84|0.369|0.331|0.408
Observed|Oesophageal cancer|2015–2019|Males|1|85+|0.291|0.253|0.33
Observed|Oesophageal cancer|2015–2019|Males|1|All ages combined|0.506|0.493|0.519
Observed|Oesophageal cancer|2015–2019|Males|2|00–04|||
Observed|Oesophageal cancer|2015–2019|Males|2|05–09|||
Observed|Oesophageal cancer|2015–2019|Males|2|10–14|||
Observed|Oesophageal cancer|2015–2019|Males|2|15–19|||
Observed|Oesophageal cancer|2015–2019|Males|2|20–24|||
Observed|Oesophageal cancer|2015–2019|Males|2|25–29|||
Observed|Oesophageal cancer|2015–2019|Males|2|30–34|||
Observed|Oesophageal cancer|2015–2019|Males|2|35–39|||
Observed|Oesophageal cancer|2015–2019|Males|2|40–44|0.497|0.373|0.609
Observed|Oesophageal cancer|2015–2019|Males|2|45–49|0.388|0.302|0.472
Observed|Oesophageal cancer|2015–2019|Males|2|50–54|0.343|0.29|0.396
Observed|Oesophageal cancer|2015–2019|Males|2|55–59|0.391|0.349|0.433
Observed|Oesophageal cancer|2015–2019|Males|2|60–64|0.365|0.33|0.401
Observed|Oesophageal cancer|2015–2019|Males|2|65–69|0.394|0.362|0.425
Observed|Oesophageal cancer|2015–2019|Males|2|70–74|0.368|0.337|0.399
Observed|Oesophageal cancer|2015–2019|Males|2|75–79|0.319|0.286|0.352
Observed|Oesophageal cancer|2015–2019|Males|2|80–84|0.228|0.194|0.263
Observed|Oesophageal cancer|2015–2019|Males|2|85+|0.141|0.112|0.173
Observed|Oesophageal cancer|2015–2019|Males|2|All ages combined|0.333|0.321|0.346
Observed|Oesophageal cancer|2015–2019|Males|3|00–04|||
Observed|Oesophageal cancer|2015–2019|Males|3|05–09|||
Observed|Oesophageal cancer|2015–2019|Males|3|10–14|||
Observed|Oesophageal cancer|2015–2019|Males|3|15–19|||
Observed|Oesophageal cancer|2015–2019|Males|3|20–24|||
Observed|Oesophageal cancer|2015–2019|Males|3|25–29|||
Observed|Oesophageal cancer|2015–2019|Males|3|30–34|||
Observed|Oesophageal cancer|2015–2019|Males|3|35–39|||
Observed|Oesophageal cancer|2015–2019|Males|3|40–44|0.431|0.31|0.546
Observed|Oesophageal cancer|2015–2019|Males|3|45–49|0.32|0.241|0.402
Observed|Oesophageal cancer|2015–2019|Males|3|50–54|0.283|0.233|0.334
Observed|Oesophageal cancer|2015–2019|Males|3|55–59|0.309|0.27|0.349
Observed|Oesophageal cancer|2015–2019|Males|3|60–64|0.298|0.264|0.332
Observed|Oesophageal cancer|2015–2019|Males|3|65–69|0.325|0.295|0.355
Observed|Oesophageal cancer|2015–2019|Males|3|70–74|0.29|0.26|0.319
Observed|Oesophageal cancer|2015–2019|Males|3|75–79|0.254|0.224|0.286
Observed|Oesophageal cancer|2015–2019|Males|3|80–84|0.159|0.13|0.191
Observed|Oesophageal cancer|2015–2019|Males|3|85+|0.074|0.053|0.099
Observed|Oesophageal cancer|2015–2019|Males|3|All ages combined|0.263|0.251|0.275
Observed|Oesophageal cancer|2015–2019|Males|4|00–04|||
Observed|Oesophageal cancer|2015–2019|Males|4|05–09|||
Observed|Oesophageal cancer|2015–2019|Males|4|10–14|||
Observed|Oesophageal cancer|2015–2019|Males|4|15–19|||
Observed|Oesophageal cancer|2015–2019|Males|4|20–24|||
Observed|Oesophageal cancer|2015–2019|Males|4|25–29|||
Observed|Oesophageal cancer|2015–2019|Males|4|30–34|||
Observed|Oesophageal cancer|2015–2019|Males|4|35–39|||
Observed|Oesophageal cancer|2015–2019|Males|4|40–44|0.397|0.278|0.513
Observed|Oesophageal cancer|2015–2019|Males|4|45–49|0.258|0.186|0.337
Observed|Oesophageal cancer|2015–2019|Males|4|50–54|0.264|0.216|0.314
Observed|Oesophageal cancer|2015–2019|Males|4|55–59|0.275|0.238|0.314
Observed|Oesophageal cancer|2015–2019|Males|4|60–64|0.268|0.236|0.302
Observed|Oesophageal cancer|2015–2019|Males|4|65–69|0.288|0.258|0.318
Observed|Oesophageal cancer|2015–2019|Males|4|70–74|0.261|0.233|0.291
Observed|Oesophageal cancer|2015–2019|Males|4|75–79|0.214|0.185|0.245
Observed|Oesophageal cancer|2015–2019|Males|4|80–84|0.11|0.085|0.138
Observed|Oesophageal cancer|2015–2019|Males|4|85+|0.048|0.031|0.07
Observed|Oesophageal cancer|2015–2019|Males|4|All ages combined|0.229|0.218|0.241
Observed|Oesophageal cancer|2015–2019|Males|5|00–04|||
Observed|Oesophageal cancer|2015–2019|Males|5|05–09|||
Observed|Oesophageal cancer|2015–2019|Males|5|10–14|||
Observed|Oesophageal cancer|2015–2019|Males|5|15–19|||
Observed|Oesophageal cancer|2015–2019|Males|5|20–24|||
Observed|Oesophageal cancer|2015–2019|Males|5|25–29|||
Observed|Oesophageal cancer|2015–2019|Males|5|30–34|||
Observed|Oesophageal cancer|2015–2019|Males|5|35–39|||
Observed|Oesophageal cancer|2015–2019|Males|5|40–44|0.397|0.278|0.513
Observed|Oesophageal cancer|2015–2019|Males|5|45–49|0.241|0.172|0.317
Observed|Oesophageal cancer|2015–2019|Males|5|50–54|0.252|0.205|0.302
Observed|Oesophageal cancer|2015–2019|Males|5|55–59|0.255|0.219|0.292
Observed|Oesophageal cancer|2015–2019|Males|5|60–64|0.237|0.206|0.27
Observed|Oesophageal cancer|2015–2019|Males|5|65–69|0.263|0.234|0.292
Observed|Oesophageal cancer|2015–2019|Males|5|70–74|0.233|0.206|0.262
Observed|Oesophageal cancer|2015–2019|Males|5|75–79|0.186|0.158|0.216
Observed|Oesophageal cancer|2015–2019|Males|5|80–84|0.087|0.064|0.113
Observed|Oesophageal cancer|2015–2019|Males|5|85+|0.027|0.015|0.045
Observed|Oesophageal cancer|2015–2019|Males|5|All ages combined|0.205|0.194|0.216
Relative|Oesophageal cancer|2015–2019|Males|1|00–04|||
Relative|Oesophageal cancer|2015–2019|Males|1|05–09|||
Relative|Oesophageal cancer|2015–2019|Males|1|10–14|||
Relative|Oesophageal cancer|2015–2019|Males|1|15–19|||
Relative|Oesophageal cancer|2015–2019|Males|1|20–24|||
Relative|Oesophageal cancer|2015–2019|Males|1|25–29|||
Relative|Oesophageal cancer|2015–2019|Males|1|30–34|||
Relative|Oesophageal cancer|2015–2019|Males|1|35–39|||
Relative|Oesophageal cancer|2015–2019|Males|1|40–44|0.701|0.58|0.794
Relative|Oesophageal cancer|2015–2019|Males|1|45–49|0.631|0.542|0.708
Relative|Oesophageal cancer|2015–2019|Males|1|50–54|0.527|0.47|0.582
Relative|Oesophageal cancer|2015–2019|Males|1|55–59|0.584|0.541|0.625
Relative|Oesophageal cancer|2015–2019|Males|1|60–64|0.545|0.509|0.581
Relative|Oesophageal cancer|2015–2019|Males|1|65–69|0.583|0.55|0.615
Relative|Oesophageal cancer|2015–2019|Males|1|70–74|0.536|0.504|0.568
Relative|Oesophageal cancer|2015–2019|Males|1|75–79|0.521|0.485|0.556
Relative|Oesophageal cancer|2015–2019|Males|1|80–84|0.393|0.351|0.434
Relative|Oesophageal cancer|2015–2019|Males|1|85+|0.335|0.291|0.38
Relative|Oesophageal cancer|2015–2019|Males|1|All ages combined|0.521|0.508|0.535
Relative|Oesophageal cancer|2015–2019|Males|2|00–04|||
Relative|Oesophageal cancer|2015–2019|Males|2|05–09|||
Relative|Oesophageal cancer|2015–2019|Males|2|10–14|||
Relative|Oesophageal cancer|2015–2019|Males|2|15–19|||
Relative|Oesophageal cancer|2015–2019|Males|2|20–24|||
Relative|Oesophageal cancer|2015–2019|Males|2|25–29|||
Relative|Oesophageal cancer|2015–2019|Males|2|30–34|||
Relative|Oesophageal cancer|2015–2019|Males|2|35–39|||
Relative|Oesophageal cancer|2015–2019|Males|2|40–44|0.499|0.374|0.611
Relative|Oesophageal cancer|2015–2019|Males|2|45–49|0.39|0.304|0.474
Relative|Oesophageal cancer|2015–2019|Males|2|50–54|0.345|0.292|0.399
Relative|Oesophageal cancer|2015–2019|Males|2|55–59|0.395|0.353|0.437
Relative|Oesophageal cancer|2015–2019|Males|2|60–64|0.371|0.335|0.407
Relative|Oesophageal cancer|2015–2019|Males|2|65–69|0.404|0.371|0.436
Relative|Oesophageal cancer|2015–2019|Males|2|70–74|0.384|0.351|0.416
Relative|Oesophageal cancer|2015–2019|Males|2|75–79|0.342|0.307|0.378
Relative|Oesophageal cancer|2015–2019|Males|2|80–84|0.26|0.221|0.3
Relative|Oesophageal cancer|2015–2019|Males|2|85+|0.189|0.15|0.232
Relative|Oesophageal cancer|2015–2019|Males|2|All ages combined|0.352|0.339|0.365
Relative|Oesophageal cancer|2015–2019|Males|3|00–04|||
Relative|Oesophageal cancer|2015–2019|Males|3|05–09|||
Relative|Oesophageal cancer|2015–2019|Males|3|10–14|||
Relative|Oesophageal cancer|2015–2019|Males|3|15–19|||
Relative|Oesophageal cancer|2015–2019|Males|3|20–24|||
Relative|Oesophageal cancer|2015–2019|Males|3|25–29|||
Relative|Oesophageal cancer|2015–2019|Males|3|30–34|||
Relative|Oesophageal cancer|2015–2019|Males|3|35–39|||
Relative|Oesophageal cancer|2015–2019|Males|3|40–44|0.433|0.312|0.549
Relative|Oesophageal cancer|2015–2019|Males|3|45–49|0.323|0.243|0.405
Relative|Oesophageal cancer|2015–2019|Males|3|50–54|0.286|0.236|0.338
Relative|Oesophageal cancer|2015–2019|Males|3|55–59|0.314|0.275|0.355
Relative|Oesophageal cancer|2015–2019|Males|3|60–64|0.306|0.271|0.341
Relative|Oesophageal cancer|2015–2019|Males|3|65–69|0.338|0.307|0.37
Relative|Oesophageal cancer|2015–2019|Males|3|70–74|0.309|0.278|0.341
Relative|Oesophageal cancer|2015–2019|Males|3|75–79|0.285|0.251|0.32
Relative|Oesophageal cancer|2015–2019|Males|3|80–84|0.196|0.16|0.235
Relative|Oesophageal cancer|2015–2019|Males|3|85+|0.115|0.083|0.155
Relative|Oesophageal cancer|2015–2019|Males|3|All ages combined|0.285|0.273|0.298
Relative|Oesophageal cancer|2015–2019|Males|4|00–04|||
Relative|Oesophageal cancer|2015–2019|Males|4|05–09|||
Relative|Oesophageal cancer|2015–2019|Males|4|10–14|||
Relative|Oesophageal cancer|2015–2019|Males|4|15–19|||
Relative|Oesophageal cancer|2015–2019|Males|4|20–24|||
Relative|Oesophageal cancer|2015–2019|Males|4|25–29|||
Relative|Oesophageal cancer|2015–2019|Males|4|30–34|||
Relative|Oesophageal cancer|2015–2019|Males|4|35–39|||
Relative|Oesophageal cancer|2015–2019|Males|4|40–44|0.4|0.28|0.517
Relative|Oesophageal cancer|2015–2019|Males|4|45–49|0.261|0.188|0.34
Relative|Oesophageal cancer|2015–2019|Males|4|50–54|0.268|0.219|0.319
Relative|Oesophageal cancer|2015–2019|Males|4|55–59|0.282|0.244|0.321
Relative|Oesophageal cancer|2015–2019|Males|4|60–64|0.278|0.245|0.313
Relative|Oesophageal cancer|2015–2019|Males|4|65–69|0.304|0.273|0.336
Relative|Oesophageal cancer|2015–2019|Males|4|70–74|0.286|0.255|0.318
Relative|Oesophageal cancer|2015–2019|Males|4|75–79|0.252|0.217|0.288
Relative|Oesophageal cancer|2015–2019|Males|4|80–84|0.147|0.114|0.186
Relative|Oesophageal cancer|2015–2019|Males|4|85+|0.09|0.058|0.132
Relative|Oesophageal cancer|2015–2019|Males|4|All ages combined|0.255|0.243|0.268
Relative|Oesophageal cancer|2015–2019|Males|5|00–04|||
Relative|Oesophageal cancer|2015–2019|Males|5|05–09|||
Relative|Oesophageal cancer|2015–2019|Males|5|10–14|||
Relative|Oesophageal cancer|2015–2019|Males|5|15–19|||
Relative|Oesophageal cancer|2015–2019|Males|5|20–24|||
Relative|Oesophageal cancer|2015–2019|Males|5|25–29|||
Relative|Oesophageal cancer|2015–2019|Males|5|30–34|||
Relative|Oesophageal cancer|2015–2019|Males|5|35–39|||
Relative|Oesophageal cancer|2015–2019|Males|5|40–44|0.401|0.281|0.518
Relative|Oesophageal cancer|2015–2019|Males|5|45–49|0.244|0.174|0.321
Relative|Oesophageal cancer|2015–2019|Males|5|50–54|0.257|0.209|0.308
Relative|Oesophageal cancer|2015–2019|Males|5|55–59|0.263|0.226|0.302
Relative|Oesophageal cancer|2015–2019|Males|5|60–64|0.249|0.216|0.283
Relative|Oesophageal cancer|2015–2019|Males|5|65–69|0.283|0.252|0.315
Relative|Oesophageal cancer|2015–2019|Males|5|70–74|0.263|0.232|0.296
Relative|Oesophageal cancer|2015–2019|Males|5|75–79|0.23|0.195|0.268
Relative|Oesophageal cancer|2015–2019|Males|5|80–84|0.129|0.095|0.169
Relative|Oesophageal cancer|2015–2019|Males|5|85+|0.062|0.034|0.104
Relative|Oesophageal cancer|2015–2019|Males|5|All ages combined|0.234|0.222|0.247
Observed|Oesophageal cancer|2015–2019|Females|1|00–04|||
Observed|Oesophageal cancer|2015–2019|Females|1|05–09|||
Observed|Oesophageal cancer|2015–2019|Females|1|10–14|||
Observed|Oesophageal cancer|2015–2019|Females|1|15–19|||
Observed|Oesophageal cancer|2015–2019|Females|1|20–24|||
Observed|Oesophageal cancer|2015–2019|Females|1|25–29|||
Observed|Oesophageal cancer|2015–2019|Females|1|30–34|||
Observed|Oesophageal cancer|2015–2019|Females|1|35–39|||
Observed|Oesophageal cancer|2015–2019|Females|1|40–44|||
Observed|Oesophageal cancer|2015–2019|Females|1|45–49|0.611|0.453|0.736
Observed|Oesophageal cancer|2015–2019|Females|1|50–54|0.673|0.561|0.762
Observed|Oesophageal cancer|2015–2019|Females|1|55–59|0.689|0.604|0.759
Observed|Oesophageal cancer|2015–2019|Females|1|60–64|0.657|0.588|0.717
Observed|Oesophageal cancer|2015–2019|Females|1|65–69|0.607|0.547|0.661
Observed|Oesophageal cancer|2015–2019|Females|1|70–74|0.547|0.489|0.601
Observed|Oesophageal cancer|2015–2019|Females|1|75–79|0.478|0.422|0.531
Observed|Oesophageal cancer|2015–2019|Females|1|80–84|0.353|0.299|0.406
Observed|Oesophageal cancer|2015–2019|Females|1|85+|0.236|0.199|0.276
Observed|Oesophageal cancer|2015–2019|Females|1|All ages combined|0.484|0.462|0.505
Observed|Oesophageal cancer|2015–2019|Females|2|00–04|||
Observed|Oesophageal cancer|2015–2019|Females|2|05–09|||
Observed|Oesophageal cancer|2015–2019|Females|2|10–14|||
Observed|Oesophageal cancer|2015–2019|Females|2|15–19|||
Observed|Oesophageal cancer|2015–2019|Females|2|20–24|||
Observed|Oesophageal cancer|2015–2019|Females|2|25–29|||
Observed|Oesophageal cancer|2015–2019|Females|2|30–34|||
Observed|Oesophageal cancer|2015–2019|Females|2|35–39|||
Observed|Oesophageal cancer|2015–2019|Females|2|40–44|||
Observed|Oesophageal cancer|2015–2019|Females|2|45–49|0.503|0.344|0.642
Observed|Oesophageal cancer|2015–2019|Females|2|50–54|0.525|0.413|0.626
Observed|Oesophageal cancer|2015–2019|Females|2|55–59|0.491|0.404|0.573
Observed|Oesophageal cancer|2015–2019|Females|2|60–64|0.509|0.437|0.576
Observed|Oesophageal cancer|2015–2019|Females|2|65–69|0.452|0.393|0.51
Observed|Oesophageal cancer|2015–2019|Females|2|70–74|0.373|0.318|0.427
Observed|Oesophageal cancer|2015–2019|Females|2|75–79|0.334|0.283|0.385
Observed|Oesophageal cancer|2015–2019|Females|2|80–84|0.239|0.193|0.288
Observed|Oesophageal cancer|2015–2019|Females|2|85+|0.104|0.078|0.133
Observed|Oesophageal cancer|2015–2019|Females|2|All ages combined|0.334|0.314|0.354
Observed|Oesophageal cancer|2015–2019|Females|3|00–04|||
Observed|Oesophageal cancer|2015–2019|Females|3|05–09|||
Observed|Oesophageal cancer|2015–2019|Females|3|10–14|||
Observed|Oesophageal cancer|2015–2019|Females|3|15–19|||
Observed|Oesophageal cancer|2015–2019|Females|3|20–24|||
Observed|Oesophageal cancer|2015–2019|Females|3|25–29|||
Observed|Oesophageal cancer|2015–2019|Females|3|30–34|||
Observed|Oesophageal cancer|2015–2019|Females|3|35–39|||
Observed|Oesophageal cancer|2015–2019|Females|3|40–44|||
Observed|Oesophageal cancer|2015–2019|Females|3|45–49|||
Observed|Oesophageal cancer|2015–2019|Females|3|50–54|0.405|0.291|0.516
Observed|Oesophageal cancer|2015–2019|Females|3|55–59|0.394|0.31|0.477
Observed|Oesophageal cancer|2015–2019|Females|3|60–64|0.46|0.388|0.529
Observed|Oesophageal cancer|2015–2019|Females|3|65–69|0.412|0.354|0.469
Observed|Oesophageal cancer|2015–2019|Females|3|70–74|0.316|0.264|0.368
Observed|Oesophageal cancer|2015–2019|Females|3|75–79|0.258|0.211|0.306
Observed|Oesophageal cancer|2015–2019|Females|3|80–84|0.177|0.137|0.222
Observed|Oesophageal cancer|2015–2019|Females|3|85+|0.08|0.058|0.108
Observed|Oesophageal cancer|2015–2019|Females|3|All ages combined|0.277|0.258|0.296
Observed|Oesophageal cancer|2015–2019|Females|4|00–04|||
Observed|Oesophageal cancer|2015–2019|Females|4|05–09|||
Observed|Oesophageal cancer|2015–2019|Females|4|10–14|||
Observed|Oesophageal cancer|2015–2019|Females|4|15–19|||
Observed|Oesophageal cancer|2015–2019|Females|4|20–24|||
Observed|Oesophageal cancer|2015–2019|Females|4|25–29|||
Observed|Oesophageal cancer|2015–2019|Females|4|30–34|||
Observed|Oesophageal cancer|2015–2019|Females|4|35–39|||
Observed|Oesophageal cancer|2015–2019|Females|4|40–44|||
Observed|Oesophageal cancer|2015–2019|Females|4|45–49|||
Observed|Oesophageal cancer|2015–2019|Females|4|50–54|0.382|0.267|0.495
Observed|Oesophageal cancer|2015–2019|Females|4|55–59|0.368|0.285|0.451
Observed|Oesophageal cancer|2015–2019|Females|4|60–64|0.4|0.328|0.471
Observed|Oesophageal cancer|2015–2019|Females|4|65–69|0.374|0.317|0.43
Observed|Oesophageal cancer|2015–2019|Females|4|70–74|0.272|0.222|0.323
Observed|Oesophageal cancer|2015–2019|Females|4|75–79|0.217|0.174|0.263
Observed|Oesophageal cancer|2015–2019|Females|4|80–84|0.141|0.105|0.182
Observed|Oesophageal cancer|2015–2019|Females|4|85+|0.049|0.032|0.071
Observed|Oesophageal cancer|2015–2019|Females|4|All ages combined|0.236|0.218|0.254
Observed|Oesophageal cancer|2015–2019|Females|5|00–04|||
Observed|Oesophageal cancer|2015–2019|Females|5|05–09|||
Observed|Oesophageal cancer|2015–2019|Females|5|10–14|||
Observed|Oesophageal cancer|2015–2019|Females|5|15–19|||
Observed|Oesophageal cancer|2015–2019|Females|5|20–24|||
Observed|Oesophageal cancer|2015–2019|Females|5|25–29|||
Observed|Oesophageal cancer|2015–2019|Females|5|30–34|||
Observed|Oesophageal cancer|2015–2019|Females|5|35–39|||
Observed|Oesophageal cancer|2015–2019|Females|5|40–44|||
Observed|Oesophageal cancer|2015–2019|Females|5|45–49|||
Observed|Oesophageal cancer|2015–2019|Females|5|50–54|0.359|0.244|0.475
Observed|Oesophageal cancer|2015–2019|Females|5|55–59|0.358|0.275|0.441
Observed|Oesophageal cancer|2015–2019|Females|5|60–64|0.372|0.3|0.443
Observed|Oesophageal cancer|2015–2019|Females|5|65–69|0.341|0.285|0.398
Observed|Oesophageal cancer|2015–2019|Females|5|70–74|0.238|0.192|0.288
Observed|Oesophageal cancer|2015–2019|Females|5|75–79|0.187|0.147|0.231
Observed|Oesophageal cancer|2015–2019|Females|5|80–84|0.12|0.087|0.158
Observed|Oesophageal cancer|2015–2019|Females|5|85+|0.045|0.029|0.066
Observed|Oesophageal cancer|2015–2019|Females|5|All ages combined|0.212|0.195|0.23
Relative|Oesophageal cancer|2015–2019|Females|1|00–04|||
Relative|Oesophageal cancer|2015–2019|Females|1|05–09|||
Relative|Oesophageal cancer|2015–2019|Females|1|10–14|||
Relative|Oesophageal cancer|2015–2019|Females|1|15–19|||
Relative|Oesophageal cancer|2015–2019|Females|1|20–24|||
Relative|Oesophageal cancer|2015–2019|Females|1|25–29|||
Relative|Oesophageal cancer|2015–2019|Females|1|30–34|||
Relative|Oesophageal cancer|2015–2019|Females|1|35–39|||
Relative|Oesophageal cancer|2015–2019|Females|1|40–44|||
Relative|Oesophageal cancer|2015–2019|Females|1|45–49|0.612|0.453|0.737
Relative|Oesophageal cancer|2015–2019|Females|1|50–54|0.674|0.562|0.763
Relative|Oesophageal cancer|2015–2019|Females|1|55–59|0.691|0.606|0.762
Relative|Oesophageal cancer|2015–2019|Females|1|60–64|0.66|0.591|0.72
Relative|Oesophageal cancer|2015–2019|Females|1|65–69|0.611|0.551|0.665
Relative|Oesophageal cancer|2015–2019|Females|1|70–74|0.554|0.495|0.609
Relative|Oesophageal cancer|2015–2019|Females|1|75–79|0.488|0.432|0.543
Relative|Oesophageal cancer|2015–2019|Females|1|80–84|0.368|0.312|0.424
Relative|Oesophageal cancer|2015–2019|Females|1|85+|0.266|0.224|0.311
Relative|Oesophageal cancer|2015–2019|Females|1|All ages combined|0.501|0.478|0.522
Relative|Oesophageal cancer|2015–2019|Females|2|00–04|||
Relative|Oesophageal cancer|2015–2019|Females|2|05–09|||
Relative|Oesophageal cancer|2015–2019|Females|2|10–14|||
Relative|Oesophageal cancer|2015–2019|Females|2|15–19|||
Relative|Oesophageal cancer|2015–2019|Females|2|20–24|||
Relative|Oesophageal cancer|2015–2019|Females|2|25–29|||
Relative|Oesophageal cancer|2015–2019|Females|2|30–34|||
Relative|Oesophageal cancer|2015–2019|Females|2|35–39|||
Relative|Oesophageal cancer|2015–2019|Females|2|40–44|||
Relative|Oesophageal cancer|2015–2019|Females|2|45–49|0.505|0.345|0.644
Relative|Oesophageal cancer|2015–2019|Females|2|50–54|0.528|0.415|0.629
Relative|Oesophageal cancer|2015–2019|Females|2|55–59|0.495|0.406|0.577
Relative|Oesophageal cancer|2015–2019|Females|2|60–64|0.514|0.441|0.582
Relative|Oesophageal cancer|2015–2019|Females|2|65–69|0.459|0.399|0.517
Relative|Oesophageal cancer|2015–2019|Females|2|70–74|0.382|0.327|0.438
Relative|Oesophageal cancer|2015–2019|Females|2|75–79|0.35|0.297|0.403
Relative|Oesophageal cancer|2015–2019|Females|2|80–84|0.262|0.211|0.316
Relative|Oesophageal cancer|2015–2019|Females|2|85+|0.133|0.1|0.17
Relative|Oesophageal cancer|2015–2019|Females|2|All ages combined|0.354|0.333|0.376
Relative|Oesophageal cancer|2015–2019|Females|3|00–04|||
Relative|Oesophageal cancer|2015–2019|Females|3|05–09|||
Relative|Oesophageal cancer|2015–2019|Females|3|10–14|||
Relative|Oesophageal cancer|2015–2019|Females|3|15–19|||
Relative|Oesophageal cancer|2015–2019|Females|3|20–24|||
Relative|Oesophageal cancer|2015–2019|Females|3|25–29|||
Relative|Oesophageal cancer|2015–2019|Females|3|30–34|||
Relative|Oesophageal cancer|2015–2019|Females|3|35–39|||
Relative|Oesophageal cancer|2015–2019|Females|3|40–44|||
Relative|Oesophageal cancer|2015–2019|Females|3|45–49|||
Relative|Oesophageal cancer|2015–2019|Females|3|50–54|0.408|0.293|0.519
Relative|Oesophageal cancer|2015–2019|Females|3|55–59|0.398|0.313|0.482
Relative|Oesophageal cancer|2015–2019|Females|3|60–64|0.467|0.394|0.537
Relative|Oesophageal cancer|2015–2019|Females|3|65–69|0.422|0.362|0.48
Relative|Oesophageal cancer|2015–2019|Females|3|70–74|0.329|0.275|0.384
Relative|Oesophageal cancer|2015–2019|Females|3|75–79|0.278|0.228|0.33
Relative|Oesophageal cancer|2015–2019|Females|3|80–84|0.205|0.158|0.257
Relative|Oesophageal cancer|2015–2019|Females|3|85+|0.118|0.085|0.158
Relative|Oesophageal cancer|2015–2019|Females|3|All ages combined|0.301|0.28|0.322
Relative|Oesophageal cancer|2015–2019|Females|4|00–04|||
Relative|Oesophageal cancer|2015–2019|Females|4|05–09|||
Relative|Oesophageal cancer|2015–2019|Females|4|10–14|||
Relative|Oesophageal cancer|2015–2019|Females|4|15–19|||
Relative|Oesophageal cancer|2015–2019|Females|4|20–24|||
Relative|Oesophageal cancer|2015–2019|Females|4|25–29|||
Relative|Oesophageal cancer|2015–2019|Females|4|30–34|||
Relative|Oesophageal cancer|2015–2019|Females|4|35–39|||
Relative|Oesophageal cancer|2015–2019|Females|4|40–44|||
Relative|Oesophageal cancer|2015–2019|Females|4|45–49|||
Relative|Oesophageal cancer|2015–2019|Females|4|50–54|0.385|0.269|0.5
Relative|Oesophageal cancer|2015–2019|Females|4|55–59|0.373|0.289|0.458
Relative|Oesophageal cancer|2015–2019|Females|4|60–64|0.409|0.335|0.481
Relative|Oesophageal cancer|2015–2019|Females|4|65–69|0.387|0.328|0.445
Relative|Oesophageal cancer|2015–2019|Females|4|70–74|0.288|0.236|0.342
Relative|Oesophageal cancer|2015–2019|Females|4|75–79|0.241|0.193|0.293
Relative|Oesophageal cancer|2015–2019|Females|4|80–84|0.173|0.129|0.224
Relative|Oesophageal cancer|2015–2019|Females|4|85+|0.084|0.055|0.122
Relative|Oesophageal cancer|2015–2019|Females|4|All ages combined|0.264|0.243|0.285
Relative|Oesophageal cancer|2015–2019|Females|5|00–04|||
Relative|Oesophageal cancer|2015–2019|Females|5|05–09|||
Relative|Oesophageal cancer|2015–2019|Females|5|10–14|||
Relative|Oesophageal cancer|2015–2019|Females|5|15–19|||
Relative|Oesophageal cancer|2015–2019|Females|5|20–24|||
Relative|Oesophageal cancer|2015–2019|Females|5|25–29|||
Relative|Oesophageal cancer|2015–2019|Females|5|30–34|||
Relative|Oesophageal cancer|2015–2019|Females|5|35–39|||
Relative|Oesophageal cancer|2015–2019|Females|5|40–44|||
Relative|Oesophageal cancer|2015–2019|Females|5|45–49|||
Relative|Oesophageal cancer|2015–2019|Females|5|50–54|0.364|0.248|0.481
Relative|Oesophageal cancer|2015–2019|Females|5|55–59|0.365|0.28|0.45
Relative|Oesophageal cancer|2015–2019|Females|5|60–64|0.382|0.309|0.456
Relative|Oesophageal cancer|2015–2019|Females|5|65–69|0.357|0.299|0.416
Relative|Oesophageal cancer|2015–2019|Females|5|70–74|0.257|0.207|0.311
Relative|Oesophageal cancer|2015–2019|Females|5|75–79|0.216|0.169|0.267
Relative|Oesophageal cancer|2015–2019|Females|5|80–84|0.158|0.114|0.209
Relative|Oesophageal cancer|2015–2019|Females|5|85+|0.089|0.057|0.131
Relative|Oesophageal cancer|2015–2019|Females|5|All ages combined|0.244|0.224|0.265
Observed|Oesophageal cancer|2015–2019|Persons|1|00–04|||
Observed|Oesophageal cancer|2015–2019|Persons|1|05–09|||
Observed|Oesophageal cancer|2015–2019|Persons|1|10–14|||
Observed|Oesophageal cancer|2015–2019|Persons|1|15–19|||
Observed|Oesophageal cancer|2015–2019|Persons|1|20–24|||
Observed|Oesophageal cancer|2015–2019|Persons|1|25–29|||
Observed|Oesophageal cancer|2015–2019|Persons|1|30–34|||
Observed|Oesophageal cancer|2015–2019|Persons|1|35–39|||
Observed|Oesophageal cancer|2015–2019|Persons|1|40–44|0.699|0.589|0.785
Observed|Oesophageal cancer|2015–2019|Persons|1|45–49|0.625|0.548|0.692
Observed|Oesophageal cancer|2015–2019|Persons|1|50–54|0.558|0.507|0.605
Observed|Oesophageal cancer|2015–2019|Persons|1|55–59|0.603|0.565|0.639
Observed|Oesophageal cancer|2015–2019|Persons|1|60–64|0.567|0.535|0.597
Observed|Oesophageal cancer|2015–2019|Persons|1|65–69|0.583|0.555|0.61
Observed|Oesophageal cancer|2015–2019|Persons|1|70–74|0.531|0.503|0.558
Observed|Oesophageal cancer|2015–2019|Persons|1|75–79|0.497|0.467|0.525
Observed|Oesophageal cancer|2015–2019|Persons|1|80–84|0.364|0.332|0.395
Observed|Oesophageal cancer|2015–2019|Persons|1|85+|0.266|0.239|0.294
Observed|Oesophageal cancer|2015–2019|Persons|1|All ages combined|0.5|0.489|0.511
Observed|Oesophageal cancer|2015–2019|Persons|2|00–04|||
Observed|Oesophageal cancer|2015–2019|Persons|2|05–09|||
Observed|Oesophageal cancer|2015–2019|Persons|2|10–14|||
Observed|Oesophageal cancer|2015–2019|Persons|2|15–19|||
Observed|Oesophageal cancer|2015–2019|Persons|2|20–24|||
Observed|Oesophageal cancer|2015–2019|Persons|2|25–29|||
Observed|Oesophageal cancer|2015–2019|Persons|2|30–34|||
Observed|Oesophageal cancer|2015–2019|Persons|2|35–39|||
Observed|Oesophageal cancer|2015–2019|Persons|2|40–44|0.498|0.383|0.602
Observed|Oesophageal cancer|2015–2019|Persons|2|45–49|0.414|0.339|0.488
Observed|Oesophageal cancer|2015–2019|Persons|2|50–54|0.382|0.334|0.43
Observed|Oesophageal cancer|2015–2019|Persons|2|55–59|0.411|0.373|0.449
Observed|Oesophageal cancer|2015–2019|Persons|2|60–64|0.396|0.364|0.428
Observed|Oesophageal cancer|2015–2019|Persons|2|65–69|0.408|0.38|0.435
Observed|Oesophageal cancer|2015–2019|Persons|2|70–74|0.369|0.342|0.396
Observed|Oesophageal cancer|2015–2019|Persons|2|75–79|0.324|0.297|0.352
Observed|Oesophageal cancer|2015–2019|Persons|2|80–84|0.232|0.205|0.261
Observed|Oesophageal cancer|2015–2019|Persons|2|85+|0.124|0.104|0.145
Observed|Oesophageal cancer|2015–2019|Persons|2|All ages combined|0.334|0.323|0.344
Observed|Oesophageal cancer|2015–2019|Persons|3|00–04|||
Observed|Oesophageal cancer|2015–2019|Persons|3|05–09|||
Observed|Oesophageal cancer|2015–2019|Persons|3|10–14|||
Observed|Oesophageal cancer|2015–2019|Persons|3|15–19|||
Observed|Oesophageal cancer|2015–2019|Persons|3|20–24|||
Observed|Oesophageal cancer|2015–2019|Persons|3|25–29|||
Observed|Oesophageal cancer|2015–2019|Persons|3|30–34|||
Observed|Oesophageal cancer|2015–2019|Persons|3|35–39|||
Observed|Oesophageal cancer|2015–2019|Persons|3|40–44|0.427|0.315|0.534
Observed|Oesophageal cancer|2015–2019|Persons|3|45–49|0.343|0.271|0.415
Observed|Oesophageal cancer|2015–2019|Persons|3|50–54|0.311|0.265|0.358
Observed|Oesophageal cancer|2015–2019|Persons|3|55–59|0.326|0.29|0.362
Observed|Oesophageal cancer|2015–2019|Persons|3|60–64|0.332|0.302|0.364
Observed|Oesophageal cancer|2015–2019|Persons|3|65–69|0.345|0.318|0.372
Observed|Oesophageal cancer|2015–2019|Persons|3|70–74|0.296|0.271|0.322
Observed|Oesophageal cancer|2015–2019|Persons|3|75–79|0.256|0.23|0.282
Observed|Oesophageal cancer|2015–2019|Persons|3|80–84|0.166|0.142|0.191
Observed|Oesophageal cancer|2015–2019|Persons|3|85+|0.077|0.061|0.095
Observed|Oesophageal cancer|2015–2019|Persons|3|All ages combined|0.267|0.257|0.277
Observed|Oesophageal cancer|2015–2019|Persons|4|00–04|||
Observed|Oesophageal cancer|2015–2019|Persons|4|05–09|||
Observed|Oesophageal cancer|2015–2019|Persons|4|10–14|||
Observed|Oesophageal cancer|2015–2019|Persons|4|15–19|||
Observed|Oesophageal cancer|2015–2019|Persons|4|20–24|||
Observed|Oesophageal cancer|2015–2019|Persons|4|25–29|||
Observed|Oesophageal cancer|2015–2019|Persons|4|30–34|||
Observed|Oesophageal cancer|2015–2019|Persons|4|35–39|||
Observed|Oesophageal cancer|2015–2019|Persons|4|40–44|0.382|0.272|0.49
Observed|Oesophageal cancer|2015–2019|Persons|4|45–49|0.294|0.227|0.365
Observed|Oesophageal cancer|2015–2019|Persons|4|50–54|0.29|0.245|0.337
Observed|Oesophageal cancer|2015–2019|Persons|4|55–59|0.293|0.259|0.329
Observed|Oesophageal cancer|2015–2019|Persons|4|60–64|0.297|0.267|0.327
Observed|Oesophageal cancer|2015–2019|Persons|4|65–69|0.308|0.282|0.334
Observed|Oesophageal cancer|2015–2019|Persons|4|70–74|0.264|0.239|0.289
Observed|Oesophageal cancer|2015–2019|Persons|4|75–79|0.215|0.191|0.241
Observed|Oesophageal cancer|2015–2019|Persons|4|80–84|0.122|0.101|0.145
Observed|Oesophageal cancer|2015–2019|Persons|4|85+|0.048|0.036|0.063
Observed|Oesophageal cancer|2015–2019|Persons|4|All ages combined|0.231|0.222|0.241
Observed|Oesophageal cancer|2015–2019|Persons|5|00–04|||
Observed|Oesophageal cancer|2015–2019|Persons|5|05–09|||
Observed|Oesophageal cancer|2015–2019|Persons|5|10–14|||
Observed|Oesophageal cancer|2015–2019|Persons|5|15–19|||
Observed|Oesophageal cancer|2015–2019|Persons|5|20–24|||
Observed|Oesophageal cancer|2015–2019|Persons|5|25–29|||
Observed|Oesophageal cancer|2015–2019|Persons|5|30–34|||
Observed|Oesophageal cancer|2015–2019|Persons|5|35–39|||
Observed|Oesophageal cancer|2015–2019|Persons|5|40–44|0.366|0.258|0.475
Observed|Oesophageal cancer|2015–2019|Persons|5|45–49|0.276|0.211|0.345
Observed|Oesophageal cancer|2015–2019|Persons|5|50–54|0.277|0.232|0.323
Observed|Oesophageal cancer|2015–2019|Persons|5|55–59|0.274|0.241|0.309
Observed|Oesophageal cancer|2015–2019|Persons|5|60–64|0.266|0.237|0.296
Observed|Oesophageal cancer|2015–2019|Persons|5|65–69|0.281|0.255|0.307
Observed|Oesophageal cancer|2015–2019|Persons|5|70–74|0.234|0.21|0.259
Observed|Oesophageal cancer|2015–2019|Persons|5|75–79|0.186|0.163|0.211
Observed|Oesophageal cancer|2015–2019|Persons|5|80–84|0.1|0.081|0.122
Observed|Oesophageal cancer|2015–2019|Persons|5|85+|0.036|0.025|0.049
Observed|Oesophageal cancer|2015–2019|Persons|5|All ages combined|0.207|0.198|0.217
Relative|Oesophageal cancer|2015–2019|Persons|1|00–04|||
Relative|Oesophageal cancer|2015–2019|Persons|1|05–09|||
Relative|Oesophageal cancer|2015–2019|Persons|1|10–14|||
Relative|Oesophageal cancer|2015–2019|Persons|1|15–19|||
Relative|Oesophageal cancer|2015–2019|Persons|1|20–24|||
Relative|Oesophageal cancer|2015–2019|Persons|1|25–29|||
Relative|Oesophageal cancer|2015–2019|Persons|1|30–34|||
Relative|Oesophageal cancer|2015–2019|Persons|1|35–39|||
Relative|Oesophageal cancer|2015–2019|Persons|1|40–44|0.7|0.59|0.787
Relative|Oesophageal cancer|2015–2019|Persons|1|45–49|0.626|0.55|0.694
Relative|Oesophageal cancer|2015–2019|Persons|1|50–54|0.559|0.508|0.607
Relative|Oesophageal cancer|2015–2019|Persons|1|55–59|0.606|0.568|0.642
Relative|Oesophageal cancer|2015–2019|Persons|1|60–64|0.571|0.538|0.602
Relative|Oesophageal cancer|2015–2019|Persons|1|65–69|0.59|0.561|0.617
Relative|Oesophageal cancer|2015–2019|Persons|1|70–74|0.54|0.512|0.568
Relative|Oesophageal cancer|2015–2019|Persons|1|75–79|0.512|0.482|0.541
Relative|Oesophageal cancer|2015–2019|Persons|1|80–84|0.384|0.351|0.417
Relative|Oesophageal cancer|2015–2019|Persons|1|85+|0.303|0.272|0.334
Relative|Oesophageal cancer|2015–2019|Persons|1|All ages combined|0.516|0.504|0.527
Relative|Oesophageal cancer|2015–2019|Persons|2|00–04|||
Relative|Oesophageal cancer|2015–2019|Persons|2|05–09|||
Relative|Oesophageal cancer|2015–2019|Persons|2|10–14|||
Relative|Oesophageal cancer|2015–2019|Persons|2|15–19|||
Relative|Oesophageal cancer|2015–2019|Persons|2|20–24|||
Relative|Oesophageal cancer|2015–2019|Persons|2|25–29|||
Relative|Oesophageal cancer|2015–2019|Persons|2|30–34|||
Relative|Oesophageal cancer|2015–2019|Persons|2|35–39|||
Relative|Oesophageal cancer|2015–2019|Persons|2|40–44|0.499|0.384|0.604
Relative|Oesophageal cancer|2015–2019|Persons|2|45–49|0.416|0.34|0.49
Relative|Oesophageal cancer|2015–2019|Persons|2|50–54|0.385|0.336|0.433
Relative|Oesophageal cancer|2015–2019|Persons|2|55–59|0.416|0.377|0.454
Relative|Oesophageal cancer|2015–2019|Persons|2|60–64|0.402|0.37|0.435
Relative|Oesophageal cancer|2015–2019|Persons|2|65–69|0.417|0.388|0.446
Relative|Oesophageal cancer|2015–2019|Persons|2|70–74|0.383|0.355|0.411
Relative|Oesophageal cancer|2015–2019|Persons|2|75–79|0.345|0.316|0.375
Relative|Oesophageal cancer|2015–2019|Persons|2|80–84|0.261|0.23|0.293
Relative|Oesophageal cancer|2015–2019|Persons|2|85+|0.162|0.136|0.19
Relative|Oesophageal cancer|2015–2019|Persons|2|All ages combined|0.353|0.342|0.364
Relative|Oesophageal cancer|2015–2019|Persons|3|00–04|||
Relative|Oesophageal cancer|2015–2019|Persons|3|05–09|||
Relative|Oesophageal cancer|2015–2019|Persons|3|10–14|||
Relative|Oesophageal cancer|2015–2019|Persons|3|15–19|||
Relative|Oesophageal cancer|2015–2019|Persons|3|20–24|||
Relative|Oesophageal cancer|2015–2019|Persons|3|25–29|||
Relative|Oesophageal cancer|2015–2019|Persons|3|30–34|||
Relative|Oesophageal cancer|2015–2019|Persons|3|35–39|||
Relative|Oesophageal cancer|2015–2019|Persons|3|40–44|0.429|0.317|0.537
Relative|Oesophageal cancer|2015–2019|Persons|3|45–49|0.345|0.273|0.418
Relative|Oesophageal cancer|2015–2019|Persons|3|50–54|0.314|0.267|0.362
Relative|Oesophageal cancer|2015–2019|Persons|3|55–59|0.331|0.295|0.368
Relative|Oesophageal cancer|2015–2019|Persons|3|60–64|0.34|0.309|0.372
Relative|Oesophageal cancer|2015–2019|Persons|3|65–69|0.358|0.33|0.386
Relative|Oesophageal cancer|2015–2019|Persons|3|70–74|0.314|0.287|0.341
Relative|Oesophageal cancer|2015–2019|Persons|3|75–79|0.283|0.255|0.312
Relative|Oesophageal cancer|2015–2019|Persons|3|80–84|0.2|0.171|0.23
Relative|Oesophageal cancer|2015–2019|Persons|3|85+|0.117|0.093|0.144
Relative|Oesophageal cancer|2015–2019|Persons|3|All ages combined|0.29|0.279|0.301
Relative|Oesophageal cancer|2015–2019|Persons|4|00–04|||
Relative|Oesophageal cancer|2015–2019|Persons|4|05–09|||
Relative|Oesophageal cancer|2015–2019|Persons|4|10–14|||
Relative|Oesophageal cancer|2015–2019|Persons|4|15–19|||
Relative|Oesophageal cancer|2015–2019|Persons|4|20–24|||
Relative|Oesophageal cancer|2015–2019|Persons|4|25–29|||
Relative|Oesophageal cancer|2015–2019|Persons|4|30–34|||
Relative|Oesophageal cancer|2015–2019|Persons|4|35–39|||
Relative|Oesophageal cancer|2015–2019|Persons|4|40–44|0.384|0.274|0.493
Relative|Oesophageal cancer|2015–2019|Persons|4|45–49|0.297|0.229|0.368
Relative|Oesophageal cancer|2015–2019|Persons|4|50–54|0.294|0.249|0.342
Relative|Oesophageal cancer|2015–2019|Persons|4|55–59|0.3|0.265|0.336
Relative|Oesophageal cancer|2015–2019|Persons|4|60–64|0.307|0.276|0.338
Relative|Oesophageal cancer|2015–2019|Persons|4|65–69|0.324|0.296|0.352
Relative|Oesophageal cancer|2015–2019|Persons|4|70–74|0.287|0.26|0.314
Relative|Oesophageal cancer|2015–2019|Persons|4|75–79|0.249|0.22|0.278
Relative|Oesophageal cancer|2015–2019|Persons|4|80–84|0.158|0.131|0.188
Relative|Oesophageal cancer|2015–2019|Persons|4|85+|0.086|0.064|0.114
Relative|Oesophageal cancer|2015–2019|Persons|4|All ages combined|0.258|0.247|0.268
Relative|Oesophageal cancer|2015–2019|Persons|5|00–04|||
Relative|Oesophageal cancer|2015–2019|Persons|5|05–09|||
Relative|Oesophageal cancer|2015–2019|Persons|5|10–14|||
Relative|Oesophageal cancer|2015–2019|Persons|5|15–19|||
Relative|Oesophageal cancer|2015–2019|Persons|5|20–24|||
Relative|Oesophageal cancer|2015–2019|Persons|5|25–29|||
Relative|Oesophageal cancer|2015–2019|Persons|5|30–34|||
Relative|Oesophageal cancer|2015–2019|Persons|5|35–39|||
Relative|Oesophageal cancer|2015–2019|Persons|5|40–44|0.369|0.26|0.479
Relative|Oesophageal cancer|2015–2019|Persons|5|45–49|0.28|0.214|0.349
Relative|Oesophageal cancer|2015–2019|Persons|5|50–54|0.282|0.237|0.329
Relative|Oesophageal cancer|2015–2019|Persons|5|55–59|0.282|0.248|0.318
Relative|Oesophageal cancer|2015–2019|Persons|5|60–64|0.277|0.247|0.309
Relative|Oesophageal cancer|2015–2019|Persons|5|65–69|0.3|0.273|0.328
Relative|Oesophageal cancer|2015–2019|Persons|5|70–74|0.261|0.235|0.289
Relative|Oesophageal cancer|2015–2019|Persons|5|75–79|0.226|0.198|0.256
Relative|Oesophageal cancer|2015–2019|Persons|5|80–84|0.141|0.114|0.172
Relative|Oesophageal cancer|2015–2019|Persons|5|85+|0.076|0.054|0.105
Relative|Oesophageal cancer|2015–2019|Persons|5|All ages combined|0.237|0.226|0.248
Observed|Oral cancer|2015–2019|Males|1|00–04|||
Observed|Oral cancer|2015–2019|Males|1|05–09|||
Observed|Oral cancer|2015–2019|Males|1|10–14|||
Observed|Oral cancer|2015–2019|Males|1|15–19|||
Observed|Oral cancer|2015–2019|Males|1|20–24|0.941|0.785|0.985
Observed|Oral cancer|2015–2019|Males|1|25–29|0.972|0.891|0.993
Observed|Oral cancer|2015–2019|Males|1|30–34|0.968|0.918|0.988
Observed|Oral cancer|2015–2019|Males|1|35–39|0.973|0.94|0.988
Observed|Oral cancer|2015–2019|Males|1|40–44|0.962|0.939|0.977
Observed|Oral cancer|2015–2019|Males|1|45–49|0.95|0.933|0.963
Observed|Oral cancer|2015–2019|Males|1|50–54|0.948|0.934|0.958
Observed|Oral cancer|2015–2019|Males|1|55–59|0.922|0.909|0.933
Observed|Oral cancer|2015–2019|Males|1|60–64|0.9|0.886|0.913
Observed|Oral cancer|2015–2019|Males|1|65–69|0.863|0.846|0.877
Observed|Oral cancer|2015–2019|Males|1|70–74|0.856|0.837|0.874
Observed|Oral cancer|2015–2019|Males|1|75–79|0.803|0.776|0.827
Observed|Oral cancer|2015–2019|Males|1|80–84|0.754|0.72|0.785
Observed|Oral cancer|2015–2019|Males|1|85+|0.654|0.611|0.693
Observed|Oral cancer|2015–2019|Males|1|All ages combined|0.881|0.875|0.886
Observed|Oral cancer|2015–2019|Males|2|00–04|||
Observed|Oral cancer|2015–2019|Males|2|05–09|||
Observed|Oral cancer|2015–2019|Males|2|10–14|||
Observed|Oral cancer|2015–2019|Males|2|15–19|||
Observed|Oral cancer|2015–2019|Males|2|20–24|0.941|0.785|0.985
Observed|Oral cancer|2015–2019|Males|2|25–29|0.944|0.858|0.979
Observed|Oral cancer|2015–2019|Males|2|30–34|0.947|0.891|0.974
Observed|Oral cancer|2015–2019|Males|2|35–39|0.944|0.903|0.968
Observed|Oral cancer|2015–2019|Males|2|40–44|0.932|0.904|0.952
Observed|Oral cancer|2015–2019|Males|2|45–49|0.897|0.875|0.916
Observed|Oral cancer|2015–2019|Males|2|50–54|0.894|0.877|0.91
Observed|Oral cancer|2015–2019|Males|2|55–59|0.865|0.848|0.88
Observed|Oral cancer|2015–2019|Males|2|60–64|0.831|0.813|0.847
Observed|Oral cancer|2015–2019|Males|2|65–69|0.788|0.769|0.806
Observed|Oral cancer|2015–2019|Males|2|70–74|0.761|0.738|0.783
Observed|Oral cancer|2015–2019|Males|2|75–79|0.715|0.685|0.743
Observed|Oral cancer|2015–2019|Males|2|80–84|0.642|0.604|0.677
Observed|Oral cancer|2015–2019|Males|2|85+|0.528|0.484|0.57
Observed|Oral cancer|2015–2019|Males|2|All ages combined|0.81|0.803|0.816
Observed|Oral cancer|2015–2019|Males|3|00–04|||
Observed|Oral cancer|2015–2019|Males|3|05–09|||
Observed|Oral cancer|2015–2019|Males|3|10–14|||
Observed|Oral cancer|2015–2019|Males|3|15–19|||
Observed|Oral cancer|2015–2019|Males|3|20–24|0.941|0.785|0.985
Observed|Oral cancer|2015–2019|Males|3|25–29|0.931|0.842|0.971
Observed|Oral cancer|2015–2019|Males|3|30–34|0.92|0.86|0.955
Observed|Oral cancer|2015–2019|Males|3|35–39|0.935|0.892|0.961
Observed|Oral cancer|2015–2019|Males|3|40–44|0.915|0.886|0.938
Observed|Oral cancer|2015–2019|Males|3|45–49|0.868|0.843|0.889
Observed|Oral cancer|2015–2019|Males|3|50–54|0.856|0.837|0.874
Observed|Oral cancer|2015–2019|Males|3|55–59|0.818|0.799|0.835
Observed|Oral cancer|2015–2019|Males|3|60–64|0.788|0.769|0.806
Observed|Oral cancer|2015–2019|Males|3|65–69|0.737|0.716|0.756
Observed|Oral cancer|2015–2019|Males|3|70–74|0.698|0.672|0.722
Observed|Oral cancer|2015–2019|Males|3|75–79|0.636|0.604|0.666
Observed|Oral cancer|2015–2019|Males|3|80–84|0.568|0.529|0.605
Observed|Oral cancer|2015–2019|Males|3|85+|0.423|0.381|0.464
Observed|Oral cancer|2015–2019|Males|3|All ages combined|0.759|0.751|0.767
Observed|Oral cancer|2015–2019|Males|4|00–04|||
Observed|Oral cancer|2015–2019|Males|4|05–09|||
Observed|Oral cancer|2015–2019|Males|4|10–14|||
Observed|Oral cancer|2015–2019|Males|4|15–19|||
Observed|Oral cancer|2015–2019|Males|4|20–24|0.941|0.785|0.985
Observed|Oral cancer|2015–2019|Males|4|25–29|0.906|0.813|0.954
Observed|Oral cancer|2015–2019|Males|4|30–34|0.913|0.852|0.95
Observed|Oral cancer|2015–2019|Males|4|35–39|0.927|0.883|0.955
Observed|Oral cancer|2015–2019|Males|4|40–44|0.907|0.877|0.931
Observed|Oral cancer|2015–2019|Males|4|45–49|0.851|0.825|0.873
Observed|Oral cancer|2015–2019|Males|4|50–54|0.829|0.808|0.848
Observed|Oral cancer|2015–2019|Males|4|55–59|0.781|0.761|0.799
Observed|Oral cancer|2015–2019|Males|4|60–64|0.752|0.732|0.771
Observed|Oral cancer|2015–2019|Males|4|65–69|0.695|0.673|0.716
Observed|Oral cancer|2015–2019|Males|4|70–74|0.645|0.618|0.67
Observed|Oral cancer|2015–2019|Males|4|75–79|0.588|0.555|0.619
Observed|Oral cancer|2015–2019|Males|4|80–84|0.484|0.445|0.521
Observed|Oral cancer|2015–2019|Males|4|85+|0.338|0.298|0.378
Observed|Oral cancer|2015–2019|Males|4|All ages combined|0.719|0.711|0.727
Observed|Oral cancer|2015–2019|Males|5|00–04|||
Observed|Oral cancer|2015–2019|Males|5|05–09|||
Observed|Oral cancer|2015–2019|Males|5|10–14|||
Observed|Oral cancer|2015–2019|Males|5|15–19|||
Observed|Oral cancer|2015–2019|Males|5|20–24|0.941|0.785|0.985
Observed|Oral cancer|2015–2019|Males|5|25–29|0.894|0.799|0.946
Observed|Oral cancer|2015–2019|Males|5|30–34|0.907|0.845|0.945
Observed|Oral cancer|2015–2019|Males|5|35–39|0.912|0.867|0.942
Observed|Oral cancer|2015–2019|Males|5|40–44|0.892|0.859|0.917
Observed|Oral cancer|2015–2019|Males|5|45–49|0.842|0.815|0.865
Observed|Oral cancer|2015–2019|Males|5|50–54|0.813|0.792|0.833
Observed|Oral cancer|2015–2019|Males|5|55–59|0.758|0.738|0.777
Observed|Oral cancer|2015–2019|Males|5|60–64|0.726|0.705|0.746
Observed|Oral cancer|2015–2019|Males|5|65–69|0.665|0.643|0.687
Observed|Oral cancer|2015–2019|Males|5|70–74|0.591|0.564|0.618
Observed|Oral cancer|2015–2019|Males|5|75–79|0.538|0.505|0.57
Observed|Oral cancer|2015–2019|Males|5|80–84|0.415|0.377|0.453
Observed|Oral cancer|2015–2019|Males|5|85+|0.276|0.239|0.315
Observed|Oral cancer|2015–2019|Males|5|All ages combined|0.689|0.68|0.697
Relative|Oral cancer|2015–2019|Males|1|00–04|||
Relative|Oral cancer|2015–2019|Males|1|05–09|||
Relative|Oral cancer|2015–2019|Males|1|10–14|||
Relative|Oral cancer|2015–2019|Males|1|15–19|||
Relative|Oral cancer|2015–2019|Males|1|20–24|0.942|0.785|0.986
Relative|Oral cancer|2015–2019|Males|1|25–29|0.972|0.892|0.994
Relative|Oral cancer|2015–2019|Males|1|30–34|0.969|0.919|0.989
Relative|Oral cancer|2015–2019|Males|1|35–39|0.974|0.942|0.989
Relative|Oral cancer|2015–2019|Males|1|40–44|0.964|0.941|0.978
Relative|Oral cancer|2015–2019|Males|1|45–49|0.952|0.935|0.965
Relative|Oral cancer|2015–2019|Males|1|50–54|0.951|0.938|0.962
Relative|Oral cancer|2015–2019|Males|1|55–59|0.927|0.914|0.938
Relative|Oral cancer|2015–2019|Males|1|60–64|0.908|0.894|0.92
Relative|Oral cancer|2015–2019|Males|1|65–69|0.873|0.856|0.888
Relative|Oral cancer|2015–2019|Males|1|70–74|0.873|0.853|0.891
Relative|Oral cancer|2015–2019|Males|1|75–79|0.83|0.802|0.854
Relative|Oral cancer|2015–2019|Males|1|80–84|0.801|0.764|0.833
Relative|Oral cancer|2015–2019|Males|1|85+|0.754|0.705|0.8
Relative|Oral cancer|2015–2019|Males|1|All ages combined|0.897|0.891|0.902
Relative|Oral cancer|2015–2019|Males|2|00–04|||
Relative|Oral cancer|2015–2019|Males|2|05–09|||
Relative|Oral cancer|2015–2019|Males|2|10–14|||
Relative|Oral cancer|2015–2019|Males|2|15–19|||
Relative|Oral cancer|2015–2019|Males|2|20–24|0.942|0.786|0.986
Relative|Oral cancer|2015–2019|Males|2|25–29|0.946|0.859|0.98
Relative|Oral cancer|2015–2019|Males|2|30–34|0.948|0.893|0.976
Relative|Oral cancer|2015–2019|Males|2|35–39|0.946|0.905|0.97
Relative|Oral cancer|2015–2019|Males|2|40–44|0.935|0.907|0.955
Relative|Oral cancer|2015–2019|Males|2|45–49|0.902|0.879|0.921
Relative|Oral cancer|2015–2019|Males|2|50–54|0.901|0.883|0.916
Relative|Oral cancer|2015–2019|Males|2|55–59|0.874|0.858|0.889
Relative|Oral cancer|2015–2019|Males|2|60–64|0.845|0.827|0.861
Relative|Oral cancer|2015–2019|Males|2|65–69|0.808|0.789|0.827
Relative|Oral cancer|2015–2019|Males|2|70–74|0.793|0.768|0.816
Relative|Oral cancer|2015–2019|Males|2|75–79|0.767|0.735|0.797
Relative|Oral cancer|2015–2019|Males|2|80–84|0.73|0.687|0.769
Relative|Oral cancer|2015–2019|Males|2|85+|0.713|0.654|0.769
Relative|Oral cancer|2015–2019|Males|2|All ages combined|0.839|0.832|0.846
Relative|Oral cancer|2015–2019|Males|3|00–04|||
Relative|Oral cancer|2015–2019|Males|3|05–09|||
Relative|Oral cancer|2015–2019|Males|3|10–14|||
Relative|Oral cancer|2015–2019|Males|3|15–19|||
Relative|Oral cancer|2015–2019|Males|3|20–24|0.943|0.786|0.987
Relative|Oral cancer|2015–2019|Males|3|25–29|0.933|0.843|0.973
Relative|Oral cancer|2015–2019|Males|3|30–34|0.922|0.862|0.957
Relative|Oral cancer|2015–2019|Males|3|35–39|0.938|0.896|0.965
Relative|Oral cancer|2015–2019|Males|3|40–44|0.92|0.89|0.943
Relative|Oral cancer|2015–2019|Males|3|45–49|0.874|0.849|0.896
Relative|Oral cancer|2015–2019|Males|3|50–54|0.866|0.846|0.884
Relative|Oral cancer|2015–2019|Males|3|55–59|0.832|0.813|0.849
Relative|Oral cancer|2015–2019|Males|3|60–64|0.809|0.79|0.827
Relative|Oral cancer|2015–2019|Males|3|65–69|0.767|0.745|0.787
Relative|Oral cancer|2015–2019|Males|3|70–74|0.744|0.717|0.77
Relative|Oral cancer|2015–2019|Males|3|75–79|0.712|0.676|0.745
Relative|Oral cancer|2015–2019|Males|3|80–84|0.697|0.65|0.742
Relative|Oral cancer|2015–2019|Males|3|85+|0.676|0.609|0.743
Relative|Oral cancer|2015–2019|Males|3|All ages combined|0.801|0.793|0.809
Relative|Oral cancer|2015–2019|Males|4|00–04|||
Relative|Oral cancer|2015–2019|Males|4|05–09|||
Relative|Oral cancer|2015–2019|Males|4|10–14|||
Relative|Oral cancer|2015–2019|Males|4|15–19|||
Relative|Oral cancer|2015–2019|Males|4|20–24|0.944|0.787|0.987
Relative|Oral cancer|2015–2019|Males|4|25–29|0.909|0.815|0.957
Relative|Oral cancer|2015–2019|Males|4|30–34|0.917|0.855|0.953
Relative|Oral cancer|2015–2019|Males|4|35–39|0.932|0.888|0.96
Relative|Oral cancer|2015–2019|Males|4|40–44|0.914|0.883|0.938
Relative|Oral cancer|2015–2019|Males|4|45–49|0.86|0.834|0.883
Relative|Oral cancer|2015–2019|Males|4|50–54|0.843|0.821|0.862
Relative|Oral cancer|2015–2019|Males|4|55–59|0.8|0.779|0.819
Relative|Oral cancer|2015–2019|Males|4|60–64|0.779|0.759|0.799
Relative|Oral cancer|2015–2019|Males|4|65–69|0.735|0.712|0.757
Relative|Oral cancer|2015–2019|Males|4|70–74|0.706|0.677|0.734
Relative|Oral cancer|2015–2019|Males|4|75–79|0.689|0.651|0.726
Relative|Oral cancer|2015–2019|Males|4|80–84|0.648|0.596|0.698
Relative|Oral cancer|2015–2019|Males|4|85+|0.651|0.574|0.728
Relative|Oral cancer|2015–2019|Males|4|All ages combined|0.774|0.765|0.783
Relative|Oral cancer|2015–2019|Males|5|00–04|||
Relative|Oral cancer|2015–2019|Males|5|05–09|||
Relative|Oral cancer|2015–2019|Males|5|10–14|||
Relative|Oral cancer|2015–2019|Males|5|15–19|||
Relative|Oral cancer|2015–2019|Males|5|20–24|0.944|0.787|0.988
Relative|Oral cancer|2015–2019|Males|5|25–29|0.897|0.802|0.949
Relative|Oral cancer|2015–2019|Males|5|30–34|0.911|0.849|0.95
Relative|Oral cancer|2015–2019|Males|5|35–39|0.918|0.872|0.949
Relative|Oral cancer|2015–2019|Males|5|40–44|0.9|0.868|0.926
Relative|Oral cancer|2015–2019|Males|5|45–49|0.853|0.827|0.877
Relative|Oral cancer|2015–2019|Males|5|50–54|0.83|0.808|0.851
Relative|Oral cancer|2015–2019|Males|5|55–59|0.782|0.761|0.802
Relative|Oral cancer|2015–2019|Males|5|60–64|0.761|0.739|0.782
Relative|Oral cancer|2015–2019|Males|5|65–69|0.716|0.691|0.739
Relative|Oral cancer|2015–2019|Males|5|70–74|0.668|0.636|0.698
Relative|Oral cancer|2015–2019|Males|5|75–79|0.665|0.624|0.704
Relative|Oral cancer|2015–2019|Males|5|80–84|0.614|0.557|0.669
Relative|Oral cancer|2015–2019|Males|5|85+|0.649|0.561|0.74
Relative|Oral cancer|2015–2019|Males|5|All ages combined|0.756|0.746|0.765
Observed|Oral cancer|2015–2019|Females|1|00–04|||
Observed|Oral cancer|2015–2019|Females|1|05–09|||
Observed|Oral cancer|2015–2019|Females|1|10–14|||
Observed|Oral cancer|2015–2019|Females|1|15–19|1|0.895|1
Observed|Oral cancer|2015–2019|Females|1|20–24|0.968|0.794|0.995
Observed|Oral cancer|2015–2019|Females|1|25–29|0.916|0.791|0.968
Observed|Oral cancer|2015–2019|Females|1|30–34|0.971|0.891|0.993
Observed|Oral cancer|2015–2019|Females|1|35–39|0.969|0.907|0.99
Observed|Oral cancer|2015–2019|Females|1|40–44|0.969|0.928|0.987
Observed|Oral cancer|2015–2019|Females|1|45–49|0.954|0.922|0.973
Observed|Oral cancer|2015–2019|Females|1|50–54|0.938|0.911|0.957
Observed|Oral cancer|2015–2019|Females|1|55–59|0.938|0.915|0.955
Observed|Oral cancer|2015–2019|Females|1|60–64|0.939|0.917|0.956
Observed|Oral cancer|2015–2019|Females|1|65–69|0.915|0.89|0.934
Observed|Oral cancer|2015–2019|Females|1|70–74|0.876|0.847|0.899
Observed|Oral cancer|2015–2019|Females|1|75–79|0.869|0.836|0.896
Observed|Oral cancer|2015–2019|Females|1|80–84|0.769|0.725|0.806
Observed|Oral cancer|2015–2019|Females|1|85+|0.623|0.583|0.661
Observed|Oral cancer|2015–2019|Females|1|All ages combined|0.874|0.864|0.883
Observed|Oral cancer|2015–2019|Females|2|00–04|||
Observed|Oral cancer|2015–2019|Females|2|05–09|||
Observed|Oral cancer|2015–2019|Females|2|10–14|||
Observed|Oral cancer|2015–2019|Females|2|15–19|1|0.889|1
Observed|Oral cancer|2015–2019|Females|2|20–24|0.968|0.794|0.995
Observed|Oral cancer|2015–2019|Females|2|25–29|0.896|0.768|0.955
Observed|Oral cancer|2015–2019|Females|2|30–34|0.96|0.88|0.987
Observed|Oral cancer|2015–2019|Females|2|35–39|0.93|0.859|0.966
Observed|Oral cancer|2015–2019|Females|2|40–44|0.925|0.874|0.956
Observed|Oral cancer|2015–2019|Females|2|45–49|0.936|0.9|0.959
Observed|Oral cancer|2015–2019|Females|2|50–54|0.894|0.862|0.92
Observed|Oral cancer|2015–2019|Females|2|55–59|0.885|0.856|0.909
Observed|Oral cancer|2015–2019|Females|2|60–64|0.875|0.846|0.9
Observed|Oral cancer|2015–2019|Females|2|65–69|0.859|0.828|0.884
Observed|Oral cancer|2015–2019|Females|2|70–74|0.791|0.756|0.821
Observed|Oral cancer|2015–2019|Females|2|75–79|0.805|0.767|0.838
Observed|Oral cancer|2015–2019|Females|2|80–84|0.665|0.618|0.708
Observed|Oral cancer|2015–2019|Females|2|85+|0.492|0.452|0.532
Observed|Oral cancer|2015–2019|Females|2|All ages combined|0.806|0.795|0.817
Observed|Oral cancer|2015–2019|Females|3|00–04|||
Observed|Oral cancer|2015–2019|Females|3|05–09|||
Observed|Oral cancer|2015–2019|Females|3|10–14|||
Observed|Oral cancer|2015–2019|Females|3|15–19|||
Observed|Oral cancer|2015–2019|Females|3|20–24|0.968|0.794|0.995
Observed|Oral cancer|2015–2019|Females|3|25–29|0.896|0.768|0.955
Observed|Oral cancer|2015–2019|Females|3|30–34|0.96|0.88|0.987
Observed|Oral cancer|2015–2019|Females|3|35–39|0.921|0.849|0.96
Observed|Oral cancer|2015–2019|Females|3|40–44|0.915|0.862|0.948
Observed|Oral cancer|2015–2019|Females|3|45–49|0.898|0.857|0.928
Observed|Oral cancer|2015–2019|Females|3|50–54|0.863|0.827|0.892
Observed|Oral cancer|2015–2019|Females|3|55–59|0.853|0.821|0.88
Observed|Oral cancer|2015–2019|Females|3|60–64|0.845|0.812|0.872
Observed|Oral cancer|2015–2019|Females|3|65–69|0.815|0.782|0.844
Observed|Oral cancer|2015–2019|Females|3|70–74|0.748|0.711|0.781
Observed|Oral cancer|2015–2019|Females|3|75–79|0.736|0.694|0.773
Observed|Oral cancer|2015–2019|Females|3|80–84|0.6|0.552|0.646
Observed|Oral cancer|2015–2019|Females|3|85+|0.413|0.374|0.452
Observed|Oral cancer|2015–2019|Females|3|All ages combined|0.762|0.75|0.773
Observed|Oral cancer|2015–2019|Females|4|00–04|||
Observed|Oral cancer|2015–2019|Females|4|05–09|||
Observed|Oral cancer|2015–2019|Females|4|10–14|||
Observed|Oral cancer|2015–2019|Females|4|15–19|||
Observed|Oral cancer|2015–2019|Females|4|20–24|0.934|0.762|0.983
Observed|Oral cancer|2015–2019|Females|4|25–29|0.878|0.748|0.943
Observed|Oral cancer|2015–2019|Females|4|30–34|0.96|0.88|0.987
Observed|Oral cancer|2015–2019|Females|4|35–39|0.913|0.84|0.954
Observed|Oral cancer|2015–2019|Females|4|40–44|0.88|0.824|0.92
Observed|Oral cancer|2015–2019|Females|4|45–49|0.885|0.842|0.917
Observed|Oral cancer|2015–2019|Females|4|50–54|0.83|0.791|0.862
Observed|Oral cancer|2015–2019|Females|4|55–59|0.834|0.801|0.863
Observed|Oral cancer|2015–2019|Females|4|60–64|0.817|0.783|0.846
Observed|Oral cancer|2015–2019|Females|4|65–69|0.791|0.757|0.821
Observed|Oral cancer|2015–2019|Females|4|70–74|0.724|0.686|0.758
Observed|Oral cancer|2015–2019|Females|4|75–79|0.702|0.659|0.741
Observed|Oral cancer|2015–2019|Females|4|80–84|0.538|0.489|0.584
Observed|Oral cancer|2015–2019|Females|4|85+|0.323|0.286|0.36
Observed|Oral cancer|2015–2019|Females|4|All ages combined|0.726|0.713|0.738
Observed|Oral cancer|2015–2019|Females|5|00–04|||
Observed|Oral cancer|2015–2019|Females|5|05–09|||
Observed|Oral cancer|2015–2019|Females|5|10–14|||
Observed|Oral cancer|2015–2019|Females|5|15–19|||
Observed|Oral cancer|2015–2019|Females|5|20–24|0.934|0.762|0.983
Observed|Oral cancer|2015–2019|Females|5|25–29|0.878|0.748|0.943
Observed|Oral cancer|2015–2019|Females|5|30–34|0.96|0.88|0.987
Observed|Oral cancer|2015–2019|Females|5|35–39|0.899|0.824|0.943
Observed|Oral cancer|2015–2019|Females|5|40–44|0.88|0.824|0.92
Observed|Oral cancer|2015–2019|Females|5|45–49|0.871|0.827|0.905
Observed|Oral cancer|2015–2019|Females|5|50–54|0.807|0.767|0.841
Observed|Oral cancer|2015–2019|Females|5|55–59|0.828|0.794|0.857
Observed|Oral cancer|2015–2019|Females|5|60–64|0.803|0.768|0.833
Observed|Oral cancer|2015–2019|Females|5|65–69|0.755|0.719|0.788
Observed|Oral cancer|2015–2019|Females|5|70–74|0.674|0.635|0.711
Observed|Oral cancer|2015–2019|Females|5|75–79|0.643|0.598|0.684
Observed|Oral cancer|2015–2019|Females|5|80–84|0.464|0.417|0.51
Observed|Oral cancer|2015–2019|Females|5|85+|0.243|0.21|0.277
Observed|Oral cancer|2015–2019|Females|5|All ages combined|0.688|0.675|0.701
Relative|Oral cancer|2015–2019|Females|1|00–04|||
Relative|Oral cancer|2015–2019|Females|1|05–09|||
Relative|Oral cancer|2015–2019|Females|1|10–14|||
Relative|Oral cancer|2015–2019|Females|1|15–19|1|0.895|1
Relative|Oral cancer|2015–2019|Females|1|20–24|0.968|0.794|0.996
Relative|Oral cancer|2015–2019|Females|1|25–29|0.916|0.791|0.968
Relative|Oral cancer|2015–2019|Females|1|30–34|0.972|0.891|0.993
Relative|Oral cancer|2015–2019|Females|1|35–39|0.97|0.908|0.991
Relative|Oral cancer|2015–2019|Females|1|40–44|0.97|0.929|0.988
Relative|Oral cancer|2015–2019|Females|1|45–49|0.955|0.923|0.974
Relative|Oral cancer|2015–2019|Females|1|50–54|0.94|0.913|0.959
Relative|Oral cancer|2015–2019|Females|1|55–59|0.941|0.917|0.958
Relative|Oral cancer|2015–2019|Females|1|60–64|0.943|0.921|0.96
Relative|Oral cancer|2015–2019|Females|1|65–69|0.921|0.896|0.941
Relative|Oral cancer|2015–2019|Females|1|70–74|0.886|0.857|0.91
Relative|Oral cancer|2015–2019|Females|1|75–79|0.888|0.854|0.915
Relative|Oral cancer|2015–2019|Females|1|80–84|0.801|0.756|0.841
Relative|Oral cancer|2015–2019|Females|1|85+|0.705|0.66|0.748
Relative|Oral cancer|2015–2019|Females|1|All ages combined|0.894|0.884|0.903
Relative|Oral cancer|2015–2019|Females|2|00–04|||
Relative|Oral cancer|2015–2019|Females|2|05–09|||
Relative|Oral cancer|2015–2019|Females|2|10–14|||
Relative|Oral cancer|2015–2019|Females|2|15–19|1|0.89|1
Relative|Oral cancer|2015–2019|Females|2|20–24|0.968|0.794|0.996
Relative|Oral cancer|2015–2019|Females|2|25–29|0.897|0.769|0.956
Relative|Oral cancer|2015–2019|Females|2|30–34|0.96|0.88|0.988
Relative|Oral cancer|2015–2019|Females|2|35–39|0.931|0.86|0.967
Relative|Oral cancer|2015–2019|Females|2|40–44|0.927|0.876|0.958
Relative|Oral cancer|2015–2019|Females|2|45–49|0.938|0.903|0.962
Relative|Oral cancer|2015–2019|Females|2|50–54|0.898|0.865|0.924
Relative|Oral cancer|2015–2019|Females|2|55–59|0.891|0.861|0.915
Relative|Oral cancer|2015–2019|Females|2|60–64|0.884|0.854|0.909
Relative|Oral cancer|2015–2019|Females|2|65–69|0.872|0.841|0.897
Relative|Oral cancer|2015–2019|Females|2|70–74|0.811|0.776|0.843
Relative|Oral cancer|2015–2019|Females|2|75–79|0.843|0.803|0.877
Relative|Oral cancer|2015–2019|Females|2|80–84|0.728|0.676|0.775
Relative|Oral cancer|2015–2019|Females|2|85+|0.637|0.584|0.688
Relative|Oral cancer|2015–2019|Females|2|All ages combined|0.841|0.83|0.853
Relative|Oral cancer|2015–2019|Females|3|00–04|||
Relative|Oral cancer|2015–2019|Females|3|05–09|||
Relative|Oral cancer|2015–2019|Females|3|10–14|||
Relative|Oral cancer|2015–2019|Females|3|15–19|||
Relative|Oral cancer|2015–2019|Females|3|20–24|0.969|0.794|0.996
Relative|Oral cancer|2015–2019|Females|3|25–29|0.897|0.769|0.956
Relative|Oral cancer|2015–2019|Females|3|30–34|0.961|0.881|0.988
Relative|Oral cancer|2015–2019|Females|3|35–39|0.923|0.851|0.962
Relative|Oral cancer|2015–2019|Females|3|40–44|0.918|0.865|0.951
Relative|Oral cancer|2015–2019|Females|3|45–49|0.902|0.861|0.932
Relative|Oral cancer|2015–2019|Females|3|50–54|0.869|0.833|0.898
Relative|Oral cancer|2015–2019|Females|3|55–59|0.862|0.829|0.889
Relative|Oral cancer|2015–2019|Females|3|60–64|0.858|0.825|0.885
Relative|Oral cancer|2015–2019|Females|3|65–69|0.835|0.801|0.864
Relative|Oral cancer|2015–2019|Females|3|70–74|0.78|0.741|0.814
Relative|Oral cancer|2015–2019|Females|3|75–79|0.792|0.747|0.832
Relative|Oral cancer|2015–2019|Females|3|80–84|0.694|0.638|0.747
Relative|Oral cancer|2015–2019|Females|3|85+|0.62|0.561|0.679
Relative|Oral cancer|2015–2019|Females|3|All ages combined|0.812|0.8|0.825
Relative|Oral cancer|2015–2019|Females|4|00–04|||
Relative|Oral cancer|2015–2019|Females|4|05–09|||
Relative|Oral cancer|2015–2019|Females|4|10–14|||
Relative|Oral cancer|2015–2019|Females|4|15–19|||
Relative|Oral cancer|2015–2019|Females|4|20–24|0.935|0.763|0.984
Relative|Oral cancer|2015–2019|Females|4|25–29|0.879|0.749|0.944
Relative|Oral cancer|2015–2019|Females|4|30–34|0.961|0.881|0.989
Relative|Oral cancer|2015–2019|Females|4|35–39|0.916|0.842|0.957
Relative|Oral cancer|2015–2019|Females|4|40–44|0.884|0.827|0.923
Relative|Oral cancer|2015–2019|Females|4|45–49|0.891|0.847|0.923
Relative|Oral cancer|2015–2019|Females|4|50–54|0.838|0.799|0.87
Relative|Oral cancer|2015–2019|Females|4|55–59|0.846|0.812|0.875
Relative|Oral cancer|2015–2019|Females|4|60–64|0.834|0.8|0.864
Relative|Oral cancer|2015–2019|Females|4|65–69|0.818|0.783|0.85
Relative|Oral cancer|2015–2019|Females|4|70–74|0.768|0.728|0.804
Relative|Oral cancer|2015–2019|Females|4|75–79|0.78|0.733|0.823
Relative|Oral cancer|2015–2019|Females|4|80–84|0.663|0.603|0.72
Relative|Oral cancer|2015–2019|Females|4|85+|0.571|0.506|0.637
Relative|Oral cancer|2015–2019|Females|4|All ages combined|0.792|0.778|0.805
Relative|Oral cancer|2015–2019|Females|5|00–04|||
Relative|Oral cancer|2015–2019|Females|5|05–09|||
Relative|Oral cancer|2015–2019|Females|5|10–14|||
Relative|Oral cancer|2015–2019|Females|5|15–19|||
Relative|Oral cancer|2015–2019|Females|5|20–24|0.936|0.763|0.984
Relative|Oral cancer|2015–2019|Females|5|25–29|0.879|0.749|0.945
Relative|Oral cancer|2015–2019|Females|5|30–34|0.962|0.882|0.989
Relative|Oral cancer|2015–2019|Females|5|35–39|0.902|0.827|0.946
Relative|Oral cancer|2015–2019|Females|5|40–44|0.885|0.829|0.925
Relative|Oral cancer|2015–2019|Females|5|45–49|0.879|0.834|0.913
Relative|Oral cancer|2015–2019|Females|5|50–54|0.817|0.777|0.852
Relative|Oral cancer|2015–2019|Females|5|55–59|0.844|0.809|0.873
Relative|Oral cancer|2015–2019|Females|5|60–64|0.825|0.789|0.856
Relative|Oral cancer|2015–2019|Females|5|65–69|0.79|0.751|0.824
Relative|Oral cancer|2015–2019|Females|5|70–74|0.729|0.686|0.768
Relative|Oral cancer|2015–2019|Females|5|75–79|0.741|0.69|0.789
Relative|Oral cancer|2015–2019|Females|5|80–84|0.617|0.554|0.678
Relative|Oral cancer|2015–2019|Females|5|85+|0.516|0.446|0.588
Relative|Oral cancer|2015–2019|Females|5|All ages combined|0.768|0.753|0.782
Observed|Oral cancer|2015–2019|Persons|1|00–04|||
Observed|Oral cancer|2015–2019|Persons|1|05–09|||
Observed|Oral cancer|2015–2019|Persons|1|10–14|||
Observed|Oral cancer|2015–2019|Persons|1|15–19|1|0.933|1
Observed|Oral cancer|2015–2019|Persons|1|20–24|0.954|0.864|0.985
Observed|Oral cancer|2015–2019|Persons|1|25–29|0.949|0.89|0.977
Observed|Oral cancer|2015–2019|Persons|1|30–34|0.969|0.933|0.986
Observed|Oral cancer|2015–2019|Persons|1|35–39|0.972|0.946|0.985
Observed|Oral cancer|2015–2019|Persons|1|40–44|0.964|0.946|0.977
Observed|Oral cancer|2015–2019|Persons|1|45–49|0.951|0.937|0.962
Observed|Oral cancer|2015–2019|Persons|1|50–54|0.945|0.934|0.955
Observed|Oral cancer|2015–2019|Persons|1|55–59|0.926|0.915|0.936
Observed|Oral cancer|2015–2019|Persons|1|60–64|0.909|0.897|0.92
Observed|Oral cancer|2015–2019|Persons|1|65–69|0.876|0.862|0.888
Observed|Oral cancer|2015–2019|Persons|1|70–74|0.862|0.846|0.877
Observed|Oral cancer|2015–2019|Persons|1|75–79|0.825|0.805|0.844
Observed|Oral cancer|2015–2019|Persons|1|80–84|0.759|0.733|0.784
Observed|Oral cancer|2015–2019|Persons|1|85+|0.637|0.608|0.665
Observed|Oral cancer|2015–2019|Persons|1|All ages combined|0.879|0.874|0.883
Observed|Oral cancer|2015–2019|Persons|2|00–04|||
Observed|Oral cancer|2015–2019|Persons|2|05–09|||
Observed|Oral cancer|2015–2019|Persons|2|10–14|||
Observed|Oral cancer|2015–2019|Persons|2|15–19|1|0.928|1
Observed|Oral cancer|2015–2019|Persons|2|20–24|0.954|0.864|0.985
Observed|Oral cancer|2015–2019|Persons|2|25–29|0.925|0.861|0.96
Observed|Oral cancer|2015–2019|Persons|2|30–34|0.951|0.912|0.974
Observed|Oral cancer|2015–2019|Persons|2|35–39|0.939|0.906|0.961
Observed|Oral cancer|2015–2019|Persons|2|40–44|0.93|0.907|0.948
Observed|Oral cancer|2015–2019|Persons|2|45–49|0.907|0.888|0.922
Observed|Oral cancer|2015–2019|Persons|2|50–54|0.894|0.879|0.908
Observed|Oral cancer|2015–2019|Persons|2|55–59|0.87|0.855|0.882
Observed|Oral cancer|2015–2019|Persons|2|60–64|0.841|0.826|0.855
Observed|Oral cancer|2015–2019|Persons|2|65–69|0.806|0.79|0.821
Observed|Oral cancer|2015–2019|Persons|2|70–74|0.77|0.751|0.789
Observed|Oral cancer|2015–2019|Persons|2|75–79|0.746|0.723|0.768
Observed|Oral cancer|2015–2019|Persons|2|80–84|0.651|0.622|0.678
Observed|Oral cancer|2015–2019|Persons|2|85+|0.509|0.479|0.538
Observed|Oral cancer|2015–2019|Persons|2|All ages combined|0.809|0.803|0.814
Observed|Oral cancer|2015–2019|Persons|3|00–04|||
Observed|Oral cancer|2015–2019|Persons|3|05–09|||
Observed|Oral cancer|2015–2019|Persons|3|10–14|||
Observed|Oral cancer|2015–2019|Persons|3|15–19|0.97|0.804|0.996
Observed|Oral cancer|2015–2019|Persons|3|20–24|0.954|0.864|0.985
Observed|Oral cancer|2015–2019|Persons|3|25–29|0.917|0.851|0.954
Observed|Oral cancer|2015–2019|Persons|3|30–34|0.935|0.892|0.961
Observed|Oral cancer|2015–2019|Persons|3|35–39|0.93|0.896|0.954
Observed|Oral cancer|2015–2019|Persons|3|40–44|0.915|0.891|0.935
Observed|Oral cancer|2015–2019|Persons|3|45–49|0.875|0.854|0.893
Observed|Oral cancer|2015–2019|Persons|3|50–54|0.858|0.841|0.873
Observed|Oral cancer|2015–2019|Persons|3|55–59|0.826|0.81|0.841
Observed|Oral cancer|2015–2019|Persons|3|60–64|0.801|0.785|0.817
Observed|Oral cancer|2015–2019|Persons|3|65–69|0.757|0.739|0.773
Observed|Oral cancer|2015–2019|Persons|3|70–74|0.714|0.693|0.733
Observed|Oral cancer|2015–2019|Persons|3|75–79|0.67|0.645|0.694
Observed|Oral cancer|2015–2019|Persons|3|80–84|0.581|0.551|0.609
Observed|Oral cancer|2015–2019|Persons|3|85+|0.418|0.389|0.446
Observed|Oral cancer|2015–2019|Persons|3|All ages combined|0.76|0.754|0.766
Observed|Oral cancer|2015–2019|Persons|4|00–04|||
Observed|Oral cancer|2015–2019|Persons|4|05–09|||
Observed|Oral cancer|2015–2019|Persons|4|10–14|||
Observed|Oral cancer|2015–2019|Persons|4|15–19|0.938|0.772|0.984
Observed|Oral cancer|2015–2019|Persons|4|20–24|0.936|0.838|0.976
Observed|Oral cancer|2015–2019|Persons|4|25–29|0.895|0.825|0.937
Observed|Oral cancer|2015–2019|Persons|4|30–34|0.93|0.887|0.957
Observed|Oral cancer|2015–2019|Persons|4|35–39|0.922|0.887|0.947
Observed|Oral cancer|2015–2019|Persons|4|40–44|0.9|0.873|0.92
Observed|Oral cancer|2015–2019|Persons|4|45–49|0.859|0.838|0.878
Observed|Oral cancer|2015–2019|Persons|4|50–54|0.829|0.811|0.846
Observed|Oral cancer|2015–2019|Persons|4|55–59|0.793|0.776|0.809
Observed|Oral cancer|2015–2019|Persons|4|60–64|0.767|0.75|0.783
Observed|Oral cancer|2015–2019|Persons|4|65–69|0.72|0.701|0.737
Observed|Oral cancer|2015–2019|Persons|4|70–74|0.67|0.648|0.691
Observed|Oral cancer|2015–2019|Persons|4|75–79|0.627|0.601|0.652
Observed|Oral cancer|2015–2019|Persons|4|80–84|0.505|0.475|0.535
Observed|Oral cancer|2015–2019|Persons|4|85+|0.33|0.303|0.357
Observed|Oral cancer|2015–2019|Persons|4|All ages combined|0.721|0.715|0.728
Observed|Oral cancer|2015–2019|Persons|5|00–04|||
Observed|Oral cancer|2015–2019|Persons|5|05–09|||
Observed|Oral cancer|2015–2019|Persons|5|10–14|||
Observed|Oral cancer|2015–2019|Persons|5|15–19|0.938|0.772|0.984
Observed|Oral cancer|2015–2019|Persons|5|20–24|0.936|0.838|0.976
Observed|Oral cancer|2015–2019|Persons|5|25–29|0.887|0.817|0.932
Observed|Oral cancer|2015–2019|Persons|5|30–34|0.926|0.882|0.954
Observed|Oral cancer|2015–2019|Persons|5|35–39|0.907|0.871|0.934
Observed|Oral cancer|2015–2019|Persons|5|40–44|0.888|0.861|0.91
Observed|Oral cancer|2015–2019|Persons|5|45–49|0.849|0.827|0.869
Observed|Oral cancer|2015–2019|Persons|5|50–54|0.812|0.793|0.829
Observed|Oral cancer|2015–2019|Persons|5|55–59|0.775|0.757|0.791
Observed|Oral cancer|2015–2019|Persons|5|60–64|0.744|0.727|0.761
Observed|Oral cancer|2015–2019|Persons|5|65–69|0.688|0.669|0.707
Observed|Oral cancer|2015–2019|Persons|5|70–74|0.618|0.596|0.64
Observed|Oral cancer|2015–2019|Persons|5|75–79|0.574|0.548|0.6
Observed|Oral cancer|2015–2019|Persons|5|80–84|0.435|0.405|0.464
Observed|Oral cancer|2015–2019|Persons|5|85+|0.258|0.233|0.283
Observed|Oral cancer|2015–2019|Persons|5|All ages combined|0.689|0.682|0.696
Relative|Oral cancer|2015–2019|Persons|1|00–04|||
Relative|Oral cancer|2015–2019|Persons|1|05–09|||
Relative|Oral cancer|2015–2019|Persons|1|10–14|||
Relative|Oral cancer|2015–2019|Persons|1|15–19|1|0.933|1
Relative|Oral cancer|2015–2019|Persons|1|20–24|0.954|0.865|0.985
Relative|Oral cancer|2015–2019|Persons|1|25–29|0.95|0.891|0.977
Relative|Oral cancer|2015–2019|Persons|1|30–34|0.97|0.934|0.987
Relative|Oral cancer|2015–2019|Persons|1|35–39|0.973|0.947|0.986
Relative|Oral cancer|2015–2019|Persons|1|40–44|0.966|0.947|0.978
Relative|Oral cancer|2015–2019|Persons|1|45–49|0.953|0.939|0.964
Relative|Oral cancer|2015–2019|Persons|1|50–54|0.948|0.937|0.958
Relative|Oral cancer|2015–2019|Persons|1|55–59|0.93|0.919|0.94
Relative|Oral cancer|2015–2019|Persons|1|60–64|0.916|0.904|0.926
Relative|Oral cancer|2015–2019|Persons|1|65–69|0.885|0.871|0.898
Relative|Oral cancer|2015–2019|Persons|1|70–74|0.877|0.861|0.892
Relative|Oral cancer|2015–2019|Persons|1|75–79|0.85|0.829|0.869
Relative|Oral cancer|2015–2019|Persons|1|80–84|0.801|0.773|0.826
Relative|Oral cancer|2015–2019|Persons|1|85+|0.728|0.695|0.759
Relative|Oral cancer|2015–2019|Persons|1|All ages combined|0.896|0.891|0.901
Relative|Oral cancer|2015–2019|Persons|2|00–04|||
Relative|Oral cancer|2015–2019|Persons|2|05–09|||
Relative|Oral cancer|2015–2019|Persons|2|10–14|||
Relative|Oral cancer|2015–2019|Persons|2|15–19|1.001|0.929|1.001
Relative|Oral cancer|2015–2019|Persons|2|20–24|0.955|0.865|0.986
Relative|Oral cancer|2015–2019|Persons|2|25–29|0.926|0.862|0.961
Relative|Oral cancer|2015–2019|Persons|2|30–34|0.953|0.913|0.975
Relative|Oral cancer|2015–2019|Persons|2|35–39|0.941|0.908|0.963
Relative|Oral cancer|2015–2019|Persons|2|40–44|0.933|0.909|0.95
Relative|Oral cancer|2015–2019|Persons|2|45–49|0.911|0.892|0.927
Relative|Oral cancer|2015–2019|Persons|2|50–54|0.9|0.885|0.914
Relative|Oral cancer|2015–2019|Persons|2|55–59|0.878|0.864|0.891
Relative|Oral cancer|2015–2019|Persons|2|60–64|0.854|0.839|0.868
Relative|Oral cancer|2015–2019|Persons|2|65–69|0.824|0.808|0.84
Relative|Oral cancer|2015–2019|Persons|2|70–74|0.799|0.779|0.818
Relative|Oral cancer|2015–2019|Persons|2|75–79|0.794|0.769|0.817
Relative|Oral cancer|2015–2019|Persons|2|80–84|0.729|0.696|0.76
Relative|Oral cancer|2015–2019|Persons|2|85+|0.672|0.633|0.71
Relative|Oral cancer|2015–2019|Persons|2|All ages combined|0.84|0.834|0.846
Relative|Oral cancer|2015–2019|Persons|3|00–04|||
Relative|Oral cancer|2015–2019|Persons|3|05–09|||
Relative|Oral cancer|2015–2019|Persons|3|10–14|||
Relative|Oral cancer|2015–2019|Persons|3|15–19|0.971|0.805|0.997
Relative|Oral cancer|2015–2019|Persons|3|20–24|0.955|0.865|0.986
Relative|Oral cancer|2015–2019|Persons|3|25–29|0.918|0.853|0.956
Relative|Oral cancer|2015–2019|Persons|3|30–34|0.937|0.894|0.963
Relative|Oral cancer|2015–2019|Persons|3|35–39|0.933|0.899|0.957
Relative|Oral cancer|2015–2019|Persons|3|40–44|0.92|0.895|0.939
Relative|Oral cancer|2015–2019|Persons|3|45–49|0.881|0.86|0.899
Relative|Oral cancer|2015–2019|Persons|3|50–54|0.867|0.85|0.882
Relative|Oral cancer|2015–2019|Persons|3|55–59|0.839|0.823|0.854
Relative|Oral cancer|2015–2019|Persons|3|60–64|0.82|0.804|0.836
Relative|Oral cancer|2015–2019|Persons|3|65–69|0.784|0.766|0.801
Relative|Oral cancer|2015–2019|Persons|3|70–74|0.756|0.733|0.776
Relative|Oral cancer|2015–2019|Persons|3|75–79|0.739|0.712|0.766
Relative|Oral cancer|2015–2019|Persons|3|80–84|0.696|0.66|0.73
Relative|Oral cancer|2015–2019|Persons|3|85+|0.646|0.602|0.69
Relative|Oral cancer|2015–2019|Persons|3|All ages combined|0.805|0.798|0.811
Relative|Oral cancer|2015–2019|Persons|4|00–04|||
Relative|Oral cancer|2015–2019|Persons|4|05–09|||
Relative|Oral cancer|2015–2019|Persons|4|10–14|||
Relative|Oral cancer|2015–2019|Persons|4|15–19|0.939|0.773|0.985
Relative|Oral cancer|2015–2019|Persons|4|20–24|0.938|0.84|0.977
Relative|Oral cancer|2015–2019|Persons|4|25–29|0.897|0.827|0.94
Relative|Oral cancer|2015–2019|Persons|4|30–34|0.933|0.89|0.96
Relative|Oral cancer|2015–2019|Persons|4|35–39|0.926|0.891|0.951
Relative|Oral cancer|2015–2019|Persons|4|40–44|0.905|0.879|0.926
Relative|Oral cancer|2015–2019|Persons|4|45–49|0.868|0.846|0.887
Relative|Oral cancer|2015–2019|Persons|4|50–54|0.841|0.823|0.858
Relative|Oral cancer|2015–2019|Persons|4|55–59|0.811|0.793|0.827
Relative|Oral cancer|2015–2019|Persons|4|60–64|0.792|0.775|0.809
Relative|Oral cancer|2015–2019|Persons|4|65–69|0.756|0.737|0.775
Relative|Oral cancer|2015–2019|Persons|4|70–74|0.727|0.703|0.749
Relative|Oral cancer|2015–2019|Persons|4|75–79|0.721|0.691|0.749
Relative|Oral cancer|2015–2019|Persons|4|80–84|0.655|0.615|0.693
Relative|Oral cancer|2015–2019|Persons|4|85+|0.607|0.558|0.658
Relative|Oral cancer|2015–2019|Persons|4|All ages combined|0.779|0.772|0.787
Relative|Oral cancer|2015–2019|Persons|5|00–04|||
Relative|Oral cancer|2015–2019|Persons|5|05–09|||
Relative|Oral cancer|2015–2019|Persons|5|10–14|||
Relative|Oral cancer|2015–2019|Persons|5|15–19|0.939|0.774|0.986
Relative|Oral cancer|2015–2019|Persons|5|20–24|0.938|0.84|0.978
Relative|Oral cancer|2015–2019|Persons|5|25–29|0.89|0.82|0.934
Relative|Oral cancer|2015–2019|Persons|5|30–34|0.93|0.886|0.958
Relative|Oral cancer|2015–2019|Persons|5|35–39|0.913|0.876|0.939
Relative|Oral cancer|2015–2019|Persons|5|40–44|0.896|0.869|0.918
Relative|Oral cancer|2015–2019|Persons|5|45–49|0.86|0.837|0.88
Relative|Oral cancer|2015–2019|Persons|5|50–54|0.827|0.808|0.845
Relative|Oral cancer|2015–2019|Persons|5|55–59|0.797|0.779|0.814
Relative|Oral cancer|2015–2019|Persons|5|60–64|0.776|0.758|0.794
Relative|Oral cancer|2015–2019|Persons|5|65–69|0.735|0.714|0.754
Relative|Oral cancer|2015–2019|Persons|5|70–74|0.688|0.663|0.712
Relative|Oral cancer|2015–2019|Persons|5|75–79|0.691|0.659|0.722
Relative|Oral cancer|2015–2019|Persons|5|80–84|0.615|0.573|0.656
Relative|Oral cancer|2015–2019|Persons|5|85+|0.573|0.518|0.63
Relative|Oral cancer|2015–2019|Persons|5|All ages combined|0.759|0.751|0.767
Observed|Oropharyngeal cancer|2015–2019|Males|1|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Males|1|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Males|1|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Males|1|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Males|1|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Males|1|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Males|1|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Males|1|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Males|1|40–44|0.934|0.859|0.97
Observed|Oropharyngeal cancer|2015–2019|Males|1|45–49|0.933|0.895|0.957
Observed|Oropharyngeal cancer|2015–2019|Males|1|50–54|0.946|0.92|0.964
Observed|Oropharyngeal cancer|2015–2019|Males|1|55–59|0.914|0.89|0.933
Observed|Oropharyngeal cancer|2015–2019|Males|1|60–64|0.909|0.882|0.929
Observed|Oropharyngeal cancer|2015–2019|Males|1|65–69|0.829|0.791|0.86
Observed|Oropharyngeal cancer|2015–2019|Males|1|70–74|0.786|0.734|0.828
Observed|Oropharyngeal cancer|2015–2019|Males|1|75–79|0.692|0.605|0.763
Observed|Oropharyngeal cancer|2015–2019|Males|1|80–84|0.541|0.423|0.645
Observed|Oropharyngeal cancer|2015–2019|Males|1|85+|0.493|0.342|0.628
Observed|Oropharyngeal cancer|2015–2019|Males|1|All ages combined|0.871|0.858|0.882
Observed|Oropharyngeal cancer|2015–2019|Males|2|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Males|2|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Males|2|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Males|2|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Males|2|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Males|2|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Males|2|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Males|2|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Males|2|40–44|0.896|0.816|0.943
Observed|Oropharyngeal cancer|2015–2019|Males|2|45–49|0.874|0.827|0.909
Observed|Oropharyngeal cancer|2015–2019|Males|2|50–54|0.902|0.869|0.927
Observed|Oropharyngeal cancer|2015–2019|Males|2|55–59|0.865|0.836|0.888
Observed|Oropharyngeal cancer|2015–2019|Males|2|60–64|0.839|0.806|0.867
Observed|Oropharyngeal cancer|2015–2019|Males|2|65–69|0.768|0.726|0.804
Observed|Oropharyngeal cancer|2015–2019|Males|2|70–74|0.676|0.618|0.727
Observed|Oropharyngeal cancer|2015–2019|Males|2|75–79|0.55|0.462|0.63
Observed|Oropharyngeal cancer|2015–2019|Males|2|80–84|0.421|0.31|0.529
Observed|Oropharyngeal cancer|2015–2019|Males|2|85+|||
Observed|Oropharyngeal cancer|2015–2019|Males|2|All ages combined|0.802|0.787|0.815
Observed|Oropharyngeal cancer|2015–2019|Males|3|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Males|3|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Males|3|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Males|3|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Males|3|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Males|3|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Males|3|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Males|3|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Males|3|40–44|0.861|0.777|0.915
Observed|Oropharyngeal cancer|2015–2019|Males|3|45–49|0.853|0.804|0.891
Observed|Oropharyngeal cancer|2015–2019|Males|3|50–54|0.854|0.816|0.884
Observed|Oropharyngeal cancer|2015–2019|Males|3|55–59|0.823|0.791|0.85
Observed|Oropharyngeal cancer|2015–2019|Males|3|60–64|0.79|0.753|0.823
Observed|Oropharyngeal cancer|2015–2019|Males|3|65–69|0.718|0.673|0.758
Observed|Oropharyngeal cancer|2015–2019|Males|3|70–74|0.597|0.535|0.653
Observed|Oropharyngeal cancer|2015–2019|Males|3|75–79|0.475|0.388|0.557
Observed|Oropharyngeal cancer|2015–2019|Males|3|80–84|0.367|0.26|0.474
Observed|Oropharyngeal cancer|2015–2019|Males|3|85+|||
Observed|Oropharyngeal cancer|2015–2019|Males|3|All ages combined|0.753|0.737|0.768
Observed|Oropharyngeal cancer|2015–2019|Males|4|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Males|4|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Males|4|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Males|4|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Males|4|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Males|4|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Males|4|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Males|4|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Males|4|40–44|0.837|0.751|0.895
Observed|Oropharyngeal cancer|2015–2019|Males|4|45–49|0.836|0.785|0.876
Observed|Oropharyngeal cancer|2015–2019|Males|4|50–54|0.816|0.775|0.85
Observed|Oropharyngeal cancer|2015–2019|Males|4|55–59|0.8|0.766|0.829
Observed|Oropharyngeal cancer|2015–2019|Males|4|60–64|0.749|0.708|0.784
Observed|Oropharyngeal cancer|2015–2019|Males|4|65–69|0.685|0.638|0.727
Observed|Oropharyngeal cancer|2015–2019|Males|4|70–74|0.54|0.477|0.599
Observed|Oropharyngeal cancer|2015–2019|Males|4|75–79|0.427|0.341|0.509
Observed|Oropharyngeal cancer|2015–2019|Males|4|80–84|0.305|0.204|0.412
Observed|Oropharyngeal cancer|2015–2019|Males|4|85+|||
Observed|Oropharyngeal cancer|2015–2019|Males|4|All ages combined|0.718|0.701|0.734
Observed|Oropharyngeal cancer|2015–2019|Males|5|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Males|5|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Males|5|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Males|5|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Males|5|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Males|5|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Males|5|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Males|5|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Males|5|40–44|0.82|0.732|0.881
Observed|Oropharyngeal cancer|2015–2019|Males|5|45–49|0.831|0.779|0.872
Observed|Oropharyngeal cancer|2015–2019|Males|5|50–54|0.803|0.761|0.838
Observed|Oropharyngeal cancer|2015–2019|Males|5|55–59|0.78|0.745|0.811
Observed|Oropharyngeal cancer|2015–2019|Males|5|60–64|0.708|0.665|0.747
Observed|Oropharyngeal cancer|2015–2019|Males|5|65–69|0.668|0.619|0.712
Observed|Oropharyngeal cancer|2015–2019|Males|5|70–74|0.495|0.43|0.556
Observed|Oropharyngeal cancer|2015–2019|Males|5|75–79|0.363|0.28|0.446
Observed|Oropharyngeal cancer|2015–2019|Males|5|80–84|0.26|0.161|0.371
Observed|Oropharyngeal cancer|2015–2019|Males|5|85+|||
Observed|Oropharyngeal cancer|2015–2019|Males|5|All ages combined|0.693|0.676|0.71
Relative|Oropharyngeal cancer|2015–2019|Males|1|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Males|1|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Males|1|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Males|1|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Males|1|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Males|1|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Males|1|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Males|1|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Males|1|40–44|0.936|0.861|0.971
Relative|Oropharyngeal cancer|2015–2019|Males|1|45–49|0.935|0.897|0.959
Relative|Oropharyngeal cancer|2015–2019|Males|1|50–54|0.949|0.923|0.967
Relative|Oropharyngeal cancer|2015–2019|Males|1|55–59|0.919|0.895|0.938
Relative|Oropharyngeal cancer|2015–2019|Males|1|60–64|0.916|0.889|0.937
Relative|Oropharyngeal cancer|2015–2019|Males|1|65–69|0.839|0.801|0.87
Relative|Oropharyngeal cancer|2015–2019|Males|1|70–74|0.801|0.748|0.844
Relative|Oropharyngeal cancer|2015–2019|Males|1|75–79|0.715|0.625|0.788
Relative|Oropharyngeal cancer|2015–2019|Males|1|80–84|0.573|0.448|0.683
Relative|Oropharyngeal cancer|2015–2019|Males|1|85+|0.566|0.393|0.721
Relative|Oropharyngeal cancer|2015–2019|Males|1|All ages combined|0.881|0.868|0.892
Relative|Oropharyngeal cancer|2015–2019|Males|2|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Males|2|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Males|2|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Males|2|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Males|2|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Males|2|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Males|2|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Males|2|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Males|2|40–44|0.899|0.818|0.946
Relative|Oropharyngeal cancer|2015–2019|Males|2|45–49|0.878|0.831|0.913
Relative|Oropharyngeal cancer|2015–2019|Males|2|50–54|0.909|0.876|0.934
Relative|Oropharyngeal cancer|2015–2019|Males|2|55–59|0.874|0.845|0.898
Relative|Oropharyngeal cancer|2015–2019|Males|2|60–64|0.853|0.819|0.881
Relative|Oropharyngeal cancer|2015–2019|Males|2|65–69|0.787|0.744|0.824
Relative|Oropharyngeal cancer|2015–2019|Males|2|70–74|0.704|0.643|0.758
Relative|Oropharyngeal cancer|2015–2019|Males|2|75–79|0.59|0.495|0.675
Relative|Oropharyngeal cancer|2015–2019|Males|2|80–84|0.477|0.35|0.598
Relative|Oropharyngeal cancer|2015–2019|Males|2|85+|||
Relative|Oropharyngeal cancer|2015–2019|Males|2|All ages combined|0.82|0.805|0.834
Relative|Oropharyngeal cancer|2015–2019|Males|3|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Males|3|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Males|3|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Males|3|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Males|3|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Males|3|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Males|3|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Males|3|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Males|3|40–44|0.866|0.781|0.921
Relative|Oropharyngeal cancer|2015–2019|Males|3|45–49|0.86|0.81|0.898
Relative|Oropharyngeal cancer|2015–2019|Males|3|50–54|0.863|0.825|0.894
Relative|Oropharyngeal cancer|2015–2019|Males|3|55–59|0.837|0.805|0.865
Relative|Oropharyngeal cancer|2015–2019|Males|3|60–64|0.811|0.773|0.844
Relative|Oropharyngeal cancer|2015–2019|Males|3|65–69|0.746|0.7|0.788
Relative|Oropharyngeal cancer|2015–2019|Males|3|70–74|0.636|0.57|0.696
Relative|Oropharyngeal cancer|2015–2019|Males|3|75–79|0.53|0.433|0.621
Relative|Oropharyngeal cancer|2015–2019|Males|3|80–84|0.447|0.317|0.578
Relative|Oropharyngeal cancer|2015–2019|Males|3|85+|||
Relative|Oropharyngeal cancer|2015–2019|Males|3|All ages combined|0.778|0.762|0.794
Relative|Oropharyngeal cancer|2015–2019|Males|4|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Males|4|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Males|4|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Males|4|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Males|4|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Males|4|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Males|4|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Males|4|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Males|4|40–44|0.843|0.756|0.902
Relative|Oropharyngeal cancer|2015–2019|Males|4|45–49|0.845|0.793|0.886
Relative|Oropharyngeal cancer|2015–2019|Males|4|50–54|0.829|0.787|0.864
Relative|Oropharyngeal cancer|2015–2019|Males|4|55–59|0.819|0.785|0.849
Relative|Oropharyngeal cancer|2015–2019|Males|4|60–64|0.776|0.734|0.813
Relative|Oropharyngeal cancer|2015–2019|Males|4|65–69|0.723|0.673|0.768
Relative|Oropharyngeal cancer|2015–2019|Males|4|70–74|0.591|0.522|0.656
Relative|Oropharyngeal cancer|2015–2019|Males|4|75–79|0.498|0.398|0.594
Relative|Oropharyngeal cancer|2015–2019|Males|4|80–84|0.406|0.272|0.549
Relative|Oropharyngeal cancer|2015–2019|Males|4|85+|||
Relative|Oropharyngeal cancer|2015–2019|Males|4|All ages combined|0.75|0.733|0.767
Relative|Oropharyngeal cancer|2015–2019|Males|5|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Males|5|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Males|5|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Males|5|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Males|5|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Males|5|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Males|5|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Males|5|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Males|5|40–44|0.828|0.739|0.89
Relative|Oropharyngeal cancer|2015–2019|Males|5|45–49|0.843|0.79|0.885
Relative|Oropharyngeal cancer|2015–2019|Males|5|50–54|0.82|0.777|0.856
Relative|Oropharyngeal cancer|2015–2019|Males|5|55–59|0.805|0.769|0.837
Relative|Oropharyngeal cancer|2015–2019|Males|5|60–64|0.742|0.697|0.783
Relative|Oropharyngeal cancer|2015–2019|Males|5|65–69|0.717|0.665|0.764
Relative|Oropharyngeal cancer|2015–2019|Males|5|70–74|0.557|0.485|0.626
Relative|Oropharyngeal cancer|2015–2019|Males|5|75–79|0.446|0.343|0.548
Relative|Oropharyngeal cancer|2015–2019|Males|5|80–84|0.382|0.236|0.545
Relative|Oropharyngeal cancer|2015–2019|Males|5|85+|||
Relative|Oropharyngeal cancer|2015–2019|Males|5|All ages combined|0.733|0.714|0.75
Observed|Oropharyngeal cancer|2015–2019|Females|1|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Females|1|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Females|1|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Females|1|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Females|1|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Females|1|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Females|1|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Females|1|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Females|1|40–44|||
Observed|Oropharyngeal cancer|2015–2019|Females|1|45–49|0.918|0.813|0.965
Observed|Oropharyngeal cancer|2015–2019|Females|1|50–54|0.935|0.85|0.972
Observed|Oropharyngeal cancer|2015–2019|Females|1|55–59|0.926|0.862|0.961
Observed|Oropharyngeal cancer|2015–2019|Females|1|60–64|0.906|0.832|0.948
Observed|Oropharyngeal cancer|2015–2019|Females|1|65–69|0.813|0.713|0.881
Observed|Oropharyngeal cancer|2015–2019|Females|1|70–74|0.825|0.707|0.899
Observed|Oropharyngeal cancer|2015–2019|Females|1|75–79|0.735|0.553|0.852
Observed|Oropharyngeal cancer|2015–2019|Females|1|80–84|0.667|0.459|0.81
Observed|Oropharyngeal cancer|2015–2019|Females|1|85+|||
Observed|Oropharyngeal cancer|2015–2019|Females|1|All ages combined|0.843|0.813|0.87
Observed|Oropharyngeal cancer|2015–2019|Females|2|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|40–44|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|45–49|0.884|0.773|0.943
Observed|Oropharyngeal cancer|2015–2019|Females|2|50–54|0.882|0.785|0.937
Observed|Oropharyngeal cancer|2015–2019|Females|2|55–59|0.867|0.788|0.918
Observed|Oropharyngeal cancer|2015–2019|Females|2|60–64|0.808|0.718|0.872
Observed|Oropharyngeal cancer|2015–2019|Females|2|65–69|0.778|0.675|0.852
Observed|Oropharyngeal cancer|2015–2019|Females|2|70–74|0.678|0.541|0.781
Observed|Oropharyngeal cancer|2015–2019|Females|2|75–79|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|80–84|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|85+|||
Observed|Oropharyngeal cancer|2015–2019|Females|2|All ages combined|0.771|0.736|0.802
Observed|Oropharyngeal cancer|2015–2019|Females|3|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|40–44|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|45–49|0.835|0.715|0.908
Observed|Oropharyngeal cancer|2015–2019|Females|3|50–54|0.869|0.77|0.927
Observed|Oropharyngeal cancer|2015–2019|Females|3|55–59|0.845|0.762|0.901
Observed|Oropharyngeal cancer|2015–2019|Females|3|60–64|0.788|0.696|0.855
Observed|Oropharyngeal cancer|2015–2019|Females|3|65–69|0.765|0.66|0.841
Observed|Oropharyngeal cancer|2015–2019|Females|3|70–74|0.639|0.5|0.749
Observed|Oropharyngeal cancer|2015–2019|Females|3|75–79|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|80–84|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|85+|||
Observed|Oropharyngeal cancer|2015–2019|Females|3|All ages combined|0.745|0.708|0.778
Observed|Oropharyngeal cancer|2015–2019|Females|4|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|40–44|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|45–49|0.835|0.715|0.908
Observed|Oropharyngeal cancer|2015–2019|Females|4|50–54|0.83|0.726|0.898
Observed|Oropharyngeal cancer|2015–2019|Females|4|55–59|0.812|0.723|0.875
Observed|Oropharyngeal cancer|2015–2019|Females|4|60–64|0.747|0.651|0.82
Observed|Oropharyngeal cancer|2015–2019|Females|4|65–69|0.738|0.63|0.819
Observed|Oropharyngeal cancer|2015–2019|Females|4|70–74|0.595|0.453|0.712
Observed|Oropharyngeal cancer|2015–2019|Females|4|75–79|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|80–84|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|85+|||
Observed|Oropharyngeal cancer|2015–2019|Females|4|All ages combined|0.706|0.668|0.741
Observed|Oropharyngeal cancer|2015–2019|Females|5|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|40–44|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|45–49|0.816|0.692|0.894
Observed|Oropharyngeal cancer|2015–2019|Females|5|50–54|0.803|0.694|0.876
Observed|Oropharyngeal cancer|2015–2019|Females|5|55–59|0.8|0.708|0.866
Observed|Oropharyngeal cancer|2015–2019|Females|5|60–64|0.735|0.637|0.81
Observed|Oropharyngeal cancer|2015–2019|Females|5|65–69|0.723|0.612|0.807
Observed|Oropharyngeal cancer|2015–2019|Females|5|70–74|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|75–79|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|80–84|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|85+|||
Observed|Oropharyngeal cancer|2015–2019|Females|5|All ages combined|0.678|0.639|0.715
Relative|Oropharyngeal cancer|2015–2019|Females|1|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Females|1|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Females|1|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Females|1|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Females|1|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Females|1|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Females|1|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Females|1|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Females|1|40–44|||
Relative|Oropharyngeal cancer|2015–2019|Females|1|45–49|0.919|0.815|0.966
Relative|Oropharyngeal cancer|2015–2019|Females|1|50–54|0.937|0.852|0.974
Relative|Oropharyngeal cancer|2015–2019|Females|1|55–59|0.929|0.865|0.964
Relative|Oropharyngeal cancer|2015–2019|Females|1|60–64|0.91|0.836|0.953
Relative|Oropharyngeal cancer|2015–2019|Females|1|65–69|0.819|0.719|0.887
Relative|Oropharyngeal cancer|2015–2019|Females|1|70–74|0.835|0.716|0.91
Relative|Oropharyngeal cancer|2015–2019|Females|1|75–79|0.752|0.566|0.871
Relative|Oropharyngeal cancer|2015–2019|Females|1|80–84|0.695|0.479|0.844
Relative|Oropharyngeal cancer|2015–2019|Females|1|85+|||
Relative|Oropharyngeal cancer|2015–2019|Females|1|All ages combined|0.853|0.822|0.88
Relative|Oropharyngeal cancer|2015–2019|Females|2|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|40–44|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|45–49|0.887|0.775|0.946
Relative|Oropharyngeal cancer|2015–2019|Females|2|50–54|0.886|0.788|0.941
Relative|Oropharyngeal cancer|2015–2019|Females|2|55–59|0.872|0.793|0.924
Relative|Oropharyngeal cancer|2015–2019|Females|2|60–64|0.816|0.725|0.88
Relative|Oropharyngeal cancer|2015–2019|Females|2|65–69|0.79|0.685|0.866
Relative|Oropharyngeal cancer|2015–2019|Females|2|70–74|0.695|0.555|0.802
Relative|Oropharyngeal cancer|2015–2019|Females|2|75–79|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|80–84|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|85+|||
Relative|Oropharyngeal cancer|2015–2019|Females|2|All ages combined|0.787|0.751|0.819
Relative|Oropharyngeal cancer|2015–2019|Females|3|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|40–44|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|45–49|0.839|0.719|0.912
Relative|Oropharyngeal cancer|2015–2019|Females|3|50–54|0.875|0.776|0.934
Relative|Oropharyngeal cancer|2015–2019|Females|3|55–59|0.854|0.769|0.91
Relative|Oropharyngeal cancer|2015–2019|Females|3|60–64|0.8|0.707|0.868
Relative|Oropharyngeal cancer|2015–2019|Females|3|65–69|0.784|0.676|0.862
Relative|Oropharyngeal cancer|2015–2019|Females|3|70–74|0.666|0.521|0.78
Relative|Oropharyngeal cancer|2015–2019|Females|3|75–79|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|80–84|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|85+|||
Relative|Oropharyngeal cancer|2015–2019|Females|3|All ages combined|0.767|0.729|0.8
Relative|Oropharyngeal cancer|2015–2019|Females|4|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|40–44|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|45–49|0.841|0.72|0.914
Relative|Oropharyngeal cancer|2015–2019|Females|4|50–54|0.838|0.733|0.907
Relative|Oropharyngeal cancer|2015–2019|Females|4|55–59|0.824|0.734|0.888
Relative|Oropharyngeal cancer|2015–2019|Females|4|60–64|0.763|0.665|0.838
Relative|Oropharyngeal cancer|2015–2019|Females|4|65–69|0.764|0.652|0.848
Relative|Oropharyngeal cancer|2015–2019|Females|4|70–74|0.63|0.48|0.753
Relative|Oropharyngeal cancer|2015–2019|Females|4|75–79|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|80–84|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|85+|||
Relative|Oropharyngeal cancer|2015–2019|Females|4|All ages combined|0.733|0.693|0.769
Relative|Oropharyngeal cancer|2015–2019|Females|5|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|40–44|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|45–49|0.823|0.698|0.901
Relative|Oropharyngeal cancer|2015–2019|Females|5|50–54|0.813|0.703|0.887
Relative|Oropharyngeal cancer|2015–2019|Females|5|55–59|0.815|0.722|0.882
Relative|Oropharyngeal cancer|2015–2019|Females|5|60–64|0.755|0.654|0.832
Relative|Oropharyngeal cancer|2015–2019|Females|5|65–69|0.756|0.64|0.844
Relative|Oropharyngeal cancer|2015–2019|Females|5|70–74|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|75–79|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|80–84|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|85+|||
Relative|Oropharyngeal cancer|2015–2019|Females|5|All ages combined|0.71|0.669|0.748
Observed|Oropharyngeal cancer|2015–2019|Persons|1|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Persons|1|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Persons|1|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Persons|1|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Persons|1|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Persons|1|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Persons|1|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Persons|1|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Persons|1|40–44|0.926|0.858|0.963
Observed|Oropharyngeal cancer|2015–2019|Persons|1|45–49|0.93|0.896|0.953
Observed|Oropharyngeal cancer|2015–2019|Persons|1|50–54|0.944|0.92|0.961
Observed|Oropharyngeal cancer|2015–2019|Persons|1|55–59|0.916|0.894|0.933
Observed|Oropharyngeal cancer|2015–2019|Persons|1|60–64|0.908|0.884|0.928
Observed|Oropharyngeal cancer|2015–2019|Persons|1|65–69|0.826|0.792|0.855
Observed|Oropharyngeal cancer|2015–2019|Persons|1|70–74|0.793|0.747|0.831
Observed|Oropharyngeal cancer|2015–2019|Persons|1|75–79|0.701|0.625|0.764
Observed|Oropharyngeal cancer|2015–2019|Persons|1|80–84|0.574|0.473|0.663
Observed|Oropharyngeal cancer|2015–2019|Persons|1|85+|0.398|0.288|0.505
Observed|Oropharyngeal cancer|2015–2019|Persons|1|All ages combined|0.866|0.855|0.877
Observed|Oropharyngeal cancer|2015–2019|Persons|2|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Persons|2|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Persons|2|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Persons|2|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Persons|2|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Persons|2|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Persons|2|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Persons|2|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Persons|2|40–44|0.887|0.813|0.933
Observed|Oropharyngeal cancer|2015–2019|Persons|2|45–49|0.876|0.835|0.907
Observed|Oropharyngeal cancer|2015–2019|Persons|2|50–54|0.899|0.869|0.922
Observed|Oropharyngeal cancer|2015–2019|Persons|2|55–59|0.865|0.839|0.887
Observed|Oropharyngeal cancer|2015–2019|Persons|2|60–64|0.834|0.803|0.86
Observed|Oropharyngeal cancer|2015–2019|Persons|2|65–69|0.77|0.732|0.803
Observed|Oropharyngeal cancer|2015–2019|Persons|2|70–74|0.677|0.624|0.724
Observed|Oropharyngeal cancer|2015–2019|Persons|2|75–79|0.572|0.492|0.643
Observed|Oropharyngeal cancer|2015–2019|Persons|2|80–84|0.447|0.35|0.54
Observed|Oropharyngeal cancer|2015–2019|Persons|2|85+|0.2|0.117|0.3
Observed|Oropharyngeal cancer|2015–2019|Persons|2|All ages combined|0.796|0.783|0.809
Observed|Oropharyngeal cancer|2015–2019|Persons|3|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Persons|3|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Persons|3|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Persons|3|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Persons|3|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Persons|3|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Persons|3|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Persons|3|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Persons|3|40–44|0.857|0.78|0.909
Observed|Oropharyngeal cancer|2015–2019|Persons|3|45–49|0.85|0.806|0.885
Observed|Oropharyngeal cancer|2015–2019|Persons|3|50–54|0.856|0.822|0.884
Observed|Oropharyngeal cancer|2015–2019|Persons|3|55–59|0.826|0.797|0.851
Observed|Oropharyngeal cancer|2015–2019|Persons|3|60–64|0.79|0.757|0.82
Observed|Oropharyngeal cancer|2015–2019|Persons|3|65–69|0.726|0.685|0.762
Observed|Oropharyngeal cancer|2015–2019|Persons|3|70–74|0.604|0.549|0.655
Observed|Oropharyngeal cancer|2015–2019|Persons|3|75–79|0.493|0.415|0.567
Observed|Oropharyngeal cancer|2015–2019|Persons|3|80–84|0.405|0.309|0.498
Observed|Oropharyngeal cancer|2015–2019|Persons|3|85+|0.134|0.066|0.227
Observed|Oropharyngeal cancer|2015–2019|Persons|3|All ages combined|0.752|0.737|0.766
Observed|Oropharyngeal cancer|2015–2019|Persons|4|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Persons|4|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Persons|4|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Persons|4|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Persons|4|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Persons|4|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Persons|4|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Persons|4|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Persons|4|40–44|0.829|0.75|0.885
Observed|Oropharyngeal cancer|2015–2019|Persons|4|45–49|0.836|0.79|0.872
Observed|Oropharyngeal cancer|2015–2019|Persons|4|50–54|0.818|0.781|0.85
Observed|Oropharyngeal cancer|2015–2019|Persons|4|55–59|0.802|0.771|0.829
Observed|Oropharyngeal cancer|2015–2019|Persons|4|60–64|0.749|0.712|0.781
Observed|Oropharyngeal cancer|2015–2019|Persons|4|65–69|0.694|0.651|0.732
Observed|Oropharyngeal cancer|2015–2019|Persons|4|70–74|0.55|0.493|0.604
Observed|Oropharyngeal cancer|2015–2019|Persons|4|75–79|0.449|0.372|0.523
Observed|Oropharyngeal cancer|2015–2019|Persons|4|80–84|0.299|0.211|0.392
Observed|Oropharyngeal cancer|2015–2019|Persons|4|85+|0.084|0.032|0.167
Observed|Oropharyngeal cancer|2015–2019|Persons|4|All ages combined|0.716|0.701|0.731
Observed|Oropharyngeal cancer|2015–2019|Persons|5|00–04|||
Observed|Oropharyngeal cancer|2015–2019|Persons|5|05–09|||
Observed|Oropharyngeal cancer|2015–2019|Persons|5|10–14|||
Observed|Oropharyngeal cancer|2015–2019|Persons|5|15–19|||
Observed|Oropharyngeal cancer|2015–2019|Persons|5|20–24|||
Observed|Oropharyngeal cancer|2015–2019|Persons|5|25–29|||
Observed|Oropharyngeal cancer|2015–2019|Persons|5|30–34|||
Observed|Oropharyngeal cancer|2015–2019|Persons|5|35–39|||
Observed|Oropharyngeal cancer|2015–2019|Persons|5|40–44|0.815|0.735|0.873
Observed|Oropharyngeal cancer|2015–2019|Persons|5|45–49|0.829|0.782|0.866
Observed|Oropharyngeal cancer|2015–2019|Persons|5|50–54|0.803|0.765|0.836
Observed|Oropharyngeal cancer|2015–2019|Persons|5|55–59|0.783|0.751|0.811
Observed|Oropharyngeal cancer|2015–2019|Persons|5|60–64|0.713|0.675|0.748
Observed|Oropharyngeal cancer|2015–2019|Persons|5|65–69|0.677|0.634|0.717
Observed|Oropharyngeal cancer|2015–2019|Persons|5|70–74|0.494|0.435|0.55
Observed|Oropharyngeal cancer|2015–2019|Persons|5|75–79|0.374|0.299|0.448
Observed|Oropharyngeal cancer|2015–2019|Persons|5|80–84|0.265|0.177|0.36
Observed|Oropharyngeal cancer|2015–2019|Persons|5|85+|||
Observed|Oropharyngeal cancer|2015–2019|Persons|5|All ages combined|0.691|0.675|0.706
Relative|Oropharyngeal cancer|2015–2019|Persons|1|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Persons|1|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Persons|1|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Persons|1|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Persons|1|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Persons|1|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Persons|1|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Persons|1|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Persons|1|40–44|0.928|0.86|0.964
Relative|Oropharyngeal cancer|2015–2019|Persons|1|45–49|0.932|0.898|0.955
Relative|Oropharyngeal cancer|2015–2019|Persons|1|50–54|0.947|0.923|0.964
Relative|Oropharyngeal cancer|2015–2019|Persons|1|55–59|0.921|0.899|0.938
Relative|Oropharyngeal cancer|2015–2019|Persons|1|60–64|0.915|0.891|0.934
Relative|Oropharyngeal cancer|2015–2019|Persons|1|65–69|0.836|0.801|0.865
Relative|Oropharyngeal cancer|2015–2019|Persons|1|70–74|0.807|0.76|0.846
Relative|Oropharyngeal cancer|2015–2019|Persons|1|75–79|0.722|0.644|0.788
Relative|Oropharyngeal cancer|2015–2019|Persons|1|80–84|0.606|0.499|0.699
Relative|Oropharyngeal cancer|2015–2019|Persons|1|85+|0.453|0.329|0.575
Relative|Oropharyngeal cancer|2015–2019|Persons|1|All ages combined|0.876|0.865|0.887
Relative|Oropharyngeal cancer|2015–2019|Persons|2|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Persons|2|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Persons|2|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Persons|2|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Persons|2|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Persons|2|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Persons|2|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Persons|2|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Persons|2|40–44|0.89|0.815|0.936
Relative|Oropharyngeal cancer|2015–2019|Persons|2|45–49|0.88|0.839|0.912
Relative|Oropharyngeal cancer|2015–2019|Persons|2|50–54|0.905|0.875|0.929
Relative|Oropharyngeal cancer|2015–2019|Persons|2|55–59|0.874|0.848|0.896
Relative|Oropharyngeal cancer|2015–2019|Persons|2|60–64|0.847|0.816|0.874
Relative|Oropharyngeal cancer|2015–2019|Persons|2|65–69|0.788|0.749|0.822
Relative|Oropharyngeal cancer|2015–2019|Persons|2|70–74|0.703|0.648|0.752
Relative|Oropharyngeal cancer|2015–2019|Persons|2|75–79|0.61|0.525|0.686
Relative|Oropharyngeal cancer|2015–2019|Persons|2|80–84|0.501|0.392|0.605
Relative|Oropharyngeal cancer|2015–2019|Persons|2|85+|0.264|0.154|0.394
Relative|Oropharyngeal cancer|2015–2019|Persons|2|All ages combined|0.814|0.8|0.827
Relative|Oropharyngeal cancer|2015–2019|Persons|3|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Persons|3|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Persons|3|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Persons|3|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Persons|3|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Persons|3|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Persons|3|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Persons|3|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Persons|3|40–44|0.862|0.784|0.913
Relative|Oropharyngeal cancer|2015–2019|Persons|3|45–49|0.856|0.811|0.891
Relative|Oropharyngeal cancer|2015–2019|Persons|3|50–54|0.866|0.831|0.894
Relative|Oropharyngeal cancer|2015–2019|Persons|3|55–59|0.84|0.81|0.865
Relative|Oropharyngeal cancer|2015–2019|Persons|3|60–64|0.81|0.775|0.84
Relative|Oropharyngeal cancer|2015–2019|Persons|3|65–69|0.753|0.711|0.791
Relative|Oropharyngeal cancer|2015–2019|Persons|3|70–74|0.642|0.583|0.696
Relative|Oropharyngeal cancer|2015–2019|Persons|3|75–79|0.547|0.46|0.628
Relative|Oropharyngeal cancer|2015–2019|Persons|3|80–84|0.485|0.371|0.597
Relative|Oropharyngeal cancer|2015–2019|Persons|3|85+|0.204|0.1|0.345
Relative|Oropharyngeal cancer|2015–2019|Persons|3|All ages combined|0.776|0.761|0.791
Relative|Oropharyngeal cancer|2015–2019|Persons|4|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Persons|4|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Persons|4|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Persons|4|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Persons|4|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Persons|4|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Persons|4|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Persons|4|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Persons|4|40–44|0.835|0.756|0.891
Relative|Oropharyngeal cancer|2015–2019|Persons|4|45–49|0.844|0.798|0.881
Relative|Oropharyngeal cancer|2015–2019|Persons|4|50–54|0.831|0.793|0.862
Relative|Oropharyngeal cancer|2015–2019|Persons|4|55–59|0.82|0.788|0.848
Relative|Oropharyngeal cancer|2015–2019|Persons|4|60–64|0.774|0.737|0.808
Relative|Oropharyngeal cancer|2015–2019|Persons|4|65–69|0.73|0.686|0.771
Relative|Oropharyngeal cancer|2015–2019|Persons|4|70–74|0.599|0.536|0.657
Relative|Oropharyngeal cancer|2015–2019|Persons|4|75–79|0.519|0.429|0.604
Relative|Oropharyngeal cancer|2015–2019|Persons|4|80–84|0.388|0.273|0.509
Relative|Oropharyngeal cancer|2015–2019|Persons|4|85+|0.148|0.057|0.295
Relative|Oropharyngeal cancer|2015–2019|Persons|4|All ages combined|0.747|0.731|0.763
Relative|Oropharyngeal cancer|2015–2019|Persons|5|00–04|||
Relative|Oropharyngeal cancer|2015–2019|Persons|5|05–09|||
Relative|Oropharyngeal cancer|2015–2019|Persons|5|10–14|||
Relative|Oropharyngeal cancer|2015–2019|Persons|5|15–19|||
Relative|Oropharyngeal cancer|2015–2019|Persons|5|20–24|||
Relative|Oropharyngeal cancer|2015–2019|Persons|5|25–29|||
Relative|Oropharyngeal cancer|2015–2019|Persons|5|30–34|||
Relative|Oropharyngeal cancer|2015–2019|Persons|5|35–39|||
Relative|Oropharyngeal cancer|2015–2019|Persons|5|40–44|0.823|0.742|0.881
Relative|Oropharyngeal cancer|2015–2019|Persons|5|45–49|0.839|0.792|0.877
Relative|Oropharyngeal cancer|2015–2019|Persons|5|50–54|0.819|0.78|0.852
Relative|Oropharyngeal cancer|2015–2019|Persons|5|55–59|0.806|0.773|0.836
Relative|Oropharyngeal cancer|2015–2019|Persons|5|60–64|0.745|0.705|0.782
Relative|Oropharyngeal cancer|2015–2019|Persons|5|65–69|0.724|0.678|0.767
Relative|Oropharyngeal cancer|2015–2019|Persons|5|70–74|0.553|0.487|0.616
Relative|Oropharyngeal cancer|2015–2019|Persons|5|75–79|0.452|0.362|0.543
Relative|Oropharyngeal cancer|2015–2019|Persons|5|80–84|0.376|0.252|0.512
Relative|Oropharyngeal cancer|2015–2019|Persons|5|85+|||
Relative|Oropharyngeal cancer|2015–2019|Persons|5|All ages combined|0.729|0.712|0.745
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|60–64|0.258|0.152|0.378
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|65–69|0.335|0.229|0.445
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|70–74|0.158|0.094|0.236
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|75–79|0.099|0.054|0.16
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|80–84|0.154|0.09|0.235
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|85+|0.047|0.022|0.086
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|All ages combined|0.182|0.153|0.214
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|60–64|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|65–69|0.275|0.177|0.383
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|70–74|0.14|0.081|0.215
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|75–79|0.067|0.032|0.121
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|80–84|0.124|0.067|0.199
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|85+|0.02|0.007|0.047
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|All ages combined|0.143|0.117|0.171
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|60–64|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|65–69|0.237|0.143|0.345
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|70–74|0.099|0.052|0.164
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|75–79|0.043|0.017|0.09
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|80–84|0.109|0.056|0.184
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|85+|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|All ages combined|0.121|0.097|0.147
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|60–64|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|65–69|0.215|0.123|0.323
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|70–74|0.069|0.032|0.125
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|75–79|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|80–84|0.091|0.04|0.166
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|85+|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|All ages combined|0.104|0.081|0.129
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|60–64|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|65–69|0.215|0.123|0.323
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|70–74|0.051|0.021|0.102
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|75–79|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|80–84|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|85+|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|All ages combined|0.093|0.071|0.118
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|60–64|0.26|0.153|0.381
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|65–69|0.339|0.232|0.45
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|70–74|0.161|0.096|0.24
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|75–79|0.102|0.055|0.166
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|80–84|0.164|0.095|0.25
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|85+|0.054|0.025|0.099
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|1|All ages combined|0.19|0.16|0.223
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|60–64|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|65–69|0.282|0.182|0.392
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|70–74|0.146|0.085|0.224
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|75–79|0.072|0.034|0.13
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|80–84|0.14|0.076|0.225
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|85+|0.026|0.009|0.062
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|2|All ages combined|0.154|0.126|0.184
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|60–64|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|65–69|0.247|0.149|0.358
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|70–74|0.106|0.056|0.175
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|75–79|0.049|0.019|0.1
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|80–84|0.132|0.067|0.222
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|85+|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|3|All ages combined|0.133|0.107|0.162
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|60–64|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|65–69|0.227|0.13|0.341
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|70–74|0.075|0.035|0.137
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|75–79|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|80–84|0.118|0.053|0.216
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|85+|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|4|All ages combined|0.117|0.092|0.146
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|60–64|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|65–69|0.23|0.132|0.346
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|70–74|0.057|0.023|0.115
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|75–79|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|80–84|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|85+|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Males|5|All ages combined|0.108|0.083|0.137
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|60–64|0.471|0.297|0.626
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|65–69|0.289|0.173|0.416
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|70–74|0.202|0.108|0.317
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|75–79|0.099|0.049|0.169
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|80–84|0.074|0.034|0.137
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|85+|0.053|0.028|0.089
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|All ages combined|0.176|0.145|0.21
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|60–64|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|65–69|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|70–74|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|75–79|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|80–84|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|85+|0.034|0.016|0.062
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|All ages combined|0.128|0.101|0.157
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|60–64|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|65–69|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|70–74|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|75–79|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|80–84|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|85+|0.02|0.008|0.043
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|All ages combined|0.103|0.079|0.131
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|60–64|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|65–69|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|70–74|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|75–79|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|80–84|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|85+|0.02|0.008|0.043
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|All ages combined|0.092|0.069|0.118
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|60–64|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|65–69|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|70–74|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|75–79|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|80–84|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|85+|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|All ages combined|0.09|0.068|0.116
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|60–64|0.473|0.299|0.629
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|65–69|0.291|0.174|0.419
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|70–74|0.205|0.109|0.321
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|75–79|0.101|0.05|0.173
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|80–84|0.078|0.035|0.143
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|85+|0.06|0.032|0.101
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|1|All ages combined|0.184|0.151|0.22
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|60–64|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|65–69|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|70–74|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|75–79|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|80–84|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|85+|0.043|0.021|0.08
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|2|All ages combined|0.137|0.109|0.169
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|60–64|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|65–69|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|70–74|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|75–79|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|80–84|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|85+|0.031|0.012|0.065
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|3|All ages combined|0.114|0.088|0.144
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|60–64|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|65–69|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|70–74|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|75–79|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|80–84|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|85+|0.035|0.014|0.073
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|4|All ages combined|0.104|0.079|0.134
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|60–64|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|65–69|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|70–74|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|75–79|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|80–84|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|85+|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Females|5|All ages combined|0.105|0.079|0.135
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|50–54|0.375|0.225|0.524
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|55–59|0.316|0.204|0.434
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|60–64|0.342|0.244|0.441
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|65–69|0.316|0.236|0.399
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|70–74|0.174|0.119|0.237
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|75–79|0.099|0.063|0.143
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|80–84|0.116|0.075|0.166
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|85+|0.05|0.031|0.075
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|All ages combined|0.18|0.158|0.203
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|55–59|0.26|0.16|0.373
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|60–64|0.275|0.188|0.369
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|65–69|0.229|0.159|0.306
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|70–74|0.134|0.087|0.192
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|75–79|0.069|0.04|0.107
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|80–84|0.089|0.054|0.134
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|85+|0.028|0.015|0.046
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|All ages combined|0.136|0.117|0.156
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|60–64|0.254|0.17|0.346
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|65–69|0.18|0.117|0.254
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|70–74|0.101|0.061|0.152
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|75–79|0.044|0.021|0.079
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|80–84|0.071|0.04|0.113
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|85+|0.02|0.01|0.036
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|All ages combined|0.113|0.095|0.132
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|60–64|0.231|0.151|0.322
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|65–69|0.148|0.09|0.22
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|70–74|0.077|0.043|0.124
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|75–79|0.044|0.021|0.079
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|80–84|0.046|0.022|0.084
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|85+|0.017|0.008|0.033
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|All ages combined|0.098|0.082|0.116
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|00–04|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|05–09|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|10–14|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|15–19|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|20–24|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|25–29|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|30–34|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|35–39|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|40–44|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|45–49|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|50–54|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|55–59|||
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|60–64|0.231|0.151|0.322
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|65–69|0.148|0.09|0.22
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|70–74|0.064|0.033|0.108
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|75–79|0.039|0.018|0.073
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|80–84|0.039|0.017|0.076
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|85+|0.015|0.006|0.03
Observed|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|All ages combined|0.092|0.076|0.11
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|50–54|0.376|0.226|0.526
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|55–59|0.318|0.205|0.436
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|60–64|0.344|0.246|0.444
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|65–69|0.319|0.238|0.403
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|70–74|0.177|0.121|0.241
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|75–79|0.102|0.065|0.147
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|80–84|0.122|0.079|0.175
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|85+|0.057|0.036|0.086
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|1|All ages combined|0.187|0.165|0.211
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|55–59|0.263|0.161|0.376
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|60–64|0.279|0.19|0.374
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|65–69|0.233|0.163|0.312
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|70–74|0.139|0.09|0.199
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|75–79|0.073|0.043|0.114
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|80–84|0.098|0.06|0.149
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|85+|0.036|0.02|0.061
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|2|All ages combined|0.146|0.126|0.168
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|60–64|0.259|0.174|0.354
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|65–69|0.186|0.12|0.262
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|70–74|0.107|0.064|0.161
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|75–79|0.049|0.023|0.087
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|80–84|0.084|0.047|0.134
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|85+|0.03|0.015|0.054
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|3|All ages combined|0.124|0.105|0.145
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|60–64|0.238|0.155|0.331
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|65–69|0.155|0.094|0.231
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|70–74|0.084|0.047|0.134
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|75–79|0.05|0.024|0.091
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|80–84|0.058|0.027|0.106
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|85+|0.031|0.014|0.057
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|4|All ages combined|0.111|0.093|0.132
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|00–04|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|05–09|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|10–14|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|15–19|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|20–24|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|25–29|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|30–34|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|35–39|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|40–44|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|45–49|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|50–54|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|55–59|||
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|60–64|0.24|0.156|0.333
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|65–69|0.158|0.096|0.234
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|70–74|0.071|0.037|0.121
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|75–79|0.047|0.022|0.088
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|80–84|0.053|0.023|0.103
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|85+|0.03|0.013|0.06
Relative|Other and ill-defined digestive organs (cancer of)|2015–2019|Persons|5|All ages combined|0.107|0.089|0.128
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|55–59|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|60–64|0.791|0.626|0.89
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|65–69|0.833|0.665|0.921
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|70–74|0.744|0.553|0.862
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|75–79|0.658|0.47|0.793
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|80–84|0.718|0.54|0.837
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|85+|0.578|0.418|0.708
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|1|All ages combined|0.767|0.714|0.812
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|55–59|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|60–64|0.726|0.548|0.843
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|65–69|0.767|0.587|0.877
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|80–84|0.587|0.413|0.726
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|85+|0.473|0.317|0.614
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|2|All ages combined|0.673|0.614|0.724
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|55–59|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|60–64|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|65–69|0.767|0.587|0.877
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|80–84|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|85+|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|3|All ages combined|0.627|0.566|0.681
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|55–59|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|60–64|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|65–69|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|80–84|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|85+|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|4|All ages combined|0.604|0.543|0.66
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|55–59|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|60–64|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|65–69|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|80–84|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|85+|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Males|5|All ages combined|0.578|0.515|0.636
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|55–59|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|60–64|0.798|0.631|0.897
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|65–69|0.843|0.673|0.932
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|70–74|0.758|0.564|0.879
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|75–79|0.68|0.485|0.82
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|80–84|0.763|0.574|0.889
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|85+|0.668|0.484|0.819
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|1|All ages combined|0.797|0.742|0.843
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|55–59|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|60–64|0.738|0.558|0.857
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|65–69|0.787|0.602|0.899
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|80–84|0.67|0.471|0.829
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|85+|0.635|0.426|0.824
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|2|All ages combined|0.723|0.66|0.778
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|55–59|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|60–64|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|65–69|0.798|0.611|0.912
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|80–84|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|85+|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|3|All ages combined|0.697|0.63|0.758
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|55–59|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|60–64|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|65–69|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|80–84|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|85+|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|4|All ages combined|0.693|0.623|0.758
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|55–59|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|60–64|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|65–69|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|80–84|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|85+|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Males|5|All ages combined|0.685|0.61|0.753
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|55–59|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|60–64|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|65–69|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|80–84|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|85+|0.667|0.53|0.772
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|1|All ages combined|0.783|0.718|0.834
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|55–59|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|60–64|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|65–69|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|80–84|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|85+|0.522|0.381|0.646
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|2|All ages combined|0.705|0.634|0.766
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|55–59|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|60–64|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|65–69|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|80–84|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|85+|0.454|0.314|0.583
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|3|All ages combined|0.659|0.584|0.724
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|55–59|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|60–64|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|65–69|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|80–84|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|85+|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|4|All ages combined|0.613|0.535|0.682
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|55–59|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|60–64|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|65–69|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|80–84|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|85+|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Females|5|All ages combined|0.613|0.535|0.682
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|55–59|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|60–64|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|65–69|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|80–84|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|85+|0.766|0.608|0.887
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|1|All ages combined|0.823|0.754|0.877
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|55–59|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|60–64|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|65–69|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|80–84|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|85+|0.684|0.499|0.845
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|2|All ages combined|0.771|0.693|0.836
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|55–59|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|60–64|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|65–69|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|80–84|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|85+|0.695|0.481|0.894
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|3|All ages combined|0.749|0.664|0.823
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|55–59|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|60–64|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|65–69|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|80–84|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|85+|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|4|All ages combined|0.726|0.633|0.808
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|55–59|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|60–64|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|65–69|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|80–84|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|85+|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Females|5|All ages combined|0.749|0.654|0.834
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|50–54|0.924|0.729|0.98
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|55–59|0.821|0.644|0.915
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|60–64|0.799|0.666|0.883
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|65–69|0.827|0.694|0.906
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|70–74|0.734|0.588|0.836
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|75–79|0.735|0.594|0.833
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|80–84|0.735|0.6|0.831
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|85+|0.629|0.527|0.714
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|All ages combined|0.773|0.733|0.808
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|50–54|0.884|0.683|0.961
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|55–59|0.79|0.609|0.894
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|60–64|0.733|0.591|0.833
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|65–69|0.738|0.591|0.839
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|70–74|0.687|0.535|0.798
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|75–79|0.57|0.418|0.697
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|80–84|0.594|0.455|0.708
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|85+|0.501|0.397|0.597
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|All ages combined|0.686|0.641|0.726
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|50–54|0.884|0.683|0.961
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|55–59|0.79|0.609|0.894
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|60–64|0.733|0.591|0.833
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|65–69|0.715|0.565|0.821
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|70–74|0.687|0.535|0.798
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|80–84|0.521|0.384|0.641
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|85+|0.384|0.284|0.482
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|All ages combined|0.64|0.593|0.682
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|55–59|0.79|0.609|0.894
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|60–64|0.733|0.591|0.833
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|65–69|0.664|0.508|0.78
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|80–84|0.503|0.367|0.624
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|85+|0.291|0.196|0.392
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|All ages combined|0.608|0.56|0.652
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|00–04|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|05–09|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|10–14|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|15–19|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|20–24|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|25–29|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|30–34|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|35–39|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|40–44|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|45–49|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|50–54|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|55–59|0.756|0.57|0.87
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|60–64|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|65–69|0.664|0.508|0.78
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|70–74|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|75–79|||
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|80–84|0.466|0.332|0.589
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|85+|0.268|0.173|0.372
Observed|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|All ages combined|0.592|0.543|0.637
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|50–54|0.927|0.731|0.983
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|55–59|0.825|0.647|0.919
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|60–64|0.804|0.671|0.889
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|65–69|0.836|0.702|0.916
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|70–74|0.747|0.598|0.85
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|75–79|0.756|0.612|0.858
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|80–84|0.776|0.634|0.877
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|85+|0.724|0.607|0.823
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|1|All ages combined|0.807|0.765|0.843
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|50–54|0.89|0.687|0.967
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|55–59|0.797|0.615|0.902
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|60–64|0.744|0.599|0.845
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|65–69|0.755|0.605|0.858
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|70–74|0.712|0.554|0.827
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|75–79|0.606|0.444|0.741
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|80–84|0.667|0.511|0.796
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|85+|0.663|0.525|0.789
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|2|All ages combined|0.742|0.694|0.785
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|50–54|0.893|0.69|0.971
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|55–59|0.801|0.618|0.907
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|60–64|0.75|0.604|0.852
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|65–69|0.74|0.585|0.85
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|70–74|0.727|0.566|0.845
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|80–84|0.627|0.462|0.772
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|85+|0.594|0.441|0.746
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|3|All ages combined|0.718|0.666|0.765
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|55–59|0.806|0.622|0.912
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|60–64|0.757|0.61|0.86
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|65–69|0.697|0.533|0.819
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|80–84|0.655|0.478|0.813
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|85+|0.533|0.36|0.719
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|4|All ages combined|0.706|0.651|0.758
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|00–04|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|05–09|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|10–14|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|15–19|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|20–24|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|25–29|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|30–34|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|35–39|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|40–44|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|45–49|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|50–54|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|55–59|0.777|0.586|0.894
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|60–64|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|65–69|0.708|0.542|0.832
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|70–74|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|75–79|||
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|80–84|0.663|0.473|0.839
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|85+|0.584|0.377|0.81
Relative|Other and ill-defined sites (cancer of)|2015–2019|Persons|5|All ages combined|0.71|0.651|0.764
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|60–64|0.706|0.524|0.829
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|65–69|0.539|0.375|0.677
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|70–74|0.558|0.392|0.696
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|All ages combined|0.583|0.513|0.646
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|60–64|0.544|0.369|0.689
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|65–69|0.481|0.326|0.621
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|All ages combined|0.473|0.406|0.537
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|60–64|0.494|0.325|0.642
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|65–69|0.417|0.27|0.557
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|All ages combined|0.395|0.331|0.459
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|60–64|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|65–69|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|All ages combined|0.36|0.298|0.422
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|60–64|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|65–69|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|All ages combined|0.337|0.277|0.399
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|60–64|0.712|0.528|0.836
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|65–69|0.545|0.379|0.685
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|70–74|0.569|0.399|0.709
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|1|All ages combined|0.598|0.526|0.662
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|60–64|0.553|0.375|0.701
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|65–69|0.494|0.334|0.637
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|2|All ages combined|0.493|0.423|0.56
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|60–64|0.507|0.334|0.659
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|65–69|0.434|0.281|0.58
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|3|All ages combined|0.419|0.351|0.486
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|60–64|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|65–69|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|4|All ages combined|0.387|0.321|0.455
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|60–64|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|65–69|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Males|5|All ages combined|0.37|0.304|0.437
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|60–64|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|65–69|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|All ages combined|0.562|0.426|0.678
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|60–64|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|65–69|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|All ages combined|0.476|0.348|0.594
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|60–64|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|65–69|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|All ages combined|0.37|0.253|0.487
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|60–64|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|65–69|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|All ages combined|0.356|0.241|0.473
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|60–64|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|65–69|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|All ages combined|0.304|0.199|0.417
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|60–64|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|65–69|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|1|All ages combined|0.577|0.438|0.695
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|60–64|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|65–69|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|2|All ages combined|0.497|0.363|0.619
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|60–64|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|65–69|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|3|All ages combined|0.392|0.268|0.516
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|60–64|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|65–69|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|4|All ages combined|0.382|0.259|0.507
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|60–64|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|65–69|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Females|5|All ages combined|0.331|0.216|0.453
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|55–59|0.693|0.495|0.827
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|60–64|0.712|0.557|0.821
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|65–69|0.566|0.41|0.696
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|70–74|0.553|0.404|0.68
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|All ages combined|0.578|0.517|0.635
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|55–59|0.602|0.409|0.75
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|60–64|0.549|0.397|0.677
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|65–69|0.516|0.366|0.647
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|70–74|0.424|0.283|0.558
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|All ages combined|0.474|0.415|0.531
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|55–59|0.549|0.363|0.702
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|60–64|0.467|0.322|0.6
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|65–69|0.445|0.304|0.577
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|All ages combined|0.39|0.334|0.446
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|55–59|0.504|0.326|0.657
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|60–64|0.411|0.273|0.543
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|65–69|0.41|0.274|0.541
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|All ages combined|0.359|0.304|0.414
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|00–04|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|05–09|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|10–14|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|15–19|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|20–24|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|25–29|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|30–34|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|35–39|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|40–44|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|45–49|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|50–54|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|55–59|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|60–64|0.395|0.261|0.527
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|65–69|0.36|0.233|0.489
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|70–74|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|75–79|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|80–84|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|85+|||
Observed|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|All ages combined|0.33|0.277|0.384
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|55–59|0.697|0.497|0.831
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|60–64|0.717|0.561|0.827
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|65–69|0.573|0.415|0.704
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|70–74|0.563|0.411|0.692
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|1|All ages combined|0.593|0.53|0.651
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|55–59|0.608|0.413|0.758
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|60–64|0.557|0.403|0.687
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|65–69|0.528|0.374|0.662
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|70–74|0.44|0.294|0.579
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|2|All ages combined|0.494|0.432|0.554
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|55–59|0.558|0.369|0.713
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|60–64|0.479|0.33|0.614
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|65–69|0.462|0.316|0.599
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|3|All ages combined|0.413|0.353|0.473
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|55–59|0.515|0.333|0.672
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|60–64|0.424|0.282|0.562
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|65–69|0.432|0.288|0.57
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|4|All ages combined|0.386|0.327|0.446
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|00–04|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|05–09|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|10–14|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|15–19|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|20–24|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|25–29|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|30–34|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|35–39|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|40–44|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|45–49|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|50–54|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|55–59|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|60–64|0.413|0.272|0.551
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|65–69|0.386|0.25|0.524
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|70–74|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|75–79|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|80–84|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|85+|||
Relative|Other and ill-defined sites in the lip, oral cavity and pharynx (cancer of)|2015–2019|Persons|5|All ages combined|0.362|0.304|0.421
Observed|Other and unspecified leukaemia|2015–2019|Males|1|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Males|1|All ages combined|0.336|0.253|0.421
Observed|Other and unspecified leukaemia|2015–2019|Males|2|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Males|2|All ages combined|0.275|0.201|0.355
Observed|Other and unspecified leukaemia|2015–2019|Males|3|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Males|3|All ages combined|0.246|0.175|0.323
Observed|Other and unspecified leukaemia|2015–2019|Males|4|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Males|4|All ages combined|0.224|0.154|0.301
Observed|Other and unspecified leukaemia|2015–2019|Males|5|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Males|5|All ages combined|0.224|0.154|0.301
Relative|Other and unspecified leukaemia|2015–2019|Males|1|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Males|1|All ages combined|0.353|0.266|0.442
Relative|Other and unspecified leukaemia|2015–2019|Males|2|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Males|2|All ages combined|0.295|0.215|0.38
Relative|Other and unspecified leukaemia|2015–2019|Males|3|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Males|3|All ages combined|0.267|0.19|0.351
Relative|Other and unspecified leukaemia|2015–2019|Males|4|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Males|4|All ages combined|0.247|0.17|0.332
Relative|Other and unspecified leukaemia|2015–2019|Males|5|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Males|5|All ages combined|0.249|0.172|0.335
Observed|Other and unspecified leukaemia|2015–2019|Females|1|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Females|1|All ages combined|0.185|0.114|0.27
Observed|Other and unspecified leukaemia|2015–2019|Females|2|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Females|2|All ages combined|0.178|0.109|0.261
Observed|Other and unspecified leukaemia|2015–2019|Females|3|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Females|3|All ages combined|0.156|0.093|0.235
Observed|Other and unspecified leukaemia|2015–2019|Females|4|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Females|4|All ages combined|0.149|0.088|0.226
Observed|Other and unspecified leukaemia|2015–2019|Females|5|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Females|5|All ages combined|0.142|0.083|0.217
Relative|Other and unspecified leukaemia|2015–2019|Females|1|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Females|1|All ages combined|0.195|0.12|0.285
Relative|Other and unspecified leukaemia|2015–2019|Females|2|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Females|2|All ages combined|0.191|0.117|0.28
Relative|Other and unspecified leukaemia|2015–2019|Females|3|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Females|3|All ages combined|0.17|0.101|0.256
Relative|Other and unspecified leukaemia|2015–2019|Females|4|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Females|4|All ages combined|0.166|0.098|0.252
Relative|Other and unspecified leukaemia|2015–2019|Females|5|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Females|5|All ages combined|0.164|0.095|0.25
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|1|All ages combined|0.273|0.214|0.334
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|2|All ages combined|0.237|0.183|0.295
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|3|All ages combined|0.21|0.159|0.265
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|4|All ages combined|0.196|0.146|0.25
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|00–04|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|05–09|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|10–14|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|15–19|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|20–24|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|25–29|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|30–34|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|35–39|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|40–44|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|45–49|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|50–54|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|55–59|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|60–64|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|65–69|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|70–74|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|75–79|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|80–84|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|85+|||
Observed|Other and unspecified leukaemia|2015–2019|Persons|5|All ages combined|0.19|0.142|0.245
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|1|All ages combined|0.287|0.225|0.352
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|2|All ages combined|0.254|0.196|0.316
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|3|All ages combined|0.228|0.173|0.289
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|4|All ages combined|0.217|0.162|0.278
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|00–04|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|05–09|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|10–14|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|15–19|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|20–24|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|25–29|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|30–34|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|35–39|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|40–44|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|45–49|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|50–54|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|55–59|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|60–64|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|65–69|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|70–74|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|75–79|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|80–84|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|85+|||
Relative|Other and unspecified leukaemia|2015–2019|Persons|5|All ages combined|0.216|0.16|0.277
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|35–39|0.953|0.713|0.993
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|40–44|0.931|0.752|0.982
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|45–49|0.969|0.8|0.996
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|50–54|0.941|0.828|0.981
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|55–59|0.983|0.884|0.998
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|60–64|0.951|0.856|0.984
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|65–69|0.907|0.815|0.955
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|70–74|0.888|0.789|0.942
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|75–79|0.902|0.78|0.958
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|80–84|0.631|0.46|0.762
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|85+|0.629|0.442|0.769
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|All ages combined|0.892|0.863|0.916
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|35–39|0.953|0.713|0.993
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|40–44|0.931|0.752|0.982
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|45–49|0.936|0.767|0.984
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|50–54|0.905|0.787|0.959
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|55–59|0.897|0.785|0.952
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|60–64|0.904|0.798|0.955
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|65–69|0.881|0.784|0.936
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|70–74|0.862|0.759|0.923
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|75–79|0.825|0.691|0.905
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|80–84|0.57|0.405|0.705
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|All ages combined|0.843|0.81|0.871
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|35–39|0.953|0.713|0.993
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|40–44|0.931|0.752|0.982
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|45–49|0.936|0.767|0.984
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|50–54|0.905|0.787|0.959
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|55–59|0.897|0.785|0.952
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|60–64|0.855|0.74|0.922
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|65–69|0.834|0.731|0.9
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|70–74|0.793|0.681|0.87
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|75–79|0.696|0.553|0.801
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|80–84|0.515|0.357|0.651
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|All ages combined|0.8|0.765|0.831
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|35–39|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|40–44|0.931|0.752|0.982
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|45–49|0.936|0.767|0.984
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|50–54|0.889|0.77|0.949
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|55–59|0.897|0.785|0.952
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|60–64|0.838|0.72|0.91
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|65–69|0.797|0.691|0.87
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|70–74|0.732|0.612|0.82
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|75–79|0.635|0.489|0.749
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|80–84|0.422|0.278|0.558
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|All ages combined|0.767|0.73|0.8
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|35–39|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|40–44|0.931|0.752|0.982
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|45–49|0.936|0.767|0.984
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|50–54|0.874|0.754|0.938
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|55–59|0.879|0.763|0.94
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|60–64|0.822|0.701|0.897
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|65–69|0.77|0.661|0.849
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|70–74|0.683|0.558|0.779
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|75–79|0.593|0.446|0.713
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|80–84|0.404|0.264|0.54
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|All ages combined|0.744|0.706|0.778
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|35–39|0.955|0.714|0.994
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|40–44|0.933|0.753|0.984
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|45–49|0.971|0.802|0.998
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|50–54|0.944|0.831|0.984
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|55–59|0.988|0.889|1.003
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|60–64|0.958|0.862|0.992
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|65–69|0.918|0.825|0.966
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|70–74|0.906|0.805|0.962
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|75–79|0.932|0.806|0.99
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|80–84|0.672|0.49|0.811
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|85+|0.732|0.514|0.894
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|1|All ages combined|0.912|0.882|0.935
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|35–39|0.956|0.714|0.996
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|40–44|0.934|0.755|0.986
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|45–49|0.94|0.771|0.988
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|50–54|0.912|0.793|0.966
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|55–59|0.907|0.793|0.963
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|60–64|0.919|0.811|0.971
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|65–69|0.904|0.805|0.961
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|70–74|0.899|0.791|0.963
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|75–79|0.884|0.741|0.97
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|80–84|0.652|0.463|0.807
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|2|All ages combined|0.879|0.845|0.908
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|35–39|0.957|0.715|0.997
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|40–44|0.936|0.756|0.987
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|45–49|0.943|0.773|0.991
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|50–54|0.916|0.796|0.97
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|55–59|0.912|0.798|0.969
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|60–64|0.878|0.759|0.946
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|65–69|0.868|0.761|0.937
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|70–74|0.848|0.728|0.93
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|75–79|0.776|0.617|0.894
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|80–84|0.639|0.443|0.808
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|3|All ages combined|0.852|0.814|0.884
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|35–39|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|40–44|0.938|0.758|0.99
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|45–49|0.946|0.775|0.994
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|50–54|0.903|0.782|0.964
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|55–59|0.918|0.804|0.975
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|60–64|0.87|0.747|0.944
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|65–69|0.843|0.731|0.921
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|70–74|0.804|0.672|0.901
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|75–79|0.742|0.571|0.875
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|80–84|0.574|0.379|0.76
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|4|All ages combined|0.833|0.793|0.869
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|35–39|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|40–44|0.94|0.759|0.992
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|45–49|0.949|0.777|0.997
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|50–54|0.893|0.77|0.958
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|55–59|0.907|0.787|0.97
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|60–64|0.862|0.736|0.941
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|65–69|0.83|0.711|0.914
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|70–74|0.774|0.633|0.883
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|75–79|0.731|0.55|0.878
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|80–84|0.611|0.399|0.816
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Males|5|All ages combined|0.825|0.783|0.863
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|35–39|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|40–44|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|45–49|0.951|0.702|0.993
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|50–54|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|55–59|0.871|0.651|0.956
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|60–64|0.902|0.728|0.967
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|65–69|0.94|0.782|0.985
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|70–74|0.938|0.773|0.984
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|75–79|0.795|0.6|0.902
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|80–84|0.69|0.491|0.825
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|All ages combined|0.846|0.798|0.883
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|35–39|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|40–44|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|45–49|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|50–54|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|55–59|0.871|0.651|0.956
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|60–64|0.812|0.629|0.911
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|65–69|0.879|0.709|0.953
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|70–74|0.867|0.683|0.948
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|75–79|0.736|0.542|0.858
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|80–84|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|All ages combined|0.794|0.742|0.836
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|35–39|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|40–44|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|45–49|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|50–54|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|55–59|0.794|0.575|0.909
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|60–64|0.784|0.601|0.891
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|65–69|0.815|0.633|0.912
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|70–74|0.8|0.608|0.905
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|75–79|0.706|0.512|0.834
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|80–84|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|All ages combined|0.747|0.692|0.793
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|35–39|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|40–44|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|45–49|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|50–54|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|55–59|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|60–64|0.754|0.568|0.868
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|65–69|0.815|0.633|0.912
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|70–74|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|75–79|0.674|0.48|0.809
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|80–84|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|All ages combined|0.717|0.66|0.766
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|35–39|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|40–44|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|45–49|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|50–54|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|55–59|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|60–64|0.721|0.532|0.844
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|65–69|0.815|0.633|0.912
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|70–74|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|75–79|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|80–84|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|All ages combined|0.664|0.605|0.717
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|35–39|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|40–44|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|45–49|0.953|0.703|0.994
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|50–54|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|55–59|0.874|0.653|0.959
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|60–64|0.907|0.731|0.972
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|65–69|0.947|0.787|0.992
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|70–74|0.949|0.783|0.996
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|75–79|0.812|0.613|0.921
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|80–84|0.719|0.511|0.859
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|1|All ages combined|0.862|0.813|0.899
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|35–39|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|40–44|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|45–49|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|50–54|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|55–59|0.877|0.656|0.963
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|60–64|0.82|0.635|0.92
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|65–69|0.893|0.72|0.968
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|70–74|0.89|0.701|0.973
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|75–79|0.771|0.567|0.898
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|80–84|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|2|All ages combined|0.822|0.769|0.866
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|35–39|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|40–44|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|45–49|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|50–54|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|55–59|0.802|0.581|0.918
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|60–64|0.796|0.61|0.904
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|65–69|0.835|0.649|0.935
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|70–74|0.834|0.634|0.944
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|75–79|0.759|0.55|0.897
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|80–84|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|3|All ages combined|0.788|0.73|0.837
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|35–39|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|40–44|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|45–49|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|50–54|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|55–59|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|60–64|0.77|0.58|0.887
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|65–69|0.843|0.655|0.944
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|70–74|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|75–79|0.747|0.532|0.897
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|80–84|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|4|All ages combined|0.772|0.711|0.825
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|35–39|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|40–44|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|45–49|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|50–54|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|55–59|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|60–64|0.741|0.547|0.868
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|65–69|0.853|0.662|0.955
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|70–74|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|75–79|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|80–84|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Females|5|All ages combined|0.73|0.665|0.788
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|35–39|0.966|0.785|0.995
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|40–44|0.934|0.808|0.978
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|45–49|0.962|0.857|0.99
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|50–54|0.93|0.839|0.97
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|55–59|0.951|0.874|0.981
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|60–64|0.935|0.86|0.97
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|65–69|0.917|0.847|0.956
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|70–74|0.904|0.828|0.947
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|75–79|0.862|0.766|0.921
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|80–84|0.657|0.531|0.756
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|85+|0.587|0.452|0.7
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|All ages combined|0.876|0.852|0.897
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|35–39|0.966|0.785|0.995
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|40–44|0.934|0.808|0.978
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|45–49|0.921|0.803|0.97
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|50–54|0.904|0.809|0.953
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|55–59|0.893|0.804|0.943
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|60–64|0.872|0.786|0.925
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|65–69|0.881|0.804|0.929
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|70–74|0.865|0.783|0.918
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|75–79|0.793|0.689|0.866
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|80–84|0.579|0.455|0.684
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|85+|0.456|0.327|0.575
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|All ages combined|0.826|0.799|0.85
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|35–39|0.966|0.785|0.995
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|40–44|0.934|0.808|0.978
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|45–49|0.902|0.781|0.958
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|50–54|0.904|0.809|0.953
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|55–59|0.871|0.778|0.926
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|60–64|0.831|0.74|0.893
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|65–69|0.829|0.745|0.887
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|70–74|0.797|0.706|0.863
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|75–79|0.701|0.59|0.786
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|80–84|0.54|0.418|0.648
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|All ages combined|0.782|0.753|0.809
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|35–39|0.966|0.785|0.995
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|40–44|0.934|0.808|0.978
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|45–49|0.902|0.781|0.958
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|50–54|0.891|0.794|0.944
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|55–59|0.871|0.778|0.926
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|60–64|0.81|0.715|0.876
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|65–69|0.803|0.716|0.865
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|70–74|0.741|0.642|0.816
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|75–79|0.651|0.538|0.742
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|80–84|0.426|0.313|0.535
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|All ages combined|0.75|0.72|0.778
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|00–04|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|05–09|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|10–14|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|15–19|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|20–24|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|25–29|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|30–34|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|35–39|0.927|0.738|0.981
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|40–44|0.913|0.785|0.966
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|45–49|0.902|0.781|0.958
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|50–54|0.879|0.781|0.935
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|55–59|0.845|0.748|0.907
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|60–64|0.788|0.691|0.857
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|65–69|0.783|0.694|0.849
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|70–74|0.657|0.552|0.744
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|75–79|0.611|0.497|0.707
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|80–84|0.4|0.289|0.509
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|85+|||
Observed|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|All ages combined|0.718|0.686|0.747
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|35–39|0.967|0.785|0.996
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|40–44|0.935|0.809|0.979
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|45–49|0.964|0.859|0.992
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|50–54|0.932|0.842|0.973
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|55–59|0.955|0.878|0.986
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|60–64|0.941|0.866|0.977
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|65–69|0.927|0.856|0.967
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|70–74|0.92|0.843|0.964
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|75–79|0.888|0.788|0.948
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|80–84|0.693|0.56|0.798
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|85+|0.67|0.515|0.799
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|1|All ages combined|0.895|0.87|0.915
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|35–39|0.968|0.786|0.997
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|40–44|0.936|0.811|0.981
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|45–49|0.925|0.807|0.974
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|50–54|0.91|0.814|0.959
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|55–59|0.901|0.812|0.952
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|60–64|0.885|0.798|0.939
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|65–69|0.901|0.822|0.951
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|70–74|0.898|0.813|0.953
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|75–79|0.843|0.732|0.92
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|80–84|0.649|0.51|0.767
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|85+|0.598|0.43|0.755
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|2|All ages combined|0.86|0.831|0.885
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|35–39|0.969|0.787|0.998
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|40–44|0.938|0.812|0.983
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|45–49|0.908|0.786|0.964
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|50–54|0.913|0.817|0.963
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|55–59|0.884|0.79|0.94
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|60–64|0.85|0.757|0.914
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|65–69|0.859|0.772|0.92
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|70–74|0.846|0.749|0.915
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|75–79|0.772|0.65|0.866
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|80–84|0.651|0.504|0.78
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|3|All ages combined|0.83|0.799|0.858
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|35–39|0.971|0.788|1
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|40–44|0.94|0.813|0.984
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|45–49|0.91|0.788|0.967
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|50–54|0.904|0.806|0.958
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|55–59|0.889|0.795|0.946
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|60–64|0.836|0.738|0.904
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|65–69|0.844|0.753|0.91
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|70–74|0.806|0.699|0.887
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|75–79|0.746|0.617|0.851
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|80–84|0.557|0.408|0.699
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|4|All ages combined|0.812|0.779|0.843
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|00–04|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|05–09|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|10–14|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|15–19|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|20–24|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|25–29|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|30–34|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|35–39|0.932|0.742|0.987
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|40–44|0.921|0.791|0.975
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|45–49|0.913|0.79|0.97
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|50–54|0.896|0.796|0.953
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|55–59|0.869|0.769|0.932
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|60–64|0.821|0.72|0.894
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|65–69|0.836|0.741|0.907
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|70–74|0.735|0.617|0.831
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|75–79|0.734|0.597|0.849
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|80–84|0.575|0.415|0.73
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|85+|||
Relative|Other and unspecified lymphoid leukaemia|2015–2019|Persons|5|All ages combined|0.794|0.759|0.826
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|1|All ages combined|0.642|0.473|0.769
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|2|All ages combined|0.492|0.336|0.63
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|3|All ages combined|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|4|All ages combined|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Males|5|All ages combined|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|1|All ages combined|0.673|0.496|0.806
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|2|All ages combined|0.542|0.37|0.694
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|3|All ages combined|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|4|All ages combined|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Males|5|All ages combined|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|1|All ages combined|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|2|All ages combined|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|3|All ages combined|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|4|All ages combined|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Females|5|All ages combined|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|1|All ages combined|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|2|All ages combined|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|3|All ages combined|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|4|All ages combined|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Females|5|All ages combined|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|All ages combined|0.629|0.495|0.737
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|All ages combined|0.502|0.375|0.616
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|All ages combined|0.378|0.262|0.494
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|All ages combined|0.332|0.222|0.447
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|00–04|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|05–09|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|10–14|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|15–19|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|20–24|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|25–29|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|30–34|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|35–39|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|40–44|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|45–49|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|50–54|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|55–59|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|60–64|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|65–69|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|70–74|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|75–79|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|80–84|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|85+|||
Observed|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|All ages combined|0.291|0.187|0.402
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|1|All ages combined|0.656|0.516|0.768
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|2|All ages combined|0.544|0.406|0.668
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|3|All ages combined|0.428|0.296|0.559
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|4|All ages combined|0.392|0.261|0.527
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|00–04|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|05–09|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|10–14|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|15–19|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|20–24|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|25–29|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|30–34|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|35–39|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|40–44|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|45–49|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|50–54|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|55–59|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|60–64|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|65–69|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|70–74|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|75–79|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|80–84|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|85+|||
Relative|Other and unspecified myeloid leukaemia|2015–2019|Persons|5|All ages combined|0.357|0.23|0.493
Observed|Other blood cancers|2015–2019|Males|1|00–04|0.972|0.818|0.996
Observed|Other blood cancers|2015–2019|Males|1|05–09|||
Observed|Other blood cancers|2015–2019|Males|1|10–14|||
Observed|Other blood cancers|2015–2019|Males|1|15–19|||
Observed|Other blood cancers|2015–2019|Males|1|20–24|||
Observed|Other blood cancers|2015–2019|Males|1|25–29|||
Observed|Other blood cancers|2015–2019|Males|1|30–34|||
Observed|Other blood cancers|2015–2019|Males|1|35–39|||
Observed|Other blood cancers|2015–2019|Males|1|40–44|1|0.905|1
Observed|Other blood cancers|2015–2019|Males|1|45–49|||
Observed|Other blood cancers|2015–2019|Males|1|50–54|||
Observed|Other blood cancers|2015–2019|Males|1|55–59|||
Observed|Other blood cancers|2015–2019|Males|1|60–64|0.863|0.633|0.954
Observed|Other blood cancers|2015–2019|Males|1|65–69|||
Observed|Other blood cancers|2015–2019|Males|1|70–74|||
Observed|Other blood cancers|2015–2019|Males|1|75–79|||
Observed|Other blood cancers|2015–2019|Males|1|80–84|||
Observed|Other blood cancers|2015–2019|Males|1|85+|||
Observed|Other blood cancers|2015–2019|Males|1|All ages combined|0.832|0.785|0.869
Observed|Other blood cancers|2015–2019|Males|2|00–04|0.972|0.818|0.996
Observed|Other blood cancers|2015–2019|Males|2|05–09|||
Observed|Other blood cancers|2015–2019|Males|2|10–14|||
Observed|Other blood cancers|2015–2019|Males|2|15–19|||
Observed|Other blood cancers|2015–2019|Males|2|20–24|||
Observed|Other blood cancers|2015–2019|Males|2|25–29|||
Observed|Other blood cancers|2015–2019|Males|2|30–34|||
Observed|Other blood cancers|2015–2019|Males|2|35–39|||
Observed|Other blood cancers|2015–2019|Males|2|40–44|0.973|0.822|0.996
Observed|Other blood cancers|2015–2019|Males|2|45–49|||
Observed|Other blood cancers|2015–2019|Males|2|50–54|||
Observed|Other blood cancers|2015–2019|Males|2|55–59|||
Observed|Other blood cancers|2015–2019|Males|2|60–64|||
Observed|Other blood cancers|2015–2019|Males|2|65–69|||
Observed|Other blood cancers|2015–2019|Males|2|70–74|||
Observed|Other blood cancers|2015–2019|Males|2|75–79|||
Observed|Other blood cancers|2015–2019|Males|2|80–84|||
Observed|Other blood cancers|2015–2019|Males|2|85+|||
Observed|Other blood cancers|2015–2019|Males|2|All ages combined|0.786|0.736|0.827
Observed|Other blood cancers|2015–2019|Males|3|00–04|0.972|0.818|0.996
Observed|Other blood cancers|2015–2019|Males|3|05–09|||
Observed|Other blood cancers|2015–2019|Males|3|10–14|||
Observed|Other blood cancers|2015–2019|Males|3|15–19|||
Observed|Other blood cancers|2015–2019|Males|3|20–24|||
Observed|Other blood cancers|2015–2019|Males|3|25–29|||
Observed|Other blood cancers|2015–2019|Males|3|30–34|||
Observed|Other blood cancers|2015–2019|Males|3|35–39|||
Observed|Other blood cancers|2015–2019|Males|3|40–44|0.946|0.802|0.986
Observed|Other blood cancers|2015–2019|Males|3|45–49|||
Observed|Other blood cancers|2015–2019|Males|3|50–54|||
Observed|Other blood cancers|2015–2019|Males|3|55–59|||
Observed|Other blood cancers|2015–2019|Males|3|60–64|||
Observed|Other blood cancers|2015–2019|Males|3|65–69|||
Observed|Other blood cancers|2015–2019|Males|3|70–74|||
Observed|Other blood cancers|2015–2019|Males|3|75–79|||
Observed|Other blood cancers|2015–2019|Males|3|80–84|||
Observed|Other blood cancers|2015–2019|Males|3|85+|||
Observed|Other blood cancers|2015–2019|Males|3|All ages combined|0.759|0.708|0.802
Observed|Other blood cancers|2015–2019|Males|4|00–04|0.972|0.818|0.996
Observed|Other blood cancers|2015–2019|Males|4|05–09|||
Observed|Other blood cancers|2015–2019|Males|4|10–14|||
Observed|Other blood cancers|2015–2019|Males|4|15–19|||
Observed|Other blood cancers|2015–2019|Males|4|20–24|||
Observed|Other blood cancers|2015–2019|Males|4|25–29|||
Observed|Other blood cancers|2015–2019|Males|4|30–34|||
Observed|Other blood cancers|2015–2019|Males|4|35–39|||
Observed|Other blood cancers|2015–2019|Males|4|40–44|0.917|0.765|0.973
Observed|Other blood cancers|2015–2019|Males|4|45–49|||
Observed|Other blood cancers|2015–2019|Males|4|50–54|||
Observed|Other blood cancers|2015–2019|Males|4|55–59|||
Observed|Other blood cancers|2015–2019|Males|4|60–64|||
Observed|Other blood cancers|2015–2019|Males|4|65–69|||
Observed|Other blood cancers|2015–2019|Males|4|70–74|||
Observed|Other blood cancers|2015–2019|Males|4|75–79|||
Observed|Other blood cancers|2015–2019|Males|4|80–84|||
Observed|Other blood cancers|2015–2019|Males|4|85+|||
Observed|Other blood cancers|2015–2019|Males|4|All ages combined|0.748|0.696|0.792
Observed|Other blood cancers|2015–2019|Males|5|00–04|0.972|0.818|0.996
Observed|Other blood cancers|2015–2019|Males|5|05–09|||
Observed|Other blood cancers|2015–2019|Males|5|10–14|||
Observed|Other blood cancers|2015–2019|Males|5|15–19|||
Observed|Other blood cancers|2015–2019|Males|5|20–24|||
Observed|Other blood cancers|2015–2019|Males|5|25–29|||
Observed|Other blood cancers|2015–2019|Males|5|30–34|||
Observed|Other blood cancers|2015–2019|Males|5|35–39|||
Observed|Other blood cancers|2015–2019|Males|5|40–44|0.917|0.765|0.973
Observed|Other blood cancers|2015–2019|Males|5|45–49|||
Observed|Other blood cancers|2015–2019|Males|5|50–54|||
Observed|Other blood cancers|2015–2019|Males|5|55–59|||
Observed|Other blood cancers|2015–2019|Males|5|60–64|||
Observed|Other blood cancers|2015–2019|Males|5|65–69|||
Observed|Other blood cancers|2015–2019|Males|5|70–74|||
Observed|Other blood cancers|2015–2019|Males|5|75–79|||
Observed|Other blood cancers|2015–2019|Males|5|80–84|||
Observed|Other blood cancers|2015–2019|Males|5|85+|||
Observed|Other blood cancers|2015–2019|Males|5|All ages combined|0.729|0.676|0.774
Relative|Other blood cancers|2015–2019|Males|1|00–04|0.973|0.819|0.997
Relative|Other blood cancers|2015–2019|Males|1|05–09|||
Relative|Other blood cancers|2015–2019|Males|1|10–14|||
Relative|Other blood cancers|2015–2019|Males|1|15–19|||
Relative|Other blood cancers|2015–2019|Males|1|20–24|||
Relative|Other blood cancers|2015–2019|Males|1|25–29|||
Relative|Other blood cancers|2015–2019|Males|1|30–34|||
Relative|Other blood cancers|2015–2019|Males|1|35–39|||
Relative|Other blood cancers|2015–2019|Males|1|40–44|1.002|0.907|1.002
Relative|Other blood cancers|2015–2019|Males|1|45–49|||
Relative|Other blood cancers|2015–2019|Males|1|50–54|||
Relative|Other blood cancers|2015–2019|Males|1|55–59|||
Relative|Other blood cancers|2015–2019|Males|1|60–64|0.87|0.638|0.961
Relative|Other blood cancers|2015–2019|Males|1|65–69|||
Relative|Other blood cancers|2015–2019|Males|1|70–74|||
Relative|Other blood cancers|2015–2019|Males|1|75–79|||
Relative|Other blood cancers|2015–2019|Males|1|80–84|||
Relative|Other blood cancers|2015–2019|Males|1|85+|||
Relative|Other blood cancers|2015–2019|Males|1|All ages combined|0.841|0.794|0.879
Relative|Other blood cancers|2015–2019|Males|2|00–04|0.973|0.819|0.997
Relative|Other blood cancers|2015–2019|Males|2|05–09|||
Relative|Other blood cancers|2015–2019|Males|2|10–14|||
Relative|Other blood cancers|2015–2019|Males|2|15–19|||
Relative|Other blood cancers|2015–2019|Males|2|20–24|||
Relative|Other blood cancers|2015–2019|Males|2|25–29|||
Relative|Other blood cancers|2015–2019|Males|2|30–34|||
Relative|Other blood cancers|2015–2019|Males|2|35–39|||
Relative|Other blood cancers|2015–2019|Males|2|40–44|0.976|0.825|1
Relative|Other blood cancers|2015–2019|Males|2|45–49|||
Relative|Other blood cancers|2015–2019|Males|2|50–54|||
Relative|Other blood cancers|2015–2019|Males|2|55–59|||
Relative|Other blood cancers|2015–2019|Males|2|60–64|||
Relative|Other blood cancers|2015–2019|Males|2|65–69|||
Relative|Other blood cancers|2015–2019|Males|2|70–74|||
Relative|Other blood cancers|2015–2019|Males|2|75–79|||
Relative|Other blood cancers|2015–2019|Males|2|80–84|||
Relative|Other blood cancers|2015–2019|Males|2|85+|||
Relative|Other blood cancers|2015–2019|Males|2|All ages combined|0.801|0.75|0.843
Relative|Other blood cancers|2015–2019|Males|3|00–04|0.973|0.819|0.997
Relative|Other blood cancers|2015–2019|Males|3|05–09|||
Relative|Other blood cancers|2015–2019|Males|3|10–14|||
Relative|Other blood cancers|2015–2019|Males|3|15–19|||
Relative|Other blood cancers|2015–2019|Males|3|20–24|||
Relative|Other blood cancers|2015–2019|Males|3|25–29|||
Relative|Other blood cancers|2015–2019|Males|3|30–34|||
Relative|Other blood cancers|2015–2019|Males|3|35–39|||
Relative|Other blood cancers|2015–2019|Males|3|40–44|0.951|0.806|0.992
Relative|Other blood cancers|2015–2019|Males|3|45–49|||
Relative|Other blood cancers|2015–2019|Males|3|50–54|||
Relative|Other blood cancers|2015–2019|Males|3|55–59|||
Relative|Other blood cancers|2015–2019|Males|3|60–64|||
Relative|Other blood cancers|2015–2019|Males|3|65–69|||
Relative|Other blood cancers|2015–2019|Males|3|70–74|||
Relative|Other blood cancers|2015–2019|Males|3|75–79|||
Relative|Other blood cancers|2015–2019|Males|3|80–84|||
Relative|Other blood cancers|2015–2019|Males|3|85+|||
Relative|Other blood cancers|2015–2019|Males|3|All ages combined|0.779|0.726|0.823
Relative|Other blood cancers|2015–2019|Males|4|00–04|0.974|0.819|0.997
Relative|Other blood cancers|2015–2019|Males|4|05–09|||
Relative|Other blood cancers|2015–2019|Males|4|10–14|||
Relative|Other blood cancers|2015–2019|Males|4|15–19|||
Relative|Other blood cancers|2015–2019|Males|4|20–24|||
Relative|Other blood cancers|2015–2019|Males|4|25–29|||
Relative|Other blood cancers|2015–2019|Males|4|30–34|||
Relative|Other blood cancers|2015–2019|Males|4|35–39|||
Relative|Other blood cancers|2015–2019|Males|4|40–44|0.924|0.77|0.98
Relative|Other blood cancers|2015–2019|Males|4|45–49|||
Relative|Other blood cancers|2015–2019|Males|4|50–54|||
Relative|Other blood cancers|2015–2019|Males|4|55–59|||
Relative|Other blood cancers|2015–2019|Males|4|60–64|||
Relative|Other blood cancers|2015–2019|Males|4|65–69|||
Relative|Other blood cancers|2015–2019|Males|4|70–74|||
Relative|Other blood cancers|2015–2019|Males|4|75–79|||
Relative|Other blood cancers|2015–2019|Males|4|80–84|||
Relative|Other blood cancers|2015–2019|Males|4|85+|||
Relative|Other blood cancers|2015–2019|Males|4|All ages combined|0.771|0.718|0.817
Relative|Other blood cancers|2015–2019|Males|5|00–04|0.974|0.819|0.998
Relative|Other blood cancers|2015–2019|Males|5|05–09|||
Relative|Other blood cancers|2015–2019|Males|5|10–14|||
Relative|Other blood cancers|2015–2019|Males|5|15–19|||
Relative|Other blood cancers|2015–2019|Males|5|20–24|||
Relative|Other blood cancers|2015–2019|Males|5|25–29|||
Relative|Other blood cancers|2015–2019|Males|5|30–34|||
Relative|Other blood cancers|2015–2019|Males|5|35–39|||
Relative|Other blood cancers|2015–2019|Males|5|40–44|0.926|0.772|0.982
Relative|Other blood cancers|2015–2019|Males|5|45–49|||
Relative|Other blood cancers|2015–2019|Males|5|50–54|||
Relative|Other blood cancers|2015–2019|Males|5|55–59|||
Relative|Other blood cancers|2015–2019|Males|5|60–64|||
Relative|Other blood cancers|2015–2019|Males|5|65–69|||
Relative|Other blood cancers|2015–2019|Males|5|70–74|||
Relative|Other blood cancers|2015–2019|Males|5|75–79|||
Relative|Other blood cancers|2015–2019|Males|5|80–84|||
Relative|Other blood cancers|2015–2019|Males|5|85+|||
Relative|Other blood cancers|2015–2019|Males|5|All ages combined|0.756|0.702|0.803
Observed|Other blood cancers|2015–2019|Females|1|00–04|||
Observed|Other blood cancers|2015–2019|Females|1|05–09|||
Observed|Other blood cancers|2015–2019|Females|1|10–14|||
Observed|Other blood cancers|2015–2019|Females|1|15–19|||
Observed|Other blood cancers|2015–2019|Females|1|20–24|||
Observed|Other blood cancers|2015–2019|Females|1|25–29|||
Observed|Other blood cancers|2015–2019|Females|1|30–34|||
Observed|Other blood cancers|2015–2019|Females|1|35–39|||
Observed|Other blood cancers|2015–2019|Females|1|40–44|||
Observed|Other blood cancers|2015–2019|Females|1|45–49|||
Observed|Other blood cancers|2015–2019|Females|1|50–54|||
Observed|Other blood cancers|2015–2019|Females|1|55–59|||
Observed|Other blood cancers|2015–2019|Females|1|60–64|||
Observed|Other blood cancers|2015–2019|Females|1|65–69|||
Observed|Other blood cancers|2015–2019|Females|1|70–74|||
Observed|Other blood cancers|2015–2019|Females|1|75–79|||
Observed|Other blood cancers|2015–2019|Females|1|80–84|||
Observed|Other blood cancers|2015–2019|Females|1|85+|||
Observed|Other blood cancers|2015–2019|Females|1|All ages combined|0.912|0.858|0.946
Observed|Other blood cancers|2015–2019|Females|2|00–04|||
Observed|Other blood cancers|2015–2019|Females|2|05–09|||
Observed|Other blood cancers|2015–2019|Females|2|10–14|||
Observed|Other blood cancers|2015–2019|Females|2|15–19|||
Observed|Other blood cancers|2015–2019|Females|2|20–24|||
Observed|Other blood cancers|2015–2019|Females|2|25–29|||
Observed|Other blood cancers|2015–2019|Females|2|30–34|||
Observed|Other blood cancers|2015–2019|Females|2|35–39|||
Observed|Other blood cancers|2015–2019|Females|2|40–44|||
Observed|Other blood cancers|2015–2019|Females|2|45–49|||
Observed|Other blood cancers|2015–2019|Females|2|50–54|||
Observed|Other blood cancers|2015–2019|Females|2|55–59|||
Observed|Other blood cancers|2015–2019|Females|2|60–64|||
Observed|Other blood cancers|2015–2019|Females|2|65–69|||
Observed|Other blood cancers|2015–2019|Females|2|70–74|||
Observed|Other blood cancers|2015–2019|Females|2|75–79|||
Observed|Other blood cancers|2015–2019|Females|2|80–84|||
Observed|Other blood cancers|2015–2019|Females|2|85+|||
Observed|Other blood cancers|2015–2019|Females|2|All ages combined|0.877|0.817|0.918
Observed|Other blood cancers|2015–2019|Females|3|00–04|||
Observed|Other blood cancers|2015–2019|Females|3|05–09|||
Observed|Other blood cancers|2015–2019|Females|3|10–14|||
Observed|Other blood cancers|2015–2019|Females|3|15–19|||
Observed|Other blood cancers|2015–2019|Females|3|20–24|||
Observed|Other blood cancers|2015–2019|Females|3|25–29|||
Observed|Other blood cancers|2015–2019|Females|3|30–34|||
Observed|Other blood cancers|2015–2019|Females|3|35–39|||
Observed|Other blood cancers|2015–2019|Females|3|40–44|||
Observed|Other blood cancers|2015–2019|Females|3|45–49|||
Observed|Other blood cancers|2015–2019|Females|3|50–54|||
Observed|Other blood cancers|2015–2019|Females|3|55–59|||
Observed|Other blood cancers|2015–2019|Females|3|60–64|||
Observed|Other blood cancers|2015–2019|Females|3|65–69|||
Observed|Other blood cancers|2015–2019|Females|3|70–74|||
Observed|Other blood cancers|2015–2019|Females|3|75–79|||
Observed|Other blood cancers|2015–2019|Females|3|80–84|||
Observed|Other blood cancers|2015–2019|Females|3|85+|||
Observed|Other blood cancers|2015–2019|Females|3|All ages combined|0.86|0.798|0.904
Observed|Other blood cancers|2015–2019|Females|4|00–04|||
Observed|Other blood cancers|2015–2019|Females|4|05–09|||
Observed|Other blood cancers|2015–2019|Females|4|10–14|||
Observed|Other blood cancers|2015–2019|Females|4|15–19|||
Observed|Other blood cancers|2015–2019|Females|4|20–24|||
Observed|Other blood cancers|2015–2019|Females|4|25–29|||
Observed|Other blood cancers|2015–2019|Females|4|30–34|||
Observed|Other blood cancers|2015–2019|Females|4|35–39|||
Observed|Other blood cancers|2015–2019|Females|4|40–44|||
Observed|Other blood cancers|2015–2019|Females|4|45–49|||
Observed|Other blood cancers|2015–2019|Females|4|50–54|||
Observed|Other blood cancers|2015–2019|Females|4|55–59|||
Observed|Other blood cancers|2015–2019|Females|4|60–64|||
Observed|Other blood cancers|2015–2019|Females|4|65–69|||
Observed|Other blood cancers|2015–2019|Females|4|70–74|||
Observed|Other blood cancers|2015–2019|Females|4|75–79|||
Observed|Other blood cancers|2015–2019|Females|4|80–84|||
Observed|Other blood cancers|2015–2019|Females|4|85+|||
Observed|Other blood cancers|2015–2019|Females|4|All ages combined|0.833|0.769|0.881
Observed|Other blood cancers|2015–2019|Females|5|00–04|||
Observed|Other blood cancers|2015–2019|Females|5|05–09|||
Observed|Other blood cancers|2015–2019|Females|5|10–14|||
Observed|Other blood cancers|2015–2019|Females|5|15–19|||
Observed|Other blood cancers|2015–2019|Females|5|20–24|||
Observed|Other blood cancers|2015–2019|Females|5|25–29|||
Observed|Other blood cancers|2015–2019|Females|5|30–34|||
Observed|Other blood cancers|2015–2019|Females|5|35–39|||
Observed|Other blood cancers|2015–2019|Females|5|40–44|||
Observed|Other blood cancers|2015–2019|Females|5|45–49|||
Observed|Other blood cancers|2015–2019|Females|5|50–54|||
Observed|Other blood cancers|2015–2019|Females|5|55–59|||
Observed|Other blood cancers|2015–2019|Females|5|60–64|||
Observed|Other blood cancers|2015–2019|Females|5|65–69|||
Observed|Other blood cancers|2015–2019|Females|5|70–74|||
Observed|Other blood cancers|2015–2019|Females|5|75–79|||
Observed|Other blood cancers|2015–2019|Females|5|80–84|||
Observed|Other blood cancers|2015–2019|Females|5|85+|||
Observed|Other blood cancers|2015–2019|Females|5|All ages combined|0.822|0.757|0.871
Relative|Other blood cancers|2015–2019|Females|1|00–04|||
Relative|Other blood cancers|2015–2019|Females|1|05–09|||
Relative|Other blood cancers|2015–2019|Females|1|10–14|||
Relative|Other blood cancers|2015–2019|Females|1|15–19|||
Relative|Other blood cancers|2015–2019|Females|1|20–24|||
Relative|Other blood cancers|2015–2019|Females|1|25–29|||
Relative|Other blood cancers|2015–2019|Females|1|30–34|||
Relative|Other blood cancers|2015–2019|Females|1|35–39|||
Relative|Other blood cancers|2015–2019|Females|1|40–44|||
Relative|Other blood cancers|2015–2019|Females|1|45–49|||
Relative|Other blood cancers|2015–2019|Females|1|50–54|||
Relative|Other blood cancers|2015–2019|Females|1|55–59|||
Relative|Other blood cancers|2015–2019|Females|1|60–64|||
Relative|Other blood cancers|2015–2019|Females|1|65–69|||
Relative|Other blood cancers|2015–2019|Females|1|70–74|||
Relative|Other blood cancers|2015–2019|Females|1|75–79|||
Relative|Other blood cancers|2015–2019|Females|1|80–84|||
Relative|Other blood cancers|2015–2019|Females|1|85+|||
Relative|Other blood cancers|2015–2019|Females|1|All ages combined|0.916|0.862|0.951
Relative|Other blood cancers|2015–2019|Females|2|00–04|||
Relative|Other blood cancers|2015–2019|Females|2|05–09|||
Relative|Other blood cancers|2015–2019|Females|2|10–14|||
Relative|Other blood cancers|2015–2019|Females|2|15–19|||
Relative|Other blood cancers|2015–2019|Females|2|20–24|||
Relative|Other blood cancers|2015–2019|Females|2|25–29|||
Relative|Other blood cancers|2015–2019|Females|2|30–34|||
Relative|Other blood cancers|2015–2019|Females|2|35–39|||
Relative|Other blood cancers|2015–2019|Females|2|40–44|||
Relative|Other blood cancers|2015–2019|Females|2|45–49|||
Relative|Other blood cancers|2015–2019|Females|2|50–54|||
Relative|Other blood cancers|2015–2019|Females|2|55–59|||
Relative|Other blood cancers|2015–2019|Females|2|60–64|||
Relative|Other blood cancers|2015–2019|Females|2|65–69|||
Relative|Other blood cancers|2015–2019|Females|2|70–74|||
Relative|Other blood cancers|2015–2019|Females|2|75–79|||
Relative|Other blood cancers|2015–2019|Females|2|80–84|||
Relative|Other blood cancers|2015–2019|Females|2|85+|||
Relative|Other blood cancers|2015–2019|Females|2|All ages combined|0.885|0.825|0.926
Relative|Other blood cancers|2015–2019|Females|3|00–04|||
Relative|Other blood cancers|2015–2019|Females|3|05–09|||
Relative|Other blood cancers|2015–2019|Females|3|10–14|||
Relative|Other blood cancers|2015–2019|Females|3|15–19|||
Relative|Other blood cancers|2015–2019|Females|3|20–24|||
Relative|Other blood cancers|2015–2019|Females|3|25–29|||
Relative|Other blood cancers|2015–2019|Females|3|30–34|||
Relative|Other blood cancers|2015–2019|Females|3|35–39|||
Relative|Other blood cancers|2015–2019|Females|3|40–44|||
Relative|Other blood cancers|2015–2019|Females|3|45–49|||
Relative|Other blood cancers|2015–2019|Females|3|50–54|||
Relative|Other blood cancers|2015–2019|Females|3|55–59|||
Relative|Other blood cancers|2015–2019|Females|3|60–64|||
Relative|Other blood cancers|2015–2019|Females|3|65–69|||
Relative|Other blood cancers|2015–2019|Females|3|70–74|||
Relative|Other blood cancers|2015–2019|Females|3|75–79|||
Relative|Other blood cancers|2015–2019|Females|3|80–84|||
Relative|Other blood cancers|2015–2019|Females|3|85+|||
Relative|Other blood cancers|2015–2019|Females|3|All ages combined|0.871|0.808|0.915
Relative|Other blood cancers|2015–2019|Females|4|00–04|||
Relative|Other blood cancers|2015–2019|Females|4|05–09|||
Relative|Other blood cancers|2015–2019|Females|4|10–14|||
Relative|Other blood cancers|2015–2019|Females|4|15–19|||
Relative|Other blood cancers|2015–2019|Females|4|20–24|||
Relative|Other blood cancers|2015–2019|Females|4|25–29|||
Relative|Other blood cancers|2015–2019|Females|4|30–34|||
Relative|Other blood cancers|2015–2019|Females|4|35–39|||
Relative|Other blood cancers|2015–2019|Females|4|40–44|||
Relative|Other blood cancers|2015–2019|Females|4|45–49|||
Relative|Other blood cancers|2015–2019|Females|4|50–54|||
Relative|Other blood cancers|2015–2019|Females|4|55–59|||
Relative|Other blood cancers|2015–2019|Females|4|60–64|||
Relative|Other blood cancers|2015–2019|Females|4|65–69|||
Relative|Other blood cancers|2015–2019|Females|4|70–74|||
Relative|Other blood cancers|2015–2019|Females|4|75–79|||
Relative|Other blood cancers|2015–2019|Females|4|80–84|||
Relative|Other blood cancers|2015–2019|Females|4|85+|||
Relative|Other blood cancers|2015–2019|Females|4|All ages combined|0.846|0.781|0.895
Relative|Other blood cancers|2015–2019|Females|5|00–04|||
Relative|Other blood cancers|2015–2019|Females|5|05–09|||
Relative|Other blood cancers|2015–2019|Females|5|10–14|||
Relative|Other blood cancers|2015–2019|Females|5|15–19|||
Relative|Other blood cancers|2015–2019|Females|5|20–24|||
Relative|Other blood cancers|2015–2019|Females|5|25–29|||
Relative|Other blood cancers|2015–2019|Females|5|30–34|||
Relative|Other blood cancers|2015–2019|Females|5|35–39|||
Relative|Other blood cancers|2015–2019|Females|5|40–44|||
Relative|Other blood cancers|2015–2019|Females|5|45–49|||
Relative|Other blood cancers|2015–2019|Females|5|50–54|||
Relative|Other blood cancers|2015–2019|Females|5|55–59|||
Relative|Other blood cancers|2015–2019|Females|5|60–64|||
Relative|Other blood cancers|2015–2019|Females|5|65–69|||
Relative|Other blood cancers|2015–2019|Females|5|70–74|||
Relative|Other blood cancers|2015–2019|Females|5|75–79|||
Relative|Other blood cancers|2015–2019|Females|5|80–84|||
Relative|Other blood cancers|2015–2019|Females|5|85+|||
Relative|Other blood cancers|2015–2019|Females|5|All ages combined|0.838|0.772|0.888
Observed|Other blood cancers|2015–2019|Persons|1|00–04|0.982|0.877|0.997
Observed|Other blood cancers|2015–2019|Persons|1|05–09|1|0.902|1
Observed|Other blood cancers|2015–2019|Persons|1|10–14|0.961|0.757|0.994
Observed|Other blood cancers|2015–2019|Persons|1|15–19|||
Observed|Other blood cancers|2015–2019|Persons|1|20–24|||
Observed|Other blood cancers|2015–2019|Persons|1|25–29|||
Observed|Other blood cancers|2015–2019|Persons|1|30–34|||
Observed|Other blood cancers|2015–2019|Persons|1|35–39|1|0.873|1
Observed|Other blood cancers|2015–2019|Persons|1|40–44|1|0.922|1
Observed|Other blood cancers|2015–2019|Persons|1|45–49|0.904|0.731|0.968
Observed|Other blood cancers|2015–2019|Persons|1|50–54|0.846|0.669|0.933
Observed|Other blood cancers|2015–2019|Persons|1|55–59|0.837|0.622|0.935
Observed|Other blood cancers|2015–2019|Persons|1|60–64|0.82|0.659|0.91
Observed|Other blood cancers|2015–2019|Persons|1|65–69|0.646|0.463|0.78
Observed|Other blood cancers|2015–2019|Persons|1|70–74|0.677|0.485|0.811
Observed|Other blood cancers|2015–2019|Persons|1|75–79|0.597|0.393|0.751
Observed|Other blood cancers|2015–2019|Persons|1|80–84|||
Observed|Other blood cancers|2015–2019|Persons|1|85+|||
Observed|Other blood cancers|2015–2019|Persons|1|All ages combined|0.86|0.826|0.888
Observed|Other blood cancers|2015–2019|Persons|2|00–04|0.982|0.877|0.997
Observed|Other blood cancers|2015–2019|Persons|2|05–09|1|0.904|1
Observed|Other blood cancers|2015–2019|Persons|2|10–14|0.961|0.757|0.994
Observed|Other blood cancers|2015–2019|Persons|2|15–19|||
Observed|Other blood cancers|2015–2019|Persons|2|20–24|||
Observed|Other blood cancers|2015–2019|Persons|2|25–29|||
Observed|Other blood cancers|2015–2019|Persons|2|30–34|||
Observed|Other blood cancers|2015–2019|Persons|2|35–39|1|0.878|1
Observed|Other blood cancers|2015–2019|Persons|2|40–44|0.93|0.798|0.977
Observed|Other blood cancers|2015–2019|Persons|2|45–49|0.837|0.652|0.929
Observed|Other blood cancers|2015–2019|Persons|2|50–54|0.751|0.563|0.867
Observed|Other blood cancers|2015–2019|Persons|2|55–59|0.837|0.622|0.935
Observed|Other blood cancers|2015–2019|Persons|2|60–64|0.767|0.599|0.871
Observed|Other blood cancers|2015–2019|Persons|2|65–69|0.62|0.439|0.758
Observed|Other blood cancers|2015–2019|Persons|2|70–74|||
Observed|Other blood cancers|2015–2019|Persons|2|75–79|||
Observed|Other blood cancers|2015–2019|Persons|2|80–84|||
Observed|Other blood cancers|2015–2019|Persons|2|85+|||
Observed|Other blood cancers|2015–2019|Persons|2|All ages combined|0.818|0.78|0.849
Observed|Other blood cancers|2015–2019|Persons|3|00–04|0.982|0.877|0.997
Observed|Other blood cancers|2015–2019|Persons|3|05–09|1|0.909|1
Observed|Other blood cancers|2015–2019|Persons|3|10–14|0.961|0.757|0.994
Observed|Other blood cancers|2015–2019|Persons|3|15–19|||
Observed|Other blood cancers|2015–2019|Persons|3|20–24|||
Observed|Other blood cancers|2015–2019|Persons|3|25–29|||
Observed|Other blood cancers|2015–2019|Persons|3|30–34|||
Observed|Other blood cancers|2015–2019|Persons|3|35–39|1|0.884|1
Observed|Other blood cancers|2015–2019|Persons|3|40–44|0.908|0.773|0.964
Observed|Other blood cancers|2015–2019|Persons|3|45–49|0.805|0.617|0.908
Observed|Other blood cancers|2015–2019|Persons|3|50–54|0.751|0.563|0.867
Observed|Other blood cancers|2015–2019|Persons|3|55–59|0.802|0.588|0.912
Observed|Other blood cancers|2015–2019|Persons|3|60–64|0.742|0.574|0.852
Observed|Other blood cancers|2015–2019|Persons|3|65–69|0.513|0.34|0.661
Observed|Other blood cancers|2015–2019|Persons|3|70–74|||
Observed|Other blood cancers|2015–2019|Persons|3|75–79|||
Observed|Other blood cancers|2015–2019|Persons|3|80–84|||
Observed|Other blood cancers|2015–2019|Persons|3|85+|||
Observed|Other blood cancers|2015–2019|Persons|3|All ages combined|0.795|0.756|0.828
Observed|Other blood cancers|2015–2019|Persons|4|00–04|0.982|0.877|0.997
Observed|Other blood cancers|2015–2019|Persons|4|05–09|1|0.914|1
Observed|Other blood cancers|2015–2019|Persons|4|10–14|0.961|0.757|0.994
Observed|Other blood cancers|2015–2019|Persons|4|15–19|||
Observed|Other blood cancers|2015–2019|Persons|4|20–24|||
Observed|Other blood cancers|2015–2019|Persons|4|25–29|||
Observed|Other blood cancers|2015–2019|Persons|4|30–34|||
Observed|Other blood cancers|2015–2019|Persons|4|35–39|1|0.889|1
Observed|Other blood cancers|2015–2019|Persons|4|40–44|0.885|0.746|0.95
Observed|Other blood cancers|2015–2019|Persons|4|45–49|0.805|0.617|0.908
Observed|Other blood cancers|2015–2019|Persons|4|50–54|0.721|0.532|0.844
Observed|Other blood cancers|2015–2019|Persons|4|55–59|0.704|0.496|0.839
Observed|Other blood cancers|2015–2019|Persons|4|60–64|0.714|0.543|0.83
Observed|Other blood cancers|2015–2019|Persons|4|65–69|||
Observed|Other blood cancers|2015–2019|Persons|4|70–74|||
Observed|Other blood cancers|2015–2019|Persons|4|75–79|||
Observed|Other blood cancers|2015–2019|Persons|4|80–84|||
Observed|Other blood cancers|2015–2019|Persons|4|85+|||
Observed|Other blood cancers|2015–2019|Persons|4|All ages combined|0.778|0.738|0.812
Observed|Other blood cancers|2015–2019|Persons|5|00–04|0.982|0.877|0.997
Observed|Other blood cancers|2015–2019|Persons|5|05–09|1|0.915|1
Observed|Other blood cancers|2015–2019|Persons|5|10–14|0.961|0.757|0.994
Observed|Other blood cancers|2015–2019|Persons|5|15–19|||
Observed|Other blood cancers|2015–2019|Persons|5|20–24|||
Observed|Other blood cancers|2015–2019|Persons|5|25–29|||
Observed|Other blood cancers|2015–2019|Persons|5|30–34|||
Observed|Other blood cancers|2015–2019|Persons|5|35–39|1|0.891|1
Observed|Other blood cancers|2015–2019|Persons|5|40–44|0.885|0.746|0.95
Observed|Other blood cancers|2015–2019|Persons|5|45–49|0.805|0.617|0.908
Observed|Other blood cancers|2015–2019|Persons|5|50–54|0.692|0.504|0.821
Observed|Other blood cancers|2015–2019|Persons|5|55–59|0.704|0.496|0.839
Observed|Other blood cancers|2015–2019|Persons|5|60–64|0.681|0.505|0.805
Observed|Other blood cancers|2015–2019|Persons|5|65–69|||
Observed|Other blood cancers|2015–2019|Persons|5|70–74|||
Observed|Other blood cancers|2015–2019|Persons|5|75–79|||
Observed|Other blood cancers|2015–2019|Persons|5|80–84|||
Observed|Other blood cancers|2015–2019|Persons|5|85+|||
Observed|Other blood cancers|2015–2019|Persons|5|All ages combined|0.762|0.722|0.797
Relative|Other blood cancers|2015–2019|Persons|1|00–04|0.983|0.878|0.999
Relative|Other blood cancers|2015–2019|Persons|1|05–09|1|0.902|1
Relative|Other blood cancers|2015–2019|Persons|1|10–14|0.962|0.757|0.995
Relative|Other blood cancers|2015–2019|Persons|1|15–19|||
Relative|Other blood cancers|2015–2019|Persons|1|20–24|||
Relative|Other blood cancers|2015–2019|Persons|1|25–29|||
Relative|Other blood cancers|2015–2019|Persons|1|30–34|||
Relative|Other blood cancers|2015–2019|Persons|1|35–39|1.001|0.874|1.001
Relative|Other blood cancers|2015–2019|Persons|1|40–44|1.002|0.923|1.002
Relative|Other blood cancers|2015–2019|Persons|1|45–49|0.906|0.732|0.97
Relative|Other blood cancers|2015–2019|Persons|1|50–54|0.848|0.671|0.935
Relative|Other blood cancers|2015–2019|Persons|1|55–59|0.841|0.625|0.94
Relative|Other blood cancers|2015–2019|Persons|1|60–64|0.825|0.664|0.916
Relative|Other blood cancers|2015–2019|Persons|1|65–69|0.652|0.467|0.788
Relative|Other blood cancers|2015–2019|Persons|1|70–74|0.689|0.493|0.825
Relative|Other blood cancers|2015–2019|Persons|1|75–79|0.616|0.406|0.775
Relative|Other blood cancers|2015–2019|Persons|1|80–84|||
Relative|Other blood cancers|2015–2019|Persons|1|85+|||
Relative|Other blood cancers|2015–2019|Persons|1|All ages combined|0.868|0.833|0.896
Relative|Other blood cancers|2015–2019|Persons|2|00–04|0.983|0.878|0.999
Relative|Other blood cancers|2015–2019|Persons|2|05–09|1|0.904|1
Relative|Other blood cancers|2015–2019|Persons|2|10–14|0.962|0.757|0.995
Relative|Other blood cancers|2015–2019|Persons|2|15–19|||
Relative|Other blood cancers|2015–2019|Persons|2|20–24|||
Relative|Other blood cancers|2015–2019|Persons|2|25–29|||
Relative|Other blood cancers|2015–2019|Persons|2|30–34|||
Relative|Other blood cancers|2015–2019|Persons|2|35–39|1.002|0.879|1.002
Relative|Other blood cancers|2015–2019|Persons|2|40–44|0.933|0.801|0.98
Relative|Other blood cancers|2015–2019|Persons|2|45–49|0.841|0.654|0.933
Relative|Other blood cancers|2015–2019|Persons|2|50–54|0.755|0.566|0.872
Relative|Other blood cancers|2015–2019|Persons|2|55–59|0.845|0.628|0.944
Relative|Other blood cancers|2015–2019|Persons|2|60–64|0.777|0.607|0.883
Relative|Other blood cancers|2015–2019|Persons|2|65–69|0.633|0.448|0.774
Relative|Other blood cancers|2015–2019|Persons|2|70–74|||
Relative|Other blood cancers|2015–2019|Persons|2|75–79|||
Relative|Other blood cancers|2015–2019|Persons|2|80–84|||
Relative|Other blood cancers|2015–2019|Persons|2|85+|||
Relative|Other blood cancers|2015–2019|Persons|2|All ages combined|0.831|0.793|0.863
Relative|Other blood cancers|2015–2019|Persons|3|00–04|0.983|0.879|0.999
Relative|Other blood cancers|2015–2019|Persons|3|05–09|1|0.91|1
Relative|Other blood cancers|2015–2019|Persons|3|10–14|0.962|0.757|0.995
Relative|Other blood cancers|2015–2019|Persons|3|15–19|||
Relative|Other blood cancers|2015–2019|Persons|3|20–24|||
Relative|Other blood cancers|2015–2019|Persons|3|25–29|||
Relative|Other blood cancers|2015–2019|Persons|3|30–34|||
Relative|Other blood cancers|2015–2019|Persons|3|35–39|1.003|0.887|1.003
Relative|Other blood cancers|2015–2019|Persons|3|40–44|0.912|0.777|0.969
Relative|Other blood cancers|2015–2019|Persons|3|45–49|0.811|0.621|0.914
Relative|Other blood cancers|2015–2019|Persons|3|50–54|0.758|0.568|0.875
Relative|Other blood cancers|2015–2019|Persons|3|55–59|0.813|0.596|0.926
Relative|Other blood cancers|2015–2019|Persons|3|60–64|0.757|0.586|0.87
Relative|Other blood cancers|2015–2019|Persons|3|65–69|0.53|0.352|0.684
Relative|Other blood cancers|2015–2019|Persons|3|70–74|||
Relative|Other blood cancers|2015–2019|Persons|3|75–79|||
Relative|Other blood cancers|2015–2019|Persons|3|80–84|||
Relative|Other blood cancers|2015–2019|Persons|3|85+|||
Relative|Other blood cancers|2015–2019|Persons|3|All ages combined|0.811|0.772|0.845
Relative|Other blood cancers|2015–2019|Persons|4|00–04|0.983|0.879|0.999
Relative|Other blood cancers|2015–2019|Persons|4|05–09|1|0.915|1
Relative|Other blood cancers|2015–2019|Persons|4|10–14|0.962|0.757|0.995
Relative|Other blood cancers|2015–2019|Persons|4|15–19|||
Relative|Other blood cancers|2015–2019|Persons|4|20–24|||
Relative|Other blood cancers|2015–2019|Persons|4|25–29|||
Relative|Other blood cancers|2015–2019|Persons|4|30–34|||
Relative|Other blood cancers|2015–2019|Persons|4|35–39|1.004|0.893|1.004
Relative|Other blood cancers|2015–2019|Persons|4|40–44|0.891|0.751|0.957
Relative|Other blood cancers|2015–2019|Persons|4|45–49|0.813|0.623|0.916
Relative|Other blood cancers|2015–2019|Persons|4|50–54|0.73|0.539|0.855
Relative|Other blood cancers|2015–2019|Persons|4|55–59|0.718|0.506|0.856
Relative|Other blood cancers|2015–2019|Persons|4|60–64|0.734|0.558|0.854
Relative|Other blood cancers|2015–2019|Persons|4|65–69|||
Relative|Other blood cancers|2015–2019|Persons|4|70–74|||
Relative|Other blood cancers|2015–2019|Persons|4|75–79|||
Relative|Other blood cancers|2015–2019|Persons|4|80–84|||
Relative|Other blood cancers|2015–2019|Persons|4|85+|||
Relative|Other blood cancers|2015–2019|Persons|4|All ages combined|0.798|0.757|0.833
Relative|Other blood cancers|2015–2019|Persons|5|00–04|0.983|0.879|0.999
Relative|Other blood cancers|2015–2019|Persons|5|05–09|1|0.915|1
Relative|Other blood cancers|2015–2019|Persons|5|10–14|0.962|0.757|0.995
Relative|Other blood cancers|2015–2019|Persons|5|15–19|||
Relative|Other blood cancers|2015–2019|Persons|5|20–24|||
Relative|Other blood cancers|2015–2019|Persons|5|25–29|||
Relative|Other blood cancers|2015–2019|Persons|5|30–34|||
Relative|Other blood cancers|2015–2019|Persons|5|35–39|1.005|0.896|1.005
Relative|Other blood cancers|2015–2019|Persons|5|40–44|0.893|0.752|0.959
Relative|Other blood cancers|2015–2019|Persons|5|45–49|0.815|0.625|0.918
Relative|Other blood cancers|2015–2019|Persons|5|50–54|0.704|0.513|0.835
Relative|Other blood cancers|2015–2019|Persons|5|55–59|0.723|0.509|0.861
Relative|Other blood cancers|2015–2019|Persons|5|60–64|0.705|0.523|0.835
Relative|Other blood cancers|2015–2019|Persons|5|65–69|||
Relative|Other blood cancers|2015–2019|Persons|5|70–74|||
Relative|Other blood cancers|2015–2019|Persons|5|75–79|||
Relative|Other blood cancers|2015–2019|Persons|5|80–84|||
Relative|Other blood cancers|2015–2019|Persons|5|85+|||
Relative|Other blood cancers|2015–2019|Persons|5|All ages combined|0.785|0.744|0.821
Observed|Other central nervous system cancers|2015–2019|Males|1|00–04|||
Observed|Other central nervous system cancers|2015–2019|Males|1|05–09|||
Observed|Other central nervous system cancers|2015–2019|Males|1|10–14|0.953|0.71|0.993
Observed|Other central nervous system cancers|2015–2019|Males|1|15–19|0.954|0.714|0.993
Observed|Other central nervous system cancers|2015–2019|Males|1|20–24|||
Observed|Other central nervous system cancers|2015–2019|Males|1|25–29|||
Observed|Other central nervous system cancers|2015–2019|Males|1|30–34|||
Observed|Other central nervous system cancers|2015–2019|Males|1|35–39|||
Observed|Other central nervous system cancers|2015–2019|Males|1|40–44|||
Observed|Other central nervous system cancers|2015–2019|Males|1|45–49|||
Observed|Other central nervous system cancers|2015–2019|Males|1|50–54|||
Observed|Other central nervous system cancers|2015–2019|Males|1|55–59|0.963|0.764|0.995
Observed|Other central nervous system cancers|2015–2019|Males|1|60–64|||
Observed|Other central nervous system cancers|2015–2019|Males|1|65–69|0.779|0.55|0.902
Observed|Other central nervous system cancers|2015–2019|Males|1|70–74|||
Observed|Other central nervous system cancers|2015–2019|Males|1|75–79|||
Observed|Other central nervous system cancers|2015–2019|Males|1|80–84|||
Observed|Other central nervous system cancers|2015–2019|Males|1|85+|||
Observed|Other central nervous system cancers|2015–2019|Males|1|All ages combined|0.841|0.795|0.878
Observed|Other central nervous system cancers|2015–2019|Males|2|00–04|||
Observed|Other central nervous system cancers|2015–2019|Males|2|05–09|||
Observed|Other central nervous system cancers|2015–2019|Males|2|10–14|||
Observed|Other central nervous system cancers|2015–2019|Males|2|15–19|0.876|0.663|0.958
Observed|Other central nervous system cancers|2015–2019|Males|2|20–24|||
Observed|Other central nervous system cancers|2015–2019|Males|2|25–29|||
Observed|Other central nervous system cancers|2015–2019|Males|2|30–34|||
Observed|Other central nervous system cancers|2015–2019|Males|2|35–39|||
Observed|Other central nervous system cancers|2015–2019|Males|2|40–44|||
Observed|Other central nervous system cancers|2015–2019|Males|2|45–49|||
Observed|Other central nervous system cancers|2015–2019|Males|2|50–54|||
Observed|Other central nervous system cancers|2015–2019|Males|2|55–59|0.927|0.738|0.981
Observed|Other central nervous system cancers|2015–2019|Males|2|60–64|||
Observed|Other central nervous system cancers|2015–2019|Males|2|65–69|||
Observed|Other central nervous system cancers|2015–2019|Males|2|70–74|||
Observed|Other central nervous system cancers|2015–2019|Males|2|75–79|||
Observed|Other central nervous system cancers|2015–2019|Males|2|80–84|||
Observed|Other central nervous system cancers|2015–2019|Males|2|85+|||
Observed|Other central nervous system cancers|2015–2019|Males|2|All ages combined|0.761|0.708|0.805
Observed|Other central nervous system cancers|2015–2019|Males|3|00–04|||
Observed|Other central nervous system cancers|2015–2019|Males|3|05–09|||
Observed|Other central nervous system cancers|2015–2019|Males|3|10–14|||
Observed|Other central nervous system cancers|2015–2019|Males|3|15–19|||
Observed|Other central nervous system cancers|2015–2019|Males|3|20–24|||
Observed|Other central nervous system cancers|2015–2019|Males|3|25–29|||
Observed|Other central nervous system cancers|2015–2019|Males|3|30–34|||
Observed|Other central nervous system cancers|2015–2019|Males|3|35–39|||
Observed|Other central nervous system cancers|2015–2019|Males|3|40–44|||
Observed|Other central nervous system cancers|2015–2019|Males|3|45–49|||
Observed|Other central nervous system cancers|2015–2019|Males|3|50–54|||
Observed|Other central nervous system cancers|2015–2019|Males|3|55–59|0.885|0.683|0.962
Observed|Other central nervous system cancers|2015–2019|Males|3|60–64|||
Observed|Other central nervous system cancers|2015–2019|Males|3|65–69|||
Observed|Other central nervous system cancers|2015–2019|Males|3|70–74|||
Observed|Other central nervous system cancers|2015–2019|Males|3|75–79|||
Observed|Other central nervous system cancers|2015–2019|Males|3|80–84|||
Observed|Other central nervous system cancers|2015–2019|Males|3|85+|||
Observed|Other central nervous system cancers|2015–2019|Males|3|All ages combined|0.719|0.665|0.766
Observed|Other central nervous system cancers|2015–2019|Males|4|00–04|||
Observed|Other central nervous system cancers|2015–2019|Males|4|05–09|||
Observed|Other central nervous system cancers|2015–2019|Males|4|10–14|||
Observed|Other central nervous system cancers|2015–2019|Males|4|15–19|||
Observed|Other central nervous system cancers|2015–2019|Males|4|20–24|||
Observed|Other central nervous system cancers|2015–2019|Males|4|25–29|||
Observed|Other central nervous system cancers|2015–2019|Males|4|30–34|||
Observed|Other central nervous system cancers|2015–2019|Males|4|35–39|||
Observed|Other central nervous system cancers|2015–2019|Males|4|40–44|||
Observed|Other central nervous system cancers|2015–2019|Males|4|45–49|||
Observed|Other central nervous system cancers|2015–2019|Males|4|50–54|||
Observed|Other central nervous system cancers|2015–2019|Males|4|55–59|||
Observed|Other central nervous system cancers|2015–2019|Males|4|60–64|||
Observed|Other central nervous system cancers|2015–2019|Males|4|65–69|||
Observed|Other central nervous system cancers|2015–2019|Males|4|70–74|||
Observed|Other central nervous system cancers|2015–2019|Males|4|75–79|||
Observed|Other central nervous system cancers|2015–2019|Males|4|80–84|||
Observed|Other central nervous system cancers|2015–2019|Males|4|85+|||
Observed|Other central nervous system cancers|2015–2019|Males|4|All ages combined|0.706|0.652|0.754
Observed|Other central nervous system cancers|2015–2019|Males|5|00–04|||
Observed|Other central nervous system cancers|2015–2019|Males|5|05–09|||
Observed|Other central nervous system cancers|2015–2019|Males|5|10–14|||
Observed|Other central nervous system cancers|2015–2019|Males|5|15–19|||
Observed|Other central nervous system cancers|2015–2019|Males|5|20–24|||
Observed|Other central nervous system cancers|2015–2019|Males|5|25–29|||
Observed|Other central nervous system cancers|2015–2019|Males|5|30–34|||
Observed|Other central nervous system cancers|2015–2019|Males|5|35–39|||
Observed|Other central nervous system cancers|2015–2019|Males|5|40–44|||
Observed|Other central nervous system cancers|2015–2019|Males|5|45–49|||
Observed|Other central nervous system cancers|2015–2019|Males|5|50–54|||
Observed|Other central nervous system cancers|2015–2019|Males|5|55–59|||
Observed|Other central nervous system cancers|2015–2019|Males|5|60–64|||
Observed|Other central nervous system cancers|2015–2019|Males|5|65–69|||
Observed|Other central nervous system cancers|2015–2019|Males|5|70–74|||
Observed|Other central nervous system cancers|2015–2019|Males|5|75–79|||
Observed|Other central nervous system cancers|2015–2019|Males|5|80–84|||
Observed|Other central nervous system cancers|2015–2019|Males|5|85+|||
Observed|Other central nervous system cancers|2015–2019|Males|5|All ages combined|0.684|0.629|0.733
Relative|Other central nervous system cancers|2015–2019|Males|1|00–04|||
Relative|Other central nervous system cancers|2015–2019|Males|1|05–09|||
Relative|Other central nervous system cancers|2015–2019|Males|1|10–14|0.953|0.71|0.993
Relative|Other central nervous system cancers|2015–2019|Males|1|15–19|0.954|0.715|0.994
Relative|Other central nervous system cancers|2015–2019|Males|1|20–24|||
Relative|Other central nervous system cancers|2015–2019|Males|1|25–29|||
Relative|Other central nervous system cancers|2015–2019|Males|1|30–34|||
Relative|Other central nervous system cancers|2015–2019|Males|1|35–39|||
Relative|Other central nervous system cancers|2015–2019|Males|1|40–44|||
Relative|Other central nervous system cancers|2015–2019|Males|1|45–49|||
Relative|Other central nervous system cancers|2015–2019|Males|1|50–54|||
Relative|Other central nervous system cancers|2015–2019|Males|1|55–59|0.968|0.768|1
Relative|Other central nervous system cancers|2015–2019|Males|1|60–64|||
Relative|Other central nervous system cancers|2015–2019|Males|1|65–69|0.789|0.556|0.912
Relative|Other central nervous system cancers|2015–2019|Males|1|70–74|||
Relative|Other central nervous system cancers|2015–2019|Males|1|75–79|||
Relative|Other central nervous system cancers|2015–2019|Males|1|80–84|||
Relative|Other central nervous system cancers|2015–2019|Males|1|85+|||
Relative|Other central nervous system cancers|2015–2019|Males|1|All ages combined|0.85|0.803|0.888
Relative|Other central nervous system cancers|2015–2019|Males|2|00–04|||
Relative|Other central nervous system cancers|2015–2019|Males|2|05–09|||
Relative|Other central nervous system cancers|2015–2019|Males|2|10–14|||
Relative|Other central nervous system cancers|2015–2019|Males|2|15–19|0.877|0.664|0.959
Relative|Other central nervous system cancers|2015–2019|Males|2|20–24|||
Relative|Other central nervous system cancers|2015–2019|Males|2|25–29|||
Relative|Other central nervous system cancers|2015–2019|Males|2|30–34|||
Relative|Other central nervous system cancers|2015–2019|Males|2|35–39|||
Relative|Other central nervous system cancers|2015–2019|Males|2|40–44|||
Relative|Other central nervous system cancers|2015–2019|Males|2|45–49|||
Relative|Other central nervous system cancers|2015–2019|Males|2|50–54|||
Relative|Other central nervous system cancers|2015–2019|Males|2|55–59|0.937|0.746|0.992
Relative|Other central nervous system cancers|2015–2019|Males|2|60–64|||
Relative|Other central nervous system cancers|2015–2019|Males|2|65–69|||
Relative|Other central nervous system cancers|2015–2019|Males|2|70–74|||
Relative|Other central nervous system cancers|2015–2019|Males|2|75–79|||
Relative|Other central nervous system cancers|2015–2019|Males|2|80–84|||
Relative|Other central nervous system cancers|2015–2019|Males|2|85+|||
Relative|Other central nervous system cancers|2015–2019|Males|2|All ages combined|0.774|0.721|0.819
Relative|Other central nervous system cancers|2015–2019|Males|3|00–04|||
Relative|Other central nervous system cancers|2015–2019|Males|3|05–09|||
Relative|Other central nervous system cancers|2015–2019|Males|3|10–14|||
Relative|Other central nervous system cancers|2015–2019|Males|3|15–19|||
Relative|Other central nervous system cancers|2015–2019|Males|3|20–24|||
Relative|Other central nervous system cancers|2015–2019|Males|3|25–29|||
Relative|Other central nervous system cancers|2015–2019|Males|3|30–34|||
Relative|Other central nervous system cancers|2015–2019|Males|3|35–39|||
Relative|Other central nervous system cancers|2015–2019|Males|3|40–44|||
Relative|Other central nervous system cancers|2015–2019|Males|3|45–49|||
Relative|Other central nervous system cancers|2015–2019|Males|3|50–54|||
Relative|Other central nervous system cancers|2015–2019|Males|3|55–59|0.9|0.695|0.978
Relative|Other central nervous system cancers|2015–2019|Males|3|60–64|||
Relative|Other central nervous system cancers|2015–2019|Males|3|65–69|||
Relative|Other central nervous system cancers|2015–2019|Males|3|70–74|||
Relative|Other central nervous system cancers|2015–2019|Males|3|75–79|||
Relative|Other central nervous system cancers|2015–2019|Males|3|80–84|||
Relative|Other central nervous system cancers|2015–2019|Males|3|85+|||
Relative|Other central nervous system cancers|2015–2019|Males|3|All ages combined|0.738|0.682|0.786
Relative|Other central nervous system cancers|2015–2019|Males|4|00–04|||
Relative|Other central nervous system cancers|2015–2019|Males|4|05–09|||
Relative|Other central nervous system cancers|2015–2019|Males|4|10–14|||
Relative|Other central nervous system cancers|2015–2019|Males|4|15–19|||
Relative|Other central nervous system cancers|2015–2019|Males|4|20–24|||
Relative|Other central nervous system cancers|2015–2019|Males|4|25–29|||
Relative|Other central nervous system cancers|2015–2019|Males|4|30–34|||
Relative|Other central nervous system cancers|2015–2019|Males|4|35–39|||
Relative|Other central nervous system cancers|2015–2019|Males|4|40–44|||
Relative|Other central nervous system cancers|2015–2019|Males|4|45–49|||
Relative|Other central nervous system cancers|2015–2019|Males|4|50–54|||
Relative|Other central nervous system cancers|2015–2019|Males|4|55–59|||
Relative|Other central nervous system cancers|2015–2019|Males|4|60–64|||
Relative|Other central nervous system cancers|2015–2019|Males|4|65–69|||
Relative|Other central nervous system cancers|2015–2019|Males|4|70–74|||
Relative|Other central nervous system cancers|2015–2019|Males|4|75–79|||
Relative|Other central nervous system cancers|2015–2019|Males|4|80–84|||
Relative|Other central nervous system cancers|2015–2019|Males|4|85+|||
Relative|Other central nervous system cancers|2015–2019|Males|4|All ages combined|0.731|0.674|0.78
Relative|Other central nervous system cancers|2015–2019|Males|5|00–04|||
Relative|Other central nervous system cancers|2015–2019|Males|5|05–09|||
Relative|Other central nervous system cancers|2015–2019|Males|5|10–14|||
Relative|Other central nervous system cancers|2015–2019|Males|5|15–19|||
Relative|Other central nervous system cancers|2015–2019|Males|5|20–24|||
Relative|Other central nervous system cancers|2015–2019|Males|5|25–29|||
Relative|Other central nervous system cancers|2015–2019|Males|5|30–34|||
Relative|Other central nervous system cancers|2015–2019|Males|5|35–39|||
Relative|Other central nervous system cancers|2015–2019|Males|5|40–44|||
Relative|Other central nervous system cancers|2015–2019|Males|5|45–49|||
Relative|Other central nervous system cancers|2015–2019|Males|5|50–54|||
Relative|Other central nervous system cancers|2015–2019|Males|5|55–59|||
Relative|Other central nervous system cancers|2015–2019|Males|5|60–64|||
Relative|Other central nervous system cancers|2015–2019|Males|5|65–69|||
Relative|Other central nervous system cancers|2015–2019|Males|5|70–74|||
Relative|Other central nervous system cancers|2015–2019|Males|5|75–79|||
Relative|Other central nervous system cancers|2015–2019|Males|5|80–84|||
Relative|Other central nervous system cancers|2015–2019|Males|5|85+|||
Relative|Other central nervous system cancers|2015–2019|Males|5|All ages combined|0.714|0.656|0.765
Observed|Other central nervous system cancers|2015–2019|Females|1|00–04|0.918|0.709|0.979
Observed|Other central nervous system cancers|2015–2019|Females|1|05–09|||
Observed|Other central nervous system cancers|2015–2019|Females|1|10–14|||
Observed|Other central nervous system cancers|2015–2019|Females|1|15–19|||
Observed|Other central nervous system cancers|2015–2019|Females|1|20–24|||
Observed|Other central nervous system cancers|2015–2019|Females|1|25–29|||
Observed|Other central nervous system cancers|2015–2019|Females|1|30–34|||
Observed|Other central nervous system cancers|2015–2019|Females|1|35–39|||
Observed|Other central nervous system cancers|2015–2019|Females|1|40–44|||
Observed|Other central nervous system cancers|2015–2019|Females|1|45–49|||
Observed|Other central nervous system cancers|2015–2019|Females|1|50–54|0.96|0.746|0.994
Observed|Other central nervous system cancers|2015–2019|Females|1|55–59|0.881|0.676|0.96
Observed|Other central nervous system cancers|2015–2019|Females|1|60–64|0.936|0.768|0.984
Observed|Other central nervous system cancers|2015–2019|Females|1|65–69|0.839|0.656|0.93
Observed|Other central nervous system cancers|2015–2019|Females|1|70–74|0.874|0.659|0.958
Observed|Other central nervous system cancers|2015–2019|Females|1|75–79|||
Observed|Other central nervous system cancers|2015–2019|Females|1|80–84|||
Observed|Other central nervous system cancers|2015–2019|Females|1|85+|||
Observed|Other central nervous system cancers|2015–2019|Females|1|All ages combined|0.843|0.797|0.88
Observed|Other central nervous system cancers|2015–2019|Females|2|00–04|0.876|0.664|0.958
Observed|Other central nervous system cancers|2015–2019|Females|2|05–09|||
Observed|Other central nervous system cancers|2015–2019|Females|2|10–14|||
Observed|Other central nervous system cancers|2015–2019|Females|2|15–19|||
Observed|Other central nervous system cancers|2015–2019|Females|2|20–24|||
Observed|Other central nervous system cancers|2015–2019|Females|2|25–29|||
Observed|Other central nervous system cancers|2015–2019|Females|2|30–34|||
Observed|Other central nervous system cancers|2015–2019|Females|2|35–39|||
Observed|Other central nervous system cancers|2015–2019|Females|2|40–44|||
Observed|Other central nervous system cancers|2015–2019|Females|2|45–49|||
Observed|Other central nervous system cancers|2015–2019|Females|2|50–54|0.876|0.663|0.958
Observed|Other central nervous system cancers|2015–2019|Females|2|55–59|0.881|0.676|0.96
Observed|Other central nervous system cancers|2015–2019|Females|2|60–64|0.799|0.607|0.905
Observed|Other central nervous system cancers|2015–2019|Females|2|65–69|0.728|0.528|0.854
Observed|Other central nervous system cancers|2015–2019|Females|2|70–74|0.874|0.659|0.958
Observed|Other central nervous system cancers|2015–2019|Females|2|75–79|||
Observed|Other central nervous system cancers|2015–2019|Females|2|80–84|||
Observed|Other central nervous system cancers|2015–2019|Females|2|85+|||
Observed|Other central nervous system cancers|2015–2019|Females|2|All ages combined|0.78|0.729|0.823
Observed|Other central nervous system cancers|2015–2019|Females|3|00–04|0.838|0.623|0.936
Observed|Other central nervous system cancers|2015–2019|Females|3|05–09|||
Observed|Other central nervous system cancers|2015–2019|Females|3|10–14|||
Observed|Other central nervous system cancers|2015–2019|Females|3|15–19|||
Observed|Other central nervous system cancers|2015–2019|Females|3|20–24|||
Observed|Other central nervous system cancers|2015–2019|Females|3|25–29|||
Observed|Other central nervous system cancers|2015–2019|Females|3|30–34|||
Observed|Other central nervous system cancers|2015–2019|Females|3|35–39|||
Observed|Other central nervous system cancers|2015–2019|Females|3|40–44|||
Observed|Other central nervous system cancers|2015–2019|Females|3|45–49|||
Observed|Other central nervous system cancers|2015–2019|Females|3|50–54|0.835|0.619|0.935
Observed|Other central nervous system cancers|2015–2019|Females|3|55–59|0.815|0.611|0.918
Observed|Other central nervous system cancers|2015–2019|Females|3|60–64|0.724|0.521|0.852
Observed|Other central nervous system cancers|2015–2019|Females|3|65–69|0.673|0.477|0.809
Observed|Other central nervous system cancers|2015–2019|Females|3|70–74|||
Observed|Other central nervous system cancers|2015–2019|Females|3|75–79|||
Observed|Other central nervous system cancers|2015–2019|Females|3|80–84|||
Observed|Other central nervous system cancers|2015–2019|Females|3|85+|||
Observed|Other central nervous system cancers|2015–2019|Females|3|All ages combined|0.731|0.677|0.778
Observed|Other central nervous system cancers|2015–2019|Females|4|00–04|0.838|0.623|0.936
Observed|Other central nervous system cancers|2015–2019|Females|4|05–09|||
Observed|Other central nervous system cancers|2015–2019|Females|4|10–14|||
Observed|Other central nervous system cancers|2015–2019|Females|4|15–19|||
Observed|Other central nervous system cancers|2015–2019|Females|4|20–24|||
Observed|Other central nervous system cancers|2015–2019|Females|4|25–29|||
Observed|Other central nervous system cancers|2015–2019|Females|4|30–34|||
Observed|Other central nervous system cancers|2015–2019|Females|4|35–39|||
Observed|Other central nervous system cancers|2015–2019|Females|4|40–44|||
Observed|Other central nervous system cancers|2015–2019|Females|4|45–49|||
Observed|Other central nervous system cancers|2015–2019|Females|4|50–54|0.835|0.619|0.935
Observed|Other central nervous system cancers|2015–2019|Females|4|55–59|0.815|0.611|0.918
Observed|Other central nervous system cancers|2015–2019|Females|4|60–64|||
Observed|Other central nervous system cancers|2015–2019|Females|4|65–69|0.673|0.477|0.809
Observed|Other central nervous system cancers|2015–2019|Females|4|70–74|||
Observed|Other central nervous system cancers|2015–2019|Females|4|75–79|||
Observed|Other central nervous system cancers|2015–2019|Females|4|80–84|||
Observed|Other central nervous system cancers|2015–2019|Females|4|85+|||
Observed|Other central nervous system cancers|2015–2019|Females|4|All ages combined|0.703|0.648|0.751
Observed|Other central nervous system cancers|2015–2019|Females|5|00–04|0.808|0.598|0.915
Observed|Other central nervous system cancers|2015–2019|Females|5|05–09|||
Observed|Other central nervous system cancers|2015–2019|Females|5|10–14|||
Observed|Other central nervous system cancers|2015–2019|Females|5|15–19|||
Observed|Other central nervous system cancers|2015–2019|Females|5|20–24|||
Observed|Other central nervous system cancers|2015–2019|Females|5|25–29|||
Observed|Other central nervous system cancers|2015–2019|Females|5|30–34|||
Observed|Other central nervous system cancers|2015–2019|Females|5|35–39|||
Observed|Other central nervous system cancers|2015–2019|Females|5|40–44|||
Observed|Other central nervous system cancers|2015–2019|Females|5|45–49|||
Observed|Other central nervous system cancers|2015–2019|Females|5|50–54|||
Observed|Other central nervous system cancers|2015–2019|Females|5|55–59|0.732|0.535|0.855
Observed|Other central nervous system cancers|2015–2019|Females|5|60–64|||
Observed|Other central nervous system cancers|2015–2019|Females|5|65–69|0.644|0.45|0.785
Observed|Other central nervous system cancers|2015–2019|Females|5|70–74|||
Observed|Other central nervous system cancers|2015–2019|Females|5|75–79|||
Observed|Other central nervous system cancers|2015–2019|Females|5|80–84|||
Observed|Other central nervous system cancers|2015–2019|Females|5|85+|||
Observed|Other central nervous system cancers|2015–2019|Females|5|All ages combined|0.672|0.616|0.721
Relative|Other central nervous system cancers|2015–2019|Females|1|00–04|0.918|0.709|0.979
Relative|Other central nervous system cancers|2015–2019|Females|1|05–09|||
Relative|Other central nervous system cancers|2015–2019|Females|1|10–14|||
Relative|Other central nervous system cancers|2015–2019|Females|1|15–19|||
Relative|Other central nervous system cancers|2015–2019|Females|1|20–24|||
Relative|Other central nervous system cancers|2015–2019|Females|1|25–29|||
Relative|Other central nervous system cancers|2015–2019|Females|1|30–34|||
Relative|Other central nervous system cancers|2015–2019|Females|1|35–39|||
Relative|Other central nervous system cancers|2015–2019|Females|1|40–44|||
Relative|Other central nervous system cancers|2015–2019|Females|1|45–49|||
Relative|Other central nervous system cancers|2015–2019|Females|1|50–54|0.962|0.747|0.996
Relative|Other central nervous system cancers|2015–2019|Females|1|55–59|0.884|0.678|0.963
Relative|Other central nervous system cancers|2015–2019|Females|1|60–64|0.941|0.772|0.988
Relative|Other central nervous system cancers|2015–2019|Females|1|65–69|0.845|0.661|0.937
Relative|Other central nervous system cancers|2015–2019|Females|1|70–74|0.885|0.667|0.97
Relative|Other central nervous system cancers|2015–2019|Females|1|75–79|||
Relative|Other central nervous system cancers|2015–2019|Females|1|80–84|||
Relative|Other central nervous system cancers|2015–2019|Females|1|85+|||
Relative|Other central nervous system cancers|2015–2019|Females|1|All ages combined|0.855|0.808|0.892
Relative|Other central nervous system cancers|2015–2019|Females|2|00–04|0.877|0.664|0.959
Relative|Other central nervous system cancers|2015–2019|Females|2|05–09|||
Relative|Other central nervous system cancers|2015–2019|Females|2|10–14|||
Relative|Other central nervous system cancers|2015–2019|Females|2|15–19|||
Relative|Other central nervous system cancers|2015–2019|Females|2|20–24|||
Relative|Other central nervous system cancers|2015–2019|Females|2|25–29|||
Relative|Other central nervous system cancers|2015–2019|Females|2|30–34|||
Relative|Other central nervous system cancers|2015–2019|Females|2|35–39|||
Relative|Other central nervous system cancers|2015–2019|Females|2|40–44|||
Relative|Other central nervous system cancers|2015–2019|Females|2|45–49|||
Relative|Other central nervous system cancers|2015–2019|Females|2|50–54|0.88|0.665|0.962
Relative|Other central nervous system cancers|2015–2019|Females|2|55–59|0.887|0.681|0.967
Relative|Other central nervous system cancers|2015–2019|Females|2|60–64|0.807|0.613|0.914
Relative|Other central nervous system cancers|2015–2019|Females|2|65–69|0.74|0.536|0.868
Relative|Other central nervous system cancers|2015–2019|Females|2|70–74|0.897|0.677|0.983
Relative|Other central nervous system cancers|2015–2019|Females|2|75–79|||
Relative|Other central nervous system cancers|2015–2019|Females|2|80–84|||
Relative|Other central nervous system cancers|2015–2019|Females|2|85+|||
Relative|Other central nervous system cancers|2015–2019|Females|2|All ages combined|0.797|0.745|0.841
Relative|Other central nervous system cancers|2015–2019|Females|3|00–04|0.838|0.624|0.936
Relative|Other central nervous system cancers|2015–2019|Females|3|05–09|||
Relative|Other central nervous system cancers|2015–2019|Females|3|10–14|||
Relative|Other central nervous system cancers|2015–2019|Females|3|15–19|||
Relative|Other central nervous system cancers|2015–2019|Females|3|20–24|||
Relative|Other central nervous system cancers|2015–2019|Females|3|25–29|||
Relative|Other central nervous system cancers|2015–2019|Females|3|30–34|||
Relative|Other central nervous system cancers|2015–2019|Females|3|35–39|||
Relative|Other central nervous system cancers|2015–2019|Females|3|40–44|||
Relative|Other central nervous system cancers|2015–2019|Females|3|45–49|||
Relative|Other central nervous system cancers|2015–2019|Females|3|50–54|0.841|0.623|0.941
Relative|Other central nervous system cancers|2015–2019|Females|3|55–59|0.823|0.617|0.928
Relative|Other central nervous system cancers|2015–2019|Females|3|60–64|0.735|0.53|0.865
Relative|Other central nervous system cancers|2015–2019|Females|3|65–69|0.69|0.489|0.829
Relative|Other central nervous system cancers|2015–2019|Females|3|70–74|||
Relative|Other central nervous system cancers|2015–2019|Females|3|75–79|||
Relative|Other central nervous system cancers|2015–2019|Females|3|80–84|||
Relative|Other central nervous system cancers|2015–2019|Females|3|85+|||
Relative|Other central nervous system cancers|2015–2019|Females|3|All ages combined|0.754|0.699|0.802
Relative|Other central nervous system cancers|2015–2019|Females|4|00–04|0.838|0.624|0.936
Relative|Other central nervous system cancers|2015–2019|Females|4|05–09|||
Relative|Other central nervous system cancers|2015–2019|Females|4|10–14|||
Relative|Other central nervous system cancers|2015–2019|Females|4|15–19|||
Relative|Other central nervous system cancers|2015–2019|Females|4|20–24|||
Relative|Other central nervous system cancers|2015–2019|Females|4|25–29|||
Relative|Other central nervous system cancers|2015–2019|Females|4|30–34|||
Relative|Other central nervous system cancers|2015–2019|Females|4|35–39|||
Relative|Other central nervous system cancers|2015–2019|Females|4|40–44|||
Relative|Other central nervous system cancers|2015–2019|Females|4|45–49|||
Relative|Other central nervous system cancers|2015–2019|Females|4|50–54|0.843|0.625|0.944
Relative|Other central nervous system cancers|2015–2019|Females|4|55–59|0.827|0.62|0.932
Relative|Other central nervous system cancers|2015–2019|Females|4|60–64|||
Relative|Other central nervous system cancers|2015–2019|Females|4|65–69|0.697|0.494|0.838
Relative|Other central nervous system cancers|2015–2019|Females|4|70–74|||
Relative|Other central nervous system cancers|2015–2019|Females|4|75–79|||
Relative|Other central nervous system cancers|2015–2019|Females|4|80–84|||
Relative|Other central nervous system cancers|2015–2019|Females|4|85+|||
Relative|Other central nervous system cancers|2015–2019|Females|4|All ages combined|0.731|0.674|0.781
Relative|Other central nervous system cancers|2015–2019|Females|5|00–04|0.808|0.598|0.916
Relative|Other central nervous system cancers|2015–2019|Females|5|05–09|||
Relative|Other central nervous system cancers|2015–2019|Females|5|10–14|||
Relative|Other central nervous system cancers|2015–2019|Females|5|15–19|||
Relative|Other central nervous system cancers|2015–2019|Females|5|20–24|||
Relative|Other central nervous system cancers|2015–2019|Females|5|25–29|||
Relative|Other central nervous system cancers|2015–2019|Females|5|30–34|||
Relative|Other central nervous system cancers|2015–2019|Females|5|35–39|||
Relative|Other central nervous system cancers|2015–2019|Females|5|40–44|||
Relative|Other central nervous system cancers|2015–2019|Females|5|45–49|||
Relative|Other central nervous system cancers|2015–2019|Females|5|50–54|||
Relative|Other central nervous system cancers|2015–2019|Females|5|55–59|0.745|0.545|0.872
Relative|Other central nervous system cancers|2015–2019|Females|5|60–64|||
Relative|Other central nervous system cancers|2015–2019|Females|5|65–69|0.674|0.471|0.822
Relative|Other central nervous system cancers|2015–2019|Females|5|70–74|||
Relative|Other central nervous system cancers|2015–2019|Females|5|75–79|||
Relative|Other central nervous system cancers|2015–2019|Females|5|80–84|||
Relative|Other central nervous system cancers|2015–2019|Females|5|85+|||
Relative|Other central nervous system cancers|2015–2019|Females|5|All ages combined|0.704|0.646|0.756
Observed|Other central nervous system cancers|2015–2019|Persons|1|00–04|0.884|0.744|0.95
Observed|Other central nervous system cancers|2015–2019|Persons|1|05–09|0.956|0.726|0.994
Observed|Other central nervous system cancers|2015–2019|Persons|1|10–14|0.894|0.707|0.965
Observed|Other central nervous system cancers|2015–2019|Persons|1|15–19|0.93|0.749|0.982
Observed|Other central nervous system cancers|2015–2019|Persons|1|20–24|0.96|0.746|0.994
Observed|Other central nervous system cancers|2015–2019|Persons|1|25–29|||
Observed|Other central nervous system cancers|2015–2019|Persons|1|30–34|0.921|0.721|0.98
Observed|Other central nervous system cancers|2015–2019|Persons|1|35–39|0.965|0.775|0.995
Observed|Other central nervous system cancers|2015–2019|Persons|1|40–44|0.895|0.709|0.965
Observed|Other central nervous system cancers|2015–2019|Persons|1|45–49|0.968|0.794|0.995
Observed|Other central nervous system cancers|2015–2019|Persons|1|50–54|0.933|0.806|0.978
Observed|Other central nervous system cancers|2015–2019|Persons|1|55–59|0.923|0.808|0.97
Observed|Other central nervous system cancers|2015–2019|Persons|1|60–64|0.892|0.759|0.953
Observed|Other central nervous system cancers|2015–2019|Persons|1|65–69|0.814|0.682|0.895
Observed|Other central nervous system cancers|2015–2019|Persons|1|70–74|0.824|0.667|0.912
Observed|Other central nervous system cancers|2015–2019|Persons|1|75–79|0.739|0.53|0.866
Observed|Other central nervous system cancers|2015–2019|Persons|1|80–84|||
Observed|Other central nervous system cancers|2015–2019|Persons|1|85+|||
Observed|Other central nervous system cancers|2015–2019|Persons|1|All ages combined|0.842|0.811|0.869
Observed|Other central nervous system cancers|2015–2019|Persons|2|00–04|0.821|0.674|0.906
Observed|Other central nervous system cancers|2015–2019|Persons|2|05–09|0.956|0.726|0.994
Observed|Other central nervous system cancers|2015–2019|Persons|2|10–14|0.855|0.659|0.943
Observed|Other central nervous system cancers|2015–2019|Persons|2|15–19|0.868|0.686|0.948
Observed|Other central nervous system cancers|2015–2019|Persons|2|20–24|||
Observed|Other central nervous system cancers|2015–2019|Persons|2|25–29|||
Observed|Other central nervous system cancers|2015–2019|Persons|2|30–34|||
Observed|Other central nervous system cancers|2015–2019|Persons|2|35–39|0.846|0.64|0.94
Observed|Other central nervous system cancers|2015–2019|Persons|2|40–44|0.769|0.576|0.882
Observed|Other central nervous system cancers|2015–2019|Persons|2|45–49|0.968|0.794|0.995
Observed|Other central nervous system cancers|2015–2019|Persons|2|50–54|0.825|0.681|0.908
Observed|Other central nervous system cancers|2015–2019|Persons|2|55–59|0.905|0.786|0.959
Observed|Other central nervous system cancers|2015–2019|Persons|2|60–64|0.804|0.658|0.893
Observed|Other central nervous system cancers|2015–2019|Persons|2|65–69|0.727|0.582|0.829
Observed|Other central nervous system cancers|2015–2019|Persons|2|70–74|0.775|0.612|0.876
Observed|Other central nervous system cancers|2015–2019|Persons|2|75–79|||
Observed|Other central nervous system cancers|2015–2019|Persons|2|80–84|||
Observed|Other central nervous system cancers|2015–2019|Persons|2|85+|||
Observed|Other central nervous system cancers|2015–2019|Persons|2|All ages combined|0.77|0.734|0.802
Observed|Other central nervous system cancers|2015–2019|Persons|3|00–04|0.803|0.655|0.892
Observed|Other central nervous system cancers|2015–2019|Persons|3|05–09|0.923|0.724|0.98
Observed|Other central nervous system cancers|2015–2019|Persons|3|10–14|0.855|0.659|0.943
Observed|Other central nervous system cancers|2015–2019|Persons|3|15–19|0.868|0.686|0.948
Observed|Other central nervous system cancers|2015–2019|Persons|3|20–24|||
Observed|Other central nervous system cancers|2015–2019|Persons|3|25–29|||
Observed|Other central nervous system cancers|2015–2019|Persons|3|30–34|||
Observed|Other central nervous system cancers|2015–2019|Persons|3|35–39|0.846|0.64|0.94
Observed|Other central nervous system cancers|2015–2019|Persons|3|40–44|||
Observed|Other central nervous system cancers|2015–2019|Persons|3|45–49|0.943|0.79|0.986
Observed|Other central nervous system cancers|2015–2019|Persons|3|50–54|0.787|0.64|0.879
Observed|Other central nervous system cancers|2015–2019|Persons|3|55–59|0.849|0.721|0.921
Observed|Other central nervous system cancers|2015–2019|Persons|3|60–64|0.697|0.542|0.808
Observed|Other central nervous system cancers|2015–2019|Persons|3|65–69|0.662|0.519|0.772
Observed|Other central nervous system cancers|2015–2019|Persons|3|70–74|0.657|0.482|0.786
Observed|Other central nervous system cancers|2015–2019|Persons|3|75–79|||
Observed|Other central nervous system cancers|2015–2019|Persons|3|80–84|||
Observed|Other central nervous system cancers|2015–2019|Persons|3|85+|||
Observed|Other central nervous system cancers|2015–2019|Persons|3|All ages combined|0.725|0.688|0.759
Observed|Other central nervous system cancers|2015–2019|Persons|4|00–04|0.803|0.655|0.892
Observed|Other central nervous system cancers|2015–2019|Persons|4|05–09|0.923|0.724|0.98
Observed|Other central nervous system cancers|2015–2019|Persons|4|10–14|0.855|0.659|0.943
Observed|Other central nervous system cancers|2015–2019|Persons|4|15–19|0.868|0.686|0.948
Observed|Other central nervous system cancers|2015–2019|Persons|4|20–24|||
Observed|Other central nervous system cancers|2015–2019|Persons|4|25–29|||
Observed|Other central nervous system cancers|2015–2019|Persons|4|30–34|||
Observed|Other central nervous system cancers|2015–2019|Persons|4|35–39|0.776|0.568|0.892
Observed|Other central nervous system cancers|2015–2019|Persons|4|40–44|||
Observed|Other central nervous system cancers|2015–2019|Persons|4|45–49|0.918|0.767|0.973
Observed|Other central nervous system cancers|2015–2019|Persons|4|50–54|0.787|0.64|0.879
Observed|Other central nervous system cancers|2015–2019|Persons|4|55–59|0.849|0.721|0.921
Observed|Other central nervous system cancers|2015–2019|Persons|4|60–64|0.617|0.463|0.738
Observed|Other central nervous system cancers|2015–2019|Persons|4|65–69|0.662|0.519|0.772
Observed|Other central nervous system cancers|2015–2019|Persons|4|70–74|0.603|0.428|0.739
Observed|Other central nervous system cancers|2015–2019|Persons|4|75–79|||
Observed|Other central nervous system cancers|2015–2019|Persons|4|80–84|||
Observed|Other central nervous system cancers|2015–2019|Persons|4|85+|||
Observed|Other central nervous system cancers|2015–2019|Persons|4|All ages combined|0.704|0.666|0.739
Observed|Other central nervous system cancers|2015–2019|Persons|5|00–04|0.77|0.623|0.865
Observed|Other central nervous system cancers|2015–2019|Persons|5|05–09|0.893|0.702|0.965
Observed|Other central nervous system cancers|2015–2019|Persons|5|10–14|||
Observed|Other central nervous system cancers|2015–2019|Persons|5|15–19|0.868|0.686|0.948
Observed|Other central nervous system cancers|2015–2019|Persons|5|20–24|||
Observed|Other central nervous system cancers|2015–2019|Persons|5|25–29|||
Observed|Other central nervous system cancers|2015–2019|Persons|5|30–34|||
Observed|Other central nervous system cancers|2015–2019|Persons|5|35–39|0.776|0.568|0.892
Observed|Other central nervous system cancers|2015–2019|Persons|5|40–44|||
Observed|Other central nervous system cancers|2015–2019|Persons|5|45–49|0.866|0.707|0.942
Observed|Other central nervous system cancers|2015–2019|Persons|5|50–54|0.787|0.64|0.879
Observed|Other central nervous system cancers|2015–2019|Persons|5|55–59|0.772|0.633|0.863
Observed|Other central nervous system cancers|2015–2019|Persons|5|60–64|0.579|0.428|0.704
Observed|Other central nervous system cancers|2015–2019|Persons|5|65–69|0.644|0.5|0.756
Observed|Other central nervous system cancers|2015–2019|Persons|5|70–74|0.55|0.379|0.692
Observed|Other central nervous system cancers|2015–2019|Persons|5|75–79|||
Observed|Other central nervous system cancers|2015–2019|Persons|5|80–84|||
Observed|Other central nervous system cancers|2015–2019|Persons|5|85+|||
Observed|Other central nervous system cancers|2015–2019|Persons|5|All ages combined|0.678|0.639|0.713
Relative|Other central nervous system cancers|2015–2019|Persons|1|00–04|0.885|0.745|0.951
Relative|Other central nervous system cancers|2015–2019|Persons|1|05–09|0.956|0.727|0.994
Relative|Other central nervous system cancers|2015–2019|Persons|1|10–14|0.894|0.707|0.965
Relative|Other central nervous system cancers|2015–2019|Persons|1|15–19|0.93|0.749|0.982
Relative|Other central nervous system cancers|2015–2019|Persons|1|20–24|0.96|0.747|0.995
Relative|Other central nervous system cancers|2015–2019|Persons|1|25–29|||
Relative|Other central nervous system cancers|2015–2019|Persons|1|30–34|0.922|0.722|0.98
Relative|Other central nervous system cancers|2015–2019|Persons|1|35–39|0.966|0.776|0.996
Relative|Other central nervous system cancers|2015–2019|Persons|1|40–44|0.896|0.71|0.966
Relative|Other central nervous system cancers|2015–2019|Persons|1|45–49|0.97|0.795|0.997
Relative|Other central nervous system cancers|2015–2019|Persons|1|50–54|0.935|0.808|0.981
Relative|Other central nervous system cancers|2015–2019|Persons|1|55–59|0.927|0.812|0.975
Relative|Other central nervous system cancers|2015–2019|Persons|1|60–64|0.897|0.764|0.959
Relative|Other central nervous system cancers|2015–2019|Persons|1|65–69|0.821|0.688|0.903
Relative|Other central nervous system cancers|2015–2019|Persons|1|70–74|0.837|0.677|0.926
Relative|Other central nervous system cancers|2015–2019|Persons|1|75–79|0.758|0.544|0.888
Relative|Other central nervous system cancers|2015–2019|Persons|1|80–84|||
Relative|Other central nervous system cancers|2015–2019|Persons|1|85+|||
Relative|Other central nervous system cancers|2015–2019|Persons|1|All ages combined|0.853|0.82|0.88
Relative|Other central nervous system cancers|2015–2019|Persons|2|00–04|0.822|0.675|0.907
Relative|Other central nervous system cancers|2015–2019|Persons|2|05–09|0.956|0.727|0.994
Relative|Other central nervous system cancers|2015–2019|Persons|2|10–14|0.856|0.659|0.943
Relative|Other central nervous system cancers|2015–2019|Persons|2|15–19|0.869|0.687|0.949
Relative|Other central nervous system cancers|2015–2019|Persons|2|20–24|||
Relative|Other central nervous system cancers|2015–2019|Persons|2|25–29|||
Relative|Other central nervous system cancers|2015–2019|Persons|2|30–34|||
Relative|Other central nervous system cancers|2015–2019|Persons|2|35–39|0.848|0.642|0.941
Relative|Other central nervous system cancers|2015–2019|Persons|2|40–44|0.771|0.577|0.885
Relative|Other central nervous system cancers|2015–2019|Persons|2|45–49|0.972|0.797|0.999
Relative|Other central nervous system cancers|2015–2019|Persons|2|50–54|0.83|0.685|0.914
Relative|Other central nervous system cancers|2015–2019|Persons|2|55–59|0.913|0.793|0.968
Relative|Other central nervous system cancers|2015–2019|Persons|2|60–64|0.814|0.666|0.904
Relative|Other central nervous system cancers|2015–2019|Persons|2|65–69|0.742|0.594|0.846
Relative|Other central nervous system cancers|2015–2019|Persons|2|70–74|0.8|0.632|0.904
Relative|Other central nervous system cancers|2015–2019|Persons|2|75–79|||
Relative|Other central nervous system cancers|2015–2019|Persons|2|80–84|||
Relative|Other central nervous system cancers|2015–2019|Persons|2|85+|||
Relative|Other central nervous system cancers|2015–2019|Persons|2|All ages combined|0.786|0.749|0.818
Relative|Other central nervous system cancers|2015–2019|Persons|3|00–04|0.803|0.656|0.893
Relative|Other central nervous system cancers|2015–2019|Persons|3|05–09|0.923|0.724|0.981
Relative|Other central nervous system cancers|2015–2019|Persons|3|10–14|0.856|0.659|0.944
Relative|Other central nervous system cancers|2015–2019|Persons|3|15–19|0.869|0.687|0.95
Relative|Other central nervous system cancers|2015–2019|Persons|3|20–24|||
Relative|Other central nervous system cancers|2015–2019|Persons|3|25–29|||
Relative|Other central nervous system cancers|2015–2019|Persons|3|30–34|||
Relative|Other central nervous system cancers|2015–2019|Persons|3|35–39|0.849|0.642|0.942
Relative|Other central nervous system cancers|2015–2019|Persons|3|40–44|||
Relative|Other central nervous system cancers|2015–2019|Persons|3|45–49|0.949|0.795|0.992
Relative|Other central nervous system cancers|2015–2019|Persons|3|50–54|0.794|0.646|0.887
Relative|Other central nervous system cancers|2015–2019|Persons|3|55–59|0.861|0.731|0.934
Relative|Other central nervous system cancers|2015–2019|Persons|3|60–64|0.71|0.553|0.823
Relative|Other central nervous system cancers|2015–2019|Persons|3|65–69|0.683|0.535|0.797
Relative|Other central nervous system cancers|2015–2019|Persons|3|70–74|0.692|0.508|0.827
Relative|Other central nervous system cancers|2015–2019|Persons|3|75–79|||
Relative|Other central nervous system cancers|2015–2019|Persons|3|80–84|||
Relative|Other central nervous system cancers|2015–2019|Persons|3|85+|||
Relative|Other central nervous system cancers|2015–2019|Persons|3|All ages combined|0.746|0.707|0.78
Relative|Other central nervous system cancers|2015–2019|Persons|4|00–04|0.803|0.656|0.893
Relative|Other central nervous system cancers|2015–2019|Persons|4|05–09|0.923|0.724|0.981
Relative|Other central nervous system cancers|2015–2019|Persons|4|10–14|0.856|0.659|0.944
Relative|Other central nervous system cancers|2015–2019|Persons|4|15–19|0.87|0.687|0.95
Relative|Other central nervous system cancers|2015–2019|Persons|4|20–24|||
Relative|Other central nervous system cancers|2015–2019|Persons|4|25–29|||
Relative|Other central nervous system cancers|2015–2019|Persons|4|30–34|||
Relative|Other central nervous system cancers|2015–2019|Persons|4|35–39|0.779|0.57|0.896
Relative|Other central nervous system cancers|2015–2019|Persons|4|40–44|||
Relative|Other central nervous system cancers|2015–2019|Persons|4|45–49|0.926|0.773|0.982
Relative|Other central nervous system cancers|2015–2019|Persons|4|50–54|0.796|0.648|0.89
Relative|Other central nervous system cancers|2015–2019|Persons|4|55–59|0.865|0.734|0.939
Relative|Other central nervous system cancers|2015–2019|Persons|4|60–64|0.634|0.476|0.759
Relative|Other central nervous system cancers|2015–2019|Persons|4|65–69|0.692|0.542|0.806
Relative|Other central nervous system cancers|2015–2019|Persons|4|70–74|0.649|0.461|0.796
Relative|Other central nervous system cancers|2015–2019|Persons|4|75–79|||
Relative|Other central nervous system cancers|2015–2019|Persons|4|80–84|||
Relative|Other central nervous system cancers|2015–2019|Persons|4|85+|||
Relative|Other central nervous system cancers|2015–2019|Persons|4|All ages combined|0.731|0.691|0.767
Relative|Other central nervous system cancers|2015–2019|Persons|5|00–04|0.77|0.624|0.866
Relative|Other central nervous system cancers|2015–2019|Persons|5|05–09|0.894|0.702|0.965
Relative|Other central nervous system cancers|2015–2019|Persons|5|10–14|||
Relative|Other central nervous system cancers|2015–2019|Persons|5|15–19|0.87|0.688|0.95
Relative|Other central nervous system cancers|2015–2019|Persons|5|20–24|||
Relative|Other central nervous system cancers|2015–2019|Persons|5|25–29|||
Relative|Other central nervous system cancers|2015–2019|Persons|5|30–34|||
Relative|Other central nervous system cancers|2015–2019|Persons|5|35–39|0.78|0.57|0.897
Relative|Other central nervous system cancers|2015–2019|Persons|5|40–44|||
Relative|Other central nervous system cancers|2015–2019|Persons|5|45–49|0.876|0.715|0.953
Relative|Other central nervous system cancers|2015–2019|Persons|5|50–54|0.799|0.651|0.893
Relative|Other central nervous system cancers|2015–2019|Persons|5|55–59|0.791|0.649|0.885
Relative|Other central nervous system cancers|2015–2019|Persons|5|60–64|0.6|0.443|0.729
Relative|Other central nervous system cancers|2015–2019|Persons|5|65–69|0.681|0.529|0.8
Relative|Other central nervous system cancers|2015–2019|Persons|5|70–74|0.607|0.418|0.764
Relative|Other central nervous system cancers|2015–2019|Persons|5|75–79|||
Relative|Other central nervous system cancers|2015–2019|Persons|5|80–84|||
Relative|Other central nervous system cancers|2015–2019|Persons|5|85+|||
Relative|Other central nervous system cancers|2015–2019|Persons|5|All ages combined|0.708|0.668|0.745
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|00–04|0.934|0.849|0.972
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|40–44|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|45–49|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|50–54|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|55–59|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|60–64|0.824|0.65|0.917
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|65–69|0.779|0.573|0.894
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|70–74|0.815|0.612|0.919
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|1|All ages combined|0.848|0.803|0.883
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|00–04|0.845|0.738|0.911
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|40–44|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|45–49|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|50–54|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|55–59|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|60–64|0.824|0.65|0.917
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|65–69|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|70–74|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|2|All ages combined|0.761|0.709|0.805
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|00–04|0.845|0.738|0.911
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|40–44|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|45–49|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|50–54|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|55–59|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|60–64|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|65–69|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|70–74|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|3|All ages combined|0.732|0.678|0.779
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|00–04|0.845|0.738|0.911
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|40–44|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|45–49|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|50–54|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|55–59|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|60–64|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|65–69|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|70–74|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|4|All ages combined|0.703|0.647|0.751
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|00–04|0.809|0.693|0.885
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|40–44|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|45–49|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|50–54|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|55–59|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|60–64|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|65–69|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|70–74|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Males|5|All ages combined|0.68|0.623|0.73
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|00–04|0.936|0.85|0.974
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|40–44|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|45–49|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|50–54|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|55–59|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|60–64|0.831|0.655|0.924
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|65–69|0.788|0.58|0.904
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|70–74|0.831|0.624|0.936
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|1|All ages combined|0.857|0.812|0.893
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|00–04|0.847|0.739|0.913
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|40–44|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|45–49|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|50–54|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|55–59|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|60–64|0.838|0.661|0.932
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|65–69|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|70–74|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|2|All ages combined|0.777|0.723|0.822
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|00–04|0.847|0.739|0.913
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|40–44|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|45–49|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|50–54|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|55–59|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|60–64|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|65–69|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|70–74|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|3|All ages combined|0.754|0.699|0.802
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|00–04|0.847|0.739|0.913
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|40–44|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|45–49|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|50–54|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|55–59|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|60–64|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|65–69|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|70–74|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|4|All ages combined|0.731|0.673|0.781
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|00–04|0.811|0.694|0.887
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|40–44|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|45–49|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|50–54|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|55–59|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|60–64|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|65–69|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|70–74|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Males|5|All ages combined|0.714|0.654|0.767
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|00–04|0.948|0.846|0.983
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|40–44|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|45–49|0.868|0.645|0.955
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|50–54|0.865|0.638|0.954
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|55–59|0.9|0.721|0.967
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|60–64|0.915|0.702|0.978
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|65–69|0.891|0.7|0.964
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|70–74|0.713|0.493|0.851
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|1|All ages combined|0.874|0.833|0.906
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|00–04|0.86|0.74|0.928
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|40–44|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|45–49|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|50–54|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|55–59|0.782|0.576|0.896
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|60–64|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|65–69|0.813|0.608|0.918
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|70–74|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|2|All ages combined|0.801|0.752|0.841
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|00–04|0.842|0.718|0.914
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|40–44|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|45–49|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|50–54|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|55–59|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|60–64|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|65–69|0.706|0.498|0.841
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|70–74|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|3|All ages combined|0.75|0.697|0.795
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|00–04|0.842|0.718|0.914
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|40–44|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|45–49|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|50–54|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|55–59|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|60–64|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|65–69|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|70–74|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|4|All ages combined|0.712|0.657|0.761
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|00–04|0.82|0.69|0.899
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|40–44|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|45–49|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|50–54|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|55–59|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|60–64|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|65–69|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|70–74|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Females|5|All ages combined|0.684|0.627|0.735
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|00–04|0.949|0.847|0.984
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|40–44|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|45–49|0.869|0.646|0.957
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|50–54|0.867|0.639|0.957
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|55–59|0.903|0.723|0.97
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|60–64|0.919|0.705|0.983
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|65–69|0.898|0.705|0.97
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|70–74|0.722|0.499|0.862
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|1|All ages combined|0.881|0.839|0.913
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|00–04|0.862|0.741|0.929
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|40–44|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|45–49|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|50–54|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|55–59|0.787|0.579|0.902
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|60–64|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|65–69|0.826|0.617|0.932
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|70–74|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|2|All ages combined|0.812|0.762|0.853
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|00–04|0.843|0.719|0.916
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|40–44|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|45–49|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|50–54|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|55–59|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|60–64|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|65–69|0.723|0.51|0.861
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|70–74|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|3|All ages combined|0.765|0.71|0.811
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|00–04|0.843|0.719|0.916
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|40–44|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|45–49|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|50–54|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|55–59|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|60–64|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|65–69|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|70–74|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|4|All ages combined|0.731|0.675|0.781
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|00–04|0.821|0.691|0.9
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|40–44|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|45–49|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|50–54|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|55–59|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|60–64|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|65–69|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|70–74|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Females|5|All ages combined|0.707|0.648|0.759
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|00–04|0.94|0.884|0.97
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|30–34|0.923|0.727|0.98
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|35–39|0.932|0.755|0.983
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|40–44|0.974|0.828|0.996
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|45–49|0.884|0.744|0.95
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|50–54|0.85|0.696|0.929
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|55–59|0.808|0.664|0.895
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|60–64|0.861|0.742|0.928
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|65–69|0.835|0.708|0.911
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|70–74|0.767|0.627|0.86
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|75–79|0.789|0.566|0.906
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|1|All ages combined|0.861|0.832|0.886
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|00–04|0.852|0.778|0.903
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|35–39|0.858|0.664|0.944
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|40–44|0.944|0.792|0.986
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|45–49|0.801|0.639|0.896
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|50–54|0.824|0.666|0.912
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|55–59|0.708|0.549|0.819
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|60–64|0.861|0.742|0.928
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|65–69|0.752|0.61|0.848
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|70–74|0.706|0.561|0.811
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|2|All ages combined|0.781|0.746|0.812
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|00–04|0.844|0.768|0.896
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|40–44|0.911|0.747|0.971
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|45–49|0.801|0.639|0.896
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|50–54|0.793|0.628|0.891
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|55–59|0.659|0.498|0.78
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|60–64|0.809|0.67|0.894
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|65–69|0.646|0.497|0.761
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|70–74|0.641|0.492|0.757
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|3|All ages combined|0.741|0.704|0.774
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|00–04|0.844|0.768|0.896
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|40–44|0.806|0.617|0.909
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|45–49|0.772|0.606|0.875
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|50–54|0.729|0.552|0.845
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|55–59|0.659|0.498|0.78
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|60–64|0.755|0.602|0.856
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|65–69|0.646|0.497|0.761
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|70–74|0.594|0.443|0.717
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|4|All ages combined|0.708|0.669|0.743
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|00–04|0.814|0.732|0.872
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|05–09|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|10–14|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|15–19|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|20–24|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|25–29|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|30–34|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|35–39|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|40–44|0.772|0.578|0.885
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|45–49|0.747|0.58|0.856
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|50–54|0.729|0.552|0.845
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|55–59|0.659|0.498|0.78
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|60–64|0.729|0.573|0.836
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|65–69|0.602|0.452|0.723
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|70–74|0.571|0.42|0.697
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|75–79|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|80–84|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|85+|||
Observed|Other endocrine glands (cancer of)|2015–2019|Persons|5|All ages combined|0.682|0.643|0.718
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|00–04|0.941|0.885|0.971
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|30–34|0.924|0.727|0.981
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|35–39|0.933|0.756|0.983
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|40–44|0.975|0.829|0.998
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|45–49|0.886|0.746|0.952
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|50–54|0.852|0.698|0.932
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|55–59|0.811|0.666|0.898
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|60–64|0.867|0.747|0.934
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|65–69|0.843|0.715|0.919
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|70–74|0.779|0.637|0.874
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|75–79|0.812|0.582|0.932
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|1|All ages combined|0.869|0.84|0.894
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|00–04|0.853|0.779|0.904
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|35–39|0.859|0.665|0.946
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|40–44|0.946|0.794|0.988
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|45–49|0.804|0.642|0.899
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|50–54|0.829|0.67|0.917
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|55–59|0.714|0.554|0.826
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|60–64|0.873|0.752|0.941
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|65–69|0.766|0.622|0.865
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|70–74|0.73|0.579|0.838
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|2|All ages combined|0.794|0.759|0.826
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|00–04|0.845|0.769|0.898
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|40–44|0.915|0.751|0.975
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|45–49|0.806|0.643|0.901
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|50–54|0.801|0.634|0.899
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|55–59|0.668|0.505|0.79
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|60–64|0.826|0.684|0.913
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|65–69|0.666|0.512|0.785
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|70–74|0.675|0.518|0.797
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|3|All ages combined|0.76|0.722|0.794
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|00–04|0.845|0.769|0.898
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|40–44|0.811|0.62|0.914
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|45–49|0.778|0.61|0.882
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|50–54|0.738|0.559|0.856
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|55–59|0.672|0.508|0.794
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|60–64|0.777|0.62|0.881
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|65–69|0.674|0.519|0.794
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|70–74|0.639|0.476|0.772
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|4|All ages combined|0.731|0.691|0.767
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|00–04|0.815|0.734|0.874
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|05–09|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|10–14|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|15–19|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|20–24|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|25–29|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|30–34|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|35–39|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|40–44|0.778|0.582|0.892
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|45–49|0.755|0.586|0.865
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|50–54|0.741|0.561|0.859
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|55–59|0.676|0.511|0.799
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|60–64|0.757|0.595|0.868
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|65–69|0.638|0.479|0.766
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|70–74|0.63|0.463|0.768
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|75–79|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|80–84|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|85+|||
Relative|Other endocrine glands (cancer of)|2015–2019|Persons|5|All ages combined|0.711|0.669|0.748
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|00–04|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|05–09|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|10–14|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|15–19|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|20–24|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|25–29|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|30–34|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|35–39|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|40–44|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|45–49|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|50–54|0.752|0.55|0.873
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|55–59|0.801|0.652|0.891
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|60–64|0.713|0.552|0.825
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|65–69|0.8|0.652|0.891
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|70–74|0.567|0.432|0.681
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|75–79|0.537|0.404|0.653
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|80–84|0.374|0.228|0.52
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|85+|0.25|0.161|0.35
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|All ages combined|0.596|0.547|0.641
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|00–04|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|05–09|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|10–14|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|15–19|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|20–24|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|25–29|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|30–34|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|35–39|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|40–44|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|45–49|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|50–54|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|55–59|0.71|0.554|0.82
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|60–64|0.606|0.446|0.732
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|65–69|0.631|0.477|0.752
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|70–74|0.426|0.299|0.548
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|75–79|0.321|0.206|0.441
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|80–84|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|85+|0.146|0.078|0.233
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|All ages combined|0.461|0.412|0.508
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|00–04|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|05–09|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|10–14|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|15–19|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|20–24|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|25–29|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|30–34|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|35–39|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|40–44|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|45–49|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|50–54|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|55–59|0.601|0.445|0.727
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|60–64|0.492|0.343|0.625
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|65–69|0.547|0.395|0.676
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|70–74|0.38|0.258|0.501
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|75–79|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|80–84|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|85+|0.097|0.045|0.174
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|All ages combined|0.396|0.349|0.442
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|00–04|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|05–09|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|10–14|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|15–19|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|20–24|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|25–29|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|30–34|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|35–39|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|40–44|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|45–49|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|50–54|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|55–59|0.572|0.413|0.703
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|60–64|0.332|0.205|0.464
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|65–69|0.523|0.371|0.655
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|70–74|0.329|0.214|0.448
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|75–79|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|80–84|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|85+|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|All ages combined|0.342|0.296|0.387
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|00–04|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|05–09|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|10–14|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|15–19|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|20–24|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|25–29|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|30–34|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|35–39|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|40–44|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|45–49|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|50–54|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|55–59|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|60–64|0.301|0.181|0.429
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|65–69|0.478|0.329|0.612
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|70–74|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|75–79|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|80–84|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|85+|||
Observed|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|All ages combined|0.313|0.269|0.358
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|00–04|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|05–09|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|10–14|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|15–19|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|20–24|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|25–29|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|30–34|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|35–39|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|40–44|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|45–49|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|50–54|0.754|0.551|0.875
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|55–59|0.803|0.654|0.894
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|60–64|0.717|0.554|0.829
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|65–69|0.806|0.657|0.897
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|70–74|0.574|0.437|0.69
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|75–79|0.549|0.413|0.667
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|80–84|0.391|0.238|0.544
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|85+|0.281|0.181|0.394
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|1|All ages combined|0.614|0.563|0.66
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|00–04|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|05–09|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|10–14|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|15–19|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|20–24|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|25–29|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|30–34|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|35–39|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|40–44|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|45–49|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|50–54|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|55–59|0.715|0.558|0.826
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|60–64|0.612|0.45|0.74
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|65–69|0.641|0.484|0.763
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|70–74|0.438|0.307|0.563
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|75–79|0.336|0.216|0.462
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|80–84|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|85+|0.183|0.099|0.293
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|2|All ages combined|0.484|0.433|0.533
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|00–04|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|05–09|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|10–14|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|15–19|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|20–24|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|25–29|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|30–34|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|35–39|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|40–44|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|45–49|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|50–54|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|55–59|0.608|0.449|0.734
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|60–64|0.5|0.349|0.635
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|65–69|0.561|0.405|0.693
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|70–74|0.396|0.269|0.522
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|75–79|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|80–84|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|85+|0.14|0.065|0.251
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|3|All ages combined|0.423|0.373|0.473
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|00–04|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|05–09|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|10–14|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|15–19|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|20–24|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|25–29|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|30–34|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|35–39|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|40–44|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|45–49|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|50–54|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|55–59|0.58|0.419|0.713
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|60–64|0.339|0.21|0.474
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|65–69|0.541|0.384|0.677
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|70–74|0.348|0.227|0.475
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|75–79|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|80–84|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|85+|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|4|All ages combined|0.372|0.323|0.422
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|00–04|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|05–09|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|10–14|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|15–19|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|20–24|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|25–29|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|30–34|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|35–39|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|40–44|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|45–49|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|50–54|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|55–59|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|60–64|0.309|0.187|0.441
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|65–69|0.5|0.344|0.641
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|70–74|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|75–79|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|80–84|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|85+|||
Relative|Other female genital organs excluding serous carcinomas of the fallopian tube (cancer of)|2015–2019|Females|5|All ages combined|0.348|0.299|0.398
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|00–04|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|05–09|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|10–14|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|15–19|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|20–24|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|25–29|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|30–34|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|35–39|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|40–44|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|45–49|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|50–54|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|55–59|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|60–64|0.967|0.788|0.995
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|65–69|1|0.888|1
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|70–74|0.889|0.695|0.963
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|75–79|1|0.873|1
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|80–84|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|85+|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|1|All ages combined|0.914|0.863|0.946
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|00–04|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|05–09|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|10–14|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|15–19|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|20–24|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|25–29|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|30–34|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|35–39|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|40–44|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|45–49|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|50–54|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|55–59|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|60–64|0.967|0.788|0.995
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|65–69|0.919|0.715|0.979
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|70–74|0.889|0.695|0.963
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|75–79|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|80–84|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|85+|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|2|All ages combined|0.859|0.8|0.902
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|00–04|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|05–09|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|10–14|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|15–19|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|20–24|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|25–29|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|30–34|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|35–39|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|40–44|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|45–49|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|50–54|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|55–59|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|60–64|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|65–69|0.882|0.678|0.96
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|70–74|0.81|0.602|0.916
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|75–79|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|80–84|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|85+|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|3|All ages combined|0.808|0.743|0.858
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|00–04|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|05–09|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|10–14|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|15–19|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|20–24|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|25–29|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|30–34|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|35–39|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|40–44|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|45–49|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|50–54|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|55–59|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|60–64|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|65–69|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|70–74|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|75–79|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|80–84|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|85+|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|4|All ages combined|0.778|0.71|0.832
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|00–04|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|05–09|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|10–14|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|15–19|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|20–24|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|25–29|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|30–34|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|35–39|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|40–44|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|45–49|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|50–54|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|55–59|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|60–64|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|65–69|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|70–74|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|75–79|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|80–84|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|85+|||
Observed|Other male genital organs (cancer of)|2015–2019|Males|5|All ages combined|0.753|0.683|0.81
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|00–04|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|05–09|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|10–14|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|15–19|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|20–24|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|25–29|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|30–34|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|35–39|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|40–44|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|45–49|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|50–54|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|55–59|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|60–64|0.975|0.794|1.003
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|65–69|1.012|0.898|1.012
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|70–74|0.906|0.708|0.981
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|75–79|1.034|0.903|1.034
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|80–84|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|85+|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|1|All ages combined|0.94|0.888|0.974
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|00–04|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|05–09|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|10–14|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|15–19|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|20–24|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|25–29|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|30–34|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|35–39|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|40–44|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|45–49|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|50–54|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|55–59|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|60–64|0.983|0.801|1.012
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|65–69|0.942|0.732|1.004
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|70–74|0.925|0.723|1.002
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|75–79|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|80–84|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|85+|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|2|All ages combined|0.909|0.846|0.954
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|00–04|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|05–09|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|10–14|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|15–19|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|20–24|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|25–29|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|30–34|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|35–39|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|40–44|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|45–49|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|50–54|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|55–59|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|60–64|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|65–69|0.917|0.705|0.998
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|70–74|0.863|0.641|0.975
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|75–79|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|80–84|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|85+|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|3|All ages combined|0.879|0.808|0.933
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|00–04|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|05–09|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|10–14|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|15–19|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|20–24|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|25–29|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|30–34|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|35–39|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|40–44|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|45–49|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|50–54|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|55–59|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|60–64|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|65–69|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|70–74|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|75–79|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|80–84|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|85+|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|4|All ages combined|0.872|0.796|0.933
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|00–04|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|05–09|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|10–14|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|15–19|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|20–24|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|25–29|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|30–34|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|35–39|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|40–44|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|45–49|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|50–54|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|55–59|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|60–64|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|65–69|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|70–74|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|75–79|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|80–84|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|85+|||
Relative|Other male genital organs (cancer of)|2015–2019|Males|5|All ages combined|0.87|0.788|0.936
Observed|Other plasma cell cancers|2015–2019|Males|1|00–04|||
Observed|Other plasma cell cancers|2015–2019|Males|1|05–09|||
Observed|Other plasma cell cancers|2015–2019|Males|1|10–14|||
Observed|Other plasma cell cancers|2015–2019|Males|1|15–19|||
Observed|Other plasma cell cancers|2015–2019|Males|1|20–24|||
Observed|Other plasma cell cancers|2015–2019|Males|1|25–29|||
Observed|Other plasma cell cancers|2015–2019|Males|1|30–34|||
Observed|Other plasma cell cancers|2015–2019|Males|1|35–39|||
Observed|Other plasma cell cancers|2015–2019|Males|1|40–44|||
Observed|Other plasma cell cancers|2015–2019|Males|1|45–49|||
Observed|Other plasma cell cancers|2015–2019|Males|1|50–54|||
Observed|Other plasma cell cancers|2015–2019|Males|1|55–59|0.958|0.737|0.994
Observed|Other plasma cell cancers|2015–2019|Males|1|60–64|0.939|0.779|0.984
Observed|Other plasma cell cancers|2015–2019|Males|1|65–69|0.923|0.78|0.974
Observed|Other plasma cell cancers|2015–2019|Males|1|70–74|0.946|0.8|0.986
Observed|Other plasma cell cancers|2015–2019|Males|1|75–79|0.83|0.638|0.925
Observed|Other plasma cell cancers|2015–2019|Males|1|80–84|||
Observed|Other plasma cell cancers|2015–2019|Males|1|85+|||
Observed|Other plasma cell cancers|2015–2019|Males|1|All ages combined|0.885|0.838|0.919
Observed|Other plasma cell cancers|2015–2019|Males|2|00–04|||
Observed|Other plasma cell cancers|2015–2019|Males|2|05–09|||
Observed|Other plasma cell cancers|2015–2019|Males|2|10–14|||
Observed|Other plasma cell cancers|2015–2019|Males|2|15–19|||
Observed|Other plasma cell cancers|2015–2019|Males|2|20–24|||
Observed|Other plasma cell cancers|2015–2019|Males|2|25–29|||
Observed|Other plasma cell cancers|2015–2019|Males|2|30–34|||
Observed|Other plasma cell cancers|2015–2019|Males|2|35–39|||
Observed|Other plasma cell cancers|2015–2019|Males|2|40–44|||
Observed|Other plasma cell cancers|2015–2019|Males|2|45–49|||
Observed|Other plasma cell cancers|2015–2019|Males|2|50–54|||
Observed|Other plasma cell cancers|2015–2019|Males|2|55–59|0.917|0.708|0.979
Observed|Other plasma cell cancers|2015–2019|Males|2|60–64|0.911|0.75|0.97
Observed|Other plasma cell cancers|2015–2019|Males|2|65–69|0.876|0.727|0.946
Observed|Other plasma cell cancers|2015–2019|Males|2|70–74|0.858|0.691|0.938
Observed|Other plasma cell cancers|2015–2019|Males|2|75–79|0.759|0.559|0.877
Observed|Other plasma cell cancers|2015–2019|Males|2|80–84|||
Observed|Other plasma cell cancers|2015–2019|Males|2|85+|||
Observed|Other plasma cell cancers|2015–2019|Males|2|All ages combined|0.825|0.771|0.867
Observed|Other plasma cell cancers|2015–2019|Males|3|00–04|||
Observed|Other plasma cell cancers|2015–2019|Males|3|05–09|||
Observed|Other plasma cell cancers|2015–2019|Males|3|10–14|||
Observed|Other plasma cell cancers|2015–2019|Males|3|15–19|||
Observed|Other plasma cell cancers|2015–2019|Males|3|20–24|||
Observed|Other plasma cell cancers|2015–2019|Males|3|25–29|||
Observed|Other plasma cell cancers|2015–2019|Males|3|30–34|||
Observed|Other plasma cell cancers|2015–2019|Males|3|35–39|||
Observed|Other plasma cell cancers|2015–2019|Males|3|40–44|||
Observed|Other plasma cell cancers|2015–2019|Males|3|45–49|||
Observed|Other plasma cell cancers|2015–2019|Males|3|50–54|||
Observed|Other plasma cell cancers|2015–2019|Males|3|55–59|0.917|0.708|0.979
Observed|Other plasma cell cancers|2015–2019|Males|3|60–64|0.911|0.75|0.97
Observed|Other plasma cell cancers|2015–2019|Males|3|65–69|0.83|0.676|0.915
Observed|Other plasma cell cancers|2015–2019|Males|3|70–74|0.792|0.61|0.895
Observed|Other plasma cell cancers|2015–2019|Males|3|75–79|||
Observed|Other plasma cell cancers|2015–2019|Males|3|80–84|||
Observed|Other plasma cell cancers|2015–2019|Males|3|85+|||
Observed|Other plasma cell cancers|2015–2019|Males|3|All ages combined|0.778|0.721|0.825
Observed|Other plasma cell cancers|2015–2019|Males|4|00–04|||
Observed|Other plasma cell cancers|2015–2019|Males|4|05–09|||
Observed|Other plasma cell cancers|2015–2019|Males|4|10–14|||
Observed|Other plasma cell cancers|2015–2019|Males|4|15–19|||
Observed|Other plasma cell cancers|2015–2019|Males|4|20–24|||
Observed|Other plasma cell cancers|2015–2019|Males|4|25–29|||
Observed|Other plasma cell cancers|2015–2019|Males|4|30–34|||
Observed|Other plasma cell cancers|2015–2019|Males|4|35–39|||
Observed|Other plasma cell cancers|2015–2019|Males|4|40–44|||
Observed|Other plasma cell cancers|2015–2019|Males|4|45–49|||
Observed|Other plasma cell cancers|2015–2019|Males|4|50–54|||
Observed|Other plasma cell cancers|2015–2019|Males|4|55–59|0.837|0.622|0.935
Observed|Other plasma cell cancers|2015–2019|Males|4|60–64|0.883|0.717|0.954
Observed|Other plasma cell cancers|2015–2019|Males|4|65–69|0.786|0.629|0.882
Observed|Other plasma cell cancers|2015–2019|Males|4|70–74|0.761|0.577|0.873
Observed|Other plasma cell cancers|2015–2019|Males|4|75–79|||
Observed|Other plasma cell cancers|2015–2019|Males|4|80–84|||
Observed|Other plasma cell cancers|2015–2019|Males|4|85+|||
Observed|Other plasma cell cancers|2015–2019|Males|4|All ages combined|0.733|0.674|0.783
Observed|Other plasma cell cancers|2015–2019|Males|5|00–04|||
Observed|Other plasma cell cancers|2015–2019|Males|5|05–09|||
Observed|Other plasma cell cancers|2015–2019|Males|5|10–14|||
Observed|Other plasma cell cancers|2015–2019|Males|5|15–19|||
Observed|Other plasma cell cancers|2015–2019|Males|5|20–24|||
Observed|Other plasma cell cancers|2015–2019|Males|5|25–29|||
Observed|Other plasma cell cancers|2015–2019|Males|5|30–34|||
Observed|Other plasma cell cancers|2015–2019|Males|5|35–39|||
Observed|Other plasma cell cancers|2015–2019|Males|5|40–44|||
Observed|Other plasma cell cancers|2015–2019|Males|5|45–49|||
Observed|Other plasma cell cancers|2015–2019|Males|5|50–54|||
Observed|Other plasma cell cancers|2015–2019|Males|5|55–59|||
Observed|Other plasma cell cancers|2015–2019|Males|5|60–64|0.854|0.683|0.936
Observed|Other plasma cell cancers|2015–2019|Males|5|65–69|0.709|0.545|0.823
Observed|Other plasma cell cancers|2015–2019|Males|5|70–74|0.656|0.462|0.794
Observed|Other plasma cell cancers|2015–2019|Males|5|75–79|||
Observed|Other plasma cell cancers|2015–2019|Males|5|80–84|||
Observed|Other plasma cell cancers|2015–2019|Males|5|85+|||
Observed|Other plasma cell cancers|2015–2019|Males|5|All ages combined|0.684|0.622|0.737
Relative|Other plasma cell cancers|2015–2019|Males|1|00–04|||
Relative|Other plasma cell cancers|2015–2019|Males|1|05–09|||
Relative|Other plasma cell cancers|2015–2019|Males|1|10–14|||
Relative|Other plasma cell cancers|2015–2019|Males|1|15–19|||
Relative|Other plasma cell cancers|2015–2019|Males|1|20–24|||
Relative|Other plasma cell cancers|2015–2019|Males|1|25–29|||
Relative|Other plasma cell cancers|2015–2019|Males|1|30–34|||
Relative|Other plasma cell cancers|2015–2019|Males|1|35–39|||
Relative|Other plasma cell cancers|2015–2019|Males|1|40–44|||
Relative|Other plasma cell cancers|2015–2019|Males|1|45–49|||
Relative|Other plasma cell cancers|2015–2019|Males|1|50–54|||
Relative|Other plasma cell cancers|2015–2019|Males|1|55–59|0.963|0.741|0.999
Relative|Other plasma cell cancers|2015–2019|Males|1|60–64|0.947|0.785|0.992
Relative|Other plasma cell cancers|2015–2019|Males|1|65–69|0.934|0.79|0.986
Relative|Other plasma cell cancers|2015–2019|Males|1|70–74|0.964|0.815|1.005
Relative|Other plasma cell cancers|2015–2019|Males|1|75–79|0.858|0.661|0.957
Relative|Other plasma cell cancers|2015–2019|Males|1|80–84|||
Relative|Other plasma cell cancers|2015–2019|Males|1|85+|||
Relative|Other plasma cell cancers|2015–2019|Males|1|All ages combined|0.907|0.859|0.942
Relative|Other plasma cell cancers|2015–2019|Males|2|00–04|||
Relative|Other plasma cell cancers|2015–2019|Males|2|05–09|||
Relative|Other plasma cell cancers|2015–2019|Males|2|10–14|||
Relative|Other plasma cell cancers|2015–2019|Males|2|15–19|||
Relative|Other plasma cell cancers|2015–2019|Males|2|20–24|||
Relative|Other plasma cell cancers|2015–2019|Males|2|25–29|||
Relative|Other plasma cell cancers|2015–2019|Males|2|30–34|||
Relative|Other plasma cell cancers|2015–2019|Males|2|35–39|||
Relative|Other plasma cell cancers|2015–2019|Males|2|40–44|||
Relative|Other plasma cell cancers|2015–2019|Males|2|45–49|||
Relative|Other plasma cell cancers|2015–2019|Males|2|50–54|||
Relative|Other plasma cell cancers|2015–2019|Males|2|55–59|0.928|0.716|0.99
Relative|Other plasma cell cancers|2015–2019|Males|2|60–64|0.926|0.762|0.987
Relative|Other plasma cell cancers|2015–2019|Males|2|65–69|0.898|0.746|0.971
Relative|Other plasma cell cancers|2015–2019|Males|2|70–74|0.893|0.72|0.977
Relative|Other plasma cell cancers|2015–2019|Males|2|75–79|0.815|0.601|0.942
Relative|Other plasma cell cancers|2015–2019|Males|2|80–84|||
Relative|Other plasma cell cancers|2015–2019|Males|2|85+|||
Relative|Other plasma cell cancers|2015–2019|Males|2|All ages combined|0.865|0.809|0.909
Relative|Other plasma cell cancers|2015–2019|Males|3|00–04|||
Relative|Other plasma cell cancers|2015–2019|Males|3|05–09|||
Relative|Other plasma cell cancers|2015–2019|Males|3|10–14|||
Relative|Other plasma cell cancers|2015–2019|Males|3|15–19|||
Relative|Other plasma cell cancers|2015–2019|Males|3|20–24|||
Relative|Other plasma cell cancers|2015–2019|Males|3|25–29|||
Relative|Other plasma cell cancers|2015–2019|Males|3|30–34|||
Relative|Other plasma cell cancers|2015–2019|Males|3|35–39|||
Relative|Other plasma cell cancers|2015–2019|Males|3|40–44|||
Relative|Other plasma cell cancers|2015–2019|Males|3|45–49|||
Relative|Other plasma cell cancers|2015–2019|Males|3|50–54|||
Relative|Other plasma cell cancers|2015–2019|Males|3|55–59|0.933|0.721|0.996
Relative|Other plasma cell cancers|2015–2019|Males|3|60–64|0.935|0.769|0.996
Relative|Other plasma cell cancers|2015–2019|Males|3|65–69|0.864|0.704|0.953
Relative|Other plasma cell cancers|2015–2019|Males|3|70–74|0.844|0.651|0.954
Relative|Other plasma cell cancers|2015–2019|Males|3|75–79|||
Relative|Other plasma cell cancers|2015–2019|Males|3|80–84|||
Relative|Other plasma cell cancers|2015–2019|Males|3|85+|||
Relative|Other plasma cell cancers|2015–2019|Males|3|All ages combined|0.835|0.774|0.885
Relative|Other plasma cell cancers|2015–2019|Males|4|00–04|||
Relative|Other plasma cell cancers|2015–2019|Males|4|05–09|||
Relative|Other plasma cell cancers|2015–2019|Males|4|10–14|||
Relative|Other plasma cell cancers|2015–2019|Males|4|15–19|||
Relative|Other plasma cell cancers|2015–2019|Males|4|20–24|||
Relative|Other plasma cell cancers|2015–2019|Males|4|25–29|||
Relative|Other plasma cell cancers|2015–2019|Males|4|30–34|||
Relative|Other plasma cell cancers|2015–2019|Males|4|35–39|||
Relative|Other plasma cell cancers|2015–2019|Males|4|40–44|||
Relative|Other plasma cell cancers|2015–2019|Males|4|45–49|||
Relative|Other plasma cell cancers|2015–2019|Males|4|50–54|||
Relative|Other plasma cell cancers|2015–2019|Males|4|55–59|0.857|0.637|0.958
Relative|Other plasma cell cancers|2015–2019|Males|4|60–64|0.915|0.744|0.989
Relative|Other plasma cell cancers|2015–2019|Males|4|65–69|0.831|0.665|0.933
Relative|Other plasma cell cancers|2015–2019|Males|4|70–74|0.833|0.632|0.956
Relative|Other plasma cell cancers|2015–2019|Males|4|75–79|||
Relative|Other plasma cell cancers|2015–2019|Males|4|80–84|||
Relative|Other plasma cell cancers|2015–2019|Males|4|85+|||
Relative|Other plasma cell cancers|2015–2019|Males|4|All ages combined|0.805|0.74|0.86
Relative|Other plasma cell cancers|2015–2019|Males|5|00–04|||
Relative|Other plasma cell cancers|2015–2019|Males|5|05–09|||
Relative|Other plasma cell cancers|2015–2019|Males|5|10–14|||
Relative|Other plasma cell cancers|2015–2019|Males|5|15–19|||
Relative|Other plasma cell cancers|2015–2019|Males|5|20–24|||
Relative|Other plasma cell cancers|2015–2019|Males|5|25–29|||
Relative|Other plasma cell cancers|2015–2019|Males|5|30–34|||
Relative|Other plasma cell cancers|2015–2019|Males|5|35–39|||
Relative|Other plasma cell cancers|2015–2019|Males|5|40–44|||
Relative|Other plasma cell cancers|2015–2019|Males|5|45–49|||
Relative|Other plasma cell cancers|2015–2019|Males|5|50–54|||
Relative|Other plasma cell cancers|2015–2019|Males|5|55–59|||
Relative|Other plasma cell cancers|2015–2019|Males|5|60–64|0.895|0.716|0.981
Relative|Other plasma cell cancers|2015–2019|Males|5|65–69|0.764|0.587|0.886
Relative|Other plasma cell cancers|2015–2019|Males|5|70–74|0.74|0.522|0.896
Relative|Other plasma cell cancers|2015–2019|Males|5|75–79|||
Relative|Other plasma cell cancers|2015–2019|Males|5|80–84|||
Relative|Other plasma cell cancers|2015–2019|Males|5|85+|||
Relative|Other plasma cell cancers|2015–2019|Males|5|All ages combined|0.767|0.698|0.827
Observed|Other plasma cell cancers|2015–2019|Females|1|00–04|||
Observed|Other plasma cell cancers|2015–2019|Females|1|05–09|||
Observed|Other plasma cell cancers|2015–2019|Females|1|10–14|||
Observed|Other plasma cell cancers|2015–2019|Females|1|15–19|||
Observed|Other plasma cell cancers|2015–2019|Females|1|20–24|||
Observed|Other plasma cell cancers|2015–2019|Females|1|25–29|||
Observed|Other plasma cell cancers|2015–2019|Females|1|30–34|||
Observed|Other plasma cell cancers|2015–2019|Females|1|35–39|||
Observed|Other plasma cell cancers|2015–2019|Females|1|40–44|||
Observed|Other plasma cell cancers|2015–2019|Females|1|45–49|||
Observed|Other plasma cell cancers|2015–2019|Females|1|50–54|||
Observed|Other plasma cell cancers|2015–2019|Females|1|55–59|||
Observed|Other plasma cell cancers|2015–2019|Females|1|60–64|0.908|0.68|0.976
Observed|Other plasma cell cancers|2015–2019|Females|1|65–69|||
Observed|Other plasma cell cancers|2015–2019|Females|1|70–74|0.865|0.638|0.954
Observed|Other plasma cell cancers|2015–2019|Females|1|75–79|||
Observed|Other plasma cell cancers|2015–2019|Females|1|80–84|||
Observed|Other plasma cell cancers|2015–2019|Females|1|85+|||
Observed|Other plasma cell cancers|2015–2019|Females|1|All ages combined|0.809|0.738|0.862
Observed|Other plasma cell cancers|2015–2019|Females|2|00–04|||
Observed|Other plasma cell cancers|2015–2019|Females|2|05–09|||
Observed|Other plasma cell cancers|2015–2019|Females|2|10–14|||
Observed|Other plasma cell cancers|2015–2019|Females|2|15–19|||
Observed|Other plasma cell cancers|2015–2019|Females|2|20–24|||
Observed|Other plasma cell cancers|2015–2019|Females|2|25–29|||
Observed|Other plasma cell cancers|2015–2019|Females|2|30–34|||
Observed|Other plasma cell cancers|2015–2019|Females|2|35–39|||
Observed|Other plasma cell cancers|2015–2019|Females|2|40–44|||
Observed|Other plasma cell cancers|2015–2019|Females|2|45–49|||
Observed|Other plasma cell cancers|2015–2019|Females|2|50–54|||
Observed|Other plasma cell cancers|2015–2019|Females|2|55–59|||
Observed|Other plasma cell cancers|2015–2019|Females|2|60–64|0.825|0.599|0.93
Observed|Other plasma cell cancers|2015–2019|Females|2|65–69|||
Observed|Other plasma cell cancers|2015–2019|Females|2|70–74|||
Observed|Other plasma cell cancers|2015–2019|Females|2|75–79|||
Observed|Other plasma cell cancers|2015–2019|Females|2|80–84|||
Observed|Other plasma cell cancers|2015–2019|Females|2|85+|||
Observed|Other plasma cell cancers|2015–2019|Females|2|All ages combined|0.728|0.651|0.791
Observed|Other plasma cell cancers|2015–2019|Females|3|00–04|||
Observed|Other plasma cell cancers|2015–2019|Females|3|05–09|||
Observed|Other plasma cell cancers|2015–2019|Females|3|10–14|||
Observed|Other plasma cell cancers|2015–2019|Females|3|15–19|||
Observed|Other plasma cell cancers|2015–2019|Females|3|20–24|||
Observed|Other plasma cell cancers|2015–2019|Females|3|25–29|||
Observed|Other plasma cell cancers|2015–2019|Females|3|30–34|||
Observed|Other plasma cell cancers|2015–2019|Females|3|35–39|||
Observed|Other plasma cell cancers|2015–2019|Females|3|40–44|||
Observed|Other plasma cell cancers|2015–2019|Females|3|45–49|||
Observed|Other plasma cell cancers|2015–2019|Females|3|50–54|||
Observed|Other plasma cell cancers|2015–2019|Females|3|55–59|||
Observed|Other plasma cell cancers|2015–2019|Females|3|60–64|0.785|0.559|0.904
Observed|Other plasma cell cancers|2015–2019|Females|3|65–69|||
Observed|Other plasma cell cancers|2015–2019|Females|3|70–74|||
Observed|Other plasma cell cancers|2015–2019|Females|3|75–79|||
Observed|Other plasma cell cancers|2015–2019|Females|3|80–84|||
Observed|Other plasma cell cancers|2015–2019|Females|3|85+|||
Observed|Other plasma cell cancers|2015–2019|Females|3|All ages combined|0.693|0.614|0.76
Observed|Other plasma cell cancers|2015–2019|Females|4|00–04|||
Observed|Other plasma cell cancers|2015–2019|Females|4|05–09|||
Observed|Other plasma cell cancers|2015–2019|Females|4|10–14|||
Observed|Other plasma cell cancers|2015–2019|Females|4|15–19|||
Observed|Other plasma cell cancers|2015–2019|Females|4|20–24|||
Observed|Other plasma cell cancers|2015–2019|Females|4|25–29|||
Observed|Other plasma cell cancers|2015–2019|Females|4|30–34|||
Observed|Other plasma cell cancers|2015–2019|Females|4|35–39|||
Observed|Other plasma cell cancers|2015–2019|Females|4|40–44|||
Observed|Other plasma cell cancers|2015–2019|Females|4|45–49|||
Observed|Other plasma cell cancers|2015–2019|Females|4|50–54|||
Observed|Other plasma cell cancers|2015–2019|Females|4|55–59|||
Observed|Other plasma cell cancers|2015–2019|Females|4|60–64|||
Observed|Other plasma cell cancers|2015–2019|Females|4|65–69|||
Observed|Other plasma cell cancers|2015–2019|Females|4|70–74|||
Observed|Other plasma cell cancers|2015–2019|Females|4|75–79|||
Observed|Other plasma cell cancers|2015–2019|Females|4|80–84|||
Observed|Other plasma cell cancers|2015–2019|Females|4|85+|||
Observed|Other plasma cell cancers|2015–2019|Females|4|All ages combined|0.659|0.578|0.729
Observed|Other plasma cell cancers|2015–2019|Females|5|00–04|||
Observed|Other plasma cell cancers|2015–2019|Females|5|05–09|||
Observed|Other plasma cell cancers|2015–2019|Females|5|10–14|||
Observed|Other plasma cell cancers|2015–2019|Females|5|15–19|||
Observed|Other plasma cell cancers|2015–2019|Females|5|20–24|||
Observed|Other plasma cell cancers|2015–2019|Females|5|25–29|||
Observed|Other plasma cell cancers|2015–2019|Females|5|30–34|||
Observed|Other plasma cell cancers|2015–2019|Females|5|35–39|||
Observed|Other plasma cell cancers|2015–2019|Females|5|40–44|||
Observed|Other plasma cell cancers|2015–2019|Females|5|45–49|||
Observed|Other plasma cell cancers|2015–2019|Females|5|50–54|||
Observed|Other plasma cell cancers|2015–2019|Females|5|55–59|||
Observed|Other plasma cell cancers|2015–2019|Females|5|60–64|||
Observed|Other plasma cell cancers|2015–2019|Females|5|65–69|||
Observed|Other plasma cell cancers|2015–2019|Females|5|70–74|||
Observed|Other plasma cell cancers|2015–2019|Females|5|75–79|||
Observed|Other plasma cell cancers|2015–2019|Females|5|80–84|||
Observed|Other plasma cell cancers|2015–2019|Females|5|85+|||
Observed|Other plasma cell cancers|2015–2019|Females|5|All ages combined|0.621|0.538|0.694
Relative|Other plasma cell cancers|2015–2019|Females|1|00–04|||
Relative|Other plasma cell cancers|2015–2019|Females|1|05–09|||
Relative|Other plasma cell cancers|2015–2019|Females|1|10–14|||
Relative|Other plasma cell cancers|2015–2019|Females|1|15–19|||
Relative|Other plasma cell cancers|2015–2019|Females|1|20–24|||
Relative|Other plasma cell cancers|2015–2019|Females|1|25–29|||
Relative|Other plasma cell cancers|2015–2019|Females|1|30–34|||
Relative|Other plasma cell cancers|2015–2019|Females|1|35–39|||
Relative|Other plasma cell cancers|2015–2019|Females|1|40–44|||
Relative|Other plasma cell cancers|2015–2019|Females|1|45–49|||
Relative|Other plasma cell cancers|2015–2019|Females|1|50–54|||
Relative|Other plasma cell cancers|2015–2019|Females|1|55–59|||
Relative|Other plasma cell cancers|2015–2019|Females|1|60–64|0.912|0.683|0.981
Relative|Other plasma cell cancers|2015–2019|Females|1|65–69|||
Relative|Other plasma cell cancers|2015–2019|Females|1|70–74|0.875|0.646|0.966
Relative|Other plasma cell cancers|2015–2019|Females|1|75–79|||
Relative|Other plasma cell cancers|2015–2019|Females|1|80–84|||
Relative|Other plasma cell cancers|2015–2019|Females|1|85+|||
Relative|Other plasma cell cancers|2015–2019|Females|1|All ages combined|0.828|0.756|0.883
Relative|Other plasma cell cancers|2015–2019|Females|2|00–04|||
Relative|Other plasma cell cancers|2015–2019|Females|2|05–09|||
Relative|Other plasma cell cancers|2015–2019|Females|2|10–14|||
Relative|Other plasma cell cancers|2015–2019|Females|2|15–19|||
Relative|Other plasma cell cancers|2015–2019|Females|2|20–24|||
Relative|Other plasma cell cancers|2015–2019|Females|2|25–29|||
Relative|Other plasma cell cancers|2015–2019|Females|2|30–34|||
Relative|Other plasma cell cancers|2015–2019|Females|2|35–39|||
Relative|Other plasma cell cancers|2015–2019|Females|2|40–44|||
Relative|Other plasma cell cancers|2015–2019|Females|2|45–49|||
Relative|Other plasma cell cancers|2015–2019|Females|2|50–54|||
Relative|Other plasma cell cancers|2015–2019|Females|2|55–59|||
Relative|Other plasma cell cancers|2015–2019|Females|2|60–64|0.833|0.605|0.939
Relative|Other plasma cell cancers|2015–2019|Females|2|65–69|||
Relative|Other plasma cell cancers|2015–2019|Females|2|70–74|||
Relative|Other plasma cell cancers|2015–2019|Females|2|75–79|||
Relative|Other plasma cell cancers|2015–2019|Females|2|80–84|||
Relative|Other plasma cell cancers|2015–2019|Females|2|85+|||
Relative|Other plasma cell cancers|2015–2019|Females|2|All ages combined|0.758|0.677|0.824
Relative|Other plasma cell cancers|2015–2019|Females|3|00–04|||
Relative|Other plasma cell cancers|2015–2019|Females|3|05–09|||
Relative|Other plasma cell cancers|2015–2019|Females|3|10–14|||
Relative|Other plasma cell cancers|2015–2019|Females|3|15–19|||
Relative|Other plasma cell cancers|2015–2019|Females|3|20–24|||
Relative|Other plasma cell cancers|2015–2019|Females|3|25–29|||
Relative|Other plasma cell cancers|2015–2019|Females|3|30–34|||
Relative|Other plasma cell cancers|2015–2019|Females|3|35–39|||
Relative|Other plasma cell cancers|2015–2019|Females|3|40–44|||
Relative|Other plasma cell cancers|2015–2019|Females|3|45–49|||
Relative|Other plasma cell cancers|2015–2019|Females|3|50–54|||
Relative|Other plasma cell cancers|2015–2019|Females|3|55–59|||
Relative|Other plasma cell cancers|2015–2019|Females|3|60–64|0.797|0.568|0.917
Relative|Other plasma cell cancers|2015–2019|Females|3|65–69|||
Relative|Other plasma cell cancers|2015–2019|Females|3|70–74|||
Relative|Other plasma cell cancers|2015–2019|Females|3|75–79|||
Relative|Other plasma cell cancers|2015–2019|Females|3|80–84|||
Relative|Other plasma cell cancers|2015–2019|Females|3|85+|||
Relative|Other plasma cell cancers|2015–2019|Females|3|All ages combined|0.734|0.649|0.804
Relative|Other plasma cell cancers|2015–2019|Females|4|00–04|||
Relative|Other plasma cell cancers|2015–2019|Females|4|05–09|||
Relative|Other plasma cell cancers|2015–2019|Females|4|10–14|||
Relative|Other plasma cell cancers|2015–2019|Females|4|15–19|||
Relative|Other plasma cell cancers|2015–2019|Females|4|20–24|||
Relative|Other plasma cell cancers|2015–2019|Females|4|25–29|||
Relative|Other plasma cell cancers|2015–2019|Females|4|30–34|||
Relative|Other plasma cell cancers|2015–2019|Females|4|35–39|||
Relative|Other plasma cell cancers|2015–2019|Females|4|40–44|||
Relative|Other plasma cell cancers|2015–2019|Females|4|45–49|||
Relative|Other plasma cell cancers|2015–2019|Females|4|50–54|||
Relative|Other plasma cell cancers|2015–2019|Females|4|55–59|||
Relative|Other plasma cell cancers|2015–2019|Females|4|60–64|||
Relative|Other plasma cell cancers|2015–2019|Females|4|65–69|||
Relative|Other plasma cell cancers|2015–2019|Females|4|70–74|||
Relative|Other plasma cell cancers|2015–2019|Females|4|75–79|||
Relative|Other plasma cell cancers|2015–2019|Females|4|80–84|||
Relative|Other plasma cell cancers|2015–2019|Females|4|85+|||
Relative|Other plasma cell cancers|2015–2019|Females|4|All ages combined|0.711|0.623|0.786
Relative|Other plasma cell cancers|2015–2019|Females|5|00–04|||
Relative|Other plasma cell cancers|2015–2019|Females|5|05–09|||
Relative|Other plasma cell cancers|2015–2019|Females|5|10–14|||
Relative|Other plasma cell cancers|2015–2019|Females|5|15–19|||
Relative|Other plasma cell cancers|2015–2019|Females|5|20–24|||
Relative|Other plasma cell cancers|2015–2019|Females|5|25–29|||
Relative|Other plasma cell cancers|2015–2019|Females|5|30–34|||
Relative|Other plasma cell cancers|2015–2019|Females|5|35–39|||
Relative|Other plasma cell cancers|2015–2019|Females|5|40–44|||
Relative|Other plasma cell cancers|2015–2019|Females|5|45–49|||
Relative|Other plasma cell cancers|2015–2019|Females|5|50–54|||
Relative|Other plasma cell cancers|2015–2019|Females|5|55–59|||
Relative|Other plasma cell cancers|2015–2019|Females|5|60–64|||
Relative|Other plasma cell cancers|2015–2019|Females|5|65–69|||
Relative|Other plasma cell cancers|2015–2019|Females|5|70–74|||
Relative|Other plasma cell cancers|2015–2019|Females|5|75–79|||
Relative|Other plasma cell cancers|2015–2019|Females|5|80–84|||
Relative|Other plasma cell cancers|2015–2019|Females|5|85+|||
Relative|Other plasma cell cancers|2015–2019|Females|5|All ages combined|0.683|0.591|0.763
Observed|Other plasma cell cancers|2015–2019|Persons|1|00–04|||
Observed|Other plasma cell cancers|2015–2019|Persons|1|05–09|||
Observed|Other plasma cell cancers|2015–2019|Persons|1|10–14|||
Observed|Other plasma cell cancers|2015–2019|Persons|1|15–19|||
Observed|Other plasma cell cancers|2015–2019|Persons|1|20–24|||
Observed|Other plasma cell cancers|2015–2019|Persons|1|25–29|||
Observed|Other plasma cell cancers|2015–2019|Persons|1|30–34|||
Observed|Other plasma cell cancers|2015–2019|Persons|1|35–39|||
Observed|Other plasma cell cancers|2015–2019|Persons|1|40–44|||
Observed|Other plasma cell cancers|2015–2019|Persons|1|45–49|||
Observed|Other plasma cell cancers|2015–2019|Persons|1|50–54|0.914|0.699|0.978
Observed|Other plasma cell cancers|2015–2019|Persons|1|55–59|0.929|0.796|0.977
Observed|Other plasma cell cancers|2015–2019|Persons|1|60–64|0.927|0.817|0.972
Observed|Other plasma cell cancers|2015–2019|Persons|1|65–69|0.91|0.797|0.961
Observed|Other plasma cell cancers|2015–2019|Persons|1|70–74|0.915|0.808|0.964
Observed|Other plasma cell cancers|2015–2019|Persons|1|75–79|0.842|0.709|0.918
Observed|Other plasma cell cancers|2015–2019|Persons|1|80–84|0.756|0.583|0.864
Observed|Other plasma cell cancers|2015–2019|Persons|1|85+|0.449|0.285|0.6
Observed|Other plasma cell cancers|2015–2019|Persons|1|All ages combined|0.855|0.817|0.886
Observed|Other plasma cell cancers|2015–2019|Persons|2|00–04|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|05–09|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|10–14|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|15–19|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|20–24|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|25–29|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|30–34|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|35–39|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|40–44|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|45–49|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|50–54|0.876|0.662|0.958
Observed|Other plasma cell cancers|2015–2019|Persons|2|55–59|0.907|0.77|0.964
Observed|Other plasma cell cancers|2015–2019|Persons|2|60–64|0.877|0.759|0.939
Observed|Other plasma cell cancers|2015–2019|Persons|2|65–69|0.874|0.754|0.938
Observed|Other plasma cell cancers|2015–2019|Persons|2|70–74|0.798|0.663|0.883
Observed|Other plasma cell cancers|2015–2019|Persons|2|75–79|0.757|0.612|0.854
Observed|Other plasma cell cancers|2015–2019|Persons|2|80–84|0.724|0.548|0.841
Observed|Other plasma cell cancers|2015–2019|Persons|2|85+|||
Observed|Other plasma cell cancers|2015–2019|Persons|2|All ages combined|0.787|0.744|0.824
Observed|Other plasma cell cancers|2015–2019|Persons|3|00–04|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|05–09|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|10–14|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|15–19|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|20–24|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|25–29|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|30–34|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|35–39|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|40–44|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|45–49|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|50–54|0.809|0.601|0.916
Observed|Other plasma cell cancers|2015–2019|Persons|3|55–59|0.885|0.746|0.951
Observed|Other plasma cell cancers|2015–2019|Persons|3|60–64|0.861|0.741|0.928
Observed|Other plasma cell cancers|2015–2019|Persons|3|65–69|0.838|0.712|0.912
Observed|Other plasma cell cancers|2015–2019|Persons|3|70–74|0.754|0.612|0.85
Observed|Other plasma cell cancers|2015–2019|Persons|3|75–79|0.713|0.564|0.82
Observed|Other plasma cell cancers|2015–2019|Persons|3|80–84|0.632|0.451|0.768
Observed|Other plasma cell cancers|2015–2019|Persons|3|85+|||
Observed|Other plasma cell cancers|2015–2019|Persons|3|All ages combined|0.745|0.7|0.785
Observed|Other plasma cell cancers|2015–2019|Persons|4|00–04|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|05–09|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|10–14|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|15–19|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|20–24|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|25–29|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|30–34|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|35–39|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|40–44|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|45–49|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|50–54|0.809|0.601|0.916
Observed|Other plasma cell cancers|2015–2019|Persons|4|55–59|0.817|0.668|0.904
Observed|Other plasma cell cancers|2015–2019|Persons|4|60–64|0.826|0.7|0.902
Observed|Other plasma cell cancers|2015–2019|Persons|4|65–69|0.804|0.674|0.886
Observed|Other plasma cell cancers|2015–2019|Persons|4|70–74|0.733|0.589|0.833
Observed|Other plasma cell cancers|2015–2019|Persons|4|75–79|0.663|0.508|0.779
Observed|Other plasma cell cancers|2015–2019|Persons|4|80–84|0.579|0.401|0.721
Observed|Other plasma cell cancers|2015–2019|Persons|4|85+|||
Observed|Other plasma cell cancers|2015–2019|Persons|4|All ages combined|0.704|0.657|0.746
Observed|Other plasma cell cancers|2015–2019|Persons|5|00–04|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|05–09|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|10–14|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|15–19|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|20–24|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|25–29|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|30–34|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|35–39|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|40–44|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|45–49|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|50–54|0.778|0.571|0.893
Observed|Other plasma cell cancers|2015–2019|Persons|5|55–59|0.766|0.608|0.867
Observed|Other plasma cell cancers|2015–2019|Persons|5|60–64|0.788|0.657|0.874
Observed|Other plasma cell cancers|2015–2019|Persons|5|65–69|0.748|0.612|0.842
Observed|Other plasma cell cancers|2015–2019|Persons|5|70–74|0.64|0.488|0.758
Observed|Other plasma cell cancers|2015–2019|Persons|5|75–79|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|80–84|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|85+|||
Observed|Other plasma cell cancers|2015–2019|Persons|5|All ages combined|0.659|0.61|0.703
Relative|Other plasma cell cancers|2015–2019|Persons|1|00–04|||
Relative|Other plasma cell cancers|2015–2019|Persons|1|05–09|||
Relative|Other plasma cell cancers|2015–2019|Persons|1|10–14|||
Relative|Other plasma cell cancers|2015–2019|Persons|1|15–19|||
Relative|Other plasma cell cancers|2015–2019|Persons|1|20–24|||
Relative|Other plasma cell cancers|2015–2019|Persons|1|25–29|||
Relative|Other plasma cell cancers|2015–2019|Persons|1|30–34|||
Relative|Other plasma cell cancers|2015–2019|Persons|1|35–39|||
Relative|Other plasma cell cancers|2015–2019|Persons|1|40–44|||
Relative|Other plasma cell cancers|2015–2019|Persons|1|45–49|||
Relative|Other plasma cell cancers|2015–2019|Persons|1|50–54|0.917|0.701|0.981
Relative|Other plasma cell cancers|2015–2019|Persons|1|55–59|0.933|0.799|0.981
Relative|Other plasma cell cancers|2015–2019|Persons|1|60–64|0.933|0.823|0.978
Relative|Other plasma cell cancers|2015–2019|Persons|1|65–69|0.92|0.806|0.972
Relative|Other plasma cell cancers|2015–2019|Persons|1|70–74|0.931|0.822|0.98
Relative|Other plasma cell cancers|2015–2019|Persons|1|75–79|0.867|0.73|0.945
Relative|Other plasma cell cancers|2015–2019|Persons|1|80–84|0.795|0.614|0.909
Relative|Other plasma cell cancers|2015–2019|Persons|1|85+|0.513|0.326|0.686
Relative|Other plasma cell cancers|2015–2019|Persons|1|All ages combined|0.876|0.837|0.908
Relative|Other plasma cell cancers|2015–2019|Persons|2|00–04|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|05–09|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|10–14|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|15–19|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|20–24|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|25–29|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|30–34|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|35–39|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|40–44|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|45–49|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|50–54|0.881|0.666|0.964
Relative|Other plasma cell cancers|2015–2019|Persons|2|55–59|0.915|0.777|0.973
Relative|Other plasma cell cancers|2015–2019|Persons|2|60–64|0.889|0.769|0.952
Relative|Other plasma cell cancers|2015–2019|Persons|2|65–69|0.894|0.771|0.96
Relative|Other plasma cell cancers|2015–2019|Persons|2|70–74|0.826|0.687|0.914
Relative|Other plasma cell cancers|2015–2019|Persons|2|75–79|0.806|0.651|0.909
Relative|Other plasma cell cancers|2015–2019|Persons|2|80–84|0.808|0.611|0.938
Relative|Other plasma cell cancers|2015–2019|Persons|2|85+|||
Relative|Other plasma cell cancers|2015–2019|Persons|2|All ages combined|0.824|0.778|0.862
Relative|Other plasma cell cancers|2015–2019|Persons|3|00–04|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|05–09|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|10–14|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|15–19|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|20–24|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|25–29|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|30–34|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|35–39|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|40–44|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|45–49|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|50–54|0.817|0.606|0.924
Relative|Other plasma cell cancers|2015–2019|Persons|3|55–59|0.898|0.757|0.964
Relative|Other plasma cell cancers|2015–2019|Persons|3|60–64|0.88|0.757|0.948
Relative|Other plasma cell cancers|2015–2019|Persons|3|65–69|0.869|0.738|0.946
Relative|Other plasma cell cancers|2015–2019|Persons|3|70–74|0.797|0.648|0.899
Relative|Other plasma cell cancers|2015–2019|Persons|3|75–79|0.788|0.623|0.905
Relative|Other plasma cell cancers|2015–2019|Persons|3|80–84|0.754|0.538|0.916
Relative|Other plasma cell cancers|2015–2019|Persons|3|85+|||
Relative|Other plasma cell cancers|2015–2019|Persons|3|All ages combined|0.796|0.747|0.838
Relative|Other plasma cell cancers|2015–2019|Persons|4|00–04|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|05–09|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|10–14|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|15–19|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|20–24|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|25–29|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|30–34|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|35–39|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|40–44|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|45–49|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|50–54|0.82|0.609|0.928
Relative|Other plasma cell cancers|2015–2019|Persons|4|55–59|0.834|0.682|0.923
Relative|Other plasma cell cancers|2015–2019|Persons|4|60–64|0.851|0.722|0.93
Relative|Other plasma cell cancers|2015–2019|Persons|4|65–69|0.846|0.709|0.932
Relative|Other plasma cell cancers|2015–2019|Persons|4|70–74|0.794|0.638|0.903
Relative|Other plasma cell cancers|2015–2019|Persons|4|75–79|0.763|0.585|0.897
Relative|Other plasma cell cancers|2015–2019|Persons|4|80–84|0.747|0.517|0.931
Relative|Other plasma cell cancers|2015–2019|Persons|4|85+|||
Relative|Other plasma cell cancers|2015–2019|Persons|4|All ages combined|0.768|0.717|0.814
Relative|Other plasma cell cancers|2015–2019|Persons|5|00–04|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|05–09|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|10–14|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|15–19|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|20–24|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|25–29|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|30–34|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|35–39|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|40–44|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|45–49|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|50–54|0.792|0.581|0.91
Relative|Other plasma cell cancers|2015–2019|Persons|5|55–59|0.786|0.624|0.89
Relative|Other plasma cell cancers|2015–2019|Persons|5|60–64|0.82|0.683|0.909
Relative|Other plasma cell cancers|2015–2019|Persons|5|65–69|0.8|0.654|0.9
Relative|Other plasma cell cancers|2015–2019|Persons|5|70–74|0.713|0.543|0.843
Relative|Other plasma cell cancers|2015–2019|Persons|5|75–79|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|80–84|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|85+|||
Relative|Other plasma cell cancers|2015–2019|Persons|5|All ages combined|0.734|0.68|0.783
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|35–39|0.877|0.665|0.958
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|40–44|0.918|0.709|0.979
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|45–49|0.932|0.753|0.982
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|50–54|0.9|0.722|0.967
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|55–59|0.924|0.811|0.971
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|60–64|0.879|0.733|0.948
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|65–69|0.858|0.737|0.926
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|70–74|0.789|0.635|0.884
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|75–79|0.703|0.537|0.818
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|80–84|0.516|0.327|0.676
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|All ages combined|0.811|0.773|0.844
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|40–44|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|45–49|0.808|0.597|0.916
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|50–54|0.866|0.682|0.948
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|55–59|0.777|0.633|0.87
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|60–64|0.853|0.702|0.931
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|65–69|0.753|0.619|0.845
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|70–74|0.72|0.56|0.83
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|75–79|0.658|0.493|0.781
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|All ages combined|0.726|0.683|0.765
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|40–44|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|45–49|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|50–54|0.806|0.619|0.908
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|55–59|0.725|0.571|0.831
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|60–64|0.827|0.671|0.914
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|65–69|0.716|0.578|0.815
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|70–74|0.67|0.507|0.79
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|75–79|0.498|0.341|0.636
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|All ages combined|0.658|0.612|0.7
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|40–44|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|45–49|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|50–54|0.745|0.554|0.863
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|55–59|0.664|0.5|0.785
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|60–64|0.749|0.584|0.857
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|65–69|0.651|0.507|0.762
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|70–74|0.641|0.475|0.766
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|75–79|0.414|0.269|0.553
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|All ages combined|0.598|0.55|0.642
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|40–44|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|45–49|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|50–54|0.714|0.524|0.84
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|55–59|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|60–64|0.699|0.531|0.817
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|65–69|0.6|0.451|0.721
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|70–74|0.641|0.475|0.766
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|75–79|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|All ages combined|0.576|0.528|0.621
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|35–39|0.878|0.665|0.96
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|40–44|0.919|0.71|0.98
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|45–49|0.934|0.755|0.985
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|50–54|0.903|0.724|0.97
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|55–59|0.929|0.815|0.976
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|60–64|0.886|0.739|0.955
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|65–69|0.869|0.746|0.938
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|70–74|0.805|0.647|0.902
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|75–79|0.726|0.555|0.846
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|80–84|0.549|0.348|0.719
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|1|All ages combined|0.825|0.786|0.859
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|40–44|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|45–49|0.812|0.599|0.92
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|50–54|0.872|0.687|0.954
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|55–59|0.786|0.64|0.88
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|60–64|0.867|0.713|0.947
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|65–69|0.772|0.635|0.867
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|70–74|0.75|0.584|0.864
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|75–79|0.706|0.529|0.837
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|2|All ages combined|0.75|0.705|0.789
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|40–44|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|45–49|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|50–54|0.815|0.625|0.918
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|55–59|0.737|0.581|0.845
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|60–64|0.849|0.689|0.938
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|65–69|0.744|0.602|0.848
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|70–74|0.714|0.541|0.842
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|75–79|0.557|0.382|0.711
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|3|All ages combined|0.69|0.642|0.734
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|40–44|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|45–49|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|50–54|0.756|0.563|0.876
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|55–59|0.68|0.512|0.804
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|60–64|0.777|0.605|0.888
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|65–69|0.688|0.536|0.805
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|70–74|0.701|0.52|0.838
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|75–79|0.485|0.315|0.648
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|4|All ages combined|0.636|0.585|0.683
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|40–44|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|45–49|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|50–54|0.729|0.534|0.857
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|55–59|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|60–64|0.733|0.557|0.856
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|65–69|0.646|0.485|0.775
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|70–74|0.721|0.535|0.862
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|75–79|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Males|5|All ages combined|0.622|0.57|0.671
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|40–44|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|45–49|0.918|0.709|0.979
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|50–54|0.934|0.76|0.983
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|55–59|1|0.894|1
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|60–64|0.914|0.756|0.971
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|65–69|0.907|0.792|0.96
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|70–74|0.847|0.705|0.924
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|75–79|0.723|0.506|0.857
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|All ages combined|0.877|0.836|0.908
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|40–44|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|45–49|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|50–54|0.875|0.7|0.951
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|55–59|0.879|0.671|0.959
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|60–64|0.82|0.641|0.915
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|65–69|0.854|0.729|0.924
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|70–74|0.847|0.705|0.924
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|75–79|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|All ages combined|0.794|0.745|0.835
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|40–44|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|45–49|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|50–54|0.807|0.619|0.908
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|55–59|0.846|0.64|0.939
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|60–64|0.789|0.607|0.893
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|65–69|0.835|0.706|0.91
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|70–74|0.847|0.705|0.924
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|75–79|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|All ages combined|0.767|0.716|0.81
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|40–44|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|45–49|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|50–54|0.773|0.581|0.885
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|55–59|0.758|0.558|0.876
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|60–64|0.735|0.553|0.852
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|65–69|0.835|0.706|0.91
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|70–74|0.817|0.665|0.905
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|75–79|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|All ages combined|0.73|0.677|0.776
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|40–44|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|45–49|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|50–54|0.773|0.581|0.885
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|55–59|0.758|0.558|0.876
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|60–64|0.735|0.553|0.852
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|65–69|0.809|0.673|0.893
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|70–74|0.817|0.665|0.905
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|75–79|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|All ages combined|0.716|0.662|0.763
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|40–44|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|45–49|0.919|0.71|0.98
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|50–54|0.936|0.762|0.985
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|55–59|1.003|0.897|1.003
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|60–64|0.918|0.76|0.976
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|65–69|0.914|0.798|0.968
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|70–74|0.857|0.714|0.935
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|75–79|0.738|0.517|0.875
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|1|All ages combined|0.887|0.846|0.919
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|40–44|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|45–49|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|50–54|0.878|0.703|0.955
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|55–59|0.885|0.675|0.966
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|60–64|0.828|0.647|0.924
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|65–69|0.867|0.741|0.939
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|70–74|0.868|0.724|0.947
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|75–79|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|2|All ages combined|0.813|0.763|0.855
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|40–44|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|45–49|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|50–54|0.812|0.623|0.914
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|55–59|0.855|0.647|0.949
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|60–64|0.801|0.616|0.907
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|65–69|0.856|0.724|0.933
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|70–74|0.882|0.735|0.962
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|75–79|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|3|All ages combined|0.794|0.741|0.838
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|40–44|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|45–49|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|50–54|0.78|0.586|0.893
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|55–59|0.769|0.566|0.889
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|60–64|0.751|0.565|0.871
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|65–69|0.865|0.732|0.943
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|70–74|0.865|0.705|0.958
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|75–79|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|4|All ages combined|0.765|0.709|0.813
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|40–44|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|45–49|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|50–54|0.782|0.588|0.896
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|55–59|0.772|0.569|0.893
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|60–64|0.756|0.568|0.877
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|65–69|0.848|0.705|0.935
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|70–74|0.883|0.718|0.977
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|75–79|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Females|5|All ages combined|0.759|0.701|0.808
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|25–29|0.861|0.629|0.953
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|30–34|0.955|0.723|0.994
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|35–39|0.889|0.731|0.957
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|40–44|0.927|0.792|0.976
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|45–49|0.925|0.813|0.971
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|50–54|0.917|0.812|0.965
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|55–59|0.95|0.872|0.981
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|60–64|0.895|0.801|0.946
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|65–69|0.882|0.806|0.93
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|70–74|0.819|0.722|0.885
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|75–79|0.71|0.585|0.804
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|80–84|0.561|0.409|0.689
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|All ages combined|0.838|0.811|0.862
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|35–39|0.853|0.68|0.937
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|40–44|0.762|0.591|0.868
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|45–49|0.859|0.726|0.93
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|50–54|0.87|0.756|0.933
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|55–59|0.812|0.702|0.884
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|60–64|0.838|0.733|0.905
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|65–69|0.803|0.716|0.865
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|70–74|0.784|0.682|0.856
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|75–79|0.594|0.467|0.7
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|80–84|0.517|0.366|0.648
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|All ages combined|0.754|0.722|0.783
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|40–44|0.653|0.478|0.782
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|45–49|0.787|0.639|0.88
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|50–54|0.806|0.684|0.885
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|55–59|0.768|0.654|0.849
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|60–64|0.81|0.7|0.883
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|65–69|0.774|0.685|0.841
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|70–74|0.758|0.653|0.835
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|75–79|0.474|0.352|0.587
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|All ages combined|0.703|0.669|0.734
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|40–44|0.653|0.478|0.782
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|45–49|0.733|0.575|0.841
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|50–54|0.758|0.631|0.846
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|55–59|0.695|0.575|0.788
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|60–64|0.744|0.628|0.828
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|65–69|0.741|0.647|0.814
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|70–74|0.729|0.62|0.811
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|75–79|0.397|0.282|0.509
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|All ages combined|0.653|0.617|0.686
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|00–04|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|05–09|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|10–14|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|15–19|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|20–24|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|25–29|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|30–34|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|35–39|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|40–44|0.653|0.478|0.782
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|45–49|0.701|0.537|0.817
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|50–54|0.742|0.613|0.833
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|55–59|0.695|0.575|0.788
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|60–64|0.719|0.603|0.807
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|65–69|0.704|0.604|0.783
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|70–74|0.729|0.62|0.811
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|75–79|0.368|0.257|0.48
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|80–84|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|85+|||
Observed|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|All ages combined|0.634|0.598|0.668
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|25–29|0.862|0.63|0.954
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|30–34|0.956|0.724|0.994
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|35–39|0.89|0.732|0.958
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|40–44|0.929|0.793|0.977
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|45–49|0.927|0.814|0.973
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|50–54|0.919|0.814|0.967
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|55–59|0.954|0.876|0.985
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|60–64|0.9|0.806|0.952
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|65–69|0.891|0.814|0.939
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|70–74|0.832|0.733|0.899
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|75–79|0.731|0.602|0.827
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|80–84|0.593|0.432|0.728
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|1|All ages combined|0.851|0.823|0.875
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|35–39|0.855|0.681|0.938
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|40–44|0.764|0.593|0.871
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|45–49|0.862|0.728|0.934
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|50–54|0.875|0.761|0.938
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|55–59|0.819|0.709|0.892
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|60–64|0.849|0.742|0.917
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|65–69|0.819|0.731|0.883
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|70–74|0.809|0.705|0.884
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|75–79|0.631|0.496|0.744
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|80–84|0.58|0.411|0.727
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|2|All ages combined|0.776|0.743|0.805
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|40–44|0.656|0.48|0.785
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|45–49|0.792|0.643|0.886
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|50–54|0.813|0.69|0.893
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|55–59|0.78|0.663|0.862
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|60–64|0.827|0.715|0.902
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|65–69|0.8|0.707|0.869
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|70–74|0.798|0.688|0.879
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|75–79|0.522|0.387|0.647
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|3|All ages combined|0.733|0.697|0.765
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|40–44|0.657|0.481|0.787
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|45–49|0.74|0.58|0.848
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|50–54|0.767|0.638|0.857
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|55–59|0.709|0.586|0.804
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|60–64|0.766|0.647|0.853
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|65–69|0.776|0.677|0.852
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|70–74|0.783|0.666|0.872
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|75–79|0.455|0.324|0.584
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|4|All ages combined|0.69|0.652|0.724
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|00–04|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|05–09|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|10–14|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|15–19|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|20–24|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|25–29|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|30–34|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|35–39|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|40–44|0.658|0.482|0.788
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|45–49|0.709|0.543|0.826
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|50–54|0.754|0.624|0.847
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|55–59|0.713|0.589|0.808
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|60–64|0.747|0.626|0.838
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|65–69|0.746|0.641|0.83
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|70–74|0.802|0.682|0.893
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|75–79|0.443|0.309|0.577
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|80–84|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|85+|||
Relative|Other thoracic and respiratory organs (cancer of)|2015–2019|Persons|5|All ages combined|0.679|0.641|0.715
Observed|Ovarian cancer|2015–2019|Females|1|00–04|||
Observed|Ovarian cancer|2015–2019|Females|1|05–09|||
Observed|Ovarian cancer|2015–2019|Females|1|10–14|1|0.891|1
Observed|Ovarian cancer|2015–2019|Females|1|15–19|0.978|0.854|0.997
Observed|Ovarian cancer|2015–2019|Females|1|20–24|0.938|0.857|0.974
Observed|Ovarian cancer|2015–2019|Females|1|25–29|0.989|0.924|0.998
Observed|Ovarian cancer|2015–2019|Females|1|30–34|0.938|0.881|0.969
Observed|Ovarian cancer|2015–2019|Females|1|35–39|0.957|0.913|0.979
Observed|Ovarian cancer|2015–2019|Females|1|40–44|0.917|0.875|0.945
Observed|Ovarian cancer|2015–2019|Females|1|45–49|0.925|0.895|0.946
Observed|Ovarian cancer|2015–2019|Females|1|50–54|0.907|0.879|0.929
Observed|Ovarian cancer|2015–2019|Females|1|55–59|0.889|0.862|0.911
Observed|Ovarian cancer|2015–2019|Females|1|60–64|0.859|0.83|0.882
Observed|Ovarian cancer|2015–2019|Females|1|65–69|0.834|0.806|0.858
Observed|Ovarian cancer|2015–2019|Females|1|70–74|0.771|0.74|0.799
Observed|Ovarian cancer|2015–2019|Females|1|75–79|0.68|0.641|0.715
Observed|Ovarian cancer|2015–2019|Females|1|80–84|0.46|0.418|0.501
Observed|Ovarian cancer|2015–2019|Females|1|85+|0.221|0.191|0.252
Observed|Ovarian cancer|2015–2019|Females|1|All ages combined|0.757|0.746|0.768
Observed|Ovarian cancer|2015–2019|Females|2|00–04|||
Observed|Ovarian cancer|2015–2019|Females|2|05–09|||
Observed|Ovarian cancer|2015–2019|Females|2|10–14|1|0.904|1
Observed|Ovarian cancer|2015–2019|Females|2|15–19|0.978|0.854|0.997
Observed|Ovarian cancer|2015–2019|Females|2|20–24|0.938|0.857|0.974
Observed|Ovarian cancer|2015–2019|Females|2|25–29|0.93|0.851|0.968
Observed|Ovarian cancer|2015–2019|Females|2|30–34|0.837|0.763|0.889
Observed|Ovarian cancer|2015–2019|Females|2|35–39|0.933|0.883|0.963
Observed|Ovarian cancer|2015–2019|Females|2|40–44|0.849|0.799|0.887
Observed|Ovarian cancer|2015–2019|Females|2|45–49|0.86|0.823|0.889
Observed|Ovarian cancer|2015–2019|Females|2|50–54|0.827|0.793|0.856
Observed|Ovarian cancer|2015–2019|Females|2|55–59|0.796|0.762|0.825
Observed|Ovarian cancer|2015–2019|Females|2|60–64|0.741|0.706|0.772
Observed|Ovarian cancer|2015–2019|Females|2|65–69|0.715|0.683|0.745
Observed|Ovarian cancer|2015–2019|Females|2|70–74|0.629|0.594|0.663
Observed|Ovarian cancer|2015–2019|Females|2|75–79|0.528|0.488|0.566
Observed|Ovarian cancer|2015–2019|Females|2|80–84|0.288|0.252|0.325
Observed|Ovarian cancer|2015–2019|Females|2|85+|0.132|0.11|0.157
Observed|Ovarian cancer|2015–2019|Females|2|All ages combined|0.646|0.634|0.657
Observed|Ovarian cancer|2015–2019|Females|3|00–04|||
Observed|Ovarian cancer|2015–2019|Females|3|05–09|||
Observed|Ovarian cancer|2015–2019|Females|3|10–14|1|0.907|1
Observed|Ovarian cancer|2015–2019|Females|3|15–19|0.978|0.854|0.997
Observed|Ovarian cancer|2015–2019|Females|3|20–24|0.915|0.83|0.958
Observed|Ovarian cancer|2015–2019|Females|3|25–29|0.896|0.81|0.945
Observed|Ovarian cancer|2015–2019|Females|3|30–34|0.823|0.747|0.877
Observed|Ovarian cancer|2015–2019|Females|3|35–39|0.897|0.84|0.935
Observed|Ovarian cancer|2015–2019|Females|3|40–44|0.8|0.746|0.843
Observed|Ovarian cancer|2015–2019|Females|3|45–49|0.796|0.755|0.831
Observed|Ovarian cancer|2015–2019|Females|3|50–54|0.764|0.726|0.797
Observed|Ovarian cancer|2015–2019|Females|3|55–59|0.699|0.661|0.733
Observed|Ovarian cancer|2015–2019|Females|3|60–64|0.648|0.612|0.682
Observed|Ovarian cancer|2015–2019|Females|3|65–69|0.602|0.568|0.634
Observed|Ovarian cancer|2015–2019|Females|3|70–74|0.522|0.486|0.557
Observed|Ovarian cancer|2015–2019|Females|3|75–79|0.409|0.371|0.447
Observed|Ovarian cancer|2015–2019|Females|3|80–84|0.193|0.162|0.225
Observed|Ovarian cancer|2015–2019|Females|3|85+|0.088|0.07|0.109
Observed|Ovarian cancer|2015–2019|Females|3|All ages combined|0.561|0.549|0.573
Observed|Ovarian cancer|2015–2019|Females|4|00–04|||
Observed|Ovarian cancer|2015–2019|Females|4|05–09|||
Observed|Ovarian cancer|2015–2019|Females|4|10–14|1|0.905|1
Observed|Ovarian cancer|2015–2019|Females|4|15–19|0.952|0.819|0.988
Observed|Ovarian cancer|2015–2019|Females|4|20–24|0.915|0.83|0.958
Observed|Ovarian cancer|2015–2019|Females|4|25–29|0.885|0.796|0.936
Observed|Ovarian cancer|2015–2019|Females|4|30–34|0.809|0.732|0.865
Observed|Ovarian cancer|2015–2019|Females|4|35–39|0.851|0.788|0.897
Observed|Ovarian cancer|2015–2019|Females|4|40–44|0.761|0.705|0.809
Observed|Ovarian cancer|2015–2019|Females|4|45–49|0.717|0.672|0.757
Observed|Ovarian cancer|2015–2019|Females|4|50–54|0.701|0.662|0.737
Observed|Ovarian cancer|2015–2019|Females|4|55–59|0.612|0.574|0.649
Observed|Ovarian cancer|2015–2019|Females|4|60–64|0.571|0.535|0.606
Observed|Ovarian cancer|2015–2019|Females|4|65–69|0.504|0.469|0.537
Observed|Ovarian cancer|2015–2019|Females|4|70–74|0.427|0.392|0.462
Observed|Ovarian cancer|2015–2019|Females|4|75–79|0.312|0.276|0.349
Observed|Ovarian cancer|2015–2019|Females|4|80–84|0.144|0.118|0.173
Observed|Ovarian cancer|2015–2019|Females|4|85+|0.062|0.047|0.08
Observed|Ovarian cancer|2015–2019|Females|4|All ages combined|0.491|0.479|0.503
Observed|Ovarian cancer|2015–2019|Females|5|00–04|||
Observed|Ovarian cancer|2015–2019|Females|5|05–09|||
Observed|Ovarian cancer|2015–2019|Females|5|10–14|1|0.906|1
Observed|Ovarian cancer|2015–2019|Females|5|15–19|0.952|0.819|0.988
Observed|Ovarian cancer|2015–2019|Females|5|20–24|0.902|0.814|0.95
Observed|Ovarian cancer|2015–2019|Females|5|25–29|0.885|0.796|0.936
Observed|Ovarian cancer|2015–2019|Females|5|30–34|0.794|0.716|0.853
Observed|Ovarian cancer|2015–2019|Females|5|35–39|0.827|0.761|0.877
Observed|Ovarian cancer|2015–2019|Females|5|40–44|0.728|0.67|0.778
Observed|Ovarian cancer|2015–2019|Females|5|45–49|0.67|0.623|0.712
Observed|Ovarian cancer|2015–2019|Females|5|50–54|0.659|0.619|0.696
Observed|Ovarian cancer|2015–2019|Females|5|55–59|0.557|0.518|0.594
Observed|Ovarian cancer|2015–2019|Females|5|60–64|0.518|0.481|0.553
Observed|Ovarian cancer|2015–2019|Females|5|65–69|0.434|0.4|0.468
Observed|Ovarian cancer|2015–2019|Females|5|70–74|0.363|0.328|0.397
Observed|Ovarian cancer|2015–2019|Females|5|75–79|0.248|0.215|0.283
Observed|Ovarian cancer|2015–2019|Females|5|80–84|0.116|0.092|0.142
Observed|Ovarian cancer|2015–2019|Females|5|85+|0.046|0.034|0.062
Observed|Ovarian cancer|2015–2019|Females|5|All ages combined|0.445|0.433|0.457
Relative|Ovarian cancer|2015–2019|Females|1|00–04|||
Relative|Ovarian cancer|2015–2019|Females|1|05–09|||
Relative|Ovarian cancer|2015–2019|Females|1|10–14|1|0.891|1
Relative|Ovarian cancer|2015–2019|Females|1|15–19|0.978|0.854|0.997
Relative|Ovarian cancer|2015–2019|Females|1|20–24|0.938|0.858|0.974
Relative|Ovarian cancer|2015–2019|Females|1|25–29|0.989|0.924|0.999
Relative|Ovarian cancer|2015–2019|Females|1|30–34|0.939|0.881|0.969
Relative|Ovarian cancer|2015–2019|Females|1|35–39|0.958|0.913|0.98
Relative|Ovarian cancer|2015–2019|Females|1|40–44|0.918|0.876|0.946
Relative|Ovarian cancer|2015–2019|Females|1|45–49|0.926|0.896|0.948
Relative|Ovarian cancer|2015–2019|Females|1|50–54|0.909|0.881|0.931
Relative|Ovarian cancer|2015–2019|Females|1|55–59|0.892|0.865|0.914
Relative|Ovarian cancer|2015–2019|Females|1|60–64|0.863|0.834|0.887
Relative|Ovarian cancer|2015–2019|Females|1|65–69|0.84|0.812|0.864
Relative|Ovarian cancer|2015–2019|Females|1|70–74|0.78|0.749|0.809
Relative|Ovarian cancer|2015–2019|Females|1|75–79|0.695|0.656|0.731
Relative|Ovarian cancer|2015–2019|Females|1|80–84|0.479|0.435|0.522
Relative|Ovarian cancer|2015–2019|Females|1|85+|0.248|0.214|0.283
Relative|Ovarian cancer|2015–2019|Females|1|All ages combined|0.772|0.761|0.782
Relative|Ovarian cancer|2015–2019|Females|2|00–04|||
Relative|Ovarian cancer|2015–2019|Females|2|05–09|||
Relative|Ovarian cancer|2015–2019|Females|2|10–14|1|0.904|1
Relative|Ovarian cancer|2015–2019|Females|2|15–19|0.978|0.855|0.997
Relative|Ovarian cancer|2015–2019|Females|2|20–24|0.938|0.858|0.974
Relative|Ovarian cancer|2015–2019|Females|2|25–29|0.93|0.851|0.968
Relative|Ovarian cancer|2015–2019|Females|2|30–34|0.838|0.764|0.89
Relative|Ovarian cancer|2015–2019|Females|2|35–39|0.934|0.884|0.964
Relative|Ovarian cancer|2015–2019|Females|2|40–44|0.851|0.801|0.889
Relative|Ovarian cancer|2015–2019|Females|2|45–49|0.862|0.825|0.892
Relative|Ovarian cancer|2015–2019|Females|2|50–54|0.831|0.796|0.86
Relative|Ovarian cancer|2015–2019|Females|2|55–59|0.801|0.767|0.83
Relative|Ovarian cancer|2015–2019|Females|2|60–64|0.748|0.713|0.779
Relative|Ovarian cancer|2015–2019|Females|2|65–69|0.726|0.693|0.756
Relative|Ovarian cancer|2015–2019|Females|2|70–74|0.646|0.61|0.68
Relative|Ovarian cancer|2015–2019|Females|2|75–79|0.553|0.511|0.592
Relative|Ovarian cancer|2015–2019|Females|2|80–84|0.315|0.275|0.356
Relative|Ovarian cancer|2015–2019|Females|2|85+|0.166|0.138|0.198
Relative|Ovarian cancer|2015–2019|Females|2|All ages combined|0.667|0.654|0.678
Relative|Ovarian cancer|2015–2019|Females|3|00–04|||
Relative|Ovarian cancer|2015–2019|Females|3|05–09|||
Relative|Ovarian cancer|2015–2019|Females|3|10–14|1|0.908|1
Relative|Ovarian cancer|2015–2019|Females|3|15–19|0.979|0.855|0.998
Relative|Ovarian cancer|2015–2019|Females|3|20–24|0.915|0.83|0.959
Relative|Ovarian cancer|2015–2019|Females|3|25–29|0.897|0.811|0.945
Relative|Ovarian cancer|2015–2019|Females|3|30–34|0.824|0.748|0.879
Relative|Ovarian cancer|2015–2019|Females|3|35–39|0.899|0.842|0.937
Relative|Ovarian cancer|2015–2019|Females|3|40–44|0.802|0.748|0.846
Relative|Ovarian cancer|2015–2019|Females|3|45–49|0.8|0.758|0.835
Relative|Ovarian cancer|2015–2019|Females|3|50–54|0.769|0.731|0.802
Relative|Ovarian cancer|2015–2019|Females|3|55–59|0.706|0.668|0.74
Relative|Ovarian cancer|2015–2019|Females|3|60–64|0.658|0.622|0.693
Relative|Ovarian cancer|2015–2019|Females|3|65–69|0.616|0.581|0.65
Relative|Ovarian cancer|2015–2019|Females|3|70–74|0.544|0.506|0.58
Relative|Ovarian cancer|2015–2019|Females|3|75–79|0.44|0.399|0.481
Relative|Ovarian cancer|2015–2019|Females|3|80–84|0.222|0.187|0.259
Relative|Ovarian cancer|2015–2019|Females|3|85+|0.126|0.1|0.156
Relative|Ovarian cancer|2015–2019|Females|3|All ages combined|0.586|0.574|0.599
Relative|Ovarian cancer|2015–2019|Females|4|00–04|||
Relative|Ovarian cancer|2015–2019|Females|4|05–09|||
Relative|Ovarian cancer|2015–2019|Females|4|10–14|1.001|0.906|1.001
Relative|Ovarian cancer|2015–2019|Females|4|15–19|0.953|0.82|0.989
Relative|Ovarian cancer|2015–2019|Females|4|20–24|0.916|0.83|0.959
Relative|Ovarian cancer|2015–2019|Females|4|25–29|0.886|0.797|0.937
Relative|Ovarian cancer|2015–2019|Females|4|30–34|0.81|0.734|0.867
Relative|Ovarian cancer|2015–2019|Females|4|35–39|0.854|0.79|0.899
Relative|Ovarian cancer|2015–2019|Females|4|40–44|0.765|0.708|0.812
Relative|Ovarian cancer|2015–2019|Females|4|45–49|0.722|0.677|0.762
Relative|Ovarian cancer|2015–2019|Females|4|50–54|0.708|0.668|0.744
Relative|Ovarian cancer|2015–2019|Females|4|55–59|0.621|0.582|0.658
Relative|Ovarian cancer|2015–2019|Females|4|60–64|0.584|0.546|0.619
Relative|Ovarian cancer|2015–2019|Females|4|65–69|0.521|0.485|0.555
Relative|Ovarian cancer|2015–2019|Females|4|70–74|0.453|0.415|0.49
Relative|Ovarian cancer|2015–2019|Females|4|75–79|0.346|0.307|0.387
Relative|Ovarian cancer|2015–2019|Females|4|80–84|0.177|0.144|0.212
Relative|Ovarian cancer|2015–2019|Females|4|85+|0.103|0.078|0.133
Relative|Ovarian cancer|2015–2019|Females|4|All ages combined|0.519|0.507|0.532
Relative|Ovarian cancer|2015–2019|Females|5|00–04|||
Relative|Ovarian cancer|2015–2019|Females|5|05–09|||
Relative|Ovarian cancer|2015–2019|Females|5|10–14|1.001|0.907|1.001
Relative|Ovarian cancer|2015–2019|Females|5|15–19|0.953|0.82|0.989
Relative|Ovarian cancer|2015–2019|Females|5|20–24|0.904|0.815|0.951
Relative|Ovarian cancer|2015–2019|Females|5|25–29|0.886|0.797|0.938
Relative|Ovarian cancer|2015–2019|Females|5|30–34|0.796|0.718|0.855
Relative|Ovarian cancer|2015–2019|Females|5|35–39|0.83|0.764|0.88
Relative|Ovarian cancer|2015–2019|Females|5|40–44|0.732|0.674|0.782
Relative|Ovarian cancer|2015–2019|Females|5|45–49|0.676|0.629|0.718
Relative|Ovarian cancer|2015–2019|Females|5|50–54|0.668|0.627|0.705
Relative|Ovarian cancer|2015–2019|Females|5|55–59|0.568|0.528|0.606
Relative|Ovarian cancer|2015–2019|Females|5|60–64|0.532|0.495|0.569
Relative|Ovarian cancer|2015–2019|Females|5|65–69|0.454|0.419|0.489
Relative|Ovarian cancer|2015–2019|Females|5|70–74|0.392|0.354|0.429
Relative|Ovarian cancer|2015–2019|Females|5|75–79|0.285|0.247|0.325
Relative|Ovarian cancer|2015–2019|Females|5|80–84|0.152|0.121|0.187
Relative|Ovarian cancer|2015–2019|Females|5|85+|0.09|0.066|0.12
Relative|Ovarian cancer|2015–2019|Females|5|All ages combined|0.476|0.463|0.488
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|00–04|||
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|05–09|||
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|10–14|1|0.891|1
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|15–19|0.978|0.854|0.997
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|20–24|0.939|0.859|0.974
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|25–29|0.989|0.924|0.998
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|30–34|0.94|0.884|0.97
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|35–39|0.96|0.918|0.981
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|40–44|0.92|0.881|0.947
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|45–49|0.931|0.904|0.95
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|50–54|0.915|0.89|0.934
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|55–59|0.905|0.882|0.923
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|60–64|0.878|0.855|0.898
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|65–69|0.866|0.844|0.886
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|70–74|0.813|0.787|0.835
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|75–79|0.731|0.699|0.761
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|80–84|0.504|0.465|0.542
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|85+|0.254|0.223|0.286
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|All ages combined|0.788|0.778|0.796
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|00–04|||
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|05–09|||
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|10–14|1|0.904|1
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|15–19|0.978|0.854|0.997
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|20–24|0.939|0.859|0.974
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|25–29|0.93|0.851|0.968
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|30–34|0.842|0.77|0.893
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|35–39|0.937|0.89|0.965
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|40–44|0.854|0.807|0.89
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|45–49|0.867|0.833|0.894
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|50–54|0.839|0.809|0.865
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|55–59|0.809|0.779|0.835
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|60–64|0.763|0.734|0.79
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|65–69|0.75|0.723|0.775
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|70–74|0.66|0.629|0.689
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|75–79|0.582|0.547|0.615
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|80–84|0.322|0.287|0.359
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|85+|0.161|0.136|0.187
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|All ages combined|0.674|0.664|0.685
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|00–04|||
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|05–09|||
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|10–14|1|0.907|1
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|15–19|0.978|0.854|0.997
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|20–24|0.916|0.831|0.959
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|25–29|0.896|0.81|0.945
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|30–34|0.828|0.755|0.881
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|35–39|0.903|0.849|0.939
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|40–44|0.803|0.751|0.845
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|45–49|0.798|0.759|0.831
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|50–54|0.768|0.735|0.799
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|55–59|0.701|0.667|0.732
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|60–64|0.661|0.628|0.691
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|65–69|0.635|0.605|0.664
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|70–74|0.543|0.511|0.574
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|75–79|0.449|0.413|0.483
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|80–84|0.221|0.19|0.254
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|85+|0.109|0.089|0.132
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|All ages combined|0.582|0.571|0.593
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|00–04|||
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|05–09|||
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|10–14|1|0.905|1
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|15–19|0.952|0.819|0.988
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|20–24|0.916|0.831|0.959
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|25–29|0.885|0.796|0.936
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|30–34|0.807|0.732|0.863
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|35–39|0.854|0.793|0.898
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|40–44|0.762|0.708|0.808
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|45–49|0.716|0.673|0.754
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|50–54|0.697|0.66|0.73
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|55–59|0.613|0.577|0.647
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|60–64|0.577|0.543|0.609
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|65–69|0.531|0.5|0.562
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|70–74|0.451|0.418|0.483
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|75–79|0.351|0.317|0.385
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|80–84|0.171|0.144|0.201
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|85+|0.077|0.06|0.096
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|All ages combined|0.507|0.496|0.519
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|00–04|||
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|05–09|||
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|10–14|1|0.906|1
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|15–19|0.952|0.819|0.988
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|20–24|0.903|0.816|0.95
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|25–29|0.885|0.796|0.936
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|30–34|0.793|0.716|0.851
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|35–39|0.831|0.767|0.878
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|40–44|0.726|0.67|0.775
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|45–49|0.669|0.624|0.709
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|50–54|0.654|0.617|0.689
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|55–59|0.554|0.517|0.588
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|60–64|0.523|0.489|0.555
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|65–69|0.46|0.428|0.491
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|70–74|0.38|0.348|0.412
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|75–79|0.279|0.246|0.313
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|80–84|0.134|0.11|0.161
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|85+|0.057|0.043|0.075
Observed|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|All ages combined|0.457|0.446|0.468
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|00–04|||
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|05–09|||
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|10–14|1|0.891|1
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|15–19|0.978|0.854|0.997
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|20–24|0.939|0.859|0.974
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|25–29|0.989|0.924|0.999
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|30–34|0.941|0.885|0.97
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|35–39|0.961|0.919|0.981
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|40–44|0.921|0.882|0.948
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|45–49|0.932|0.905|0.952
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|50–54|0.917|0.892|0.936
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|55–59|0.907|0.885|0.926
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|60–64|0.882|0.859|0.902
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|65–69|0.873|0.85|0.892
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|70–74|0.822|0.797|0.846
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|75–79|0.747|0.714|0.777
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|80–84|0.525|0.484|0.565
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|85+|0.285|0.25|0.321
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|1|All ages combined|0.802|0.792|0.811
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|00–04|||
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|05–09|||
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|10–14|1|0.904|1
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|15–19|0.978|0.855|0.997
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|20–24|0.939|0.859|0.974
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|25–29|0.93|0.851|0.968
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|30–34|0.843|0.771|0.894
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|35–39|0.939|0.891|0.966
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|40–44|0.856|0.809|0.892
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|45–49|0.87|0.836|0.897
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|50–54|0.843|0.812|0.869
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|55–59|0.814|0.784|0.84
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|60–64|0.771|0.741|0.798
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|65–69|0.762|0.734|0.787
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|70–74|0.677|0.646|0.707
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|75–79|0.609|0.572|0.644
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|80–84|0.352|0.313|0.392
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|85+|0.202|0.171|0.235
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|2|All ages combined|0.696|0.685|0.706
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|00–04|||
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|05–09|||
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|10–14|1|0.908|1
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|15–19|0.979|0.855|0.998
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|20–24|0.916|0.832|0.959
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|25–29|0.897|0.811|0.945
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|30–34|0.829|0.756|0.882
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|35–39|0.905|0.851|0.941
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|40–44|0.806|0.754|0.848
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|45–49|0.802|0.763|0.835
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|50–54|0.774|0.74|0.804
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|55–59|0.708|0.673|0.739
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|60–64|0.671|0.638|0.702
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|65–69|0.651|0.62|0.68
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|70–74|0.566|0.532|0.598
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|75–79|0.482|0.444|0.519
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|80–84|0.255|0.219|0.292
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|85+|0.155|0.126|0.187
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|3|All ages combined|0.607|0.596|0.619
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|00–04|||
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|05–09|||
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|10–14|1.001|0.906|1.001
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|15–19|0.953|0.82|0.989
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|20–24|0.916|0.832|0.96
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|25–29|0.886|0.797|0.937
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|30–34|0.809|0.733|0.865
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|35–39|0.856|0.795|0.9
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|40–44|0.766|0.711|0.812
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|45–49|0.721|0.678|0.759
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|50–54|0.704|0.667|0.737
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|55–59|0.622|0.585|0.656
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|60–64|0.589|0.555|0.622
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|65–69|0.549|0.517|0.581
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|70–74|0.478|0.443|0.512
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|75–79|0.389|0.351|0.427
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|80–84|0.209|0.176|0.246
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|85+|0.126|0.098|0.159
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|4|All ages combined|0.536|0.524|0.548
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|00–04|||
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|05–09|||
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|10–14|1.001|0.907|1.001
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|15–19|0.953|0.82|0.989
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|20–24|0.904|0.817|0.952
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|25–29|0.886|0.797|0.938
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|30–34|0.794|0.717|0.853
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|35–39|0.834|0.77|0.882
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|40–44|0.731|0.674|0.779
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|45–49|0.674|0.63|0.715
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|50–54|0.663|0.625|0.698
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|55–59|0.564|0.527|0.6
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|60–64|0.538|0.503|0.571
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|65–69|0.481|0.448|0.513
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|70–74|0.41|0.375|0.445
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|75–79|0.32|0.282|0.359
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|80–84|0.177|0.144|0.212
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|85+|0.111|0.083|0.144
Relative|Ovarian cancer and serous carcinomas of the fallopian tube|2015–2019|Females|5|All ages combined|0.489|0.477|0.501
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|65–69|0.216|0.126|0.322
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|70–74|0.306|0.2|0.418
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|75–79|0.187|0.111|0.279
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|80–84|0.195|0.107|0.303
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|All ages combined|0.24|0.2|0.283
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|70–74|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|80–84|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|All ages combined|0.11|0.081|0.145
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|70–74|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|80–84|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|All ages combined|0.065|0.042|0.096
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|70–74|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|80–84|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|All ages combined|0.051|0.03|0.08
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|70–74|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|80–84|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|All ages combined|0.041|0.022|0.067
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|65–69|0.219|0.127|0.326
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|70–74|0.312|0.204|0.426
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|75–79|0.194|0.115|0.289
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|80–84|0.207|0.113|0.321
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|1|All ages combined|0.25|0.208|0.294
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|70–74|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|80–84|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|2|All ages combined|0.119|0.087|0.157
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|70–74|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|80–84|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|3|All ages combined|0.072|0.046|0.107
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|70–74|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|80–84|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|4|All ages combined|0.059|0.035|0.092
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|70–74|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|80–84|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Males|5|All ages combined|0.049|0.027|0.082
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|60–64|0.234|0.128|0.358
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|70–74|0.295|0.184|0.415
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|75–79|0.199|0.117|0.298
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|80–84|0.134|0.068|0.223
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|85+|0.139|0.075|0.222
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|All ages combined|0.222|0.183|0.263
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|70–74|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|80–84|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|All ages combined|0.084|0.059|0.113
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|70–74|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|80–84|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|All ages combined|0.045|0.028|0.069
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|70–74|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|80–84|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|All ages combined|0.022|0.011|0.042
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|70–74|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|80–84|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|All ages combined|0.019|0.009|0.038
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|60–64|0.235|0.129|0.36
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|70–74|0.298|0.186|0.419
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|75–79|0.204|0.119|0.304
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|80–84|0.14|0.071|0.232
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|85+|0.158|0.085|0.253
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|1|All ages combined|0.23|0.19|0.273
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|70–74|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|80–84|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|2|All ages combined|0.09|0.063|0.121
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|70–74|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|80–84|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|3|All ages combined|0.051|0.031|0.077
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|70–74|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|80–84|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|4|All ages combined|0.026|0.012|0.049
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|70–74|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|80–84|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Females|5|All ages combined|0.024|0.01|0.046
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|55–59|0.38|0.227|0.532
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|60–64|0.281|0.19|0.38
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|65–69|0.229|0.155|0.312
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|70–74|0.301|0.223|0.382
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|75–79|0.193|0.135|0.259
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|80–84|0.163|0.106|0.231
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|85+|0.117|0.072|0.174
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|All ages combined|0.231|0.203|0.261
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|60–64|0.083|0.033|0.165
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|65–69|0.129|0.071|0.206
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|70–74|0.145|0.087|0.218
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|75–79|0.048|0.021|0.09
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|80–84|0.049|0.019|0.099
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|85+|0.05|0.023|0.094
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|All ages combined|0.096|0.077|0.119
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|65–69|0.045|0.014|0.106
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|70–74|0.06|0.024|0.12
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|80–84|0.049|0.019|0.099
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|85+|0.022|0.007|0.052
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|All ages combined|0.054|0.039|0.073
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|70–74|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|80–84|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|All ages combined|0.036|0.024|0.052
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|00–04|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|05–09|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|10–14|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|15–19|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|20–24|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|25–29|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|30–34|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|35–39|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|40–44|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|45–49|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|50–54|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|55–59|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|60–64|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|65–69|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|70–74|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|75–79|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|80–84|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|85+|||
Observed|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|All ages combined|0.029|0.018|0.044
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|55–59|0.381|0.228|0.534
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|60–64|0.283|0.191|0.382
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|65–69|0.231|0.156|0.315
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|70–74|0.305|0.226|0.389
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|75–79|0.199|0.139|0.266
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|80–84|0.171|0.111|0.242
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|85+|0.134|0.083|0.199
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|1|All ages combined|0.24|0.211|0.27
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|60–64|0.085|0.033|0.167
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|65–69|0.132|0.072|0.21
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|70–74|0.15|0.09|0.225
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|75–79|0.051|0.023|0.095
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|80–84|0.054|0.021|0.11
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|85+|0.067|0.03|0.127
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|2|All ages combined|0.103|0.082|0.127
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|65–69|0.047|0.015|0.109
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|70–74|0.063|0.025|0.126
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|80–84|0.057|0.023|0.117
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|85+|0.035|0.012|0.082
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|3|All ages combined|0.061|0.044|0.081
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|70–74|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|80–84|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|4|All ages combined|0.042|0.027|0.06
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|00–04|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|05–09|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|10–14|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|15–19|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|20–24|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|25–29|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|30–34|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|35–39|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|40–44|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|45–49|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|50–54|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|55–59|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|60–64|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|65–69|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|70–74|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|75–79|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|80–84|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|85+|||
Relative|Overlapping and unspecified sites in biliary tract (cancer of)|2015–2019|Persons|5|All ages combined|0.036|0.022|0.054
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|All ages combined|0.912|0.782|0.966
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|All ages combined|0.802|0.654|0.892
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|All ages combined|0.754|0.6|0.856
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|All ages combined|0.701|0.54|0.815
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|All ages combined|0.675|0.512|0.794
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|1|All ages combined|0.928|0.796|0.983
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|2|All ages combined|0.839|0.684|0.933
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|3|All ages combined|0.816|0.649|0.926
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|4|All ages combined|0.786|0.605|0.914
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Males|5|All ages combined|0.785|0.595|0.923
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|All ages combined|0.927|0.791|0.976
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|All ages combined|0.902|0.759|0.962
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|All ages combined|0.902|0.759|0.962
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|All ages combined|0.811|0.642|0.906
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|All ages combined|0.738|0.552|0.856
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|1|All ages combined|0.957|0.816|1.007
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|2|All ages combined|0.945|0.795|1.008
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|3|All ages combined|0.963|0.811|1.028
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|4|All ages combined|0.886|0.701|0.99
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Females|5|All ages combined|0.824|0.616|0.956
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|All ages combined|0.919|0.838|0.961
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|All ages combined|0.848|0.753|0.909
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|All ages combined|0.823|0.724|0.889
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|All ages combined|0.752|0.642|0.833
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|00–04|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|05–09|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|10–14|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|15–19|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|20–24|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|25–29|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|30–34|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|35–39|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|40–44|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|45–49|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|50–54|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|55–59|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|60–64|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|65–69|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|70–74|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|75–79|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|80–84|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|85+|||
Observed|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|All ages combined|0.707|0.591|0.796
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|1|All ages combined|0.941|0.858|0.984
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|2|All ages combined|0.888|0.788|0.951
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|3|All ages combined|0.884|0.778|0.956
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|4|All ages combined|0.833|0.71|0.922
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|00–04|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|05–09|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|10–14|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|15–19|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|20–24|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|25–29|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|30–34|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|35–39|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|40–44|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|45–49|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|50–54|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|55–59|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|60–64|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|65–69|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|70–74|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|75–79|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|80–84|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|85+|||
Relative|Overlapping and unspecified sites in major salivary glands (cancer of)|2015–2019|Persons|5|All ages combined|0.805|0.672|0.906
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|All ages combined|0.436|0.341|0.527
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|All ages combined|0.336|0.249|0.425
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|All ages combined|0.302|0.217|0.391
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|All ages combined|0.266|0.184|0.354
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|All ages combined|0.266|0.184|0.354
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|1|All ages combined|0.455|0.356|0.55
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|2|All ages combined|0.366|0.271|0.462
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|3|All ages combined|0.339|0.244|0.439
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|4|All ages combined|0.307|0.212|0.41
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Males|5|All ages combined|0.316|0.219|0.422
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|All ages combined|0.337|0.207|0.472
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|All ages combined|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|All ages combined|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|All ages combined|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|All ages combined|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|1|All ages combined|0.359|0.22|0.502
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|2|All ages combined|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|3|All ages combined|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|4|All ages combined|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Females|5|All ages combined|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|80–84|0.322|0.184|0.467
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|All ages combined|0.406|0.328|0.483
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|All ages combined|0.318|0.245|0.392
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|All ages combined|0.263|0.195|0.337
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|All ages combined|0.231|0.165|0.303
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|00–04|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|05–09|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|10–14|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|15–19|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|20–24|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|25–29|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|30–34|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|35–39|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|40–44|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|45–49|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|50–54|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|55–59|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|60–64|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|65–69|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|70–74|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|75–79|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|80–84|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|85+|||
Observed|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|All ages combined|0.231|0.165|0.303
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|80–84|0.339|0.194|0.493
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|1|All ages combined|0.427|0.345|0.507
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|2|All ages combined|0.348|0.269|0.43
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|3|All ages combined|0.301|0.222|0.385
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|4|All ages combined|0.273|0.195|0.358
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|00–04|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|05–09|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|10–14|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|15–19|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|20–24|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|25–29|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|30–34|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|35–39|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|40–44|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|45–49|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|50–54|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|55–59|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|60–64|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|65–69|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|70–74|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|75–79|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|80–84|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|85+|||
Relative|Overlapping and unspecified sites in urinary tract (cancer of)|2015–2019|Persons|5|All ages combined|0.282|0.202|0.37
Observed|Pancreatic cancer|2015–2019|Males|1|00–04|||
Observed|Pancreatic cancer|2015–2019|Males|1|05–09|||
Observed|Pancreatic cancer|2015–2019|Males|1|10–14|||
Observed|Pancreatic cancer|2015–2019|Males|1|15–19|||
Observed|Pancreatic cancer|2015–2019|Males|1|20–24|||
Observed|Pancreatic cancer|2015–2019|Males|1|25–29|||
Observed|Pancreatic cancer|2015–2019|Males|1|30–34|0.719|0.5|0.854
Observed|Pancreatic cancer|2015–2019|Males|1|35–39|0.554|0.4|0.683
Observed|Pancreatic cancer|2015–2019|Males|1|40–44|0.544|0.459|0.621
Observed|Pancreatic cancer|2015–2019|Males|1|45–49|0.564|0.503|0.621
Observed|Pancreatic cancer|2015–2019|Males|1|50–54|0.531|0.485|0.575
Observed|Pancreatic cancer|2015–2019|Males|1|55–59|0.518|0.48|0.553
Observed|Pancreatic cancer|2015–2019|Males|1|60–64|0.435|0.406|0.464
Observed|Pancreatic cancer|2015–2019|Males|1|65–69|0.442|0.416|0.467
Observed|Pancreatic cancer|2015–2019|Males|1|70–74|0.371|0.346|0.395
Observed|Pancreatic cancer|2015–2019|Males|1|75–79|0.284|0.262|0.307
Observed|Pancreatic cancer|2015–2019|Males|1|80–84|0.193|0.172|0.215
Observed|Pancreatic cancer|2015–2019|Males|1|85+|0.082|0.069|0.096
Observed|Pancreatic cancer|2015–2019|Males|1|All ages combined|0.35|0.341|0.36
Observed|Pancreatic cancer|2015–2019|Males|2|00–04|||
Observed|Pancreatic cancer|2015–2019|Males|2|05–09|||
Observed|Pancreatic cancer|2015–2019|Males|2|10–14|||
Observed|Pancreatic cancer|2015–2019|Males|2|15–19|||
Observed|Pancreatic cancer|2015–2019|Males|2|20–24|||
Observed|Pancreatic cancer|2015–2019|Males|2|25–29|||
Observed|Pancreatic cancer|2015–2019|Males|2|30–34|||
Observed|Pancreatic cancer|2015–2019|Males|2|35–39|||
Observed|Pancreatic cancer|2015–2019|Males|2|40–44|0.388|0.309|0.467
Observed|Pancreatic cancer|2015–2019|Males|2|45–49|0.371|0.312|0.43
Observed|Pancreatic cancer|2015–2019|Males|2|50–54|0.338|0.295|0.381
Observed|Pancreatic cancer|2015–2019|Males|2|55–59|0.318|0.284|0.353
Observed|Pancreatic cancer|2015–2019|Males|2|60–64|0.25|0.225|0.277
Observed|Pancreatic cancer|2015–2019|Males|2|65–69|0.267|0.244|0.29
Observed|Pancreatic cancer|2015–2019|Males|2|70–74|0.188|0.168|0.208
Observed|Pancreatic cancer|2015–2019|Males|2|75–79|0.144|0.127|0.163
Observed|Pancreatic cancer|2015–2019|Males|2|80–84|0.085|0.071|0.102
Observed|Pancreatic cancer|2015–2019|Males|2|85+|0.028|0.021|0.037
Observed|Pancreatic cancer|2015–2019|Males|2|All ages combined|0.197|0.189|0.205
Observed|Pancreatic cancer|2015–2019|Males|3|00–04|||
Observed|Pancreatic cancer|2015–2019|Males|3|05–09|||
Observed|Pancreatic cancer|2015–2019|Males|3|10–14|||
Observed|Pancreatic cancer|2015–2019|Males|3|15–19|||
Observed|Pancreatic cancer|2015–2019|Males|3|20–24|||
Observed|Pancreatic cancer|2015–2019|Males|3|25–29|||
Observed|Pancreatic cancer|2015–2019|Males|3|30–34|||
Observed|Pancreatic cancer|2015–2019|Males|3|35–39|||
Observed|Pancreatic cancer|2015–2019|Males|3|40–44|0.314|0.239|0.391
Observed|Pancreatic cancer|2015–2019|Males|3|45–49|0.263|0.21|0.319
Observed|Pancreatic cancer|2015–2019|Males|3|50–54|0.251|0.213|0.292
Observed|Pancreatic cancer|2015–2019|Males|3|55–59|0.243|0.211|0.277
Observed|Pancreatic cancer|2015–2019|Males|3|60–64|0.195|0.171|0.22
Observed|Pancreatic cancer|2015–2019|Males|3|65–69|0.197|0.176|0.219
Observed|Pancreatic cancer|2015–2019|Males|3|70–74|0.136|0.119|0.155
Observed|Pancreatic cancer|2015–2019|Males|3|75–79|0.099|0.084|0.115
Observed|Pancreatic cancer|2015–2019|Males|3|80–84|0.055|0.043|0.069
Observed|Pancreatic cancer|2015–2019|Males|3|85+|0.018|0.013|0.026
Observed|Pancreatic cancer|2015–2019|Males|3|All ages combined|0.145|0.138|0.152
Observed|Pancreatic cancer|2015–2019|Males|4|00–04|||
Observed|Pancreatic cancer|2015–2019|Males|4|05–09|||
Observed|Pancreatic cancer|2015–2019|Males|4|10–14|||
Observed|Pancreatic cancer|2015–2019|Males|4|15–19|||
Observed|Pancreatic cancer|2015–2019|Males|4|20–24|||
Observed|Pancreatic cancer|2015–2019|Males|4|25–29|||
Observed|Pancreatic cancer|2015–2019|Males|4|30–34|||
Observed|Pancreatic cancer|2015–2019|Males|4|35–39|||
Observed|Pancreatic cancer|2015–2019|Males|4|40–44|0.3|0.227|0.376
Observed|Pancreatic cancer|2015–2019|Males|4|45–49|0.238|0.187|0.292
Observed|Pancreatic cancer|2015–2019|Males|4|50–54|0.225|0.188|0.264
Observed|Pancreatic cancer|2015–2019|Males|4|55–59|0.195|0.165|0.227
Observed|Pancreatic cancer|2015–2019|Males|4|60–64|0.153|0.131|0.176
Observed|Pancreatic cancer|2015–2019|Males|4|65–69|0.167|0.147|0.188
Observed|Pancreatic cancer|2015–2019|Males|4|70–74|0.11|0.094|0.127
Observed|Pancreatic cancer|2015–2019|Males|4|75–79|0.079|0.065|0.094
Observed|Pancreatic cancer|2015–2019|Males|4|80–84|0.045|0.034|0.058
Observed|Pancreatic cancer|2015–2019|Males|4|85+|0.014|0.009|0.021
Observed|Pancreatic cancer|2015–2019|Males|4|All ages combined|0.121|0.114|0.128
Observed|Pancreatic cancer|2015–2019|Males|5|00–04|||
Observed|Pancreatic cancer|2015–2019|Males|5|05–09|||
Observed|Pancreatic cancer|2015–2019|Males|5|10–14|||
Observed|Pancreatic cancer|2015–2019|Males|5|15–19|||
Observed|Pancreatic cancer|2015–2019|Males|5|20–24|||
Observed|Pancreatic cancer|2015–2019|Males|5|25–29|||
Observed|Pancreatic cancer|2015–2019|Males|5|30–34|||
Observed|Pancreatic cancer|2015–2019|Males|5|35–39|||
Observed|Pancreatic cancer|2015–2019|Males|5|40–44|0.284|0.212|0.36
Observed|Pancreatic cancer|2015–2019|Males|5|45–49|0.238|0.187|0.292
Observed|Pancreatic cancer|2015–2019|Males|5|50–54|0.197|0.162|0.235
Observed|Pancreatic cancer|2015–2019|Males|5|55–59|0.168|0.139|0.199
Observed|Pancreatic cancer|2015–2019|Males|5|60–64|0.135|0.114|0.157
Observed|Pancreatic cancer|2015–2019|Males|5|65–69|0.151|0.132|0.172
Observed|Pancreatic cancer|2015–2019|Males|5|70–74|0.093|0.078|0.11
Observed|Pancreatic cancer|2015–2019|Males|5|75–79|0.061|0.049|0.074
Observed|Pancreatic cancer|2015–2019|Males|5|80–84|0.035|0.026|0.047
Observed|Pancreatic cancer|2015–2019|Males|5|85+|0.011|0.007|0.017
Observed|Pancreatic cancer|2015–2019|Males|5|All ages combined|0.105|0.099|0.112
Relative|Pancreatic cancer|2015–2019|Males|1|00–04|||
Relative|Pancreatic cancer|2015–2019|Males|1|05–09|||
Relative|Pancreatic cancer|2015–2019|Males|1|10–14|||
Relative|Pancreatic cancer|2015–2019|Males|1|15–19|||
Relative|Pancreatic cancer|2015–2019|Males|1|20–24|||
Relative|Pancreatic cancer|2015–2019|Males|1|25–29|||
Relative|Pancreatic cancer|2015–2019|Males|1|30–34|0.719|0.5|0.855
Relative|Pancreatic cancer|2015–2019|Males|1|35–39|0.554|0.4|0.684
Relative|Pancreatic cancer|2015–2019|Males|1|40–44|0.545|0.46|0.622
Relative|Pancreatic cancer|2015–2019|Males|1|45–49|0.566|0.504|0.622
Relative|Pancreatic cancer|2015–2019|Males|1|50–54|0.533|0.487|0.577
Relative|Pancreatic cancer|2015–2019|Males|1|55–59|0.52|0.483|0.556
Relative|Pancreatic cancer|2015–2019|Males|1|60–64|0.439|0.409|0.468
Relative|Pancreatic cancer|2015–2019|Males|1|65–69|0.447|0.421|0.473
Relative|Pancreatic cancer|2015–2019|Males|1|70–74|0.378|0.353|0.403
Relative|Pancreatic cancer|2015–2019|Males|1|75–79|0.294|0.271|0.318
Relative|Pancreatic cancer|2015–2019|Males|1|80–84|0.205|0.182|0.229
Relative|Pancreatic cancer|2015–2019|Males|1|85+|0.094|0.079|0.111
Relative|Pancreatic cancer|2015–2019|Males|1|All ages combined|0.362|0.352|0.372
Relative|Pancreatic cancer|2015–2019|Males|2|00–04|||
Relative|Pancreatic cancer|2015–2019|Males|2|05–09|||
Relative|Pancreatic cancer|2015–2019|Males|2|10–14|||
Relative|Pancreatic cancer|2015–2019|Males|2|15–19|||
Relative|Pancreatic cancer|2015–2019|Males|2|20–24|||
Relative|Pancreatic cancer|2015–2019|Males|2|25–29|||
Relative|Pancreatic cancer|2015–2019|Males|2|30–34|||
Relative|Pancreatic cancer|2015–2019|Males|2|35–39|||
Relative|Pancreatic cancer|2015–2019|Males|2|40–44|0.39|0.31|0.469
Relative|Pancreatic cancer|2015–2019|Males|2|45–49|0.373|0.314|0.432
Relative|Pancreatic cancer|2015–2019|Males|2|50–54|0.34|0.298|0.383
Relative|Pancreatic cancer|2015–2019|Males|2|55–59|0.322|0.287|0.357
Relative|Pancreatic cancer|2015–2019|Males|2|60–64|0.255|0.228|0.282
Relative|Pancreatic cancer|2015–2019|Males|2|65–69|0.274|0.25|0.298
Relative|Pancreatic cancer|2015–2019|Males|2|70–74|0.196|0.175|0.217
Relative|Pancreatic cancer|2015–2019|Males|2|75–79|0.155|0.136|0.175
Relative|Pancreatic cancer|2015–2019|Males|2|80–84|0.097|0.08|0.116
Relative|Pancreatic cancer|2015–2019|Males|2|85+|0.037|0.028|0.049
Relative|Pancreatic cancer|2015–2019|Males|2|All ages combined|0.208|0.2|0.217
Relative|Pancreatic cancer|2015–2019|Males|3|00–04|||
Relative|Pancreatic cancer|2015–2019|Males|3|05–09|||
Relative|Pancreatic cancer|2015–2019|Males|3|10–14|||
Relative|Pancreatic cancer|2015–2019|Males|3|15–19|||
Relative|Pancreatic cancer|2015–2019|Males|3|20–24|||
Relative|Pancreatic cancer|2015–2019|Males|3|25–29|||
Relative|Pancreatic cancer|2015–2019|Males|3|30–34|||
Relative|Pancreatic cancer|2015–2019|Males|3|35–39|||
Relative|Pancreatic cancer|2015–2019|Males|3|40–44|0.316|0.241|0.393
Relative|Pancreatic cancer|2015–2019|Males|3|45–49|0.265|0.212|0.321
Relative|Pancreatic cancer|2015–2019|Males|3|50–54|0.254|0.215|0.295
Relative|Pancreatic cancer|2015–2019|Males|3|55–59|0.247|0.215|0.281
Relative|Pancreatic cancer|2015–2019|Males|3|60–64|0.2|0.176|0.226
Relative|Pancreatic cancer|2015–2019|Males|3|65–69|0.205|0.183|0.228
Relative|Pancreatic cancer|2015–2019|Males|3|70–74|0.145|0.127|0.165
Relative|Pancreatic cancer|2015–2019|Males|3|75–79|0.11|0.094|0.128
Relative|Pancreatic cancer|2015–2019|Males|3|80–84|0.068|0.053|0.085
Relative|Pancreatic cancer|2015–2019|Males|3|85+|0.029|0.02|0.04
Relative|Pancreatic cancer|2015–2019|Males|3|All ages combined|0.157|0.149|0.165
Relative|Pancreatic cancer|2015–2019|Males|4|00–04|||
Relative|Pancreatic cancer|2015–2019|Males|4|05–09|||
Relative|Pancreatic cancer|2015–2019|Males|4|10–14|||
Relative|Pancreatic cancer|2015–2019|Males|4|15–19|||
Relative|Pancreatic cancer|2015–2019|Males|4|20–24|||
Relative|Pancreatic cancer|2015–2019|Males|4|25–29|||
Relative|Pancreatic cancer|2015–2019|Males|4|30–34|||
Relative|Pancreatic cancer|2015–2019|Males|4|35–39|||
Relative|Pancreatic cancer|2015–2019|Males|4|40–44|0.302|0.228|0.379
Relative|Pancreatic cancer|2015–2019|Males|4|45–49|0.24|0.189|0.295
Relative|Pancreatic cancer|2015–2019|Males|4|50–54|0.229|0.191|0.268
Relative|Pancreatic cancer|2015–2019|Males|4|55–59|0.199|0.169|0.232
Relative|Pancreatic cancer|2015–2019|Males|4|60–64|0.159|0.136|0.183
Relative|Pancreatic cancer|2015–2019|Males|4|65–69|0.177|0.156|0.199
Relative|Pancreatic cancer|2015–2019|Males|4|70–74|0.12|0.103|0.139
Relative|Pancreatic cancer|2015–2019|Males|4|75–79|0.092|0.076|0.11
Relative|Pancreatic cancer|2015–2019|Males|4|80–84|0.06|0.046|0.077
Relative|Pancreatic cancer|2015–2019|Males|4|85+|0.026|0.017|0.038
Relative|Pancreatic cancer|2015–2019|Males|4|All ages combined|0.134|0.126|0.141
Relative|Pancreatic cancer|2015–2019|Males|5|00–04|||
Relative|Pancreatic cancer|2015–2019|Males|5|05–09|||
Relative|Pancreatic cancer|2015–2019|Males|5|10–14|||
Relative|Pancreatic cancer|2015–2019|Males|5|15–19|||
Relative|Pancreatic cancer|2015–2019|Males|5|20–24|||
Relative|Pancreatic cancer|2015–2019|Males|5|25–29|||
Relative|Pancreatic cancer|2015–2019|Males|5|30–34|||
Relative|Pancreatic cancer|2015–2019|Males|5|35–39|||
Relative|Pancreatic cancer|2015–2019|Males|5|40–44|0.286|0.214|0.363
Relative|Pancreatic cancer|2015–2019|Males|5|45–49|0.241|0.189|0.296
Relative|Pancreatic cancer|2015–2019|Males|5|50–54|0.202|0.166|0.24
Relative|Pancreatic cancer|2015–2019|Males|5|55–59|0.173|0.143|0.205
Relative|Pancreatic cancer|2015–2019|Males|5|60–64|0.141|0.12|0.165
Relative|Pancreatic cancer|2015–2019|Males|5|65–69|0.163|0.142|0.185
Relative|Pancreatic cancer|2015–2019|Males|5|70–74|0.105|0.088|0.124
Relative|Pancreatic cancer|2015–2019|Males|5|75–79|0.075|0.06|0.092
Relative|Pancreatic cancer|2015–2019|Males|5|80–84|0.052|0.038|0.069
Relative|Pancreatic cancer|2015–2019|Males|5|85+|0.025|0.015|0.039
Relative|Pancreatic cancer|2015–2019|Males|5|All ages combined|0.119|0.112|0.127
Observed|Pancreatic cancer|2015–2019|Females|1|00–04|||
Observed|Pancreatic cancer|2015–2019|Females|1|05–09|||
Observed|Pancreatic cancer|2015–2019|Females|1|10–14|||
Observed|Pancreatic cancer|2015–2019|Females|1|15–19|||
Observed|Pancreatic cancer|2015–2019|Females|1|20–24|||
Observed|Pancreatic cancer|2015–2019|Females|1|25–29|0.97|0.803|0.996
Observed|Pancreatic cancer|2015–2019|Females|1|30–34|0.881|0.713|0.953
Observed|Pancreatic cancer|2015–2019|Females|1|35–39|0.71|0.58|0.806
Observed|Pancreatic cancer|2015–2019|Females|1|40–44|0.696|0.592|0.779
Observed|Pancreatic cancer|2015–2019|Females|1|45–49|0.655|0.584|0.717
Observed|Pancreatic cancer|2015–2019|Females|1|50–54|0.614|0.561|0.662
Observed|Pancreatic cancer|2015–2019|Females|1|55–59|0.597|0.555|0.636
Observed|Pancreatic cancer|2015–2019|Females|1|60–64|0.54|0.504|0.574
Observed|Pancreatic cancer|2015–2019|Females|1|65–69|0.485|0.456|0.514
Observed|Pancreatic cancer|2015–2019|Females|1|70–74|0.404|0.376|0.43
Observed|Pancreatic cancer|2015–2019|Females|1|75–79|0.285|0.261|0.31
Observed|Pancreatic cancer|2015–2019|Females|1|80–84|0.196|0.174|0.218
Observed|Pancreatic cancer|2015–2019|Females|1|85+|0.064|0.055|0.074
Observed|Pancreatic cancer|2015–2019|Females|1|All ages combined|0.356|0.346|0.366
Observed|Pancreatic cancer|2015–2019|Females|2|00–04|||
Observed|Pancreatic cancer|2015–2019|Females|2|05–09|||
Observed|Pancreatic cancer|2015–2019|Females|2|10–14|||
Observed|Pancreatic cancer|2015–2019|Females|2|15–19|||
Observed|Pancreatic cancer|2015–2019|Females|2|20–24|||
Observed|Pancreatic cancer|2015–2019|Females|2|25–29|0.936|0.766|0.984
Observed|Pancreatic cancer|2015–2019|Females|2|30–34|0.881|0.713|0.953
Observed|Pancreatic cancer|2015–2019|Females|2|35–39|0.593|0.456|0.707
Observed|Pancreatic cancer|2015–2019|Females|2|40–44|0.525|0.42|0.62
Observed|Pancreatic cancer|2015–2019|Females|2|45–49|0.473|0.401|0.541
Observed|Pancreatic cancer|2015–2019|Females|2|50–54|0.377|0.325|0.429
Observed|Pancreatic cancer|2015–2019|Females|2|55–59|0.39|0.349|0.431
Observed|Pancreatic cancer|2015–2019|Females|2|60–64|0.34|0.306|0.374
Observed|Pancreatic cancer|2015–2019|Females|2|65–69|0.282|0.256|0.309
Observed|Pancreatic cancer|2015–2019|Females|2|70–74|0.218|0.195|0.242
Observed|Pancreatic cancer|2015–2019|Females|2|75–79|0.142|0.123|0.162
Observed|Pancreatic cancer|2015–2019|Females|2|80–84|0.086|0.071|0.102
Observed|Pancreatic cancer|2015–2019|Females|2|85+|0.026|0.02|0.033
Observed|Pancreatic cancer|2015–2019|Females|2|All ages combined|0.209|0.2|0.218
Observed|Pancreatic cancer|2015–2019|Females|3|00–04|||
Observed|Pancreatic cancer|2015–2019|Females|3|05–09|||
Observed|Pancreatic cancer|2015–2019|Females|3|10–14|||
Observed|Pancreatic cancer|2015–2019|Females|3|15–19|||
Observed|Pancreatic cancer|2015–2019|Females|3|20–24|||
Observed|Pancreatic cancer|2015–2019|Females|3|25–29|0.936|0.766|0.984
Observed|Pancreatic cancer|2015–2019|Females|3|30–34|0.807|0.618|0.909
Observed|Pancreatic cancer|2015–2019|Females|3|35–39|0.523|0.382|0.647
Observed|Pancreatic cancer|2015–2019|Females|3|40–44|0.451|0.348|0.548
Observed|Pancreatic cancer|2015–2019|Females|3|45–49|0.415|0.344|0.484
Observed|Pancreatic cancer|2015–2019|Females|3|50–54|0.288|0.239|0.338
Observed|Pancreatic cancer|2015–2019|Females|3|55–59|0.291|0.253|0.33
Observed|Pancreatic cancer|2015–2019|Females|3|60–64|0.255|0.224|0.287
Observed|Pancreatic cancer|2015–2019|Females|3|65–69|0.196|0.173|0.22
Observed|Pancreatic cancer|2015–2019|Females|3|70–74|0.16|0.139|0.182
Observed|Pancreatic cancer|2015–2019|Females|3|75–79|0.099|0.083|0.116
Observed|Pancreatic cancer|2015–2019|Females|3|80–84|0.053|0.041|0.067
Observed|Pancreatic cancer|2015–2019|Females|3|85+|0.017|0.012|0.023
Observed|Pancreatic cancer|2015–2019|Females|3|All ages combined|0.155|0.147|0.163
Observed|Pancreatic cancer|2015–2019|Females|4|00–04|||
Observed|Pancreatic cancer|2015–2019|Females|4|05–09|||
Observed|Pancreatic cancer|2015–2019|Females|4|10–14|||
Observed|Pancreatic cancer|2015–2019|Females|4|15–19|||
Observed|Pancreatic cancer|2015–2019|Females|4|20–24|||
Observed|Pancreatic cancer|2015–2019|Females|4|25–29|0.891|0.694|0.964
Observed|Pancreatic cancer|2015–2019|Females|4|30–34|||
Observed|Pancreatic cancer|2015–2019|Females|4|35–39|0.523|0.382|0.647
Observed|Pancreatic cancer|2015–2019|Females|4|40–44|0.407|0.308|0.505
Observed|Pancreatic cancer|2015–2019|Females|4|45–49|0.389|0.319|0.459
Observed|Pancreatic cancer|2015–2019|Females|4|50–54|0.267|0.219|0.316
Observed|Pancreatic cancer|2015–2019|Females|4|55–59|0.256|0.219|0.294
Observed|Pancreatic cancer|2015–2019|Females|4|60–64|0.216|0.187|0.247
Observed|Pancreatic cancer|2015–2019|Females|4|65–69|0.161|0.14|0.184
Observed|Pancreatic cancer|2015–2019|Females|4|70–74|0.126|0.107|0.147
Observed|Pancreatic cancer|2015–2019|Females|4|75–79|0.079|0.064|0.095
Observed|Pancreatic cancer|2015–2019|Females|4|80–84|0.038|0.028|0.051
Observed|Pancreatic cancer|2015–2019|Females|4|85+|0.012|0.008|0.017
Observed|Pancreatic cancer|2015–2019|Females|4|All ages combined|0.131|0.124|0.139
Observed|Pancreatic cancer|2015–2019|Females|5|00–04|||
Observed|Pancreatic cancer|2015–2019|Females|5|05–09|||
Observed|Pancreatic cancer|2015–2019|Females|5|10–14|||
Observed|Pancreatic cancer|2015–2019|Females|5|15–19|||
Observed|Pancreatic cancer|2015–2019|Females|5|20–24|||
Observed|Pancreatic cancer|2015–2019|Females|5|25–29|||
Observed|Pancreatic cancer|2015–2019|Females|5|30–34|||
Observed|Pancreatic cancer|2015–2019|Females|5|35–39|0.523|0.382|0.647
Observed|Pancreatic cancer|2015–2019|Females|5|40–44|0.383|0.284|0.481
Observed|Pancreatic cancer|2015–2019|Females|5|45–49|0.374|0.304|0.444
Observed|Pancreatic cancer|2015–2019|Females|5|50–54|0.245|0.198|0.294
Observed|Pancreatic cancer|2015–2019|Females|5|55–59|0.229|0.194|0.267
Observed|Pancreatic cancer|2015–2019|Females|5|60–64|0.193|0.165|0.224
Observed|Pancreatic cancer|2015–2019|Females|5|65–69|0.147|0.126|0.17
Observed|Pancreatic cancer|2015–2019|Females|5|70–74|0.114|0.095|0.135
Observed|Pancreatic cancer|2015–2019|Females|5|75–79|0.07|0.057|0.086
Observed|Pancreatic cancer|2015–2019|Females|5|80–84|0.031|0.022|0.042
Observed|Pancreatic cancer|2015–2019|Females|5|85+|0.009|0.006|0.014
Observed|Pancreatic cancer|2015–2019|Females|5|All ages combined|0.119|0.112|0.126
Relative|Pancreatic cancer|2015–2019|Females|1|00–04|||
Relative|Pancreatic cancer|2015–2019|Females|1|05–09|||
Relative|Pancreatic cancer|2015–2019|Females|1|10–14|||
Relative|Pancreatic cancer|2015–2019|Females|1|15–19|||
Relative|Pancreatic cancer|2015–2019|Females|1|20–24|||
Relative|Pancreatic cancer|2015–2019|Females|1|25–29|0.97|0.803|0.996
Relative|Pancreatic cancer|2015–2019|Females|1|30–34|0.881|0.713|0.954
Relative|Pancreatic cancer|2015–2019|Females|1|35–39|0.71|0.581|0.806
Relative|Pancreatic cancer|2015–2019|Females|1|40–44|0.697|0.593|0.78
Relative|Pancreatic cancer|2015–2019|Females|1|45–49|0.656|0.585|0.718
Relative|Pancreatic cancer|2015–2019|Females|1|50–54|0.615|0.562|0.664
Relative|Pancreatic cancer|2015–2019|Females|1|55–59|0.599|0.557|0.638
Relative|Pancreatic cancer|2015–2019|Females|1|60–64|0.542|0.506|0.577
Relative|Pancreatic cancer|2015–2019|Females|1|65–69|0.489|0.459|0.518
Relative|Pancreatic cancer|2015–2019|Females|1|70–74|0.409|0.381|0.436
Relative|Pancreatic cancer|2015–2019|Females|1|75–79|0.292|0.267|0.317
Relative|Pancreatic cancer|2015–2019|Females|1|80–84|0.204|0.182|0.228
Relative|Pancreatic cancer|2015–2019|Females|1|85+|0.072|0.061|0.083
Relative|Pancreatic cancer|2015–2019|Females|1|All ages combined|0.367|0.357|0.378
Relative|Pancreatic cancer|2015–2019|Females|2|00–04|||
Relative|Pancreatic cancer|2015–2019|Females|2|05–09|||
Relative|Pancreatic cancer|2015–2019|Females|2|10–14|||
Relative|Pancreatic cancer|2015–2019|Females|2|15–19|||
Relative|Pancreatic cancer|2015–2019|Females|2|20–24|||
Relative|Pancreatic cancer|2015–2019|Females|2|25–29|0.936|0.766|0.984
Relative|Pancreatic cancer|2015–2019|Females|2|30–34|0.881|0.713|0.954
Relative|Pancreatic cancer|2015–2019|Females|2|35–39|0.594|0.456|0.708
Relative|Pancreatic cancer|2015–2019|Females|2|40–44|0.526|0.421|0.622
Relative|Pancreatic cancer|2015–2019|Females|2|45–49|0.474|0.402|0.543
Relative|Pancreatic cancer|2015–2019|Females|2|50–54|0.379|0.327|0.431
Relative|Pancreatic cancer|2015–2019|Females|2|55–59|0.393|0.351|0.434
Relative|Pancreatic cancer|2015–2019|Females|2|60–64|0.344|0.309|0.378
Relative|Pancreatic cancer|2015–2019|Females|2|65–69|0.287|0.26|0.314
Relative|Pancreatic cancer|2015–2019|Females|2|70–74|0.224|0.2|0.248
Relative|Pancreatic cancer|2015–2019|Females|2|75–79|0.149|0.129|0.169
Relative|Pancreatic cancer|2015–2019|Females|2|80–84|0.094|0.078|0.112
Relative|Pancreatic cancer|2015–2019|Females|2|85+|0.033|0.026|0.042
Relative|Pancreatic cancer|2015–2019|Females|2|All ages combined|0.219|0.21|0.228
Relative|Pancreatic cancer|2015–2019|Females|3|00–04|||
Relative|Pancreatic cancer|2015–2019|Females|3|05–09|||
Relative|Pancreatic cancer|2015–2019|Females|3|10–14|||
Relative|Pancreatic cancer|2015–2019|Females|3|15–19|||
Relative|Pancreatic cancer|2015–2019|Females|3|20–24|||
Relative|Pancreatic cancer|2015–2019|Females|3|25–29|0.937|0.767|0.984
Relative|Pancreatic cancer|2015–2019|Females|3|30–34|0.808|0.619|0.91
Relative|Pancreatic cancer|2015–2019|Females|3|35–39|0.524|0.383|0.648
Relative|Pancreatic cancer|2015–2019|Females|3|40–44|0.452|0.349|0.549
Relative|Pancreatic cancer|2015–2019|Females|3|45–49|0.417|0.346|0.486
Relative|Pancreatic cancer|2015–2019|Females|3|50–54|0.29|0.241|0.34
Relative|Pancreatic cancer|2015–2019|Females|3|55–59|0.294|0.256|0.334
Relative|Pancreatic cancer|2015–2019|Females|3|60–64|0.259|0.227|0.292
Relative|Pancreatic cancer|2015–2019|Females|3|65–69|0.201|0.177|0.225
Relative|Pancreatic cancer|2015–2019|Females|3|70–74|0.166|0.145|0.19
Relative|Pancreatic cancer|2015–2019|Females|3|75–79|0.106|0.089|0.125
Relative|Pancreatic cancer|2015–2019|Females|3|80–84|0.061|0.048|0.077
Relative|Pancreatic cancer|2015–2019|Females|3|85+|0.025|0.018|0.033
Relative|Pancreatic cancer|2015–2019|Females|3|All ages combined|0.165|0.157|0.174
Relative|Pancreatic cancer|2015–2019|Females|4|00–04|||
Relative|Pancreatic cancer|2015–2019|Females|4|05–09|||
Relative|Pancreatic cancer|2015–2019|Females|4|10–14|||
Relative|Pancreatic cancer|2015–2019|Females|4|15–19|||
Relative|Pancreatic cancer|2015–2019|Females|4|20–24|||
Relative|Pancreatic cancer|2015–2019|Females|4|25–29|0.892|0.695|0.966
Relative|Pancreatic cancer|2015–2019|Females|4|30–34|||
Relative|Pancreatic cancer|2015–2019|Females|4|35–39|0.525|0.383|0.648
Relative|Pancreatic cancer|2015–2019|Females|4|40–44|0.409|0.309|0.507
Relative|Pancreatic cancer|2015–2019|Females|4|45–49|0.391|0.321|0.462
Relative|Pancreatic cancer|2015–2019|Females|4|50–54|0.269|0.221|0.319
Relative|Pancreatic cancer|2015–2019|Females|4|55–59|0.26|0.222|0.298
Relative|Pancreatic cancer|2015–2019|Females|4|60–64|0.221|0.191|0.253
Relative|Pancreatic cancer|2015–2019|Females|4|65–69|0.167|0.145|0.191
Relative|Pancreatic cancer|2015–2019|Females|4|70–74|0.134|0.113|0.156
Relative|Pancreatic cancer|2015–2019|Females|4|75–79|0.087|0.071|0.105
Relative|Pancreatic cancer|2015–2019|Females|4|80–84|0.047|0.035|0.062
Relative|Pancreatic cancer|2015–2019|Females|4|85+|0.021|0.014|0.03
Relative|Pancreatic cancer|2015–2019|Females|4|All ages combined|0.143|0.135|0.151
Relative|Pancreatic cancer|2015–2019|Females|5|00–04|||
Relative|Pancreatic cancer|2015–2019|Females|5|05–09|||
Relative|Pancreatic cancer|2015–2019|Females|5|10–14|||
Relative|Pancreatic cancer|2015–2019|Females|5|15–19|||
Relative|Pancreatic cancer|2015–2019|Females|5|20–24|||
Relative|Pancreatic cancer|2015–2019|Females|5|25–29|||
Relative|Pancreatic cancer|2015–2019|Females|5|30–34|||
Relative|Pancreatic cancer|2015–2019|Females|5|35–39|0.525|0.383|0.649
Relative|Pancreatic cancer|2015–2019|Females|5|40–44|0.385|0.286|0.483
Relative|Pancreatic cancer|2015–2019|Females|5|45–49|0.377|0.306|0.448
Relative|Pancreatic cancer|2015–2019|Females|5|50–54|0.248|0.201|0.298
Relative|Pancreatic cancer|2015–2019|Females|5|55–59|0.234|0.197|0.272
Relative|Pancreatic cancer|2015–2019|Females|5|60–64|0.199|0.17|0.23
Relative|Pancreatic cancer|2015–2019|Females|5|65–69|0.154|0.132|0.178
Relative|Pancreatic cancer|2015–2019|Females|5|70–74|0.123|0.103|0.146
Relative|Pancreatic cancer|2015–2019|Females|5|75–79|0.081|0.065|0.099
Relative|Pancreatic cancer|2015–2019|Females|5|80–84|0.041|0.029|0.056
Relative|Pancreatic cancer|2015–2019|Females|5|85+|0.019|0.012|0.028
Relative|Pancreatic cancer|2015–2019|Females|5|All ages combined|0.131|0.124|0.14
Observed|Pancreatic cancer|2015–2019|Persons|1|00–04|||
Observed|Pancreatic cancer|2015–2019|Persons|1|05–09|||
Observed|Pancreatic cancer|2015–2019|Persons|1|10–14|||
Observed|Pancreatic cancer|2015–2019|Persons|1|15–19|||
Observed|Pancreatic cancer|2015–2019|Persons|1|20–24|||
Observed|Pancreatic cancer|2015–2019|Persons|1|25–29|0.952|0.821|0.988
Observed|Pancreatic cancer|2015–2019|Persons|1|30–34|0.812|0.686|0.891
Observed|Pancreatic cancer|2015–2019|Persons|1|35–39|0.644|0.546|0.726
Observed|Pancreatic cancer|2015–2019|Persons|1|40–44|0.604|0.539|0.663
Observed|Pancreatic cancer|2015–2019|Persons|1|45–49|0.602|0.557|0.645
Observed|Pancreatic cancer|2015–2019|Persons|1|50–54|0.566|0.532|0.599
Observed|Pancreatic cancer|2015–2019|Persons|1|55–59|0.552|0.525|0.579
Observed|Pancreatic cancer|2015–2019|Persons|1|60–64|0.479|0.456|0.501
Observed|Pancreatic cancer|2015–2019|Persons|1|65–69|0.461|0.442|0.48
Observed|Pancreatic cancer|2015–2019|Persons|1|70–74|0.386|0.368|0.404
Observed|Pancreatic cancer|2015–2019|Persons|1|75–79|0.285|0.268|0.302
Observed|Pancreatic cancer|2015–2019|Persons|1|80–84|0.194|0.179|0.21
Observed|Pancreatic cancer|2015–2019|Persons|1|85+|0.071|0.063|0.079
Observed|Pancreatic cancer|2015–2019|Persons|1|All ages combined|0.353|0.346|0.36
Observed|Pancreatic cancer|2015–2019|Persons|2|00–04|||
Observed|Pancreatic cancer|2015–2019|Persons|2|05–09|||
Observed|Pancreatic cancer|2015–2019|Persons|2|10–14|||
Observed|Pancreatic cancer|2015–2019|Persons|2|15–19|||
Observed|Pancreatic cancer|2015–2019|Persons|2|20–24|||
Observed|Pancreatic cancer|2015–2019|Persons|2|25–29|0.925|0.786|0.975
Observed|Pancreatic cancer|2015–2019|Persons|2|30–34|0.773|0.641|0.862
Observed|Pancreatic cancer|2015–2019|Persons|2|35–39|0.499|0.398|0.593
Observed|Pancreatic cancer|2015–2019|Persons|2|40–44|0.442|0.379|0.504
Observed|Pancreatic cancer|2015–2019|Persons|2|45–49|0.415|0.369|0.46
Observed|Pancreatic cancer|2015–2019|Persons|2|50–54|0.355|0.322|0.388
Observed|Pancreatic cancer|2015–2019|Persons|2|55–59|0.35|0.323|0.377
Observed|Pancreatic cancer|2015–2019|Persons|2|60–64|0.288|0.267|0.309
Observed|Pancreatic cancer|2015–2019|Persons|2|65–69|0.274|0.256|0.291
Observed|Pancreatic cancer|2015–2019|Persons|2|70–74|0.202|0.187|0.217
Observed|Pancreatic cancer|2015–2019|Persons|2|75–79|0.143|0.13|0.156
Observed|Pancreatic cancer|2015–2019|Persons|2|80–84|0.086|0.075|0.097
Observed|Pancreatic cancer|2015–2019|Persons|2|85+|0.027|0.022|0.032
Observed|Pancreatic cancer|2015–2019|Persons|2|All ages combined|0.202|0.197|0.208
Observed|Pancreatic cancer|2015–2019|Persons|3|00–04|||
Observed|Pancreatic cancer|2015–2019|Persons|3|05–09|||
Observed|Pancreatic cancer|2015–2019|Persons|3|10–14|||
Observed|Pancreatic cancer|2015–2019|Persons|3|15–19|||
Observed|Pancreatic cancer|2015–2019|Persons|3|20–24|||
Observed|Pancreatic cancer|2015–2019|Persons|3|25–29|0.894|0.741|0.959
Observed|Pancreatic cancer|2015–2019|Persons|3|30–34|0.715|0.577|0.815
Observed|Pancreatic cancer|2015–2019|Persons|3|35–39|0.431|0.331|0.527
Observed|Pancreatic cancer|2015–2019|Persons|3|40–44|0.368|0.307|0.43
Observed|Pancreatic cancer|2015–2019|Persons|3|45–49|0.327|0.284|0.372
Observed|Pancreatic cancer|2015–2019|Persons|3|50–54|0.267|0.237|0.299
Observed|Pancreatic cancer|2015–2019|Persons|3|55–59|0.264|0.239|0.289
Observed|Pancreatic cancer|2015–2019|Persons|3|60–64|0.22|0.201|0.24
Observed|Pancreatic cancer|2015–2019|Persons|3|65–69|0.196|0.181|0.212
Observed|Pancreatic cancer|2015–2019|Persons|3|70–74|0.147|0.133|0.161
Observed|Pancreatic cancer|2015–2019|Persons|3|75–79|0.099|0.088|0.11
Observed|Pancreatic cancer|2015–2019|Persons|3|80–84|0.054|0.046|0.064
Observed|Pancreatic cancer|2015–2019|Persons|3|85+|0.018|0.014|0.022
Observed|Pancreatic cancer|2015–2019|Persons|3|All ages combined|0.15|0.145|0.155
Observed|Pancreatic cancer|2015–2019|Persons|4|00–04|||
Observed|Pancreatic cancer|2015–2019|Persons|4|05–09|||
Observed|Pancreatic cancer|2015–2019|Persons|4|10–14|||
Observed|Pancreatic cancer|2015–2019|Persons|4|15–19|||
Observed|Pancreatic cancer|2015–2019|Persons|4|20–24|||
Observed|Pancreatic cancer|2015–2019|Persons|4|25–29|0.862|0.696|0.941
Observed|Pancreatic cancer|2015–2019|Persons|4|30–34|0.667|0.521|0.777
Observed|Pancreatic cancer|2015–2019|Persons|4|35–39|0.408|0.309|0.504
Observed|Pancreatic cancer|2015–2019|Persons|4|40–44|0.343|0.283|0.403
Observed|Pancreatic cancer|2015–2019|Persons|4|45–49|0.301|0.259|0.345
Observed|Pancreatic cancer|2015–2019|Persons|4|50–54|0.243|0.213|0.273
Observed|Pancreatic cancer|2015–2019|Persons|4|55–59|0.222|0.199|0.247
Observed|Pancreatic cancer|2015–2019|Persons|4|60–64|0.18|0.162|0.198
Observed|Pancreatic cancer|2015–2019|Persons|4|65–69|0.164|0.15|0.18
Observed|Pancreatic cancer|2015–2019|Persons|4|70–74|0.117|0.105|0.131
Observed|Pancreatic cancer|2015–2019|Persons|4|75–79|0.079|0.069|0.089
Observed|Pancreatic cancer|2015–2019|Persons|4|80–84|0.042|0.034|0.051
Observed|Pancreatic cancer|2015–2019|Persons|4|85+|0.013|0.01|0.017
Observed|Pancreatic cancer|2015–2019|Persons|4|All ages combined|0.126|0.121|0.131
Observed|Pancreatic cancer|2015–2019|Persons|5|00–04|||
Observed|Pancreatic cancer|2015–2019|Persons|5|05–09|||
Observed|Pancreatic cancer|2015–2019|Persons|5|10–14|||
Observed|Pancreatic cancer|2015–2019|Persons|5|15–19|||
Observed|Pancreatic cancer|2015–2019|Persons|5|20–24|||
Observed|Pancreatic cancer|2015–2019|Persons|5|25–29|0.862|0.696|0.941
Observed|Pancreatic cancer|2015–2019|Persons|5|30–34|0.607|0.451|0.731
Observed|Pancreatic cancer|2015–2019|Persons|5|35–39|0.408|0.309|0.504
Observed|Pancreatic cancer|2015–2019|Persons|5|40–44|0.323|0.264|0.384
Observed|Pancreatic cancer|2015–2019|Persons|5|45–49|0.295|0.253|0.339
Observed|Pancreatic cancer|2015–2019|Persons|5|50–54|0.217|0.188|0.247
Observed|Pancreatic cancer|2015–2019|Persons|5|55–59|0.195|0.173|0.219
Observed|Pancreatic cancer|2015–2019|Persons|5|60–64|0.159|0.142|0.177
Observed|Pancreatic cancer|2015–2019|Persons|5|65–69|0.149|0.135|0.164
Observed|Pancreatic cancer|2015–2019|Persons|5|70–74|0.103|0.091|0.116
Observed|Pancreatic cancer|2015–2019|Persons|5|75–79|0.065|0.056|0.075
Observed|Pancreatic cancer|2015–2019|Persons|5|80–84|0.033|0.026|0.041
Observed|Pancreatic cancer|2015–2019|Persons|5|85+|0.01|0.007|0.013
Observed|Pancreatic cancer|2015–2019|Persons|5|All ages combined|0.112|0.107|0.117
Relative|Pancreatic cancer|2015–2019|Persons|1|00–04|||
Relative|Pancreatic cancer|2015–2019|Persons|1|05–09|||
Relative|Pancreatic cancer|2015–2019|Persons|1|10–14|||
Relative|Pancreatic cancer|2015–2019|Persons|1|15–19|||
Relative|Pancreatic cancer|2015–2019|Persons|1|20–24|||
Relative|Pancreatic cancer|2015–2019|Persons|1|25–29|0.952|0.821|0.988
Relative|Pancreatic cancer|2015–2019|Persons|1|30–34|0.812|0.686|0.891
Relative|Pancreatic cancer|2015–2019|Persons|1|35–39|0.644|0.547|0.727
Relative|Pancreatic cancer|2015–2019|Persons|1|40–44|0.605|0.539|0.664
Relative|Pancreatic cancer|2015–2019|Persons|1|45–49|0.604|0.558|0.646
Relative|Pancreatic cancer|2015–2019|Persons|1|50–54|0.568|0.533|0.601
Relative|Pancreatic cancer|2015–2019|Persons|1|55–59|0.555|0.527|0.582
Relative|Pancreatic cancer|2015–2019|Persons|1|60–64|0.482|0.459|0.505
Relative|Pancreatic cancer|2015–2019|Persons|1|65–69|0.466|0.446|0.485
Relative|Pancreatic cancer|2015–2019|Persons|1|70–74|0.392|0.374|0.41
Relative|Pancreatic cancer|2015–2019|Persons|1|75–79|0.293|0.276|0.31
Relative|Pancreatic cancer|2015–2019|Persons|1|80–84|0.205|0.188|0.221
Relative|Pancreatic cancer|2015–2019|Persons|1|85+|0.08|0.072|0.09
Relative|Pancreatic cancer|2015–2019|Persons|1|All ages combined|0.364|0.357|0.372
Relative|Pancreatic cancer|2015–2019|Persons|2|00–04|||
Relative|Pancreatic cancer|2015–2019|Persons|2|05–09|||
Relative|Pancreatic cancer|2015–2019|Persons|2|10–14|||
Relative|Pancreatic cancer|2015–2019|Persons|2|15–19|||
Relative|Pancreatic cancer|2015–2019|Persons|2|20–24|||
Relative|Pancreatic cancer|2015–2019|Persons|2|25–29|0.926|0.787|0.976
Relative|Pancreatic cancer|2015–2019|Persons|2|30–34|0.774|0.642|0.863
Relative|Pancreatic cancer|2015–2019|Persons|2|35–39|0.5|0.398|0.594
Relative|Pancreatic cancer|2015–2019|Persons|2|40–44|0.444|0.38|0.506
Relative|Pancreatic cancer|2015–2019|Persons|2|45–49|0.416|0.37|0.462
Relative|Pancreatic cancer|2015–2019|Persons|2|50–54|0.357|0.324|0.391
Relative|Pancreatic cancer|2015–2019|Persons|2|55–59|0.353|0.326|0.38
Relative|Pancreatic cancer|2015–2019|Persons|2|60–64|0.292|0.271|0.313
Relative|Pancreatic cancer|2015–2019|Persons|2|65–69|0.279|0.262|0.297
Relative|Pancreatic cancer|2015–2019|Persons|2|70–74|0.209|0.193|0.225
Relative|Pancreatic cancer|2015–2019|Persons|2|75–79|0.152|0.138|0.166
Relative|Pancreatic cancer|2015–2019|Persons|2|80–84|0.095|0.084|0.108
Relative|Pancreatic cancer|2015–2019|Persons|2|85+|0.035|0.029|0.042
Relative|Pancreatic cancer|2015–2019|Persons|2|All ages combined|0.213|0.207|0.22
Relative|Pancreatic cancer|2015–2019|Persons|3|00–04|||
Relative|Pancreatic cancer|2015–2019|Persons|3|05–09|||
Relative|Pancreatic cancer|2015–2019|Persons|3|10–14|||
Relative|Pancreatic cancer|2015–2019|Persons|3|15–19|||
Relative|Pancreatic cancer|2015–2019|Persons|3|20–24|||
Relative|Pancreatic cancer|2015–2019|Persons|3|25–29|0.895|0.741|0.96
Relative|Pancreatic cancer|2015–2019|Persons|3|30–34|0.717|0.578|0.817
Relative|Pancreatic cancer|2015–2019|Persons|3|35–39|0.432|0.332|0.528
Relative|Pancreatic cancer|2015–2019|Persons|3|40–44|0.37|0.308|0.431
Relative|Pancreatic cancer|2015–2019|Persons|3|45–49|0.33|0.286|0.374
Relative|Pancreatic cancer|2015–2019|Persons|3|50–54|0.27|0.239|0.301
Relative|Pancreatic cancer|2015–2019|Persons|3|55–59|0.268|0.243|0.293
Relative|Pancreatic cancer|2015–2019|Persons|3|60–64|0.225|0.205|0.245
Relative|Pancreatic cancer|2015–2019|Persons|3|65–69|0.203|0.187|0.22
Relative|Pancreatic cancer|2015–2019|Persons|3|70–74|0.155|0.141|0.17
Relative|Pancreatic cancer|2015–2019|Persons|3|75–79|0.108|0.096|0.121
Relative|Pancreatic cancer|2015–2019|Persons|3|80–84|0.065|0.054|0.076
Relative|Pancreatic cancer|2015–2019|Persons|3|85+|0.026|0.021|0.033
Relative|Pancreatic cancer|2015–2019|Persons|3|All ages combined|0.161|0.155|0.167
Relative|Pancreatic cancer|2015–2019|Persons|4|00–04|||
Relative|Pancreatic cancer|2015–2019|Persons|4|05–09|||
Relative|Pancreatic cancer|2015–2019|Persons|4|10–14|||
Relative|Pancreatic cancer|2015–2019|Persons|4|15–19|||
Relative|Pancreatic cancer|2015–2019|Persons|4|20–24|||
Relative|Pancreatic cancer|2015–2019|Persons|4|25–29|0.863|0.697|0.942
Relative|Pancreatic cancer|2015–2019|Persons|4|30–34|0.668|0.523|0.779
Relative|Pancreatic cancer|2015–2019|Persons|4|35–39|0.409|0.31|0.506
Relative|Pancreatic cancer|2015–2019|Persons|4|40–44|0.345|0.284|0.406
Relative|Pancreatic cancer|2015–2019|Persons|4|45–49|0.304|0.261|0.348
Relative|Pancreatic cancer|2015–2019|Persons|4|50–54|0.246|0.216|0.277
Relative|Pancreatic cancer|2015–2019|Persons|4|55–59|0.226|0.202|0.251
Relative|Pancreatic cancer|2015–2019|Persons|4|60–64|0.185|0.167|0.204
Relative|Pancreatic cancer|2015–2019|Persons|4|65–69|0.172|0.157|0.188
Relative|Pancreatic cancer|2015–2019|Persons|4|70–74|0.127|0.113|0.141
Relative|Pancreatic cancer|2015–2019|Persons|4|75–79|0.09|0.078|0.102
Relative|Pancreatic cancer|2015–2019|Persons|4|80–84|0.054|0.044|0.065
Relative|Pancreatic cancer|2015–2019|Persons|4|85+|0.023|0.017|0.03
Relative|Pancreatic cancer|2015–2019|Persons|4|All ages combined|0.138|0.132|0.143
Relative|Pancreatic cancer|2015–2019|Persons|5|00–04|||
Relative|Pancreatic cancer|2015–2019|Persons|5|05–09|||
Relative|Pancreatic cancer|2015–2019|Persons|5|10–14|||
Relative|Pancreatic cancer|2015–2019|Persons|5|15–19|||
Relative|Pancreatic cancer|2015–2019|Persons|5|20–24|||
Relative|Pancreatic cancer|2015–2019|Persons|5|25–29|0.864|0.698|0.943
Relative|Pancreatic cancer|2015–2019|Persons|5|30–34|0.609|0.453|0.733
Relative|Pancreatic cancer|2015–2019|Persons|5|35–39|0.41|0.31|0.506
Relative|Pancreatic cancer|2015–2019|Persons|5|40–44|0.326|0.266|0.387
Relative|Pancreatic cancer|2015–2019|Persons|5|45–49|0.299|0.256|0.343
Relative|Pancreatic cancer|2015–2019|Persons|5|50–54|0.221|0.191|0.251
Relative|Pancreatic cancer|2015–2019|Persons|5|55–59|0.2|0.177|0.225
Relative|Pancreatic cancer|2015–2019|Persons|5|60–64|0.165|0.148|0.184
Relative|Pancreatic cancer|2015–2019|Persons|5|65–69|0.159|0.143|0.175
Relative|Pancreatic cancer|2015–2019|Persons|5|70–74|0.114|0.1|0.128
Relative|Pancreatic cancer|2015–2019|Persons|5|75–79|0.078|0.067|0.09
Relative|Pancreatic cancer|2015–2019|Persons|5|80–84|0.047|0.037|0.058
Relative|Pancreatic cancer|2015–2019|Persons|5|85+|0.021|0.015|0.028
Relative|Pancreatic cancer|2015–2019|Persons|5|All ages combined|0.125|0.12|0.131
Observed|Parotid gland cancer|2015–2019|Males|1|00–04|||
Observed|Parotid gland cancer|2015–2019|Males|1|05–09|||
Observed|Parotid gland cancer|2015–2019|Males|1|10–14|||
Observed|Parotid gland cancer|2015–2019|Males|1|15–19|||
Observed|Parotid gland cancer|2015–2019|Males|1|20–24|||
Observed|Parotid gland cancer|2015–2019|Males|1|25–29|||
Observed|Parotid gland cancer|2015–2019|Males|1|30–34|||
Observed|Parotid gland cancer|2015–2019|Males|1|35–39|||
Observed|Parotid gland cancer|2015–2019|Males|1|40–44|||
Observed|Parotid gland cancer|2015–2019|Males|1|45–49|1|0.893|1
Observed|Parotid gland cancer|2015–2019|Males|1|50–54|0.953|0.825|0.988
Observed|Parotid gland cancer|2015–2019|Males|1|55–59|0.929|0.821|0.973
Observed|Parotid gland cancer|2015–2019|Males|1|60–64|0.906|0.812|0.954
Observed|Parotid gland cancer|2015–2019|Males|1|65–69|0.926|0.851|0.964
Observed|Parotid gland cancer|2015–2019|Males|1|70–74|0.929|0.85|0.968
Observed|Parotid gland cancer|2015–2019|Males|1|75–79|0.769|0.662|0.846
Observed|Parotid gland cancer|2015–2019|Males|1|80–84|0.655|0.54|0.748
Observed|Parotid gland cancer|2015–2019|Males|1|85+|0.592|0.476|0.69
Observed|Parotid gland cancer|2015–2019|Males|1|All ages combined|0.848|0.82|0.873
Observed|Parotid gland cancer|2015–2019|Males|2|00–04|||
Observed|Parotid gland cancer|2015–2019|Males|2|05–09|||
Observed|Parotid gland cancer|2015–2019|Males|2|10–14|||
Observed|Parotid gland cancer|2015–2019|Males|2|15–19|||
Observed|Parotid gland cancer|2015–2019|Males|2|20–24|||
Observed|Parotid gland cancer|2015–2019|Males|2|25–29|||
Observed|Parotid gland cancer|2015–2019|Males|2|30–34|||
Observed|Parotid gland cancer|2015–2019|Males|2|35–39|||
Observed|Parotid gland cancer|2015–2019|Males|2|40–44|||
Observed|Parotid gland cancer|2015–2019|Males|2|45–49|0.921|0.721|0.98
Observed|Parotid gland cancer|2015–2019|Males|2|50–54|0.885|0.746|0.95
Observed|Parotid gland cancer|2015–2019|Males|2|55–59|0.872|0.749|0.937
Observed|Parotid gland cancer|2015–2019|Males|2|60–64|0.864|0.762|0.924
Observed|Parotid gland cancer|2015–2019|Males|2|65–69|0.806|0.712|0.871
Observed|Parotid gland cancer|2015–2019|Males|2|70–74|0.805|0.705|0.874
Observed|Parotid gland cancer|2015–2019|Males|2|75–79|0.626|0.514|0.72
Observed|Parotid gland cancer|2015–2019|Males|2|80–84|0.523|0.409|0.625
Observed|Parotid gland cancer|2015–2019|Males|2|85+|0.489|0.377|0.591
Observed|Parotid gland cancer|2015–2019|Males|2|All ages combined|0.755|0.721|0.785
Observed|Parotid gland cancer|2015–2019|Males|3|00–04|||
Observed|Parotid gland cancer|2015–2019|Males|3|05–09|||
Observed|Parotid gland cancer|2015–2019|Males|3|10–14|||
Observed|Parotid gland cancer|2015–2019|Males|3|15–19|||
Observed|Parotid gland cancer|2015–2019|Males|3|20–24|||
Observed|Parotid gland cancer|2015–2019|Males|3|25–29|||
Observed|Parotid gland cancer|2015–2019|Males|3|30–34|||
Observed|Parotid gland cancer|2015–2019|Males|3|35–39|||
Observed|Parotid gland cancer|2015–2019|Males|3|40–44|||
Observed|Parotid gland cancer|2015–2019|Males|3|45–49|0.877|0.665|0.959
Observed|Parotid gland cancer|2015–2019|Males|3|50–54|0.808|0.651|0.899
Observed|Parotid gland cancer|2015–2019|Males|3|55–59|0.808|0.671|0.892
Observed|Parotid gland cancer|2015–2019|Males|3|60–64|0.82|0.71|0.891
Observed|Parotid gland cancer|2015–2019|Males|3|65–69|0.763|0.666|0.836
Observed|Parotid gland cancer|2015–2019|Males|3|70–74|0.738|0.632|0.817
Observed|Parotid gland cancer|2015–2019|Males|3|75–79|0.56|0.448|0.657
Observed|Parotid gland cancer|2015–2019|Males|3|80–84|0.49|0.378|0.592
Observed|Parotid gland cancer|2015–2019|Males|3|85+|0.398|0.294|0.5
Observed|Parotid gland cancer|2015–2019|Males|3|All ages combined|0.702|0.666|0.734
Observed|Parotid gland cancer|2015–2019|Males|4|00–04|||
Observed|Parotid gland cancer|2015–2019|Males|4|05–09|||
Observed|Parotid gland cancer|2015–2019|Males|4|10–14|||
Observed|Parotid gland cancer|2015–2019|Males|4|15–19|||
Observed|Parotid gland cancer|2015–2019|Males|4|20–24|||
Observed|Parotid gland cancer|2015–2019|Males|4|25–29|||
Observed|Parotid gland cancer|2015–2019|Males|4|30–34|||
Observed|Parotid gland cancer|2015–2019|Males|4|35–39|||
Observed|Parotid gland cancer|2015–2019|Males|4|40–44|||
Observed|Parotid gland cancer|2015–2019|Males|4|45–49|||
Observed|Parotid gland cancer|2015–2019|Males|4|50–54|0.781|0.621|0.88
Observed|Parotid gland cancer|2015–2019|Males|4|55–59|0.784|0.643|0.875
Observed|Parotid gland cancer|2015–2019|Males|4|60–64|0.82|0.71|0.891
Observed|Parotid gland cancer|2015–2019|Males|4|65–69|0.699|0.596|0.78
Observed|Parotid gland cancer|2015–2019|Males|4|70–74|0.639|0.528|0.731
Observed|Parotid gland cancer|2015–2019|Males|4|75–79|0.515|0.405|0.615
Observed|Parotid gland cancer|2015–2019|Males|4|80–84|0.328|0.232|0.427
Observed|Parotid gland cancer|2015–2019|Males|4|85+|0.361|0.259|0.462
Observed|Parotid gland cancer|2015–2019|Males|4|All ages combined|0.644|0.607|0.678
Observed|Parotid gland cancer|2015–2019|Males|5|00–04|||
Observed|Parotid gland cancer|2015–2019|Males|5|05–09|||
Observed|Parotid gland cancer|2015–2019|Males|5|10–14|||
Observed|Parotid gland cancer|2015–2019|Males|5|15–19|||
Observed|Parotid gland cancer|2015–2019|Males|5|20–24|||
Observed|Parotid gland cancer|2015–2019|Males|5|25–29|||
Observed|Parotid gland cancer|2015–2019|Males|5|30–34|||
Observed|Parotid gland cancer|2015–2019|Males|5|35–39|||
Observed|Parotid gland cancer|2015–2019|Males|5|40–44|||
Observed|Parotid gland cancer|2015–2019|Males|5|45–49|||
Observed|Parotid gland cancer|2015–2019|Males|5|50–54|0.736|0.574|0.844
Observed|Parotid gland cancer|2015–2019|Males|5|55–59|0.741|0.594|0.841
Observed|Parotid gland cancer|2015–2019|Males|5|60–64|0.805|0.692|0.879
Observed|Parotid gland cancer|2015–2019|Males|5|65–69|0.652|0.546|0.738
Observed|Parotid gland cancer|2015–2019|Males|5|70–74|0.559|0.445|0.658
Observed|Parotid gland cancer|2015–2019|Males|5|75–79|0.467|0.358|0.568
Observed|Parotid gland cancer|2015–2019|Males|5|80–84|0.294|0.203|0.391
Observed|Parotid gland cancer|2015–2019|Males|5|85+|0.309|0.21|0.413
Observed|Parotid gland cancer|2015–2019|Males|5|All ages combined|0.605|0.568|0.64
Relative|Parotid gland cancer|2015–2019|Males|1|00–04|||
Relative|Parotid gland cancer|2015–2019|Males|1|05–09|||
Relative|Parotid gland cancer|2015–2019|Males|1|10–14|||
Relative|Parotid gland cancer|2015–2019|Males|1|15–19|||
Relative|Parotid gland cancer|2015–2019|Males|1|20–24|||
Relative|Parotid gland cancer|2015–2019|Males|1|25–29|||
Relative|Parotid gland cancer|2015–2019|Males|1|30–34|||
Relative|Parotid gland cancer|2015–2019|Males|1|35–39|||
Relative|Parotid gland cancer|2015–2019|Males|1|40–44|||
Relative|Parotid gland cancer|2015–2019|Males|1|45–49|1.002|0.895|1.002
Relative|Parotid gland cancer|2015–2019|Males|1|50–54|0.956|0.828|0.992
Relative|Parotid gland cancer|2015–2019|Males|1|55–59|0.934|0.826|0.978
Relative|Parotid gland cancer|2015–2019|Males|1|60–64|0.913|0.819|0.962
Relative|Parotid gland cancer|2015–2019|Males|1|65–69|0.937|0.862|0.976
Relative|Parotid gland cancer|2015–2019|Males|1|70–74|0.948|0.866|0.987
Relative|Parotid gland cancer|2015–2019|Males|1|75–79|0.795|0.684|0.874
Relative|Parotid gland cancer|2015–2019|Males|1|80–84|0.698|0.575|0.797
Relative|Parotid gland cancer|2015–2019|Males|1|85+|0.691|0.556|0.806
Relative|Parotid gland cancer|2015–2019|Males|1|All ages combined|0.877|0.847|0.902
Relative|Parotid gland cancer|2015–2019|Males|2|00–04|||
Relative|Parotid gland cancer|2015–2019|Males|2|05–09|||
Relative|Parotid gland cancer|2015–2019|Males|2|10–14|||
Relative|Parotid gland cancer|2015–2019|Males|2|15–19|||
Relative|Parotid gland cancer|2015–2019|Males|2|20–24|||
Relative|Parotid gland cancer|2015–2019|Males|2|25–29|||
Relative|Parotid gland cancer|2015–2019|Males|2|30–34|||
Relative|Parotid gland cancer|2015–2019|Males|2|35–39|||
Relative|Parotid gland cancer|2015–2019|Males|2|40–44|||
Relative|Parotid gland cancer|2015–2019|Males|2|45–49|0.926|0.725|0.985
Relative|Parotid gland cancer|2015–2019|Males|2|50–54|0.892|0.751|0.957
Relative|Parotid gland cancer|2015–2019|Males|2|55–59|0.881|0.757|0.947
Relative|Parotid gland cancer|2015–2019|Males|2|60–64|0.878|0.774|0.94
Relative|Parotid gland cancer|2015–2019|Males|2|65–69|0.826|0.731|0.893
Relative|Parotid gland cancer|2015–2019|Males|2|70–74|0.839|0.735|0.911
Relative|Parotid gland cancer|2015–2019|Males|2|75–79|0.672|0.551|0.773
Relative|Parotid gland cancer|2015–2019|Males|2|80–84|0.6|0.469|0.716
Relative|Parotid gland cancer|2015–2019|Males|2|85+|0.67|0.518|0.811
Relative|Parotid gland cancer|2015–2019|Males|2|All ages combined|0.803|0.768|0.835
Relative|Parotid gland cancer|2015–2019|Males|3|00–04|||
Relative|Parotid gland cancer|2015–2019|Males|3|05–09|||
Relative|Parotid gland cancer|2015–2019|Males|3|10–14|||
Relative|Parotid gland cancer|2015–2019|Males|3|15–19|||
Relative|Parotid gland cancer|2015–2019|Males|3|20–24|||
Relative|Parotid gland cancer|2015–2019|Males|3|25–29|||
Relative|Parotid gland cancer|2015–2019|Males|3|30–34|||
Relative|Parotid gland cancer|2015–2019|Males|3|35–39|||
Relative|Parotid gland cancer|2015–2019|Males|3|40–44|||
Relative|Parotid gland cancer|2015–2019|Males|3|45–49|0.884|0.67|0.966
Relative|Parotid gland cancer|2015–2019|Males|3|50–54|0.817|0.659|0.91
Relative|Parotid gland cancer|2015–2019|Males|3|55–59|0.821|0.682|0.907
Relative|Parotid gland cancer|2015–2019|Males|3|60–64|0.842|0.729|0.915
Relative|Parotid gland cancer|2015–2019|Males|3|65–69|0.794|0.693|0.87
Relative|Parotid gland cancer|2015–2019|Males|3|70–74|0.788|0.675|0.873
Relative|Parotid gland cancer|2015–2019|Males|3|75–79|0.626|0.501|0.735
Relative|Parotid gland cancer|2015–2019|Males|3|80–84|0.609|0.47|0.736
Relative|Parotid gland cancer|2015–2019|Males|3|85+|0.649|0.479|0.815
Relative|Parotid gland cancer|2015–2019|Males|3|All ages combined|0.77|0.732|0.806
Relative|Parotid gland cancer|2015–2019|Males|4|00–04|||
Relative|Parotid gland cancer|2015–2019|Males|4|05–09|||
Relative|Parotid gland cancer|2015–2019|Males|4|10–14|||
Relative|Parotid gland cancer|2015–2019|Males|4|15–19|||
Relative|Parotid gland cancer|2015–2019|Males|4|20–24|||
Relative|Parotid gland cancer|2015–2019|Males|4|25–29|||
Relative|Parotid gland cancer|2015–2019|Males|4|30–34|||
Relative|Parotid gland cancer|2015–2019|Males|4|35–39|||
Relative|Parotid gland cancer|2015–2019|Males|4|40–44|||
Relative|Parotid gland cancer|2015–2019|Males|4|45–49|||
Relative|Parotid gland cancer|2015–2019|Males|4|50–54|0.794|0.631|0.895
Relative|Parotid gland cancer|2015–2019|Males|4|55–59|0.803|0.658|0.896
Relative|Parotid gland cancer|2015–2019|Males|4|60–64|0.85|0.736|0.924
Relative|Parotid gland cancer|2015–2019|Males|4|65–69|0.739|0.63|0.825
Relative|Parotid gland cancer|2015–2019|Males|4|70–74|0.701|0.579|0.802
Relative|Parotid gland cancer|2015–2019|Males|4|75–79|0.603|0.474|0.72
Relative|Parotid gland cancer|2015–2019|Males|4|80–84|0.446|0.316|0.58
Relative|Parotid gland cancer|2015–2019|Males|4|85+|0.708|0.51|0.909
Relative|Parotid gland cancer|2015–2019|Males|4|All ages combined|0.73|0.689|0.769
Relative|Parotid gland cancer|2015–2019|Males|5|00–04|||
Relative|Parotid gland cancer|2015–2019|Males|5|05–09|||
Relative|Parotid gland cancer|2015–2019|Males|5|10–14|||
Relative|Parotid gland cancer|2015–2019|Males|5|15–19|||
Relative|Parotid gland cancer|2015–2019|Males|5|20–24|||
Relative|Parotid gland cancer|2015–2019|Males|5|25–29|||
Relative|Parotid gland cancer|2015–2019|Males|5|30–34|||
Relative|Parotid gland cancer|2015–2019|Males|5|35–39|||
Relative|Parotid gland cancer|2015–2019|Males|5|40–44|||
Relative|Parotid gland cancer|2015–2019|Males|5|45–49|||
Relative|Parotid gland cancer|2015–2019|Males|5|50–54|0.752|0.586|0.862
Relative|Parotid gland cancer|2015–2019|Males|5|55–59|0.764|0.613|0.868
Relative|Parotid gland cancer|2015–2019|Males|5|60–64|0.844|0.726|0.922
Relative|Parotid gland cancer|2015–2019|Males|5|65–69|0.701|0.587|0.794
Relative|Parotid gland cancer|2015–2019|Males|5|70–74|0.632|0.504|0.744
Relative|Parotid gland cancer|2015–2019|Males|5|75–79|0.576|0.442|0.701
Relative|Parotid gland cancer|2015–2019|Males|5|80–84|0.443|0.306|0.589
Relative|Parotid gland cancer|2015–2019|Males|5|85+|0.738|0.501|0.988
Relative|Parotid gland cancer|2015–2019|Males|5|All ages combined|0.707|0.663|0.748
Observed|Parotid gland cancer|2015–2019|Females|1|00–04|||
Observed|Parotid gland cancer|2015–2019|Females|1|05–09|||
Observed|Parotid gland cancer|2015–2019|Females|1|10–14|||
Observed|Parotid gland cancer|2015–2019|Females|1|15–19|||
Observed|Parotid gland cancer|2015–2019|Females|1|20–24|||
Observed|Parotid gland cancer|2015–2019|Females|1|25–29|||
Observed|Parotid gland cancer|2015–2019|Females|1|30–34|||
Observed|Parotid gland cancer|2015–2019|Females|1|35–39|1|0.875|1
Observed|Parotid gland cancer|2015–2019|Females|1|40–44|1|0.896|1
Observed|Parotid gland cancer|2015–2019|Females|1|45–49|0.923|0.78|0.974
Observed|Parotid gland cancer|2015–2019|Females|1|50–54|1|0.943|1
Observed|Parotid gland cancer|2015–2019|Females|1|55–59|1|0.938|1
Observed|Parotid gland cancer|2015–2019|Females|1|60–64|1|0.937|1
Observed|Parotid gland cancer|2015–2019|Females|1|65–69|0.975|0.836|0.996
Observed|Parotid gland cancer|2015–2019|Females|1|70–74|0.98|0.864|0.997
Observed|Parotid gland cancer|2015–2019|Females|1|75–79|0.928|0.794|0.976
Observed|Parotid gland cancer|2015–2019|Females|1|80–84|0.828|0.657|0.919
Observed|Parotid gland cancer|2015–2019|Females|1|85+|0.588|0.442|0.707
Observed|Parotid gland cancer|2015–2019|Females|1|All ages combined|0.932|0.907|0.951
Observed|Parotid gland cancer|2015–2019|Females|2|00–04|||
Observed|Parotid gland cancer|2015–2019|Females|2|05–09|||
Observed|Parotid gland cancer|2015–2019|Females|2|10–14|||
Observed|Parotid gland cancer|2015–2019|Females|2|15–19|||
Observed|Parotid gland cancer|2015–2019|Females|2|20–24|||
Observed|Parotid gland cancer|2015–2019|Females|2|25–29|||
Observed|Parotid gland cancer|2015–2019|Females|2|30–34|||
Observed|Parotid gland cancer|2015–2019|Females|2|35–39|1|0.873|1
Observed|Parotid gland cancer|2015–2019|Females|2|40–44|1|0.902|1
Observed|Parotid gland cancer|2015–2019|Females|2|45–49|0.923|0.78|0.974
Observed|Parotid gland cancer|2015–2019|Females|2|50–54|0.944|0.836|0.982
Observed|Parotid gland cancer|2015–2019|Females|2|55–59|1|0.94|1
Observed|Parotid gland cancer|2015–2019|Females|2|60–64|0.974|0.832|0.996
Observed|Parotid gland cancer|2015–2019|Females|2|65–69|0.947|0.804|0.987
Observed|Parotid gland cancer|2015–2019|Females|2|70–74|0.933|0.805|0.978
Observed|Parotid gland cancer|2015–2019|Females|2|75–79|0.884|0.743|0.95
Observed|Parotid gland cancer|2015–2019|Females|2|80–84|0.693|0.515|0.816
Observed|Parotid gland cancer|2015–2019|Females|2|85+|0.414|0.281|0.542
Observed|Parotid gland cancer|2015–2019|Females|2|All ages combined|0.887|0.857|0.912
Observed|Parotid gland cancer|2015–2019|Females|3|00–04|||
Observed|Parotid gland cancer|2015–2019|Females|3|05–09|||
Observed|Parotid gland cancer|2015–2019|Females|3|10–14|||
Observed|Parotid gland cancer|2015–2019|Females|3|15–19|||
Observed|Parotid gland cancer|2015–2019|Females|3|20–24|||
Observed|Parotid gland cancer|2015–2019|Females|3|25–29|||
Observed|Parotid gland cancer|2015–2019|Females|3|30–34|||
Observed|Parotid gland cancer|2015–2019|Females|3|35–39|1|0.878|1
Observed|Parotid gland cancer|2015–2019|Females|3|40–44|1|0.908|1
Observed|Parotid gland cancer|2015–2019|Females|3|45–49|0.896|0.746|0.96
Observed|Parotid gland cancer|2015–2019|Females|3|50–54|0.944|0.836|0.982
Observed|Parotid gland cancer|2015–2019|Females|3|55–59|0.982|0.878|0.997
Observed|Parotid gland cancer|2015–2019|Females|3|60–64|0.928|0.793|0.976
Observed|Parotid gland cancer|2015–2019|Females|3|65–69|0.837|0.673|0.923
Observed|Parotid gland cancer|2015–2019|Females|3|70–74|0.816|0.666|0.904
Observed|Parotid gland cancer|2015–2019|Females|3|75–79|0.813|0.661|0.902
Observed|Parotid gland cancer|2015–2019|Females|3|80–84|0.599|0.419|0.74
Observed|Parotid gland cancer|2015–2019|Females|3|85+|0.309|0.192|0.433
Observed|Parotid gland cancer|2015–2019|Females|3|All ages combined|0.839|0.805|0.868
Observed|Parotid gland cancer|2015–2019|Females|4|00–04|||
Observed|Parotid gland cancer|2015–2019|Females|4|05–09|||
Observed|Parotid gland cancer|2015–2019|Females|4|10–14|||
Observed|Parotid gland cancer|2015–2019|Females|4|15–19|||
Observed|Parotid gland cancer|2015–2019|Females|4|20–24|||
Observed|Parotid gland cancer|2015–2019|Females|4|25–29|||
Observed|Parotid gland cancer|2015–2019|Females|4|30–34|||
Observed|Parotid gland cancer|2015–2019|Females|4|35–39|1|0.881|1
Observed|Parotid gland cancer|2015–2019|Females|4|40–44|0.971|0.812|0.996
Observed|Parotid gland cancer|2015–2019|Females|4|45–49|0.896|0.746|0.96
Observed|Parotid gland cancer|2015–2019|Females|4|50–54|0.923|0.807|0.97
Observed|Parotid gland cancer|2015–2019|Females|4|55–59|0.963|0.86|0.991
Observed|Parotid gland cancer|2015–2019|Females|4|60–64|0.89|0.755|0.953
Observed|Parotid gland cancer|2015–2019|Females|4|65–69|0.837|0.673|0.923
Observed|Parotid gland cancer|2015–2019|Females|4|70–74|0.794|0.641|0.887
Observed|Parotid gland cancer|2015–2019|Females|4|75–79|0.789|0.633|0.884
Observed|Parotid gland cancer|2015–2019|Females|4|80–84|||
Observed|Parotid gland cancer|2015–2019|Females|4|85+|||
Observed|Parotid gland cancer|2015–2019|Females|4|All ages combined|0.822|0.786|0.853
Observed|Parotid gland cancer|2015–2019|Females|5|00–04|||
Observed|Parotid gland cancer|2015–2019|Females|5|05–09|||
Observed|Parotid gland cancer|2015–2019|Females|5|10–14|||
Observed|Parotid gland cancer|2015–2019|Females|5|15–19|||
Observed|Parotid gland cancer|2015–2019|Females|5|20–24|||
Observed|Parotid gland cancer|2015–2019|Females|5|25–29|||
Observed|Parotid gland cancer|2015–2019|Females|5|30–34|||
Observed|Parotid gland cancer|2015–2019|Females|5|35–39|1|0.885|1
Observed|Parotid gland cancer|2015–2019|Females|5|40–44|0.971|0.812|0.996
Observed|Parotid gland cancer|2015–2019|Females|5|45–49|0.896|0.746|0.96
Observed|Parotid gland cancer|2015–2019|Females|5|50–54|0.901|0.778|0.958
Observed|Parotid gland cancer|2015–2019|Females|5|55–59|0.963|0.86|0.991
Observed|Parotid gland cancer|2015–2019|Females|5|60–64|0.874|0.739|0.942
Observed|Parotid gland cancer|2015–2019|Females|5|65–69|0.809|0.641|0.904
Observed|Parotid gland cancer|2015–2019|Females|5|70–74|0.772|0.618|0.87
Observed|Parotid gland cancer|2015–2019|Females|5|75–79|0.682|0.515|0.802
Observed|Parotid gland cancer|2015–2019|Females|5|80–84|||
Observed|Parotid gland cancer|2015–2019|Females|5|85+|||
Observed|Parotid gland cancer|2015–2019|Females|5|All ages combined|0.791|0.754|0.824
Relative|Parotid gland cancer|2015–2019|Females|1|00–04|||
Relative|Parotid gland cancer|2015–2019|Females|1|05–09|||
Relative|Parotid gland cancer|2015–2019|Females|1|10–14|||
Relative|Parotid gland cancer|2015–2019|Females|1|15–19|||
Relative|Parotid gland cancer|2015–2019|Females|1|20–24|||
Relative|Parotid gland cancer|2015–2019|Females|1|25–29|||
Relative|Parotid gland cancer|2015–2019|Females|1|30–34|||
Relative|Parotid gland cancer|2015–2019|Females|1|35–39|1.001|0.876|1.001
Relative|Parotid gland cancer|2015–2019|Females|1|40–44|1.001|0.897|1.001
Relative|Parotid gland cancer|2015–2019|Females|1|45–49|0.924|0.781|0.976
Relative|Parotid gland cancer|2015–2019|Females|1|50–54|1.002|0.945|1.002
Relative|Parotid gland cancer|2015–2019|Females|1|55–59|1.003|0.941|1.003
Relative|Parotid gland cancer|2015–2019|Females|1|60–64|1.005|0.942|1.005
Relative|Parotid gland cancer|2015–2019|Females|1|65–69|0.982|0.842|1.004
Relative|Parotid gland cancer|2015–2019|Females|1|70–74|0.991|0.874|1.009
Relative|Parotid gland cancer|2015–2019|Females|1|75–79|0.949|0.812|0.998
Relative|Parotid gland cancer|2015–2019|Females|1|80–84|0.865|0.686|0.959
Relative|Parotid gland cancer|2015–2019|Females|1|85+|0.673|0.507|0.81
Relative|Parotid gland cancer|2015–2019|Females|1|All ages combined|0.951|0.925|0.97
Relative|Parotid gland cancer|2015–2019|Females|2|00–04|||
Relative|Parotid gland cancer|2015–2019|Females|2|05–09|||
Relative|Parotid gland cancer|2015–2019|Females|2|10–14|||
Relative|Parotid gland cancer|2015–2019|Females|2|15–19|||
Relative|Parotid gland cancer|2015–2019|Females|2|20–24|||
Relative|Parotid gland cancer|2015–2019|Females|2|25–29|||
Relative|Parotid gland cancer|2015–2019|Females|2|30–34|||
Relative|Parotid gland cancer|2015–2019|Females|2|35–39|1.001|0.874|1.001
Relative|Parotid gland cancer|2015–2019|Females|2|40–44|1.002|0.904|1.002
Relative|Parotid gland cancer|2015–2019|Females|2|45–49|0.925|0.782|0.977
Relative|Parotid gland cancer|2015–2019|Females|2|50–54|0.948|0.84|0.986
Relative|Parotid gland cancer|2015–2019|Females|2|55–59|1.007|0.946|1.007
Relative|Parotid gland cancer|2015–2019|Females|2|60–64|0.984|0.84|1.006
Relative|Parotid gland cancer|2015–2019|Females|2|65–69|0.962|0.816|1.002
Relative|Parotid gland cancer|2015–2019|Females|2|70–74|0.957|0.826|1.003
Relative|Parotid gland cancer|2015–2019|Females|2|75–79|0.926|0.779|0.995
Relative|Parotid gland cancer|2015–2019|Females|2|80–84|0.759|0.564|0.894
Relative|Parotid gland cancer|2015–2019|Females|2|85+|0.543|0.368|0.711
Relative|Parotid gland cancer|2015–2019|Females|2|All ages combined|0.92|0.888|0.945
Relative|Parotid gland cancer|2015–2019|Females|3|00–04|||
Relative|Parotid gland cancer|2015–2019|Females|3|05–09|||
Relative|Parotid gland cancer|2015–2019|Females|3|10–14|||
Relative|Parotid gland cancer|2015–2019|Females|3|15–19|||
Relative|Parotid gland cancer|2015–2019|Females|3|20–24|||
Relative|Parotid gland cancer|2015–2019|Females|3|25–29|||
Relative|Parotid gland cancer|2015–2019|Females|3|30–34|||
Relative|Parotid gland cancer|2015–2019|Females|3|35–39|1.002|0.88|1.002
Relative|Parotid gland cancer|2015–2019|Females|3|40–44|1.003|0.911|1.003
Relative|Parotid gland cancer|2015–2019|Females|3|45–49|0.9|0.749|0.964
Relative|Parotid gland cancer|2015–2019|Females|3|50–54|0.951|0.842|0.989
Relative|Parotid gland cancer|2015–2019|Females|3|55–59|0.992|0.887|1.008
Relative|Parotid gland cancer|2015–2019|Females|3|60–64|0.942|0.805|0.991
Relative|Parotid gland cancer|2015–2019|Females|3|65–69|0.858|0.69|0.947
Relative|Parotid gland cancer|2015–2019|Females|3|70–74|0.85|0.694|0.941
Relative|Parotid gland cancer|2015–2019|Females|3|75–79|0.877|0.713|0.972
Relative|Parotid gland cancer|2015–2019|Females|3|80–84|0.695|0.485|0.858
Relative|Parotid gland cancer|2015–2019|Females|3|85+|0.472|0.294|0.662
Relative|Parotid gland cancer|2015–2019|Females|3|All ages combined|0.884|0.847|0.914
Relative|Parotid gland cancer|2015–2019|Females|4|00–04|||
Relative|Parotid gland cancer|2015–2019|Females|4|05–09|||
Relative|Parotid gland cancer|2015–2019|Females|4|10–14|||
Relative|Parotid gland cancer|2015–2019|Females|4|15–19|||
Relative|Parotid gland cancer|2015–2019|Females|4|20–24|||
Relative|Parotid gland cancer|2015–2019|Females|4|25–29|||
Relative|Parotid gland cancer|2015–2019|Females|4|30–34|||
Relative|Parotid gland cancer|2015–2019|Females|4|35–39|1.003|0.883|1.003
Relative|Parotid gland cancer|2015–2019|Females|4|40–44|0.975|0.815|1
Relative|Parotid gland cancer|2015–2019|Females|4|45–49|0.901|0.75|0.965
Relative|Parotid gland cancer|2015–2019|Females|4|50–54|0.932|0.815|0.98
Relative|Parotid gland cancer|2015–2019|Females|4|55–59|0.977|0.873|1.005
Relative|Parotid gland cancer|2015–2019|Females|4|60–64|0.909|0.771|0.973
Relative|Parotid gland cancer|2015–2019|Females|4|65–69|0.867|0.697|0.956
Relative|Parotid gland cancer|2015–2019|Females|4|70–74|0.841|0.679|0.94
Relative|Parotid gland cancer|2015–2019|Females|4|75–79|0.877|0.704|0.984
Relative|Parotid gland cancer|2015–2019|Females|4|80–84|||
Relative|Parotid gland cancer|2015–2019|Females|4|85+|||
Relative|Parotid gland cancer|2015–2019|Females|4|All ages combined|0.879|0.841|0.911
Relative|Parotid gland cancer|2015–2019|Females|5|00–04|||
Relative|Parotid gland cancer|2015–2019|Females|5|05–09|||
Relative|Parotid gland cancer|2015–2019|Females|5|10–14|||
Relative|Parotid gland cancer|2015–2019|Females|5|15–19|||
Relative|Parotid gland cancer|2015–2019|Females|5|20–24|||
Relative|Parotid gland cancer|2015–2019|Females|5|25–29|||
Relative|Parotid gland cancer|2015–2019|Females|5|30–34|||
Relative|Parotid gland cancer|2015–2019|Females|5|35–39|1.004|0.888|1.004
Relative|Parotid gland cancer|2015–2019|Females|5|40–44|0.976|0.816|1.001
Relative|Parotid gland cancer|2015–2019|Females|5|45–49|0.903|0.752|0.967
Relative|Parotid gland cancer|2015–2019|Females|5|50–54|0.913|0.788|0.97
Relative|Parotid gland cancer|2015–2019|Females|5|55–59|0.981|0.877|1.009
Relative|Parotid gland cancer|2015–2019|Females|5|60–64|0.899|0.76|0.968
Relative|Parotid gland cancer|2015–2019|Females|5|65–69|0.847|0.671|0.947
Relative|Parotid gland cancer|2015–2019|Females|5|70–74|0.835|0.668|0.941
Relative|Parotid gland cancer|2015–2019|Females|5|75–79|0.787|0.594|0.925
Relative|Parotid gland cancer|2015–2019|Females|5|80–84|||
Relative|Parotid gland cancer|2015–2019|Females|5|85+|||
Relative|Parotid gland cancer|2015–2019|Females|5|All ages combined|0.86|0.819|0.895
Observed|Parotid gland cancer|2015–2019|Persons|1|00–04|||
Observed|Parotid gland cancer|2015–2019|Persons|1|05–09|||
Observed|Parotid gland cancer|2015–2019|Persons|1|10–14|||
Observed|Parotid gland cancer|2015–2019|Persons|1|15–19|1|0.881|1
Observed|Parotid gland cancer|2015–2019|Persons|1|20–24|1|0.895|1
Observed|Parotid gland cancer|2015–2019|Persons|1|25–29|0.964|0.771|0.995
Observed|Parotid gland cancer|2015–2019|Persons|1|30–34|1|0.916|1
Observed|Parotid gland cancer|2015–2019|Persons|1|35–39|0.977|0.846|0.997
Observed|Parotid gland cancer|2015–2019|Persons|1|40–44|0.958|0.842|0.989
Observed|Parotid gland cancer|2015–2019|Persons|1|45–49|0.954|0.865|0.985
Observed|Parotid gland cancer|2015–2019|Persons|1|50–54|0.979|0.918|0.995
Observed|Parotid gland cancer|2015–2019|Persons|1|55–59|0.961|0.9|0.985
Observed|Parotid gland cancer|2015–2019|Persons|1|60–64|0.942|0.882|0.972
Observed|Parotid gland cancer|2015–2019|Persons|1|65–69|0.941|0.885|0.97
Observed|Parotid gland cancer|2015–2019|Persons|1|70–74|0.948|0.893|0.975
Observed|Parotid gland cancer|2015–2019|Persons|1|75–79|0.823|0.743|0.879
Observed|Parotid gland cancer|2015–2019|Persons|1|80–84|0.708|0.615|0.782
Observed|Parotid gland cancer|2015–2019|Persons|1|85+|0.59|0.501|0.668
Observed|Parotid gland cancer|2015–2019|Persons|1|All ages combined|0.884|0.864|0.9
Observed|Parotid gland cancer|2015–2019|Persons|2|00–04|||
Observed|Parotid gland cancer|2015–2019|Persons|2|05–09|||
Observed|Parotid gland cancer|2015–2019|Persons|2|10–14|||
Observed|Parotid gland cancer|2015–2019|Persons|2|15–19|||
Observed|Parotid gland cancer|2015–2019|Persons|2|20–24|1|0.892|1
Observed|Parotid gland cancer|2015–2019|Persons|2|25–29|0.964|0.771|0.995
Observed|Parotid gland cancer|2015–2019|Persons|2|30–34|1|0.919|1
Observed|Parotid gland cancer|2015–2019|Persons|2|35–39|0.977|0.846|0.997
Observed|Parotid gland cancer|2015–2019|Persons|2|40–44|0.939|0.823|0.98
Observed|Parotid gland cancer|2015–2019|Persons|2|45–49|0.921|0.82|0.966
Observed|Parotid gland cancer|2015–2019|Persons|2|50–54|0.917|0.841|0.958
Observed|Parotid gland cancer|2015–2019|Persons|2|55–59|0.932|0.862|0.967
Observed|Parotid gland cancer|2015–2019|Persons|2|60–64|0.906|0.836|0.947
Observed|Parotid gland cancer|2015–2019|Persons|2|65–69|0.844|0.771|0.896
Observed|Parotid gland cancer|2015–2019|Persons|2|70–74|0.848|0.775|0.899
Observed|Parotid gland cancer|2015–2019|Persons|2|75–79|0.714|0.627|0.785
Observed|Parotid gland cancer|2015–2019|Persons|2|80–84|0.575|0.48|0.659
Observed|Parotid gland cancer|2015–2019|Persons|2|85+|0.461|0.375|0.542
Observed|Parotid gland cancer|2015–2019|Persons|2|All ages combined|0.81|0.787|0.831
Observed|Parotid gland cancer|2015–2019|Persons|3|00–04|||
Observed|Parotid gland cancer|2015–2019|Persons|3|05–09|||
Observed|Parotid gland cancer|2015–2019|Persons|3|10–14|||
Observed|Parotid gland cancer|2015–2019|Persons|3|15–19|||
Observed|Parotid gland cancer|2015–2019|Persons|3|20–24|1|0.891|1
Observed|Parotid gland cancer|2015–2019|Persons|3|25–29|0.964|0.771|0.995
Observed|Parotid gland cancer|2015–2019|Persons|3|30–34|1|0.921|1
Observed|Parotid gland cancer|2015–2019|Persons|3|35–39|0.977|0.846|0.997
Observed|Parotid gland cancer|2015–2019|Persons|3|40–44|0.939|0.823|0.98
Observed|Parotid gland cancer|2015–2019|Persons|3|45–49|0.887|0.778|0.945
Observed|Parotid gland cancer|2015–2019|Persons|3|50–54|0.884|0.8|0.934
Observed|Parotid gland cancer|2015–2019|Persons|3|55–59|0.893|0.815|0.939
Observed|Parotid gland cancer|2015–2019|Persons|3|60–64|0.861|0.783|0.912
Observed|Parotid gland cancer|2015–2019|Persons|3|65–69|0.783|0.703|0.844
Observed|Parotid gland cancer|2015–2019|Persons|3|70–74|0.765|0.683|0.828
Observed|Parotid gland cancer|2015–2019|Persons|3|75–79|0.646|0.556|0.722
Observed|Parotid gland cancer|2015–2019|Persons|3|80–84|0.525|0.431|0.611
Observed|Parotid gland cancer|2015–2019|Persons|3|85+|0.364|0.285|0.444
Observed|Parotid gland cancer|2015–2019|Persons|3|All ages combined|0.759|0.734|0.782
Observed|Parotid gland cancer|2015–2019|Persons|4|00–04|||
Observed|Parotid gland cancer|2015–2019|Persons|4|05–09|||
Observed|Parotid gland cancer|2015–2019|Persons|4|10–14|||
Observed|Parotid gland cancer|2015–2019|Persons|4|15–19|||
Observed|Parotid gland cancer|2015–2019|Persons|4|20–24|1|0.888|1
Observed|Parotid gland cancer|2015–2019|Persons|4|25–29|0.964|0.771|0.995
Observed|Parotid gland cancer|2015–2019|Persons|4|30–34|1|0.921|1
Observed|Parotid gland cancer|2015–2019|Persons|4|35–39|0.952|0.821|0.988
Observed|Parotid gland cancer|2015–2019|Persons|4|40–44|0.922|0.806|0.97
Observed|Parotid gland cancer|2015–2019|Persons|4|45–49|0.887|0.778|0.945
Observed|Parotid gland cancer|2015–2019|Persons|4|50–54|0.86|0.771|0.917
Observed|Parotid gland cancer|2015–2019|Persons|4|55–59|0.872|0.79|0.924
Observed|Parotid gland cancer|2015–2019|Persons|4|60–64|0.844|0.764|0.899
Observed|Parotid gland cancer|2015–2019|Persons|4|65–69|0.738|0.655|0.805
Observed|Parotid gland cancer|2015–2019|Persons|4|70–74|0.693|0.606|0.764
Observed|Parotid gland cancer|2015–2019|Persons|4|75–79|0.607|0.517|0.685
Observed|Parotid gland cancer|2015–2019|Persons|4|80–84|0.393|0.306|0.479
Observed|Parotid gland cancer|2015–2019|Persons|4|85+|0.335|0.257|0.414
Observed|Parotid gland cancer|2015–2019|Persons|4|All ages combined|0.719|0.693|0.744
Observed|Parotid gland cancer|2015–2019|Persons|5|00–04|||
Observed|Parotid gland cancer|2015–2019|Persons|5|05–09|||
Observed|Parotid gland cancer|2015–2019|Persons|5|10–14|||
Observed|Parotid gland cancer|2015–2019|Persons|5|15–19|||
Observed|Parotid gland cancer|2015–2019|Persons|5|20–24|1|0.886|1
Observed|Parotid gland cancer|2015–2019|Persons|5|25–29|0.964|0.771|0.995
Observed|Parotid gland cancer|2015–2019|Persons|5|30–34|1|0.921|1
Observed|Parotid gland cancer|2015–2019|Persons|5|35–39|0.952|0.821|0.988
Observed|Parotid gland cancer|2015–2019|Persons|5|40–44|0.922|0.806|0.97
Observed|Parotid gland cancer|2015–2019|Persons|5|45–49|0.887|0.778|0.945
Observed|Parotid gland cancer|2015–2019|Persons|5|50–54|0.827|0.732|0.89
Observed|Parotid gland cancer|2015–2019|Persons|5|55–59|0.851|0.765|0.908
Observed|Parotid gland cancer|2015–2019|Persons|5|60–64|0.828|0.747|0.886
Observed|Parotid gland cancer|2015–2019|Persons|5|65–69|0.697|0.61|0.768
Observed|Parotid gland cancer|2015–2019|Persons|5|70–74|0.636|0.546|0.713
Observed|Parotid gland cancer|2015–2019|Persons|5|75–79|0.54|0.449|0.622
Observed|Parotid gland cancer|2015–2019|Persons|5|80–84|0.351|0.267|0.436
Observed|Parotid gland cancer|2015–2019|Persons|5|85+|0.254|0.183|0.332
Observed|Parotid gland cancer|2015–2019|Persons|5|All ages combined|0.685|0.658|0.71
Relative|Parotid gland cancer|2015–2019|Persons|1|00–04|||
Relative|Parotid gland cancer|2015–2019|Persons|1|05–09|||
Relative|Parotid gland cancer|2015–2019|Persons|1|10–14|||
Relative|Parotid gland cancer|2015–2019|Persons|1|15–19|1|0.881|1
Relative|Parotid gland cancer|2015–2019|Persons|1|20–24|1|0.895|1
Relative|Parotid gland cancer|2015–2019|Persons|1|25–29|0.965|0.772|0.995
Relative|Parotid gland cancer|2015–2019|Persons|1|30–34|1.001|0.917|1.001
Relative|Parotid gland cancer|2015–2019|Persons|1|35–39|0.978|0.847|0.998
Relative|Parotid gland cancer|2015–2019|Persons|1|40–44|0.959|0.843|0.991
Relative|Parotid gland cancer|2015–2019|Persons|1|45–49|0.956|0.866|0.987
Relative|Parotid gland cancer|2015–2019|Persons|1|50–54|0.981|0.92|0.997
Relative|Parotid gland cancer|2015–2019|Persons|1|55–59|0.965|0.904|0.989
Relative|Parotid gland cancer|2015–2019|Persons|1|60–64|0.948|0.888|0.978
Relative|Parotid gland cancer|2015–2019|Persons|1|65–69|0.951|0.894|0.98
Relative|Parotid gland cancer|2015–2019|Persons|1|70–74|0.964|0.909|0.992
Relative|Parotid gland cancer|2015–2019|Persons|1|75–79|0.847|0.765|0.905
Relative|Parotid gland cancer|2015–2019|Persons|1|80–84|0.75|0.652|0.829
Relative|Parotid gland cancer|2015–2019|Persons|1|85+|0.684|0.581|0.775
Relative|Parotid gland cancer|2015–2019|Persons|1|All ages combined|0.908|0.888|0.925
Relative|Parotid gland cancer|2015–2019|Persons|2|00–04|||
Relative|Parotid gland cancer|2015–2019|Persons|2|05–09|||
Relative|Parotid gland cancer|2015–2019|Persons|2|10–14|||
Relative|Parotid gland cancer|2015–2019|Persons|2|15–19|||
Relative|Parotid gland cancer|2015–2019|Persons|2|20–24|1.001|0.893|1.001
Relative|Parotid gland cancer|2015–2019|Persons|2|25–29|0.965|0.772|0.996
Relative|Parotid gland cancer|2015–2019|Persons|2|30–34|1.001|0.92|1.001
Relative|Parotid gland cancer|2015–2019|Persons|2|35–39|0.978|0.848|0.998
Relative|Parotid gland cancer|2015–2019|Persons|2|40–44|0.942|0.825|0.982
Relative|Parotid gland cancer|2015–2019|Persons|2|45–49|0.924|0.823|0.97
Relative|Parotid gland cancer|2015–2019|Persons|2|50–54|0.923|0.846|0.963
Relative|Parotid gland cancer|2015–2019|Persons|2|55–59|0.94|0.87|0.975
Relative|Parotid gland cancer|2015–2019|Persons|2|60–64|0.918|0.848|0.96
Relative|Parotid gland cancer|2015–2019|Persons|2|65–69|0.863|0.789|0.916
Relative|Parotid gland cancer|2015–2019|Persons|2|70–74|0.879|0.803|0.932
Relative|Parotid gland cancer|2015–2019|Persons|2|75–79|0.76|0.667|0.834
Relative|Parotid gland cancer|2015–2019|Persons|2|80–84|0.649|0.542|0.744
Relative|Parotid gland cancer|2015–2019|Persons|2|85+|0.621|0.506|0.73
Relative|Parotid gland cancer|2015–2019|Persons|2|All ages combined|0.852|0.828|0.874
Relative|Parotid gland cancer|2015–2019|Persons|3|00–04|||
Relative|Parotid gland cancer|2015–2019|Persons|3|05–09|||
Relative|Parotid gland cancer|2015–2019|Persons|3|10–14|||
Relative|Parotid gland cancer|2015–2019|Persons|3|15–19|||
Relative|Parotid gland cancer|2015–2019|Persons|3|20–24|1.001|0.892|1.001
Relative|Parotid gland cancer|2015–2019|Persons|3|25–29|0.966|0.773|0.996
Relative|Parotid gland cancer|2015–2019|Persons|3|30–34|1.002|0.922|1.002
Relative|Parotid gland cancer|2015–2019|Persons|3|35–39|0.979|0.848|0.999
Relative|Parotid gland cancer|2015–2019|Persons|3|40–44|0.943|0.826|0.984
Relative|Parotid gland cancer|2015–2019|Persons|3|45–49|0.892|0.782|0.95
Relative|Parotid gland cancer|2015–2019|Persons|3|50–54|0.892|0.807|0.942
Relative|Parotid gland cancer|2015–2019|Persons|3|55–59|0.905|0.826|0.952
Relative|Parotid gland cancer|2015–2019|Persons|3|60–64|0.88|0.8|0.932
Relative|Parotid gland cancer|2015–2019|Persons|3|65–69|0.811|0.728|0.874
Relative|Parotid gland cancer|2015–2019|Persons|3|70–74|0.81|0.723|0.877
Relative|Parotid gland cancer|2015–2019|Persons|3|75–79|0.712|0.613|0.796
Relative|Parotid gland cancer|2015–2019|Persons|3|80–84|0.639|0.524|0.743
Relative|Parotid gland cancer|2015–2019|Persons|3|85+|0.579|0.453|0.706
Relative|Parotid gland cancer|2015–2019|Persons|3|All ages combined|0.818|0.791|0.843
Relative|Parotid gland cancer|2015–2019|Persons|4|00–04|||
Relative|Parotid gland cancer|2015–2019|Persons|4|05–09|||
Relative|Parotid gland cancer|2015–2019|Persons|4|10–14|||
Relative|Parotid gland cancer|2015–2019|Persons|4|15–19|||
Relative|Parotid gland cancer|2015–2019|Persons|4|20–24|1.002|0.89|1.002
Relative|Parotid gland cancer|2015–2019|Persons|4|25–29|0.966|0.773|0.997
Relative|Parotid gland cancer|2015–2019|Persons|4|30–34|1.003|0.923|1.003
Relative|Parotid gland cancer|2015–2019|Persons|4|35–39|0.955|0.824|0.991
Relative|Parotid gland cancer|2015–2019|Persons|4|40–44|0.927|0.81|0.975
Relative|Parotid gland cancer|2015–2019|Persons|4|45–49|0.894|0.784|0.952
Relative|Parotid gland cancer|2015–2019|Persons|4|50–54|0.871|0.781|0.928
Relative|Parotid gland cancer|2015–2019|Persons|4|55–59|0.889|0.805|0.941
Relative|Parotid gland cancer|2015–2019|Persons|4|60–64|0.87|0.787|0.926
Relative|Parotid gland cancer|2015–2019|Persons|4|65–69|0.776|0.688|0.845
Relative|Parotid gland cancer|2015–2019|Persons|4|70–74|0.751|0.656|0.829
Relative|Parotid gland cancer|2015–2019|Persons|4|75–79|0.697|0.593|0.787
Relative|Parotid gland cancer|2015–2019|Persons|4|80–84|0.519|0.403|0.633
Relative|Parotid gland cancer|2015–2019|Persons|4|85+|0.631|0.486|0.78
Relative|Parotid gland cancer|2015–2019|Persons|4|All ages combined|0.794|0.765|0.821
Relative|Parotid gland cancer|2015–2019|Persons|5|00–04|||
Relative|Parotid gland cancer|2015–2019|Persons|5|05–09|||
Relative|Parotid gland cancer|2015–2019|Persons|5|10–14|||
Relative|Parotid gland cancer|2015–2019|Persons|5|15–19|||
Relative|Parotid gland cancer|2015–2019|Persons|5|20–24|1.002|0.888|1.002
Relative|Parotid gland cancer|2015–2019|Persons|5|25–29|0.967|0.773|0.997
Relative|Parotid gland cancer|2015–2019|Persons|5|30–34|1.003|0.924|1.003
Relative|Parotid gland cancer|2015–2019|Persons|5|35–39|0.956|0.825|0.992
Relative|Parotid gland cancer|2015–2019|Persons|5|40–44|0.929|0.811|0.977
Relative|Parotid gland cancer|2015–2019|Persons|5|45–49|0.897|0.786|0.955
Relative|Parotid gland cancer|2015–2019|Persons|5|50–54|0.84|0.744|0.905
Relative|Parotid gland cancer|2015–2019|Persons|5|55–59|0.872|0.784|0.93
Relative|Parotid gland cancer|2015–2019|Persons|5|60–64|0.861|0.776|0.921
Relative|Parotid gland cancer|2015–2019|Persons|5|65–69|0.743|0.651|0.819
Relative|Parotid gland cancer|2015–2019|Persons|5|70–74|0.707|0.608|0.792
Relative|Parotid gland cancer|2015–2019|Persons|5|75–79|0.649|0.539|0.748
Relative|Parotid gland cancer|2015–2019|Persons|5|80–84|0.508|0.386|0.632
Relative|Parotid gland cancer|2015–2019|Persons|5|85+|0.575|0.413|0.75
Relative|Parotid gland cancer|2015–2019|Persons|5|All ages combined|0.773|0.743|0.802
Observed|Penile cancer|2015–2019|Males|1|00–04|||
Observed|Penile cancer|2015–2019|Males|1|05–09|||
Observed|Penile cancer|2015–2019|Males|1|10–14|||
Observed|Penile cancer|2015–2019|Males|1|15–19|||
Observed|Penile cancer|2015–2019|Males|1|20–24|||
Observed|Penile cancer|2015–2019|Males|1|25–29|||
Observed|Penile cancer|2015–2019|Males|1|30–34|||
Observed|Penile cancer|2015–2019|Males|1|35–39|||
Observed|Penile cancer|2015–2019|Males|1|40–44|||
Observed|Penile cancer|2015–2019|Males|1|45–49|0.909|0.743|0.97
Observed|Penile cancer|2015–2019|Males|1|50–54|0.976|0.844|0.997
Observed|Penile cancer|2015–2019|Males|1|55–59|0.937|0.818|0.979
Observed|Penile cancer|2015–2019|Males|1|60–64|0.886|0.785|0.941
Observed|Penile cancer|2015–2019|Males|1|65–69|0.814|0.71|0.883
Observed|Penile cancer|2015–2019|Males|1|70–74|0.816|0.705|0.889
Observed|Penile cancer|2015–2019|Males|1|75–79|0.798|0.698|0.867
Observed|Penile cancer|2015–2019|Males|1|80–84|0.765|0.663|0.84
Observed|Penile cancer|2015–2019|Males|1|85+|0.701|0.569|0.799
Observed|Penile cancer|2015–2019|Males|1|All ages combined|0.835|0.804|0.862
Observed|Penile cancer|2015–2019|Males|2|00–04|||
Observed|Penile cancer|2015–2019|Males|2|05–09|||
Observed|Penile cancer|2015–2019|Males|2|10–14|||
Observed|Penile cancer|2015–2019|Males|2|15–19|||
Observed|Penile cancer|2015–2019|Males|2|20–24|||
Observed|Penile cancer|2015–2019|Males|2|25–29|||
Observed|Penile cancer|2015–2019|Males|2|30–34|||
Observed|Penile cancer|2015–2019|Males|2|35–39|||
Observed|Penile cancer|2015–2019|Males|2|40–44|||
Observed|Penile cancer|2015–2019|Males|2|45–49|0.909|0.743|0.97
Observed|Penile cancer|2015–2019|Males|2|50–54|0.928|0.794|0.976
Observed|Penile cancer|2015–2019|Males|2|55–59|0.894|0.763|0.954
Observed|Penile cancer|2015–2019|Males|2|60–64|0.825|0.711|0.896
Observed|Penile cancer|2015–2019|Males|2|65–69|0.735|0.619|0.821
Observed|Penile cancer|2015–2019|Males|2|70–74|0.764|0.648|0.846
Observed|Penile cancer|2015–2019|Males|2|75–79|0.684|0.574|0.772
Observed|Penile cancer|2015–2019|Males|2|80–84|0.677|0.57|0.763
Observed|Penile cancer|2015–2019|Males|2|85+|0.438|0.307|0.562
Observed|Penile cancer|2015–2019|Males|2|All ages combined|0.749|0.712|0.781
Observed|Penile cancer|2015–2019|Males|3|00–04|||
Observed|Penile cancer|2015–2019|Males|3|05–09|||
Observed|Penile cancer|2015–2019|Males|3|10–14|||
Observed|Penile cancer|2015–2019|Males|3|15–19|||
Observed|Penile cancer|2015–2019|Males|3|20–24|||
Observed|Penile cancer|2015–2019|Males|3|25–29|||
Observed|Penile cancer|2015–2019|Males|3|30–34|||
Observed|Penile cancer|2015–2019|Males|3|35–39|||
Observed|Penile cancer|2015–2019|Males|3|40–44|||
Observed|Penile cancer|2015–2019|Males|3|45–49|0.873|0.696|0.951
Observed|Penile cancer|2015–2019|Males|3|50–54|0.856|0.707|0.933
Observed|Penile cancer|2015–2019|Males|3|55–59|0.848|0.707|0.925
Observed|Penile cancer|2015–2019|Males|3|60–64|0.759|0.637|0.845
Observed|Penile cancer|2015–2019|Males|3|65–69|0.701|0.579|0.793
Observed|Penile cancer|2015–2019|Males|3|70–74|0.7|0.581|0.791
Observed|Penile cancer|2015–2019|Males|3|75–79|0.627|0.516|0.72
Observed|Penile cancer|2015–2019|Males|3|80–84|0.548|0.438|0.644
Observed|Penile cancer|2015–2019|Males|3|85+|||
Observed|Penile cancer|2015–2019|Males|3|All ages combined|0.678|0.639|0.714
Observed|Penile cancer|2015–2019|Males|4|00–04|||
Observed|Penile cancer|2015–2019|Males|4|05–09|||
Observed|Penile cancer|2015–2019|Males|4|10–14|||
Observed|Penile cancer|2015–2019|Males|4|15–19|||
Observed|Penile cancer|2015–2019|Males|4|20–24|||
Observed|Penile cancer|2015–2019|Males|4|25–29|||
Observed|Penile cancer|2015–2019|Males|4|30–34|||
Observed|Penile cancer|2015–2019|Males|4|35–39|||
Observed|Penile cancer|2015–2019|Males|4|40–44|||
Observed|Penile cancer|2015–2019|Males|4|45–49|0.873|0.696|0.951
Observed|Penile cancer|2015–2019|Males|4|50–54|0.832|0.68|0.916
Observed|Penile cancer|2015–2019|Males|4|55–59|0.848|0.707|0.925
Observed|Penile cancer|2015–2019|Males|4|60–64|0.71|0.583|0.805
Observed|Penile cancer|2015–2019|Males|4|65–69|0.683|0.56|0.779
Observed|Penile cancer|2015–2019|Males|4|70–74|0.651|0.532|0.747
Observed|Penile cancer|2015–2019|Males|4|75–79|0.528|0.416|0.628
Observed|Penile cancer|2015–2019|Males|4|80–84|0.445|0.337|0.547
Observed|Penile cancer|2015–2019|Males|4|85+|||
Observed|Penile cancer|2015–2019|Males|4|All ages combined|0.632|0.592|0.669
Observed|Penile cancer|2015–2019|Males|5|00–04|||
Observed|Penile cancer|2015–2019|Males|5|05–09|||
Observed|Penile cancer|2015–2019|Males|5|10–14|||
Observed|Penile cancer|2015–2019|Males|5|15–19|||
Observed|Penile cancer|2015–2019|Males|5|20–24|||
Observed|Penile cancer|2015–2019|Males|5|25–29|||
Observed|Penile cancer|2015–2019|Males|5|30–34|||
Observed|Penile cancer|2015–2019|Males|5|35–39|||
Observed|Penile cancer|2015–2019|Males|5|40–44|||
Observed|Penile cancer|2015–2019|Males|5|45–49|0.84|0.657|0.93
Observed|Penile cancer|2015–2019|Males|5|50–54|0.832|0.68|0.916
Observed|Penile cancer|2015–2019|Males|5|55–59|0.81|0.666|0.896
Observed|Penile cancer|2015–2019|Males|5|60–64|0.692|0.563|0.79
Observed|Penile cancer|2015–2019|Males|5|65–69|0.647|0.52|0.748
Observed|Penile cancer|2015–2019|Males|5|70–74|0.626|0.507|0.724
Observed|Penile cancer|2015–2019|Males|5|75–79|0.5|0.388|0.602
Observed|Penile cancer|2015–2019|Males|5|80–84|0.418|0.311|0.521
Observed|Penile cancer|2015–2019|Males|5|85+|||
Observed|Penile cancer|2015–2019|Males|5|All ages combined|0.606|0.565|0.644
Relative|Penile cancer|2015–2019|Males|1|00–04|||
Relative|Penile cancer|2015–2019|Males|1|05–09|||
Relative|Penile cancer|2015–2019|Males|1|10–14|||
Relative|Penile cancer|2015–2019|Males|1|15–19|||
Relative|Penile cancer|2015–2019|Males|1|20–24|||
Relative|Penile cancer|2015–2019|Males|1|25–29|||
Relative|Penile cancer|2015–2019|Males|1|30–34|||
Relative|Penile cancer|2015–2019|Males|1|35–39|||
Relative|Penile cancer|2015–2019|Males|1|40–44|||
Relative|Penile cancer|2015–2019|Males|1|45–49|0.911|0.745|0.972
Relative|Penile cancer|2015–2019|Males|1|50–54|0.98|0.847|1
Relative|Penile cancer|2015–2019|Males|1|55–59|0.942|0.822|0.984
Relative|Penile cancer|2015–2019|Males|1|60–64|0.893|0.791|0.949
Relative|Penile cancer|2015–2019|Males|1|65–69|0.824|0.719|0.894
Relative|Penile cancer|2015–2019|Males|1|70–74|0.833|0.719|0.907
Relative|Penile cancer|2015–2019|Males|1|75–79|0.825|0.722|0.897
Relative|Penile cancer|2015–2019|Males|1|80–84|0.811|0.703|0.89
Relative|Penile cancer|2015–2019|Males|1|85+|0.815|0.661|0.929
Relative|Penile cancer|2015–2019|Males|1|All ages combined|0.862|0.83|0.89
Relative|Penile cancer|2015–2019|Males|2|00–04|||
Relative|Penile cancer|2015–2019|Males|2|05–09|||
Relative|Penile cancer|2015–2019|Males|2|10–14|||
Relative|Penile cancer|2015–2019|Males|2|15–19|||
Relative|Penile cancer|2015–2019|Males|2|20–24|||
Relative|Penile cancer|2015–2019|Males|2|25–29|||
Relative|Penile cancer|2015–2019|Males|2|30–34|||
Relative|Penile cancer|2015–2019|Males|2|35–39|||
Relative|Penile cancer|2015–2019|Males|2|40–44|||
Relative|Penile cancer|2015–2019|Males|2|45–49|0.913|0.747|0.974
Relative|Penile cancer|2015–2019|Males|2|50–54|0.935|0.8|0.983
Relative|Penile cancer|2015–2019|Males|2|55–59|0.903|0.772|0.965
Relative|Penile cancer|2015–2019|Males|2|60–64|0.838|0.723|0.911
Relative|Penile cancer|2015–2019|Males|2|65–69|0.754|0.635|0.842
Relative|Penile cancer|2015–2019|Males|2|70–74|0.796|0.676|0.882
Relative|Penile cancer|2015–2019|Males|2|75–79|0.735|0.616|0.828
Relative|Penile cancer|2015–2019|Males|2|80–84|0.767|0.646|0.864
Relative|Penile cancer|2015–2019|Males|2|85+|0.599|0.419|0.768
Relative|Penile cancer|2015–2019|Males|2|All ages combined|0.798|0.759|0.832
Relative|Penile cancer|2015–2019|Males|3|00–04|||
Relative|Penile cancer|2015–2019|Males|3|05–09|||
Relative|Penile cancer|2015–2019|Males|3|10–14|||
Relative|Penile cancer|2015–2019|Males|3|15–19|||
Relative|Penile cancer|2015–2019|Males|3|20–24|||
Relative|Penile cancer|2015–2019|Males|3|25–29|||
Relative|Penile cancer|2015–2019|Males|3|30–34|||
Relative|Penile cancer|2015–2019|Males|3|35–39|||
Relative|Penile cancer|2015–2019|Males|3|40–44|||
Relative|Penile cancer|2015–2019|Males|3|45–49|0.88|0.701|0.958
Relative|Penile cancer|2015–2019|Males|3|50–54|0.866|0.716|0.943
Relative|Penile cancer|2015–2019|Males|3|55–59|0.863|0.719|0.941
Relative|Penile cancer|2015–2019|Males|3|60–64|0.779|0.653|0.867
Relative|Penile cancer|2015–2019|Males|3|65–69|0.729|0.603|0.826
Relative|Penile cancer|2015–2019|Males|3|70–74|0.747|0.621|0.844
Relative|Penile cancer|2015–2019|Males|3|75–79|0.702|0.577|0.806
Relative|Penile cancer|2015–2019|Males|3|80–84|0.669|0.535|0.787
Relative|Penile cancer|2015–2019|Males|3|85+|||
Relative|Penile cancer|2015–2019|Males|3|All ages combined|0.745|0.702|0.784
Relative|Penile cancer|2015–2019|Males|4|00–04|||
Relative|Penile cancer|2015–2019|Males|4|05–09|||
Relative|Penile cancer|2015–2019|Males|4|10–14|||
Relative|Penile cancer|2015–2019|Males|4|15–19|||
Relative|Penile cancer|2015–2019|Males|4|20–24|||
Relative|Penile cancer|2015–2019|Males|4|25–29|||
Relative|Penile cancer|2015–2019|Males|4|30–34|||
Relative|Penile cancer|2015–2019|Males|4|35–39|||
Relative|Penile cancer|2015–2019|Males|4|40–44|||
Relative|Penile cancer|2015–2019|Males|4|45–49|0.883|0.703|0.961
Relative|Penile cancer|2015–2019|Males|4|50–54|0.845|0.691|0.931
Relative|Penile cancer|2015–2019|Males|4|55–59|0.868|0.724|0.947
Relative|Penile cancer|2015–2019|Males|4|60–64|0.736|0.604|0.834
Relative|Penile cancer|2015–2019|Males|4|65–69|0.723|0.593|0.824
Relative|Penile cancer|2015–2019|Males|4|70–74|0.714|0.584|0.819
Relative|Penile cancer|2015–2019|Males|4|75–79|0.62|0.488|0.737
Relative|Penile cancer|2015–2019|Males|4|80–84|0.593|0.449|0.729
Relative|Penile cancer|2015–2019|Males|4|85+|||
Relative|Penile cancer|2015–2019|Males|4|All ages combined|0.715|0.669|0.757
Relative|Penile cancer|2015–2019|Males|5|00–04|||
Relative|Penile cancer|2015–2019|Males|5|05–09|||
Relative|Penile cancer|2015–2019|Males|5|10–14|||
Relative|Penile cancer|2015–2019|Males|5|15–19|||
Relative|Penile cancer|2015–2019|Males|5|20–24|||
Relative|Penile cancer|2015–2019|Males|5|25–29|||
Relative|Penile cancer|2015–2019|Males|5|30–34|||
Relative|Penile cancer|2015–2019|Males|5|35–39|||
Relative|Penile cancer|2015–2019|Males|5|40–44|||
Relative|Penile cancer|2015–2019|Males|5|45–49|0.852|0.666|0.944
Relative|Penile cancer|2015–2019|Males|5|50–54|0.85|0.694|0.935
Relative|Penile cancer|2015–2019|Males|5|55–59|0.836|0.688|0.925
Relative|Penile cancer|2015–2019|Males|5|60–64|0.725|0.589|0.827
Relative|Penile cancer|2015–2019|Males|5|65–69|0.697|0.56|0.807
Relative|Penile cancer|2015–2019|Males|5|70–74|0.708|0.574|0.819
Relative|Penile cancer|2015–2019|Males|5|75–79|0.618|0.479|0.744
Relative|Penile cancer|2015–2019|Males|5|80–84|0.615|0.458|0.766
Relative|Penile cancer|2015–2019|Males|5|85+|||
Relative|Penile cancer|2015–2019|Males|5|All ages combined|0.707|0.659|0.752
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|00–04|1|0.883|1
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|All ages combined|0.922|0.856|0.959
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|00–04|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|All ages combined|0.837|0.754|0.894
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|00–04|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|All ages combined|0.791|0.702|0.856
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|00–04|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|All ages combined|0.752|0.659|0.823
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|00–04|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|All ages combined|0.72|0.624|0.795
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|00–04|1.001|0.884|1.001
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|1|All ages combined|0.935|0.868|0.972
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|00–04|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|2|All ages combined|0.858|0.772|0.916
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|00–04|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|3|All ages combined|0.819|0.727|0.887
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|00–04|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|4|All ages combined|0.787|0.69|0.861
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|00–04|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Males|5|All ages combined|0.761|0.659|0.841
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|00–04|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|All ages combined|0.893|0.815|0.939
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|00–04|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|All ages combined|0.832|0.743|0.892
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|00–04|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|All ages combined|0.738|0.636|0.815
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|00–04|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|All ages combined|0.703|0.598|0.785
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|00–04|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|All ages combined|0.691|0.585|0.775
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|00–04|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|1|All ages combined|0.896|0.818|0.943
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|00–04|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|2|All ages combined|0.838|0.749|0.899
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|00–04|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|3|All ages combined|0.747|0.644|0.825
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|00–04|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|4|All ages combined|0.715|0.609|0.799
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|00–04|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Females|5|All ages combined|0.707|0.599|0.793
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|00–04|1|0.919|1
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|All ages combined|0.909|0.862|0.94
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|00–04|1|0.913|1
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|All ages combined|0.835|0.778|0.879
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|00–04|1|0.91|1
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|All ages combined|0.768|0.703|0.82
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|00–04|1|0.907|1
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|All ages combined|0.73|0.663|0.786
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|00–04|0.96|0.751|0.994
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|05–09|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|10–14|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|15–19|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|20–24|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|25–29|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|30–34|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|35–39|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|40–44|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|45–49|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|50–54|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|55–59|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|60–64|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|65–69|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|70–74|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|75–79|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|80–84|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|85+|||
Observed|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|All ages combined|0.708|0.639|0.766
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|00–04|1.001|0.92|1.001
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|1|All ages combined|0.917|0.87|0.949
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|00–04|1.001|0.914|1.001
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|2|All ages combined|0.848|0.79|0.893
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|00–04|1.001|0.911|1.001
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|3|All ages combined|0.787|0.721|0.84
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|00–04|1.002|0.908|1.002
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|4|All ages combined|0.755|0.685|0.812
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|00–04|0.962|0.752|0.996
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|05–09|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|10–14|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|15–19|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|20–24|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|25–29|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|30–34|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|35–39|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|40–44|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|45–49|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|50–54|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|55–59|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|60–64|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|65–69|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|70–74|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|75–79|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|80–84|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|85+|||
Relative|Peripheral nerves and autonomic nervous system (cancer of the)|2015–2019|Persons|5|All ages combined|0.737|0.665|0.797
Observed|Placenta cancer|2015–2019|Females|1|00–04|||
Observed|Placenta cancer|2015–2019|Females|1|05–09|||
Observed|Placenta cancer|2015–2019|Females|1|10–14|||
Observed|Placenta cancer|2015–2019|Females|1|15–19|||
Observed|Placenta cancer|2015–2019|Females|1|20–24|||
Observed|Placenta cancer|2015–2019|Females|1|25–29|||
Observed|Placenta cancer|2015–2019|Females|1|30–34|||
Observed|Placenta cancer|2015–2019|Females|1|35–39|||
Observed|Placenta cancer|2015–2019|Females|1|40–44|||
Observed|Placenta cancer|2015–2019|Females|1|45–49|||
Observed|Placenta cancer|2015–2019|Females|1|50–54|||
Observed|Placenta cancer|2015–2019|Females|1|55–59|||
Observed|Placenta cancer|2015–2019|Females|1|60–64|||
Observed|Placenta cancer|2015–2019|Females|1|65–69|||
Observed|Placenta cancer|2015–2019|Females|1|70–74|||
Observed|Placenta cancer|2015–2019|Females|1|75–79|||
Observed|Placenta cancer|2015–2019|Females|1|80–84|||
Observed|Placenta cancer|2015–2019|Females|1|85+|||
Observed|Placenta cancer|2015–2019|Females|1|All ages combined|0.884|0.744|0.95
Observed|Placenta cancer|2015–2019|Females|2|00–04|||
Observed|Placenta cancer|2015–2019|Females|2|05–09|||
Observed|Placenta cancer|2015–2019|Females|2|10–14|||
Observed|Placenta cancer|2015–2019|Females|2|15–19|||
Observed|Placenta cancer|2015–2019|Females|2|20–24|||
Observed|Placenta cancer|2015–2019|Females|2|25–29|||
Observed|Placenta cancer|2015–2019|Females|2|30–34|||
Observed|Placenta cancer|2015–2019|Females|2|35–39|||
Observed|Placenta cancer|2015–2019|Females|2|40–44|||
Observed|Placenta cancer|2015–2019|Females|2|45–49|||
Observed|Placenta cancer|2015–2019|Females|2|50–54|||
Observed|Placenta cancer|2015–2019|Females|2|55–59|||
Observed|Placenta cancer|2015–2019|Females|2|60–64|||
Observed|Placenta cancer|2015–2019|Females|2|65–69|||
Observed|Placenta cancer|2015–2019|Females|2|70–74|||
Observed|Placenta cancer|2015–2019|Females|2|75–79|||
Observed|Placenta cancer|2015–2019|Females|2|80–84|||
Observed|Placenta cancer|2015–2019|Females|2|85+|||
Observed|Placenta cancer|2015–2019|Females|2|All ages combined|0.862|0.719|0.936
Observed|Placenta cancer|2015–2019|Females|3|00–04|||
Observed|Placenta cancer|2015–2019|Females|3|05–09|||
Observed|Placenta cancer|2015–2019|Females|3|10–14|||
Observed|Placenta cancer|2015–2019|Females|3|15–19|||
Observed|Placenta cancer|2015–2019|Females|3|20–24|||
Observed|Placenta cancer|2015–2019|Females|3|25–29|||
Observed|Placenta cancer|2015–2019|Females|3|30–34|||
Observed|Placenta cancer|2015–2019|Females|3|35–39|||
Observed|Placenta cancer|2015–2019|Females|3|40–44|||
Observed|Placenta cancer|2015–2019|Females|3|45–49|||
Observed|Placenta cancer|2015–2019|Females|3|50–54|||
Observed|Placenta cancer|2015–2019|Females|3|55–59|||
Observed|Placenta cancer|2015–2019|Females|3|60–64|||
Observed|Placenta cancer|2015–2019|Females|3|65–69|||
Observed|Placenta cancer|2015–2019|Females|3|70–74|||
Observed|Placenta cancer|2015–2019|Females|3|75–79|||
Observed|Placenta cancer|2015–2019|Females|3|80–84|||
Observed|Placenta cancer|2015–2019|Females|3|85+|||
Observed|Placenta cancer|2015–2019|Females|3|All ages combined|0.842|0.696|0.921
Observed|Placenta cancer|2015–2019|Females|4|00–04|||
Observed|Placenta cancer|2015–2019|Females|4|05–09|||
Observed|Placenta cancer|2015–2019|Females|4|10–14|||
Observed|Placenta cancer|2015–2019|Females|4|15–19|||
Observed|Placenta cancer|2015–2019|Females|4|20–24|||
Observed|Placenta cancer|2015–2019|Females|4|25–29|||
Observed|Placenta cancer|2015–2019|Females|4|30–34|||
Observed|Placenta cancer|2015–2019|Females|4|35–39|||
Observed|Placenta cancer|2015–2019|Females|4|40–44|||
Observed|Placenta cancer|2015–2019|Females|4|45–49|||
Observed|Placenta cancer|2015–2019|Females|4|50–54|||
Observed|Placenta cancer|2015–2019|Females|4|55–59|||
Observed|Placenta cancer|2015–2019|Females|4|60–64|||
Observed|Placenta cancer|2015–2019|Females|4|65–69|||
Observed|Placenta cancer|2015–2019|Females|4|70–74|||
Observed|Placenta cancer|2015–2019|Females|4|75–79|||
Observed|Placenta cancer|2015–2019|Females|4|80–84|||
Observed|Placenta cancer|2015–2019|Females|4|85+|||
Observed|Placenta cancer|2015–2019|Females|4|All ages combined|0.842|0.696|0.921
Observed|Placenta cancer|2015–2019|Females|5|00–04|||
Observed|Placenta cancer|2015–2019|Females|5|05–09|||
Observed|Placenta cancer|2015–2019|Females|5|10–14|||
Observed|Placenta cancer|2015–2019|Females|5|15–19|||
Observed|Placenta cancer|2015–2019|Females|5|20–24|||
Observed|Placenta cancer|2015–2019|Females|5|25–29|||
Observed|Placenta cancer|2015–2019|Females|5|30–34|||
Observed|Placenta cancer|2015–2019|Females|5|35–39|||
Observed|Placenta cancer|2015–2019|Females|5|40–44|||
Observed|Placenta cancer|2015–2019|Females|5|45–49|||
Observed|Placenta cancer|2015–2019|Females|5|50–54|||
Observed|Placenta cancer|2015–2019|Females|5|55–59|||
Observed|Placenta cancer|2015–2019|Females|5|60–64|||
Observed|Placenta cancer|2015–2019|Females|5|65–69|||
Observed|Placenta cancer|2015–2019|Females|5|70–74|||
Observed|Placenta cancer|2015–2019|Females|5|75–79|||
Observed|Placenta cancer|2015–2019|Females|5|80–84|||
Observed|Placenta cancer|2015–2019|Females|5|85+|||
Observed|Placenta cancer|2015–2019|Females|5|All ages combined|0.842|0.696|0.921
Relative|Placenta cancer|2015–2019|Females|1|00–04|||
Relative|Placenta cancer|2015–2019|Females|1|05–09|||
Relative|Placenta cancer|2015–2019|Females|1|10–14|||
Relative|Placenta cancer|2015–2019|Females|1|15–19|||
Relative|Placenta cancer|2015–2019|Females|1|20–24|||
Relative|Placenta cancer|2015–2019|Females|1|25–29|||
Relative|Placenta cancer|2015–2019|Females|1|30–34|||
Relative|Placenta cancer|2015–2019|Females|1|35–39|||
Relative|Placenta cancer|2015–2019|Females|1|40–44|||
Relative|Placenta cancer|2015–2019|Females|1|45–49|||
Relative|Placenta cancer|2015–2019|Females|1|50–54|||
Relative|Placenta cancer|2015–2019|Females|1|55–59|||
Relative|Placenta cancer|2015–2019|Females|1|60–64|||
Relative|Placenta cancer|2015–2019|Females|1|65–69|||
Relative|Placenta cancer|2015–2019|Females|1|70–74|||
Relative|Placenta cancer|2015–2019|Females|1|75–79|||
Relative|Placenta cancer|2015–2019|Females|1|80–84|||
Relative|Placenta cancer|2015–2019|Females|1|85+|||
Relative|Placenta cancer|2015–2019|Females|1|All ages combined|0.885|0.745|0.951
Relative|Placenta cancer|2015–2019|Females|2|00–04|||
Relative|Placenta cancer|2015–2019|Females|2|05–09|||
Relative|Placenta cancer|2015–2019|Females|2|10–14|||
Relative|Placenta cancer|2015–2019|Females|2|15–19|||
Relative|Placenta cancer|2015–2019|Females|2|20–24|||
Relative|Placenta cancer|2015–2019|Females|2|25–29|||
Relative|Placenta cancer|2015–2019|Females|2|30–34|||
Relative|Placenta cancer|2015–2019|Females|2|35–39|||
Relative|Placenta cancer|2015–2019|Females|2|40–44|||
Relative|Placenta cancer|2015–2019|Females|2|45–49|||
Relative|Placenta cancer|2015–2019|Females|2|50–54|||
Relative|Placenta cancer|2015–2019|Females|2|55–59|||
Relative|Placenta cancer|2015–2019|Females|2|60–64|||
Relative|Placenta cancer|2015–2019|Females|2|65–69|||
Relative|Placenta cancer|2015–2019|Females|2|70–74|||
Relative|Placenta cancer|2015–2019|Females|2|75–79|||
Relative|Placenta cancer|2015–2019|Females|2|80–84|||
Relative|Placenta cancer|2015–2019|Females|2|85+|||
Relative|Placenta cancer|2015–2019|Females|2|All ages combined|0.863|0.72|0.937
Relative|Placenta cancer|2015–2019|Females|3|00–04|||
Relative|Placenta cancer|2015–2019|Females|3|05–09|||
Relative|Placenta cancer|2015–2019|Females|3|10–14|||
Relative|Placenta cancer|2015–2019|Females|3|15–19|||
Relative|Placenta cancer|2015–2019|Females|3|20–24|||
Relative|Placenta cancer|2015–2019|Females|3|25–29|||
Relative|Placenta cancer|2015–2019|Females|3|30–34|||
Relative|Placenta cancer|2015–2019|Females|3|35–39|||
Relative|Placenta cancer|2015–2019|Females|3|40–44|||
Relative|Placenta cancer|2015–2019|Females|3|45–49|||
Relative|Placenta cancer|2015–2019|Females|3|50–54|||
Relative|Placenta cancer|2015–2019|Females|3|55–59|||
Relative|Placenta cancer|2015–2019|Females|3|60–64|||
Relative|Placenta cancer|2015–2019|Females|3|65–69|||
Relative|Placenta cancer|2015–2019|Females|3|70–74|||
Relative|Placenta cancer|2015–2019|Females|3|75–79|||
Relative|Placenta cancer|2015–2019|Females|3|80–84|||
Relative|Placenta cancer|2015–2019|Females|3|85+|||
Relative|Placenta cancer|2015–2019|Females|3|All ages combined|0.843|0.698|0.923
Relative|Placenta cancer|2015–2019|Females|4|00–04|||
Relative|Placenta cancer|2015–2019|Females|4|05–09|||
Relative|Placenta cancer|2015–2019|Females|4|10–14|||
Relative|Placenta cancer|2015–2019|Females|4|15–19|||
Relative|Placenta cancer|2015–2019|Females|4|20–24|||
Relative|Placenta cancer|2015–2019|Females|4|25–29|||
Relative|Placenta cancer|2015–2019|Females|4|30–34|||
Relative|Placenta cancer|2015–2019|Females|4|35–39|||
Relative|Placenta cancer|2015–2019|Females|4|40–44|||
Relative|Placenta cancer|2015–2019|Females|4|45–49|||
Relative|Placenta cancer|2015–2019|Females|4|50–54|||
Relative|Placenta cancer|2015–2019|Females|4|55–59|||
Relative|Placenta cancer|2015–2019|Females|4|60–64|||
Relative|Placenta cancer|2015–2019|Females|4|65–69|||
Relative|Placenta cancer|2015–2019|Females|4|70–74|||
Relative|Placenta cancer|2015–2019|Females|4|75–79|||
Relative|Placenta cancer|2015–2019|Females|4|80–84|||
Relative|Placenta cancer|2015–2019|Females|4|85+|||
Relative|Placenta cancer|2015–2019|Females|4|All ages combined|0.844|0.698|0.924
Relative|Placenta cancer|2015–2019|Females|5|00–04|||
Relative|Placenta cancer|2015–2019|Females|5|05–09|||
Relative|Placenta cancer|2015–2019|Females|5|10–14|||
Relative|Placenta cancer|2015–2019|Females|5|15–19|||
Relative|Placenta cancer|2015–2019|Females|5|20–24|||
Relative|Placenta cancer|2015–2019|Females|5|25–29|||
Relative|Placenta cancer|2015–2019|Females|5|30–34|||
Relative|Placenta cancer|2015–2019|Females|5|35–39|||
Relative|Placenta cancer|2015–2019|Females|5|40–44|||
Relative|Placenta cancer|2015–2019|Females|5|45–49|||
Relative|Placenta cancer|2015–2019|Females|5|50–54|||
Relative|Placenta cancer|2015–2019|Females|5|55–59|||
Relative|Placenta cancer|2015–2019|Females|5|60–64|||
Relative|Placenta cancer|2015–2019|Females|5|65–69|||
Relative|Placenta cancer|2015–2019|Females|5|70–74|||
Relative|Placenta cancer|2015–2019|Females|5|75–79|||
Relative|Placenta cancer|2015–2019|Females|5|80–84|||
Relative|Placenta cancer|2015–2019|Females|5|85+|||
Relative|Placenta cancer|2015–2019|Females|5|All ages combined|0.845|0.699|0.925
Observed|Prostate cancer|2015–2019|Males|1|00–04|||
Observed|Prostate cancer|2015–2019|Males|1|05–09|||
Observed|Prostate cancer|2015–2019|Males|1|10–14|||
Observed|Prostate cancer|2015–2019|Males|1|15–19|||
Observed|Prostate cancer|2015–2019|Males|1|20–24|||
Observed|Prostate cancer|2015–2019|Males|1|25–29|||
Observed|Prostate cancer|2015–2019|Males|1|30–34|||
Observed|Prostate cancer|2015–2019|Males|1|35–39|0.966|0.781|0.995
Observed|Prostate cancer|2015–2019|Males|1|40–44|0.995|0.981|0.999
Observed|Prostate cancer|2015–2019|Males|1|45–49|0.995|0.99|0.997
Observed|Prostate cancer|2015–2019|Males|1|50–54|0.994|0.991|0.996
Observed|Prostate cancer|2015–2019|Males|1|55–59|0.993|0.992|0.995
Observed|Prostate cancer|2015–2019|Males|1|60–64|0.99|0.988|0.991
Observed|Prostate cancer|2015–2019|Males|1|65–69|0.987|0.986|0.989
Observed|Prostate cancer|2015–2019|Males|1|70–74|0.976|0.973|0.978
Observed|Prostate cancer|2015–2019|Males|1|75–79|0.96|0.957|0.964
Observed|Prostate cancer|2015–2019|Males|1|80–84|0.907|0.9|0.914
Observed|Prostate cancer|2015–2019|Males|1|85+|0.74|0.728|0.752
Observed|Prostate cancer|2015–2019|Males|1|All ages combined|0.965|0.964|0.966
Observed|Prostate cancer|2015–2019|Males|2|00–04|||
Observed|Prostate cancer|2015–2019|Males|2|05–09|||
Observed|Prostate cancer|2015–2019|Males|2|10–14|||
Observed|Prostate cancer|2015–2019|Males|2|15–19|||
Observed|Prostate cancer|2015–2019|Males|2|20–24|||
Observed|Prostate cancer|2015–2019|Males|2|25–29|||
Observed|Prostate cancer|2015–2019|Males|2|30–34|||
Observed|Prostate cancer|2015–2019|Males|2|35–39|0.966|0.781|0.995
Observed|Prostate cancer|2015–2019|Males|2|40–44|0.988|0.972|0.995
Observed|Prostate cancer|2015–2019|Males|2|45–49|0.986|0.979|0.991
Observed|Prostate cancer|2015–2019|Males|2|50–54|0.987|0.983|0.99
Observed|Prostate cancer|2015–2019|Males|2|55–59|0.983|0.98|0.985
Observed|Prostate cancer|2015–2019|Males|2|60–64|0.976|0.973|0.978
Observed|Prostate cancer|2015–2019|Males|2|65–69|0.972|0.97|0.974
Observed|Prostate cancer|2015–2019|Males|2|70–74|0.949|0.946|0.952
Observed|Prostate cancer|2015–2019|Males|2|75–79|0.915|0.91|0.92
Observed|Prostate cancer|2015–2019|Males|2|80–84|0.82|0.81|0.828
Observed|Prostate cancer|2015–2019|Males|2|85+|0.585|0.571|0.598
Observed|Prostate cancer|2015–2019|Males|2|All ages combined|0.933|0.932|0.935
Observed|Prostate cancer|2015–2019|Males|3|00–04|||
Observed|Prostate cancer|2015–2019|Males|3|05–09|||
Observed|Prostate cancer|2015–2019|Males|3|10–14|||
Observed|Prostate cancer|2015–2019|Males|3|15–19|||
Observed|Prostate cancer|2015–2019|Males|3|20–24|||
Observed|Prostate cancer|2015–2019|Males|3|25–29|||
Observed|Prostate cancer|2015–2019|Males|3|30–34|||
Observed|Prostate cancer|2015–2019|Males|3|35–39|0.938|0.774|0.984
Observed|Prostate cancer|2015–2019|Males|3|40–44|0.986|0.969|0.994
Observed|Prostate cancer|2015–2019|Males|3|45–49|0.979|0.971|0.985
Observed|Prostate cancer|2015–2019|Males|3|50–54|0.974|0.969|0.978
Observed|Prostate cancer|2015–2019|Males|3|55–59|0.972|0.968|0.975
Observed|Prostate cancer|2015–2019|Males|3|60–64|0.961|0.958|0.964
Observed|Prostate cancer|2015–2019|Males|3|65–69|0.955|0.952|0.958
Observed|Prostate cancer|2015–2019|Males|3|70–74|0.919|0.915|0.923
Observed|Prostate cancer|2015–2019|Males|3|75–79|0.868|0.862|0.874
Observed|Prostate cancer|2015–2019|Males|3|80–84|0.738|0.727|0.748
Observed|Prostate cancer|2015–2019|Males|3|85+|0.466|0.452|0.479
Observed|Prostate cancer|2015–2019|Males|3|All ages combined|0.902|0.9|0.904
Observed|Prostate cancer|2015–2019|Males|4|00–04|||
Observed|Prostate cancer|2015–2019|Males|4|05–09|||
Observed|Prostate cancer|2015–2019|Males|4|10–14|||
Observed|Prostate cancer|2015–2019|Males|4|15–19|||
Observed|Prostate cancer|2015–2019|Males|4|20–24|||
Observed|Prostate cancer|2015–2019|Males|4|25–29|||
Observed|Prostate cancer|2015–2019|Males|4|30–34|||
Observed|Prostate cancer|2015–2019|Males|4|35–39|0.938|0.774|0.984
Observed|Prostate cancer|2015–2019|Males|4|40–44|0.982|0.964|0.991
Observed|Prostate cancer|2015–2019|Males|4|45–49|0.973|0.964|0.979
Observed|Prostate cancer|2015–2019|Males|4|50–54|0.966|0.96|0.971
Observed|Prostate cancer|2015–2019|Males|4|55–59|0.962|0.958|0.966
Observed|Prostate cancer|2015–2019|Males|4|60–64|0.948|0.945|0.952
Observed|Prostate cancer|2015–2019|Males|4|65–69|0.935|0.932|0.939
Observed|Prostate cancer|2015–2019|Males|4|70–74|0.891|0.886|0.896
Observed|Prostate cancer|2015–2019|Males|4|75–79|0.821|0.814|0.828
Observed|Prostate cancer|2015–2019|Males|4|80–84|0.653|0.641|0.664
Observed|Prostate cancer|2015–2019|Males|4|85+|0.369|0.355|0.382
Observed|Prostate cancer|2015–2019|Males|4|All ages combined|0.873|0.871|0.875
Observed|Prostate cancer|2015–2019|Males|5|00–04|||
Observed|Prostate cancer|2015–2019|Males|5|05–09|||
Observed|Prostate cancer|2015–2019|Males|5|10–14|||
Observed|Prostate cancer|2015–2019|Males|5|15–19|||
Observed|Prostate cancer|2015–2019|Males|5|20–24|||
Observed|Prostate cancer|2015–2019|Males|5|25–29|||
Observed|Prostate cancer|2015–2019|Males|5|30–34|||
Observed|Prostate cancer|2015–2019|Males|5|35–39|0.938|0.774|0.984
Observed|Prostate cancer|2015–2019|Males|5|40–44|0.976|0.957|0.987
Observed|Prostate cancer|2015–2019|Males|5|45–49|0.967|0.958|0.974
Observed|Prostate cancer|2015–2019|Males|5|50–54|0.959|0.953|0.964
Observed|Prostate cancer|2015–2019|Males|5|55–59|0.953|0.948|0.956
Observed|Prostate cancer|2015–2019|Males|5|60–64|0.935|0.931|0.938
Observed|Prostate cancer|2015–2019|Males|5|65–69|0.916|0.912|0.92
Observed|Prostate cancer|2015–2019|Males|5|70–74|0.859|0.854|0.864
Observed|Prostate cancer|2015–2019|Males|5|75–79|0.772|0.765|0.78
Observed|Prostate cancer|2015–2019|Males|5|80–84|0.579|0.567|0.591
Observed|Prostate cancer|2015–2019|Males|5|85+|0.289|0.277|0.301
Observed|Prostate cancer|2015–2019|Males|5|All ages combined|0.844|0.842|0.846
Relative|Prostate cancer|2015–2019|Males|1|00–04|||
Relative|Prostate cancer|2015–2019|Males|1|05–09|||
Relative|Prostate cancer|2015–2019|Males|1|10–14|||
Relative|Prostate cancer|2015–2019|Males|1|15–19|||
Relative|Prostate cancer|2015–2019|Males|1|20–24|||
Relative|Prostate cancer|2015–2019|Males|1|25–29|||
Relative|Prostate cancer|2015–2019|Males|1|30–34|||
Relative|Prostate cancer|2015–2019|Males|1|35–39|0.967|0.782|0.996
Relative|Prostate cancer|2015–2019|Males|1|40–44|0.997|0.982|1
Relative|Prostate cancer|2015–2019|Males|1|45–49|0.997|0.992|1
Relative|Prostate cancer|2015–2019|Males|1|50–54|0.998|0.995|0.999
Relative|Prostate cancer|2015–2019|Males|1|55–59|0.999|0.997|1
Relative|Prostate cancer|2015–2019|Males|1|60–64|0.998|0.996|0.999
Relative|Prostate cancer|2015–2019|Males|1|65–69|0.999|0.998|1.001
Relative|Prostate cancer|2015–2019|Males|1|70–74|0.995|0.992|0.997
Relative|Prostate cancer|2015–2019|Males|1|75–79|0.992|0.989|0.996
Relative|Prostate cancer|2015–2019|Males|1|80–84|0.963|0.956|0.97
Relative|Prostate cancer|2015–2019|Males|1|85+|0.849|0.835|0.863
Relative|Prostate cancer|2015–2019|Males|1|All ages combined|0.988|0.987|0.989
Relative|Prostate cancer|2015–2019|Males|2|00–04|||
Relative|Prostate cancer|2015–2019|Males|2|05–09|||
Relative|Prostate cancer|2015–2019|Males|2|10–14|||
Relative|Prostate cancer|2015–2019|Males|2|15–19|||
Relative|Prostate cancer|2015–2019|Males|2|20–24|||
Relative|Prostate cancer|2015–2019|Males|2|25–29|||
Relative|Prostate cancer|2015–2019|Males|2|30–34|||
Relative|Prostate cancer|2015–2019|Males|2|35–39|0.968|0.783|0.998
Relative|Prostate cancer|2015–2019|Males|2|40–44|0.992|0.975|0.999
Relative|Prostate cancer|2015–2019|Males|2|45–49|0.991|0.984|0.996
Relative|Prostate cancer|2015–2019|Males|2|50–54|0.994|0.99|0.997
Relative|Prostate cancer|2015–2019|Males|2|55–59|0.994|0.991|0.996
Relative|Prostate cancer|2015–2019|Males|2|60–64|0.992|0.99|0.994
Relative|Prostate cancer|2015–2019|Males|2|65–69|0.997|0.995|0.999
Relative|Prostate cancer|2015–2019|Males|2|70–74|0.989|0.985|0.992
Relative|Prostate cancer|2015–2019|Males|2|75–79|0.981|0.975|0.986
Relative|Prostate cancer|2015–2019|Males|2|80–84|0.931|0.921|0.942
Relative|Prostate cancer|2015–2019|Males|2|85+|0.777|0.759|0.795
Relative|Prostate cancer|2015–2019|Males|2|All ages combined|0.978|0.976|0.98
Relative|Prostate cancer|2015–2019|Males|3|00–04|||
Relative|Prostate cancer|2015–2019|Males|3|05–09|||
Relative|Prostate cancer|2015–2019|Males|3|10–14|||
Relative|Prostate cancer|2015–2019|Males|3|15–19|||
Relative|Prostate cancer|2015–2019|Males|3|20–24|||
Relative|Prostate cancer|2015–2019|Males|3|25–29|||
Relative|Prostate cancer|2015–2019|Males|3|30–34|||
Relative|Prostate cancer|2015–2019|Males|3|35–39|0.942|0.777|0.988
Relative|Prostate cancer|2015–2019|Males|3|40–44|0.991|0.975|0.999
Relative|Prostate cancer|2015–2019|Males|3|45–49|0.987|0.979|0.993
Relative|Prostate cancer|2015–2019|Males|3|50–54|0.986|0.981|0.99
Relative|Prostate cancer|2015–2019|Males|3|55–59|0.989|0.985|0.992
Relative|Prostate cancer|2015–2019|Males|3|60–64|0.986|0.983|0.989
Relative|Prostate cancer|2015–2019|Males|3|65–69|0.994|0.991|0.997
Relative|Prostate cancer|2015–2019|Males|3|70–74|0.981|0.977|0.985
Relative|Prostate cancer|2015–2019|Males|3|75–79|0.969|0.963|0.976
Relative|Prostate cancer|2015–2019|Males|3|80–84|0.906|0.893|0.919
Relative|Prostate cancer|2015–2019|Males|3|85+|0.725|0.704|0.747
Relative|Prostate cancer|2015–2019|Males|3|All ages combined|0.969|0.967|0.971
Relative|Prostate cancer|2015–2019|Males|4|00–04|||
Relative|Prostate cancer|2015–2019|Males|4|05–09|||
Relative|Prostate cancer|2015–2019|Males|4|10–14|||
Relative|Prostate cancer|2015–2019|Males|4|15–19|||
Relative|Prostate cancer|2015–2019|Males|4|20–24|||
Relative|Prostate cancer|2015–2019|Males|4|25–29|||
Relative|Prostate cancer|2015–2019|Males|4|30–34|||
Relative|Prostate cancer|2015–2019|Males|4|35–39|0.943|0.778|0.99
Relative|Prostate cancer|2015–2019|Males|4|40–44|0.989|0.972|0.998
Relative|Prostate cancer|2015–2019|Males|4|45–49|0.983|0.975|0.99
Relative|Prostate cancer|2015–2019|Males|4|50–54|0.982|0.976|0.987
Relative|Prostate cancer|2015–2019|Males|4|55–59|0.986|0.982|0.989
Relative|Prostate cancer|2015–2019|Males|4|60–64|0.984|0.98|0.987
Relative|Prostate cancer|2015–2019|Males|4|65–69|0.989|0.986|0.993
Relative|Prostate cancer|2015–2019|Males|4|70–74|0.976|0.971|0.981
Relative|Prostate cancer|2015–2019|Males|4|75–79|0.962|0.953|0.969
Relative|Prostate cancer|2015–2019|Males|4|80–84|0.875|0.86|0.89
Relative|Prostate cancer|2015–2019|Males|4|85+|0.683|0.659|0.708
Relative|Prostate cancer|2015–2019|Males|4|All ages combined|0.962|0.96|0.964
Relative|Prostate cancer|2015–2019|Males|5|00–04|||
Relative|Prostate cancer|2015–2019|Males|5|05–09|||
Relative|Prostate cancer|2015–2019|Males|5|10–14|||
Relative|Prostate cancer|2015–2019|Males|5|15–19|||
Relative|Prostate cancer|2015–2019|Males|5|20–24|||
Relative|Prostate cancer|2015–2019|Males|5|25–29|||
Relative|Prostate cancer|2015–2019|Males|5|30–34|||
Relative|Prostate cancer|2015–2019|Males|5|35–39|0.945|0.779|0.991
Relative|Prostate cancer|2015–2019|Males|5|40–44|0.986|0.967|0.997
Relative|Prostate cancer|2015–2019|Males|5|45–49|0.981|0.971|0.988
Relative|Prostate cancer|2015–2019|Males|5|50–54|0.979|0.973|0.985
Relative|Prostate cancer|2015–2019|Males|5|55–59|0.984|0.979|0.987
Relative|Prostate cancer|2015–2019|Males|5|60–64|0.981|0.977|0.985
Relative|Prostate cancer|2015–2019|Males|5|65–69|0.986|0.982|0.99
Relative|Prostate cancer|2015–2019|Males|5|70–74|0.97|0.964|0.976
Relative|Prostate cancer|2015–2019|Males|5|75–79|0.953|0.944|0.962
Relative|Prostate cancer|2015–2019|Males|5|80–84|0.857|0.84|0.875
Relative|Prostate cancer|2015–2019|Males|5|85+|0.647|0.619|0.675
Relative|Prostate cancer|2015–2019|Males|5|All ages combined|0.956|0.954|0.959
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|20–24|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|25–29|0.909|0.809|0.958
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|30–34|0.955|0.909|0.978
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|35–39|0.939|0.898|0.964
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|40–44|0.953|0.924|0.972
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|45–49|0.963|0.943|0.976
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|50–54|0.942|0.926|0.955
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|55–59|0.935|0.919|0.947
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|60–64|0.938|0.925|0.948
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|65–69|0.913|0.899|0.925
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|70–74|0.889|0.874|0.903
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|75–79|0.833|0.812|0.852
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|80–84|0.785|0.758|0.809
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|85+|0.62|0.584|0.653
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|All ages combined|0.883|0.877|0.889
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|20–24|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|25–29|0.82|0.705|0.893
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|30–34|0.887|0.824|0.928
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|35–39|0.914|0.866|0.945
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|40–44|0.895|0.856|0.924
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|45–49|0.895|0.865|0.919
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|50–54|0.893|0.872|0.911
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|55–59|0.875|0.856|0.893
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|60–64|0.873|0.856|0.888
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|65–69|0.832|0.814|0.849
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|70–74|0.816|0.798|0.833
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|75–79|0.729|0.704|0.751
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|80–84|0.678|0.648|0.706
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|85+|0.458|0.422|0.492
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|All ages combined|0.802|0.795|0.809
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|20–24|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|25–29|0.753|0.633|0.838
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|30–34|0.822|0.747|0.876
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|35–39|0.869|0.813|0.909
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|40–44|0.847|0.803|0.882
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|45–49|0.834|0.798|0.864
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|50–54|0.822|0.796|0.845
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|55–59|0.821|0.799|0.841
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|60–64|0.817|0.798|0.835
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|65–69|0.778|0.758|0.796
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|70–74|0.748|0.727|0.767
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|75–79|0.651|0.626|0.676
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|80–84|0.571|0.54|0.601
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|85+|0.346|0.313|0.38
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|All ages combined|0.733|0.725|0.741
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|20–24|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|25–29|0.724|0.603|0.814
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|30–34|0.785|0.704|0.846
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|35–39|0.828|0.766|0.875
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|40–44|0.8|0.751|0.84
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|45–49|0.796|0.758|0.828
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|50–54|0.785|0.757|0.81
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|55–59|0.782|0.758|0.804
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|60–64|0.771|0.75|0.791
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|65–69|0.735|0.714|0.755
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|70–74|0.687|0.665|0.708
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|75–79|0.582|0.556|0.607
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|80–84|0.493|0.462|0.524
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|85+|0.267|0.236|0.298
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|All ages combined|0.68|0.671|0.688
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|20–24|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|25–29|0.708|0.585|0.8
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|30–34|0.756|0.671|0.822
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|35–39|0.803|0.738|0.854
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|40–44|0.767|0.716|0.81
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|45–49|0.764|0.725|0.798
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|50–54|0.745|0.716|0.771
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|55–59|0.745|0.719|0.768
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|60–64|0.731|0.71|0.752
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|65–69|0.689|0.668|0.71
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|70–74|0.641|0.619|0.663
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|75–79|0.538|0.512|0.564
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|80–84|0.425|0.395|0.455
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|85+|0.211|0.183|0.24
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|All ages combined|0.635|0.626|0.644
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|20–24|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|25–29|0.91|0.81|0.959
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|30–34|0.956|0.909|0.979
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|35–39|0.941|0.899|0.966
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|40–44|0.955|0.925|0.973
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|45–49|0.965|0.945|0.979
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|50–54|0.946|0.929|0.959
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|55–59|0.94|0.924|0.952
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|60–64|0.945|0.932|0.956
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|65–69|0.924|0.91|0.937
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|70–74|0.907|0.891|0.92
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|75–79|0.862|0.84|0.881
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|80–84|0.833|0.805|0.859
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|85+|0.71|0.67|0.748
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|1|All ages combined|0.905|0.899|0.91
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|20–24|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|25–29|0.821|0.706|0.895
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|30–34|0.888|0.825|0.93
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|35–39|0.916|0.868|0.947
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|40–44|0.898|0.859|0.927
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|45–49|0.899|0.869|0.923
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|50–54|0.899|0.878|0.918
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|55–59|0.885|0.865|0.902
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|60–64|0.887|0.87|0.903
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|65–69|0.853|0.835|0.87
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|70–74|0.85|0.831|0.868
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|75–79|0.783|0.757|0.807
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|80–84|0.771|0.737|0.803
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|85+|0.607|0.56|0.653
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|2|All ages combined|0.841|0.833|0.848
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|20–24|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|25–29|0.754|0.634|0.84
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|30–34|0.824|0.749|0.879
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|35–39|0.872|0.816|0.912
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|40–44|0.852|0.807|0.887
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|45–49|0.84|0.804|0.87
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|50–54|0.832|0.805|0.855
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|55–59|0.835|0.812|0.856
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|60–64|0.839|0.819|0.857
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|65–69|0.809|0.789|0.828
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|70–74|0.798|0.776|0.819
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|75–79|0.73|0.701|0.757
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|80–84|0.702|0.664|0.739
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|85+|0.538|0.487|0.59
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|3|All ages combined|0.787|0.779|0.796
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|20–24|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|25–29|0.727|0.605|0.817
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|30–34|0.788|0.707|0.85
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|35–39|0.832|0.77|0.879
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|40–44|0.805|0.757|0.846
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|45–49|0.804|0.766|0.837
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|50–54|0.797|0.769|0.823
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|55–59|0.801|0.776|0.823
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|60–64|0.8|0.778|0.82
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|65–69|0.776|0.754|0.797
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|70–74|0.754|0.729|0.776
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|75–79|0.684|0.653|0.714
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|80–84|0.662|0.62|0.702
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|85+|0.494|0.437|0.552
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|4|All ages combined|0.749|0.739|0.758
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|20–24|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|25–29|0.71|0.587|0.804
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|30–34|0.76|0.674|0.826
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|35–39|0.809|0.743|0.859
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|40–44|0.774|0.723|0.817
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|45–49|0.775|0.735|0.81
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|50–54|0.76|0.73|0.787
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|55–59|0.768|0.742|0.792
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|60–64|0.767|0.744|0.788
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|65–69|0.741|0.717|0.763
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|70–74|0.725|0.699|0.749
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|75–79|0.667|0.635|0.699
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|80–84|0.629|0.585|0.673
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|85+|0.474|0.411|0.54
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Males|5|All ages combined|0.718|0.709|0.728
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|20–24|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|25–29|0.926|0.814|0.971
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|30–34|0.983|0.934|0.996
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|35–39|0.975|0.935|0.991
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|40–44|0.974|0.947|0.988
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|45–49|0.949|0.923|0.966
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|50–54|0.958|0.938|0.971
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|55–59|0.952|0.933|0.965
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|60–64|0.943|0.926|0.957
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|65–69|0.922|0.902|0.937
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|70–74|0.902|0.88|0.92
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|75–79|0.834|0.804|0.859
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|80–84|0.791|0.755|0.822
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|85+|0.654|0.616|0.689
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|All ages combined|0.889|0.882|0.896
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|20–24|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|25–29|0.849|0.72|0.921
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|30–34|0.876|0.799|0.924
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|35–39|0.918|0.859|0.953
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|40–44|0.94|0.905|0.963
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|45–49|0.898|0.865|0.923
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|50–54|0.905|0.878|0.926
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|55–59|0.908|0.884|0.927
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|60–64|0.897|0.875|0.915
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|65–69|0.851|0.826|0.873
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|70–74|0.833|0.807|0.856
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|75–79|0.751|0.718|0.781
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|80–84|0.665|0.625|0.702
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|85+|0.499|0.46|0.536
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|All ages combined|0.814|0.805|0.823
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|20–24|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|25–29|0.795|0.66|0.881
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|30–34|0.845|0.763|0.901
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|35–39|0.86|0.791|0.908
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|40–44|0.873|0.826|0.908
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|45–49|0.845|0.807|0.876
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|50–54|0.842|0.81|0.869
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|55–59|0.865|0.838|0.888
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|60–64|0.848|0.822|0.87
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|65–69|0.809|0.782|0.833
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|70–74|0.782|0.754|0.808
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|75–79|0.689|0.654|0.721
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|80–84|0.598|0.557|0.636
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|85+|0.398|0.361|0.435
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|All ages combined|0.756|0.746|0.766
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|20–24|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|25–29|0.708|0.569|0.81
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|30–34|0.823|0.736|0.884
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|35–39|0.825|0.751|0.878
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|40–44|0.848|0.798|0.887
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|45–49|0.798|0.757|0.834
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|50–54|0.814|0.78|0.844
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|55–59|0.822|0.791|0.848
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|60–64|0.802|0.774|0.828
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|65–69|0.77|0.741|0.796
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|70–74|0.747|0.717|0.774
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|75–79|0.643|0.607|0.676
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|80–84|0.533|0.492|0.572
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|85+|0.33|0.294|0.366
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|All ages combined|0.711|0.701|0.722
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|20–24|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|25–29|0.708|0.569|0.81
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|30–34|0.772|0.675|0.844
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|35–39|0.797|0.722|0.855
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|40–44|0.816|0.761|0.859
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|45–49|0.774|0.731|0.811
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|50–54|0.796|0.761|0.826
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|55–59|0.8|0.768|0.828
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|60–64|0.767|0.737|0.794
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|65–69|0.719|0.689|0.747
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|70–74|0.7|0.669|0.729
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|75–79|0.601|0.565|0.634
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|80–84|0.478|0.438|0.517
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|85+|0.26|0.228|0.294
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|All ages combined|0.67|0.659|0.681
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|20–24|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|25–29|0.926|0.815|0.972
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|30–34|0.983|0.934|0.996
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|35–39|0.976|0.936|0.991
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|40–44|0.975|0.948|0.989
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|45–49|0.95|0.924|0.967
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|50–54|0.96|0.94|0.973
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|55–59|0.955|0.936|0.968
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|60–64|0.948|0.93|0.961
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|65–69|0.928|0.908|0.944
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|70–74|0.913|0.891|0.931
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|75–79|0.852|0.822|0.878
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|80–84|0.825|0.787|0.857
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|85+|0.736|0.693|0.775
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|1|All ages combined|0.907|0.899|0.914
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|20–24|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|25–29|0.849|0.721|0.922
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|30–34|0.876|0.8|0.925
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|35–39|0.919|0.861|0.954
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|40–44|0.942|0.906|0.965
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|45–49|0.9|0.867|0.925
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|50–54|0.909|0.882|0.93
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|55–59|0.914|0.89|0.933
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|60–64|0.906|0.883|0.924
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|65–69|0.864|0.839|0.886
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|70–74|0.855|0.828|0.878
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|75–79|0.787|0.752|0.818
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|80–84|0.728|0.684|0.768
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|85+|0.635|0.586|0.682
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|2|All ages combined|0.846|0.836|0.855
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|20–24|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|25–29|0.795|0.661|0.881
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|30–34|0.846|0.764|0.902
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|35–39|0.862|0.793|0.909
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|40–44|0.876|0.829|0.911
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|45–49|0.849|0.811|0.88
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|50–54|0.848|0.815|0.875
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|55–59|0.874|0.846|0.898
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|60–64|0.861|0.834|0.883
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|65–69|0.828|0.8|0.853
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|70–74|0.815|0.785|0.842
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|75–79|0.742|0.704|0.776
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|80–84|0.691|0.644|0.736
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|85+|0.58|0.525|0.634
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|3|All ages combined|0.801|0.79|0.811
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|20–24|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|25–29|0.709|0.57|0.811
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|30–34|0.825|0.738|0.885
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|35–39|0.827|0.753|0.88
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|40–44|0.852|0.802|0.891
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|45–49|0.804|0.762|0.839
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|50–54|0.822|0.788|0.852
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|55–59|0.834|0.802|0.861
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|60–64|0.82|0.791|0.845
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|65–69|0.796|0.766|0.822
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|70–74|0.792|0.76|0.821
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|75–79|0.714|0.675|0.751
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|80–84|0.657|0.606|0.705
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|85+|0.555|0.495|0.615
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|4|All ages combined|0.768|0.756|0.78
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|20–24|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|25–29|0.709|0.57|0.811
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|30–34|0.774|0.677|0.846
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|35–39|0.8|0.724|0.858
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|40–44|0.82|0.766|0.864
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|45–49|0.781|0.737|0.818
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|50–54|0.806|0.77|0.837
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|55–59|0.814|0.782|0.843
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|60–64|0.789|0.758|0.817
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|65–69|0.751|0.719|0.781
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|70–74|0.757|0.723|0.788
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|75–79|0.692|0.651|0.731
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|80–84|0.634|0.581|0.686
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|85+|0.514|0.45|0.581
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Females|5|All ages combined|0.739|0.727|0.752
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|20–24|0.912|0.692|0.977
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|25–29|0.917|0.851|0.954
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|30–34|0.967|0.938|0.983
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|35–39|0.955|0.928|0.972
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|40–44|0.963|0.944|0.975
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|45–49|0.956|0.941|0.968
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|50–54|0.948|0.936|0.958
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|55–59|0.941|0.93|0.951
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|60–64|0.94|0.93|0.948
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|65–69|0.916|0.905|0.926
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|70–74|0.893|0.881|0.904
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|75–79|0.833|0.817|0.849
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|80–84|0.787|0.766|0.806
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|85+|0.636|0.61|0.66
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|All ages combined|0.885|0.881|0.89
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|20–24|0.872|0.654|0.957
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|25–29|0.833|0.753|0.889
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|30–34|0.882|0.836|0.915
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|35–39|0.916|0.881|0.94
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|40–44|0.916|0.89|0.935
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|45–49|0.896|0.875|0.914
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|50–54|0.898|0.881|0.912
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|55–59|0.887|0.872|0.9
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|60–64|0.881|0.868|0.893
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|65–69|0.839|0.824|0.852
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|70–74|0.821|0.807|0.835
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|75–79|0.737|0.717|0.755
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|80–84|0.673|0.649|0.696
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|85+|0.477|0.45|0.502
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|All ages combined|0.807|0.801|0.812
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|20–24|0.835|0.618|0.934
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|25–29|0.771|0.686|0.836
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|30–34|0.832|0.78|0.873
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|35–39|0.865|0.824|0.897
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|40–44|0.859|0.828|0.885
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|45–49|0.839|0.814|0.861
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|50–54|0.83|0.81|0.848
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|55–59|0.837|0.82|0.853
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|60–64|0.827|0.812|0.842
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|65–69|0.788|0.772|0.803
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|70–74|0.759|0.743|0.775
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|75–79|0.665|0.644|0.684
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|80–84|0.581|0.557|0.605
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|85+|0.37|0.345|0.395
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|All ages combined|0.742|0.735|0.748
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|20–24|0.835|0.618|0.934
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|25–29|0.717|0.629|0.787
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|30–34|0.802|0.746|0.848
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|35–39|0.827|0.781|0.863
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|40–44|0.821|0.788|0.85
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|45–49|0.797|0.77|0.822
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|50–54|0.796|0.775|0.816
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|55–59|0.796|0.777|0.814
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|60–64|0.782|0.765|0.797
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|65–69|0.747|0.73|0.762
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|70–74|0.707|0.689|0.724
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|75–79|0.603|0.582|0.624
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|80–84|0.508|0.483|0.532
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|85+|0.296|0.273|0.32
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|All ages combined|0.691|0.685|0.698
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|00–04|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|05–09|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|10–14|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|15–19|||
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|20–24|0.799|0.583|0.911
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|25–29|0.708|0.619|0.78
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|30–34|0.764|0.702|0.814
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|35–39|0.801|0.753|0.84
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|40–44|0.789|0.753|0.82
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|45–49|0.769|0.74|0.794
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|50–54|0.764|0.742|0.785
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|55–59|0.764|0.745|0.783
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|60–64|0.743|0.726|0.76
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|65–69|0.699|0.682|0.716
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|70–74|0.661|0.642|0.678
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|75–79|0.56|0.539|0.581
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|80–84|0.445|0.421|0.469
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|85+|0.234|0.212|0.256
Observed|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|All ages combined|0.648|0.641|0.655
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|20–24|0.913|0.693|0.978
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|25–29|0.917|0.851|0.955
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|30–34|0.968|0.938|0.983
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|35–39|0.956|0.929|0.973
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|40–44|0.964|0.946|0.977
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|45–49|0.958|0.943|0.97
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|50–54|0.951|0.939|0.961
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|55–59|0.945|0.934|0.955
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|60–64|0.946|0.936|0.955
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|65–69|0.926|0.914|0.936
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|70–74|0.909|0.896|0.92
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|75–79|0.858|0.841|0.874
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|80–84|0.83|0.808|0.851
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|85+|0.722|0.693|0.75
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|1|All ages combined|0.905|0.901|0.91
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|20–24|0.873|0.654|0.958
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|25–29|0.834|0.754|0.89
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|30–34|0.883|0.837|0.917
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|35–39|0.917|0.883|0.942
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|40–44|0.918|0.893|0.938
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|45–49|0.9|0.878|0.918
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|50–54|0.903|0.887|0.917
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|55–59|0.895|0.88|0.909
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|60–64|0.893|0.88|0.906
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|65–69|0.857|0.842|0.871
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|70–74|0.852|0.836|0.866
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|75–79|0.784|0.764|0.804
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|80–84|0.755|0.728|0.78
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|85+|0.62|0.586|0.653
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|2|All ages combined|0.843|0.837|0.849
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|20–24|0.836|0.619|0.936
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|25–29|0.772|0.687|0.837
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|30–34|0.834|0.781|0.875
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|35–39|0.868|0.826|0.9
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|40–44|0.863|0.832|0.889
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|45–49|0.844|0.819|0.867
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|50–54|0.838|0.818|0.856
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|55–59|0.849|0.832|0.865
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|60–64|0.846|0.831|0.861
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|65–69|0.815|0.799|0.831
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|70–74|0.804|0.786|0.82
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|75–79|0.734|0.712|0.756
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|80–84|0.698|0.669|0.727
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|85+|0.558|0.52|0.595
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|3|All ages combined|0.792|0.786|0.799
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|20–24|0.836|0.619|0.936
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|25–29|0.718|0.63|0.789
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|30–34|0.805|0.748|0.85
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|35–39|0.83|0.785|0.867
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|40–44|0.826|0.792|0.855
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|45–49|0.804|0.777|0.829
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|50–54|0.807|0.785|0.826
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|55–59|0.812|0.793|0.83
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|60–64|0.807|0.789|0.823
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|65–69|0.783|0.765|0.799
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|70–74|0.766|0.747|0.784
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|75–79|0.695|0.671|0.718
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|80–84|0.66|0.628|0.691
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|85+|0.523|0.482|0.565
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|4|All ages combined|0.756|0.749|0.763
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|00–04|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|05–09|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|10–14|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|15–19|||
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|20–24|0.801|0.585|0.913
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|25–29|0.71|0.621|0.782
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|30–34|0.767|0.705|0.817
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|35–39|0.805|0.757|0.845
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|40–44|0.795|0.758|0.826
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|45–49|0.778|0.749|0.804
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|50–54|0.778|0.755|0.799
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|55–59|0.785|0.765|0.804
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|60–64|0.774|0.756|0.792
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|65–69|0.744|0.726|0.762
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|70–74|0.735|0.715|0.755
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|75–79|0.676|0.651|0.701
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|80–84|0.631|0.597|0.665
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|85+|0.493|0.447|0.539
Relative|Rectal cancer (excluding rectosigmoid junction)|2015–2019|Persons|5|All ages combined|0.726|0.719|0.734
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|20–24|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|25–29|0.891|0.793|0.944
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|30–34|0.947|0.904|0.971
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|35–39|0.928|0.888|0.954
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|40–44|0.942|0.913|0.961
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|45–49|0.951|0.931|0.966
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|50–54|0.932|0.916|0.945
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|55–59|0.925|0.911|0.938
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|60–64|0.93|0.918|0.94
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|65–69|0.897|0.884|0.909
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|70–74|0.876|0.862|0.889
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|75–79|0.821|0.802|0.839
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|80–84|0.759|0.735|0.781
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|85+|0.563|0.533|0.593
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|All ages combined|0.865|0.86|0.871
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|20–24|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|25–29|0.809|0.698|0.882
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|30–34|0.886|0.83|0.924
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|35–39|0.891|0.845|0.925
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|40–44|0.883|0.846|0.912
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|45–49|0.875|0.846|0.899
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|50–54|0.876|0.855|0.894
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|55–59|0.861|0.842|0.877
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|60–64|0.861|0.845|0.875
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|65–69|0.82|0.803|0.835
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|70–74|0.799|0.782|0.815
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|75–79|0.717|0.696|0.738
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|80–84|0.646|0.619|0.671
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|85+|0.42|0.39|0.449
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|All ages combined|0.782|0.775|0.789
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|20–24|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|25–29|0.748|0.634|0.831
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|30–34|0.819|0.753|0.87
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|35–39|0.852|0.799|0.893
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|40–44|0.837|0.796|0.871
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|45–49|0.811|0.778|0.84
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|50–54|0.808|0.784|0.83
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|55–59|0.805|0.784|0.825
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|60–64|0.803|0.785|0.819
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|65–69|0.766|0.748|0.783
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|70–74|0.73|0.711|0.748
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|75–79|0.639|0.616|0.661
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|80–84|0.545|0.517|0.571
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|85+|0.322|0.294|0.35
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|All ages combined|0.713|0.706|0.721
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|20–24|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|25–29|0.723|0.608|0.81
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|30–34|0.783|0.711|0.839
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|35–39|0.812|0.753|0.858
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|40–44|0.788|0.743|0.826
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|45–49|0.768|0.732|0.799
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|50–54|0.772|0.746|0.795
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|55–59|0.764|0.742|0.785
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|60–64|0.755|0.736|0.773
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|65–69|0.721|0.702|0.738
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|70–74|0.672|0.652|0.691
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|75–79|0.572|0.549|0.595
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|80–84|0.472|0.445|0.498
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|85+|0.254|0.229|0.281
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|All ages combined|0.66|0.653|0.668
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|20–24|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|25–29|0.708|0.592|0.797
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|30–34|0.743|0.666|0.805
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|35–39|0.785|0.723|0.834
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|40–44|0.757|0.71|0.797
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|45–49|0.74|0.703|0.772
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|50–54|0.735|0.709|0.76
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|55–59|0.729|0.706|0.751
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|60–64|0.717|0.697|0.735
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|65–69|0.679|0.66|0.698
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|70–74|0.629|0.609|0.649
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|75–79|0.529|0.506|0.552
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|80–84|0.405|0.379|0.431
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|85+|0.201|0.178|0.226
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|All ages combined|0.618|0.61|0.625
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|20–24|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|25–29|0.891|0.794|0.944
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|30–34|0.948|0.905|0.972
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|35–39|0.929|0.889|0.955
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|40–44|0.943|0.914|0.963
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|45–49|0.954|0.934|0.968
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|50–54|0.935|0.919|0.949
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|55–59|0.93|0.916|0.943
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|60–64|0.937|0.925|0.947
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|65–69|0.908|0.894|0.92
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|70–74|0.893|0.879|0.906
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|75–79|0.849|0.83|0.867
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|80–84|0.806|0.78|0.83
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|85+|0.647|0.611|0.681
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|1|All ages combined|0.887|0.881|0.893
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|20–24|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|25–29|0.81|0.699|0.883
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|30–34|0.887|0.831|0.926
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|35–39|0.894|0.847|0.927
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|40–44|0.886|0.849|0.915
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|45–49|0.879|0.851|0.903
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|50–54|0.882|0.862|0.9
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|55–59|0.87|0.852|0.887
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|60–64|0.875|0.859|0.889
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|65–69|0.84|0.824|0.856
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|70–74|0.833|0.815|0.849
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|75–79|0.77|0.747|0.793
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|80–84|0.734|0.704|0.763
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|85+|0.557|0.518|0.597
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|2|All ages combined|0.821|0.814|0.828
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|20–24|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|25–29|0.75|0.636|0.833
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|30–34|0.822|0.755|0.872
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|35–39|0.856|0.802|0.896
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|40–44|0.842|0.8|0.875
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|45–49|0.818|0.784|0.847
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|50–54|0.818|0.793|0.839
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|55–59|0.819|0.798|0.839
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|60–64|0.824|0.806|0.841
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|65–69|0.797|0.778|0.814
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|70–74|0.779|0.759|0.798
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|75–79|0.716|0.69|0.741
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|80–84|0.669|0.636|0.702
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|85+|0.5|0.457|0.544
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|3|All ages combined|0.768|0.76|0.775
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|20–24|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|25–29|0.725|0.61|0.812
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|30–34|0.786|0.714|0.842
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|35–39|0.816|0.757|0.862
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|40–44|0.794|0.748|0.832
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|45–49|0.776|0.74|0.808
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|50–54|0.784|0.758|0.808
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|55–59|0.783|0.76|0.804
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|60–64|0.783|0.764|0.802
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|65–69|0.761|0.741|0.78
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|70–74|0.737|0.715|0.757
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|75–79|0.672|0.645|0.699
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|80–84|0.633|0.596|0.668
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|85+|0.471|0.423|0.519
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|4|All ages combined|0.729|0.721|0.737
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|20–24|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|25–29|0.711|0.594|0.8
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|30–34|0.747|0.669|0.809
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|35–39|0.79|0.728|0.84
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|40–44|0.764|0.717|0.805
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|45–49|0.75|0.713|0.783
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|50–54|0.751|0.723|0.776
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|55–59|0.752|0.728|0.774
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|60–64|0.751|0.731|0.771
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|65–69|0.729|0.709|0.749
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|70–74|0.711|0.688|0.733
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|75–79|0.656|0.627|0.684
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|80–84|0.599|0.561|0.638
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|85+|0.452|0.399|0.507
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Males|5|All ages combined|0.701|0.692|0.71
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|20–24|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|25–29|0.926|0.832|0.969
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|30–34|0.979|0.936|0.993
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|35–39|0.959|0.92|0.979
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|40–44|0.967|0.941|0.981
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|45–49|0.937|0.913|0.955
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|50–54|0.947|0.928|0.961
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|55–59|0.937|0.919|0.951
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|60–64|0.933|0.916|0.946
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|65–69|0.916|0.899|0.931
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|70–74|0.888|0.869|0.905
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|75–79|0.806|0.779|0.83
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|80–84|0.736|0.704|0.765
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|85+|0.588|0.556|0.619
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|All ages combined|0.863|0.856|0.87
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|20–24|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|25–29|0.864|0.754|0.927
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|30–34|0.883|0.816|0.926
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|35–39|0.905|0.851|0.94
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|40–44|0.924|0.889|0.948
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|45–49|0.881|0.851|0.906
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|50–54|0.893|0.869|0.914
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|55–59|0.885|0.862|0.904
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|60–64|0.888|0.868|0.906
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|65–69|0.839|0.817|0.859
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|70–74|0.82|0.797|0.841
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|75–79|0.724|0.694|0.751
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|80–84|0.623|0.589|0.655
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|85+|0.452|0.42|0.483
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|All ages combined|0.787|0.779|0.796
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|20–24|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|25–29|0.803|0.685|0.88
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|30–34|0.858|0.786|0.907
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|35–39|0.849|0.786|0.895
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|40–44|0.858|0.814|0.891
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|45–49|0.828|0.793|0.857
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|50–54|0.833|0.805|0.858
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|55–59|0.843|0.818|0.866
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|60–64|0.842|0.819|0.863
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|65–69|0.794|0.77|0.816
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|70–74|0.763|0.738|0.787
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|75–79|0.666|0.636|0.695
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|80–84|0.564|0.53|0.597
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|85+|0.355|0.325|0.385
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|All ages combined|0.73|0.721|0.739
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|20–24|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|25–29|0.73|0.607|0.821
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|30–34|0.83|0.753|0.885
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|35–39|0.813|0.745|0.864
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|40–44|0.832|0.786|0.869
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|45–49|0.784|0.747|0.816
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|50–54|0.805|0.775|0.832
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|55–59|0.802|0.774|0.827
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|60–64|0.8|0.775|0.823
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|65–69|0.756|0.73|0.779
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|70–74|0.723|0.696|0.748
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|75–79|0.62|0.589|0.649
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|80–84|0.507|0.472|0.54
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|85+|0.293|0.265|0.322
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|All ages combined|0.686|0.677|0.696
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|20–24|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|25–29|0.716|0.591|0.808
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|30–34|0.787|0.701|0.851
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|35–39|0.783|0.713|0.838
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|40–44|0.807|0.758|0.846
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|45–49|0.761|0.723|0.795
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|50–54|0.789|0.757|0.816
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|55–59|0.78|0.751|0.806
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|60–64|0.765|0.739|0.79
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|65–69|0.712|0.686|0.737
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|70–74|0.679|0.651|0.705
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|75–79|0.573|0.541|0.603
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|80–84|0.461|0.427|0.495
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|85+|0.234|0.207|0.261
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|All ages combined|0.648|0.638|0.657
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|20–24|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|25–29|0.926|0.832|0.969
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|30–34|0.979|0.936|0.994
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|35–39|0.96|0.921|0.98
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|40–44|0.968|0.941|0.982
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|45–49|0.939|0.915|0.956
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|50–54|0.949|0.93|0.963
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|55–59|0.94|0.922|0.954
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|60–64|0.937|0.92|0.951
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|65–69|0.923|0.905|0.938
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|70–74|0.899|0.879|0.916
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|75–79|0.824|0.796|0.848
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|80–84|0.768|0.734|0.798
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|85+|0.662|0.626|0.696
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|1|All ages combined|0.882|0.874|0.889
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|20–24|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|25–29|0.864|0.755|0.927
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|30–34|0.883|0.816|0.927
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|35–39|0.906|0.852|0.941
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|40–44|0.926|0.891|0.95
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|45–49|0.884|0.854|0.908
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|50–54|0.897|0.873|0.918
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|55–59|0.89|0.867|0.91
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|60–64|0.897|0.877|0.915
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|65–69|0.852|0.829|0.872
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|70–74|0.841|0.817|0.863
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|75–79|0.758|0.728|0.787
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|80–84|0.682|0.644|0.717
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|85+|0.574|0.534|0.614
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|2|All ages combined|0.82|0.811|0.828
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|20–24|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|25–29|0.804|0.685|0.881
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|30–34|0.859|0.787|0.908
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|35–39|0.851|0.788|0.897
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|40–44|0.86|0.817|0.894
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|45–49|0.831|0.797|0.861
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|50–54|0.839|0.81|0.864
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|55–59|0.852|0.826|0.875
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|60–64|0.855|0.832|0.876
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|65–69|0.813|0.788|0.836
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|70–74|0.795|0.769|0.82
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|75–79|0.717|0.685|0.748
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|80–84|0.652|0.612|0.69
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|85+|0.516|0.472|0.559
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|3|All ages combined|0.775|0.765|0.785
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|20–24|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|25–29|0.731|0.608|0.822
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|30–34|0.832|0.754|0.887
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|35–39|0.815|0.747|0.866
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|40–44|0.835|0.79|0.872
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|45–49|0.789|0.752|0.822
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|50–54|0.813|0.782|0.84
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|55–59|0.813|0.785|0.838
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|60–64|0.817|0.792|0.841
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|65–69|0.781|0.755|0.805
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|70–74|0.767|0.738|0.793
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|75–79|0.689|0.654|0.722
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|80–84|0.625|0.582|0.666
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|85+|0.491|0.444|0.539
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|4|All ages combined|0.743|0.733|0.754
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|20–24|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|25–29|0.717|0.592|0.809
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|30–34|0.789|0.702|0.853
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|35–39|0.786|0.716|0.841
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|40–44|0.811|0.763|0.851
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|45–49|0.768|0.729|0.802
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|50–54|0.799|0.767|0.827
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|55–59|0.794|0.765|0.821
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|60–64|0.787|0.76|0.812
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|65–69|0.744|0.716|0.77
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|70–74|0.733|0.703|0.762
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|75–79|0.66|0.624|0.695
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|80–84|0.612|0.566|0.656
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|85+|0.459|0.407|0.512
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Females|5|All ages combined|0.717|0.706|0.728
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|20–24|0.928|0.742|0.981
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|25–29|0.908|0.846|0.945
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|30–34|0.961|0.934|0.977
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|35–39|0.942|0.916|0.96
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|40–44|0.953|0.935|0.967
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|45–49|0.945|0.93|0.957
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|50–54|0.938|0.926|0.948
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|55–59|0.93|0.919|0.939
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|60–64|0.931|0.921|0.939
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|65–69|0.903|0.893|0.913
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|70–74|0.88|0.869|0.89
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|75–79|0.816|0.801|0.83
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|80–84|0.75|0.731|0.768
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|85+|0.575|0.553|0.597
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|All ages combined|0.864|0.86|0.869
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|20–24|0.895|0.71|0.965
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|25–29|0.835|0.762|0.887
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|30–34|0.884|0.844|0.915
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|35–39|0.897|0.864|0.923
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|40–44|0.902|0.878|0.922
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|45–49|0.878|0.858|0.896
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|50–54|0.883|0.867|0.896
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|55–59|0.87|0.856|0.883
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|60–64|0.87|0.858|0.881
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|65–69|0.826|0.813|0.838
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|70–74|0.806|0.792|0.819
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|75–79|0.72|0.703|0.736
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|80–84|0.637|0.616|0.657
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|85+|0.435|0.413|0.456
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|All ages combined|0.784|0.779|0.789
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|20–24|0.864|0.677|0.947
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|25–29|0.774|0.696|0.834
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|30–34|0.836|0.79|0.874
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|35–39|0.851|0.812|0.883
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|40–44|0.847|0.818|0.871
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|45–49|0.819|0.796|0.84
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|50–54|0.818|0.8|0.835
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|55–59|0.819|0.803|0.834
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|60–64|0.816|0.802|0.829
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|65–69|0.775|0.761|0.789
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|70–74|0.741|0.726|0.756
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|75–79|0.649|0.631|0.667
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|80–84|0.552|0.531|0.573
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|85+|0.337|0.317|0.358
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|All ages combined|0.72|0.714|0.725
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|20–24|0.83|0.639|0.925
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|25–29|0.727|0.646|0.792
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|30–34|0.804|0.753|0.845
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|35–39|0.812|0.77|0.848
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|40–44|0.808|0.777|0.836
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|45–49|0.776|0.751|0.799
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|50–54|0.785|0.766|0.803
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|55–59|0.778|0.761|0.794
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|60–64|0.771|0.755|0.785
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|65–69|0.732|0.717|0.747
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|70–74|0.689|0.673|0.704
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|75–79|0.589|0.571|0.607
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|80–84|0.486|0.464|0.506
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|85+|0.273|0.254|0.292
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|All ages combined|0.67|0.664|0.676
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|00–04|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|05–09|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|10–14|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|15–19|||
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|20–24|0.8|0.609|0.905
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|25–29|0.712|0.63|0.779
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|30–34|0.763|0.707|0.809
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|35–39|0.784|0.739|0.822
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|40–44|0.78|0.747|0.809
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|45–49|0.75|0.724|0.774
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|50–54|0.756|0.736|0.775
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|55–59|0.748|0.73|0.765
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|60–64|0.733|0.717|0.748
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|65–69|0.69|0.675|0.705
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|70–74|0.646|0.629|0.662
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|75–79|0.545|0.526|0.563
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|80–84|0.427|0.406|0.447
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|85+|0.217|0.199|0.235
Observed|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|All ages combined|0.629|0.623|0.635
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|20–24|0.928|0.742|0.982
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|25–29|0.908|0.847|0.946
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|30–34|0.962|0.934|0.978
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|35–39|0.943|0.916|0.961
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|40–44|0.954|0.936|0.968
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|45–49|0.947|0.932|0.958
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|50–54|0.941|0.929|0.951
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|55–59|0.934|0.923|0.943
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|60–64|0.937|0.928|0.946
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|65–69|0.913|0.902|0.922
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|70–74|0.895|0.884|0.906
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|75–79|0.84|0.825|0.855
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|80–84|0.791|0.771|0.81
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|85+|0.654|0.629|0.678
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|1|All ages combined|0.885|0.88|0.889
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|20–24|0.896|0.71|0.966
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|25–29|0.836|0.763|0.888
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|30–34|0.886|0.845|0.916
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|35–39|0.899|0.866|0.925
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|40–44|0.905|0.88|0.924
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|45–49|0.882|0.862|0.899
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|50–54|0.888|0.873|0.902
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|55–59|0.878|0.864|0.891
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|60–64|0.883|0.87|0.894
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|65–69|0.844|0.831|0.857
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|70–74|0.836|0.822|0.849
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|75–79|0.766|0.748|0.784
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|80–84|0.714|0.69|0.736
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|85+|0.565|0.537|0.593
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|2|All ages combined|0.82|0.815|0.826
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|20–24|0.865|0.678|0.948
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|25–29|0.775|0.697|0.836
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|30–34|0.838|0.791|0.875
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|35–39|0.854|0.815|0.885
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|40–44|0.85|0.821|0.875
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|45–49|0.824|0.801|0.846
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|50–54|0.826|0.808|0.843
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|55–59|0.831|0.815|0.847
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|60–64|0.835|0.82|0.848
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|65–69|0.802|0.787|0.816
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|70–74|0.785|0.769|0.8
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|75–79|0.717|0.697|0.736
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|80–84|0.663|0.638|0.688
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|85+|0.508|0.477|0.538
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|3|All ages combined|0.77|0.764|0.776
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|20–24|0.832|0.64|0.927
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|25–29|0.729|0.648|0.794
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|30–34|0.806|0.755|0.848
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|35–39|0.816|0.773|0.851
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|40–44|0.813|0.782|0.841
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|45–49|0.783|0.757|0.806
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|50–54|0.795|0.776|0.813
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|55–59|0.794|0.777|0.811
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|60–64|0.795|0.779|0.81
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|65–69|0.768|0.752|0.783
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|70–74|0.747|0.73|0.763
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|75–79|0.679|0.657|0.7
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|80–84|0.63|0.603|0.657
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|85+|0.48|0.447|0.515
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|4|All ages combined|0.735|0.728|0.741
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|00–04|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|05–09|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|10–14|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|15–19|||
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|20–24|0.802|0.61|0.907
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|25–29|0.714|0.632|0.781
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|30–34|0.765|0.71|0.812
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|35–39|0.788|0.743|0.826
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|40–44|0.786|0.752|0.815
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|45–49|0.758|0.732|0.783
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|50–54|0.769|0.749|0.788
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|55–59|0.768|0.749|0.785
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|60–64|0.764|0.747|0.779
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|65–69|0.734|0.718|0.75
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|70–74|0.719|0.7|0.736
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|75–79|0.658|0.635|0.68
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|80–84|0.605|0.576|0.634
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|85+|0.455|0.418|0.493
Relative|Rectal cancer (including rectosigmoid junction)|2015–2019|Persons|5|All ages combined|0.707|0.7|0.714
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|30–34|0.91|0.747|0.97
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|35–39|0.856|0.689|0.938
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|40–44|0.871|0.748|0.936
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|45–49|0.901|0.833|0.943
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|50–54|0.882|0.827|0.92
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|55–59|0.881|0.836|0.915
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|60–64|0.898|0.865|0.924
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|65–69|0.838|0.803|0.868
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|70–74|0.821|0.782|0.853
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|75–79|0.775|0.727|0.815
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|80–84|0.675|0.619|0.724
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|85+|0.399|0.341|0.457
Observed|Rectosigmoid junction cancer|2015–2019|Males|1|All ages combined|0.793|0.778|0.807
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|30–34|0.88|0.711|0.953
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|35–39|0.742|0.546|0.864
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|40–44|0.812|0.679|0.894
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|45–49|0.787|0.699|0.852
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|50–54|0.792|0.728|0.842
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|55–59|0.792|0.738|0.837
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|60–64|0.811|0.77|0.846
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|65–69|0.773|0.734|0.808
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|70–74|0.729|0.686|0.768
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|75–79|0.673|0.621|0.719
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|80–84|0.542|0.485|0.595
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|85+|0.307|0.255|0.361
Observed|Rectosigmoid junction cancer|2015–2019|Males|2|All ages combined|0.7|0.684|0.716
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|30–34|0.806|0.616|0.909
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|35–39|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|40–44|0.775|0.639|0.866
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|45–49|0.709|0.614|0.785
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|50–54|0.739|0.673|0.795
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|55–59|0.73|0.672|0.78
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|60–64|0.744|0.698|0.783
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|65–69|0.723|0.682|0.76
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|70–74|0.656|0.61|0.698
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|75–79|0.591|0.539|0.639
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|80–84|0.458|0.402|0.513
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|85+|0.246|0.199|0.297
Observed|Rectosigmoid junction cancer|2015–2019|Males|3|All ages combined|0.634|0.616|0.651
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|30–34|0.771|0.576|0.884
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|35–39|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|40–44|0.719|0.578|0.82
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|45–49|0.639|0.54|0.722
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|50–54|0.707|0.64|0.765
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|55–59|0.683|0.623|0.735
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|60–64|0.691|0.643|0.733
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|65–69|0.668|0.625|0.707
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|70–74|0.607|0.561|0.651
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|75–79|0.532|0.48|0.581
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|80–84|0.403|0.348|0.456
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|85+|0.212|0.167|0.259
Observed|Rectosigmoid junction cancer|2015–2019|Males|4|All ages combined|0.583|0.565|0.6
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|30–34|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|35–39|||
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|40–44|0.698|0.554|0.803
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|45–49|0.628|0.528|0.712
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|50–54|0.686|0.617|0.744
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|55–59|0.654|0.593|0.708
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|60–64|0.656|0.608|0.7
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|65–69|0.642|0.598|0.682
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|70–74|0.576|0.529|0.62
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|75–79|0.492|0.441|0.541
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|80–84|0.341|0.289|0.393
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|85+|0.168|0.128|0.213
Observed|Rectosigmoid junction cancer|2015–2019|Males|5|All ages combined|0.548|0.53|0.565
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|30–34|0.911|0.748|0.971
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|35–39|0.857|0.69|0.939
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|40–44|0.872|0.749|0.938
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|45–49|0.903|0.835|0.945
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|50–54|0.885|0.83|0.923
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|55–59|0.886|0.84|0.92
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|60–64|0.905|0.872|0.931
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|65–69|0.848|0.812|0.878
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|70–74|0.837|0.798|0.87
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|75–79|0.801|0.752|0.843
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|80–84|0.717|0.658|0.769
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|85+|0.461|0.393|0.527
Relative|Rectosigmoid junction cancer|2015–2019|Males|1|All ages combined|0.816|0.8|0.83
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|30–34|0.881|0.712|0.955
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|35–39|0.744|0.547|0.866
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|40–44|0.815|0.681|0.897
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|45–49|0.791|0.702|0.856
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|50–54|0.798|0.734|0.848
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|55–59|0.801|0.746|0.846
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|60–64|0.825|0.783|0.86
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|65–69|0.793|0.752|0.828
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|70–74|0.76|0.715|0.801
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|75–79|0.723|0.667|0.772
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|80–84|0.616|0.551|0.677
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|85+|0.41|0.34|0.482
Relative|Rectosigmoid junction cancer|2015–2019|Males|2|All ages combined|0.739|0.722|0.756
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|30–34|0.809|0.618|0.911
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|35–39|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|40–44|0.779|0.642|0.87
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|45–49|0.715|0.619|0.791
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|50–54|0.748|0.68|0.804
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|55–59|0.743|0.683|0.793
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|60–64|0.763|0.717|0.804
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|65–69|0.751|0.708|0.79
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|70–74|0.701|0.652|0.745
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|75–79|0.663|0.604|0.717
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|80–84|0.563|0.494|0.629
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|85+|0.383|0.309|0.462
Relative|Rectosigmoid junction cancer|2015–2019|Males|3|All ages combined|0.687|0.668|0.705
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|30–34|0.774|0.578|0.888
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|35–39|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|40–44|0.724|0.582|0.826
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|45–49|0.646|0.546|0.73
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|50–54|0.719|0.65|0.777
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|55–59|0.699|0.638|0.753
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|60–64|0.716|0.667|0.76
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|65–69|0.705|0.66|0.746
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|70–74|0.667|0.616|0.714
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|75–79|0.626|0.565|0.684
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|80–84|0.539|0.466|0.611
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|85+|0.39|0.309|0.479
Relative|Rectosigmoid junction cancer|2015–2019|Males|4|All ages combined|0.65|0.63|0.67
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|30–34|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|35–39|||
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|40–44|0.704|0.56|0.81
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|45–49|0.637|0.535|0.722
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|50–54|0.7|0.63|0.76
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|55–59|0.675|0.612|0.73
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|60–64|0.688|0.638|0.734
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|65–69|0.689|0.642|0.732
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|70–74|0.652|0.599|0.702
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|75–79|0.611|0.547|0.672
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|80–84|0.503|0.427|0.58
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|85+|0.376|0.286|0.476
Relative|Rectosigmoid junction cancer|2015–2019|Males|5|All ages combined|0.629|0.609|0.65
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|30–34|0.959|0.745|0.994
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|35–39|0.888|0.728|0.956
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|40–44|0.931|0.826|0.973
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|45–49|0.896|0.824|0.94
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|50–54|0.907|0.851|0.943
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|55–59|0.878|0.821|0.918
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|60–64|0.892|0.843|0.926
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|65–69|0.898|0.853|0.929
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|70–74|0.842|0.792|0.881
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|75–79|0.72|0.657|0.773
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|80–84|0.604|0.538|0.663
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|85+|0.436|0.379|0.492
Observed|Rectosigmoid junction cancer|2015–2019|Females|1|All ages combined|0.776|0.757|0.793
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|30–34|0.917|0.706|0.979
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|35–39|0.848|0.667|0.935
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|40–44|0.848|0.728|0.918
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|45–49|0.821|0.74|0.88
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|50–54|0.851|0.786|0.898
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|55–59|0.794|0.727|0.846
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|60–64|0.855|0.802|0.896
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|65–69|0.796|0.741|0.84
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|70–74|0.775|0.719|0.821
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|75–79|0.64|0.575|0.698
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|80–84|0.52|0.455|0.581
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|85+|0.342|0.289|0.395
Observed|Rectosigmoid junction cancer|2015–2019|Females|2|All ages combined|0.698|0.678|0.717
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|30–34|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|35–39|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|40–44|0.787|0.662|0.87
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|45–49|0.764|0.677|0.831
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|50–54|0.802|0.732|0.856
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|55–59|0.757|0.688|0.813
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|60–64|0.82|0.763|0.865
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|65–69|0.743|0.685|0.792
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|70–74|0.699|0.639|0.75
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|75–79|0.596|0.532|0.655
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|80–84|0.481|0.417|0.542
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|85+|0.257|0.21|0.306
Observed|Rectosigmoid junction cancer|2015–2019|Females|3|All ages combined|0.643|0.623|0.663
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|30–34|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|35–39|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|40–44|0.759|0.633|0.847
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|45–49|0.731|0.642|0.801
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|50–54|0.77|0.697|0.828
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|55–59|0.723|0.652|0.781
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|60–64|0.79|0.73|0.838
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|65–69|0.706|0.647|0.758
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|70–74|0.644|0.583|0.698
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|75–79|0.549|0.485|0.609
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|80–84|0.444|0.38|0.505
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|85+|0.21|0.167|0.256
Observed|Rectosigmoid junction cancer|2015–2019|Females|4|All ages combined|0.603|0.581|0.623
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|30–34|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|35–39|||
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|40–44|0.759|0.633|0.847
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|45–49|0.714|0.624|0.786
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|50–54|0.763|0.689|0.822
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|55–59|0.703|0.632|0.763
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|60–64|0.757|0.695|0.807
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|65–69|0.687|0.627|0.74
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|70–74|0.607|0.545|0.662
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|75–79|0.488|0.425|0.548
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|80–84|0.422|0.359|0.484
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|85+|0.172|0.133|0.216
Observed|Rectosigmoid junction cancer|2015–2019|Females|5|All ages combined|0.572|0.551|0.593
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|30–34|0.96|0.745|0.995
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|35–39|0.888|0.729|0.957
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|40–44|0.932|0.827|0.974
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|45–49|0.897|0.826|0.941
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|50–54|0.909|0.853|0.945
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|55–59|0.881|0.823|0.921
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|60–64|0.896|0.847|0.93
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|65–69|0.904|0.859|0.936
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|70–74|0.852|0.801|0.892
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|75–79|0.736|0.671|0.79
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|80–84|0.63|0.561|0.692
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|85+|0.491|0.427|0.554
Relative|Rectosigmoid junction cancer|2015–2019|Females|1|All ages combined|0.796|0.777|0.814
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|30–34|0.918|0.707|0.979
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|35–39|0.849|0.668|0.936
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|40–44|0.85|0.73|0.92
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|45–49|0.824|0.742|0.882
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|50–54|0.855|0.79|0.902
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|55–59|0.799|0.732|0.852
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|60–64|0.864|0.81|0.904
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|65–69|0.808|0.752|0.853
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|70–74|0.795|0.738|0.842
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|75–79|0.671|0.603|0.731
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|80–84|0.569|0.498|0.636
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|85+|0.433|0.366|0.5
Relative|Rectosigmoid junction cancer|2015–2019|Females|2|All ages combined|0.732|0.711|0.752
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|30–34|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|35–39|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|40–44|0.789|0.664|0.873
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|45–49|0.768|0.681|0.835
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|50–54|0.807|0.737|0.861
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|55–59|0.765|0.695|0.821
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|60–64|0.833|0.775|0.878
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|65–69|0.761|0.701|0.811
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|70–74|0.728|0.666|0.782
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|75–79|0.643|0.573|0.706
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|80–84|0.556|0.482|0.627
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|85+|0.369|0.302|0.44
Relative|Rectosigmoid junction cancer|2015–2019|Females|3|All ages combined|0.689|0.667|0.711
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|30–34|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|35–39|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|40–44|0.762|0.636|0.851
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|45–49|0.736|0.646|0.806
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|50–54|0.778|0.704|0.836
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|55–59|0.733|0.661|0.792
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|60–64|0.807|0.746|0.856
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|65–69|0.73|0.668|0.783
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|70–74|0.682|0.618|0.74
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|75–79|0.611|0.54|0.677
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|80–84|0.547|0.469|0.623
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|85+|0.347|0.276|0.424
Relative|Rectosigmoid junction cancer|2015–2019|Females|4|All ages combined|0.66|0.637|0.682
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|30–34|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|35–39|||
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|40–44|0.763|0.637|0.852
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|45–49|0.72|0.629|0.793
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|50–54|0.773|0.698|0.832
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|55–59|0.716|0.643|0.777
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|60–64|0.778|0.715|0.831
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|65–69|0.718|0.655|0.773
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|70–74|0.656|0.589|0.716
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|75–79|0.564|0.491|0.633
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|80–84|0.56|0.476|0.641
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|85+|0.332|0.256|0.417
Relative|Rectosigmoid junction cancer|2015–2019|Females|5|All ages combined|0.641|0.617|0.664
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|30–34|0.931|0.827|0.974
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|35–39|0.872|0.769|0.931
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|40–44|0.902|0.83|0.944
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|45–49|0.899|0.853|0.931
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|50–54|0.893|0.856|0.921
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|55–59|0.88|0.846|0.907
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|60–64|0.896|0.869|0.917
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|65–69|0.858|0.831|0.881
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|70–74|0.829|0.799|0.854
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|75–79|0.753|0.716|0.786
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|80–84|0.644|0.602|0.683
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|85+|0.419|0.378|0.459
Observed|Rectosigmoid junction cancer|2015–2019|Persons|1|All ages combined|0.786|0.774|0.797
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|30–34|0.896|0.782|0.952
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|35–39|0.794|0.669|0.876
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|40–44|0.83|0.747|0.888
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|45–49|0.806|0.748|0.851
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|50–54|0.818|0.775|0.855
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|55–59|0.793|0.752|0.828
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|60–64|0.827|0.795|0.854
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|65–69|0.781|0.75|0.809
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|70–74|0.746|0.713|0.776
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|75–79|0.66|0.62|0.696
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|80–84|0.533|0.49|0.573
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|85+|0.325|0.288|0.363
Observed|Rectosigmoid junction cancer|2015–2019|Persons|2|All ages combined|0.7|0.687|0.712
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|30–34|0.854|0.728|0.924
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|35–39|0.774|0.644|0.861
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|40–44|0.78|0.692|0.846
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|45–49|0.739|0.677|0.791
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|50–54|0.767|0.72|0.808
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|55–59|0.742|0.698|0.78
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|60–64|0.771|0.736|0.802
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|65–69|0.73|0.697|0.76
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|70–74|0.672|0.636|0.705
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|75–79|0.593|0.553|0.631
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|80–84|0.469|0.427|0.51
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|85+|0.252|0.218|0.287
Observed|Rectosigmoid junction cancer|2015–2019|Persons|3|All ages combined|0.638|0.624|0.651
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|30–34|0.81|0.674|0.894
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|35–39|0.733|0.597|0.829
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|40–44|0.74|0.65|0.81
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|45–49|0.689|0.624|0.745
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|50–54|0.735|0.687|0.778
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|55–59|0.7|0.655|0.74
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|60–64|0.726|0.689|0.759
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|65–69|0.681|0.647|0.713
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|70–74|0.621|0.584|0.655
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|75–79|0.539|0.5|0.578
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|80–84|0.421|0.38|0.462
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|85+|0.211|0.18|0.244
Observed|Rectosigmoid junction cancer|2015–2019|Persons|4|All ages combined|0.591|0.578|0.605
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|00–04|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|05–09|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|10–14|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|15–19|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|20–24|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|25–29|||
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|30–34|0.756|0.606|0.855
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|35–39|0.686|0.543|0.792
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|40–44|0.731|0.641|0.803
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|45–49|0.674|0.609|0.731
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|50–54|0.719|0.67|0.762
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|55–59|0.675|0.629|0.716
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|60–64|0.692|0.655|0.726
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|65–69|0.658|0.623|0.69
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|70–74|0.587|0.551|0.622
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|75–79|0.491|0.451|0.529
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|80–84|0.375|0.335|0.415
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|85+|0.171|0.142|0.202
Observed|Rectosigmoid junction cancer|2015–2019|Persons|5|All ages combined|0.558|0.544|0.571
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|30–34|0.932|0.827|0.974
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|35–39|0.873|0.77|0.932
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|40–44|0.903|0.831|0.946
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|45–49|0.9|0.854|0.933
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|50–54|0.896|0.859|0.924
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|55–59|0.884|0.85|0.911
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|60–64|0.902|0.875|0.924
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|65–69|0.867|0.84|0.891
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|70–74|0.843|0.812|0.869
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|75–79|0.775|0.737|0.809
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|80–84|0.679|0.634|0.719
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|85+|0.477|0.43|0.523
Relative|Rectosigmoid junction cancer|2015–2019|Persons|1|All ages combined|0.808|0.796|0.819
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|30–34|0.897|0.783|0.953
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|35–39|0.795|0.67|0.878
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|40–44|0.832|0.749|0.89
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|45–49|0.809|0.751|0.854
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|50–54|0.823|0.779|0.86
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|55–59|0.8|0.759|0.835
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|60–64|0.839|0.807|0.867
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|65–69|0.798|0.766|0.827
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|70–74|0.773|0.739|0.805
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|75–79|0.702|0.66|0.741
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|80–84|0.596|0.548|0.641
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|85+|0.422|0.373|0.471
Relative|Rectosigmoid junction cancer|2015–2019|Persons|2|All ages combined|0.736|0.723|0.749
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|30–34|0.856|0.73|0.926
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|35–39|0.776|0.646|0.863
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|40–44|0.783|0.695|0.849
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|45–49|0.744|0.681|0.796
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|50–54|0.775|0.727|0.815
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|55–59|0.752|0.708|0.791
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|60–64|0.788|0.753|0.82
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|65–69|0.755|0.72|0.786
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|70–74|0.711|0.673|0.746
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|75–79|0.655|0.611|0.697
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|80–84|0.561|0.511|0.61
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|85+|0.376|0.326|0.428
Relative|Rectosigmoid junction cancer|2015–2019|Persons|3|All ages combined|0.688|0.674|0.702
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|30–34|0.812|0.676|0.896
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|35–39|0.735|0.599|0.832
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|40–44|0.744|0.654|0.815
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|45–49|0.695|0.63|0.751
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|50–54|0.745|0.696|0.788
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|55–59|0.714|0.668|0.755
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|60–64|0.749|0.711|0.783
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|65–69|0.714|0.678|0.747
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|70–74|0.673|0.633|0.71
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|75–79|0.621|0.575|0.665
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|80–84|0.544|0.491|0.597
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|85+|0.367|0.313|0.425
Relative|Rectosigmoid junction cancer|2015–2019|Persons|4|All ages combined|0.654|0.639|0.669
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|00–04|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|05–09|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|10–14|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|15–19|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|20–24|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|25–29|||
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|30–34|0.759|0.608|0.859
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|35–39|0.689|0.546|0.796
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|40–44|0.737|0.645|0.808
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|45–49|0.682|0.616|0.739
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|50–54|0.731|0.681|0.775
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|55–59|0.692|0.646|0.734
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|60–64|0.721|0.682|0.756
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|65–69|0.699|0.662|0.734
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|70–74|0.653|0.612|0.692
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|75–79|0.592|0.544|0.638
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|80–84|0.529|0.472|0.585
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|85+|0.352|0.293|0.416
Relative|Rectosigmoid junction cancer|2015–2019|Persons|5|All ages combined|0.635|0.619|0.65
Observed|Renal pelvis cancer|2015–2019|Males|1|00–04|||
Observed|Renal pelvis cancer|2015–2019|Males|1|05–09|||
Observed|Renal pelvis cancer|2015–2019|Males|1|10–14|||
Observed|Renal pelvis cancer|2015–2019|Males|1|15–19|||
Observed|Renal pelvis cancer|2015–2019|Males|1|20–24|||
Observed|Renal pelvis cancer|2015–2019|Males|1|25–29|||
Observed|Renal pelvis cancer|2015–2019|Males|1|30–34|||
Observed|Renal pelvis cancer|2015–2019|Males|1|35–39|||
Observed|Renal pelvis cancer|2015–2019|Males|1|40–44|||
Observed|Renal pelvis cancer|2015–2019|Males|1|45–49|||
Observed|Renal pelvis cancer|2015–2019|Males|1|50–54|0.711|0.489|0.85
Observed|Renal pelvis cancer|2015–2019|Males|1|55–59|0.775|0.638|0.865
Observed|Renal pelvis cancer|2015–2019|Males|1|60–64|0.798|0.677|0.877
Observed|Renal pelvis cancer|2015–2019|Males|1|65–69|0.738|0.651|0.807
Observed|Renal pelvis cancer|2015–2019|Males|1|70–74|0.694|0.614|0.761
Observed|Renal pelvis cancer|2015–2019|Males|1|75–79|0.623|0.539|0.697
Observed|Renal pelvis cancer|2015–2019|Males|1|80–84|0.654|0.571|0.725
Observed|Renal pelvis cancer|2015–2019|Males|1|85+|0.462|0.378|0.543
Observed|Renal pelvis cancer|2015–2019|Males|1|All ages combined|0.66|0.628|0.691
Observed|Renal pelvis cancer|2015–2019|Males|2|00–04|||
Observed|Renal pelvis cancer|2015–2019|Males|2|05–09|||
Observed|Renal pelvis cancer|2015–2019|Males|2|10–14|||
Observed|Renal pelvis cancer|2015–2019|Males|2|15–19|||
Observed|Renal pelvis cancer|2015–2019|Males|2|20–24|||
Observed|Renal pelvis cancer|2015–2019|Males|2|25–29|||
Observed|Renal pelvis cancer|2015–2019|Males|2|30–34|||
Observed|Renal pelvis cancer|2015–2019|Males|2|35–39|||
Observed|Renal pelvis cancer|2015–2019|Males|2|40–44|||
Observed|Renal pelvis cancer|2015–2019|Males|2|45–49|||
Observed|Renal pelvis cancer|2015–2019|Males|2|50–54|||
Observed|Renal pelvis cancer|2015–2019|Males|2|55–59|0.664|0.522|0.773
Observed|Renal pelvis cancer|2015–2019|Males|2|60–64|0.689|0.561|0.787
Observed|Renal pelvis cancer|2015–2019|Males|2|65–69|0.613|0.52|0.693
Observed|Renal pelvis cancer|2015–2019|Males|2|70–74|0.588|0.504|0.662
Observed|Renal pelvis cancer|2015–2019|Males|2|75–79|0.496|0.41|0.577
Observed|Renal pelvis cancer|2015–2019|Males|2|80–84|0.461|0.378|0.541
Observed|Renal pelvis cancer|2015–2019|Males|2|85+|0.278|0.208|0.351
Observed|Renal pelvis cancer|2015–2019|Males|2|All ages combined|0.519|0.486|0.552
Observed|Renal pelvis cancer|2015–2019|Males|3|00–04|||
Observed|Renal pelvis cancer|2015–2019|Males|3|05–09|||
Observed|Renal pelvis cancer|2015–2019|Males|3|10–14|||
Observed|Renal pelvis cancer|2015–2019|Males|3|15–19|||
Observed|Renal pelvis cancer|2015–2019|Males|3|20–24|||
Observed|Renal pelvis cancer|2015–2019|Males|3|25–29|||
Observed|Renal pelvis cancer|2015–2019|Males|3|30–34|||
Observed|Renal pelvis cancer|2015–2019|Males|3|35–39|||
Observed|Renal pelvis cancer|2015–2019|Males|3|40–44|||
Observed|Renal pelvis cancer|2015–2019|Males|3|45–49|||
Observed|Renal pelvis cancer|2015–2019|Males|3|50–54|||
Observed|Renal pelvis cancer|2015–2019|Males|3|55–59|0.646|0.503|0.757
Observed|Renal pelvis cancer|2015–2019|Males|3|60–64|0.605|0.473|0.713
Observed|Renal pelvis cancer|2015–2019|Males|3|65–69|0.508|0.415|0.593
Observed|Renal pelvis cancer|2015–2019|Males|3|70–74|0.529|0.445|0.606
Observed|Renal pelvis cancer|2015–2019|Males|3|75–79|0.4|0.318|0.481
Observed|Renal pelvis cancer|2015–2019|Males|3|80–84|0.392|0.311|0.472
Observed|Renal pelvis cancer|2015–2019|Males|3|85+|0.178|0.121|0.244
Observed|Renal pelvis cancer|2015–2019|Males|3|All ages combined|0.443|0.409|0.476
Observed|Renal pelvis cancer|2015–2019|Males|4|00–04|||
Observed|Renal pelvis cancer|2015–2019|Males|4|05–09|||
Observed|Renal pelvis cancer|2015–2019|Males|4|10–14|||
Observed|Renal pelvis cancer|2015–2019|Males|4|15–19|||
Observed|Renal pelvis cancer|2015–2019|Males|4|20–24|||
Observed|Renal pelvis cancer|2015–2019|Males|4|25–29|||
Observed|Renal pelvis cancer|2015–2019|Males|4|30–34|||
Observed|Renal pelvis cancer|2015–2019|Males|4|35–39|||
Observed|Renal pelvis cancer|2015–2019|Males|4|40–44|||
Observed|Renal pelvis cancer|2015–2019|Males|4|45–49|||
Observed|Renal pelvis cancer|2015–2019|Males|4|50–54|||
Observed|Renal pelvis cancer|2015–2019|Males|4|55–59|0.593|0.451|0.71
Observed|Renal pelvis cancer|2015–2019|Males|4|60–64|0.575|0.444|0.685
Observed|Renal pelvis cancer|2015–2019|Males|4|65–69|0.472|0.38|0.559
Observed|Renal pelvis cancer|2015–2019|Males|4|70–74|0.451|0.368|0.531
Observed|Renal pelvis cancer|2015–2019|Males|4|75–79|0.376|0.295|0.457
Observed|Renal pelvis cancer|2015–2019|Males|4|80–84|0.281|0.206|0.36
Observed|Renal pelvis cancer|2015–2019|Males|4|85+|0.098|0.056|0.153
Observed|Renal pelvis cancer|2015–2019|Males|4|All ages combined|0.383|0.351|0.416
Observed|Renal pelvis cancer|2015–2019|Males|5|00–04|||
Observed|Renal pelvis cancer|2015–2019|Males|5|05–09|||
Observed|Renal pelvis cancer|2015–2019|Males|5|10–14|||
Observed|Renal pelvis cancer|2015–2019|Males|5|15–19|||
Observed|Renal pelvis cancer|2015–2019|Males|5|20–24|||
Observed|Renal pelvis cancer|2015–2019|Males|5|25–29|||
Observed|Renal pelvis cancer|2015–2019|Males|5|30–34|||
Observed|Renal pelvis cancer|2015–2019|Males|5|35–39|||
Observed|Renal pelvis cancer|2015–2019|Males|5|40–44|||
Observed|Renal pelvis cancer|2015–2019|Males|5|45–49|||
Observed|Renal pelvis cancer|2015–2019|Males|5|50–54|||
Observed|Renal pelvis cancer|2015–2019|Males|5|55–59|0.574|0.433|0.693
Observed|Renal pelvis cancer|2015–2019|Males|5|60–64|0.522|0.394|0.634
Observed|Renal pelvis cancer|2015–2019|Males|5|65–69|0.443|0.352|0.531
Observed|Renal pelvis cancer|2015–2019|Males|5|70–74|0.38|0.299|0.461
Observed|Renal pelvis cancer|2015–2019|Males|5|75–79|0.349|0.269|0.431
Observed|Renal pelvis cancer|2015–2019|Males|5|80–84|0.248|0.177|0.326
Observed|Renal pelvis cancer|2015–2019|Males|5|85+|0.074|0.038|0.126
Observed|Renal pelvis cancer|2015–2019|Males|5|All ages combined|0.349|0.317|0.381
Relative|Renal pelvis cancer|2015–2019|Males|1|00–04|||
Relative|Renal pelvis cancer|2015–2019|Males|1|05–09|||
Relative|Renal pelvis cancer|2015–2019|Males|1|10–14|||
Relative|Renal pelvis cancer|2015–2019|Males|1|15–19|||
Relative|Renal pelvis cancer|2015–2019|Males|1|20–24|||
Relative|Renal pelvis cancer|2015–2019|Males|1|25–29|||
Relative|Renal pelvis cancer|2015–2019|Males|1|30–34|||
Relative|Renal pelvis cancer|2015–2019|Males|1|35–39|||
Relative|Renal pelvis cancer|2015–2019|Males|1|40–44|||
Relative|Renal pelvis cancer|2015–2019|Males|1|45–49|||
Relative|Renal pelvis cancer|2015–2019|Males|1|50–54|0.713|0.49|0.853
Relative|Renal pelvis cancer|2015–2019|Males|1|55–59|0.779|0.642|0.87
Relative|Renal pelvis cancer|2015–2019|Males|1|60–64|0.804|0.683|0.884
Relative|Renal pelvis cancer|2015–2019|Males|1|65–69|0.747|0.659|0.817
Relative|Renal pelvis cancer|2015–2019|Males|1|70–74|0.708|0.626|0.776
Relative|Renal pelvis cancer|2015–2019|Males|1|75–79|0.644|0.556|0.72
Relative|Renal pelvis cancer|2015–2019|Males|1|80–84|0.695|0.607|0.771
Relative|Renal pelvis cancer|2015–2019|Males|1|85+|0.53|0.433|0.622
Relative|Renal pelvis cancer|2015–2019|Males|1|All ages combined|0.688|0.654|0.72
Relative|Renal pelvis cancer|2015–2019|Males|2|00–04|||
Relative|Renal pelvis cancer|2015–2019|Males|2|05–09|||
Relative|Renal pelvis cancer|2015–2019|Males|2|10–14|||
Relative|Renal pelvis cancer|2015–2019|Males|2|15–19|||
Relative|Renal pelvis cancer|2015–2019|Males|2|20–24|||
Relative|Renal pelvis cancer|2015–2019|Males|2|25–29|||
Relative|Renal pelvis cancer|2015–2019|Males|2|30–34|||
Relative|Renal pelvis cancer|2015–2019|Males|2|35–39|||
Relative|Renal pelvis cancer|2015–2019|Males|2|40–44|||
Relative|Renal pelvis cancer|2015–2019|Males|2|45–49|||
Relative|Renal pelvis cancer|2015–2019|Males|2|50–54|||
Relative|Renal pelvis cancer|2015–2019|Males|2|55–59|0.672|0.528|0.782
Relative|Renal pelvis cancer|2015–2019|Males|2|60–64|0.701|0.571|0.8
Relative|Renal pelvis cancer|2015–2019|Males|2|65–69|0.628|0.533|0.711
Relative|Renal pelvis cancer|2015–2019|Males|2|70–74|0.612|0.525|0.69
Relative|Renal pelvis cancer|2015–2019|Males|2|75–79|0.532|0.439|0.618
Relative|Renal pelvis cancer|2015–2019|Males|2|80–84|0.525|0.43|0.616
Relative|Renal pelvis cancer|2015–2019|Males|2|85+|0.367|0.275|0.465
Relative|Renal pelvis cancer|2015–2019|Males|2|All ages combined|0.563|0.527|0.599
Relative|Renal pelvis cancer|2015–2019|Males|3|00–04|||
Relative|Renal pelvis cancer|2015–2019|Males|3|05–09|||
Relative|Renal pelvis cancer|2015–2019|Males|3|10–14|||
Relative|Renal pelvis cancer|2015–2019|Males|3|15–19|||
Relative|Renal pelvis cancer|2015–2019|Males|3|20–24|||
Relative|Renal pelvis cancer|2015–2019|Males|3|25–29|||
Relative|Renal pelvis cancer|2015–2019|Males|3|30–34|||
Relative|Renal pelvis cancer|2015–2019|Males|3|35–39|||
Relative|Renal pelvis cancer|2015–2019|Males|3|40–44|||
Relative|Renal pelvis cancer|2015–2019|Males|3|45–49|||
Relative|Renal pelvis cancer|2015–2019|Males|3|50–54|||
Relative|Renal pelvis cancer|2015–2019|Males|3|55–59|0.657|0.512|0.77
Relative|Renal pelvis cancer|2015–2019|Males|3|60–64|0.621|0.486|0.732
Relative|Renal pelvis cancer|2015–2019|Males|3|65–69|0.528|0.432|0.617
Relative|Renal pelvis cancer|2015–2019|Males|3|70–74|0.564|0.475|0.647
Relative|Renal pelvis cancer|2015–2019|Males|3|75–79|0.447|0.355|0.537
Relative|Renal pelvis cancer|2015–2019|Males|3|80–84|0.483|0.382|0.581
Relative|Renal pelvis cancer|2015–2019|Males|3|85+|0.276|0.188|0.379
Relative|Renal pelvis cancer|2015–2019|Males|3|All ages combined|0.5|0.462|0.537
Relative|Renal pelvis cancer|2015–2019|Males|4|00–04|||
Relative|Renal pelvis cancer|2015–2019|Males|4|05–09|||
Relative|Renal pelvis cancer|2015–2019|Males|4|10–14|||
Relative|Renal pelvis cancer|2015–2019|Males|4|15–19|||
Relative|Renal pelvis cancer|2015–2019|Males|4|20–24|||
Relative|Renal pelvis cancer|2015–2019|Males|4|25–29|||
Relative|Renal pelvis cancer|2015–2019|Males|4|30–34|||
Relative|Renal pelvis cancer|2015–2019|Males|4|35–39|||
Relative|Renal pelvis cancer|2015–2019|Males|4|40–44|||
Relative|Renal pelvis cancer|2015–2019|Males|4|45–49|||
Relative|Renal pelvis cancer|2015–2019|Males|4|50–54|||
Relative|Renal pelvis cancer|2015–2019|Males|4|55–59|0.607|0.462|0.727
Relative|Renal pelvis cancer|2015–2019|Males|4|60–64|0.596|0.461|0.711
Relative|Renal pelvis cancer|2015–2019|Males|4|65–69|0.5|0.402|0.591
Relative|Renal pelvis cancer|2015–2019|Males|4|70–74|0.494|0.403|0.582
Relative|Renal pelvis cancer|2015–2019|Males|4|75–79|0.44|0.345|0.535
Relative|Renal pelvis cancer|2015–2019|Males|4|80–84|0.378|0.278|0.484
Relative|Renal pelvis cancer|2015–2019|Males|4|85+|0.18|0.104|0.282
Relative|Renal pelvis cancer|2015–2019|Males|4|All ages combined|0.45|0.411|0.488
Relative|Renal pelvis cancer|2015–2019|Males|5|00–04|||
Relative|Renal pelvis cancer|2015–2019|Males|5|05–09|||
Relative|Renal pelvis cancer|2015–2019|Males|5|10–14|||
Relative|Renal pelvis cancer|2015–2019|Males|5|15–19|||
Relative|Renal pelvis cancer|2015–2019|Males|5|20–24|||
Relative|Renal pelvis cancer|2015–2019|Males|5|25–29|||
Relative|Renal pelvis cancer|2015–2019|Males|5|30–34|||
Relative|Renal pelvis cancer|2015–2019|Males|5|35–39|||
Relative|Renal pelvis cancer|2015–2019|Males|5|40–44|||
Relative|Renal pelvis cancer|2015–2019|Males|5|45–49|||
Relative|Renal pelvis cancer|2015–2019|Males|5|50–54|||
Relative|Renal pelvis cancer|2015–2019|Males|5|55–59|0.593|0.447|0.715
Relative|Renal pelvis cancer|2015–2019|Males|5|60–64|0.547|0.414|0.665
Relative|Renal pelvis cancer|2015–2019|Males|5|65–69|0.477|0.379|0.571
Relative|Renal pelvis cancer|2015–2019|Males|5|70–74|0.429|0.338|0.52
Relative|Renal pelvis cancer|2015–2019|Males|5|75–79|0.431|0.332|0.532
Relative|Renal pelvis cancer|2015–2019|Males|5|80–84|0.368|0.263|0.482
Relative|Renal pelvis cancer|2015–2019|Males|5|85+|0.165|0.085|0.279
Relative|Renal pelvis cancer|2015–2019|Males|5|All ages combined|0.425|0.386|0.464
Observed|Renal pelvis cancer|2015–2019|Females|1|00–04|||
Observed|Renal pelvis cancer|2015–2019|Females|1|05–09|||
Observed|Renal pelvis cancer|2015–2019|Females|1|10–14|||
Observed|Renal pelvis cancer|2015–2019|Females|1|15–19|||
Observed|Renal pelvis cancer|2015–2019|Females|1|20–24|||
Observed|Renal pelvis cancer|2015–2019|Females|1|25–29|||
Observed|Renal pelvis cancer|2015–2019|Females|1|30–34|||
Observed|Renal pelvis cancer|2015–2019|Females|1|35–39|||
Observed|Renal pelvis cancer|2015–2019|Females|1|40–44|||
Observed|Renal pelvis cancer|2015–2019|Females|1|45–49|||
Observed|Renal pelvis cancer|2015–2019|Females|1|50–54|||
Observed|Renal pelvis cancer|2015–2019|Females|1|55–59|0.766|0.572|0.881
Observed|Renal pelvis cancer|2015–2019|Females|1|60–64|0.821|0.624|0.921
Observed|Renal pelvis cancer|2015–2019|Females|1|65–69|0.79|0.666|0.872
Observed|Renal pelvis cancer|2015–2019|Females|1|70–74|0.678|0.583|0.757
Observed|Renal pelvis cancer|2015–2019|Females|1|75–79|0.69|0.606|0.76
Observed|Renal pelvis cancer|2015–2019|Females|1|80–84|0.615|0.529|0.689
Observed|Renal pelvis cancer|2015–2019|Females|1|85+|0.5|0.412|0.582
Observed|Renal pelvis cancer|2015–2019|Females|1|All ages combined|0.657|0.62|0.692
Observed|Renal pelvis cancer|2015–2019|Females|2|00–04|||
Observed|Renal pelvis cancer|2015–2019|Females|2|05–09|||
Observed|Renal pelvis cancer|2015–2019|Females|2|10–14|||
Observed|Renal pelvis cancer|2015–2019|Females|2|15–19|||
Observed|Renal pelvis cancer|2015–2019|Females|2|20–24|||
Observed|Renal pelvis cancer|2015–2019|Females|2|25–29|||
Observed|Renal pelvis cancer|2015–2019|Females|2|30–34|||
Observed|Renal pelvis cancer|2015–2019|Females|2|35–39|||
Observed|Renal pelvis cancer|2015–2019|Females|2|40–44|||
Observed|Renal pelvis cancer|2015–2019|Females|2|45–49|||
Observed|Renal pelvis cancer|2015–2019|Females|2|50–54|||
Observed|Renal pelvis cancer|2015–2019|Females|2|55–59|||
Observed|Renal pelvis cancer|2015–2019|Females|2|60–64|0.634|0.439|0.777
Observed|Renal pelvis cancer|2015–2019|Females|2|65–69|0.606|0.472|0.716
Observed|Renal pelvis cancer|2015–2019|Females|2|70–74|0.497|0.401|0.586
Observed|Renal pelvis cancer|2015–2019|Females|2|75–79|0.48|0.394|0.561
Observed|Renal pelvis cancer|2015–2019|Females|2|80–84|0.429|0.346|0.509
Observed|Renal pelvis cancer|2015–2019|Females|2|85+|0.347|0.267|0.428
Observed|Renal pelvis cancer|2015–2019|Females|2|All ages combined|0.479|0.44|0.516
Observed|Renal pelvis cancer|2015–2019|Females|3|00–04|||
Observed|Renal pelvis cancer|2015–2019|Females|3|05–09|||
Observed|Renal pelvis cancer|2015–2019|Females|3|10–14|||
Observed|Renal pelvis cancer|2015–2019|Females|3|15–19|||
Observed|Renal pelvis cancer|2015–2019|Females|3|20–24|||
Observed|Renal pelvis cancer|2015–2019|Females|3|25–29|||
Observed|Renal pelvis cancer|2015–2019|Females|3|30–34|||
Observed|Renal pelvis cancer|2015–2019|Females|3|35–39|||
Observed|Renal pelvis cancer|2015–2019|Females|3|40–44|||
Observed|Renal pelvis cancer|2015–2019|Females|3|45–49|||
Observed|Renal pelvis cancer|2015–2019|Females|3|50–54|||
Observed|Renal pelvis cancer|2015–2019|Females|3|55–59|||
Observed|Renal pelvis cancer|2015–2019|Females|3|60–64|0.556|0.371|0.707
Observed|Renal pelvis cancer|2015–2019|Females|3|65–69|0.516|0.383|0.634
Observed|Renal pelvis cancer|2015–2019|Females|3|70–74|0.397|0.307|0.485
Observed|Renal pelvis cancer|2015–2019|Females|3|75–79|0.419|0.335|0.5
Observed|Renal pelvis cancer|2015–2019|Females|3|80–84|0.321|0.246|0.399
Observed|Renal pelvis cancer|2015–2019|Females|3|85+|0.258|0.186|0.336
Observed|Renal pelvis cancer|2015–2019|Females|3|All ages combined|0.395|0.357|0.432
Observed|Renal pelvis cancer|2015–2019|Females|4|00–04|||
Observed|Renal pelvis cancer|2015–2019|Females|4|05–09|||
Observed|Renal pelvis cancer|2015–2019|Females|4|10–14|||
Observed|Renal pelvis cancer|2015–2019|Females|4|15–19|||
Observed|Renal pelvis cancer|2015–2019|Females|4|20–24|||
Observed|Renal pelvis cancer|2015–2019|Females|4|25–29|||
Observed|Renal pelvis cancer|2015–2019|Females|4|30–34|||
Observed|Renal pelvis cancer|2015–2019|Females|4|35–39|||
Observed|Renal pelvis cancer|2015–2019|Females|4|40–44|||
Observed|Renal pelvis cancer|2015–2019|Females|4|45–49|||
Observed|Renal pelvis cancer|2015–2019|Females|4|50–54|||
Observed|Renal pelvis cancer|2015–2019|Females|4|55–59|||
Observed|Renal pelvis cancer|2015–2019|Females|4|60–64|0.514|0.337|0.665
Observed|Renal pelvis cancer|2015–2019|Females|4|65–69|0.416|0.286|0.54
Observed|Renal pelvis cancer|2015–2019|Females|4|70–74|0.358|0.272|0.445
Observed|Renal pelvis cancer|2015–2019|Females|4|75–79|0.395|0.312|0.477
Observed|Renal pelvis cancer|2015–2019|Females|4|80–84|0.251|0.183|0.325
Observed|Renal pelvis cancer|2015–2019|Females|4|85+|0.176|0.116|0.247
Observed|Renal pelvis cancer|2015–2019|Females|4|All ages combined|0.343|0.307|0.379
Observed|Renal pelvis cancer|2015–2019|Females|5|00–04|||
Observed|Renal pelvis cancer|2015–2019|Females|5|05–09|||
Observed|Renal pelvis cancer|2015–2019|Females|5|10–14|||
Observed|Renal pelvis cancer|2015–2019|Females|5|15–19|||
Observed|Renal pelvis cancer|2015–2019|Females|5|20–24|||
Observed|Renal pelvis cancer|2015–2019|Females|5|25–29|||
Observed|Renal pelvis cancer|2015–2019|Females|5|30–34|||
Observed|Renal pelvis cancer|2015–2019|Females|5|35–39|||
Observed|Renal pelvis cancer|2015–2019|Females|5|40–44|||
Observed|Renal pelvis cancer|2015–2019|Females|5|45–49|||
Observed|Renal pelvis cancer|2015–2019|Females|5|50–54|||
Observed|Renal pelvis cancer|2015–2019|Females|5|55–59|||
Observed|Renal pelvis cancer|2015–2019|Females|5|60–64|0.514|0.337|0.665
Observed|Renal pelvis cancer|2015–2019|Females|5|65–69|0.365|0.242|0.489
Observed|Renal pelvis cancer|2015–2019|Females|5|70–74|0.327|0.244|0.413
Observed|Renal pelvis cancer|2015–2019|Females|5|75–79|0.349|0.269|0.43
Observed|Renal pelvis cancer|2015–2019|Females|5|80–84|0.207|0.145|0.276
Observed|Renal pelvis cancer|2015–2019|Females|5|85+|0.132|0.08|0.198
Observed|Renal pelvis cancer|2015–2019|Females|5|All ages combined|0.305|0.271|0.341
Relative|Renal pelvis cancer|2015–2019|Females|1|00–04|||
Relative|Renal pelvis cancer|2015–2019|Females|1|05–09|||
Relative|Renal pelvis cancer|2015–2019|Females|1|10–14|||
Relative|Renal pelvis cancer|2015–2019|Females|1|15–19|||
Relative|Renal pelvis cancer|2015–2019|Females|1|20–24|||
Relative|Renal pelvis cancer|2015–2019|Females|1|25–29|||
Relative|Renal pelvis cancer|2015–2019|Females|1|30–34|||
Relative|Renal pelvis cancer|2015–2019|Females|1|35–39|||
Relative|Renal pelvis cancer|2015–2019|Females|1|40–44|||
Relative|Renal pelvis cancer|2015–2019|Females|1|45–49|||
Relative|Renal pelvis cancer|2015–2019|Females|1|50–54|||
Relative|Renal pelvis cancer|2015–2019|Females|1|55–59|0.768|0.573|0.883
Relative|Renal pelvis cancer|2015–2019|Females|1|60–64|0.825|0.626|0.926
Relative|Renal pelvis cancer|2015–2019|Females|1|65–69|0.796|0.671|0.878
Relative|Renal pelvis cancer|2015–2019|Females|1|70–74|0.687|0.59|0.766
Relative|Renal pelvis cancer|2015–2019|Females|1|75–79|0.705|0.619|0.777
Relative|Renal pelvis cancer|2015–2019|Females|1|80–84|0.64|0.551|0.718
Relative|Renal pelvis cancer|2015–2019|Females|1|85+|0.556|0.458|0.647
Relative|Renal pelvis cancer|2015–2019|Females|1|All ages combined|0.681|0.643|0.718
Relative|Renal pelvis cancer|2015–2019|Females|2|00–04|||
Relative|Renal pelvis cancer|2015–2019|Females|2|05–09|||
Relative|Renal pelvis cancer|2015–2019|Females|2|10–14|||
Relative|Renal pelvis cancer|2015–2019|Females|2|15–19|||
Relative|Renal pelvis cancer|2015–2019|Females|2|20–24|||
Relative|Renal pelvis cancer|2015–2019|Females|2|25–29|||
Relative|Renal pelvis cancer|2015–2019|Females|2|30–34|||
Relative|Renal pelvis cancer|2015–2019|Females|2|35–39|||
Relative|Renal pelvis cancer|2015–2019|Females|2|40–44|||
Relative|Renal pelvis cancer|2015–2019|Females|2|45–49|||
Relative|Renal pelvis cancer|2015–2019|Females|2|50–54|||
Relative|Renal pelvis cancer|2015–2019|Females|2|55–59|||
Relative|Renal pelvis cancer|2015–2019|Females|2|60–64|0.641|0.444|0.785
Relative|Renal pelvis cancer|2015–2019|Females|2|65–69|0.615|0.479|0.727
Relative|Renal pelvis cancer|2015–2019|Females|2|70–74|0.51|0.411|0.601
Relative|Renal pelvis cancer|2015–2019|Females|2|75–79|0.502|0.412|0.587
Relative|Renal pelvis cancer|2015–2019|Females|2|80–84|0.469|0.378|0.556
Relative|Renal pelvis cancer|2015–2019|Females|2|85+|0.433|0.333|0.535
Relative|Renal pelvis cancer|2015–2019|Females|2|All ages combined|0.515|0.473|0.555
Relative|Renal pelvis cancer|2015–2019|Females|3|00–04|||
Relative|Renal pelvis cancer|2015–2019|Females|3|05–09|||
Relative|Renal pelvis cancer|2015–2019|Females|3|10–14|||
Relative|Renal pelvis cancer|2015–2019|Females|3|15–19|||
Relative|Renal pelvis cancer|2015–2019|Females|3|20–24|||
Relative|Renal pelvis cancer|2015–2019|Females|3|25–29|||
Relative|Renal pelvis cancer|2015–2019|Females|3|30–34|||
Relative|Renal pelvis cancer|2015–2019|Females|3|35–39|||
Relative|Renal pelvis cancer|2015–2019|Females|3|40–44|||
Relative|Renal pelvis cancer|2015–2019|Females|3|45–49|||
Relative|Renal pelvis cancer|2015–2019|Females|3|50–54|||
Relative|Renal pelvis cancer|2015–2019|Females|3|55–59|||
Relative|Renal pelvis cancer|2015–2019|Females|3|60–64|0.565|0.377|0.718
Relative|Renal pelvis cancer|2015–2019|Females|3|65–69|0.529|0.392|0.65
Relative|Renal pelvis cancer|2015–2019|Females|3|70–74|0.414|0.321|0.507
Relative|Renal pelvis cancer|2015–2019|Females|3|75–79|0.451|0.361|0.539
Relative|Renal pelvis cancer|2015–2019|Females|3|80–84|0.371|0.284|0.461
Relative|Renal pelvis cancer|2015–2019|Females|3|85+|0.368|0.266|0.479
Relative|Renal pelvis cancer|2015–2019|Females|3|All ages combined|0.44|0.398|0.481
Relative|Renal pelvis cancer|2015–2019|Females|4|00–04|||
Relative|Renal pelvis cancer|2015–2019|Females|4|05–09|||
Relative|Renal pelvis cancer|2015–2019|Females|4|10–14|||
Relative|Renal pelvis cancer|2015–2019|Females|4|15–19|||
Relative|Renal pelvis cancer|2015–2019|Females|4|20–24|||
Relative|Renal pelvis cancer|2015–2019|Females|4|25–29|||
Relative|Renal pelvis cancer|2015–2019|Females|4|30–34|||
Relative|Renal pelvis cancer|2015–2019|Females|4|35–39|||
Relative|Renal pelvis cancer|2015–2019|Females|4|40–44|||
Relative|Renal pelvis cancer|2015–2019|Females|4|45–49|||
Relative|Renal pelvis cancer|2015–2019|Females|4|50–54|||
Relative|Renal pelvis cancer|2015–2019|Females|4|55–59|||
Relative|Renal pelvis cancer|2015–2019|Females|4|60–64|0.525|0.344|0.68
Relative|Renal pelvis cancer|2015–2019|Females|4|65–69|0.43|0.296|0.559
Relative|Renal pelvis cancer|2015–2019|Females|4|70–74|0.381|0.289|0.473
Relative|Renal pelvis cancer|2015–2019|Females|4|75–79|0.439|0.347|0.529
Relative|Renal pelvis cancer|2015–2019|Females|4|80–84|0.31|0.226|0.401
Relative|Renal pelvis cancer|2015–2019|Females|4|85+|0.288|0.189|0.404
Relative|Renal pelvis cancer|2015–2019|Females|4|All ages combined|0.397|0.356|0.439
Relative|Renal pelvis cancer|2015–2019|Females|5|00–04|||
Relative|Renal pelvis cancer|2015–2019|Females|5|05–09|||
Relative|Renal pelvis cancer|2015–2019|Females|5|10–14|||
Relative|Renal pelvis cancer|2015–2019|Females|5|15–19|||
Relative|Renal pelvis cancer|2015–2019|Females|5|20–24|||
Relative|Renal pelvis cancer|2015–2019|Females|5|25–29|||
Relative|Renal pelvis cancer|2015–2019|Females|5|30–34|||
Relative|Renal pelvis cancer|2015–2019|Females|5|35–39|||
Relative|Renal pelvis cancer|2015–2019|Females|5|40–44|||
Relative|Renal pelvis cancer|2015–2019|Females|5|45–49|||
Relative|Renal pelvis cancer|2015–2019|Females|5|50–54|||
Relative|Renal pelvis cancer|2015–2019|Females|5|55–59|||
Relative|Renal pelvis cancer|2015–2019|Females|5|60–64|0.529|0.347|0.684
Relative|Renal pelvis cancer|2015–2019|Females|5|65–69|0.382|0.254|0.512
Relative|Renal pelvis cancer|2015–2019|Females|5|70–74|0.354|0.265|0.447
Relative|Renal pelvis cancer|2015–2019|Females|5|75–79|0.402|0.31|0.495
Relative|Renal pelvis cancer|2015–2019|Females|5|80–84|0.276|0.194|0.368
Relative|Renal pelvis cancer|2015–2019|Females|5|85+|0.254|0.153|0.38
Relative|Renal pelvis cancer|2015–2019|Females|5|All ages combined|0.368|0.327|0.411
Observed|Renal pelvis cancer|2015–2019|Persons|1|00–04|||
Observed|Renal pelvis cancer|2015–2019|Persons|1|05–09|||
Observed|Renal pelvis cancer|2015–2019|Persons|1|10–14|||
Observed|Renal pelvis cancer|2015–2019|Persons|1|15–19|||
Observed|Renal pelvis cancer|2015–2019|Persons|1|20–24|||
Observed|Renal pelvis cancer|2015–2019|Persons|1|25–29|||
Observed|Renal pelvis cancer|2015–2019|Persons|1|30–34|||
Observed|Renal pelvis cancer|2015–2019|Persons|1|35–39|||
Observed|Renal pelvis cancer|2015–2019|Persons|1|40–44|||
Observed|Renal pelvis cancer|2015–2019|Persons|1|45–49|0.685|0.47|0.828
Observed|Renal pelvis cancer|2015–2019|Persons|1|50–54|0.73|0.557|0.844
Observed|Renal pelvis cancer|2015–2019|Persons|1|55–59|0.772|0.666|0.848
Observed|Renal pelvis cancer|2015–2019|Persons|1|60–64|0.805|0.708|0.872
Observed|Renal pelvis cancer|2015–2019|Persons|1|65–69|0.755|0.687|0.811
Observed|Renal pelvis cancer|2015–2019|Persons|1|70–74|0.688|0.628|0.74
Observed|Renal pelvis cancer|2015–2019|Persons|1|75–79|0.656|0.597|0.708
Observed|Renal pelvis cancer|2015–2019|Persons|1|80–84|0.635|0.576|0.688
Observed|Renal pelvis cancer|2015–2019|Persons|1|85+|0.481|0.42|0.539
Observed|Renal pelvis cancer|2015–2019|Persons|1|All ages combined|0.659|0.635|0.682
Observed|Renal pelvis cancer|2015–2019|Persons|2|00–04|||
Observed|Renal pelvis cancer|2015–2019|Persons|2|05–09|||
Observed|Renal pelvis cancer|2015–2019|Persons|2|10–14|||
Observed|Renal pelvis cancer|2015–2019|Persons|2|15–19|||
Observed|Renal pelvis cancer|2015–2019|Persons|2|20–24|||
Observed|Renal pelvis cancer|2015–2019|Persons|2|25–29|||
Observed|Renal pelvis cancer|2015–2019|Persons|2|30–34|||
Observed|Renal pelvis cancer|2015–2019|Persons|2|35–39|||
Observed|Renal pelvis cancer|2015–2019|Persons|2|40–44|||
Observed|Renal pelvis cancer|2015–2019|Persons|2|45–49|||
Observed|Renal pelvis cancer|2015–2019|Persons|2|50–54|0.647|0.471|0.777
Observed|Renal pelvis cancer|2015–2019|Persons|2|55–59|0.662|0.55|0.753
Observed|Renal pelvis cancer|2015–2019|Persons|2|60–64|0.671|0.566|0.755
Observed|Renal pelvis cancer|2015–2019|Persons|2|65–69|0.61|0.536|0.677
Observed|Renal pelvis cancer|2015–2019|Persons|2|70–74|0.548|0.485|0.606
Observed|Renal pelvis cancer|2015–2019|Persons|2|75–79|0.487|0.426|0.545
Observed|Renal pelvis cancer|2015–2019|Persons|2|80–84|0.445|0.387|0.502
Observed|Renal pelvis cancer|2015–2019|Persons|2|85+|0.31|0.257|0.365
Observed|Renal pelvis cancer|2015–2019|Persons|2|All ages combined|0.502|0.476|0.526
Observed|Renal pelvis cancer|2015–2019|Persons|3|00–04|||
Observed|Renal pelvis cancer|2015–2019|Persons|3|05–09|||
Observed|Renal pelvis cancer|2015–2019|Persons|3|10–14|||
Observed|Renal pelvis cancer|2015–2019|Persons|3|15–19|||
Observed|Renal pelvis cancer|2015–2019|Persons|3|20–24|||
Observed|Renal pelvis cancer|2015–2019|Persons|3|25–29|||
Observed|Renal pelvis cancer|2015–2019|Persons|3|30–34|||
Observed|Renal pelvis cancer|2015–2019|Persons|3|35–39|||
Observed|Renal pelvis cancer|2015–2019|Persons|3|40–44|||
Observed|Renal pelvis cancer|2015–2019|Persons|3|45–49|||
Observed|Renal pelvis cancer|2015–2019|Persons|3|50–54|0.597|0.424|0.733
Observed|Renal pelvis cancer|2015–2019|Persons|3|55–59|0.638|0.525|0.731
Observed|Renal pelvis cancer|2015–2019|Persons|3|60–64|0.588|0.483|0.679
Observed|Renal pelvis cancer|2015–2019|Persons|3|65–69|0.51|0.435|0.581
Observed|Renal pelvis cancer|2015–2019|Persons|3|70–74|0.47|0.408|0.529
Observed|Renal pelvis cancer|2015–2019|Persons|3|75–79|0.408|0.349|0.466
Observed|Renal pelvis cancer|2015–2019|Persons|3|80–84|0.356|0.3|0.412
Observed|Renal pelvis cancer|2015–2019|Persons|3|85+|0.216|0.169|0.266
Observed|Renal pelvis cancer|2015–2019|Persons|3|All ages combined|0.421|0.397|0.446
Observed|Renal pelvis cancer|2015–2019|Persons|4|00–04|||
Observed|Renal pelvis cancer|2015–2019|Persons|4|05–09|||
Observed|Renal pelvis cancer|2015–2019|Persons|4|10–14|||
Observed|Renal pelvis cancer|2015–2019|Persons|4|15–19|||
Observed|Renal pelvis cancer|2015–2019|Persons|4|20–24|||
Observed|Renal pelvis cancer|2015–2019|Persons|4|25–29|||
Observed|Renal pelvis cancer|2015–2019|Persons|4|30–34|||
Observed|Renal pelvis cancer|2015–2019|Persons|4|35–39|||
Observed|Renal pelvis cancer|2015–2019|Persons|4|40–44|||
Observed|Renal pelvis cancer|2015–2019|Persons|4|45–49|||
Observed|Renal pelvis cancer|2015–2019|Persons|4|50–54|0.551|0.382|0.691
Observed|Renal pelvis cancer|2015–2019|Persons|4|55–59|0.602|0.489|0.698
Observed|Renal pelvis cancer|2015–2019|Persons|4|60–64|0.553|0.449|0.645
Observed|Renal pelvis cancer|2015–2019|Persons|4|65–69|0.455|0.38|0.527
Observed|Renal pelvis cancer|2015–2019|Persons|4|70–74|0.411|0.35|0.47
Observed|Renal pelvis cancer|2015–2019|Persons|4|75–79|0.384|0.326|0.442
Observed|Renal pelvis cancer|2015–2019|Persons|4|80–84|0.267|0.216|0.321
Observed|Renal pelvis cancer|2015–2019|Persons|4|85+|0.135|0.097|0.178
Observed|Renal pelvis cancer|2015–2019|Persons|4|All ages combined|0.366|0.341|0.39
Observed|Renal pelvis cancer|2015–2019|Persons|5|00–04|||
Observed|Renal pelvis cancer|2015–2019|Persons|5|05–09|||
Observed|Renal pelvis cancer|2015–2019|Persons|5|10–14|||
Observed|Renal pelvis cancer|2015–2019|Persons|5|15–19|||
Observed|Renal pelvis cancer|2015–2019|Persons|5|20–24|||
Observed|Renal pelvis cancer|2015–2019|Persons|5|25–29|||
Observed|Renal pelvis cancer|2015–2019|Persons|5|30–34|||
Observed|Renal pelvis cancer|2015–2019|Persons|5|35–39|||
Observed|Renal pelvis cancer|2015–2019|Persons|5|40–44|||
Observed|Renal pelvis cancer|2015–2019|Persons|5|45–49|||
Observed|Renal pelvis cancer|2015–2019|Persons|5|50–54|0.551|0.382|0.691
Observed|Renal pelvis cancer|2015–2019|Persons|5|55–59|0.59|0.476|0.687
Observed|Renal pelvis cancer|2015–2019|Persons|5|60–64|0.519|0.417|0.612
Observed|Renal pelvis cancer|2015–2019|Persons|5|65–69|0.418|0.344|0.49
Observed|Renal pelvis cancer|2015–2019|Persons|5|70–74|0.359|0.3|0.418
Observed|Renal pelvis cancer|2015–2019|Persons|5|75–79|0.347|0.29|0.405
Observed|Renal pelvis cancer|2015–2019|Persons|5|80–84|0.227|0.179|0.278
Observed|Renal pelvis cancer|2015–2019|Persons|5|85+|0.101|0.069|0.142
Observed|Renal pelvis cancer|2015–2019|Persons|5|All ages combined|0.33|0.306|0.354
Relative|Renal pelvis cancer|2015–2019|Persons|1|00–04|||
Relative|Renal pelvis cancer|2015–2019|Persons|1|05–09|||
Relative|Renal pelvis cancer|2015–2019|Persons|1|10–14|||
Relative|Renal pelvis cancer|2015–2019|Persons|1|15–19|||
Relative|Renal pelvis cancer|2015–2019|Persons|1|20–24|||
Relative|Renal pelvis cancer|2015–2019|Persons|1|25–29|||
Relative|Renal pelvis cancer|2015–2019|Persons|1|30–34|||
Relative|Renal pelvis cancer|2015–2019|Persons|1|35–39|||
Relative|Renal pelvis cancer|2015–2019|Persons|1|40–44|||
Relative|Renal pelvis cancer|2015–2019|Persons|1|45–49|0.687|0.471|0.83
Relative|Renal pelvis cancer|2015–2019|Persons|1|50–54|0.732|0.559|0.847
Relative|Renal pelvis cancer|2015–2019|Persons|1|55–59|0.775|0.669|0.852
Relative|Renal pelvis cancer|2015–2019|Persons|1|60–64|0.81|0.713|0.878
Relative|Renal pelvis cancer|2015–2019|Persons|1|65–69|0.763|0.694|0.82
Relative|Renal pelvis cancer|2015–2019|Persons|1|70–74|0.699|0.638|0.752
Relative|Renal pelvis cancer|2015–2019|Persons|1|75–79|0.674|0.614|0.728
Relative|Renal pelvis cancer|2015–2019|Persons|1|80–84|0.668|0.607|0.724
Relative|Renal pelvis cancer|2015–2019|Persons|1|85+|0.543|0.474|0.608
Relative|Renal pelvis cancer|2015–2019|Persons|1|All ages combined|0.685|0.66|0.709
Relative|Renal pelvis cancer|2015–2019|Persons|2|00–04|||
Relative|Renal pelvis cancer|2015–2019|Persons|2|05–09|||
Relative|Renal pelvis cancer|2015–2019|Persons|2|10–14|||
Relative|Renal pelvis cancer|2015–2019|Persons|2|15–19|||
Relative|Renal pelvis cancer|2015–2019|Persons|2|20–24|||
Relative|Renal pelvis cancer|2015–2019|Persons|2|25–29|||
Relative|Renal pelvis cancer|2015–2019|Persons|2|30–34|||
Relative|Renal pelvis cancer|2015–2019|Persons|2|35–39|||
Relative|Renal pelvis cancer|2015–2019|Persons|2|40–44|||
Relative|Renal pelvis cancer|2015–2019|Persons|2|45–49|||
Relative|Renal pelvis cancer|2015–2019|Persons|2|50–54|0.651|0.474|0.782
Relative|Renal pelvis cancer|2015–2019|Persons|2|55–59|0.669|0.555|0.76
Relative|Renal pelvis cancer|2015–2019|Persons|2|60–64|0.68|0.575|0.766
Relative|Renal pelvis cancer|2015–2019|Persons|2|65–69|0.624|0.548|0.692
Relative|Renal pelvis cancer|2015–2019|Persons|2|70–74|0.567|0.502|0.628
Relative|Renal pelvis cancer|2015–2019|Persons|2|75–79|0.515|0.451|0.577
Relative|Renal pelvis cancer|2015–2019|Persons|2|80–84|0.497|0.431|0.561
Relative|Renal pelvis cancer|2015–2019|Persons|2|85+|0.399|0.33|0.469
Relative|Renal pelvis cancer|2015–2019|Persons|2|All ages combined|0.542|0.515|0.569
Relative|Renal pelvis cancer|2015–2019|Persons|3|00–04|||
Relative|Renal pelvis cancer|2015–2019|Persons|3|05–09|||
Relative|Renal pelvis cancer|2015–2019|Persons|3|10–14|||
Relative|Renal pelvis cancer|2015–2019|Persons|3|15–19|||
Relative|Renal pelvis cancer|2015–2019|Persons|3|20–24|||
Relative|Renal pelvis cancer|2015–2019|Persons|3|25–29|||
Relative|Renal pelvis cancer|2015–2019|Persons|3|30–34|||
Relative|Renal pelvis cancer|2015–2019|Persons|3|35–39|||
Relative|Renal pelvis cancer|2015–2019|Persons|3|40–44|||
Relative|Renal pelvis cancer|2015–2019|Persons|3|45–49|||
Relative|Renal pelvis cancer|2015–2019|Persons|3|50–54|0.603|0.428|0.741
Relative|Renal pelvis cancer|2015–2019|Persons|3|55–59|0.647|0.533|0.742
Relative|Renal pelvis cancer|2015–2019|Persons|3|60–64|0.602|0.494|0.695
Relative|Renal pelvis cancer|2015–2019|Persons|3|65–69|0.528|0.45|0.601
Relative|Renal pelvis cancer|2015–2019|Persons|3|70–74|0.496|0.431|0.559
Relative|Renal pelvis cancer|2015–2019|Persons|3|75–79|0.447|0.383|0.511
Relative|Renal pelvis cancer|2015–2019|Persons|3|80–84|0.425|0.358|0.492
Relative|Renal pelvis cancer|2015–2019|Persons|3|85+|0.321|0.252|0.396
Relative|Renal pelvis cancer|2015–2019|Persons|3|All ages combined|0.473|0.445|0.501
Relative|Renal pelvis cancer|2015–2019|Persons|4|00–04|||
Relative|Renal pelvis cancer|2015–2019|Persons|4|05–09|||
Relative|Renal pelvis cancer|2015–2019|Persons|4|10–14|||
Relative|Renal pelvis cancer|2015–2019|Persons|4|15–19|||
Relative|Renal pelvis cancer|2015–2019|Persons|4|20–24|||
Relative|Renal pelvis cancer|2015–2019|Persons|4|25–29|||
Relative|Renal pelvis cancer|2015–2019|Persons|4|30–34|||
Relative|Renal pelvis cancer|2015–2019|Persons|4|35–39|||
Relative|Renal pelvis cancer|2015–2019|Persons|4|40–44|||
Relative|Renal pelvis cancer|2015–2019|Persons|4|45–49|||
Relative|Renal pelvis cancer|2015–2019|Persons|4|50–54|0.559|0.388|0.701
Relative|Renal pelvis cancer|2015–2019|Persons|4|55–59|0.615|0.499|0.713
Relative|Renal pelvis cancer|2015–2019|Persons|4|60–64|0.571|0.463|0.666
Relative|Renal pelvis cancer|2015–2019|Persons|4|65–69|0.478|0.399|0.554
Relative|Renal pelvis cancer|2015–2019|Persons|4|70–74|0.444|0.378|0.508
Relative|Renal pelvis cancer|2015–2019|Persons|4|75–79|0.438|0.372|0.504
Relative|Renal pelvis cancer|2015–2019|Persons|4|80–84|0.344|0.278|0.413
Relative|Renal pelvis cancer|2015–2019|Persons|4|85+|0.233|0.168|0.309
Relative|Renal pelvis cancer|2015–2019|Persons|4|All ages combined|0.427|0.398|0.455
Relative|Renal pelvis cancer|2015–2019|Persons|5|00–04|||
Relative|Renal pelvis cancer|2015–2019|Persons|5|05–09|||
Relative|Renal pelvis cancer|2015–2019|Persons|5|10–14|||
Relative|Renal pelvis cancer|2015–2019|Persons|5|15–19|||
Relative|Renal pelvis cancer|2015–2019|Persons|5|20–24|||
Relative|Renal pelvis cancer|2015–2019|Persons|5|25–29|||
Relative|Renal pelvis cancer|2015–2019|Persons|5|30–34|||
Relative|Renal pelvis cancer|2015–2019|Persons|5|35–39|||
Relative|Renal pelvis cancer|2015–2019|Persons|5|40–44|||
Relative|Renal pelvis cancer|2015–2019|Persons|5|45–49|||
Relative|Renal pelvis cancer|2015–2019|Persons|5|50–54|0.561|0.389|0.704
Relative|Renal pelvis cancer|2015–2019|Persons|5|55–59|0.606|0.49|0.706
Relative|Renal pelvis cancer|2015–2019|Persons|5|60–64|0.541|0.435|0.637
Relative|Renal pelvis cancer|2015–2019|Persons|5|65–69|0.446|0.367|0.523
Relative|Renal pelvis cancer|2015–2019|Persons|5|70–74|0.398|0.333|0.463
Relative|Renal pelvis cancer|2015–2019|Persons|5|75–79|0.414|0.346|0.482
Relative|Renal pelvis cancer|2015–2019|Persons|5|80–84|0.319|0.252|0.391
Relative|Renal pelvis cancer|2015–2019|Persons|5|85+|0.208|0.141|0.291
Relative|Renal pelvis cancer|2015–2019|Persons|5|All ages combined|0.4|0.371|0.429
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|40–44|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|45–49|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|50–54|0.814|0.61|0.918
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|55–59|0.753|0.59|0.858
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|60–64|0.917|0.795|0.968
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|65–69|0.822|0.663|0.911
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|70–74|0.638|0.49|0.753
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|75–79|0.736|0.574|0.844
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|80–84|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|85+|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|All ages combined|0.771|0.723|0.812
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|40–44|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|45–49|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|50–54|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|55–59|0.635|0.461|0.766
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|60–64|0.816|0.676|0.899
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|65–69|0.675|0.507|0.796
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|70–74|0.438|0.299|0.568
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|75–79|0.614|0.45|0.742
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|80–84|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|85+|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|All ages combined|0.628|0.575|0.676
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|40–44|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|45–49|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|50–54|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|55–59|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|60–64|0.681|0.527|0.794
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|65–69|0.588|0.417|0.725
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|70–74|0.379|0.248|0.509
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|75–79|0.536|0.373|0.674
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|80–84|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|85+|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|All ages combined|0.553|0.5|0.603
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|40–44|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|45–49|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|50–54|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|55–59|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|60–64|0.632|0.475|0.754
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|65–69|0.536|0.368|0.678
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|70–74|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|75–79|0.51|0.349|0.651
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|80–84|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|85+|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|All ages combined|0.52|0.466|0.57
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|40–44|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|45–49|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|50–54|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|55–59|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|60–64|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|65–69|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|70–74|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|75–79|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|80–84|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|85+|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|All ages combined|0.479|0.426|0.53
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|40–44|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|45–49|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|50–54|0.817|0.612|0.921
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|55–59|0.757|0.593|0.863
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|60–64|0.925|0.801|0.976
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|65–69|0.832|0.671|0.922
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|70–74|0.651|0.5|0.768
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|75–79|0.76|0.593|0.872
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|80–84|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|85+|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|1|All ages combined|0.787|0.738|0.828
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|40–44|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|45–49|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|50–54|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|55–59|0.642|0.467|0.775
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|60–64|0.829|0.687|0.915
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|65–69|0.692|0.52|0.816
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|70–74|0.456|0.312|0.592
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|75–79|0.659|0.482|0.796
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|80–84|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|85+|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|2|All ages combined|0.652|0.598|0.702
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|40–44|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|45–49|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|50–54|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|55–59|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|60–64|0.7|0.542|0.816
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|65–69|0.612|0.434|0.754
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|70–74|0.405|0.265|0.545
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|75–79|0.599|0.417|0.754
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|80–84|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|85+|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|3|All ages combined|0.585|0.529|0.638
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|40–44|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|45–49|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|50–54|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|55–59|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|60–64|0.655|0.492|0.782
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|65–69|0.567|0.389|0.717
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|70–74|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|75–79|0.598|0.409|0.762
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|80–84|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|85+|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|4|All ages combined|0.559|0.502|0.614
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|40–44|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|45–49|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|50–54|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|55–59|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|60–64|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|65–69|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|70–74|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|75–79|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|80–84|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|85+|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Males|5|All ages combined|0.525|0.467|0.581
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|40–44|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|45–49|0.924|0.728|0.98
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|50–54|0.933|0.806|0.978
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|55–59|0.933|0.847|0.972
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|60–64|0.897|0.816|0.943
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|65–69|0.893|0.822|0.936
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|70–74|0.846|0.766|0.9
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|75–79|0.756|0.665|0.826
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|80–84|0.629|0.5|0.733
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|85+|0.392|0.271|0.51
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|All ages combined|0.81|0.78|0.836
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|40–44|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|45–49|0.824|0.628|0.923
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|50–54|0.816|0.676|0.899
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|55–59|0.755|0.639|0.838
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|60–64|0.805|0.708|0.872
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|65–69|0.759|0.675|0.825
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|70–74|0.676|0.582|0.754
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|75–79|0.609|0.515|0.691
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|80–84|0.445|0.321|0.562
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|85+|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|All ages combined|0.669|0.635|0.701
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|40–44|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|45–49|0.756|0.556|0.875
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|50–54|0.736|0.589|0.837
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|55–59|0.617|0.496|0.718
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|60–64|0.663|0.554|0.751
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|65–69|0.627|0.537|0.703
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|70–74|0.535|0.441|0.621
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|75–79|0.484|0.391|0.57
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|80–84|0.344|0.229|0.461
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|85+|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|All ages combined|0.556|0.521|0.59
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|40–44|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|45–49|0.638|0.444|0.78
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|50–54|0.647|0.494|0.764
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|55–59|0.475|0.354|0.587
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|60–64|0.51|0.401|0.61
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|65–69|0.507|0.417|0.589
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|70–74|0.381|0.294|0.468
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|75–79|0.358|0.272|0.445
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|80–84|0.251|0.155|0.36
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|85+|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|All ages combined|0.439|0.404|0.474
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|40–44|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|45–49|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|50–54|0.605|0.452|0.727
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|55–59|0.384|0.27|0.497
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|60–64|0.437|0.33|0.538
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|65–69|0.396|0.309|0.482
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|70–74|0.247|0.172|0.33
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|75–79|0.243|0.167|0.327
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|80–84|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|85+|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|All ages combined|0.363|0.329|0.397
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|40–44|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|45–49|0.925|0.729|0.982
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|50–54|0.935|0.808|0.98
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|55–59|0.936|0.85|0.975
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|60–64|0.901|0.82|0.947
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|65–69|0.899|0.828|0.943
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|70–74|0.856|0.775|0.91
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|75–79|0.773|0.68|0.844
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|80–84|0.655|0.521|0.763
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|85+|0.434|0.301|0.566
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|1|All ages combined|0.825|0.795|0.852
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|40–44|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|45–49|0.826|0.63|0.925
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|50–54|0.819|0.679|0.904
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|55–59|0.76|0.643|0.843
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|60–64|0.813|0.715|0.881
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|65–69|0.771|0.685|0.838
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|70–74|0.694|0.597|0.773
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|75–79|0.638|0.539|0.723
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|80–84|0.486|0.35|0.613
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|85+|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|2|All ages combined|0.691|0.656|0.724
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|40–44|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|45–49|0.76|0.559|0.879
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|50–54|0.741|0.593|0.843
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|55–59|0.624|0.501|0.725
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|60–64|0.673|0.563|0.763
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|65–69|0.642|0.55|0.72
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|70–74|0.558|0.46|0.646
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|75–79|0.521|0.421|0.614
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|80–84|0.395|0.263|0.53
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|85+|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|3|All ages combined|0.582|0.545|0.618
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|40–44|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|45–49|0.642|0.447|0.785
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|50–54|0.653|0.499|0.771
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|55–59|0.482|0.359|0.595
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|60–64|0.522|0.41|0.623
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|65–69|0.524|0.432|0.609
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|70–74|0.404|0.311|0.496
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|75–79|0.397|0.301|0.493
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|80–84|0.306|0.189|0.439
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|85+|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|4|All ages combined|0.467|0.429|0.503
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|40–44|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|45–49|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|50–54|0.613|0.458|0.736
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|55–59|0.391|0.275|0.507
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|60–64|0.449|0.34|0.554
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|65–69|0.414|0.323|0.504
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|70–74|0.267|0.186|0.357
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|75–79|0.279|0.191|0.376
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|80–84|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|85+|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Females|5|All ages combined|0.391|0.355|0.428
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|40–44|0.832|0.613|0.933
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|45–49|0.948|0.808|0.987
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|50–54|0.888|0.789|0.942
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|55–59|0.87|0.793|0.919
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|60–64|0.904|0.843|0.942
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|65–69|0.875|0.813|0.918
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|70–74|0.783|0.713|0.838
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|75–79|0.751|0.674|0.812
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|80–84|0.624|0.516|0.715
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|85+|0.364|0.259|0.47
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|All ages combined|0.798|0.773|0.82
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|40–44|0.832|0.613|0.933
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|45–49|0.854|0.704|0.932
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|50–54|0.76|0.647|0.841
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|55–59|0.712|0.618|0.787
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|60–64|0.808|0.733|0.864
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|65–69|0.739|0.665|0.799
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|70–74|0.604|0.525|0.674
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|75–79|0.61|0.53|0.681
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|80–84|0.444|0.338|0.545
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|85+|0.217|0.132|0.314
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|All ages combined|0.656|0.628|0.683
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|40–44|0.758|0.54|0.883
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|45–49|0.81|0.656|0.9
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|50–54|0.685|0.568|0.776
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|55–59|0.592|0.493|0.679
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|60–64|0.669|0.583|0.742
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|65–69|0.616|0.538|0.685
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|70–74|0.488|0.41|0.561
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|75–79|0.496|0.416|0.571
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|80–84|0.359|0.259|0.46
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|85+|0.158|0.086|0.249
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|All ages combined|0.555|0.526|0.584
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|40–44|0.724|0.507|0.857
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|45–49|0.735|0.582|0.84
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|50–54|0.603|0.484|0.703
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|55–59|0.469|0.368|0.563
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|60–64|0.549|0.46|0.63
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|65–69|0.512|0.434|0.585
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|70–74|0.371|0.298|0.444
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|75–79|0.397|0.32|0.472
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|80–84|0.271|0.183|0.367
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|85+|0.13|0.065|0.217
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|All ages combined|0.464|0.435|0.493
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|00–04|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|05–09|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|10–14|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|15–19|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|20–24|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|25–29|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|30–34|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|35–39|||
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|40–44|0.724|0.507|0.857
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|45–49|0.735|0.582|0.84
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|50–54|0.549|0.43|0.653
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|55–59|0.404|0.306|0.499
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|60–64|0.477|0.387|0.561
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|65–69|0.421|0.343|0.496
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|70–74|0.261|0.196|0.33
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|75–79|0.305|0.233|0.38
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|80–84|0.2|0.125|0.287
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|85+|0.114|0.054|0.199
Observed|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|All ages combined|0.399|0.37|0.428
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|40–44|0.833|0.614|0.935
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|45–49|0.95|0.81|0.988
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|50–54|0.891|0.791|0.945
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|55–59|0.873|0.796|0.923
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|60–64|0.909|0.848|0.947
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|65–69|0.883|0.82|0.926
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|70–74|0.794|0.723|0.851
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|75–79|0.769|0.691|0.832
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|80–84|0.653|0.539|0.748
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|85+|0.408|0.29|0.527
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|1|All ages combined|0.813|0.788|0.836
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|40–44|0.835|0.615|0.936
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|45–49|0.857|0.707|0.935
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|50–54|0.764|0.651|0.846
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|55–59|0.717|0.622|0.793
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|60–64|0.818|0.742|0.875
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|65–69|0.752|0.676|0.813
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|70–74|0.622|0.541|0.694
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|75–79|0.643|0.558|0.717
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|80–84|0.489|0.372|0.6
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|85+|0.273|0.167|0.396
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|2|All ages combined|0.679|0.649|0.707
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|40–44|0.761|0.542|0.887
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|45–49|0.814|0.659|0.905
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|50–54|0.691|0.573|0.783
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|55–59|0.6|0.499|0.687
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|60–64|0.682|0.594|0.756
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|65–69|0.633|0.553|0.704
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|70–74|0.511|0.43|0.588
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|75–79|0.539|0.452|0.621
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|80–84|0.419|0.302|0.536
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|85+|0.228|0.124|0.361
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|3|All ages combined|0.583|0.552|0.613
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|40–44|0.728|0.51|0.862
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|45–49|0.741|0.586|0.847
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|50–54|0.61|0.49|0.711
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|55–59|0.477|0.375|0.573
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|60–64|0.564|0.473|0.647
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|65–69|0.532|0.451|0.608
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|70–74|0.396|0.318|0.474
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|75–79|0.446|0.36|0.531
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|80–84|0.337|0.227|0.456
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|85+|0.216|0.108|0.361
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|4|All ages combined|0.495|0.464|0.526
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|00–04|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|05–09|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|10–14|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|15–19|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|20–24|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|25–29|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|30–34|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|35–39|||
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|40–44|0.729|0.511|0.864
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|45–49|0.743|0.588|0.849
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|50–54|0.557|0.437|0.663
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|55–59|0.413|0.313|0.51
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|60–64|0.493|0.401|0.581
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|65–69|0.443|0.361|0.522
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|70–74|0.286|0.215|0.362
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|75–79|0.357|0.273|0.446
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|80–84|0.267|0.167|0.384
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|85+|0.224|0.106|0.392
Relative|Retroperitoneal and peritoneal cancer|2015–2019|Persons|5|All ages combined|0.433|0.402|0.464
Observed|Sinuses cancer|2015–2019|Males|1|00–04|||
Observed|Sinuses cancer|2015–2019|Males|1|05–09|||
Observed|Sinuses cancer|2015–2019|Males|1|10–14|||
Observed|Sinuses cancer|2015–2019|Males|1|15–19|||
Observed|Sinuses cancer|2015–2019|Males|1|20–24|||
Observed|Sinuses cancer|2015–2019|Males|1|25–29|||
Observed|Sinuses cancer|2015–2019|Males|1|30–34|||
Observed|Sinuses cancer|2015–2019|Males|1|35–39|||
Observed|Sinuses cancer|2015–2019|Males|1|40–44|||
Observed|Sinuses cancer|2015–2019|Males|1|45–49|||
Observed|Sinuses cancer|2015–2019|Males|1|50–54|0.798|0.581|0.91
Observed|Sinuses cancer|2015–2019|Males|1|55–59|||
Observed|Sinuses cancer|2015–2019|Males|1|60–64|0.848|0.693|0.929
Observed|Sinuses cancer|2015–2019|Males|1|65–69|0.8|0.608|0.905
Observed|Sinuses cancer|2015–2019|Males|1|70–74|0.833|0.645|0.927
Observed|Sinuses cancer|2015–2019|Males|1|75–79|||
Observed|Sinuses cancer|2015–2019|Males|1|80–84|0.682|0.465|0.826
Observed|Sinuses cancer|2015–2019|Males|1|85+|||
Observed|Sinuses cancer|2015–2019|Males|1|All ages combined|0.763|0.706|0.81
Observed|Sinuses cancer|2015–2019|Males|2|00–04|||
Observed|Sinuses cancer|2015–2019|Males|2|05–09|||
Observed|Sinuses cancer|2015–2019|Males|2|10–14|||
Observed|Sinuses cancer|2015–2019|Males|2|15–19|||
Observed|Sinuses cancer|2015–2019|Males|2|20–24|||
Observed|Sinuses cancer|2015–2019|Males|2|25–29|||
Observed|Sinuses cancer|2015–2019|Males|2|30–34|||
Observed|Sinuses cancer|2015–2019|Males|2|35–39|||
Observed|Sinuses cancer|2015–2019|Males|2|40–44|||
Observed|Sinuses cancer|2015–2019|Males|2|45–49|||
Observed|Sinuses cancer|2015–2019|Males|2|50–54|0.798|0.581|0.91
Observed|Sinuses cancer|2015–2019|Males|2|55–59|||
Observed|Sinuses cancer|2015–2019|Males|2|60–64|0.667|0.487|0.796
Observed|Sinuses cancer|2015–2019|Males|2|65–69|||
Observed|Sinuses cancer|2015–2019|Males|2|70–74|||
Observed|Sinuses cancer|2015–2019|Males|2|75–79|||
Observed|Sinuses cancer|2015–2019|Males|2|80–84|||
Observed|Sinuses cancer|2015–2019|Males|2|85+|||
Observed|Sinuses cancer|2015–2019|Males|2|All ages combined|0.649|0.586|0.705
Observed|Sinuses cancer|2015–2019|Males|3|00–04|||
Observed|Sinuses cancer|2015–2019|Males|3|05–09|||
Observed|Sinuses cancer|2015–2019|Males|3|10–14|||
Observed|Sinuses cancer|2015–2019|Males|3|15–19|||
Observed|Sinuses cancer|2015–2019|Males|3|20–24|||
Observed|Sinuses cancer|2015–2019|Males|3|25–29|||
Observed|Sinuses cancer|2015–2019|Males|3|30–34|||
Observed|Sinuses cancer|2015–2019|Males|3|35–39|||
Observed|Sinuses cancer|2015–2019|Males|3|40–44|||
Observed|Sinuses cancer|2015–2019|Males|3|45–49|||
Observed|Sinuses cancer|2015–2019|Males|3|50–54|0.725|0.51|0.858
Observed|Sinuses cancer|2015–2019|Males|3|55–59|||
Observed|Sinuses cancer|2015–2019|Males|3|60–64|||
Observed|Sinuses cancer|2015–2019|Males|3|65–69|||
Observed|Sinuses cancer|2015–2019|Males|3|70–74|||
Observed|Sinuses cancer|2015–2019|Males|3|75–79|||
Observed|Sinuses cancer|2015–2019|Males|3|80–84|||
Observed|Sinuses cancer|2015–2019|Males|3|85+|||
Observed|Sinuses cancer|2015–2019|Males|3|All ages combined|0.567|0.501|0.628
Observed|Sinuses cancer|2015–2019|Males|4|00–04|||
Observed|Sinuses cancer|2015–2019|Males|4|05–09|||
Observed|Sinuses cancer|2015–2019|Males|4|10–14|||
Observed|Sinuses cancer|2015–2019|Males|4|15–19|||
Observed|Sinuses cancer|2015–2019|Males|4|20–24|||
Observed|Sinuses cancer|2015–2019|Males|4|25–29|||
Observed|Sinuses cancer|2015–2019|Males|4|30–34|||
Observed|Sinuses cancer|2015–2019|Males|4|35–39|||
Observed|Sinuses cancer|2015–2019|Males|4|40–44|||
Observed|Sinuses cancer|2015–2019|Males|4|45–49|||
Observed|Sinuses cancer|2015–2019|Males|4|50–54|||
Observed|Sinuses cancer|2015–2019|Males|4|55–59|||
Observed|Sinuses cancer|2015–2019|Males|4|60–64|||
Observed|Sinuses cancer|2015–2019|Males|4|65–69|||
Observed|Sinuses cancer|2015–2019|Males|4|70–74|||
Observed|Sinuses cancer|2015–2019|Males|4|75–79|||
Observed|Sinuses cancer|2015–2019|Males|4|80–84|||
Observed|Sinuses cancer|2015–2019|Males|4|85+|||
Observed|Sinuses cancer|2015–2019|Males|4|All ages combined|0.498|0.431|0.561
Observed|Sinuses cancer|2015–2019|Males|5|00–04|||
Observed|Sinuses cancer|2015–2019|Males|5|05–09|||
Observed|Sinuses cancer|2015–2019|Males|5|10–14|||
Observed|Sinuses cancer|2015–2019|Males|5|15–19|||
Observed|Sinuses cancer|2015–2019|Males|5|20–24|||
Observed|Sinuses cancer|2015–2019|Males|5|25–29|||
Observed|Sinuses cancer|2015–2019|Males|5|30–34|||
Observed|Sinuses cancer|2015–2019|Males|5|35–39|||
Observed|Sinuses cancer|2015–2019|Males|5|40–44|||
Observed|Sinuses cancer|2015–2019|Males|5|45–49|||
Observed|Sinuses cancer|2015–2019|Males|5|50–54|||
Observed|Sinuses cancer|2015–2019|Males|5|55–59|||
Observed|Sinuses cancer|2015–2019|Males|5|60–64|||
Observed|Sinuses cancer|2015–2019|Males|5|65–69|||
Observed|Sinuses cancer|2015–2019|Males|5|70–74|||
Observed|Sinuses cancer|2015–2019|Males|5|75–79|||
Observed|Sinuses cancer|2015–2019|Males|5|80–84|||
Observed|Sinuses cancer|2015–2019|Males|5|85+|||
Observed|Sinuses cancer|2015–2019|Males|5|All ages combined|0.466|0.399|0.53
Relative|Sinuses cancer|2015–2019|Males|1|00–04|||
Relative|Sinuses cancer|2015–2019|Males|1|05–09|||
Relative|Sinuses cancer|2015–2019|Males|1|10–14|||
Relative|Sinuses cancer|2015–2019|Males|1|15–19|||
Relative|Sinuses cancer|2015–2019|Males|1|20–24|||
Relative|Sinuses cancer|2015–2019|Males|1|25–29|||
Relative|Sinuses cancer|2015–2019|Males|1|30–34|||
Relative|Sinuses cancer|2015–2019|Males|1|35–39|||
Relative|Sinuses cancer|2015–2019|Males|1|40–44|||
Relative|Sinuses cancer|2015–2019|Males|1|45–49|||
Relative|Sinuses cancer|2015–2019|Males|1|50–54|0.801|0.583|0.913
Relative|Sinuses cancer|2015–2019|Males|1|55–59|||
Relative|Sinuses cancer|2015–2019|Males|1|60–64|0.855|0.699|0.936
Relative|Sinuses cancer|2015–2019|Males|1|65–69|0.809|0.616|0.915
Relative|Sinuses cancer|2015–2019|Males|1|70–74|0.849|0.657|0.944
Relative|Sinuses cancer|2015–2019|Males|1|75–79|||
Relative|Sinuses cancer|2015–2019|Males|1|80–84|0.725|0.494|0.878
Relative|Sinuses cancer|2015–2019|Males|1|85+|||
Relative|Sinuses cancer|2015–2019|Males|1|All ages combined|0.781|0.723|0.829
Relative|Sinuses cancer|2015–2019|Males|2|00–04|||
Relative|Sinuses cancer|2015–2019|Males|2|05–09|||
Relative|Sinuses cancer|2015–2019|Males|2|10–14|||
Relative|Sinuses cancer|2015–2019|Males|2|15–19|||
Relative|Sinuses cancer|2015–2019|Males|2|20–24|||
Relative|Sinuses cancer|2015–2019|Males|2|25–29|||
Relative|Sinuses cancer|2015–2019|Males|2|30–34|||
Relative|Sinuses cancer|2015–2019|Males|2|35–39|||
Relative|Sinuses cancer|2015–2019|Males|2|40–44|||
Relative|Sinuses cancer|2015–2019|Males|2|45–49|||
Relative|Sinuses cancer|2015–2019|Males|2|50–54|0.804|0.585|0.917
Relative|Sinuses cancer|2015–2019|Males|2|55–59|||
Relative|Sinuses cancer|2015–2019|Males|2|60–64|0.678|0.495|0.81
Relative|Sinuses cancer|2015–2019|Males|2|65–69|||
Relative|Sinuses cancer|2015–2019|Males|2|70–74|||
Relative|Sinuses cancer|2015–2019|Males|2|75–79|||
Relative|Sinuses cancer|2015–2019|Males|2|80–84|||
Relative|Sinuses cancer|2015–2019|Males|2|85+|||
Relative|Sinuses cancer|2015–2019|Males|2|All ages combined|0.678|0.612|0.736
Relative|Sinuses cancer|2015–2019|Males|3|00–04|||
Relative|Sinuses cancer|2015–2019|Males|3|05–09|||
Relative|Sinuses cancer|2015–2019|Males|3|10–14|||
Relative|Sinuses cancer|2015–2019|Males|3|15–19|||
Relative|Sinuses cancer|2015–2019|Males|3|20–24|||
Relative|Sinuses cancer|2015–2019|Males|3|25–29|||
Relative|Sinuses cancer|2015–2019|Males|3|30–34|||
Relative|Sinuses cancer|2015–2019|Males|3|35–39|||
Relative|Sinuses cancer|2015–2019|Males|3|40–44|||
Relative|Sinuses cancer|2015–2019|Males|3|45–49|||
Relative|Sinuses cancer|2015–2019|Males|3|50–54|0.734|0.516|0.868
Relative|Sinuses cancer|2015–2019|Males|3|55–59|||
Relative|Sinuses cancer|2015–2019|Males|3|60–64|||
Relative|Sinuses cancer|2015–2019|Males|3|65–69|||
Relative|Sinuses cancer|2015–2019|Males|3|70–74|||
Relative|Sinuses cancer|2015–2019|Males|3|75–79|||
Relative|Sinuses cancer|2015–2019|Males|3|80–84|||
Relative|Sinuses cancer|2015–2019|Males|3|85+|||
Relative|Sinuses cancer|2015–2019|Males|3|All ages combined|0.605|0.534|0.67
Relative|Sinuses cancer|2015–2019|Males|4|00–04|||
Relative|Sinuses cancer|2015–2019|Males|4|05–09|||
Relative|Sinuses cancer|2015–2019|Males|4|10–14|||
Relative|Sinuses cancer|2015–2019|Males|4|15–19|||
Relative|Sinuses cancer|2015–2019|Males|4|20–24|||
Relative|Sinuses cancer|2015–2019|Males|4|25–29|||
Relative|Sinuses cancer|2015–2019|Males|4|30–34|||
Relative|Sinuses cancer|2015–2019|Males|4|35–39|||
Relative|Sinuses cancer|2015–2019|Males|4|40–44|||
Relative|Sinuses cancer|2015–2019|Males|4|45–49|||
Relative|Sinuses cancer|2015–2019|Males|4|50–54|||
Relative|Sinuses cancer|2015–2019|Males|4|55–59|||
Relative|Sinuses cancer|2015–2019|Males|4|60–64|||
Relative|Sinuses cancer|2015–2019|Males|4|65–69|||
Relative|Sinuses cancer|2015–2019|Males|4|70–74|||
Relative|Sinuses cancer|2015–2019|Males|4|75–79|||
Relative|Sinuses cancer|2015–2019|Males|4|80–84|||
Relative|Sinuses cancer|2015–2019|Males|4|85+|||
Relative|Sinuses cancer|2015–2019|Males|4|All ages combined|0.545|0.471|0.614
Relative|Sinuses cancer|2015–2019|Males|5|00–04|||
Relative|Sinuses cancer|2015–2019|Males|5|05–09|||
Relative|Sinuses cancer|2015–2019|Males|5|10–14|||
Relative|Sinuses cancer|2015–2019|Males|5|15–19|||
Relative|Sinuses cancer|2015–2019|Males|5|20–24|||
Relative|Sinuses cancer|2015–2019|Males|5|25–29|||
Relative|Sinuses cancer|2015–2019|Males|5|30–34|||
Relative|Sinuses cancer|2015–2019|Males|5|35–39|||
Relative|Sinuses cancer|2015–2019|Males|5|40–44|||
Relative|Sinuses cancer|2015–2019|Males|5|45–49|||
Relative|Sinuses cancer|2015–2019|Males|5|50–54|||
Relative|Sinuses cancer|2015–2019|Males|5|55–59|||
Relative|Sinuses cancer|2015–2019|Males|5|60–64|||
Relative|Sinuses cancer|2015–2019|Males|5|65–69|||
Relative|Sinuses cancer|2015–2019|Males|5|70–74|||
Relative|Sinuses cancer|2015–2019|Males|5|75–79|||
Relative|Sinuses cancer|2015–2019|Males|5|80–84|||
Relative|Sinuses cancer|2015–2019|Males|5|85+|||
Relative|Sinuses cancer|2015–2019|Males|5|All ages combined|0.521|0.446|0.593
Observed|Sinuses cancer|2015–2019|Females|1|00–04|||
Observed|Sinuses cancer|2015–2019|Females|1|05–09|||
Observed|Sinuses cancer|2015–2019|Females|1|10–14|||
Observed|Sinuses cancer|2015–2019|Females|1|15–19|||
Observed|Sinuses cancer|2015–2019|Females|1|20–24|||
Observed|Sinuses cancer|2015–2019|Females|1|25–29|||
Observed|Sinuses cancer|2015–2019|Females|1|30–34|||
Observed|Sinuses cancer|2015–2019|Females|1|35–39|||
Observed|Sinuses cancer|2015–2019|Females|1|40–44|||
Observed|Sinuses cancer|2015–2019|Females|1|45–49|||
Observed|Sinuses cancer|2015–2019|Females|1|50–54|||
Observed|Sinuses cancer|2015–2019|Females|1|55–59|||
Observed|Sinuses cancer|2015–2019|Females|1|60–64|||
Observed|Sinuses cancer|2015–2019|Females|1|65–69|||
Observed|Sinuses cancer|2015–2019|Females|1|70–74|||
Observed|Sinuses cancer|2015–2019|Females|1|75–79|||
Observed|Sinuses cancer|2015–2019|Females|1|80–84|||
Observed|Sinuses cancer|2015–2019|Females|1|85+|||
Observed|Sinuses cancer|2015–2019|Females|1|All ages combined|0.763|0.685|0.824
Observed|Sinuses cancer|2015–2019|Females|2|00–04|||
Observed|Sinuses cancer|2015–2019|Females|2|05–09|||
Observed|Sinuses cancer|2015–2019|Females|2|10–14|||
Observed|Sinuses cancer|2015–2019|Females|2|15–19|||
Observed|Sinuses cancer|2015–2019|Females|2|20–24|||
Observed|Sinuses cancer|2015–2019|Females|2|25–29|||
Observed|Sinuses cancer|2015–2019|Females|2|30–34|||
Observed|Sinuses cancer|2015–2019|Females|2|35–39|||
Observed|Sinuses cancer|2015–2019|Females|2|40–44|||
Observed|Sinuses cancer|2015–2019|Females|2|45–49|||
Observed|Sinuses cancer|2015–2019|Females|2|50–54|||
Observed|Sinuses cancer|2015–2019|Females|2|55–59|||
Observed|Sinuses cancer|2015–2019|Females|2|60–64|||
Observed|Sinuses cancer|2015–2019|Females|2|65–69|||
Observed|Sinuses cancer|2015–2019|Females|2|70–74|||
Observed|Sinuses cancer|2015–2019|Females|2|75–79|||
Observed|Sinuses cancer|2015–2019|Females|2|80–84|||
Observed|Sinuses cancer|2015–2019|Females|2|85+|||
Observed|Sinuses cancer|2015–2019|Females|2|All ages combined|0.662|0.578|0.734
Observed|Sinuses cancer|2015–2019|Females|3|00–04|||
Observed|Sinuses cancer|2015–2019|Females|3|05–09|||
Observed|Sinuses cancer|2015–2019|Females|3|10–14|||
Observed|Sinuses cancer|2015–2019|Females|3|15–19|||
Observed|Sinuses cancer|2015–2019|Females|3|20–24|||
Observed|Sinuses cancer|2015–2019|Females|3|25–29|||
Observed|Sinuses cancer|2015–2019|Females|3|30–34|||
Observed|Sinuses cancer|2015–2019|Females|3|35–39|||
Observed|Sinuses cancer|2015–2019|Females|3|40–44|||
Observed|Sinuses cancer|2015–2019|Females|3|45–49|||
Observed|Sinuses cancer|2015–2019|Females|3|50–54|||
Observed|Sinuses cancer|2015–2019|Females|3|55–59|||
Observed|Sinuses cancer|2015–2019|Females|3|60–64|||
Observed|Sinuses cancer|2015–2019|Females|3|65–69|||
Observed|Sinuses cancer|2015–2019|Females|3|70–74|||
Observed|Sinuses cancer|2015–2019|Females|3|75–79|||
Observed|Sinuses cancer|2015–2019|Females|3|80–84|||
Observed|Sinuses cancer|2015–2019|Females|3|85+|||
Observed|Sinuses cancer|2015–2019|Females|3|All ages combined|0.551|0.463|0.63
Observed|Sinuses cancer|2015–2019|Females|4|00–04|||
Observed|Sinuses cancer|2015–2019|Females|4|05–09|||
Observed|Sinuses cancer|2015–2019|Females|4|10–14|||
Observed|Sinuses cancer|2015–2019|Females|4|15–19|||
Observed|Sinuses cancer|2015–2019|Females|4|20–24|||
Observed|Sinuses cancer|2015–2019|Females|4|25–29|||
Observed|Sinuses cancer|2015–2019|Females|4|30–34|||
Observed|Sinuses cancer|2015–2019|Females|4|35–39|||
Observed|Sinuses cancer|2015–2019|Females|4|40–44|||
Observed|Sinuses cancer|2015–2019|Females|4|45–49|||
Observed|Sinuses cancer|2015–2019|Females|4|50–54|||
Observed|Sinuses cancer|2015–2019|Females|4|55–59|||
Observed|Sinuses cancer|2015–2019|Females|4|60–64|||
Observed|Sinuses cancer|2015–2019|Females|4|65–69|||
Observed|Sinuses cancer|2015–2019|Females|4|70–74|||
Observed|Sinuses cancer|2015–2019|Females|4|75–79|||
Observed|Sinuses cancer|2015–2019|Females|4|80–84|||
Observed|Sinuses cancer|2015–2019|Females|4|85+|||
Observed|Sinuses cancer|2015–2019|Females|4|All ages combined|0.461|0.372|0.544
Observed|Sinuses cancer|2015–2019|Females|5|00–04|||
Observed|Sinuses cancer|2015–2019|Females|5|05–09|||
Observed|Sinuses cancer|2015–2019|Females|5|10–14|||
Observed|Sinuses cancer|2015–2019|Females|5|15–19|||
Observed|Sinuses cancer|2015–2019|Females|5|20–24|||
Observed|Sinuses cancer|2015–2019|Females|5|25–29|||
Observed|Sinuses cancer|2015–2019|Females|5|30–34|||
Observed|Sinuses cancer|2015–2019|Females|5|35–39|||
Observed|Sinuses cancer|2015–2019|Females|5|40–44|||
Observed|Sinuses cancer|2015–2019|Females|5|45–49|||
Observed|Sinuses cancer|2015–2019|Females|5|50–54|||
Observed|Sinuses cancer|2015–2019|Females|5|55–59|||
Observed|Sinuses cancer|2015–2019|Females|5|60–64|||
Observed|Sinuses cancer|2015–2019|Females|5|65–69|||
Observed|Sinuses cancer|2015–2019|Females|5|70–74|||
Observed|Sinuses cancer|2015–2019|Females|5|75–79|||
Observed|Sinuses cancer|2015–2019|Females|5|80–84|||
Observed|Sinuses cancer|2015–2019|Females|5|85+|||
Observed|Sinuses cancer|2015–2019|Females|5|All ages combined|0.441|0.353|0.526
Relative|Sinuses cancer|2015–2019|Females|1|00–04|||
Relative|Sinuses cancer|2015–2019|Females|1|05–09|||
Relative|Sinuses cancer|2015–2019|Females|1|10–14|||
Relative|Sinuses cancer|2015–2019|Females|1|15–19|||
Relative|Sinuses cancer|2015–2019|Females|1|20–24|||
Relative|Sinuses cancer|2015–2019|Females|1|25–29|||
Relative|Sinuses cancer|2015–2019|Females|1|30–34|||
Relative|Sinuses cancer|2015–2019|Females|1|35–39|||
Relative|Sinuses cancer|2015–2019|Females|1|40–44|||
Relative|Sinuses cancer|2015–2019|Females|1|45–49|||
Relative|Sinuses cancer|2015–2019|Females|1|50–54|||
Relative|Sinuses cancer|2015–2019|Females|1|55–59|||
Relative|Sinuses cancer|2015–2019|Females|1|60–64|||
Relative|Sinuses cancer|2015–2019|Females|1|65–69|||
Relative|Sinuses cancer|2015–2019|Females|1|70–74|||
Relative|Sinuses cancer|2015–2019|Females|1|75–79|||
Relative|Sinuses cancer|2015–2019|Females|1|80–84|||
Relative|Sinuses cancer|2015–2019|Females|1|85+|||
Relative|Sinuses cancer|2015–2019|Females|1|All ages combined|0.78|0.7|0.843
Relative|Sinuses cancer|2015–2019|Females|2|00–04|||
Relative|Sinuses cancer|2015–2019|Females|2|05–09|||
Relative|Sinuses cancer|2015–2019|Females|2|10–14|||
Relative|Sinuses cancer|2015–2019|Females|2|15–19|||
Relative|Sinuses cancer|2015–2019|Females|2|20–24|||
Relative|Sinuses cancer|2015–2019|Females|2|25–29|||
Relative|Sinuses cancer|2015–2019|Females|2|30–34|||
Relative|Sinuses cancer|2015–2019|Females|2|35–39|||
Relative|Sinuses cancer|2015–2019|Females|2|40–44|||
Relative|Sinuses cancer|2015–2019|Females|2|45–49|||
Relative|Sinuses cancer|2015–2019|Females|2|50–54|||
Relative|Sinuses cancer|2015–2019|Females|2|55–59|||
Relative|Sinuses cancer|2015–2019|Females|2|60–64|||
Relative|Sinuses cancer|2015–2019|Females|2|65–69|||
Relative|Sinuses cancer|2015–2019|Females|2|70–74|||
Relative|Sinuses cancer|2015–2019|Females|2|75–79|||
Relative|Sinuses cancer|2015–2019|Females|2|80–84|||
Relative|Sinuses cancer|2015–2019|Females|2|85+|||
Relative|Sinuses cancer|2015–2019|Females|2|All ages combined|0.689|0.602|0.764
Relative|Sinuses cancer|2015–2019|Females|3|00–04|||
Relative|Sinuses cancer|2015–2019|Females|3|05–09|||
Relative|Sinuses cancer|2015–2019|Females|3|10–14|||
Relative|Sinuses cancer|2015–2019|Females|3|15–19|||
Relative|Sinuses cancer|2015–2019|Females|3|20–24|||
Relative|Sinuses cancer|2015–2019|Females|3|25–29|||
Relative|Sinuses cancer|2015–2019|Females|3|30–34|||
Relative|Sinuses cancer|2015–2019|Females|3|35–39|||
Relative|Sinuses cancer|2015–2019|Females|3|40–44|||
Relative|Sinuses cancer|2015–2019|Females|3|45–49|||
Relative|Sinuses cancer|2015–2019|Females|3|50–54|||
Relative|Sinuses cancer|2015–2019|Females|3|55–59|||
Relative|Sinuses cancer|2015–2019|Females|3|60–64|||
Relative|Sinuses cancer|2015–2019|Females|3|65–69|||
Relative|Sinuses cancer|2015–2019|Females|3|70–74|||
Relative|Sinuses cancer|2015–2019|Females|3|75–79|||
Relative|Sinuses cancer|2015–2019|Females|3|80–84|||
Relative|Sinuses cancer|2015–2019|Females|3|85+|||
Relative|Sinuses cancer|2015–2019|Females|3|All ages combined|0.585|0.492|0.669
Relative|Sinuses cancer|2015–2019|Females|4|00–04|||
Relative|Sinuses cancer|2015–2019|Females|4|05–09|||
Relative|Sinuses cancer|2015–2019|Females|4|10–14|||
Relative|Sinuses cancer|2015–2019|Females|4|15–19|||
Relative|Sinuses cancer|2015–2019|Females|4|20–24|||
Relative|Sinuses cancer|2015–2019|Females|4|25–29|||
Relative|Sinuses cancer|2015–2019|Females|4|30–34|||
Relative|Sinuses cancer|2015–2019|Females|4|35–39|||
Relative|Sinuses cancer|2015–2019|Females|4|40–44|||
Relative|Sinuses cancer|2015–2019|Females|4|45–49|||
Relative|Sinuses cancer|2015–2019|Females|4|50–54|||
Relative|Sinuses cancer|2015–2019|Females|4|55–59|||
Relative|Sinuses cancer|2015–2019|Females|4|60–64|||
Relative|Sinuses cancer|2015–2019|Females|4|65–69|||
Relative|Sinuses cancer|2015–2019|Females|4|70–74|||
Relative|Sinuses cancer|2015–2019|Females|4|75–79|||
Relative|Sinuses cancer|2015–2019|Females|4|80–84|||
Relative|Sinuses cancer|2015–2019|Females|4|85+|||
Relative|Sinuses cancer|2015–2019|Females|4|All ages combined|0.498|0.402|0.588
Relative|Sinuses cancer|2015–2019|Females|5|00–04|||
Relative|Sinuses cancer|2015–2019|Females|5|05–09|||
Relative|Sinuses cancer|2015–2019|Females|5|10–14|||
Relative|Sinuses cancer|2015–2019|Females|5|15–19|||
Relative|Sinuses cancer|2015–2019|Females|5|20–24|||
Relative|Sinuses cancer|2015–2019|Females|5|25–29|||
Relative|Sinuses cancer|2015–2019|Females|5|30–34|||
Relative|Sinuses cancer|2015–2019|Females|5|35–39|||
Relative|Sinuses cancer|2015–2019|Females|5|40–44|||
Relative|Sinuses cancer|2015–2019|Females|5|45–49|||
Relative|Sinuses cancer|2015–2019|Females|5|50–54|||
Relative|Sinuses cancer|2015–2019|Females|5|55–59|||
Relative|Sinuses cancer|2015–2019|Females|5|60–64|||
Relative|Sinuses cancer|2015–2019|Females|5|65–69|||
Relative|Sinuses cancer|2015–2019|Females|5|70–74|||
Relative|Sinuses cancer|2015–2019|Females|5|75–79|||
Relative|Sinuses cancer|2015–2019|Females|5|80–84|||
Relative|Sinuses cancer|2015–2019|Females|5|85+|||
Relative|Sinuses cancer|2015–2019|Females|5|All ages combined|0.486|0.389|0.579
Observed|Sinuses cancer|2015–2019|Persons|1|00–04|||
Observed|Sinuses cancer|2015–2019|Persons|1|05–09|||
Observed|Sinuses cancer|2015–2019|Persons|1|10–14|||
Observed|Sinuses cancer|2015–2019|Persons|1|15–19|||
Observed|Sinuses cancer|2015–2019|Persons|1|20–24|||
Observed|Sinuses cancer|2015–2019|Persons|1|25–29|||
Observed|Sinuses cancer|2015–2019|Persons|1|30–34|||
Observed|Sinuses cancer|2015–2019|Persons|1|35–39|||
Observed|Sinuses cancer|2015–2019|Persons|1|40–44|||
Observed|Sinuses cancer|2015–2019|Persons|1|45–49|0.876|0.704|0.952
Observed|Sinuses cancer|2015–2019|Persons|1|50–54|0.852|0.681|0.936
Observed|Sinuses cancer|2015–2019|Persons|1|55–59|0.689|0.5|0.818
Observed|Sinuses cancer|2015–2019|Persons|1|60–64|0.843|0.719|0.915
Observed|Sinuses cancer|2015–2019|Persons|1|65–69|0.819|0.681|0.901
Observed|Sinuses cancer|2015–2019|Persons|1|70–74|0.777|0.616|0.877
Observed|Sinuses cancer|2015–2019|Persons|1|75–79|0.634|0.463|0.763
Observed|Sinuses cancer|2015–2019|Persons|1|80–84|0.622|0.455|0.751
Observed|Sinuses cancer|2015–2019|Persons|1|85+|0.542|0.368|0.687
Observed|Sinuses cancer|2015–2019|Persons|1|All ages combined|0.763|0.718|0.801
Observed|Sinuses cancer|2015–2019|Persons|2|00–04|||
Observed|Sinuses cancer|2015–2019|Persons|2|05–09|||
Observed|Sinuses cancer|2015–2019|Persons|2|10–14|||
Observed|Sinuses cancer|2015–2019|Persons|2|15–19|||
Observed|Sinuses cancer|2015–2019|Persons|2|20–24|||
Observed|Sinuses cancer|2015–2019|Persons|2|25–29|||
Observed|Sinuses cancer|2015–2019|Persons|2|30–34|||
Observed|Sinuses cancer|2015–2019|Persons|2|35–39|||
Observed|Sinuses cancer|2015–2019|Persons|2|40–44|||
Observed|Sinuses cancer|2015–2019|Persons|2|45–49|0.807|0.619|0.909
Observed|Sinuses cancer|2015–2019|Persons|2|50–54|0.852|0.681|0.936
Observed|Sinuses cancer|2015–2019|Persons|2|55–59|||
Observed|Sinuses cancer|2015–2019|Persons|2|60–64|0.676|0.537|0.782
Observed|Sinuses cancer|2015–2019|Persons|2|65–69|0.793|0.649|0.883
Observed|Sinuses cancer|2015–2019|Persons|2|70–74|0.606|0.432|0.741
Observed|Sinuses cancer|2015–2019|Persons|2|75–79|0.553|0.384|0.693
Observed|Sinuses cancer|2015–2019|Persons|2|80–84|0.494|0.333|0.637
Observed|Sinuses cancer|2015–2019|Persons|2|85+|||
Observed|Sinuses cancer|2015–2019|Persons|2|All ages combined|0.654|0.604|0.699
Observed|Sinuses cancer|2015–2019|Persons|3|00–04|||
Observed|Sinuses cancer|2015–2019|Persons|3|05–09|||
Observed|Sinuses cancer|2015–2019|Persons|3|10–14|||
Observed|Sinuses cancer|2015–2019|Persons|3|15–19|||
Observed|Sinuses cancer|2015–2019|Persons|3|20–24|||
Observed|Sinuses cancer|2015–2019|Persons|3|25–29|||
Observed|Sinuses cancer|2015–2019|Persons|3|30–34|||
Observed|Sinuses cancer|2015–2019|Persons|3|35–39|||
Observed|Sinuses cancer|2015–2019|Persons|3|40–44|||
Observed|Sinuses cancer|2015–2019|Persons|3|45–49|||
Observed|Sinuses cancer|2015–2019|Persons|3|50–54|0.794|0.616|0.896
Observed|Sinuses cancer|2015–2019|Persons|3|55–59|||
Observed|Sinuses cancer|2015–2019|Persons|3|60–64|0.571|0.427|0.692
Observed|Sinuses cancer|2015–2019|Persons|3|65–69|0.647|0.478|0.774
Observed|Sinuses cancer|2015–2019|Persons|3|70–74|||
Observed|Sinuses cancer|2015–2019|Persons|3|75–79|||
Observed|Sinuses cancer|2015–2019|Persons|3|80–84|||
Observed|Sinuses cancer|2015–2019|Persons|3|85+|||
Observed|Sinuses cancer|2015–2019|Persons|3|All ages combined|0.561|0.508|0.61
Observed|Sinuses cancer|2015–2019|Persons|4|00–04|||
Observed|Sinuses cancer|2015–2019|Persons|4|05–09|||
Observed|Sinuses cancer|2015–2019|Persons|4|10–14|||
Observed|Sinuses cancer|2015–2019|Persons|4|15–19|||
Observed|Sinuses cancer|2015–2019|Persons|4|20–24|||
Observed|Sinuses cancer|2015–2019|Persons|4|25–29|||
Observed|Sinuses cancer|2015–2019|Persons|4|30–34|||
Observed|Sinuses cancer|2015–2019|Persons|4|35–39|||
Observed|Sinuses cancer|2015–2019|Persons|4|40–44|||
Observed|Sinuses cancer|2015–2019|Persons|4|45–49|||
Observed|Sinuses cancer|2015–2019|Persons|4|50–54|0.758|0.572|0.871
Observed|Sinuses cancer|2015–2019|Persons|4|55–59|||
Observed|Sinuses cancer|2015–2019|Persons|4|60–64|0.526|0.381|0.652
Observed|Sinuses cancer|2015–2019|Persons|4|65–69|||
Observed|Sinuses cancer|2015–2019|Persons|4|70–74|||
Observed|Sinuses cancer|2015–2019|Persons|4|75–79|||
Observed|Sinuses cancer|2015–2019|Persons|4|80–84|||
Observed|Sinuses cancer|2015–2019|Persons|4|85+|||
Observed|Sinuses cancer|2015–2019|Persons|4|All ages combined|0.484|0.431|0.535
Observed|Sinuses cancer|2015–2019|Persons|5|00–04|||
Observed|Sinuses cancer|2015–2019|Persons|5|05–09|||
Observed|Sinuses cancer|2015–2019|Persons|5|10–14|||
Observed|Sinuses cancer|2015–2019|Persons|5|15–19|||
Observed|Sinuses cancer|2015–2019|Persons|5|20–24|||
Observed|Sinuses cancer|2015–2019|Persons|5|25–29|||
Observed|Sinuses cancer|2015–2019|Persons|5|30–34|||
Observed|Sinuses cancer|2015–2019|Persons|5|35–39|||
Observed|Sinuses cancer|2015–2019|Persons|5|40–44|||
Observed|Sinuses cancer|2015–2019|Persons|5|45–49|||
Observed|Sinuses cancer|2015–2019|Persons|5|50–54|||
Observed|Sinuses cancer|2015–2019|Persons|5|55–59|||
Observed|Sinuses cancer|2015–2019|Persons|5|60–64|0.504|0.359|0.631
Observed|Sinuses cancer|2015–2019|Persons|5|65–69|||
Observed|Sinuses cancer|2015–2019|Persons|5|70–74|||
Observed|Sinuses cancer|2015–2019|Persons|5|75–79|||
Observed|Sinuses cancer|2015–2019|Persons|5|80–84|||
Observed|Sinuses cancer|2015–2019|Persons|5|85+|||
Observed|Sinuses cancer|2015–2019|Persons|5|All ages combined|0.457|0.404|0.509
Relative|Sinuses cancer|2015–2019|Persons|1|00–04|||
Relative|Sinuses cancer|2015–2019|Persons|1|05–09|||
Relative|Sinuses cancer|2015–2019|Persons|1|10–14|||
Relative|Sinuses cancer|2015–2019|Persons|1|15–19|||
Relative|Sinuses cancer|2015–2019|Persons|1|20–24|||
Relative|Sinuses cancer|2015–2019|Persons|1|25–29|||
Relative|Sinuses cancer|2015–2019|Persons|1|30–34|||
Relative|Sinuses cancer|2015–2019|Persons|1|35–39|||
Relative|Sinuses cancer|2015–2019|Persons|1|40–44|||
Relative|Sinuses cancer|2015–2019|Persons|1|45–49|0.878|0.705|0.954
Relative|Sinuses cancer|2015–2019|Persons|1|50–54|0.855|0.683|0.938
Relative|Sinuses cancer|2015–2019|Persons|1|55–59|0.692|0.502|0.822
Relative|Sinuses cancer|2015–2019|Persons|1|60–64|0.848|0.724|0.921
Relative|Sinuses cancer|2015–2019|Persons|1|65–69|0.827|0.687|0.91
Relative|Sinuses cancer|2015–2019|Persons|1|70–74|0.79|0.626|0.892
Relative|Sinuses cancer|2015–2019|Persons|1|75–79|0.651|0.476|0.784
Relative|Sinuses cancer|2015–2019|Persons|1|80–84|0.657|0.48|0.793
Relative|Sinuses cancer|2015–2019|Persons|1|85+|0.607|0.412|0.769
Relative|Sinuses cancer|2015–2019|Persons|1|All ages combined|0.78|0.735|0.82
Relative|Sinuses cancer|2015–2019|Persons|2|00–04|||
Relative|Sinuses cancer|2015–2019|Persons|2|05–09|||
Relative|Sinuses cancer|2015–2019|Persons|2|10–14|||
Relative|Sinuses cancer|2015–2019|Persons|2|15–19|||
Relative|Sinuses cancer|2015–2019|Persons|2|20–24|||
Relative|Sinuses cancer|2015–2019|Persons|2|25–29|||
Relative|Sinuses cancer|2015–2019|Persons|2|30–34|||
Relative|Sinuses cancer|2015–2019|Persons|2|35–39|||
Relative|Sinuses cancer|2015–2019|Persons|2|40–44|||
Relative|Sinuses cancer|2015–2019|Persons|2|45–49|0.81|0.622|0.912
Relative|Sinuses cancer|2015–2019|Persons|2|50–54|0.858|0.685|0.942
Relative|Sinuses cancer|2015–2019|Persons|2|55–59|||
Relative|Sinuses cancer|2015–2019|Persons|2|60–64|0.686|0.544|0.794
Relative|Sinuses cancer|2015–2019|Persons|2|65–69|0.81|0.663|0.902
Relative|Sinuses cancer|2015–2019|Persons|2|70–74|0.628|0.448|0.769
Relative|Sinuses cancer|2015–2019|Persons|2|75–79|0.586|0.407|0.734
Relative|Sinuses cancer|2015–2019|Persons|2|80–84|0.556|0.374|0.716
Relative|Sinuses cancer|2015–2019|Persons|2|85+|||
Relative|Sinuses cancer|2015–2019|Persons|2|All ages combined|0.682|0.63|0.729
Relative|Sinuses cancer|2015–2019|Persons|3|00–04|||
Relative|Sinuses cancer|2015–2019|Persons|3|05–09|||
Relative|Sinuses cancer|2015–2019|Persons|3|10–14|||
Relative|Sinuses cancer|2015–2019|Persons|3|15–19|||
Relative|Sinuses cancer|2015–2019|Persons|3|20–24|||
Relative|Sinuses cancer|2015–2019|Persons|3|25–29|||
Relative|Sinuses cancer|2015–2019|Persons|3|30–34|||
Relative|Sinuses cancer|2015–2019|Persons|3|35–39|||
Relative|Sinuses cancer|2015–2019|Persons|3|40–44|||
Relative|Sinuses cancer|2015–2019|Persons|3|45–49|||
Relative|Sinuses cancer|2015–2019|Persons|3|50–54|0.802|0.623|0.905
Relative|Sinuses cancer|2015–2019|Persons|3|55–59|||
Relative|Sinuses cancer|2015–2019|Persons|3|60–64|0.584|0.436|0.708
Relative|Sinuses cancer|2015–2019|Persons|3|65–69|0.669|0.494|0.799
Relative|Sinuses cancer|2015–2019|Persons|3|70–74|||
Relative|Sinuses cancer|2015–2019|Persons|3|75–79|||
Relative|Sinuses cancer|2015–2019|Persons|3|80–84|||
Relative|Sinuses cancer|2015–2019|Persons|3|85+|||
Relative|Sinuses cancer|2015–2019|Persons|3|All ages combined|0.598|0.542|0.65
Relative|Sinuses cancer|2015–2019|Persons|4|00–04|||
Relative|Sinuses cancer|2015–2019|Persons|4|05–09|||
Relative|Sinuses cancer|2015–2019|Persons|4|10–14|||
Relative|Sinuses cancer|2015–2019|Persons|4|15–19|||
Relative|Sinuses cancer|2015–2019|Persons|4|20–24|||
Relative|Sinuses cancer|2015–2019|Persons|4|25–29|||
Relative|Sinuses cancer|2015–2019|Persons|4|30–34|||
Relative|Sinuses cancer|2015–2019|Persons|4|35–39|||
Relative|Sinuses cancer|2015–2019|Persons|4|40–44|||
Relative|Sinuses cancer|2015–2019|Persons|4|45–49|||
Relative|Sinuses cancer|2015–2019|Persons|4|50–54|0.769|0.58|0.884
Relative|Sinuses cancer|2015–2019|Persons|4|55–59|||
Relative|Sinuses cancer|2015–2019|Persons|4|60–64|0.543|0.393|0.673
Relative|Sinuses cancer|2015–2019|Persons|4|65–69|||
Relative|Sinuses cancer|2015–2019|Persons|4|70–74|||
Relative|Sinuses cancer|2015–2019|Persons|4|75–79|||
Relative|Sinuses cancer|2015–2019|Persons|4|80–84|||
Relative|Sinuses cancer|2015–2019|Persons|4|85+|||
Relative|Sinuses cancer|2015–2019|Persons|4|All ages combined|0.527|0.47|0.583
Relative|Sinuses cancer|2015–2019|Persons|5|00–04|||
Relative|Sinuses cancer|2015–2019|Persons|5|05–09|||
Relative|Sinuses cancer|2015–2019|Persons|5|10–14|||
Relative|Sinuses cancer|2015–2019|Persons|5|15–19|||
Relative|Sinuses cancer|2015–2019|Persons|5|20–24|||
Relative|Sinuses cancer|2015–2019|Persons|5|25–29|||
Relative|Sinuses cancer|2015–2019|Persons|5|30–34|||
Relative|Sinuses cancer|2015–2019|Persons|5|35–39|||
Relative|Sinuses cancer|2015–2019|Persons|5|40–44|||
Relative|Sinuses cancer|2015–2019|Persons|5|45–49|||
Relative|Sinuses cancer|2015–2019|Persons|5|50–54|||
Relative|Sinuses cancer|2015–2019|Persons|5|55–59|||
Relative|Sinuses cancer|2015–2019|Persons|5|60–64|0.525|0.374|0.658
Relative|Sinuses cancer|2015–2019|Persons|5|65–69|||
Relative|Sinuses cancer|2015–2019|Persons|5|70–74|||
Relative|Sinuses cancer|2015–2019|Persons|5|75–79|||
Relative|Sinuses cancer|2015–2019|Persons|5|80–84|||
Relative|Sinuses cancer|2015–2019|Persons|5|85+|||
Relative|Sinuses cancer|2015–2019|Persons|5|All ages combined|0.508|0.449|0.566
Observed|Small intestine cancer|2015–2019|Males|1|00–04|||
Observed|Small intestine cancer|2015–2019|Males|1|05–09|||
Observed|Small intestine cancer|2015–2019|Males|1|10–14|||
Observed|Small intestine cancer|2015–2019|Males|1|15–19|||
Observed|Small intestine cancer|2015–2019|Males|1|20–24|||
Observed|Small intestine cancer|2015–2019|Males|1|25–29|||
Observed|Small intestine cancer|2015–2019|Males|1|30–34|||
Observed|Small intestine cancer|2015–2019|Males|1|35–39|0.908|0.741|0.969
Observed|Small intestine cancer|2015–2019|Males|1|40–44|0.95|0.853|0.984
Observed|Small intestine cancer|2015–2019|Males|1|45–49|0.926|0.843|0.966
Observed|Small intestine cancer|2015–2019|Males|1|50–54|0.922|0.87|0.954
Observed|Small intestine cancer|2015–2019|Males|1|55–59|0.91|0.861|0.942
Observed|Small intestine cancer|2015–2019|Males|1|60–64|0.87|0.821|0.906
Observed|Small intestine cancer|2015–2019|Males|1|65–69|0.854|0.808|0.89
Observed|Small intestine cancer|2015–2019|Males|1|70–74|0.813|0.761|0.855
Observed|Small intestine cancer|2015–2019|Males|1|75–79|0.72|0.66|0.772
Observed|Small intestine cancer|2015–2019|Males|1|80–84|0.656|0.575|0.725
Observed|Small intestine cancer|2015–2019|Males|1|85+|0.536|0.443|0.621
Observed|Small intestine cancer|2015–2019|Males|1|All ages combined|0.817|0.799|0.834
Observed|Small intestine cancer|2015–2019|Males|2|00–04|||
Observed|Small intestine cancer|2015–2019|Males|2|05–09|||
Observed|Small intestine cancer|2015–2019|Males|2|10–14|||
Observed|Small intestine cancer|2015–2019|Males|2|15–19|||
Observed|Small intestine cancer|2015–2019|Males|2|20–24|||
Observed|Small intestine cancer|2015–2019|Males|2|25–29|||
Observed|Small intestine cancer|2015–2019|Males|2|30–34|||
Observed|Small intestine cancer|2015–2019|Males|2|35–39|0.873|0.696|0.951
Observed|Small intestine cancer|2015–2019|Males|2|40–44|0.868|0.754|0.932
Observed|Small intestine cancer|2015–2019|Males|2|45–49|0.871|0.772|0.928
Observed|Small intestine cancer|2015–2019|Males|2|50–54|0.857|0.793|0.903
Observed|Small intestine cancer|2015–2019|Males|2|55–59|0.844|0.785|0.887
Observed|Small intestine cancer|2015–2019|Males|2|60–64|0.797|0.741|0.842
Observed|Small intestine cancer|2015–2019|Males|2|65–69|0.775|0.722|0.818
Observed|Small intestine cancer|2015–2019|Males|2|70–74|0.7|0.641|0.752
Observed|Small intestine cancer|2015–2019|Males|2|75–79|0.641|0.578|0.697
Observed|Small intestine cancer|2015–2019|Males|2|80–84|0.525|0.443|0.601
Observed|Small intestine cancer|2015–2019|Males|2|85+|0.362|0.28|0.445
Observed|Small intestine cancer|2015–2019|Males|2|All ages combined|0.728|0.708|0.748
Observed|Small intestine cancer|2015–2019|Males|3|00–04|||
Observed|Small intestine cancer|2015–2019|Males|3|05–09|||
Observed|Small intestine cancer|2015–2019|Males|3|10–14|||
Observed|Small intestine cancer|2015–2019|Males|3|15–19|||
Observed|Small intestine cancer|2015–2019|Males|3|20–24|||
Observed|Small intestine cancer|2015–2019|Males|3|25–29|||
Observed|Small intestine cancer|2015–2019|Males|3|30–34|||
Observed|Small intestine cancer|2015–2019|Males|3|35–39|0.835|0.645|0.928
Observed|Small intestine cancer|2015–2019|Males|3|40–44|0.851|0.733|0.919
Observed|Small intestine cancer|2015–2019|Males|3|45–49|0.817|0.71|0.887
Observed|Small intestine cancer|2015–2019|Males|3|50–54|0.829|0.761|0.88
Observed|Small intestine cancer|2015–2019|Males|3|55–59|0.812|0.75|0.86
Observed|Small intestine cancer|2015–2019|Males|3|60–64|0.749|0.691|0.799
Observed|Small intestine cancer|2015–2019|Males|3|65–69|0.737|0.683|0.784
Observed|Small intestine cancer|2015–2019|Males|3|70–74|0.66|0.599|0.714
Observed|Small intestine cancer|2015–2019|Males|3|75–79|0.579|0.514|0.637
Observed|Small intestine cancer|2015–2019|Males|3|80–84|0.447|0.365|0.526
Observed|Small intestine cancer|2015–2019|Males|3|85+|0.269|0.195|0.347
Observed|Small intestine cancer|2015–2019|Males|3|All ages combined|0.681|0.659|0.701
Observed|Small intestine cancer|2015–2019|Males|4|00–04|||
Observed|Small intestine cancer|2015–2019|Males|4|05–09|||
Observed|Small intestine cancer|2015–2019|Males|4|10–14|||
Observed|Small intestine cancer|2015–2019|Males|4|15–19|||
Observed|Small intestine cancer|2015–2019|Males|4|20–24|||
Observed|Small intestine cancer|2015–2019|Males|4|25–29|||
Observed|Small intestine cancer|2015–2019|Males|4|30–34|||
Observed|Small intestine cancer|2015–2019|Males|4|35–39|||
Observed|Small intestine cancer|2015–2019|Males|4|40–44|0.81|0.682|0.89
Observed|Small intestine cancer|2015–2019|Males|4|45–49|0.791|0.681|0.866
Observed|Small intestine cancer|2015–2019|Males|4|50–54|0.815|0.744|0.868
Observed|Small intestine cancer|2015–2019|Males|4|55–59|0.801|0.738|0.85
Observed|Small intestine cancer|2015–2019|Males|4|60–64|0.725|0.665|0.776
Observed|Small intestine cancer|2015–2019|Males|4|65–69|0.701|0.645|0.75
Observed|Small intestine cancer|2015–2019|Males|4|70–74|0.6|0.537|0.658
Observed|Small intestine cancer|2015–2019|Males|4|75–79|0.512|0.447|0.572
Observed|Small intestine cancer|2015–2019|Males|4|80–84|0.391|0.311|0.471
Observed|Small intestine cancer|2015–2019|Males|4|85+|0.217|0.149|0.293
Observed|Small intestine cancer|2015–2019|Males|4|All ages combined|0.642|0.619|0.663
Observed|Small intestine cancer|2015–2019|Males|5|00–04|||
Observed|Small intestine cancer|2015–2019|Males|5|05–09|||
Observed|Small intestine cancer|2015–2019|Males|5|10–14|||
Observed|Small intestine cancer|2015–2019|Males|5|15–19|||
Observed|Small intestine cancer|2015–2019|Males|5|20–24|||
Observed|Small intestine cancer|2015–2019|Males|5|25–29|||
Observed|Small intestine cancer|2015–2019|Males|5|30–34|||
Observed|Small intestine cancer|2015–2019|Males|5|35–39|||
Observed|Small intestine cancer|2015–2019|Males|5|40–44|0.79|0.658|0.876
Observed|Small intestine cancer|2015–2019|Males|5|45–49|0.778|0.667|0.856
Observed|Small intestine cancer|2015–2019|Males|5|50–54|0.791|0.716|0.847
Observed|Small intestine cancer|2015–2019|Males|5|55–59|0.795|0.732|0.846
Observed|Small intestine cancer|2015–2019|Males|5|60–64|0.704|0.643|0.757
Observed|Small intestine cancer|2015–2019|Males|5|65–69|0.659|0.601|0.712
Observed|Small intestine cancer|2015–2019|Males|5|70–74|0.572|0.507|0.631
Observed|Small intestine cancer|2015–2019|Males|5|75–79|0.463|0.398|0.525
Observed|Small intestine cancer|2015–2019|Males|5|80–84|0.354|0.275|0.433
Observed|Small intestine cancer|2015–2019|Males|5|85+|0.147|0.09|0.215
Observed|Small intestine cancer|2015–2019|Males|5|All ages combined|0.611|0.588|0.633
Relative|Small intestine cancer|2015–2019|Males|1|00–04|||
Relative|Small intestine cancer|2015–2019|Males|1|05–09|||
Relative|Small intestine cancer|2015–2019|Males|1|10–14|||
Relative|Small intestine cancer|2015–2019|Males|1|15–19|||
Relative|Small intestine cancer|2015–2019|Males|1|20–24|||
Relative|Small intestine cancer|2015–2019|Males|1|25–29|||
Relative|Small intestine cancer|2015–2019|Males|1|30–34|||
Relative|Small intestine cancer|2015–2019|Males|1|35–39|0.909|0.742|0.97
Relative|Small intestine cancer|2015–2019|Males|1|40–44|0.952|0.854|0.985
Relative|Small intestine cancer|2015–2019|Males|1|45–49|0.928|0.845|0.968
Relative|Small intestine cancer|2015–2019|Males|1|50–54|0.925|0.873|0.957
Relative|Small intestine cancer|2015–2019|Males|1|55–59|0.915|0.865|0.947
Relative|Small intestine cancer|2015–2019|Males|1|60–64|0.877|0.827|0.913
Relative|Small intestine cancer|2015–2019|Males|1|65–69|0.864|0.818|0.9
Relative|Small intestine cancer|2015–2019|Males|1|70–74|0.829|0.776|0.871
Relative|Small intestine cancer|2015–2019|Males|1|75–79|0.745|0.682|0.798
Relative|Small intestine cancer|2015–2019|Males|1|80–84|0.696|0.61|0.769
Relative|Small intestine cancer|2015–2019|Males|1|85+|0.614|0.507|0.71
Relative|Small intestine cancer|2015–2019|Males|1|All ages combined|0.837|0.818|0.854
Relative|Small intestine cancer|2015–2019|Males|2|00–04|||
Relative|Small intestine cancer|2015–2019|Males|2|05–09|||
Relative|Small intestine cancer|2015–2019|Males|2|10–14|||
Relative|Small intestine cancer|2015–2019|Males|2|15–19|||
Relative|Small intestine cancer|2015–2019|Males|2|20–24|||
Relative|Small intestine cancer|2015–2019|Males|2|25–29|||
Relative|Small intestine cancer|2015–2019|Males|2|30–34|||
Relative|Small intestine cancer|2015–2019|Males|2|35–39|0.876|0.698|0.953
Relative|Small intestine cancer|2015–2019|Males|2|40–44|0.871|0.756|0.935
Relative|Small intestine cancer|2015–2019|Males|2|45–49|0.875|0.776|0.933
Relative|Small intestine cancer|2015–2019|Males|2|50–54|0.864|0.799|0.909
Relative|Small intestine cancer|2015–2019|Males|2|55–59|0.853|0.794|0.897
Relative|Small intestine cancer|2015–2019|Males|2|60–64|0.81|0.754|0.856
Relative|Small intestine cancer|2015–2019|Males|2|65–69|0.795|0.741|0.839
Relative|Small intestine cancer|2015–2019|Males|2|70–74|0.729|0.667|0.783
Relative|Small intestine cancer|2015–2019|Males|2|75–79|0.688|0.62|0.748
Relative|Small intestine cancer|2015–2019|Males|2|80–84|0.595|0.502|0.681
Relative|Small intestine cancer|2015–2019|Males|2|85+|0.477|0.368|0.587
Relative|Small intestine cancer|2015–2019|Males|2|All ages combined|0.763|0.741|0.783
Relative|Small intestine cancer|2015–2019|Males|3|00–04|||
Relative|Small intestine cancer|2015–2019|Males|3|05–09|||
Relative|Small intestine cancer|2015–2019|Males|3|10–14|||
Relative|Small intestine cancer|2015–2019|Males|3|15–19|||
Relative|Small intestine cancer|2015–2019|Males|3|20–24|||
Relative|Small intestine cancer|2015–2019|Males|3|25–29|||
Relative|Small intestine cancer|2015–2019|Males|3|30–34|||
Relative|Small intestine cancer|2015–2019|Males|3|35–39|0.838|0.648|0.932
Relative|Small intestine cancer|2015–2019|Males|3|40–44|0.855|0.737|0.924
Relative|Small intestine cancer|2015–2019|Males|3|45–49|0.823|0.716|0.894
Relative|Small intestine cancer|2015–2019|Males|3|50–54|0.839|0.77|0.89
Relative|Small intestine cancer|2015–2019|Males|3|55–59|0.826|0.763|0.875
Relative|Small intestine cancer|2015–2019|Males|3|60–64|0.769|0.709|0.82
Relative|Small intestine cancer|2015–2019|Males|3|65–69|0.767|0.711|0.816
Relative|Small intestine cancer|2015–2019|Males|3|70–74|0.704|0.638|0.762
Relative|Small intestine cancer|2015–2019|Males|3|75–79|0.647|0.575|0.712
Relative|Small intestine cancer|2015–2019|Males|3|80–84|0.547|0.447|0.643
Relative|Small intestine cancer|2015–2019|Males|3|85+|0.409|0.297|0.529
Relative|Small intestine cancer|2015–2019|Males|3|All ages combined|0.728|0.705|0.75
Relative|Small intestine cancer|2015–2019|Males|4|00–04|||
Relative|Small intestine cancer|2015–2019|Males|4|05–09|||
Relative|Small intestine cancer|2015–2019|Males|4|10–14|||
Relative|Small intestine cancer|2015–2019|Males|4|15–19|||
Relative|Small intestine cancer|2015–2019|Males|4|20–24|||
Relative|Small intestine cancer|2015–2019|Males|4|25–29|||
Relative|Small intestine cancer|2015–2019|Males|4|30–34|||
Relative|Small intestine cancer|2015–2019|Males|4|35–39|||
Relative|Small intestine cancer|2015–2019|Males|4|40–44|0.816|0.687|0.897
Relative|Small intestine cancer|2015–2019|Males|4|45–49|0.799|0.688|0.876
Relative|Small intestine cancer|2015–2019|Males|4|50–54|0.828|0.756|0.881
Relative|Small intestine cancer|2015–2019|Males|4|55–59|0.82|0.756|0.871
Relative|Small intestine cancer|2015–2019|Males|4|60–64|0.752|0.69|0.805
Relative|Small intestine cancer|2015–2019|Males|4|65–69|0.741|0.682|0.793
Relative|Small intestine cancer|2015–2019|Males|4|70–74|0.658|0.588|0.721
Relative|Small intestine cancer|2015–2019|Males|4|75–79|0.6|0.524|0.671
Relative|Small intestine cancer|2015–2019|Males|4|80–84|0.522|0.415|0.628
Relative|Small intestine cancer|2015–2019|Males|4|85+|0.389|0.268|0.525
Relative|Small intestine cancer|2015–2019|Males|4|All ages combined|0.702|0.678|0.726
Relative|Small intestine cancer|2015–2019|Males|5|00–04|||
Relative|Small intestine cancer|2015–2019|Males|5|05–09|||
Relative|Small intestine cancer|2015–2019|Males|5|10–14|||
Relative|Small intestine cancer|2015–2019|Males|5|15–19|||
Relative|Small intestine cancer|2015–2019|Males|5|20–24|||
Relative|Small intestine cancer|2015–2019|Males|5|25–29|||
Relative|Small intestine cancer|2015–2019|Males|5|30–34|||
Relative|Small intestine cancer|2015–2019|Males|5|35–39|||
Relative|Small intestine cancer|2015–2019|Males|5|40–44|0.798|0.665|0.884
Relative|Small intestine cancer|2015–2019|Males|5|45–49|0.789|0.677|0.868
Relative|Small intestine cancer|2015–2019|Males|5|50–54|0.807|0.731|0.865
Relative|Small intestine cancer|2015–2019|Males|5|55–59|0.82|0.755|0.872
Relative|Small intestine cancer|2015–2019|Males|5|60–64|0.738|0.674|0.794
Relative|Small intestine cancer|2015–2019|Males|5|65–69|0.709|0.646|0.766
Relative|Small intestine cancer|2015–2019|Males|5|70–74|0.645|0.573|0.712
Relative|Small intestine cancer|2015–2019|Males|5|75–79|0.573|0.493|0.65
Relative|Small intestine cancer|2015–2019|Males|5|80–84|0.521|0.406|0.637
Relative|Small intestine cancer|2015–2019|Males|5|85+|0.315|0.194|0.462
Relative|Small intestine cancer|2015–2019|Males|5|All ages combined|0.685|0.659|0.71
Observed|Small intestine cancer|2015–2019|Females|1|00–04|||
Observed|Small intestine cancer|2015–2019|Females|1|05–09|||
Observed|Small intestine cancer|2015–2019|Females|1|10–14|||
Observed|Small intestine cancer|2015–2019|Females|1|15–19|||
Observed|Small intestine cancer|2015–2019|Females|1|20–24|||
Observed|Small intestine cancer|2015–2019|Females|1|25–29|||
Observed|Small intestine cancer|2015–2019|Females|1|30–34|||
Observed|Small intestine cancer|2015–2019|Females|1|35–39|0.927|0.738|0.981
Observed|Small intestine cancer|2015–2019|Females|1|40–44|0.878|0.749|0.943
Observed|Small intestine cancer|2015–2019|Females|1|45–49|0.976|0.906|0.994
Observed|Small intestine cancer|2015–2019|Females|1|50–54|0.94|0.884|0.97
Observed|Small intestine cancer|2015–2019|Females|1|55–59|0.927|0.872|0.959
Observed|Small intestine cancer|2015–2019|Females|1|60–64|0.877|0.82|0.918
Observed|Small intestine cancer|2015–2019|Females|1|65–69|0.891|0.84|0.926
Observed|Small intestine cancer|2015–2019|Females|1|70–74|0.833|0.769|0.881
Observed|Small intestine cancer|2015–2019|Females|1|75–79|0.806|0.74|0.856
Observed|Small intestine cancer|2015–2019|Females|1|80–84|0.635|0.547|0.71
Observed|Small intestine cancer|2015–2019|Females|1|85+|0.476|0.384|0.562
Observed|Small intestine cancer|2015–2019|Females|1|All ages combined|0.83|0.81|0.848
Observed|Small intestine cancer|2015–2019|Females|2|00–04|||
Observed|Small intestine cancer|2015–2019|Females|2|05–09|||
Observed|Small intestine cancer|2015–2019|Females|2|10–14|||
Observed|Small intestine cancer|2015–2019|Females|2|15–19|||
Observed|Small intestine cancer|2015–2019|Females|2|20–24|||
Observed|Small intestine cancer|2015–2019|Females|2|25–29|||
Observed|Small intestine cancer|2015–2019|Females|2|30–34|||
Observed|Small intestine cancer|2015–2019|Females|2|35–39|0.844|0.635|0.939
Observed|Small intestine cancer|2015–2019|Females|2|40–44|0.859|0.727|0.93
Observed|Small intestine cancer|2015–2019|Females|2|45–49|0.951|0.874|0.981
Observed|Small intestine cancer|2015–2019|Females|2|50–54|0.917|0.855|0.953
Observed|Small intestine cancer|2015–2019|Females|2|55–59|0.88|0.816|0.923
Observed|Small intestine cancer|2015–2019|Females|2|60–64|0.833|0.77|0.88
Observed|Small intestine cancer|2015–2019|Females|2|65–69|0.802|0.741|0.849
Observed|Small intestine cancer|2015–2019|Females|2|70–74|0.746|0.673|0.805
Observed|Small intestine cancer|2015–2019|Females|2|75–79|0.726|0.655|0.785
Observed|Small intestine cancer|2015–2019|Females|2|80–84|0.565|0.477|0.643
Observed|Small intestine cancer|2015–2019|Females|2|85+|0.378|0.292|0.463
Observed|Small intestine cancer|2015–2019|Females|2|All ages combined|0.766|0.743|0.787
Observed|Small intestine cancer|2015–2019|Females|3|00–04|||
Observed|Small intestine cancer|2015–2019|Females|3|05–09|||
Observed|Small intestine cancer|2015–2019|Females|3|10–14|||
Observed|Small intestine cancer|2015–2019|Females|3|15–19|||
Observed|Small intestine cancer|2015–2019|Females|3|20–24|||
Observed|Small intestine cancer|2015–2019|Females|3|25–29|||
Observed|Small intestine cancer|2015–2019|Females|3|30–34|||
Observed|Small intestine cancer|2015–2019|Females|3|35–39|||
Observed|Small intestine cancer|2015–2019|Females|3|40–44|0.859|0.727|0.93
Observed|Small intestine cancer|2015–2019|Females|3|45–49|0.897|0.805|0.947
Observed|Small intestine cancer|2015–2019|Females|3|50–54|0.892|0.824|0.935
Observed|Small intestine cancer|2015–2019|Females|3|55–59|0.826|0.753|0.879
Observed|Small intestine cancer|2015–2019|Females|3|60–64|0.783|0.715|0.836
Observed|Small intestine cancer|2015–2019|Females|3|65–69|0.742|0.676|0.796
Observed|Small intestine cancer|2015–2019|Females|3|70–74|0.69|0.614|0.755
Observed|Small intestine cancer|2015–2019|Females|3|75–79|0.653|0.578|0.718
Observed|Small intestine cancer|2015–2019|Females|3|80–84|0.511|0.424|0.591
Observed|Small intestine cancer|2015–2019|Females|3|85+|0.269|0.194|0.35
Observed|Small intestine cancer|2015–2019|Females|3|All ages combined|0.708|0.684|0.731
Observed|Small intestine cancer|2015–2019|Females|4|00–04|||
Observed|Small intestine cancer|2015–2019|Females|4|05–09|||
Observed|Small intestine cancer|2015–2019|Females|4|10–14|||
Observed|Small intestine cancer|2015–2019|Females|4|15–19|||
Observed|Small intestine cancer|2015–2019|Females|4|20–24|||
Observed|Small intestine cancer|2015–2019|Females|4|25–29|||
Observed|Small intestine cancer|2015–2019|Females|4|30–34|||
Observed|Small intestine cancer|2015–2019|Females|4|35–39|||
Observed|Small intestine cancer|2015–2019|Females|4|40–44|0.859|0.727|0.93
Observed|Small intestine cancer|2015–2019|Females|4|45–49|0.867|0.766|0.926
Observed|Small intestine cancer|2015–2019|Females|4|50–54|0.867|0.795|0.915
Observed|Small intestine cancer|2015–2019|Females|4|55–59|0.826|0.753|0.879
Observed|Small intestine cancer|2015–2019|Females|4|60–64|0.76|0.69|0.816
Observed|Small intestine cancer|2015–2019|Females|4|65–69|0.698|0.63|0.755
Observed|Small intestine cancer|2015–2019|Females|4|70–74|0.671|0.594|0.737
Observed|Small intestine cancer|2015–2019|Females|4|75–79|0.585|0.508|0.654
Observed|Small intestine cancer|2015–2019|Females|4|80–84|0.467|0.38|0.55
Observed|Small intestine cancer|2015–2019|Females|4|85+|0.222|0.153|0.299
Observed|Small intestine cancer|2015–2019|Females|4|All ages combined|0.676|0.651|0.7
Observed|Small intestine cancer|2015–2019|Females|5|00–04|||
Observed|Small intestine cancer|2015–2019|Females|5|05–09|||
Observed|Small intestine cancer|2015–2019|Females|5|10–14|||
Observed|Small intestine cancer|2015–2019|Females|5|15–19|||
Observed|Small intestine cancer|2015–2019|Females|5|20–24|||
Observed|Small intestine cancer|2015–2019|Females|5|25–29|||
Observed|Small intestine cancer|2015–2019|Females|5|30–34|||
Observed|Small intestine cancer|2015–2019|Females|5|35–39|||
Observed|Small intestine cancer|2015–2019|Females|5|40–44|0.834|0.695|0.914
Observed|Small intestine cancer|2015–2019|Females|5|45–49|0.819|0.707|0.891
Observed|Small intestine cancer|2015–2019|Females|5|50–54|0.867|0.795|0.915
Observed|Small intestine cancer|2015–2019|Females|5|55–59|0.793|0.715|0.852
Observed|Small intestine cancer|2015–2019|Females|5|60–64|0.723|0.65|0.783
Observed|Small intestine cancer|2015–2019|Females|5|65–69|0.656|0.586|0.716
Observed|Small intestine cancer|2015–2019|Females|5|70–74|0.657|0.579|0.724
Observed|Small intestine cancer|2015–2019|Females|5|75–79|0.544|0.466|0.616
Observed|Small intestine cancer|2015–2019|Females|5|80–84|0.422|0.335|0.506
Observed|Small intestine cancer|2015–2019|Females|5|85+|0.191|0.128|0.265
Observed|Small intestine cancer|2015–2019|Females|5|All ages combined|0.645|0.619|0.669
Relative|Small intestine cancer|2015–2019|Females|1|00–04|||
Relative|Small intestine cancer|2015–2019|Females|1|05–09|||
Relative|Small intestine cancer|2015–2019|Females|1|10–14|||
Relative|Small intestine cancer|2015–2019|Females|1|15–19|||
Relative|Small intestine cancer|2015–2019|Females|1|20–24|||
Relative|Small intestine cancer|2015–2019|Females|1|25–29|||
Relative|Small intestine cancer|2015–2019|Females|1|30–34|||
Relative|Small intestine cancer|2015–2019|Females|1|35–39|0.928|0.739|0.982
Relative|Small intestine cancer|2015–2019|Females|1|40–44|0.879|0.75|0.944
Relative|Small intestine cancer|2015–2019|Females|1|45–49|0.977|0.907|0.995
Relative|Small intestine cancer|2015–2019|Females|1|50–54|0.942|0.886|0.972
Relative|Small intestine cancer|2015–2019|Females|1|55–59|0.93|0.875|0.962
Relative|Small intestine cancer|2015–2019|Females|1|60–64|0.882|0.824|0.922
Relative|Small intestine cancer|2015–2019|Females|1|65–69|0.897|0.846|0.933
Relative|Small intestine cancer|2015–2019|Females|1|70–74|0.843|0.779|0.892
Relative|Small intestine cancer|2015–2019|Females|1|75–79|0.824|0.757|0.875
Relative|Small intestine cancer|2015–2019|Females|1|80–84|0.662|0.571|0.741
Relative|Small intestine cancer|2015–2019|Females|1|85+|0.531|0.429|0.627
Relative|Small intestine cancer|2015–2019|Females|1|All ages combined|0.846|0.825|0.864
Relative|Small intestine cancer|2015–2019|Females|2|00–04|||
Relative|Small intestine cancer|2015–2019|Females|2|05–09|||
Relative|Small intestine cancer|2015–2019|Females|2|10–14|||
Relative|Small intestine cancer|2015–2019|Females|2|15–19|||
Relative|Small intestine cancer|2015–2019|Females|2|20–24|||
Relative|Small intestine cancer|2015–2019|Females|2|25–29|||
Relative|Small intestine cancer|2015–2019|Females|2|30–34|||
Relative|Small intestine cancer|2015–2019|Females|2|35–39|0.845|0.636|0.94
Relative|Small intestine cancer|2015–2019|Females|2|40–44|0.861|0.728|0.932
Relative|Small intestine cancer|2015–2019|Females|2|45–49|0.953|0.876|0.984
Relative|Small intestine cancer|2015–2019|Females|2|50–54|0.921|0.858|0.957
Relative|Small intestine cancer|2015–2019|Females|2|55–59|0.886|0.821|0.929
Relative|Small intestine cancer|2015–2019|Females|2|60–64|0.841|0.778|0.889
Relative|Small intestine cancer|2015–2019|Females|2|65–69|0.814|0.753|0.862
Relative|Small intestine cancer|2015–2019|Females|2|70–74|0.765|0.69|0.825
Relative|Small intestine cancer|2015–2019|Females|2|75–79|0.761|0.686|0.823
Relative|Small intestine cancer|2015–2019|Females|2|80–84|0.618|0.522|0.704
Relative|Small intestine cancer|2015–2019|Females|2|85+|0.474|0.366|0.581
Relative|Small intestine cancer|2015–2019|Females|2|All ages combined|0.793|0.769|0.814
Relative|Small intestine cancer|2015–2019|Females|3|00–04|||
Relative|Small intestine cancer|2015–2019|Females|3|05–09|||
Relative|Small intestine cancer|2015–2019|Females|3|10–14|||
Relative|Small intestine cancer|2015–2019|Females|3|15–19|||
Relative|Small intestine cancer|2015–2019|Females|3|20–24|||
Relative|Small intestine cancer|2015–2019|Females|3|25–29|||
Relative|Small intestine cancer|2015–2019|Females|3|30–34|||
Relative|Small intestine cancer|2015–2019|Females|3|35–39|||
Relative|Small intestine cancer|2015–2019|Females|3|40–44|0.862|0.729|0.933
Relative|Small intestine cancer|2015–2019|Females|3|45–49|0.901|0.808|0.952
Relative|Small intestine cancer|2015–2019|Females|3|50–54|0.898|0.83|0.941
Relative|Small intestine cancer|2015–2019|Females|3|55–59|0.835|0.761|0.888
Relative|Small intestine cancer|2015–2019|Females|3|60–64|0.795|0.726|0.849
Relative|Small intestine cancer|2015–2019|Females|3|65–69|0.76|0.693|0.815
Relative|Small intestine cancer|2015–2019|Females|3|70–74|0.719|0.639|0.786
Relative|Small intestine cancer|2015–2019|Females|3|75–79|0.704|0.623|0.774
Relative|Small intestine cancer|2015–2019|Females|3|80–84|0.59|0.49|0.684
Relative|Small intestine cancer|2015–2019|Females|3|85+|0.383|0.276|0.499
Relative|Small intestine cancer|2015–2019|Females|3|All ages combined|0.746|0.72|0.77
Relative|Small intestine cancer|2015–2019|Females|4|00–04|||
Relative|Small intestine cancer|2015–2019|Females|4|05–09|||
Relative|Small intestine cancer|2015–2019|Females|4|10–14|||
Relative|Small intestine cancer|2015–2019|Females|4|15–19|||
Relative|Small intestine cancer|2015–2019|Females|4|20–24|||
Relative|Small intestine cancer|2015–2019|Females|4|25–29|||
Relative|Small intestine cancer|2015–2019|Females|4|30–34|||
Relative|Small intestine cancer|2015–2019|Females|4|35–39|||
Relative|Small intestine cancer|2015–2019|Females|4|40–44|0.863|0.73|0.934
Relative|Small intestine cancer|2015–2019|Females|4|45–49|0.872|0.771|0.932
Relative|Small intestine cancer|2015–2019|Females|4|50–54|0.875|0.802|0.924
Relative|Small intestine cancer|2015–2019|Females|4|55–59|0.838|0.764|0.892
Relative|Small intestine cancer|2015–2019|Females|4|60–64|0.776|0.705|0.833
Relative|Small intestine cancer|2015–2019|Females|4|65–69|0.722|0.652|0.781
Relative|Small intestine cancer|2015–2019|Females|4|70–74|0.711|0.629|0.78
Relative|Small intestine cancer|2015–2019|Females|4|75–79|0.651|0.565|0.728
Relative|Small intestine cancer|2015–2019|Females|4|80–84|0.575|0.468|0.677
Relative|Small intestine cancer|2015–2019|Females|4|85+|0.363|0.25|0.489
Relative|Small intestine cancer|2015–2019|Females|4|All ages combined|0.724|0.697|0.749
Relative|Small intestine cancer|2015–2019|Females|5|00–04|||
Relative|Small intestine cancer|2015–2019|Females|5|05–09|||
Relative|Small intestine cancer|2015–2019|Females|5|10–14|||
Relative|Small intestine cancer|2015–2019|Females|5|15–19|||
Relative|Small intestine cancer|2015–2019|Females|5|20–24|||
Relative|Small intestine cancer|2015–2019|Females|5|25–29|||
Relative|Small intestine cancer|2015–2019|Females|5|30–34|||
Relative|Small intestine cancer|2015–2019|Females|5|35–39|||
Relative|Small intestine cancer|2015–2019|Females|5|40–44|0.839|0.699|0.919
Relative|Small intestine cancer|2015–2019|Females|5|45–49|0.826|0.713|0.899
Relative|Small intestine cancer|2015–2019|Females|5|50–54|0.878|0.805|0.927
Relative|Small intestine cancer|2015–2019|Females|5|55–59|0.808|0.729|0.868
Relative|Small intestine cancer|2015–2019|Females|5|60–64|0.743|0.669|0.805
Relative|Small intestine cancer|2015–2019|Females|5|65–69|0.686|0.613|0.749
Relative|Small intestine cancer|2015–2019|Females|5|70–74|0.71|0.626|0.782
Relative|Small intestine cancer|2015–2019|Females|5|75–79|0.628|0.538|0.71
Relative|Small intestine cancer|2015–2019|Females|5|80–84|0.558|0.444|0.669
Relative|Small intestine cancer|2015–2019|Females|5|85+|0.367|0.245|0.508
Relative|Small intestine cancer|2015–2019|Females|5|All ages combined|0.704|0.676|0.73
Observed|Small intestine cancer|2015–2019|Persons|1|00–04|||
Observed|Small intestine cancer|2015–2019|Persons|1|05–09|||
Observed|Small intestine cancer|2015–2019|Persons|1|10–14|||
Observed|Small intestine cancer|2015–2019|Persons|1|15–19|||
Observed|Small intestine cancer|2015–2019|Persons|1|20–24|||
Observed|Small intestine cancer|2015–2019|Persons|1|25–29|||
Observed|Small intestine cancer|2015–2019|Persons|1|30–34|0.938|0.774|0.984
Observed|Small intestine cancer|2015–2019|Persons|1|35–39|0.917|0.811|0.964
Observed|Small intestine cancer|2015–2019|Persons|1|40–44|0.918|0.848|0.956
Observed|Small intestine cancer|2015–2019|Persons|1|45–49|0.951|0.904|0.975
Observed|Small intestine cancer|2015–2019|Persons|1|50–54|0.93|0.895|0.954
Observed|Small intestine cancer|2015–2019|Persons|1|55–59|0.917|0.883|0.942
Observed|Small intestine cancer|2015–2019|Persons|1|60–64|0.873|0.837|0.901
Observed|Small intestine cancer|2015–2019|Persons|1|65–69|0.869|0.837|0.896
Observed|Small intestine cancer|2015–2019|Persons|1|70–74|0.821|0.782|0.854
Observed|Small intestine cancer|2015–2019|Persons|1|75–79|0.756|0.713|0.794
Observed|Small intestine cancer|2015–2019|Persons|1|80–84|0.646|0.588|0.698
Observed|Small intestine cancer|2015–2019|Persons|1|85+|0.506|0.441|0.567
Observed|Small intestine cancer|2015–2019|Persons|1|All ages combined|0.823|0.81|0.835
Observed|Small intestine cancer|2015–2019|Persons|2|00–04|||
Observed|Small intestine cancer|2015–2019|Persons|2|05–09|||
Observed|Small intestine cancer|2015–2019|Persons|2|10–14|||
Observed|Small intestine cancer|2015–2019|Persons|2|15–19|||
Observed|Small intestine cancer|2015–2019|Persons|2|20–24|||
Observed|Small intestine cancer|2015–2019|Persons|2|25–29|||
Observed|Small intestine cancer|2015–2019|Persons|2|30–34|0.938|0.774|0.984
Observed|Small intestine cancer|2015–2019|Persons|2|35–39|0.86|0.739|0.928
Observed|Small intestine cancer|2015–2019|Persons|2|40–44|0.864|0.785|0.916
Observed|Small intestine cancer|2015–2019|Persons|2|45–49|0.912|0.855|0.947
Observed|Small intestine cancer|2015–2019|Persons|2|50–54|0.884|0.841|0.916
Observed|Small intestine cancer|2015–2019|Persons|2|55–59|0.859|0.818|0.892
Observed|Small intestine cancer|2015–2019|Persons|2|60–64|0.812|0.772|0.846
Observed|Small intestine cancer|2015–2019|Persons|2|65–69|0.786|0.747|0.819
Observed|Small intestine cancer|2015–2019|Persons|2|70–74|0.718|0.673|0.758
Observed|Small intestine cancer|2015–2019|Persons|2|75–79|0.677|0.63|0.719
Observed|Small intestine cancer|2015–2019|Persons|2|80–84|0.545|0.486|0.6
Observed|Small intestine cancer|2015–2019|Persons|2|85+|0.369|0.309|0.429
Observed|Small intestine cancer|2015–2019|Persons|2|All ages combined|0.745|0.73|0.759
Observed|Small intestine cancer|2015–2019|Persons|3|00–04|||
Observed|Small intestine cancer|2015–2019|Persons|3|05–09|||
Observed|Small intestine cancer|2015–2019|Persons|3|10–14|||
Observed|Small intestine cancer|2015–2019|Persons|3|15–19|||
Observed|Small intestine cancer|2015–2019|Persons|3|20–24|||
Observed|Small intestine cancer|2015–2019|Persons|3|25–29|||
Observed|Small intestine cancer|2015–2019|Persons|3|30–34|0.861|0.668|0.946
Observed|Small intestine cancer|2015–2019|Persons|3|35–39|0.838|0.711|0.913
Observed|Small intestine cancer|2015–2019|Persons|3|40–44|0.855|0.774|0.908
Observed|Small intestine cancer|2015–2019|Persons|3|45–49|0.858|0.792|0.904
Observed|Small intestine cancer|2015–2019|Persons|3|50–54|0.858|0.811|0.893
Observed|Small intestine cancer|2015–2019|Persons|3|55–59|0.819|0.774|0.856
Observed|Small intestine cancer|2015–2019|Persons|3|60–64|0.763|0.72|0.801
Observed|Small intestine cancer|2015–2019|Persons|3|65–69|0.739|0.698|0.775
Observed|Small intestine cancer|2015–2019|Persons|3|70–74|0.672|0.625|0.714
Observed|Small intestine cancer|2015–2019|Persons|3|75–79|0.61|0.562|0.654
Observed|Small intestine cancer|2015–2019|Persons|3|80–84|0.479|0.42|0.536
Observed|Small intestine cancer|2015–2019|Persons|3|85+|0.268|0.215|0.325
Observed|Small intestine cancer|2015–2019|Persons|3|All ages combined|0.693|0.677|0.708
Observed|Small intestine cancer|2015–2019|Persons|4|00–04|||
Observed|Small intestine cancer|2015–2019|Persons|4|05–09|||
Observed|Small intestine cancer|2015–2019|Persons|4|10–14|||
Observed|Small intestine cancer|2015–2019|Persons|4|15–19|||
Observed|Small intestine cancer|2015–2019|Persons|4|20–24|||
Observed|Small intestine cancer|2015–2019|Persons|4|25–29|||
Observed|Small intestine cancer|2015–2019|Persons|4|30–34|||
Observed|Small intestine cancer|2015–2019|Persons|4|35–39|0.838|0.711|0.913
Observed|Small intestine cancer|2015–2019|Persons|4|40–44|0.834|0.749|0.892
Observed|Small intestine cancer|2015–2019|Persons|4|45–49|0.83|0.76|0.881
Observed|Small intestine cancer|2015–2019|Persons|4|50–54|0.838|0.79|0.876
Observed|Small intestine cancer|2015–2019|Persons|4|55–59|0.812|0.766|0.85
Observed|Small intestine cancer|2015–2019|Persons|4|60–64|0.74|0.695|0.779
Observed|Small intestine cancer|2015–2019|Persons|4|65–69|0.7|0.657|0.738
Observed|Small intestine cancer|2015–2019|Persons|4|70–74|0.628|0.58|0.673
Observed|Small intestine cancer|2015–2019|Persons|4|75–79|0.542|0.493|0.589
Observed|Small intestine cancer|2015–2019|Persons|4|80–84|0.429|0.369|0.486
Observed|Small intestine cancer|2015–2019|Persons|4|85+|0.219|0.17|0.272
Observed|Small intestine cancer|2015–2019|Persons|4|All ages combined|0.657|0.64|0.673
Observed|Small intestine cancer|2015–2019|Persons|5|00–04|||
Observed|Small intestine cancer|2015–2019|Persons|5|05–09|||
Observed|Small intestine cancer|2015–2019|Persons|5|10–14|||
Observed|Small intestine cancer|2015–2019|Persons|5|15–19|||
Observed|Small intestine cancer|2015–2019|Persons|5|20–24|||
Observed|Small intestine cancer|2015–2019|Persons|5|25–29|||
Observed|Small intestine cancer|2015–2019|Persons|5|30–34|||
Observed|Small intestine cancer|2015–2019|Persons|5|35–39|0.838|0.711|0.913
Observed|Small intestine cancer|2015–2019|Persons|5|40–44|0.812|0.723|0.875
Observed|Small intestine cancer|2015–2019|Persons|5|45–49|0.801|0.728|0.857
Observed|Small intestine cancer|2015–2019|Persons|5|50–54|0.826|0.776|0.865
Observed|Small intestine cancer|2015–2019|Persons|5|55–59|0.795|0.748|0.835
Observed|Small intestine cancer|2015–2019|Persons|5|60–64|0.712|0.667|0.753
Observed|Small intestine cancer|2015–2019|Persons|5|65–69|0.658|0.614|0.698
Observed|Small intestine cancer|2015–2019|Persons|5|70–74|0.606|0.557|0.651
Observed|Small intestine cancer|2015–2019|Persons|5|75–79|0.497|0.447|0.545
Observed|Small intestine cancer|2015–2019|Persons|5|80–84|0.387|0.329|0.445
Observed|Small intestine cancer|2015–2019|Persons|5|85+|0.17|0.126|0.219
Observed|Small intestine cancer|2015–2019|Persons|5|All ages combined|0.626|0.609|0.642
Relative|Small intestine cancer|2015–2019|Persons|1|00–04|||
Relative|Small intestine cancer|2015–2019|Persons|1|05–09|||
Relative|Small intestine cancer|2015–2019|Persons|1|10–14|||
Relative|Small intestine cancer|2015–2019|Persons|1|15–19|||
Relative|Small intestine cancer|2015–2019|Persons|1|20–24|||
Relative|Small intestine cancer|2015–2019|Persons|1|25–29|||
Relative|Small intestine cancer|2015–2019|Persons|1|30–34|0.938|0.774|0.985
Relative|Small intestine cancer|2015–2019|Persons|1|35–39|0.917|0.812|0.965
Relative|Small intestine cancer|2015–2019|Persons|1|40–44|0.919|0.849|0.958
Relative|Small intestine cancer|2015–2019|Persons|1|45–49|0.953|0.906|0.977
Relative|Small intestine cancer|2015–2019|Persons|1|50–54|0.933|0.897|0.957
Relative|Small intestine cancer|2015–2019|Persons|1|55–59|0.921|0.887|0.946
Relative|Small intestine cancer|2015–2019|Persons|1|60–64|0.879|0.843|0.907
Relative|Small intestine cancer|2015–2019|Persons|1|65–69|0.878|0.845|0.905
Relative|Small intestine cancer|2015–2019|Persons|1|70–74|0.835|0.795|0.868
Relative|Small intestine cancer|2015–2019|Persons|1|75–79|0.778|0.733|0.817
Relative|Small intestine cancer|2015–2019|Persons|1|80–84|0.68|0.619|0.735
Relative|Small intestine cancer|2015–2019|Persons|1|85+|0.572|0.499|0.641
Relative|Small intestine cancer|2015–2019|Persons|1|All ages combined|0.841|0.827|0.853
Relative|Small intestine cancer|2015–2019|Persons|2|00–04|||
Relative|Small intestine cancer|2015–2019|Persons|2|05–09|||
Relative|Small intestine cancer|2015–2019|Persons|2|10–14|||
Relative|Small intestine cancer|2015–2019|Persons|2|15–19|||
Relative|Small intestine cancer|2015–2019|Persons|2|20–24|||
Relative|Small intestine cancer|2015–2019|Persons|2|25–29|||
Relative|Small intestine cancer|2015–2019|Persons|2|30–34|0.939|0.775|0.985
Relative|Small intestine cancer|2015–2019|Persons|2|35–39|0.862|0.741|0.929
Relative|Small intestine cancer|2015–2019|Persons|2|40–44|0.867|0.787|0.918
Relative|Small intestine cancer|2015–2019|Persons|2|45–49|0.915|0.858|0.95
Relative|Small intestine cancer|2015–2019|Persons|2|50–54|0.889|0.847|0.921
Relative|Small intestine cancer|2015–2019|Persons|2|55–59|0.867|0.825|0.9
Relative|Small intestine cancer|2015–2019|Persons|2|60–64|0.823|0.783|0.858
Relative|Small intestine cancer|2015–2019|Persons|2|65–69|0.803|0.763|0.837
Relative|Small intestine cancer|2015–2019|Persons|2|70–74|0.743|0.697|0.785
Relative|Small intestine cancer|2015–2019|Persons|2|75–79|0.719|0.669|0.763
Relative|Small intestine cancer|2015–2019|Persons|2|80–84|0.607|0.541|0.669
Relative|Small intestine cancer|2015–2019|Persons|2|85+|0.475|0.398|0.552
Relative|Small intestine cancer|2015–2019|Persons|2|All ages combined|0.776|0.76|0.791
Relative|Small intestine cancer|2015–2019|Persons|3|00–04|||
Relative|Small intestine cancer|2015–2019|Persons|3|05–09|||
Relative|Small intestine cancer|2015–2019|Persons|3|10–14|||
Relative|Small intestine cancer|2015–2019|Persons|3|15–19|||
Relative|Small intestine cancer|2015–2019|Persons|3|20–24|||
Relative|Small intestine cancer|2015–2019|Persons|3|25–29|||
Relative|Small intestine cancer|2015–2019|Persons|3|30–34|0.863|0.67|0.948
Relative|Small intestine cancer|2015–2019|Persons|3|35–39|0.841|0.713|0.916
Relative|Small intestine cancer|2015–2019|Persons|3|40–44|0.859|0.777|0.912
Relative|Small intestine cancer|2015–2019|Persons|3|45–49|0.863|0.797|0.91
Relative|Small intestine cancer|2015–2019|Persons|3|50–54|0.866|0.819|0.902
Relative|Small intestine cancer|2015–2019|Persons|3|55–59|0.83|0.784|0.868
Relative|Small intestine cancer|2015–2019|Persons|3|60–64|0.78|0.736|0.818
Relative|Small intestine cancer|2015–2019|Persons|3|65–69|0.764|0.722|0.802
Relative|Small intestine cancer|2015–2019|Persons|3|70–74|0.71|0.66|0.755
Relative|Small intestine cancer|2015–2019|Persons|3|75–79|0.671|0.618|0.72
Relative|Small intestine cancer|2015–2019|Persons|3|80–84|0.57|0.499|0.637
Relative|Small intestine cancer|2015–2019|Persons|3|85+|0.396|0.317|0.478
Relative|Small intestine cancer|2015–2019|Persons|3|All ages combined|0.736|0.719|0.752
Relative|Small intestine cancer|2015–2019|Persons|4|00–04|||
Relative|Small intestine cancer|2015–2019|Persons|4|05–09|||
Relative|Small intestine cancer|2015–2019|Persons|4|10–14|||
Relative|Small intestine cancer|2015–2019|Persons|4|15–19|||
Relative|Small intestine cancer|2015–2019|Persons|4|20–24|||
Relative|Small intestine cancer|2015–2019|Persons|4|25–29|||
Relative|Small intestine cancer|2015–2019|Persons|4|30–34|||
Relative|Small intestine cancer|2015–2019|Persons|4|35–39|0.842|0.714|0.917
Relative|Small intestine cancer|2015–2019|Persons|4|40–44|0.839|0.754|0.897
Relative|Small intestine cancer|2015–2019|Persons|4|45–49|0.837|0.766|0.888
Relative|Small intestine cancer|2015–2019|Persons|4|50–54|0.849|0.8|0.888
Relative|Small intestine cancer|2015–2019|Persons|4|55–59|0.828|0.781|0.867
Relative|Small intestine cancer|2015–2019|Persons|4|60–64|0.762|0.717|0.802
Relative|Small intestine cancer|2015–2019|Persons|4|65–69|0.733|0.689|0.773
Relative|Small intestine cancer|2015–2019|Persons|4|70–74|0.679|0.627|0.727
Relative|Small intestine cancer|2015–2019|Persons|4|75–79|0.621|0.565|0.674
Relative|Small intestine cancer|2015–2019|Persons|4|80–84|0.55|0.474|0.624
Relative|Small intestine cancer|2015–2019|Persons|4|85+|0.375|0.291|0.466
Relative|Small intestine cancer|2015–2019|Persons|4|All ages combined|0.712|0.694|0.729
Relative|Small intestine cancer|2015–2019|Persons|5|00–04|||
Relative|Small intestine cancer|2015–2019|Persons|5|05–09|||
Relative|Small intestine cancer|2015–2019|Persons|5|10–14|||
Relative|Small intestine cancer|2015–2019|Persons|5|15–19|||
Relative|Small intestine cancer|2015–2019|Persons|5|20–24|||
Relative|Small intestine cancer|2015–2019|Persons|5|25–29|||
Relative|Small intestine cancer|2015–2019|Persons|5|30–34|||
Relative|Small intestine cancer|2015–2019|Persons|5|35–39|0.843|0.715|0.918
Relative|Small intestine cancer|2015–2019|Persons|5|40–44|0.818|0.729|0.881
Relative|Small intestine cancer|2015–2019|Persons|5|45–49|0.81|0.736|0.866
Relative|Small intestine cancer|2015–2019|Persons|5|50–54|0.84|0.789|0.88
Relative|Small intestine cancer|2015–2019|Persons|5|55–59|0.816|0.768|0.857
Relative|Small intestine cancer|2015–2019|Persons|5|60–64|0.741|0.693|0.783
Relative|Small intestine cancer|2015–2019|Persons|5|65–69|0.7|0.653|0.742
Relative|Small intestine cancer|2015–2019|Persons|5|70–74|0.671|0.617|0.721
Relative|Small intestine cancer|2015–2019|Persons|5|75–79|0.596|0.537|0.653
Relative|Small intestine cancer|2015–2019|Persons|5|80–84|0.541|0.46|0.622
Relative|Small intestine cancer|2015–2019|Persons|5|85+|0.345|0.256|0.445
Relative|Small intestine cancer|2015–2019|Persons|5|All ages combined|0.693|0.674|0.712
Observed|Soft tissue sarcoma|2015–2019|Males|1|00–04|0.843|0.72|0.915
Observed|Soft tissue sarcoma|2015–2019|Males|1|05–09|0.936|0.767|0.984
Observed|Soft tissue sarcoma|2015–2019|Males|1|10–14|0.968|0.795|0.995
Observed|Soft tissue sarcoma|2015–2019|Males|1|15–19|0.939|0.847|0.977
Observed|Soft tissue sarcoma|2015–2019|Males|1|20–24|0.815|0.704|0.888
Observed|Soft tissue sarcoma|2015–2019|Males|1|25–29|0.84|0.744|0.902
Observed|Soft tissue sarcoma|2015–2019|Males|1|30–34|0.976|0.909|0.994
Observed|Soft tissue sarcoma|2015–2019|Males|1|35–39|0.935|0.875|0.967
Observed|Soft tissue sarcoma|2015–2019|Males|1|40–44|0.942|0.891|0.969
Observed|Soft tissue sarcoma|2015–2019|Males|1|45–49|0.915|0.87|0.945
Observed|Soft tissue sarcoma|2015–2019|Males|1|50–54|0.929|0.892|0.954
Observed|Soft tissue sarcoma|2015–2019|Males|1|55–59|0.882|0.845|0.91
Observed|Soft tissue sarcoma|2015–2019|Males|1|60–64|0.874|0.841|0.9
Observed|Soft tissue sarcoma|2015–2019|Males|1|65–69|0.861|0.829|0.888
Observed|Soft tissue sarcoma|2015–2019|Males|1|70–74|0.806|0.773|0.836
Observed|Soft tissue sarcoma|2015–2019|Males|1|75–79|0.808|0.773|0.838
Observed|Soft tissue sarcoma|2015–2019|Males|1|80–84|0.781|0.742|0.814
Observed|Soft tissue sarcoma|2015–2019|Males|1|85+|0.668|0.626|0.707
Observed|Soft tissue sarcoma|2015–2019|Males|1|All ages combined|0.836|0.825|0.846
Observed|Soft tissue sarcoma|2015–2019|Males|2|00–04|0.73|0.592|0.828
Observed|Soft tissue sarcoma|2015–2019|Males|2|05–09|0.872|0.694|0.95
Observed|Soft tissue sarcoma|2015–2019|Males|2|10–14|0.938|0.776|0.984
Observed|Soft tissue sarcoma|2015–2019|Males|2|15–19|0.812|0.684|0.891
Observed|Soft tissue sarcoma|2015–2019|Males|2|20–24|0.701|0.579|0.794
Observed|Soft tissue sarcoma|2015–2019|Males|2|25–29|0.706|0.6|0.789
Observed|Soft tissue sarcoma|2015–2019|Males|2|30–34|0.889|0.797|0.94
Observed|Soft tissue sarcoma|2015–2019|Males|2|35–39|0.862|0.787|0.912
Observed|Soft tissue sarcoma|2015–2019|Males|2|40–44|0.878|0.816|0.92
Observed|Soft tissue sarcoma|2015–2019|Males|2|45–49|0.863|0.811|0.902
Observed|Soft tissue sarcoma|2015–2019|Males|2|50–54|0.838|0.79|0.876
Observed|Soft tissue sarcoma|2015–2019|Males|2|55–59|0.833|0.792|0.867
Observed|Soft tissue sarcoma|2015–2019|Males|2|60–64|0.812|0.775|0.844
Observed|Soft tissue sarcoma|2015–2019|Males|2|65–69|0.764|0.726|0.798
Observed|Soft tissue sarcoma|2015–2019|Males|2|70–74|0.72|0.682|0.755
Observed|Soft tissue sarcoma|2015–2019|Males|2|75–79|0.727|0.688|0.762
Observed|Soft tissue sarcoma|2015–2019|Males|2|80–84|0.664|0.621|0.704
Observed|Soft tissue sarcoma|2015–2019|Males|2|85+|0.49|0.445|0.532
Observed|Soft tissue sarcoma|2015–2019|Males|2|All ages combined|0.743|0.73|0.755
Observed|Soft tissue sarcoma|2015–2019|Males|3|00–04|0.73|0.592|0.828
Observed|Soft tissue sarcoma|2015–2019|Males|3|05–09|0.842|0.661|0.931
Observed|Soft tissue sarcoma|2015–2019|Males|3|10–14|0.858|0.691|0.938
Observed|Soft tissue sarcoma|2015–2019|Males|3|15–19|0.769|0.633|0.86
Observed|Soft tissue sarcoma|2015–2019|Males|3|20–24|0.688|0.566|0.782
Observed|Soft tissue sarcoma|2015–2019|Males|3|25–29|0.655|0.547|0.743
Observed|Soft tissue sarcoma|2015–2019|Males|3|30–34|0.855|0.759|0.915
Observed|Soft tissue sarcoma|2015–2019|Males|3|35–39|0.837|0.759|0.892
Observed|Soft tissue sarcoma|2015–2019|Males|3|40–44|0.818|0.748|0.871
Observed|Soft tissue sarcoma|2015–2019|Males|3|45–49|0.812|0.755|0.857
Observed|Soft tissue sarcoma|2015–2019|Males|3|50–54|0.801|0.75|0.843
Observed|Soft tissue sarcoma|2015–2019|Males|3|55–59|0.802|0.758|0.838
Observed|Soft tissue sarcoma|2015–2019|Males|3|60–64|0.765|0.725|0.8
Observed|Soft tissue sarcoma|2015–2019|Males|3|65–69|0.7|0.659|0.737
Observed|Soft tissue sarcoma|2015–2019|Males|3|70–74|0.668|0.628|0.705
Observed|Soft tissue sarcoma|2015–2019|Males|3|75–79|0.641|0.599|0.68
Observed|Soft tissue sarcoma|2015–2019|Males|3|80–84|0.556|0.51|0.599
Observed|Soft tissue sarcoma|2015–2019|Males|3|85+|0.364|0.322|0.406
Observed|Soft tissue sarcoma|2015–2019|Males|3|All ages combined|0.678|0.665|0.692
Observed|Soft tissue sarcoma|2015–2019|Males|4|00–04|0.676|0.536|0.782
Observed|Soft tissue sarcoma|2015–2019|Males|4|05–09|0.842|0.661|0.931
Observed|Soft tissue sarcoma|2015–2019|Males|4|10–14|0.804|0.633|0.901
Observed|Soft tissue sarcoma|2015–2019|Males|4|15–19|0.722|0.579|0.824
Observed|Soft tissue sarcoma|2015–2019|Males|4|20–24|0.641|0.52|0.739
Observed|Soft tissue sarcoma|2015–2019|Males|4|25–29|0.655|0.547|0.743
Observed|Soft tissue sarcoma|2015–2019|Males|4|30–34|0.823|0.724|0.889
Observed|Soft tissue sarcoma|2015–2019|Males|4|35–39|0.811|0.73|0.87
Observed|Soft tissue sarcoma|2015–2019|Males|4|40–44|0.753|0.676|0.813
Observed|Soft tissue sarcoma|2015–2019|Males|4|45–49|0.78|0.721|0.828
Observed|Soft tissue sarcoma|2015–2019|Males|4|50–54|0.769|0.716|0.813
Observed|Soft tissue sarcoma|2015–2019|Males|4|55–59|0.764|0.718|0.804
Observed|Soft tissue sarcoma|2015–2019|Males|4|60–64|0.735|0.693|0.771
Observed|Soft tissue sarcoma|2015–2019|Males|4|65–69|0.66|0.618|0.699
Observed|Soft tissue sarcoma|2015–2019|Males|4|70–74|0.631|0.59|0.67
Observed|Soft tissue sarcoma|2015–2019|Males|4|75–79|0.584|0.54|0.624
Observed|Soft tissue sarcoma|2015–2019|Males|4|80–84|0.479|0.433|0.524
Observed|Soft tissue sarcoma|2015–2019|Males|4|85+|0.284|0.244|0.326
Observed|Soft tissue sarcoma|2015–2019|Males|4|All ages combined|0.633|0.619|0.647
Observed|Soft tissue sarcoma|2015–2019|Males|5|00–04|0.676|0.536|0.782
Observed|Soft tissue sarcoma|2015–2019|Males|5|05–09|0.842|0.661|0.931
Observed|Soft tissue sarcoma|2015–2019|Males|5|10–14|0.777|0.604|0.882
Observed|Soft tissue sarcoma|2015–2019|Males|5|15–19|0.678|0.53|0.788
Observed|Soft tissue sarcoma|2015–2019|Males|5|20–24|0.641|0.52|0.739
Observed|Soft tissue sarcoma|2015–2019|Males|5|25–29|0.645|0.537|0.733
Observed|Soft tissue sarcoma|2015–2019|Males|5|30–34|0.802|0.701|0.872
Observed|Soft tissue sarcoma|2015–2019|Males|5|35–39|0.803|0.721|0.864
Observed|Soft tissue sarcoma|2015–2019|Males|5|40–44|0.715|0.637|0.779
Observed|Soft tissue sarcoma|2015–2019|Males|5|45–49|0.76|0.7|0.81
Observed|Soft tissue sarcoma|2015–2019|Males|5|50–54|0.756|0.702|0.801
Observed|Soft tissue sarcoma|2015–2019|Males|5|55–59|0.756|0.71|0.796
Observed|Soft tissue sarcoma|2015–2019|Males|5|60–64|0.712|0.669|0.75
Observed|Soft tissue sarcoma|2015–2019|Males|5|65–69|0.633|0.59|0.672
Observed|Soft tissue sarcoma|2015–2019|Males|5|70–74|0.592|0.55|0.632
Observed|Soft tissue sarcoma|2015–2019|Males|5|75–79|0.535|0.49|0.577
Observed|Soft tissue sarcoma|2015–2019|Males|5|80–84|0.407|0.36|0.452
Observed|Soft tissue sarcoma|2015–2019|Males|5|85+|0.217|0.18|0.257
Observed|Soft tissue sarcoma|2015–2019|Males|5|All ages combined|0.601|0.586|0.614
Relative|Soft tissue sarcoma|2015–2019|Males|1|00–04|0.844|0.721|0.916
Relative|Soft tissue sarcoma|2015–2019|Males|1|05–09|0.936|0.767|0.984
Relative|Soft tissue sarcoma|2015–2019|Males|1|10–14|0.968|0.795|0.996
Relative|Soft tissue sarcoma|2015–2019|Males|1|15–19|0.94|0.847|0.977
Relative|Soft tissue sarcoma|2015–2019|Males|1|20–24|0.816|0.704|0.889
Relative|Soft tissue sarcoma|2015–2019|Males|1|25–29|0.84|0.745|0.902
Relative|Soft tissue sarcoma|2015–2019|Males|1|30–34|0.977|0.909|0.995
Relative|Soft tissue sarcoma|2015–2019|Males|1|35–39|0.936|0.876|0.968
Relative|Soft tissue sarcoma|2015–2019|Males|1|40–44|0.943|0.892|0.971
Relative|Soft tissue sarcoma|2015–2019|Males|1|45–49|0.917|0.873|0.947
Relative|Soft tissue sarcoma|2015–2019|Males|1|50–54|0.932|0.896|0.957
Relative|Soft tissue sarcoma|2015–2019|Males|1|55–59|0.887|0.85|0.915
Relative|Soft tissue sarcoma|2015–2019|Males|1|60–64|0.881|0.848|0.907
Relative|Soft tissue sarcoma|2015–2019|Males|1|65–69|0.872|0.84|0.898
Relative|Soft tissue sarcoma|2015–2019|Males|1|70–74|0.822|0.788|0.852
Relative|Soft tissue sarcoma|2015–2019|Males|1|75–79|0.835|0.799|0.867
Relative|Soft tissue sarcoma|2015–2019|Males|1|80–84|0.829|0.788|0.865
Relative|Soft tissue sarcoma|2015–2019|Males|1|85+|0.773|0.725|0.818
Relative|Soft tissue sarcoma|2015–2019|Males|1|All ages combined|0.862|0.851|0.872
Relative|Soft tissue sarcoma|2015–2019|Males|2|00–04|0.731|0.593|0.829
Relative|Soft tissue sarcoma|2015–2019|Males|2|05–09|0.872|0.694|0.95
Relative|Soft tissue sarcoma|2015–2019|Males|2|10–14|0.939|0.776|0.984
Relative|Soft tissue sarcoma|2015–2019|Males|2|15–19|0.812|0.685|0.892
Relative|Soft tissue sarcoma|2015–2019|Males|2|20–24|0.702|0.58|0.795
Relative|Soft tissue sarcoma|2015–2019|Males|2|25–29|0.707|0.601|0.79
Relative|Soft tissue sarcoma|2015–2019|Males|2|30–34|0.89|0.798|0.942
Relative|Soft tissue sarcoma|2015–2019|Males|2|35–39|0.864|0.789|0.914
Relative|Soft tissue sarcoma|2015–2019|Males|2|40–44|0.881|0.818|0.924
Relative|Soft tissue sarcoma|2015–2019|Males|2|45–49|0.867|0.815|0.906
Relative|Soft tissue sarcoma|2015–2019|Males|2|50–54|0.844|0.796|0.882
Relative|Soft tissue sarcoma|2015–2019|Males|2|55–59|0.843|0.801|0.877
Relative|Soft tissue sarcoma|2015–2019|Males|2|60–64|0.826|0.788|0.858
Relative|Soft tissue sarcoma|2015–2019|Males|2|65–69|0.784|0.745|0.818
Relative|Soft tissue sarcoma|2015–2019|Males|2|70–74|0.751|0.711|0.786
Relative|Soft tissue sarcoma|2015–2019|Males|2|75–79|0.781|0.739|0.819
Relative|Soft tissue sarcoma|2015–2019|Males|2|80–84|0.755|0.706|0.8
Relative|Soft tissue sarcoma|2015–2019|Males|2|85+|0.661|0.601|0.719
Relative|Soft tissue sarcoma|2015–2019|Males|2|All ages combined|0.789|0.775|0.801
Relative|Soft tissue sarcoma|2015–2019|Males|3|00–04|0.731|0.593|0.829
Relative|Soft tissue sarcoma|2015–2019|Males|3|05–09|0.842|0.661|0.931
Relative|Soft tissue sarcoma|2015–2019|Males|3|10–14|0.858|0.692|0.939
Relative|Soft tissue sarcoma|2015–2019|Males|3|15–19|0.77|0.634|0.861
Relative|Soft tissue sarcoma|2015–2019|Males|3|20–24|0.689|0.567|0.783
Relative|Soft tissue sarcoma|2015–2019|Males|3|25–29|0.656|0.548|0.744
Relative|Soft tissue sarcoma|2015–2019|Males|3|30–34|0.857|0.761|0.917
Relative|Soft tissue sarcoma|2015–2019|Males|3|35–39|0.84|0.762|0.895
Relative|Soft tissue sarcoma|2015–2019|Males|3|40–44|0.823|0.752|0.875
Relative|Soft tissue sarcoma|2015–2019|Males|3|45–49|0.818|0.761|0.863
Relative|Soft tissue sarcoma|2015–2019|Males|3|50–54|0.81|0.759|0.852
Relative|Soft tissue sarcoma|2015–2019|Males|3|55–59|0.816|0.772|0.853
Relative|Soft tissue sarcoma|2015–2019|Males|3|60–64|0.785|0.745|0.821
Relative|Soft tissue sarcoma|2015–2019|Males|3|65–69|0.729|0.686|0.767
Relative|Soft tissue sarcoma|2015–2019|Males|3|70–74|0.713|0.67|0.753
Relative|Soft tissue sarcoma|2015–2019|Males|3|75–79|0.718|0.671|0.762
Relative|Soft tissue sarcoma|2015–2019|Males|3|80–84|0.683|0.627|0.736
Relative|Soft tissue sarcoma|2015–2019|Males|3|85+|0.579|0.512|0.646
Relative|Soft tissue sarcoma|2015–2019|Males|3|All ages combined|0.74|0.726|0.755
Relative|Soft tissue sarcoma|2015–2019|Males|4|00–04|0.677|0.537|0.784
Relative|Soft tissue sarcoma|2015–2019|Males|4|05–09|0.842|0.661|0.931
Relative|Soft tissue sarcoma|2015–2019|Males|4|10–14|0.805|0.634|0.902
Relative|Soft tissue sarcoma|2015–2019|Males|4|15–19|0.724|0.58|0.826
Relative|Soft tissue sarcoma|2015–2019|Males|4|20–24|0.643|0.521|0.741
Relative|Soft tissue sarcoma|2015–2019|Males|4|25–29|0.657|0.549|0.745
Relative|Soft tissue sarcoma|2015–2019|Males|4|30–34|0.826|0.726|0.893
Relative|Soft tissue sarcoma|2015–2019|Males|4|35–39|0.816|0.734|0.875
Relative|Soft tissue sarcoma|2015–2019|Males|4|40–44|0.758|0.681|0.819
Relative|Soft tissue sarcoma|2015–2019|Males|4|45–49|0.788|0.729|0.837
Relative|Soft tissue sarcoma|2015–2019|Males|4|50–54|0.781|0.728|0.826
Relative|Soft tissue sarcoma|2015–2019|Males|4|55–59|0.783|0.736|0.823
Relative|Soft tissue sarcoma|2015–2019|Males|4|60–64|0.762|0.719|0.8
Relative|Soft tissue sarcoma|2015–2019|Males|4|65–69|0.698|0.654|0.739
Relative|Soft tissue sarcoma|2015–2019|Males|4|70–74|0.692|0.647|0.735
Relative|Soft tissue sarcoma|2015–2019|Males|4|75–79|0.685|0.634|0.734
Relative|Soft tissue sarcoma|2015–2019|Males|4|80–84|0.642|0.58|0.702
Relative|Soft tissue sarcoma|2015–2019|Males|4|85+|0.541|0.465|0.619
Relative|Soft tissue sarcoma|2015–2019|Males|4|All ages combined|0.709|0.694|0.725
Relative|Soft tissue sarcoma|2015–2019|Males|5|00–04|0.677|0.537|0.784
Relative|Soft tissue sarcoma|2015–2019|Males|5|05–09|0.842|0.661|0.931
Relative|Soft tissue sarcoma|2015–2019|Males|5|10–14|0.778|0.605|0.883
Relative|Soft tissue sarcoma|2015–2019|Males|5|15–19|0.68|0.531|0.79
Relative|Soft tissue sarcoma|2015–2019|Males|5|20–24|0.643|0.522|0.741
Relative|Soft tissue sarcoma|2015–2019|Males|5|25–29|0.647|0.539|0.736
Relative|Soft tissue sarcoma|2015–2019|Males|5|30–34|0.806|0.705|0.876
Relative|Soft tissue sarcoma|2015–2019|Males|5|35–39|0.809|0.726|0.869
Relative|Soft tissue sarcoma|2015–2019|Males|5|40–44|0.722|0.643|0.787
Relative|Soft tissue sarcoma|2015–2019|Males|5|45–49|0.771|0.71|0.821
Relative|Soft tissue sarcoma|2015–2019|Males|5|50–54|0.772|0.717|0.818
Relative|Soft tissue sarcoma|2015–2019|Males|5|55–59|0.78|0.732|0.821
Relative|Soft tissue sarcoma|2015–2019|Males|5|60–64|0.746|0.702|0.786
Relative|Soft tissue sarcoma|2015–2019|Males|5|65–69|0.681|0.635|0.724
Relative|Soft tissue sarcoma|2015–2019|Males|5|70–74|0.67|0.621|0.715
Relative|Soft tissue sarcoma|2015–2019|Males|5|75–79|0.663|0.608|0.716
Relative|Soft tissue sarcoma|2015–2019|Males|5|80–84|0.602|0.533|0.67
Relative|Soft tissue sarcoma|2015–2019|Males|5|85+|0.502|0.415|0.594
Relative|Soft tissue sarcoma|2015–2019|Males|5|All ages combined|0.691|0.674|0.707
Observed|Soft tissue sarcoma|2015–2019|Females|1|00–04|0.891|0.736|0.958
Observed|Soft tissue sarcoma|2015–2019|Females|1|05–09|0.888|0.692|0.962
Observed|Soft tissue sarcoma|2015–2019|Females|1|10–14|0.88|0.711|0.953
Observed|Soft tissue sarcoma|2015–2019|Females|1|15–19|0.938|0.844|0.976
Observed|Soft tissue sarcoma|2015–2019|Females|1|20–24|0.936|0.838|0.975
Observed|Soft tissue sarcoma|2015–2019|Females|1|25–29|0.932|0.83|0.974
Observed|Soft tissue sarcoma|2015–2019|Females|1|30–34|0.966|0.911|0.987
Observed|Soft tissue sarcoma|2015–2019|Females|1|35–39|0.943|0.89|0.971
Observed|Soft tissue sarcoma|2015–2019|Females|1|40–44|0.962|0.925|0.981
Observed|Soft tissue sarcoma|2015–2019|Females|1|45–49|0.933|0.899|0.956
Observed|Soft tissue sarcoma|2015–2019|Females|1|50–54|0.915|0.882|0.939
Observed|Soft tissue sarcoma|2015–2019|Females|1|55–59|0.873|0.836|0.902
Observed|Soft tissue sarcoma|2015–2019|Females|1|60–64|0.892|0.858|0.918
Observed|Soft tissue sarcoma|2015–2019|Females|1|65–69|0.858|0.821|0.887
Observed|Soft tissue sarcoma|2015–2019|Females|1|70–74|0.824|0.783|0.857
Observed|Soft tissue sarcoma|2015–2019|Females|1|75–79|0.773|0.725|0.814
Observed|Soft tissue sarcoma|2015–2019|Females|1|80–84|0.736|0.683|0.782
Observed|Soft tissue sarcoma|2015–2019|Females|1|85+|0.66|0.606|0.709
Observed|Soft tissue sarcoma|2015–2019|Females|1|All ages combined|0.854|0.843|0.865
Observed|Soft tissue sarcoma|2015–2019|Females|2|00–04|0.891|0.736|0.958
Observed|Soft tissue sarcoma|2015–2019|Females|2|05–09|0.849|0.646|0.941
Observed|Soft tissue sarcoma|2015–2019|Females|2|10–14|0.791|0.612|0.895
Observed|Soft tissue sarcoma|2015–2019|Females|2|15–19|0.883|0.769|0.943
Observed|Soft tissue sarcoma|2015–2019|Females|2|20–24|0.817|0.693|0.894
Observed|Soft tissue sarcoma|2015–2019|Females|2|25–29|0.885|0.774|0.943
Observed|Soft tissue sarcoma|2015–2019|Females|2|30–34|0.912|0.843|0.952
Observed|Soft tissue sarcoma|2015–2019|Females|2|35–39|0.884|0.817|0.927
Observed|Soft tissue sarcoma|2015–2019|Females|2|40–44|0.894|0.844|0.929
Observed|Soft tissue sarcoma|2015–2019|Females|2|45–49|0.889|0.849|0.919
Observed|Soft tissue sarcoma|2015–2019|Females|2|50–54|0.842|0.801|0.875
Observed|Soft tissue sarcoma|2015–2019|Females|2|55–59|0.782|0.738|0.819
Observed|Soft tissue sarcoma|2015–2019|Females|2|60–64|0.818|0.776|0.852
Observed|Soft tissue sarcoma|2015–2019|Females|2|65–69|0.788|0.747|0.824
Observed|Soft tissue sarcoma|2015–2019|Females|2|70–74|0.742|0.696|0.782
Observed|Soft tissue sarcoma|2015–2019|Females|2|75–79|0.675|0.623|0.722
Observed|Soft tissue sarcoma|2015–2019|Females|2|80–84|0.644|0.587|0.695
Observed|Soft tissue sarcoma|2015–2019|Females|2|85+|0.514|0.458|0.567
Observed|Soft tissue sarcoma|2015–2019|Females|2|All ages combined|0.774|0.76|0.786
Observed|Soft tissue sarcoma|2015–2019|Females|3|00–04|0.891|0.736|0.958
Observed|Soft tissue sarcoma|2015–2019|Females|3|05–09|0.849|0.646|0.941
Observed|Soft tissue sarcoma|2015–2019|Females|3|10–14|0.74|0.56|0.855
Observed|Soft tissue sarcoma|2015–2019|Females|3|15–19|0.784|0.65|0.872
Observed|Soft tissue sarcoma|2015–2019|Females|3|20–24|0.772|0.645|0.858
Observed|Soft tissue sarcoma|2015–2019|Females|3|25–29|0.885|0.774|0.943
Observed|Soft tissue sarcoma|2015–2019|Females|3|30–34|0.877|0.801|0.925
Observed|Soft tissue sarcoma|2015–2019|Females|3|35–39|0.859|0.788|0.908
Observed|Soft tissue sarcoma|2015–2019|Females|3|40–44|0.868|0.814|0.908
Observed|Soft tissue sarcoma|2015–2019|Females|3|45–49|0.834|0.787|0.871
Observed|Soft tissue sarcoma|2015–2019|Females|3|50–54|0.792|0.748|0.83
Observed|Soft tissue sarcoma|2015–2019|Females|3|55–59|0.734|0.688|0.775
Observed|Soft tissue sarcoma|2015–2019|Females|3|60–64|0.78|0.736|0.818
Observed|Soft tissue sarcoma|2015–2019|Females|3|65–69|0.72|0.675|0.76
Observed|Soft tissue sarcoma|2015–2019|Females|3|70–74|0.695|0.647|0.737
Observed|Soft tissue sarcoma|2015–2019|Females|3|75–79|0.608|0.554|0.658
Observed|Soft tissue sarcoma|2015–2019|Females|3|80–84|0.578|0.519|0.632
Observed|Soft tissue sarcoma|2015–2019|Females|3|85+|0.397|0.343|0.45
Observed|Soft tissue sarcoma|2015–2019|Females|3|All ages combined|0.719|0.705|0.732
Observed|Soft tissue sarcoma|2015–2019|Females|4|00–04|0.891|0.736|0.958
Observed|Soft tissue sarcoma|2015–2019|Females|4|05–09|||
Observed|Soft tissue sarcoma|2015–2019|Females|4|10–14|0.635|0.458|0.769
Observed|Soft tissue sarcoma|2015–2019|Females|4|15–19|0.723|0.581|0.824
Observed|Soft tissue sarcoma|2015–2019|Females|4|20–24|0.757|0.63|0.846
Observed|Soft tissue sarcoma|2015–2019|Females|4|25–29|0.87|0.757|0.933
Observed|Soft tissue sarcoma|2015–2019|Females|4|30–34|0.836|0.752|0.893
Observed|Soft tissue sarcoma|2015–2019|Females|4|35–39|0.833|0.756|0.887
Observed|Soft tissue sarcoma|2015–2019|Females|4|40–44|0.846|0.787|0.889
Observed|Soft tissue sarcoma|2015–2019|Females|4|45–49|0.792|0.742|0.833
Observed|Soft tissue sarcoma|2015–2019|Females|4|50–54|0.769|0.723|0.808
Observed|Soft tissue sarcoma|2015–2019|Females|4|55–59|0.707|0.66|0.75
Observed|Soft tissue sarcoma|2015–2019|Females|4|60–64|0.724|0.677|0.766
Observed|Soft tissue sarcoma|2015–2019|Females|4|65–69|0.68|0.634|0.723
Observed|Soft tissue sarcoma|2015–2019|Females|4|70–74|0.649|0.599|0.694
Observed|Soft tissue sarcoma|2015–2019|Females|4|75–79|0.548|0.493|0.598
Observed|Soft tissue sarcoma|2015–2019|Females|4|80–84|0.508|0.448|0.564
Observed|Soft tissue sarcoma|2015–2019|Females|4|85+|0.286|0.236|0.338
Observed|Soft tissue sarcoma|2015–2019|Females|4|All ages combined|0.672|0.657|0.686
Observed|Soft tissue sarcoma|2015–2019|Females|5|00–04|0.891|0.736|0.958
Observed|Soft tissue sarcoma|2015–2019|Females|5|05–09|||
Observed|Soft tissue sarcoma|2015–2019|Females|5|10–14|0.635|0.458|0.769
Observed|Soft tissue sarcoma|2015–2019|Females|5|15–19|0.697|0.551|0.804
Observed|Soft tissue sarcoma|2015–2019|Females|5|20–24|0.713|0.585|0.808
Observed|Soft tissue sarcoma|2015–2019|Females|5|25–29|0.831|0.716|0.903
Observed|Soft tissue sarcoma|2015–2019|Females|5|30–34|0.814|0.727|0.876
Observed|Soft tissue sarcoma|2015–2019|Females|5|35–39|0.807|0.728|0.866
Observed|Soft tissue sarcoma|2015–2019|Females|5|40–44|0.812|0.75|0.86
Observed|Soft tissue sarcoma|2015–2019|Females|5|45–49|0.767|0.715|0.81
Observed|Soft tissue sarcoma|2015–2019|Females|5|50–54|0.766|0.72|0.806
Observed|Soft tissue sarcoma|2015–2019|Females|5|55–59|0.682|0.633|0.726
Observed|Soft tissue sarcoma|2015–2019|Females|5|60–64|0.689|0.641|0.733
Observed|Soft tissue sarcoma|2015–2019|Females|5|65–69|0.649|0.601|0.693
Observed|Soft tissue sarcoma|2015–2019|Females|5|70–74|0.615|0.565|0.662
Observed|Soft tissue sarcoma|2015–2019|Females|5|75–79|0.502|0.448|0.554
Observed|Soft tissue sarcoma|2015–2019|Females|5|80–84|0.442|0.383|0.5
Observed|Soft tissue sarcoma|2015–2019|Females|5|85+|0.214|0.169|0.263
Observed|Soft tissue sarcoma|2015–2019|Females|5|All ages combined|0.639|0.623|0.653
Relative|Soft tissue sarcoma|2015–2019|Females|1|00–04|0.892|0.737|0.959
Relative|Soft tissue sarcoma|2015–2019|Females|1|05–09|0.888|0.692|0.963
Relative|Soft tissue sarcoma|2015–2019|Females|1|10–14|0.88|0.712|0.953
Relative|Soft tissue sarcoma|2015–2019|Females|1|15–19|0.939|0.844|0.977
Relative|Soft tissue sarcoma|2015–2019|Females|1|20–24|0.936|0.838|0.976
Relative|Soft tissue sarcoma|2015–2019|Females|1|25–29|0.933|0.83|0.974
Relative|Soft tissue sarcoma|2015–2019|Females|1|30–34|0.966|0.911|0.987
Relative|Soft tissue sarcoma|2015–2019|Females|1|35–39|0.944|0.89|0.972
Relative|Soft tissue sarcoma|2015–2019|Females|1|40–44|0.963|0.926|0.982
Relative|Soft tissue sarcoma|2015–2019|Females|1|45–49|0.935|0.901|0.957
Relative|Soft tissue sarcoma|2015–2019|Females|1|50–54|0.917|0.884|0.941
Relative|Soft tissue sarcoma|2015–2019|Females|1|55–59|0.876|0.839|0.905
Relative|Soft tissue sarcoma|2015–2019|Females|1|60–64|0.896|0.862|0.923
Relative|Soft tissue sarcoma|2015–2019|Females|1|65–69|0.864|0.827|0.893
Relative|Soft tissue sarcoma|2015–2019|Females|1|70–74|0.834|0.792|0.868
Relative|Soft tissue sarcoma|2015–2019|Females|1|75–79|0.79|0.741|0.832
Relative|Soft tissue sarcoma|2015–2019|Females|1|80–84|0.767|0.712|0.815
Relative|Soft tissue sarcoma|2015–2019|Females|1|85+|0.74|0.679|0.794
Relative|Soft tissue sarcoma|2015–2019|Females|1|All ages combined|0.869|0.857|0.879
Relative|Soft tissue sarcoma|2015–2019|Females|2|00–04|0.892|0.737|0.959
Relative|Soft tissue sarcoma|2015–2019|Females|2|05–09|0.849|0.647|0.941
Relative|Soft tissue sarcoma|2015–2019|Females|2|10–14|0.792|0.612|0.895
Relative|Soft tissue sarcoma|2015–2019|Females|2|15–19|0.883|0.769|0.943
Relative|Soft tissue sarcoma|2015–2019|Females|2|20–24|0.817|0.693|0.894
Relative|Soft tissue sarcoma|2015–2019|Females|2|25–29|0.886|0.775|0.944
Relative|Soft tissue sarcoma|2015–2019|Females|2|30–34|0.913|0.844|0.953
Relative|Soft tissue sarcoma|2015–2019|Females|2|35–39|0.885|0.818|0.928
Relative|Soft tissue sarcoma|2015–2019|Females|2|40–44|0.896|0.845|0.931
Relative|Soft tissue sarcoma|2015–2019|Females|2|45–49|0.891|0.851|0.922
Relative|Soft tissue sarcoma|2015–2019|Females|2|50–54|0.846|0.805|0.879
Relative|Soft tissue sarcoma|2015–2019|Females|2|55–59|0.787|0.743|0.825
Relative|Soft tissue sarcoma|2015–2019|Females|2|60–64|0.825|0.784|0.86
Relative|Soft tissue sarcoma|2015–2019|Females|2|65–69|0.8|0.758|0.836
Relative|Soft tissue sarcoma|2015–2019|Females|2|70–74|0.761|0.714|0.802
Relative|Soft tissue sarcoma|2015–2019|Females|2|75–79|0.707|0.652|0.757
Relative|Soft tissue sarcoma|2015–2019|Females|2|80–84|0.704|0.642|0.76
Relative|Soft tissue sarcoma|2015–2019|Females|2|85+|0.652|0.582|0.719
Relative|Soft tissue sarcoma|2015–2019|Females|2|All ages combined|0.799|0.785|0.812
Relative|Soft tissue sarcoma|2015–2019|Females|3|00–04|0.892|0.737|0.959
Relative|Soft tissue sarcoma|2015–2019|Females|3|05–09|0.849|0.647|0.941
Relative|Soft tissue sarcoma|2015–2019|Females|3|10–14|0.74|0.56|0.855
Relative|Soft tissue sarcoma|2015–2019|Females|3|15–19|0.785|0.65|0.872
Relative|Soft tissue sarcoma|2015–2019|Females|3|20–24|0.772|0.646|0.859
Relative|Soft tissue sarcoma|2015–2019|Females|3|25–29|0.886|0.775|0.944
Relative|Soft tissue sarcoma|2015–2019|Females|3|30–34|0.878|0.802|0.926
Relative|Soft tissue sarcoma|2015–2019|Females|3|35–39|0.861|0.79|0.91
Relative|Soft tissue sarcoma|2015–2019|Females|3|40–44|0.871|0.816|0.911
Relative|Soft tissue sarcoma|2015–2019|Females|3|45–49|0.837|0.791|0.875
Relative|Soft tissue sarcoma|2015–2019|Females|3|50–54|0.798|0.753|0.836
Relative|Soft tissue sarcoma|2015–2019|Females|3|55–59|0.742|0.695|0.783
Relative|Soft tissue sarcoma|2015–2019|Females|3|60–64|0.792|0.748|0.831
Relative|Soft tissue sarcoma|2015–2019|Females|3|65–69|0.738|0.692|0.779
Relative|Soft tissue sarcoma|2015–2019|Females|3|70–74|0.724|0.674|0.768
Relative|Soft tissue sarcoma|2015–2019|Females|3|75–79|0.655|0.597|0.709
Relative|Soft tissue sarcoma|2015–2019|Females|3|80–84|0.668|0.6|0.731
Relative|Soft tissue sarcoma|2015–2019|Females|3|85+|0.576|0.498|0.654
Relative|Soft tissue sarcoma|2015–2019|Females|3|All ages combined|0.754|0.739|0.769
Relative|Soft tissue sarcoma|2015–2019|Females|4|00–04|0.893|0.737|0.959
Relative|Soft tissue sarcoma|2015–2019|Females|4|05–09|||
Relative|Soft tissue sarcoma|2015–2019|Females|4|10–14|0.636|0.458|0.769
Relative|Soft tissue sarcoma|2015–2019|Females|4|15–19|0.723|0.581|0.824
Relative|Soft tissue sarcoma|2015–2019|Females|4|20–24|0.758|0.63|0.846
Relative|Soft tissue sarcoma|2015–2019|Females|4|25–29|0.871|0.758|0.934
Relative|Soft tissue sarcoma|2015–2019|Females|4|30–34|0.837|0.753|0.895
Relative|Soft tissue sarcoma|2015–2019|Females|4|35–39|0.835|0.758|0.889
Relative|Soft tissue sarcoma|2015–2019|Females|4|40–44|0.849|0.791|0.893
Relative|Soft tissue sarcoma|2015–2019|Females|4|45–49|0.797|0.747|0.838
Relative|Soft tissue sarcoma|2015–2019|Females|4|50–54|0.776|0.73|0.816
Relative|Soft tissue sarcoma|2015–2019|Females|4|55–59|0.718|0.669|0.761
Relative|Soft tissue sarcoma|2015–2019|Females|4|60–64|0.739|0.691|0.782
Relative|Soft tissue sarcoma|2015–2019|Females|4|65–69|0.704|0.656|0.748
Relative|Soft tissue sarcoma|2015–2019|Females|4|70–74|0.687|0.635|0.735
Relative|Soft tissue sarcoma|2015–2019|Females|4|75–79|0.609|0.549|0.666
Relative|Soft tissue sarcoma|2015–2019|Females|4|80–84|0.625|0.552|0.695
Relative|Soft tissue sarcoma|2015–2019|Females|4|85+|0.482|0.399|0.569
Relative|Soft tissue sarcoma|2015–2019|Females|4|All ages combined|0.716|0.7|0.732
Relative|Soft tissue sarcoma|2015–2019|Females|5|00–04|0.893|0.737|0.959
Relative|Soft tissue sarcoma|2015–2019|Females|5|05–09|||
Relative|Soft tissue sarcoma|2015–2019|Females|5|10–14|0.636|0.458|0.769
Relative|Soft tissue sarcoma|2015–2019|Females|5|15–19|0.698|0.551|0.805
Relative|Soft tissue sarcoma|2015–2019|Females|5|20–24|0.714|0.585|0.809
Relative|Soft tissue sarcoma|2015–2019|Females|5|25–29|0.832|0.717|0.904
Relative|Soft tissue sarcoma|2015–2019|Females|5|30–34|0.816|0.728|0.879
Relative|Soft tissue sarcoma|2015–2019|Females|5|35–39|0.81|0.73|0.869
Relative|Soft tissue sarcoma|2015–2019|Females|5|40–44|0.817|0.754|0.865
Relative|Soft tissue sarcoma|2015–2019|Females|5|45–49|0.773|0.721|0.817
Relative|Soft tissue sarcoma|2015–2019|Females|5|50–54|0.776|0.729|0.816
Relative|Soft tissue sarcoma|2015–2019|Females|5|55–59|0.695|0.645|0.74
Relative|Soft tissue sarcoma|2015–2019|Females|5|60–64|0.709|0.659|0.754
Relative|Soft tissue sarcoma|2015–2019|Females|5|65–69|0.679|0.629|0.724
Relative|Soft tissue sarcoma|2015–2019|Females|5|70–74|0.665|0.611|0.715
Relative|Soft tissue sarcoma|2015–2019|Females|5|75–79|0.58|0.517|0.639
Relative|Soft tissue sarcoma|2015–2019|Females|5|80–84|0.586|0.507|0.662
Relative|Soft tissue sarcoma|2015–2019|Females|5|85+|0.424|0.335|0.521
Relative|Soft tissue sarcoma|2015–2019|Females|5|All ages combined|0.692|0.675|0.708
Observed|Soft tissue sarcoma|2015–2019|Persons|1|00–04|0.862|0.774|0.917
Observed|Soft tissue sarcoma|2015–2019|Persons|1|05–09|0.914|0.805|0.963
Observed|Soft tissue sarcoma|2015–2019|Persons|1|10–14|0.923|0.824|0.967
Observed|Soft tissue sarcoma|2015–2019|Persons|1|15–19|0.939|0.882|0.969
Observed|Soft tissue sarcoma|2015–2019|Persons|1|20–24|0.872|0.802|0.918
Observed|Soft tissue sarcoma|2015–2019|Persons|1|25–29|0.877|0.812|0.921
Observed|Soft tissue sarcoma|2015–2019|Persons|1|30–34|0.97|0.935|0.986
Observed|Soft tissue sarcoma|2015–2019|Persons|1|35–39|0.94|0.903|0.963
Observed|Soft tissue sarcoma|2015–2019|Persons|1|40–44|0.953|0.926|0.971
Observed|Soft tissue sarcoma|2015–2019|Persons|1|45–49|0.926|0.9|0.945
Observed|Soft tissue sarcoma|2015–2019|Persons|1|50–54|0.921|0.898|0.939
Observed|Soft tissue sarcoma|2015–2019|Persons|1|55–59|0.877|0.852|0.898
Observed|Soft tissue sarcoma|2015–2019|Persons|1|60–64|0.882|0.859|0.901
Observed|Soft tissue sarcoma|2015–2019|Persons|1|65–69|0.86|0.836|0.88
Observed|Soft tissue sarcoma|2015–2019|Persons|1|70–74|0.813|0.788|0.836
Observed|Soft tissue sarcoma|2015–2019|Persons|1|75–79|0.795|0.767|0.82
Observed|Soft tissue sarcoma|2015–2019|Persons|1|80–84|0.764|0.733|0.792
Observed|Soft tissue sarcoma|2015–2019|Persons|1|85+|0.665|0.632|0.696
Observed|Soft tissue sarcoma|2015–2019|Persons|1|All ages combined|0.844|0.837|0.852
Observed|Soft tissue sarcoma|2015–2019|Persons|2|00–04|0.796|0.699|0.865
Observed|Soft tissue sarcoma|2015–2019|Persons|2|05–09|0.861|0.742|0.928
Observed|Soft tissue sarcoma|2015–2019|Persons|2|10–14|0.864|0.754|0.927
Observed|Soft tissue sarcoma|2015–2019|Persons|2|15–19|0.847|0.767|0.901
Observed|Soft tissue sarcoma|2015–2019|Persons|2|20–24|0.755|0.672|0.82
Observed|Soft tissue sarcoma|2015–2019|Persons|2|25–29|0.779|0.704|0.838
Observed|Soft tissue sarcoma|2015–2019|Persons|2|30–34|0.903|0.852|0.937
Observed|Soft tissue sarcoma|2015–2019|Persons|2|35–39|0.873|0.827|0.908
Observed|Soft tissue sarcoma|2015–2019|Persons|2|40–44|0.887|0.85|0.916
Observed|Soft tissue sarcoma|2015–2019|Persons|2|45–49|0.878|0.847|0.903
Observed|Soft tissue sarcoma|2015–2019|Persons|2|50–54|0.84|0.81|0.866
Observed|Soft tissue sarcoma|2015–2019|Persons|2|55–59|0.807|0.778|0.833
Observed|Soft tissue sarcoma|2015–2019|Persons|2|60–64|0.815|0.788|0.839
Observed|Soft tissue sarcoma|2015–2019|Persons|2|65–69|0.775|0.747|0.8
Observed|Soft tissue sarcoma|2015–2019|Persons|2|70–74|0.729|0.7|0.756
Observed|Soft tissue sarcoma|2015–2019|Persons|2|75–79|0.707|0.676|0.736
Observed|Soft tissue sarcoma|2015–2019|Persons|2|80–84|0.656|0.622|0.688
Observed|Soft tissue sarcoma|2015–2019|Persons|2|85+|0.499|0.465|0.533
Observed|Soft tissue sarcoma|2015–2019|Persons|2|All ages combined|0.757|0.748|0.766
Observed|Soft tissue sarcoma|2015–2019|Persons|3|00–04|0.796|0.699|0.865
Observed|Soft tissue sarcoma|2015–2019|Persons|3|05–09|0.844|0.721|0.915
Observed|Soft tissue sarcoma|2015–2019|Persons|3|10–14|0.798|0.682|0.875
Observed|Soft tissue sarcoma|2015–2019|Persons|3|15–19|0.775|0.684|0.843
Observed|Soft tissue sarcoma|2015–2019|Persons|3|20–24|0.727|0.643|0.795
Observed|Soft tissue sarcoma|2015–2019|Persons|3|25–29|0.749|0.672|0.81
Observed|Soft tissue sarcoma|2015–2019|Persons|3|30–34|0.868|0.812|0.908
Observed|Soft tissue sarcoma|2015–2019|Persons|3|35–39|0.849|0.799|0.887
Observed|Soft tissue sarcoma|2015–2019|Persons|3|40–44|0.847|0.805|0.88
Observed|Soft tissue sarcoma|2015–2019|Persons|3|45–49|0.825|0.79|0.854
Observed|Soft tissue sarcoma|2015–2019|Persons|3|50–54|0.796|0.764|0.825
Observed|Soft tissue sarcoma|2015–2019|Persons|3|55–59|0.768|0.737|0.796
Observed|Soft tissue sarcoma|2015–2019|Persons|3|60–64|0.772|0.743|0.798
Observed|Soft tissue sarcoma|2015–2019|Persons|3|65–69|0.709|0.679|0.737
Observed|Soft tissue sarcoma|2015–2019|Persons|3|70–74|0.679|0.649|0.707
Observed|Soft tissue sarcoma|2015–2019|Persons|3|75–79|0.629|0.596|0.66
Observed|Soft tissue sarcoma|2015–2019|Persons|3|80–84|0.564|0.529|0.599
Observed|Soft tissue sarcoma|2015–2019|Persons|3|85+|0.377|0.344|0.41
Observed|Soft tissue sarcoma|2015–2019|Persons|3|All ages combined|0.697|0.687|0.706
Observed|Soft tissue sarcoma|2015–2019|Persons|4|00–04|0.765|0.666|0.838
Observed|Soft tissue sarcoma|2015–2019|Persons|4|05–09|0.844|0.721|0.915
Observed|Soft tissue sarcoma|2015–2019|Persons|4|10–14|0.719|0.599|0.808
Observed|Soft tissue sarcoma|2015–2019|Persons|4|15–19|0.721|0.624|0.797
Observed|Soft tissue sarcoma|2015–2019|Persons|4|20–24|0.694|0.609|0.765
Observed|Soft tissue sarcoma|2015–2019|Persons|4|25–29|0.743|0.666|0.805
Observed|Soft tissue sarcoma|2015–2019|Persons|4|30–34|0.831|0.771|0.877
Observed|Soft tissue sarcoma|2015–2019|Persons|4|35–39|0.823|0.769|0.864
Observed|Soft tissue sarcoma|2015–2019|Persons|4|40–44|0.804|0.758|0.842
Observed|Soft tissue sarcoma|2015–2019|Persons|4|45–49|0.787|0.75|0.819
Observed|Soft tissue sarcoma|2015–2019|Persons|4|50–54|0.769|0.735|0.799
Observed|Soft tissue sarcoma|2015–2019|Persons|4|55–59|0.736|0.703|0.765
Observed|Soft tissue sarcoma|2015–2019|Persons|4|60–64|0.73|0.7|0.758
Observed|Soft tissue sarcoma|2015–2019|Persons|4|65–69|0.669|0.638|0.698
Observed|Soft tissue sarcoma|2015–2019|Persons|4|70–74|0.638|0.607|0.668
Observed|Soft tissue sarcoma|2015–2019|Persons|4|75–79|0.57|0.536|0.602
Observed|Soft tissue sarcoma|2015–2019|Persons|4|80–84|0.49|0.454|0.526
Observed|Soft tissue sarcoma|2015–2019|Persons|4|85+|0.285|0.254|0.317
Observed|Soft tissue sarcoma|2015–2019|Persons|4|All ages combined|0.651|0.641|0.661
Observed|Soft tissue sarcoma|2015–2019|Persons|5|00–04|0.765|0.666|0.838
Observed|Soft tissue sarcoma|2015–2019|Persons|5|05–09|0.844|0.721|0.915
Observed|Soft tissue sarcoma|2015–2019|Persons|5|10–14|0.705|0.585|0.796
Observed|Soft tissue sarcoma|2015–2019|Persons|5|15–19|0.685|0.584|0.766
Observed|Soft tissue sarcoma|2015–2019|Persons|5|20–24|0.675|0.589|0.746
Observed|Soft tissue sarcoma|2015–2019|Persons|5|25–29|0.72|0.643|0.784
Observed|Soft tissue sarcoma|2015–2019|Persons|5|30–34|0.81|0.748|0.859
Observed|Soft tissue sarcoma|2015–2019|Persons|5|35–39|0.806|0.751|0.85
Observed|Soft tissue sarcoma|2015–2019|Persons|5|40–44|0.768|0.72|0.809
Observed|Soft tissue sarcoma|2015–2019|Persons|5|45–49|0.765|0.727|0.798
Observed|Soft tissue sarcoma|2015–2019|Persons|5|50–54|0.762|0.727|0.792
Observed|Soft tissue sarcoma|2015–2019|Persons|5|55–59|0.719|0.686|0.749
Observed|Soft tissue sarcoma|2015–2019|Persons|5|60–64|0.702|0.671|0.731
Observed|Soft tissue sarcoma|2015–2019|Persons|5|65–69|0.64|0.608|0.669
Observed|Soft tissue sarcoma|2015–2019|Persons|5|70–74|0.602|0.57|0.633
Observed|Soft tissue sarcoma|2015–2019|Persons|5|75–79|0.522|0.488|0.556
Observed|Soft tissue sarcoma|2015–2019|Persons|5|80–84|0.42|0.384|0.456
Observed|Soft tissue sarcoma|2015–2019|Persons|5|85+|0.216|0.186|0.246
Observed|Soft tissue sarcoma|2015–2019|Persons|5|All ages combined|0.618|0.608|0.628
Relative|Soft tissue sarcoma|2015–2019|Persons|1|00–04|0.863|0.775|0.918
Relative|Soft tissue sarcoma|2015–2019|Persons|1|05–09|0.914|0.805|0.963
Relative|Soft tissue sarcoma|2015–2019|Persons|1|10–14|0.923|0.824|0.967
Relative|Soft tissue sarcoma|2015–2019|Persons|1|15–19|0.939|0.882|0.969
Relative|Soft tissue sarcoma|2015–2019|Persons|1|20–24|0.872|0.802|0.919
Relative|Soft tissue sarcoma|2015–2019|Persons|1|25–29|0.877|0.812|0.921
Relative|Soft tissue sarcoma|2015–2019|Persons|1|30–34|0.971|0.935|0.987
Relative|Soft tissue sarcoma|2015–2019|Persons|1|35–39|0.94|0.904|0.963
Relative|Soft tissue sarcoma|2015–2019|Persons|1|40–44|0.955|0.927|0.972
Relative|Soft tissue sarcoma|2015–2019|Persons|1|45–49|0.927|0.902|0.947
Relative|Soft tissue sarcoma|2015–2019|Persons|1|50–54|0.924|0.9|0.942
Relative|Soft tissue sarcoma|2015–2019|Persons|1|55–59|0.881|0.856|0.902
Relative|Soft tissue sarcoma|2015–2019|Persons|1|60–64|0.888|0.865|0.907
Relative|Soft tissue sarcoma|2015–2019|Persons|1|65–69|0.868|0.845|0.889
Relative|Soft tissue sarcoma|2015–2019|Persons|1|70–74|0.827|0.801|0.85
Relative|Soft tissue sarcoma|2015–2019|Persons|1|75–79|0.818|0.79|0.844
Relative|Soft tissue sarcoma|2015–2019|Persons|1|80–84|0.805|0.773|0.835
Relative|Soft tissue sarcoma|2015–2019|Persons|1|85+|0.76|0.723|0.795
Relative|Soft tissue sarcoma|2015–2019|Persons|1|All ages combined|0.865|0.857|0.873
Relative|Soft tissue sarcoma|2015–2019|Persons|2|00–04|0.797|0.7|0.866
Relative|Soft tissue sarcoma|2015–2019|Persons|2|05–09|0.861|0.742|0.928
Relative|Soft tissue sarcoma|2015–2019|Persons|2|10–14|0.864|0.755|0.927
Relative|Soft tissue sarcoma|2015–2019|Persons|2|15–19|0.847|0.768|0.901
Relative|Soft tissue sarcoma|2015–2019|Persons|2|20–24|0.756|0.672|0.821
Relative|Soft tissue sarcoma|2015–2019|Persons|2|25–29|0.78|0.705|0.839
Relative|Soft tissue sarcoma|2015–2019|Persons|2|30–34|0.904|0.853|0.938
Relative|Soft tissue sarcoma|2015–2019|Persons|2|35–39|0.875|0.828|0.91
Relative|Soft tissue sarcoma|2015–2019|Persons|2|40–44|0.89|0.852|0.918
Relative|Soft tissue sarcoma|2015–2019|Persons|2|45–49|0.881|0.851|0.906
Relative|Soft tissue sarcoma|2015–2019|Persons|2|50–54|0.845|0.815|0.871
Relative|Soft tissue sarcoma|2015–2019|Persons|2|55–59|0.815|0.785|0.841
Relative|Soft tissue sarcoma|2015–2019|Persons|2|60–64|0.826|0.798|0.85
Relative|Soft tissue sarcoma|2015–2019|Persons|2|65–69|0.791|0.763|0.817
Relative|Soft tissue sarcoma|2015–2019|Persons|2|70–74|0.755|0.725|0.782
Relative|Soft tissue sarcoma|2015–2019|Persons|2|75–79|0.752|0.719|0.783
Relative|Soft tissue sarcoma|2015–2019|Persons|2|80–84|0.735|0.697|0.771
Relative|Soft tissue sarcoma|2015–2019|Persons|2|85+|0.658|0.613|0.703
Relative|Soft tissue sarcoma|2015–2019|Persons|2|All ages combined|0.793|0.784|0.803
Relative|Soft tissue sarcoma|2015–2019|Persons|3|00–04|0.797|0.7|0.866
Relative|Soft tissue sarcoma|2015–2019|Persons|3|05–09|0.844|0.721|0.916
Relative|Soft tissue sarcoma|2015–2019|Persons|3|10–14|0.798|0.683|0.875
Relative|Soft tissue sarcoma|2015–2019|Persons|3|15–19|0.776|0.685|0.844
Relative|Soft tissue sarcoma|2015–2019|Persons|3|20–24|0.728|0.643|0.796
Relative|Soft tissue sarcoma|2015–2019|Persons|3|25–29|0.75|0.673|0.812
Relative|Soft tissue sarcoma|2015–2019|Persons|3|30–34|0.869|0.813|0.91
Relative|Soft tissue sarcoma|2015–2019|Persons|3|35–39|0.851|0.801|0.89
Relative|Soft tissue sarcoma|2015–2019|Persons|3|40–44|0.85|0.808|0.884
Relative|Soft tissue sarcoma|2015–2019|Persons|3|45–49|0.829|0.795|0.859
Relative|Soft tissue sarcoma|2015–2019|Persons|3|50–54|0.803|0.77|0.832
Relative|Soft tissue sarcoma|2015–2019|Persons|3|55–59|0.779|0.747|0.807
Relative|Soft tissue sarcoma|2015–2019|Persons|3|60–64|0.789|0.759|0.815
Relative|Soft tissue sarcoma|2015–2019|Persons|3|65–69|0.733|0.702|0.761
Relative|Soft tissue sarcoma|2015–2019|Persons|3|70–74|0.718|0.686|0.748
Relative|Soft tissue sarcoma|2015–2019|Persons|3|75–79|0.694|0.657|0.728
Relative|Soft tissue sarcoma|2015–2019|Persons|3|80–84|0.678|0.635|0.719
Relative|Soft tissue sarcoma|2015–2019|Persons|3|85+|0.579|0.528|0.63
Relative|Soft tissue sarcoma|2015–2019|Persons|3|All ages combined|0.747|0.736|0.757
Relative|Soft tissue sarcoma|2015–2019|Persons|4|00–04|0.766|0.667|0.84
Relative|Soft tissue sarcoma|2015–2019|Persons|4|05–09|0.844|0.721|0.916
Relative|Soft tissue sarcoma|2015–2019|Persons|4|10–14|0.719|0.599|0.809
Relative|Soft tissue sarcoma|2015–2019|Persons|4|15–19|0.722|0.625|0.798
Relative|Soft tissue sarcoma|2015–2019|Persons|4|20–24|0.696|0.61|0.766
Relative|Soft tissue sarcoma|2015–2019|Persons|4|25–29|0.745|0.667|0.807
Relative|Soft tissue sarcoma|2015–2019|Persons|4|30–34|0.833|0.773|0.879
Relative|Soft tissue sarcoma|2015–2019|Persons|4|35–39|0.826|0.772|0.868
Relative|Soft tissue sarcoma|2015–2019|Persons|4|40–44|0.808|0.763|0.847
Relative|Soft tissue sarcoma|2015–2019|Persons|4|45–49|0.794|0.756|0.826
Relative|Soft tissue sarcoma|2015–2019|Persons|4|50–54|0.779|0.744|0.809
Relative|Soft tissue sarcoma|2015–2019|Persons|4|55–59|0.75|0.717|0.78
Relative|Soft tissue sarcoma|2015–2019|Persons|4|60–64|0.752|0.721|0.781
Relative|Soft tissue sarcoma|2015–2019|Persons|4|65–69|0.701|0.668|0.731
Relative|Soft tissue sarcoma|2015–2019|Persons|4|70–74|0.69|0.656|0.722
Relative|Soft tissue sarcoma|2015–2019|Persons|4|75–79|0.655|0.616|0.692
Relative|Soft tissue sarcoma|2015–2019|Persons|4|80–84|0.636|0.589|0.682
Relative|Soft tissue sarcoma|2015–2019|Persons|4|85+|0.517|0.46|0.575
Relative|Soft tissue sarcoma|2015–2019|Persons|4|All ages combined|0.713|0.701|0.723
Relative|Soft tissue sarcoma|2015–2019|Persons|5|00–04|0.766|0.667|0.84
Relative|Soft tissue sarcoma|2015–2019|Persons|5|05–09|0.844|0.721|0.916
Relative|Soft tissue sarcoma|2015–2019|Persons|5|10–14|0.705|0.585|0.797
Relative|Soft tissue sarcoma|2015–2019|Persons|5|15–19|0.686|0.585|0.768
Relative|Soft tissue sarcoma|2015–2019|Persons|5|20–24|0.676|0.59|0.748
Relative|Soft tissue sarcoma|2015–2019|Persons|5|25–29|0.722|0.644|0.786
Relative|Soft tissue sarcoma|2015–2019|Persons|5|30–34|0.813|0.75|0.862
Relative|Soft tissue sarcoma|2015–2019|Persons|5|35–39|0.81|0.755|0.854
Relative|Soft tissue sarcoma|2015–2019|Persons|5|40–44|0.774|0.726|0.815
Relative|Soft tissue sarcoma|2015–2019|Persons|5|45–49|0.773|0.735|0.807
Relative|Soft tissue sarcoma|2015–2019|Persons|5|50–54|0.774|0.739|0.805
Relative|Soft tissue sarcoma|2015–2019|Persons|5|55–59|0.737|0.703|0.768
Relative|Soft tissue sarcoma|2015–2019|Persons|5|60–64|0.73|0.697|0.76
Relative|Soft tissue sarcoma|2015–2019|Persons|5|65–69|0.68|0.646|0.712
Relative|Soft tissue sarcoma|2015–2019|Persons|5|70–74|0.667|0.632|0.701
Relative|Soft tissue sarcoma|2015–2019|Persons|5|75–79|0.629|0.588|0.669
Relative|Soft tissue sarcoma|2015–2019|Persons|5|80–84|0.596|0.544|0.647
Relative|Soft tissue sarcoma|2015–2019|Persons|5|85+|0.469|0.405|0.535
Relative|Soft tissue sarcoma|2015–2019|Persons|5|All ages combined|0.691|0.679|0.703
Observed|Stomach cancer|2015–2019|Males|1|00–04|||
Observed|Stomach cancer|2015–2019|Males|1|05–09|||
Observed|Stomach cancer|2015–2019|Males|1|10–14|||
Observed|Stomach cancer|2015–2019|Males|1|15–19|||
Observed|Stomach cancer|2015–2019|Males|1|20–24|||
Observed|Stomach cancer|2015–2019|Males|1|25–29|||
Observed|Stomach cancer|2015–2019|Males|1|30–34|0.674|0.491|0.804
Observed|Stomach cancer|2015–2019|Males|1|35–39|0.723|0.608|0.809
Observed|Stomach cancer|2015–2019|Males|1|40–44|0.598|0.505|0.679
Observed|Stomach cancer|2015–2019|Males|1|45–49|0.658|0.597|0.713
Observed|Stomach cancer|2015–2019|Males|1|50–54|0.692|0.645|0.734
Observed|Stomach cancer|2015–2019|Males|1|55–59|0.696|0.658|0.73
Observed|Stomach cancer|2015–2019|Males|1|60–64|0.676|0.644|0.706
Observed|Stomach cancer|2015–2019|Males|1|65–69|0.683|0.655|0.71
Observed|Stomach cancer|2015–2019|Males|1|70–74|0.634|0.606|0.661
Observed|Stomach cancer|2015–2019|Males|1|75–79|0.562|0.532|0.59
Observed|Stomach cancer|2015–2019|Males|1|80–84|0.514|0.481|0.546
Observed|Stomach cancer|2015–2019|Males|1|85+|0.312|0.28|0.344
Observed|Stomach cancer|2015–2019|Males|1|All ages combined|0.6|0.589|0.611
Observed|Stomach cancer|2015–2019|Males|2|00–04|||
Observed|Stomach cancer|2015–2019|Males|2|05–09|||
Observed|Stomach cancer|2015–2019|Males|2|10–14|||
Observed|Stomach cancer|2015–2019|Males|2|15–19|||
Observed|Stomach cancer|2015–2019|Males|2|20–24|||
Observed|Stomach cancer|2015–2019|Males|2|25–29|||
Observed|Stomach cancer|2015–2019|Males|2|30–34|0.621|0.44|0.758
Observed|Stomach cancer|2015–2019|Males|2|35–39|0.642|0.519|0.741
Observed|Stomach cancer|2015–2019|Males|2|40–44|0.499|0.407|0.584
Observed|Stomach cancer|2015–2019|Males|2|45–49|0.523|0.458|0.583
Observed|Stomach cancer|2015–2019|Males|2|50–54|0.536|0.487|0.583
Observed|Stomach cancer|2015–2019|Males|2|55–59|0.55|0.511|0.588
Observed|Stomach cancer|2015–2019|Males|2|60–64|0.522|0.488|0.554
Observed|Stomach cancer|2015–2019|Males|2|65–69|0.525|0.495|0.554
Observed|Stomach cancer|2015–2019|Males|2|70–74|0.479|0.45|0.508
Observed|Stomach cancer|2015–2019|Males|2|75–79|0.435|0.405|0.464
Observed|Stomach cancer|2015–2019|Males|2|80–84|0.346|0.315|0.377
Observed|Stomach cancer|2015–2019|Males|2|85+|0.181|0.155|0.208
Observed|Stomach cancer|2015–2019|Males|2|All ages combined|0.452|0.441|0.464
Observed|Stomach cancer|2015–2019|Males|3|00–04|||
Observed|Stomach cancer|2015–2019|Males|3|05–09|||
Observed|Stomach cancer|2015–2019|Males|3|10–14|||
Observed|Stomach cancer|2015–2019|Males|3|15–19|||
Observed|Stomach cancer|2015–2019|Males|3|20–24|||
Observed|Stomach cancer|2015–2019|Males|3|25–29|||
Observed|Stomach cancer|2015–2019|Males|3|30–34|0.548|0.375|0.692
Observed|Stomach cancer|2015–2019|Males|3|35–39|0.55|0.421|0.661
Observed|Stomach cancer|2015–2019|Males|3|40–44|0.414|0.327|0.499
Observed|Stomach cancer|2015–2019|Males|3|45–49|0.466|0.402|0.527
Observed|Stomach cancer|2015–2019|Males|3|50–54|0.458|0.409|0.505
Observed|Stomach cancer|2015–2019|Males|3|55–59|0.47|0.43|0.509
Observed|Stomach cancer|2015–2019|Males|3|60–64|0.449|0.416|0.482
Observed|Stomach cancer|2015–2019|Males|3|65–69|0.441|0.412|0.47
Observed|Stomach cancer|2015–2019|Males|3|70–74|0.403|0.374|0.432
Observed|Stomach cancer|2015–2019|Males|3|75–79|0.359|0.33|0.388
Observed|Stomach cancer|2015–2019|Males|3|80–84|0.271|0.242|0.3
Observed|Stomach cancer|2015–2019|Males|3|85+|0.126|0.104|0.149
Observed|Stomach cancer|2015–2019|Males|3|All ages combined|0.377|0.366|0.389
Observed|Stomach cancer|2015–2019|Males|4|00–04|||
Observed|Stomach cancer|2015–2019|Males|4|05–09|||
Observed|Stomach cancer|2015–2019|Males|4|10–14|||
Observed|Stomach cancer|2015–2019|Males|4|15–19|||
Observed|Stomach cancer|2015–2019|Males|4|20–24|||
Observed|Stomach cancer|2015–2019|Males|4|25–29|||
Observed|Stomach cancer|2015–2019|Males|4|30–34|0.504|0.336|0.649
Observed|Stomach cancer|2015–2019|Males|4|35–39|0.511|0.381|0.626
Observed|Stomach cancer|2015–2019|Males|4|40–44|0.368|0.285|0.452
Observed|Stomach cancer|2015–2019|Males|4|45–49|0.441|0.377|0.502
Observed|Stomach cancer|2015–2019|Males|4|50–54|0.433|0.385|0.48
Observed|Stomach cancer|2015–2019|Males|4|55–59|0.43|0.391|0.469
Observed|Stomach cancer|2015–2019|Males|4|60–64|0.398|0.366|0.43
Observed|Stomach cancer|2015–2019|Males|4|65–69|0.399|0.369|0.428
Observed|Stomach cancer|2015–2019|Males|4|70–74|0.349|0.32|0.377
Observed|Stomach cancer|2015–2019|Males|4|75–79|0.317|0.289|0.345
Observed|Stomach cancer|2015–2019|Males|4|80–84|0.225|0.198|0.253
Observed|Stomach cancer|2015–2019|Males|4|85+|0.092|0.074|0.112
Observed|Stomach cancer|2015–2019|Males|4|All ages combined|0.334|0.323|0.345
Observed|Stomach cancer|2015–2019|Males|5|00–04|||
Observed|Stomach cancer|2015–2019|Males|5|05–09|||
Observed|Stomach cancer|2015–2019|Males|5|10–14|||
Observed|Stomach cancer|2015–2019|Males|5|15–19|||
Observed|Stomach cancer|2015–2019|Males|5|20–24|||
Observed|Stomach cancer|2015–2019|Males|5|25–29|||
Observed|Stomach cancer|2015–2019|Males|5|30–34|||
Observed|Stomach cancer|2015–2019|Males|5|35–39|0.463|0.331|0.585
Observed|Stomach cancer|2015–2019|Males|5|40–44|0.346|0.264|0.428
Observed|Stomach cancer|2015–2019|Males|5|45–49|0.423|0.361|0.485
Observed|Stomach cancer|2015–2019|Males|5|50–54|0.42|0.372|0.467
Observed|Stomach cancer|2015–2019|Males|5|55–59|0.413|0.373|0.452
Observed|Stomach cancer|2015–2019|Males|5|60–64|0.375|0.343|0.406
Observed|Stomach cancer|2015–2019|Males|5|65–69|0.38|0.351|0.409
Observed|Stomach cancer|2015–2019|Males|5|70–74|0.323|0.295|0.351
Observed|Stomach cancer|2015–2019|Males|5|75–79|0.293|0.266|0.321
Observed|Stomach cancer|2015–2019|Males|5|80–84|0.197|0.172|0.224
Observed|Stomach cancer|2015–2019|Males|5|85+|0.067|0.051|0.085
Observed|Stomach cancer|2015–2019|Males|5|All ages combined|0.311|0.3|0.322
Relative|Stomach cancer|2015–2019|Males|1|00–04|||
Relative|Stomach cancer|2015–2019|Males|1|05–09|||
Relative|Stomach cancer|2015–2019|Males|1|10–14|||
Relative|Stomach cancer|2015–2019|Males|1|15–19|||
Relative|Stomach cancer|2015–2019|Males|1|20–24|||
Relative|Stomach cancer|2015–2019|Males|1|25–29|||
Relative|Stomach cancer|2015–2019|Males|1|30–34|0.675|0.491|0.805
Relative|Stomach cancer|2015–2019|Males|1|35–39|0.723|0.608|0.81
Relative|Stomach cancer|2015–2019|Males|1|40–44|0.599|0.506|0.68
Relative|Stomach cancer|2015–2019|Males|1|45–49|0.66|0.598|0.715
Relative|Stomach cancer|2015–2019|Males|1|50–54|0.694|0.647|0.737
Relative|Stomach cancer|2015–2019|Males|1|55–59|0.7|0.662|0.734
Relative|Stomach cancer|2015–2019|Males|1|60–64|0.682|0.65|0.711
Relative|Stomach cancer|2015–2019|Males|1|65–69|0.692|0.664|0.718
Relative|Stomach cancer|2015–2019|Males|1|70–74|0.647|0.618|0.674
Relative|Stomach cancer|2015–2019|Males|1|75–79|0.581|0.55|0.61
Relative|Stomach cancer|2015–2019|Males|1|80–84|0.546|0.511|0.58
Relative|Stomach cancer|2015–2019|Males|1|85+|0.358|0.322|0.396
Relative|Stomach cancer|2015–2019|Males|1|All ages combined|0.62|0.608|0.631
Relative|Stomach cancer|2015–2019|Males|2|00–04|||
Relative|Stomach cancer|2015–2019|Males|2|05–09|||
Relative|Stomach cancer|2015–2019|Males|2|10–14|||
Relative|Stomach cancer|2015–2019|Males|2|15–19|||
Relative|Stomach cancer|2015–2019|Males|2|20–24|||
Relative|Stomach cancer|2015–2019|Males|2|25–29|||
Relative|Stomach cancer|2015–2019|Males|2|30–34|0.622|0.44|0.76
Relative|Stomach cancer|2015–2019|Males|2|35–39|0.643|0.52|0.743
Relative|Stomach cancer|2015–2019|Males|2|40–44|0.5|0.408|0.586
Relative|Stomach cancer|2015–2019|Males|2|45–49|0.525|0.461|0.586
Relative|Stomach cancer|2015–2019|Males|2|50–54|0.54|0.49|0.587
Relative|Stomach cancer|2015–2019|Males|2|55–59|0.557|0.516|0.595
Relative|Stomach cancer|2015–2019|Males|2|60–64|0.53|0.496|0.563
Relative|Stomach cancer|2015–2019|Males|2|65–69|0.539|0.508|0.568
Relative|Stomach cancer|2015–2019|Males|2|70–74|0.499|0.469|0.529
Relative|Stomach cancer|2015–2019|Males|2|75–79|0.466|0.435|0.498
Relative|Stomach cancer|2015–2019|Males|2|80–84|0.393|0.358|0.429
Relative|Stomach cancer|2015–2019|Males|2|85+|0.241|0.207|0.277
Relative|Stomach cancer|2015–2019|Males|2|All ages combined|0.48|0.468|0.492
Relative|Stomach cancer|2015–2019|Males|3|00–04|||
Relative|Stomach cancer|2015–2019|Males|3|05–09|||
Relative|Stomach cancer|2015–2019|Males|3|10–14|||
Relative|Stomach cancer|2015–2019|Males|3|15–19|||
Relative|Stomach cancer|2015–2019|Males|3|20–24|||
Relative|Stomach cancer|2015–2019|Males|3|25–29|||
Relative|Stomach cancer|2015–2019|Males|3|30–34|0.55|0.376|0.694
Relative|Stomach cancer|2015–2019|Males|3|35–39|0.552|0.423|0.663
Relative|Stomach cancer|2015–2019|Males|3|40–44|0.416|0.329|0.502
Relative|Stomach cancer|2015–2019|Males|3|45–49|0.47|0.406|0.531
Relative|Stomach cancer|2015–2019|Males|3|50–54|0.463|0.414|0.511
Relative|Stomach cancer|2015–2019|Males|3|55–59|0.478|0.438|0.518
Relative|Stomach cancer|2015–2019|Males|3|60–64|0.461|0.427|0.494
Relative|Stomach cancer|2015–2019|Males|3|65–69|0.46|0.429|0.49
Relative|Stomach cancer|2015–2019|Males|3|70–74|0.43|0.399|0.461
Relative|Stomach cancer|2015–2019|Males|3|75–79|0.402|0.37|0.434
Relative|Stomach cancer|2015–2019|Males|3|80–84|0.332|0.297|0.368
Relative|Stomach cancer|2015–2019|Males|3|85+|0.196|0.163|0.233
Relative|Stomach cancer|2015–2019|Males|3|All ages combined|0.412|0.4|0.424
Relative|Stomach cancer|2015–2019|Males|4|00–04|||
Relative|Stomach cancer|2015–2019|Males|4|05–09|||
Relative|Stomach cancer|2015–2019|Males|4|10–14|||
Relative|Stomach cancer|2015–2019|Males|4|15–19|||
Relative|Stomach cancer|2015–2019|Males|4|20–24|||
Relative|Stomach cancer|2015–2019|Males|4|25–29|||
Relative|Stomach cancer|2015–2019|Males|4|30–34|0.506|0.337|0.652
Relative|Stomach cancer|2015–2019|Males|4|35–39|0.513|0.383|0.629
Relative|Stomach cancer|2015–2019|Males|4|40–44|0.371|0.287|0.455
Relative|Stomach cancer|2015–2019|Males|4|45–49|0.445|0.381|0.507
Relative|Stomach cancer|2015–2019|Males|4|50–54|0.44|0.391|0.488
Relative|Stomach cancer|2015–2019|Males|4|55–59|0.441|0.4|0.481
Relative|Stomach cancer|2015–2019|Males|4|60–64|0.412|0.379|0.446
Relative|Stomach cancer|2015–2019|Males|4|65–69|0.422|0.391|0.452
Relative|Stomach cancer|2015–2019|Males|4|70–74|0.382|0.351|0.413
Relative|Stomach cancer|2015–2019|Males|4|75–79|0.372|0.339|0.405
Relative|Stomach cancer|2015–2019|Males|4|80–84|0.3|0.264|0.338
Relative|Stomach cancer|2015–2019|Males|4|85+|0.17|0.136|0.208
Relative|Stomach cancer|2015–2019|Males|4|All ages combined|0.375|0.363|0.388
Relative|Stomach cancer|2015–2019|Males|5|00–04|||
Relative|Stomach cancer|2015–2019|Males|5|05–09|||
Relative|Stomach cancer|2015–2019|Males|5|10–14|||
Relative|Stomach cancer|2015–2019|Males|5|15–19|||
Relative|Stomach cancer|2015–2019|Males|5|20–24|||
Relative|Stomach cancer|2015–2019|Males|5|25–29|||
Relative|Stomach cancer|2015–2019|Males|5|30–34|||
Relative|Stomach cancer|2015–2019|Males|5|35–39|0.466|0.333|0.588
Relative|Stomach cancer|2015–2019|Males|5|40–44|0.349|0.266|0.433
Relative|Stomach cancer|2015–2019|Males|5|45–49|0.429|0.366|0.491
Relative|Stomach cancer|2015–2019|Males|5|50–54|0.429|0.38|0.477
Relative|Stomach cancer|2015–2019|Males|5|55–59|0.426|0.385|0.466
Relative|Stomach cancer|2015–2019|Males|5|60–64|0.393|0.359|0.426
Relative|Stomach cancer|2015–2019|Males|5|65–69|0.409|0.378|0.44
Relative|Stomach cancer|2015–2019|Males|5|70–74|0.365|0.333|0.397
Relative|Stomach cancer|2015–2019|Males|5|75–79|0.363|0.329|0.397
Relative|Stomach cancer|2015–2019|Males|5|80–84|0.291|0.253|0.331
Relative|Stomach cancer|2015–2019|Males|5|85+|0.149|0.114|0.19
Relative|Stomach cancer|2015–2019|Males|5|All ages combined|0.361|0.348|0.373
Observed|Stomach cancer|2015–2019|Females|1|00–04|||
Observed|Stomach cancer|2015–2019|Females|1|05–09|||
Observed|Stomach cancer|2015–2019|Females|1|10–14|||
Observed|Stomach cancer|2015–2019|Females|1|15–19|||
Observed|Stomach cancer|2015–2019|Females|1|20–24|||
Observed|Stomach cancer|2015–2019|Females|1|25–29|0.804|0.593|0.913
Observed|Stomach cancer|2015–2019|Females|1|30–34|0.709|0.528|0.831
Observed|Stomach cancer|2015–2019|Females|1|35–39|0.739|0.605|0.833
Observed|Stomach cancer|2015–2019|Females|1|40–44|0.749|0.661|0.817
Observed|Stomach cancer|2015–2019|Females|1|45–49|0.766|0.693|0.825
Observed|Stomach cancer|2015–2019|Females|1|50–54|0.732|0.667|0.787
Observed|Stomach cancer|2015–2019|Females|1|55–59|0.74|0.689|0.785
Observed|Stomach cancer|2015–2019|Females|1|60–64|0.7|0.654|0.741
Observed|Stomach cancer|2015–2019|Females|1|65–69|0.734|0.692|0.771
Observed|Stomach cancer|2015–2019|Females|1|70–74|0.662|0.62|0.701
Observed|Stomach cancer|2015–2019|Females|1|75–79|0.591|0.547|0.632
Observed|Stomach cancer|2015–2019|Females|1|80–84|0.454|0.41|0.496
Observed|Stomach cancer|2015–2019|Females|1|85+|0.295|0.26|0.331
Observed|Stomach cancer|2015–2019|Females|1|All ages combined|0.604|0.589|0.619
Observed|Stomach cancer|2015–2019|Females|2|00–04|||
Observed|Stomach cancer|2015–2019|Females|2|05–09|||
Observed|Stomach cancer|2015–2019|Females|2|10–14|||
Observed|Stomach cancer|2015–2019|Females|2|15–19|||
Observed|Stomach cancer|2015–2019|Females|2|20–24|||
Observed|Stomach cancer|2015–2019|Females|2|25–29|||
Observed|Stomach cancer|2015–2019|Females|2|30–34|0.588|0.406|0.731
Observed|Stomach cancer|2015–2019|Females|2|35–39|0.52|0.383|0.64
Observed|Stomach cancer|2015–2019|Females|2|40–44|0.57|0.475|0.654
Observed|Stomach cancer|2015–2019|Females|2|45–49|0.615|0.534|0.686
Observed|Stomach cancer|2015–2019|Females|2|50–54|0.596|0.527|0.658
Observed|Stomach cancer|2015–2019|Females|2|55–59|0.577|0.52|0.63
Observed|Stomach cancer|2015–2019|Females|2|60–64|0.585|0.536|0.632
Observed|Stomach cancer|2015–2019|Females|2|65–69|0.607|0.561|0.649
Observed|Stomach cancer|2015–2019|Females|2|70–74|0.53|0.486|0.572
Observed|Stomach cancer|2015–2019|Females|2|75–79|0.458|0.414|0.5
Observed|Stomach cancer|2015–2019|Females|2|80–84|0.337|0.296|0.378
Observed|Stomach cancer|2015–2019|Females|2|85+|0.192|0.163|0.223
Observed|Stomach cancer|2015–2019|Females|2|All ages combined|0.474|0.458|0.489
Observed|Stomach cancer|2015–2019|Females|3|00–04|||
Observed|Stomach cancer|2015–2019|Females|3|05–09|||
Observed|Stomach cancer|2015–2019|Females|3|10–14|||
Observed|Stomach cancer|2015–2019|Females|3|15–19|||
Observed|Stomach cancer|2015–2019|Females|3|20–24|||
Observed|Stomach cancer|2015–2019|Females|3|25–29|||
Observed|Stomach cancer|2015–2019|Females|3|30–34|0.465|0.299|0.615
Observed|Stomach cancer|2015–2019|Females|3|35–39|0.52|0.383|0.64
Observed|Stomach cancer|2015–2019|Females|3|40–44|0.528|0.434|0.614
Observed|Stomach cancer|2015–2019|Females|3|45–49|0.579|0.497|0.653
Observed|Stomach cancer|2015–2019|Females|3|50–54|0.544|0.475|0.608
Observed|Stomach cancer|2015–2019|Females|3|55–59|0.499|0.44|0.555
Observed|Stomach cancer|2015–2019|Females|3|60–64|0.522|0.472|0.57
Observed|Stomach cancer|2015–2019|Females|3|65–69|0.552|0.506|0.597
Observed|Stomach cancer|2015–2019|Females|3|70–74|0.463|0.419|0.506
Observed|Stomach cancer|2015–2019|Females|3|75–79|0.407|0.365|0.449
Observed|Stomach cancer|2015–2019|Females|3|80–84|0.294|0.255|0.335
Observed|Stomach cancer|2015–2019|Females|3|85+|0.13|0.106|0.157
Observed|Stomach cancer|2015–2019|Females|3|All ages combined|0.417|0.401|0.432
Observed|Stomach cancer|2015–2019|Females|4|00–04|||
Observed|Stomach cancer|2015–2019|Females|4|05–09|||
Observed|Stomach cancer|2015–2019|Females|4|10–14|||
Observed|Stomach cancer|2015–2019|Females|4|15–19|||
Observed|Stomach cancer|2015–2019|Females|4|20–24|||
Observed|Stomach cancer|2015–2019|Females|4|25–29|||
Observed|Stomach cancer|2015–2019|Females|4|30–34|||
Observed|Stomach cancer|2015–2019|Females|4|35–39|0.52|0.383|0.64
Observed|Stomach cancer|2015–2019|Females|4|40–44|0.489|0.394|0.577
Observed|Stomach cancer|2015–2019|Females|4|45–49|0.571|0.489|0.645
Observed|Stomach cancer|2015–2019|Females|4|50–54|0.531|0.462|0.594
Observed|Stomach cancer|2015–2019|Females|4|55–59|0.475|0.416|0.532
Observed|Stomach cancer|2015–2019|Females|4|60–64|0.48|0.429|0.528
Observed|Stomach cancer|2015–2019|Females|4|65–69|0.531|0.484|0.575
Observed|Stomach cancer|2015–2019|Females|4|70–74|0.442|0.398|0.485
Observed|Stomach cancer|2015–2019|Females|4|75–79|0.367|0.326|0.409
Observed|Stomach cancer|2015–2019|Females|4|80–84|0.257|0.219|0.296
Observed|Stomach cancer|2015–2019|Females|4|85+|0.1|0.078|0.124
Observed|Stomach cancer|2015–2019|Females|4|All ages combined|0.388|0.373|0.404
Observed|Stomach cancer|2015–2019|Females|5|00–04|||
Observed|Stomach cancer|2015–2019|Females|5|05–09|||
Observed|Stomach cancer|2015–2019|Females|5|10–14|||
Observed|Stomach cancer|2015–2019|Females|5|15–19|||
Observed|Stomach cancer|2015–2019|Females|5|20–24|||
Observed|Stomach cancer|2015–2019|Females|5|25–29|||
Observed|Stomach cancer|2015–2019|Females|5|30–34|||
Observed|Stomach cancer|2015–2019|Females|5|35–39|0.52|0.383|0.64
Observed|Stomach cancer|2015–2019|Females|5|40–44|0.489|0.394|0.577
Observed|Stomach cancer|2015–2019|Females|5|45–49|0.546|0.463|0.622
Observed|Stomach cancer|2015–2019|Females|5|50–54|0.499|0.43|0.563
Observed|Stomach cancer|2015–2019|Females|5|55–59|0.464|0.405|0.521
Observed|Stomach cancer|2015–2019|Females|5|60–64|0.443|0.393|0.492
Observed|Stomach cancer|2015–2019|Females|5|65–69|0.513|0.466|0.558
Observed|Stomach cancer|2015–2019|Females|5|70–74|0.422|0.378|0.465
Observed|Stomach cancer|2015–2019|Females|5|75–79|0.345|0.304|0.386
Observed|Stomach cancer|2015–2019|Females|5|80–84|0.228|0.191|0.266
Observed|Stomach cancer|2015–2019|Females|5|85+|0.072|0.053|0.094
Observed|Stomach cancer|2015–2019|Females|5|All ages combined|0.364|0.349|0.38
Relative|Stomach cancer|2015–2019|Females|1|00–04|||
Relative|Stomach cancer|2015–2019|Females|1|05–09|||
Relative|Stomach cancer|2015–2019|Females|1|10–14|||
Relative|Stomach cancer|2015–2019|Females|1|15–19|||
Relative|Stomach cancer|2015–2019|Females|1|20–24|||
Relative|Stomach cancer|2015–2019|Females|1|25–29|0.805|0.593|0.914
Relative|Stomach cancer|2015–2019|Females|1|30–34|0.709|0.528|0.831
Relative|Stomach cancer|2015–2019|Females|1|35–39|0.739|0.605|0.834
Relative|Stomach cancer|2015–2019|Females|1|40–44|0.749|0.662|0.818
Relative|Stomach cancer|2015–2019|Females|1|45–49|0.767|0.694|0.826
Relative|Stomach cancer|2015–2019|Females|1|50–54|0.734|0.668|0.788
Relative|Stomach cancer|2015–2019|Females|1|55–59|0.742|0.691|0.787
Relative|Stomach cancer|2015–2019|Females|1|60–64|0.703|0.657|0.745
Relative|Stomach cancer|2015–2019|Females|1|65–69|0.74|0.697|0.777
Relative|Stomach cancer|2015–2019|Females|1|70–74|0.671|0.628|0.71
Relative|Stomach cancer|2015–2019|Females|1|75–79|0.604|0.559|0.646
Relative|Stomach cancer|2015–2019|Females|1|80–84|0.473|0.428|0.517
Relative|Stomach cancer|2015–2019|Females|1|85+|0.331|0.292|0.371
Relative|Stomach cancer|2015–2019|Females|1|All ages combined|0.621|0.605|0.636
Relative|Stomach cancer|2015–2019|Females|2|00–04|||
Relative|Stomach cancer|2015–2019|Females|2|05–09|||
Relative|Stomach cancer|2015–2019|Females|2|10–14|||
Relative|Stomach cancer|2015–2019|Females|2|15–19|||
Relative|Stomach cancer|2015–2019|Females|2|20–24|||
Relative|Stomach cancer|2015–2019|Females|2|25–29|||
Relative|Stomach cancer|2015–2019|Females|2|30–34|0.588|0.406|0.732
Relative|Stomach cancer|2015–2019|Females|2|35–39|0.521|0.383|0.641
Relative|Stomach cancer|2015–2019|Females|2|40–44|0.571|0.476|0.656
Relative|Stomach cancer|2015–2019|Females|2|45–49|0.617|0.535|0.688
Relative|Stomach cancer|2015–2019|Females|2|50–54|0.599|0.529|0.661
Relative|Stomach cancer|2015–2019|Females|2|55–59|0.581|0.523|0.635
Relative|Stomach cancer|2015–2019|Females|2|60–64|0.591|0.541|0.638
Relative|Stomach cancer|2015–2019|Females|2|65–69|0.616|0.57|0.659
Relative|Stomach cancer|2015–2019|Females|2|70–74|0.544|0.499|0.587
Relative|Stomach cancer|2015–2019|Females|2|75–79|0.479|0.434|0.523
Relative|Stomach cancer|2015–2019|Females|2|80–84|0.368|0.324|0.413
Relative|Stomach cancer|2015–2019|Females|2|85+|0.241|0.205|0.28
Relative|Stomach cancer|2015–2019|Females|2|All ages combined|0.498|0.481|0.514
Relative|Stomach cancer|2015–2019|Females|3|00–04|||
Relative|Stomach cancer|2015–2019|Females|3|05–09|||
Relative|Stomach cancer|2015–2019|Females|3|10–14|||
Relative|Stomach cancer|2015–2019|Females|3|15–19|||
Relative|Stomach cancer|2015–2019|Females|3|20–24|||
Relative|Stomach cancer|2015–2019|Females|3|25–29|||
Relative|Stomach cancer|2015–2019|Females|3|30–34|0.465|0.299|0.616
Relative|Stomach cancer|2015–2019|Females|3|35–39|0.521|0.384|0.642
Relative|Stomach cancer|2015–2019|Females|3|40–44|0.53|0.435|0.616
Relative|Stomach cancer|2015–2019|Females|3|45–49|0.582|0.499|0.656
Relative|Stomach cancer|2015–2019|Females|3|50–54|0.548|0.478|0.612
Relative|Stomach cancer|2015–2019|Females|3|55–59|0.504|0.444|0.56
Relative|Stomach cancer|2015–2019|Females|3|60–64|0.53|0.479|0.578
Relative|Stomach cancer|2015–2019|Females|3|65–69|0.566|0.518|0.611
Relative|Stomach cancer|2015–2019|Females|3|70–74|0.483|0.437|0.527
Relative|Stomach cancer|2015–2019|Females|3|75–79|0.438|0.393|0.483
Relative|Stomach cancer|2015–2019|Females|3|80–84|0.341|0.295|0.388
Relative|Stomach cancer|2015–2019|Females|3|85+|0.187|0.152|0.225
Relative|Stomach cancer|2015–2019|Females|3|All ages combined|0.447|0.431|0.464
Relative|Stomach cancer|2015–2019|Females|4|00–04|||
Relative|Stomach cancer|2015–2019|Females|4|05–09|||
Relative|Stomach cancer|2015–2019|Females|4|10–14|||
Relative|Stomach cancer|2015–2019|Females|4|15–19|||
Relative|Stomach cancer|2015–2019|Females|4|20–24|||
Relative|Stomach cancer|2015–2019|Females|4|25–29|||
Relative|Stomach cancer|2015–2019|Females|4|30–34|||
Relative|Stomach cancer|2015–2019|Females|4|35–39|0.521|0.384|0.642
Relative|Stomach cancer|2015–2019|Females|4|40–44|0.491|0.396|0.579
Relative|Stomach cancer|2015–2019|Females|4|45–49|0.575|0.492|0.65
Relative|Stomach cancer|2015–2019|Females|4|50–54|0.536|0.466|0.6
Relative|Stomach cancer|2015–2019|Females|4|55–59|0.482|0.422|0.539
Relative|Stomach cancer|2015–2019|Females|4|60–64|0.49|0.438|0.539
Relative|Stomach cancer|2015–2019|Females|4|65–69|0.549|0.5|0.595
Relative|Stomach cancer|2015–2019|Females|4|70–74|0.468|0.422|0.514
Relative|Stomach cancer|2015–2019|Females|4|75–79|0.408|0.362|0.454
Relative|Stomach cancer|2015–2019|Females|4|80–84|0.317|0.27|0.365
Relative|Stomach cancer|2015–2019|Females|4|85+|0.164|0.129|0.205
Relative|Stomach cancer|2015–2019|Females|4|All ages combined|0.426|0.409|0.442
Relative|Stomach cancer|2015–2019|Females|5|00–04|||
Relative|Stomach cancer|2015–2019|Females|5|05–09|||
Relative|Stomach cancer|2015–2019|Females|5|10–14|||
Relative|Stomach cancer|2015–2019|Females|5|15–19|||
Relative|Stomach cancer|2015–2019|Females|5|20–24|||
Relative|Stomach cancer|2015–2019|Females|5|25–29|||
Relative|Stomach cancer|2015–2019|Females|5|30–34|||
Relative|Stomach cancer|2015–2019|Females|5|35–39|0.522|0.384|0.643
Relative|Stomach cancer|2015–2019|Females|5|40–44|0.492|0.397|0.58
Relative|Stomach cancer|2015–2019|Females|5|45–49|0.551|0.467|0.628
Relative|Stomach cancer|2015–2019|Females|5|50–54|0.505|0.436|0.57
Relative|Stomach cancer|2015–2019|Females|5|55–59|0.473|0.413|0.53
Relative|Stomach cancer|2015–2019|Females|5|60–64|0.456|0.404|0.506
Relative|Stomach cancer|2015–2019|Females|5|65–69|0.537|0.488|0.584
Relative|Stomach cancer|2015–2019|Females|5|70–74|0.456|0.409|0.502
Relative|Stomach cancer|2015–2019|Females|5|75–79|0.398|0.351|0.445
Relative|Stomach cancer|2015–2019|Females|5|80–84|0.301|0.253|0.352
Relative|Stomach cancer|2015–2019|Females|5|85+|0.139|0.103|0.181
Relative|Stomach cancer|2015–2019|Females|5|All ages combined|0.409|0.392|0.426
Observed|Stomach cancer|2015–2019|Persons|1|00–04|||
Observed|Stomach cancer|2015–2019|Persons|1|05–09|||
Observed|Stomach cancer|2015–2019|Persons|1|10–14|||
Observed|Stomach cancer|2015–2019|Persons|1|15–19|||
Observed|Stomach cancer|2015–2019|Persons|1|20–24|||
Observed|Stomach cancer|2015–2019|Persons|1|25–29|0.773|0.628|0.867
Observed|Stomach cancer|2015–2019|Persons|1|30–34|0.692|0.568|0.787
Observed|Stomach cancer|2015–2019|Persons|1|35–39|0.73|0.646|0.797
Observed|Stomach cancer|2015–2019|Persons|1|40–44|0.673|0.61|0.728
Observed|Stomach cancer|2015–2019|Persons|1|45–49|0.7|0.653|0.742
Observed|Stomach cancer|2015–2019|Persons|1|50–54|0.705|0.668|0.74
Observed|Stomach cancer|2015–2019|Persons|1|55–59|0.711|0.681|0.739
Observed|Stomach cancer|2015–2019|Persons|1|60–64|0.684|0.658|0.708
Observed|Stomach cancer|2015–2019|Persons|1|65–69|0.698|0.675|0.72
Observed|Stomach cancer|2015–2019|Persons|1|70–74|0.643|0.62|0.665
Observed|Stomach cancer|2015–2019|Persons|1|75–79|0.571|0.546|0.595
Observed|Stomach cancer|2015–2019|Persons|1|80–84|0.492|0.466|0.518
Observed|Stomach cancer|2015–2019|Persons|1|85+|0.304|0.281|0.328
Observed|Stomach cancer|2015–2019|Persons|1|All ages combined|0.602|0.593|0.61
Observed|Stomach cancer|2015–2019|Persons|2|00–04|||
Observed|Stomach cancer|2015–2019|Persons|2|05–09|||
Observed|Stomach cancer|2015–2019|Persons|2|10–14|||
Observed|Stomach cancer|2015–2019|Persons|2|15–19|||
Observed|Stomach cancer|2015–2019|Persons|2|20–24|||
Observed|Stomach cancer|2015–2019|Persons|2|25–29|0.702|0.548|0.812
Observed|Stomach cancer|2015–2019|Persons|2|30–34|0.606|0.481|0.71
Observed|Stomach cancer|2015–2019|Persons|2|35–39|0.584|0.492|0.664
Observed|Stomach cancer|2015–2019|Persons|2|40–44|0.535|0.47|0.596
Observed|Stomach cancer|2015–2019|Persons|2|45–49|0.558|0.508|0.605
Observed|Stomach cancer|2015–2019|Persons|2|50–54|0.557|0.517|0.595
Observed|Stomach cancer|2015–2019|Persons|2|55–59|0.56|0.527|0.591
Observed|Stomach cancer|2015–2019|Persons|2|60–64|0.541|0.514|0.568
Observed|Stomach cancer|2015–2019|Persons|2|65–69|0.549|0.524|0.573
Observed|Stomach cancer|2015–2019|Persons|2|70–74|0.495|0.471|0.519
Observed|Stomach cancer|2015–2019|Persons|2|75–79|0.442|0.418|0.466
Observed|Stomach cancer|2015–2019|Persons|2|80–84|0.342|0.318|0.367
Observed|Stomach cancer|2015–2019|Persons|2|85+|0.186|0.166|0.206
Observed|Stomach cancer|2015–2019|Persons|2|All ages combined|0.46|0.451|0.469
Observed|Stomach cancer|2015–2019|Persons|3|00–04|||
Observed|Stomach cancer|2015–2019|Persons|3|05–09|||
Observed|Stomach cancer|2015–2019|Persons|3|10–14|||
Observed|Stomach cancer|2015–2019|Persons|3|15–19|||
Observed|Stomach cancer|2015–2019|Persons|3|20–24|||
Observed|Stomach cancer|2015–2019|Persons|3|25–29|0.674|0.517|0.79
Observed|Stomach cancer|2015–2019|Persons|3|30–34|0.508|0.389|0.616
Observed|Stomach cancer|2015–2019|Persons|3|35–39|0.538|0.446|0.622
Observed|Stomach cancer|2015–2019|Persons|3|40–44|0.471|0.406|0.532
Observed|Stomach cancer|2015–2019|Persons|3|45–49|0.51|0.459|0.558
Observed|Stomach cancer|2015–2019|Persons|3|50–54|0.488|0.448|0.526
Observed|Stomach cancer|2015–2019|Persons|3|55–59|0.48|0.447|0.512
Observed|Stomach cancer|2015–2019|Persons|3|60–64|0.472|0.444|0.499
Observed|Stomach cancer|2015–2019|Persons|3|65–69|0.474|0.449|0.498
Observed|Stomach cancer|2015–2019|Persons|3|70–74|0.422|0.398|0.446
Observed|Stomach cancer|2015–2019|Persons|3|75–79|0.375|0.351|0.398
Observed|Stomach cancer|2015–2019|Persons|3|80–84|0.279|0.255|0.302
Observed|Stomach cancer|2015–2019|Persons|3|85+|0.128|0.111|0.145
Observed|Stomach cancer|2015–2019|Persons|3|All ages combined|0.391|0.382|0.4
Observed|Stomach cancer|2015–2019|Persons|4|00–04|||
Observed|Stomach cancer|2015–2019|Persons|4|05–09|||
Observed|Stomach cancer|2015–2019|Persons|4|10–14|||
Observed|Stomach cancer|2015–2019|Persons|4|15–19|||
Observed|Stomach cancer|2015–2019|Persons|4|20–24|||
Observed|Stomach cancer|2015–2019|Persons|4|25–29|||
Observed|Stomach cancer|2015–2019|Persons|4|30–34|0.485|0.367|0.592
Observed|Stomach cancer|2015–2019|Persons|4|35–39|0.52|0.428|0.604
Observed|Stomach cancer|2015–2019|Persons|4|40–44|0.427|0.364|0.489
Observed|Stomach cancer|2015–2019|Persons|4|45–49|0.49|0.44|0.538
Observed|Stomach cancer|2015–2019|Persons|4|50–54|0.467|0.428|0.505
Observed|Stomach cancer|2015–2019|Persons|4|55–59|0.445|0.412|0.477
Observed|Stomach cancer|2015–2019|Persons|4|60–64|0.423|0.395|0.45
Observed|Stomach cancer|2015–2019|Persons|4|65–69|0.437|0.412|0.462
Observed|Stomach cancer|2015–2019|Persons|4|70–74|0.378|0.354|0.402
Observed|Stomach cancer|2015–2019|Persons|4|75–79|0.334|0.311|0.357
Observed|Stomach cancer|2015–2019|Persons|4|80–84|0.235|0.213|0.258
Observed|Stomach cancer|2015–2019|Persons|4|85+|0.095|0.081|0.111
Observed|Stomach cancer|2015–2019|Persons|4|All ages combined|0.352|0.344|0.361
Observed|Stomach cancer|2015–2019|Persons|5|00–04|||
Observed|Stomach cancer|2015–2019|Persons|5|05–09|||
Observed|Stomach cancer|2015–2019|Persons|5|10–14|||
Observed|Stomach cancer|2015–2019|Persons|5|15–19|||
Observed|Stomach cancer|2015–2019|Persons|5|20–24|||
Observed|Stomach cancer|2015–2019|Persons|5|25–29|||
Observed|Stomach cancer|2015–2019|Persons|5|30–34|0.441|0.325|0.55
Observed|Stomach cancer|2015–2019|Persons|5|35–39|0.499|0.406|0.584
Observed|Stomach cancer|2015–2019|Persons|5|40–44|0.414|0.351|0.475
Observed|Stomach cancer|2015–2019|Persons|5|45–49|0.47|0.42|0.519
Observed|Stomach cancer|2015–2019|Persons|5|50–54|0.447|0.408|0.486
Observed|Stomach cancer|2015–2019|Persons|5|55–59|0.43|0.397|0.462
Observed|Stomach cancer|2015–2019|Persons|5|60–64|0.396|0.369|0.422
Observed|Stomach cancer|2015–2019|Persons|5|65–69|0.419|0.394|0.443
Observed|Stomach cancer|2015–2019|Persons|5|70–74|0.354|0.331|0.378
Observed|Stomach cancer|2015–2019|Persons|5|75–79|0.31|0.287|0.333
Observed|Stomach cancer|2015–2019|Persons|5|80–84|0.208|0.186|0.23
Observed|Stomach cancer|2015–2019|Persons|5|85+|0.069|0.057|0.083
Observed|Stomach cancer|2015–2019|Persons|5|All ages combined|0.329|0.32|0.338
Relative|Stomach cancer|2015–2019|Persons|1|00–04|||
Relative|Stomach cancer|2015–2019|Persons|1|05–09|||
Relative|Stomach cancer|2015–2019|Persons|1|10–14|||
Relative|Stomach cancer|2015–2019|Persons|1|15–19|||
Relative|Stomach cancer|2015–2019|Persons|1|20–24|||
Relative|Stomach cancer|2015–2019|Persons|1|25–29|0.773|0.628|0.867
Relative|Stomach cancer|2015–2019|Persons|1|30–34|0.692|0.569|0.787
Relative|Stomach cancer|2015–2019|Persons|1|35–39|0.73|0.646|0.797
Relative|Stomach cancer|2015–2019|Persons|1|40–44|0.674|0.611|0.729
Relative|Stomach cancer|2015–2019|Persons|1|45–49|0.701|0.655|0.743
Relative|Stomach cancer|2015–2019|Persons|1|50–54|0.708|0.67|0.742
Relative|Stomach cancer|2015–2019|Persons|1|55–59|0.714|0.684|0.742
Relative|Stomach cancer|2015–2019|Persons|1|60–64|0.689|0.663|0.713
Relative|Stomach cancer|2015–2019|Persons|1|65–69|0.706|0.683|0.728
Relative|Stomach cancer|2015–2019|Persons|1|70–74|0.654|0.63|0.677
Relative|Stomach cancer|2015–2019|Persons|1|75–79|0.588|0.563|0.612
Relative|Stomach cancer|2015–2019|Persons|1|80–84|0.52|0.492|0.547
Relative|Stomach cancer|2015–2019|Persons|1|85+|0.346|0.319|0.373
Relative|Stomach cancer|2015–2019|Persons|1|All ages combined|0.62|0.611|0.629
Relative|Stomach cancer|2015–2019|Persons|2|00–04|||
Relative|Stomach cancer|2015–2019|Persons|2|05–09|||
Relative|Stomach cancer|2015–2019|Persons|2|10–14|||
Relative|Stomach cancer|2015–2019|Persons|2|15–19|||
Relative|Stomach cancer|2015–2019|Persons|2|20–24|||
Relative|Stomach cancer|2015–2019|Persons|2|25–29|0.703|0.549|0.813
Relative|Stomach cancer|2015–2019|Persons|2|30–34|0.607|0.482|0.711
Relative|Stomach cancer|2015–2019|Persons|2|35–39|0.585|0.493|0.666
Relative|Stomach cancer|2015–2019|Persons|2|40–44|0.537|0.471|0.598
Relative|Stomach cancer|2015–2019|Persons|2|45–49|0.561|0.51|0.608
Relative|Stomach cancer|2015–2019|Persons|2|50–54|0.56|0.52|0.599
Relative|Stomach cancer|2015–2019|Persons|2|55–59|0.565|0.532|0.597
Relative|Stomach cancer|2015–2019|Persons|2|60–64|0.549|0.521|0.576
Relative|Stomach cancer|2015–2019|Persons|2|65–69|0.561|0.536|0.586
Relative|Stomach cancer|2015–2019|Persons|2|70–74|0.513|0.488|0.538
Relative|Stomach cancer|2015–2019|Persons|2|75–79|0.47|0.444|0.496
Relative|Stomach cancer|2015–2019|Persons|2|80–84|0.384|0.357|0.412
Relative|Stomach cancer|2015–2019|Persons|2|85+|0.241|0.216|0.267
Relative|Stomach cancer|2015–2019|Persons|2|All ages combined|0.486|0.476|0.496
Relative|Stomach cancer|2015–2019|Persons|3|00–04|||
Relative|Stomach cancer|2015–2019|Persons|3|05–09|||
Relative|Stomach cancer|2015–2019|Persons|3|10–14|||
Relative|Stomach cancer|2015–2019|Persons|3|15–19|||
Relative|Stomach cancer|2015–2019|Persons|3|20–24|||
Relative|Stomach cancer|2015–2019|Persons|3|25–29|0.675|0.518|0.792
Relative|Stomach cancer|2015–2019|Persons|3|30–34|0.509|0.39|0.617
Relative|Stomach cancer|2015–2019|Persons|3|35–39|0.54|0.447|0.623
Relative|Stomach cancer|2015–2019|Persons|3|40–44|0.473|0.408|0.534
Relative|Stomach cancer|2015–2019|Persons|3|45–49|0.513|0.462|0.561
Relative|Stomach cancer|2015–2019|Persons|3|50–54|0.493|0.452|0.531
Relative|Stomach cancer|2015–2019|Persons|3|55–59|0.487|0.454|0.52
Relative|Stomach cancer|2015–2019|Persons|3|60–64|0.482|0.454|0.51
Relative|Stomach cancer|2015–2019|Persons|3|65–69|0.491|0.465|0.516
Relative|Stomach cancer|2015–2019|Persons|3|70–74|0.447|0.421|0.472
Relative|Stomach cancer|2015–2019|Persons|3|75–79|0.414|0.388|0.44
Relative|Stomach cancer|2015–2019|Persons|3|80–84|0.335|0.307|0.364
Relative|Stomach cancer|2015–2019|Persons|3|85+|0.192|0.167|0.218
Relative|Stomach cancer|2015–2019|Persons|3|All ages combined|0.424|0.414|0.434
Relative|Stomach cancer|2015–2019|Persons|4|00–04|||
Relative|Stomach cancer|2015–2019|Persons|4|05–09|||
Relative|Stomach cancer|2015–2019|Persons|4|10–14|||
Relative|Stomach cancer|2015–2019|Persons|4|15–19|||
Relative|Stomach cancer|2015–2019|Persons|4|20–24|||
Relative|Stomach cancer|2015–2019|Persons|4|25–29|||
Relative|Stomach cancer|2015–2019|Persons|4|30–34|0.486|0.368|0.594
Relative|Stomach cancer|2015–2019|Persons|4|35–39|0.522|0.429|0.607
Relative|Stomach cancer|2015–2019|Persons|4|40–44|0.429|0.366|0.492
Relative|Stomach cancer|2015–2019|Persons|4|45–49|0.494|0.444|0.543
Relative|Stomach cancer|2015–2019|Persons|4|50–54|0.473|0.433|0.512
Relative|Stomach cancer|2015–2019|Persons|4|55–59|0.455|0.421|0.488
Relative|Stomach cancer|2015–2019|Persons|4|60–64|0.436|0.408|0.464
Relative|Stomach cancer|2015–2019|Persons|4|65–69|0.459|0.433|0.485
Relative|Stomach cancer|2015–2019|Persons|4|70–74|0.41|0.384|0.436
Relative|Stomach cancer|2015–2019|Persons|4|75–79|0.384|0.358|0.411
Relative|Stomach cancer|2015–2019|Persons|4|80–84|0.306|0.277|0.336
Relative|Stomach cancer|2015–2019|Persons|4|85+|0.168|0.143|0.195
Relative|Stomach cancer|2015–2019|Persons|4|All ages combined|0.393|0.383|0.403
Relative|Stomach cancer|2015–2019|Persons|5|00–04|||
Relative|Stomach cancer|2015–2019|Persons|5|05–09|||
Relative|Stomach cancer|2015–2019|Persons|5|10–14|||
Relative|Stomach cancer|2015–2019|Persons|5|15–19|||
Relative|Stomach cancer|2015–2019|Persons|5|20–24|||
Relative|Stomach cancer|2015–2019|Persons|5|25–29|||
Relative|Stomach cancer|2015–2019|Persons|5|30–34|0.442|0.327|0.552
Relative|Stomach cancer|2015–2019|Persons|5|35–39|0.501|0.408|0.588
Relative|Stomach cancer|2015–2019|Persons|5|40–44|0.417|0.353|0.479
Relative|Stomach cancer|2015–2019|Persons|5|45–49|0.475|0.424|0.525
Relative|Stomach cancer|2015–2019|Persons|5|50–54|0.455|0.415|0.494
Relative|Stomach cancer|2015–2019|Persons|5|55–59|0.442|0.408|0.475
Relative|Stomach cancer|2015–2019|Persons|5|60–64|0.412|0.384|0.44
Relative|Stomach cancer|2015–2019|Persons|5|65–69|0.446|0.42|0.473
Relative|Stomach cancer|2015–2019|Persons|5|70–74|0.394|0.368|0.42
Relative|Stomach cancer|2015–2019|Persons|5|75–79|0.374|0.347|0.402
Relative|Stomach cancer|2015–2019|Persons|5|80–84|0.295|0.265|0.326
Relative|Stomach cancer|2015–2019|Persons|5|85+|0.144|0.119|0.173
Relative|Stomach cancer|2015–2019|Persons|5|All ages combined|0.377|0.367|0.388
Observed|Sublingual gland cancer|2015–2019|Males|1|00–04|||
Observed|Sublingual gland cancer|2015–2019|Males|1|05–09|||
Observed|Sublingual gland cancer|2015–2019|Males|1|10–14|||
Observed|Sublingual gland cancer|2015–2019|Males|1|15–19|||
Observed|Sublingual gland cancer|2015–2019|Males|1|20–24|||
Observed|Sublingual gland cancer|2015–2019|Males|1|25–29|||
Observed|Sublingual gland cancer|2015–2019|Males|1|30–34|||
Observed|Sublingual gland cancer|2015–2019|Males|1|35–39|||
Observed|Sublingual gland cancer|2015–2019|Males|1|40–44|||
Observed|Sublingual gland cancer|2015–2019|Males|1|45–49|||
Observed|Sublingual gland cancer|2015–2019|Males|1|50–54|||
Observed|Sublingual gland cancer|2015–2019|Males|1|55–59|||
Observed|Sublingual gland cancer|2015–2019|Males|1|60–64|||
Observed|Sublingual gland cancer|2015–2019|Males|1|65–69|||
Observed|Sublingual gland cancer|2015–2019|Males|1|70–74|||
Observed|Sublingual gland cancer|2015–2019|Males|1|75–79|||
Observed|Sublingual gland cancer|2015–2019|Males|1|80–84|||
Observed|Sublingual gland cancer|2015–2019|Males|1|85+|||
Observed|Sublingual gland cancer|2015–2019|Males|1|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Males|2|00–04|||
Observed|Sublingual gland cancer|2015–2019|Males|2|05–09|||
Observed|Sublingual gland cancer|2015–2019|Males|2|10–14|||
Observed|Sublingual gland cancer|2015–2019|Males|2|15–19|||
Observed|Sublingual gland cancer|2015–2019|Males|2|20–24|||
Observed|Sublingual gland cancer|2015–2019|Males|2|25–29|||
Observed|Sublingual gland cancer|2015–2019|Males|2|30–34|||
Observed|Sublingual gland cancer|2015–2019|Males|2|35–39|||
Observed|Sublingual gland cancer|2015–2019|Males|2|40–44|||
Observed|Sublingual gland cancer|2015–2019|Males|2|45–49|||
Observed|Sublingual gland cancer|2015–2019|Males|2|50–54|||
Observed|Sublingual gland cancer|2015–2019|Males|2|55–59|||
Observed|Sublingual gland cancer|2015–2019|Males|2|60–64|||
Observed|Sublingual gland cancer|2015–2019|Males|2|65–69|||
Observed|Sublingual gland cancer|2015–2019|Males|2|70–74|||
Observed|Sublingual gland cancer|2015–2019|Males|2|75–79|||
Observed|Sublingual gland cancer|2015–2019|Males|2|80–84|||
Observed|Sublingual gland cancer|2015–2019|Males|2|85+|||
Observed|Sublingual gland cancer|2015–2019|Males|2|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Males|3|00–04|||
Observed|Sublingual gland cancer|2015–2019|Males|3|05–09|||
Observed|Sublingual gland cancer|2015–2019|Males|3|10–14|||
Observed|Sublingual gland cancer|2015–2019|Males|3|15–19|||
Observed|Sublingual gland cancer|2015–2019|Males|3|20–24|||
Observed|Sublingual gland cancer|2015–2019|Males|3|25–29|||
Observed|Sublingual gland cancer|2015–2019|Males|3|30–34|||
Observed|Sublingual gland cancer|2015–2019|Males|3|35–39|||
Observed|Sublingual gland cancer|2015–2019|Males|3|40–44|||
Observed|Sublingual gland cancer|2015–2019|Males|3|45–49|||
Observed|Sublingual gland cancer|2015–2019|Males|3|50–54|||
Observed|Sublingual gland cancer|2015–2019|Males|3|55–59|||
Observed|Sublingual gland cancer|2015–2019|Males|3|60–64|||
Observed|Sublingual gland cancer|2015–2019|Males|3|65–69|||
Observed|Sublingual gland cancer|2015–2019|Males|3|70–74|||
Observed|Sublingual gland cancer|2015–2019|Males|3|75–79|||
Observed|Sublingual gland cancer|2015–2019|Males|3|80–84|||
Observed|Sublingual gland cancer|2015–2019|Males|3|85+|||
Observed|Sublingual gland cancer|2015–2019|Males|3|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Males|4|00–04|||
Observed|Sublingual gland cancer|2015–2019|Males|4|05–09|||
Observed|Sublingual gland cancer|2015–2019|Males|4|10–14|||
Observed|Sublingual gland cancer|2015–2019|Males|4|15–19|||
Observed|Sublingual gland cancer|2015–2019|Males|4|20–24|||
Observed|Sublingual gland cancer|2015–2019|Males|4|25–29|||
Observed|Sublingual gland cancer|2015–2019|Males|4|30–34|||
Observed|Sublingual gland cancer|2015–2019|Males|4|35–39|||
Observed|Sublingual gland cancer|2015–2019|Males|4|40–44|||
Observed|Sublingual gland cancer|2015–2019|Males|4|45–49|||
Observed|Sublingual gland cancer|2015–2019|Males|4|50–54|||
Observed|Sublingual gland cancer|2015–2019|Males|4|55–59|||
Observed|Sublingual gland cancer|2015–2019|Males|4|60–64|||
Observed|Sublingual gland cancer|2015–2019|Males|4|65–69|||
Observed|Sublingual gland cancer|2015–2019|Males|4|70–74|||
Observed|Sublingual gland cancer|2015–2019|Males|4|75–79|||
Observed|Sublingual gland cancer|2015–2019|Males|4|80–84|||
Observed|Sublingual gland cancer|2015–2019|Males|4|85+|||
Observed|Sublingual gland cancer|2015–2019|Males|4|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Males|5|00–04|||
Observed|Sublingual gland cancer|2015–2019|Males|5|05–09|||
Observed|Sublingual gland cancer|2015–2019|Males|5|10–14|||
Observed|Sublingual gland cancer|2015–2019|Males|5|15–19|||
Observed|Sublingual gland cancer|2015–2019|Males|5|20–24|||
Observed|Sublingual gland cancer|2015–2019|Males|5|25–29|||
Observed|Sublingual gland cancer|2015–2019|Males|5|30–34|||
Observed|Sublingual gland cancer|2015–2019|Males|5|35–39|||
Observed|Sublingual gland cancer|2015–2019|Males|5|40–44|||
Observed|Sublingual gland cancer|2015–2019|Males|5|45–49|||
Observed|Sublingual gland cancer|2015–2019|Males|5|50–54|||
Observed|Sublingual gland cancer|2015–2019|Males|5|55–59|||
Observed|Sublingual gland cancer|2015–2019|Males|5|60–64|||
Observed|Sublingual gland cancer|2015–2019|Males|5|65–69|||
Observed|Sublingual gland cancer|2015–2019|Males|5|70–74|||
Observed|Sublingual gland cancer|2015–2019|Males|5|75–79|||
Observed|Sublingual gland cancer|2015–2019|Males|5|80–84|||
Observed|Sublingual gland cancer|2015–2019|Males|5|85+|||
Observed|Sublingual gland cancer|2015–2019|Males|5|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Males|1|00–04|||
Relative|Sublingual gland cancer|2015–2019|Males|1|05–09|||
Relative|Sublingual gland cancer|2015–2019|Males|1|10–14|||
Relative|Sublingual gland cancer|2015–2019|Males|1|15–19|||
Relative|Sublingual gland cancer|2015–2019|Males|1|20–24|||
Relative|Sublingual gland cancer|2015–2019|Males|1|25–29|||
Relative|Sublingual gland cancer|2015–2019|Males|1|30–34|||
Relative|Sublingual gland cancer|2015–2019|Males|1|35–39|||
Relative|Sublingual gland cancer|2015–2019|Males|1|40–44|||
Relative|Sublingual gland cancer|2015–2019|Males|1|45–49|||
Relative|Sublingual gland cancer|2015–2019|Males|1|50–54|||
Relative|Sublingual gland cancer|2015–2019|Males|1|55–59|||
Relative|Sublingual gland cancer|2015–2019|Males|1|60–64|||
Relative|Sublingual gland cancer|2015–2019|Males|1|65–69|||
Relative|Sublingual gland cancer|2015–2019|Males|1|70–74|||
Relative|Sublingual gland cancer|2015–2019|Males|1|75–79|||
Relative|Sublingual gland cancer|2015–2019|Males|1|80–84|||
Relative|Sublingual gland cancer|2015–2019|Males|1|85+|||
Relative|Sublingual gland cancer|2015–2019|Males|1|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Males|2|00–04|||
Relative|Sublingual gland cancer|2015–2019|Males|2|05–09|||
Relative|Sublingual gland cancer|2015–2019|Males|2|10–14|||
Relative|Sublingual gland cancer|2015–2019|Males|2|15–19|||
Relative|Sublingual gland cancer|2015–2019|Males|2|20–24|||
Relative|Sublingual gland cancer|2015–2019|Males|2|25–29|||
Relative|Sublingual gland cancer|2015–2019|Males|2|30–34|||
Relative|Sublingual gland cancer|2015–2019|Males|2|35–39|||
Relative|Sublingual gland cancer|2015–2019|Males|2|40–44|||
Relative|Sublingual gland cancer|2015–2019|Males|2|45–49|||
Relative|Sublingual gland cancer|2015–2019|Males|2|50–54|||
Relative|Sublingual gland cancer|2015–2019|Males|2|55–59|||
Relative|Sublingual gland cancer|2015–2019|Males|2|60–64|||
Relative|Sublingual gland cancer|2015–2019|Males|2|65–69|||
Relative|Sublingual gland cancer|2015–2019|Males|2|70–74|||
Relative|Sublingual gland cancer|2015–2019|Males|2|75–79|||
Relative|Sublingual gland cancer|2015–2019|Males|2|80–84|||
Relative|Sublingual gland cancer|2015–2019|Males|2|85+|||
Relative|Sublingual gland cancer|2015–2019|Males|2|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Males|3|00–04|||
Relative|Sublingual gland cancer|2015–2019|Males|3|05–09|||
Relative|Sublingual gland cancer|2015–2019|Males|3|10–14|||
Relative|Sublingual gland cancer|2015–2019|Males|3|15–19|||
Relative|Sublingual gland cancer|2015–2019|Males|3|20–24|||
Relative|Sublingual gland cancer|2015–2019|Males|3|25–29|||
Relative|Sublingual gland cancer|2015–2019|Males|3|30–34|||
Relative|Sublingual gland cancer|2015–2019|Males|3|35–39|||
Relative|Sublingual gland cancer|2015–2019|Males|3|40–44|||
Relative|Sublingual gland cancer|2015–2019|Males|3|45–49|||
Relative|Sublingual gland cancer|2015–2019|Males|3|50–54|||
Relative|Sublingual gland cancer|2015–2019|Males|3|55–59|||
Relative|Sublingual gland cancer|2015–2019|Males|3|60–64|||
Relative|Sublingual gland cancer|2015–2019|Males|3|65–69|||
Relative|Sublingual gland cancer|2015–2019|Males|3|70–74|||
Relative|Sublingual gland cancer|2015–2019|Males|3|75–79|||
Relative|Sublingual gland cancer|2015–2019|Males|3|80–84|||
Relative|Sublingual gland cancer|2015–2019|Males|3|85+|||
Relative|Sublingual gland cancer|2015–2019|Males|3|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Males|4|00–04|||
Relative|Sublingual gland cancer|2015–2019|Males|4|05–09|||
Relative|Sublingual gland cancer|2015–2019|Males|4|10–14|||
Relative|Sublingual gland cancer|2015–2019|Males|4|15–19|||
Relative|Sublingual gland cancer|2015–2019|Males|4|20–24|||
Relative|Sublingual gland cancer|2015–2019|Males|4|25–29|||
Relative|Sublingual gland cancer|2015–2019|Males|4|30–34|||
Relative|Sublingual gland cancer|2015–2019|Males|4|35–39|||
Relative|Sublingual gland cancer|2015–2019|Males|4|40–44|||
Relative|Sublingual gland cancer|2015–2019|Males|4|45–49|||
Relative|Sublingual gland cancer|2015–2019|Males|4|50–54|||
Relative|Sublingual gland cancer|2015–2019|Males|4|55–59|||
Relative|Sublingual gland cancer|2015–2019|Males|4|60–64|||
Relative|Sublingual gland cancer|2015–2019|Males|4|65–69|||
Relative|Sublingual gland cancer|2015–2019|Males|4|70–74|||
Relative|Sublingual gland cancer|2015–2019|Males|4|75–79|||
Relative|Sublingual gland cancer|2015–2019|Males|4|80–84|||
Relative|Sublingual gland cancer|2015–2019|Males|4|85+|||
Relative|Sublingual gland cancer|2015–2019|Males|4|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Males|5|00–04|||
Relative|Sublingual gland cancer|2015–2019|Males|5|05–09|||
Relative|Sublingual gland cancer|2015–2019|Males|5|10–14|||
Relative|Sublingual gland cancer|2015–2019|Males|5|15–19|||
Relative|Sublingual gland cancer|2015–2019|Males|5|20–24|||
Relative|Sublingual gland cancer|2015–2019|Males|5|25–29|||
Relative|Sublingual gland cancer|2015–2019|Males|5|30–34|||
Relative|Sublingual gland cancer|2015–2019|Males|5|35–39|||
Relative|Sublingual gland cancer|2015–2019|Males|5|40–44|||
Relative|Sublingual gland cancer|2015–2019|Males|5|45–49|||
Relative|Sublingual gland cancer|2015–2019|Males|5|50–54|||
Relative|Sublingual gland cancer|2015–2019|Males|5|55–59|||
Relative|Sublingual gland cancer|2015–2019|Males|5|60–64|||
Relative|Sublingual gland cancer|2015–2019|Males|5|65–69|||
Relative|Sublingual gland cancer|2015–2019|Males|5|70–74|||
Relative|Sublingual gland cancer|2015–2019|Males|5|75–79|||
Relative|Sublingual gland cancer|2015–2019|Males|5|80–84|||
Relative|Sublingual gland cancer|2015–2019|Males|5|85+|||
Relative|Sublingual gland cancer|2015–2019|Males|5|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Females|1|00–04|||
Observed|Sublingual gland cancer|2015–2019|Females|1|05–09|||
Observed|Sublingual gland cancer|2015–2019|Females|1|10–14|||
Observed|Sublingual gland cancer|2015–2019|Females|1|15–19|||
Observed|Sublingual gland cancer|2015–2019|Females|1|20–24|||
Observed|Sublingual gland cancer|2015–2019|Females|1|25–29|||
Observed|Sublingual gland cancer|2015–2019|Females|1|30–34|||
Observed|Sublingual gland cancer|2015–2019|Females|1|35–39|||
Observed|Sublingual gland cancer|2015–2019|Females|1|40–44|||
Observed|Sublingual gland cancer|2015–2019|Females|1|45–49|||
Observed|Sublingual gland cancer|2015–2019|Females|1|50–54|||
Observed|Sublingual gland cancer|2015–2019|Females|1|55–59|||
Observed|Sublingual gland cancer|2015–2019|Females|1|60–64|||
Observed|Sublingual gland cancer|2015–2019|Females|1|65–69|||
Observed|Sublingual gland cancer|2015–2019|Females|1|70–74|||
Observed|Sublingual gland cancer|2015–2019|Females|1|75–79|||
Observed|Sublingual gland cancer|2015–2019|Females|1|80–84|||
Observed|Sublingual gland cancer|2015–2019|Females|1|85+|||
Observed|Sublingual gland cancer|2015–2019|Females|1|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Females|2|00–04|||
Observed|Sublingual gland cancer|2015–2019|Females|2|05–09|||
Observed|Sublingual gland cancer|2015–2019|Females|2|10–14|||
Observed|Sublingual gland cancer|2015–2019|Females|2|15–19|||
Observed|Sublingual gland cancer|2015–2019|Females|2|20–24|||
Observed|Sublingual gland cancer|2015–2019|Females|2|25–29|||
Observed|Sublingual gland cancer|2015–2019|Females|2|30–34|||
Observed|Sublingual gland cancer|2015–2019|Females|2|35–39|||
Observed|Sublingual gland cancer|2015–2019|Females|2|40–44|||
Observed|Sublingual gland cancer|2015–2019|Females|2|45–49|||
Observed|Sublingual gland cancer|2015–2019|Females|2|50–54|||
Observed|Sublingual gland cancer|2015–2019|Females|2|55–59|||
Observed|Sublingual gland cancer|2015–2019|Females|2|60–64|||
Observed|Sublingual gland cancer|2015–2019|Females|2|65–69|||
Observed|Sublingual gland cancer|2015–2019|Females|2|70–74|||
Observed|Sublingual gland cancer|2015–2019|Females|2|75–79|||
Observed|Sublingual gland cancer|2015–2019|Females|2|80–84|||
Observed|Sublingual gland cancer|2015–2019|Females|2|85+|||
Observed|Sublingual gland cancer|2015–2019|Females|2|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Females|3|00–04|||
Observed|Sublingual gland cancer|2015–2019|Females|3|05–09|||
Observed|Sublingual gland cancer|2015–2019|Females|3|10–14|||
Observed|Sublingual gland cancer|2015–2019|Females|3|15–19|||
Observed|Sublingual gland cancer|2015–2019|Females|3|20–24|||
Observed|Sublingual gland cancer|2015–2019|Females|3|25–29|||
Observed|Sublingual gland cancer|2015–2019|Females|3|30–34|||
Observed|Sublingual gland cancer|2015–2019|Females|3|35–39|||
Observed|Sublingual gland cancer|2015–2019|Females|3|40–44|||
Observed|Sublingual gland cancer|2015–2019|Females|3|45–49|||
Observed|Sublingual gland cancer|2015–2019|Females|3|50–54|||
Observed|Sublingual gland cancer|2015–2019|Females|3|55–59|||
Observed|Sublingual gland cancer|2015–2019|Females|3|60–64|||
Observed|Sublingual gland cancer|2015–2019|Females|3|65–69|||
Observed|Sublingual gland cancer|2015–2019|Females|3|70–74|||
Observed|Sublingual gland cancer|2015–2019|Females|3|75–79|||
Observed|Sublingual gland cancer|2015–2019|Females|3|80–84|||
Observed|Sublingual gland cancer|2015–2019|Females|3|85+|||
Observed|Sublingual gland cancer|2015–2019|Females|3|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Females|4|00–04|||
Observed|Sublingual gland cancer|2015–2019|Females|4|05–09|||
Observed|Sublingual gland cancer|2015–2019|Females|4|10–14|||
Observed|Sublingual gland cancer|2015–2019|Females|4|15–19|||
Observed|Sublingual gland cancer|2015–2019|Females|4|20–24|||
Observed|Sublingual gland cancer|2015–2019|Females|4|25–29|||
Observed|Sublingual gland cancer|2015–2019|Females|4|30–34|||
Observed|Sublingual gland cancer|2015–2019|Females|4|35–39|||
Observed|Sublingual gland cancer|2015–2019|Females|4|40–44|||
Observed|Sublingual gland cancer|2015–2019|Females|4|45–49|||
Observed|Sublingual gland cancer|2015–2019|Females|4|50–54|||
Observed|Sublingual gland cancer|2015–2019|Females|4|55–59|||
Observed|Sublingual gland cancer|2015–2019|Females|4|60–64|||
Observed|Sublingual gland cancer|2015–2019|Females|4|65–69|||
Observed|Sublingual gland cancer|2015–2019|Females|4|70–74|||
Observed|Sublingual gland cancer|2015–2019|Females|4|75–79|||
Observed|Sublingual gland cancer|2015–2019|Females|4|80–84|||
Observed|Sublingual gland cancer|2015–2019|Females|4|85+|||
Observed|Sublingual gland cancer|2015–2019|Females|4|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Females|5|00–04|||
Observed|Sublingual gland cancer|2015–2019|Females|5|05–09|||
Observed|Sublingual gland cancer|2015–2019|Females|5|10–14|||
Observed|Sublingual gland cancer|2015–2019|Females|5|15–19|||
Observed|Sublingual gland cancer|2015–2019|Females|5|20–24|||
Observed|Sublingual gland cancer|2015–2019|Females|5|25–29|||
Observed|Sublingual gland cancer|2015–2019|Females|5|30–34|||
Observed|Sublingual gland cancer|2015–2019|Females|5|35–39|||
Observed|Sublingual gland cancer|2015–2019|Females|5|40–44|||
Observed|Sublingual gland cancer|2015–2019|Females|5|45–49|||
Observed|Sublingual gland cancer|2015–2019|Females|5|50–54|||
Observed|Sublingual gland cancer|2015–2019|Females|5|55–59|||
Observed|Sublingual gland cancer|2015–2019|Females|5|60–64|||
Observed|Sublingual gland cancer|2015–2019|Females|5|65–69|||
Observed|Sublingual gland cancer|2015–2019|Females|5|70–74|||
Observed|Sublingual gland cancer|2015–2019|Females|5|75–79|||
Observed|Sublingual gland cancer|2015–2019|Females|5|80–84|||
Observed|Sublingual gland cancer|2015–2019|Females|5|85+|||
Observed|Sublingual gland cancer|2015–2019|Females|5|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Females|1|00–04|||
Relative|Sublingual gland cancer|2015–2019|Females|1|05–09|||
Relative|Sublingual gland cancer|2015–2019|Females|1|10–14|||
Relative|Sublingual gland cancer|2015–2019|Females|1|15–19|||
Relative|Sublingual gland cancer|2015–2019|Females|1|20–24|||
Relative|Sublingual gland cancer|2015–2019|Females|1|25–29|||
Relative|Sublingual gland cancer|2015–2019|Females|1|30–34|||
Relative|Sublingual gland cancer|2015–2019|Females|1|35–39|||
Relative|Sublingual gland cancer|2015–2019|Females|1|40–44|||
Relative|Sublingual gland cancer|2015–2019|Females|1|45–49|||
Relative|Sublingual gland cancer|2015–2019|Females|1|50–54|||
Relative|Sublingual gland cancer|2015–2019|Females|1|55–59|||
Relative|Sublingual gland cancer|2015–2019|Females|1|60–64|||
Relative|Sublingual gland cancer|2015–2019|Females|1|65–69|||
Relative|Sublingual gland cancer|2015–2019|Females|1|70–74|||
Relative|Sublingual gland cancer|2015–2019|Females|1|75–79|||
Relative|Sublingual gland cancer|2015–2019|Females|1|80–84|||
Relative|Sublingual gland cancer|2015–2019|Females|1|85+|||
Relative|Sublingual gland cancer|2015–2019|Females|1|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Females|2|00–04|||
Relative|Sublingual gland cancer|2015–2019|Females|2|05–09|||
Relative|Sublingual gland cancer|2015–2019|Females|2|10–14|||
Relative|Sublingual gland cancer|2015–2019|Females|2|15–19|||
Relative|Sublingual gland cancer|2015–2019|Females|2|20–24|||
Relative|Sublingual gland cancer|2015–2019|Females|2|25–29|||
Relative|Sublingual gland cancer|2015–2019|Females|2|30–34|||
Relative|Sublingual gland cancer|2015–2019|Females|2|35–39|||
Relative|Sublingual gland cancer|2015–2019|Females|2|40–44|||
Relative|Sublingual gland cancer|2015–2019|Females|2|45–49|||
Relative|Sublingual gland cancer|2015–2019|Females|2|50–54|||
Relative|Sublingual gland cancer|2015–2019|Females|2|55–59|||
Relative|Sublingual gland cancer|2015–2019|Females|2|60–64|||
Relative|Sublingual gland cancer|2015–2019|Females|2|65–69|||
Relative|Sublingual gland cancer|2015–2019|Females|2|70–74|||
Relative|Sublingual gland cancer|2015–2019|Females|2|75–79|||
Relative|Sublingual gland cancer|2015–2019|Females|2|80–84|||
Relative|Sublingual gland cancer|2015–2019|Females|2|85+|||
Relative|Sublingual gland cancer|2015–2019|Females|2|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Females|3|00–04|||
Relative|Sublingual gland cancer|2015–2019|Females|3|05–09|||
Relative|Sublingual gland cancer|2015–2019|Females|3|10–14|||
Relative|Sublingual gland cancer|2015–2019|Females|3|15–19|||
Relative|Sublingual gland cancer|2015–2019|Females|3|20–24|||
Relative|Sublingual gland cancer|2015–2019|Females|3|25–29|||
Relative|Sublingual gland cancer|2015–2019|Females|3|30–34|||
Relative|Sublingual gland cancer|2015–2019|Females|3|35–39|||
Relative|Sublingual gland cancer|2015–2019|Females|3|40–44|||
Relative|Sublingual gland cancer|2015–2019|Females|3|45–49|||
Relative|Sublingual gland cancer|2015–2019|Females|3|50–54|||
Relative|Sublingual gland cancer|2015–2019|Females|3|55–59|||
Relative|Sublingual gland cancer|2015–2019|Females|3|60–64|||
Relative|Sublingual gland cancer|2015–2019|Females|3|65–69|||
Relative|Sublingual gland cancer|2015–2019|Females|3|70–74|||
Relative|Sublingual gland cancer|2015–2019|Females|3|75–79|||
Relative|Sublingual gland cancer|2015–2019|Females|3|80–84|||
Relative|Sublingual gland cancer|2015–2019|Females|3|85+|||
Relative|Sublingual gland cancer|2015–2019|Females|3|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Females|4|00–04|||
Relative|Sublingual gland cancer|2015–2019|Females|4|05–09|||
Relative|Sublingual gland cancer|2015–2019|Females|4|10–14|||
Relative|Sublingual gland cancer|2015–2019|Females|4|15–19|||
Relative|Sublingual gland cancer|2015–2019|Females|4|20–24|||
Relative|Sublingual gland cancer|2015–2019|Females|4|25–29|||
Relative|Sublingual gland cancer|2015–2019|Females|4|30–34|||
Relative|Sublingual gland cancer|2015–2019|Females|4|35–39|||
Relative|Sublingual gland cancer|2015–2019|Females|4|40–44|||
Relative|Sublingual gland cancer|2015–2019|Females|4|45–49|||
Relative|Sublingual gland cancer|2015–2019|Females|4|50–54|||
Relative|Sublingual gland cancer|2015–2019|Females|4|55–59|||
Relative|Sublingual gland cancer|2015–2019|Females|4|60–64|||
Relative|Sublingual gland cancer|2015–2019|Females|4|65–69|||
Relative|Sublingual gland cancer|2015–2019|Females|4|70–74|||
Relative|Sublingual gland cancer|2015–2019|Females|4|75–79|||
Relative|Sublingual gland cancer|2015–2019|Females|4|80–84|||
Relative|Sublingual gland cancer|2015–2019|Females|4|85+|||
Relative|Sublingual gland cancer|2015–2019|Females|4|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Females|5|00–04|||
Relative|Sublingual gland cancer|2015–2019|Females|5|05–09|||
Relative|Sublingual gland cancer|2015–2019|Females|5|10–14|||
Relative|Sublingual gland cancer|2015–2019|Females|5|15–19|||
Relative|Sublingual gland cancer|2015–2019|Females|5|20–24|||
Relative|Sublingual gland cancer|2015–2019|Females|5|25–29|||
Relative|Sublingual gland cancer|2015–2019|Females|5|30–34|||
Relative|Sublingual gland cancer|2015–2019|Females|5|35–39|||
Relative|Sublingual gland cancer|2015–2019|Females|5|40–44|||
Relative|Sublingual gland cancer|2015–2019|Females|5|45–49|||
Relative|Sublingual gland cancer|2015–2019|Females|5|50–54|||
Relative|Sublingual gland cancer|2015–2019|Females|5|55–59|||
Relative|Sublingual gland cancer|2015–2019|Females|5|60–64|||
Relative|Sublingual gland cancer|2015–2019|Females|5|65–69|||
Relative|Sublingual gland cancer|2015–2019|Females|5|70–74|||
Relative|Sublingual gland cancer|2015–2019|Females|5|75–79|||
Relative|Sublingual gland cancer|2015–2019|Females|5|80–84|||
Relative|Sublingual gland cancer|2015–2019|Females|5|85+|||
Relative|Sublingual gland cancer|2015–2019|Females|5|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|00–04|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|05–09|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|10–14|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|15–19|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|20–24|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|25–29|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|30–34|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|35–39|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|40–44|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|45–49|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|50–54|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|55–59|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|60–64|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|65–69|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|70–74|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|75–79|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|80–84|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|85+|||
Observed|Sublingual gland cancer|2015–2019|Persons|1|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|00–04|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|05–09|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|10–14|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|15–19|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|20–24|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|25–29|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|30–34|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|35–39|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|40–44|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|45–49|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|50–54|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|55–59|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|60–64|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|65–69|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|70–74|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|75–79|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|80–84|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|85+|||
Observed|Sublingual gland cancer|2015–2019|Persons|2|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|00–04|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|05–09|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|10–14|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|15–19|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|20–24|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|25–29|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|30–34|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|35–39|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|40–44|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|45–49|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|50–54|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|55–59|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|60–64|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|65–69|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|70–74|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|75–79|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|80–84|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|85+|||
Observed|Sublingual gland cancer|2015–2019|Persons|3|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|00–04|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|05–09|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|10–14|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|15–19|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|20–24|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|25–29|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|30–34|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|35–39|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|40–44|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|45–49|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|50–54|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|55–59|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|60–64|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|65–69|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|70–74|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|75–79|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|80–84|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|85+|||
Observed|Sublingual gland cancer|2015–2019|Persons|4|All ages combined|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|00–04|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|05–09|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|10–14|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|15–19|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|20–24|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|25–29|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|30–34|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|35–39|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|40–44|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|45–49|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|50–54|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|55–59|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|60–64|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|65–69|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|70–74|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|75–79|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|80–84|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|85+|||
Observed|Sublingual gland cancer|2015–2019|Persons|5|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|00–04|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|05–09|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|10–14|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|15–19|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|20–24|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|25–29|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|30–34|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|35–39|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|40–44|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|45–49|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|50–54|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|55–59|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|60–64|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|65–69|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|70–74|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|75–79|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|80–84|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|85+|||
Relative|Sublingual gland cancer|2015–2019|Persons|1|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|00–04|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|05–09|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|10–14|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|15–19|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|20–24|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|25–29|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|30–34|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|35–39|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|40–44|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|45–49|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|50–54|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|55–59|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|60–64|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|65–69|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|70–74|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|75–79|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|80–84|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|85+|||
Relative|Sublingual gland cancer|2015–2019|Persons|2|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|00–04|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|05–09|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|10–14|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|15–19|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|20–24|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|25–29|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|30–34|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|35–39|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|40–44|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|45–49|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|50–54|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|55–59|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|60–64|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|65–69|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|70–74|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|75–79|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|80–84|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|85+|||
Relative|Sublingual gland cancer|2015–2019|Persons|3|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|00–04|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|05–09|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|10–14|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|15–19|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|20–24|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|25–29|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|30–34|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|35–39|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|40–44|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|45–49|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|50–54|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|55–59|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|60–64|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|65–69|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|70–74|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|75–79|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|80–84|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|85+|||
Relative|Sublingual gland cancer|2015–2019|Persons|4|All ages combined|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|00–04|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|05–09|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|10–14|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|15–19|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|20–24|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|25–29|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|30–34|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|35–39|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|40–44|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|45–49|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|50–54|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|55–59|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|60–64|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|65–69|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|70–74|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|75–79|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|80–84|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|85+|||
Relative|Sublingual gland cancer|2015–2019|Persons|5|All ages combined|||
Observed|Submandibular gland cancer|2015–2019|Males|1|00–04|||
Observed|Submandibular gland cancer|2015–2019|Males|1|05–09|||
Observed|Submandibular gland cancer|2015–2019|Males|1|10–14|||
Observed|Submandibular gland cancer|2015–2019|Males|1|15–19|||
Observed|Submandibular gland cancer|2015–2019|Males|1|20–24|||
Observed|Submandibular gland cancer|2015–2019|Males|1|25–29|||
Observed|Submandibular gland cancer|2015–2019|Males|1|30–34|||
Observed|Submandibular gland cancer|2015–2019|Males|1|35–39|||
Observed|Submandibular gland cancer|2015–2019|Males|1|40–44|||
Observed|Submandibular gland cancer|2015–2019|Males|1|45–49|||
Observed|Submandibular gland cancer|2015–2019|Males|1|50–54|||
Observed|Submandibular gland cancer|2015–2019|Males|1|55–59|||
Observed|Submandibular gland cancer|2015–2019|Males|1|60–64|||
Observed|Submandibular gland cancer|2015–2019|Males|1|65–69|||
Observed|Submandibular gland cancer|2015–2019|Males|1|70–74|||
Observed|Submandibular gland cancer|2015–2019|Males|1|75–79|||
Observed|Submandibular gland cancer|2015–2019|Males|1|80–84|||
Observed|Submandibular gland cancer|2015–2019|Males|1|85+|||
Observed|Submandibular gland cancer|2015–2019|Males|1|All ages combined|0.905|0.839|0.945
Observed|Submandibular gland cancer|2015–2019|Males|2|00–04|||
Observed|Submandibular gland cancer|2015–2019|Males|2|05–09|||
Observed|Submandibular gland cancer|2015–2019|Males|2|10–14|||
Observed|Submandibular gland cancer|2015–2019|Males|2|15–19|||
Observed|Submandibular gland cancer|2015–2019|Males|2|20–24|||
Observed|Submandibular gland cancer|2015–2019|Males|2|25–29|||
Observed|Submandibular gland cancer|2015–2019|Males|2|30–34|||
Observed|Submandibular gland cancer|2015–2019|Males|2|35–39|||
Observed|Submandibular gland cancer|2015–2019|Males|2|40–44|||
Observed|Submandibular gland cancer|2015–2019|Males|2|45–49|||
Observed|Submandibular gland cancer|2015–2019|Males|2|50–54|||
Observed|Submandibular gland cancer|2015–2019|Males|2|55–59|||
Observed|Submandibular gland cancer|2015–2019|Males|2|60–64|||
Observed|Submandibular gland cancer|2015–2019|Males|2|65–69|||
Observed|Submandibular gland cancer|2015–2019|Males|2|70–74|||
Observed|Submandibular gland cancer|2015–2019|Males|2|75–79|||
Observed|Submandibular gland cancer|2015–2019|Males|2|80–84|||
Observed|Submandibular gland cancer|2015–2019|Males|2|85+|||
Observed|Submandibular gland cancer|2015–2019|Males|2|All ages combined|0.838|0.762|0.891
Observed|Submandibular gland cancer|2015–2019|Males|3|00–04|||
Observed|Submandibular gland cancer|2015–2019|Males|3|05–09|||
Observed|Submandibular gland cancer|2015–2019|Males|3|10–14|||
Observed|Submandibular gland cancer|2015–2019|Males|3|15–19|||
Observed|Submandibular gland cancer|2015–2019|Males|3|20–24|||
Observed|Submandibular gland cancer|2015–2019|Males|3|25–29|||
Observed|Submandibular gland cancer|2015–2019|Males|3|30–34|||
Observed|Submandibular gland cancer|2015–2019|Males|3|35–39|||
Observed|Submandibular gland cancer|2015–2019|Males|3|40–44|||
Observed|Submandibular gland cancer|2015–2019|Males|3|45–49|||
Observed|Submandibular gland cancer|2015–2019|Males|3|50–54|||
Observed|Submandibular gland cancer|2015–2019|Males|3|55–59|||
Observed|Submandibular gland cancer|2015–2019|Males|3|60–64|||
Observed|Submandibular gland cancer|2015–2019|Males|3|65–69|||
Observed|Submandibular gland cancer|2015–2019|Males|3|70–74|||
Observed|Submandibular gland cancer|2015–2019|Males|3|75–79|||
Observed|Submandibular gland cancer|2015–2019|Males|3|80–84|||
Observed|Submandibular gland cancer|2015–2019|Males|3|85+|||
Observed|Submandibular gland cancer|2015–2019|Males|3|All ages combined|0.754|0.67|0.819
Observed|Submandibular gland cancer|2015–2019|Males|4|00–04|||
Observed|Submandibular gland cancer|2015–2019|Males|4|05–09|||
Observed|Submandibular gland cancer|2015–2019|Males|4|10–14|||
Observed|Submandibular gland cancer|2015–2019|Males|4|15–19|||
Observed|Submandibular gland cancer|2015–2019|Males|4|20–24|||
Observed|Submandibular gland cancer|2015–2019|Males|4|25–29|||
Observed|Submandibular gland cancer|2015–2019|Males|4|30–34|||
Observed|Submandibular gland cancer|2015–2019|Males|4|35–39|||
Observed|Submandibular gland cancer|2015–2019|Males|4|40–44|||
Observed|Submandibular gland cancer|2015–2019|Males|4|45–49|||
Observed|Submandibular gland cancer|2015–2019|Males|4|50–54|||
Observed|Submandibular gland cancer|2015–2019|Males|4|55–59|||
Observed|Submandibular gland cancer|2015–2019|Males|4|60–64|||
Observed|Submandibular gland cancer|2015–2019|Males|4|65–69|||
Observed|Submandibular gland cancer|2015–2019|Males|4|70–74|||
Observed|Submandibular gland cancer|2015–2019|Males|4|75–79|||
Observed|Submandibular gland cancer|2015–2019|Males|4|80–84|||
Observed|Submandibular gland cancer|2015–2019|Males|4|85+|||
Observed|Submandibular gland cancer|2015–2019|Males|4|All ages combined|0.71|0.622|0.781
Observed|Submandibular gland cancer|2015–2019|Males|5|00–04|||
Observed|Submandibular gland cancer|2015–2019|Males|5|05–09|||
Observed|Submandibular gland cancer|2015–2019|Males|5|10–14|||
Observed|Submandibular gland cancer|2015–2019|Males|5|15–19|||
Observed|Submandibular gland cancer|2015–2019|Males|5|20–24|||
Observed|Submandibular gland cancer|2015–2019|Males|5|25–29|||
Observed|Submandibular gland cancer|2015–2019|Males|5|30–34|||
Observed|Submandibular gland cancer|2015–2019|Males|5|35–39|||
Observed|Submandibular gland cancer|2015–2019|Males|5|40–44|||
Observed|Submandibular gland cancer|2015–2019|Males|5|45–49|||
Observed|Submandibular gland cancer|2015–2019|Males|5|50–54|||
Observed|Submandibular gland cancer|2015–2019|Males|5|55–59|||
Observed|Submandibular gland cancer|2015–2019|Males|5|60–64|||
Observed|Submandibular gland cancer|2015–2019|Males|5|65–69|||
Observed|Submandibular gland cancer|2015–2019|Males|5|70–74|||
Observed|Submandibular gland cancer|2015–2019|Males|5|75–79|||
Observed|Submandibular gland cancer|2015–2019|Males|5|80–84|||
Observed|Submandibular gland cancer|2015–2019|Males|5|85+|||
Observed|Submandibular gland cancer|2015–2019|Males|5|All ages combined|0.646|0.554|0.723
Relative|Submandibular gland cancer|2015–2019|Males|1|00–04|||
Relative|Submandibular gland cancer|2015–2019|Males|1|05–09|||
Relative|Submandibular gland cancer|2015–2019|Males|1|10–14|||
Relative|Submandibular gland cancer|2015–2019|Males|1|15–19|||
Relative|Submandibular gland cancer|2015–2019|Males|1|20–24|||
Relative|Submandibular gland cancer|2015–2019|Males|1|25–29|||
Relative|Submandibular gland cancer|2015–2019|Males|1|30–34|||
Relative|Submandibular gland cancer|2015–2019|Males|1|35–39|||
Relative|Submandibular gland cancer|2015–2019|Males|1|40–44|||
Relative|Submandibular gland cancer|2015–2019|Males|1|45–49|||
Relative|Submandibular gland cancer|2015–2019|Males|1|50–54|||
Relative|Submandibular gland cancer|2015–2019|Males|1|55–59|||
Relative|Submandibular gland cancer|2015–2019|Males|1|60–64|||
Relative|Submandibular gland cancer|2015–2019|Males|1|65–69|||
Relative|Submandibular gland cancer|2015–2019|Males|1|70–74|||
Relative|Submandibular gland cancer|2015–2019|Males|1|75–79|||
Relative|Submandibular gland cancer|2015–2019|Males|1|80–84|||
Relative|Submandibular gland cancer|2015–2019|Males|1|85+|||
Relative|Submandibular gland cancer|2015–2019|Males|1|All ages combined|0.927|0.859|0.967
Relative|Submandibular gland cancer|2015–2019|Males|2|00–04|||
Relative|Submandibular gland cancer|2015–2019|Males|2|05–09|||
Relative|Submandibular gland cancer|2015–2019|Males|2|10–14|||
Relative|Submandibular gland cancer|2015–2019|Males|2|15–19|||
Relative|Submandibular gland cancer|2015–2019|Males|2|20–24|||
Relative|Submandibular gland cancer|2015–2019|Males|2|25–29|||
Relative|Submandibular gland cancer|2015–2019|Males|2|30–34|||
Relative|Submandibular gland cancer|2015–2019|Males|2|35–39|||
Relative|Submandibular gland cancer|2015–2019|Males|2|40–44|||
Relative|Submandibular gland cancer|2015–2019|Males|2|45–49|||
Relative|Submandibular gland cancer|2015–2019|Males|2|50–54|||
Relative|Submandibular gland cancer|2015–2019|Males|2|55–59|||
Relative|Submandibular gland cancer|2015–2019|Males|2|60–64|||
Relative|Submandibular gland cancer|2015–2019|Males|2|65–69|||
Relative|Submandibular gland cancer|2015–2019|Males|2|70–74|||
Relative|Submandibular gland cancer|2015–2019|Males|2|75–79|||
Relative|Submandibular gland cancer|2015–2019|Males|2|80–84|||
Relative|Submandibular gland cancer|2015–2019|Males|2|85+|||
Relative|Submandibular gland cancer|2015–2019|Males|2|All ages combined|0.875|0.796|0.931
Relative|Submandibular gland cancer|2015–2019|Males|3|00–04|||
Relative|Submandibular gland cancer|2015–2019|Males|3|05–09|||
Relative|Submandibular gland cancer|2015–2019|Males|3|10–14|||
Relative|Submandibular gland cancer|2015–2019|Males|3|15–19|||
Relative|Submandibular gland cancer|2015–2019|Males|3|20–24|||
Relative|Submandibular gland cancer|2015–2019|Males|3|25–29|||
Relative|Submandibular gland cancer|2015–2019|Males|3|30–34|||
Relative|Submandibular gland cancer|2015–2019|Males|3|35–39|||
Relative|Submandibular gland cancer|2015–2019|Males|3|40–44|||
Relative|Submandibular gland cancer|2015–2019|Males|3|45–49|||
Relative|Submandibular gland cancer|2015–2019|Males|3|50–54|||
Relative|Submandibular gland cancer|2015–2019|Males|3|55–59|||
Relative|Submandibular gland cancer|2015–2019|Males|3|60–64|||
Relative|Submandibular gland cancer|2015–2019|Males|3|65–69|||
Relative|Submandibular gland cancer|2015–2019|Males|3|70–74|||
Relative|Submandibular gland cancer|2015–2019|Males|3|75–79|||
Relative|Submandibular gland cancer|2015–2019|Males|3|80–84|||
Relative|Submandibular gland cancer|2015–2019|Males|3|85+|||
Relative|Submandibular gland cancer|2015–2019|Males|3|All ages combined|0.804|0.715|0.874
Relative|Submandibular gland cancer|2015–2019|Males|4|00–04|||
Relative|Submandibular gland cancer|2015–2019|Males|4|05–09|||
Relative|Submandibular gland cancer|2015–2019|Males|4|10–14|||
Relative|Submandibular gland cancer|2015–2019|Males|4|15–19|||
Relative|Submandibular gland cancer|2015–2019|Males|4|20–24|||
Relative|Submandibular gland cancer|2015–2019|Males|4|25–29|||
Relative|Submandibular gland cancer|2015–2019|Males|4|30–34|||
Relative|Submandibular gland cancer|2015–2019|Males|4|35–39|||
Relative|Submandibular gland cancer|2015–2019|Males|4|40–44|||
Relative|Submandibular gland cancer|2015–2019|Males|4|45–49|||
Relative|Submandibular gland cancer|2015–2019|Males|4|50–54|||
Relative|Submandibular gland cancer|2015–2019|Males|4|55–59|||
Relative|Submandibular gland cancer|2015–2019|Males|4|60–64|||
Relative|Submandibular gland cancer|2015–2019|Males|4|65–69|||
Relative|Submandibular gland cancer|2015–2019|Males|4|70–74|||
Relative|Submandibular gland cancer|2015–2019|Males|4|75–79|||
Relative|Submandibular gland cancer|2015–2019|Males|4|80–84|||
Relative|Submandibular gland cancer|2015–2019|Males|4|85+|||
Relative|Submandibular gland cancer|2015–2019|Males|4|All ages combined|0.775|0.68|0.853
Relative|Submandibular gland cancer|2015–2019|Males|5|00–04|||
Relative|Submandibular gland cancer|2015–2019|Males|5|05–09|||
Relative|Submandibular gland cancer|2015–2019|Males|5|10–14|||
Relative|Submandibular gland cancer|2015–2019|Males|5|15–19|||
Relative|Submandibular gland cancer|2015–2019|Males|5|20–24|||
Relative|Submandibular gland cancer|2015–2019|Males|5|25–29|||
Relative|Submandibular gland cancer|2015–2019|Males|5|30–34|||
Relative|Submandibular gland cancer|2015–2019|Males|5|35–39|||
Relative|Submandibular gland cancer|2015–2019|Males|5|40–44|||
Relative|Submandibular gland cancer|2015–2019|Males|5|45–49|||
Relative|Submandibular gland cancer|2015–2019|Males|5|50–54|||
Relative|Submandibular gland cancer|2015–2019|Males|5|55–59|||
Relative|Submandibular gland cancer|2015–2019|Males|5|60–64|||
Relative|Submandibular gland cancer|2015–2019|Males|5|65–69|||
Relative|Submandibular gland cancer|2015–2019|Males|5|70–74|||
Relative|Submandibular gland cancer|2015–2019|Males|5|75–79|||
Relative|Submandibular gland cancer|2015–2019|Males|5|80–84|||
Relative|Submandibular gland cancer|2015–2019|Males|5|85+|||
Relative|Submandibular gland cancer|2015–2019|Males|5|All ages combined|0.722|0.619|0.808
Observed|Submandibular gland cancer|2015–2019|Females|1|00–04|||
Observed|Submandibular gland cancer|2015–2019|Females|1|05–09|||
Observed|Submandibular gland cancer|2015–2019|Females|1|10–14|||
Observed|Submandibular gland cancer|2015–2019|Females|1|15–19|||
Observed|Submandibular gland cancer|2015–2019|Females|1|20–24|||
Observed|Submandibular gland cancer|2015–2019|Females|1|25–29|||
Observed|Submandibular gland cancer|2015–2019|Females|1|30–34|||
Observed|Submandibular gland cancer|2015–2019|Females|1|35–39|||
Observed|Submandibular gland cancer|2015–2019|Females|1|40–44|||
Observed|Submandibular gland cancer|2015–2019|Females|1|45–49|||
Observed|Submandibular gland cancer|2015–2019|Females|1|50–54|||
Observed|Submandibular gland cancer|2015–2019|Females|1|55–59|||
Observed|Submandibular gland cancer|2015–2019|Females|1|60–64|||
Observed|Submandibular gland cancer|2015–2019|Females|1|65–69|||
Observed|Submandibular gland cancer|2015–2019|Females|1|70–74|||
Observed|Submandibular gland cancer|2015–2019|Females|1|75–79|||
Observed|Submandibular gland cancer|2015–2019|Females|1|80–84|||
Observed|Submandibular gland cancer|2015–2019|Females|1|85+|||
Observed|Submandibular gland cancer|2015–2019|Females|1|All ages combined|0.928|0.854|0.965
Observed|Submandibular gland cancer|2015–2019|Females|2|00–04|||
Observed|Submandibular gland cancer|2015–2019|Females|2|05–09|||
Observed|Submandibular gland cancer|2015–2019|Females|2|10–14|||
Observed|Submandibular gland cancer|2015–2019|Females|2|15–19|||
Observed|Submandibular gland cancer|2015–2019|Females|2|20–24|||
Observed|Submandibular gland cancer|2015–2019|Females|2|25–29|||
Observed|Submandibular gland cancer|2015–2019|Females|2|30–34|||
Observed|Submandibular gland cancer|2015–2019|Females|2|35–39|||
Observed|Submandibular gland cancer|2015–2019|Females|2|40–44|||
Observed|Submandibular gland cancer|2015–2019|Females|2|45–49|||
Observed|Submandibular gland cancer|2015–2019|Females|2|50–54|||
Observed|Submandibular gland cancer|2015–2019|Females|2|55–59|||
Observed|Submandibular gland cancer|2015–2019|Females|2|60–64|||
Observed|Submandibular gland cancer|2015–2019|Females|2|65–69|||
Observed|Submandibular gland cancer|2015–2019|Females|2|70–74|||
Observed|Submandibular gland cancer|2015–2019|Females|2|75–79|||
Observed|Submandibular gland cancer|2015–2019|Females|2|80–84|||
Observed|Submandibular gland cancer|2015–2019|Females|2|85+|||
Observed|Submandibular gland cancer|2015–2019|Females|2|All ages combined|0.88|0.798|0.93
Observed|Submandibular gland cancer|2015–2019|Females|3|00–04|||
Observed|Submandibular gland cancer|2015–2019|Females|3|05–09|||
Observed|Submandibular gland cancer|2015–2019|Females|3|10–14|||
Observed|Submandibular gland cancer|2015–2019|Females|3|15–19|||
Observed|Submandibular gland cancer|2015–2019|Females|3|20–24|||
Observed|Submandibular gland cancer|2015–2019|Females|3|25–29|||
Observed|Submandibular gland cancer|2015–2019|Females|3|30–34|||
Observed|Submandibular gland cancer|2015–2019|Females|3|35–39|||
Observed|Submandibular gland cancer|2015–2019|Females|3|40–44|||
Observed|Submandibular gland cancer|2015–2019|Females|3|45–49|||
Observed|Submandibular gland cancer|2015–2019|Females|3|50–54|||
Observed|Submandibular gland cancer|2015–2019|Females|3|55–59|||
Observed|Submandibular gland cancer|2015–2019|Females|3|60–64|||
Observed|Submandibular gland cancer|2015–2019|Females|3|65–69|||
Observed|Submandibular gland cancer|2015–2019|Females|3|70–74|||
Observed|Submandibular gland cancer|2015–2019|Females|3|75–79|||
Observed|Submandibular gland cancer|2015–2019|Females|3|80–84|||
Observed|Submandibular gland cancer|2015–2019|Females|3|85+|||
Observed|Submandibular gland cancer|2015–2019|Females|3|All ages combined|0.83|0.741|0.891
Observed|Submandibular gland cancer|2015–2019|Females|4|00–04|||
Observed|Submandibular gland cancer|2015–2019|Females|4|05–09|||
Observed|Submandibular gland cancer|2015–2019|Females|4|10–14|||
Observed|Submandibular gland cancer|2015–2019|Females|4|15–19|||
Observed|Submandibular gland cancer|2015–2019|Females|4|20–24|||
Observed|Submandibular gland cancer|2015–2019|Females|4|25–29|||
Observed|Submandibular gland cancer|2015–2019|Females|4|30–34|||
Observed|Submandibular gland cancer|2015–2019|Females|4|35–39|||
Observed|Submandibular gland cancer|2015–2019|Females|4|40–44|||
Observed|Submandibular gland cancer|2015–2019|Females|4|45–49|||
Observed|Submandibular gland cancer|2015–2019|Females|4|50–54|||
Observed|Submandibular gland cancer|2015–2019|Females|4|55–59|||
Observed|Submandibular gland cancer|2015–2019|Females|4|60–64|||
Observed|Submandibular gland cancer|2015–2019|Females|4|65–69|||
Observed|Submandibular gland cancer|2015–2019|Females|4|70–74|||
Observed|Submandibular gland cancer|2015–2019|Females|4|75–79|||
Observed|Submandibular gland cancer|2015–2019|Females|4|80–84|||
Observed|Submandibular gland cancer|2015–2019|Females|4|85+|||
Observed|Submandibular gland cancer|2015–2019|Females|4|All ages combined|0.789|0.694|0.857
Observed|Submandibular gland cancer|2015–2019|Females|5|00–04|||
Observed|Submandibular gland cancer|2015–2019|Females|5|05–09|||
Observed|Submandibular gland cancer|2015–2019|Females|5|10–14|||
Observed|Submandibular gland cancer|2015–2019|Females|5|15–19|||
Observed|Submandibular gland cancer|2015–2019|Females|5|20–24|||
Observed|Submandibular gland cancer|2015–2019|Females|5|25–29|||
Observed|Submandibular gland cancer|2015–2019|Females|5|30–34|||
Observed|Submandibular gland cancer|2015–2019|Females|5|35–39|||
Observed|Submandibular gland cancer|2015–2019|Females|5|40–44|||
Observed|Submandibular gland cancer|2015–2019|Females|5|45–49|||
Observed|Submandibular gland cancer|2015–2019|Females|5|50–54|||
Observed|Submandibular gland cancer|2015–2019|Females|5|55–59|||
Observed|Submandibular gland cancer|2015–2019|Females|5|60–64|||
Observed|Submandibular gland cancer|2015–2019|Females|5|65–69|||
Observed|Submandibular gland cancer|2015–2019|Females|5|70–74|||
Observed|Submandibular gland cancer|2015–2019|Females|5|75–79|||
Observed|Submandibular gland cancer|2015–2019|Females|5|80–84|||
Observed|Submandibular gland cancer|2015–2019|Females|5|85+|||
Observed|Submandibular gland cancer|2015–2019|Females|5|All ages combined|0.779|0.684|0.848
Relative|Submandibular gland cancer|2015–2019|Females|1|00–04|||
Relative|Submandibular gland cancer|2015–2019|Females|1|05–09|||
Relative|Submandibular gland cancer|2015–2019|Females|1|10–14|||
Relative|Submandibular gland cancer|2015–2019|Females|1|15–19|||
Relative|Submandibular gland cancer|2015–2019|Females|1|20–24|||
Relative|Submandibular gland cancer|2015–2019|Females|1|25–29|||
Relative|Submandibular gland cancer|2015–2019|Females|1|30–34|||
Relative|Submandibular gland cancer|2015–2019|Females|1|35–39|||
Relative|Submandibular gland cancer|2015–2019|Females|1|40–44|||
Relative|Submandibular gland cancer|2015–2019|Females|1|45–49|||
Relative|Submandibular gland cancer|2015–2019|Females|1|50–54|||
Relative|Submandibular gland cancer|2015–2019|Females|1|55–59|||
Relative|Submandibular gland cancer|2015–2019|Females|1|60–64|||
Relative|Submandibular gland cancer|2015–2019|Females|1|65–69|||
Relative|Submandibular gland cancer|2015–2019|Females|1|70–74|||
Relative|Submandibular gland cancer|2015–2019|Females|1|75–79|||
Relative|Submandibular gland cancer|2015–2019|Females|1|80–84|||
Relative|Submandibular gland cancer|2015–2019|Females|1|85+|||
Relative|Submandibular gland cancer|2015–2019|Females|1|All ages combined|0.94|0.866|0.978
Relative|Submandibular gland cancer|2015–2019|Females|2|00–04|||
Relative|Submandibular gland cancer|2015–2019|Females|2|05–09|||
Relative|Submandibular gland cancer|2015–2019|Females|2|10–14|||
Relative|Submandibular gland cancer|2015–2019|Females|2|15–19|||
Relative|Submandibular gland cancer|2015–2019|Females|2|20–24|||
Relative|Submandibular gland cancer|2015–2019|Females|2|25–29|||
Relative|Submandibular gland cancer|2015–2019|Females|2|30–34|||
Relative|Submandibular gland cancer|2015–2019|Females|2|35–39|||
Relative|Submandibular gland cancer|2015–2019|Females|2|40–44|||
Relative|Submandibular gland cancer|2015–2019|Females|2|45–49|||
Relative|Submandibular gland cancer|2015–2019|Females|2|50–54|||
Relative|Submandibular gland cancer|2015–2019|Females|2|55–59|||
Relative|Submandibular gland cancer|2015–2019|Females|2|60–64|||
Relative|Submandibular gland cancer|2015–2019|Females|2|65–69|||
Relative|Submandibular gland cancer|2015–2019|Females|2|70–74|||
Relative|Submandibular gland cancer|2015–2019|Females|2|75–79|||
Relative|Submandibular gland cancer|2015–2019|Females|2|80–84|||
Relative|Submandibular gland cancer|2015–2019|Females|2|85+|||
Relative|Submandibular gland cancer|2015–2019|Females|2|All ages combined|0.903|0.819|0.954
Relative|Submandibular gland cancer|2015–2019|Females|3|00–04|||
Relative|Submandibular gland cancer|2015–2019|Females|3|05–09|||
Relative|Submandibular gland cancer|2015–2019|Females|3|10–14|||
Relative|Submandibular gland cancer|2015–2019|Females|3|15–19|||
Relative|Submandibular gland cancer|2015–2019|Females|3|20–24|||
Relative|Submandibular gland cancer|2015–2019|Females|3|25–29|||
Relative|Submandibular gland cancer|2015–2019|Females|3|30–34|||
Relative|Submandibular gland cancer|2015–2019|Females|3|35–39|||
Relative|Submandibular gland cancer|2015–2019|Females|3|40–44|||
Relative|Submandibular gland cancer|2015–2019|Females|3|45–49|||
Relative|Submandibular gland cancer|2015–2019|Females|3|50–54|||
Relative|Submandibular gland cancer|2015–2019|Females|3|55–59|||
Relative|Submandibular gland cancer|2015–2019|Females|3|60–64|||
Relative|Submandibular gland cancer|2015–2019|Females|3|65–69|||
Relative|Submandibular gland cancer|2015–2019|Females|3|70–74|||
Relative|Submandibular gland cancer|2015–2019|Females|3|75–79|||
Relative|Submandibular gland cancer|2015–2019|Females|3|80–84|||
Relative|Submandibular gland cancer|2015–2019|Females|3|85+|||
Relative|Submandibular gland cancer|2015–2019|Females|3|All ages combined|0.861|0.769|0.924
Relative|Submandibular gland cancer|2015–2019|Females|4|00–04|||
Relative|Submandibular gland cancer|2015–2019|Females|4|05–09|||
Relative|Submandibular gland cancer|2015–2019|Females|4|10–14|||
Relative|Submandibular gland cancer|2015–2019|Females|4|15–19|||
Relative|Submandibular gland cancer|2015–2019|Females|4|20–24|||
Relative|Submandibular gland cancer|2015–2019|Females|4|25–29|||
Relative|Submandibular gland cancer|2015–2019|Females|4|30–34|||
Relative|Submandibular gland cancer|2015–2019|Females|4|35–39|||
Relative|Submandibular gland cancer|2015–2019|Females|4|40–44|||
Relative|Submandibular gland cancer|2015–2019|Females|4|45–49|||
Relative|Submandibular gland cancer|2015–2019|Females|4|50–54|||
Relative|Submandibular gland cancer|2015–2019|Females|4|55–59|||
Relative|Submandibular gland cancer|2015–2019|Females|4|60–64|||
Relative|Submandibular gland cancer|2015–2019|Females|4|65–69|||
Relative|Submandibular gland cancer|2015–2019|Females|4|70–74|||
Relative|Submandibular gland cancer|2015–2019|Females|4|75–79|||
Relative|Submandibular gland cancer|2015–2019|Females|4|80–84|||
Relative|Submandibular gland cancer|2015–2019|Females|4|85+|||
Relative|Submandibular gland cancer|2015–2019|Females|4|All ages combined|0.826|0.728|0.898
Relative|Submandibular gland cancer|2015–2019|Females|5|00–04|||
Relative|Submandibular gland cancer|2015–2019|Females|5|05–09|||
Relative|Submandibular gland cancer|2015–2019|Females|5|10–14|||
Relative|Submandibular gland cancer|2015–2019|Females|5|15–19|||
Relative|Submandibular gland cancer|2015–2019|Females|5|20–24|||
Relative|Submandibular gland cancer|2015–2019|Females|5|25–29|||
Relative|Submandibular gland cancer|2015–2019|Females|5|30–34|||
Relative|Submandibular gland cancer|2015–2019|Females|5|35–39|||
Relative|Submandibular gland cancer|2015–2019|Females|5|40–44|||
Relative|Submandibular gland cancer|2015–2019|Females|5|45–49|||
Relative|Submandibular gland cancer|2015–2019|Females|5|50–54|||
Relative|Submandibular gland cancer|2015–2019|Females|5|55–59|||
Relative|Submandibular gland cancer|2015–2019|Females|5|60–64|||
Relative|Submandibular gland cancer|2015–2019|Females|5|65–69|||
Relative|Submandibular gland cancer|2015–2019|Females|5|70–74|||
Relative|Submandibular gland cancer|2015–2019|Females|5|75–79|||
Relative|Submandibular gland cancer|2015–2019|Females|5|80–84|||
Relative|Submandibular gland cancer|2015–2019|Females|5|85+|||
Relative|Submandibular gland cancer|2015–2019|Females|5|All ages combined|0.826|0.725|0.9
Observed|Submandibular gland cancer|2015–2019|Persons|1|00–04|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|05–09|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|10–14|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|15–19|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|20–24|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|25–29|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|30–34|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|35–39|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|40–44|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|45–49|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|50–54|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|55–59|1|0.875|1
Observed|Submandibular gland cancer|2015–2019|Persons|1|60–64|0.926|0.735|0.981
Observed|Submandibular gland cancer|2015–2019|Persons|1|65–69|1|0.874|1
Observed|Submandibular gland cancer|2015–2019|Persons|1|70–74|0.889|0.694|0.963
Observed|Submandibular gland cancer|2015–2019|Persons|1|75–79|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|80–84|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|85+|||
Observed|Submandibular gland cancer|2015–2019|Persons|1|All ages combined|0.915|0.87|0.945
Observed|Submandibular gland cancer|2015–2019|Persons|2|00–04|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|05–09|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|10–14|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|15–19|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|20–24|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|25–29|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|30–34|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|35–39|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|40–44|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|45–49|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|50–54|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|55–59|0.962|0.758|0.995
Observed|Submandibular gland cancer|2015–2019|Persons|2|60–64|0.926|0.735|0.981
Observed|Submandibular gland cancer|2015–2019|Persons|2|65–69|0.894|0.706|0.964
Observed|Submandibular gland cancer|2015–2019|Persons|2|70–74|0.85|0.648|0.941
Observed|Submandibular gland cancer|2015–2019|Persons|2|75–79|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|80–84|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|85+|||
Observed|Submandibular gland cancer|2015–2019|Persons|2|All ages combined|0.856|0.804|0.895
Observed|Submandibular gland cancer|2015–2019|Persons|3|00–04|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|05–09|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|10–14|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|15–19|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|20–24|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|25–29|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|30–34|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|35–39|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|40–44|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|45–49|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|50–54|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|55–59|0.886|0.687|0.962
Observed|Submandibular gland cancer|2015–2019|Persons|3|60–64|0.926|0.735|0.981
Observed|Submandibular gland cancer|2015–2019|Persons|3|65–69|0.816|0.613|0.919
Observed|Submandibular gland cancer|2015–2019|Persons|3|70–74|0.782|0.578|0.896
Observed|Submandibular gland cancer|2015–2019|Persons|3|75–79|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|80–84|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|85+|||
Observed|Submandibular gland cancer|2015–2019|Persons|3|All ages combined|0.787|0.728|0.835
Observed|Submandibular gland cancer|2015–2019|Persons|4|00–04|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|05–09|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|10–14|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|15–19|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|20–24|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|25–29|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|30–34|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|35–39|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|40–44|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|45–49|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|50–54|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|55–59|0.848|0.644|0.94
Observed|Submandibular gland cancer|2015–2019|Persons|4|60–64|0.767|0.553|0.888
Observed|Submandibular gland cancer|2015–2019|Persons|4|65–69|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|70–74|0.71|0.503|0.843
Observed|Submandibular gland cancer|2015–2019|Persons|4|75–79|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|80–84|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|85+|||
Observed|Submandibular gland cancer|2015–2019|Persons|4|All ages combined|0.744|0.682|0.796
Observed|Submandibular gland cancer|2015–2019|Persons|5|00–04|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|05–09|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|10–14|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|15–19|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|20–24|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|25–29|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|30–34|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|35–39|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|40–44|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|45–49|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|50–54|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|55–59|0.813|0.608|0.918
Observed|Submandibular gland cancer|2015–2019|Persons|5|60–64|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|65–69|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|70–74|0.676|0.47|0.816
Observed|Submandibular gland cancer|2015–2019|Persons|5|75–79|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|80–84|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|85+|||
Observed|Submandibular gland cancer|2015–2019|Persons|5|All ages combined|0.707|0.642|0.762
Relative|Submandibular gland cancer|2015–2019|Persons|1|00–04|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|05–09|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|10–14|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|15–19|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|20–24|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|25–29|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|30–34|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|35–39|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|40–44|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|45–49|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|50–54|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|55–59|1.004|0.879|1.004
Relative|Submandibular gland cancer|2015–2019|Persons|1|60–64|0.932|0.74|0.988
Relative|Submandibular gland cancer|2015–2019|Persons|1|65–69|1.01|0.883|1.01
Relative|Submandibular gland cancer|2015–2019|Persons|1|70–74|0.903|0.706|0.979
Relative|Submandibular gland cancer|2015–2019|Persons|1|75–79|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|80–84|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|85+|||
Relative|Submandibular gland cancer|2015–2019|Persons|1|All ages combined|0.933|0.887|0.963
Relative|Submandibular gland cancer|2015–2019|Persons|2|00–04|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|05–09|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|10–14|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|15–19|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|20–24|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|25–29|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|30–34|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|35–39|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|40–44|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|45–49|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|50–54|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|55–59|0.971|0.765|1.004
Relative|Submandibular gland cancer|2015–2019|Persons|2|60–64|0.939|0.745|0.995
Relative|Submandibular gland cancer|2015–2019|Persons|2|65–69|0.913|0.721|0.985
Relative|Submandibular gland cancer|2015–2019|Persons|2|70–74|0.88|0.671|0.974
Relative|Submandibular gland cancer|2015–2019|Persons|2|75–79|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|80–84|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|85+|||
Relative|Submandibular gland cancer|2015–2019|Persons|2|All ages combined|0.887|0.833|0.928
Relative|Submandibular gland cancer|2015–2019|Persons|3|00–04|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|05–09|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|10–14|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|15–19|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|20–24|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|25–29|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|30–34|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|35–39|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|40–44|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|45–49|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|50–54|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|55–59|0.899|0.697|0.976
Relative|Submandibular gland cancer|2015–2019|Persons|3|60–64|0.946|0.751|1.002
Relative|Submandibular gland cancer|2015–2019|Persons|3|65–69|0.844|0.634|0.951
Relative|Submandibular gland cancer|2015–2019|Persons|3|70–74|0.828|0.612|0.948
Relative|Submandibular gland cancer|2015–2019|Persons|3|75–79|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|80–84|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|85+|||
Relative|Submandibular gland cancer|2015–2019|Persons|3|All ages combined|0.829|0.767|0.879
Relative|Submandibular gland cancer|2015–2019|Persons|4|00–04|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|05–09|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|10–14|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|15–19|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|20–24|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|25–29|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|30–34|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|35–39|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|40–44|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|45–49|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|50–54|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|55–59|0.865|0.657|0.959
Relative|Submandibular gland cancer|2015–2019|Persons|4|60–64|0.79|0.57|0.915
Relative|Submandibular gland cancer|2015–2019|Persons|4|65–69|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|70–74|0.77|0.546|0.914
Relative|Submandibular gland cancer|2015–2019|Persons|4|75–79|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|80–84|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|85+|||
Relative|Submandibular gland cancer|2015–2019|Persons|4|All ages combined|0.798|0.731|0.853
Relative|Submandibular gland cancer|2015–2019|Persons|5|00–04|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|05–09|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|10–14|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|15–19|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|20–24|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|25–29|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|30–34|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|35–39|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|40–44|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|45–49|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|50–54|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|55–59|0.834|0.624|0.942
Relative|Submandibular gland cancer|2015–2019|Persons|5|60–64|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|65–69|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|70–74|0.753|0.524|0.909
Relative|Submandibular gland cancer|2015–2019|Persons|5|75–79|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|80–84|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|85+|||
Relative|Submandibular gland cancer|2015–2019|Persons|5|All ages combined|0.771|0.7|0.831
Observed|Testicular cancer|2015–2019|Males|1|00–04|||
Observed|Testicular cancer|2015–2019|Males|1|05–09|||
Observed|Testicular cancer|2015–2019|Males|1|10–14|||
Observed|Testicular cancer|2015–2019|Males|1|15–19|1|0.977|1
Observed|Testicular cancer|2015–2019|Males|1|20–24|0.986|0.971|0.993
Observed|Testicular cancer|2015–2019|Males|1|25–29|0.996|0.988|0.999
Observed|Testicular cancer|2015–2019|Males|1|30–34|0.996|0.989|0.999
Observed|Testicular cancer|2015–2019|Males|1|35–39|0.988|0.976|0.994
Observed|Testicular cancer|2015–2019|Males|1|40–44|0.994|0.982|0.998
Observed|Testicular cancer|2015–2019|Males|1|45–49|0.982|0.96|0.992
Observed|Testicular cancer|2015–2019|Males|1|50–54|0.976|0.943|0.99
Observed|Testicular cancer|2015–2019|Males|1|55–59|0.978|0.933|0.993
Observed|Testicular cancer|2015–2019|Males|1|60–64|0.946|0.875|0.977
Observed|Testicular cancer|2015–2019|Males|1|65–69|0.911|0.781|0.966
Observed|Testicular cancer|2015–2019|Males|1|70–74|0.941|0.784|0.985
Observed|Testicular cancer|2015–2019|Males|1|75–79|||
Observed|Testicular cancer|2015–2019|Males|1|80–84|||
Observed|Testicular cancer|2015–2019|Males|1|85+|||
Observed|Testicular cancer|2015–2019|Males|1|All ages combined|0.986|0.983|0.989
Observed|Testicular cancer|2015–2019|Males|2|00–04|||
Observed|Testicular cancer|2015–2019|Males|2|05–09|||
Observed|Testicular cancer|2015–2019|Males|2|10–14|||
Observed|Testicular cancer|2015–2019|Males|2|15–19|0.985|0.941|0.996
Observed|Testicular cancer|2015–2019|Males|2|20–24|0.978|0.96|0.988
Observed|Testicular cancer|2015–2019|Males|2|25–29|0.988|0.977|0.994
Observed|Testicular cancer|2015–2019|Males|2|30–34|0.994|0.986|0.997
Observed|Testicular cancer|2015–2019|Males|2|35–39|0.977|0.963|0.986
Observed|Testicular cancer|2015–2019|Males|2|40–44|0.99|0.977|0.996
Observed|Testicular cancer|2015–2019|Males|2|45–49|0.979|0.956|0.99
Observed|Testicular cancer|2015–2019|Males|2|50–54|0.961|0.924|0.98
Observed|Testicular cancer|2015–2019|Males|2|55–59|0.978|0.933|0.993
Observed|Testicular cancer|2015–2019|Males|2|60–64|0.946|0.875|0.977
Observed|Testicular cancer|2015–2019|Males|2|65–69|0.911|0.781|0.966
Observed|Testicular cancer|2015–2019|Males|2|70–74|0.843|0.662|0.931
Observed|Testicular cancer|2015–2019|Males|2|75–79|||
Observed|Testicular cancer|2015–2019|Males|2|80–84|||
Observed|Testicular cancer|2015–2019|Males|2|85+|||
Observed|Testicular cancer|2015–2019|Males|2|All ages combined|0.978|0.973|0.982
Observed|Testicular cancer|2015–2019|Males|3|00–04|||
Observed|Testicular cancer|2015–2019|Males|3|05–09|||
Observed|Testicular cancer|2015–2019|Males|3|10–14|||
Observed|Testicular cancer|2015–2019|Males|3|15–19|0.971|0.926|0.989
Observed|Testicular cancer|2015–2019|Males|3|20–24|0.975|0.957|0.986
Observed|Testicular cancer|2015–2019|Males|3|25–29|0.985|0.974|0.992
Observed|Testicular cancer|2015–2019|Males|3|30–34|0.991|0.982|0.996
Observed|Testicular cancer|2015–2019|Males|3|35–39|0.974|0.959|0.984
Observed|Testicular cancer|2015–2019|Males|3|40–44|0.984|0.969|0.992
Observed|Testicular cancer|2015–2019|Males|3|45–49|0.973|0.948|0.986
Observed|Testicular cancer|2015–2019|Males|3|50–54|0.956|0.918|0.977
Observed|Testicular cancer|2015–2019|Males|3|55–59|0.948|0.894|0.975
Observed|Testicular cancer|2015–2019|Males|3|60–64|0.934|0.858|0.97
Observed|Testicular cancer|2015–2019|Males|3|65–69|0.887|0.75|0.952
Observed|Testicular cancer|2015–2019|Males|3|70–74|0.779|0.591|0.888
Observed|Testicular cancer|2015–2019|Males|3|75–79|||
Observed|Testicular cancer|2015–2019|Males|3|80–84|||
Observed|Testicular cancer|2015–2019|Males|3|85+|||
Observed|Testicular cancer|2015–2019|Males|3|All ages combined|0.972|0.966|0.976
Observed|Testicular cancer|2015–2019|Males|4|00–04|||
Observed|Testicular cancer|2015–2019|Males|4|05–09|||
Observed|Testicular cancer|2015–2019|Males|4|10–14|||
Observed|Testicular cancer|2015–2019|Males|4|15–19|0.971|0.926|0.989
Observed|Testicular cancer|2015–2019|Males|4|20–24|0.973|0.954|0.984
Observed|Testicular cancer|2015–2019|Males|4|25–29|0.983|0.97|0.99
Observed|Testicular cancer|2015–2019|Males|4|30–34|0.984|0.972|0.991
Observed|Testicular cancer|2015–2019|Males|4|35–39|0.973|0.957|0.983
Observed|Testicular cancer|2015–2019|Males|4|40–44|0.978|0.961|0.988
Observed|Testicular cancer|2015–2019|Males|4|45–49|0.963|0.937|0.979
Observed|Testicular cancer|2015–2019|Males|4|50–54|0.956|0.918|0.977
Observed|Testicular cancer|2015–2019|Males|4|55–59|0.924|0.862|0.958
Observed|Testicular cancer|2015–2019|Males|4|60–64|0.906|0.821|0.952
Observed|Testicular cancer|2015–2019|Males|4|65–69|0.863|0.72|0.936
Observed|Testicular cancer|2015–2019|Males|4|70–74|0.72|0.531|0.843
Observed|Testicular cancer|2015–2019|Males|4|75–79|||
Observed|Testicular cancer|2015–2019|Males|4|80–84|||
Observed|Testicular cancer|2015–2019|Males|4|85+|||
Observed|Testicular cancer|2015–2019|Males|4|All ages combined|0.965|0.959|0.97
Observed|Testicular cancer|2015–2019|Males|5|00–04|||
Observed|Testicular cancer|2015–2019|Males|5|05–09|||
Observed|Testicular cancer|2015–2019|Males|5|10–14|||
Observed|Testicular cancer|2015–2019|Males|5|15–19|0.971|0.926|0.989
Observed|Testicular cancer|2015–2019|Males|5|20–24|0.973|0.954|0.984
Observed|Testicular cancer|2015–2019|Males|5|25–29|0.98|0.967|0.988
Observed|Testicular cancer|2015–2019|Males|5|30–34|0.983|0.97|0.99
Observed|Testicular cancer|2015–2019|Males|5|35–39|0.973|0.957|0.983
Observed|Testicular cancer|2015–2019|Males|5|40–44|0.972|0.953|0.983
Observed|Testicular cancer|2015–2019|Males|5|45–49|0.96|0.933|0.977
Observed|Testicular cancer|2015–2019|Males|5|50–54|0.951|0.911|0.974
Observed|Testicular cancer|2015–2019|Males|5|55–59|0.881|0.811|0.927
Observed|Testicular cancer|2015–2019|Males|5|60–64|0.892|0.801|0.943
Observed|Testicular cancer|2015–2019|Males|5|65–69|0.837|0.686|0.919
Observed|Testicular cancer|2015–2019|Males|5|70–74|0.72|0.531|0.843
Observed|Testicular cancer|2015–2019|Males|5|75–79|||
Observed|Testicular cancer|2015–2019|Males|5|80–84|||
Observed|Testicular cancer|2015–2019|Males|5|85+|||
Observed|Testicular cancer|2015–2019|Males|5|All ages combined|0.961|0.954|0.966
Relative|Testicular cancer|2015–2019|Males|1|00–04|||
Relative|Testicular cancer|2015–2019|Males|1|05–09|||
Relative|Testicular cancer|2015–2019|Males|1|10–14|||
Relative|Testicular cancer|2015–2019|Males|1|15–19|1|0.978|1
Relative|Testicular cancer|2015–2019|Males|1|20–24|0.987|0.971|0.994
Relative|Testicular cancer|2015–2019|Males|1|25–29|0.997|0.989|0.999
Relative|Testicular cancer|2015–2019|Males|1|30–34|0.997|0.99|1
Relative|Testicular cancer|2015–2019|Males|1|35–39|0.989|0.978|0.995
Relative|Testicular cancer|2015–2019|Males|1|40–44|0.996|0.984|1
Relative|Testicular cancer|2015–2019|Males|1|45–49|0.984|0.962|0.994
Relative|Testicular cancer|2015–2019|Males|1|50–54|0.979|0.946|0.993
Relative|Testicular cancer|2015–2019|Males|1|55–59|0.983|0.938|0.998
Relative|Testicular cancer|2015–2019|Males|1|60–64|0.953|0.882|0.985
Relative|Testicular cancer|2015–2019|Males|1|65–69|0.922|0.79|0.977
Relative|Testicular cancer|2015–2019|Males|1|70–74|0.959|0.799|1.004
Relative|Testicular cancer|2015–2019|Males|1|75–79|||
Relative|Testicular cancer|2015–2019|Males|1|80–84|||
Relative|Testicular cancer|2015–2019|Males|1|85+|||
Relative|Testicular cancer|2015–2019|Males|1|All ages combined|0.989|0.985|0.992
Relative|Testicular cancer|2015–2019|Males|2|00–04|||
Relative|Testicular cancer|2015–2019|Males|2|05–09|||
Relative|Testicular cancer|2015–2019|Males|2|10–14|||
Relative|Testicular cancer|2015–2019|Males|2|15–19|0.986|0.942|0.997
Relative|Testicular cancer|2015–2019|Males|2|20–24|0.979|0.961|0.989
Relative|Testicular cancer|2015–2019|Males|2|25–29|0.989|0.979|0.995
Relative|Testicular cancer|2015–2019|Males|2|30–34|0.996|0.987|0.999
Relative|Testicular cancer|2015–2019|Males|2|35–39|0.98|0.965|0.989
Relative|Testicular cancer|2015–2019|Males|2|40–44|0.994|0.98|0.999
Relative|Testicular cancer|2015–2019|Males|2|45–49|0.984|0.961|0.995
Relative|Testicular cancer|2015–2019|Males|2|50–54|0.968|0.931|0.987
Relative|Testicular cancer|2015–2019|Males|2|55–59|0.988|0.943|1.003
Relative|Testicular cancer|2015–2019|Males|2|60–64|0.961|0.889|0.993
Relative|Testicular cancer|2015–2019|Males|2|65–69|0.934|0.8|0.99
Relative|Testicular cancer|2015–2019|Males|2|70–74|0.878|0.689|0.97
Relative|Testicular cancer|2015–2019|Males|2|75–79|||
Relative|Testicular cancer|2015–2019|Males|2|80–84|||
Relative|Testicular cancer|2015–2019|Males|2|85+|||
Relative|Testicular cancer|2015–2019|Males|2|All ages combined|0.982|0.977|0.986
Relative|Testicular cancer|2015–2019|Males|3|00–04|||
Relative|Testicular cancer|2015–2019|Males|3|05–09|||
Relative|Testicular cancer|2015–2019|Males|3|10–14|||
Relative|Testicular cancer|2015–2019|Males|3|15–19|0.973|0.927|0.991
Relative|Testicular cancer|2015–2019|Males|3|20–24|0.977|0.959|0.988
Relative|Testicular cancer|2015–2019|Males|3|25–29|0.987|0.976|0.994
Relative|Testicular cancer|2015–2019|Males|3|30–34|0.994|0.984|0.999
Relative|Testicular cancer|2015–2019|Males|3|35–39|0.978|0.962|0.987
Relative|Testicular cancer|2015–2019|Males|3|40–44|0.989|0.974|0.997
Relative|Testicular cancer|2015–2019|Males|3|45–49|0.98|0.955|0.993
Relative|Testicular cancer|2015–2019|Males|3|50–54|0.967|0.928|0.988
Relative|Testicular cancer|2015–2019|Males|3|55–59|0.964|0.909|0.991
Relative|Testicular cancer|2015–2019|Males|3|60–64|0.958|0.88|0.995
Relative|Testicular cancer|2015–2019|Males|3|65–69|0.922|0.78|0.989
Relative|Testicular cancer|2015–2019|Males|3|70–74|0.832|0.631|0.948
Relative|Testicular cancer|2015–2019|Males|3|75–79|||
Relative|Testicular cancer|2015–2019|Males|3|80–84|||
Relative|Testicular cancer|2015–2019|Males|3|85+|||
Relative|Testicular cancer|2015–2019|Males|3|All ages combined|0.978|0.973|0.983
Relative|Testicular cancer|2015–2019|Males|4|00–04|||
Relative|Testicular cancer|2015–2019|Males|4|05–09|||
Relative|Testicular cancer|2015–2019|Males|4|10–14|||
Relative|Testicular cancer|2015–2019|Males|4|15–19|0.973|0.927|0.991
Relative|Testicular cancer|2015–2019|Males|4|20–24|0.976|0.957|0.987
Relative|Testicular cancer|2015–2019|Males|4|25–29|0.985|0.973|0.993
Relative|Testicular cancer|2015–2019|Males|4|30–34|0.988|0.976|0.995
Relative|Testicular cancer|2015–2019|Males|4|35–39|0.977|0.962|0.988
Relative|Testicular cancer|2015–2019|Males|4|40–44|0.985|0.968|0.995
Relative|Testicular cancer|2015–2019|Males|4|45–49|0.973|0.946|0.989
Relative|Testicular cancer|2015–2019|Males|4|50–54|0.971|0.932|0.992
Relative|Testicular cancer|2015–2019|Males|4|55–59|0.945|0.883|0.981
Relative|Testicular cancer|2015–2019|Males|4|60–64|0.939|0.85|0.986
Relative|Testicular cancer|2015–2019|Males|4|65–69|0.911|0.76|0.988
Relative|Testicular cancer|2015–2019|Males|4|70–74|0.789|0.582|0.924
Relative|Testicular cancer|2015–2019|Males|4|75–79|||
Relative|Testicular cancer|2015–2019|Males|4|80–84|||
Relative|Testicular cancer|2015–2019|Males|4|85+|||
Relative|Testicular cancer|2015–2019|Males|4|All ages combined|0.974|0.968|0.979
Relative|Testicular cancer|2015–2019|Males|5|00–04|||
Relative|Testicular cancer|2015–2019|Males|5|05–09|||
Relative|Testicular cancer|2015–2019|Males|5|10–14|||
Relative|Testicular cancer|2015–2019|Males|5|15–19|0.974|0.928|0.992
Relative|Testicular cancer|2015–2019|Males|5|20–24|0.976|0.957|0.988
Relative|Testicular cancer|2015–2019|Males|5|25–29|0.983|0.97|0.991
Relative|Testicular cancer|2015–2019|Males|5|30–34|0.988|0.975|0.995
Relative|Testicular cancer|2015–2019|Males|5|35–39|0.979|0.963|0.989
Relative|Testicular cancer|2015–2019|Males|5|40–44|0.981|0.962|0.992
Relative|Testicular cancer|2015–2019|Males|5|45–49|0.973|0.945|0.99
Relative|Testicular cancer|2015–2019|Males|5|50–54|0.971|0.93|0.993
Relative|Testicular cancer|2015–2019|Males|5|55–59|0.908|0.835|0.955
Relative|Testicular cancer|2015–2019|Males|5|60–64|0.934|0.839|0.987
Relative|Testicular cancer|2015–2019|Males|5|65–69|0.898|0.737|0.987
Relative|Testicular cancer|2015–2019|Males|5|70–74|0.813|0.599|0.952
Relative|Testicular cancer|2015–2019|Males|5|75–79|||
Relative|Testicular cancer|2015–2019|Males|5|80–84|||
Relative|Testicular cancer|2015–2019|Males|5|85+|||
Relative|Testicular cancer|2015–2019|Males|5|All ages combined|0.972|0.966|0.978
Observed|Thyroid cancer|2015–2019|Males|1|00–04|||
Observed|Thyroid cancer|2015–2019|Males|1|05–09|||
Observed|Thyroid cancer|2015–2019|Males|1|10–14|||
Observed|Thyroid cancer|2015–2019|Males|1|15–19|1|0.929|1
Observed|Thyroid cancer|2015–2019|Males|1|20–24|1|0.961|1
Observed|Thyroid cancer|2015–2019|Males|1|25–29|0.981|0.943|0.994
Observed|Thyroid cancer|2015–2019|Males|1|30–34|1|0.986|1
Observed|Thyroid cancer|2015–2019|Males|1|35–39|0.996|0.974|0.999
Observed|Thyroid cancer|2015–2019|Males|1|40–44|0.987|0.965|0.995
Observed|Thyroid cancer|2015–2019|Males|1|45–49|0.973|0.952|0.985
Observed|Thyroid cancer|2015–2019|Males|1|50–54|0.98|0.963|0.99
Observed|Thyroid cancer|2015–2019|Males|1|55–59|0.96|0.94|0.974
Observed|Thyroid cancer|2015–2019|Males|1|60–64|0.96|0.939|0.974
Observed|Thyroid cancer|2015–2019|Males|1|65–69|0.946|0.922|0.962
Observed|Thyroid cancer|2015–2019|Males|1|70–74|0.921|0.889|0.945
Observed|Thyroid cancer|2015–2019|Males|1|75–79|0.885|0.837|0.92
Observed|Thyroid cancer|2015–2019|Males|1|80–84|0.777|0.697|0.838
Observed|Thyroid cancer|2015–2019|Males|1|85+|0.639|0.515|0.739
Observed|Thyroid cancer|2015–2019|Males|1|All ages combined|0.952|0.945|0.958
Observed|Thyroid cancer|2015–2019|Males|2|00–04|||
Observed|Thyroid cancer|2015–2019|Males|2|05–09|||
Observed|Thyroid cancer|2015–2019|Males|2|10–14|||
Observed|Thyroid cancer|2015–2019|Males|2|15–19|1|0.929|1
Observed|Thyroid cancer|2015–2019|Males|2|20–24|0.985|0.901|0.998
Observed|Thyroid cancer|2015–2019|Males|2|25–29|0.981|0.943|0.994
Observed|Thyroid cancer|2015–2019|Males|2|30–34|1|0.986|1
Observed|Thyroid cancer|2015–2019|Males|2|35–39|0.992|0.97|0.998
Observed|Thyroid cancer|2015–2019|Males|2|40–44|0.984|0.961|0.993
Observed|Thyroid cancer|2015–2019|Males|2|45–49|0.962|0.938|0.977
Observed|Thyroid cancer|2015–2019|Males|2|50–54|0.969|0.948|0.982
Observed|Thyroid cancer|2015–2019|Males|2|55–59|0.942|0.918|0.959
Observed|Thyroid cancer|2015–2019|Males|2|60–64|0.945|0.921|0.962
Observed|Thyroid cancer|2015–2019|Males|2|65–69|0.915|0.886|0.936
Observed|Thyroid cancer|2015–2019|Males|2|70–74|0.882|0.844|0.912
Observed|Thyroid cancer|2015–2019|Males|2|75–79|0.834|0.779|0.877
Observed|Thyroid cancer|2015–2019|Males|2|80–84|0.722|0.638|0.79
Observed|Thyroid cancer|2015–2019|Males|2|85+|0.576|0.454|0.68
Observed|Thyroid cancer|2015–2019|Males|2|All ages combined|0.932|0.924|0.939
Observed|Thyroid cancer|2015–2019|Males|3|00–04|||
Observed|Thyroid cancer|2015–2019|Males|3|05–09|||
Observed|Thyroid cancer|2015–2019|Males|3|10–14|||
Observed|Thyroid cancer|2015–2019|Males|3|15–19|1|0.929|1
Observed|Thyroid cancer|2015–2019|Males|3|20–24|0.985|0.901|0.998
Observed|Thyroid cancer|2015–2019|Males|3|25–29|0.981|0.943|0.994
Observed|Thyroid cancer|2015–2019|Males|3|30–34|0.995|0.962|0.999
Observed|Thyroid cancer|2015–2019|Males|3|35–39|0.98|0.953|0.992
Observed|Thyroid cancer|2015–2019|Males|3|40–44|0.971|0.944|0.985
Observed|Thyroid cancer|2015–2019|Males|3|45–49|0.957|0.931|0.973
Observed|Thyroid cancer|2015–2019|Males|3|50–54|0.962|0.94|0.976
Observed|Thyroid cancer|2015–2019|Males|3|55–59|0.922|0.895|0.943
Observed|Thyroid cancer|2015–2019|Males|3|60–64|0.927|0.899|0.947
Observed|Thyroid cancer|2015–2019|Males|3|65–69|0.892|0.861|0.917
Observed|Thyroid cancer|2015–2019|Males|3|70–74|0.853|0.81|0.886
Observed|Thyroid cancer|2015–2019|Males|3|75–79|0.775|0.714|0.825
Observed|Thyroid cancer|2015–2019|Males|3|80–84|0.604|0.515|0.682
Observed|Thyroid cancer|2015–2019|Males|3|85+|0.502|0.384|0.609
Observed|Thyroid cancer|2015–2019|Males|3|All ages combined|0.911|0.902|0.919
Observed|Thyroid cancer|2015–2019|Males|4|00–04|||
Observed|Thyroid cancer|2015–2019|Males|4|05–09|||
Observed|Thyroid cancer|2015–2019|Males|4|10–14|||
Observed|Thyroid cancer|2015–2019|Males|4|15–19|0.977|0.845|0.997
Observed|Thyroid cancer|2015–2019|Males|4|20–24|0.969|0.883|0.992
Observed|Thyroid cancer|2015–2019|Males|4|25–29|0.968|0.924|0.986
Observed|Thyroid cancer|2015–2019|Males|4|30–34|0.989|0.957|0.997
Observed|Thyroid cancer|2015–2019|Males|4|35–39|0.98|0.953|0.992
Observed|Thyroid cancer|2015–2019|Males|4|40–44|0.971|0.944|0.985
Observed|Thyroid cancer|2015–2019|Males|4|45–49|0.951|0.924|0.968
Observed|Thyroid cancer|2015–2019|Males|4|50–54|0.955|0.931|0.971
Observed|Thyroid cancer|2015–2019|Males|4|55–59|0.916|0.887|0.937
Observed|Thyroid cancer|2015–2019|Males|4|60–64|0.904|0.873|0.928
Observed|Thyroid cancer|2015–2019|Males|4|65–69|0.874|0.841|0.901
Observed|Thyroid cancer|2015–2019|Males|4|70–74|0.814|0.767|0.852
Observed|Thyroid cancer|2015–2019|Males|4|75–79|0.728|0.663|0.783
Observed|Thyroid cancer|2015–2019|Males|4|80–84|0.571|0.481|0.651
Observed|Thyroid cancer|2015–2019|Males|4|85+|0.432|0.317|0.541
Observed|Thyroid cancer|2015–2019|Males|4|All ages combined|0.895|0.885|0.904
Observed|Thyroid cancer|2015–2019|Males|5|00–04|||
Observed|Thyroid cancer|2015–2019|Males|5|05–09|||
Observed|Thyroid cancer|2015–2019|Males|5|10–14|||
Observed|Thyroid cancer|2015–2019|Males|5|15–19|0.977|0.845|0.997
Observed|Thyroid cancer|2015–2019|Males|5|20–24|0.969|0.883|0.992
Observed|Thyroid cancer|2015–2019|Males|5|25–29|0.968|0.924|0.986
Observed|Thyroid cancer|2015–2019|Males|5|30–34|0.989|0.957|0.997
Observed|Thyroid cancer|2015–2019|Males|5|35–39|0.98|0.953|0.992
Observed|Thyroid cancer|2015–2019|Males|5|40–44|0.967|0.939|0.982
Observed|Thyroid cancer|2015–2019|Males|5|45–49|0.945|0.916|0.964
Observed|Thyroid cancer|2015–2019|Males|5|50–54|0.948|0.922|0.965
Observed|Thyroid cancer|2015–2019|Males|5|55–59|0.908|0.879|0.931
Observed|Thyroid cancer|2015–2019|Males|5|60–64|0.881|0.847|0.908
Observed|Thyroid cancer|2015–2019|Males|5|65–69|0.847|0.81|0.877
Observed|Thyroid cancer|2015–2019|Males|5|70–74|0.78|0.73|0.822
Observed|Thyroid cancer|2015–2019|Males|5|75–79|0.692|0.624|0.751
Observed|Thyroid cancer|2015–2019|Males|5|80–84|0.515|0.425|0.597
Observed|Thyroid cancer|2015–2019|Males|5|85+|0.281|0.184|0.386
Observed|Thyroid cancer|2015–2019|Males|5|All ages combined|0.877|0.866|0.887
Relative|Thyroid cancer|2015–2019|Males|1|00–04|||
Relative|Thyroid cancer|2015–2019|Males|1|05–09|||
Relative|Thyroid cancer|2015–2019|Males|1|10–14|||
Relative|Thyroid cancer|2015–2019|Males|1|15–19|1|0.93|1
Relative|Thyroid cancer|2015–2019|Males|1|20–24|1.001|0.961|1.001
Relative|Thyroid cancer|2015–2019|Males|1|25–29|0.982|0.944|0.995
Relative|Thyroid cancer|2015–2019|Males|1|30–34|1.001|0.987|1.001
Relative|Thyroid cancer|2015–2019|Males|1|35–39|0.997|0.975|1.001
Relative|Thyroid cancer|2015–2019|Males|1|40–44|0.988|0.967|0.997
Relative|Thyroid cancer|2015–2019|Males|1|45–49|0.975|0.954|0.987
Relative|Thyroid cancer|2015–2019|Males|1|50–54|0.984|0.966|0.993
Relative|Thyroid cancer|2015–2019|Males|1|55–59|0.965|0.945|0.979
Relative|Thyroid cancer|2015–2019|Males|1|60–64|0.968|0.947|0.982
Relative|Thyroid cancer|2015–2019|Males|1|65–69|0.957|0.934|0.974
Relative|Thyroid cancer|2015–2019|Males|1|70–74|0.939|0.906|0.963
Relative|Thyroid cancer|2015–2019|Males|1|75–79|0.915|0.865|0.95
Relative|Thyroid cancer|2015–2019|Males|1|80–84|0.825|0.74|0.89
Relative|Thyroid cancer|2015–2019|Males|1|85+|0.73|0.589|0.844
Relative|Thyroid cancer|2015–2019|Males|1|All ages combined|0.963|0.956|0.969
Relative|Thyroid cancer|2015–2019|Males|2|00–04|||
Relative|Thyroid cancer|2015–2019|Males|2|05–09|||
Relative|Thyroid cancer|2015–2019|Males|2|10–14|||
Relative|Thyroid cancer|2015–2019|Males|2|15–19|1.001|0.93|1.001
Relative|Thyroid cancer|2015–2019|Males|2|20–24|0.987|0.902|0.999
Relative|Thyroid cancer|2015–2019|Males|2|25–29|0.983|0.944|0.995
Relative|Thyroid cancer|2015–2019|Males|2|30–34|1.002|0.988|1.002
Relative|Thyroid cancer|2015–2019|Males|2|35–39|0.995|0.973|1
Relative|Thyroid cancer|2015–2019|Males|2|40–44|0.987|0.964|0.996
Relative|Thyroid cancer|2015–2019|Males|2|45–49|0.967|0.943|0.982
Relative|Thyroid cancer|2015–2019|Males|2|50–54|0.976|0.955|0.989
Relative|Thyroid cancer|2015–2019|Males|2|55–59|0.952|0.928|0.97
Relative|Thyroid cancer|2015–2019|Males|2|60–64|0.961|0.936|0.978
Relative|Thyroid cancer|2015–2019|Males|2|65–69|0.938|0.909|0.96
Relative|Thyroid cancer|2015–2019|Males|2|70–74|0.918|0.879|0.949
Relative|Thyroid cancer|2015–2019|Males|2|75–79|0.894|0.835|0.939
Relative|Thyroid cancer|2015–2019|Males|2|80–84|0.821|0.725|0.898
Relative|Thyroid cancer|2015–2019|Males|2|85+|0.765|0.603|0.903
Relative|Thyroid cancer|2015–2019|Males|2|All ages combined|0.954|0.945|0.961
Relative|Thyroid cancer|2015–2019|Males|3|00–04|||
Relative|Thyroid cancer|2015–2019|Males|3|05–09|||
Relative|Thyroid cancer|2015–2019|Males|3|10–14|||
Relative|Thyroid cancer|2015–2019|Males|3|15–19|1.001|0.931|1.001
Relative|Thyroid cancer|2015–2019|Males|3|20–24|0.987|0.903|1
Relative|Thyroid cancer|2015–2019|Males|3|25–29|0.983|0.945|0.996
Relative|Thyroid cancer|2015–2019|Males|3|30–34|0.997|0.965|1.002
Relative|Thyroid cancer|2015–2019|Males|3|35–39|0.984|0.957|0.995
Relative|Thyroid cancer|2015–2019|Males|3|40–44|0.976|0.949|0.99
Relative|Thyroid cancer|2015–2019|Males|3|45–49|0.964|0.938|0.98
Relative|Thyroid cancer|2015–2019|Males|3|50–54|0.973|0.951|0.988
Relative|Thyroid cancer|2015–2019|Males|3|55–59|0.938|0.911|0.959
Relative|Thyroid cancer|2015–2019|Males|3|60–64|0.951|0.922|0.971
Relative|Thyroid cancer|2015–2019|Males|3|65–69|0.928|0.896|0.954
Relative|Thyroid cancer|2015–2019|Males|3|70–74|0.909|0.864|0.945
Relative|Thyroid cancer|2015–2019|Males|3|75–79|0.865|0.797|0.921
Relative|Thyroid cancer|2015–2019|Males|3|80–84|0.741|0.632|0.837
Relative|Thyroid cancer|2015–2019|Males|3|85+|0.787|0.602|0.954
Relative|Thyroid cancer|2015–2019|Males|3|All ages combined|0.943|0.933|0.951
Relative|Thyroid cancer|2015–2019|Males|4|00–04|||
Relative|Thyroid cancer|2015–2019|Males|4|05–09|||
Relative|Thyroid cancer|2015–2019|Males|4|10–14|||
Relative|Thyroid cancer|2015–2019|Males|4|15–19|0.979|0.847|0.999
Relative|Thyroid cancer|2015–2019|Males|4|20–24|0.972|0.885|0.995
Relative|Thyroid cancer|2015–2019|Males|4|25–29|0.97|0.926|0.989
Relative|Thyroid cancer|2015–2019|Males|4|30–34|0.993|0.96|1.001
Relative|Thyroid cancer|2015–2019|Males|4|35–39|0.985|0.958|0.997
Relative|Thyroid cancer|2015–2019|Males|4|40–44|0.978|0.951|0.992
Relative|Thyroid cancer|2015–2019|Males|4|45–49|0.961|0.933|0.979
Relative|Thyroid cancer|2015–2019|Males|4|50–54|0.97|0.946|0.986
Relative|Thyroid cancer|2015–2019|Males|4|55–59|0.938|0.909|0.96
Relative|Thyroid cancer|2015–2019|Males|4|60–64|0.937|0.905|0.962
Relative|Thyroid cancer|2015–2019|Males|4|65–69|0.924|0.889|0.952
Relative|Thyroid cancer|2015–2019|Males|4|70–74|0.89|0.839|0.932
Relative|Thyroid cancer|2015–2019|Males|4|75–79|0.851|0.775|0.915
Relative|Thyroid cancer|2015–2019|Males|4|80–84|0.763|0.643|0.87
Relative|Thyroid cancer|2015–2019|Males|4|85+|0.818|0.601|1.024
Relative|Thyroid cancer|2015–2019|Males|4|All ages combined|0.938|0.928|0.947
Relative|Thyroid cancer|2015–2019|Males|5|00–04|||
Relative|Thyroid cancer|2015–2019|Males|5|05–09|||
Relative|Thyroid cancer|2015–2019|Males|5|10–14|||
Relative|Thyroid cancer|2015–2019|Males|5|15–19|0.979|0.848|0.999
Relative|Thyroid cancer|2015–2019|Males|5|20–24|0.973|0.886|0.995
Relative|Thyroid cancer|2015–2019|Males|5|25–29|0.971|0.927|0.99
Relative|Thyroid cancer|2015–2019|Males|5|30–34|0.994|0.961|1.002
Relative|Thyroid cancer|2015–2019|Males|5|35–39|0.987|0.959|0.998
Relative|Thyroid cancer|2015–2019|Males|5|40–44|0.976|0.948|0.991
Relative|Thyroid cancer|2015–2019|Males|5|45–49|0.958|0.929|0.977
Relative|Thyroid cancer|2015–2019|Males|5|50–54|0.968|0.942|0.985
Relative|Thyroid cancer|2015–2019|Males|5|55–59|0.937|0.906|0.96
Relative|Thyroid cancer|2015–2019|Males|5|60–64|0.923|0.887|0.951
Relative|Thyroid cancer|2015–2019|Males|5|65–69|0.911|0.871|0.943
Relative|Thyroid cancer|2015–2019|Males|5|70–74|0.879|0.822|0.926
Relative|Thyroid cancer|2015–2019|Males|5|75–79|0.853|0.769|0.925
Relative|Thyroid cancer|2015–2019|Males|5|80–84|0.759|0.627|0.88
Relative|Thyroid cancer|2015–2019|Males|5|85+|0.655|0.429|0.899
Relative|Thyroid cancer|2015–2019|Males|5|All ages combined|0.932|0.92|0.942
Observed|Thyroid cancer|2015–2019|Females|1|00–04|||
Observed|Thyroid cancer|2015–2019|Females|1|05–09|||
Observed|Thyroid cancer|2015–2019|Females|1|10–14|1|0.911|1
Observed|Thyroid cancer|2015–2019|Females|1|15–19|1|0.979|1
Observed|Thyroid cancer|2015–2019|Females|1|20–24|1|0.991|1
Observed|Thyroid cancer|2015–2019|Females|1|25–29|0.998|0.987|1
Observed|Thyroid cancer|2015–2019|Females|1|30–34|1|0.997|1
Observed|Thyroid cancer|2015–2019|Females|1|35–39|0.998|0.992|0.999
Observed|Thyroid cancer|2015–2019|Females|1|40–44|0.997|0.991|0.999
Observed|Thyroid cancer|2015–2019|Females|1|45–49|0.998|0.993|1
Observed|Thyroid cancer|2015–2019|Females|1|50–54|0.993|0.987|0.996
Observed|Thyroid cancer|2015–2019|Females|1|55–59|0.992|0.986|0.996
Observed|Thyroid cancer|2015–2019|Females|1|60–64|0.978|0.967|0.985
Observed|Thyroid cancer|2015–2019|Females|1|65–69|0.978|0.966|0.985
Observed|Thyroid cancer|2015–2019|Females|1|70–74|0.965|0.948|0.977
Observed|Thyroid cancer|2015–2019|Females|1|75–79|0.942|0.915|0.96
Observed|Thyroid cancer|2015–2019|Females|1|80–84|0.834|0.778|0.877
Observed|Thyroid cancer|2015–2019|Females|1|85+|0.645|0.556|0.721
Observed|Thyroid cancer|2015–2019|Females|1|All ages combined|0.982|0.979|0.984
Observed|Thyroid cancer|2015–2019|Females|2|00–04|||
Observed|Thyroid cancer|2015–2019|Females|2|05–09|||
Observed|Thyroid cancer|2015–2019|Females|2|10–14|1|0.914|1
Observed|Thyroid cancer|2015–2019|Females|2|15–19|1|0.978|1
Observed|Thyroid cancer|2015–2019|Females|2|20–24|0.997|0.977|1
Observed|Thyroid cancer|2015–2019|Females|2|25–29|0.998|0.987|1
Observed|Thyroid cancer|2015–2019|Females|2|30–34|0.999|0.991|1
Observed|Thyroid cancer|2015–2019|Females|2|35–39|0.994|0.986|0.997
Observed|Thyroid cancer|2015–2019|Females|2|40–44|0.996|0.99|0.999
Observed|Thyroid cancer|2015–2019|Females|2|45–49|0.993|0.987|0.997
Observed|Thyroid cancer|2015–2019|Females|2|50–54|0.988|0.98|0.992
Observed|Thyroid cancer|2015–2019|Females|2|55–59|0.986|0.977|0.991
Observed|Thyroid cancer|2015–2019|Females|2|60–64|0.97|0.958|0.979
Observed|Thyroid cancer|2015–2019|Females|2|65–69|0.966|0.952|0.976
Observed|Thyroid cancer|2015–2019|Females|2|70–74|0.943|0.922|0.958
Observed|Thyroid cancer|2015–2019|Females|2|75–79|0.913|0.882|0.936
Observed|Thyroid cancer|2015–2019|Females|2|80–84|0.778|0.717|0.828
Observed|Thyroid cancer|2015–2019|Females|2|85+|0.567|0.479|0.647
Observed|Thyroid cancer|2015–2019|Females|2|All ages combined|0.973|0.97|0.976
Observed|Thyroid cancer|2015–2019|Females|3|00–04|||
Observed|Thyroid cancer|2015–2019|Females|3|05–09|||
Observed|Thyroid cancer|2015–2019|Females|3|10–14|1|0.915|1
Observed|Thyroid cancer|2015–2019|Females|3|15–19|1|0.977|1
Observed|Thyroid cancer|2015–2019|Females|3|20–24|0.997|0.977|1
Observed|Thyroid cancer|2015–2019|Females|3|25–29|0.998|0.987|1
Observed|Thyroid cancer|2015–2019|Females|3|30–34|0.999|0.991|1
Observed|Thyroid cancer|2015–2019|Females|3|35–39|0.992|0.984|0.996
Observed|Thyroid cancer|2015–2019|Females|3|40–44|0.995|0.988|0.998
Observed|Thyroid cancer|2015–2019|Females|3|45–49|0.992|0.985|0.996
Observed|Thyroid cancer|2015–2019|Females|3|50–54|0.985|0.976|0.99
Observed|Thyroid cancer|2015–2019|Females|3|55–59|0.98|0.97|0.987
Observed|Thyroid cancer|2015–2019|Females|3|60–64|0.962|0.949|0.972
Observed|Thyroid cancer|2015–2019|Females|3|65–69|0.955|0.94|0.967
Observed|Thyroid cancer|2015–2019|Females|3|70–74|0.915|0.889|0.934
Observed|Thyroid cancer|2015–2019|Females|3|75–79|0.897|0.864|0.923
Observed|Thyroid cancer|2015–2019|Females|3|80–84|0.741|0.677|0.794
Observed|Thyroid cancer|2015–2019|Females|3|85+|0.472|0.384|0.555
Observed|Thyroid cancer|2015–2019|Females|3|All ages combined|0.966|0.963|0.969
Observed|Thyroid cancer|2015–2019|Females|4|00–04|||
Observed|Thyroid cancer|2015–2019|Females|4|05–09|||
Observed|Thyroid cancer|2015–2019|Females|4|10–14|1|0.914|1
Observed|Thyroid cancer|2015–2019|Females|4|15–19|1|0.977|1
Observed|Thyroid cancer|2015–2019|Females|4|20–24|0.997|0.977|1
Observed|Thyroid cancer|2015–2019|Females|4|25–29|0.996|0.984|0.999
Observed|Thyroid cancer|2015–2019|Females|4|30–34|0.996|0.988|0.999
Observed|Thyroid cancer|2015–2019|Females|4|35–39|0.991|0.983|0.996
Observed|Thyroid cancer|2015–2019|Females|4|40–44|0.994|0.987|0.997
Observed|Thyroid cancer|2015–2019|Females|4|45–49|0.988|0.98|0.993
Observed|Thyroid cancer|2015–2019|Females|4|50–54|0.982|0.973|0.988
Observed|Thyroid cancer|2015–2019|Females|4|55–59|0.97|0.959|0.979
Observed|Thyroid cancer|2015–2019|Females|4|60–64|0.956|0.941|0.967
Observed|Thyroid cancer|2015–2019|Females|4|65–69|0.937|0.919|0.952
Observed|Thyroid cancer|2015–2019|Females|4|70–74|0.903|0.877|0.924
Observed|Thyroid cancer|2015–2019|Females|4|75–79|0.861|0.822|0.891
Observed|Thyroid cancer|2015–2019|Females|4|80–84|0.698|0.632|0.755
Observed|Thyroid cancer|2015–2019|Females|4|85+|0.425|0.34|0.508
Observed|Thyroid cancer|2015–2019|Females|4|All ages combined|0.958|0.955|0.962
Observed|Thyroid cancer|2015–2019|Females|5|00–04|||
Observed|Thyroid cancer|2015–2019|Females|5|05–09|||
Observed|Thyroid cancer|2015–2019|Females|5|10–14|1|0.913|1
Observed|Thyroid cancer|2015–2019|Females|5|15–19|1|0.976|1
Observed|Thyroid cancer|2015–2019|Females|5|20–24|0.993|0.971|0.998
Observed|Thyroid cancer|2015–2019|Females|5|25–29|0.996|0.984|0.999
Observed|Thyroid cancer|2015–2019|Females|5|30–34|0.995|0.986|0.998
Observed|Thyroid cancer|2015–2019|Females|5|35–39|0.99|0.981|0.995
Observed|Thyroid cancer|2015–2019|Females|5|40–44|0.993|0.985|0.996
Observed|Thyroid cancer|2015–2019|Females|5|45–49|0.984|0.975|0.99
Observed|Thyroid cancer|2015–2019|Females|5|50–54|0.98|0.971|0.986
Observed|Thyroid cancer|2015–2019|Females|5|55–59|0.963|0.949|0.972
Observed|Thyroid cancer|2015–2019|Females|5|60–64|0.949|0.933|0.961
Observed|Thyroid cancer|2015–2019|Females|5|65–69|0.929|0.909|0.944
Observed|Thyroid cancer|2015–2019|Females|5|70–74|0.887|0.859|0.91
Observed|Thyroid cancer|2015–2019|Females|5|75–79|0.811|0.767|0.847
Observed|Thyroid cancer|2015–2019|Females|5|80–84|0.651|0.583|0.71
Observed|Thyroid cancer|2015–2019|Females|5|85+|0.369|0.287|0.452
Observed|Thyroid cancer|2015–2019|Females|5|All ages combined|0.951|0.947|0.955
Relative|Thyroid cancer|2015–2019|Females|1|00–04|||
Relative|Thyroid cancer|2015–2019|Females|1|05–09|||
Relative|Thyroid cancer|2015–2019|Females|1|10–14|1|0.911|1
Relative|Thyroid cancer|2015–2019|Females|1|15–19|1|0.979|1
Relative|Thyroid cancer|2015–2019|Females|1|20–24|1|0.991|1
Relative|Thyroid cancer|2015–2019|Females|1|25–29|0.998|0.987|1
Relative|Thyroid cancer|2015–2019|Females|1|30–34|1|0.997|1
Relative|Thyroid cancer|2015–2019|Females|1|35–39|0.999|0.992|1
Relative|Thyroid cancer|2015–2019|Females|1|40–44|0.998|0.992|1
Relative|Thyroid cancer|2015–2019|Females|1|45–49|1|0.995|1.001
Relative|Thyroid cancer|2015–2019|Females|1|50–54|0.995|0.989|0.999
Relative|Thyroid cancer|2015–2019|Females|1|55–59|0.996|0.989|0.999
Relative|Thyroid cancer|2015–2019|Females|1|60–64|0.982|0.971|0.99
Relative|Thyroid cancer|2015–2019|Females|1|65–69|0.985|0.973|0.992
Relative|Thyroid cancer|2015–2019|Females|1|70–74|0.977|0.96|0.989
Relative|Thyroid cancer|2015–2019|Females|1|75–79|0.962|0.934|0.981
Relative|Thyroid cancer|2015–2019|Females|1|80–84|0.869|0.811|0.914
Relative|Thyroid cancer|2015–2019|Females|1|85+|0.721|0.622|0.806
Relative|Thyroid cancer|2015–2019|Females|1|All ages combined|0.988|0.985|0.99
Relative|Thyroid cancer|2015–2019|Females|2|00–04|||
Relative|Thyroid cancer|2015–2019|Females|2|05–09|||
Relative|Thyroid cancer|2015–2019|Females|2|10–14|1|0.914|1
Relative|Thyroid cancer|2015–2019|Females|2|15–19|1|0.978|1
Relative|Thyroid cancer|2015–2019|Females|2|20–24|0.997|0.977|1
Relative|Thyroid cancer|2015–2019|Females|2|25–29|0.999|0.987|1
Relative|Thyroid cancer|2015–2019|Females|2|30–34|1|0.992|1.001
Relative|Thyroid cancer|2015–2019|Females|2|35–39|0.995|0.987|0.998
Relative|Thyroid cancer|2015–2019|Females|2|40–44|0.998|0.992|1.001
Relative|Thyroid cancer|2015–2019|Females|2|45–49|0.996|0.99|1
Relative|Thyroid cancer|2015–2019|Females|2|50–54|0.992|0.984|0.997
Relative|Thyroid cancer|2015–2019|Females|2|55–59|0.992|0.983|0.997
Relative|Thyroid cancer|2015–2019|Females|2|60–64|0.979|0.967|0.988
Relative|Thyroid cancer|2015–2019|Females|2|65–69|0.981|0.967|0.99
Relative|Thyroid cancer|2015–2019|Females|2|70–74|0.968|0.946|0.983
Relative|Thyroid cancer|2015–2019|Females|2|75–79|0.955|0.923|0.979
Relative|Thyroid cancer|2015–2019|Females|2|80–84|0.851|0.784|0.905
Relative|Thyroid cancer|2015–2019|Females|2|85+|0.712|0.601|0.812
Relative|Thyroid cancer|2015–2019|Females|2|All ages combined|0.984|0.981|0.987
Relative|Thyroid cancer|2015–2019|Females|3|00–04|||
Relative|Thyroid cancer|2015–2019|Females|3|05–09|||
Relative|Thyroid cancer|2015–2019|Females|3|10–14|1|0.915|1
Relative|Thyroid cancer|2015–2019|Females|3|15–19|1.001|0.978|1.001
Relative|Thyroid cancer|2015–2019|Females|3|20–24|0.997|0.978|1
Relative|Thyroid cancer|2015–2019|Females|3|25–29|0.999|0.987|1.001
Relative|Thyroid cancer|2015–2019|Females|3|30–34|1|0.993|1.001
Relative|Thyroid cancer|2015–2019|Females|3|35–39|0.994|0.986|0.998
Relative|Thyroid cancer|2015–2019|Females|3|40–44|0.998|0.991|1.001
Relative|Thyroid cancer|2015–2019|Females|3|45–49|0.996|0.989|1
Relative|Thyroid cancer|2015–2019|Females|3|50–54|0.991|0.983|0.997
Relative|Thyroid cancer|2015–2019|Females|3|55–59|0.99|0.98|0.997
Relative|Thyroid cancer|2015–2019|Females|3|60–64|0.977|0.963|0.987
Relative|Thyroid cancer|2015–2019|Females|3|65–69|0.978|0.963|0.99
Relative|Thyroid cancer|2015–2019|Females|3|70–74|0.953|0.927|0.973
Relative|Thyroid cancer|2015–2019|Females|3|75–79|0.965|0.929|0.992
Relative|Thyroid cancer|2015–2019|Females|3|80–84|0.856|0.783|0.918
Relative|Thyroid cancer|2015–2019|Females|3|85+|0.671|0.546|0.788
Relative|Thyroid cancer|2015–2019|Females|3|All ages combined|0.983|0.979|0.986
Relative|Thyroid cancer|2015–2019|Females|4|00–04|||
Relative|Thyroid cancer|2015–2019|Females|4|05–09|||
Relative|Thyroid cancer|2015–2019|Females|4|10–14|1.001|0.915|1.001
Relative|Thyroid cancer|2015–2019|Females|4|15–19|1.001|0.978|1.001
Relative|Thyroid cancer|2015–2019|Females|4|20–24|0.998|0.978|1.001
Relative|Thyroid cancer|2015–2019|Females|4|25–29|0.997|0.985|1
Relative|Thyroid cancer|2015–2019|Females|4|30–34|0.998|0.99|1.001
Relative|Thyroid cancer|2015–2019|Females|4|35–39|0.994|0.985|0.998
Relative|Thyroid cancer|2015–2019|Females|4|40–44|0.998|0.991|1.001
Relative|Thyroid cancer|2015–2019|Females|4|45–49|0.995|0.987|0.999
Relative|Thyroid cancer|2015–2019|Females|4|50–54|0.992|0.983|0.998
Relative|Thyroid cancer|2015–2019|Females|4|55–59|0.984|0.972|0.993
Relative|Thyroid cancer|2015–2019|Females|4|60–64|0.976|0.961|0.987
Relative|Thyroid cancer|2015–2019|Females|4|65–69|0.969|0.951|0.984
Relative|Thyroid cancer|2015–2019|Females|4|70–74|0.957|0.929|0.979
Relative|Thyroid cancer|2015–2019|Females|4|75–79|0.954|0.912|0.988
Relative|Thyroid cancer|2015–2019|Females|4|80–84|0.859|0.778|0.929
Relative|Thyroid cancer|2015–2019|Females|4|85+|0.69|0.551|0.824
Relative|Thyroid cancer|2015–2019|Females|4|All ages combined|0.981|0.977|0.985
Relative|Thyroid cancer|2015–2019|Females|5|00–04|||
Relative|Thyroid cancer|2015–2019|Females|5|05–09|||
Relative|Thyroid cancer|2015–2019|Females|5|10–14|1.001|0.914|1.001
Relative|Thyroid cancer|2015–2019|Females|5|15–19|1.001|0.977|1.001
Relative|Thyroid cancer|2015–2019|Females|5|20–24|0.994|0.972|0.999
Relative|Thyroid cancer|2015–2019|Females|5|25–29|0.998|0.986|1.001
Relative|Thyroid cancer|2015–2019|Females|5|30–34|0.997|0.988|1
Relative|Thyroid cancer|2015–2019|Females|5|35–39|0.994|0.985|0.998
Relative|Thyroid cancer|2015–2019|Females|5|40–44|0.998|0.991|1.002
Relative|Thyroid cancer|2015–2019|Females|5|45–49|0.992|0.983|0.998
Relative|Thyroid cancer|2015–2019|Females|5|50–54|0.992|0.983|0.999
Relative|Thyroid cancer|2015–2019|Females|5|55–59|0.98|0.967|0.99
Relative|Thyroid cancer|2015–2019|Females|5|60–64|0.975|0.959|0.988
Relative|Thyroid cancer|2015–2019|Females|5|65–69|0.971|0.95|0.987
Relative|Thyroid cancer|2015–2019|Females|5|70–74|0.958|0.927|0.983
Relative|Thyroid cancer|2015–2019|Females|5|75–79|0.932|0.881|0.973
Relative|Thyroid cancer|2015–2019|Females|5|80–84|0.861|0.771|0.94
Relative|Thyroid cancer|2015–2019|Females|5|85+|0.695|0.54|0.851
Relative|Thyroid cancer|2015–2019|Females|5|All ages combined|0.979|0.975|0.984
Observed|Thyroid cancer|2015–2019|Persons|1|00–04|||
Observed|Thyroid cancer|2015–2019|Persons|1|05–09|||
Observed|Thyroid cancer|2015–2019|Persons|1|10–14|1|0.942|1
Observed|Thyroid cancer|2015–2019|Persons|1|15–19|1|0.983|1
Observed|Thyroid cancer|2015–2019|Persons|1|20–24|1|0.992|1
Observed|Thyroid cancer|2015–2019|Persons|1|25–29|0.994|0.985|0.998
Observed|Thyroid cancer|2015–2019|Persons|1|30–34|1|0.997|1
Observed|Thyroid cancer|2015–2019|Persons|1|35–39|0.998|0.993|0.999
Observed|Thyroid cancer|2015–2019|Persons|1|40–44|0.995|0.989|0.998
Observed|Thyroid cancer|2015–2019|Persons|1|45–49|0.992|0.986|0.995
Observed|Thyroid cancer|2015–2019|Persons|1|50–54|0.99|0.984|0.994
Observed|Thyroid cancer|2015–2019|Persons|1|55–59|0.983|0.975|0.988
Observed|Thyroid cancer|2015–2019|Persons|1|60–64|0.972|0.963|0.979
Observed|Thyroid cancer|2015–2019|Persons|1|65–69|0.967|0.956|0.975
Observed|Thyroid cancer|2015–2019|Persons|1|70–74|0.95|0.934|0.961
Observed|Thyroid cancer|2015–2019|Persons|1|75–79|0.922|0.898|0.94
Observed|Thyroid cancer|2015–2019|Persons|1|80–84|0.812|0.767|0.849
Observed|Thyroid cancer|2015–2019|Persons|1|85+|0.643|0.572|0.705
Observed|Thyroid cancer|2015–2019|Persons|1|All ages combined|0.974|0.971|0.976
Observed|Thyroid cancer|2015–2019|Persons|2|00–04|||
Observed|Thyroid cancer|2015–2019|Persons|2|05–09|||
Observed|Thyroid cancer|2015–2019|Persons|2|10–14|1|0.942|1
Observed|Thyroid cancer|2015–2019|Persons|2|15–19|1|0.983|1
Observed|Thyroid cancer|2015–2019|Persons|2|20–24|0.995|0.979|0.999
Observed|Thyroid cancer|2015–2019|Persons|2|25–29|0.994|0.985|0.998
Observed|Thyroid cancer|2015–2019|Persons|2|30–34|0.999|0.993|1
Observed|Thyroid cancer|2015–2019|Persons|2|35–39|0.993|0.987|0.997
Observed|Thyroid cancer|2015–2019|Persons|2|40–44|0.994|0.988|0.997
Observed|Thyroid cancer|2015–2019|Persons|2|45–49|0.986|0.979|0.991
Observed|Thyroid cancer|2015–2019|Persons|2|50–54|0.983|0.976|0.988
Observed|Thyroid cancer|2015–2019|Persons|2|55–59|0.972|0.963|0.979
Observed|Thyroid cancer|2015–2019|Persons|2|60–64|0.962|0.951|0.971
Observed|Thyroid cancer|2015–2019|Persons|2|65–69|0.948|0.936|0.959
Observed|Thyroid cancer|2015–2019|Persons|2|70–74|0.921|0.903|0.936
Observed|Thyroid cancer|2015–2019|Persons|2|75–79|0.885|0.858|0.907
Observed|Thyroid cancer|2015–2019|Persons|2|80–84|0.757|0.708|0.798
Observed|Thyroid cancer|2015–2019|Persons|2|85+|0.571|0.5|0.635
Observed|Thyroid cancer|2015–2019|Persons|2|All ages combined|0.962|0.959|0.965
Observed|Thyroid cancer|2015–2019|Persons|3|00–04|||
Observed|Thyroid cancer|2015–2019|Persons|3|05–09|||
Observed|Thyroid cancer|2015–2019|Persons|3|10–14|1|0.94|1
Observed|Thyroid cancer|2015–2019|Persons|3|15–19|1|0.983|1
Observed|Thyroid cancer|2015–2019|Persons|3|20–24|0.995|0.979|0.999
Observed|Thyroid cancer|2015–2019|Persons|3|25–29|0.994|0.985|0.998
Observed|Thyroid cancer|2015–2019|Persons|3|30–34|0.998|0.992|0.999
Observed|Thyroid cancer|2015–2019|Persons|3|35–39|0.99|0.982|0.994
Observed|Thyroid cancer|2015–2019|Persons|3|40–44|0.989|0.982|0.994
Observed|Thyroid cancer|2015–2019|Persons|3|45–49|0.983|0.976|0.988
Observed|Thyroid cancer|2015–2019|Persons|3|50–54|0.979|0.971|0.985
Observed|Thyroid cancer|2015–2019|Persons|3|55–59|0.963|0.952|0.971
Observed|Thyroid cancer|2015–2019|Persons|3|60–64|0.951|0.939|0.961
Observed|Thyroid cancer|2015–2019|Persons|3|65–69|0.934|0.92|0.946
Observed|Thyroid cancer|2015–2019|Persons|3|70–74|0.893|0.871|0.911
Observed|Thyroid cancer|2015–2019|Persons|3|75–79|0.855|0.825|0.88
Observed|Thyroid cancer|2015–2019|Persons|3|80–84|0.69|0.638|0.736
Observed|Thyroid cancer|2015–2019|Persons|3|85+|0.483|0.414|0.55
Observed|Thyroid cancer|2015–2019|Persons|3|All ages combined|0.951|0.947|0.954
Observed|Thyroid cancer|2015–2019|Persons|4|00–04|||
Observed|Thyroid cancer|2015–2019|Persons|4|05–09|||
Observed|Thyroid cancer|2015–2019|Persons|4|10–14|1|0.939|1
Observed|Thyroid cancer|2015–2019|Persons|4|15–19|0.994|0.957|0.999
Observed|Thyroid cancer|2015–2019|Persons|4|20–24|0.992|0.974|0.997
Observed|Thyroid cancer|2015–2019|Persons|4|25–29|0.989|0.978|0.995
Observed|Thyroid cancer|2015–2019|Persons|4|30–34|0.995|0.987|0.998
Observed|Thyroid cancer|2015–2019|Persons|4|35–39|0.989|0.981|0.994
Observed|Thyroid cancer|2015–2019|Persons|4|40–44|0.989|0.981|0.993
Observed|Thyroid cancer|2015–2019|Persons|4|45–49|0.979|0.971|0.985
Observed|Thyroid cancer|2015–2019|Persons|4|50–54|0.975|0.967|0.982
Observed|Thyroid cancer|2015–2019|Persons|4|55–59|0.954|0.942|0.963
Observed|Thyroid cancer|2015–2019|Persons|4|60–64|0.94|0.926|0.951
Observed|Thyroid cancer|2015–2019|Persons|4|65–69|0.916|0.9|0.929
Observed|Thyroid cancer|2015–2019|Persons|4|70–74|0.872|0.848|0.892
Observed|Thyroid cancer|2015–2019|Persons|4|75–79|0.814|0.781|0.843
Observed|Thyroid cancer|2015–2019|Persons|4|80–84|0.65|0.597|0.698
Observed|Thyroid cancer|2015–2019|Persons|4|85+|0.428|0.36|0.495
Observed|Thyroid cancer|2015–2019|Persons|4|All ages combined|0.941|0.937|0.945
Observed|Thyroid cancer|2015–2019|Persons|5|00–04|||
Observed|Thyroid cancer|2015–2019|Persons|5|05–09|||
Observed|Thyroid cancer|2015–2019|Persons|5|10–14|1|0.936|1
Observed|Thyroid cancer|2015–2019|Persons|5|15–19|0.994|0.957|0.999
Observed|Thyroid cancer|2015–2019|Persons|5|20–24|0.988|0.969|0.996
Observed|Thyroid cancer|2015–2019|Persons|5|25–29|0.989|0.978|0.995
Observed|Thyroid cancer|2015–2019|Persons|5|30–34|0.994|0.986|0.997
Observed|Thyroid cancer|2015–2019|Persons|5|35–39|0.988|0.98|0.993
Observed|Thyroid cancer|2015–2019|Persons|5|40–44|0.987|0.979|0.992
Observed|Thyroid cancer|2015–2019|Persons|5|45–49|0.974|0.965|0.981
Observed|Thyroid cancer|2015–2019|Persons|5|50–54|0.972|0.963|0.979
Observed|Thyroid cancer|2015–2019|Persons|5|55–59|0.946|0.934|0.956
Observed|Thyroid cancer|2015–2019|Persons|5|60–64|0.928|0.913|0.94
Observed|Thyroid cancer|2015–2019|Persons|5|65–69|0.9|0.883|0.915
Observed|Thyroid cancer|2015–2019|Persons|5|70–74|0.85|0.825|0.871
Observed|Thyroid cancer|2015–2019|Persons|5|75–79|0.77|0.733|0.802
Observed|Thyroid cancer|2015–2019|Persons|5|80–84|0.6|0.546|0.649
Observed|Thyroid cancer|2015–2019|Persons|5|85+|0.337|0.273|0.402
Observed|Thyroid cancer|2015–2019|Persons|5|All ages combined|0.931|0.927|0.935
Relative|Thyroid cancer|2015–2019|Persons|1|00–04|||
Relative|Thyroid cancer|2015–2019|Persons|1|05–09|||
Relative|Thyroid cancer|2015–2019|Persons|1|10–14|1|0.943|1
Relative|Thyroid cancer|2015–2019|Persons|1|15–19|1|0.984|1
Relative|Thyroid cancer|2015–2019|Persons|1|20–24|1|0.993|1
Relative|Thyroid cancer|2015–2019|Persons|1|25–29|0.995|0.985|0.998
Relative|Thyroid cancer|2015–2019|Persons|1|30–34|1|0.998|1
Relative|Thyroid cancer|2015–2019|Persons|1|35–39|0.998|0.993|1
Relative|Thyroid cancer|2015–2019|Persons|1|40–44|0.996|0.99|0.999
Relative|Thyroid cancer|2015–2019|Persons|1|45–49|0.994|0.988|0.997
Relative|Thyroid cancer|2015–2019|Persons|1|50–54|0.992|0.986|0.996
Relative|Thyroid cancer|2015–2019|Persons|1|55–59|0.986|0.979|0.992
Relative|Thyroid cancer|2015–2019|Persons|1|60–64|0.978|0.968|0.985
Relative|Thyroid cancer|2015–2019|Persons|1|65–69|0.975|0.965|0.983
Relative|Thyroid cancer|2015–2019|Persons|1|70–74|0.964|0.948|0.976
Relative|Thyroid cancer|2015–2019|Persons|1|75–79|0.945|0.921|0.964
Relative|Thyroid cancer|2015–2019|Persons|1|80–84|0.853|0.806|0.892
Relative|Thyroid cancer|2015–2019|Persons|1|85+|0.724|0.645|0.794
Relative|Thyroid cancer|2015–2019|Persons|1|All ages combined|0.981|0.978|0.983
Relative|Thyroid cancer|2015–2019|Persons|2|00–04|||
Relative|Thyroid cancer|2015–2019|Persons|2|05–09|||
Relative|Thyroid cancer|2015–2019|Persons|2|10–14|1|0.942|1
Relative|Thyroid cancer|2015–2019|Persons|2|15–19|1.001|0.984|1.001
Relative|Thyroid cancer|2015–2019|Persons|2|20–24|0.995|0.979|0.999
Relative|Thyroid cancer|2015–2019|Persons|2|25–29|0.995|0.985|0.999
Relative|Thyroid cancer|2015–2019|Persons|2|30–34|1|0.994|1.001
Relative|Thyroid cancer|2015–2019|Persons|2|35–39|0.995|0.988|0.998
Relative|Thyroid cancer|2015–2019|Persons|2|40–44|0.996|0.99|0.999
Relative|Thyroid cancer|2015–2019|Persons|2|45–49|0.989|0.982|0.994
Relative|Thyroid cancer|2015–2019|Persons|2|50–54|0.988|0.981|0.993
Relative|Thyroid cancer|2015–2019|Persons|2|55–59|0.98|0.971|0.987
Relative|Thyroid cancer|2015–2019|Persons|2|60–64|0.974|0.963|0.982
Relative|Thyroid cancer|2015–2019|Persons|2|65–69|0.966|0.953|0.976
Relative|Thyroid cancer|2015–2019|Persons|2|70–74|0.95|0.931|0.966
Relative|Thyroid cancer|2015–2019|Persons|2|75–79|0.934|0.905|0.957
Relative|Thyroid cancer|2015–2019|Persons|2|80–84|0.84|0.786|0.886
Relative|Thyroid cancer|2015–2019|Persons|2|85+|0.731|0.64|0.814
Relative|Thyroid cancer|2015–2019|Persons|2|All ages combined|0.976|0.972|0.979
Relative|Thyroid cancer|2015–2019|Persons|3|00–04|||
Relative|Thyroid cancer|2015–2019|Persons|3|05–09|||
Relative|Thyroid cancer|2015–2019|Persons|3|10–14|1|0.941|1
Relative|Thyroid cancer|2015–2019|Persons|3|15–19|1.001|0.984|1.001
Relative|Thyroid cancer|2015–2019|Persons|3|20–24|0.996|0.98|1
Relative|Thyroid cancer|2015–2019|Persons|3|25–29|0.995|0.986|0.999
Relative|Thyroid cancer|2015–2019|Persons|3|30–34|1|0.994|1.001
Relative|Thyroid cancer|2015–2019|Persons|3|35–39|0.992|0.984|0.997
Relative|Thyroid cancer|2015–2019|Persons|3|40–44|0.993|0.986|0.997
Relative|Thyroid cancer|2015–2019|Persons|3|45–49|0.988|0.981|0.994
Relative|Thyroid cancer|2015–2019|Persons|3|50–54|0.987|0.979|0.993
Relative|Thyroid cancer|2015–2019|Persons|3|55–59|0.974|0.964|0.983
Relative|Thyroid cancer|2015–2019|Persons|3|60–64|0.969|0.956|0.979
Relative|Thyroid cancer|2015–2019|Persons|3|65–69|0.961|0.947|0.974
Relative|Thyroid cancer|2015–2019|Persons|3|70–74|0.937|0.915|0.956
Relative|Thyroid cancer|2015–2019|Persons|3|75–79|0.93|0.898|0.958
Relative|Thyroid cancer|2015–2019|Persons|3|80–84|0.815|0.754|0.869
Relative|Thyroid cancer|2015–2019|Persons|3|85+|0.712|0.609|0.81
Relative|Thyroid cancer|2015–2019|Persons|3|All ages combined|0.972|0.968|0.975
Relative|Thyroid cancer|2015–2019|Persons|4|00–04|||
Relative|Thyroid cancer|2015–2019|Persons|4|05–09|||
Relative|Thyroid cancer|2015–2019|Persons|4|10–14|1.001|0.939|1.001
Relative|Thyroid cancer|2015–2019|Persons|4|15–19|0.995|0.958|1
Relative|Thyroid cancer|2015–2019|Persons|4|20–24|0.993|0.976|0.999
Relative|Thyroid cancer|2015–2019|Persons|4|25–29|0.991|0.979|0.997
Relative|Thyroid cancer|2015–2019|Persons|4|30–34|0.997|0.989|1
Relative|Thyroid cancer|2015–2019|Persons|4|35–39|0.992|0.984|0.997
Relative|Thyroid cancer|2015–2019|Persons|4|40–44|0.993|0.986|0.998
Relative|Thyroid cancer|2015–2019|Persons|4|45–49|0.986|0.978|0.992
Relative|Thyroid cancer|2015–2019|Persons|4|50–54|0.986|0.978|0.993
Relative|Thyroid cancer|2015–2019|Persons|4|55–59|0.97|0.958|0.979
Relative|Thyroid cancer|2015–2019|Persons|4|60–64|0.964|0.95|0.975
Relative|Thyroid cancer|2015–2019|Persons|4|65–69|0.954|0.937|0.968
Relative|Thyroid cancer|2015–2019|Persons|4|70–74|0.934|0.909|0.955
Relative|Thyroid cancer|2015–2019|Persons|4|75–79|0.919|0.881|0.951
Relative|Thyroid cancer|2015–2019|Persons|4|80–84|0.824|0.757|0.885
Relative|Thyroid cancer|2015–2019|Persons|4|85+|0.735|0.618|0.85
Relative|Thyroid cancer|2015–2019|Persons|4|All ages combined|0.969|0.965|0.973
Relative|Thyroid cancer|2015–2019|Persons|5|00–04|||
Relative|Thyroid cancer|2015–2019|Persons|5|05–09|||
Relative|Thyroid cancer|2015–2019|Persons|5|10–14|1.001|0.937|1.001
Relative|Thyroid cancer|2015–2019|Persons|5|15–19|0.995|0.958|1.001
Relative|Thyroid cancer|2015–2019|Persons|5|20–24|0.99|0.971|0.997
Relative|Thyroid cancer|2015–2019|Persons|5|25–29|0.991|0.98|0.997
Relative|Thyroid cancer|2015–2019|Persons|5|30–34|0.996|0.989|1
Relative|Thyroid cancer|2015–2019|Persons|5|35–39|0.992|0.984|0.997
Relative|Thyroid cancer|2015–2019|Persons|5|40–44|0.993|0.986|0.998
Relative|Thyroid cancer|2015–2019|Persons|5|45–49|0.984|0.975|0.991
Relative|Thyroid cancer|2015–2019|Persons|5|50–54|0.986|0.977|0.993
Relative|Thyroid cancer|2015–2019|Persons|5|55–59|0.967|0.954|0.977
Relative|Thyroid cancer|2015–2019|Persons|5|60–64|0.959|0.944|0.972
Relative|Thyroid cancer|2015–2019|Persons|5|65–69|0.95|0.932|0.966
Relative|Thyroid cancer|2015–2019|Persons|5|70–74|0.931|0.903|0.955
Relative|Thyroid cancer|2015–2019|Persons|5|75–79|0.905|0.862|0.943
Relative|Thyroid cancer|2015–2019|Persons|5|80–84|0.824|0.75|0.892
Relative|Thyroid cancer|2015–2019|Persons|5|85+|0.685|0.555|0.818
Relative|Thyroid cancer|2015–2019|Persons|5|All ages combined|0.967|0.962|0.971
Observed|Tongue cancer|2015–2019|Males|1|00–04|||
Observed|Tongue cancer|2015–2019|Males|1|05–09|||
Observed|Tongue cancer|2015–2019|Males|1|10–14|||
Observed|Tongue cancer|2015–2019|Males|1|15–19|||
Observed|Tongue cancer|2015–2019|Males|1|20–24|||
Observed|Tongue cancer|2015–2019|Males|1|25–29|||
Observed|Tongue cancer|2015–2019|Males|1|30–34|0.87|0.69|0.949
Observed|Tongue cancer|2015–2019|Males|1|35–39|0.933|0.805|0.978
Observed|Tongue cancer|2015–2019|Males|1|40–44|0.972|0.892|0.993
Observed|Tongue cancer|2015–2019|Males|1|45–49|0.933|0.886|0.962
Observed|Tongue cancer|2015–2019|Males|1|50–54|0.939|0.909|0.959
Observed|Tongue cancer|2015–2019|Males|1|55–59|0.929|0.903|0.948
Observed|Tongue cancer|2015–2019|Males|1|60–64|0.876|0.849|0.899
Observed|Tongue cancer|2015–2019|Males|1|65–69|0.828|0.795|0.855
Observed|Tongue cancer|2015–2019|Males|1|70–74|0.826|0.786|0.86
Observed|Tongue cancer|2015–2019|Males|1|75–79|0.738|0.683|0.785
Observed|Tongue cancer|2015–2019|Males|1|80–84|0.666|0.585|0.735
Observed|Tongue cancer|2015–2019|Males|1|85+|0.513|0.404|0.612
Observed|Tongue cancer|2015–2019|Males|1|All ages combined|0.853|0.841|0.864
Observed|Tongue cancer|2015–2019|Males|2|00–04|||
Observed|Tongue cancer|2015–2019|Males|2|05–09|||
Observed|Tongue cancer|2015–2019|Males|2|10–14|||
Observed|Tongue cancer|2015–2019|Males|2|15–19|||
Observed|Tongue cancer|2015–2019|Males|2|20–24|||
Observed|Tongue cancer|2015–2019|Males|2|25–29|||
Observed|Tongue cancer|2015–2019|Males|2|30–34|0.837|0.652|0.929
Observed|Tongue cancer|2015–2019|Males|2|35–39|0.832|0.679|0.916
Observed|Tongue cancer|2015–2019|Males|2|40–44|0.917|0.824|0.962
Observed|Tongue cancer|2015–2019|Males|2|45–49|0.87|0.812|0.911
Observed|Tongue cancer|2015–2019|Males|2|50–54|0.849|0.809|0.881
Observed|Tongue cancer|2015–2019|Males|2|55–59|0.861|0.828|0.888
Observed|Tongue cancer|2015–2019|Males|2|60–64|0.807|0.774|0.835
Observed|Tongue cancer|2015–2019|Males|2|65–69|0.73|0.692|0.764
Observed|Tongue cancer|2015–2019|Males|2|70–74|0.716|0.668|0.758
Observed|Tongue cancer|2015–2019|Males|2|75–79|0.673|0.614|0.724
Observed|Tongue cancer|2015–2019|Males|2|80–84|0.536|0.451|0.614
Observed|Tongue cancer|2015–2019|Males|2|85+|0.453|0.346|0.554
Observed|Tongue cancer|2015–2019|Males|2|All ages combined|0.771|0.757|0.785
Observed|Tongue cancer|2015–2019|Males|3|00–04|||
Observed|Tongue cancer|2015–2019|Males|3|05–09|||
Observed|Tongue cancer|2015–2019|Males|3|10–14|||
Observed|Tongue cancer|2015–2019|Males|3|15–19|||
Observed|Tongue cancer|2015–2019|Males|3|20–24|||
Observed|Tongue cancer|2015–2019|Males|3|25–29|||
Observed|Tongue cancer|2015–2019|Males|3|30–34|0.837|0.652|0.929
Observed|Tongue cancer|2015–2019|Males|3|35–39|0.782|0.623|0.881
Observed|Tongue cancer|2015–2019|Males|3|40–44|0.891|0.794|0.944
Observed|Tongue cancer|2015–2019|Males|3|45–49|0.821|0.759|0.869
Observed|Tongue cancer|2015–2019|Males|3|50–54|0.82|0.777|0.855
Observed|Tongue cancer|2015–2019|Males|3|55–59|0.801|0.763|0.833
Observed|Tongue cancer|2015–2019|Males|3|60–64|0.756|0.72|0.788
Observed|Tongue cancer|2015–2019|Males|3|65–69|0.674|0.634|0.711
Observed|Tongue cancer|2015–2019|Males|3|70–74|0.658|0.607|0.705
Observed|Tongue cancer|2015–2019|Males|3|75–79|0.581|0.519|0.637
Observed|Tongue cancer|2015–2019|Males|3|80–84|0.44|0.354|0.522
Observed|Tongue cancer|2015–2019|Males|3|85+|0.372|0.272|0.473
Observed|Tongue cancer|2015–2019|Males|3|All ages combined|0.717|0.701|0.732
Observed|Tongue cancer|2015–2019|Males|4|00–04|||
Observed|Tongue cancer|2015–2019|Males|4|05–09|||
Observed|Tongue cancer|2015–2019|Males|4|10–14|||
Observed|Tongue cancer|2015–2019|Males|4|15–19|||
Observed|Tongue cancer|2015–2019|Males|4|20–24|||
Observed|Tongue cancer|2015–2019|Males|4|25–29|||
Observed|Tongue cancer|2015–2019|Males|4|30–34|0.837|0.652|0.929
Observed|Tongue cancer|2015–2019|Males|4|35–39|0.782|0.623|0.881
Observed|Tongue cancer|2015–2019|Males|4|40–44|0.891|0.794|0.944
Observed|Tongue cancer|2015–2019|Males|4|45–49|0.793|0.729|0.844
Observed|Tongue cancer|2015–2019|Males|4|50–54|0.795|0.751|0.833
Observed|Tongue cancer|2015–2019|Males|4|55–59|0.742|0.7|0.778
Observed|Tongue cancer|2015–2019|Males|4|60–64|0.716|0.678|0.751
Observed|Tongue cancer|2015–2019|Males|4|65–69|0.626|0.585|0.665
Observed|Tongue cancer|2015–2019|Males|4|70–74|0.607|0.553|0.656
Observed|Tongue cancer|2015–2019|Males|4|75–79|0.516|0.452|0.576
Observed|Tongue cancer|2015–2019|Males|4|80–84|0.403|0.318|0.487
Observed|Tongue cancer|2015–2019|Males|4|85+|0.289|0.197|0.386
Observed|Tongue cancer|2015–2019|Males|4|All ages combined|0.674|0.657|0.69
Observed|Tongue cancer|2015–2019|Males|5|00–04|||
Observed|Tongue cancer|2015–2019|Males|5|05–09|||
Observed|Tongue cancer|2015–2019|Males|5|10–14|||
Observed|Tongue cancer|2015–2019|Males|5|15–19|||
Observed|Tongue cancer|2015–2019|Males|5|20–24|||
Observed|Tongue cancer|2015–2019|Males|5|25–29|||
Observed|Tongue cancer|2015–2019|Males|5|30–34|0.837|0.652|0.929
Observed|Tongue cancer|2015–2019|Males|5|35–39|0.725|0.556|0.838
Observed|Tongue cancer|2015–2019|Males|5|40–44|0.879|0.781|0.935
Observed|Tongue cancer|2015–2019|Males|5|45–49|0.779|0.714|0.831
Observed|Tongue cancer|2015–2019|Males|5|50–54|0.779|0.733|0.817
Observed|Tongue cancer|2015–2019|Males|5|55–59|0.707|0.664|0.745
Observed|Tongue cancer|2015–2019|Males|5|60–64|0.693|0.653|0.728
Observed|Tongue cancer|2015–2019|Males|5|65–69|0.594|0.552|0.634
Observed|Tongue cancer|2015–2019|Males|5|70–74|0.551|0.496|0.603
Observed|Tongue cancer|2015–2019|Males|5|75–79|0.46|0.394|0.523
Observed|Tongue cancer|2015–2019|Males|5|80–84|0.306|0.227|0.389
Observed|Tongue cancer|2015–2019|Males|5|85+|0.227|0.145|0.321
Observed|Tongue cancer|2015–2019|Males|5|All ages combined|0.64|0.623|0.656
Relative|Tongue cancer|2015–2019|Males|1|00–04|||
Relative|Tongue cancer|2015–2019|Males|1|05–09|||
Relative|Tongue cancer|2015–2019|Males|1|10–14|||
Relative|Tongue cancer|2015–2019|Males|1|15–19|||
Relative|Tongue cancer|2015–2019|Males|1|20–24|||
Relative|Tongue cancer|2015–2019|Males|1|25–29|||
Relative|Tongue cancer|2015–2019|Males|1|30–34|0.871|0.69|0.95
Relative|Tongue cancer|2015–2019|Males|1|35–39|0.934|0.806|0.979
Relative|Tongue cancer|2015–2019|Males|1|40–44|0.973|0.894|0.995
Relative|Tongue cancer|2015–2019|Males|1|45–49|0.936|0.888|0.964
Relative|Tongue cancer|2015–2019|Males|1|50–54|0.942|0.912|0.962
Relative|Tongue cancer|2015–2019|Males|1|55–59|0.934|0.908|0.953
Relative|Tongue cancer|2015–2019|Males|1|60–64|0.883|0.855|0.906
Relative|Tongue cancer|2015–2019|Males|1|65–69|0.838|0.805|0.866
Relative|Tongue cancer|2015–2019|Males|1|70–74|0.842|0.801|0.876
Relative|Tongue cancer|2015–2019|Males|1|75–79|0.762|0.706|0.811
Relative|Tongue cancer|2015–2019|Males|1|80–84|0.706|0.62|0.779
Relative|Tongue cancer|2015–2019|Males|1|85+|0.586|0.461|0.698
Relative|Tongue cancer|2015–2019|Males|1|All ages combined|0.866|0.854|0.878
Relative|Tongue cancer|2015–2019|Males|2|00–04|||
Relative|Tongue cancer|2015–2019|Males|2|05–09|||
Relative|Tongue cancer|2015–2019|Males|2|10–14|||
Relative|Tongue cancer|2015–2019|Males|2|15–19|||
Relative|Tongue cancer|2015–2019|Males|2|20–24|||
Relative|Tongue cancer|2015–2019|Males|2|25–29|||
Relative|Tongue cancer|2015–2019|Males|2|30–34|0.839|0.653|0.93
Relative|Tongue cancer|2015–2019|Males|2|35–39|0.834|0.681|0.919
Relative|Tongue cancer|2015–2019|Males|2|40–44|0.92|0.827|0.965
Relative|Tongue cancer|2015–2019|Males|2|45–49|0.874|0.816|0.915
Relative|Tongue cancer|2015–2019|Males|2|50–54|0.855|0.815|0.888
Relative|Tongue cancer|2015–2019|Males|2|55–59|0.871|0.837|0.898
Relative|Tongue cancer|2015–2019|Males|2|60–64|0.82|0.787|0.849
Relative|Tongue cancer|2015–2019|Males|2|65–69|0.748|0.71|0.783
Relative|Tongue cancer|2015–2019|Males|2|70–74|0.745|0.695|0.789
Relative|Tongue cancer|2015–2019|Males|2|75–79|0.721|0.659|0.777
Relative|Tongue cancer|2015–2019|Males|2|80–84|0.607|0.51|0.695
Relative|Tongue cancer|2015–2019|Males|2|85+|0.601|0.46|0.735
Relative|Tongue cancer|2015–2019|Males|2|All ages combined|0.795|0.78|0.809
Relative|Tongue cancer|2015–2019|Males|3|00–04|||
Relative|Tongue cancer|2015–2019|Males|3|05–09|||
Relative|Tongue cancer|2015–2019|Males|3|10–14|||
Relative|Tongue cancer|2015–2019|Males|3|15–19|||
Relative|Tongue cancer|2015–2019|Males|3|20–24|||
Relative|Tongue cancer|2015–2019|Males|3|25–29|||
Relative|Tongue cancer|2015–2019|Males|3|30–34|0.839|0.654|0.931
Relative|Tongue cancer|2015–2019|Males|3|35–39|0.785|0.625|0.884
Relative|Tongue cancer|2015–2019|Males|3|40–44|0.896|0.798|0.949
Relative|Tongue cancer|2015–2019|Males|3|45–49|0.827|0.765|0.875
Relative|Tongue cancer|2015–2019|Males|3|50–54|0.829|0.786|0.865
Relative|Tongue cancer|2015–2019|Males|3|55–59|0.815|0.777|0.848
Relative|Tongue cancer|2015–2019|Males|3|60–64|0.776|0.739|0.809
Relative|Tongue cancer|2015–2019|Males|3|65–69|0.701|0.66|0.739
Relative|Tongue cancer|2015–2019|Males|3|70–74|0.702|0.647|0.751
Relative|Tongue cancer|2015–2019|Males|3|75–79|0.649|0.58|0.712
Relative|Tongue cancer|2015–2019|Males|3|80–84|0.537|0.432|0.637
Relative|Tongue cancer|2015–2019|Males|3|85+|0.584|0.426|0.742
Relative|Tongue cancer|2015–2019|Males|3|All ages combined|0.75|0.734|0.766
Relative|Tongue cancer|2015–2019|Males|4|00–04|||
Relative|Tongue cancer|2015–2019|Males|4|05–09|||
Relative|Tongue cancer|2015–2019|Males|4|10–14|||
Relative|Tongue cancer|2015–2019|Males|4|15–19|||
Relative|Tongue cancer|2015–2019|Males|4|20–24|||
Relative|Tongue cancer|2015–2019|Males|4|25–29|||
Relative|Tongue cancer|2015–2019|Males|4|30–34|0.84|0.655|0.932
Relative|Tongue cancer|2015–2019|Males|4|35–39|0.786|0.626|0.885
Relative|Tongue cancer|2015–2019|Males|4|40–44|0.898|0.8|0.951
Relative|Tongue cancer|2015–2019|Males|4|45–49|0.802|0.737|0.853
Relative|Tongue cancer|2015–2019|Males|4|50–54|0.808|0.763|0.846
Relative|Tongue cancer|2015–2019|Males|4|55–59|0.76|0.717|0.797
Relative|Tongue cancer|2015–2019|Males|4|60–64|0.742|0.703|0.778
Relative|Tongue cancer|2015–2019|Males|4|65–69|0.662|0.618|0.702
Relative|Tongue cancer|2015–2019|Males|4|70–74|0.664|0.605|0.718
Relative|Tongue cancer|2015–2019|Males|4|75–79|0.605|0.53|0.675
Relative|Tongue cancer|2015–2019|Males|4|80–84|0.538|0.424|0.649
Relative|Tongue cancer|2015–2019|Males|4|85+|0.541|0.37|0.724
Relative|Tongue cancer|2015–2019|Males|4|All ages combined|0.717|0.699|0.734
Relative|Tongue cancer|2015–2019|Males|5|00–04|||
Relative|Tongue cancer|2015–2019|Males|5|05–09|||
Relative|Tongue cancer|2015–2019|Males|5|10–14|||
Relative|Tongue cancer|2015–2019|Males|5|15–19|||
Relative|Tongue cancer|2015–2019|Males|5|20–24|||
Relative|Tongue cancer|2015–2019|Males|5|25–29|||
Relative|Tongue cancer|2015–2019|Males|5|30–34|0.841|0.655|0.933
Relative|Tongue cancer|2015–2019|Males|5|35–39|0.73|0.56|0.844
Relative|Tongue cancer|2015–2019|Males|5|40–44|0.888|0.788|0.944
Relative|Tongue cancer|2015–2019|Males|5|45–49|0.79|0.724|0.842
Relative|Tongue cancer|2015–2019|Males|5|50–54|0.795|0.748|0.835
Relative|Tongue cancer|2015–2019|Males|5|55–59|0.729|0.685|0.769
Relative|Tongue cancer|2015–2019|Males|5|60–64|0.726|0.685|0.763
Relative|Tongue cancer|2015–2019|Males|5|65–69|0.639|0.593|0.681
Relative|Tongue cancer|2015–2019|Males|5|70–74|0.621|0.558|0.679
Relative|Tongue cancer|2015–2019|Males|5|75–79|0.567|0.486|0.645
Relative|Tongue cancer|2015–2019|Males|5|80–84|0.45|0.334|0.571
Relative|Tongue cancer|2015–2019|Males|5|85+|0.519|0.331|0.733
Relative|Tongue cancer|2015–2019|Males|5|All ages combined|0.692|0.674|0.71
Observed|Tongue cancer|2015–2019|Females|1|00–04|||
Observed|Tongue cancer|2015–2019|Females|1|05–09|||
Observed|Tongue cancer|2015–2019|Females|1|10–14|||
Observed|Tongue cancer|2015–2019|Females|1|15–19|||
Observed|Tongue cancer|2015–2019|Females|1|20–24|||
Observed|Tongue cancer|2015–2019|Females|1|25–29|||
Observed|Tongue cancer|2015–2019|Females|1|30–34|0.916|0.704|0.978
Observed|Tongue cancer|2015–2019|Females|1|35–39|0.969|0.8|0.996
Observed|Tongue cancer|2015–2019|Females|1|40–44|0.957|0.84|0.989
Observed|Tongue cancer|2015–2019|Females|1|45–49|0.977|0.913|0.994
Observed|Tongue cancer|2015–2019|Females|1|50–54|0.889|0.822|0.931
Observed|Tongue cancer|2015–2019|Females|1|55–59|0.924|0.872|0.955
Observed|Tongue cancer|2015–2019|Females|1|60–64|0.902|0.851|0.937
Observed|Tongue cancer|2015–2019|Females|1|65–69|0.908|0.858|0.941
Observed|Tongue cancer|2015–2019|Females|1|70–74|0.817|0.751|0.868
Observed|Tongue cancer|2015–2019|Females|1|75–79|0.835|0.764|0.886
Observed|Tongue cancer|2015–2019|Females|1|80–84|0.664|0.559|0.75
Observed|Tongue cancer|2015–2019|Females|1|85+|0.515|0.428|0.596
Observed|Tongue cancer|2015–2019|Females|1|All ages combined|0.844|0.825|0.862
Observed|Tongue cancer|2015–2019|Females|2|00–04|||
Observed|Tongue cancer|2015–2019|Females|2|05–09|||
Observed|Tongue cancer|2015–2019|Females|2|10–14|||
Observed|Tongue cancer|2015–2019|Females|2|15–19|||
Observed|Tongue cancer|2015–2019|Females|2|20–24|||
Observed|Tongue cancer|2015–2019|Females|2|25–29|||
Observed|Tongue cancer|2015–2019|Females|2|30–34|0.877|0.666|0.959
Observed|Tongue cancer|2015–2019|Females|2|35–39|0.879|0.71|0.953
Observed|Tongue cancer|2015–2019|Females|2|40–44|0.878|0.748|0.943
Observed|Tongue cancer|2015–2019|Females|2|45–49|0.953|0.88|0.982
Observed|Tongue cancer|2015–2019|Females|2|50–54|0.842|0.768|0.894
Observed|Tongue cancer|2015–2019|Females|2|55–59|0.836|0.77|0.885
Observed|Tongue cancer|2015–2019|Females|2|60–64|0.832|0.77|0.878
Observed|Tongue cancer|2015–2019|Females|2|65–69|0.841|0.78|0.886
Observed|Tongue cancer|2015–2019|Females|2|70–74|0.71|0.634|0.773
Observed|Tongue cancer|2015–2019|Females|2|75–79|0.763|0.683|0.826
Observed|Tongue cancer|2015–2019|Females|2|80–84|0.517|0.41|0.613
Observed|Tongue cancer|2015–2019|Females|2|85+|0.409|0.325|0.491
Observed|Tongue cancer|2015–2019|Females|2|All ages combined|0.766|0.743|0.787
Observed|Tongue cancer|2015–2019|Females|3|00–04|||
Observed|Tongue cancer|2015–2019|Females|3|05–09|||
Observed|Tongue cancer|2015–2019|Females|3|10–14|||
Observed|Tongue cancer|2015–2019|Females|3|15–19|||
Observed|Tongue cancer|2015–2019|Females|3|20–24|||
Observed|Tongue cancer|2015–2019|Females|3|25–29|||
Observed|Tongue cancer|2015–2019|Females|3|30–34|0.877|0.666|0.959
Observed|Tongue cancer|2015–2019|Females|3|35–39|0.879|0.71|0.953
Observed|Tongue cancer|2015–2019|Females|3|40–44|0.859|0.728|0.93
Observed|Tongue cancer|2015–2019|Females|3|45–49|0.929|0.849|0.968
Observed|Tongue cancer|2015–2019|Females|3|50–54|0.797|0.718|0.856
Observed|Tongue cancer|2015–2019|Females|3|55–59|0.77|0.697|0.828
Observed|Tongue cancer|2015–2019|Females|3|60–64|0.8|0.735|0.85
Observed|Tongue cancer|2015–2019|Females|3|65–69|0.787|0.719|0.84
Observed|Tongue cancer|2015–2019|Females|3|70–74|0.665|0.586|0.731
Observed|Tongue cancer|2015–2019|Females|3|75–79|0.664|0.577|0.738
Observed|Tongue cancer|2015–2019|Females|3|80–84|0.468|0.364|0.565
Observed|Tongue cancer|2015–2019|Females|3|85+|0.336|0.258|0.416
Observed|Tongue cancer|2015–2019|Females|3|All ages combined|0.716|0.692|0.739
Observed|Tongue cancer|2015–2019|Females|4|00–04|||
Observed|Tongue cancer|2015–2019|Females|4|05–09|||
Observed|Tongue cancer|2015–2019|Females|4|10–14|||
Observed|Tongue cancer|2015–2019|Females|4|15–19|||
Observed|Tongue cancer|2015–2019|Females|4|20–24|||
Observed|Tongue cancer|2015–2019|Females|4|25–29|||
Observed|Tongue cancer|2015–2019|Females|4|30–34|0.877|0.666|0.959
Observed|Tongue cancer|2015–2019|Females|4|35–39|0.842|0.66|0.932
Observed|Tongue cancer|2015–2019|Females|4|40–44|0.792|0.656|0.879
Observed|Tongue cancer|2015–2019|Females|4|45–49|0.884|0.795|0.936
Observed|Tongue cancer|2015–2019|Females|4|50–54|0.751|0.669|0.816
Observed|Tongue cancer|2015–2019|Females|4|55–59|0.756|0.681|0.816
Observed|Tongue cancer|2015–2019|Females|4|60–64|0.771|0.704|0.825
Observed|Tongue cancer|2015–2019|Females|4|65–69|0.78|0.711|0.834
Observed|Tongue cancer|2015–2019|Females|4|70–74|0.638|0.559|0.707
Observed|Tongue cancer|2015–2019|Females|4|75–79|0.624|0.535|0.701
Observed|Tongue cancer|2015–2019|Females|4|80–84|0.41|0.311|0.507
Observed|Tongue cancer|2015–2019|Females|4|85+|0.276|0.204|0.353
Observed|Tongue cancer|2015–2019|Females|4|All ages combined|0.681|0.656|0.705
Observed|Tongue cancer|2015–2019|Females|5|00–04|||
Observed|Tongue cancer|2015–2019|Females|5|05–09|||
Observed|Tongue cancer|2015–2019|Females|5|10–14|||
Observed|Tongue cancer|2015–2019|Females|5|15–19|||
Observed|Tongue cancer|2015–2019|Females|5|20–24|||
Observed|Tongue cancer|2015–2019|Females|5|25–29|||
Observed|Tongue cancer|2015–2019|Females|5|30–34|||
Observed|Tongue cancer|2015–2019|Females|5|35–39|0.809|0.621|0.91
Observed|Tongue cancer|2015–2019|Females|5|40–44|0.792|0.656|0.879
Observed|Tongue cancer|2015–2019|Females|5|45–49|0.884|0.795|0.936
Observed|Tongue cancer|2015–2019|Females|5|50–54|0.751|0.669|0.816
Observed|Tongue cancer|2015–2019|Females|5|55–59|0.739|0.662|0.801
Observed|Tongue cancer|2015–2019|Females|5|60–64|0.759|0.691|0.814
Observed|Tongue cancer|2015–2019|Females|5|65–69|0.764|0.693|0.82
Observed|Tongue cancer|2015–2019|Females|5|70–74|0.561|0.48|0.635
Observed|Tongue cancer|2015–2019|Females|5|75–79|0.582|0.492|0.662
Observed|Tongue cancer|2015–2019|Females|5|80–84|0.335|0.244|0.428
Observed|Tongue cancer|2015–2019|Females|5|85+|0.225|0.159|0.298
Observed|Tongue cancer|2015–2019|Females|5|All ages combined|0.651|0.625|0.675
Relative|Tongue cancer|2015–2019|Females|1|00–04|||
Relative|Tongue cancer|2015–2019|Females|1|05–09|||
Relative|Tongue cancer|2015–2019|Females|1|10–14|||
Relative|Tongue cancer|2015–2019|Females|1|15–19|||
Relative|Tongue cancer|2015–2019|Females|1|20–24|||
Relative|Tongue cancer|2015–2019|Females|1|25–29|||
Relative|Tongue cancer|2015–2019|Females|1|30–34|0.916|0.704|0.979
Relative|Tongue cancer|2015–2019|Females|1|35–39|0.97|0.8|0.996
Relative|Tongue cancer|2015–2019|Females|1|40–44|0.958|0.84|0.99
Relative|Tongue cancer|2015–2019|Females|1|45–49|0.979|0.914|0.996
Relative|Tongue cancer|2015–2019|Females|1|50–54|0.891|0.824|0.933
Relative|Tongue cancer|2015–2019|Females|1|55–59|0.927|0.875|0.958
Relative|Tongue cancer|2015–2019|Females|1|60–64|0.907|0.855|0.941
Relative|Tongue cancer|2015–2019|Females|1|65–69|0.915|0.865|0.948
Relative|Tongue cancer|2015–2019|Females|1|70–74|0.827|0.76|0.878
Relative|Tongue cancer|2015–2019|Females|1|75–79|0.853|0.781|0.905
Relative|Tongue cancer|2015–2019|Females|1|80–84|0.693|0.583|0.782
Relative|Tongue cancer|2015–2019|Females|1|85+|0.579|0.481|0.67
Relative|Tongue cancer|2015–2019|Females|1|All ages combined|0.86|0.84|0.878
Relative|Tongue cancer|2015–2019|Females|2|00–04|||
Relative|Tongue cancer|2015–2019|Females|2|05–09|||
Relative|Tongue cancer|2015–2019|Females|2|10–14|||
Relative|Tongue cancer|2015–2019|Females|2|15–19|||
Relative|Tongue cancer|2015–2019|Females|2|20–24|||
Relative|Tongue cancer|2015–2019|Females|2|25–29|||
Relative|Tongue cancer|2015–2019|Females|2|30–34|0.878|0.666|0.959
Relative|Tongue cancer|2015–2019|Females|2|35–39|0.881|0.711|0.954
Relative|Tongue cancer|2015–2019|Females|2|40–44|0.879|0.749|0.945
Relative|Tongue cancer|2015–2019|Females|2|45–49|0.956|0.882|0.985
Relative|Tongue cancer|2015–2019|Females|2|50–54|0.846|0.771|0.898
Relative|Tongue cancer|2015–2019|Females|2|55–59|0.842|0.775|0.891
Relative|Tongue cancer|2015–2019|Females|2|60–64|0.84|0.778|0.886
Relative|Tongue cancer|2015–2019|Females|2|65–69|0.854|0.792|0.9
Relative|Tongue cancer|2015–2019|Females|2|70–74|0.729|0.651|0.793
Relative|Tongue cancer|2015–2019|Females|2|75–79|0.799|0.716|0.865
Relative|Tongue cancer|2015–2019|Females|2|80–84|0.566|0.449|0.672
Relative|Tongue cancer|2015–2019|Females|2|85+|0.525|0.418|0.63
Relative|Tongue cancer|2015–2019|Females|2|All ages combined|0.793|0.769|0.815
Relative|Tongue cancer|2015–2019|Females|3|00–04|||
Relative|Tongue cancer|2015–2019|Females|3|05–09|||
Relative|Tongue cancer|2015–2019|Females|3|10–14|||
Relative|Tongue cancer|2015–2019|Females|3|15–19|||
Relative|Tongue cancer|2015–2019|Females|3|20–24|||
Relative|Tongue cancer|2015–2019|Females|3|25–29|||
Relative|Tongue cancer|2015–2019|Females|3|30–34|0.878|0.667|0.96
Relative|Tongue cancer|2015–2019|Females|3|35–39|0.881|0.712|0.955
Relative|Tongue cancer|2015–2019|Females|3|40–44|0.862|0.73|0.933
Relative|Tongue cancer|2015–2019|Females|3|45–49|0.933|0.853|0.972
Relative|Tongue cancer|2015–2019|Females|3|50–54|0.802|0.723|0.862
Relative|Tongue cancer|2015–2019|Females|3|55–59|0.778|0.704|0.836
Relative|Tongue cancer|2015–2019|Females|3|60–64|0.812|0.747|0.863
Relative|Tongue cancer|2015–2019|Females|3|65–69|0.806|0.737|0.86
Relative|Tongue cancer|2015–2019|Females|3|70–74|0.693|0.611|0.762
Relative|Tongue cancer|2015–2019|Females|3|75–79|0.716|0.621|0.795
Relative|Tongue cancer|2015–2019|Females|3|80–84|0.541|0.421|0.653
Relative|Tongue cancer|2015–2019|Females|3|85+|0.501|0.384|0.619
Relative|Tongue cancer|2015–2019|Females|3|All ages combined|0.754|0.729|0.778
Relative|Tongue cancer|2015–2019|Females|4|00–04|||
Relative|Tongue cancer|2015–2019|Females|4|05–09|||
Relative|Tongue cancer|2015–2019|Females|4|10–14|||
Relative|Tongue cancer|2015–2019|Females|4|15–19|||
Relative|Tongue cancer|2015–2019|Females|4|20–24|||
Relative|Tongue cancer|2015–2019|Females|4|25–29|||
Relative|Tongue cancer|2015–2019|Females|4|30–34|0.879|0.667|0.96
Relative|Tongue cancer|2015–2019|Females|4|35–39|0.845|0.662|0.934
Relative|Tongue cancer|2015–2019|Females|4|40–44|0.795|0.659|0.882
Relative|Tongue cancer|2015–2019|Females|4|45–49|0.89|0.8|0.942
Relative|Tongue cancer|2015–2019|Females|4|50–54|0.759|0.675|0.824
Relative|Tongue cancer|2015–2019|Females|4|55–59|0.767|0.691|0.827
Relative|Tongue cancer|2015–2019|Females|4|60–64|0.788|0.72|0.843
Relative|Tongue cancer|2015–2019|Females|4|65–69|0.806|0.736|0.862
Relative|Tongue cancer|2015–2019|Females|4|70–74|0.677|0.592|0.75
Relative|Tongue cancer|2015–2019|Females|4|75–79|0.694|0.595|0.78
Relative|Tongue cancer|2015–2019|Females|4|80–84|0.506|0.383|0.624
Relative|Tongue cancer|2015–2019|Females|4|85+|0.486|0.359|0.622
Relative|Tongue cancer|2015–2019|Females|4|All ages combined|0.731|0.704|0.756
Relative|Tongue cancer|2015–2019|Females|5|00–04|||
Relative|Tongue cancer|2015–2019|Females|5|05–09|||
Relative|Tongue cancer|2015–2019|Females|5|10–14|||
Relative|Tongue cancer|2015–2019|Females|5|15–19|||
Relative|Tongue cancer|2015–2019|Females|5|20–24|||
Relative|Tongue cancer|2015–2019|Females|5|25–29|||
Relative|Tongue cancer|2015–2019|Females|5|30–34|||
Relative|Tongue cancer|2015–2019|Females|5|35–39|0.812|0.624|0.913
Relative|Tongue cancer|2015–2019|Females|5|40–44|0.796|0.659|0.884
Relative|Tongue cancer|2015–2019|Females|5|45–49|0.892|0.802|0.944
Relative|Tongue cancer|2015–2019|Females|5|50–54|0.761|0.677|0.827
Relative|Tongue cancer|2015–2019|Females|5|55–59|0.753|0.674|0.816
Relative|Tongue cancer|2015–2019|Females|5|60–64|0.781|0.71|0.837
Relative|Tongue cancer|2015–2019|Females|5|65–69|0.798|0.724|0.857
Relative|Tongue cancer|2015–2019|Females|5|70–74|0.607|0.519|0.687
Relative|Tongue cancer|2015–2019|Females|5|75–79|0.671|0.567|0.763
Relative|Tongue cancer|2015–2019|Females|5|80–84|0.444|0.323|0.568
Relative|Tongue cancer|2015–2019|Females|5|85+|0.475|0.335|0.63
Relative|Tongue cancer|2015–2019|Females|5|All ages combined|0.712|0.684|0.739
Observed|Tongue cancer|2015–2019|Persons|1|00–04|||
Observed|Tongue cancer|2015–2019|Persons|1|05–09|||
Observed|Tongue cancer|2015–2019|Persons|1|10–14|||
Observed|Tongue cancer|2015–2019|Persons|1|15–19|||
Observed|Tongue cancer|2015–2019|Persons|1|20–24|||
Observed|Tongue cancer|2015–2019|Persons|1|25–29|0.867|0.709|0.942
Observed|Tongue cancer|2015–2019|Persons|1|30–34|0.89|0.771|0.949
Observed|Tongue cancer|2015–2019|Persons|1|35–39|0.948|0.867|0.98
Observed|Tongue cancer|2015–2019|Persons|1|40–44|0.966|0.912|0.987
Observed|Tongue cancer|2015–2019|Persons|1|45–49|0.948|0.914|0.969
Observed|Tongue cancer|2015–2019|Persons|1|50–54|0.925|0.899|0.945
Observed|Tongue cancer|2015–2019|Persons|1|55–59|0.927|0.905|0.945
Observed|Tongue cancer|2015–2019|Persons|1|60–64|0.882|0.859|0.902
Observed|Tongue cancer|2015–2019|Persons|1|65–69|0.847|0.82|0.87
Observed|Tongue cancer|2015–2019|Persons|1|70–74|0.824|0.79|0.852
Observed|Tongue cancer|2015–2019|Persons|1|75–79|0.771|0.728|0.807
Observed|Tongue cancer|2015–2019|Persons|1|80–84|0.666|0.603|0.721
Observed|Tongue cancer|2015–2019|Persons|1|85+|0.514|0.447|0.578
Observed|Tongue cancer|2015–2019|Persons|1|All ages combined|0.85|0.84|0.86
Observed|Tongue cancer|2015–2019|Persons|2|00–04|||
Observed|Tongue cancer|2015–2019|Persons|2|05–09|||
Observed|Tongue cancer|2015–2019|Persons|2|10–14|||
Observed|Tongue cancer|2015–2019|Persons|2|15–19|||
Observed|Tongue cancer|2015–2019|Persons|2|20–24|||
Observed|Tongue cancer|2015–2019|Persons|2|25–29|0.839|0.676|0.924
Observed|Tongue cancer|2015–2019|Persons|2|30–34|0.854|0.73|0.924
Observed|Tongue cancer|2015–2019|Persons|2|35–39|0.853|0.75|0.916
Observed|Tongue cancer|2015–2019|Persons|2|40–44|0.901|0.832|0.942
Observed|Tongue cancer|2015–2019|Persons|2|45–49|0.896|0.853|0.927
Observed|Tongue cancer|2015–2019|Persons|2|50–54|0.847|0.812|0.875
Observed|Tongue cancer|2015–2019|Persons|2|55–59|0.855|0.826|0.88
Observed|Tongue cancer|2015–2019|Persons|2|60–64|0.812|0.784|0.837
Observed|Tongue cancer|2015–2019|Persons|2|65–69|0.757|0.725|0.785
Observed|Tongue cancer|2015–2019|Persons|2|70–74|0.714|0.674|0.75
Observed|Tongue cancer|2015–2019|Persons|2|75–79|0.703|0.657|0.745
Observed|Tongue cancer|2015–2019|Persons|2|80–84|0.528|0.462|0.59
Observed|Tongue cancer|2015–2019|Persons|2|85+|0.426|0.36|0.49
Observed|Tongue cancer|2015–2019|Persons|2|All ages combined|0.77|0.757|0.781
Observed|Tongue cancer|2015–2019|Persons|3|00–04|||
Observed|Tongue cancer|2015–2019|Persons|3|05–09|||
Observed|Tongue cancer|2015–2019|Persons|3|10–14|||
Observed|Tongue cancer|2015–2019|Persons|3|15–19|||
Observed|Tongue cancer|2015–2019|Persons|3|20–24|||
Observed|Tongue cancer|2015–2019|Persons|3|25–29|0.839|0.676|0.924
Observed|Tongue cancer|2015–2019|Persons|3|30–34|0.854|0.73|0.924
Observed|Tongue cancer|2015–2019|Persons|3|35–39|0.823|0.715|0.894
Observed|Tongue cancer|2015–2019|Persons|3|40–44|0.878|0.806|0.925
Observed|Tongue cancer|2015–2019|Persons|3|45–49|0.854|0.807|0.891
Observed|Tongue cancer|2015–2019|Persons|3|50–54|0.813|0.777|0.845
Observed|Tongue cancer|2015–2019|Persons|3|55–59|0.794|0.761|0.823
Observed|Tongue cancer|2015–2019|Persons|3|60–64|0.767|0.736|0.794
Observed|Tongue cancer|2015–2019|Persons|3|65–69|0.701|0.667|0.732
Observed|Tongue cancer|2015–2019|Persons|3|70–74|0.661|0.619|0.699
Observed|Tongue cancer|2015–2019|Persons|3|75–79|0.609|0.559|0.655
Observed|Tongue cancer|2015–2019|Persons|3|80–84|0.454|0.389|0.517
Observed|Tongue cancer|2015–2019|Persons|3|85+|0.35|0.288|0.413
Observed|Tongue cancer|2015–2019|Persons|3|All ages combined|0.717|0.703|0.729
Observed|Tongue cancer|2015–2019|Persons|4|00–04|||
Observed|Tongue cancer|2015–2019|Persons|4|05–09|||
Observed|Tongue cancer|2015–2019|Persons|4|10–14|||
Observed|Tongue cancer|2015–2019|Persons|4|15–19|||
Observed|Tongue cancer|2015–2019|Persons|4|20–24|||
Observed|Tongue cancer|2015–2019|Persons|4|25–29|0.839|0.676|0.924
Observed|Tongue cancer|2015–2019|Persons|4|30–34|0.854|0.73|0.924
Observed|Tongue cancer|2015–2019|Persons|4|35–39|0.807|0.696|0.881
Observed|Tongue cancer|2015–2019|Persons|4|40–44|0.849|0.773|0.901
Observed|Tongue cancer|2015–2019|Persons|4|45–49|0.821|0.771|0.861
Observed|Tongue cancer|2015–2019|Persons|4|50–54|0.783|0.745|0.817
Observed|Tongue cancer|2015–2019|Persons|4|55–59|0.745|0.709|0.777
Observed|Tongue cancer|2015–2019|Persons|4|60–64|0.73|0.697|0.759
Observed|Tongue cancer|2015–2019|Persons|4|65–69|0.663|0.627|0.695
Observed|Tongue cancer|2015–2019|Persons|4|70–74|0.617|0.574|0.658
Observed|Tongue cancer|2015–2019|Persons|4|75–79|0.554|0.503|0.602
Observed|Tongue cancer|2015–2019|Persons|4|80–84|0.407|0.343|0.47
Observed|Tongue cancer|2015–2019|Persons|4|85+|0.281|0.223|0.341
Observed|Tongue cancer|2015–2019|Persons|4|All ages combined|0.676|0.663|0.69
Observed|Tongue cancer|2015–2019|Persons|5|00–04|||
Observed|Tongue cancer|2015–2019|Persons|5|05–09|||
Observed|Tongue cancer|2015–2019|Persons|5|10–14|||
Observed|Tongue cancer|2015–2019|Persons|5|15–19|||
Observed|Tongue cancer|2015–2019|Persons|5|20–24|||
Observed|Tongue cancer|2015–2019|Persons|5|25–29|0.839|0.676|0.924
Observed|Tongue cancer|2015–2019|Persons|5|30–34|0.854|0.73|0.924
Observed|Tongue cancer|2015–2019|Persons|5|35–39|0.761|0.643|0.845
Observed|Tongue cancer|2015–2019|Persons|5|40–44|0.842|0.766|0.895
Observed|Tongue cancer|2015–2019|Persons|5|45–49|0.811|0.76|0.852
Observed|Tongue cancer|2015–2019|Persons|5|50–54|0.771|0.732|0.805
Observed|Tongue cancer|2015–2019|Persons|5|55–59|0.714|0.677|0.747
Observed|Tongue cancer|2015–2019|Persons|5|60–64|0.709|0.675|0.74
Observed|Tongue cancer|2015–2019|Persons|5|65–69|0.633|0.597|0.668
Observed|Tongue cancer|2015–2019|Persons|5|70–74|0.555|0.509|0.597
Observed|Tongue cancer|2015–2019|Persons|5|75–79|0.504|0.451|0.554
Observed|Tongue cancer|2015–2019|Persons|5|80–84|0.321|0.261|0.382
Observed|Tongue cancer|2015–2019|Persons|5|85+|0.226|0.173|0.283
Observed|Tongue cancer|2015–2019|Persons|5|All ages combined|0.643|0.629|0.657
Relative|Tongue cancer|2015–2019|Persons|1|00–04|||
Relative|Tongue cancer|2015–2019|Persons|1|05–09|||
Relative|Tongue cancer|2015–2019|Persons|1|10–14|||
Relative|Tongue cancer|2015–2019|Persons|1|15–19|||
Relative|Tongue cancer|2015–2019|Persons|1|20–24|||
Relative|Tongue cancer|2015–2019|Persons|1|25–29|0.867|0.71|0.943
Relative|Tongue cancer|2015–2019|Persons|1|30–34|0.891|0.772|0.95
Relative|Tongue cancer|2015–2019|Persons|1|35–39|0.949|0.868|0.981
Relative|Tongue cancer|2015–2019|Persons|1|40–44|0.967|0.913|0.988
Relative|Tongue cancer|2015–2019|Persons|1|45–49|0.95|0.916|0.971
Relative|Tongue cancer|2015–2019|Persons|1|50–54|0.928|0.902|0.948
Relative|Tongue cancer|2015–2019|Persons|1|55–59|0.932|0.91|0.949
Relative|Tongue cancer|2015–2019|Persons|1|60–64|0.888|0.865|0.908
Relative|Tongue cancer|2015–2019|Persons|1|65–69|0.857|0.829|0.88
Relative|Tongue cancer|2015–2019|Persons|1|70–74|0.838|0.804|0.867
Relative|Tongue cancer|2015–2019|Persons|1|75–79|0.793|0.749|0.831
Relative|Tongue cancer|2015–2019|Persons|1|80–84|0.701|0.635|0.759
Relative|Tongue cancer|2015–2019|Persons|1|85+|0.582|0.505|0.653
Relative|Tongue cancer|2015–2019|Persons|1|All ages combined|0.864|0.854|0.874
Relative|Tongue cancer|2015–2019|Persons|2|00–04|||
Relative|Tongue cancer|2015–2019|Persons|2|05–09|||
Relative|Tongue cancer|2015–2019|Persons|2|10–14|||
Relative|Tongue cancer|2015–2019|Persons|2|15–19|||
Relative|Tongue cancer|2015–2019|Persons|2|20–24|||
Relative|Tongue cancer|2015–2019|Persons|2|25–29|0.84|0.677|0.925
Relative|Tongue cancer|2015–2019|Persons|2|30–34|0.856|0.731|0.926
Relative|Tongue cancer|2015–2019|Persons|2|35–39|0.854|0.751|0.917
Relative|Tongue cancer|2015–2019|Persons|2|40–44|0.903|0.834|0.945
Relative|Tongue cancer|2015–2019|Persons|2|45–49|0.9|0.857|0.931
Relative|Tongue cancer|2015–2019|Persons|2|50–54|0.852|0.818|0.881
Relative|Tongue cancer|2015–2019|Persons|2|55–59|0.864|0.835|0.888
Relative|Tongue cancer|2015–2019|Persons|2|60–64|0.825|0.796|0.85
Relative|Tongue cancer|2015–2019|Persons|2|65–69|0.774|0.741|0.803
Relative|Tongue cancer|2015–2019|Persons|2|70–74|0.74|0.699|0.777
Relative|Tongue cancer|2015–2019|Persons|2|75–79|0.748|0.699|0.792
Relative|Tongue cancer|2015–2019|Persons|2|80–84|0.59|0.516|0.659
Relative|Tongue cancer|2015–2019|Persons|2|85+|0.554|0.468|0.638
Relative|Tongue cancer|2015–2019|Persons|2|All ages combined|0.794|0.782|0.806
Relative|Tongue cancer|2015–2019|Persons|3|00–04|||
Relative|Tongue cancer|2015–2019|Persons|3|05–09|||
Relative|Tongue cancer|2015–2019|Persons|3|10–14|||
Relative|Tongue cancer|2015–2019|Persons|3|15–19|||
Relative|Tongue cancer|2015–2019|Persons|3|20–24|||
Relative|Tongue cancer|2015–2019|Persons|3|25–29|0.84|0.677|0.926
Relative|Tongue cancer|2015–2019|Persons|3|30–34|0.856|0.732|0.926
Relative|Tongue cancer|2015–2019|Persons|3|35–39|0.826|0.717|0.896
Relative|Tongue cancer|2015–2019|Persons|3|40–44|0.882|0.81|0.929
Relative|Tongue cancer|2015–2019|Persons|3|45–49|0.86|0.812|0.897
Relative|Tongue cancer|2015–2019|Persons|3|50–54|0.822|0.785|0.853
Relative|Tongue cancer|2015–2019|Persons|3|55–59|0.806|0.773|0.835
Relative|Tongue cancer|2015–2019|Persons|3|60–64|0.785|0.753|0.813
Relative|Tongue cancer|2015–2019|Persons|3|65–69|0.727|0.691|0.759
Relative|Tongue cancer|2015–2019|Persons|3|70–74|0.699|0.655|0.74
Relative|Tongue cancer|2015–2019|Persons|3|75–79|0.671|0.616|0.722
Relative|Tongue cancer|2015–2019|Persons|3|80–84|0.542|0.464|0.617
Relative|Tongue cancer|2015–2019|Persons|3|85+|0.533|0.438|0.628
Relative|Tongue cancer|2015–2019|Persons|3|All ages combined|0.752|0.738|0.765
Relative|Tongue cancer|2015–2019|Persons|4|00–04|||
Relative|Tongue cancer|2015–2019|Persons|4|05–09|||
Relative|Tongue cancer|2015–2019|Persons|4|10–14|||
Relative|Tongue cancer|2015–2019|Persons|4|15–19|||
Relative|Tongue cancer|2015–2019|Persons|4|20–24|||
Relative|Tongue cancer|2015–2019|Persons|4|25–29|0.841|0.677|0.926
Relative|Tongue cancer|2015–2019|Persons|4|30–34|0.857|0.732|0.927
Relative|Tongue cancer|2015–2019|Persons|4|35–39|0.811|0.699|0.885
Relative|Tongue cancer|2015–2019|Persons|4|40–44|0.854|0.778|0.906
Relative|Tongue cancer|2015–2019|Persons|4|45–49|0.829|0.779|0.87
Relative|Tongue cancer|2015–2019|Persons|4|50–54|0.795|0.756|0.829
Relative|Tongue cancer|2015–2019|Persons|4|55–59|0.761|0.725|0.794
Relative|Tongue cancer|2015–2019|Persons|4|60–64|0.754|0.72|0.784
Relative|Tongue cancer|2015–2019|Persons|4|65–69|0.696|0.659|0.731
Relative|Tongue cancer|2015–2019|Persons|4|70–74|0.669|0.622|0.713
Relative|Tongue cancer|2015–2019|Persons|4|75–79|0.636|0.577|0.692
Relative|Tongue cancer|2015–2019|Persons|4|80–84|0.524|0.442|0.606
Relative|Tongue cancer|2015–2019|Persons|4|85+|0.508|0.403|0.617
Relative|Tongue cancer|2015–2019|Persons|4|All ages combined|0.721|0.707|0.735
Relative|Tongue cancer|2015–2019|Persons|5|00–04|||
Relative|Tongue cancer|2015–2019|Persons|5|05–09|||
Relative|Tongue cancer|2015–2019|Persons|5|10–14|||
Relative|Tongue cancer|2015–2019|Persons|5|15–19|||
Relative|Tongue cancer|2015–2019|Persons|5|20–24|||
Relative|Tongue cancer|2015–2019|Persons|5|25–29|0.841|0.678|0.927
Relative|Tongue cancer|2015–2019|Persons|5|30–34|0.858|0.733|0.928
Relative|Tongue cancer|2015–2019|Persons|5|35–39|0.765|0.646|0.849
Relative|Tongue cancer|2015–2019|Persons|5|40–44|0.849|0.772|0.902
Relative|Tongue cancer|2015–2019|Persons|5|45–49|0.821|0.769|0.863
Relative|Tongue cancer|2015–2019|Persons|5|50–54|0.786|0.746|0.82
Relative|Tongue cancer|2015–2019|Persons|5|55–59|0.734|0.696|0.769
Relative|Tongue cancer|2015–2019|Persons|5|60–64|0.739|0.704|0.771
Relative|Tongue cancer|2015–2019|Persons|5|65–69|0.676|0.637|0.713
Relative|Tongue cancer|2015–2019|Persons|5|70–74|0.616|0.566|0.664
Relative|Tongue cancer|2015–2019|Persons|5|75–79|0.605|0.542|0.665
Relative|Tongue cancer|2015–2019|Persons|5|80–84|0.45|0.365|0.536
Relative|Tongue cancer|2015–2019|Persons|5|85+|0.492|0.377|0.617
Relative|Tongue cancer|2015–2019|Persons|5|All ages combined|0.698|0.683|0.713
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|35–39|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|40–44|0.694|0.546|0.802
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|45–49|0.447|0.361|0.529
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|50–54|0.475|0.414|0.534
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|55–59|0.413|0.365|0.459
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|60–64|0.348|0.308|0.389
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|65–69|0.332|0.297|0.368
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|70–74|0.255|0.226|0.284
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|75–79|0.171|0.149|0.195
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|80–84|0.128|0.109|0.148
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|85+|0.06|0.051|0.071
Observed|Unknown primary site (cancer of)|2015–2019|Males|1|All ages combined|0.225|0.215|0.235
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|35–39|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|40–44|0.531|0.392|0.652
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|45–49|0.391|0.308|0.472
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|50–54|0.409|0.35|0.466
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|55–59|0.349|0.304|0.394
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|60–64|0.295|0.258|0.333
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|65–69|0.268|0.236|0.301
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|70–74|0.195|0.17|0.222
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|75–79|0.126|0.108|0.147
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|80–84|0.082|0.068|0.098
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|85+|0.039|0.032|0.048
Observed|Unknown primary site (cancer of)|2015–2019|Males|2|All ages combined|0.175|0.166|0.184
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|35–39|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|40–44|0.516|0.379|0.638
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|45–49|0.365|0.285|0.445
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|50–54|0.391|0.334|0.448
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|55–59|0.325|0.281|0.369
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|60–64|0.267|0.232|0.304
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|65–69|0.238|0.208|0.27
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|70–74|0.175|0.151|0.201
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|75–79|0.113|0.095|0.132
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|80–84|0.068|0.055|0.082
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|85+|0.026|0.021|0.033
Observed|Unknown primary site (cancer of)|2015–2019|Males|3|All ages combined|0.154|0.146|0.163
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|35–39|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|40–44|0.502|0.366|0.624
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|45–49|0.345|0.267|0.424
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|50–54|0.383|0.326|0.439
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|55–59|0.319|0.275|0.362
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|60–64|0.251|0.216|0.287
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|65–69|0.218|0.189|0.248
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|70–74|0.16|0.137|0.184
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|75–79|0.1|0.083|0.118
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|80–84|0.057|0.046|0.07
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|85+|0.021|0.016|0.027
Observed|Unknown primary site (cancer of)|2015–2019|Males|4|All ages combined|0.142|0.134|0.15
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|35–39|||
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|40–44|0.489|0.354|0.61
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|45–49|0.333|0.256|0.411
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|50–54|0.362|0.307|0.418
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|55–59|0.302|0.26|0.345
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|60–64|0.242|0.208|0.277
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|65–69|0.208|0.18|0.237
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|70–74|0.148|0.125|0.171
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|75–79|0.086|0.071|0.103
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|80–84|0.05|0.039|0.062
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|85+|0.016|0.012|0.021
Observed|Unknown primary site (cancer of)|2015–2019|Males|5|All ages combined|0.131|0.124|0.139
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|35–39|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|40–44|0.695|0.547|0.804
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|45–49|0.448|0.362|0.53
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|50–54|0.477|0.416|0.536
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|55–59|0.415|0.367|0.462
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|60–64|0.351|0.311|0.392
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|65–69|0.336|0.301|0.372
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|70–74|0.26|0.231|0.29
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|75–79|0.177|0.154|0.202
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|80–84|0.136|0.116|0.157
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|85+|0.07|0.059|0.083
Relative|Unknown primary site (cancer of)|2015–2019|Males|1|All ages combined|0.236|0.225|0.247
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|35–39|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|40–44|0.533|0.393|0.654
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|45–49|0.392|0.31|0.474
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|50–54|0.412|0.353|0.47
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|55–59|0.353|0.308|0.399
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|60–64|0.3|0.262|0.339
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|65–69|0.275|0.242|0.309
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|70–74|0.203|0.177|0.231
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|75–79|0.136|0.116|0.158
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|80–84|0.094|0.077|0.112
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|85+|0.054|0.044|0.065
Relative|Unknown primary site (cancer of)|2015–2019|Males|2|All ages combined|0.189|0.18|0.199
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|35–39|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|40–44|0.519|0.381|0.641
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|45–49|0.368|0.287|0.448
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|50–54|0.396|0.338|0.454
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|55–59|0.33|0.286|0.375
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|60–64|0.274|0.238|0.312
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|65–69|0.248|0.217|0.281
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|70–74|0.187|0.162|0.214
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|75–79|0.127|0.107|0.148
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|80–84|0.083|0.068|0.101
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|85+|0.043|0.034|0.054
Relative|Unknown primary site (cancer of)|2015–2019|Males|3|All ages combined|0.173|0.164|0.183
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|35–39|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|40–44|0.506|0.369|0.628
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|45–49|0.349|0.27|0.429
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|50–54|0.389|0.331|0.446
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|55–59|0.326|0.282|0.371
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|60–64|0.26|0.224|0.298
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|65–69|0.231|0.2|0.263
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|70–74|0.175|0.15|0.202
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|75–79|0.117|0.098|0.139
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|80–84|0.077|0.061|0.094
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|85+|0.04|0.03|0.052
Relative|Unknown primary site (cancer of)|2015–2019|Males|4|All ages combined|0.164|0.155|0.174
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|35–39|||
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|40–44|0.493|0.358|0.616
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|45–49|0.338|0.26|0.417
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|50–54|0.37|0.313|0.427
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|55–59|0.312|0.268|0.356
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|60–64|0.254|0.218|0.291
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|65–69|0.224|0.193|0.256
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|70–74|0.167|0.142|0.194
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|75–79|0.107|0.088|0.128
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|80–84|0.074|0.058|0.091
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|85+|0.038|0.028|0.05
Relative|Unknown primary site (cancer of)|2015–2019|Males|5|All ages combined|0.157|0.148|0.166
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|30–34|0.564|0.373|0.717
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|35–39|0.637|0.46|0.769
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|40–44|0.312|0.197|0.433
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|45–49|0.475|0.376|0.567
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|50–54|0.381|0.303|0.458
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|55–59|0.372|0.312|0.432
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|60–64|0.318|0.27|0.366
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|65–69|0.277|0.237|0.318
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|70–74|0.213|0.18|0.247
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|75–79|0.123|0.101|0.147
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|80–84|0.096|0.079|0.115
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|85+|0.048|0.04|0.056
Observed|Unknown primary site (cancer of)|2015–2019|Females|1|All ages combined|0.162|0.153|0.172
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|35–39|0.476|0.31|0.625
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|40–44|0.278|0.172|0.394
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|45–49|0.406|0.311|0.499
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|50–54|0.302|0.233|0.374
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|55–59|0.301|0.246|0.359
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|60–64|0.27|0.226|0.315
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|65–69|0.223|0.187|0.261
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|70–74|0.162|0.134|0.192
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|75–79|0.089|0.071|0.109
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|80–84|0.072|0.058|0.089
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|85+|0.028|0.023|0.034
Observed|Unknown primary site (cancer of)|2015–2019|Females|2|All ages combined|0.122|0.114|0.13
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|35–39|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|40–44|0.237|0.143|0.346
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|45–49|0.371|0.279|0.463
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|50–54|0.277|0.211|0.347
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|55–59|0.275|0.222|0.331
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|60–64|0.242|0.2|0.286
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|65–69|0.185|0.153|0.221
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|70–74|0.141|0.114|0.17
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|75–79|0.076|0.059|0.095
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|80–84|0.056|0.044|0.07
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|85+|0.018|0.014|0.023
Observed|Unknown primary site (cancer of)|2015–2019|Females|3|All ages combined|0.102|0.095|0.11
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|35–39|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|40–44|0.217|0.128|0.321
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|45–49|0.371|0.279|0.463
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|50–54|0.268|0.202|0.337
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|55–59|0.261|0.209|0.316
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|60–64|0.229|0.188|0.272
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|65–69|0.166|0.135|0.2
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|70–74|0.133|0.107|0.161
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|75–79|0.067|0.051|0.085
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|80–84|0.044|0.034|0.057
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|85+|0.013|0.009|0.017
Observed|Unknown primary site (cancer of)|2015–2019|Females|4|All ages combined|0.091|0.084|0.099
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|35–39|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|40–44|||
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|45–49|0.362|0.271|0.453
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|50–54|0.268|0.202|0.337
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|55–59|0.257|0.205|0.312
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|60–64|0.213|0.173|0.255
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|65–69|0.162|0.131|0.195
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|70–74|0.126|0.102|0.154
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|75–79|0.061|0.046|0.078
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|80–84|0.039|0.029|0.051
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|85+|0.009|0.006|0.012
Observed|Unknown primary site (cancer of)|2015–2019|Females|5|All ages combined|0.085|0.078|0.092
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|30–34|0.564|0.373|0.717
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|35–39|0.637|0.46|0.77
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|40–44|0.312|0.198|0.434
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|45–49|0.475|0.377|0.568
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|50–54|0.382|0.304|0.459
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|55–59|0.373|0.313|0.434
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|60–64|0.319|0.272|0.368
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|65–69|0.279|0.239|0.321
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|70–74|0.215|0.182|0.25
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|75–79|0.125|0.103|0.15
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|80–84|0.1|0.082|0.12
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|85+|0.055|0.046|0.064
Relative|Unknown primary site (cancer of)|2015–2019|Females|1|All ages combined|0.17|0.16|0.181
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|35–39|0.477|0.311|0.626
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|40–44|0.278|0.172|0.395
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|45–49|0.407|0.312|0.5
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|50–54|0.303|0.234|0.376
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|55–59|0.303|0.248|0.361
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|60–64|0.272|0.228|0.319
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|65–69|0.226|0.189|0.265
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|70–74|0.166|0.137|0.197
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|75–79|0.093|0.074|0.115
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|80–84|0.079|0.064|0.097
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|85+|0.036|0.029|0.044
Relative|Unknown primary site (cancer of)|2015–2019|Females|2|All ages combined|0.133|0.124|0.142
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|35–39|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|40–44|0.238|0.143|0.347
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|45–49|0.373|0.281|0.465
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|50–54|0.279|0.212|0.35
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|55–59|0.278|0.224|0.335
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|60–64|0.246|0.203|0.291
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|65–69|0.19|0.156|0.226
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|70–74|0.146|0.119|0.177
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|75–79|0.082|0.064|0.102
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|80–84|0.065|0.05|0.081
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|85+|0.028|0.022|0.035
Relative|Unknown primary site (cancer of)|2015–2019|Females|3|All ages combined|0.115|0.107|0.123
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|35–39|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|40–44|0.218|0.128|0.322
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|45–49|0.373|0.281|0.465
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|50–54|0.27|0.204|0.34
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|55–59|0.265|0.212|0.32
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|60–64|0.233|0.192|0.278
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|65–69|0.172|0.14|0.207
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|70–74|0.141|0.114|0.171
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|75–79|0.074|0.057|0.094
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|80–84|0.055|0.041|0.07
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|85+|0.023|0.017|0.03
Relative|Unknown primary site (cancer of)|2015–2019|Females|4|All ages combined|0.106|0.098|0.114
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|35–39|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|40–44|||
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|45–49|0.365|0.273|0.457
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|50–54|0.271|0.205|0.341
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|55–59|0.262|0.209|0.318
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|60–64|0.219|0.178|0.262
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|65–69|0.169|0.137|0.204
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|70–74|0.136|0.11|0.166
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|75–79|0.07|0.053|0.09
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|80–84|0.051|0.038|0.067
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|85+|0.019|0.014|0.027
Relative|Unknown primary site (cancer of)|2015–2019|Females|5|All ages combined|0.101|0.093|0.11
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|30–34|0.471|0.325|0.604
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|35–39|0.639|0.499|0.749
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|40–44|0.495|0.396|0.587
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|45–49|0.459|0.395|0.521
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|50–54|0.442|0.393|0.489
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|55–59|0.398|0.36|0.435
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|60–64|0.336|0.305|0.367
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|65–69|0.31|0.284|0.337
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|70–74|0.238|0.217|0.26
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|75–79|0.151|0.134|0.168
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|80–84|0.113|0.1|0.127
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|85+|0.053|0.047|0.06
Observed|Unknown primary site (cancer of)|2015–2019|Persons|1|All ages combined|0.196|0.189|0.204
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|30–34|0.381|0.248|0.512
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|35–39|0.536|0.4|0.655
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|40–44|0.403|0.313|0.492
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|45–49|0.397|0.335|0.459
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|50–54|0.37|0.324|0.416
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|55–59|0.332|0.297|0.367
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|60–64|0.285|0.256|0.314
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|65–69|0.25|0.226|0.275
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|70–74|0.182|0.163|0.202
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|75–79|0.111|0.097|0.125
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|80–84|0.078|0.068|0.089
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|85+|0.033|0.028|0.038
Observed|Unknown primary site (cancer of)|2015–2019|Persons|2|All ages combined|0.151|0.144|0.157
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|35–39|0.5|0.364|0.621
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|40–44|0.371|0.285|0.458
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|45–49|0.368|0.307|0.428
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|50–54|0.35|0.305|0.395
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|55–59|0.307|0.273|0.341
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|60–64|0.257|0.23|0.285
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|65–69|0.217|0.195|0.241
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|70–74|0.162|0.144|0.181
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|75–79|0.097|0.085|0.111
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|80–84|0.063|0.054|0.073
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|85+|0.022|0.018|0.026
Observed|Unknown primary site (cancer of)|2015–2019|Persons|3|All ages combined|0.131|0.125|0.136
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|35–39|0.48|0.345|0.603
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|40–44|0.353|0.268|0.438
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|45–49|0.356|0.296|0.416
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|50–54|0.341|0.297|0.385
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|55–59|0.298|0.264|0.332
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|60–64|0.242|0.215|0.27
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|65–69|0.197|0.176|0.22
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|70–74|0.149|0.132|0.168
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|75–79|0.086|0.074|0.099
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|80–84|0.051|0.043|0.06
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|85+|0.016|0.013|0.019
Observed|Unknown primary site (cancer of)|2015–2019|Persons|4|All ages combined|0.119|0.113|0.124
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|00–04|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|05–09|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|10–14|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|15–19|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|20–24|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|25–29|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|30–34|||
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|35–39|0.458|0.324|0.583
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|40–44|0.334|0.252|0.418
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|45–49|0.345|0.286|0.405
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|50–54|0.328|0.285|0.372
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|55–59|0.285|0.252|0.319
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|60–64|0.23|0.204|0.257
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|65–69|0.189|0.168|0.212
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|70–74|0.139|0.122|0.157
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|75–79|0.075|0.065|0.087
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|80–84|0.045|0.037|0.053
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|85+|0.012|0.01|0.015
Observed|Unknown primary site (cancer of)|2015–2019|Persons|5|All ages combined|0.11|0.105|0.115
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|30–34|0.471|0.325|0.604
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|35–39|0.639|0.499|0.749
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|40–44|0.496|0.396|0.588
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|45–49|0.46|0.395|0.522
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|50–54|0.443|0.395|0.49
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|55–59|0.4|0.362|0.437
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|60–64|0.338|0.308|0.37
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|65–69|0.314|0.287|0.341
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|70–74|0.242|0.22|0.265
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|75–79|0.155|0.138|0.173
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|80–84|0.119|0.106|0.134
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|85+|0.061|0.054|0.069
Relative|Unknown primary site (cancer of)|2015–2019|Persons|1|All ages combined|0.206|0.199|0.214
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|30–34|0.381|0.249|0.513
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|35–39|0.537|0.4|0.656
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|40–44|0.404|0.313|0.493
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|45–49|0.399|0.337|0.461
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|50–54|0.372|0.327|0.418
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|55–59|0.335|0.3|0.371
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|60–64|0.289|0.26|0.319
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|65–69|0.256|0.231|0.281
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|70–74|0.188|0.169|0.209
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|75–79|0.118|0.103|0.133
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|80–84|0.087|0.076|0.1
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|85+|0.044|0.038|0.05
Relative|Unknown primary site (cancer of)|2015–2019|Persons|2|All ages combined|0.164|0.157|0.17
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|35–39|0.501|0.365|0.622
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|40–44|0.373|0.286|0.46
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|45–49|0.37|0.309|0.431
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|50–54|0.353|0.309|0.399
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|55–59|0.311|0.277|0.346
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|60–64|0.263|0.235|0.292
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|65–69|0.225|0.202|0.249
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|70–74|0.171|0.152|0.191
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|75–79|0.108|0.094|0.123
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|80–84|0.075|0.064|0.087
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|85+|0.034|0.029|0.04
Relative|Unknown primary site (cancer of)|2015–2019|Persons|3|All ages combined|0.147|0.14|0.153
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|35–39|0.482|0.347|0.605
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|40–44|0.355|0.27|0.441
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|45–49|0.359|0.299|0.42
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|50–54|0.345|0.301|0.39
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|55–59|0.304|0.27|0.339
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|60–64|0.25|0.222|0.278
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|65–69|0.207|0.185|0.231
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|70–74|0.162|0.143|0.181
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|75–79|0.099|0.086|0.114
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|80–84|0.067|0.056|0.078
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|85+|0.03|0.024|0.036
Relative|Unknown primary site (cancer of)|2015–2019|Persons|4|All ages combined|0.137|0.131|0.144
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|00–04|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|05–09|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|10–14|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|15–19|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|20–24|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|25–29|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|30–34|||
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|35–39|0.46|0.326|0.585
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|40–44|0.337|0.254|0.421
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|45–49|0.349|0.289|0.41
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|50–54|0.334|0.29|0.379
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|55–59|0.293|0.259|0.328
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|60–64|0.24|0.213|0.268
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|65–69|0.202|0.18|0.226
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|70–74|0.155|0.136|0.175
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|75–79|0.091|0.078|0.106
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|80–84|0.063|0.053|0.075
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|85+|0.027|0.021|0.033
Relative|Unknown primary site (cancer of)|2015–2019|Persons|5|All ages combined|0.131|0.125|0.138
Observed|Ureteral cancer|2015–2019|Males|1|00–04|||
Observed|Ureteral cancer|2015–2019|Males|1|05–09|||
Observed|Ureteral cancer|2015–2019|Males|1|10–14|||
Observed|Ureteral cancer|2015–2019|Males|1|15–19|||
Observed|Ureteral cancer|2015–2019|Males|1|20–24|||
Observed|Ureteral cancer|2015–2019|Males|1|25–29|||
Observed|Ureteral cancer|2015–2019|Males|1|30–34|||
Observed|Ureteral cancer|2015–2019|Males|1|35–39|||
Observed|Ureteral cancer|2015–2019|Males|1|40–44|||
Observed|Ureteral cancer|2015–2019|Males|1|45–49|||
Observed|Ureteral cancer|2015–2019|Males|1|50–54|||
Observed|Ureteral cancer|2015–2019|Males|1|55–59|0.924|0.729|0.98
Observed|Ureteral cancer|2015–2019|Males|1|60–64|0.787|0.619|0.887
Observed|Ureteral cancer|2015–2019|Males|1|65–69|0.751|0.626|0.839
Observed|Ureteral cancer|2015–2019|Males|1|70–74|0.88|0.782|0.936
Observed|Ureteral cancer|2015–2019|Males|1|75–79|0.72|0.615|0.801
Observed|Ureteral cancer|2015–2019|Males|1|80–84|0.741|0.617|0.83
Observed|Ureteral cancer|2015–2019|Males|1|85+|0.593|0.459|0.705
Observed|Ureteral cancer|2015–2019|Males|1|All ages combined|0.764|0.721|0.801
Observed|Ureteral cancer|2015–2019|Males|2|00–04|||
Observed|Ureteral cancer|2015–2019|Males|2|05–09|||
Observed|Ureteral cancer|2015–2019|Males|2|10–14|||
Observed|Ureteral cancer|2015–2019|Males|2|15–19|||
Observed|Ureteral cancer|2015–2019|Males|2|20–24|||
Observed|Ureteral cancer|2015–2019|Males|2|25–29|||
Observed|Ureteral cancer|2015–2019|Males|2|30–34|||
Observed|Ureteral cancer|2015–2019|Males|2|35–39|||
Observed|Ureteral cancer|2015–2019|Males|2|40–44|||
Observed|Ureteral cancer|2015–2019|Males|2|45–49|||
Observed|Ureteral cancer|2015–2019|Males|2|50–54|||
Observed|Ureteral cancer|2015–2019|Males|2|55–59|0.885|0.684|0.961
Observed|Ureteral cancer|2015–2019|Males|2|60–64|0.653|0.467|0.788
Observed|Ureteral cancer|2015–2019|Males|2|65–69|0.637|0.509|0.739
Observed|Ureteral cancer|2015–2019|Males|2|70–74|0.736|0.617|0.823
Observed|Ureteral cancer|2015–2019|Males|2|75–79|0.55|0.443|0.644
Observed|Ureteral cancer|2015–2019|Males|2|80–84|0.589|0.461|0.696
Observed|Ureteral cancer|2015–2019|Males|2|85+|0.405|0.281|0.526
Observed|Ureteral cancer|2015–2019|Males|2|All ages combined|0.621|0.574|0.665
Observed|Ureteral cancer|2015–2019|Males|3|00–04|||
Observed|Ureteral cancer|2015–2019|Males|3|05–09|||
Observed|Ureteral cancer|2015–2019|Males|3|10–14|||
Observed|Ureteral cancer|2015–2019|Males|3|15–19|||
Observed|Ureteral cancer|2015–2019|Males|3|20–24|||
Observed|Ureteral cancer|2015–2019|Males|3|25–29|||
Observed|Ureteral cancer|2015–2019|Males|3|30–34|||
Observed|Ureteral cancer|2015–2019|Males|3|35–39|||
Observed|Ureteral cancer|2015–2019|Males|3|40–44|||
Observed|Ureteral cancer|2015–2019|Males|3|45–49|||
Observed|Ureteral cancer|2015–2019|Males|3|50–54|||
Observed|Ureteral cancer|2015–2019|Males|3|55–59|||
Observed|Ureteral cancer|2015–2019|Males|3|60–64|0.572|0.392|0.717
Observed|Ureteral cancer|2015–2019|Males|3|65–69|0.49|0.367|0.602
Observed|Ureteral cancer|2015–2019|Males|3|70–74|0.6|0.475|0.705
Observed|Ureteral cancer|2015–2019|Males|3|75–79|0.41|0.31|0.508
Observed|Ureteral cancer|2015–2019|Males|3|80–84|0.451|0.331|0.563
Observed|Ureteral cancer|2015–2019|Males|3|85+|||
Observed|Ureteral cancer|2015–2019|Males|3|All ages combined|0.486|0.438|0.532
Observed|Ureteral cancer|2015–2019|Males|4|00–04|||
Observed|Ureteral cancer|2015–2019|Males|4|05–09|||
Observed|Ureteral cancer|2015–2019|Males|4|10–14|||
Observed|Ureteral cancer|2015–2019|Males|4|15–19|||
Observed|Ureteral cancer|2015–2019|Males|4|20–24|||
Observed|Ureteral cancer|2015–2019|Males|4|25–29|||
Observed|Ureteral cancer|2015–2019|Males|4|30–34|||
Observed|Ureteral cancer|2015–2019|Males|4|35–39|||
Observed|Ureteral cancer|2015–2019|Males|4|40–44|||
Observed|Ureteral cancer|2015–2019|Males|4|45–49|||
Observed|Ureteral cancer|2015–2019|Males|4|50–54|||
Observed|Ureteral cancer|2015–2019|Males|4|55–59|||
Observed|Ureteral cancer|2015–2019|Males|4|60–64|0.499|0.329|0.648
Observed|Ureteral cancer|2015–2019|Males|4|65–69|0.476|0.354|0.589
Observed|Ureteral cancer|2015–2019|Males|4|70–74|0.538|0.414|0.648
Observed|Ureteral cancer|2015–2019|Males|4|75–79|0.369|0.272|0.466
Observed|Ureteral cancer|2015–2019|Males|4|80–84|0.36|0.248|0.473
Observed|Ureteral cancer|2015–2019|Males|4|85+|||
Observed|Ureteral cancer|2015–2019|Males|4|All ages combined|0.43|0.383|0.476
Observed|Ureteral cancer|2015–2019|Males|5|00–04|||
Observed|Ureteral cancer|2015–2019|Males|5|05–09|||
Observed|Ureteral cancer|2015–2019|Males|5|10–14|||
Observed|Ureteral cancer|2015–2019|Males|5|15–19|||
Observed|Ureteral cancer|2015–2019|Males|5|20–24|||
Observed|Ureteral cancer|2015–2019|Males|5|25–29|||
Observed|Ureteral cancer|2015–2019|Males|5|30–34|||
Observed|Ureteral cancer|2015–2019|Males|5|35–39|||
Observed|Ureteral cancer|2015–2019|Males|5|40–44|||
Observed|Ureteral cancer|2015–2019|Males|5|45–49|||
Observed|Ureteral cancer|2015–2019|Males|5|50–54|||
Observed|Ureteral cancer|2015–2019|Males|5|55–59|||
Observed|Ureteral cancer|2015–2019|Males|5|60–64|0.455|0.292|0.604
Observed|Ureteral cancer|2015–2019|Males|5|65–69|0.449|0.329|0.562
Observed|Ureteral cancer|2015–2019|Males|5|70–74|0.456|0.333|0.57
Observed|Ureteral cancer|2015–2019|Males|5|75–79|0.335|0.242|0.431
Observed|Ureteral cancer|2015–2019|Males|5|80–84|||
Observed|Ureteral cancer|2015–2019|Males|5|85+|||
Observed|Ureteral cancer|2015–2019|Males|5|All ages combined|0.379|0.333|0.424
Relative|Ureteral cancer|2015–2019|Males|1|00–04|||
Relative|Ureteral cancer|2015–2019|Males|1|05–09|||
Relative|Ureteral cancer|2015–2019|Males|1|10–14|||
Relative|Ureteral cancer|2015–2019|Males|1|15–19|||
Relative|Ureteral cancer|2015–2019|Males|1|20–24|||
Relative|Ureteral cancer|2015–2019|Males|1|25–29|||
Relative|Ureteral cancer|2015–2019|Males|1|30–34|||
Relative|Ureteral cancer|2015–2019|Males|1|35–39|||
Relative|Ureteral cancer|2015–2019|Males|1|40–44|||
Relative|Ureteral cancer|2015–2019|Males|1|45–49|||
Relative|Ureteral cancer|2015–2019|Males|1|50–54|||
Relative|Ureteral cancer|2015–2019|Males|1|55–59|0.929|0.733|0.986
Relative|Ureteral cancer|2015–2019|Males|1|60–64|0.793|0.624|0.894
Relative|Ureteral cancer|2015–2019|Males|1|65–69|0.76|0.634|0.849
Relative|Ureteral cancer|2015–2019|Males|1|70–74|0.898|0.798|0.954
Relative|Ureteral cancer|2015–2019|Males|1|75–79|0.745|0.636|0.828
Relative|Ureteral cancer|2015–2019|Males|1|80–84|0.788|0.656|0.883
Relative|Ureteral cancer|2015–2019|Males|1|85+|0.677|0.524|0.804
Relative|Ureteral cancer|2015–2019|Males|1|All ages combined|0.795|0.751|0.834
Relative|Ureteral cancer|2015–2019|Males|2|00–04|||
Relative|Ureteral cancer|2015–2019|Males|2|05–09|||
Relative|Ureteral cancer|2015–2019|Males|2|10–14|||
Relative|Ureteral cancer|2015–2019|Males|2|15–19|||
Relative|Ureteral cancer|2015–2019|Males|2|20–24|||
Relative|Ureteral cancer|2015–2019|Males|2|25–29|||
Relative|Ureteral cancer|2015–2019|Males|2|30–34|||
Relative|Ureteral cancer|2015–2019|Males|2|35–39|||
Relative|Ureteral cancer|2015–2019|Males|2|40–44|||
Relative|Ureteral cancer|2015–2019|Males|2|45–49|||
Relative|Ureteral cancer|2015–2019|Males|2|50–54|||
Relative|Ureteral cancer|2015–2019|Males|2|55–59|0.895|0.692|0.972
Relative|Ureteral cancer|2015–2019|Males|2|60–64|0.664|0.475|0.801
Relative|Ureteral cancer|2015–2019|Males|2|65–69|0.653|0.523|0.758
Relative|Ureteral cancer|2015–2019|Males|2|70–74|0.767|0.643|0.857
Relative|Ureteral cancer|2015–2019|Males|2|75–79|0.59|0.476|0.692
Relative|Ureteral cancer|2015–2019|Males|2|80–84|0.671|0.525|0.794
Relative|Ureteral cancer|2015–2019|Males|2|85+|0.532|0.369|0.69
Relative|Ureteral cancer|2015–2019|Males|2|All ages combined|0.673|0.621|0.72
Relative|Ureteral cancer|2015–2019|Males|3|00–04|||
Relative|Ureteral cancer|2015–2019|Males|3|05–09|||
Relative|Ureteral cancer|2015–2019|Males|3|10–14|||
Relative|Ureteral cancer|2015–2019|Males|3|15–19|||
Relative|Ureteral cancer|2015–2019|Males|3|20–24|||
Relative|Ureteral cancer|2015–2019|Males|3|25–29|||
Relative|Ureteral cancer|2015–2019|Males|3|30–34|||
Relative|Ureteral cancer|2015–2019|Males|3|35–39|||
Relative|Ureteral cancer|2015–2019|Males|3|40–44|||
Relative|Ureteral cancer|2015–2019|Males|3|45–49|||
Relative|Ureteral cancer|2015–2019|Males|3|50–54|||
Relative|Ureteral cancer|2015–2019|Males|3|55–59|||
Relative|Ureteral cancer|2015–2019|Males|3|60–64|0.587|0.402|0.736
Relative|Ureteral cancer|2015–2019|Males|3|65–69|0.51|0.382|0.627
Relative|Ureteral cancer|2015–2019|Males|3|70–74|0.641|0.507|0.752
Relative|Ureteral cancer|2015–2019|Males|3|75–79|0.46|0.348|0.569
Relative|Ureteral cancer|2015–2019|Males|3|80–84|0.558|0.409|0.697
Relative|Ureteral cancer|2015–2019|Males|3|85+|||
Relative|Ureteral cancer|2015–2019|Males|3|All ages combined|0.548|0.494|0.6
Relative|Ureteral cancer|2015–2019|Males|4|00–04|||
Relative|Ureteral cancer|2015–2019|Males|4|05–09|||
Relative|Ureteral cancer|2015–2019|Males|4|10–14|||
Relative|Ureteral cancer|2015–2019|Males|4|15–19|||
Relative|Ureteral cancer|2015–2019|Males|4|20–24|||
Relative|Ureteral cancer|2015–2019|Males|4|25–29|||
Relative|Ureteral cancer|2015–2019|Males|4|30–34|||
Relative|Ureteral cancer|2015–2019|Males|4|35–39|||
Relative|Ureteral cancer|2015–2019|Males|4|40–44|||
Relative|Ureteral cancer|2015–2019|Males|4|45–49|||
Relative|Ureteral cancer|2015–2019|Males|4|50–54|||
Relative|Ureteral cancer|2015–2019|Males|4|55–59|||
Relative|Ureteral cancer|2015–2019|Males|4|60–64|0.518|0.341|0.673
Relative|Ureteral cancer|2015–2019|Males|4|65–69|0.504|0.375|0.623
Relative|Ureteral cancer|2015–2019|Males|4|70–74|0.591|0.454|0.711
Relative|Ureteral cancer|2015–2019|Males|4|75–79|0.434|0.32|0.547
Relative|Ureteral cancer|2015–2019|Males|4|80–84|0.486|0.335|0.638
Relative|Ureteral cancer|2015–2019|Males|4|85+|||
Relative|Ureteral cancer|2015–2019|Males|4|All ages combined|0.505|0.45|0.56
Relative|Ureteral cancer|2015–2019|Males|5|00–04|||
Relative|Ureteral cancer|2015–2019|Males|5|05–09|||
Relative|Ureteral cancer|2015–2019|Males|5|10–14|||
Relative|Ureteral cancer|2015–2019|Males|5|15–19|||
Relative|Ureteral cancer|2015–2019|Males|5|20–24|||
Relative|Ureteral cancer|2015–2019|Males|5|25–29|||
Relative|Ureteral cancer|2015–2019|Males|5|30–34|||
Relative|Ureteral cancer|2015–2019|Males|5|35–39|||
Relative|Ureteral cancer|2015–2019|Males|5|40–44|||
Relative|Ureteral cancer|2015–2019|Males|5|45–49|||
Relative|Ureteral cancer|2015–2019|Males|5|50–54|||
Relative|Ureteral cancer|2015–2019|Males|5|55–59|||
Relative|Ureteral cancer|2015–2019|Males|5|60–64|0.477|0.306|0.634
Relative|Ureteral cancer|2015–2019|Males|5|65–69|0.484|0.355|0.605
Relative|Ureteral cancer|2015–2019|Males|5|70–74|0.515|0.376|0.645
Relative|Ureteral cancer|2015–2019|Males|5|75–79|0.416|0.3|0.535
Relative|Ureteral cancer|2015–2019|Males|5|80–84|||
Relative|Ureteral cancer|2015–2019|Males|5|85+|||
Relative|Ureteral cancer|2015–2019|Males|5|All ages combined|0.465|0.409|0.522
Observed|Ureteral cancer|2015–2019|Females|1|00–04|||
Observed|Ureteral cancer|2015–2019|Females|1|05–09|||
Observed|Ureteral cancer|2015–2019|Females|1|10–14|||
Observed|Ureteral cancer|2015–2019|Females|1|15–19|||
Observed|Ureteral cancer|2015–2019|Females|1|20–24|||
Observed|Ureteral cancer|2015–2019|Females|1|25–29|||
Observed|Ureteral cancer|2015–2019|Females|1|30–34|||
Observed|Ureteral cancer|2015–2019|Females|1|35–39|||
Observed|Ureteral cancer|2015–2019|Females|1|40–44|||
Observed|Ureteral cancer|2015–2019|Females|1|45–49|||
Observed|Ureteral cancer|2015–2019|Females|1|50–54|||
Observed|Ureteral cancer|2015–2019|Females|1|55–59|||
Observed|Ureteral cancer|2015–2019|Females|1|60–64|0.713|0.491|0.851
Observed|Ureteral cancer|2015–2019|Females|1|65–69|0.848|0.672|0.934
Observed|Ureteral cancer|2015–2019|Females|1|70–74|0.867|0.684|0.948
Observed|Ureteral cancer|2015–2019|Females|1|75–79|0.723|0.589|0.82
Observed|Ureteral cancer|2015–2019|Females|1|80–84|0.693|0.563|0.791
Observed|Ureteral cancer|2015–2019|Females|1|85+|0.502|0.377|0.614
Observed|Ureteral cancer|2015–2019|Females|1|All ages combined|0.702|0.646|0.751
Observed|Ureteral cancer|2015–2019|Females|2|00–04|||
Observed|Ureteral cancer|2015–2019|Females|2|05–09|||
Observed|Ureteral cancer|2015–2019|Females|2|10–14|||
Observed|Ureteral cancer|2015–2019|Females|2|15–19|||
Observed|Ureteral cancer|2015–2019|Females|2|20–24|||
Observed|Ureteral cancer|2015–2019|Females|2|25–29|||
Observed|Ureteral cancer|2015–2019|Females|2|30–34|||
Observed|Ureteral cancer|2015–2019|Females|2|35–39|||
Observed|Ureteral cancer|2015–2019|Females|2|40–44|||
Observed|Ureteral cancer|2015–2019|Females|2|45–49|||
Observed|Ureteral cancer|2015–2019|Females|2|50–54|||
Observed|Ureteral cancer|2015–2019|Females|2|55–59|||
Observed|Ureteral cancer|2015–2019|Females|2|60–64|||
Observed|Ureteral cancer|2015–2019|Females|2|65–69|0.79|0.61|0.894
Observed|Ureteral cancer|2015–2019|Females|2|70–74|0.693|0.493|0.827
Observed|Ureteral cancer|2015–2019|Females|2|75–79|0.545|0.408|0.663
Observed|Ureteral cancer|2015–2019|Females|2|80–84|0.4|0.268|0.528
Observed|Ureteral cancer|2015–2019|Females|2|85+|0.336|0.226|0.449
Observed|Ureteral cancer|2015–2019|Females|2|All ages combined|0.533|0.473|0.589
Observed|Ureteral cancer|2015–2019|Females|3|00–04|||
Observed|Ureteral cancer|2015–2019|Females|3|05–09|||
Observed|Ureteral cancer|2015–2019|Females|3|10–14|||
Observed|Ureteral cancer|2015–2019|Females|3|15–19|||
Observed|Ureteral cancer|2015–2019|Females|3|20–24|||
Observed|Ureteral cancer|2015–2019|Females|3|25–29|||
Observed|Ureteral cancer|2015–2019|Females|3|30–34|||
Observed|Ureteral cancer|2015–2019|Females|3|35–39|||
Observed|Ureteral cancer|2015–2019|Females|3|40–44|||
Observed|Ureteral cancer|2015–2019|Females|3|45–49|||
Observed|Ureteral cancer|2015–2019|Females|3|50–54|||
Observed|Ureteral cancer|2015–2019|Females|3|55–59|||
Observed|Ureteral cancer|2015–2019|Females|3|60–64|||
Observed|Ureteral cancer|2015–2019|Females|3|65–69|0.58|0.397|0.726
Observed|Ureteral cancer|2015–2019|Females|3|70–74|0.664|0.467|0.803
Observed|Ureteral cancer|2015–2019|Females|3|75–79|0.446|0.317|0.567
Observed|Ureteral cancer|2015–2019|Females|3|80–84|||
Observed|Ureteral cancer|2015–2019|Females|3|85+|||
Observed|Ureteral cancer|2015–2019|Females|3|All ages combined|0.439|0.38|0.496
Observed|Ureteral cancer|2015–2019|Females|4|00–04|||
Observed|Ureteral cancer|2015–2019|Females|4|05–09|||
Observed|Ureteral cancer|2015–2019|Females|4|10–14|||
Observed|Ureteral cancer|2015–2019|Females|4|15–19|||
Observed|Ureteral cancer|2015–2019|Females|4|20–24|||
Observed|Ureteral cancer|2015–2019|Females|4|25–29|||
Observed|Ureteral cancer|2015–2019|Females|4|30–34|||
Observed|Ureteral cancer|2015–2019|Females|4|35–39|||
Observed|Ureteral cancer|2015–2019|Females|4|40–44|||
Observed|Ureteral cancer|2015–2019|Females|4|45–49|||
Observed|Ureteral cancer|2015–2019|Females|4|50–54|||
Observed|Ureteral cancer|2015–2019|Females|4|55–59|||
Observed|Ureteral cancer|2015–2019|Females|4|60–64|||
Observed|Ureteral cancer|2015–2019|Females|4|65–69|||
Observed|Ureteral cancer|2015–2019|Females|4|70–74|||
Observed|Ureteral cancer|2015–2019|Females|4|75–79|0.345|0.228|0.466
Observed|Ureteral cancer|2015–2019|Females|4|80–84|||
Observed|Ureteral cancer|2015–2019|Females|4|85+|||
Observed|Ureteral cancer|2015–2019|Females|4|All ages combined|0.375|0.318|0.432
Observed|Ureteral cancer|2015–2019|Females|5|00–04|||
Observed|Ureteral cancer|2015–2019|Females|5|05–09|||
Observed|Ureteral cancer|2015–2019|Females|5|10–14|||
Observed|Ureteral cancer|2015–2019|Females|5|15–19|||
Observed|Ureteral cancer|2015–2019|Females|5|20–24|||
Observed|Ureteral cancer|2015–2019|Females|5|25–29|||
Observed|Ureteral cancer|2015–2019|Females|5|30–34|||
Observed|Ureteral cancer|2015–2019|Females|5|35–39|||
Observed|Ureteral cancer|2015–2019|Females|5|40–44|||
Observed|Ureteral cancer|2015–2019|Females|5|45–49|||
Observed|Ureteral cancer|2015–2019|Females|5|50–54|||
Observed|Ureteral cancer|2015–2019|Females|5|55–59|||
Observed|Ureteral cancer|2015–2019|Females|5|60–64|||
Observed|Ureteral cancer|2015–2019|Females|5|65–69|||
Observed|Ureteral cancer|2015–2019|Females|5|70–74|||
Observed|Ureteral cancer|2015–2019|Females|5|75–79|||
Observed|Ureteral cancer|2015–2019|Females|5|80–84|||
Observed|Ureteral cancer|2015–2019|Females|5|85+|||
Observed|Ureteral cancer|2015–2019|Females|5|All ages combined|0.308|0.254|0.363
Relative|Ureteral cancer|2015–2019|Females|1|00–04|||
Relative|Ureteral cancer|2015–2019|Females|1|05–09|||
Relative|Ureteral cancer|2015–2019|Females|1|10–14|||
Relative|Ureteral cancer|2015–2019|Females|1|15–19|||
Relative|Ureteral cancer|2015–2019|Females|1|20–24|||
Relative|Ureteral cancer|2015–2019|Females|1|25–29|||
Relative|Ureteral cancer|2015–2019|Females|1|30–34|||
Relative|Ureteral cancer|2015–2019|Females|1|35–39|||
Relative|Ureteral cancer|2015–2019|Females|1|40–44|||
Relative|Ureteral cancer|2015–2019|Females|1|45–49|||
Relative|Ureteral cancer|2015–2019|Females|1|50–54|||
Relative|Ureteral cancer|2015–2019|Females|1|55–59|||
Relative|Ureteral cancer|2015–2019|Females|1|60–64|0.716|0.494|0.855
Relative|Ureteral cancer|2015–2019|Females|1|65–69|0.854|0.677|0.94
Relative|Ureteral cancer|2015–2019|Females|1|70–74|0.878|0.692|0.96
Relative|Ureteral cancer|2015–2019|Females|1|75–79|0.74|0.603|0.839
Relative|Ureteral cancer|2015–2019|Females|1|80–84|0.722|0.586|0.825
Relative|Ureteral cancer|2015–2019|Females|1|85+|0.556|0.418|0.68
Relative|Ureteral cancer|2015–2019|Females|1|All ages combined|0.729|0.671|0.78
Relative|Ureteral cancer|2015–2019|Females|2|00–04|||
Relative|Ureteral cancer|2015–2019|Females|2|05–09|||
Relative|Ureteral cancer|2015–2019|Females|2|10–14|||
Relative|Ureteral cancer|2015–2019|Females|2|15–19|||
Relative|Ureteral cancer|2015–2019|Females|2|20–24|||
Relative|Ureteral cancer|2015–2019|Females|2|25–29|||
Relative|Ureteral cancer|2015–2019|Females|2|30–34|||
Relative|Ureteral cancer|2015–2019|Females|2|35–39|||
Relative|Ureteral cancer|2015–2019|Females|2|40–44|||
Relative|Ureteral cancer|2015–2019|Females|2|45–49|||
Relative|Ureteral cancer|2015–2019|Females|2|50–54|||
Relative|Ureteral cancer|2015–2019|Females|2|55–59|||
Relative|Ureteral cancer|2015–2019|Females|2|60–64|||
Relative|Ureteral cancer|2015–2019|Females|2|65–69|0.802|0.62|0.907
Relative|Ureteral cancer|2015–2019|Females|2|70–74|0.713|0.507|0.85
Relative|Ureteral cancer|2015–2019|Females|2|75–79|0.571|0.428|0.695
Relative|Ureteral cancer|2015–2019|Females|2|80–84|0.436|0.292|0.577
Relative|Ureteral cancer|2015–2019|Females|2|85+|0.415|0.28|0.555
Relative|Ureteral cancer|2015–2019|Females|2|All ages combined|0.574|0.509|0.634
Relative|Ureteral cancer|2015–2019|Females|3|00–04|||
Relative|Ureteral cancer|2015–2019|Females|3|05–09|||
Relative|Ureteral cancer|2015–2019|Females|3|10–14|||
Relative|Ureteral cancer|2015–2019|Females|3|15–19|||
Relative|Ureteral cancer|2015–2019|Females|3|20–24|||
Relative|Ureteral cancer|2015–2019|Females|3|25–29|||
Relative|Ureteral cancer|2015–2019|Females|3|30–34|||
Relative|Ureteral cancer|2015–2019|Females|3|35–39|||
Relative|Ureteral cancer|2015–2019|Females|3|40–44|||
Relative|Ureteral cancer|2015–2019|Females|3|45–49|||
Relative|Ureteral cancer|2015–2019|Females|3|50–54|||
Relative|Ureteral cancer|2015–2019|Females|3|55–59|||
Relative|Ureteral cancer|2015–2019|Females|3|60–64|||
Relative|Ureteral cancer|2015–2019|Females|3|65–69|0.594|0.407|0.743
Relative|Ureteral cancer|2015–2019|Females|3|70–74|0.694|0.487|0.838
Relative|Ureteral cancer|2015–2019|Females|3|75–79|0.481|0.341|0.612
Relative|Ureteral cancer|2015–2019|Females|3|80–84|||
Relative|Ureteral cancer|2015–2019|Females|3|85+|||
Relative|Ureteral cancer|2015–2019|Females|3|All ages combined|0.49|0.424|0.553
Relative|Ureteral cancer|2015–2019|Females|4|00–04|||
Relative|Ureteral cancer|2015–2019|Females|4|05–09|||
Relative|Ureteral cancer|2015–2019|Females|4|10–14|||
Relative|Ureteral cancer|2015–2019|Females|4|15–19|||
Relative|Ureteral cancer|2015–2019|Females|4|20–24|||
Relative|Ureteral cancer|2015–2019|Females|4|25–29|||
Relative|Ureteral cancer|2015–2019|Females|4|30–34|||
Relative|Ureteral cancer|2015–2019|Females|4|35–39|||
Relative|Ureteral cancer|2015–2019|Females|4|40–44|||
Relative|Ureteral cancer|2015–2019|Females|4|45–49|||
Relative|Ureteral cancer|2015–2019|Females|4|50–54|||
Relative|Ureteral cancer|2015–2019|Females|4|55–59|||
Relative|Ureteral cancer|2015–2019|Females|4|60–64|||
Relative|Ureteral cancer|2015–2019|Females|4|65–69|||
Relative|Ureteral cancer|2015–2019|Females|4|70–74|||
Relative|Ureteral cancer|2015–2019|Females|4|75–79|0.385|0.254|0.519
Relative|Ureteral cancer|2015–2019|Females|4|80–84|||
Relative|Ureteral cancer|2015–2019|Females|4|85+|||
Relative|Ureteral cancer|2015–2019|Females|4|All ages combined|0.434|0.368|0.5
Relative|Ureteral cancer|2015–2019|Females|5|00–04|||
Relative|Ureteral cancer|2015–2019|Females|5|05–09|||
Relative|Ureteral cancer|2015–2019|Females|5|10–14|||
Relative|Ureteral cancer|2015–2019|Females|5|15–19|||
Relative|Ureteral cancer|2015–2019|Females|5|20–24|||
Relative|Ureteral cancer|2015–2019|Females|5|25–29|||
Relative|Ureteral cancer|2015–2019|Females|5|30–34|||
Relative|Ureteral cancer|2015–2019|Females|5|35–39|||
Relative|Ureteral cancer|2015–2019|Females|5|40–44|||
Relative|Ureteral cancer|2015–2019|Females|5|45–49|||
Relative|Ureteral cancer|2015–2019|Females|5|50–54|||
Relative|Ureteral cancer|2015–2019|Females|5|55–59|||
Relative|Ureteral cancer|2015–2019|Females|5|60–64|||
Relative|Ureteral cancer|2015–2019|Females|5|65–69|||
Relative|Ureteral cancer|2015–2019|Females|5|70–74|||
Relative|Ureteral cancer|2015–2019|Females|5|75–79|||
Relative|Ureteral cancer|2015–2019|Females|5|80–84|||
Relative|Ureteral cancer|2015–2019|Females|5|85+|||
Relative|Ureteral cancer|2015–2019|Females|5|All ages combined|0.371|0.306|0.438
Observed|Ureteral cancer|2015–2019|Persons|1|00–04|||
Observed|Ureteral cancer|2015–2019|Persons|1|05–09|||
Observed|Ureteral cancer|2015–2019|Persons|1|10–14|||
Observed|Ureteral cancer|2015–2019|Persons|1|15–19|||
Observed|Ureteral cancer|2015–2019|Persons|1|20–24|||
Observed|Ureteral cancer|2015–2019|Persons|1|25–29|||
Observed|Ureteral cancer|2015–2019|Persons|1|30–34|||
Observed|Ureteral cancer|2015–2019|Persons|1|35–39|||
Observed|Ureteral cancer|2015–2019|Persons|1|40–44|||
Observed|Ureteral cancer|2015–2019|Persons|1|45–49|||
Observed|Ureteral cancer|2015–2019|Persons|1|50–54|||
Observed|Ureteral cancer|2015–2019|Persons|1|55–59|0.89|0.734|0.957
Observed|Ureteral cancer|2015–2019|Persons|1|60–64|0.758|0.631|0.846
Observed|Ureteral cancer|2015–2019|Persons|1|65–69|0.784|0.688|0.853
Observed|Ureteral cancer|2015–2019|Persons|1|70–74|0.876|0.797|0.926
Observed|Ureteral cancer|2015–2019|Persons|1|75–79|0.721|0.642|0.786
Observed|Ureteral cancer|2015–2019|Persons|1|80–84|0.717|0.631|0.787
Observed|Ureteral cancer|2015–2019|Persons|1|85+|0.545|0.455|0.627
Observed|Ureteral cancer|2015–2019|Persons|1|All ages combined|0.739|0.706|0.77
Observed|Ureteral cancer|2015–2019|Persons|2|00–04|||
Observed|Ureteral cancer|2015–2019|Persons|2|05–09|||
Observed|Ureteral cancer|2015–2019|Persons|2|10–14|||
Observed|Ureteral cancer|2015–2019|Persons|2|15–19|||
Observed|Ureteral cancer|2015–2019|Persons|2|20–24|||
Observed|Ureteral cancer|2015–2019|Persons|2|25–29|||
Observed|Ureteral cancer|2015–2019|Persons|2|30–34|||
Observed|Ureteral cancer|2015–2019|Persons|2|35–39|||
Observed|Ureteral cancer|2015–2019|Persons|2|40–44|||
Observed|Ureteral cancer|2015–2019|Persons|2|45–49|||
Observed|Ureteral cancer|2015–2019|Persons|2|50–54|||
Observed|Ureteral cancer|2015–2019|Persons|2|55–59|0.803|0.63|0.901
Observed|Ureteral cancer|2015–2019|Persons|2|60–64|0.66|0.522|0.766
Observed|Ureteral cancer|2015–2019|Persons|2|65–69|0.688|0.588|0.769
Observed|Ureteral cancer|2015–2019|Persons|2|70–74|0.723|0.625|0.8
Observed|Ureteral cancer|2015–2019|Persons|2|75–79|0.548|0.465|0.624
Observed|Ureteral cancer|2015–2019|Persons|2|80–84|0.507|0.414|0.592
Observed|Ureteral cancer|2015–2019|Persons|2|85+|0.369|0.285|0.452
Observed|Ureteral cancer|2015–2019|Persons|2|All ages combined|0.586|0.549|0.621
Observed|Ureteral cancer|2015–2019|Persons|3|00–04|||
Observed|Ureteral cancer|2015–2019|Persons|3|05–09|||
Observed|Ureteral cancer|2015–2019|Persons|3|10–14|||
Observed|Ureteral cancer|2015–2019|Persons|3|15–19|||
Observed|Ureteral cancer|2015–2019|Persons|3|20–24|||
Observed|Ureteral cancer|2015–2019|Persons|3|25–29|||
Observed|Ureteral cancer|2015–2019|Persons|3|30–34|||
Observed|Ureteral cancer|2015–2019|Persons|3|35–39|||
Observed|Ureteral cancer|2015–2019|Persons|3|40–44|||
Observed|Ureteral cancer|2015–2019|Persons|3|45–49|||
Observed|Ureteral cancer|2015–2019|Persons|3|50–54|||
Observed|Ureteral cancer|2015–2019|Persons|3|55–59|0.704|0.517|0.829
Observed|Ureteral cancer|2015–2019|Persons|3|60–64|0.557|0.42|0.673
Observed|Ureteral cancer|2015–2019|Persons|3|65–69|0.52|0.419|0.612
Observed|Ureteral cancer|2015–2019|Persons|3|70–74|0.624|0.522|0.71
Observed|Ureteral cancer|2015–2019|Persons|3|75–79|0.425|0.345|0.502
Observed|Ureteral cancer|2015–2019|Persons|3|80–84|0.413|0.324|0.499
Observed|Ureteral cancer|2015–2019|Persons|3|85+|0.246|0.174|0.324
Observed|Ureteral cancer|2015–2019|Persons|3|All ages combined|0.467|0.43|0.504
Observed|Ureteral cancer|2015–2019|Persons|4|00–04|||
Observed|Ureteral cancer|2015–2019|Persons|4|05–09|||
Observed|Ureteral cancer|2015–2019|Persons|4|10–14|||
Observed|Ureteral cancer|2015–2019|Persons|4|15–19|||
Observed|Ureteral cancer|2015–2019|Persons|4|20–24|||
Observed|Ureteral cancer|2015–2019|Persons|4|25–29|||
Observed|Ureteral cancer|2015–2019|Persons|4|30–34|||
Observed|Ureteral cancer|2015–2019|Persons|4|35–39|||
Observed|Ureteral cancer|2015–2019|Persons|4|40–44|||
Observed|Ureteral cancer|2015–2019|Persons|4|45–49|||
Observed|Ureteral cancer|2015–2019|Persons|4|50–54|||
Observed|Ureteral cancer|2015–2019|Persons|4|55–59|0.67|0.481|0.803
Observed|Ureteral cancer|2015–2019|Persons|4|60–64|0.508|0.374|0.627
Observed|Ureteral cancer|2015–2019|Persons|4|65–69|0.501|0.401|0.594
Observed|Ureteral cancer|2015–2019|Persons|4|70–74|0.551|0.448|0.642
Observed|Ureteral cancer|2015–2019|Persons|4|75–79|0.36|0.285|0.436
Observed|Ureteral cancer|2015–2019|Persons|4|80–84|0.344|0.26|0.429
Observed|Ureteral cancer|2015–2019|Persons|4|85+|0.182|0.12|0.256
Observed|Ureteral cancer|2015–2019|Persons|4|All ages combined|0.408|0.372|0.444
Observed|Ureteral cancer|2015–2019|Persons|5|00–04|||
Observed|Ureteral cancer|2015–2019|Persons|5|05–09|||
Observed|Ureteral cancer|2015–2019|Persons|5|10–14|||
Observed|Ureteral cancer|2015–2019|Persons|5|15–19|||
Observed|Ureteral cancer|2015–2019|Persons|5|20–24|||
Observed|Ureteral cancer|2015–2019|Persons|5|25–29|||
Observed|Ureteral cancer|2015–2019|Persons|5|30–34|||
Observed|Ureteral cancer|2015–2019|Persons|5|35–39|||
Observed|Ureteral cancer|2015–2019|Persons|5|40–44|||
Observed|Ureteral cancer|2015–2019|Persons|5|45–49|||
Observed|Ureteral cancer|2015–2019|Persons|5|50–54|||
Observed|Ureteral cancer|2015–2019|Persons|5|55–59|||
Observed|Ureteral cancer|2015–2019|Persons|5|60–64|0.461|0.332|0.581
Observed|Ureteral cancer|2015–2019|Persons|5|65–69|0.464|0.365|0.557
Observed|Ureteral cancer|2015–2019|Persons|5|70–74|0.459|0.357|0.555
Observed|Ureteral cancer|2015–2019|Persons|5|75–79|0.31|0.238|0.385
Observed|Ureteral cancer|2015–2019|Persons|5|80–84|0.279|0.2|0.362
Observed|Ureteral cancer|2015–2019|Persons|5|85+|0.12|0.069|0.185
Observed|Ureteral cancer|2015–2019|Persons|5|All ages combined|0.351|0.316|0.386
Relative|Ureteral cancer|2015–2019|Persons|1|00–04|||
Relative|Ureteral cancer|2015–2019|Persons|1|05–09|||
Relative|Ureteral cancer|2015–2019|Persons|1|10–14|||
Relative|Ureteral cancer|2015–2019|Persons|1|15–19|||
Relative|Ureteral cancer|2015–2019|Persons|1|20–24|||
Relative|Ureteral cancer|2015–2019|Persons|1|25–29|||
Relative|Ureteral cancer|2015–2019|Persons|1|30–34|||
Relative|Ureteral cancer|2015–2019|Persons|1|35–39|||
Relative|Ureteral cancer|2015–2019|Persons|1|40–44|||
Relative|Ureteral cancer|2015–2019|Persons|1|45–49|||
Relative|Ureteral cancer|2015–2019|Persons|1|50–54|||
Relative|Ureteral cancer|2015–2019|Persons|1|55–59|0.895|0.737|0.962
Relative|Ureteral cancer|2015–2019|Persons|1|60–64|0.763|0.635|0.852
Relative|Ureteral cancer|2015–2019|Persons|1|65–69|0.792|0.695|0.862
Relative|Ureteral cancer|2015–2019|Persons|1|70–74|0.892|0.811|0.943
Relative|Ureteral cancer|2015–2019|Persons|1|75–79|0.743|0.661|0.81
Relative|Ureteral cancer|2015–2019|Persons|1|80–84|0.756|0.665|0.829
Relative|Ureteral cancer|2015–2019|Persons|1|85+|0.613|0.511|0.704
Relative|Ureteral cancer|2015–2019|Persons|1|All ages combined|0.769|0.734|0.8
Relative|Ureteral cancer|2015–2019|Persons|2|00–04|||
Relative|Ureteral cancer|2015–2019|Persons|2|05–09|||
Relative|Ureteral cancer|2015–2019|Persons|2|10–14|||
Relative|Ureteral cancer|2015–2019|Persons|2|15–19|||
Relative|Ureteral cancer|2015–2019|Persons|2|20–24|||
Relative|Ureteral cancer|2015–2019|Persons|2|25–29|||
Relative|Ureteral cancer|2015–2019|Persons|2|30–34|||
Relative|Ureteral cancer|2015–2019|Persons|2|35–39|||
Relative|Ureteral cancer|2015–2019|Persons|2|40–44|||
Relative|Ureteral cancer|2015–2019|Persons|2|45–49|||
Relative|Ureteral cancer|2015–2019|Persons|2|50–54|||
Relative|Ureteral cancer|2015–2019|Persons|2|55–59|0.811|0.636|0.91
Relative|Ureteral cancer|2015–2019|Persons|2|60–64|0.669|0.53|0.777
Relative|Ureteral cancer|2015–2019|Persons|2|65–69|0.703|0.601|0.786
Relative|Ureteral cancer|2015–2019|Persons|2|70–74|0.751|0.648|0.83
Relative|Ureteral cancer|2015–2019|Persons|2|75–79|0.583|0.494|0.663
Relative|Ureteral cancer|2015–2019|Persons|2|80–84|0.567|0.464|0.662
Relative|Ureteral cancer|2015–2019|Persons|2|85+|0.469|0.363|0.576
Relative|Ureteral cancer|2015–2019|Persons|2|All ages combined|0.634|0.594|0.672
Relative|Ureteral cancer|2015–2019|Persons|3|00–04|||
Relative|Ureteral cancer|2015–2019|Persons|3|05–09|||
Relative|Ureteral cancer|2015–2019|Persons|3|10–14|||
Relative|Ureteral cancer|2015–2019|Persons|3|15–19|||
Relative|Ureteral cancer|2015–2019|Persons|3|20–24|||
Relative|Ureteral cancer|2015–2019|Persons|3|25–29|||
Relative|Ureteral cancer|2015–2019|Persons|3|30–34|||
Relative|Ureteral cancer|2015–2019|Persons|3|35–39|||
Relative|Ureteral cancer|2015–2019|Persons|3|40–44|||
Relative|Ureteral cancer|2015–2019|Persons|3|45–49|||
Relative|Ureteral cancer|2015–2019|Persons|3|50–54|||
Relative|Ureteral cancer|2015–2019|Persons|3|55–59|0.715|0.526|0.843
Relative|Ureteral cancer|2015–2019|Persons|3|60–64|0.569|0.429|0.688
Relative|Ureteral cancer|2015–2019|Persons|3|65–69|0.539|0.434|0.634
Relative|Ureteral cancer|2015–2019|Persons|3|70–74|0.662|0.554|0.754
Relative|Ureteral cancer|2015–2019|Persons|3|75–79|0.469|0.381|0.553
Relative|Ureteral cancer|2015–2019|Persons|3|80–84|0.498|0.391|0.602
Relative|Ureteral cancer|2015–2019|Persons|3|85+|0.357|0.253|0.47
Relative|Ureteral cancer|2015–2019|Persons|3|All ages combined|0.525|0.483|0.566
Relative|Ureteral cancer|2015–2019|Persons|4|00–04|||
Relative|Ureteral cancer|2015–2019|Persons|4|05–09|||
Relative|Ureteral cancer|2015–2019|Persons|4|10–14|||
Relative|Ureteral cancer|2015–2019|Persons|4|15–19|||
Relative|Ureteral cancer|2015–2019|Persons|4|20–24|||
Relative|Ureteral cancer|2015–2019|Persons|4|25–29|||
Relative|Ureteral cancer|2015–2019|Persons|4|30–34|||
Relative|Ureteral cancer|2015–2019|Persons|4|35–39|||
Relative|Ureteral cancer|2015–2019|Persons|4|40–44|||
Relative|Ureteral cancer|2015–2019|Persons|4|45–49|||
Relative|Ureteral cancer|2015–2019|Persons|4|50–54|||
Relative|Ureteral cancer|2015–2019|Persons|4|55–59|0.685|0.492|0.822
Relative|Ureteral cancer|2015–2019|Persons|4|60–64|0.524|0.386|0.647
Relative|Ureteral cancer|2015–2019|Persons|4|65–69|0.526|0.42|0.623
Relative|Ureteral cancer|2015–2019|Persons|4|70–74|0.598|0.486|0.697
Relative|Ureteral cancer|2015–2019|Persons|4|75–79|0.415|0.328|0.502
Relative|Ureteral cancer|2015–2019|Persons|4|80–84|0.448|0.339|0.56
Relative|Ureteral cancer|2015–2019|Persons|4|85+|0.309|0.202|0.434
Relative|Ureteral cancer|2015–2019|Persons|4|All ages combined|0.477|0.435|0.519
Relative|Ureteral cancer|2015–2019|Persons|5|00–04|||
Relative|Ureteral cancer|2015–2019|Persons|5|05–09|||
Relative|Ureteral cancer|2015–2019|Persons|5|10–14|||
Relative|Ureteral cancer|2015–2019|Persons|5|15–19|||
Relative|Ureteral cancer|2015–2019|Persons|5|20–24|||
Relative|Ureteral cancer|2015–2019|Persons|5|25–29|||
Relative|Ureteral cancer|2015–2019|Persons|5|30–34|||
Relative|Ureteral cancer|2015–2019|Persons|5|35–39|||
Relative|Ureteral cancer|2015–2019|Persons|5|40–44|||
Relative|Ureteral cancer|2015–2019|Persons|5|45–49|||
Relative|Ureteral cancer|2015–2019|Persons|5|50–54|||
Relative|Ureteral cancer|2015–2019|Persons|5|55–59|||
Relative|Ureteral cancer|2015–2019|Persons|5|60–64|0.481|0.346|0.606
Relative|Ureteral cancer|2015–2019|Persons|5|65–69|0.494|0.389|0.593
Relative|Ureteral cancer|2015–2019|Persons|5|70–74|0.512|0.398|0.619
Relative|Ureteral cancer|2015–2019|Persons|5|75–79|0.375|0.287|0.465
Relative|Ureteral cancer|2015–2019|Persons|5|80–84|0.396|0.285|0.515
Relative|Ureteral cancer|2015–2019|Persons|5|85+|0.241|0.139|0.374
Relative|Ureteral cancer|2015–2019|Persons|5|All ages combined|0.428|0.385|0.471
Observed|Urethral cancer|2015–2019|Males|1|00–04|||
Observed|Urethral cancer|2015–2019|Males|1|05–09|||
Observed|Urethral cancer|2015–2019|Males|1|10–14|||
Observed|Urethral cancer|2015–2019|Males|1|15–19|||
Observed|Urethral cancer|2015–2019|Males|1|20–24|||
Observed|Urethral cancer|2015–2019|Males|1|25–29|||
Observed|Urethral cancer|2015–2019|Males|1|30–34|||
Observed|Urethral cancer|2015–2019|Males|1|35–39|||
Observed|Urethral cancer|2015–2019|Males|1|40–44|||
Observed|Urethral cancer|2015–2019|Males|1|45–49|||
Observed|Urethral cancer|2015–2019|Males|1|50–54|||
Observed|Urethral cancer|2015–2019|Males|1|55–59|||
Observed|Urethral cancer|2015–2019|Males|1|60–64|||
Observed|Urethral cancer|2015–2019|Males|1|65–69|||
Observed|Urethral cancer|2015–2019|Males|1|70–74|0.787|0.563|0.905
Observed|Urethral cancer|2015–2019|Males|1|75–79|||
Observed|Urethral cancer|2015–2019|Males|1|80–84|||
Observed|Urethral cancer|2015–2019|Males|1|85+|||
Observed|Urethral cancer|2015–2019|Males|1|All ages combined|0.757|0.67|0.824
Observed|Urethral cancer|2015–2019|Males|2|00–04|||
Observed|Urethral cancer|2015–2019|Males|2|05–09|||
Observed|Urethral cancer|2015–2019|Males|2|10–14|||
Observed|Urethral cancer|2015–2019|Males|2|15–19|||
Observed|Urethral cancer|2015–2019|Males|2|20–24|||
Observed|Urethral cancer|2015–2019|Males|2|25–29|||
Observed|Urethral cancer|2015–2019|Males|2|30–34|||
Observed|Urethral cancer|2015–2019|Males|2|35–39|||
Observed|Urethral cancer|2015–2019|Males|2|40–44|||
Observed|Urethral cancer|2015–2019|Males|2|45–49|||
Observed|Urethral cancer|2015–2019|Males|2|50–54|||
Observed|Urethral cancer|2015–2019|Males|2|55–59|||
Observed|Urethral cancer|2015–2019|Males|2|60–64|||
Observed|Urethral cancer|2015–2019|Males|2|65–69|||
Observed|Urethral cancer|2015–2019|Males|2|70–74|||
Observed|Urethral cancer|2015–2019|Males|2|75–79|||
Observed|Urethral cancer|2015–2019|Males|2|80–84|||
Observed|Urethral cancer|2015–2019|Males|2|85+|||
Observed|Urethral cancer|2015–2019|Males|2|All ages combined|0.596|0.501|0.679
Observed|Urethral cancer|2015–2019|Males|3|00–04|||
Observed|Urethral cancer|2015–2019|Males|3|05–09|||
Observed|Urethral cancer|2015–2019|Males|3|10–14|||
Observed|Urethral cancer|2015–2019|Males|3|15–19|||
Observed|Urethral cancer|2015–2019|Males|3|20–24|||
Observed|Urethral cancer|2015–2019|Males|3|25–29|||
Observed|Urethral cancer|2015–2019|Males|3|30–34|||
Observed|Urethral cancer|2015–2019|Males|3|35–39|||
Observed|Urethral cancer|2015–2019|Males|3|40–44|||
Observed|Urethral cancer|2015–2019|Males|3|45–49|||
Observed|Urethral cancer|2015–2019|Males|3|50–54|||
Observed|Urethral cancer|2015–2019|Males|3|55–59|||
Observed|Urethral cancer|2015–2019|Males|3|60–64|||
Observed|Urethral cancer|2015–2019|Males|3|65–69|||
Observed|Urethral cancer|2015–2019|Males|3|70–74|||
Observed|Urethral cancer|2015–2019|Males|3|75–79|||
Observed|Urethral cancer|2015–2019|Males|3|80–84|||
Observed|Urethral cancer|2015–2019|Males|3|85+|||
Observed|Urethral cancer|2015–2019|Males|3|All ages combined|0.512|0.417|0.599
Observed|Urethral cancer|2015–2019|Males|4|00–04|||
Observed|Urethral cancer|2015–2019|Males|4|05–09|||
Observed|Urethral cancer|2015–2019|Males|4|10–14|||
Observed|Urethral cancer|2015–2019|Males|4|15–19|||
Observed|Urethral cancer|2015–2019|Males|4|20–24|||
Observed|Urethral cancer|2015–2019|Males|4|25–29|||
Observed|Urethral cancer|2015–2019|Males|4|30–34|||
Observed|Urethral cancer|2015–2019|Males|4|35–39|||
Observed|Urethral cancer|2015–2019|Males|4|40–44|||
Observed|Urethral cancer|2015–2019|Males|4|45–49|||
Observed|Urethral cancer|2015–2019|Males|4|50–54|||
Observed|Urethral cancer|2015–2019|Males|4|55–59|||
Observed|Urethral cancer|2015–2019|Males|4|60–64|||
Observed|Urethral cancer|2015–2019|Males|4|65–69|||
Observed|Urethral cancer|2015–2019|Males|4|70–74|||
Observed|Urethral cancer|2015–2019|Males|4|75–79|||
Observed|Urethral cancer|2015–2019|Males|4|80–84|||
Observed|Urethral cancer|2015–2019|Males|4|85+|||
Observed|Urethral cancer|2015–2019|Males|4|All ages combined|0.434|0.34|0.524
Observed|Urethral cancer|2015–2019|Males|5|00–04|||
Observed|Urethral cancer|2015–2019|Males|5|05–09|||
Observed|Urethral cancer|2015–2019|Males|5|10–14|||
Observed|Urethral cancer|2015–2019|Males|5|15–19|||
Observed|Urethral cancer|2015–2019|Males|5|20–24|||
Observed|Urethral cancer|2015–2019|Males|5|25–29|||
Observed|Urethral cancer|2015–2019|Males|5|30–34|||
Observed|Urethral cancer|2015–2019|Males|5|35–39|||
Observed|Urethral cancer|2015–2019|Males|5|40–44|||
Observed|Urethral cancer|2015–2019|Males|5|45–49|||
Observed|Urethral cancer|2015–2019|Males|5|50–54|||
Observed|Urethral cancer|2015–2019|Males|5|55–59|||
Observed|Urethral cancer|2015–2019|Males|5|60–64|||
Observed|Urethral cancer|2015–2019|Males|5|65–69|||
Observed|Urethral cancer|2015–2019|Males|5|70–74|||
Observed|Urethral cancer|2015–2019|Males|5|75–79|||
Observed|Urethral cancer|2015–2019|Males|5|80–84|||
Observed|Urethral cancer|2015–2019|Males|5|85+|||
Observed|Urethral cancer|2015–2019|Males|5|All ages combined|0.367|0.278|0.457
Relative|Urethral cancer|2015–2019|Males|1|00–04|||
Relative|Urethral cancer|2015–2019|Males|1|05–09|||
Relative|Urethral cancer|2015–2019|Males|1|10–14|||
Relative|Urethral cancer|2015–2019|Males|1|15–19|||
Relative|Urethral cancer|2015–2019|Males|1|20–24|||
Relative|Urethral cancer|2015–2019|Males|1|25–29|||
Relative|Urethral cancer|2015–2019|Males|1|30–34|||
Relative|Urethral cancer|2015–2019|Males|1|35–39|||
Relative|Urethral cancer|2015–2019|Males|1|40–44|||
Relative|Urethral cancer|2015–2019|Males|1|45–49|||
Relative|Urethral cancer|2015–2019|Males|1|50–54|||
Relative|Urethral cancer|2015–2019|Males|1|55–59|||
Relative|Urethral cancer|2015–2019|Males|1|60–64|||
Relative|Urethral cancer|2015–2019|Males|1|65–69|||
Relative|Urethral cancer|2015–2019|Males|1|70–74|0.803|0.575|0.924
Relative|Urethral cancer|2015–2019|Males|1|75–79|||
Relative|Urethral cancer|2015–2019|Males|1|80–84|||
Relative|Urethral cancer|2015–2019|Males|1|85+|||
Relative|Urethral cancer|2015–2019|Males|1|All ages combined|0.789|0.698|0.859
Relative|Urethral cancer|2015–2019|Males|2|00–04|||
Relative|Urethral cancer|2015–2019|Males|2|05–09|||
Relative|Urethral cancer|2015–2019|Males|2|10–14|||
Relative|Urethral cancer|2015–2019|Males|2|15–19|||
Relative|Urethral cancer|2015–2019|Males|2|20–24|||
Relative|Urethral cancer|2015–2019|Males|2|25–29|||
Relative|Urethral cancer|2015–2019|Males|2|30–34|||
Relative|Urethral cancer|2015–2019|Males|2|35–39|||
Relative|Urethral cancer|2015–2019|Males|2|40–44|||
Relative|Urethral cancer|2015–2019|Males|2|45–49|||
Relative|Urethral cancer|2015–2019|Males|2|50–54|||
Relative|Urethral cancer|2015–2019|Males|2|55–59|||
Relative|Urethral cancer|2015–2019|Males|2|60–64|||
Relative|Urethral cancer|2015–2019|Males|2|65–69|||
Relative|Urethral cancer|2015–2019|Males|2|70–74|||
Relative|Urethral cancer|2015–2019|Males|2|75–79|||
Relative|Urethral cancer|2015–2019|Males|2|80–84|||
Relative|Urethral cancer|2015–2019|Males|2|85+|||
Relative|Urethral cancer|2015–2019|Males|2|All ages combined|0.645|0.542|0.735
Relative|Urethral cancer|2015–2019|Males|3|00–04|||
Relative|Urethral cancer|2015–2019|Males|3|05–09|||
Relative|Urethral cancer|2015–2019|Males|3|10–14|||
Relative|Urethral cancer|2015–2019|Males|3|15–19|||
Relative|Urethral cancer|2015–2019|Males|3|20–24|||
Relative|Urethral cancer|2015–2019|Males|3|25–29|||
Relative|Urethral cancer|2015–2019|Males|3|30–34|||
Relative|Urethral cancer|2015–2019|Males|3|35–39|||
Relative|Urethral cancer|2015–2019|Males|3|40–44|||
Relative|Urethral cancer|2015–2019|Males|3|45–49|||
Relative|Urethral cancer|2015–2019|Males|3|50–54|||
Relative|Urethral cancer|2015–2019|Males|3|55–59|||
Relative|Urethral cancer|2015–2019|Males|3|60–64|||
Relative|Urethral cancer|2015–2019|Males|3|65–69|||
Relative|Urethral cancer|2015–2019|Males|3|70–74|||
Relative|Urethral cancer|2015–2019|Males|3|75–79|||
Relative|Urethral cancer|2015–2019|Males|3|80–84|||
Relative|Urethral cancer|2015–2019|Males|3|85+|||
Relative|Urethral cancer|2015–2019|Males|3|All ages combined|0.579|0.471|0.678
Relative|Urethral cancer|2015–2019|Males|4|00–04|||
Relative|Urethral cancer|2015–2019|Males|4|05–09|||
Relative|Urethral cancer|2015–2019|Males|4|10–14|||
Relative|Urethral cancer|2015–2019|Males|4|15–19|||
Relative|Urethral cancer|2015–2019|Males|4|20–24|||
Relative|Urethral cancer|2015–2019|Males|4|25–29|||
Relative|Urethral cancer|2015–2019|Males|4|30–34|||
Relative|Urethral cancer|2015–2019|Males|4|35–39|||
Relative|Urethral cancer|2015–2019|Males|4|40–44|||
Relative|Urethral cancer|2015–2019|Males|4|45–49|||
Relative|Urethral cancer|2015–2019|Males|4|50–54|||
Relative|Urethral cancer|2015–2019|Males|4|55–59|||
Relative|Urethral cancer|2015–2019|Males|4|60–64|||
Relative|Urethral cancer|2015–2019|Males|4|65–69|||
Relative|Urethral cancer|2015–2019|Males|4|70–74|||
Relative|Urethral cancer|2015–2019|Males|4|75–79|||
Relative|Urethral cancer|2015–2019|Males|4|80–84|||
Relative|Urethral cancer|2015–2019|Males|4|85+|||
Relative|Urethral cancer|2015–2019|Males|4|All ages combined|0.519|0.407|0.626
Relative|Urethral cancer|2015–2019|Males|5|00–04|||
Relative|Urethral cancer|2015–2019|Males|5|05–09|||
Relative|Urethral cancer|2015–2019|Males|5|10–14|||
Relative|Urethral cancer|2015–2019|Males|5|15–19|||
Relative|Urethral cancer|2015–2019|Males|5|20–24|||
Relative|Urethral cancer|2015–2019|Males|5|25–29|||
Relative|Urethral cancer|2015–2019|Males|5|30–34|||
Relative|Urethral cancer|2015–2019|Males|5|35–39|||
Relative|Urethral cancer|2015–2019|Males|5|40–44|||
Relative|Urethral cancer|2015–2019|Males|5|45–49|||
Relative|Urethral cancer|2015–2019|Males|5|50–54|||
Relative|Urethral cancer|2015–2019|Males|5|55–59|||
Relative|Urethral cancer|2015–2019|Males|5|60–64|||
Relative|Urethral cancer|2015–2019|Males|5|65–69|||
Relative|Urethral cancer|2015–2019|Males|5|70–74|||
Relative|Urethral cancer|2015–2019|Males|5|75–79|||
Relative|Urethral cancer|2015–2019|Males|5|80–84|||
Relative|Urethral cancer|2015–2019|Males|5|85+|||
Relative|Urethral cancer|2015–2019|Males|5|All ages combined|0.461|0.348|0.573
Observed|Urethral cancer|2015–2019|Females|1|00–04|||
Observed|Urethral cancer|2015–2019|Females|1|05–09|||
Observed|Urethral cancer|2015–2019|Females|1|10–14|||
Observed|Urethral cancer|2015–2019|Females|1|15–19|||
Observed|Urethral cancer|2015–2019|Females|1|20–24|||
Observed|Urethral cancer|2015–2019|Females|1|25–29|||
Observed|Urethral cancer|2015–2019|Females|1|30–34|||
Observed|Urethral cancer|2015–2019|Females|1|35–39|||
Observed|Urethral cancer|2015–2019|Females|1|40–44|||
Observed|Urethral cancer|2015–2019|Females|1|45–49|||
Observed|Urethral cancer|2015–2019|Females|1|50–54|||
Observed|Urethral cancer|2015–2019|Females|1|55–59|||
Observed|Urethral cancer|2015–2019|Females|1|60–64|||
Observed|Urethral cancer|2015–2019|Females|1|65–69|||
Observed|Urethral cancer|2015–2019|Females|1|70–74|||
Observed|Urethral cancer|2015–2019|Females|1|75–79|||
Observed|Urethral cancer|2015–2019|Females|1|80–84|||
Observed|Urethral cancer|2015–2019|Females|1|85+|||
Observed|Urethral cancer|2015–2019|Females|1|All ages combined|0.728|0.572|0.835
Observed|Urethral cancer|2015–2019|Females|2|00–04|||
Observed|Urethral cancer|2015–2019|Females|2|05–09|||
Observed|Urethral cancer|2015–2019|Females|2|10–14|||
Observed|Urethral cancer|2015–2019|Females|2|15–19|||
Observed|Urethral cancer|2015–2019|Females|2|20–24|||
Observed|Urethral cancer|2015–2019|Females|2|25–29|||
Observed|Urethral cancer|2015–2019|Females|2|30–34|||
Observed|Urethral cancer|2015–2019|Females|2|35–39|||
Observed|Urethral cancer|2015–2019|Females|2|40–44|||
Observed|Urethral cancer|2015–2019|Females|2|45–49|||
Observed|Urethral cancer|2015–2019|Females|2|50–54|||
Observed|Urethral cancer|2015–2019|Females|2|55–59|||
Observed|Urethral cancer|2015–2019|Females|2|60–64|||
Observed|Urethral cancer|2015–2019|Females|2|65–69|||
Observed|Urethral cancer|2015–2019|Females|2|70–74|||
Observed|Urethral cancer|2015–2019|Females|2|75–79|||
Observed|Urethral cancer|2015–2019|Females|2|80–84|||
Observed|Urethral cancer|2015–2019|Females|2|85+|||
Observed|Urethral cancer|2015–2019|Females|2|All ages combined|0.528|0.368|0.665
Observed|Urethral cancer|2015–2019|Females|3|00–04|||
Observed|Urethral cancer|2015–2019|Females|3|05–09|||
Observed|Urethral cancer|2015–2019|Females|3|10–14|||
Observed|Urethral cancer|2015–2019|Females|3|15–19|||
Observed|Urethral cancer|2015–2019|Females|3|20–24|||
Observed|Urethral cancer|2015–2019|Females|3|25–29|||
Observed|Urethral cancer|2015–2019|Females|3|30–34|||
Observed|Urethral cancer|2015–2019|Females|3|35–39|||
Observed|Urethral cancer|2015–2019|Females|3|40–44|||
Observed|Urethral cancer|2015–2019|Females|3|45–49|||
Observed|Urethral cancer|2015–2019|Females|3|50–54|||
Observed|Urethral cancer|2015–2019|Females|3|55–59|||
Observed|Urethral cancer|2015–2019|Females|3|60–64|||
Observed|Urethral cancer|2015–2019|Females|3|65–69|||
Observed|Urethral cancer|2015–2019|Females|3|70–74|||
Observed|Urethral cancer|2015–2019|Females|3|75–79|||
Observed|Urethral cancer|2015–2019|Females|3|80–84|||
Observed|Urethral cancer|2015–2019|Females|3|85+|||
Observed|Urethral cancer|2015–2019|Females|3|All ages combined|0.462|0.309|0.601
Observed|Urethral cancer|2015–2019|Females|4|00–04|||
Observed|Urethral cancer|2015–2019|Females|4|05–09|||
Observed|Urethral cancer|2015–2019|Females|4|10–14|||
Observed|Urethral cancer|2015–2019|Females|4|15–19|||
Observed|Urethral cancer|2015–2019|Females|4|20–24|||
Observed|Urethral cancer|2015–2019|Females|4|25–29|||
Observed|Urethral cancer|2015–2019|Females|4|30–34|||
Observed|Urethral cancer|2015–2019|Females|4|35–39|||
Observed|Urethral cancer|2015–2019|Females|4|40–44|||
Observed|Urethral cancer|2015–2019|Females|4|45–49|||
Observed|Urethral cancer|2015–2019|Females|4|50–54|||
Observed|Urethral cancer|2015–2019|Females|4|55–59|||
Observed|Urethral cancer|2015–2019|Females|4|60–64|||
Observed|Urethral cancer|2015–2019|Females|4|65–69|||
Observed|Urethral cancer|2015–2019|Females|4|70–74|||
Observed|Urethral cancer|2015–2019|Females|4|75–79|||
Observed|Urethral cancer|2015–2019|Females|4|80–84|||
Observed|Urethral cancer|2015–2019|Females|4|85+|||
Observed|Urethral cancer|2015–2019|Females|4|All ages combined|0.384|0.244|0.522
Observed|Urethral cancer|2015–2019|Females|5|00–04|||
Observed|Urethral cancer|2015–2019|Females|5|05–09|||
Observed|Urethral cancer|2015–2019|Females|5|10–14|||
Observed|Urethral cancer|2015–2019|Females|5|15–19|||
Observed|Urethral cancer|2015–2019|Females|5|20–24|||
Observed|Urethral cancer|2015–2019|Females|5|25–29|||
Observed|Urethral cancer|2015–2019|Females|5|30–34|||
Observed|Urethral cancer|2015–2019|Females|5|35–39|||
Observed|Urethral cancer|2015–2019|Females|5|40–44|||
Observed|Urethral cancer|2015–2019|Females|5|45–49|||
Observed|Urethral cancer|2015–2019|Females|5|50–54|||
Observed|Urethral cancer|2015–2019|Females|5|55–59|||
Observed|Urethral cancer|2015–2019|Females|5|60–64|||
Observed|Urethral cancer|2015–2019|Females|5|65–69|||
Observed|Urethral cancer|2015–2019|Females|5|70–74|||
Observed|Urethral cancer|2015–2019|Females|5|75–79|||
Observed|Urethral cancer|2015–2019|Females|5|80–84|||
Observed|Urethral cancer|2015–2019|Females|5|85+|||
Observed|Urethral cancer|2015–2019|Females|5|All ages combined|0.349|0.217|0.485
Relative|Urethral cancer|2015–2019|Females|1|00–04|||
Relative|Urethral cancer|2015–2019|Females|1|05–09|||
Relative|Urethral cancer|2015–2019|Females|1|10–14|||
Relative|Urethral cancer|2015–2019|Females|1|15–19|||
Relative|Urethral cancer|2015–2019|Females|1|20–24|||
Relative|Urethral cancer|2015–2019|Females|1|25–29|||
Relative|Urethral cancer|2015–2019|Females|1|30–34|||
Relative|Urethral cancer|2015–2019|Females|1|35–39|||
Relative|Urethral cancer|2015–2019|Females|1|40–44|||
Relative|Urethral cancer|2015–2019|Females|1|45–49|||
Relative|Urethral cancer|2015–2019|Females|1|50–54|||
Relative|Urethral cancer|2015–2019|Females|1|55–59|||
Relative|Urethral cancer|2015–2019|Females|1|60–64|||
Relative|Urethral cancer|2015–2019|Females|1|65–69|||
Relative|Urethral cancer|2015–2019|Females|1|70–74|||
Relative|Urethral cancer|2015–2019|Females|1|75–79|||
Relative|Urethral cancer|2015–2019|Females|1|80–84|||
Relative|Urethral cancer|2015–2019|Females|1|85+|||
Relative|Urethral cancer|2015–2019|Females|1|All ages combined|0.752|0.591|0.863
Relative|Urethral cancer|2015–2019|Females|2|00–04|||
Relative|Urethral cancer|2015–2019|Females|2|05–09|||
Relative|Urethral cancer|2015–2019|Females|2|10–14|||
Relative|Urethral cancer|2015–2019|Females|2|15–19|||
Relative|Urethral cancer|2015–2019|Females|2|20–24|||
Relative|Urethral cancer|2015–2019|Females|2|25–29|||
Relative|Urethral cancer|2015–2019|Females|2|30–34|||
Relative|Urethral cancer|2015–2019|Females|2|35–39|||
Relative|Urethral cancer|2015–2019|Females|2|40–44|||
Relative|Urethral cancer|2015–2019|Females|2|45–49|||
Relative|Urethral cancer|2015–2019|Females|2|50–54|||
Relative|Urethral cancer|2015–2019|Females|2|55–59|||
Relative|Urethral cancer|2015–2019|Females|2|60–64|||
Relative|Urethral cancer|2015–2019|Females|2|65–69|||
Relative|Urethral cancer|2015–2019|Females|2|70–74|||
Relative|Urethral cancer|2015–2019|Females|2|75–79|||
Relative|Urethral cancer|2015–2019|Females|2|80–84|||
Relative|Urethral cancer|2015–2019|Females|2|85+|||
Relative|Urethral cancer|2015–2019|Females|2|All ages combined|0.561|0.391|0.707
Relative|Urethral cancer|2015–2019|Females|3|00–04|||
Relative|Urethral cancer|2015–2019|Females|3|05–09|||
Relative|Urethral cancer|2015–2019|Females|3|10–14|||
Relative|Urethral cancer|2015–2019|Females|3|15–19|||
Relative|Urethral cancer|2015–2019|Females|3|20–24|||
Relative|Urethral cancer|2015–2019|Females|3|25–29|||
Relative|Urethral cancer|2015–2019|Females|3|30–34|||
Relative|Urethral cancer|2015–2019|Females|3|35–39|||
Relative|Urethral cancer|2015–2019|Females|3|40–44|||
Relative|Urethral cancer|2015–2019|Females|3|45–49|||
Relative|Urethral cancer|2015–2019|Females|3|50–54|||
Relative|Urethral cancer|2015–2019|Females|3|55–59|||
Relative|Urethral cancer|2015–2019|Females|3|60–64|||
Relative|Urethral cancer|2015–2019|Females|3|65–69|||
Relative|Urethral cancer|2015–2019|Females|3|70–74|||
Relative|Urethral cancer|2015–2019|Females|3|75–79|||
Relative|Urethral cancer|2015–2019|Females|3|80–84|||
Relative|Urethral cancer|2015–2019|Females|3|85+|||
Relative|Urethral cancer|2015–2019|Females|3|All ages combined|0.499|0.334|0.651
Relative|Urethral cancer|2015–2019|Females|4|00–04|||
Relative|Urethral cancer|2015–2019|Females|4|05–09|||
Relative|Urethral cancer|2015–2019|Females|4|10–14|||
Relative|Urethral cancer|2015–2019|Females|4|15–19|||
Relative|Urethral cancer|2015–2019|Females|4|20–24|||
Relative|Urethral cancer|2015–2019|Females|4|25–29|||
Relative|Urethral cancer|2015–2019|Females|4|30–34|||
Relative|Urethral cancer|2015–2019|Females|4|35–39|||
Relative|Urethral cancer|2015–2019|Females|4|40–44|||
Relative|Urethral cancer|2015–2019|Females|4|45–49|||
Relative|Urethral cancer|2015–2019|Females|4|50–54|||
Relative|Urethral cancer|2015–2019|Females|4|55–59|||
Relative|Urethral cancer|2015–2019|Females|4|60–64|||
Relative|Urethral cancer|2015–2019|Females|4|65–69|||
Relative|Urethral cancer|2015–2019|Females|4|70–74|||
Relative|Urethral cancer|2015–2019|Females|4|75–79|||
Relative|Urethral cancer|2015–2019|Females|4|80–84|||
Relative|Urethral cancer|2015–2019|Females|4|85+|||
Relative|Urethral cancer|2015–2019|Females|4|All ages combined|0.427|0.271|0.58
Relative|Urethral cancer|2015–2019|Females|5|00–04|||
Relative|Urethral cancer|2015–2019|Females|5|05–09|||
Relative|Urethral cancer|2015–2019|Females|5|10–14|||
Relative|Urethral cancer|2015–2019|Females|5|15–19|||
Relative|Urethral cancer|2015–2019|Females|5|20–24|||
Relative|Urethral cancer|2015–2019|Females|5|25–29|||
Relative|Urethral cancer|2015–2019|Females|5|30–34|||
Relative|Urethral cancer|2015–2019|Females|5|35–39|||
Relative|Urethral cancer|2015–2019|Females|5|40–44|||
Relative|Urethral cancer|2015–2019|Females|5|45–49|||
Relative|Urethral cancer|2015–2019|Females|5|50–54|||
Relative|Urethral cancer|2015–2019|Females|5|55–59|||
Relative|Urethral cancer|2015–2019|Females|5|60–64|||
Relative|Urethral cancer|2015–2019|Females|5|65–69|||
Relative|Urethral cancer|2015–2019|Females|5|70–74|||
Relative|Urethral cancer|2015–2019|Females|5|75–79|||
Relative|Urethral cancer|2015–2019|Females|5|80–84|||
Relative|Urethral cancer|2015–2019|Females|5|85+|||
Relative|Urethral cancer|2015–2019|Females|5|All ages combined|0.398|0.247|0.552
Observed|Urethral cancer|2015–2019|Persons|1|00–04|||
Observed|Urethral cancer|2015–2019|Persons|1|05–09|||
Observed|Urethral cancer|2015–2019|Persons|1|10–14|||
Observed|Urethral cancer|2015–2019|Persons|1|15–19|||
Observed|Urethral cancer|2015–2019|Persons|1|20–24|||
Observed|Urethral cancer|2015–2019|Persons|1|25–29|||
Observed|Urethral cancer|2015–2019|Persons|1|30–34|||
Observed|Urethral cancer|2015–2019|Persons|1|35–39|||
Observed|Urethral cancer|2015–2019|Persons|1|40–44|||
Observed|Urethral cancer|2015–2019|Persons|1|45–49|||
Observed|Urethral cancer|2015–2019|Persons|1|50–54|||
Observed|Urethral cancer|2015–2019|Persons|1|55–59|||
Observed|Urethral cancer|2015–2019|Persons|1|60–64|||
Observed|Urethral cancer|2015–2019|Persons|1|65–69|||
Observed|Urethral cancer|2015–2019|Persons|1|70–74|0.758|0.559|0.876
Observed|Urethral cancer|2015–2019|Persons|1|75–79|0.764|0.549|0.886
Observed|Urethral cancer|2015–2019|Persons|1|80–84|0.669|0.462|0.811
Observed|Urethral cancer|2015–2019|Persons|1|85+|||
Observed|Urethral cancer|2015–2019|Persons|1|All ages combined|0.75|0.676|0.809
Observed|Urethral cancer|2015–2019|Persons|2|00–04|||
Observed|Urethral cancer|2015–2019|Persons|2|05–09|||
Observed|Urethral cancer|2015–2019|Persons|2|10–14|||
Observed|Urethral cancer|2015–2019|Persons|2|15–19|||
Observed|Urethral cancer|2015–2019|Persons|2|20–24|||
Observed|Urethral cancer|2015–2019|Persons|2|25–29|||
Observed|Urethral cancer|2015–2019|Persons|2|30–34|||
Observed|Urethral cancer|2015–2019|Persons|2|35–39|||
Observed|Urethral cancer|2015–2019|Persons|2|40–44|||
Observed|Urethral cancer|2015–2019|Persons|2|45–49|||
Observed|Urethral cancer|2015–2019|Persons|2|50–54|||
Observed|Urethral cancer|2015–2019|Persons|2|55–59|||
Observed|Urethral cancer|2015–2019|Persons|2|60–64|||
Observed|Urethral cancer|2015–2019|Persons|2|65–69|||
Observed|Urethral cancer|2015–2019|Persons|2|70–74|||
Observed|Urethral cancer|2015–2019|Persons|2|75–79|||
Observed|Urethral cancer|2015–2019|Persons|2|80–84|||
Observed|Urethral cancer|2015–2019|Persons|2|85+|||
Observed|Urethral cancer|2015–2019|Persons|2|All ages combined|0.578|0.497|0.65
Observed|Urethral cancer|2015–2019|Persons|3|00–04|||
Observed|Urethral cancer|2015–2019|Persons|3|05–09|||
Observed|Urethral cancer|2015–2019|Persons|3|10–14|||
Observed|Urethral cancer|2015–2019|Persons|3|15–19|||
Observed|Urethral cancer|2015–2019|Persons|3|20–24|||
Observed|Urethral cancer|2015–2019|Persons|3|25–29|||
Observed|Urethral cancer|2015–2019|Persons|3|30–34|||
Observed|Urethral cancer|2015–2019|Persons|3|35–39|||
Observed|Urethral cancer|2015–2019|Persons|3|40–44|||
Observed|Urethral cancer|2015–2019|Persons|3|45–49|||
Observed|Urethral cancer|2015–2019|Persons|3|50–54|||
Observed|Urethral cancer|2015–2019|Persons|3|55–59|||
Observed|Urethral cancer|2015–2019|Persons|3|60–64|||
Observed|Urethral cancer|2015–2019|Persons|3|65–69|||
Observed|Urethral cancer|2015–2019|Persons|3|70–74|||
Observed|Urethral cancer|2015–2019|Persons|3|75–79|||
Observed|Urethral cancer|2015–2019|Persons|3|80–84|||
Observed|Urethral cancer|2015–2019|Persons|3|85+|||
Observed|Urethral cancer|2015–2019|Persons|3|All ages combined|0.499|0.418|0.574
Observed|Urethral cancer|2015–2019|Persons|4|00–04|||
Observed|Urethral cancer|2015–2019|Persons|4|05–09|||
Observed|Urethral cancer|2015–2019|Persons|4|10–14|||
Observed|Urethral cancer|2015–2019|Persons|4|15–19|||
Observed|Urethral cancer|2015–2019|Persons|4|20–24|||
Observed|Urethral cancer|2015–2019|Persons|4|25–29|||
Observed|Urethral cancer|2015–2019|Persons|4|30–34|||
Observed|Urethral cancer|2015–2019|Persons|4|35–39|||
Observed|Urethral cancer|2015–2019|Persons|4|40–44|||
Observed|Urethral cancer|2015–2019|Persons|4|45–49|||
Observed|Urethral cancer|2015–2019|Persons|4|50–54|||
Observed|Urethral cancer|2015–2019|Persons|4|55–59|||
Observed|Urethral cancer|2015–2019|Persons|4|60–64|||
Observed|Urethral cancer|2015–2019|Persons|4|65–69|||
Observed|Urethral cancer|2015–2019|Persons|4|70–74|||
Observed|Urethral cancer|2015–2019|Persons|4|75–79|||
Observed|Urethral cancer|2015–2019|Persons|4|80–84|||
Observed|Urethral cancer|2015–2019|Persons|4|85+|||
Observed|Urethral cancer|2015–2019|Persons|4|All ages combined|0.42|0.342|0.496
Observed|Urethral cancer|2015–2019|Persons|5|00–04|||
Observed|Urethral cancer|2015–2019|Persons|5|05–09|||
Observed|Urethral cancer|2015–2019|Persons|5|10–14|||
Observed|Urethral cancer|2015–2019|Persons|5|15–19|||
Observed|Urethral cancer|2015–2019|Persons|5|20–24|||
Observed|Urethral cancer|2015–2019|Persons|5|25–29|||
Observed|Urethral cancer|2015–2019|Persons|5|30–34|||
Observed|Urethral cancer|2015–2019|Persons|5|35–39|||
Observed|Urethral cancer|2015–2019|Persons|5|40–44|||
Observed|Urethral cancer|2015–2019|Persons|5|45–49|||
Observed|Urethral cancer|2015–2019|Persons|5|50–54|||
Observed|Urethral cancer|2015–2019|Persons|5|55–59|||
Observed|Urethral cancer|2015–2019|Persons|5|60–64|||
Observed|Urethral cancer|2015–2019|Persons|5|65–69|||
Observed|Urethral cancer|2015–2019|Persons|5|70–74|||
Observed|Urethral cancer|2015–2019|Persons|5|75–79|||
Observed|Urethral cancer|2015–2019|Persons|5|80–84|||
Observed|Urethral cancer|2015–2019|Persons|5|85+|||
Observed|Urethral cancer|2015–2019|Persons|5|All ages combined|0.364|0.289|0.439
Relative|Urethral cancer|2015–2019|Persons|1|00–04|||
Relative|Urethral cancer|2015–2019|Persons|1|05–09|||
Relative|Urethral cancer|2015–2019|Persons|1|10–14|||
Relative|Urethral cancer|2015–2019|Persons|1|15–19|||
Relative|Urethral cancer|2015–2019|Persons|1|20–24|||
Relative|Urethral cancer|2015–2019|Persons|1|25–29|||
Relative|Urethral cancer|2015–2019|Persons|1|30–34|||
Relative|Urethral cancer|2015–2019|Persons|1|35–39|||
Relative|Urethral cancer|2015–2019|Persons|1|40–44|||
Relative|Urethral cancer|2015–2019|Persons|1|45–49|||
Relative|Urethral cancer|2015–2019|Persons|1|50–54|||
Relative|Urethral cancer|2015–2019|Persons|1|55–59|||
Relative|Urethral cancer|2015–2019|Persons|1|60–64|||
Relative|Urethral cancer|2015–2019|Persons|1|65–69|||
Relative|Urethral cancer|2015–2019|Persons|1|70–74|0.772|0.569|0.892
Relative|Urethral cancer|2015–2019|Persons|1|75–79|0.788|0.566|0.914
Relative|Urethral cancer|2015–2019|Persons|1|80–84|0.71|0.49|0.861
Relative|Urethral cancer|2015–2019|Persons|1|85+|||
Relative|Urethral cancer|2015–2019|Persons|1|All ages combined|0.779|0.703|0.841
Relative|Urethral cancer|2015–2019|Persons|2|00–04|||
Relative|Urethral cancer|2015–2019|Persons|2|05–09|||
Relative|Urethral cancer|2015–2019|Persons|2|10–14|||
Relative|Urethral cancer|2015–2019|Persons|2|15–19|||
Relative|Urethral cancer|2015–2019|Persons|2|20–24|||
Relative|Urethral cancer|2015–2019|Persons|2|25–29|||
Relative|Urethral cancer|2015–2019|Persons|2|30–34|||
Relative|Urethral cancer|2015–2019|Persons|2|35–39|||
Relative|Urethral cancer|2015–2019|Persons|2|40–44|||
Relative|Urethral cancer|2015–2019|Persons|2|45–49|||
Relative|Urethral cancer|2015–2019|Persons|2|50–54|||
Relative|Urethral cancer|2015–2019|Persons|2|55–59|||
Relative|Urethral cancer|2015–2019|Persons|2|60–64|||
Relative|Urethral cancer|2015–2019|Persons|2|65–69|||
Relative|Urethral cancer|2015–2019|Persons|2|70–74|||
Relative|Urethral cancer|2015–2019|Persons|2|75–79|||
Relative|Urethral cancer|2015–2019|Persons|2|80–84|||
Relative|Urethral cancer|2015–2019|Persons|2|85+|||
Relative|Urethral cancer|2015–2019|Persons|2|All ages combined|0.622|0.535|0.701
Relative|Urethral cancer|2015–2019|Persons|3|00–04|||
Relative|Urethral cancer|2015–2019|Persons|3|05–09|||
Relative|Urethral cancer|2015–2019|Persons|3|10–14|||
Relative|Urethral cancer|2015–2019|Persons|3|15–19|||
Relative|Urethral cancer|2015–2019|Persons|3|20–24|||
Relative|Urethral cancer|2015–2019|Persons|3|25–29|||
Relative|Urethral cancer|2015–2019|Persons|3|30–34|||
Relative|Urethral cancer|2015–2019|Persons|3|35–39|||
Relative|Urethral cancer|2015–2019|Persons|3|40–44|||
Relative|Urethral cancer|2015–2019|Persons|3|45–49|||
Relative|Urethral cancer|2015–2019|Persons|3|50–54|||
Relative|Urethral cancer|2015–2019|Persons|3|55–59|||
Relative|Urethral cancer|2015–2019|Persons|3|60–64|||
Relative|Urethral cancer|2015–2019|Persons|3|65–69|||
Relative|Urethral cancer|2015–2019|Persons|3|70–74|||
Relative|Urethral cancer|2015–2019|Persons|3|75–79|||
Relative|Urethral cancer|2015–2019|Persons|3|80–84|||
Relative|Urethral cancer|2015–2019|Persons|3|85+|||
Relative|Urethral cancer|2015–2019|Persons|3|All ages combined|0.557|0.467|0.642
Relative|Urethral cancer|2015–2019|Persons|4|00–04|||
Relative|Urethral cancer|2015–2019|Persons|4|05–09|||
Relative|Urethral cancer|2015–2019|Persons|4|10–14|||
Relative|Urethral cancer|2015–2019|Persons|4|15–19|||
Relative|Urethral cancer|2015–2019|Persons|4|20–24|||
Relative|Urethral cancer|2015–2019|Persons|4|25–29|||
Relative|Urethral cancer|2015–2019|Persons|4|30–34|||
Relative|Urethral cancer|2015–2019|Persons|4|35–39|||
Relative|Urethral cancer|2015–2019|Persons|4|40–44|||
Relative|Urethral cancer|2015–2019|Persons|4|45–49|||
Relative|Urethral cancer|2015–2019|Persons|4|50–54|||
Relative|Urethral cancer|2015–2019|Persons|4|55–59|||
Relative|Urethral cancer|2015–2019|Persons|4|60–64|||
Relative|Urethral cancer|2015–2019|Persons|4|65–69|||
Relative|Urethral cancer|2015–2019|Persons|4|70–74|||
Relative|Urethral cancer|2015–2019|Persons|4|75–79|||
Relative|Urethral cancer|2015–2019|Persons|4|80–84|||
Relative|Urethral cancer|2015–2019|Persons|4|85+|||
Relative|Urethral cancer|2015–2019|Persons|4|All ages combined|0.492|0.401|0.581
Relative|Urethral cancer|2015–2019|Persons|5|00–04|||
Relative|Urethral cancer|2015–2019|Persons|5|05–09|||
Relative|Urethral cancer|2015–2019|Persons|5|10–14|||
Relative|Urethral cancer|2015–2019|Persons|5|15–19|||
Relative|Urethral cancer|2015–2019|Persons|5|20–24|||
Relative|Urethral cancer|2015–2019|Persons|5|25–29|||
Relative|Urethral cancer|2015–2019|Persons|5|30–34|||
Relative|Urethral cancer|2015–2019|Persons|5|35–39|||
Relative|Urethral cancer|2015–2019|Persons|5|40–44|||
Relative|Urethral cancer|2015–2019|Persons|5|45–49|||
Relative|Urethral cancer|2015–2019|Persons|5|50–54|||
Relative|Urethral cancer|2015–2019|Persons|5|55–59|||
Relative|Urethral cancer|2015–2019|Persons|5|60–64|||
Relative|Urethral cancer|2015–2019|Persons|5|65–69|||
Relative|Urethral cancer|2015–2019|Persons|5|70–74|||
Relative|Urethral cancer|2015–2019|Persons|5|75–79|||
Relative|Urethral cancer|2015–2019|Persons|5|80–84|||
Relative|Urethral cancer|2015–2019|Persons|5|85+|||
Relative|Urethral cancer|2015–2019|Persons|5|All ages combined|0.444|0.353|0.536
Observed|Uterine cancer|2015–2019|Females|1|00–04|||
Observed|Uterine cancer|2015–2019|Females|1|05–09|||
Observed|Uterine cancer|2015–2019|Females|1|10–14|||
Observed|Uterine cancer|2015–2019|Females|1|15–19|||
Observed|Uterine cancer|2015–2019|Females|1|20–24|||
Observed|Uterine cancer|2015–2019|Females|1|25–29|1|0.94|1
Observed|Uterine cancer|2015–2019|Females|1|30–34|0.984|0.937|0.996
Observed|Uterine cancer|2015–2019|Females|1|35–39|0.975|0.944|0.989
Observed|Uterine cancer|2015–2019|Females|1|40–44|0.975|0.954|0.987
Observed|Uterine cancer|2015–2019|Females|1|45–49|0.963|0.946|0.975
Observed|Uterine cancer|2015–2019|Females|1|50–54|0.96|0.947|0.969
Observed|Uterine cancer|2015–2019|Females|1|55–59|0.958|0.948|0.966
Observed|Uterine cancer|2015–2019|Females|1|60–64|0.949|0.939|0.958
Observed|Uterine cancer|2015–2019|Females|1|65–69|0.94|0.929|0.948
Observed|Uterine cancer|2015–2019|Females|1|70–74|0.924|0.91|0.935
Observed|Uterine cancer|2015–2019|Females|1|75–79|0.873|0.853|0.89
Observed|Uterine cancer|2015–2019|Females|1|80–84|0.842|0.815|0.865
Observed|Uterine cancer|2015–2019|Females|1|85+|0.677|0.64|0.71
Observed|Uterine cancer|2015–2019|Females|1|All ages combined|0.922|0.917|0.926
Observed|Uterine cancer|2015–2019|Females|2|00–04|||
Observed|Uterine cancer|2015–2019|Females|2|05–09|||
Observed|Uterine cancer|2015–2019|Females|2|10–14|||
Observed|Uterine cancer|2015–2019|Females|2|15–19|||
Observed|Uterine cancer|2015–2019|Females|2|20–24|||
Observed|Uterine cancer|2015–2019|Females|2|25–29|1|0.938|1
Observed|Uterine cancer|2015–2019|Females|2|30–34|0.984|0.937|0.996
Observed|Uterine cancer|2015–2019|Females|2|35–39|0.956|0.92|0.976
Observed|Uterine cancer|2015–2019|Females|2|40–44|0.939|0.91|0.958
Observed|Uterine cancer|2015–2019|Females|2|45–49|0.938|0.917|0.953
Observed|Uterine cancer|2015–2019|Females|2|50–54|0.933|0.917|0.946
Observed|Uterine cancer|2015–2019|Females|2|55–59|0.924|0.911|0.935
Observed|Uterine cancer|2015–2019|Females|2|60–64|0.916|0.903|0.927
Observed|Uterine cancer|2015–2019|Females|2|65–69|0.887|0.873|0.899
Observed|Uterine cancer|2015–2019|Females|2|70–74|0.854|0.837|0.87
Observed|Uterine cancer|2015–2019|Females|2|75–79|0.781|0.757|0.803
Observed|Uterine cancer|2015–2019|Females|2|80–84|0.742|0.711|0.77
Observed|Uterine cancer|2015–2019|Females|2|85+|0.515|0.476|0.552
Observed|Uterine cancer|2015–2019|Females|2|All ages combined|0.866|0.86|0.872
Observed|Uterine cancer|2015–2019|Females|3|00–04|||
Observed|Uterine cancer|2015–2019|Females|3|05–09|||
Observed|Uterine cancer|2015–2019|Females|3|10–14|||
Observed|Uterine cancer|2015–2019|Females|3|15–19|||
Observed|Uterine cancer|2015–2019|Females|3|20–24|||
Observed|Uterine cancer|2015–2019|Females|3|25–29|1|0.936|1
Observed|Uterine cancer|2015–2019|Females|3|30–34|0.95|0.891|0.977
Observed|Uterine cancer|2015–2019|Females|3|35–39|0.956|0.92|0.976
Observed|Uterine cancer|2015–2019|Females|3|40–44|0.925|0.893|0.947
Observed|Uterine cancer|2015–2019|Females|3|45–49|0.913|0.889|0.932
Observed|Uterine cancer|2015–2019|Females|3|50–54|0.913|0.896|0.928
Observed|Uterine cancer|2015–2019|Females|3|55–59|0.897|0.882|0.91
Observed|Uterine cancer|2015–2019|Females|3|60–64|0.881|0.866|0.894
Observed|Uterine cancer|2015–2019|Females|3|65–69|0.849|0.833|0.862
Observed|Uterine cancer|2015–2019|Females|3|70–74|0.804|0.784|0.822
Observed|Uterine cancer|2015–2019|Females|3|75–79|0.723|0.698|0.747
Observed|Uterine cancer|2015–2019|Females|3|80–84|0.652|0.619|0.684
Observed|Uterine cancer|2015–2019|Females|3|85+|0.418|0.381|0.456
Observed|Uterine cancer|2015–2019|Females|3|All ages combined|0.824|0.818|0.831
Observed|Uterine cancer|2015–2019|Females|4|00–04|||
Observed|Uterine cancer|2015–2019|Females|4|05–09|||
Observed|Uterine cancer|2015–2019|Females|4|10–14|||
Observed|Uterine cancer|2015–2019|Females|4|15–19|||
Observed|Uterine cancer|2015–2019|Females|4|20–24|||
Observed|Uterine cancer|2015–2019|Females|4|25–29|0.976|0.841|0.997
Observed|Uterine cancer|2015–2019|Females|4|30–34|0.931|0.867|0.965
Observed|Uterine cancer|2015–2019|Females|4|35–39|0.951|0.912|0.972
Observed|Uterine cancer|2015–2019|Females|4|40–44|0.913|0.879|0.937
Observed|Uterine cancer|2015–2019|Females|4|45–49|0.887|0.86|0.909
Observed|Uterine cancer|2015–2019|Females|4|50–54|0.894|0.875|0.91
Observed|Uterine cancer|2015–2019|Females|4|55–59|0.882|0.866|0.895
Observed|Uterine cancer|2015–2019|Females|4|60–64|0.858|0.843|0.872
Observed|Uterine cancer|2015–2019|Females|4|65–69|0.818|0.802|0.833
Observed|Uterine cancer|2015–2019|Females|4|70–74|0.764|0.743|0.783
Observed|Uterine cancer|2015–2019|Females|4|75–79|0.666|0.638|0.691
Observed|Uterine cancer|2015–2019|Females|4|80–84|0.59|0.555|0.623
Observed|Uterine cancer|2015–2019|Females|4|85+|0.345|0.309|0.381
Observed|Uterine cancer|2015–2019|Females|4|All ages combined|0.792|0.785|0.799
Observed|Uterine cancer|2015–2019|Females|5|00–04|||
Observed|Uterine cancer|2015–2019|Females|5|05–09|||
Observed|Uterine cancer|2015–2019|Females|5|10–14|||
Observed|Uterine cancer|2015–2019|Females|5|15–19|||
Observed|Uterine cancer|2015–2019|Females|5|20–24|||
Observed|Uterine cancer|2015–2019|Females|5|25–29|0.976|0.841|0.997
Observed|Uterine cancer|2015–2019|Females|5|30–34|0.931|0.867|0.965
Observed|Uterine cancer|2015–2019|Females|5|35–39|0.945|0.905|0.969
Observed|Uterine cancer|2015–2019|Females|5|40–44|0.91|0.876|0.935
Observed|Uterine cancer|2015–2019|Females|5|45–49|0.877|0.85|0.9
Observed|Uterine cancer|2015–2019|Females|5|50–54|0.887|0.868|0.904
Observed|Uterine cancer|2015–2019|Females|5|55–59|0.871|0.855|0.885
Observed|Uterine cancer|2015–2019|Females|5|60–64|0.842|0.826|0.856
Observed|Uterine cancer|2015–2019|Females|5|65–69|0.792|0.775|0.808
Observed|Uterine cancer|2015–2019|Females|5|70–74|0.734|0.711|0.754
Observed|Uterine cancer|2015–2019|Females|5|75–79|0.631|0.603|0.658
Observed|Uterine cancer|2015–2019|Females|5|80–84|0.541|0.506|0.575
Observed|Uterine cancer|2015–2019|Females|5|85+|0.283|0.25|0.318
Observed|Uterine cancer|2015–2019|Females|5|All ages combined|0.769|0.762|0.776
Relative|Uterine cancer|2015–2019|Females|1|00–04|||
Relative|Uterine cancer|2015–2019|Females|1|05–09|||
Relative|Uterine cancer|2015–2019|Females|1|10–14|||
Relative|Uterine cancer|2015–2019|Females|1|15–19|||
Relative|Uterine cancer|2015–2019|Females|1|20–24|||
Relative|Uterine cancer|2015–2019|Females|1|25–29|1|0.94|1
Relative|Uterine cancer|2015–2019|Females|1|30–34|0.984|0.938|0.996
Relative|Uterine cancer|2015–2019|Females|1|35–39|0.975|0.945|0.989
Relative|Uterine cancer|2015–2019|Females|1|40–44|0.976|0.955|0.987
Relative|Uterine cancer|2015–2019|Females|1|45–49|0.964|0.947|0.976
Relative|Uterine cancer|2015–2019|Females|1|50–54|0.962|0.949|0.972
Relative|Uterine cancer|2015–2019|Females|1|55–59|0.961|0.951|0.969
Relative|Uterine cancer|2015–2019|Females|1|60–64|0.954|0.943|0.962
Relative|Uterine cancer|2015–2019|Females|1|65–69|0.946|0.936|0.955
Relative|Uterine cancer|2015–2019|Females|1|70–74|0.935|0.921|0.946
Relative|Uterine cancer|2015–2019|Females|1|75–79|0.891|0.872|0.909
Relative|Uterine cancer|2015–2019|Females|1|80–84|0.877|0.849|0.9
Relative|Uterine cancer|2015–2019|Females|1|85+|0.756|0.715|0.794
Relative|Uterine cancer|2015–2019|Females|1|All ages combined|0.935|0.93|0.939
Relative|Uterine cancer|2015–2019|Females|2|00–04|||
Relative|Uterine cancer|2015–2019|Females|2|05–09|||
Relative|Uterine cancer|2015–2019|Females|2|10–14|||
Relative|Uterine cancer|2015–2019|Females|2|15–19|||
Relative|Uterine cancer|2015–2019|Females|2|20–24|||
Relative|Uterine cancer|2015–2019|Females|2|25–29|1.001|0.938|1.001
Relative|Uterine cancer|2015–2019|Females|2|30–34|0.985|0.938|0.997
Relative|Uterine cancer|2015–2019|Females|2|35–39|0.957|0.921|0.977
Relative|Uterine cancer|2015–2019|Females|2|40–44|0.94|0.911|0.96
Relative|Uterine cancer|2015–2019|Females|2|45–49|0.94|0.92|0.956
Relative|Uterine cancer|2015–2019|Females|2|50–54|0.937|0.921|0.95
Relative|Uterine cancer|2015–2019|Females|2|55–59|0.93|0.917|0.941
Relative|Uterine cancer|2015–2019|Females|2|60–64|0.925|0.912|0.936
Relative|Uterine cancer|2015–2019|Females|2|65–69|0.9|0.887|0.913
Relative|Uterine cancer|2015–2019|Females|2|70–74|0.876|0.858|0.892
Relative|Uterine cancer|2015–2019|Females|2|75–79|0.818|0.793|0.84
Relative|Uterine cancer|2015–2019|Females|2|80–84|0.81|0.776|0.841
Relative|Uterine cancer|2015–2019|Females|2|85+|0.646|0.598|0.692
Relative|Uterine cancer|2015–2019|Females|2|All ages combined|0.89|0.884|0.896
Relative|Uterine cancer|2015–2019|Females|3|00–04|||
Relative|Uterine cancer|2015–2019|Females|3|05–09|||
Relative|Uterine cancer|2015–2019|Females|3|10–14|||
Relative|Uterine cancer|2015–2019|Females|3|15–19|||
Relative|Uterine cancer|2015–2019|Females|3|20–24|||
Relative|Uterine cancer|2015–2019|Females|3|25–29|1.001|0.937|1.001
Relative|Uterine cancer|2015–2019|Females|3|30–34|0.951|0.892|0.978
Relative|Uterine cancer|2015–2019|Females|3|35–39|0.958|0.922|0.978
Relative|Uterine cancer|2015–2019|Females|3|40–44|0.928|0.896|0.95
Relative|Uterine cancer|2015–2019|Females|3|45–49|0.917|0.893|0.936
Relative|Uterine cancer|2015–2019|Females|3|50–54|0.92|0.902|0.935
Relative|Uterine cancer|2015–2019|Females|3|55–59|0.906|0.891|0.919
Relative|Uterine cancer|2015–2019|Females|3|60–64|0.894|0.88|0.907
Relative|Uterine cancer|2015–2019|Females|3|65–69|0.869|0.853|0.883
Relative|Uterine cancer|2015–2019|Females|3|70–74|0.837|0.817|0.856
Relative|Uterine cancer|2015–2019|Females|3|75–79|0.778|0.75|0.804
Relative|Uterine cancer|2015–2019|Females|3|80–84|0.751|0.712|0.787
Relative|Uterine cancer|2015–2019|Females|3|85+|0.597|0.543|0.65
Relative|Uterine cancer|2015–2019|Females|3|All ages combined|0.859|0.852|0.865
Relative|Uterine cancer|2015–2019|Females|4|00–04|||
Relative|Uterine cancer|2015–2019|Females|4|05–09|||
Relative|Uterine cancer|2015–2019|Females|4|10–14|||
Relative|Uterine cancer|2015–2019|Females|4|15–19|||
Relative|Uterine cancer|2015–2019|Females|4|20–24|||
Relative|Uterine cancer|2015–2019|Females|4|25–29|0.977|0.842|0.998
Relative|Uterine cancer|2015–2019|Females|4|30–34|0.933|0.869|0.967
Relative|Uterine cancer|2015–2019|Females|4|35–39|0.953|0.915|0.975
Relative|Uterine cancer|2015–2019|Females|4|40–44|0.917|0.883|0.941
Relative|Uterine cancer|2015–2019|Females|4|45–49|0.893|0.866|0.915
Relative|Uterine cancer|2015–2019|Females|4|50–54|0.903|0.883|0.919
Relative|Uterine cancer|2015–2019|Females|4|55–59|0.894|0.879|0.908
Relative|Uterine cancer|2015–2019|Females|4|60–64|0.877|0.861|0.891
Relative|Uterine cancer|2015–2019|Females|4|65–69|0.846|0.829|0.862
Relative|Uterine cancer|2015–2019|Females|4|70–74|0.809|0.787|0.83
Relative|Uterine cancer|2015–2019|Females|4|75–79|0.739|0.708|0.767
Relative|Uterine cancer|2015–2019|Females|4|80–84|0.722|0.68|0.763
Relative|Uterine cancer|2015–2019|Females|4|85+|0.567|0.508|0.627
Relative|Uterine cancer|2015–2019|Females|4|All ages combined|0.837|0.83|0.844
Relative|Uterine cancer|2015–2019|Females|5|00–04|||
Relative|Uterine cancer|2015–2019|Females|5|05–09|||
Relative|Uterine cancer|2015–2019|Females|5|10–14|||
Relative|Uterine cancer|2015–2019|Females|5|15–19|||
Relative|Uterine cancer|2015–2019|Females|5|20–24|||
Relative|Uterine cancer|2015–2019|Females|5|25–29|0.977|0.842|0.998
Relative|Uterine cancer|2015–2019|Females|5|30–34|0.934|0.869|0.967
Relative|Uterine cancer|2015–2019|Females|5|35–39|0.949|0.908|0.972
Relative|Uterine cancer|2015–2019|Females|5|40–44|0.915|0.881|0.94
Relative|Uterine cancer|2015–2019|Females|5|45–49|0.885|0.857|0.908
Relative|Uterine cancer|2015–2019|Females|5|50–54|0.898|0.879|0.915
Relative|Uterine cancer|2015–2019|Females|5|55–59|0.887|0.871|0.902
Relative|Uterine cancer|2015–2019|Females|5|60–64|0.865|0.849|0.88
Relative|Uterine cancer|2015–2019|Females|5|65–69|0.828|0.81|0.845
Relative|Uterine cancer|2015–2019|Females|5|70–74|0.792|0.768|0.814
Relative|Uterine cancer|2015–2019|Females|5|75–79|0.726|0.694|0.757
Relative|Uterine cancer|2015–2019|Females|5|80–84|0.711|0.665|0.755
Relative|Uterine cancer|2015–2019|Females|5|85+|0.545|0.481|0.612
Relative|Uterine cancer|2015–2019|Females|5|All ages combined|0.826|0.818|0.833
Observed|Vaginal cancer|2015–2019|Females|1|00–04|||
Observed|Vaginal cancer|2015–2019|Females|1|05–09|||
Observed|Vaginal cancer|2015–2019|Females|1|10–14|||
Observed|Vaginal cancer|2015–2019|Females|1|15–19|||
Observed|Vaginal cancer|2015–2019|Females|1|20–24|||
Observed|Vaginal cancer|2015–2019|Females|1|25–29|||
Observed|Vaginal cancer|2015–2019|Females|1|30–34|||
Observed|Vaginal cancer|2015–2019|Females|1|35–39|||
Observed|Vaginal cancer|2015–2019|Females|1|40–44|||
Observed|Vaginal cancer|2015–2019|Females|1|45–49|||
Observed|Vaginal cancer|2015–2019|Females|1|50–54|0.743|0.575|0.852
Observed|Vaginal cancer|2015–2019|Females|1|55–59|0.871|0.735|0.94
Observed|Vaginal cancer|2015–2019|Females|1|60–64|0.804|0.674|0.886
Observed|Vaginal cancer|2015–2019|Females|1|65–69|0.853|0.737|0.921
Observed|Vaginal cancer|2015–2019|Females|1|70–74|0.798|0.678|0.877
Observed|Vaginal cancer|2015–2019|Females|1|75–79|0.687|0.53|0.8
Observed|Vaginal cancer|2015–2019|Females|1|80–84|||
Observed|Vaginal cancer|2015–2019|Females|1|85+|0.564|0.439|0.672
Observed|Vaginal cancer|2015–2019|Females|1|All ages combined|0.773|0.731|0.808
Observed|Vaginal cancer|2015–2019|Females|2|00–04|||
Observed|Vaginal cancer|2015–2019|Females|2|05–09|||
Observed|Vaginal cancer|2015–2019|Females|2|10–14|||
Observed|Vaginal cancer|2015–2019|Females|2|15–19|||
Observed|Vaginal cancer|2015–2019|Females|2|20–24|||
Observed|Vaginal cancer|2015–2019|Females|2|25–29|||
Observed|Vaginal cancer|2015–2019|Females|2|30–34|||
Observed|Vaginal cancer|2015–2019|Females|2|35–39|||
Observed|Vaginal cancer|2015–2019|Females|2|40–44|||
Observed|Vaginal cancer|2015–2019|Females|2|45–49|||
Observed|Vaginal cancer|2015–2019|Females|2|50–54|0.716|0.546|0.831
Observed|Vaginal cancer|2015–2019|Females|2|55–59|0.756|0.603|0.857
Observed|Vaginal cancer|2015–2019|Females|2|60–64|0.749|0.613|0.843
Observed|Vaginal cancer|2015–2019|Females|2|65–69|0.647|0.511|0.753
Observed|Vaginal cancer|2015–2019|Females|2|70–74|0.631|0.488|0.744
Observed|Vaginal cancer|2015–2019|Females|2|75–79|0.486|0.339|0.617
Observed|Vaginal cancer|2015–2019|Females|2|80–84|||
Observed|Vaginal cancer|2015–2019|Females|2|85+|0.338|0.233|0.446
Observed|Vaginal cancer|2015–2019|Females|2|All ages combined|0.626|0.579|0.669
Observed|Vaginal cancer|2015–2019|Females|3|00–04|||
Observed|Vaginal cancer|2015–2019|Females|3|05–09|||
Observed|Vaginal cancer|2015–2019|Females|3|10–14|||
Observed|Vaginal cancer|2015–2019|Females|3|15–19|||
Observed|Vaginal cancer|2015–2019|Females|3|20–24|||
Observed|Vaginal cancer|2015–2019|Females|3|25–29|||
Observed|Vaginal cancer|2015–2019|Females|3|30–34|||
Observed|Vaginal cancer|2015–2019|Females|3|35–39|||
Observed|Vaginal cancer|2015–2019|Females|3|40–44|||
Observed|Vaginal cancer|2015–2019|Females|3|45–49|||
Observed|Vaginal cancer|2015–2019|Females|3|50–54|0.688|0.516|0.809
Observed|Vaginal cancer|2015–2019|Females|3|55–59|0.692|0.537|0.805
Observed|Vaginal cancer|2015–2019|Females|3|60–64|0.687|0.544|0.793
Observed|Vaginal cancer|2015–2019|Females|3|65–69|0.564|0.43|0.679
Observed|Vaginal cancer|2015–2019|Females|3|70–74|0.573|0.422|0.698
Observed|Vaginal cancer|2015–2019|Females|3|75–79|||
Observed|Vaginal cancer|2015–2019|Females|3|80–84|||
Observed|Vaginal cancer|2015–2019|Females|3|85+|0.265|0.169|0.37
Observed|Vaginal cancer|2015–2019|Females|3|All ages combined|0.556|0.508|0.601
Observed|Vaginal cancer|2015–2019|Females|4|00–04|||
Observed|Vaginal cancer|2015–2019|Females|4|05–09|||
Observed|Vaginal cancer|2015–2019|Females|4|10–14|||
Observed|Vaginal cancer|2015–2019|Females|4|15–19|||
Observed|Vaginal cancer|2015–2019|Females|4|20–24|||
Observed|Vaginal cancer|2015–2019|Females|4|25–29|||
Observed|Vaginal cancer|2015–2019|Females|4|30–34|||
Observed|Vaginal cancer|2015–2019|Females|4|35–39|||
Observed|Vaginal cancer|2015–2019|Females|4|40–44|||
Observed|Vaginal cancer|2015–2019|Females|4|45–49|||
Observed|Vaginal cancer|2015–2019|Females|4|50–54|||
Observed|Vaginal cancer|2015–2019|Females|4|55–59|0.692|0.537|0.805
Observed|Vaginal cancer|2015–2019|Females|4|60–64|0.616|0.467|0.734
Observed|Vaginal cancer|2015–2019|Females|4|65–69|0.516|0.383|0.633
Observed|Vaginal cancer|2015–2019|Females|4|70–74|||
Observed|Vaginal cancer|2015–2019|Females|4|75–79|||
Observed|Vaginal cancer|2015–2019|Females|4|80–84|||
Observed|Vaginal cancer|2015–2019|Females|4|85+|||
Observed|Vaginal cancer|2015–2019|Females|4|All ages combined|0.526|0.477|0.572
Observed|Vaginal cancer|2015–2019|Females|5|00–04|||
Observed|Vaginal cancer|2015–2019|Females|5|05–09|||
Observed|Vaginal cancer|2015–2019|Females|5|10–14|||
Observed|Vaginal cancer|2015–2019|Females|5|15–19|||
Observed|Vaginal cancer|2015–2019|Females|5|20–24|||
Observed|Vaginal cancer|2015–2019|Females|5|25–29|||
Observed|Vaginal cancer|2015–2019|Females|5|30–34|||
Observed|Vaginal cancer|2015–2019|Females|5|35–39|||
Observed|Vaginal cancer|2015–2019|Females|5|40–44|||
Observed|Vaginal cancer|2015–2019|Females|5|45–49|||
Observed|Vaginal cancer|2015–2019|Females|5|50–54|||
Observed|Vaginal cancer|2015–2019|Females|5|55–59|0.692|0.537|0.805
Observed|Vaginal cancer|2015–2019|Females|5|60–64|0.573|0.424|0.697
Observed|Vaginal cancer|2015–2019|Females|5|65–69|0.497|0.365|0.615
Observed|Vaginal cancer|2015–2019|Females|5|70–74|||
Observed|Vaginal cancer|2015–2019|Females|5|75–79|||
Observed|Vaginal cancer|2015–2019|Females|5|80–84|||
Observed|Vaginal cancer|2015–2019|Females|5|85+|||
Observed|Vaginal cancer|2015–2019|Females|5|All ages combined|0.498|0.449|0.546
Relative|Vaginal cancer|2015–2019|Females|1|00–04|||
Relative|Vaginal cancer|2015–2019|Females|1|05–09|||
Relative|Vaginal cancer|2015–2019|Females|1|10–14|||
Relative|Vaginal cancer|2015–2019|Females|1|15–19|||
Relative|Vaginal cancer|2015–2019|Females|1|20–24|||
Relative|Vaginal cancer|2015–2019|Females|1|25–29|||
Relative|Vaginal cancer|2015–2019|Females|1|30–34|||
Relative|Vaginal cancer|2015–2019|Females|1|35–39|||
Relative|Vaginal cancer|2015–2019|Females|1|40–44|||
Relative|Vaginal cancer|2015–2019|Females|1|45–49|||
Relative|Vaginal cancer|2015–2019|Females|1|50–54|0.744|0.576|0.854
Relative|Vaginal cancer|2015–2019|Females|1|55–59|0.874|0.737|0.943
Relative|Vaginal cancer|2015–2019|Females|1|60–64|0.807|0.677|0.89
Relative|Vaginal cancer|2015–2019|Females|1|65–69|0.859|0.742|0.927
Relative|Vaginal cancer|2015–2019|Females|1|70–74|0.808|0.686|0.888
Relative|Vaginal cancer|2015–2019|Females|1|75–79|0.702|0.542|0.819
Relative|Vaginal cancer|2015–2019|Females|1|80–84|||
Relative|Vaginal cancer|2015–2019|Females|1|85+|0.631|0.491|0.752
Relative|Vaginal cancer|2015–2019|Females|1|All ages combined|0.791|0.749|0.827
Relative|Vaginal cancer|2015–2019|Females|2|00–04|||
Relative|Vaginal cancer|2015–2019|Females|2|05–09|||
Relative|Vaginal cancer|2015–2019|Females|2|10–14|||
Relative|Vaginal cancer|2015–2019|Females|2|15–19|||
Relative|Vaginal cancer|2015–2019|Females|2|20–24|||
Relative|Vaginal cancer|2015–2019|Females|2|25–29|||
Relative|Vaginal cancer|2015–2019|Females|2|30–34|||
Relative|Vaginal cancer|2015–2019|Females|2|35–39|||
Relative|Vaginal cancer|2015–2019|Females|2|40–44|||
Relative|Vaginal cancer|2015–2019|Females|2|45–49|||
Relative|Vaginal cancer|2015–2019|Females|2|50–54|0.719|0.548|0.835
Relative|Vaginal cancer|2015–2019|Females|2|55–59|0.762|0.607|0.863
Relative|Vaginal cancer|2015–2019|Females|2|60–64|0.756|0.619|0.851
Relative|Vaginal cancer|2015–2019|Females|2|65–69|0.657|0.519|0.765
Relative|Vaginal cancer|2015–2019|Females|2|70–74|0.647|0.501|0.763
Relative|Vaginal cancer|2015–2019|Females|2|75–79|0.51|0.356|0.648
Relative|Vaginal cancer|2015–2019|Females|2|80–84|||
Relative|Vaginal cancer|2015–2019|Females|2|85+|0.425|0.293|0.561
Relative|Vaginal cancer|2015–2019|Females|2|All ages combined|0.655|0.606|0.7
Relative|Vaginal cancer|2015–2019|Females|3|00–04|||
Relative|Vaginal cancer|2015–2019|Females|3|05–09|||
Relative|Vaginal cancer|2015–2019|Females|3|10–14|||
Relative|Vaginal cancer|2015–2019|Females|3|15–19|||
Relative|Vaginal cancer|2015–2019|Females|3|20–24|||
Relative|Vaginal cancer|2015–2019|Females|3|25–29|||
Relative|Vaginal cancer|2015–2019|Females|3|30–34|||
Relative|Vaginal cancer|2015–2019|Females|3|35–39|||
Relative|Vaginal cancer|2015–2019|Females|3|40–44|||
Relative|Vaginal cancer|2015–2019|Females|3|45–49|||
Relative|Vaginal cancer|2015–2019|Females|3|50–54|0.692|0.52|0.815
Relative|Vaginal cancer|2015–2019|Females|3|55–59|0.7|0.542|0.813
Relative|Vaginal cancer|2015–2019|Females|3|60–64|0.697|0.553|0.805
Relative|Vaginal cancer|2015–2019|Females|3|65–69|0.578|0.44|0.695
Relative|Vaginal cancer|2015–2019|Females|3|70–74|0.597|0.44|0.728
Relative|Vaginal cancer|2015–2019|Females|3|75–79|||
Relative|Vaginal cancer|2015–2019|Females|3|80–84|||
Relative|Vaginal cancer|2015–2019|Females|3|85+|0.376|0.24|0.525
Relative|Vaginal cancer|2015–2019|Females|3|All ages combined|0.594|0.543|0.643
Relative|Vaginal cancer|2015–2019|Females|4|00–04|||
Relative|Vaginal cancer|2015–2019|Females|4|05–09|||
Relative|Vaginal cancer|2015–2019|Females|4|10–14|||
Relative|Vaginal cancer|2015–2019|Females|4|15–19|||
Relative|Vaginal cancer|2015–2019|Females|4|20–24|||
Relative|Vaginal cancer|2015–2019|Females|4|25–29|||
Relative|Vaginal cancer|2015–2019|Females|4|30–34|||
Relative|Vaginal cancer|2015–2019|Females|4|35–39|||
Relative|Vaginal cancer|2015–2019|Females|4|40–44|||
Relative|Vaginal cancer|2015–2019|Females|4|45–49|||
Relative|Vaginal cancer|2015–2019|Females|4|50–54|||
Relative|Vaginal cancer|2015–2019|Females|4|55–59|0.703|0.545|0.817
Relative|Vaginal cancer|2015–2019|Females|4|60–64|0.629|0.477|0.75
Relative|Vaginal cancer|2015–2019|Females|4|65–69|0.534|0.397|0.655
Relative|Vaginal cancer|2015–2019|Females|4|70–74|||
Relative|Vaginal cancer|2015–2019|Females|4|75–79|||
Relative|Vaginal cancer|2015–2019|Females|4|80–84|||
Relative|Vaginal cancer|2015–2019|Females|4|85+|||
Relative|Vaginal cancer|2015–2019|Females|4|All ages combined|0.573|0.52|0.623
Relative|Vaginal cancer|2015–2019|Females|5|00–04|||
Relative|Vaginal cancer|2015–2019|Females|5|05–09|||
Relative|Vaginal cancer|2015–2019|Females|5|10–14|||
Relative|Vaginal cancer|2015–2019|Females|5|15–19|||
Relative|Vaginal cancer|2015–2019|Females|5|20–24|||
Relative|Vaginal cancer|2015–2019|Females|5|25–29|||
Relative|Vaginal cancer|2015–2019|Females|5|30–34|||
Relative|Vaginal cancer|2015–2019|Females|5|35–39|||
Relative|Vaginal cancer|2015–2019|Females|5|40–44|||
Relative|Vaginal cancer|2015–2019|Females|5|45–49|||
Relative|Vaginal cancer|2015–2019|Females|5|50–54|||
Relative|Vaginal cancer|2015–2019|Females|5|55–59|0.706|0.547|0.821
Relative|Vaginal cancer|2015–2019|Females|5|60–64|0.589|0.436|0.716
Relative|Vaginal cancer|2015–2019|Females|5|65–69|0.519|0.381|0.643
Relative|Vaginal cancer|2015–2019|Females|5|70–74|||
Relative|Vaginal cancer|2015–2019|Females|5|75–79|||
Relative|Vaginal cancer|2015–2019|Females|5|80–84|||
Relative|Vaginal cancer|2015–2019|Females|5|85+|||
Relative|Vaginal cancer|2015–2019|Females|5|All ages combined|0.553|0.498|0.605
Observed|Vulvar cancer|2015–2019|Females|1|00–04|||
Observed|Vulvar cancer|2015–2019|Females|1|05–09|||
Observed|Vulvar cancer|2015–2019|Females|1|10–14|||
Observed|Vulvar cancer|2015–2019|Females|1|15–19|||
Observed|Vulvar cancer|2015–2019|Females|1|20–24|||
Observed|Vulvar cancer|2015–2019|Females|1|25–29|||
Observed|Vulvar cancer|2015–2019|Females|1|30–34|1|0.874|1
Observed|Vulvar cancer|2015–2019|Females|1|35–39|1|0.922|1
Observed|Vulvar cancer|2015–2019|Females|1|40–44|1|0.952|1
Observed|Vulvar cancer|2015–2019|Females|1|45–49|0.981|0.927|0.995
Observed|Vulvar cancer|2015–2019|Females|1|50–54|0.986|0.945|0.996
Observed|Vulvar cancer|2015–2019|Females|1|55–59|0.979|0.937|0.993
Observed|Vulvar cancer|2015–2019|Females|1|60–64|0.979|0.946|0.992
Observed|Vulvar cancer|2015–2019|Females|1|65–69|0.906|0.858|0.938
Observed|Vulvar cancer|2015–2019|Females|1|70–74|0.914|0.869|0.944
Observed|Vulvar cancer|2015–2019|Females|1|75–79|0.861|0.803|0.902
Observed|Vulvar cancer|2015–2019|Females|1|80–84|0.792|0.728|0.842
Observed|Vulvar cancer|2015–2019|Females|1|85+|0.679|0.622|0.73
Observed|Vulvar cancer|2015–2019|Females|1|All ages combined|0.886|0.87|0.899
Observed|Vulvar cancer|2015–2019|Females|2|00–04|||
Observed|Vulvar cancer|2015–2019|Females|2|05–09|||
Observed|Vulvar cancer|2015–2019|Females|2|10–14|||
Observed|Vulvar cancer|2015–2019|Females|2|15–19|||
Observed|Vulvar cancer|2015–2019|Females|2|20–24|||
Observed|Vulvar cancer|2015–2019|Females|2|25–29|||
Observed|Vulvar cancer|2015–2019|Females|2|30–34|||
Observed|Vulvar cancer|2015–2019|Females|2|35–39|0.972|0.815|0.996
Observed|Vulvar cancer|2015–2019|Females|2|40–44|0.968|0.879|0.992
Observed|Vulvar cancer|2015–2019|Females|2|45–49|0.954|0.892|0.98
Observed|Vulvar cancer|2015–2019|Females|2|50–54|0.928|0.871|0.961
Observed|Vulvar cancer|2015–2019|Females|2|55–59|0.882|0.817|0.925
Observed|Vulvar cancer|2015–2019|Females|2|60–64|0.9|0.848|0.935
Observed|Vulvar cancer|2015–2019|Females|2|65–69|0.772|0.71|0.823
Observed|Vulvar cancer|2015–2019|Females|2|70–74|0.827|0.77|0.871
Observed|Vulvar cancer|2015–2019|Females|2|75–79|0.756|0.688|0.811
Observed|Vulvar cancer|2015–2019|Females|2|80–84|0.674|0.604|0.735
Observed|Vulvar cancer|2015–2019|Females|2|85+|0.466|0.408|0.523
Observed|Vulvar cancer|2015–2019|Females|2|All ages combined|0.778|0.758|0.797
Observed|Vulvar cancer|2015–2019|Females|3|00–04|||
Observed|Vulvar cancer|2015–2019|Females|3|05–09|||
Observed|Vulvar cancer|2015–2019|Females|3|10–14|||
Observed|Vulvar cancer|2015–2019|Females|3|15–19|||
Observed|Vulvar cancer|2015–2019|Females|3|20–24|||
Observed|Vulvar cancer|2015–2019|Females|3|25–29|||
Observed|Vulvar cancer|2015–2019|Females|3|30–34|||
Observed|Vulvar cancer|2015–2019|Females|3|35–39|0.947|0.804|0.987
Observed|Vulvar cancer|2015–2019|Females|3|40–44|0.951|0.856|0.984
Observed|Vulvar cancer|2015–2019|Females|3|45–49|0.916|0.845|0.955
Observed|Vulvar cancer|2015–2019|Females|3|50–54|0.922|0.863|0.956
Observed|Vulvar cancer|2015–2019|Females|3|55–59|0.855|0.786|0.903
Observed|Vulvar cancer|2015–2019|Females|3|60–64|0.849|0.79|0.892
Observed|Vulvar cancer|2015–2019|Females|3|65–69|0.726|0.661|0.781
Observed|Vulvar cancer|2015–2019|Females|3|70–74|0.772|0.709|0.822
Observed|Vulvar cancer|2015–2019|Females|3|75–79|0.724|0.654|0.782
Observed|Vulvar cancer|2015–2019|Females|3|80–84|0.586|0.513|0.651
Observed|Vulvar cancer|2015–2019|Females|3|85+|0.361|0.307|0.416
Observed|Vulvar cancer|2015–2019|Females|3|All ages combined|0.725|0.704|0.745
Observed|Vulvar cancer|2015–2019|Females|4|00–04|||
Observed|Vulvar cancer|2015–2019|Females|4|05–09|||
Observed|Vulvar cancer|2015–2019|Females|4|10–14|||
Observed|Vulvar cancer|2015–2019|Females|4|15–19|||
Observed|Vulvar cancer|2015–2019|Females|4|20–24|||
Observed|Vulvar cancer|2015–2019|Females|4|25–29|||
Observed|Vulvar cancer|2015–2019|Females|4|30–34|||
Observed|Vulvar cancer|2015–2019|Females|4|35–39|0.947|0.804|0.987
Observed|Vulvar cancer|2015–2019|Females|4|40–44|0.918|0.813|0.965
Observed|Vulvar cancer|2015–2019|Females|4|45–49|0.906|0.832|0.948
Observed|Vulvar cancer|2015–2019|Females|4|50–54|0.902|0.839|0.94
Observed|Vulvar cancer|2015–2019|Females|4|55–59|0.84|0.77|0.891
Observed|Vulvar cancer|2015–2019|Females|4|60–64|0.816|0.753|0.864
Observed|Vulvar cancer|2015–2019|Females|4|65–69|0.692|0.626|0.749
Observed|Vulvar cancer|2015–2019|Females|4|70–74|0.713|0.646|0.77
Observed|Vulvar cancer|2015–2019|Females|4|75–79|0.656|0.584|0.719
Observed|Vulvar cancer|2015–2019|Females|4|80–84|0.523|0.45|0.591
Observed|Vulvar cancer|2015–2019|Females|4|85+|0.297|0.246|0.35
Observed|Vulvar cancer|2015–2019|Females|4|All ages combined|0.681|0.659|0.702
Observed|Vulvar cancer|2015–2019|Females|5|00–04|||
Observed|Vulvar cancer|2015–2019|Females|5|05–09|||
Observed|Vulvar cancer|2015–2019|Females|5|10–14|||
Observed|Vulvar cancer|2015–2019|Females|5|15–19|||
Observed|Vulvar cancer|2015–2019|Females|5|20–24|||
Observed|Vulvar cancer|2015–2019|Females|5|25–29|||
Observed|Vulvar cancer|2015–2019|Females|5|30–34|||
Observed|Vulvar cancer|2015–2019|Females|5|35–39|0.947|0.804|0.987
Observed|Vulvar cancer|2015–2019|Females|5|40–44|0.918|0.813|0.965
Observed|Vulvar cancer|2015–2019|Females|5|45–49|0.895|0.819|0.941
Observed|Vulvar cancer|2015–2019|Females|5|50–54|0.881|0.816|0.924
Observed|Vulvar cancer|2015–2019|Females|5|55–59|0.817|0.743|0.872
Observed|Vulvar cancer|2015–2019|Females|5|60–64|0.781|0.714|0.834
Observed|Vulvar cancer|2015–2019|Females|5|65–69|0.654|0.586|0.715
Observed|Vulvar cancer|2015–2019|Females|5|70–74|0.696|0.627|0.754
Observed|Vulvar cancer|2015–2019|Females|5|75–79|0.608|0.535|0.673
Observed|Vulvar cancer|2015–2019|Females|5|80–84|0.431|0.359|0.501
Observed|Vulvar cancer|2015–2019|Females|5|85+|0.252|0.204|0.303
Observed|Vulvar cancer|2015–2019|Females|5|All ages combined|0.644|0.622|0.666
Relative|Vulvar cancer|2015–2019|Females|1|00–04|||
Relative|Vulvar cancer|2015–2019|Females|1|05–09|||
Relative|Vulvar cancer|2015–2019|Females|1|10–14|||
Relative|Vulvar cancer|2015–2019|Females|1|15–19|||
Relative|Vulvar cancer|2015–2019|Females|1|20–24|||
Relative|Vulvar cancer|2015–2019|Females|1|25–29|||
Relative|Vulvar cancer|2015–2019|Females|1|30–34|1|0.874|1
Relative|Vulvar cancer|2015–2019|Females|1|35–39|1.001|0.923|1.001
Relative|Vulvar cancer|2015–2019|Females|1|40–44|1.001|0.952|1.001
Relative|Vulvar cancer|2015–2019|Females|1|45–49|0.983|0.929|0.997
Relative|Vulvar cancer|2015–2019|Females|1|50–54|0.988|0.948|0.999
Relative|Vulvar cancer|2015–2019|Females|1|55–59|0.982|0.94|0.996
Relative|Vulvar cancer|2015–2019|Females|1|60–64|0.984|0.951|0.997
Relative|Vulvar cancer|2015–2019|Females|1|65–69|0.913|0.865|0.945
Relative|Vulvar cancer|2015–2019|Females|1|70–74|0.925|0.88|0.956
Relative|Vulvar cancer|2015–2019|Females|1|75–79|0.88|0.821|0.922
Relative|Vulvar cancer|2015–2019|Females|1|80–84|0.826|0.759|0.878
Relative|Vulvar cancer|2015–2019|Females|1|85+|0.768|0.704|0.826
Relative|Vulvar cancer|2015–2019|Females|1|All ages combined|0.911|0.895|0.925
Relative|Vulvar cancer|2015–2019|Females|2|00–04|||
Relative|Vulvar cancer|2015–2019|Females|2|05–09|||
Relative|Vulvar cancer|2015–2019|Females|2|10–14|||
Relative|Vulvar cancer|2015–2019|Females|2|15–19|||
Relative|Vulvar cancer|2015–2019|Females|2|20–24|||
Relative|Vulvar cancer|2015–2019|Females|2|25–29|||
Relative|Vulvar cancer|2015–2019|Females|2|30–34|||
Relative|Vulvar cancer|2015–2019|Females|2|35–39|0.973|0.816|0.997
Relative|Vulvar cancer|2015–2019|Females|2|40–44|0.97|0.88|0.994
Relative|Vulvar cancer|2015–2019|Females|2|45–49|0.956|0.895|0.983
Relative|Vulvar cancer|2015–2019|Females|2|50–54|0.933|0.875|0.965
Relative|Vulvar cancer|2015–2019|Females|2|55–59|0.888|0.823|0.931
Relative|Vulvar cancer|2015–2019|Females|2|60–64|0.909|0.856|0.944
Relative|Vulvar cancer|2015–2019|Females|2|65–69|0.784|0.721|0.835
Relative|Vulvar cancer|2015–2019|Females|2|70–74|0.848|0.79|0.894
Relative|Vulvar cancer|2015–2019|Females|2|75–79|0.792|0.721|0.85
Relative|Vulvar cancer|2015–2019|Females|2|80–84|0.738|0.661|0.804
Relative|Vulvar cancer|2015–2019|Females|2|85+|0.604|0.528|0.676
Relative|Vulvar cancer|2015–2019|Females|2|All ages combined|0.822|0.801|0.841
Relative|Vulvar cancer|2015–2019|Females|3|00–04|||
Relative|Vulvar cancer|2015–2019|Females|3|05–09|||
Relative|Vulvar cancer|2015–2019|Females|3|10–14|||
Relative|Vulvar cancer|2015–2019|Females|3|15–19|||
Relative|Vulvar cancer|2015–2019|Females|3|20–24|||
Relative|Vulvar cancer|2015–2019|Females|3|25–29|||
Relative|Vulvar cancer|2015–2019|Females|3|30–34|||
Relative|Vulvar cancer|2015–2019|Females|3|35–39|0.949|0.806|0.989
Relative|Vulvar cancer|2015–2019|Females|3|40–44|0.954|0.858|0.987
Relative|Vulvar cancer|2015–2019|Females|3|45–49|0.92|0.849|0.96
Relative|Vulvar cancer|2015–2019|Females|3|50–54|0.928|0.869|0.962
Relative|Vulvar cancer|2015–2019|Females|3|55–59|0.864|0.795|0.912
Relative|Vulvar cancer|2015–2019|Females|3|60–64|0.862|0.802|0.906
Relative|Vulvar cancer|2015–2019|Females|3|65–69|0.744|0.678|0.8
Relative|Vulvar cancer|2015–2019|Females|3|70–74|0.804|0.739|0.857
Relative|Vulvar cancer|2015–2019|Females|3|75–79|0.78|0.704|0.843
Relative|Vulvar cancer|2015–2019|Females|3|80–84|0.677|0.593|0.752
Relative|Vulvar cancer|2015–2019|Females|3|85+|0.543|0.461|0.626
Relative|Vulvar cancer|2015–2019|Females|3|All ages combined|0.786|0.763|0.808
Relative|Vulvar cancer|2015–2019|Females|4|00–04|||
Relative|Vulvar cancer|2015–2019|Females|4|05–09|||
Relative|Vulvar cancer|2015–2019|Females|4|10–14|||
Relative|Vulvar cancer|2015–2019|Females|4|15–19|||
Relative|Vulvar cancer|2015–2019|Females|4|20–24|||
Relative|Vulvar cancer|2015–2019|Females|4|25–29|||
Relative|Vulvar cancer|2015–2019|Females|4|30–34|||
Relative|Vulvar cancer|2015–2019|Females|4|35–39|0.95|0.807|0.989
Relative|Vulvar cancer|2015–2019|Females|4|40–44|0.922|0.817|0.969
Relative|Vulvar cancer|2015–2019|Females|4|45–49|0.912|0.837|0.954
Relative|Vulvar cancer|2015–2019|Females|4|50–54|0.91|0.848|0.95
Relative|Vulvar cancer|2015–2019|Females|4|55–59|0.852|0.781|0.904
Relative|Vulvar cancer|2015–2019|Females|4|60–64|0.833|0.769|0.883
Relative|Vulvar cancer|2015–2019|Females|4|65–69|0.716|0.647|0.775
Relative|Vulvar cancer|2015–2019|Females|4|70–74|0.756|0.685|0.816
Relative|Vulvar cancer|2015–2019|Females|4|75–79|0.73|0.65|0.8
Relative|Vulvar cancer|2015–2019|Females|4|80–84|0.644|0.554|0.727
Relative|Vulvar cancer|2015–2019|Females|4|85+|0.528|0.437|0.622
Relative|Vulvar cancer|2015–2019|Females|4|All ages combined|0.758|0.734|0.781
Relative|Vulvar cancer|2015–2019|Females|5|00–04|||
Relative|Vulvar cancer|2015–2019|Females|5|05–09|||
Relative|Vulvar cancer|2015–2019|Females|5|10–14|||
Relative|Vulvar cancer|2015–2019|Females|5|15–19|||
Relative|Vulvar cancer|2015–2019|Females|5|20–24|||
Relative|Vulvar cancer|2015–2019|Females|5|25–29|||
Relative|Vulvar cancer|2015–2019|Females|5|30–34|||
Relative|Vulvar cancer|2015–2019|Females|5|35–39|0.951|0.807|0.99
Relative|Vulvar cancer|2015–2019|Females|5|40–44|0.923|0.818|0.97
Relative|Vulvar cancer|2015–2019|Females|5|45–49|0.903|0.826|0.949
Relative|Vulvar cancer|2015–2019|Females|5|50–54|0.892|0.826|0.936
Relative|Vulvar cancer|2015–2019|Females|5|55–59|0.833|0.757|0.888
Relative|Vulvar cancer|2015–2019|Females|5|60–64|0.803|0.734|0.857
Relative|Vulvar cancer|2015–2019|Females|5|65–69|0.685|0.613|0.748
Relative|Vulvar cancer|2015–2019|Females|5|70–74|0.752|0.678|0.815
Relative|Vulvar cancer|2015–2019|Females|5|75–79|0.702|0.618|0.777
Relative|Vulvar cancer|2015–2019|Females|5|80–84|0.569|0.473|0.661
Relative|Vulvar cancer|2015–2019|Females|5|85+|0.534|0.432|0.642
Relative|Vulvar cancer|2015–2019|Females|5|All ages combined|0.736|0.71|0.761
